Psyllid ID: psy2648
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 708 | 2.2.26 [Sep-21-2011] | |||||||
| Q03141 | 753 | MAP/microtubule affinity- | yes | N/A | 0.433 | 0.407 | 0.702 | 1e-140 | |
| Q8VHF0 | 797 | MAP/microtubule affinity- | yes | N/A | 0.435 | 0.386 | 0.701 | 1e-140 | |
| P27448 | 753 | MAP/microtubule affinity- | yes | N/A | 0.433 | 0.407 | 0.699 | 1e-139 | |
| Q7KZI7 | 788 | Serine/threonine-protein | no | N/A | 0.442 | 0.397 | 0.679 | 1e-138 | |
| O08679 | 722 | Serine/threonine-protein | no | N/A | 0.442 | 0.433 | 0.679 | 1e-138 | |
| Q05512 | 776 | Serine/threonine-protein | no | N/A | 0.442 | 0.403 | 0.676 | 1e-137 | |
| A8WYE4 | 1088 | Serine/threonine-protein | N/A | N/A | 0.389 | 0.253 | 0.827 | 1e-136 | |
| Q9TW45 | 1192 | Serine/threonine-protein | no | N/A | 0.368 | 0.218 | 0.854 | 1e-136 | |
| Q8CIP4 | 752 | MAP/microtubule affinity- | no | N/A | 0.391 | 0.368 | 0.807 | 1e-134 | |
| Q96L34 | 752 | MAP/microtubule affinity- | no | N/A | 0.391 | 0.368 | 0.807 | 1e-134 |
| >sp|Q03141|MARK3_MOUSE MAP/microtubule affinity-regulating kinase 3 OS=Mus musculus GN=Mark3 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 499 bits (1286), Expect = e-140, Method: Compositional matrix adjust.
Identities = 243/346 (70%), Positives = 271/346 (78%), Gaps = 39/346 (11%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKIADFGFSNEFT G+KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE-VSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 339
VLNP KR +LE + + + AG + Q ID
Sbjct: 289 VLNPVKRGTLEQIMKDRWI---------NAGHEEDELKPFVEPELDISDQKRID------ 333
Query: 340 NTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDD 385
+VG+GYS+ EI+ESLS+ KYD+
Sbjct: 334 -----------------------IMVGMGYSQEEIQESLSKMKYDE 356
|
Involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus GN=Mark3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 242/345 (70%), Positives = 269/345 (77%), Gaps = 37/345 (10%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKI DFGFSNEFT G+KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKITDFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 340
VLNP KR +L E + + AG + Q ID
Sbjct: 289 VLNPVKRGTL----EQIMKDRWI----NAGHEEEELKPFVEPELDISDQKRID------- 333
Query: 341 TARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDD 385
+VG+GYS+ EI+ESLS+ KYD+
Sbjct: 334 ----------------------IMVGMGYSQEEIQESLSKMKYDE 356
|
Involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens GN=MARK3 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-139, Method: Compositional matrix adjust.
Identities = 242/346 (69%), Positives = 270/346 (78%), Gaps = 39/346 (11%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEAR+KFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKIADFGFSNEFT G KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE-VSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 339
VLNP KR +LE + + + AG + Q ID
Sbjct: 289 VLNPIKRGTLEQIMKDRWI---------NAGHEEDELKPFVEPELDISDQKRID------ 333
Query: 340 NTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDD 385
+VG+GYS+ EI+ESLS+ KYD+
Sbjct: 334 -----------------------IMVGMGYSQEEIQESLSKMKYDE 356
|
Involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C on 'Ser-216'. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7KZI7|MARK2_HUMAN Serine/threonine-protein kinase MARK2 OS=Homo sapiens GN=MARK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 493 bits (1268), Expect = e-138, Method: Compositional matrix adjust.
Identities = 242/356 (67%), Positives = 273/356 (76%), Gaps = 43/356 (12%)
Query: 33 RESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL 92
R S+ ++PHIG Y+LLKTIGKGNFAKVKLA+H+ TGKEVA+KIIDKTQLN SLQKL
Sbjct: 38 RNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKL 97
Query: 93 FREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR 152
FREVRIMK+L+HPNIVKLF+VIETEKTLYLVMEYASGGEVFDYLV HGRMKEKEARAKFR
Sbjct: 98 FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 157
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 212
QIVSAVQYCHQK I+HRDLKAENLLLD++MNIKIADFGFSNEFT GNKLDTFCGSPPYAA
Sbjct: 158 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 217
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDC 272
PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDC
Sbjct: 218 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 277
Query: 273 ENLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNS---SISPAPTNFKRQ 329
ENLLKKFL+LNP+KR +LE + H + + P P ++K
Sbjct: 278 ENLLKKFLILNPSKRGTLEQ----------IMKDRWMNVGHEDDELKPYVEPLP-DYK-- 324
Query: 330 NTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDD 385
P T+ +V +GY+R EI++SL +Y++
Sbjct: 325 ---------------------------DPRRTELMVSMGYTREEIQDSLVGQRYNE 353
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU, and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|O08679|MARK2_RAT Serine/threonine-protein kinase MARK2 OS=Rattus norvegicus GN=Mark2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1267), Expect = e-138, Method: Compositional matrix adjust.
Identities = 242/356 (67%), Positives = 273/356 (76%), Gaps = 43/356 (12%)
Query: 33 RESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL 92
R S+ ++PHIG Y+LLKTIGKGNFAKVKLA+H+ TGKEVA+KIIDKTQLN SLQKL
Sbjct: 38 RNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKL 97
Query: 93 FREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR 152
FREVRIMK+L+HPNIVKLF+VIETEKTLYLVMEYASGGEVFDYLV HGRMKEKEARAKFR
Sbjct: 98 FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 157
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 212
QIVSAVQYCHQK I+HRDLKAENLLLD++MNIKIADFGFSNEFT GNKLDTFCGSPPYAA
Sbjct: 158 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 217
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDC 272
PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDC
Sbjct: 218 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 277
Query: 273 ENLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNS---SISPAPTNFKRQ 329
ENLLKKFL+LNP+KR +LE + H + + P P ++K
Sbjct: 278 ENLLKKFLILNPSKRGTLEQ----------IMKDRWMNVGHEDDELKPYVEPLP-DYK-- 324
Query: 330 NTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDD 385
P T+ +V +GY+R EI++SL +Y++
Sbjct: 325 ---------------------------DPRRTELMVSMGYTREEIQDSLVGQRYNE 353
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q05512|MARK2_MOUSE Serine/threonine-protein kinase MARK2 OS=Mus musculus GN=Mark2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 489 bits (1260), Expect = e-137, Method: Compositional matrix adjust.
Identities = 241/356 (67%), Positives = 272/356 (76%), Gaps = 43/356 (12%)
Query: 33 RESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL 92
R S+ ++PHIG Y+LLKTIGKGNFAKVKLA+H+ TGKEVA+KIIDKTQLN SLQKL
Sbjct: 38 RNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKL 97
Query: 93 FREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR 152
FREVRIMK+L+HPNIVKLF+VIETEKTLYLVMEYASGGEVFDYLV HGRMKEKEARAKFR
Sbjct: 98 FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 157
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 212
QIVSAVQYCHQK I+HRDLKAENLLLD++MNIKIADFGFSNEFT GNKLDTFCGSPPYAA
Sbjct: 158 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 217
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDC 272
PELFQGKK DGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDC
Sbjct: 218 PELFQGKKIDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 277
Query: 273 ENLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNS---SISPAPTNFKRQ 329
ENLLKKFL+LNP+KR +LE + H + + P P ++K
Sbjct: 278 ENLLKKFLILNPSKRGTLEQ----------IMKDRWMNVGHEDDELKPYVEPLP-DYK-- 324
Query: 330 NTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDD 385
P T+ +V +GY+R EI++SL +Y++
Sbjct: 325 ---------------------------DPRRTELMVSMGYTREEIQDSLVGQRYNE 353
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|A8WYE4|PAR1_CAEBR Serine/threonine-protein kinase par-1 OS=Caenorhabditis briggsae GN=par-1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-136, Method: Compositional matrix adjust.
Identities = 231/279 (82%), Positives = 249/279 (89%), Gaps = 3/279 (1%)
Query: 15 TGRGSENNISSSRL--MSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK 72
TG GS ++ SS MSSR + R ++D H+GKYKLLKTIGKGNFAKVKLAKHV TG
Sbjct: 94 TGGGSSSHARSSGQSGMSSRSAARRNDQDV-HVGKYKLLKTIGKGNFAKVKLAKHVITGH 152
Query: 73 EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132
EVAIKIIDKT LNP SLQKLFREV+IMK LDHPNIVKL+QV+ETE+TLYLV+EYASGGEV
Sbjct: 153 EVAIKIIDKTALNPSSLQKLFREVKIMKQLDHPNIVKLYQVMETEQTLYLVLEYASGGEV 212
Query: 133 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192
FDYLV HGRMKEKEARAKFRQIVSAVQY H K IIHRDLKAENLLLD +MNIKIADFGFS
Sbjct: 213 FDYLVAHGRMKEKEARAKFRQIVSAVQYLHSKNIIHRDLKAENLLLDQDMNIKIADFGFS 272
Query: 193 NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE 252
N F+ GNKLDTFCGSPPYAAPELF GKKYDGPEVDVWSLGVILYTLVSGSLPFDG L+E
Sbjct: 273 NTFSLGNKLDTFCGSPPYAAPELFSGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 332
Query: 253 LRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
LRERVLRGKYRIPFYMSTDCENLLKKFLV+NP +R+SL+
Sbjct: 333 LRERVLRGKYRIPFYMSTDCENLLKKFLVINPQRRSSLD 371
|
Required for cytoplasmic partitioning and asymmetric cell division in early embryogenesis. Phosphorylates and restricts the asymmetry effector mex-5 (and possibly also mex-6) to the anterior cytoplasm of the zygote. Critical role in postembryonic vulval morphogenesis. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9TW45|PAR1_CAEEL Serine/threonine-protein kinase par-1 OS=Caenorhabditis elegans GN=par-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 223/261 (85%), Positives = 239/261 (91%)
Query: 31 SRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ 90
S R ++RR + H+GKYKLLKTIGKGNFAKVKLAKHV TG EVAIKIIDKT LNP SLQ
Sbjct: 153 SSRSAARRNDQDVHVGKYKLLKTIGKGNFAKVKLAKHVITGHEVAIKIIDKTALNPSSLQ 212
Query: 91 KLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK 150
KLFREV+IMK LDHPNIVKL+QV+ETE+TLYLV+EYASGGEVFDYLV HGRMKEKEARAK
Sbjct: 213 KLFREVKIMKQLDHPNIVKLYQVMETEQTLYLVLEYASGGEVFDYLVAHGRMKEKEARAK 272
Query: 151 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPY 210
FRQIVSAVQY H K IIHRDLKAENLLLD +MNIKIADFGFSN F+ GNKLDTFCGSPPY
Sbjct: 273 FRQIVSAVQYLHSKNIIHRDLKAENLLLDQDMNIKIADFGFSNTFSLGNKLDTFCGSPPY 332
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMST 270
AAPELF GKKYDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMST
Sbjct: 333 AAPELFSGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 392
Query: 271 DCENLLKKFLVLNPAKRASLE 291
DCENLLKKFLV+NP +R+SL+
Sbjct: 393 DCENLLKKFLVINPQRRSSLD 413
|
Required for cytoplasmic partitioning and asymmetric cell division in early embryogenesis. Phosphorylates and restricts the asymmetry effector mex-5 (and possibly also mex-6) to the anterior cytoplasm of the zygote. Critical role in postembryonic vulval morphogenesis. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8CIP4|MARK4_MOUSE MAP/microtubule affinity-regulating kinase 4 OS=Mus musculus GN=Mark4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1229), Expect = e-134, Method: Compositional matrix adjust.
Identities = 226/280 (80%), Positives = 252/280 (90%), Gaps = 3/280 (1%)
Query: 15 TGRGSENNIS-SSRLMSSRRESS--RRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTG 71
+GR S+ S SSR + +R +S ++PH+G Y+LL+TIGKGNFAKVKLA+H+ TG
Sbjct: 23 SGRSSDKGPSWSSRSLGARCRNSIASCPEEQPHVGNYRLLRTIGKGNFAKVKLARHILTG 82
Query: 72 KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGE 131
+EVAIKIIDKTQLNP SLQKLFREVRIMK L+HPNIVKLF+VIETEKTLYLVMEYAS GE
Sbjct: 83 REVAIKIIDKTQLNPSSLQKLFREVRIMKGLNHPNIVKLFEVIETEKTLYLVMEYASAGE 142
Query: 132 VFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191
VFDYLV HGRMKEKEARAKFRQIVSAV YCHQK I+HRDLKAENLLLD+E NIKIADFGF
Sbjct: 143 VFDYLVSHGRMKEKEARAKFRQIVSAVHYCHQKNIVHRDLKAENLLLDAEANIKIADFGF 202
Query: 192 SNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR 251
SNEFT G+KLDTFCGSPPYAAPELFQGKKYDGPEVD+WSLGVILYTLVSGSLPFDG L+
Sbjct: 203 SNEFTLGSKLDTFCGSPPYAAPELFQGKKYDGPEVDIWSLGVILYTLVSGSLPFDGHNLK 262
Query: 252 ELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
ELRERVLRGKYR+PFYMSTDCE++L++FLVLNPAKR +LE
Sbjct: 263 ELRERVLRGKYRVPFYMSTDCESILRRFLVLNPAKRCTLE 302
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96L34|MARK4_HUMAN MAP/microtubule affinity-regulating kinase 4 OS=Homo sapiens GN=MARK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1229), Expect = e-134, Method: Compositional matrix adjust.
Identities = 226/280 (80%), Positives = 252/280 (90%), Gaps = 3/280 (1%)
Query: 15 TGRGSENNIS-SSRLMSSRRESS--RRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTG 71
+GR S+ S SSR + +R +S ++PH+G Y+LL+TIGKGNFAKVKLA+H+ TG
Sbjct: 23 SGRSSDKGPSWSSRSLGARCRNSIASCPEEQPHVGNYRLLRTIGKGNFAKVKLARHILTG 82
Query: 72 KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGE 131
+EVAIKIIDKTQLNP SLQKLFREVRIMK L+HPNIVKLF+VIETEKTLYLVMEYAS GE
Sbjct: 83 REVAIKIIDKTQLNPSSLQKLFREVRIMKGLNHPNIVKLFEVIETEKTLYLVMEYASAGE 142
Query: 132 VFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191
VFDYLV HGRMKEKEARAKFRQIVSAV YCHQK I+HRDLKAENLLLD+E NIKIADFGF
Sbjct: 143 VFDYLVSHGRMKEKEARAKFRQIVSAVHYCHQKNIVHRDLKAENLLLDAEANIKIADFGF 202
Query: 192 SNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR 251
SNEFT G+KLDTFCGSPPYAAPELFQGKKYDGPEVD+WSLGVILYTLVSGSLPFDG L+
Sbjct: 203 SNEFTLGSKLDTFCGSPPYAAPELFQGKKYDGPEVDIWSLGVILYTLVSGSLPFDGHNLK 262
Query: 252 ELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
ELRERVLRGKYR+PFYMSTDCE++L++FLVLNPAKR +LE
Sbjct: 263 ELRERVLRGKYRVPFYMSTDCESILRRFLVLNPAKRCTLE 302
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 708 | ||||||
| 242021205 | 715 | serine/threonine-protein kinase MARK2, p | 0.508 | 0.503 | 0.688 | 1e-165 | |
| 442624239 | 832 | par-1, isoform W [Drosophila melanogaste | 0.552 | 0.469 | 0.669 | 1e-164 | |
| 350419319 | 1135 | PREDICTED: serine/threonine-protein kina | 0.538 | 0.335 | 0.732 | 1e-164 | |
| 340708870 | 1141 | PREDICTED: serine/threonine-protein kina | 0.538 | 0.333 | 0.732 | 1e-164 | |
| 383864976 | 1226 | PREDICTED: serine/threonine-protein kina | 0.536 | 0.309 | 0.729 | 1e-164 | |
| 328791600 | 1127 | PREDICTED: serine/threonine-protein kina | 0.536 | 0.337 | 0.727 | 1e-163 | |
| 45552737 | 993 | par-1, isoform H [Drosophila melanogaste | 0.556 | 0.396 | 0.671 | 1e-163 | |
| 380028692 | 960 | PREDICTED: serine/threonine-protein kina | 0.536 | 0.395 | 0.727 | 1e-163 | |
| 442624241 | 951 | par-1, isoform V [Drosophila melanogaste | 0.556 | 0.414 | 0.671 | 1e-163 | |
| 195487123 | 1211 | GE12057 [Drosophila yakuba] gi|194177877 | 0.519 | 0.303 | 0.700 | 1e-163 |
| >gi|242021205|ref|XP_002431036.1| serine/threonine-protein kinase MARK2, putative [Pediculus humanus corporis] gi|212516265|gb|EEB18298.1| serine/threonine-protein kinase MARK2, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-165, Method: Compositional matrix adjust.
Identities = 312/453 (68%), Positives = 328/453 (72%), Gaps = 93/453 (20%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 30 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPVSLQKLFREVRIMK 89
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV+HGRMKEKEARAKFRQIVSAVQY
Sbjct: 90 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVMHGRMKEKEARAKFRQIVSAVQY 149
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK
Sbjct: 150 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 209
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMS+DCENLLKKFL
Sbjct: 210 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSSDCENLLKKFL 269
Query: 281 VLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNS---SISPAPTNFKRQNTIDSASI 337
VLNPA+RASLE + + + + P P +FK I+
Sbjct: 270 VLNPARRASLE----------SIMKDKWMNVGYEEDELKPYVEPEP-DFKDHKRIE---- 314
Query: 338 KENTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYD------------- 384
AL+G+GYSR EIE+SLSQ KYD
Sbjct: 315 -------------------------ALIGMGYSRGEIEDSLSQFKYDDVFATYLLLGRKN 349
Query: 385 -DPESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGA 443
DPESDGSRSGSSLS N+ + G
Sbjct: 350 TDPESDGSRSGSSLSC-NIPAAT---------------------------------PAGN 375
Query: 444 AQSP--SHRGVHRSISASNAKPSRRASSGGETL 474
AQSP HRGVHRSISA+N KP+RRASSGGETL
Sbjct: 376 AQSPLHGHRGVHRSISATNPKPNRRASSGGETL 408
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|442624239|ref|NP_001014540.2| par-1, isoform W [Drosophila melanogaster] gi|15042605|gb|AAK82365.1|AF387635_1 Ser/Thr protein kinase PAR-1alpha [Drosophila melanogaster] gi|440214529|gb|AAX52691.2| par-1, isoform W [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-164, Method: Compositional matrix adjust.
Identities = 320/478 (66%), Positives = 344/478 (71%), Gaps = 87/478 (18%)
Query: 12 KSETGRGSENNISSSRLMSSRRESSRRER-DEPHIGKYKLLKTIGKGNFAKVKLAKHVPT 70
++ + +GS N M R + R R E HIGKYKL+KTIGKGNFAKVKLAKH+PT
Sbjct: 223 RTSSAKGSPN-------MQMRSSAPMRWRATEEHIGKYKLIKTIGKGNFAKVKLAKHLPT 275
Query: 71 GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130
GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL+MEYASGG
Sbjct: 276 GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLIMEYASGG 335
Query: 131 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190
EVFDYLVLHGRMKEKEAR KFRQIVSAVQYCHQK+IIHRDLKAENLLLDSE+NIKIADFG
Sbjct: 336 EVFDYLVLHGRMKEKEARVKFRQIVSAVQYCHQKRIIHRDLKAENLLLDSELNIKIADFG 395
Query: 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
FSNEFTPG+KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL
Sbjct: 396 FSNEFTPGSKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 455
Query: 251 RELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAG 310
RELRERVLRGKYRIPFYMSTDCENLL+KFLVLNPAKRASLE T+ G + G
Sbjct: 456 RELRERVLRGKYRIPFYMSTDCENLLRKFLVLNPAKRASLE-----TIMGDKWMNMG--- 507
Query: 311 TNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYS 370
F+ K + A P +ALV +GY+
Sbjct: 508 ---------------FEEDELKPYIEPKADLAD--------------PKRIEALVAMGYN 538
Query: 371 RSEIEESLSQAKYD--------------DPESDGSRSGSSLSLRNLQPGSGGGATGGSGS 416
RSEIE SLSQ +YD DPESDGSRSGSSLSLRN+ G+ GA GS S
Sbjct: 539 RSEIEASLSQVRYDDVFATYLLLGRKSTDPESDGSRSGSSLSLRNIS-GNDAGANAGSAS 597
Query: 417 SRSWRNMQPGSGGVATGGSGGGGGGGAAQSPSHRGVHRSISASNAKPSRRASSGGETL 474
QSP+HRGVHRSISAS+ KPSRRASSG ETL
Sbjct: 598 ---------------------------VQSPTHRGVHRSISASSTKPSRRASSGAETL 628
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350419319|ref|XP_003492142.1| PREDICTED: serine/threonine-protein kinase MARK2-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 328/448 (73%), Positives = 341/448 (76%), Gaps = 67/448 (14%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK
Sbjct: 364 EEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 423
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY
Sbjct: 424 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 483
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK
Sbjct: 484 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 543
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL
Sbjct: 544 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 603
Query: 281 VLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 340
VLNP KRASLE T+ + G + + P P ++K I+
Sbjct: 604 VLNPTKRASLE-----TIMKDKWMNMG--YDDDELKPYLEPEP-DYKDHKRIE------- 648
Query: 341 TARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYD--------------DP 386
AL +GY+RSEIE+SL QAKYD DP
Sbjct: 649 ----------------------ALASMGYTRSEIEDSLGQAKYDDVFATYLLLGRKTTDP 686
Query: 387 ESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQS 446
ESDGSRSGSSLSLRN+ P +G G GG G G GGG GGA QS
Sbjct: 687 ESDGSRSGSSLSLRNIPPQAGSGGGGGGGGG----------------GGSGGGTGGAVQS 730
Query: 447 PSHRGVHRSISASNAKPSRRASSGGETL 474
PSHRGVHRSISASN KPSRR SSG ETL
Sbjct: 731 PSHRGVHRSISASNPKPSRRVSSGLETL 758
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340708870|ref|XP_003393041.1| PREDICTED: serine/threonine-protein kinase MARK2-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 328/448 (73%), Positives = 341/448 (76%), Gaps = 67/448 (14%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK
Sbjct: 364 EEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 423
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY
Sbjct: 424 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 483
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK
Sbjct: 484 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 543
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL
Sbjct: 544 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 603
Query: 281 VLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 340
VLNP KRASLE T+ + G + + P P ++K I+
Sbjct: 604 VLNPTKRASLE-----TIMKDKWMNMG--YDDDELKPYLEPEP-DYKDHKRIE------- 648
Query: 341 TARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYD--------------DP 386
AL +GY+RSEIE+SL QAKYD DP
Sbjct: 649 ----------------------ALASMGYTRSEIEDSLGQAKYDDVFATYLLLGRKTTDP 686
Query: 387 ESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQS 446
ESDGSRSGSSLSLRN+ P +G G GG G G GGG GGA QS
Sbjct: 687 ESDGSRSGSSLSLRNIPPQAGSGGGGGGGGG----------------GGSGGGTGGAVQS 730
Query: 447 PSHRGVHRSISASNAKPSRRASSGGETL 474
PSHRGVHRSISASN KPSRR SSG ETL
Sbjct: 731 PSHRGVHRSISASNPKPSRRVSSGLETL 758
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383864976|ref|XP_003707953.1| PREDICTED: serine/threonine-protein kinase MARK2-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1505), Expect = e-164, Method: Compositional matrix adjust.
Identities = 327/448 (72%), Positives = 340/448 (75%), Gaps = 68/448 (15%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK
Sbjct: 456 EEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 515
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY
Sbjct: 516 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 575
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK
Sbjct: 576 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 635
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL
Sbjct: 636 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 695
Query: 281 VLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 340
VLNP KRASLE T+ + G + + P P ++K I+
Sbjct: 696 VLNPTKRASLE-----TIMKDKWMNMG--YDDDELKPYLEPEP-DYKDHKRIE------- 740
Query: 341 TARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYD--------------DP 386
AL +GY+RSEIE+SL QAKYD DP
Sbjct: 741 ----------------------ALASMGYTRSEIEDSLGQAKYDDVFATYLLLGRKTTDP 778
Query: 387 ESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQS 446
ESDGSRSGSSLSLRN+ P +G G GG G GGG GGA QS
Sbjct: 779 ESDGSRSGSSLSLRNIPPQAGSGGGGGGGGG-----------------GTGGGTGGAVQS 821
Query: 447 PSHRGVHRSISASNAKPSRRASSGGETL 474
PSHRGVHRSISASN KPSRR SSG ETL
Sbjct: 822 PSHRGVHRSISASNPKPSRRVSSGLETL 849
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328791600|ref|XP_394194.4| PREDICTED: serine/threonine-protein kinase MARK2 isoform 1 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1503), Expect = e-163, Method: Compositional matrix adjust.
Identities = 326/448 (72%), Positives = 339/448 (75%), Gaps = 68/448 (15%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK
Sbjct: 351 EEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 410
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY
Sbjct: 411 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 470
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK
Sbjct: 471 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 530
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL
Sbjct: 531 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 590
Query: 281 VLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 340
VLNP KRASLE T+ + G + + P P ++K I+
Sbjct: 591 VLNPTKRASLE-----TIMKDKWMNMG--YDDDELKPYLEPEP-DYKDHKRIE------- 635
Query: 341 TARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYD--------------DP 386
AL +GY+RSEIE+SL QAKYD DP
Sbjct: 636 ----------------------ALASMGYTRSEIEDSLGQAKYDDVFATYLLLGRKTTDP 673
Query: 387 ESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQS 446
ESDGSRSGSSLSLRN+ P +G G G G GGG GGA QS
Sbjct: 674 ESDGSRSGSSLSLRNIPPQAGSGGGGSGGGG-----------------GSGGGTGGAVQS 716
Query: 447 PSHRGVHRSISASNAKPSRRASSGGETL 474
PSHRGVHRSISASN KPSRR SSG ETL
Sbjct: 717 PSHRGVHRSISASNPKPSRRVSSGLETL 744
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|45552737|ref|NP_995893.1| par-1, isoform H [Drosophila melanogaster] gi|45445461|gb|AAS64800.1| par-1, isoform H [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-163, Method: Compositional matrix adjust.
Identities = 323/481 (67%), Positives = 345/481 (71%), Gaps = 87/481 (18%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSRRER-DEPHIGKYKLLKTIGKGNFAKVKLAKH 67
S+ K+ RGS N M R + R R E HIGKYKL+KTIGKGNFAKVKLAKH
Sbjct: 343 SSDKARNSRGSPN-------MQMRSSAPMRWRATEEHIGKYKLIKTIGKGNFAKVKLAKH 395
Query: 68 VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127
+PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL+MEYA
Sbjct: 396 LPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLIMEYA 455
Query: 128 SGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIA 187
SGGEVFDYLVLHGRMKEKEAR KFRQIVSAVQYCHQK+IIHRDLKAENLLLDSE+NIKIA
Sbjct: 456 SGGEVFDYLVLHGRMKEKEARVKFRQIVSAVQYCHQKRIIHRDLKAENLLLDSELNIKIA 515
Query: 188 DFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 247
DFGFSNEFTPG+KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG
Sbjct: 516 DFGFSNEFTPGSKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 575
Query: 248 STLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSG 307
STLRELRERVLRGKYRIPFYMSTDCENLL+KFLVLNPAKRASLE T+ G + G
Sbjct: 576 STLRELRERVLRGKYRIPFYMSTDCENLLRKFLVLNPAKRASLE-----TIMGDKWMNMG 630
Query: 308 GAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGL 367
F+ K + A P +ALV +
Sbjct: 631 ------------------FEEDELKPYIEPKADLA--------------DPKRIEALVAM 658
Query: 368 GYSRSEIEESLSQAKYD--------------DPESDGSRSGSSLSLRNLQPGSGGGATGG 413
GY+RSEIE SLSQ +YD DPESDGSRSGSSLSLRN+ G+ GA G
Sbjct: 659 GYNRSEIEASLSQVRYDDVFATYLLLGRKSTDPESDGSRSGSSLSLRNIS-GNDAGANAG 717
Query: 414 SGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQSPSHRGVHRSISASNAKPSRRASSGGET 473
S S QSP+HRGVHRSISAS+ KPSRRASSG ET
Sbjct: 718 SAS---------------------------VQSPTHRGVHRSISASSTKPSRRASSGAET 750
Query: 474 L 474
L
Sbjct: 751 L 751
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380028692|ref|XP_003698025.1| PREDICTED: serine/threonine-protein kinase MARK2-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1501), Expect = e-163, Method: Compositional matrix adjust.
Identities = 326/448 (72%), Positives = 339/448 (75%), Gaps = 68/448 (15%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK
Sbjct: 190 EEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 249
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY
Sbjct: 250 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 309
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK
Sbjct: 310 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 369
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL
Sbjct: 370 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 429
Query: 281 VLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 340
VLNP KRASLE T+ + G + + P P ++K I+
Sbjct: 430 VLNPTKRASLE-----TIMKDKWMNMG--YDDDELKPYLEPEP-DYKDHKRIE------- 474
Query: 341 TARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYD--------------DP 386
AL +GY+RSEIE+SL QAKYD DP
Sbjct: 475 ----------------------ALASMGYTRSEIEDSLGQAKYDDVFATYLLLGRKTTDP 512
Query: 387 ESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQS 446
ESDGSRSGSSLSLRN+ P +G G G G GGG GGA QS
Sbjct: 513 ESDGSRSGSSLSLRNIPPQAGSGGGGSGGGG-----------------GSGGGTGGAVQS 555
Query: 447 PSHRGVHRSISASNAKPSRRASSGGETL 474
PSHRGVHRSISASN KPSRR SSG ETL
Sbjct: 556 PSHRGVHRSISASNPKPSRRVSSGLETL 583
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|442624241|ref|NP_995899.2| par-1, isoform V [Drosophila melanogaster] gi|440214530|gb|AAS64799.2| par-1, isoform V [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 321/478 (67%), Positives = 345/478 (72%), Gaps = 84/478 (17%)
Query: 12 KSETGRGSENNISSSRLMSSRRESSRRER-DEPHIGKYKLLKTIGKGNFAKVKLAKHVPT 70
++ + +GS N M R + R R E HIGKYKL+KTIGKGNFAKVKLAKH+PT
Sbjct: 223 RTSSAKGSPN-------MQMRSSAPMRWRATEEHIGKYKLIKTIGKGNFAKVKLAKHLPT 275
Query: 71 GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130
GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL+MEYASGG
Sbjct: 276 GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLIMEYASGG 335
Query: 131 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190
EVFDYLVLHGRMKEKEAR KFRQIVSAVQYCHQK+IIHRDLKAENLLLDSE+NIKIADFG
Sbjct: 336 EVFDYLVLHGRMKEKEARVKFRQIVSAVQYCHQKRIIHRDLKAENLLLDSELNIKIADFG 395
Query: 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
FSNEFTPG+KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL
Sbjct: 396 FSNEFTPGSKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 455
Query: 251 RELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAG 310
RELRERVLRGKYRIPFYMSTDCENLL+KFLVLNPAKRASLE T+ G + G
Sbjct: 456 RELRERVLRGKYRIPFYMSTDCENLLRKFLVLNPAKRASLE-----TIMGDKWMNMG--- 507
Query: 311 TNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYS 370
F+ K + A + R K A LV +GY+
Sbjct: 508 ---------------FEEDELKPYIEPKADLA--DPKRIGKTEA---------LVAMGYN 541
Query: 371 RSEIEESLSQAKYD--------------DPESDGSRSGSSLSLRNLQPGSGGGATGGSGS 416
RSEIE SLSQ +YD DPESDGSRSGSSLSLRN+ G+ GA GS S
Sbjct: 542 RSEIEASLSQVRYDDVFATYLLLGRKSTDPESDGSRSGSSLSLRNIS-GNDAGANAGSAS 600
Query: 417 SRSWRNMQPGSGGVATGGSGGGGGGGAAQSPSHRGVHRSISASNAKPSRRASSGGETL 474
QSP+HRGVHRSISAS+ KPSRRASSG ETL
Sbjct: 601 ---------------------------VQSPTHRGVHRSISASSTKPSRRASSGAETL 631
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195487123|ref|XP_002091776.1| GE12057 [Drosophila yakuba] gi|194177877|gb|EDW91488.1| GE12057 [Drosophila yakuba] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1496), Expect = e-163, Method: Compositional matrix adjust.
Identities = 313/447 (70%), Positives = 332/447 (74%), Gaps = 79/447 (17%)
Query: 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
E HIGKYKL+KTIGKGNFAKVKLAKH+PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM
Sbjct: 477 EEHIGKYKLIKTIGKGNFAKVKLAKHLPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 536
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
LDHPNIVKLFQVIETEKTLYL+MEYASGGEVFDYLVLHGRMKEKEAR KFRQIVSAVQYC
Sbjct: 537 LDHPNIVKLFQVIETEKTLYLIMEYASGGEVFDYLVLHGRMKEKEARVKFRQIVSAVQYC 596
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
HQK+IIHRDLKAENLLLDSE+NIKIADFGFSNEFTPG+KLDTFCGSPPYAAPELFQGKKY
Sbjct: 597 HQKRIIHRDLKAENLLLDSELNIKIADFGFSNEFTPGSKLDTFCGSPPYAAPELFQGKKY 656
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281
DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL+KFLV
Sbjct: 657 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLRKFLV 716
Query: 282 LNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENT 341
LNPAKRASLE T+ G + G F+ K +
Sbjct: 717 LNPAKRASLE-----TIMGDKWMNMG------------------FEEDELKPYIEPKADL 753
Query: 342 ARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYD--------------DPE 387
A P +ALV +GY+RSEIE SLSQ +YD DPE
Sbjct: 754 A--------------DPKRIEALVAMGYNRSEIEASLSQVRYDDVFATYLLLGRKSTDPE 799
Query: 388 SDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQSP 447
SDGSRSGSSLSLRN+ G+ GA GS S QSP
Sbjct: 800 SDGSRSGSSLSLRNIS-GNDAGANAGSAS---------------------------VQSP 831
Query: 448 SHRGVHRSISASNAKPSRRASSGGETL 474
+HRGVHRSISAS+ KPSRRASSG ETL
Sbjct: 832 THRGVHRSISASSTKPSRRASSGAETL 858
|
Source: Drosophila yakuba Species: Drosophila yakuba Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 708 | ||||||
| FB|FBgn0260934 | 1141 | par-1 "par-1" [Drosophila mela | 0.358 | 0.222 | 0.949 | 3e-167 | |
| UNIPROTKB|E1BRA3 | 729 | MARK3 "Uncharacterized protein | 0.354 | 0.344 | 0.896 | 1.2e-134 | |
| RGD|619883 | 797 | Mark3 "MAP/microtubule affinit | 0.354 | 0.314 | 0.888 | 1.3e-133 | |
| UNIPROTKB|Q8VHF0 | 797 | Mark3 "MAP/microtubule affinit | 0.354 | 0.314 | 0.888 | 1.3e-133 | |
| MGI|MGI:1341865 | 753 | Mark3 "MAP/microtubule affinit | 0.354 | 0.333 | 0.892 | 1.3e-133 | |
| UNIPROTKB|G5E5D4 | 786 | MARK1 "Uncharacterized protein | 0.354 | 0.319 | 0.900 | 1.1e-132 | |
| UNIPROTKB|D4AAH3 | 753 | Mark3 "MAP/microtubule affinit | 0.354 | 0.333 | 0.892 | 1.2e-132 | |
| UNIPROTKB|D4AE86 | 729 | Mark3 "MAP/microtubule affinit | 0.354 | 0.344 | 0.892 | 1.2e-132 | |
| UNIPROTKB|F1Q1P8 | 795 | MARK1 "Uncharacterized protein | 0.354 | 0.315 | 0.900 | 3e-132 | |
| ZFIN|ZDB-GENE-060929-80 | 754 | zgc:153725 "zgc:153725" [Danio | 0.354 | 0.332 | 0.896 | 3.1e-132 |
| FB|FBgn0260934 par-1 "par-1" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 3.0e-167, Sum P(4) = 3.0e-167
Identities = 242/255 (94%), Positives = 251/255 (98%)
Query: 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
E HIGKYKL+KTIGKGNFAKVKLAKH+PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM
Sbjct: 475 EEHIGKYKLIKTIGKGNFAKVKLAKHLPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 534
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
LDHPNIVKLFQVIETEKTLYL+MEYASGGEVFDYLVLHGRMKEKEAR KFRQIVSAVQYC
Sbjct: 535 LDHPNIVKLFQVIETEKTLYLIMEYASGGEVFDYLVLHGRMKEKEARVKFRQIVSAVQYC 594
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
HQK+IIHRDLKAENLLLDSE+NIKIADFGFSNEFTPG+KLDTFCGSPPYAAPELFQGKKY
Sbjct: 595 HQKRIIHRDLKAENLLLDSELNIKIADFGFSNEFTPGSKLDTFCGSPPYAAPELFQGKKY 654
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281
DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL+KFLV
Sbjct: 655 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLRKFLV 714
Query: 282 LNPAKRASLE-VSGE 295
LNPAKRASLE + G+
Sbjct: 715 LNPAKRASLETIMGD 729
|
|
| UNIPROTKB|E1BRA3 MARK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 1.2e-134, Sum P(3) = 1.2e-134
Identities = 225/251 (89%), Positives = 241/251 (96%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK I+HRDLKAENLLLD++MNIKIADFGFSNEFT GNKLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKHIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE 291
VLNP KR +LE
Sbjct: 289 VLNPTKRGTLE 299
|
|
| RGD|619883 Mark3 "MAP/microtubule affinity-regulating kinase 3" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1187 (422.9 bits), Expect = 1.3e-133, Sum P(4) = 1.3e-133
Identities = 223/251 (88%), Positives = 241/251 (96%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKI DFGFSNEFT G+KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKITDFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE 291
VLNP KR +LE
Sbjct: 289 VLNPVKRGTLE 299
|
|
| UNIPROTKB|Q8VHF0 Mark3 "MAP/microtubule affinity-regulating kinase 3" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1187 (422.9 bits), Expect = 1.3e-133, Sum P(4) = 1.3e-133
Identities = 223/251 (88%), Positives = 241/251 (96%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKI DFGFSNEFT G+KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKITDFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE 291
VLNP KR +LE
Sbjct: 289 VLNPVKRGTLE 299
|
|
| MGI|MGI:1341865 Mark3 "MAP/microtubule affinity-regulating kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 1.3e-133, Sum P(3) = 1.3e-133
Identities = 224/251 (89%), Positives = 242/251 (96%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKIADFGFSNEFT G+KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE 291
VLNP KR +LE
Sbjct: 289 VLNPVKRGTLE 299
|
|
| UNIPROTKB|G5E5D4 MARK1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 1.1e-132, Sum P(4) = 1.1e-132
Identities = 226/251 (90%), Positives = 239/251 (95%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+L KTIGKGNFAKVKLA+HV TG+EVA+KIIDKTQLNP SLQKLFREVRIMK
Sbjct: 44 EQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMK 103
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYLVMEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 104 ILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 163
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK I+HRDLKAENLLLD++MNIKIADFGFSNEFT GNKLDTFCGSPPYAAPELFQGKK
Sbjct: 164 CHQKCIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKK 223
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLKK L
Sbjct: 224 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLL 283
Query: 281 VLNPAKRASLE 291
VLNP KR SLE
Sbjct: 284 VLNPIKRGSLE 294
|
|
| UNIPROTKB|D4AAH3 Mark3 "MAP/microtubule affinity-regulating kinase 3" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 1.2e-132, Sum P(3) = 1.2e-132
Identities = 224/251 (89%), Positives = 242/251 (96%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKIADFGFSNEFT G+KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE 291
VLNP KR +LE
Sbjct: 289 VLNPVKRGTLE 299
|
|
| UNIPROTKB|D4AE86 Mark3 "MAP/microtubule affinity-regulating kinase 3" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 1.2e-132, Sum P(3) = 1.2e-132
Identities = 224/251 (89%), Positives = 242/251 (96%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK+I+HRDLKAENLLLD++MNIKIADFGFSNEFT G+KLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE 291
VLNP KR +LE
Sbjct: 289 VLNPVKRGTLE 299
|
|
| UNIPROTKB|F1Q1P8 MARK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 3.0e-132, Sum P(4) = 3.0e-132
Identities = 226/251 (90%), Positives = 239/251 (95%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+L KTIGKGNFAKVKLA+HV TG+EVA+KIIDKTQLNP SLQKLFREVRIMK
Sbjct: 51 EQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMK 110
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIETEKTLYLVMEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 111 ILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 170
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK I+HRDLKAENLLLD++MNIKIADFGFSNEFT GNKLDTFCGSPPYAAPELFQGKK
Sbjct: 171 CHQKCIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKK 230
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLKK L
Sbjct: 231 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLL 290
Query: 281 VLNPAKRASLE 291
VLNP KR SLE
Sbjct: 291 VLNPIKRGSLE 301
|
|
| ZFIN|ZDB-GENE-060929-80 zgc:153725 "zgc:153725" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1190 (424.0 bits), Expect = 3.1e-132, Sum P(3) = 3.1e-132
Identities = 225/251 (89%), Positives = 241/251 (96%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFREVRIMK
Sbjct: 49 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
+L+HPNIVKLF+VIET+KTLYLVMEYASGGEVFDYLV HGRMKEKEARAKFRQIVSAVQY
Sbjct: 109 ILNHPNIVKLFEVIETDKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 168
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
CHQK I+HRDLKAENLLLD++MNIKIADFGFSNEFT GNKLDTFCGSPPYAAPELFQGKK
Sbjct: 169 CHQKHIVHRDLKAENLLLDADMNIKIADFGFSNEFTIGNKLDTFCGSPPYAAPELFQGKK 228
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
YDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCENLLK+FL
Sbjct: 229 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 288
Query: 281 VLNPAKRASLE 291
VLNP KR +LE
Sbjct: 289 VLNPVKRGTLE 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q00372 | SNF1_CANGA | 2, ., 7, ., 1, 1, ., 1 | 0.5059 | 0.3516 | 0.4068 | yes | N/A |
| Q03141 | MARK3_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7023 | 0.4336 | 0.4077 | yes | N/A |
| P92958 | KIN11_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5040 | 0.3432 | 0.4746 | yes | N/A |
| Q8VHF0 | MARK3_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7014 | 0.4350 | 0.3864 | yes | N/A |
| P27448 | MARK3_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6994 | 0.4336 | 0.4077 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 708 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-112 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-97 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-81 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-80 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-78 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-69 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-69 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-65 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-63 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-62 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-58 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-58 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-57 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-56 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-56 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-54 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-52 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-51 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-50 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-50 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-50 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-49 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-49 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-49 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-48 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-47 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-46 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-46 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-46 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-45 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-45 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-45 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-45 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-44 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-44 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-44 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-43 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-43 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-42 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-42 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-42 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-42 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-41 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-41 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-40 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-40 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-40 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-40 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-40 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-39 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-39 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-39 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-39 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-39 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-38 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-38 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-38 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-38 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-38 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-38 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-38 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-38 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-38 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-37 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-37 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-37 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-36 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-36 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-36 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-35 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-35 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-35 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-35 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-34 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-34 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-34 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-33 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-33 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-33 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-32 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-32 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-32 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-32 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-32 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-32 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-31 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-31 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-31 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-31 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-31 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-30 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-30 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-30 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-30 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-29 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-29 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-28 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-28 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-27 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-27 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-27 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-27 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-27 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-26 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-26 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-26 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-26 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-25 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-25 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-25 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-25 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-25 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-24 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-24 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-24 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-23 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-23 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-23 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-22 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-22 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-21 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-21 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-21 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-21 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-20 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| PHA00370 | 297 | PHA00370, III, attachment protein | 0.001 | |
| PRK06958 | 182 | PRK06958, PRK06958, single-stranded DNA-binding pr | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 339 bits (872), Expect = e-112
Identities = 118/248 (47%), Positives = 166/248 (66%), Gaps = 6/248 (2%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y++L+ +G+G+F KV LA+ TGK VAIK+I K ++ +++ RE++I+K L HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 167
V+L+ V E E LYLVMEY GG++FD L GR+ E EAR RQI+SA++Y H K I+
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 227
HRDLK EN+LLD + ++K+ADFG + + PG KL TF G+P Y APE+ GK Y VD
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA-VD 178
Query: 228 VWSLGVILYTLVSGSLPFDGS-TLRELRERVLRGKYRIPFYM---STDCENLLKKFLVLN 283
+WSLGVILY L++G PF G L EL +++ + K P S + ++L++K LV +
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238
Query: 284 PAKRASLE 291
P KR + E
Sbjct: 239 PEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 299 bits (769), Expect = 4e-97
Identities = 109/252 (43%), Positives = 148/252 (58%), Gaps = 8/252 (3%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y+LL+ +G G+F V AKH TGK VA+KI+ K Q RE+RI++ L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 167
V+L E + LYLVMEY GG++FDYL G + E EA+ QI+ ++Y H II
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
HRDLK EN+LLD +KIADFG + + + L TF G+P Y APE+ G GP+V
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLRELRE---RVLRGKYRIPFY----MSTDCENLLKKF 279
DVWSLGVILY L++G PF G + + + R+L S + ++L+KK
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240
Query: 280 LVLNPAKRASLE 291
L +P+KR + E
Sbjct: 241 LNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 3e-81
Identities = 98/236 (41%), Positives = 147/236 (62%), Gaps = 3/236 (1%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPNIVKLFQ 112
+GKG+F KV L + TGK A+K++ K + + ++ E I+ ++HP IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 113 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172
+TE+ LYLV+EYA GGE+F +L GR E+ AR +IV A++Y H II+RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 173 AENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSL 231
EN+LLD++ +IK+ DFG + E + + +TFCG+P Y APE+ GK Y G VD WSL
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179
Query: 232 GVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
GV+LY +++G PF +E+ E++L+ R P ++S + +L+ L +P KR
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 6e-80
Identities = 92/253 (36%), Positives = 145/253 (57%), Gaps = 11/253 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY+++K IGKG+F KV L + GK +K ID + ++ + EV+I+K L+HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYL----VLHGRMKEKEARAKFRQIVSAVQYCH 162
I+K ++ E + L +VMEYA GG++ + E++ F Q+ A++Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGSPPYAAPELFQGK 219
+KI+HRD+K +N+ L S +K+ DFG S + + +D T G+P Y +PEL Q K
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPELCQNK 178
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKK 278
Y+ D+WSLG +LY L + PF+G L EL ++L+G+Y IP S++ NL+
Sbjct: 179 PYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS 237
Query: 279 FLVLNPAKRASLE 291
L +P +R S+
Sbjct: 238 LLQKDPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 4e-78
Identities = 99/241 (41%), Positives = 132/241 (54%), Gaps = 35/241 (14%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
+G+G F V LA+ TGK+VAIKII K + + L++L RE+ I+K L+HPNIVKL+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK-EDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 114 IETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172
E E LYLVMEY GG + D L G++ E E QI+ ++Y H IIHRDLK
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 173 AENLLLDS-EMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWS 230
EN+LLDS +K+ADFG S T + L T G+P Y APE+ GK Y + D+WS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 231 LGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASL 290
LGVILY L + ++L++K L +P KR S
Sbjct: 180 LGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 291 E 291
+
Sbjct: 209 K 209
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 3e-69
Identities = 93/241 (38%), Positives = 144/241 (59%), Gaps = 4/241 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
++ +KT+G G+F +V L +H +GK A+KI+ K + + ++ + E RI++ + HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+V L+ + + LYLVMEY GGE+F +L GR E AR Q+V A++Y H I
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
++RDLK ENLLLDS+ IKI DFGF+ T CG+P Y APE+ K Y V
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYGKA-V 179
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286
D W+LG+++Y +++G PF ++ E++L GK R P + S D ++L++ L ++ K
Sbjct: 180 DWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTK 239
Query: 287 R 287
R
Sbjct: 240 R 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 7e-69
Identities = 98/265 (36%), Positives = 144/265 (54%), Gaps = 28/265 (10%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK---LFREVRIMKMLD- 103
+K K IG+G+F+ V LAK T KE AIKI+DK QL +K + E ++ L+
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNG 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
HP I+KL+ + E+ LY V+EYA GE+ Y+ +G + EK R +I+ A++Y H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFG---------------------FSNEFTPGNKLD 202
K IIHRDLK EN+LLD +M+IKI DFG S +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY 262
+F G+ Y +PEL K G D+W+LG I+Y +++G PF GS +++L+ +Y
Sbjct: 181 SFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 263 RIPFYMSTDCENLLKKFLVLNPAKR 287
P D ++L++K LVL+P R
Sbjct: 240 SFPPNFPPDAKDLIEKLLVLDPQDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 1e-65
Identities = 90/239 (37%), Positives = 136/239 (56%), Gaps = 6/239 (2%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-LFREVRIMKMLDHPNIVKLFQ 112
+G G F +V+L K + A+K + K + Q+ +F E I++ +HP IVKL++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 113 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172
+ +K +Y++MEY GGE++ L G E AR +V A +Y H + II+RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 173 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 232
ENLLLDS +K+ DFGF+ + G K TFCG+P Y APE+ K YD VD WSLG
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLG 179
Query: 233 VILYTLVSGSLPFDGSTLRELR--ERVLRGKYRI--PFYMSTDCENLLKKFLVLNPAKR 287
++LY L++G PF + +L+G ++ P Y+ ++L+K+ L NP +R
Sbjct: 180 ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 3e-63
Identities = 87/250 (34%), Positives = 137/250 (54%), Gaps = 9/250 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+++L+ IGKG F +V A+H TGKEVAIK+I +K+ E++I+K HPN
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE--KKEKIINEIQILKKCKHPN 58
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
IVK + + L++VME+ SGG + D L + + E + ++++ ++Y H
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
IIHRD+KA N+LL S+ +K+ DFG S + + +T G+P + APE+ GK YD
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK- 177
Query: 226 VDVWSLGVILYTLVSGSLPF-DGSTLRELRERVLRG---KYRIPFYMSTDCENLLKKFLV 281
D+WSLG+ L G P+ + ++ L ++ R P S + ++ LKK L
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKAL-FKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236
Query: 282 LNPAKRASLE 291
NP KR + E
Sbjct: 237 KNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 1e-62
Identities = 91/246 (36%), Positives = 129/246 (52%), Gaps = 13/246 (5%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQ 112
I KG + +V LAK TG AIK+I K + + ++ E I+ P +VKL+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 113 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172
+ +K LYLVMEY GG++ L G + E AR +IV A++Y H IIHRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 173 AENLLLDSEMNIKIADFGFS---------NEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+N+L+DS ++K+ DFG S N + G+P Y APE+ G+ +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP--FYMSTDCENLLKKFLV 281
VD WSLG ILY + G PF G T E+ + +L GK P +S + +L+ K LV
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 282 LNPAKR 287
+P KR
Sbjct: 240 PDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 7e-62
Identities = 84/258 (32%), Positives = 136/258 (52%), Gaps = 14/258 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y++L+TIGKG+F V+ + GK + K ID + Q+L EV I++ L HPN
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 107 IVKLFQ--VIETEKTLYLVMEYASGGE----VFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
IV+ + + + +TLY+VMEY GG+ + ++E+ Q++ A+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 161 CH-----QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPE 214
CH ++HRDLK N+ LD+ N+K+ DFG + + T+ G+P Y +PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCE 273
YD + D+WSLG ++Y L + S PF +L ++ GK+ RIP+ S++
Sbjct: 181 QLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239
Query: 274 NLLKKFLVLNPAKRASLE 291
++K L ++P KR S E
Sbjct: 240 EVIKSMLNVDPDKRPSTE 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-58
Identities = 80/252 (31%), Positives = 140/252 (55%), Gaps = 11/252 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
++ + +G+G+F V LA TG+ +A+K ++ + + L+ L RE+RI+ L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 107 IVKLF--QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
IV+ + + E + TL + +EY SGG + L G++ E R RQI+ + Y H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
I+HRD+K N+L+DS+ +K+ADFG + + G + G+P + APE+ +G++Y
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFD--GSTLRELRERVLRGKY--RIPFYMSTDCENLLK 277
G D+WSLG + + +G P+ G+ + L ++ IP ++S + ++ L+
Sbjct: 181 -GRAADIWSLGCTVIEMATGKPPWSELGNPMAAL-YKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 278 KFLVLNPAKRAS 289
K L +P KR +
Sbjct: 239 KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 4e-58
Identities = 98/254 (38%), Positives = 150/254 (59%), Gaps = 4/254 (1%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKML-DHPNIVK 109
K +GKG+F KV LA+ T + A+K++ K + ++ E R++ + HP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +T+ L+ VMEY +GG++ ++ GR E AR +IV +Q+ H++ II+R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK +N+LLDSE +IKIADFG E G TFCG+P Y APE+ + Y GP VD
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288
W+LGV+LY +++G PF+G EL + +L + R P ++S + +++LK FL NP KR
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
Query: 289 SLEVSGEVTLGGAP 302
+GE + G P
Sbjct: 240 GCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 6e-57
Identities = 84/241 (34%), Positives = 139/241 (57%), Gaps = 4/241 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
+ +KT+G G F +V L + + A+K++ + + Q + E R++K + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
I++LF ++ LY++MEY GGE+F YL GR +IV A++Y H K+I
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
++RDLK EN+LLD E +IK+ DFGF+ + ++ T CG+P Y APE+ Q K + V
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGH-NKAV 179
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286
D W+LG+++Y ++ G PF + E++L GK P ++ ++L+KK LV++ +
Sbjct: 180 DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTR 239
Query: 287 R 287
R
Sbjct: 240 R 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 1e-56
Identities = 81/244 (33%), Positives = 134/244 (54%), Gaps = 5/244 (2%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
++LL+ IGKG F KV + + T K A+K ++K + + GS++ + E RI++ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+V L+ + E+ +YLV++ GG++ +L + E++ + +IV A++Y H K I
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
IHRD+K +N+LLD + ++ I DF + + TP + G+P Y APE+ + Y V
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAV 180
Query: 227 DVWSLGVILYTLVSGSLPFDG--STLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVLN 283
D WSLGV Y + G P+ G T+R+ P ST+ + + K L +
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD 240
Query: 284 PAKR 287
P KR
Sbjct: 241 PQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 7e-56
Identities = 89/257 (34%), Positives = 139/257 (54%), Gaps = 23/257 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
YK L+ IG+G +V A TGKEVAIK + + N + + E+ IMK HPN
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN---KELIINEILIMKDCKHPN 76
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 165
IV + L++VMEY GG + D + + RM E + R+++ ++Y H +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGP 224
+IHRD+K++N+LL + ++K+ADFGF+ + T +K ++ G+P + APE+ + K Y P
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG-P 195
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI----------PFYMSTDCEN 274
+VD+WSLG++ + G P+ LRE LR + I P S + ++
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPY-------LREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248
Query: 275 LLKKFLVLNPAKRASLE 291
L K LV +P KR S E
Sbjct: 249 FLNKCLVKDPEKRPSAE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 9e-54
Identities = 96/272 (35%), Positives = 139/272 (51%), Gaps = 31/272 (11%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF-REVRIMKMLDHP 105
Y++L+ +G+G+F +V LA+ K VA+K++ K + + F RE++I+ L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 106 -NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYC 161
NIVKL+ + E +LYLVMEY GG + D L GR + E EA QI+SA++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 162 HQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGN-------KLDTFCGSPPYAAP 213
H K IIHRD+K EN+LLD + +K+ DFG + T G+P Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 214 ELFQGKK--YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY--------- 262
E+ G Y D+WSLG+ LY L++G PF+G + L+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 263 ----RIPFYMSTDCENLLKKFLVLNPAKRASL 290
P +S +LLKK L +P R S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 3e-53
Identities = 87/241 (36%), Positives = 142/241 (58%), Gaps = 4/241 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
+++ +T+G G+F +V++AKH TG+ AIK + K + L +Q + +E I+ L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV + + E +Y ++E+ GGE+F +L GR A+ ++V A +Y H K I
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
I+RDLK ENLLLD++ ++K+ DFGF+ + ++ T CG+P Y APE+ Q K + G V
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKGH-GKAV 196
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286
D W++GV+LY ++G PF T + E++L G+ + P + +L+K L + K
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTK 256
Query: 287 R 287
R
Sbjct: 257 R 257
|
Length = 329 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 2e-52
Identities = 80/254 (31%), Positives = 122/254 (48%), Gaps = 18/254 (7%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
L K +G+G F +V G EVA+K + K + +++ RE RIM+ LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKF-RQIVSAVQ 159
PNIVKL V E+ L +VMEY GG++ DYL + + + F QI ++
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDL---LSFALQIARGME 117
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYA--APELFQ 217
Y K IHRDL A N L+ + +KI+DFG S + + G P APE +
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENL 275
K+ + DVWS GV+L+ + + G P+ G + E+ E + +G P + L
Sbjct: 178 EGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKL 236
Query: 276 LKKFLVLNPAKRAS 289
+ + +P R +
Sbjct: 237 MLQCWAEDPEDRPT 250
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 4e-52
Identities = 80/253 (31%), Positives = 123/253 (48%), Gaps = 17/253 (6%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
L K +G+G F +V K G EVA+K + K + +++ RE RIM+ LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKF-RQIVSAVQY 160
PN+VKL V E+ LY+VMEY GG++ YL + + + F QI ++Y
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDL---LSFALQIARGMEY 117
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYA--APELFQG 218
K IHRDL A N L+ + +KI+DFG S + + G P APE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 219 KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLL 276
K+ + DVWS GV+L+ + + G P+ G + E+ E + G P + +L+
Sbjct: 178 GKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLM 236
Query: 277 KKFLVLNPAKRAS 289
+ +P R +
Sbjct: 237 LQCWAEDPEDRPT 249
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 4e-51
Identities = 88/282 (31%), Positives = 132/282 (46%), Gaps = 50/282 (17%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG----SLQKLFREVRIMKMLD 103
Y+ L+ +G+G + V A+ TG+ VA+K I G +L RE+ ++K L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELK 56
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAVQ 159
HPNIVKL VI TE+ LYLV EY D YL G + ++ Q++ +
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQG 218
YCH +I+HRDLK +N+L++ + +K+ADFG + F P + Y APE+ G
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG 172
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL-------------RERVLRGKYRIP 265
K+ VD+WS+G I +++G F G + E+ E G ++P
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKIFQILGTPTEESWPGVTKLP 230
Query: 266 FY------------------MSTDCENLLKKFLVLNPAKRAS 289
Y + + +LL K L NPAKR S
Sbjct: 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 9e-51
Identities = 59/112 (52%), Positives = 79/112 (70%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+++L+ V E E LYLVMEY GG++FD L GR+ E EAR RQI+SA++Y H K I
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
+HRDLK EN+LLD + ++K+ADFG + + PG KL TF G+P Y APE+ G
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 93/252 (36%), Positives = 143/252 (56%), Gaps = 9/252 (3%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKML-DHPNIVK 109
+ +GKG+F KV LA+ +G+ A+K++ K L ++ E RI+ + +HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L+ +T L+ VME+ +GG++ ++ R E AR +I SA+ + H K II+R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK +N+LLD E + K+ADFG E G TFCG+P Y APE+ Q Y GP VD
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288
W++GV+LY ++ G PF+ +L E +L + P ++S D ++LK F+ NP R
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
Query: 289 SLEVSGEVTLGG 300
G +TLGG
Sbjct: 240 -----GSLTLGG 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 3e-50
Identities = 95/253 (37%), Positives = 135/253 (53%), Gaps = 13/253 (5%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKL 110
K +GKG F KV L + TGK A+KI+ K + + E R+++ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+T L VMEYA+GGE+F +L E AR +IVSA+ Y H +++RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 171 LKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVW 229
LK ENL+LD + +IKI DFG E + G + TFCG+P Y APE+ + Y G VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 230 SLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
LGV++Y ++ G LPF +L E +L + R P +S + ++LL L +P +R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR-- 237
Query: 290 LEVSGEVTLGGAP 302
LGG P
Sbjct: 238 --------LGGGP 242
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 6e-50
Identities = 90/248 (36%), Positives = 142/248 (57%), Gaps = 13/248 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLD--- 103
++ L +G+G+F KV LA++ TG+ AIK + K + ++ L E RI + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE-KEARAKF--RQIVSAVQY 160
HP +V LF +TE + VMEYA+GG+ L++H E RA F +V +QY
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGD----LMMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGK 219
H+ KI++RDLK +NLLLD+E +KIADFG E G++ TFCG+P + APE+
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF 279
Y VD W LGV++Y ++ G PF G E+ + ++ + R P ++S + +++++
Sbjct: 177 SY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRL 235
Query: 280 LVLNPAKR 287
L NP +R
Sbjct: 236 LRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 3e-49
Identities = 88/241 (36%), Positives = 138/241 (57%), Gaps = 8/241 (3%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKM-LDHPNIVK 109
K +GKG+F KV LA+ T + AIK++ K L + E RI+ + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKII 167
L +T+ L+ VMEY +GG++ + + R K E R++F ++ A+ + H+ +I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLM-FQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
+RDLK +N+LLD+E + K+ADFG E G TFCG+P Y APE+ Q +Y GP V
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286
D W+LGV++Y +++G PF+ +L E +L P ++S + ++LK F+ NP K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 287 R 287
R
Sbjct: 238 R 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 3e-49
Identities = 85/288 (29%), Positives = 138/288 (47%), Gaps = 57/288 (19%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y+ + IG+G + +V A++ TG+ VA+K I G RE+++++ L HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 108 VKLFQVI--ETEKTLYLVMEYASGGEVFDY--LVLHGRMKEKEARAK--FRQIVSAVQYC 161
V+L +++ + + ++Y+V EY D L+ +K E++ K +Q++ +QY
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD------TFCGSPPYAAPEL 215
H I+HRD+K N+L++++ +K+ADFG + +T N D T Y PEL
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW----YRPPEL 172
Query: 216 FQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGST------------------------- 249
G +Y GPEVD+WS+G IL L G F GST
Sbjct: 173 LLGATRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 250 --------LRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
++ +R LR ++ + +LL K L L+P KR S
Sbjct: 232 LPWFENLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-49
Identities = 87/248 (35%), Positives = 135/248 (54%), Gaps = 5/248 (2%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY+ ++ +G+G F V L + K V IK I Q+ E +++K+L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQK 164
I++ ++ +K L +VMEYA GG + +Y+ + E F QI+ A+ + H K
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 165 KIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
I+HRDLK +N+LLD +M +KI DFG S + +K T G+P Y +PEL +GK Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN- 179
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVL 282
+ D+W+LG +LY L S F+ + L L +++ G + I S D L+ L L
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 283 NPAKRASL 290
+P+KR L
Sbjct: 240 DPSKRPQL 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 4e-48
Identities = 95/248 (38%), Positives = 145/248 (58%), Gaps = 6/248 (2%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKM-LDHPNIVK 109
K +GKG+F KV LA+ T + AIK + K L ++ E R++ + +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
LF +T++ L+ VMEY +GG++ ++ GR E AR +I+ +Q+ H+K II+R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK +N+LLD + +IKIADFG E G K TFCG+P Y APE+ +G+KY+ VD
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE-SVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288
WS GV+LY ++ G PF G EL + +L + P ++S + ++ L K +P KR
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR- 238
Query: 289 SLEVSGEV 296
L V G++
Sbjct: 239 -LGVDGDI 245
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 6e-48
Identities = 80/247 (32%), Positives = 136/247 (55%), Gaps = 7/247 (2%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
+K+LK +GKG++ V K + + A+K +D ++ + E+RI+ ++HPNI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQYCHQ 163
+ + L +VMEYA G++ + + + E+E F Q++ +Q H+
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+KI+HRDLK+ N+LL + +KI D G S N T G+P Y APE+++G+ Y
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVL 282
D+WSLG +LY + + + PF+ ++++LR +V RGKY IP S D +N ++ L +
Sbjct: 181 KS-DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV 239
Query: 283 NPAKRAS 289
P R +
Sbjct: 240 KPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 6e-47
Identities = 76/253 (30%), Positives = 122/253 (48%), Gaps = 20/253 (7%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+L K +G+G F +V G+ +VA+K + K + ++ E IMK L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSH 60
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKF-RQIVSAVQY 160
PNIV+L V + LY+V EY GG++ D+L HG +K+ + QI ++Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL---LQMALQIAKGMEY 117
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSP-PYAAPELFQ 217
K +HRDL A N L+ + +KI+DFG S + + + P + APE +
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCEN 274
K+ + DVWS GV+L+ + + G P+ G + E+ E + G YR P +
Sbjct: 178 DGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-YRLPRPENCPDELYE 235
Query: 275 LLKKFLVLNPAKR 287
L+ + +P R
Sbjct: 236 LMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 88/264 (33%), Positives = 139/264 (52%), Gaps = 35/264 (13%)
Query: 48 YKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
++LL+ +G G + KV L + V GK A+K++ K + +QK K +H
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQK-------AKTAEH 50
Query: 105 --------------PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK 150
P +V L +T+ L+L+++Y +GGE+F +L E E R
Sbjct: 51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 151 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSP 208
+IV A+ + HQ II+RD+K EN+LLDSE ++ + DFG S EF + +FCG+
Sbjct: 111 IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 209 PYAAPELFQGKKYD-GPEVDVWSLGVILYTLVSGSLPF--DG--STLRELRERVLRGKYR 263
Y APE+ +G VD WSLGV+ + L++G+ PF DG ++ E+ R+L+ K
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230
Query: 264 IPFYMSTDCENLLKKFLVLNPAKR 287
P MS + + ++K L +P KR
Sbjct: 231 FPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y+ L IG+G + V A+ TG+ VAIK I + G + RE++++K L+HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK---EKEARAKFRQIVSAVQYCHQK 164
+KL V + LYLV E+ + Y ++ R + E ++ Q++ + +CH
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQGKKYDG 223
I+HRDLK ENLL+++E +K+ADFG + F + T + + Y APEL G K
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGS-----------TLRELRERVLRG--------KYRI 264
VD+WS+G I L+S F G TL V K+
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 265 PFY-----------MSTDCENLLKKFLVLNPAKRASLE 291
P S +LL + L +P KR + E
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE 275
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 76/257 (29%), Positives = 122/257 (47%), Gaps = 23/257 (8%)
Query: 52 KTIGKGNFAKVKLAK---HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
K +G+G F +V K EVA+K + K + + +E R+MK L HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIVSAVQ 159
+L V E+ LYLV+EY GG++ DYL + ++ QI ++
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP----YAAPEL 215
Y KK +HRDL A N L+ ++ +KI+DFG S + + APE
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLS-RDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPF--YMSTDC 272
+ + + DVWS GV+L+ + + G+ P+ G + E+ E + +G YR+P Y +
Sbjct: 179 LKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPDEL 236
Query: 273 ENLLKKFLVLNPAKRAS 289
L+ L+P R +
Sbjct: 237 YELMLSCWQLDPEDRPT 253
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 7e-46
Identities = 81/249 (32%), Positives = 130/249 (52%), Gaps = 14/249 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
+ +L+ +G+G++ V A H TG+ VAIK++ LQ++ +E+ I+K D P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYI 60
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKI 166
VK + L++VMEY G V D + + + + E+E A Q + ++Y H K
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK 120
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+KA N+LL+ E K+ADFG S + T K +T G+P + APE+ Q Y+ +
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN-K 179
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-----KYRIPFYMSTDCENLLKKFL 280
D+WSLG+ + G P+ S + +R + P S + + +KK L
Sbjct: 180 ADIWSLGITAIEMAEGKPPY--SDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237
Query: 281 VLNPAKRAS 289
V +P +R S
Sbjct: 238 VKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 9e-46
Identities = 93/253 (36%), Positives = 137/253 (54%), Gaps = 13/253 (5%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
K +GKG F KV L + TG+ A+KI+ K + + E R+++ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+T L VMEYA+GGE+F +L E+ AR +IVSA++Y H + +++RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 171 LKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVW 229
+K ENL+LD + +IKI DFG E + G + TFCG+P Y APE+ + Y G VD W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 230 SLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
LGV++Y ++ G LPF L E +L + R P +S + ++LL L +P +R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR-- 237
Query: 290 LEVSGEVTLGGAP 302
LGG P
Sbjct: 238 --------LGGGP 242
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 44/272 (16%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK----LFREVR-IMKML 102
++++K IG+G F +V L + TG+ A+K++ K+ + +++ R R I+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM----IKRNQIAHVRAERDILADA 58
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
D P IVKL+ + E+ LYLVMEY GG++ + L+ E+ AR ++V A+ H
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFS--------------------------NEFT 196
+ IHRD+K +N+L+D++ +IK+ADFG
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 197 PGNKLDTFC----GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE 252
+ G+P Y APE+ +G Y G E D WSLGVILY ++ G PF TL+E
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
Query: 253 LRERVLRGK--YRIPFY--MSTDCENLLKKFL 280
+++ K R P +S + +L+ + L
Sbjct: 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLL 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 90/239 (37%), Positives = 129/239 (53%), Gaps = 4/239 (1%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR--IMKMLDHPNIVK 109
K IGKG+F KV LAKH GK A+K++ K + QK R ++K + HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +T LY V++Y +GGE+F +L E AR +I SA+ Y H II+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK EN+LLDS+ ++ + DFG E +K TFCG+P Y APE+ + + YD VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
W LG +LY ++ G PF E+ + +L R+ +S +LL+ L + KR
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 89/251 (35%), Positives = 136/251 (54%), Gaps = 4/251 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKMLDHPN 106
+ L +GKG+F KV LA+ T + AIKI+ K + ++ E R++ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 107 -IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
+ +L +T LY VMEY +GG++ ++ G+ KE A +I + + H K
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
II+RDLK +N++LD+E +IKIADFG E G TFCG+P Y APE+ + Y G
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GK 180
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284
VD W+ GV+LY +++G PFDG EL + ++ P +S + ++ K L +P
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240
Query: 285 AKRASLEVSGE 295
AKR +GE
Sbjct: 241 AKRLGCGPTGE 251
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 96/253 (37%), Positives = 134/253 (52%), Gaps = 13/253 (5%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
K +GKG F KV L + +GK A+KI+ K + + E R++K HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+T+ L VMEY +GGE+F +L E R +IVSA+ Y H KI++RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 171 LKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVW 229
LK ENL+LD + +IKI DFG E T + TFCG+P Y APE+ + Y G VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 230 SLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
LGV++Y ++ G LPF +L E +L + P +S D ++LL L+ +P KR
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR-- 237
Query: 290 LEVSGEVTLGGAP 302
LGG P
Sbjct: 238 --------LGGGP 242
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-45
Identities = 79/250 (31%), Positives = 122/250 (48%), Gaps = 13/250 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+ +K +G+G+ V +H PTGK A+K I + ++L RE++ ++ + P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KII 167
K + E + +V+EY GG + D L G++ E RQI+ + Y H K II
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQGKKYDGPEV 226
HRD+K NLL++S+ +KIADFG S +TF G+ Y +PE QG+ Y
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA- 181
Query: 227 DVWSLGVILYTLVSGSLPF---DGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF---- 279
D+WSLG+ L G PF + EL + + G P + + + F
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPEFRDFISAC 239
Query: 280 LVLNPAKRAS 289
L +P KR S
Sbjct: 240 LQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 7e-45
Identities = 73/247 (29%), Positives = 126/247 (51%), Gaps = 7/247 (2%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y+L IG+G F V ++ TG VAIK I ++ +L+ + +E+ ++K L HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IVK IET +LY+++EYA G + + G E Q++ + Y H++ +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+KA N+L + +K+ADFG + + + G+P + APE+ + G
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM---SGAS 177
Query: 226 V--DVWSLGVILYTLVSGSLP-FDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVL 282
D+WSLG + L++G+ P +D + + L V +P +S + ++ L +
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237
Query: 283 NPAKRAS 289
+P R +
Sbjct: 238 DPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 90/243 (37%), Positives = 138/243 (56%), Gaps = 7/243 (2%)
Query: 51 LKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKMLDHP 105
LK +GKG + KV + V TGK A+K++ K + N E I++ + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
IV L +T LYL++EY SGGE+F +L G E A +I A+++ HQ+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
II+RDLK EN+LLD++ ++K+ DFG E G TFCG+ Y APE+ + G
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM-RSGHGK 179
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284
VD WSLG ++Y +++G+ PF ++ +++L+GK +P Y++ + +LLKK L NP
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239
Query: 285 AKR 287
+ R
Sbjct: 240 SSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 5e-44
Identities = 83/253 (32%), Positives = 143/253 (56%), Gaps = 23/253 (9%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG-------SLQKLFREVRIMKMLDH 104
+ IG+G++AKV L + T + A+K+I K +N + + +F +H
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NH 55
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
P +V L +TE L+ V+E+ SGG++ ++ ++ E+ AR +I A+ + H++
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
II+RDLK +N+LLD+E +IK+ D+G E PG+ TFCG+P Y APE+ +G+ Y G
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-G 174
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRER---------VLRGKYRIPFYMSTDCEN 274
VD W+LGV+++ +++G PFD + + ++ +L + RIP +S +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234
Query: 275 LLKKFLVLNPAKR 287
+LK FL +P +R
Sbjct: 235 VLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 74/244 (30%), Positives = 127/244 (52%), Gaps = 5/244 (2%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
+++L IGKG+F V + A+K ID +++N ++ E R++ LD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKK 165
++ ++ + L +VMEYA G++ L + + E + F QI+ + + H KK
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQGKKYDGP 224
I+HRD+K+ NL LD+ N+KI D G + + +T G+P Y +PEL + K Y+
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN-E 180
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVLN 283
+ DVW+LGV+LY +G PFD + L +++RG + + S L+ + L +
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 284 PAKR 287
+R
Sbjct: 241 YRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 8e-44
Identities = 87/248 (35%), Positives = 140/248 (56%), Gaps = 6/248 (2%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKML-DHPNIVK 109
K +GKG+F KV LA+ T + AIK + K L ++ E R++ + +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L+ +T++ L+ VMEY +GG++ ++ + A +I+ +Q+ H K I++R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK +N+LLD++ +IKIADFG E G+ K TFCG+P Y APE+ G+KY VD
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288
WS GV+LY ++ G PF G EL + + P +++ + +++L K V P +R
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR- 238
Query: 289 SLEVSGEV 296
L V G++
Sbjct: 239 -LGVKGDI 245
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 84/282 (29%), Positives = 124/282 (43%), Gaps = 46/282 (16%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+YK+L IG+G V AK TG+ VA+K + +L G + RE++ ++ HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK-------EKEARAKFRQIVSAVQ 159
+VKL V LVMEY L ++ E + ++ R ++ V
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSD-------LSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTF-CGSPPYAAPELFQ 217
Y H I+HRDLK NLL+ ++ +KIADFG + F +L + + Y APEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR------------------ 259
G + P VD+W++G I L++GS F G E V R
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233
Query: 260 -GKYRIP----------FYMSTDCE-NLLKKFLVLNPAKRAS 289
K P F ++ +LLK LV +P+KR S
Sbjct: 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 83/223 (37%), Positives = 115/223 (51%), Gaps = 16/223 (7%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-------I 98
+++L +G+G + +V LAK TG+ VA+K + K+ L KL EVR I
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKS-----LLFKL-NEVRHVLTERDI 54
Query: 99 MKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
+ +VKL + ++ LYL MEY GG+ L G + E AR ++ AV
Sbjct: 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
H+ IHRDLK EN L+D+ +IK+ DFG S ++ GSP Y APE+ +G
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG 172
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK 261
K YD VD WSLG +LY + G PF GST E E + K
Sbjct: 173 KGYDF-TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK 214
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 52/127 (40%), Positives = 70/127 (55%), Gaps = 1/127 (0%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
+++L E + LYLVMEY GG++FDYL G + E EA+ QI+ ++
Sbjct: 53 RRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLE 112
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQG 585
Y H IIHRDLK EN+LLD +KIADFG + + + L TF G+P Y APE+ G
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172
Query: 586 GAPVTSS 592
G
Sbjct: 173 GNGYGPK 179
|
Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 96/254 (37%), Positives = 136/254 (53%), Gaps = 14/254 (5%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKL 110
K +GKG F KV L K TG+ A+KI+ K + + E R+++ HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH-QKKIIHR 169
+T L VMEYA+GGE+F +L E AR +IVSA+ Y H +K +++R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK ENL+LD + +IKI DFG E G + TFCG+P Y APE+ + Y G VD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288
W LGV++Y ++ G LPF +L E +L + R P +S + ++LL L +P +R
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR- 238
Query: 289 SLEVSGEVTLGGAP 302
LGG P
Sbjct: 239 ---------LGGGP 243
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 88/250 (35%), Positives = 140/250 (56%), Gaps = 6/250 (2%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKML-DHPNIVK 109
K +GKG+F KV LA+ G+ A+K + K L ++ E R++ + ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L+ +T++ L+ VME+ +GG++ ++ GR A +IV +Q+ H K II+R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK +N++LD + +IKIADFG E G N+ TFCG+P Y APE+ QG KY VD
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF-SVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288
WS GV+LY ++ G PF G EL E + P +++ + +++L+K +P +R
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR- 238
Query: 289 SLEVSGEVTL 298
L V G +
Sbjct: 239 -LGVVGNIRG 247
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 88/251 (35%), Positives = 138/251 (54%), Gaps = 4/251 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKMLDHPN 106
+ L +GKG+F KV LA+ T + AIKI+ K + ++ E R++ + D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 107 -IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
+ +L +T LY VMEY +GG++ ++ G+ KE +A +I + + H++
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
II+RDLK +N++LDSE +IKIADFG E G TFCG+P Y APE+ + Y G
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GK 180
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284
VD W+ GV+LY +++G PFDG EL + ++ P +S + ++ K + +P
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240
Query: 285 AKRASLEVSGE 295
+KR GE
Sbjct: 241 SKRLGCGPEGE 251
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 81/250 (32%), Positives = 126/250 (50%), Gaps = 14/250 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS--LQKLFREVRIMKMLDH 104
+ LL+ IGKG+F +V A T + VAIK+ID L ++ + +E++ +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
P I K + L+++MEY GG D L+ G++ E R+++ ++Y H++
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGKKYDG 223
IHRD+KA N+LL E ++K+ADFG S + T +K +TF G+P + APE+ + YD
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF---- 279
+ D+WSLG+ L G P S L +R L K P K F
Sbjct: 178 -KADIWSLGITAIELAKGEPPL--SDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234
Query: 280 LVLNPAKRAS 289
L +P +R S
Sbjct: 235 LNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 83/252 (32%), Positives = 128/252 (50%), Gaps = 10/252 (3%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIV 108
LK I KG F V LAK TG AIK++ K+ + + + E IM + + P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 168
KL+ +++ LYLVMEY +GG+ + G + E A+ ++V V+ HQ+ IIH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 169 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
RD+K ENLL+D ++K+ DFG S G + F G+P Y APE G D D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG-DDKMSDW 176
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENLLKKFLVLNP 284
WSLG +++ + G PF T + + +L + P + S + +L+ + L ++P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 285 AKRASLEVSGEV 296
AKR E+
Sbjct: 237 AKRLGANGYQEI 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 9e-42
Identities = 80/266 (30%), Positives = 139/266 (52%), Gaps = 35/266 (13%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+++ IG G F KV A ++ TG+ +A+K I +P +++++ E++++++L HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 107 IVKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQK 164
+VK + V + EK +Y+ MEY SGG + + L+ HGR + E R Q++ + Y H
Sbjct: 61 LVKYYGVEVHREK-VYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTPGNKLDTFCGSPPYAAPELFQGK 219
I+HRD+K N+ LD IK+ DFG + N T G ++ + G+P Y APE+ G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 220 KYDGPE--VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY---------- 267
K G D+WSLG ++ + +G P+ L +++I F+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSE----------LDNEFQIMFHVGAGHKPPIP 228
Query: 268 ----MSTDCENLLKKFLVLNPAKRAS 289
+S + ++ L + L +P KR +
Sbjct: 229 DSLQLSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 91/264 (34%), Positives = 150/264 (56%), Gaps = 14/264 (5%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMKML-DHPNIVK 109
+ IG+G++AKV L + T + A+K++ K +N + + E + + +HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +TE L+ V+EY +GG++ ++ ++ E+ AR +I A+ Y H++ II+R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK +N+LLDSE +IK+ D+G E PG+ TFCG+P Y APE+ +G+ Y G VD
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 229 WSLGVILYTLVSGSLPFD--GS-------TLRELRERVLRGKYRIPFYMSTDCENLLKKF 279
W+LGV+++ +++G PFD GS T L + +L + RIP +S ++LK F
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239
Query: 280 LVLNPAKR-ASLEVSGEVTLGGAP 302
L +P +R +G + G P
Sbjct: 240 LNKDPKERLGCHPQTGFADIQGHP 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 93/269 (34%), Positives = 147/269 (54%), Gaps = 16/269 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD 103
++LLK +G G + KV L + V TGK A+K++ K L + R R +L+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTER--NVLE 59
Query: 104 H----PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 159
H P +V L +TE L+L+++Y SGGE+F +L E E R +I+ A++
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQ 217
+ H+ I++RD+K EN+LLDSE ++ + DFG S EF K T FCG+ Y APE+ +
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPF----DGSTLRELRERVLRGKYRIPFYMSTDCE 273
GK G VD WSLG++++ L++G+ PF + +T E+ R+L+ P ++ + +
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239
Query: 274 NLLKKFLVLNPAKRASLEVSGEVTLGGAP 302
+LL K L +P KR G + P
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHP 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 89/251 (35%), Positives = 132/251 (52%), Gaps = 4/251 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKMLDHPN 106
+ L +GKG+F KV LA+ T + AIKI+ K + ++ E R++ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 107 -IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
+ +L +T LY VMEY +GG++ + GR KE A +I + + H K
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
II+RDLK +N++LDSE +IKIADFG E G TFCG+P Y APE+ + Y G
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GK 180
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284
VD W+ GV+LY +++G PF+G EL + ++ P MS + + K + +P
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240
Query: 285 AKRASLEVSGE 295
KR GE
Sbjct: 241 GKRLGCGPEGE 251
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 46/282 (16%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIK---IIDKTQLNPGSLQKLFREVRIMKMLD 103
+Y+ K +G+G +A V A+ TG+ VAIK + ++ + G RE+++++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-------AKFRQIVS 156
HPNI+ L V + + LV E+ D L +K+K + +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET----D---LEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPEL 215
++Y H I+HRDLK NLL+ S+ +K+ADFG + F +P K+ + Y APEL
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELR----------ERVLRGKYRI 264
G ++ G VD+WS+G I L+ G + + +L E G +
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233
Query: 265 PFYM-----------------STDCENLLKKFLVLNPAKRAS 289
P Y+ S D +LL++ L LNP KR +
Sbjct: 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 81/244 (33%), Positives = 138/244 (56%), Gaps = 16/244 (6%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
IG+G+ V +A TG++VA+K +D + L LF EV IM+ HPNIV+++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMYSS 84
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 173
L++VME+ GG + D +V H RM E++ ++ A+ + H + +IHRD+K+
Sbjct: 85 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 174 ENLLLDSEMNIKIADFGFSNEFT---PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWS 230
+++LL S+ +K++DFGF + + P K + G+P + APE+ Y G EVD+WS
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEVISRLPY-GTEVDIWS 200
Query: 231 LGVILYTLVSGSLP-FDGSTLRELRERVLRG----KYRIPFYMSTDCENLLKKFLVLNPA 285
LG+++ +V G P F+ L+ ++ +R K + +S + L + LV +PA
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKR--IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA 258
Query: 286 KRAS 289
+RA+
Sbjct: 259 QRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 3e-40
Identities = 83/232 (35%), Positives = 123/232 (53%), Gaps = 4/232 (1%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR--IMKMLDHPNIVK 109
K IGKG+F KV LAK G A+K++ K + Q R ++K L HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +T + LY V++Y +GGE+F +L E AR ++ SA+ Y H II+R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK EN+LLDS+ ++ + DFG E P TFCG+P Y APE+ + + YD VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
W LG +LY ++ G PF + ++ + +L ++P + +LL L
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 79/249 (31%), Positives = 138/249 (55%), Gaps = 6/249 (2%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+++K IG+G+F K+ LAK + IK ID T++ + +EV ++ + HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRM-KEKEARAKFRQIVSAVQYCHQK 164
IV F + L++VMEY GG++ + G + E + + F QI +++ H +
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 165 KIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFC-GSPPYAAPELFQGKKYD 222
KI+HRD+K++N+ L M K+ DFG + + +L C G+P Y +PE+ Q + Y+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLV 281
+ D+WSLG +LY L + PF+G+ L +L ++ +G + I S D +L+ +
Sbjct: 181 N-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239
Query: 282 LNPAKRASL 290
++P R S+
Sbjct: 240 VSPRDRPSI 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 6e-40
Identities = 84/275 (30%), Positives = 142/275 (51%), Gaps = 36/275 (13%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMKMLDHPN 106
+K +K +GKG+ +V L + TGK A+K++DK ++ + ++++ E I+ LDHP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQK 164
+ L+ +TE L LVM+Y GGE+F L + E+ AR +++ A++Y H
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS---NEFT------------------------- 196
I++RDLK EN+LL +I ++DF S +
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 197 --PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR 254
P + ++F G+ Y APE+ G + G VD W+LG++LY ++ G+ PF GS E
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241
Query: 255 ERVLRGKYRIPFY--MSTDCENLLKKFLVLNPAKR 287
+L+ + P +S+ +L++K LV +P+KR
Sbjct: 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 6e-40
Identities = 79/251 (31%), Positives = 139/251 (55%), Gaps = 11/251 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY +K IG+G+F K L K GK+ IK I+ ++++P ++ +EV ++ + HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYL-----VLHGRMKEKEARAKFRQIVSAVQYC 161
IV+ + E LY+VM+Y GG+++ + VL E + F QI A+++
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL---FPEDQILDWFVQICLALKHV 117
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC-GSPPYAAPELFQGKK 220
H +KI+HRD+K++N+ L + IK+ DFG + +L C G+P Y +PE+ + +
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKF 279
Y+ + D+W+LG +LY + + F+ ++ L +++RG Y + + S D NL+ +
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 280 LVLNPAKRASL 290
NP R S+
Sbjct: 237 FKRNPRDRPSV 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 6e-40
Identities = 81/258 (31%), Positives = 133/258 (51%), Gaps = 20/258 (7%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS---LQKLFREVRIMKMLDH 104
++ K +G+G F +V L V TG+E+A+K + +P + + L E++++K L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
IV+ + + ++TL + MEY GG V D L +G + E R RQI+ V+Y H
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEF----TPGNKLDTFCGSPPYAAPELFQGKK 220
I+HRD+K N+L DS N+K+ DFG S + G + + G+P + +PE+ G+
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-------YRIPFYMSTDCE 273
Y G + DVWS+G + +++ P+ E K ++P ++S D
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWA-----EFEAMAAIFKIATQPTNPQLPSHVSPDAR 237
Query: 274 NLLKKFLVLNPAKRASLE 291
N L++ V N KR S E
Sbjct: 238 NFLRRTFVENAKKRPSAE 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 52/122 (42%), Positives = 68/122 (55%), Gaps = 3/122 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQKK 532
++KL+ V E E LYLVMEY GG + D L G++ E E QI+ ++Y H
Sbjct: 53 IVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 533 IIHRDLKAENLLLDS-EMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVT 590
IIHRDLK EN+LLDS +K+ADFG S T + L T G+P Y APE+ G +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 591 SS 592
Sbjct: 173 EK 174
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 82/241 (34%), Positives = 134/241 (55%), Gaps = 5/241 (2%)
Query: 51 LKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
LK +G+G+F KV L + + G+ A+K++ K L + E I+ ++HP I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 167
VKL +TE LYL++++ GG++F L E++ + ++ A+ + H II
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEV 226
+RDLK EN+LLD E +IK+ DFG S E K +FCG+ Y APE+ + +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSA 179
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286
D WS GV+++ +++GSLPF G +E +L+ K +P ++S + ++LL+ NPA
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239
Query: 287 R 287
R
Sbjct: 240 R 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 79/252 (31%), Positives = 123/252 (48%), Gaps = 16/252 (6%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQK-LFREVRIMKMLDHPNIV 108
L +G GN V H PTGK +A+K I +L +QK + RE+ I+ + P IV
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQK-KI 166
+ + + MEY GG + L + GR+ E+ ++ + Y H+K KI
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
IHRD+K N+L++S IK+ DFG S + + TF G+ Y APE QG Y +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY-SVKS 180
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLR-----ELRERVLRGKY-RIPFYM-STDCENLLKKF 279
D+WSLG+ L L +G P+ EL + ++ R+P S D ++ +
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240
Query: 280 LVLNPAKRASLE 291
L+ +P +R S +
Sbjct: 241 LIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 82/268 (30%), Positives = 128/268 (47%), Gaps = 35/268 (13%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y+L++ IG G A V A +P ++VAIK ID + S+ +L +EV+ M +HPN+
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNV 61
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFD---YLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
VK + L+LVM Y SGG + D G + E ++++ ++Y H
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-NEFTPGN----KLDTFCGSPPYAAPE-LFQG 218
IHRD+KA N+LL + ++KIADFG S + G+ TF G+P + APE + Q
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPF---------------DGSTLRELRERVLRGKYR 263
YD + D+WS G+ L +G+ P+ D +L + KY
Sbjct: 182 HGYDF-KADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD---YKKYS 237
Query: 264 IPFYMSTDCENLLKKFLVLNPAKRASLE 291
F ++ L +P+KR + E
Sbjct: 238 KSF------RKMISLCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 16/254 (6%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS--LQKLFREVRIMKMLDH- 104
Y+ L+ IG+G + V KHVPTG+ VA+KII+ L+ + + REV ++ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQS 59
Query: 105 --PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
PNI K + L+++MEYA GG V L+ G + EK R+++ A++Y H
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKY 221
+ +IHRD+KA N+L+ + N+K+ DFG + + K TF G+P + APE+ KY
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281
+ D+WSLG+ +Y + +G+ P+ S + R +L K + P LL++F+
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236
Query: 282 L----NPAKRASLE 291
P +R S E
Sbjct: 237 ACLDEEPKERLSAE 250
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 78/246 (31%), Positives = 130/246 (52%), Gaps = 5/246 (2%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y ++ +GKG F + L + V K ++ T+L+ + E+ I+ +L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKK 165
+ + + TL + MEYA+GG ++D +V +E+ QIVSAV Y H+
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
I+HRD+K N+ L IK+ DFG S + + +T G+P Y +PEL QG KY+
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF- 180
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVLN 283
+ D+W+LG +LY L++ FD + L ++++G Y + S++ +L+ L +
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240
Query: 284 PAKRAS 289
P KR +
Sbjct: 241 PEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 2e-38
Identities = 80/251 (31%), Positives = 144/251 (57%), Gaps = 11/251 (4%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMKMLD-HPNIVK 109
+ IG+G++AKV L + + A+K++ K ++ + + E + + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +T L+LV+EY +GG++ ++ ++ E+ AR +I A+ + H++ II+R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK +N+LLD++ +IK+ D+G E PG+ TFCG+P Y APE+ +G++Y G VD
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179
Query: 229 WSLGVILYTLVSGSLPF-------DGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281
W+LGV+++ +++G PF D +T L + +L RIP ++S ++LK FL
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239
Query: 282 LNPAKRASLEV 292
+P +R +
Sbjct: 240 KDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 84/258 (32%), Positives = 133/258 (51%), Gaps = 23/258 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG-SLQKLFREVRIMKMLDHP 105
Y+L++ IG G + V A+ + TG+ VAIK+I +L PG + + +E+ ++K HP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
NIV F L++VMEY GG + D Y V G + E + R+ + + Y H+
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKK--- 220
IHRD+K N+LL + ++K+ADFG S + T K +F G+P + APE+ ++
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 221 YDGPEVDVWSLGVILYTLVSGSLP-FDGSTLREL----RERV----LRGKYRIPFYMSTD 271
YDG + D+W+LG+ L P FD +R L + L+ K + S
Sbjct: 181 YDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK----WSPV 235
Query: 272 CENLLKKFLVLNPAKRAS 289
+ +KK L +P KR +
Sbjct: 236 FHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 4e-38
Identities = 78/247 (31%), Positives = 141/247 (57%), Gaps = 6/247 (2%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y +L+ +G+G+F + L +HV + ++ A+K I + + +++ +E ++ + HPN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRM-KEKEARAKFRQIVSAVQYCHQK 164
IV + E + LY+VMEY GG++ + L G++ E F Q+ VQ+ H+K
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGKKYDG 223
+++HRD+K++N+ L +K+ DFG + T PG T+ G+P Y PE+++ Y+
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVL 282
+ D+WSLG ILY L + PF ++ + L +V +G Y+ +P + S + +L+K+
Sbjct: 180 -KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238
Query: 283 NPAKRAS 289
NP R S
Sbjct: 239 NPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 5e-38
Identities = 84/239 (35%), Positives = 125/239 (52%), Gaps = 4/239 (1%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR--IMKMLDHPNIVK 109
K IGKG+F KV LA+H K A+K++ K + +K R ++K + HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +T LY V++Y +GGE+F +L E AR +I SA+ Y H I++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK EN+LLDS+ +I + DFG E TFCG+P Y APE+ + YD VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
W LG +LY ++ G PF E+ + +L ++ ++ +LL+ L + KR
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 81/240 (33%), Positives = 126/240 (52%), Gaps = 6/240 (2%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMK---MLDHPNIVK 109
IGKG F +V + T + A+K++ K ++ + E I+ + + P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +T+ LYLV +Y SGGE+F +L GR E A+ ++V A+++ H+ I++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK EN+LLD+ +I + DFG S NK +TFCG+ Y APE+ +K VD
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF-YMSTDCENLLKKFLVLNPAKR 287
WSLGV+++ + G PF +++ + GK R P +S + +K L NP R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 85/256 (33%), Positives = 150/256 (58%), Gaps = 19/256 (7%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKMLD 103
++LLK +G G + KV L + V +GK A+K++ K T + + R R ++L+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER--QVLE 59
Query: 104 H----PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 159
H P +V L +T+ L+L+++Y +GGE+F +L R KE+E + +IV A++
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQ 217
+ H+ II+RD+K EN+LLDS ++ + DFG S EF + +FCG+ Y AP++ +
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 218 GKK--YDGPEVDVWSLGVILYTLVSGSLPF----DGSTLRELRERVLRGKYRIPFYMSTD 271
G +D VD WS+GV++Y L++G+ PF + ++ E+ R+L+ + P MS
Sbjct: 180 GGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
Query: 272 CENLLKKFLVLNPAKR 287
++++++ L+ +P KR
Sbjct: 239 AKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 87/254 (34%), Positives = 133/254 (52%), Gaps = 22/254 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY + IG+G V A V TG+EVAIK ++ Q L + E+ +M+ HPN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPN 77
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV L++VMEY +GG + D +V M E + A R+ + A+++ H ++
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+K++N+LL + ++K+ DFGF + TP +K T G+P + APE+ K Y GP+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI----------PFYMSTDCENL 275
VD+WSLG++ +V G P+ L E LR Y I P +S +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPY-------LNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248
Query: 276 LKKFLVLNPAKRAS 289
L + L ++ KR S
Sbjct: 249 LNRCLEMDVEKRGS 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 9e-38
Identities = 81/236 (34%), Positives = 128/236 (54%), Gaps = 3/236 (1%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMKMLDHPNIVKLFQ 112
IGKG+F KV + T + A+K I K + S + E ++ ++ P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 113 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172
++ + LYLV+ + +GGE+F +L GR AR +++ A++ H+ +I+RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 173 AENLLLDSEMNIKIADFGFSN-EFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSL 231
EN+LLD + +I + DFG +K +TFCG+P Y APEL G Y VD W+L
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTL 179
Query: 232 GVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
GV+LY +++G PF + E+ ++L+ R P D ++LL L +P +R
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 9e-38
Identities = 87/260 (33%), Positives = 134/260 (51%), Gaps = 21/260 (8%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPN 106
++ +K I G + V L +H T + A+K I+K L +Q++F E I+ ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+V +F ET++ L +VMEY GG+ L G + AR F + V A++Y H I
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFS---------NEFTPGNKLDT-------FCGSPPY 210
+HRDLK +NLL+ S +IK+ DFG S N + + DT CG+P Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF---Y 267
APE+ + Y P VD W++G+ILY + G +PF G T EL +V+ P
Sbjct: 183 IAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 268 MSTDCENLLKKFLVLNPAKR 287
+ D ++L+ + L NP +R
Sbjct: 242 LPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 4/239 (1%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR--IMKMLDHPNIVK 109
K IGKG+F KV LAK GK A+K++ K + QK R ++K + HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L +T + LY V+++ +GGE+F +L E AR +I SA+ Y H I++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 170 DLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 228
DLK EN+LLDS+ ++ + DFG E + TFCG+P Y APE+ + + YD VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TVDW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
W LG +LY ++ G PF + E+ + +L + S ++L++ L + +R
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 68/205 (33%), Positives = 107/205 (52%), Gaps = 4/205 (1%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
KY++L +G+G + V ++ TG+ VAIK +++ + + REV++++ L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQK 164
NIV L + + LYLV EY + + L G + R+ Q++ A+ YCH
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFT--PGNKLDTFCGSPPYAAPELFQGKKYD 222
IIHRD+K EN+L+ +K+ DFGF+ P + L + + Y APEL G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDG 247
G VDVW++G I+ L+ G F G
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPG 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 57/293 (19%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+LLK IG G + V A TG++VAIK I + +++ RE+++++ L H N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 107 IVKLFQVI-----ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQ 159
I+ L ++ E +Y+V E E + V+ + ++ QI+ ++
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP---------Y 210
Y H +IHRDLK N+L++S ++KI DFG + P F Y
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-----LTEYVVTRWY 172
Query: 211 AAPEL-FQGKKYDGPEVDVWSLGVILYTLVSG-------------SLPFD--GSTLRELR 254
APEL +Y +D+WS+G I L++ +L + G+ E
Sbjct: 173 RAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231
Query: 255 ERVLRGKYR-----------IPF-----YMSTDCENLLKKFLVLNPAKRASLE 291
+ + K R P S + +LL+K LV +P KR + +
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 97/302 (32%), Positives = 142/302 (47%), Gaps = 65/302 (21%)
Query: 42 EPHI-GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIK-IIDKTQLNPGSLQKLFREVRIM 99
+ HI KY++L+ +GKG + V A T + VA+K I D + N Q+ FRE+ +
Sbjct: 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFL 60
Query: 100 KML-DHPNIVKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLH-----GRMKEKEARAKF 151
+ L DHPNIVKL VI E +K +YLV EY D LH +++ R
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMET----D---LHAVIRANILEDVHKRYIM 113
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-- 209
Q++ A++Y H +IHRDLK N+LL+S+ +K+ADFG + + + P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE----NPENPVL 169
Query: 210 --------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVL-- 258
Y APE+ G VD+WS+G IL ++ G F G STL +L E+++
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL-EKIIEV 228
Query: 259 --------------------------RGKYRIPFYM---STDCENLLKKFLVLNPAKRAS 289
R + + + S D +LLKK LV NP KR +
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT 288
Query: 290 LE 291
E
Sbjct: 289 AE 290
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 84/241 (34%), Positives = 128/241 (53%), Gaps = 8/241 (3%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQ 112
+GKG F +V + TGK A K +DK +L Q E +I++ + IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 113 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRD 170
ET+ L LVM +GG++ ++ G EARA F QI+ +++ HQ++I++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWS 230
LK EN+LLD N++I+D G + E G K+ G+P Y APE+ QG+ YD VD ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWFA 179
Query: 231 LGVILYTLVSGSLPF----DGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286
LG LY +++G PF + EL+ R L P S + ++L + L +P K
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239
Query: 287 R 287
R
Sbjct: 240 R 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 82/203 (40%), Positives = 118/203 (58%), Gaps = 9/203 (4%)
Query: 95 EVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG----EVFDYLVLHGRMKEKEARAK 150
E+ + DH IVK F +++ L L+MEY SGG ++ L H +E E
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 151 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGS 207
F QIV A+ H +K++HRDLK+ N+ L IK+ DFGFS +++ LD +FCG+
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 208 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPF 266
P Y APEL++ K+Y + D+WSLGVILY L++ PF G + RE+ ++VL GKY P
Sbjct: 235 PYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC 293
Query: 267 YMSTDCENLLKKFLVLNPAKRAS 289
+S+ + LL L NPA R +
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPT 316
|
Length = 478 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 53/114 (46%), Positives = 76/114 (66%), Gaps = 1/114 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++KL +TE+ LYLV+EYA GGE+F +L GR E+ AR +IV A++Y H I
Sbjct: 55 IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGG 586
I+RDLK EN+LLD++ +IK+ DFG + E + + +TFCG+P Y APE+ G
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 8/270 (2%)
Query: 23 ISSSRLMSSRRESSRRERDEPHIGKYK---LLKTIGKGNFAKVKLAKHVPTG-KEVAIKI 78
+ + +L + S +E + KY+ ++T+G G+F +V LA + VAIK
Sbjct: 4 LKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR 63
Query: 79 IDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV 137
+K+++ + +F E +I+ ++HP V L+ + E LYLV+E+ GGE F +L
Sbjct: 64 FEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123
Query: 138 LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197
+ R QIV +Y I++RDLK ENLLLD + IK+ DFGF+
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VV 181
Query: 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERV 257
+ T CG+P Y APE+ + G D W+LG+ +Y ++ G PF + + +++
Sbjct: 182 DTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240
Query: 258 LRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
L G P ++ +C++L+KK L + KR
Sbjct: 241 LEGIIYFPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 88/279 (31%), Positives = 130/279 (46%), Gaps = 43/279 (15%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y+ ++ IG+G + V A+ TG+ VA+K I + G RE+ ++K L+HPNI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFD---YLVLHGRMKEKEARAK--FRQIVSAVQYCH 162
V+L V+ +E LYLV E+ D Y+ K Q++ + YCH
Sbjct: 61 VRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP---YAAPELFQGK 219
+++HRDLK +NLL+D E +K+ADFG + F G + T+ Y APE+ G
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGS 174
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDG-STLREL----------RERVLRGKYRIPFYM 268
+ VD+WS+G I +V+ F G S + +L E V G +P Y
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234
Query: 269 ST------------------DCENLLKKFLVLNPAKRAS 289
T D +LL K LV +PAKR S
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 68/241 (28%), Positives = 121/241 (50%), Gaps = 5/241 (2%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIK---IIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
+G G+F V ++ G A+K + D Q ++++L +E+ ++ L HPNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
E LY+ +E GG + L +G E R RQI+ ++Y H + +HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWS 230
+K N+L+D+ +K+ADFG + + + +F GSP + APE+ + G D+WS
Sbjct: 128 IKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187
Query: 231 LGVILYTLVSGSLPFDGSTLRELRERVLRGKY--RIPFYMSTDCENLLKKFLVLNPAKRA 288
LG + + +G P+ ++ R K IP ++S + ++ + K L +P+ R
Sbjct: 188 LGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRP 247
Query: 289 S 289
+
Sbjct: 248 T 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 85/286 (29%), Positives = 135/286 (47%), Gaps = 50/286 (17%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY+ L IG+G++ V ++ TG+ VAIK +++ +P + RE+R++K L HPN
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH------GRMKEKEARAKFRQIVSAVQY 160
+V L +V ++ L+LV EY D+ VL+ + E + Q + AV +
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQGK 219
CH+ IHRD+K EN+L+ + IK+ DFGF+ T T + + Y APEL G
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 220 KYDGPEVDVWSLGVILYTLVSGS----------------------LP-----------FD 246
GP VDVW++G + L++G +P F
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 247 GSTLRELRERV-LRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
G ++ E R L K+ +S+ + LK L ++P +R S E
Sbjct: 236 GLSIPEPETREPLESKFP---NISSPALSFLKGCLQMDPTERLSCE 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 45/274 (16%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPNIVK 109
+K IG+G F +V+L + TG A+K + K++ L + + E I+ D+P +VK
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L+ + E LYL+MEY GG++ L+ E+E R + + A+ H+ IHR
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125
Query: 170 DLKAENLLLDSEMNIKIADFGF--------SNEF-------TPGNKLDTFC--------- 205
D+K +NLLLD++ +IK++DFG EF P N LD
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185
Query: 206 ---------------GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
G+P Y APE+F Y E D WSLGVI+Y ++ G PF
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 251 RELRERVLRGKYRIPFYM----STDCENLLKKFL 280
+E +++ K + F S + ++L+K+
Sbjct: 245 QETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC 278
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 86/270 (31%), Positives = 145/270 (53%), Gaps = 12/270 (4%)
Query: 22 NISSSRLMSSRRESSRRERD-EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIID 80
N + ++ +++ + RD Y+++K IG+G F +V+L +H T K A+K++
Sbjct: 18 NKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS 77
Query: 81 KTQLNPGSLQKLFREVR-IMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH 139
K ++ S F E R IM + P +V+LF + ++ LY+VMEY GG++ + L+ +
Sbjct: 78 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSN 136
Query: 140 GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199
+ EK AR ++V A+ H IHRD+K +N+LLD ++K+ADFG +
Sbjct: 137 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196
Query: 200 --KLDTFCGSPPYAAPELFQ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR 254
+ DT G+P Y +PE+ + G Y G E D WS+GV LY ++ G PF +L
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256
Query: 255 ERVLRGKYRIPFY----MSTDCENLLKKFL 280
+++ K + F +S + +NL+ FL
Sbjct: 257 SKIMNHKNSLTFPDDNDISKEAKNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 78/213 (36%), Positives = 103/213 (48%), Gaps = 40/213 (18%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPN 106
YK++K +G G F V LA++ TG+ VAIK + K + L REV+ + K+ +HPN
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPN 59
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK--------EKEARAKFRQIVSAV 158
IVKL +V LY V EY G L+ MK E R+ QI+ +
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGN-------LYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 209
+ H+ HRDLK ENLL+ +KIADFG + E PP
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---------RPPYTDYVSTRW 163
Query: 210 YAAPE-LFQGKKYDGPEVDVWSLGVI---LYTL 238
Y APE L + Y P VD+W+LG I LYTL
Sbjct: 164 YRAPEILLRSTSYSSP-VDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 79/243 (32%), Positives = 131/243 (53%), Gaps = 11/243 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPN 106
+ ++K IG+G F +V+L +H + + A+K++ K ++ S F E R IM +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV+L + +K LY+VMEY GG++ + L+ + + EK AR ++V A+ H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 167 IHRDLKAENLLLDSEMNIKIADFG--FSNEFTPGNKLDTFCGSPPYAAPELFQ---GKKY 221
IHRD+K +N+LLD ++K+ADFG + + DT G+P Y +PE+ + G Y
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLK 277
G E D WS+GV LY ++ G PF +L +++ K + F +S ++L+
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLIC 283
Query: 278 KFL 280
FL
Sbjct: 284 AFL 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 3e-35
Identities = 89/254 (35%), Positives = 135/254 (53%), Gaps = 22/254 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY + IG+G V A V TG+EVAIK I+ Q P + + E+ +MK L +PN
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKK-ELIINEILVMKELKNPN 77
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV L++VMEY +GG + D +V M E + A R+ + A+++ H ++
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+K++N+LL + ++K+ DFGF + TP +K T G+P + APE+ K Y GP+
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI----------PFYMSTDCENL 275
VD+WSLG++ +V G P+ L E LR Y I P +S +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPY-------LNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248
Query: 276 LKKFLVLNPAKRAS 289
L + L ++ KR S
Sbjct: 249 LNRCLEMDVEKRGS 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 82/247 (33%), Positives = 127/247 (51%), Gaps = 15/247 (6%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
+G G F KV A+H TG A KII L+ E+ I+ HPNIV L++
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172
E L++++E+ GG + ++ R + E + R RQ++ A+ + H K+IHRDLK
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130
Query: 173 AENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPEL-----FQGKKYDGPEV 226
A N+LL + ++K+ADFG S + K DTF G+P + APE+ F+ YD +
Sbjct: 131 AGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY-KA 189
Query: 227 DVWSLGVILYTLVSGSLPF-DGSTLRELRERVLRG---KYRIPFYMSTDCENLLKKFLVL 282
D+WSLG+ L L P + + +R L ++L+ P S+ + LK LV
Sbjct: 190 DIWSLGITLIELAQMEPPHHELNPMRVLL-KILKSEPPTLDQPSKWSSSFNDFLKSCLVK 248
Query: 283 NPAKRAS 289
+P R +
Sbjct: 249 DPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-34
Identities = 82/243 (33%), Positives = 135/243 (55%), Gaps = 11/243 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPN 106
Y ++K IG+G F +V+L +H + K A+K++ K ++ S F E R IM + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+V+LF + +K LY+VMEY GG++ + L+ + + EK A+ ++V A+ H +
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 167 IHRDLKAENLLLDSEMNIKIADFG--FSNEFTPGNKLDTFCGSPPYAAPELFQ---GKKY 221
IHRD+K +N+LLD ++K+ADFG + T + DT G+P Y +PE+ + G Y
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLK 277
G E D WS+GV L+ ++ G PF +L +++ K + F +S +NL+
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLIC 283
Query: 278 KFL 280
FL
Sbjct: 284 AFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DH 104
G ++L++ IG+G + KV A+H TG+ VAIKI+D + +++ E I++ +H
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILRKYSNH 62
Query: 105 PNIVKLFQV------IETEKTLYLVMEYASGGEVFD----YLVLHGRMKEKEARAKFRQI 154
PNI + + L+LVME GG V D R+KE+ R+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAP 213
+ + Y H+ K+IHRD+K +N+LL +K+ DFG S + + +TF G+P + AP
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 214 ELFQGKKYDGP----EVDVWSLGVILYTLVSGSLPF 245
E+ + DVWSLG+ L G P
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 88/276 (31%), Positives = 131/276 (47%), Gaps = 37/276 (13%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
++ ++ IG+G + V A++ TG+ VA+K I G RE+ ++K L+HPNI
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 108 VKLFQVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
VKL VI TE LYLV E+ + D L G + ++ Q++ + +CH +
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP---YAAPELFQGKKYD 222
++HRDLK +NLL+++E IK+ADFG + F G + T+ Y APE+ G KY
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDGS-----------TLRELRERVLRGKYRIPFYMST- 270
VD+WSLG I +V+ F G TL E V G +P Y +
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238
Query: 271 -----------------DCENLLKKFLVLNPAKRAS 289
D +LL + L +P KR S
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 71/208 (34%), Positives = 109/208 (52%), Gaps = 23/208 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVP----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
K +K +G+G+F KV+L ++ P TG++VA+K + RE+ I++ LDH
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDH 65
Query: 105 PNIVKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----RQIVSAV 158
NIVK V E ++L L+MEY G + DYL H +++ + QI +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGM 122
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP------YAA 212
Y ++ IHRDL A N+L++SE +KI+DFG + + P +K D + P + A
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLA-KVLPEDK-DYYYVKEPGESPIFWYA 180
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVS 240
PE + K+ DVWS GV LY L +
Sbjct: 181 PECLRTSKFSS-ASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 77/227 (33%), Positives = 116/227 (51%), Gaps = 29/227 (12%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
IGKGNF V + EVA+K ++ L P +K +E I+K DHPNIVKL V
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIV-------SAVQYCHQKKI 166
++ +Y+VME GG + +L ++K+ R ++++ + ++Y K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNE-----FTPGNKLDTFCGSPP--YAAPELFQGK 219
IHRDL A N L+ +KI+DFG S E +T + L P + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL----KQIPIKWTAPEALNYG 170
Query: 220 KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+Y E DVWS G++L+ S G P+ G + ++ RER+ G YR+P
Sbjct: 171 RYTS-ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMP 215
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 77/252 (30%), Positives = 128/252 (50%), Gaps = 14/252 (5%)
Query: 53 TIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPNIVKLF 111
+G+G+F +V++ + TG A+K++ K+ L F E R I+ + + P I +L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 112 QVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+ + LYLVMEY GG++ L + + E A+ ++V A+ HQ +HRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF--CGSPPYAAPELFQ-----GKKYDG 223
+K EN+L+D +IK+ADFG + T +++ G+P Y APE+ GK G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
E D WSLGVI Y ++ G PF T + ++ + + F +S+D +L++
Sbjct: 188 VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQS- 246
Query: 280 LVLNPAKRASLE 291
L+ +R E
Sbjct: 247 LLCGQKERLGYE 258
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 19/265 (7%)
Query: 48 YKLLKTIGKGNFAKV-KLAKHVPTGKEVAIKIIDKTQLNPG--------SLQKLFREVRI 98
Y +L+ +G G F V K+ K +A+K I+ G S+ + EV I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 99 MK-MLDHPNIVKLFQVIETEKTLYLVMEYASG---GEVFDYLV-LHGRMKEKEARAKFRQ 153
+K L HPNIV+ ++ LY+VM+ G GE F+ L R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 154 IVSAVQYCH-QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 212
+V A++Y H +K+I+HRDL N++L + + I DFG + + P +KL + G+ Y+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYM-ST 270
PE+ + + Y G + DVW+ G ILY + + PF + + L +++ Y +P M S
Sbjct: 182 PEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 271 DCENLLKKFLVLNPAKRAS-LEVSG 294
D +++ L + R ++VS
Sbjct: 241 DVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
K L +G+G V + TG A+K I T NP +++ RE+ I K P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59
Query: 106 NIVKLFQ--VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------QIVS 156
IVK + + E+ ++ + MEY GG + ++ ++K++ R + ++
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD-TFCGSPPYAAPEL 215
+ Y H +KIIHRD+K N+LL + +K+ DFG S E N L TF G+ Y APE
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFTGTSFYMAPER 174
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 245
QGK Y DVWSLG+ L + PF
Sbjct: 175 IQGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 80/250 (32%), Positives = 130/250 (52%), Gaps = 18/250 (7%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
KL TIGKG F V L + G++VA+K + + Q E +M L HPN+V
Sbjct: 9 KLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLV 63
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKF-RQIVSAVQYCHQKKI 166
+L V+ LY+V EY + G + DYL GR + + F + ++Y +K
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--YAAPELFQGKKYDGP 224
+HRDL A N+L+ ++ K++DFG + E + G D+ G P + APE + KK+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--QDS--GKLPVKWTAPEALREKKFST- 178
Query: 225 EVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI--PFYMSTDCENLLKKFLV 281
+ DVWS G++L+ + S G +P+ L+++ V +G YR+ P + ++K
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWE 237
Query: 282 LNPAKRASLE 291
L+PAKR + +
Sbjct: 238 LDPAKRPTFK 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 84/254 (33%), Positives = 132/254 (51%), Gaps = 22/254 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY + IG+G V A + TG+EVAIK ++ Q L + E+ +M+ +PN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPN 77
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV L++VMEY +GG + D +V M E + A R+ + A+ + H ++
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+K++N+LL + ++K+ DFGF + TP +K T G+P + APE+ K Y GP+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI----------PFYMSTDCENL 275
VD+WSLG++ +V G P+ L E LR Y I P +S +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPY-------LNENPLRALYLIATNGTPELQNPERLSAVFRDF 248
Query: 276 LKKFLVLNPAKRAS 289
L + L ++ +R S
Sbjct: 249 LNRCLEMDVDRRGS 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 87/286 (30%), Positives = 132/286 (46%), Gaps = 54/286 (18%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y ++ IG+G + V ++ TG+ VA+K I G RE+ ++K L HPN
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
IV L V+ E LYL+ E+ S + D L M + ++ QI+ + +CH +
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAP 213
+++HRDLK +NLL+D++ IK+ADFG + F G P Y AP
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAF----------GIPVRVYTHEVVTLWYRAP 170
Query: 214 ELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLREL----------RERVLRGK 261
E+ G +Y P VD+WS+G I + + F G S + +L E V G
Sbjct: 171 EVLLGSPRYSTP-VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229
Query: 262 YRIPFYMST------------------DCENLLKKFLVLNPAKRAS 289
+P Y +T D +LL+K L+ +PAKR S
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 70/205 (34%), Positives = 112/205 (54%), Gaps = 14/205 (6%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIK-------IIDK-TQLNPGSLQKLFREVRIMKMLDHP 105
IGKG + +V LA +V TG+ +A+K I + ++ L E+ +K LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
NIV+ TE+ L + +EY GG + L +GR +E+ R Q++ + Y H K
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFS--NEFTPGNKLD-TFCGSPPYAAPELFQ--GKK 220
I+HRDLKA+NLL+D++ KI+DFG S ++ N + + GS + APE+ +
Sbjct: 129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPF 245
Y +VD+WSLG ++ + +G P+
Sbjct: 189 YSA-KVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 84/254 (33%), Positives = 133/254 (52%), Gaps = 22/254 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY + IG+G V A V TG+EVAI+ ++ Q L + E+ +M+ +PN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPN 78
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV L++VMEY +GG + D +V M E + A R+ + A+++ H ++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+K++N+LL + ++K+ DFGF + TP +K T G+P + APE+ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 196
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI----------PFYMSTDCENL 275
VD+WSLG++ ++ G P+ L E LR Y I P +S +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY-------LNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 276 LKKFLVLNPAKRAS 289
L + L ++ KR S
Sbjct: 250 LNRCLDMDVEKRGS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 14/269 (5%)
Query: 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+P +K IG+G+ V +A TGK+VA+K +D + L LF EV IM+
Sbjct: 19 DPREYLDSFIK-IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRD 75
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
H N+V ++ L++VME+ GG + D +V H RM E++ ++ A+ Y
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYL 134
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKK 220
H + +IHRD+K++++LL S+ IK++DFGF + + K + G+P + APE+
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYRIPFYMSTDCENLL 276
Y G EVD+WSLG+++ ++ G P+ +R +R+ L + + +S+ L
Sbjct: 195 Y-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFL 252
Query: 277 KKFLVLNPAKRAS-LEVSGE--VTLGGAP 302
LV P++RA+ E+ + L G P
Sbjct: 253 DLMLVREPSQRATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 78/255 (30%), Positives = 129/255 (50%), Gaps = 18/255 (7%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y ++ +GKG++ +V L +H GK+ IK ++ + + +E +++ L HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 108 VKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--------FRQIVSAV 158
V + E E LY+VM + GG+ L+ ++KE++ + F QI A+
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGD------LYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQ 217
QY H+K I+HRDLK +N+ L IK+ D G + + T G+P Y +PELF
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLL 276
K Y+ + DVW+LG +Y + + F+ + L R++ GK +P S + L+
Sbjct: 176 NKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234
Query: 277 KKFLVLNPAKRASLE 291
L P KR S++
Sbjct: 235 ATMLSKRPEKRPSVK 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 74/258 (28%), Positives = 135/258 (52%), Gaps = 21/258 (8%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD 103
+G +K+ K IGKG F+ V A + G+ VA+K + ++ + + Q +E+ ++K LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK-----EKEARAKFRQIVSAV 158
HPN++K L +V+E A G++ ++ H + + E+ F Q+ SA+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPE 214
++ H K+I+HRD+K N+ + + +K+ D G FS++ T + L G+P Y +PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPE 176
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF--DGSTLRELRERVLRGKYRIPF---YMS 269
Y+ + D+WSLG +LY + + PF D L L +++ + Y P + S
Sbjct: 177 RIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-PLPADHYS 234
Query: 270 TDCENLLKKFLVLNPAKR 287
+ +L+ + + +P KR
Sbjct: 235 EELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 80/251 (31%), Positives = 120/251 (47%), Gaps = 30/251 (11%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK---MLDHPNI 107
LK I G F KV + KH PT K KII K F + M M D+PN
Sbjct: 22 LKLI-DGKFGKVSVLKHKPTQKLFVQKIIKA---------KNFNAIEPMVHQLMKDNPNF 71
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 167
+KL+ + T K L+M+Y G++FD L G++ E E + RQ+V A+ H+ II
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 168 HRDLKAENLLLDSEMN-IKIADFGFS-NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
H D+K EN+L D + I + D+G TP + G+ Y +PE +G YD
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYD-VS 186
Query: 226 VDVWSLGVILYTLVSGSLPFDGS-----TLRELRERVLRGKYRIPF--YMSTDCENLLKK 278
D W++GV+ Y L++G PF L L +R + ++PF +S + + ++
Sbjct: 187 FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK---KLPFIKNVSKNANDFVQS 243
Query: 279 FLVLNPAKRAS 289
L N R +
Sbjct: 244 MLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 67/216 (31%), Positives = 115/216 (53%), Gaps = 6/216 (2%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
+K L+ +G+G +A V ++ TG+ VA+K I G+ RE+ +MK L H NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHENI 60
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQK 164
V+L VI TE L LV EY ++ Y+ HG + ++ Q++ + +CH+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+++HRDLK +NLL++ +K+ADFG + F P N + Y AP++ G +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR 259
+D+WS+G I+ +++G F G+ + ++ R
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 83/244 (34%), Positives = 131/244 (53%), Gaps = 11/244 (4%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQ 112
+GKG F +V + TGK A K ++K +L + E RI+ + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 113 VIETEKTLYLVMEYASGGEV--FDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 168
+T+ L LVM +GG++ Y V E RA F QI+S +++ HQ++II+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 169 RDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVD 227
RDLK EN+LLD++ N++I+D G + E G +K + G+P + APEL QG++YD VD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF-SVD 179
Query: 228 VWSLGVILYTLVSGSLPF----DGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283
++LGV LY +++ PF + +EL++R+L P S ++ + L +
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239
Query: 284 PAKR 287
P KR
Sbjct: 240 PEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 78/230 (33%), Positives = 122/230 (53%), Gaps = 14/230 (6%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPN 106
+++LK IG+G F +V + K TG+ A+KI++K ++ + FRE R ++ D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEK--EARAKF--RQIVSAVQYCH 162
I L + E LYLVM+Y GG D L L + +++ E A+F ++V A+ H
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGG---DLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF--CGSPPYAAPELFQ--- 217
Q +HRD+K +N+LLD +I++ADFG + + G+P Y +PE+ Q
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 218 -GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF 266
GK GPE D WSLGV +Y ++ G PF +L E +++ K F
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 79/246 (32%), Positives = 130/246 (52%), Gaps = 13/246 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPN 106
+++LK IG+G F +V + K K A+KI++K ++ + FRE R ++ D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKK 165
I L + E LYLVM+Y GG++ L R+ E AR ++V A+ HQ
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQ----GK 219
+HRD+K +N+L+D +I++ADFG + + + G+P Y +PE+ Q GK
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY-----MSTDCEN 274
GPE D WSLGV +Y ++ G PF +L E +++ K R F +S D ++
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242
Query: 275 LLKKFL 280
L+++ +
Sbjct: 243 LIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-32
Identities = 84/272 (30%), Positives = 143/272 (52%), Gaps = 21/272 (7%)
Query: 34 ESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF 93
E++ +E+ + KY + + +G G V AK V G+ A+K++D ++ +
Sbjct: 24 EATAKEQAK----KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ 79
Query: 94 REVRIMKMLDHPNIVKLFQVI--------ETEKTLYLVMEYASGGEVFDYLVLHGR---- 141
EV + D +IVK + E + LV++YA+ G++ + +
Sbjct: 80 AEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT 139
Query: 142 MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201
+E EA F Q++ AV + H K +IHRD+K+ N+LL S +K+ DFGFS +
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 202 D---TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL 258
D TFCG+P Y APE+++ K Y + D++SLGV+LY L++ PFDG + E+ + L
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258
Query: 259 RGKYR-IPFYMSTDCENLLKKFLVLNPAKRAS 289
G+Y +P +S + + ++ L +P +R S
Sbjct: 259 AGRYDPLPPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 9e-32
Identities = 81/242 (33%), Positives = 135/242 (55%), Gaps = 12/242 (4%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
IG+G+ V +A +GK VA+K +D + L LF EV IM+ H N+V+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 85
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 173
L++VME+ GG + D +V H RM E++ A ++ A+ H + +IHRD+K+
Sbjct: 86 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 174 ENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWS 230
+++LL + +K++DFGF ++ P K + G+P + APEL Y GPEVD+WS
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 231 LGVILYTLVSGSLP-FDGSTLRELR--ERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
LG+++ +V G P F+ L+ ++ L K + +S + L + LV +PA+R
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 288 AS 289
A+
Sbjct: 262 AT 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 87/272 (31%), Positives = 130/272 (47%), Gaps = 57/272 (20%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG--SLQKLFREVRIMKMLDHPN 106
KL + +G G F +V + T K VA+K L PG S + +E +IMK L H
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKT-----LKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA-KFR-------QIVSAV 158
+V+L+ V E+ +Y+V EY S G + D+L K E + + QI +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPP-- 209
Y + IHRDL A N+L+ + KIADFG + +E+T G K P
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF-------PIK 169
Query: 210 YAAPEL-----FQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR 263
+ APE F K DVWS G++L +V+ G +P+ G T RE+ E+V RG YR
Sbjct: 170 WTAPEAANYGRFTIKS------DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YR 222
Query: 264 IPFYMSTDCE----NLLKKFLVLNPAKRASLE 291
+P +C +L+ + +P +R + E
Sbjct: 223 MP--RPPNCPEELYDLMLQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 80/293 (27%), Positives = 136/293 (46%), Gaps = 55/293 (18%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+ KY+ L IG+G F +V A+H T + VA+K + G RE++I+++L H
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 105 PNIVKLFQVIETEKT--------LYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFR 152
N+V L ++ T+ T YLV E+ D L + + E + +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-----TPGNKLDTFCGS 207
+++ + Y H+ KI+HRD+KA N+L+ + +K+ADFG + F + N+ +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 208 PPYAAPELFQGKKYDGPEVDVWSLGVIL------------------YTLVS---GSL--- 243
Y PEL G++ GP +D+W G I+ TL+S GS+
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
Query: 244 --P-------FDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
P F L + ++R ++ + + P+ +L+ K LVL+PAKR
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLK-PYVKDPHALDLIDKLLVLDPAKR 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 52 KTIGKGNFAKVKLAKH-VPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
K +G GNF V + + +GKE VA+K + + ++ RE +M LDHP IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIV 59
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 168
+L V + E L LVME A G + YL + + + Q+ + Y K +H
Sbjct: 60 RLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118
Query: 169 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF--CGSPP--YAAPELFQGKKYDGP 224
RDL A N+LL + KI+DFG S G+ G P + APE K+
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 225 EVDVWSLGVILYTLVS-GSLPFDGST 249
DVWS GV L+ S G+ P+
Sbjct: 179 S-DVWSYGVTLWEAFSYGAKPYGEMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 70/211 (33%), Positives = 112/211 (53%), Gaps = 15/211 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY+ L +G+G++ V KH TG+ VAIK +++ + + RE+R++K L H N
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVL-------HGRMKEKEARAKFRQIVSAVQ 159
+V L +V +K LYLV E+ D+ VL +G + E R QI+ ++
Sbjct: 62 LVNLIEVFRRKKRLYLVFEF------VDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIE 114
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 218
+CH IIHRD+K EN+L+ +K+ DFGF+ PG + + Y APEL G
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGST 249
G VD+W++G ++ +++G F G +
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 74/306 (24%)
Query: 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIK-IIDKTQLNPGSLQKLFREVRIMKML 102
+ Y++L +G+G F +V A+ + TG+ VA+K I+ + G RE++I+K L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKL 64
Query: 103 DHPNIVKLFQVI--------ETEKTLYLVMEYA----SGGEVFDYLVLHG-RMKEKEARA 149
HPN+V L + ++Y+V Y SG +L +K E++
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-------LLENPSVKLTESQI 117
Query: 150 K--FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 207
K Q++ + Y H+ I+HRD+KA N+L+D++ +KIADFG + + G + G
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD-GPPPNPKGGG 176
Query: 208 PP-------------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------------- 241
Y PEL G++ VD+W +G + + +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 242 -------------------SLP-FDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281
SLP +G R L ++ + + +LL K L
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG---KLGPEGLDLLSKLLS 293
Query: 282 LNPAKR 287
L+P KR
Sbjct: 294 LDPYKR 299
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 91/290 (31%), Positives = 133/290 (45%), Gaps = 54/290 (18%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ ++ IG+G + V A+ T + +A+K I Q + G RE+ ++K + H N
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--------FRQIVSAV 158
IV+L V+ +EK LYLV EY L L M AK QI+ +
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPP---YAAPE 214
YCH +++HRDLK +NLL+D N +K+ADFG + F G + TF Y APE
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLREL----------RERVLRGKYR 263
+ G ++ VD+WS+G I +V+ F G S + EL E G
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233
Query: 264 IPFYMST------------------DCENLLKKFLVLNPAKR----ASLE 291
+P Y S +LL K L L+P+KR A+LE
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283
|
Length = 294 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 84/267 (31%), Positives = 133/267 (49%), Gaps = 17/267 (6%)
Query: 34 ESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF 93
E RR+ D + ++++ +G G F KV AK+ TG A K+I+ + L+
Sbjct: 2 EHVRRDLDPNEV--WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYM 57
Query: 94 REVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFR 152
E+ I+ +HP IVKL + L++++E+ GG V ++ R + E + + R
Sbjct: 58 VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR 117
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYA 211
Q++ A+QY H KIIHRDLKA N+LL + +IK+ADFG S + + D+F G+P +
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177
Query: 212 APELFQGKKY-DGP---EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY 267
APE+ + D P + D+WSLG+ L + P L +R + K P
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH--HELNPMRVLLKIAKSEPPTL 235
Query: 268 M-----STDCENLLKKFLVLNPAKRAS 289
S + + LK L +P R S
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 32/231 (13%)
Query: 50 LLKTIGKGNFAKVKLAKHVPTGK-EVAIKIIDKTQLNPGSLQK--LFREVRIMKMLDHPN 106
LK +G G F V L K GK +VAIK+I G++ + E ++M L HPN
Sbjct: 8 FLKELGSGQFGVVHLGKW--RGKIDVAIKMI-----REGAMSEDDFIEEAKVMMKLSHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----RQIVSAVQYCH 162
+V+L+ V ++ +++V EY + G + +YL K K + A++Y
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPEL 215
IHRDL A N L+ + +K++DFG + +++T G K +A PE+
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-----KWAPPEV 172
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
F ++ + DVWS GV+++ + S G +P++ + E+ E V G YR+
Sbjct: 173 FDYSRFSS-KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLY 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 87/298 (29%), Positives = 128/298 (42%), Gaps = 73/298 (24%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG----SLQKLFREVRIMKMLD 103
Y+ L I +G + V A+ TG+ VA+K + + G SL RE+ I+ L
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL----REINILLKLQ 62
Query: 104 HPNIVKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK----EARAKFRQIVSA 157
HPNIV + +V+ +Y+VMEY D L MK+ E + Q++S
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVE----HDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-------- 209
V + H I+HRDLK NLLL++ +KI DFG + E+ GSP
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY----------GSPLKPYTQLVV 168
Query: 210 ---YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLR------ 259
Y APEL G K +D+WS+G I L++ F G S + +L ++ +
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPT 227
Query: 260 ------------------GKY-------RIPFYMSTDCE-NLLKKFLVLNPAKRASLE 291
KY + P +D +LL + L +PAKR S E
Sbjct: 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE 285
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 87/287 (30%), Positives = 136/287 (47%), Gaps = 48/287 (16%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL---NPGSLQKLFREVRIMKMLD 103
Y+ L+ IG+G + KV A+ TGK VA+K KT+L G RE+ +++ML
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLS 58
Query: 104 H-PNIVKLFQVIETEK-----TLYLVMEYASGGEVFDYLVLHGR-----MKEKEARAKFR 152
IV+L V E+ +LYLV EY ++ ++ +GR + K ++
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFT-PGNKLDTFCGSPPY 210
Q++ V +CH+ ++HRDLK +NLL+D + +KIAD G F+ P + Y
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLREL----------RERV-- 257
APE+ G + VD+WS+G I + F G S L++L E+V
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 258 ----LRGKYRIPFY-----------MSTDCENLLKKFLVLNPAKRAS 289
LR + P + +S + +LL+K L +PAKR S
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 41/280 (14%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL-QKLFREVRIMKMLD--- 103
Y+ L IG+G + V A+ + TG+ VA+K + + L+ + RE+ ++K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 104 HPNIVKLFQV-----IETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVS 156
HPNIV+L V + E L LV E+ ++ YL + + + + RQ++
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 216
V + H +I+HRDLK +N+L+ S+ +KIADFG + ++ L + + Y APE+
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST----LRELRE--------------RVL 258
Y P VD+WS+G I L F G++ L ++ + +
Sbjct: 179 LQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237
Query: 259 RGKY----RIPF-----YMSTDCENLLKKFLVLNPAKRAS 289
R + F + + +LLKK L NP KR S
Sbjct: 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 77/247 (31%), Positives = 130/247 (52%), Gaps = 15/247 (6%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPN 106
++++K IG+G F +V + K T + A+KI++K ++ + FRE R ++ D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKK 165
I L + E LYLVM+Y GG++ L R+ E AR ++V A+ HQ
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQGK---- 219
+HRD+K +N+LLD +I++ADFG + + + G+P Y +PE+ Q
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 220 -KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY-----MSTDCE 273
KY GPE D WSLGV +Y ++ G PF +L E +++ + R F +S + +
Sbjct: 183 GKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241
Query: 274 NLLKKFL 280
+L+++ +
Sbjct: 242 DLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 16/210 (7%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS------LQKLFREVRIMKM 101
++L K +G+G F +V L TG+E+A+K + Q +P S + L E++++K
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVK---QVQFDPESPETSKEVNALECEIQLLKN 60
Query: 102 LDHPNIVKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 159
L H IV+ + + E+TL + ME+ GG + D L +G + E R RQI+ V
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT----PGNKLDTFCGSPPYAAPEL 215
Y H I+HRD+K N+L DS N+K+ DFG S G + + G+P + +PE+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPF 245
G+ Y G + D+WS+G + +++ P+
Sbjct: 181 ISGEGY-GRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 72/244 (29%), Positives = 137/244 (56%), Gaps = 16/244 (6%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
IG+G+ V +A+ +G++VA+K++D + L LF EV IM+ H N+V++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKS 86
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 173
+ L+++ME+ GG + D +V R+ E++ ++ A+ Y H + +IHRD+K+
Sbjct: 87 YLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 174 ENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 232
+++LL + +K++DFGF + + K + G+P + APE+ Y G EVD+WSLG
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLG 204
Query: 233 VILYTLVSGSLPFDGST----LRELRER---VLRGKYRIPFYMSTDCENLLKKFLVLNPA 285
+++ +V G P+ + ++ LR+ L+ ++I S + L++ L P
Sbjct: 205 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI----SPVLRDFLERMLTREPQ 260
Query: 286 KRAS 289
+RA+
Sbjct: 261 ERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 84/248 (33%), Positives = 126/248 (50%), Gaps = 14/248 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
KLL+TIGKG F V L + G +VA+K I N + Q E +M L H N+V
Sbjct: 9 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLV 62
Query: 109 KLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVS-AVQYCHQKK 165
+L VI EK LY+V EY + G + DYL GR + + KF V A++Y
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRDL A N+L+ + K++DFG + E + DT + APE + KK+ +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFS-TK 179
Query: 226 VDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFLVLN 283
DVWS G++L+ + S G +P+ L+++ RV +G K P +++K+ L+
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLD 239
Query: 284 PAKRASLE 291
A R S
Sbjct: 240 AATRPSFL 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 5e-30
Identities = 49/102 (48%), Positives = 61/102 (59%), Gaps = 2/102 (1%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
+ LYLVMEY GGE+F +L GR E AR Q+V A++Y H I++RDLK ENL
Sbjct: 73 DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132
Query: 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
LLDS+ IKI DFGF+ T CG+P Y APE+
Sbjct: 133 LLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILS 172
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 71/195 (36%), Positives = 111/195 (56%), Gaps = 10/195 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
++++ +G G F KV A++ TG A K+ID + L+ E+ I+ DHPNI
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNI 64
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
VKL E L++++E+ +GG V ++ L + E + R +Q + A+ Y H+ KI
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELF-----QGKK 220
IHRDLKA N+L + +IK+ADFG S + T + D+F G+P + APE+ + +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 221 YDGPEVDVWSLGVIL 235
YD + DVWSLG+ L
Sbjct: 185 YDY-KADVWSLGITL 198
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 72/206 (34%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS------LQKLFREVRIMKMLDHP 105
K +G+G F +V L V TG+E+A K + Q +P S + L E++++K L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAK---QVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 106 NIVKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
IV+ + + EKTL + MEY GG V D L +G + E R RQI+ + Y H
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEF----TPGNKLDTFCGSPPYAAPELFQGK 219
I+HRD+K N+L DS N+K+ DFG S G + + G+P + +PE+ G+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPF 245
Y G + DVWSLG + +++ P+
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 79/282 (28%), Positives = 133/282 (47%), Gaps = 43/282 (15%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY+ L+ IG+G + V AK+ T + VA+K + + G RE+ ++K L H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
IV+L+ V+ ++K L LV EY + FD +G + + ++ Q++ + +CH
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----YAAPELFQGK 219
++HRDLK +NLL++ +K+ADFG + F + C S Y P++ G
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLP-FDGSTLRELRERVLR-----------GKYRIPFY 267
K +D+WS G I L + P F G+ + + +R+ R G ++P Y
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234
Query: 268 ------------------MSTDCENLLKKFLVLNPAKRASLE 291
+++ +LL+ LV NP +R S E
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE 276
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 68/291 (23%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT-----QLNPGSLQKLFREVRIMKML 102
YK+L IG+G F++V A+ TGK AIK + K Q+N RE++ ++ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN------LREIQALRRL 54
Query: 103 -DHPNIVKLFQVIETEKT--LYLVMEYASGGEVFDYLVLHGRMK---EKEARAKFRQIVS 156
HPNI++L +V+ KT L LV E +++ + GR + EK ++ Q++
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLK 111
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYA----- 211
++ + H+ I HRD+K EN+L+ + +K+ADFG PPY
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG---------SCRGIYSKPPYTEYIST 161
Query: 212 ----APELFQGKKYDGPEVDVWSLGVILYTLVS------GSLPFD---------GSTLRE 252
APE Y GP++D+W++G + + ++S G+ D G+ E
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221
Query: 253 LRERVLRGK---YRIPF-----------YMSTDCENLLKKFLVLNPAKRAS 289
+ ++ + + Y P S + +LLKK L +P +R +
Sbjct: 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 49/113 (43%), Positives = 69/113 (61%), Gaps = 1/113 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L +L +T+ L+ VMEY +GG++ ++ GR E AR +IV +Q+ H++ I
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
I+RDLK +N+LLDSE +IKIADFG E G TFCG+P Y APE+
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 75/251 (29%), Positives = 124/251 (49%), Gaps = 24/251 (9%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS------LQKLFREVRIMKM 101
++L K +G+G F +V L TG+E+A+K + +P S + L E++++K
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVK---QVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 102 LDHPNIVKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 159
L H IV+ + + EK L + +EY GG + D L +G + E R RQI+ V
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE----FTPGNKLDTFCGSPPYAAPEL 215
Y H I+HRD+K N+L DS N+K+ DFG S G + + G+P + +PE+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-----GKYRIPFYMST 270
G+ Y G + DVWS+ + +++ P+ E + + K +P +S
Sbjct: 181 ISGEGY-GRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 271 DCENLLKKFLV 281
C + LK+ V
Sbjct: 237 ACRDFLKQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
L+ IGKG+F +V T K VAIKIID + ++ + +E+ ++ D P + K
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKY 67
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+ + L+++MEY GG D L+ G + E + R+I+ + Y H +K IHRD
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVW 229
+KA N+LL +K+ADFG + + T K +TF G+P + APE+ + YD + D+W
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-KADIW 185
Query: 230 SLGVILYTLVSGSLP--------------------FDGSTLRELRERVLRGKYRIPFYMS 269
SLG+ L G P +G+ + L+E V + P +
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 270 TDCENLLKKFLVLNPAKRASL 290
T E L KF+V K + L
Sbjct: 246 TAKELLKHKFIVRFAKKTSYL 266
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 73/257 (28%), Positives = 120/257 (46%), Gaps = 33/257 (12%)
Query: 52 KTIGKGNFAKVKLAK-HVPTGK--EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
K +G G+F V+ + GK VA+K + +L+ + +E IM LDH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLI 59
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIVSAVQ 159
+L+ V+ T L +V E A G + D R++ K+A F QI + ++
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLD------RLR-KDALGHFLISTLCDYAVQIANGMR 111
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP----PYA--AP 213
Y K+ IHRDL A N+LL S+ +KI DFG D + P+A AP
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL--PQNEDHYVMEEHLKVPFAWCAP 169
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI--PFYMST 270
E + + + DVW GV L+ + + G P+ G + ++ +++ + R+ P
Sbjct: 170 ESLRTRTFSHAS-DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ 228
Query: 271 DCENLLKKFLVLNPAKR 287
D N++ + NPA R
Sbjct: 229 DIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 74/226 (32%), Positives = 117/226 (51%), Gaps = 15/226 (6%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
L+ IGKG+F +V T + VAIKIID + ++ + +E+ ++ D P I +
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRY 67
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+ L+++MEY GG D L+ G ++E R+I+ + Y H ++ IHRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRD 126
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVW 229
+KA N+LL + ++K+ADFG + + T K +TF G+P + APE+ + YD + D+W
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF-KADIW 185
Query: 230 SLGVILYTLVSGSLPFDGSTLRELR---------ERVLRGKYRIPF 266
SLG+ L G P S L +R L G+Y PF
Sbjct: 186 SLGITAIELAKGEPPN--SDLHPMRVLFLIPKNSPPTLEGQYSKPF 229
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 48/112 (42%), Positives = 69/112 (61%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++KL++ + +K +Y++MEY GGE++ L G E AR +V A +Y H + I
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
I+RDLK ENLLLDS +K+ DFGF+ + G K TFCG+P Y APE+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 39/117 (33%), Positives = 63/117 (53%), Gaps = 9/117 (7%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYL----VLHGRMKEKEARAKFRQIVSAVQYCHQK 531
K ++ E + L +VMEYA GG++ + E++ F Q+ A++Y H +
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGSPPYAAPELFQG 585
KI+HRD+K +N+ L S +K+ DFG S + + +D T G+P Y +PEL Q
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPELCQN 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 74/253 (29%), Positives = 125/253 (49%), Gaps = 20/253 (7%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-------LQKLFREVRIMKMLDHPN 106
IG G+F V L + +G+ +A+K ++ ++ S L L RE+ ++K L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV+ L + +EY GG V L +G +E R RQI+ + Y H + I
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEF-------TPGNKLDTFCGSPPYAAPELFQGK 219
IHRD+K N+L+D++ IKI+DFG S + + GS + APE+ +
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLL 276
Y + D+WSLG ++ +++G PF T + ++ G+ IP +S++ + L
Sbjct: 188 SYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--GENASPEIPSNISSEAIDFL 244
Query: 277 KKFLVLNPAKRAS 289
+K ++ KR +
Sbjct: 245 EKTFEIDHNKRPT 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 46/117 (39%), Positives = 71/117 (60%), Gaps = 2/117 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +T+ L+L+++Y +GGE+F +L E E R +IV A+ + HQ I
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGI 126
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGGAP 588
I+RD+K EN+LLDSE ++ + DFG S EF + +FCG+ Y APE+ +GG+
Sbjct: 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 4/195 (2%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
L+ IGKG+F +V T + VAIKIID + ++ + +E+ ++ D P + K
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKY 67
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+ L+++MEY GG D L+ G E + ++I+ + Y H +K IHRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVW 229
+KA N+LL + ++K+ADFG + + T K +TF G+P + APE+ Q YD + D+W
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS-KADIW 185
Query: 230 SLGVILYTLVSGSLP 244
SLG+ L G P
Sbjct: 186 SLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 7/207 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
K+++L +G+G + V +H T + VAIK ++ N + RE+++++ L N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
IV+L + LYLV EY E+ + + +G EK R+ Q++ A+ +CH+
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEK-VRSYIYQLIKAIHWCHKN 119
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD--TFCGSPPYAAPELFQGKKYD 222
I+HRD+K ENLL+ +K+ DFGF+ + G+ + + + Y +PEL G Y
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY- 178
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDGST 249
G VD+WS+G IL L G F G +
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 23/226 (10%)
Query: 50 LLKTIGKGNFAKVKLAKHVPTGK-EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
LK +G G F VK K G+ +VAIK+I + + S + E ++M L H +V
Sbjct: 8 FLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLV 62
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKII 167
+L+ V ++ +Y+V EY S G + +YL HG R + + + + + Y K+ I
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122
Query: 168 HRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPELFQGKK 220
HRDL A N L+D + +K++DFG S +E+T G+K ++ PE+ K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-----RWSPPEVLLYSK 177
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK--YR 263
+ + DVW+ GV+++ + S G +P++ E E+V +G YR
Sbjct: 178 FSS-KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR 222
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 66/251 (26%), Positives = 119/251 (47%), Gaps = 16/251 (6%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS----LQKLFREVRIMKMLDHPNI 107
+ +G G F+ A+ V TG +A+K + + ++ L +E+R+M L+HP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 167
+++ + L +E+ +GG V L +G KE Q++ + Y H+ +II
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 168 HRDLKAENLLLDSE-MNIKIADFGFSNEFTP-----GNKLDTFCGSPPYAAPELFQGKKY 221
HRD+K NLL+DS ++IADFG + G G+ + APE+ +G++Y
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-----GKYRIPFYMSTDCENLL 276
G DVWS+G ++ + + P++ + + IP ++S ++
Sbjct: 186 -GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVT 244
Query: 277 KKFLVLNPAKR 287
+ L L P R
Sbjct: 245 LRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-28
Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 51/289 (17%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
+ +KTIG G F +V L + V T A+K + K L + E I+ D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+VKL+ + + LY VM+Y GG++ L+ G +E AR ++ A++ H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGF---------SNEFTPGN--KLDTF----------- 204
IHRD+K +N+L+D + +IK+ DFG S + G+ + D+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 205 ----------------------CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 242
G+P Y APE+ Y D WS+GVILY ++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 241
Query: 243 LPFDGSTLRELRERVL--RGKYRIPFY--MSTDCENLLKKFLVLNPAKR 287
PF T E + +V+ IP +S + +L+ + L R
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 11/252 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT---QLNPGSLQKLFREVRIMKMLD 103
+Y L + +GKG+F V L K E +K++ + +LNP + +E +++ LD
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK----FRQIVSAVQ 159
HP IVK ++ EY G ++ L + + + F Q++ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQG 218
Y HQ++I+HRDLKA+N+ L + + +KI DFG S L TF G+P Y +PE +
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLK 277
+ YD + D+WSLG ILY + + F+G + R++ G +P S ++++
Sbjct: 180 QGYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 278 KFLVLNPAKRAS 289
L +P+ R S
Sbjct: 239 SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 72/193 (37%), Positives = 108/193 (55%), Gaps = 14/193 (7%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT--QLNPGSLQKLFREVRIMKMLDHP 105
+ L+ IG G+F V A+ V T + VAIK + + Q N Q + +EVR ++ L HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHP 75
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQK 164
N ++ E T +LVMEY G D L +H + ++E E A + + Y H
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSAS-DILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF----QGKK 220
+ IHRD+KA N+LL +K+ADFG ++ +P N +F G+P + APE+ +G +
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEG-Q 190
Query: 221 YDGPEVDVWSLGV 233
YDG +VDVWSLG+
Sbjct: 191 YDG-KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 78/245 (31%), Positives = 119/245 (48%), Gaps = 8/245 (3%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
IG+GNF +V + VA+K +T L P K +E RI+K HPNIV+L V
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172
++ +Y+VME GG+ +L G R+K KE + ++Y K IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 173 AENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSP-PYAAPELFQGKKYDGPEVDVW 229
A N L+ + +KI+DFG S E G T P + APE +Y E DVW
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS-ESDVW 180
Query: 230 SLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKR 287
S G++L+ S G++P+ + ++ RE + +G + P L+++ +P +R
Sbjct: 181 SFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQR 240
Query: 288 ASLEV 292
S
Sbjct: 241 PSFST 245
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 47/128 (36%), Positives = 66/128 (51%), Gaps = 21/128 (16%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
KL+ + E+ LY V+EYA GE+ Y+ +G + EK R +I+ A++Y H K IIH
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIH 125
Query: 536 RDLKAENLLLDSEMNIKIADFG---------------------FSNEFTPGNKLDTFCGS 574
RDLK EN+LLD +M+IKI DFG S + +F G+
Sbjct: 126 RDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT 185
Query: 575 PPYAAPEL 582
Y +PEL
Sbjct: 186 AEYVSPEL 193
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 85/299 (28%), Positives = 139/299 (46%), Gaps = 66/299 (22%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
K+ ++ IG+G + +V A+ TG+ VA+K + G RE++I++ L+H N
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 107 IVKLFQVIETEK-----------TLYLVMEYASG---GEVFDYLVLHGRMKEKEARAKFR 152
IV L +++ T+K YLV EY G + LV E ++ +
Sbjct: 68 IVNLKEIV-TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHIKSFMK 123
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG------NKLDTFCG 206
Q++ + YCH+K +HRD+K N+LL+++ IK+ADFG + + NK+ T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW- 182
Query: 207 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTL---------------------VSGS--- 242
Y PEL G++ GP +DVWS G IL L + GS
Sbjct: 183 ---YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 243 --------LPFDGSTLRELR--ERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
LP+ +T++ + R LR ++ ++ T +LL L L+P+KR + E
Sbjct: 240 AVWPDVIKLPY-FNTMKPKKQYRRRLREEFS---FIPTPALDLLDHMLTLDPSKRCTAE 294
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 72/289 (24%), Positives = 127/289 (43%), Gaps = 49/289 (16%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+YK ++ IG G + V A +GK+VAIK I P ++ RE++I++ H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 107 IVKLFQVIETE----KTLYLVMEYASGGEVFD-YLVLHGR--MKEKEARAKFRQIVSAVQ 159
I+ + ++ K +Y+VM+ D + ++H + E+ R Q++ ++
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGF-----SNEFTPGNKLDTFCGSPPYAAPE 214
Y H +IHRDLK NLL++ + ++I DFG S+ + + + Y APE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 215 L-FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-------------------LRELR 254
L +Y +D+WS+G I ++ F G L +
Sbjct: 182 LLLSLPEYT-TAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240
Query: 255 -ERV------LRGKYRIPF---YMSTDCE--NLLKKFLVLNPAKRASLE 291
+RV L K +P+ + E +LL + L +P +R ++E
Sbjct: 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE 289
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 88/294 (29%), Positives = 125/294 (42%), Gaps = 71/294 (24%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP--GSLQKLFREVRIMKMLDHP 105
YK L +G+G++A V + TG+ VA+K I +L G+ RE ++K L H
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHA 63
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQK 164
NIV L +I T+KTL LV EY ++ Y+ G + R Q++ + YCHQ+
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFG-----------FSNE-----FTPGNKLDTFCGSP 208
+++HRDLK +NLL+ +K+ADFG +SNE + P D GS
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPP---DVLLGST 179
Query: 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST--LREL----------RER 256
Y+ +D+W +G I Y + +G F GST +L E
Sbjct: 180 EYST------------SLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227
Query: 257 VLRG--------KYRIPFY-------------MSTDCENLLKKFLVLNPAKRAS 289
G Y PFY E L KFL P KR S
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 76/256 (29%), Positives = 125/256 (48%), Gaps = 38/256 (14%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
++ LK IG+G F +V+L + TG A+KI+ K L + + E I+ D
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+VK+F + ++ LYL+ME+ GG++ L+ + E+ + + V A+ HQ
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGF--------------------SNEFTPGN-----KL 201
IHRD+K +NLLLD++ ++K++DFG ++F+ N K
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 202 DTF-----------CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
+T+ G+P Y APE+F Y+ D WSLGVI+Y ++ G PF T
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 251 RELRERVLRGKYRIPF 266
+E +V+ K + F
Sbjct: 242 QETYRKVMNWKETLVF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 80/265 (30%), Positives = 127/265 (47%), Gaps = 16/265 (6%)
Query: 36 SRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFR 94
SRR E ++L++ IG G + V A++V TG+ AIK+I +L PG + +
Sbjct: 3 SRRNPQE----DFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQ 55
Query: 95 EVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQI 154
E+ +MK H NIV F L++ ME+ GG + D + G + E + R+
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAP 213
+ + Y H K +HRD+K N+LL ++K+ADFG S + T K +F G+P + AP
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 214 ELFQGKKYDGPE--VDVWSLGVILYTLVSGSLP-FDGSTLREL----RERVLRGKYRIPF 266
E+ ++ G D+W++G+ L P FD +R L + K +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 267 YMSTDCENLLKKFLVLNPAKRASLE 291
S + +K L NP KR + E
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 75/214 (35%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVP----TGKEVAIKIIDKTQLNPGSLQKLFREV 96
+E H+ K ++ +GKGNF V+L ++ P TG+ VA+K + + L+ RE+
Sbjct: 2 EERHL---KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREI 56
Query: 97 RIMKMLDHPNIVKLFQVIET--EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQ 153
I+K L H NIVK V + + L LVMEY G + DYL H R+ ++ Q
Sbjct: 57 EILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ 116
Query: 154 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPP- 209
I ++Y K+ +HRDL N+L++SE +KI DFG + + P +K G P
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT-KVLPQDKEYYKVREPGESPI 175
Query: 210 -YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 242
+ APE K+ DVWS GV+LY L + S
Sbjct: 176 FWYAPESLTESKFS-VASDVWSFGVVLYELFTYS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 38/112 (33%), Positives = 61/112 (54%), Gaps = 3/112 (2%)
Query: 479 QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 538
+ E + TL + +EY SGG + L G++ E R RQI+ + Y H I+HRD+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127
Query: 539 KAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPYAAPELFQGGA 587
K N+L+DS+ +K+ADFG + + G + G+P + APE+ +G
Sbjct: 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 74/247 (29%), Positives = 123/247 (49%), Gaps = 15/247 (6%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
+GKG + V A+ + T +AIK I + + +Q L E+ + L H NIV+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKF--RQIVSAVQYCHQKKIIHRD 170
+ ME GG + L G +K+ E F +QI+ ++Y H +I+HRD
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 171 LKAENLLLDSEMNI-KIADFGFSNEFTPGNKL-DTFCGSPPYAAPELF-QGKKYDGPEVD 227
+K +N+L+++ + KI+DFG S N +TF G+ Y APE+ +G + G D
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193
Query: 228 VWSLGVILYTLVSGSLPFDGSTLRELRERVLR-GKYR----IPFYMSTDCENLLKKFLVL 282
+WSLG + + +G PF L E + + + G ++ IP +S + +N + +
Sbjct: 194 IWSLGCTIVEMATGKPPF--IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEP 251
Query: 283 NPAKRAS 289
+P KRAS
Sbjct: 252 DPDKRAS 258
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 84/250 (33%), Positives = 121/250 (48%), Gaps = 30/250 (12%)
Query: 54 IGKGNFAKV---KLAKHVPTGKEVAIKIIDKTQLNPGSLQ-KLFREVRIMKMLDHPNIVK 109
+GKGNF +V L P VA+K K L P L+ K E RI+K DHPNIVK
Sbjct: 3 LGKGNFGEVFKGTLKDKTP----VAVKTC-KEDL-PQELKIKFLSEARILKQYDHPNIVK 56
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIV-------SAVQYCH 162
L V + +Y+VME GG+ +L ++K+ K +Q+V + + Y
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFL------RKKKDELKTKQLVKFALDAAAGMAYLE 110
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--YAAPELFQGKK 220
K IHRDL A N L+ +KI+DFG S + G + P + APE +
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI--PFYMSTDCENLLK 277
Y E DVWS G++L+ S G P+ G T ++ RE+V +G YR+ P D +++
Sbjct: 171 YSS-ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQ 228
Query: 278 KFLVLNPAKR 287
+ P R
Sbjct: 229 RCWDYKPENR 238
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 79/256 (30%), Positives = 126/256 (49%), Gaps = 38/256 (14%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
++ LK IG+G F +V+L + TG A+KI+ K L + + E I+ D
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+VK+F + + LYL+ME+ GG++ L+ + E+E + + V A+ HQ
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFG--------------------FSNEFTPGN-----KL 201
IHRD+K +NLLLDS+ ++K++DFG ++FT N K
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 202 DTF-----------CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
+T+ G+P Y APE+F Y+ D WSLGVI+Y ++ G PF T
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 251 RELRERVLRGKYRIPF 266
+E ++V+ K + F
Sbjct: 242 QETYKKVMNWKETLIF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 47/111 (42%), Positives = 70/111 (63%), Gaps = 2/111 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+++LF ++ LY++MEY GGE+F YL GR +IV A++Y H K+I
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
++RDLK EN+LLD E +IK+ DFGF+ + ++ T CG+P Y APE+ Q
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQ 171
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 75/239 (31%), Positives = 112/239 (46%), Gaps = 30/239 (12%)
Query: 22 NISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII-- 79
SSS SS S + + + + IG G V H PTG+ A+K+I
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 80 --DKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV 137
+ T ++ RE+ I++ ++HPN+VK + + + +++E+ GG
Sbjct: 110 NHEDTVRR-----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS------ 158
Query: 138 LHGRMKEKEARAK--FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS--- 192
L G E RQI+S + Y H++ I+HRD+K NLL++S N+KIADFG S
Sbjct: 159 LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
Query: 193 -NEFTPGNKLDTFCGSPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 245
P N + G+ Y +PE L G YDG D+WSLGV + G PF
Sbjct: 219 AQTMDPCN---SSVGTIAYMSPERINTDLNHG-AYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 48/278 (17%)
Query: 47 KYKLLKTIGKGNFAKV--KLAKHVPTGK---EVAIKIIDKTQLNPGSLQKL--FREVRIM 99
K L++ +G+G+F V LAK V G+ VAIK N +++ E +M
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT---VNENASMRERIEFLNEASVM 63
Query: 100 KMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR------- 152
K + ++V+L V+ T + +VME + G++ YL R E E
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKF 121
Query: 153 -----QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF------SNEFTPGNKL 201
+I + Y KK +HRDL A N ++ ++ +KI DFG ++ + G K
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK- 180
Query: 202 DTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258
G P + APE + + + DVWS GV+L+ + + P+ G + E+ + V+
Sbjct: 181 ----GLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235
Query: 259 RGKY-RIPFYMSTDCENLLKKFLVL----NPAKRASLE 291
G + +P +C + L + + + NP R +
Sbjct: 236 DGGHLDLP----ENCPDKLLELMRMCWQYNPKMRPTFL 269
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 45/116 (38%), Positives = 63/116 (54%), Gaps = 9/116 (7%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
KL+ + +K LYLVMEY GG++ L G + E AR +IV A++Y H IIH
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 536 RDLKAENLLLDSEMNIKIADFGFS---------NEFTPGNKLDTFCGSPPYAAPEL 582
RDLK +N+L+DS ++K+ DFG S N + G+P Y APE+
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 74/218 (33%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y L +G+G +A V + T VA+K I + + G+ REV ++K L H NI
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKI 166
V L +I TE+ L LV EY ++ YL G M + Q++ + YCH++KI
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSN-----EFTPGNKLDTFCGSPPYAAPELFQGKKY 221
+HRDLK +NLL++ + +K+ADFG + T N++ T PP L +Y
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV---LLGSTEY 181
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR 259
P +D+W +G ILY + +G F GST++E + R
Sbjct: 182 STP-IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-27
Identities = 76/293 (25%), Positives = 133/293 (45%), Gaps = 55/293 (18%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPN 106
+ +K IGKG F +V+L + TGK A+K + K+++ L + E ++ D P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+V L+ + + LYL+ME+ GG++ L+ + E R + V A++ H+
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEF------------------TPG---------- 198
IHRD+K +N+L+D +IK++DFG S F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 199 ---------NKLDTF-----------CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 238
+++ T+ G+P Y APE+F + Y G E D WSLG I++
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFEC 241
Query: 239 VSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKR 287
+ G PF E +++ + + F ++S + E+L+++ L+ N R
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LITNAENR 293
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 77/253 (30%), Positives = 126/253 (49%), Gaps = 12/253 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFR-EVRIMKMLDHPN 106
Y+L++ +G G + V A+++ TG+ A+KII +L PG L + E+ ++K H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV F + + L++ MEY GG + D + G + E + R+ + + Y H K
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRD+K N+LL ++K+ADFG + + T K +F G+P + APE+ +K G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 226 --VDVWSLGVILYTLVSGSLP-FDGSTLREL----RERVLRGKYRIPFYMSTDCENLLKK 278
D+W++G+ L P FD +R L + K + S+ N +K
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247
Query: 279 FLVLNPAKRASLE 291
L NP KR + E
Sbjct: 248 SLTKNPKKRPTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 1/103 (0%)
Query: 486 TLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
L++VME+ SGG + D L + + E + ++++ ++Y H IIHRD+KA N+L
Sbjct: 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130
Query: 545 LDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587
L S+ +K+ DFG S + + +T G+P + APE+ G
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 74/229 (32%), Positives = 119/229 (51%), Gaps = 25/229 (10%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG--SLQKLFREVRIMKMLDHPN 106
KL+K +G G F +V + + + K VA+K L PG S+Q E +MK L H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVK-----TLKPGTMSVQAFLEEANLMKTLQHDK 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQK 164
+V+L+ V+ E+ +Y++ EY + G + D+L G++ + QI + Y +K
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPELFQ 217
IHRDL+A N+L+ + KIADFG + NE+T G K + APE
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-----KWTAPEAIN 177
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + DVWS G++LY +V+ G +P+ G + ++ + RG YR+P
Sbjct: 178 FGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 47 KYKLLKTIGKGNFAKVKLA--KHVPTGKEVAIKII--DKTQLNPGSLQKLFREVRIMKML 102
KY++ IG+G + +V A K+ GKE AIK DK Q G Q RE+ +++ L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLREL 59
Query: 103 DHPNIVKLFQVI--ETEKTLYLVMEYASGGEVFDYL------------VLHGRMKEKEAR 148
H N+V L +V +K++YL+ +YA D + M +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSM----VK 111
Query: 149 AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN----IKIADFGFSNEFTPGNKLDTF 204
+ QI++ V Y H ++HRDLK N+L+ E +KI D G + F K
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-LA 170
Query: 205 CGSPP-----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 247
P Y APEL G ++ +D+W++G I L++ F G
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 86/301 (28%), Positives = 135/301 (44%), Gaps = 67/301 (22%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ LK IG G V A TG+ VAIK + + N ++ +RE+ +MK+++H N
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 107 IVKLFQVIETEKTL------YLVMEY--ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
I+ L V +K+L YLVME A+ +V + H RM Q++ +
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGI 131
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----YAAP 213
++ H IIHRDLK N+++ S+ +KI DFG + T G +F +P Y AP
Sbjct: 132 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGT---SFMMTPYVVTRYYRAP 186
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-------------------STLRELR 254
E+ G Y VD+WS+G I+ ++ G++ F G + L+
Sbjct: 187 EVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245
Query: 255 ERVL-----RGKYR-IPFYM------------------STDCENLLKKFLVLNPAKRASL 290
V R KY F ++ +LL K LV++P KR S+
Sbjct: 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305
Query: 291 E 291
+
Sbjct: 306 D 306
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 70/242 (28%), Positives = 121/242 (50%), Gaps = 9/242 (3%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL-FREVRIMKMLDHPNIVKLFQ 112
+GKG F +V + TGK A K +DK +L S +K+ E I++ ++ P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 113 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRD 170
E++ L LVM +GG++ ++ G + R QI + + H I++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWS 230
+K EN+LLD + N +++D G + E G + G+ Y APE+ + + Y P VD ++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWFA 179
Query: 231 LGVILYTLVSGSLPF----DGSTLRELRERVLRGKYRIPFY-MSTDCENLLKKFLVLNPA 285
+G +Y +V+G PF + EL+ R L + + + + +++ + FL P
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239
Query: 286 KR 287
R
Sbjct: 240 DR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 83/263 (31%), Positives = 131/263 (49%), Gaps = 40/263 (15%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+L+K +G G F +V + K VA+K + ++P + E +IMK L H +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLV 64
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA--------KFRQIVSAVQY 160
+L+ V+ +E+ +Y+V EY S G + D+L K+ E RA Q+ + + Y
Sbjct: 65 QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAP 213
+ IHRDL++ N+L+ + KIADFG + NE+T G K +P A
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMSTDC 272
F K DVWS G++L LV+ G +P+ G RE+ E+V RG YR+P DC
Sbjct: 178 GRFTIKS------DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMP--CPQDC 228
Query: 273 ENLLKKFLV----LNPAKRASLE 291
L + ++ +P +R + E
Sbjct: 229 PISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 74/242 (30%), Positives = 122/242 (50%), Gaps = 10/242 (4%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML----DHPNIVK 109
IG+G F +V + TGK A+K +DK ++ + L RIM L D P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
+ T L +++ +GG++ +L HG EKE R +I+ +++ H + +++R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ-GKKYDGPEVDV 228
DLK N+LLD +++I+D G + +F+ K G+ Y APE+ Q G YD D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGTAYDS-SADW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLR---ELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPA 285
+SLG +L+ L+ G PF + E+ L +P S + ++LL+ L + +
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239
Query: 286 KR 287
KR
Sbjct: 240 KR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 50/113 (44%), Positives = 72/113 (63%), Gaps = 1/113 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L LF +T++ L+ VMEY +GG++ ++ GR E AR +I+ +Q+ H+K I
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQG 585
I+RDLK +N+LLD + +IKIADFG E G K TFCG+P Y APE+ +G
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 72/256 (28%), Positives = 116/256 (45%), Gaps = 19/256 (7%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+ + +G GN V KH+PTG +A K++ +++ RE++IM P IV
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVV-HIGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KII 167
+ E + + ME+ G + G + + +V + Y + +I+
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQGKKYDGPEV 226
HRD+K N+L++S IK+ DFG S E N + DTF G+ Y +PE QG KY +
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGGKYT-VKS 183
Query: 227 DVWSLGVILYTLVSGSLPFDGST------------LRELRERVLRGKYRIPF-YMSTDCE 273
DVWSLG+ + L G PF S L L++ V R+P D
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 274 NLLKKFLVLNPAKRAS 289
+ + L+ +P +R +
Sbjct: 244 DFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 52/293 (17%)
Query: 44 HIGK-YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII---DKTQLNPGSLQKLFREVRIM 99
+G Y+ L IG+G + V A H PTG +VAIK I + Q+ RE++I+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTF----CQRTLREIKIL 57
Query: 100 KMLDHPNIVKLFQVI-----ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQ 153
+ H NI+ + +I E+ +Y+V E E Y ++ + + F Q
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELM---ETDLYKLIKTQHLSNDHIQYFLYQ 114
Query: 154 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS----NEFTPGNKLDTFCGSPP 209
I+ ++Y H ++HRDLK NLLL++ ++KI DFG + E L + +
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---------------------- 247
Y APE+ K +D+WS+G IL ++S F G
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234
Query: 248 STLRELRER----VLRGKYRIPF-----YMSTDCENLLKKFLVLNPAKRASLE 291
+ + LR R L K ++P+ +LL K L NP KR ++E
Sbjct: 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 21/240 (8%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQK----LFREVRIMKM 101
+ K IG G F +V + GK+ VAIK L GS K E IM
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIK-----TLKAGSSDKQRLDFLTEASIMGQ 61
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQY 160
DHPNI++L V+ + + ++ EY G + +L + G+ + R I S ++Y
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPP--YAAPELFQ 217
+ +HRDL A N+L++S + K++DFG S T G P + APE
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276
+K+ DVWS G++++ ++S G P+ + +++ + V G YR+P M DC + L
Sbjct: 182 YRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPM--DCPSAL 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 10/248 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL-FREVRIMKMLDHPN 106
++ + +GKG F +V + TGK A K ++K ++ + + E +I++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 164
+V L ET+ L LV+ +GG++ ++ G +E RA F +I ++ HQ+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD-G 223
+I++RDLK EN+LLD +I+I+D G + G + G+ Y APE+ + ++Y
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR----GKYRIPFYMSTDCENLLKKF 279
P D W+LG +LY +++G PF + RE V R + S D +L K
Sbjct: 182 P--DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239
Query: 280 LVLNPAKR 287
L +P +R
Sbjct: 240 LCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 4/207 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y L +G+G +A V + T VA+K I + + G+ REV ++K L H NI
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-QIVSAVQYCHQKKI 166
V L +I TEK+L LV EY ++ YL G F Q++ + YCH++K+
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSN-EFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRDLK +NLL++ +K+ADFG + + P + Y P++ G +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRE 252
+D+W +G I Y + +G F GST+ E
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ LK IG G V A G VA+K + + N ++ +RE+ ++K ++H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 107 IVKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
I+ L V +K+L YLVME V+H + + Q++ +++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLC---QVIHMELDHERMSYLLYQMLCGIKH 138
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGS 248
Y VD+WS+G I+ LV GS+ F G+
Sbjct: 199 YK-ENVDIWSVGCIMGELVKGSVIFQGT 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/215 (27%), Positives = 114/215 (53%), Gaps = 13/215 (6%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD 103
+ +++ K IG+G F++V A + K VA+K + ++ + + Q +E+ ++K L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQ 159
HPN++K + L +V+E A G++ + + K E+ F Q+ SAV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPEL 215
+ H ++++HRD+K N+ + + +K+ D G FS++ T + L G+P Y +PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPER 177
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
Y+ + D+WSLG +LY + + PF G +
Sbjct: 178 IHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 69/249 (27%), Positives = 124/249 (49%), Gaps = 12/249 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL-FREVRIMKMLDHPN 106
++ + +GKG F +V + TGK A K ++K ++ + + E +I++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 164
+V L ET+ L LV+ +GG++ ++ G E RA F +I ++ H++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
+I++RDLK EN+LLD +I+I+D G + E G + G+ Y APE+ + ++Y
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TF 180
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR------GKYRIPFYMSTDCENLLKK 278
D W LG ++Y ++ G PF + RE V R +Y F S ++ ++
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKF--SEAARSICRQ 238
Query: 279 FLVLNPAKR 287
L +P R
Sbjct: 239 LLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 47/104 (45%), Positives = 64/104 (61%), Gaps = 1/104 (0%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+T L VMEYA+GGE+F +L E AR +IVSA+ Y H +++RDLK E
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLE 124
Query: 542 NLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
NL+LD + +IKI DFG E + G + TFCG+P Y APE+ +
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-25
Identities = 70/211 (33%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT-QLNPGSLQKLFREVRI 98
+++P + L+ IG G+F V A+ V T + VAIK + + + + Q + +EV+
Sbjct: 20 KEDPE-KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 99 MKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSA 157
++ + HPN ++ E T +LVMEY G D L +H + ++E E A +
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
+ Y H +IHRD+KA N+LL +K+ADFG ++ +P N +F G+P + APE+
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVIL 194
Query: 218 GK---KYDGPEVDVWSLGVILYTLVSGSLPF 245
+YDG +VDVWSLG+ L P
Sbjct: 195 AMDEGQYDG-KVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 72/242 (29%), Positives = 119/242 (49%), Gaps = 10/242 (4%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML----DHPNIVK 109
IG+G F +V + TGK A+K +DK ++ + L RIM L D P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
+ T L +++ +GG++ +L HG E E R +I+ +++ H + +++R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ-GKKYDGPEVDV 228
DLK N+LLD +++I+D G + +F+ K G+ Y APE+ Q G YD D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDS-SADW 179
Query: 229 WSLGVILYTLVSGSLPFDGSTLR---ELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPA 285
+SLG +L+ L+ G PF + E+ L +P S + +LL+ L +
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239
Query: 286 KR 287
+R
Sbjct: 240 RR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 71/229 (31%), Positives = 104/229 (45%), Gaps = 41/229 (17%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPNIVKLFQ 112
IG+G F V H P+G +A+K I T ++ ++L ++ +M+ D P IVK +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRST-VDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 113 VIETEKTLYLVMEYASGGEVFD------YLVLHGRMKEKEARAKFRQIVSAVQYC----- 161
+ E ++ ME D Y VL + E +I+ +
Sbjct: 71 ALFREGDCWICMELMDIS--LDKFYKYVYEVLKSVIPE--------EILGKIAVATVKAL 120
Query: 162 -HQK---KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC-----GSPPYAA 212
+ K KIIHRD+K N+LLD NIK+ DFG S G +D+ G PY A
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMA 175
Query: 213 PELFQGKKYDGPEV--DVWSLGVILYTLVSGSLPFDG--STLRELRERV 257
PE DG +V DVWSLG+ LY + +G P+ S +L + V
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 60/216 (27%), Positives = 115/216 (53%), Gaps = 15/216 (6%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD 103
+ +++ K IG+G F++V A + G VA+K + L + + +E+ ++K L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-----MKEKEARAKFRQIVSAV 158
HPN++K + + L +V+E A G++ ++ H + + EK F Q+ SA+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPE 214
++ H ++++HRD+K N+ + + +K+ D G FS++ T + L G+P Y +PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPE 176
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
Y+ + D+WSLG +LY + + PF G +
Sbjct: 177 RIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 68/189 (35%), Positives = 104/189 (55%), Gaps = 12/189 (6%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT--QLNPGSLQKLFREVRIMKMLDHPNIV 108
L IG G+F V A + T + VA+K + + Q N Q + +EV+ ++ L HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTI 84
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKII 167
+ E T +LVMEY G D L +H + ++E E A + + Y H +I
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK---KYDGP 224
HRD+KA N+LL +K+ADFG +++ +P N +F G+P + APE+ +YDG
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDG- 199
Query: 225 EVDVWSLGV 233
+VDVWSLG+
Sbjct: 200 KVDVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 80/297 (26%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIK---IIDKTQLNPGSLQK---------LFREVRIM 99
+G+G + KV+ A TGK VAIK II+ + Q RE++IM
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 100 KMLDHPNIVKLFQVIETEKTLYLVMEYASG--GEVFDYLVLHGRMKEKEARAKFRQIVSA 157
+ H NI+ L V + LVM+ + +V D + R+ E + + QI++
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQILNG 131
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-------- 209
+ H+ +HRDL N+ ++S+ KIADFG + + DT
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 210 -------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LREL-RERVLRG 260
Y APEL G + VD+WS+G I L++G F G + +L R L G
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 261 K---------YRIPFYM-----------------STDCENLLKKFLVLNPAKRASLE 291
++P Y S D +LL+ L LNP +R S +
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308
|
Length = 335 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 49 KLLKTIGKGNFAKVKLAKHVP----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
K ++ +G+G+F KV L + P TG+ VA+K + K + + +E+ I+K L H
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYH 65
Query: 105 PNIVKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
NIVK K L L+MEY G + DYL H ++ + +QI + Y H
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLH 124
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC--GSPP--YAAPELFQG 218
+ IHRDL A N+LLD++ +KI DFG + G++ G P + A E +
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 219 KKYDGPEVDVWSLGVILYTLVS 240
K+ DVWS GV LY L++
Sbjct: 185 NKFSYAS-DVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 31/259 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ--KLFREVRIMKMLDHPN 106
+LL+ +G G F +V T VA+K L PG++ E +IMK L HP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNT-TPVAVK-----TLKPGTMDPKDFLAEAQIMKKLRHPK 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIVSAVQYCHQK 164
+++L+ V E+ +Y+V E G + +YL +K + Q+ S + Y +
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPELFQ 217
IHRDL A N+L+ K+ADFG + + + G K + APE
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI-----KWTAPEAAL 177
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276
++ + DVWS G++L +V+ G +P+ G T E+ ++V +G YR+P C L
Sbjct: 178 YNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMP--CPPGCPKEL 233
Query: 277 KKFLV----LNPAKRASLE 291
++ +P R + E
Sbjct: 234 YDIMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 64/223 (28%), Positives = 112/223 (50%), Gaps = 27/223 (12%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
+K +G G F V L K K VAIK I++ + S + E ++M L HP +V+L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQL 64
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQ---------IVSAVQYC 161
+ V +K LY+V E+ G + +YL ++ + K + + ++Y
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYL--------RQRQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP---PYAAPELFQG 218
+ IHRDL A N L+ S +K++DFG + + ++ + G+ ++ PE+F
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 219 KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260
KY + DVWS GV+++ + + G +PF+ + E+ E + RG
Sbjct: 176 SKYSS-KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 79/262 (30%), Positives = 130/262 (49%), Gaps = 23/262 (8%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPN 106
+++++TIGKG + KV + G + A+KI+D +++ E I+K L DHPN
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPN 76
Query: 107 IVKLFQV-----IETEKTLYLVMEYASGGEVFD----YLVLHGRMKEKEARAKFRQIVSA 157
+VK + + ++ L+LV+E +GG V D +L RM+E + +
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELF 216
+Q+ H K IHRD+K N+LL +E +K+ DFG S + T + +T G+P + APE+
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 217 QGKK-----YDGPEVDVWSLGVILYTLVSGSLPF-DGSTLRELRE--RVLRGKYRIPFYM 268
++ YD DVWSLG+ L G P D +R L + R P
Sbjct: 197 ACEQQLDSTYDA-RCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELW 255
Query: 269 STDCENLLKKFLVLNPAKRASL 290
S + + ++K L + KR ++
Sbjct: 256 SNEFNDFIRKCLTKDYEKRPTV 277
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 69/189 (36%), Positives = 101/189 (53%), Gaps = 12/189 (6%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT--QLNPGSLQKLFREVRIMKMLDHPNIV 108
L+ IG G+F V A+ V + VAIK + + Q N Q + +EVR ++ L HPN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTI 78
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKII 167
+ E T +LVMEY G D L +H + ++E E A + + Y H +I
Sbjct: 79 QYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 168 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK---KYDGP 224
HRD+KA N+LL +K+ DFG ++ P N F G+P + APE+ +YDG
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDG- 193
Query: 225 EVDVWSLGV 233
+VDVWSLG+
Sbjct: 194 KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 50/113 (44%), Positives = 70/113 (61%), Gaps = 8/113 (7%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE-KEARAKF--RQIVSAVQYCHQ 530
L+ LF +TE + VMEYA+GG+ L++H E RA F +V +QY H+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGD----LMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPEL 582
KI++RDLK +NLLLD+E +KIADFG E G++ TFCG+P + APE+
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 31/222 (13%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+ +++ L IG+G + V A+ +G+ VA+K + G RE+ ++ L H
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 105 PNIVKLFQVIETEK--TLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAV 158
PNIV+L +V+ + +++LVMEY D L M E + + Q++ +
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQ----DLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 209
QY H+ IIHRDLK NLLL + +KIADFG + + G P
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY----------GLPAKPMTPKVVT 171
Query: 210 --YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST 249
Y APEL G +D+W++G IL L++ G +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 69/254 (27%), Positives = 127/254 (50%), Gaps = 8/254 (3%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL-FREVRIMKMLDHPN 106
++ + +GKG F +V + TGK A K ++K ++ + + E +I++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 164
+V L ET+ L LV+ +GG++ ++ G +E RA F +I+ ++ H++
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
++RDLK EN+LLD +I+I+D G + + G + G+ Y APE+ ++Y
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRE----RVLRGKYRIPFYMSTDCENLLKKFL 280
D W LG ++Y ++ G PF G + RE RVL + S + +++ K L
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 281 VLNPAKRASLEVSG 294
+P +R + G
Sbjct: 241 TKDPKQRLGCQEEG 254
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 23/229 (10%)
Query: 48 YKLLKTIGKGNFAKV---KLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+ L + +G G F +V V VAIKI+ + Q +EV+ +K L H
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR----VAIKIL--KSDDLLKQQDFQKEVQALKRLRH 61
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFR-QIVSAVQYCH 162
+++ LF V + +Y++ E G + +L G++ + Q+ + Y
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP---PY--AAPELFQ 217
++ IHRDL A N+L+ ++ K+ADFG + K D + S PY APE
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLI----KEDVYLSSDKKIPYKWTAPEAAS 177
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + DVWS G++LY + + G +P+ G E+ +++ G YR+P
Sbjct: 178 HGTFST-KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMP 224
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 37/112 (33%), Positives = 65/112 (58%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L+ + E+ +YLV++ GG++ +L + E++ + +IV A++Y H K I
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
IHRD+K +N+LLD + ++ I DF + + TP + G+P Y APE+
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 4/214 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y L+ +G+G +A V + T VA+K I + + G+ REV ++K L H NI
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKI 166
V L ++ T+K+L LV EY ++ Y+ G M + QI+ + YCH++K+
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSN-EFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRDLK +NLL++ +K+ADFG + + P + Y P++ G +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR 259
+D+W +G I + + SG F GST+ + + R
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 22/227 (9%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
KL+K +G G F +V + + K VAIK + + ++P + E +MK L HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAF---LAEANLMKQLQHPRLV 64
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA--KFRQIVSAVQYCHQKKI 166
+L+ V+ T++ +Y++ EY G + D+L +K + QI + + +K
Sbjct: 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPELFQGK 219
IHRDL+A N+L+ + KIADFG + NE+T G K + APE
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI-----KWTAPEAINYG 178
Query: 220 KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + DVWS G++L +V+ G +P+ G T E+ + + RG YR+P
Sbjct: 179 TFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 73/249 (29%), Positives = 115/249 (46%), Gaps = 10/249 (4%)
Query: 52 KTIGKGNFAKVK--LAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVK 109
+G GNF VK + K + K VA+KI+ +P +L RE +M+ LD+P IV+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
+ + E E + LVME A G + +L + + EK Q+ ++Y + +HR
Sbjct: 61 MIGICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSP-PYAAPELFQGKKYDGPE 225
DL A N+LL ++ KI+DFG S K T P + APE K+ +
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS-K 178
Query: 226 VDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLN 283
DVWS GV+++ S G P+ G E+ + + G+ P + +L+K
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238
Query: 284 PAKRASLEV 292
+R V
Sbjct: 239 VDERPGFAV 247
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 81/251 (32%), Positives = 125/251 (49%), Gaps = 20/251 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII--DKTQLNPGSLQKLFREVRIMKMLDH 104
K L + IG+G F V ++ TG++VA+K I D T Q E +M L H
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTA------QAFLEETAVMTKLHH 58
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA-KFR-QIVSAVQYCH 162
N+V+L VI LY+VME S G + ++L GR + +F + ++Y
Sbjct: 59 KNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD 222
KK++HRDL A N+L+ + K++DFG + + G +D + APE + KK+
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFS 175
Query: 223 GPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI--PFYMSTDCENLLKKF 279
+ DVWS GV+L+ + S G P+ +L+E++E V +G YR+ P D L+
Sbjct: 176 S-KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLMTSC 233
Query: 280 LVLNPAKRASL 290
P KR S
Sbjct: 234 WETEPKKRPSF 244
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 60/229 (26%), Positives = 116/229 (50%), Gaps = 13/229 (5%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+ + +K +G G F V +P G+ VAIK++ + + +P + +++ E +M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMAS 65
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQY 160
+DHP++V+L + + + L+ + G + DY+ H + + QI + Y
Sbjct: 66 VDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPP--YAAPELFQ 217
+K+++HRDL A N+L+ + ++KI DFG + K G P + A E
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ Y + DVWS GV ++ L++ G+ P++G E+ + + +G+ R+P
Sbjct: 185 HRIYTH-KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLP 231
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 80/272 (29%), Positives = 130/272 (47%), Gaps = 39/272 (14%)
Query: 50 LLKTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKML-D 103
L K +G+G F +V A+ V VA+K++ K L L E+ +MKM+
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 74
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA----------KFRQ 153
H NI+ L V E LY+V+EYA+ G + D+L R + A +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKD 133
Query: 154 IVS-------AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---- 202
+VS +++ KK IHRDL A N+L+ + +KIADFG + + + +D
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI---HHIDYYRK 190
Query: 203 TFCGSPPYA--APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR 259
T G P APE + Y + DVWS GV+L+ + + G P+ G + EL + +L+
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LLK 248
Query: 260 GKYRI--PFYMSTDCENLLKKFLVLNPAKRAS 289
YR+ P + + +L++ P++R +
Sbjct: 249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 65/214 (30%), Positives = 114/214 (53%), Gaps = 6/214 (2%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y+ L+ +G+G++A V K GK VA+K+I + Q G+ RE ++K L H NI
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKI 166
V L +I T++TL LV EY ++ Y+ H G + + + Q++ + Y HQ+ I
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSN-EFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRDLK +NLL+ +K+ADFG + + P + + Y P++ G
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR 259
+D+W +G I ++ G F G ++++++++ R
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPG--MKDIQDQLER 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 42/280 (15%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y L+ +G G F V A+ TG+ VAIK I K P ++ +RE++++K L H N
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHEN 70
Query: 107 IVKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
I+ L + I + +Y V E G L+ ++++ + QI+ ++Y H
Sbjct: 71 IISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG 128
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE-LFQGKKYDGP 224
++HRDLK N+L++ ++KI DFG + P ++ + + Y APE + +KYD
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYD-V 185
Query: 225 EVDVWSLGVILYTLVSGSLPFDG----------------------------STLRELRER 256
EVD+WS G I ++ G F G +TLR ++
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS- 244
Query: 257 VLRGKYRIPFY-----MSTDCENLLKKFLVLNPAKRASLE 291
L + +PF +LL+K LV +P KR S
Sbjct: 245 -LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 14/266 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL-FREVRIMKMLDHPN 106
++ + +GKG F +V + TGK A K ++K ++ + + E RI++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 164
+V L ET+ L LV+ +GG++ ++ G E RA F ++ ++ ++
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD-G 223
+I++RDLK EN+LLD +I+I+D G + + G + G+ Y APE+ +KY
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR------GKYRIPFYMSTDCENLLK 277
P D W LG ++Y ++ G PF R RE V R +Y F S D +++ +
Sbjct: 182 P--DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF--SEDAKSICR 237
Query: 278 KFLVLNPAKRASLEVSGEVTLGGAPV 303
L NP +R +G + P+
Sbjct: 238 MLLTKNPKERLGCRGNGAAGVKQHPI 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 44/114 (38%), Positives = 68/114 (59%), Gaps = 5/114 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 531
L L +T+ L+ VMEY +GG++ + + R K E R++F ++ A+ + H+
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLM-FQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH 115
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
+I+RDLK +N+LLD+E + K+ADFG E G TFCG+P Y APE+ Q
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 50/258 (19%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPNIVK 109
+KT+G G F +V LA+ V T A+K + K L + + E I+ D+ +V+
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L+ + + LY VM+Y GG++ L+ G E AR ++ AV+ H+ IHR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 170 DLKAENLLLDSEMNIKIADFG--------------------------FSNEFTP------ 197
D+K +N+L+D + +IK+ DFG FSNE+
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 198 GNKLD----------------TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 241
G++L + G+P Y APE+ Y D WS+GVILY ++ G
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVG 244
Query: 242 SLPFDGSTLRELRERVLR 259
PF T E + +V+
Sbjct: 245 QPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 74/249 (29%), Positives = 120/249 (48%), Gaps = 17/249 (6%)
Query: 50 LLKTIGKGNFAKVKLA---KHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
L + IG+G F V VA+K K +P +K +E IM+ DHP+
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 165
IVKL VI E +++VME A GE+ YL ++ + + + Q+ +A+ Y K+
Sbjct: 69 IVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--YAAPELFQGKKYDG 223
+HRD+ A N+L+ S +K+ DFG S + G P + APE +++
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 224 PEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMSTDCE----NLLKK 278
DVW GV ++ ++ G PF G ++ R+ G+ R+P M +C +L+ K
Sbjct: 188 AS-DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLP--MPPNCPPTLYSLMTK 243
Query: 279 FLVLNPAKR 287
+P+KR
Sbjct: 244 CWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 44/112 (39%), Positives = 68/112 (60%), Gaps = 5/112 (4%)
Query: 473 TLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 532
++ FQ E +Y ++E+ GGE+F +L GR A+ ++V A +Y H K
Sbjct: 82 NMMCSFQ---DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
II+RDLK ENLLLD++ ++K+ DFGF+ + ++ T CG+P Y APE+ Q
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQ 188
|
Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
+ +G GN V A H+ T + +A+K+I + +++ E+ I+ D P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170
+ E + + E+ GG L ++ ++ E +V + Y KI+HRD
Sbjct: 65 YGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQGKKYDGPEVDVW 229
+K N+L+++ +K+ DFG S + N + T+ G+ Y APE G++Y G DVW
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDVW 177
Query: 230 SLGVILYTLVSGSLPF 245
SLG+ L G P+
Sbjct: 178 SLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 24/253 (9%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ LK IG G V A + VAIK + + N ++ +RE+ +MK ++H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 107 IVKLFQVIETEKTL------YLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAV 158
I+ L V +K+L YLVME +V + H RM Q++ +
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLCGI 132
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
++ H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278
Y VD+WS+G I+ +V + F G + +V+ + T C +KK
Sbjct: 193 MGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE-------QLGTPCPEFMKK 244
Query: 279 FLVLNPAKRASLE 291
L P R +E
Sbjct: 245 ---LQPTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
+Y L+ +G G+ V A K VA+K I T P S++ RE++I++ LDH
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHD 62
Query: 106 NIVKLFQVI-------------ETE-KTLYLVMEYASGGEVFDYLVL--HGRMKEKEARA 149
NIVK+++V+ TE ++Y+V EY D + G + E+ AR
Sbjct: 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARL 118
Query: 150 KFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSN----EFTPGNKLDTF 204
Q++ ++Y H ++HRDLK N+ +++E + +KI DFG + ++ L
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL 258
+ Y +P L +D+W+ G I +++G F G+ E + +L
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 70/255 (27%), Positives = 123/255 (48%), Gaps = 18/255 (7%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI-MKMLDHPNIVK 109
++ +G+G + V +HVPTG +A+K I + +N ++L ++ I M+ +D P V
Sbjct: 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 110 LFQVIETEKTLYLVMEY--ASGGEVFDYLVLHGRMKEKEARAKFR-QIVSAVQYCHQK-K 165
+ + E +++ ME S + + + G ++ K IV A++Y H K
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG----KKY 221
+IHRD+K N+L++ +K+ DFG S G PY APE K Y
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 184
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFD--GSTLRELRERVLRGKYRIP---FYMSTDCENLL 276
D + DVWSLG+ + L +G P+D + ++L++ V ++P F S + ++ +
Sbjct: 185 D-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF--SPEFQDFV 241
Query: 277 KKFLVLNPAKRASLE 291
K L N +R +
Sbjct: 242 NKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 5e-23
Identities = 78/232 (33%), Positives = 115/232 (49%), Gaps = 42/232 (18%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL--QKLFREVRIMKMLDHPNIVKLF 111
+G+G F +V + T K VAIK L PG++ + +E +IMK L H +V L+
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIK-----TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLY 67
Query: 112 QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----------RQIVSAVQYC 161
V+ +E+ +Y+V E+ G + D+L KE K+ QI + Y
Sbjct: 68 AVV-SEEPIYIVTEFMGKGSLLDFL--------KEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPE 214
+ IHRDL+A N+L+ + KIADFG + NE+T G K +P A
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
F K DVWS G++L LV+ G +P+ G RE+ E+V RG YR+P
Sbjct: 179 RFTIKS------DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 75/244 (30%), Positives = 120/244 (49%), Gaps = 18/244 (7%)
Query: 49 KLLKTIGKGNFAKVKLAK-HVPTGKEVAIKIIDKTQLNPGSLQK----LFREVRIMKMLD 103
K+ K IG G F +V + +P +E+ + I KT L G +K E IM D
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAI--KT-LKAGYTEKQRRDFLSEASIMGQFD 63
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCH 162
HPNI+ L V+ K + +V EY G + +L H G+ + R I S ++Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSN--EFTPGNKLDTFCGSPP--YAAPELFQG 218
+HRDL A N+L++S + K++DFG S E P T G P + APE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 219 KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
+K+ DVWS G++++ ++S G P+ + +++ + + G YR+P M DC L
Sbjct: 184 RKFTSAS-DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPM--DCPAALH 239
Query: 278 KFLV 281
+ ++
Sbjct: 240 QLML 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 6e-23
Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 55/283 (19%)
Query: 49 KLLKTIGKGNFAKVKLAKHVP----TGKEVAIKIIDKTQLNPGS----LQKLFREVRIMK 100
K ++ +G+G+F KV+L ++ P TG++VA+K L P S + L +E+ I++
Sbjct: 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEILR 61
Query: 101 MLDHPNIVKLFQVIETE--KTLYLVMEYASGGEVFDYL---VLHGRMKEKEARAKFRQIV 155
L H NIVK + + + L+ME+ G + +YL +K++ A QI
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QIC 119
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-------FTPGNKLDTFCGSP 208
+ Y ++ +HRDL A N+L++SE +KI DFG + +T + LD SP
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD----SP 175
Query: 209 PY-AAPE-LFQGKKYDGPEVDVWSLGVILYTLV----SGSLPFD------GSTLRELR-- 254
+ APE L Q K Y DVWS GV LY L+ S S P G T ++
Sbjct: 176 VFWYAPECLIQSKFYIAS--DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT 233
Query: 255 --ERVLRGKYRIPFYMSTDC----ENLLKKFLVLNPAKRASLE 291
RVL R+P +C L++K P+KR + +
Sbjct: 234 RLVRVLEEGKRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQ 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 72/253 (28%), Positives = 118/253 (46%), Gaps = 24/253 (9%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ LK IG G V A + VAIK + + N ++ +RE+ +MK ++H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 107 IVKLFQVIETEKTL------YLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAV 158
I+ L V +K+L Y+VME +V + H RM Q++ +
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCGI 139
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
++ H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278
Y VD+WS+G I+ ++ G + F G+ + +V+ + T C +KK
Sbjct: 200 MGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-------QLGTPCPEFMKK 251
Query: 279 FLVLNPAKRASLE 291
L P R +E
Sbjct: 252 ---LQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 48/112 (42%), Positives = 69/112 (61%), Gaps = 1/112 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L L +T L VMEYA+GGE+F +L E+ AR +IVSA++Y H + +
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
++RD+K ENL+LD + +IKI DFG E + G + TFCG+P Y APE+ +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 73/257 (28%), Positives = 113/257 (43%), Gaps = 50/257 (19%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPNIVK 109
+KT+G G F +V LA V T A+K + K LN + + E I+ D+ +VK
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
L+ + + LY VM+Y GG++ L+ E AR ++ A++ H+ IHR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEF--------------------TP------------ 197
D+K +N+L+D + +IK+ DFG F P
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185
Query: 198 GNKLDT----------------FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 241
G++L T G+P Y APE+ K Y D WS+GVIL+ ++ G
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVG 244
Query: 242 SLPFDGSTLRELRERVL 258
PF T E + +V+
Sbjct: 245 QPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 1e-22
Identities = 77/267 (28%), Positives = 133/267 (49%), Gaps = 29/267 (10%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH- 104
G ++L++ +G G + +V +HV TG+ AIK++D T +++ +E+ ++K H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHH 62
Query: 105 PNIVKLFQVI------ETEKTLYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIVS 156
NI + + L+LVME+ G V D + +KE+ R+I+
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF--TPGNKLDTFCGSPPYAAPE 214
+ + HQ K+IHRD+K +N+LL +K+ DFG S + T G + +TF G+P + APE
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAPE 181
Query: 215 LFQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF-DGSTLREL----RERVLRGKYRI 264
+ + YD + D+WSLG+ + G+ P D +R L R R K +
Sbjct: 182 VIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK- 239
Query: 265 PFYMSTDCENLLKKFLVLNPAKRASLE 291
S ++ ++ LV N ++R + E
Sbjct: 240 --KWSKKFQSFIESCLVKNHSQRPTTE 264
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 11/216 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ LK +G G + V A TG +VAIK + + + ++ +RE+R++K + H N
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 107 IVKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
++ L V + +L YLVM + G L+ H ++ E + Q++ ++Y
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H IIHRDLK NL ++ + +KI DFG + + +++ + + Y APE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWM 191
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRE 255
+ VD+WS+G I+ +++G F G L +L E
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 44/113 (38%), Positives = 72/113 (63%), Gaps = 1/113 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +TE L+ V+E+ SGG++ ++ ++ E+ AR +I A+ + H++ I
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
I+RDLK +N+LLD+E +IK+ D+G E PG+ TFCG+P Y APE+ +G
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 51/151 (33%), Positives = 85/151 (56%), Gaps = 1/151 (0%)
Query: 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKM 101
P I ++ ++K I +G F KV L + K A+K++ K + N + ++ E + +
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
P IV L+ +++ +YLVMEY GG+V L ++G E+ A ++ A+ Y
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192
H+ IIHRDLK +N+L+ +E +IK+ DFG S
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 40/277 (14%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLF 111
+ IG G F V GK VA+K + N S +++FRE++++ H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 112 QVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+++ + +Y+V E ++ +V + + QI+ ++Y H I
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSN--EFTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
+HRD+K NLL++S +KI DFG + E + + Y APE+ G ++
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 225 EVDVWSLGVILYTLVSGSLPFD-----------------------GSTLRELRERVLRGK 261
VD+WS+G I L+ + F S R +LRG
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244
Query: 262 YRIP-----FYMSTDCE----NLLKKFLVLNPAKRAS 289
++ P + +S+ +LL + LV +P KR S
Sbjct: 245 HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS 281
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 72/227 (31%), Positives = 115/227 (50%), Gaps = 22/227 (9%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+L +G+G F +V + T VAIK + ++P + +E ++MK L H +V
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 64
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKF-RQIVSAVQYCHQKKI 166
+L+ V+ +E+ +Y+V EY S G + D+L G+ QI S + Y +
Sbjct: 65 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPELFQGK 219
+HRDL+A N+L+ + K+ADFG + NE+T G K +P A F K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 220 KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
DVWS G++L L + G +P+ G RE+ ++V RG YR+P
Sbjct: 184 S------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.4 bits (246), Expect = 3e-22
Identities = 49/121 (40%), Positives = 65/121 (53%), Gaps = 11/121 (9%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKK 532
KL+ + E +LYLVMEY GG + D L GR + E EA QI+SA++Y H K
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 533 IIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGN-------KLDTFCGSPPYAAPELFQ 584
IIHRD+K EN+LLD + +K+ DFG + T G+P Y APE+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 585 G 585
G
Sbjct: 182 G 182
|
Length = 384 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI-MKMLDHPNI 107
+ L IG G +V + TG +A+K + +T N +++ ++ + +K D P I
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYI 76
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLV--LHGRMKEKEARAKFRQIVSAVQYCHQKK 165
VK + T+ +++ ME S D L+ + G + E IV A+ Y +K
Sbjct: 77 VKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 166 -IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK----K 220
+IHRD+K N+LLD+ N+K+ DFG S G Y APE K
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPK 194
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDG 247
YD DVWSLG+ L L +G P+
Sbjct: 195 YD-IRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 46/110 (41%), Positives = 65/110 (59%), Gaps = 1/110 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L +L +T LY VMEY +GG++ ++ G+ KE A +I + + H K I
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPEL 582
I+RDLK +N++LD+E +IKIADFG E G TFCG+P Y APE+
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 27/234 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
+ L+ +G+G F KV + + VAIK + + P Q+ +E +M L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQ 66
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR----------- 152
HPNIV L V E+ ++ EY + G++ ++LV + + A +
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 153 -----QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 207
QI + ++Y +HRDL A N L+ + +KI+DFG S + + S
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 208 P-P--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERV 257
P + PE K+ E D+WS GV+L+ + S G P+ G + +E+ E +
Sbjct: 187 LLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 7e-22
Identities = 47/113 (41%), Positives = 70/113 (61%), Gaps = 1/113 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L L+ +T++ L+ VME+ +GG++ ++ GR A +IV +Q+ H K I
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQG 585
I+RDLK +N++LD + +IKIADFG E G N+ TFCG+P Y APE+ QG
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-22
Identities = 44/119 (36%), Positives = 74/119 (62%), Gaps = 1/119 (0%)
Query: 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 527
+S L+ L +T L+LV+EY +GG++ ++ ++ E+ AR +I A+ +
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNF 111
Query: 528 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
H++ II+RDLK +N+LLD++ +IK+ D+G E PG+ TFCG+P Y APE+ +G
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-22
Identities = 68/226 (30%), Positives = 117/226 (51%), Gaps = 24/226 (10%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
G ++L++ +G G + +V +HV TG+ AIK++D T+ +++ E+ ++K H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHH 72
Query: 106 NIVKLFQVIETEKT-------LYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIV 155
+ + +K+ L+LVME+ G V D LV + + +KE R+I+
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREIL 131
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF--TPGNKLDTFCGSPPYAAP 213
+ + H K+IHRD+K +N+LL +K+ DFG S + T G + +TF G+P + AP
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAP 190
Query: 214 ELFQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF-DGSTLREL 253
E+ + YD D+WSLG+ + G+ P D +R L
Sbjct: 191 EVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 52/289 (17%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY +K IG+G + V AK+ T ++VAIK I N ++ RE+++++ LDH N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 107 IVKLFQVI-----ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEA------RAKFRQIV 155
++ + ++ E +Y+V E LH ++ + + Q++
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTD-------LHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN-EFTPGNKLDTFCGSPPYAAPE 214
++Y H ++HRDLK NLLL++ ++KI DFG + G+ + + + Y APE
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-------------------STLRELRE 255
L +DVWS+G I L+ F G L +R
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238
Query: 256 RVLRGKY--------RIPF-----YMSTDCENLLKKFLVLNPAKRASLE 291
R +Y R F + + +LL+K LV +P+KR ++E
Sbjct: 239 EKAR-RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE 286
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 18/215 (8%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DH 104
+++++TIGKG + KV + G A+KI+D +++ E I++ L +H
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNH 78
Query: 105 PNIVKLFQVIETEK-----TLYLVMEYASGGEVFDY----LVLHGRMKEKEARAKFRQIV 155
PN+VK + + L+LV+E +GG V + L+ R+ E +
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPE 214
+Q+ H +IIHRD+K N+LL +E +K+ DFG S + T + +T G+P + APE
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 215 LFQ-GKKYD---GPEVDVWSLGVILYTLVSGSLPF 245
+ ++YD DVWSLG+ L G P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 40/115 (34%), Positives = 59/115 (51%), Gaps = 9/115 (7%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAVQYCHQK 531
KL VI TE+ LYLV EY D YL G + ++ Q++ + YCH
Sbjct: 62 KLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQG 585
+I+HRDLK +N+L++ + +K+ADFG + F P + Y APE+ G
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 46/112 (41%), Positives = 66/112 (58%), Gaps = 1/112 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L +L+ +T L+ VME+ +GG++ ++ R E AR +I SA+ + H K I
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
I+RDLK +N+LLD E + K+ADFG E G TFCG+P Y APE+ Q
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-21
Identities = 46/113 (40%), Positives = 72/113 (63%), Gaps = 1/113 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +TE L+ V+EY +GG++ ++ ++ E+ AR +I A+ Y H++ I
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
I+RDLK +N+LLDSE +IK+ D+G E PG+ TFCG+P Y APE+ +G
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ L +G G + +V A TG++VAIK + + + ++ +RE+R++K +DH N
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 107 IVKLFQV------IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
++ L V +E + +YLV G + +V ++ + + QI+ ++Y
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKY 133
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFS--NEFTPGNKLDTFCGSPPYAAPELFQG 218
H IIHRDLK N+ ++ + +KI DFG + + ++ + + Y APE+
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLN 189
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGS 248
+ VD+WS+G I+ L++G F GS
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 46/110 (41%), Positives = 64/110 (58%), Gaps = 1/110 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +T LY V++Y +GGE+F +L E AR +I SA+ Y H I
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPEL 582
I+RDLK EN+LLDS+ ++ + DFG E +K TFCG+P Y APE+
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 38/103 (36%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 486 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545
L+++MEY GG D L+ G++ E R+++ ++Y H++ IHRD+KA N+LL
Sbjct: 73 KLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL 131
Query: 546 DSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGA 587
E ++K+ADFG S + T +K +TF G+P + APE+ +
Sbjct: 132 SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL-------QKLFREVRIMKMLDHPN 106
+GKG + V G+ +A+K + +L+ ++ +KL EV ++K L H N
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVK---QVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV+ + T+ + ME+ GG + L G + E +QI+ V Y H +
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEF-------TPGNKLDTFCGSPPYAAPELFQGK 219
+HRD+K N++L IK+ DFG + T N L + G+P + APE+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPF 245
Y G + D+WS+G ++ + +G P
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 80/295 (27%), Positives = 137/295 (46%), Gaps = 60/295 (20%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+YK+ + IGKG++ V A TG++VAIK I+ + ++ RE++++++L HP+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 107 IVKLFQVI-----ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK------FRQIV 155
IV++ ++ K +Y+V E LH +K + Q++
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESD-------LHQVIKANDDLTPEHHQFFLYQLL 113
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS----NEFTPGNKLDT-FCGSPPY 210
A++Y H + HRDLK +N+L +++ +KI DFG + N+ TP T + + Y
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFWTDYVATRWY 172
Query: 211 AAPEL---FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-------------------- 247
APEL F KY P +D+WS+G I +++G F G
Sbjct: 173 RAPELCGSFFS-KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230
Query: 248 --STLRELRER----VLRGKYRIPF---YMSTD--CENLLKKFLVLNPAKRASLE 291
S +R + R +R K +PF + + D LL++ L +P R + E
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 51/136 (37%), Positives = 73/136 (53%), Gaps = 12/136 (8%)
Query: 462 KPSRRASSGGETLLKLFQ---VIE------TEKTLYLVMEYASGGEVFDYLVLHGR--MK 510
K R A+ +LKL +IE +K L +VMEYA GG + +Y+ +
Sbjct: 40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD 99
Query: 511 EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTPGNKLD 569
E F QI+ A+ + H K I+HRDLK +N+LLD +M +KI DFG S + +K
Sbjct: 100 EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159
Query: 570 TFCGSPPYAAPELFQG 585
T G+P Y +PEL +G
Sbjct: 160 TVVGTPCYISPELCEG 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 2/104 (1%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
L++VMEY G V D + + + + E+E A Q + ++Y H K IHRD+KA
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAG 128
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQ 584
N+LL+ E K+ADFG S + T K +T G+P + APE+ Q
Sbjct: 129 NILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 74/252 (29%), Positives = 120/252 (47%), Gaps = 20/252 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
K+KL G G + +V VA+K + + + +++ +E +MK + HPN
Sbjct: 11 KHKL----GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPN 63
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQYCHQ 163
+V+L V E Y++ E+ + G + DYL R +E A QI SA++Y +
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 122
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP---PYAAPELFQGKK 220
K IHRDL A N L+ +K+ADFG S G+ G+ + APE K
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI--PFYMSTDCENLLK 277
+ + DVW+ GV+L+ + + G P+ G L ++ E + +G YR+ P L++
Sbjct: 182 FSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMR 239
Query: 278 KFLVLNPAKRAS 289
NP+ R S
Sbjct: 240 ACWQWNPSDRPS 251
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-21
Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 51/287 (17%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF-REVRIMKMLD 103
+ +Y +++ IGKG +V LA + VA+K I + L+K F RE +I L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASG-------GEVFDYLVLHGRMKEKEARAK----FR 152
HP IV ++ + +Y M Y G V+ L + EK + F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLL---------------------DSEMNIKIADFG- 190
+I + ++Y H K ++HRDLK +N+LL + ++I + +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 191 -FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST 249
+S+ PG G+P Y APE G D+++LGVILY +++ S P+
Sbjct: 181 CYSSMTIPGK----IVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 250 LREL--RERVLR----GKYR-IPFYMSTDCENLLKKFLVLNPAKRAS 289
R++ R+ +L YR IP ++S + K L ++PA+R S
Sbjct: 236 GRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYS 278
|
Length = 932 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 50 LLKTIGKGNF--AKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
LL IGK V LAKH PT VA+K I+ + L+ L +E+ + L HPNI
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLH---GRMKEKEARAKFRQIVSAVQYCHQK 164
+ + LY+V + G D L H G + E + +++A+ Y H K
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSK 120
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSP-------PYAAPELF 216
IHR +KA ++LL + + ++ +S G + P P+ +PE+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 217 QG--KKYDGPEVDVWSLGVILYTLVSGSLPF 245
Q + Y+ + D++S+G+ L +G +PF
Sbjct: 181 QQNLQGYN-EKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
H + L++ IG G F V L + ++VAIK I + + S + E ++M L
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAM---SEEDFIEEAQVMMKLS 57
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCH 162
HP +V+L+ V + LV E+ G + DYL G+ ++ + + Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP---PYAAPELFQGK 219
+IHRDL A N L+ +K++DFG + F ++ + G+ +++PE+F
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 220 KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260
KY + DVWS GV+++ + S G P++ + E+ E + G
Sbjct: 177 KYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 6e-21
Identities = 89/324 (27%), Positives = 148/324 (45%), Gaps = 44/324 (13%)
Query: 36 SRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFRE 95
+ + E + +Y+++K IG G F +V L KH T + K I L +L E
Sbjct: 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 96 VRIMKMLDHPNIVKLFQ--VIETEKTLYLVMEYASGGEVFDYLV----LHGRMKEKEARA 149
V +M+ L H NIV+ + + + LY++ME+ G++ + + G+++E
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 150 KFRQIVSAVQYCHQ-------KKIIHRDLKAENLLLDSEMN-----------------IK 185
RQ++ A+ YCH ++++HRDLK +N+ L + + K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 186 IADFGFSNEFTPGNKLDTFCGSPPYAAPELF--QGKKYDGPEVDVWSLGVILYTLVSGSL 243
I DFG S + + G+P Y +PEL + K YD + D+W+LG I+Y L SG
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKT 241
Query: 244 PF-DGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS-LEVSGEVTLG-- 299
PF + +L + RG S + L+K L L+ +R S L+ G +
Sbjct: 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301
Query: 300 GAPVTSSGGAGTNHTHNSSISPAP 323
G PV ++GG ++ AP
Sbjct: 302 GPPVGAAGGGA-------GVAAAP 318
|
Length = 1021 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 44/103 (42%), Positives = 65/103 (63%), Gaps = 1/103 (0%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+T+ LYLV +Y SGGE+F +L GR E A+ ++V A+++ H+ I++RDLK E
Sbjct: 66 QTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELF 583
N+LLD+ +I + DFG S NK +TFCG+ Y APE+
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 44/115 (38%), Positives = 73/115 (63%), Gaps = 2/115 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +T+ L+L+++Y +GGE+F +L R KE+E + +IV A+++ H+ I
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGG 586
I+RD+K EN+LLDS ++ + DFG S EF + +FCG+ Y AP++ +GG
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 42/114 (36%), Positives = 61/114 (53%), Gaps = 2/114 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-K 532
++K + E + +V+EY GG + D L G++ E RQI+ + Y H K
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQG 585
IIHRD+K NLL++S+ +KIADFG S +TF G+ Y +PE QG
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-20
Identities = 46/114 (40%), Positives = 70/114 (61%), Gaps = 2/114 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +TE L+L+++Y SGGE+F +L E E R +I+ A+++ H+ I
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI 126
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQG 585
++RD+K EN+LLDSE ++ + DFG S EF K T FCG+ Y APE+ +G
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 45/112 (40%), Positives = 65/112 (58%), Gaps = 1/112 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +T + LY V++Y +GGE+F +L E AR ++ SA+ Y H I
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
I+RDLK EN+LLDS+ ++ + DFG E P TFCG+P Y APE+ +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 18/251 (7%)
Query: 42 EPHIGKYKLLKTIGKGNFAKV-KLAKHVPTGKEVAIKIIDKTQLNPGSLQK----LFREV 96
E H K IG G F +V + +P KEVA+ I KT L PG +K E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAI--KT-LKPGYTEKQRQDFLSEA 57
Query: 97 RIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIV 155
IM H NI++L V+ K ++ EY G + YL H G + R I
Sbjct: 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIA 117
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN--EFTPGNKLDTFCGSPP--YA 211
+ ++Y +HRDL A N+L++S + K++DFG S E P T G P +
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 212 APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMST 270
APE +K+ DVWS G++++ ++S G P+ + E+ + + G +R+P M
Sbjct: 178 APEAIAYRKFTSAS-DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPM-- 233
Query: 271 DCENLLKKFLV 281
DC + + + ++
Sbjct: 234 DCPSAVYQLML 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 35/106 (33%), Positives = 65/106 (61%), Gaps = 2/106 (1%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540
L++VMEY GG + D + + RM E + R+++ ++Y H + +IHRD+K+
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKS 144
Query: 541 ENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQG 585
+N+LL + ++K+ADFGF+ + T +K ++ G+P + APE+ +
Sbjct: 145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 44/113 (38%), Positives = 69/113 (61%), Gaps = 1/113 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L L+ +T++ L+ VMEY +GG++ ++ + A +I+ +Q+ H K I
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQG 585
++RDLK +N+LLD++ +IKIADFG E G+ K TFCG+P Y APE+ G
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 48/105 (45%), Positives = 65/105 (61%), Gaps = 2/105 (1%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH-QKKIIHRDLKA 540
+T L VMEYA+GGE+F +L E AR +IVSA+ Y H +K +++RDLK
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 124
Query: 541 ENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
ENL+LD + +IKI DFG E G + TFCG+P Y APE+ +
Sbjct: 125 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 46/110 (41%), Positives = 67/110 (60%), Gaps = 1/110 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L +L +T LY VMEY +GG++ ++ G+ KE +A +I + + H++ I
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPEL 582
I+RDLK +N++LDSE +IKIADFG E G TFCG+P Y APE+
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 41/118 (34%), Positives = 65/118 (55%), Gaps = 4/118 (3%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
E +++ + + ++TL + MEY GG V D L +G + E R RQI+ V+Y H
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEF----TPGNKLDTFCGSPPYAAPELFQG 585
I+HRD+K N+L DS N+K+ DFG S + G + + G+P + +PE+ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 71/252 (28%), Positives = 108/252 (42%), Gaps = 19/252 (7%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
L +GKGN+ V H PTG +A+K I + +L+ ++ E+ I+ P IV
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV-----QYCHQKK 165
+ E +Y+ MEY G + D L G E R+I AV +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGP 224
IIHRD+K N+L++ +K+ DFG S K + C S Y APE + +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGPNQN 181
Query: 225 -----EVDVWSLGVILYTLVSGSLPFDGST----LRELRERVLRGKYRIPFYMSTDCENL 275
+ DVWSLG+ + + G P+ T +L V +P S D ++
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241
Query: 276 LKKFLVLNPAKR 287
+ K L P +R
Sbjct: 242 VAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 4/204 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y L+ +G+G++A V G+ VA+K+I + G RE ++K L H NI
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKI 166
V L +I T++TL V EY ++ Y++ H G + R Q++ + Y H + I
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRDLK +NLL+ +K+ADFG + + P + + Y P++ G
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 226 VDVWSLGVILYTLVSGSLPFDGST 249
+D+W G I ++ G F G +
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVS 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 47/104 (45%), Positives = 63/104 (60%), Gaps = 1/104 (0%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+T+ L VMEY +GGE+F +L E R +IVSA+ Y H KI++RDLK E
Sbjct: 65 QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLE 124
Query: 542 NLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
NL+LD + +IKI DFG E T + TFCG+P Y APE+ +
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 1/113 (0%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540
IET +LY+++EYA G + + G E Q++ + Y H++ +IHRD+KA
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127
Query: 541 ENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSS 592
N+L + +K+ADFG + + + G+P + APE+ + T+S
Sbjct: 128 ANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-20
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 10/219 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ L +G G + V A TG VA+K + + + ++ +RE+R++K + H N
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 107 IVKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
++ L V ++L YLV G + +V ++ + + QI+ ++Y
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H IIHRDLK NL ++ + +KI DFG + +++ + + Y APE+
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR 259
+ VD+WS+G I+ L++G F G+ + + +LR
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 73/229 (31%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL--QKLFREVRIMKMLDHPN 106
KL K +G G F +V +A + K VA+K + PGS+ + E +MK L H
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK-VAVK-----TMKPGSMSVEAFLAEANVMKTLQHDK 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFR-QIVSAVQYCHQK 164
+VKL V+ T++ +Y++ E+ + G + D+L G + F QI + + Q+
Sbjct: 63 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAPELFQ 217
IHRDL+A N+L+ + + KIADFG + NE+T G K + APE
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-----KWTAPEAIN 176
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + DVWS G++L +V+ G +P+ G + E+ + RG YR+P
Sbjct: 177 FGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 43/112 (38%), Positives = 60/112 (53%), Gaps = 2/112 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+KL + ++ LYL MEY GG+ L G + E AR ++ AV H+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
IHRDLK EN L+D+ +IK+ DFG S ++ GSP Y APE+ +G
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG 172
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 4/207 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
++ + +G GN V H P+G +A K+I ++ P ++ RE++++ + P I
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KI 166
V + ++ + + ME+ GG + L GR+ E+ ++ + Y +K KI
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
+HRD+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG Y +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYS-VQS 183
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLREL 253
D+WS+G+ L + G P +EL
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-20
Identities = 79/265 (29%), Positives = 117/265 (44%), Gaps = 35/265 (13%)
Query: 1 MNDKSF---RYSTGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKG 57
MNDK S + E + + + R ++ YKL IG G
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDNDI---NRSPNK---------SYKLGNIIGNG 77
Query: 58 NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQ----- 112
+F V A + T ++VAIK K +P Q RE+ IMK L+H NI+ L
Sbjct: 78 SFGVVYEAICIDTSEKVAIK---KVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTE 131
Query: 113 -VIETEKTLYL--VMEYASGGEVFDYLVLHGRMKEKE----ARAKFRQIVSAVQYCHQKK 165
+ EK ++L VME+ V Y+ + R + Q+ A+ Y H K
Sbjct: 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190
Query: 166 IIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
I HRDLK +NLL+D + +K+ DFG + G + ++ S Y APEL G
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTT 250
Query: 225 EVDVWSLGVILYTLVSGSLPFDGST 249
+D+WSLG I+ ++ G F G +
Sbjct: 251 HIDLWSLGCIIAEMILGYPIFSGQS 275
|
Length = 440 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 54/222 (24%), Positives = 84/222 (37%), Gaps = 39/222 (17%)
Query: 52 KTIGKGNFAKVKLAK-HVPTGKEVAIKIIDKTQLNP--------------GSLQKLFREV 96
+ +G+G F +V L + + P + + +EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 97 RIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKF---- 151
+I+ L PNI +L V + L ++MEY G++ +L H +K
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 152 ------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDT 203
QI S ++Y +HRDL N L+ IKIADFG S + ++
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ- 189
Query: 204 FCGSPP----YAAPELFQGKKYDGPEVDVWSLGVIL---YTL 238
G P + A E K+ + DVW+ GV L TL
Sbjct: 190 --GRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 10/113 (8%)
Query: 480 VIETEKTLYLVMEYASGGE----VFDYLVLHGRMKEKEARAKFRQIVSAVQYCH-----Q 530
+ + +TLY+VMEY GG+ + ++E+ Q++ A+ CH
Sbjct: 69 IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG 128
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPEL 582
++HRDLK N+ LD+ N+K+ DFG + + T+ G+P Y +PE
Sbjct: 129 NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 70/226 (30%), Positives = 115/226 (50%), Gaps = 13/226 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEV----AIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
K +K +G G F V VP G+ V AIKI+++T P + + E IM +DH
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDH 68
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQ 163
P++V+L V T+ LV + G + DY+ H + + QI + Y +
Sbjct: 69 PHLVRLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPP--YAAPELFQGKK 220
++++HRDL A N+L+ S ++KI DFG + K + G P + A E +K
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + DVWS GV ++ L++ G P+DG RE+ + + +G+ R+P
Sbjct: 188 FTH-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLP 231
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 77/258 (29%), Positives = 128/258 (49%), Gaps = 39/258 (15%)
Query: 50 LLKTIGKGNFAKVKLAKHVPTGKE-------VAIKIIDKTQLNPGSLQKLFREVRIMKML 102
L K +G+G F +V +A+ + KE VA+K++ K+ L L E+ +MKM+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMI 80
Query: 103 -DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL----------------VLHGRMKEK 145
H NI+ L + LY+++EYAS G + +YL V ++ K
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 146 EARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD--- 202
+ + Q+ ++Y KK IHRDL A N+L+ + +KIADFG + + + +D
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI---HHIDYYK 197
Query: 203 -TFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258
T G P + APE + Y + DVWS GV+L+ + + G P+ G + EL ++L
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-KLL 255
Query: 259 RGKYRIPFYMSTDCENLL 276
+ +R+ ++C N L
Sbjct: 256 KEGHRMD--KPSNCTNEL 271
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 4/195 (2%)
Query: 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
L +G GN V H P+G +A K+I ++ P ++ RE++++ + P IV
Sbjct: 6 LGELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHR 169
+ ++ + + ME+ GG + L GR+ E ++ + Y +K KI+HR
Sbjct: 65 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVW 229
D+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG Y + D+W
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHY-TVQSDIW 182
Query: 230 SLGVILYTLVSGSLP 244
SLG+ L + G P
Sbjct: 183 SLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ-KLFREVRIMKML--- 102
+Y+ + IG G + V A+ +G VA+K + + Q N L REV ++K L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 103 DHPNIVKLFQVIETEKT-----LYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIV 155
DHPNIV+L V T +T + LV E+ ++ YL V + + + RQ +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 215
+ + H I+HRDLK EN+L+ S +K+ADFG + ++ L + Y APE+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 216 FQGKKYDGPEVDVWSLGVIL 235
Y P VD+WS+G I
Sbjct: 179 LLQSTYATP-VDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 36/238 (15%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKE-------VAIKIIDKTQLNPGSLQKLFREVRIM 99
K L K +G+G F +V +A+ + K+ VA+K++ K L L E+ +M
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMM 74
Query: 100 KML-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL----------------VLHGRM 142
KM+ H NI+ L + LY+++EYAS G + +YL V +M
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 143 KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202
K+ + Q+ ++Y +K IHRDL A N+L+ +KIADFG + + N +D
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV---NNID 191
Query: 203 ----TFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253
T G P + APE + Y + DVWS GV+++ + + G P+ G + EL
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-20
Identities = 47/112 (41%), Positives = 66/112 (58%), Gaps = 4/112 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ FQ T LYL++EY SGGE+F +L G E A +I A+++ HQ+ I
Sbjct: 65 LIYAFQ---TGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
I+RDLK EN+LLD++ ++K+ DFG E G TFCG+ Y APE+
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 48/110 (43%), Positives = 64/110 (58%), Gaps = 1/110 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L +L +T LY VMEY +GG++ + GR KE A +I + + H K I
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPEL 582
I+RDLK +N++LDSE +IKIADFG E G TFCG+P Y APE+
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 54 IGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLF 111
+G GNF VK + K+ VAIK++ K + ++ RE IM LD+P IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 112 QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE---KEARAKFRQIVSAVQYCHQKKIIH 168
V E E L LVME ASGG + +L G+ E Q+ ++Y K +H
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 169 RDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSP-PYAAPELFQGKKYDGP 224
RDL A N+LL ++ KI+DFG S + K + P + APE +K+
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS- 177
Query: 225 EVDVWSLGVILYTLVS-GSLPF 245
DVWS G+ ++ S G P+
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 27/240 (11%)
Query: 50 LLKTIGKGNFAKVKLAK--HVPTGKE---VAIKIIDKTQLNPGSLQKLF-REVRIMKMLD 103
L + +G+G F KV L + H+ + VA+K + +T N +K F RE ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQ 66
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG---RMKEKEARAKFR-------- 152
H NIVK + V +V EY G++ +L HG +
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 153 ---QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF--TPGNKLDTFCGS 207
QI S + Y + +HRDL N L+ ++ +KI DFG S + T ++
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 208 P-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
P + PE +K+ E DVWS GV+L+ + + G P+ G + E+ E + +G+
Sbjct: 187 PIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 4/207 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
++ + +G GN V +H P+G +A K+I ++ P ++ RE++++ + P I
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KI 166
V + ++ + + ME+ GG + L R+ E+ ++ + Y +K +I
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
+HRD+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG Y +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYS-VQS 183
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLREL 253
D+WS+G+ L L G P +EL
Sbjct: 184 DIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 24/234 (10%)
Query: 48 YKLLKTIGKGNFAKVK---LAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMKMLD 103
+ L + +GKG F V+ L + ++VA+K++ K + S +++ RE MK D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 104 HPNIVKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEK------EARAKF 151
HPN++KL V + +++ + G++ +L L R+ E+ + +F
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFTLPLQTLVRF 118
Query: 152 R-QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP-- 208
I S ++Y K IHRDL A N +L+ M + +ADFG S + G+ C S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 209 -PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260
+ A E Y DVW+ GV ++ +++ G P+ G E+ +++G
Sbjct: 179 VKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 54/218 (24%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ L +G G + V A ++VA+K + + + ++ +RE+R++K + H N
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 107 IVKLFQV------IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
++ L V IE +YLV G + +V ++ ++ + Q++ ++Y
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H IIHRDLK N+ ++ + ++I DFG + + +++ + + Y APE+
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWM 191
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL 258
+ VD+WS+G I+ L+ G F G+ + +R++
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 48/289 (16%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKML-DH 104
Y+L+K +G+G + V A++ T +E VAIK I ++ RE+++++ H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 105 PNIVKLFQV-IETE---KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAV 158
NI L+ + I LYL E E + ++ +A + QI+ +
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELM---EADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-----NKLDTFCGSPPYAAP 213
+Y H ++HRDLK NLL++++ +KI DFG + F+ + + + Y AP
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-------------------TLRELR 254
E+ + +DVWS+G IL L+ F G TL +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 255 E-------RVLRGKYRIPF-----YMSTDCENLLKKFLVLNPAKRASLE 291
R L + PF + +LL+K L +P KR S+E
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE 287
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 41/105 (39%), Positives = 64/105 (60%), Gaps = 1/105 (0%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
++ + LYLV+ + +GGE+F +L GR AR +++ A++ H+ +I+RDLK E
Sbjct: 63 QSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPE 122
Query: 542 NLLLDSEMNIKIADFGFSN-EFTPGNKLDTFCGSPPYAAPELFQG 585
N+LLD + +I + DFG +K +TFCG+P Y APEL G
Sbjct: 123 NILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 42/115 (36%), Positives = 61/115 (53%), Gaps = 8/115 (6%)
Query: 487 LYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545
+Y+ MEY SGG + + L+ HGR + E R Q++ + Y H I+HRD+K N+ L
Sbjct: 74 VYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132
Query: 546 DSEMNIKIADFGFS-----NEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGA 595
D IK+ DFG + N T G ++ + G+P Y APE+ GG G A
Sbjct: 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG-KGKGHGRA 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 39/285 (13%)
Query: 47 KYKLLKTIGKGNFAKVKLA-----KHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
L KT+G+G F KV A K VA+K++ K + L+ L E ++K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLSEFNLLKQ 59
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--------GRMKEKEARAKFR- 152
++HP+++KL+ + L L++EYA G + +L G + +
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 153 ---------------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FT 196
QI +QY + K++HRDL A N+L+ +KI+DFG S + +
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 197 PGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253
+ + G P + A E Y + DVWS GV+L+ +V+ G P+ G L
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 254 RERVLRGKYRI--PFYMSTDCENLLKKFLVLNPAKRASL-EVSGE 295
+L+ YR+ P S + NL+ P KR + ++S E
Sbjct: 239 FN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 30/149 (20%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
A + ++KL+ + E+ LYLVMEY GG++ + L+ E+ AR ++V A+
Sbjct: 56 ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS--------------------------N 560
H+ IHRD+K +N+L+D++ +IK+ADFG
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 561 EFTPGNKLDTFC----GSPPYAAPELFQG 585
+ G+P Y APE+ +G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG 204
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 45/112 (40%), Positives = 62/112 (55%), Gaps = 1/112 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +T LY V++Y +GGE+F +L E AR +I SA+ Y H I
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
++RDLK EN+LLDS+ +I + DFG E TFCG+P Y APE+
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 43/112 (38%), Positives = 65/112 (58%), Gaps = 1/112 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +T + LY V+++ +GGE+F +L E AR +I SA+ Y H I
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 584
++RDLK EN+LLDS+ ++ + DFG E + TFCG+P Y APE+ +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKML-DHP 105
KT+G G F KV A K VA+K++ K + + L E++IM L +H
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSEREALMSELKIMSHLGNHE 99
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------QIVSAV 158
NIV L + ++ EY G++ ++L +++E+ Q+ +
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFL-----RRKRESFLTLEDLLSFSYQVAKGM 154
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF-------SNEFTPGNKLDTFCGSP-PY 210
+ K IHRDL A N+LL +KI DFG SN GN P +
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN---ARL--PVKW 209
Query: 211 AAPE-LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI--PF 266
APE +F Y E DVWS G++L+ + S GS P+ G + ++++ YR+ P
Sbjct: 210 MAPESIFNC-VYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 267 YMSTDCENLLKKFLVLNPAKRAS 289
+ + +++K +P KR +
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 65/244 (26%), Positives = 116/244 (47%), Gaps = 16/244 (6%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
K+ + IG G F +V + GK VAIK + K+ + E IM DHP
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQK 164
NI+ L V+ + + ++ E+ G + +L + G+ + R I + ++Y +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS-----P-PYAAPELFQG 218
+HRDL A N+L++S + K++DFG S T+ S P + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 219 KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
+K+ DVWS G++++ ++S G P+ + +++ + + YR+P M DC L
Sbjct: 186 RKFTSAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPM--DCPTALH 241
Query: 278 KFLV 281
+ ++
Sbjct: 242 QLML 245
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y LK +G G + V A TG++VAIK + + + ++ +RE+ ++K + H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 107 IVKLFQVIETEKTL------YLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIVSAV 158
++ L V + + YLVM Y + L ++ + E + + Q++ +
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
+Y H IIHRDLK NL ++ + +KI DFG + ++ + + Y APE+
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEVILN 188
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDG 247
+ VD+WS+G I+ +++G F G
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 28/92 (30%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 482 ETEKTLYLVMEYASGGEVFDY--LVLHGRMKEKEARAK--FRQIVSAVQYCHQKKIIHRD 537
+ + ++Y+V EY D L+ +K E++ K +Q++ +QY H I+HRD
Sbjct: 70 KGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRD 125
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 569
+K N+L++++ +K+ADFG + +T N D
Sbjct: 126 IKGSNILINNDGVLKLADFGLARPYTKRNSAD 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 43/110 (39%), Positives = 63/110 (57%), Gaps = 3/110 (2%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
KL+ +++ LYLVMEY +GG+ + G + E A+ ++V V+ HQ+ IIH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
RD+K ENLL+D ++K+ DFG S G + F G+P Y APE G
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILG 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 2/111 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKK 532
++ L++ E L++++E+ GG + ++ R + E + R RQ++ A+ + H K
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPEL 582
+IHRDLKA N+LL + ++K+ADFG S + K DTF G+P + APE+
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 74/235 (31%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 54 IGKGNFAKVKLAKHVPTGKEV--AIKIIDKTQLNPGSLQKLFREVRIM-KMLDHPNIVKL 110
IG+GNF +V A+ G + AIK + K + + E+ ++ K+ HPNI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYL----VL---------HGRMKEKEARAKFR---QI 154
E LYL +EYA G + D+L VL + ++ +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSPP--Y 210
+ Y QK+ IHRDL A N+L+ KIADFG S G + + G P +
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPVRW 177
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI 264
A E Y DVWS GV+L+ +VS G P+ G T EL E++ +G YR+
Sbjct: 178 MAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRL 230
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 72/248 (29%), Positives = 119/248 (47%), Gaps = 41/248 (16%)
Query: 50 LLKTIGKGNFAKVKLAKHVPTGKE-------VAIKIIDKTQLNPGSLQKLFREVRIMKML 102
L K +G+G F +V A+ K VA+K++ K L L E+ +MK++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLISEMELMKLI 74
Query: 103 D-HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-----------MKEKEARAK 150
H NI+ L V E LY+++EYA+ G + ++L R K E +
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL--RARRPPGPDYTFDITKVPEEQLS 132
Query: 151 FRQIVSAV-------QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD- 202
F+ +VS +Y ++ IHRDL A N+L+ + +KIADFG + + +D
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV---HDIDY 189
Query: 203 ---TFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRER 256
T G P + APE + Y + DVWS G++++ + + G P+ G + EL +
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTH-QSDVWSFGILMWEIFTLGGSPYPGIPVEELF-K 247
Query: 257 VLRGKYRI 264
+LR +R+
Sbjct: 248 LLREGHRM 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 75/235 (31%), Positives = 115/235 (48%), Gaps = 31/235 (13%)
Query: 54 IGKGNFAKVKLAKHVPTGKEV--AIKIIDKTQLNPGSLQKLFREVRIM-KMLDHPNIVKL 110
IG+GNF +V A G ++ AIK++ K + + E+ ++ K+ HPNI+ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKML-KEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYL----VL---------HGRMKEKEARAKFR---QI 154
E LY+ +EYA G + D+L VL HG ++ + +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSPP--Y 210
+ +QY +K+ IHRDL A N+L+ + KIADFG S G + + G P +
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRLPVRW 184
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI 264
A E Y + DVWS GV+L+ +VS G P+ G T EL E++ +G YR+
Sbjct: 185 MAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRM 237
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 72/238 (30%), Positives = 116/238 (48%), Gaps = 36/238 (15%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKE-------VAIKIIDKTQLNPGSLQKLFREVRIM 99
+ L K +G+G F +V +A+ + K+ VA+K++ K L L E+ +M
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVSEMEMM 71
Query: 100 KML-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH---------GRMKEKEARA 149
KM+ H NI+ L + LY+++EYAS G + +YL K E +
Sbjct: 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 150 KFRQIVS-------AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202
F+ +VS ++Y +K IHRDL A N+L+ + +KIADFG + + + +D
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV---HNID 188
Query: 203 ----TFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253
T G P + APE + Y + DVWS GV+L+ + + G P+ G + EL
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 43/107 (40%), Positives = 65/107 (60%), Gaps = 2/107 (1%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLK 539
ET+ L LVM +GG++ ++ G EARA F QI+ +++ HQ++I++RDLK
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
EN+LLD N++I+D G + E G K+ G+P Y APE+ QG
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 41/243 (16%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKH---VPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMK 100
+ ++ IG+G F +V A+ +P VA+K++ K + + RE +M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMA 63
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL----------VLHGRMK------- 143
DHPNIVKL V K + L+ EY + G++ ++L + H
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 144 -----EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG-----FSN 193
E +Q+ + + Y ++K +HRDL N L+ M +KIADFG +S
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 194 EFTPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTL 250
++ ++ D P + PE +Y E DVW+ GV+L+ + S G P+ G
Sbjct: 184 DYYKASENDAI----PIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 251 REL 253
E+
Sbjct: 239 EEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-18
Identities = 46/118 (38%), Positives = 69/118 (58%), Gaps = 7/118 (5%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGG----EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 529
++K F +++ L L+MEY SGG ++ L H +E E F QIV A+ H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGSPPYAAPELFQ 584
+K++HRDLK+ N+ L IK+ DFGFS +++ LD +FCG+P Y APEL++
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244
|
Length = 478 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 38/102 (37%), Positives = 61/102 (59%), Gaps = 2/102 (1%)
Query: 486 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545
L+++MEYA GG V L+ G + EK R+++ A++Y H+ +IHRD+KA N+L+
Sbjct: 76 RLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134
Query: 546 DSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGG 586
+ N+K+ DFG + + K TF G+P + APE+ G
Sbjct: 135 TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 62/228 (27%), Positives = 115/228 (50%), Gaps = 13/228 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKML 102
++K +K +G G F V +P G++ VAIK + + +P + +++ E +M +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 66
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYC 161
D+P++ +L + T T+ L+ + G + DY+ H + + QI + Y
Sbjct: 67 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPP--YAAPELFQG 218
+++++HRDL A N+L+ + ++KI DFG + K G P + A E
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 219 KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ Y + DVWS GV ++ L++ GS P+DG E+ + +G+ R+P
Sbjct: 186 RIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP 231
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTG-KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-- 103
+Y+ + IG+G + KV A+ + G + VA+K + G REV +++ L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 104 -HPNIVKLFQVIETEKT-----LYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIV 155
HPN+V+LF V +T L LV E+ ++ YL V + + + Q++
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 215
+ + H +++HRDLK +N+L+ S IK+ADFG + ++ L + + Y APE+
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST 249
Y P VD+WS+G I + F GS+
Sbjct: 181 LLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 30/266 (11%)
Query: 50 LLKTIGKGNFAKVK--LAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
L KT+G+G F V + +VA+K + ++ E MK DHPN+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 108 VKL----FQVIETEK--TLYLVMEYASGGEVFDYLVLHGRMKEK------EARAKF-RQI 154
++L Q +E+E + +++ + G++ +L L+ R+ + + KF I
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSP-PYA 211
S ++Y K IHRDL A N +L+ MN+ +ADFG S + G+ + P +
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 212 APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMS 269
A E + Y + DVWS GV ++ + + G P+ G E+ + + +G + + P
Sbjct: 182 AIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP---- 236
Query: 270 TDCEN----LLKKFLVLNPAKRASLE 291
DC + L+ +LNP R S E
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFE 262
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKF-RQIVSAVQYC 528
++KL V E+ L +VMEY GG++ DYL + + + F QI ++Y
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDL---LSFALQIARGMEYL 119
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K IHRDL A N L+ + +KI+DFG S
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 487 LYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
L +VMEYA G++ L + + E + F QI+ + + H KKI+HRD+K+ NL
Sbjct: 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133
Query: 545 LDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQ 584
LD+ N+KI D G + + +T G+P Y +PEL +
Sbjct: 134 LDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
PN+V L + I +E +++LV+++A GG+++ ++ + E+ + ++V A+ H++
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
I+ RDL N+LLD +I++ F +E D Y APE+ G +
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENMYCAPEV-GGISEETE 161
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KYRIPFYMSTDCENLLKKFLVL 282
D WSLG IL+ L++ G TL E + IP ++S + +LL++ L
Sbjct: 162 ACDWWSLGAILFELLT------GKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQF 215
Query: 283 NPAKRASLEVSG 294
NP +R V+G
Sbjct: 216 NPTERLGAGVAG 227
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 46/195 (23%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y ++KT+ G+ +V +A V +KI K +L E +++ ++HP++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLI----EAMLLQNVNHPSV 119
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKI 166
+++ + + +V+ + S +++ YL + +A +QI+ ++Y H ++I
Sbjct: 120 IRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQGKKYDGPE 225
IHRD+K EN+ ++ + I D G + +F G+ APE+ KY+ +
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNS-K 236
Query: 226 VDVWSLGVILYTLVS 240
D+WS G++L+ +++
Sbjct: 237 ADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKF-RQIVSAVQYCH 529
++KL V E+ LY+VMEY GG++ YL + + + F QI ++Y
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDL---LSFALQIARGMEYLE 119
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K IHRDL A N L+ + +KI+DFG S
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 34/99 (34%), Positives = 54/99 (54%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
E LY+ +E GG + L +G E R RQI+ ++Y H + +HRD+K N
Sbjct: 73 EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGAN 132
Query: 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
+L+D+ +K+ADFG + + + +F GSP + APE
Sbjct: 133 ILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 51/132 (38%), Positives = 68/132 (51%), Gaps = 19/132 (14%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536
+F ET++ L +VMEY GG+ L G + AR F + V A++Y H I+HR
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125
Query: 537 DLKAENLLLDSEMNIKIADFGFS---------NEFTPGNKLDT-------FCGSPPYAAP 580
DLK +NLL+ S +IK+ DFG S N + + DT CG+P Y AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 581 E--LFQG-GAPV 589
E L QG G PV
Sbjct: 186 EVILRQGYGKPV 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 484 EKTLYLVMEYASGGEVFD----YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 539
+ L+LVME GG V D R+KE+ R+ + + Y H+ K+IHRD+K
Sbjct: 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPE 581
+N+LL +K+ DFG S + + +TF G+P + APE
Sbjct: 141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
E+TL + ME+ GG + D L +G + E R RQI+ V Y H I+HRD+K N+
Sbjct: 78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI 137
Query: 544 LLDSEMNIKIADFGFSNEFT----PGNKLDTFCGSPPYAAPELFQG 585
L DS N+K+ DFG S G + + G+P + +PE+ G
Sbjct: 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 36/252 (14%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+ ++ +G+ F K+ G + VAIK + K NP + +E +M L H
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHH 66
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-------------GRMKEKEARAKF 151
PNIV L V+ E+ + ++ EY + G++ ++L++ G +K F
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 152 R----QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 207
QI + ++Y +H+DL A N+L+ ++++KI+D G S E D +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA---DYYRVQ 183
Query: 208 PP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260
P + PE K+ + D+WS GV+L+ + S G P+ G + +E+ E V R
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-RK 241
Query: 261 KYRIPFYMSTDC 272
+ +P S DC
Sbjct: 242 RQLLP--CSEDC 251
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-17
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 70 TGKEVAIKIIDKTQLNPGSLQKLF-REVRIMKMLDHPNIVKLFQVIETEKT-LYLVMEYA 127
TG EVAIK++ + F RE + L HPNIV L E L+ V EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 128 SGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNI 184
G + + L G + E Q++ A+ H + I+HRDLK +N+++ +
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 185 KIADFGFSNEFTPG---------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 235
K+ DFG PG + G+P Y APE +G+ P D+++ G+I
Sbjct: 122 KVLDFGIGT-LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179
Query: 236 YTLVSGSLPFDGSTLRELRERVL 258
++G G+++ E+ + L
Sbjct: 180 LECLTGQRVVQGASVAEILYQQL 202
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 64/245 (26%), Positives = 116/245 (47%), Gaps = 22/245 (8%)
Query: 49 KLLKTIGKGNFAKV-KLAKHVPTGKE--VAIKII-----DKTQLNPGSLQKLFREVRIMK 100
K+ + +G G F ++ + +P+ +E VAI + DK + E +
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG------FLAEALTLG 61
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQ 159
DH NIV+L VI T+ +V EY S G + +L H G++ + + S ++
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--YAAPELFQ 217
Y + +H+ L A +L++S++ KI+ F E T G P +AAPE Q
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276
+ DVWS G++++ ++S G P+ + +++ + V G +R+P +C NLL
Sbjct: 182 YHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP--APRNCPNLL 237
Query: 277 KKFLV 281
+ ++
Sbjct: 238 HQLML 242
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 13/114 (11%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------QIVSAVQYCHQKKII 534
E+ ++ + MEY GG + ++ ++K++ R + ++ + Y H +KII
Sbjct: 71 ESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD-TFCGSPPYAAPELFQGGA 587
HRD+K N+LL + +K+ DFG S E N L TF G+ Y APE QG
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFTGTSFYMAPERIQGKP 179
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 42/118 (35%), Positives = 69/118 (58%), Gaps = 2/118 (1%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAV 525
A+ ++KL + L++++E+ GG V ++ R + E + + RQ++ A+
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEAL 123
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPEL 582
QY H KIIHRDLKA N+LL + +IK+ADFG S + + D+F G+P + APE+
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEV 181
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 21/233 (9%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ--LNPGSLQKLFREVRIMKMLDHPNIVK 109
IG G F KV L + G A ++ + + P +EV+ + L+HPN+++
Sbjct: 1 DEIGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 110 LF-QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQ-----IVSAVQYCHQ 163
Q IE+ L LV+E+ G++ +YL + M + A+ Q + S + + HQ
Sbjct: 60 CLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF-CGSPP--YAAPELFQGKK 220
IH DL N L +++++KI D+G + E P + T C + P + APEL + +
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 221 YDGPEVD------VWSLGVILYTLVS-GSLPF-DGSTLRELRERVLRGKYRIP 265
D D +WSLGV ++ L + P+ D S + L++ V ++P
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 54 IGKGNFAKVKLA--KHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLF 111
+G+G + V A K KE A+K I+ T ++ + RE+ +++ L HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIALQ 64
Query: 112 QVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKE---------ARAKFRQIVSAVQY 160
+V +++ ++L+ +YA +++ + H K + ++ QI+ + Y
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 161 CHQKKIIHRDLKAENLLLDSEM----NIKIADFGFSNEFT----PGNKLDTFCGSPPYAA 212
H ++HRDLK N+L+ E +KIAD GF+ F P LD + Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVS 240
PEL G ++ +D+W++G I L++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 486 TLYLVMEYASGGEVFD---YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
L+LVM Y SGG + D G + E ++++ ++Y H IHRD+KA N
Sbjct: 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132
Query: 543 LLLDSEMNIKIADFGFS-NEFTPGN----KLDTFCGSPPYAAPELFQ 584
+LL + ++KIADFG S + G+ TF G+P + APE+ +
Sbjct: 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 41/106 (38%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
EKTL + MEY GG V D L +G + E R RQI+ + Y H I+HRD+K N+
Sbjct: 78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI 137
Query: 544 LLDSEMNIKIADFGFSNEF----TPGNKLDTFCGSPPYAAPELFQG 585
L DS N+K+ DFG S G + + G+P + +PE+ G
Sbjct: 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 4/107 (3%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
EK L + +EY GG + D L +G + E R RQI+ V Y H I+HRD+K N
Sbjct: 77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN 136
Query: 543 LLLDSEMNIKIADFGFSNE----FTPGNKLDTFCGSPPYAAPELFQG 585
+L DS N+K+ DFG S G + + G+P + +PE+ G
Sbjct: 137 ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 54 IGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLF 111
+G+G + V AK ++ A+K I+ T ++ + RE+ +++ L HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 64
Query: 112 QVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKE---------ARAKFRQIVSAVQY 160
+V ++ ++L+ +YA +++ + H K + ++ QI+ + Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 161 CHQKKIIHRDLKAENLLLDSEM----NIKIADFGFSNEFT----PGNKLDTFCGSPPYAA 212
H ++HRDLK N+L+ E +KIAD GF+ F P LD + Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVS 240
PEL G ++ +D+W++G I L++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 37/266 (13%)
Query: 51 LKTIGKGNFAKVKLAK---HVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
+ T+G+G F +V LAK G E V +K + KT+ + RE+ + + L H
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHK 68
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-- 163
N+V+L + + Y+++EY G++ +L + K+++ + V C Q
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRA-TKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 164 --------KKIIHRDLKAENLLLDSEMNIKIADFGFSN-----EFTPGNKLDTFCGSPP- 209
+ +HRDL A N L+ S+ +K++ S E+ P
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-----PL 182
Query: 210 -YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFY 267
+ APE Q + + DVWS GV+++ + + G LPF G + E+ R+ GK +P
Sbjct: 183 RWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP-- 239
Query: 268 MSTDCENLLKKFL----VLNPAKRAS 289
+ C + L K + +NP R S
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 81/268 (30%), Positives = 122/268 (45%), Gaps = 33/268 (12%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTG--KEVAIKIIDKTQLNPGSLQKLFREVRIM-KMLDHP 105
K IG+GNF +V A+ G + AIK + K + + E+ ++ K+ HP
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYL----VLH------------GRMKEKEARA 149
NI+ L E LYL +EYA G + D+L VL + ++
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 150 KFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGS 207
+ + Y QK+ IHRDL A N+L+ KIADFG S G + + G
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 184
Query: 208 PP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI 264
P + A E Y DVWS GV+L+ +VS G P+ G T EL E++ +G YR+
Sbjct: 185 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRL 242
Query: 265 PFYMSTDCE--NLLKKFLVLNPAKRASL 290
++ D E +L+++ P +R S
Sbjct: 243 EKPLNCDDEVYDLMRQCWREKPYERPSF 270
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKF-RQIVSAVQYCH 529
+++L V + LY+V EY GG++ D+L HG +K+ + QI ++Y
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL---LQMALQIAKGMEYLE 119
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K +HRDL A N L+ + +KI+DFG S
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 37/97 (38%), Positives = 63/97 (64%), Gaps = 2/97 (2%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L++VMEY +GG + D +V M E + A R+ + A+++ H ++IHRD+K++N+LL
Sbjct: 91 LWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149
Query: 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPEL 582
+ ++K+ DFGF + TP +K T G+P + APE+
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 43/118 (36%), Positives = 69/118 (58%), Gaps = 2/118 (1%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAV 525
AS ++KL E L++++E+ +GG V ++ L + E + R +Q + A+
Sbjct: 57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPEL 582
Y H+ KIIHRDLKA N+L + +IK+ADFG S + T + D+F G+P + APE+
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 13/226 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR----IMKMLDH 104
+ LK +G G F V +P G + I + KT + Q F+E+ M LDH
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT-FQEITDHMLAMGSLDH 68
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 163
IV+L + +L LV + + G + D++ H + + QI + Y +
Sbjct: 69 AYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC---GSPPYAAPELFQGKK 220
+++HR+L A N+LL S+ ++IADFG ++ P +K + + A E +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
Y + DVWS GV ++ ++S G+ P+ G E+ + + +G+ R+
Sbjct: 188 YTH-QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLA 231
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 22/232 (9%)
Query: 49 KLLKTIGKGNFAKV---KLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
KL K +G+G F V +L++ + +VA+K + +++ E MK DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 106 NIVKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEK------EARAKFR- 152
N++KL V +L +++ + G++ +L L+ R+ + KF
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFL-LYSRLGGLPEKLPLQTLLKFMV 120
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP---P 209
I ++Y + IHRDL A N +L +M + +ADFG S + G+ +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260
+ A E + Y + DVW+ GV ++ + + G P+ G E+ + + G
Sbjct: 181 WIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 34/99 (34%), Positives = 62/99 (62%), Gaps = 6/99 (6%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L++VME+ GG + D +V H RM E++ ++ A+ + H + +IHRD+K++++LL
Sbjct: 91 LWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT 149
Query: 547 SEMNIKIADFGFSNEFT---PGNKLDTFCGSPPYAAPEL 582
S+ +K++DFGF + + P K + G+P + APE+
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 41/110 (37%), Positives = 64/110 (58%), Gaps = 1/110 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++KL +TE LYL++++ GG++F L E++ + ++ A+ + H I
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPEL 582
I+RDLK EN+LLD E +IK+ DFG S E K +FCG+ Y APE+
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 9/92 (9%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YLVLHGRMKEKEARAK--FRQIVSAVQYCHQ 530
+L V+ +E LYLV E+ D Y+ K Q++ + YCH
Sbjct: 62 RLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562
+++HRDLK +NLL+D E +K+ADFG + F
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-16
Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 8/159 (5%)
Query: 87 GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM-EYASGGEVFDYLVLHGRMKEK 145
G E I++ ++HP+I++L K L++ Y + +++ YL +
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAIC 182
Query: 146 EARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG---FSNEFTPGNKLD 202
+ A R ++ A+QY H+ +IIHRD+KAEN+ ++ ++ + DFG F + NK
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYY 241
Query: 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 241
+ G+ APEL Y GP VD+WS G++L+ + +
Sbjct: 242 GWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 38/116 (32%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK---EKEARAKFRQIVSAVQYCHQ 530
++KL V + LYLV E+ + Y ++ R + E ++ Q++ + +CH
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQG 585
I+HRDLK ENLL+++E +K+ADFG + F + T + + Y APEL G
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 41/125 (32%), Positives = 61/125 (48%), Gaps = 8/125 (6%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 530
E ++ L + + LYLV EY + + L G + R+ Q++ A+ YCH
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT--PGNKLDTFCGSPPYAAPELFQG--- 585
IIHRD+K EN+L+ +K+ DFGF+ P + L + + Y APEL G
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 586 -GAPV 589
G PV
Sbjct: 179 YGKPV 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-16
Identities = 61/267 (22%), Positives = 115/267 (43%), Gaps = 30/267 (11%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKL-AKH 67
S+ + ++ + D+ + ++++ + G F K+ + A
Sbjct: 111 GAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALR 170
Query: 68 VPTGKEVAIKIIDKT-QLNPGSLQKLFREVR--------------IMKMLDHPNIVKLFQ 112
T + A + ++ T Q P + + + V+ + L+H NI+K+ +
Sbjct: 171 ASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEE 230
Query: 113 VIETEKTLYLVME-YASGGEVFDY---LVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 168
++ +E Y++ + Y F Y R K+ RA +Q++ AV+Y H KK+IH
Sbjct: 231 ILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIH 290
Query: 169 RDLKAENLLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
RD+K EN+ L+ + I + DFG F E + + G+ +PE+ G Y
Sbjct: 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY--GWVGTVATNSPEILAGDGY--C 346
Query: 225 EV-DVWSLGVILYTLVSGSL-PFDGST 249
E+ D+WS G+IL ++S P
Sbjct: 347 EITDIWSCGLILLDMLSHDFCPIGDGG 373
|
Length = 501 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 3/107 (2%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 539
+ TL + MEYA+GG ++D +V +E+ QIVSAV Y H+ I+HRD+K
Sbjct: 69 MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIK 128
Query: 540 AENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
N+ L IK+ DFG S + + +T G+P Y +PEL QG
Sbjct: 129 TLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 44/109 (40%), Positives = 67/109 (61%), Gaps = 5/109 (4%)
Query: 482 ETEKTLYLVMEYASGGEV--FDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRD 537
+T+ L LVM +GG++ Y V E RA F QI+S +++ HQ++II+RD
Sbjct: 63 QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRD 122
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQG 585
LK EN+LLD++ N++I+D G + E G +K + G+P + APEL QG
Sbjct: 123 LKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIVSA 524
+++L V E+ LYLV+EY GG++ DYL + ++ QI
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
++Y KK +HRDL A N L+ ++ +KI+DFG S
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 3/106 (2%)
Query: 483 TEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKA 540
+ + MEY GG + L + GR+ E+ ++ + Y H+K KIIHRD+K
Sbjct: 70 NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKP 129
Query: 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
N+L++S IK+ DFG S + + TF G+ Y APE QG
Sbjct: 130 SNILVNSRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGN 174
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 17/127 (13%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH------GRMKEKEARAKFRQIVSAVQY 527
L+ L +V ++ L+LV EY D+ VL+ + E + Q + AV +
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 528 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQG- 585
CH+ IHRD+K EN+L+ + IK+ DFGF+ T T + + Y APEL G
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 586 ---GAPV 589
G PV
Sbjct: 176 TQYGPPV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 39/102 (38%), Positives = 61/102 (59%), Gaps = 2/102 (1%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L+++MEY GG D L+ G E + ++I+ + Y H +K IHRD+KA N+LL
Sbjct: 77 LWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 547 SEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGA 587
+ ++K+ADFG + + T K +TF G+P + APE+ Q A
Sbjct: 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 2/101 (1%)
Query: 486 TLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
L++VMEY GG + D Y V G + E + R+ + + Y H+ IHRD+K N+L
Sbjct: 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANIL 133
Query: 545 LDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQ 584
L + ++K+ADFG S + T K +F G+P + APE+
Sbjct: 134 LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 37/97 (38%), Positives = 63/97 (64%), Gaps = 2/97 (2%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L++VMEY +GG + D +V M E + A R+ + A+++ H ++IHRD+K++N+LL
Sbjct: 91 LFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149
Query: 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPEL 582
+ ++K+ DFGF + TP +K T G+P + APE+
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 27/193 (13%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536
L+ +++ +YLVMEY GG+V L ++G E+ A ++ A+ Y H+ IIHR
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 537 DLKAENLLLDSEMNIKIADFGFS-------------------------NEFTPGNKLDTF 571
DLK +N+L+ +E +IK+ DFG S TPG L +
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVL-SL 187
Query: 572 CGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLN 631
S + P + V S GT+ + P +++ S + ++ +
Sbjct: 188 ISSLGFNTPVGEKDQGSVNSGQNNGTSSVRTGTSHP-LLMINKESLPMSLKLSKSCLETS 246
Query: 632 AGRPAKNTASIAP 644
P+ S+ P
Sbjct: 247 ESSPSLPVRSLTP 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 19/233 (8%)
Query: 54 IGKG--NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLF 111
IG+G N V LA+H PTG V ++I D L+ L EV + HPNI+ +
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 112 QVIETEKTLYLV---MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 168
V T L+++ M Y S + G M E + + Y HQ IH
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIH 124
Query: 169 RDLKAENLLLDSEMNIKIADFGFSNEFT---PGNKLDTFCGSP-------PYAAPELFQG 218
R++KA ++L+ + + ++ G S+ ++ G K P P+ +PEL +
Sbjct: 125 RNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ 182
Query: 219 KKYD-GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMST 270
Y + D++S+G+ L +G +PF ++ + L+G P ++T
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/226 (26%), Positives = 113/226 (50%), Gaps = 13/226 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
K +K +G G F V +P G+ VAIK++ + +P + +++ E +M +
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGS 68
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 163
P + +L + T T+ LV + G + DY+ + R+ ++ QI + Y +
Sbjct: 69 PYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPP--YAAPELFQGKK 220
+++HRDL A N+L+ S ++KI DFG + G P + A E ++
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + DVWS GV ++ L++ G+ P+DG RE+ + + +G+ R+P
Sbjct: 188 FTH-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLP 231
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 42/109 (38%), Positives = 58/109 (53%), Gaps = 2/109 (1%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+ L+ + E LYLV+E+ GGE F +L + R QIV +Y I+
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 583
+RDLK ENLLLD + IK+ DFGF+ + T CG+P Y APE+
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEIL 200
|
Length = 340 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 38/102 (37%), Positives = 62/102 (60%), Gaps = 2/102 (1%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L+++MEY GG D L+ G ++E R+I+ + Y H ++ IHRD+KA N+LL
Sbjct: 77 LWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 135
Query: 547 SEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGA 587
+ ++K+ADFG + + T K +TF G+P + APE+ + A
Sbjct: 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 60/240 (25%), Positives = 110/240 (45%), Gaps = 23/240 (9%)
Query: 44 HIGKYKLL--KTIGKGNFAKVKLAK---HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI 98
HI ++ ++ + +G+G F KV LA+ P ++ + + + + + RE +
Sbjct: 1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60
Query: 99 MKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------------RMKEK 145
+ L H +IVK + V L +V EY G++ +L HG + +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 146 EARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF--TPGNKLDT 203
+ +QI + + Y + +HRDL N L+ + +KI DFG S + T ++
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 204 FCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK 261
P + PE +K+ E DVWSLGV+L+ + + G P+ + E+ E + +G+
Sbjct: 181 HTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 33/78 (42%), Positives = 49/78 (62%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
TE+ L + +EY GG + L +GR +E+ R Q++ + Y H K I+HRDLKA+
Sbjct: 78 TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKAD 137
Query: 542 NLLLDSEMNIKIADFGFS 559
NLL+D++ KI+DFG S
Sbjct: 138 NLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 31/84 (36%), Positives = 49/84 (58%), Gaps = 1/84 (1%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL+ + T K L+M+Y G++FD L G++ E E + RQ+V A+ H+ II
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 535 HRDLKAENLLLDSEMN-IKIADFG 557
H D+K EN+L D + I + D+G
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYG 155
|
Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 37/121 (30%), Positives = 55/121 (45%), Gaps = 16/121 (13%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK-------EKEARAKFRQIVSAVQ 526
++KL V LVMEY L ++ E + ++ R ++ V
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSD-------LSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTF-CGSPPYAAPELFQ 584
Y H I+HRDLK NLL+ ++ +KIADFG + F +L + + Y APEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 585 G 585
G
Sbjct: 174 G 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 43/117 (36%), Positives = 71/117 (60%), Gaps = 5/117 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+++LF + +K LY+VMEY GG++ + L+ + + EK A+ ++V A+ H +
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 534 IHRDLKAENLLLDSEMNIKIADFG--FSNEFTPGNKLDTFCGSPPYAAPELF--QGG 586
IHRD+K +N+LLD ++K+ADFG + T + DT G+P Y +PE+ QGG
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 29/211 (13%)
Query: 54 IGKGNFAKVKLAKHV-PTGKEV--AIKIIDK-TQLNPGSLQKLFREVRIMKMLDHPNIVK 109
IGKG+F V + G+++ A+K +++ T L +++ +E IMK HPN++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLS 60
Query: 110 LFQV-IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK----F-RQIVSAVQYCHQ 163
L + + +E + +V+ Y G++ +++ R + K F Q+ ++Y
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNE------FTPGNKLDTFCGSPP--YAAPEL 215
KK +HRDL A N +LD +K+ADFG + + ++ N P + A E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG---AKLPVKWMALES 173
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVS-GSLPF 245
Q +K+ + DVWS GV+L+ L++ G+ P+
Sbjct: 174 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 42/136 (30%), Positives = 73/136 (53%), Gaps = 8/136 (5%)
Query: 457 SASNAKPSRR-----ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRM- 509
S+S + SR+ A ++ + E + LY+VMEY GG++ + L G++
Sbjct: 38 SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF 97
Query: 510 KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKL 568
E F Q+ VQ+ H+K+++HRD+K++N+ L +K+ DFG + T PG
Sbjct: 98 PEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157
Query: 569 DTFCGSPPYAAPELFQ 584
T+ G+P Y PE+++
Sbjct: 158 CTYVGTPYYVPPEIWE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 39/157 (24%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
A + ++KL+ + E LYL+MEY GG++ L+ E+E R + + A+
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAID 115
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGF--------SNEF-------TPGNKLDTF 571
H+ IHRD+K +NLLLD++ +IK++DFG EF P N LD
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 572 C------------------------GSPPYAAPELFQ 584
G+P Y APE+F
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 39/127 (30%), Positives = 52/127 (40%), Gaps = 33/127 (25%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK--------EKEARAKFRQIVSAV 525
++KL +V LY V EY G L+ MK E R+ QI+ +
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGN-------LYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 576
+ H+ HRDLK ENLL+ +KIADFG + E PP
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---------RPPYTDYVSTRW 163
Query: 577 YAAPELF 583
Y APE+
Sbjct: 164 YRAPEIL 170
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 37/97 (38%), Positives = 62/97 (63%), Gaps = 2/97 (2%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L++VMEY +GG + D +V M E + A R+ + A+ + H ++IHRD+K++N+LL
Sbjct: 91 LWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPEL 582
+ ++K+ DFGF + TP +K T G+P + APE+
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 2/105 (1%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
+ L+++MEY GG D L+ G + E + R+I+ + Y H +K IHRD+KA N+
Sbjct: 74 DTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132
Query: 544 LLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGA 587
LL +K+ADFG + + T K +TF G+P + APE+ + A
Sbjct: 133 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 32/251 (12%)
Query: 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTG-----KEVAIKII-DKTQLNPGSLQKLFRE 95
E ++ + ++ +G+ F KV T + VAIK + DK + G L++ F+
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---GPLREEFKH 57
Query: 96 VRIMKM-LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG------------RM 142
+M+ L HPNIV L V+ E+ L ++ Y S ++ ++LV+ +
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 143 KEKEARAKF----RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198
K A F QI + +++ ++H+DL N+L+ ++N+KI+D G E
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 199 NKLDTFCGS--P-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELR 254
+ S P + +PE K+ + D+WS GV+L+ + S G P+ G + +++
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
Query: 255 ERVLRGKYRIP 265
E ++R + +P
Sbjct: 237 E-MIRNRQVLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
L +VMEYA G++ + + + E+E F Q++ +Q H++KI+HRDLK+ N
Sbjct: 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133
Query: 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
+LL + +KI D G S N T G+P Y APE+++G
Sbjct: 134 ILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKG 175
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 71/297 (23%), Positives = 133/297 (44%), Gaps = 24/297 (8%)
Query: 49 KLLKTIGKG--NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+LL IG+G + V LA++ PTG+ V ++ I+ + L E+ + K+ +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQK 164
IV + L++V + + G D + H M E + ++ A+ Y H
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFT---PGNKLDTFCGSP-------PYAAPE 214
+HR +KA ++L+ + + ++ G + + G +L P P+ +PE
Sbjct: 121 GYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPE 178
Query: 215 LFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDC 272
+ Q + YD + D++S+G+ L +G +PF ++ L G +P + D
Sbjct: 179 VLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT--VPCLL--DT 233
Query: 273 ENLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQ 329
+ + L + P++ + GE T P S G ++H +N + SP +F Q
Sbjct: 234 TTIPAEELTMKPSRSGANSGLGESTTVSTP-RPSNGESSSHPYNRTFSPHFHHFVEQ 289
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 57/179 (31%), Positives = 92/179 (51%), Gaps = 22/179 (12%)
Query: 95 EVRIMKMLDHPNIVKLFQVIETEKTLYLVM-EYASGGEVFDYLVLHGR-MKEKEARAKFR 152
E R+++ L HP ++ L V LV+ +Y S +++ YL R + + A R
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVAR 267
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF----CGSP 208
Q++SA+ Y H + IIHRD+K EN+L++ +I + DFG + F G+ F G+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC-FARGSWSTPFHYGIAGTV 326
Query: 209 PYAAPELFQGKKYDGPEVDVWSLGVILY-------TLVSGSL-----PFDGSTLRELRE 255
APE+ G Y P VD+WS G++++ +L S S P+D LR +R+
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384
|
Length = 461 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 42/125 (33%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 464 SRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIV 522
S S L FQ + LYLVMEY GG++ L + + E A+ ++V
Sbjct: 56 SISNSPWIPQLQYAFQ---DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 523 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF--CGSPPYAAP 580
A+ HQ +HRD+K EN+L+D +IK+ADFG + T +++ G+P Y AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 581 ELFQG 585
E+
Sbjct: 173 EVLTT 177
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 42/117 (35%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+++LF + ++ LY+VMEY GG++ + L+ + + EK AR ++V A+ H
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELF--QGG 586
IHRD+K +N+LLD ++K+ADFG + + DT G+P Y +PE+ QGG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 37/97 (38%), Positives = 63/97 (64%), Gaps = 2/97 (2%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L++VMEY +GG + D +V M E + A R+ + A+++ H ++IHRD+K++N+LL
Sbjct: 92 LWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPEL 582
+ ++K+ DFGF + TP +K T G+P + APE+
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 38/125 (30%), Positives = 66/125 (52%), Gaps = 5/125 (4%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYC 528
E +++L VI TE L LV EY ++ Y+ HG + ++ Q++ + +C
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGA 587
H+ +++HRDLK +NLL++ +K+ADFG + F P N + Y AP++ G
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 588 PVTSS 592
++S
Sbjct: 177 TYSTS 181
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 35/237 (14%)
Query: 50 LLKTIGKGNFAKV--KLAKHVPTGK-EVAIKIIDKTQLNPGSLQKLF-REVRIMKMLDHP 105
LL+ +G G F +V L + E+ + + + + F E IM +H
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR----------MKEKEARAKFRQIV 155
NIV+L V ++++E +GG++ +L R MK+ A R +
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCA--RDVA 126
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEF-------TPGNKLDTFC 205
+Y + IHRD+ A N LL + KIADFG + + G +
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 206 GSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260
PP A + +F K DVWS GV+L+ + S G +P+ G T +E+ E V G
Sbjct: 187 WMPPEAFLDGIFTSK------TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 31/88 (35%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 477 LFQVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
L V+ E LYL+ E+ S + D L M + ++ QI+ + +CH ++++
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEF 562
HRDLK +NLL+D++ IK+ADFG + F
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAF 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 30/238 (12%)
Query: 50 LLKTIGKGNFAKVKLAKHV---PTGKE--VAIKIIDKTQLNPGSLQKLF-REVRIMKMLD 103
L + +G+G F KV LA+ PT + VA+K + L + +K F RE ++ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQ 65
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKF----- 151
H +IVK + V L +V EY G++ +L HG + ++A+ +
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 152 ----RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFC 205
QI S + Y + +HRDL N L+ + + +KI DFG S + + ++
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 206 GSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK 261
P + PE +K+ E DVWS GVIL+ + + G P+ + E+ E + +G+
Sbjct: 186 MLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 19/130 (14%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-------HGRMKEKEARAKFRQIVSA 524
E L+ L +V +K LYLV E+ D+ VL +G + E R QI+
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEF------VDHTVLDDLEKYPNG-LDESRVRKYLFQILRG 112
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELF 583
+++CH IIHRD+K EN+L+ +K+ DFGF+ PG + + Y APEL
Sbjct: 113 IEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 584 QG----GAPV 589
G G V
Sbjct: 173 VGDTKYGRAV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 28/237 (11%)
Query: 50 LLKTIGKGNFAKVKLAK--HVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
L + +G F ++ GKE V +K + K + + L +E ++ L H
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 106 NIVKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---------QIV 155
NI+ + V IE + +++ Y + G + +L R+ E QI
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC-----GSP-P 209
+ Y H++ +IH+D+ A N ++D E+ +KI D S + P D C P
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM---DYHCLGDNENRPVK 184
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ A E K+Y DVWS GV+L+ L++ G P+ E+ L+ YR+
Sbjct: 185 WMALESLVNKEYSSAS-DVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYLKDGYRLA 239
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 2/92 (2%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKF-RQIVSAVQYCH 529
L++L V+ LY+V EY + G + DYL GR + + F + ++Y
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+K +HRDL A N+L+ ++ K++DFG + E
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-14
Identities = 39/103 (37%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 489 LVMEYASGGEVFDYLVLHGR----MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
LV++YA+ G++ + + +E EA F Q++ AV + H K +IHRD+K+ N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 545 LDSEMNIKIADFGFSNEFTPGNKLD---TFCGSPPYAAPELFQ 584
L S +K+ DFGFS + D TFCG+P Y APE+++
Sbjct: 176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
|
Length = 496 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 44/124 (35%), Positives = 71/124 (57%), Gaps = 5/124 (4%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
A + E +++L + +K LY+VMEY GG++ + L+ + + EK AR ++V A+
Sbjct: 98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALD 156
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFG--FSNEFTPGNKLDTFCGSPPYAAPELF- 583
H IHRD+K +N+LLD ++K+ADFG + + DT G+P Y +PE+
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 584 -QGG 586
QGG
Sbjct: 217 SQGG 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 40/117 (34%), Positives = 63/117 (53%), Gaps = 8/117 (6%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
++KL VI TE LYLV E+ + D L G + ++ Q++ + +CH
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSH 119
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP---YAAPELFQG 585
+++HRDLK +NLL+++E IK+ADFG + F G + T+ Y APE+ G
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 38/107 (35%), Positives = 59/107 (55%), Gaps = 9/107 (8%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEK--EARAKF--RQIVSAVQYCHQKKIIHRDLK 539
E LYLVM+Y GG D L L + +++ E A+F ++V A+ HQ +HRD+K
Sbjct: 73 ENNLYLVMDYYVGG---DLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTF--CGSPPYAAPELFQ 584
+N+LLD +I++ADFG + + G+P Y +PE+ Q
Sbjct: 130 PDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 35/97 (36%), Positives = 61/97 (62%), Gaps = 2/97 (2%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L++VME+ GG + D +V H RM E++ ++ A+ Y H + +IHRD+K++++LL
Sbjct: 94 LWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPEL 582
S+ IK++DFGF + + K + G+P + APE+
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
E T +LVMEY G D L +H + ++E E A + + Y H + IHRD+KA N
Sbjct: 87 EHTAWLVMEYCLGSAS-DILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGN 145
Query: 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
+LL +K+ADFG ++ +P N +F G+P + APE+
Sbjct: 146 ILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 54 IGKGNFAKVKLAK---HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110
+G+G F KV LA+ +P ++ + + + + + Q RE ++ +L H +IV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKFR-----------QIV 155
+ V + L +V EY G++ +L HG + E A + QI
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF--TPGNKLDTFCGSP-PYAA 212
S + Y +HRDL N L+ + +KI DFG S + T ++ P +
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPF 245
PE +K+ E D+WS GV+L+ + + G P+
Sbjct: 193 PESILYRKFT-TESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L + +EY GG V L +G +E R RQI+ + Y H + IIHRD+K N+L+D
Sbjct: 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD 140
Query: 547 SEMNIKIADFGFSNEF-------TPGNKLDTFCGSPPYAAPEL 582
++ IKI+DFG S + + GS + APE+
Sbjct: 141 NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 32/96 (33%), Positives = 55/96 (57%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
A + E ++KL+ + + LY VM+Y GG++ L+ G +E AR ++ A++
Sbjct: 56 AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIE 115
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562
H+ IHRD+K +N+L+D + +IK+ DFG F
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 44/185 (23%), Positives = 80/185 (43%), Gaps = 39/185 (21%)
Query: 47 KYKLLKTIGKGNFAKVKLAK--------HVPTGKE------VAIKIIDKTQLNPGSLQKL 92
+ +L + +G+G F +V L + + VA+K++ + + +
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDF 64
Query: 93 FREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR 152
+E++IM L +PNI++L V ++ L ++ EY G++ +L ++E + F
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL------SQREIESTFT 118
Query: 153 ------------------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194
QI S ++Y +HRDL N L+ + IKIADFG S
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 195 FTPGN 199
G+
Sbjct: 179 LYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 23/196 (11%)
Query: 70 TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129
K+V +K + + PG RE+ I+K + H I+ L + T+ +VM
Sbjct: 118 QRKKVIVKAVTGGK-TPG------REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170
Query: 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 189
++F Y+ G + ++A R+++ A+ Y H + IIHRD+K EN+ LD N + DF
Sbjct: 171 -DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
Query: 190 GFS-----NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY-------T 237
G + + TP + + G+ +PEL Y + D+WS G++L+ T
Sbjct: 230 GAACKLDAHPDTP--QCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVT 286
Query: 238 LVSGSLPFDGSTLREL 253
L + S LR +
Sbjct: 287 LFGKQVKSSSSQLRSI 302
|
Length = 392 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 16/172 (9%)
Query: 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIM 99
E G+ L + G F + V + VA+K++ + N + +E++IM
Sbjct: 15 EGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLKEIKIM 73
Query: 100 KMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR------- 152
L PNI++L V T L ++ EY G++ +L H +E +A
Sbjct: 74 SRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTISYSTL 132
Query: 153 -----QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199
QI S ++Y +HRDL N L+ IKIADFG S G+
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 5/104 (4%)
Query: 487 LYLVMEYASG---GEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCH-QKKIIHRDLKAE 541
LY+VM+ G GE F+ L R E+ F Q+V A++Y H +K+I+HRDL
Sbjct: 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
N++L + + I DFG + + P +KL + G+ Y+ PE+ +
Sbjct: 144 NIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 39/113 (34%), Positives = 51/113 (45%), Gaps = 29/113 (25%)
Query: 488 YLVMEYASGGEVFDYLVLHGRMKEK----EARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
Y+VMEY D L MK+ E + Q++S V + H I+HRDLK NL
Sbjct: 82 YMVMEYVE----HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNL 137
Query: 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAPELFQG 585
LL++ +KI DFG + E+ GSP Y APEL G
Sbjct: 138 LLNNRGILKICDFGLAREY----------GSPLKPYTQLVVTLWYRAPELLLG 180
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 444 AQSPSHRGVHRSISASNAKPSRRASSGGETLL----------KLFQVIETEKTLYLVMEY 493
A+S S V + I + + +S E +L F + L++VMEY
Sbjct: 21 AKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80
Query: 494 ASGGEVFDYLVL-HGRM-KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MN 550
GG++ + G + E + + F QI +++ H +KI+HRD+K++N+ L M
Sbjct: 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMV 140
Query: 551 IKIADFGFSNEFTPGNKLDTFC-GSPPYAAPELFQ 584
K+ DFG + + +L C G+P Y +PE+ Q
Sbjct: 141 AKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 2/88 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQK 531
L L+ +TE L LVM+Y GGE+F L + E+ AR +++ A++Y H
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
I++RDLK EN+LL +I ++DF S
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 15/106 (14%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAK--------FRQIVSAVQYCHQKKIIHRDL 538
LY+VM + GG+ L+ ++KE++ + F QI A+QY H+K I+HRDL
Sbjct: 75 LYIVMGFCEGGD------LYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDL 128
Query: 539 KAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELF 583
K +N+ L IK+ D G + + T G+P Y +PELF
Sbjct: 129 KTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 30/88 (34%), Positives = 54/88 (61%)
Query: 471 GETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 530
G ++K+F + ++ LYL+ME+ GG++ L+ + E+ + + V A+ HQ
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGF 558
IHRD+K +NLLLD++ ++K++DFG
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 434 GSGGGGGGGAAQSPSHRGVHRSISASNAKPSRRASSGGETLLKLFQVIETEK-------- 485
G G G G H+ ++ K S ET L+ +++ T K
Sbjct: 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 486 -------TLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536
LYLV EY E+ + + +G EK R+ Q++ A+ +CH+ I+HR
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEK-VRSYIYQLIKAIHWCHKNDIVHR 124
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD--TFCGSPPYAAPELFQGGAP 588
D+K ENLL+ +K+ DFGF+ + G+ + + + Y +PEL GAP
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL-GAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 67/243 (27%), Positives = 103/243 (42%), Gaps = 48/243 (19%)
Query: 52 KTIGKGNFAKV--KLAKHVPTGKEVAIKIIDKTQLNPGSL----QKLFREVRIMKMLDHP 105
+G G F +V A + I++ KT L G+ ++ +E +M +HP
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT-LRKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQ------------ 153
NIVKL V + Y++ME GG++ YL ++AR +
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--------RDARVERFGPPLLTLKELLDI 111
Query: 154 ---IVSAVQYCHQKKIIHRDLKAENLLL-----DSEMNIKIADFGFSNEFTPGNKLDTFC 205
+ Y Q IHRDL A N L+ D++ +KI DFG + + K D +
Sbjct: 112 CLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY---KSDYYR 168
Query: 206 ----GSPP--YAAPE-LFQGKKYDGPEVDVWSLGVILY-TLVSGSLPFDGSTLRELRERV 257
G P + APE L GK + DVWS GV+++ L G P+ +E+ + V
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTT--QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
Query: 258 LRG 260
G
Sbjct: 227 TAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 43/246 (17%)
Query: 47 KYKLLKTIGKGNFAKV--KLAKHVPTGK---EVAIKIIDKTQLNPGSLQK---LFREVRI 98
K LL+ +G+G+F V A+ + G+ VA+K ++++ SL++ E +
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASV 62
Query: 99 MKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVL--------HGRMKE--KEAR 148
MK ++V+L V+ + +VME + G++ YL GR +E
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 149 AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE------FTPGNKLD 202
+I + Y + KK +HRDL A N ++ + +KI DFG + + + G K
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK-- 180
Query: 203 TFCGSPP--YAAPELFQGKKYDG---PEVDVWSLGVILYTLVS-GSLPFDGSTLRELRER 256
G P + APE + DG D+WS GV+L+ + S P+ G + ++ +
Sbjct: 181 ---GLLPVRWMAPESLK----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 233
Query: 257 VLRGKY 262
V+ G Y
Sbjct: 234 VMDGGY 239
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----RQIVSAVQYCHQKKIIHRDLK 539
++L L+MEY G + DYL H +++ + QI + Y ++ IHRDL
Sbjct: 80 GRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLA 136
Query: 540 AENLLLDSEMNIKIADFGFS 559
A N+L++SE +KI+DFG +
Sbjct: 137 ARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 44/124 (35%), Positives = 61/124 (49%), Gaps = 21/124 (16%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--------FRQIVSAV 525
+++L V+ +EK LYLV EY L L M AK QI+ +
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPP---YAAPE 581
YCH +++HRDLK +NLL+D N +K+ADFG + F G + TF Y APE
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173
Query: 582 LFQG 585
+ G
Sbjct: 174 ILLG 177
|
Length = 294 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
L + E LYLVM+Y GG++ L R+ E AR ++V A+ HQ +H
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQG 585
RD+K +N+LLD +I++ADFG + + + G+P Y +PE+ Q
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 1/163 (0%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
T L +++ +GG++ +L HG EKE R +I+ +++ H + +++RDLK N
Sbjct: 68 TPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPAN 127
Query: 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHN 602
+LLD +++I+D G + +F+ K G+ Y APE+ Q G SS +
Sbjct: 128 ILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCML 186
Query: 603 SSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASIAPL 645
+ + F++ T D I T +N P + + L
Sbjct: 187 FKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 32/96 (33%), Positives = 54/96 (56%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
A + E +++L+ + + LY VM+Y GG++ L+ G E AR ++ AV+
Sbjct: 56 AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVE 115
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562
H+ IHRD+K +N+L+D + +IK+ DFG F
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 54 IGKGNFAKVKLAK--------------HVPTGKE--VAIKIIDKTQLNPGSLQKLFREVR 97
+G+G F +V L + +V G+ VA+KI+ + N + +EV+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLKEVK 71
Query: 98 IMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR----- 152
I+ L PNI++L V E L ++ EY G++ +L H + +KE
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGNDAVPPAH 130
Query: 153 ---------------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197
QI S ++Y +HRDL N L+ + IKIADFG S
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 198 GN--KLDTFCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 240
G+ ++ P + A E K+ DVW+ GV L+ ++
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTAS-DVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 15/122 (12%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-------AKFRQIVSA 524
++ L V + + LV E+ D L +K+K + +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET----D---LEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELF 583
++Y H I+HRDLK NLL+ S+ +K+ADFG + F +P K+ + Y APEL
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174
Query: 584 QG 585
G
Sbjct: 175 FG 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 14/89 (15%)
Query: 476 KLFQVI--ETEKTLYLVMEYASGGEVFDYLVLH-----GRMKEKEARAKFRQIVSAVQYC 528
KL VI E +K +YLV EY D LH +++ R Q++ A++Y
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMET----D---LHAVIRANILEDVHKRYIMYQLLKALKYI 123
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFG 557
H +IHRDLK N+LL+S+ +K+ADFG
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 1/93 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+++L V + E L LVME A G + YL + + + Q+ + Y K
Sbjct: 58 IVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 566
+HRDL A N+LL + KI+DFG S G+
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
L + E LYLVM+Y GG++ L R+ E AR ++V A+ HQ +H
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQG 585
RD+K +N+L+D +I++ADFG + + + G+P Y +PE+ Q
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 36/114 (31%), Positives = 67/114 (58%), Gaps = 6/114 (5%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
E +++++ L++VME+ GG + D +V H RM E++ A ++ A+ H +
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPYAAPEL 582
+IHRD+K++++LL + +K++DFGF ++ P K + G+P + APEL
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEL 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L++ ME+ GG + D + G + E + R+ + + Y H K +HRD+K N+LL
Sbjct: 81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140
Query: 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGG 594
++K+ADFG S + T K +F G+P + APE+ A V GG
Sbjct: 141 DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV----AAVERKGG 185
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 484 EKTLYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+ L+LVME+ G V D + +KE+ R+I+ + + HQ K+IHRD+K +
Sbjct: 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140
Query: 542 NLLLDSEMNIKIADFGFSNEF--TPGNKLDTFCGSPPYAAPEL 582
N+LL +K+ DFG S + T G + +TF G+P + APE+
Sbjct: 141 NVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEV 182
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 469 SGGETLLKLFQVIETEK-----TLYLVMEYASGGEVFDYLVLHGR-----MKEKEARAKF 518
S +++L V E+ +LYLV EY ++ ++ +GR + K ++
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFT-PGNKLDTFCGSPP 576
Q++ V +CH+ ++HRDLK +NLL+D + +KIAD G F+ P +
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 577 YAAPELFQGG 586
Y APE+ G
Sbjct: 177 YRAPEVLLGS 186
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 31/85 (36%), Positives = 53/85 (62%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++K+F + + LYL+ME+ GG++ L+ + E+E + + V A+ HQ
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 534 IHRDLKAENLLLDSEMNIKIADFGF 558
IHRD+K +NLLLDS+ ++K++DFG
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 37/113 (32%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
+ + L++ MEY GG + D + G + E + R+ + + Y H K +HRD+K N
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGAN 136
Query: 543 LLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGG 594
+LL ++K+ADFG + + T K +F G+P + APE+ A V +GG
Sbjct: 137 ILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV----AAVEKNGG 185
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK--LFREVRIMKMLDHPNIVK-L 110
IG G F KV L++ + T VA ++ + + N S ++ ++ ++L HPNI++ L
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKI 166
Q +E L LV EY G++ YL + + +I + V + H+
Sbjct: 62 GQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 167 IHRDLKAENLLLDSEMNIKIADFG-----FSNEFTPGNKLDTFCGSPPYAAPEL---FQG 218
+H DL N L S++ +K+ D+G + ++ D C + APEL F G
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE--DDKCVPLRWLAPELVGEFHG 178
Query: 219 K-------KYDGPEVDVWSLGVILYTLV-SGSLPFDGSTLRELRERVLRGK 261
K +VW+LGV L+ L + + P+ + RE+ V++ +
Sbjct: 179 GLITAEQTKPS----NVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 31/96 (32%), Positives = 53/96 (55%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
A + E ++KL+ + + LY VM+Y GG++ L+ E AR ++ A++
Sbjct: 56 AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIE 115
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562
H+ IHRD+K +N+L+D + +IK+ DFG F
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 38/100 (38%), Positives = 58/100 (58%), Gaps = 5/100 (5%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
E T +LVMEY G D L +H + ++E E A + + Y H +IHRD+KA N
Sbjct: 93 EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGN 151
Query: 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
+LL +K+ADFG +++ +P N +F G+P + APE+
Sbjct: 152 ILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEV 188
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 13/97 (13%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIH 535
L +I T+KTL LV EY ++ Y+ G + R Q++ + YCHQ++++H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126
Query: 536 RDLKAENLLLDSEMNIKIADFG-----------FSNE 561
RDLK +NLL+ +K+ADFG +SNE
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
E T +LVMEY G D L +H + ++E E A + + Y H +IHRD+KA N
Sbjct: 97 EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGN 155
Query: 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
+LL +K+ADFG ++ +P N +F G+P + APE+
Sbjct: 156 ILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEV 192
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 51/276 (18%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ--KLFREVRIMKMLDHPNIVK 109
K IG G F KV L + V +G A ++ + +++ + K E + + L H N+++
Sbjct: 1 KEIGNGWFGKVILGE-VNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 110 -LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARAKFR---QIVSAVQYCH 162
L Q E L LVME+ G++ YL R E + R +I + + H
Sbjct: 60 CLGQCTEVTPYL-LVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFS-NEFTPGNKLDTFCGSPP------YAAPEL 215
+ IH DL N LL +++ +KI D+G S N++ K D + + APEL
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY----KEDYYVTPDQLWVPLRWIAPEL 173
Query: 216 F-----------QGKKYDGPEVDVWSLGVILYTLVS-GSLPFD--------GSTLRELRE 255
Q K E +VWSLGV ++ L GS P+ T+RE +
Sbjct: 174 VDEVHGNLLVVDQTK-----ESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL 228
Query: 256 RVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
++ + + ++P +D + +F L P +R S E
Sbjct: 229 KLPKPRLKLPL---SDRWYEVMQFCWLQPEQRPSAE 261
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 36/109 (33%), Positives = 60/109 (55%), Gaps = 9/109 (8%)
Query: 482 ETEKTLYLVMEYASGGEVFDYL-----VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536
E LY+VM+Y GG+++ + VL E + F QI A+++ H +KI+HR
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVL---FPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC-GSPPYAAPELFQ 584
D+K++N+ L + IK+ DFG + +L C G+P Y +PE+ +
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 7/101 (6%)
Query: 487 LYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
L+LVME+ G V D LV + + +KE R+I+ + + H K+IHRD+K +N+
Sbjct: 94 LWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152
Query: 544 LLDSEMNIKIADFGFSNEF--TPGNKLDTFCGSPPYAAPEL 582
LL +K+ DFG S + T G + +TF G+P + APE+
Sbjct: 153 LLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEV 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 481 IETEKTLYLVMEYASGGEVFD----YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536
++ L+LV+E +GG V D +L RM+E + + +Q+ H K IHR
Sbjct: 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHR 148
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPEL 582
D+K N+LL +E +K+ DFG S + T + +T G+P + APE+
Sbjct: 149 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
E T +LVMEY G D L +H + ++E E A + + Y H +IHRD+KA N
Sbjct: 87 EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
+LL +K+ DFG ++ P N F G+P + APE+
Sbjct: 146 ILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 33/112 (29%), Positives = 64/112 (57%), Gaps = 8/112 (7%)
Query: 478 FQVIETEKT------LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
V+E K+ L+++ME+ GG + D +V R+ E++ ++ A+ Y H +
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQ 136
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPEL 582
+IHRD+K++++LL + +K++DFGF + + K + G+P + APE+
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 28/91 (30%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
+++L+ V+ ++K L LV EY + FD +G + + ++ Q++ + +CH
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562
++HRDLK +NLL++ +K+ADFG + F
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 491 MEYASGGEVFDYLVLH-GRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDS 547
ME GG + L G +K+ E F +QI+ ++Y H +I+HRD+K +N+L+++
Sbjct: 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143
Query: 548 EMNI-KIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQGG 586
+ KI+DFG S N +TF G+ Y APE+ G
Sbjct: 144 YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLK 539
ET+ L LV+ +GG++ ++ G +E RA F +I ++ HQ++I++RDLK
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK 129
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
EN+LLD +I+I+D G + G + G+ Y APE+ +
Sbjct: 130 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 1/111 (0%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
T L +++ +GG++ +L HG E E R +I+ +++ H + +++RDLK
Sbjct: 67 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPA 126
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
N+LLD +++I+D G + +F+ K G+ Y APE+ Q G SS
Sbjct: 127 NILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 176
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 33/112 (29%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 474 LLKLFQVIETEK--TLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCH 529
LL + T++ L LV E+ ++ YL + + + + RQ++ V + H
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
+I+HRDLK +N+L+ S+ +KIADFG + ++ L + + Y APE
Sbjct: 125 SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQ 530
E L++L+ V ++ +Y+V EY S G + +YL HG R + + + + + Y
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K+ IHRDL A N L+D + +K++DFG S
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIV 522
E L++L+ V+ T L +V E A G + D R++ K+A F QI
Sbjct: 56 ENLIRLYGVVLTHP-LMMVTELAPLGSLLD------RLR-KDALGHFLISTLCDYAVQIA 107
Query: 523 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ ++Y K+ IHRDL A N+LL S+ +KI DFG
Sbjct: 108 NGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 13/95 (13%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIV-------SAVQ 526
++KL V ++ +Y+VME GG + +L ++K+ R ++++ + ++
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGME 107
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
Y K IHRDL A N L+ +KI+DFG S E
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE 142
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA-KFR-------QIVS 523
+ L++L+ V E+ +Y+V EY S G + D+L K E + + QI
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAE 114
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP 564
+ Y + IHRDL A N+L+ + KIADFG + +E+T
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 19/123 (15%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----RQIVSAVQY 527
L++L+ V ++ +++V EY + G + +YL K K + A++Y
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 528 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPYAAP 580
IHRDL A N L+ + +K++DFG + +++T G K +A P
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-----KWAPP 170
Query: 581 ELF 583
E+F
Sbjct: 171 EVF 173
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 41/124 (33%), Positives = 63/124 (50%), Gaps = 21/124 (16%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKK 532
++ L +I TE+ L LV EY ++ YL G M + Q++ + YCH++K
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 533 IIHRDLKAENLLLDSEMNIKIADFG-----------FSNE-----FTPGNKLDTFCGSPP 576
I+HRDLK +NLL++ + +K+ADFG +SNE + P D GS
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP---DVLLGSTE 180
Query: 577 YAAP 580
Y+ P
Sbjct: 181 YSTP 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 31/96 (32%), Positives = 53/96 (55%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
A S ++ L+ + + LYL+ME+ GG++ L+ + E R + V A++
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE 115
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562
H+ IHRD+K +N+L+D +IK++DFG S F
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 23/41 (56%), Positives = 32/41 (78%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
RQI+S + Y H++ I+HRD+K NLL++S N+KIADFG S
Sbjct: 175 RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 472 ETLLKLFQVI-----ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSA 524
E ++ L ++ E +Y+V E E + V+ + ++ QI+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
++Y H +IHRDLK N+L++S ++KI DFG +
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLK 539
ET+ L LV+ +GG++ ++ G E RA F +I ++ H+++I++RDLK
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK 129
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
EN+LLD +I+I+D G + E G + G+ Y APE+
Sbjct: 130 PENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 31/82 (37%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
K L L+MEY G + DYL H ++ + +QI + Y H + IHRDL A N+
Sbjct: 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138
Query: 544 LLDSEMNIKIADFGFSNEFTPG 565
LLD++ +KI DFG + G
Sbjct: 139 LLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 31/82 (37%), Positives = 46/82 (56%), Gaps = 2/82 (2%)
Query: 487 LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545
L LVMEY G + DYL H R+ ++ QI ++Y K+ +HRDL N+L+
Sbjct: 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141
Query: 546 DSEMNIKIADFGFSNEFTPGNK 567
+SE +KI DFG + + P +K
Sbjct: 142 ESENRVKIGDFGLT-KVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 35/237 (14%)
Query: 47 KYKLLKTIGKGNFAKV--KLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
K + + +G+G+F V +AK V + VAIK +++ ++ L E +MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKE 65
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARA-----KFRQ-- 153
+ ++V+L V+ + ++ME + G++ YL L M+ +A K Q
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 154 --IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE------FTPGNKLDTFC 205
I + Y + K +HRDL A N ++ + +KI DFG + + + G K
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK----- 180
Query: 206 GSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR 259
G P + +PE + + DVWS GV+L+ + + P+ G + E+VLR
Sbjct: 181 GLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMS----NEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 489 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548
L +E+ +GG V L +G KE Q++ + Y H+ +IIHRD+K NLL+DS
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139
Query: 549 -MNIKIADFGFSNEFTP-----GNKLDTFCGSPPYAAPELFQG 585
++IADFG + G G+ + APE+ +G
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 39/122 (31%), Positives = 54/122 (44%), Gaps = 29/122 (23%)
Query: 486 TLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+++LVMEY D L M E + + Q++ +QY H+ IIHRDLK
Sbjct: 82 SIFLVMEYCEQ----DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAPELFQGGAPVT 590
NLLL + +KIADFG + + G P Y APEL G T
Sbjct: 138 NLLLTDKGCLKIADFGLARTY----------GLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 591 SS 592
++
Sbjct: 188 TA 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 33/105 (31%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLK 539
ET+ L LV+ +GG++ ++ G +E RA F +I+ ++ H++ ++RDLK
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK 129
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
EN+LLD +I+I+D G + + G + G+ Y APE+
Sbjct: 130 PENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-QIVSAVQYCHQKK 532
++ L +I TEK+L LV EY ++ YL G F Q++ + YCH++K
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
++HRDLK +NLL++ +K+ADFG +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 487 LYLVMEYASGGEVFDY----LVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
L+LV+E +GG V + L+ R+ E + +Q+ H +IIHRD+K N
Sbjct: 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158
Query: 543 LLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPEL 582
+LL +E +K+ DFG S + T + +T G+P + APE+
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 30/87 (34%), Positives = 52/87 (59%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKK 532
++ L ++ T+K+L LV EY ++ Y+ G M + QI+ + YCH++K
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
++HRDLK +NLL++ +K+ADFG +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 17/117 (14%)
Query: 486 TLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+ YLV E+ D L + + E + + +++ + Y H+ KI+HRD+KA
Sbjct: 93 SFYLVFEFCE----HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAA 148
Query: 542 NLLLDSEMNIKIADFGFSNEF-----TPGNKLDTFCGSPPYAAPELFQG----GAPV 589
N+L+ + +K+ADFG + F + N+ + Y PEL G G P+
Sbjct: 149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 18/38 (47%), Positives = 29/38 (76%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 557
Q++ + Y H+ I+HRD+KA N+L+D++ +KIADFG
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCH 529
+ L++L+ V+ E+ +Y++ EY + G + D+L G++ + QI + Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFT 563
+K IHRDL+A N+L+ + KIADFG + NE+T
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA--KFRQIVSAVQYCH 529
L++L+ V+ T++ +Y++ EY G + D+L +K + QI + +
Sbjct: 61 PRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFT 563
+K IHRDL+A N+L+ + KIADFG + NE+T
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA----------KFRQI 521
+ ++ L V E LY+V+EYA+ G + D+L R + A + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDL 134
Query: 522 VS-------AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
VS +++ KK IHRDL A N+L+ + +KIADFG +
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 2/105 (1%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLK 539
ET+ L LV+ +GG++ ++ G E RA F ++ ++ +++I++RDLK
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK 129
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
EN+LLD +I+I+D G + + G + G+ Y APE+
Sbjct: 130 PENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
++KL VI E +++VME A GE+ YL ++ + + + Q+ +A+ Y K+
Sbjct: 69 IVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRD+ A N+L+ S +K+ DFG S
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 14/96 (14%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR------------QIVS 523
+L V+ T + +VME + G++ YL R E E +I
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ Y KK +HRDL A N ++ ++ +KI DFG +
Sbjct: 131 GMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 36/137 (26%), Positives = 55/137 (40%), Gaps = 32/137 (23%)
Query: 472 ETLLKLFQVI--ETEKTLYLVMEYASGGEVFDYL------------VLHGRMKEKEARAK 517
E ++ L +V +K++YL+ +YA D + M ++
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSM----VKSL 113
Query: 518 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN----IKIADFGFSNEFTPGNKLDTFCG 573
QI++ V Y H ++HRDLK N+L+ E +KI D G + F K
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-LADL 172
Query: 574 SPP-----YAAPELFQG 585
P Y APEL G
Sbjct: 173 DPVVVTIWYRAPELLLG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
+ T+ + ME+ GG + L G + E +QI+ V Y H ++HRD+K N+
Sbjct: 74 DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV 133
Query: 544 LLDSEMNIKIADFGFSNEF-------TPGNKLDTFCGSPPYAAPEL 582
+L IK+ DFG + T N L + G+P + APE+
Sbjct: 134 MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 41/242 (16%)
Query: 70 TGKEVAIKIIDKTQLNPG----SLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125
E IK+I K L+P SL F +M+ + H +IV L+ V + +V E
Sbjct: 27 YSYEKEIKVILKV-LDPSHRDISL-AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEE 84
Query: 126 YASGGEVFDYLVLHGRMKEKEARAKF---RQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 182
+ G + L +H + KF +Q+ SA+ Y K ++H ++ +N+LL E
Sbjct: 85 FVEFGPL--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLARE- 141
Query: 183 NIKIADFGFSNEFTPGNKLDTFCGSP-------------PYAAPELFQGKKYDGPEVDVW 229
G E P KL G P P+ APE + K D W
Sbjct: 142 -------GIDGECGPFIKLSD-PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKW 193
Query: 230 SLGVILYTLV-SGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCE---NLLKKFLVLNPA 285
S G L+ + +G +P TL E +ER G+ + ++ C+ +L+ + +P
Sbjct: 194 SFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCML---VTPSCKELADLMTHCMNYDPN 249
Query: 286 KR 287
+R
Sbjct: 250 QR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 29/65 (44%), Positives = 41/65 (63%), Gaps = 2/65 (3%)
Query: 518 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPP 576
F Q++ V Y HQ++I+HRDLKA+N+ L + + +KI DFG S L TF G+P
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPY 170
Query: 577 YAAPE 581
Y +PE
Sbjct: 171 YMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 2/113 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 531
++ L E++ L LVM +GG++ ++ G + R QI + + H
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM 114
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
I++RD+K EN+LLD + N +++D G + E G + G+ Y APE+ +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 532
+++L V ++ +Y+VME GG+ +L G R+K KE + ++Y K
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNE 561
IHRDL A N L+ + +KI+DFG S E
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE 143
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 472 ETLLKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVS-AVQYC 528
L++L VI EK LY+V EY + G + DYL GR + + KF V A++Y
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+HRDL A N+L+ + K++DFG + E
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 24/62 (38%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 521 IVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
IV A++Y H K +IHRD+K N+L++ +K+ DFG S G PY A
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171
Query: 580 PE 581
PE
Sbjct: 172 PE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 13/118 (11%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL- 545
L+ V EY G + + L G + E Q++ A+ H + I+HRDLK +N+++
Sbjct: 54 LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 546 --DSEMNIKIADFGFSNEFTPG---------NKLDTFCGSPPYAAPELFQGGAPVTSS 592
+ K+ DFG PG + G+P Y APE +G +S
Sbjct: 114 QTGVRPHAKVLDFGIGT-LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS 170
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 26/56 (46%), Positives = 36/56 (64%), Gaps = 3/56 (5%)
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQGG 586
+I+HRD+K N+L++S IK+ DFG S E N + DTF G+ Y +PE QGG
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGG 177
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 7/106 (6%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
L +I T++TL LV EY ++ Y+ H G + + + Q++ + Y HQ+ I+H
Sbjct: 68 LHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH 126
Query: 536 RDLKAENLLLDSEMNIKIADFGFSN-----EFTPGNKLDTFCGSPP 576
RDLK +NLL+ +K+ADFG + T N++ T PP
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 19/102 (18%)
Query: 499 VFDYL------VLHGRM---KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549
VF+Y+ +L + E ++ +Q++ + YCH+K +HRD+K N+LL+++
Sbjct: 94 VFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG 153
Query: 550 NIKIADFGFSNEFTPG------NKLDTFCGSPPYAAPELFQG 585
IK+ADFG + + NK+ T Y PEL G
Sbjct: 154 QIKLADFGLARLYNSEESRPYTNKVITLW----YRPPELLLG 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 12/106 (11%)
Query: 485 KTLYLVMEYASGGEVFD-YLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
K +Y+VM+ D + ++H + E+ R Q++ ++Y H +IHRDLK
Sbjct: 81 KDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPS 136
Query: 542 NLLLDSEMNIKIADFGF-----SNEFTPGNKLDTFCGSPPYAAPEL 582
NLL++ + ++I DFG S+ + + + Y APEL
Sbjct: 137 NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKF-RQIVSAVQYCH 529
E L++L+ V+ +E+ +Y+V EY S G + D+L G+ QI S + Y
Sbjct: 61 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFT 563
+ +HRDL+A N+L+ + K+ADFG + NE+T
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 25/62 (40%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 521 IVSAVQYCHQKK-IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
IV A+ Y +K +IHRD+K N+LLD+ N+K+ DFG S G Y A
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182
Query: 580 PE 581
PE
Sbjct: 183 PE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQYCHQ 530
L++L V E Y++ E+ + G + DYL R +E A QI SA++Y +
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 122
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K IHRDL A N L+ +K+ADFG S
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 437 GGGGGGAAQSPSHRG----VHRSISASNAKPSRRASSGGETLLKLFQVIETEKTLYLV-- 490
G G GG SH+ + R + KP+ R +++ QV+ + Y+V
Sbjct: 14 GAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIR-----NQIIRELQVLHECNSPYIVGF 68
Query: 491 -------------MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHR 536
ME+ GG + L GR+ E+ ++ + Y +K KI+HR
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
D+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG 176
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 57/264 (21%), Positives = 103/264 (39%), Gaps = 44/264 (16%)
Query: 54 IGKGNFAKVKLAKHVPTGKE----------VAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
+G+G F + V +K++ + + F +M L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAF---FETASLMSQLS 59
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----RQIVSAVQ 159
H ++VKL+ V ++ + +V EY G + +L R K + +Q+ SA+
Sbjct: 60 HKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFL---HREKNNVSLHWKLDVAKQLASALH 115
Query: 160 YCHQKKIIHRDLKAENLLL----DSEMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAA 212
Y KK++H ++ +N+L+ +E IK++D G + P+ A
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP---ITVLSREERVERIPWIA 172
Query: 213 PELFQGKKYDGPEV------DVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
PE + D WS G L + S G P + E +ER + ++R+P
Sbjct: 173 PEC-----IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQDQHRLP 226
Query: 266 FYMSTDCENLLKKFLVLNPAKRAS 289
+ NL+ + +P KR S
Sbjct: 227 MPDCAELANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 20/105 (19%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA--------KFRQIVS 523
+ L++L+ V+ +E+ +Y+V EY S G + D+L K+ E RA Q+ +
Sbjct: 61 DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL------KDGEGRALKLPNLVDMAAQVAA 113
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFT 563
+ Y + IHRDL++ N+L+ + KIADFG + NE+T
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 30/103 (29%), Positives = 55/103 (53%), Gaps = 11/103 (10%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
L +V+E A G++ + + K E+ F Q+ SAV++ H ++++HRD+K N
Sbjct: 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPAN 136
Query: 543 LLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPE 581
+ + + +K+ D G FS++ T + L G+P Y +PE
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-----NKLDTFCGS 574
QI+ ++Y H ++HRDLK NLL++++ +KI DFG + F+ + + +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 575 PPYAAPELFQGGAPVTSS 592
Y APE+ T +
Sbjct: 173 RWYRAPEIMLSFQSYTKA 190
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 28/109 (25%), Positives = 58/109 (53%), Gaps = 2/109 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L + I +E +++LV+++A GG+++ ++ + E+ + ++V A+ H++ I
Sbjct: 47 MVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGI 106
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
+ RDL N+LLD +I++ F +E D Y APE+
Sbjct: 107 VCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENMYCAPEV 153
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 25/208 (12%)
Query: 52 KTIGKGNFAKVKLAKHVPTGK-------EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+++G+G F K+ G EV +K++DK+ N + F +M L H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN--YSESFFEAASMMSQLSH 58
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE---KEARAKFRQIVSAVQYC 161
++V + V +V EY G + YL + + K AK Q+ A+ +
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAK--QLAWALHFL 116
Query: 162 HQKKIIHRDLKAENLLLDSEMN--------IKIADFGFSNEFTPGNKLDTFCGSPPYAAP 213
K + H ++ A+N+LL E + IK++D G S P + P+ P
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPP 173
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVSG 241
E + + D WS G L+ + SG
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 32/120 (26%), Positives = 55/120 (45%), Gaps = 9/120 (7%)
Query: 472 ETLLKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 525
+ ++ L V +K+L YLVME V+H + + Q++ +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLC---QVIHMELDHERMSYLLYQMLCGI 136
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
++ H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG 196
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
L +I T++TL V EY ++ Y++ H G + R Q++ + Y H + I+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 536 RDLKAENLLLDSEMNIKIADFGFS 559
RDLK +NLL+ +K+ADFG +
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 31/108 (28%), Positives = 57/108 (52%), Gaps = 13/108 (12%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMK-----EKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
L +V+E A G++ ++ H + + E+ F Q+ SA+++ H K+I+HRD+K
Sbjct: 77 LNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135
Query: 542 NLLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPELFQG 585
N+ + + +K+ D G FS++ T + L G+P Y +PE
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 24/77 (31%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 486 TLYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
++Y+V EY D + G + E+ AR Q++ ++Y H ++HRDLK N+
Sbjct: 90 SVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145
Query: 544 LLDSE-MNIKIADFGFS 559
+++E + +KI DFG +
Sbjct: 146 FINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN--EFTPGNKLDTFCGSPPY 577
QI+ ++Y H I+HRD+K NLL++S +KI DFG + E + + Y
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 578 AAPELFQGGAPVTSS 592
APE+ G TS+
Sbjct: 171 RAPEILMGSRHYTSA 185
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIV-------SAVQ 526
++KL V + +Y+VME GG+ +L ++K+ K +Q+V + +
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGGDFLSFL------RKKKDELKTKQLVKFALDAAAGMA 107
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
Y K IHRDL A N L+ +KI+DFG S +
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 18/61 (29%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 498 EVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 556
+++ YL + +A +QI+ ++Y H ++IIHRD+K EN+ ++ + I D
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
Query: 557 G 557
G
Sbjct: 202 G 202
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 466 RASSGGETLLKLFQVIETEKT--LYLVMEYASGGEVFDYLVLHGRMK---EKEARAKFRQ 520
R S +L+L +V+ KT L LV E +++ + GR + EK ++ Q
Sbjct: 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQ 108
Query: 521 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 557
++ ++ + H+ I HRD+K EN+L+ + +K+ADFG
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 20/122 (16%)
Query: 474 LLKLF---QVIETEKTLYLVMEY--ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 528
LL +F + +E + +YLVME A+ +V + H RM Q++ +++
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHL 134
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----YAAPELF 583
H IIHRDLK N+++ S+ +KI DFG + T G +F +P Y APE+
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGT---SFMMTPYVVTRYYRAPEVI 189
Query: 584 QG 585
G
Sbjct: 190 LG 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 31/123 (25%), Positives = 57/123 (46%), Gaps = 4/123 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+++L V+ + + ++ EY G + +L + G+ + R I S ++Y +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPP--YAAPELFQGGAPV 589
+HRDL A N+L++S + K++DFG S T G P + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 590 TSS 592
++S
Sbjct: 187 SAS 189
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 29/67 (43%), Positives = 37/67 (55%), Gaps = 11/67 (16%)
Query: 521 IVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC-----GS 574
V A+ Y ++ KIIHRD+K N+LLD NIK+ DFG S G +D+ G
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGC 170
Query: 575 PPYAAPE 581
PY APE
Sbjct: 171 RPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 31/117 (26%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-----MKEKEARAKFRQIVSAVQYC 528
++K + + L +V+E A G++ ++ H + + EK F Q+ SA+++
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPE 581
H ++++HRD+K N+ + + +K+ D G FS++ T + L G+P Y +PE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 21/122 (17%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQ---------IVSA 524
L++L+ V +K LY+V E+ G + +YL ++ + K + +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYL--------RQRQGKLSKDMLLSMCQDVCEG 112
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP---PYAAPE 581
++Y + IHRDL A N L+ S +K++DFG + + ++ + G+ ++ PE
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 582 LF 583
+F
Sbjct: 172 VF 173
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 35/123 (28%), Positives = 60/123 (48%), Gaps = 5/123 (4%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA-KFR-QIVSAVQYCH 529
+ L++L VI LY+VME S G + ++L GR + +F + ++Y
Sbjct: 59 KNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPV 589
KK++HRDL A N+L+ + K++DFG + + G +D + APE +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFS 175
Query: 590 TSS 592
+ S
Sbjct: 176 SKS 178
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 24/107 (22%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----------RQI 521
+ L+ L+ V+ +E+ +Y+V E+ G + D+L KE K+ QI
Sbjct: 61 DKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFL--------KEGDGKYLKLPQLVDMAAQI 111
Query: 522 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFT 563
+ Y + IHRDL+A N+L+ + KIADFG + NE+T
Sbjct: 112 ADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 2/96 (2%)
Query: 491 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEM 549
ME+ GG + L GR+ E ++ + Y +K KI+HRD+K N+L++S
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG 137
Query: 550 NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
IK+ DFG S + + ++F G+ Y +PE QG
Sbjct: 138 EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 31/102 (30%), Positives = 44/102 (43%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL----VL---------HGRMKEKEARAKFR- 519
++ L E LYL +EYA G + D+L VL + ++
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 520 --QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ + Y QK+ IHRDL A N+L+ KIADFG S
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 56/273 (20%), Positives = 114/273 (41%), Gaps = 43/273 (15%)
Query: 27 RLMSSRRESSRRERDEPH-IGKYK--LLKT-----IGKGNFAKVKLAKHVPTGKEVAIKI 78
+ + +R + + E I KY L+K I KG F KEV I+
Sbjct: 1 QNIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF----------NNKEVIIRT 50
Query: 79 IDKTQLNPGSLQKLF-REVRIMKMLDHPNIVKLF----QVIETEKTLYLVMEYASGGEVF 133
K L + E++ ++ +D NI+K++ +++ L L++EY + G +
Sbjct: 51 FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLR 110
Query: 134 DYLVLHGRMKEKEA--RAKFRQIVSAVQ-----YCHQKKIIHRDLKAENLLLDSEMNIKI 186
+ L KEK+ + K + + Y + K +++L + + L+ +KI
Sbjct: 111 EVL-----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKI 164
Query: 187 ADFGFSNEFT--PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 244
G + P ++ ++F +Y + D++SLGV+L+ + +G +P
Sbjct: 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS--EYT-IKDDIYSLGVVLWEIFTGKIP 221
Query: 245 FDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
F+ T +E+ + ++ + DC +K
Sbjct: 222 FENLTTKEIYDLIINKNNS--LKLPLDCPLEIK 252
|
Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPP-- 209
Q+ +++ +K IHRDL A N+LL +KI DFG + + + + + P
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252
+ APE K Y + DVWS GV+L+ + S G+ P+ G + E
Sbjct: 242 WMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 4/67 (5%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS----NEFTPGNKLDTFCGSP 575
QI+ ++Y H ++HRDLK NLLL++ ++KI DFG + E L + +
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 576 PYAAPEL 582
Y APE+
Sbjct: 174 WYRAPEI 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 36/111 (32%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV-----QYCHQKKIIHRDL 538
E +Y+ MEY G + D L G E R+I AV + IIHRD+
Sbjct: 71 EGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDV 129
Query: 539 KAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAP 588
K N+L++ +K+ DFG S K + C S Y APE + G P
Sbjct: 130 KPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGP 178
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 20/106 (18%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-----------MKEKEARAKFRQ 520
+ ++ L V E LY+++EYA+ G + ++L R K E + F+
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFL--RARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 521 IVSAV-------QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+VS +Y ++ IHRDL A N+L+ + +KIADFG +
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL----VL---------HGRMKEKEARAKFR- 519
++ L E LY+ +EYA G + D+L VL HG ++ +
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 520 --QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ + +QY +K+ IHRDL A N+L+ + KIADFG S
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 16/47 (34%), Positives = 28/47 (59%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 566
QI + Y H++ +IH+D+ A N ++D E+ +KI D S + P +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 13/122 (10%)
Query: 472 ETLLKLFQVIETEKTL------YLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVS 523
+ ++ L V +K+L YLVME +V + H RM Q++
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLC 130
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 583
+++ H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 584 QG 585
G
Sbjct: 191 LG 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 10/117 (8%)
Query: 472 ETLLKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 525
E ++ L V + +L YLVM + G L+ H ++ E + Q++ +
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
+Y H IIHRDLK NL ++ + +KI DFG + + +++ + + Y APE+
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEV 186
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 26/102 (25%), Positives = 41/102 (40%), Gaps = 14/102 (13%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG---RMKEKEARAKFR--------- 519
E ++K + V +V EY G++ +L HG +
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 520 --QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
QI S + Y + +HRDL N L+ ++ +KI DFG S
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 437 GGGGGGAAQSPSHRG----VHRSISASNAKPSRRASSGGETLLKLFQVIETEKTLYLV-- 490
G G GG H+ + R + KP+ R +++ QV+ + Y+V
Sbjct: 14 GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIR-----NQIIRELQVLHECNSPYIVGF 68
Query: 491 -------------MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHR 536
ME+ GG + L R+ E+ ++ + Y +K +I+HR
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
D+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG 176
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 24/57 (42%), Positives = 35/57 (61%), Gaps = 4/57 (7%)
Query: 512 KEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG----FSNEFTP 564
K+ RA +Q++ AV+Y H KK+IHRD+K EN+ L+ + I + DFG F E
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
|
Length = 501 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 7/125 (5%)
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPP-- 209
Q+ +++ +K IHRDL A N+LL +KI DFG + + + + + P
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR--GKYRIPF 266
+ APE + Y + DVWS GV+L+ + S G+ P+ G + E R L+ + R P
Sbjct: 247 WMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 305
Query: 267 YMSTD 271
Y + +
Sbjct: 306 YTTPE 310
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 31/112 (27%), Positives = 48/112 (42%), Gaps = 14/112 (12%)
Query: 134 DYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192
D L + GR + E+E A Q + A++ H++ L + LL G
Sbjct: 5 DILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DGSV 56
Query: 193 NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 244
TP P + APE+ QG+ Y + D++SLG+ LY + LP
Sbjct: 57 AFKTPEQSR----PDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 23/65 (35%), Positives = 36/65 (55%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYA 578
RQ + + + H I+HRDLK EN+L+ S +K+ADFG + ++ L + Y
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYR 174
Query: 579 APELF 583
APE+
Sbjct: 175 APEVL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 9/145 (6%)
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSP 208
Q+ +++ K +HRDL A N+LL +KI DFG + + + K TF
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PV 303
Query: 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI--P 265
+ APE Y DVWS G++L+ + S G P+ G + ++ YR+ P
Sbjct: 304 KWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP 362
Query: 266 FYMSTDCENLLKKFLVLNPAKRASL 290
+ + + +++ K P KR S
Sbjct: 363 DHATQEVYDIMVKCWNSEPEKRPSF 387
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++++ + E E + LVME A G + +L + + EK Q+ ++Y +
Sbjct: 58 IVRMIGICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFT 563
+HRDL A N+LL ++ KI+DFG S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALG 146
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 25/122 (20%)
Query: 461 AKPSRRASSGGETLLKLFQVIETEKTLY--------------------LVMEYASGGEVF 500
A S + SGG + L + IE + LY L+ME+ G +
Sbjct: 37 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 96
Query: 501 DYL---VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 557
+YL +K++ A QI + Y ++ +HRDL A N+L++SE +KI DFG
Sbjct: 97 EYLPRNKNKINLKQQLKYAV--QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 154
Query: 558 FS 559
+
Sbjct: 155 LT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 28/73 (38%), Positives = 40/73 (54%), Gaps = 1/73 (1%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPPYA 578
Q+ A+ Y H K I HRDLK +NLL+D + +K+ DFG + G + ++ S Y
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 579 APELFQGGAPVTS 591
APEL G T+
Sbjct: 238 APELMLGATNYTT 250
|
Length = 440 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 26/90 (28%), Positives = 37/90 (41%), Gaps = 11/90 (12%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKF----------RQIVSAVQYCHQK 531
+ L ++MEY G++ +L H +K QI S ++Y
Sbjct: 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL 149
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+HRDL N L+ IKIADFG S
Sbjct: 150 NFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFR-QIVSAVQYCH 529
+ L+KL V+ T++ +Y++ E+ + G + D+L G + F QI + +
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFT 563
Q+ IHRDL+A N+L+ + + KIADFG + NE+T
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE---KEARAKFRQIVSAVQYCHQ 530
++++ V E E L LVME ASGG + +L G+ E Q+ ++Y
Sbjct: 57 IVRMIGVCEAE-ALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K +HRDL A N+LL ++ KI+DFG S
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 21/54 (38%), Positives = 29/54 (53%)
Query: 521 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 574
I S ++Y K IHRDL A N +L+ M + +ADFG S + G+ C S
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 30/123 (24%), Positives = 56/123 (45%), Gaps = 5/123 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQKK 532
L++L+ V + LV E+ G + DYL G+ ++ + + Y
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP---PYAAPELFQGGAPV 589
+IHRDL A N L+ +K++DFG + F ++ + G+ +++PE+F
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 590 TSS 592
+ S
Sbjct: 180 SKS 182
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 35/113 (30%), Positives = 51/113 (45%), Gaps = 23/113 (20%)
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYA- 211
Q+ +++ +K IHRDL A N+LL +KI DFG + + P Y
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK---------DPDYVR 231
Query: 212 -----------APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252
APE K Y + DVWS GV+L+ + S G+ P+ G + E
Sbjct: 232 KGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 2/88 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIVSAVQYCHQK 531
L++L+ V E+ +Y+V E G + +YL +K + Q+ S + Y +
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRDL A N+L+ K+ADFG +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 33/91 (36%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP 265
G+P Y APEL GK + GP VD W+LGV L+ ++G PF+ T +++ + +L IP
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL--NRDIP 598
Query: 266 F-----YMSTDCENLLKKFLVLNPAKRASLE 291
+ +S + +N ++ L ++P KRA L+
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLK 629
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF----CGS 574
RQ++SA+ Y H + IIHRD+K EN+L++ +I + DFG + F G+ F G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC-FARGSWSTPFHYGIAGT 325
Query: 575 PPYAAPELFQGG--APVTSSGGAG----TNHTHNSSISPAPTNFKRQ 615
APE+ G P AG H +S+ A +R+
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 18/107 (16%)
Query: 94 REVRIMKMLD-HPNIV-KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR--- 148
REV I+++L V K+ E++ YL+ME+ G + KE A
Sbjct: 40 REVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET---LDEVSEEEKEDIAEQLA 96
Query: 149 ---AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192
AK Q+ V + H DL N+L+D + I D+ ++
Sbjct: 97 ELLAKLHQLPLLV-------LCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 7/113 (6%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ + E + + E+ GG L ++ ++ E +V + Y KI
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQG 585
+HRD+K N+L+++ +K+ DFG S + N + T+ G+ Y APE G
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISG 167
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 474 LLKLF---QVIETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 528
LL +F + +E + +Y+VME +V + H RM Q++ +++
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCGIKHL 142
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 5/115 (4%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 530
+++L V+ K ++ EY G + YL H G + R I + ++Y
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSN--EFTPGNKLDTFCGSPP--YAAPE 581
+HRDL A N+L++S + K++DFG S E P T G P + APE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 16/106 (15%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYL----------------VLHGRMKEKEAR 515
+ ++ L + LY+++EYAS G + +YL V +M K+
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 516 AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+ Q+ ++Y +K IHRDL A N+L+ +KIADFG + +
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 478 FQVIETEK--TLYLVMEYASGGEVFDYLVLHGRMKEK------EARAKF-RQIVSAVQYC 528
Q +E+E + +++ + G++ +L L+ R+ + + KF I S ++Y
Sbjct: 70 LQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQMLVKFMTDIASGMEYL 128
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 566
K IHRDL A N +L+ MN+ +ADFG S + G+
Sbjct: 129 SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 21/63 (33%), Positives = 37/63 (58%), Gaps = 2/63 (3%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
QI+ ++Y H ++HRDLK N+L++ ++KI DFG + P ++ + + Y A
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYRA 173
Query: 580 PEL 582
PE+
Sbjct: 174 PEI 176
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 5/113 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
++ L V+ K + +V EY G + +L H G+ + R I S ++Y
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSN--EFTPGNKLDTFCGSPP--YAAPE 581
+HRDL A N+L++S + K++DFG S E P T G P + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 16/106 (15%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYL----------------VLHGRMKEKEAR 515
+ ++ L + LY+++EYAS G + +YL V ++ K+
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 516 AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+ Q+ ++Y KK IHRDL A N+L+ + +KIADFG + +
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 9/117 (7%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQ-----IVSAVQYC 528
L L Q IE+ L LV+E+ G++ +YL + M + A+ Q + S + +
Sbjct: 58 LQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF-CGSPP--YAAPEL 582
HQ IH DL N L +++++KI D+G + E P + T C + P + APEL
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 34/289 (11%)
Query: 13 SETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK 72
+ G+G+ NI RL EP + + + +GN +L
Sbjct: 1 AHLGQGTRTNIYDGRLRV-------EGGGEPEEDEMEDEDPLVEGNNNGREL-------- 45
Query: 73 EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132
V +K++D + + F +M + H ++ + V +V E+ G +
Sbjct: 46 RVVLKVLDPSHRDIA--LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 133 FDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL-------DSEMN 183
D + GR+ +Q+ SA+ Y K ++H ++ A+N+LL +
Sbjct: 104 -DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 184 IKIADFGFS-NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV-SG 241
IK++D G S + +++ P+ APE G D WS G L + G
Sbjct: 163 IKLSDPGVSFTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218
Query: 242 SLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASL 290
+P T E +ER K+R+P + L+ + L P +R S
Sbjct: 219 EVPLKERTPSE-KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF 266
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 2/92 (2%)
Query: 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAV 525
AS +++L + + + L+ + G + DY+ H + + QI +
Sbjct: 64 ASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 557
Y +K+++HRDL A N+L+ + ++KI DFG
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFG 154
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540
+E + +YLV G + +V ++ + + QI+ ++Y H IIHRDLK
Sbjct: 89 LEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP 146
Query: 541 ENLLLDSEMNIKIADFGFS 559
N+ ++ + +KI DFG +
Sbjct: 147 SNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 41/129 (31%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF-------SNEFTPGN-KLDTF 204
Q+ + + K IHRDL A N+LL KI DFG SN GN +L
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV- 280
Query: 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR 263
+ APE Y E DVWS G++L+ + S GS P+ G + ++++ YR
Sbjct: 281 ----KWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 264 IPFYMSTDC 272
+ +S +C
Sbjct: 336 M---LSPEC 341
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 23/64 (35%), Positives = 38/64 (59%), Gaps = 1/64 (1%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN-EFTPGNKLDTFCGSPPYA 578
Q++ ++Y H ++HRDLK NLLL++ ++KI DFG + G+ + + + Y
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 579 APEL 582
APEL
Sbjct: 176 APEL 179
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 16/101 (15%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR----------------Q 520
L V E+ ++ EY + G++ ++LV + + A + Q
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 521 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
I + ++Y +HRDL A N L+ + +KI+DFG S +
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 31/102 (30%), Positives = 44/102 (43%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL----VLH------------GRMKEKEARAK 517
++ L E LYL +EYA G + D+L VL + ++
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 518 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ + Y QK+ IHRDL A N+L+ KIADFG S
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 25/68 (36%), Positives = 40/68 (58%), Gaps = 4/68 (5%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG---FSNEFTPGNKLDTFCGSP 575
R ++ A+QY H+ +IIHRD+KAEN+ ++ ++ + DFG F + NK + G+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTI 247
Query: 576 PYAAPELF 583
APEL
Sbjct: 248 ATNAPELL 255
|
Length = 391 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 2/88 (2%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFR-QIVSAVQYCH 529
+ L+ LF V + +Y++ E G + +L G++ + Q+ + Y
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFG 557
++ IHRDL A N+L+ ++ K+ADFG
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFG 149
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------------- 519
+++L V ++ L ++ EY G++ +L ++E + F
Sbjct: 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFL------SQREIESTFTHANNIPSVSIANLL 132
Query: 520 ----QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 566
QI S ++Y +HRDL N L+ + IKIADFG S G+
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 30/105 (28%), Positives = 45/105 (42%), Gaps = 13/105 (12%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR------------QI 521
+++L V T L ++ EY G++ +L H +E +A QI
Sbjct: 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTISYSTLIFMATQI 139
Query: 522 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 566
S ++Y +HRDL N L+ IKIADFG S G+
Sbjct: 140 ASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 22/76 (28%), Positives = 40/76 (52%), Gaps = 5/76 (6%)
Query: 489 LVMEYASG--GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
LVM+ + +V D + R+ E + + QI++ + H+ +HRDL N+ ++
Sbjct: 97 LVMDIMASDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN 153
Query: 547 SEMNIKIADFGFSNEF 562
S+ KIADFG + +
Sbjct: 154 SKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 22/63 (34%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
QI+ ++Y H IIHRDLK NL ++ + +KI DFG + +++ + + Y A
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRA 185
Query: 580 PEL 582
PE+
Sbjct: 186 PEI 188
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 21/113 (18%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------------- 519
+++L V E L ++ EY G++ +L H + +KE
Sbjct: 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGNDAVPPAHCLPAISYSS 139
Query: 520 ------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 566
QI S ++Y +HRDL N L+ + IKIADFG S G+
Sbjct: 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 51/231 (22%), Positives = 92/231 (39%), Gaps = 43/231 (18%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ--LNPGSLQKLFRE-VRIMKML 102
++K+L +G+G F KV A + A+KI+ ++ F E VR
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
D ++K+ + + E ++ G + D+++ HG + Q A+ Y H
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH 248
Query: 163 QK-KIIHRDLKAENLLLDSE----------------MNIKIADFGFSNEFTPGNKLDTFC 205
+ ++H DLK EN+L+++ ++I D G C
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG-------------C 295
Query: 206 GSPPYAAPELFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFD 246
++ + + Y PEV D+WS+G I+Y L +G L +D
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 16/106 (15%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH---------GRMKEKEARAKFRQIV 522
+ ++ L + LY+++EYAS G + +YL K E + F+ +V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 523 S-------AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
S ++Y +K IHRDL A N+L+ + +KIADFG + +
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 17/41 (41%), Positives = 26/41 (63%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+Q+ + + Y ++K +HRDL N L+ M +KIADFG S
Sbjct: 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 21/64 (32%), Positives = 38/64 (59%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
Q++ + + H +++HRDLK +N+L+ S IK+ADFG + ++ L + + Y A
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 177
Query: 580 PELF 583
PE+
Sbjct: 178 PEVL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 3/114 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+++L VI T+ +V EY S G + +L H G++ + + S ++Y +
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--YAAPELFQ 584
+H+ L A +L++S++ KI+ F E T G P +AAPE Q
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 8/81 (9%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFT----PGNKLDTF 571
QI+ + Y H ++HRDLK N+L+ E +KIAD GF+ F P LD
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 572 CGSPPYAAPELFQGGAPVTSS 592
+ Y APEL G T +
Sbjct: 176 VVTFWYRAPELLLGARHYTKA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 24/83 (28%), Positives = 45/83 (54%), Gaps = 1/83 (1%)
Query: 486 TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
+L LV + + G + D++ H + + QI + Y + +++HR+L A N+L
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141
Query: 545 LDSEMNIKIADFGFSNEFTPGNK 567
L S+ ++IADFG ++ P +K
Sbjct: 142 LKSDSIVQIADFGVADLLYPDDK 164
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 17/40 (42%), Positives = 25/40 (62%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ ++Y KK +HRDL A N +LD +K+ADFG +
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 22/60 (36%), Positives = 36/60 (60%)
Query: 498 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 557
++F Y+ G + ++A R+++ A+ Y H + IIHRD+K EN+ LD N + DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 37/136 (27%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF-------SNEFTPGNKLDTFC 205
Q+ + +++ K +HRDL A N+L+ +KI DFG SN + G+ TF
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS---TFL 303
Query: 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI 264
+ APE Y DVWS G++L+ + + G P+ + E ++ YR+
Sbjct: 304 -PLKWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361
Query: 265 --PFYMSTDCENLLKK 278
P + S + +++K
Sbjct: 362 AKPAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 25/102 (24%), Positives = 50/102 (49%), Gaps = 17/102 (16%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLH-------------GRMKEKEARAKFR---- 519
L V+ E+ + ++ EY + G++ ++L++ G +K F
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
QI + ++Y +H+DL A N+L+ ++++KI+D G S E
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 8/81 (9%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFT----PGNKLDTF 571
QI+ + Y H ++HRDLK N+L+ E +KIAD GF+ F P LD
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 572 CGSPPYAAPELFQGGAPVTSS 592
+ Y APEL G T +
Sbjct: 176 VVTFWYRAPELLLGARHYTKA 196
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 25/68 (36%), Positives = 40/68 (58%), Gaps = 6/68 (8%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS----NEFTPGNKLDT-FCGS 574
Q++ A++Y H + HRDLK +N+L +++ +KI DFG + N+ TP T + +
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFWTDYVAT 169
Query: 575 PPYAAPEL 582
Y APEL
Sbjct: 170 RWYRAPEL 177
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 23/69 (33%), Positives = 39/69 (56%), Gaps = 2/69 (2%)
Query: 148 RAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCG- 206
+ RQ+++ ++ H+ I+HRD+K ENLL+ + +KI DFG + + G + G
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371
Query: 207 -SPPYAAPE 214
P Y+ PE
Sbjct: 372 LDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 23/69 (33%), Positives = 39/69 (56%), Gaps = 2/69 (2%)
Query: 515 RAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCG- 573
+ RQ+++ ++ H+ I+HRD+K ENLL+ + +KI DFG + + G + G
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371
Query: 574 -SPPYAAPE 581
P Y+ PE
Sbjct: 372 LDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 28/98 (28%)
Query: 518 FRQIVSAVQYCHQKKIIHRDLKAENLLL---------------------DSEMNIKIADF 556
F +I + ++Y H K ++HRDLK +N+LL + ++I + +
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 557 G--FSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
+S+ PG G+P Y APE G P + S
Sbjct: 179 NICYSSMTIPGK----IVGTPDYMAPERLL-GVPASES 211
|
Length = 932 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 23/75 (30%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 486 TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
T+ LV + G + DY+ + R+ ++ QI + Y + +++HRDL A N+L
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141
Query: 545 LDSEMNIKIADFGFS 559
+ S ++KI DFG +
Sbjct: 142 VKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 17/46 (36%), Positives = 26/46 (56%)
Query: 521 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 566
I ++Y + IHRDL A N +L +M + +ADFG S + G+
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 19/94 (20%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------QIVSAVQYCHQKKIIHRDLK 539
+ ++ EY G++ ++L +++E+ Q+ + + K IHRDL
Sbjct: 114 ILVITEYCCYGDLLNFL-----RRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLA 168
Query: 540 AENLLLDSEMNIKIADFGF-------SNEFTPGN 566
A N+LL +KI DFG SN GN
Sbjct: 169 ARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 26/103 (25%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------------RMKEKEARAKF 518
E ++K + V L +V EY G++ +L HG + + +
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+QI + + Y + +HRDL N L+ + +KI DFG S +
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 19/63 (30%), Positives = 37/63 (58%), Gaps = 2/63 (3%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
Q++ ++Y H IIHRDLK N+ ++ + ++I DFG + + +++ + + Y A
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRWYRA 183
Query: 580 PEL 582
PE+
Sbjct: 184 PEI 186
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/112 (25%), Positives = 47/112 (41%), Gaps = 24/112 (21%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--------GRMKEKEARAKFR------ 519
++KL+ + L L++EYA G + +L G + +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 520 ----------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
QI +QY + K++HRDL A N+L+ +KI+DFG S +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 22/87 (25%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
++ L V+ + + ++ E+ G + +L + G+ + R I + ++Y +
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL A N+L++S + K++DFG S
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 50 LLKTIGKGNFAKVKLA-----KHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD- 103
L +T+G G F +V A H + +VA+K++ K+ Q L E++IM L
Sbjct: 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKML-KSTARSSEKQALMSELKIMSHLGP 99
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL 136
H NIV L +Y++ EY G++ DYL
Sbjct: 100 HLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 27/109 (24%), Positives = 47/109 (43%), Gaps = 12/109 (11%)
Query: 487 LYLVMEYASGGEVFDYLVLH---GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
LY+V + G D L H G + E + +++A+ Y H K IHR +KA ++
Sbjct: 74 LYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHI 132
Query: 544 LLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSP-------PYAAPELFQ 584
LL + + ++ +S G + P P+ +PE+ Q
Sbjct: 133 LLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 32/130 (24%), Positives = 59/130 (45%), Gaps = 28/130 (21%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYCHQ------- 530
+ + LY++ME+ G++ + + G+++E RQ++ A+ YCH
Sbjct: 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNG 143
Query: 531 KKIIHRDLKAENLLLDSEMN-----------------IKIADFGFSNEFTPGNKLDTFCG 573
++++HRDLK +N+ L + + KI DFG S + + G
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVG 203
Query: 574 SPPYAAPELF 583
+P Y +PEL
Sbjct: 204 TPYYWSPELL 213
|
Length = 1021 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 24/75 (32%), Positives = 39/75 (52%), Gaps = 7/75 (9%)
Query: 487 LYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
YLVM Y + L ++ + E + + Q++ ++Y H IIHRDLK NL
Sbjct: 95 FYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLA 149
Query: 545 LDSEMNIKIADFGFS 559
++ + +KI DFG +
Sbjct: 150 VNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 16/48 (33%), Positives = 28/48 (58%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 567
QI + Y +++++HRDL A N+L+ + ++KI DFG + K
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+ KT+G G F KV A GKE VA+K++ K + + L E++I+
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDEREALMSELKILSH 97
Query: 102 L-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL 136
L H NIV L + ++ EY G++ ++L
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
QI + Y +++++HRDL A N+L+ S ++KI DFG +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 24/101 (23%), Positives = 47/101 (46%), Gaps = 16/101 (15%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYLVLHG------------RMKEKEARAKF----RQ 520
L V+ E+ L ++ Y S ++ ++LV+ +K A F Q
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 521 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
I + +++ ++H+DL N+L+ ++N+KI+D G E
Sbjct: 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 17/146 (11%)
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF-------SNEFTPGN-KLDTF 204
Q+ + + K IHRD+ A N+LL KI DFG SN GN +L
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV- 278
Query: 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR 263
+ APE Y + DVWS G++L+ + S G P+ G + ++++ Y+
Sbjct: 279 ----KWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333
Query: 264 I--PFYMSTDCENLLKKFLVLNPAKR 287
+ P + + +++K L P +R
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTER 359
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 16/106 (15%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKF------ 518
E ++K + V L +V EY G++ +L HG + ++A+ +
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 519 ---RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
QI S + Y + +HRDL N L+ + + +KI DFG S +
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 172
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 22/90 (24%), Positives = 36/90 (40%), Gaps = 16/90 (17%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR------AKFRQIVSAVQYCH 529
K+ E++ YL+ME+ G + KE A AK Q+ V
Sbjct: 57 KVLASGESDGWSYLLMEWIEGET---LDEVSEEEKEDIAEQLAELLAKLHQLPLLV---- 109
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ H DL N+L+D + I D+ ++
Sbjct: 110 ---LCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 19/197 (9%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113
I +G K + G + +K I+ P S E+ M L HPNIVKL +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS------EIADMGKLQHPNIVKLIGL 751
Query: 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH---QKKIIHRD 170
+EK YL+ EY G + + VL E+ R I A+++ H ++ +
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSE--VLRNLSWERR-RKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCG-SPPYAAPELFQGKKYDGPEVDVW 229
L E +++D + + DT C S Y APE + K + D++
Sbjct: 809 LSPEKIIIDGKDEPHLR-LSLPGLLC----TDTKCFISSAYVAPETRETKDIT-EKSDIY 862
Query: 230 SLGVILYTLVSGSLPFD 246
G+IL L++G P D
Sbjct: 863 GFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 28/110 (25%), Positives = 45/110 (40%), Gaps = 28/110 (25%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQ----------- 520
++KL V + Y++ME GG++ YL ++AR +
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--------RDARVERFGPPLLTLKELLD 110
Query: 521 ----IVSAVQYCHQKKIIHRDLKAENLLL-----DSEMNIKIADFGFSNE 561
+ Y Q IHRDL A N L+ D++ +KI DFG + +
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 8/85 (9%)
Query: 483 TEKTLYL-VMEYASGGEVFDYLVLHGRMKEK---EARAKFR---QIVSAVQYCHQKKIIH 535
TE T YL VME+ G++ YL R E + R +I + + H+ IH
Sbjct: 65 TEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIH 123
Query: 536 RDLKAENLLLDSEMNIKIADFGFSN 560
DL N LL +++ +KI D+G S+
Sbjct: 124 SDLALRNCLLTADLTVKIGDYGLSH 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|164795 PHA00370, III, attachment protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 27/77 (35%), Positives = 30/77 (38%), Gaps = 10/77 (12%)
Query: 385 DPESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAA 444
GS +G N GSGGG TGGSG S GS G +TG S G GA
Sbjct: 88 GTGEGGSDTGGDTGGGNTGGGSGGGDTGGSGGGGS---DGGGSEGGSTGKSLTKEGVGA- 143
Query: 445 QSPSHRGVHRSISASNA 461
G +NA
Sbjct: 144 ------GDFDYPKMANA 154
|
Length = 297 |
| >gnl|CDD|180777 PRK06958, PRK06958, single-stranded DNA-binding protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 23/59 (38%), Positives = 24/59 (40%), Gaps = 1/59 (1%)
Query: 390 GSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQSPS 448
G R GS G GG GG G + G GG G GGGG GG A PS
Sbjct: 109 GGRGGSGGGGGGGDEGGYGGGGGGGGGGYG-GESRSGGGGGRASGGGGGGAGGGASRPS 166
|
Length = 182 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 27/105 (25%), Positives = 45/105 (42%), Gaps = 15/105 (14%)
Query: 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKFR-------- 519
+ +++ + V + L +V EY G++ +L HG + E A +
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 520 ---QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
QI S + Y +HRDL N L+ + +KI DFG S +
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVL--------HGRMKE--KEARAKFRQIVS 523
+++L V+ + +VME + G++ YL GR +E +I
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+ Y + KK +HRDL A N ++ + +KI DFG + +
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 9/119 (7%)
Query: 443 AAQSPSHRGVHRSISASNAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDY 502
+SP RG R++ + R + L FQ + T + + D
Sbjct: 114 REKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST--------NPPQETDD 165
Query: 503 LVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
L E F Q+ +++ +K IHRDL A N+LL +KI DFG + +
Sbjct: 166 LWKSPLTMEDLICYSF-QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 223
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 3/67 (4%)
Query: 151 FRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPG-NKL-DTFCGS 207
RQI+ A+ H I+HRD+K +N++ + KI D G + + G N + F
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD 320
Query: 208 PPYAAPE 214
P YAAPE
Sbjct: 321 PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 3/67 (4%)
Query: 518 FRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPG-NKL-DTFCGS 574
RQI+ A+ H I+HRD+K +N++ + KI D G + + G N + F
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD 320
Query: 575 PPYAAPE 581
P YAAPE
Sbjct: 321 PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARA-----KFRQ----IVS 523
+++L V+ + ++ME + G++ YL L M+ +A K Q I
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
+ Y + K +HRDL A N ++ + +KI DFG + +
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 168
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 16/42 (38%), Positives = 25/42 (59%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 561
Q+ +++ +K IHRDL A N+LL +KI DFG + +
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 228
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 16/40 (40%), Positives = 24/40 (60%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ +++ +K IHRDL A N+LL +KI DFG +
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 220
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 708 | |||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG0596|consensus | 677 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0590|consensus | 601 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| KOG0664|consensus | 449 | 99.98 | ||
| KOG0595|consensus | 429 | 99.98 | ||
| KOG3653|consensus | 534 | 99.98 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0670|consensus | 752 | 99.97 | ||
| KOG1345|consensus | 378 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290|consensus | 590 | 99.97 | ||
| KOG0616|consensus | 355 | 99.97 | ||
| KOG0615|consensus | 475 | 99.96 | ||
| KOG1024|consensus | 563 | 99.96 | ||
| KOG0581|consensus | 364 | 99.96 | ||
| KOG0583|consensus | 370 | 99.96 | ||
| KOG0592|consensus | 604 | 99.96 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG0588|consensus | 786 | 99.95 | ||
| KOG0590|consensus | 601 | 99.95 | ||
| KOG0575|consensus | 592 | 99.95 | ||
| KOG0694|consensus | 694 | 99.95 | ||
| KOG0593|consensus | 396 | 99.95 | ||
| KOG0605|consensus | 550 | 99.95 | ||
| KOG1167|consensus | 418 | 99.95 | ||
| KOG0611|consensus | 668 | 99.95 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0599|consensus | 411 | 99.94 | ||
| KOG0600|consensus | 560 | 99.94 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0658|consensus | 364 | 99.94 | ||
| KOG0663|consensus | 419 | 99.94 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0659|consensus | 318 | 99.93 | ||
| KOG1163|consensus | 341 | 99.93 | ||
| KOG0661|consensus | 538 | 99.93 | ||
| KOG0604|consensus | 400 | 99.93 | ||
| KOG1164|consensus | 322 | 99.93 | ||
| KOG0597|consensus | 808 | 99.93 | ||
| KOG0610|consensus | 459 | 99.93 | ||
| KOG0594|consensus | 323 | 99.93 | ||
| KOG1165|consensus | 449 | 99.93 | ||
| KOG0986|consensus | 591 | 99.93 | ||
| KOG0033|consensus | 355 | 99.93 | ||
| KOG0591|consensus | 375 | 99.92 | ||
| KOG0690|consensus | 516 | 99.92 | ||
| KOG0660|consensus | 359 | 99.92 | ||
| KOG0606|consensus | 1205 | 99.92 | ||
| KOG1035|consensus | 1351 | 99.92 | ||
| KOG0586|consensus | 596 | 99.92 | ||
| KOG0614|consensus | 732 | 99.91 | ||
| KOG0032|consensus | 382 | 99.91 | ||
| KOG4717|consensus | 864 | 99.91 | ||
| KOG0198|consensus | 313 | 99.91 | ||
| KOG0578|consensus | 550 | 99.91 | ||
| KOG0612|consensus | 1317 | 99.91 | ||
| KOG0585|consensus | 576 | 99.91 | ||
| KOG0608|consensus | 1034 | 99.91 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0696|consensus | 683 | 99.9 | ||
| KOG0192|consensus | 362 | 99.9 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0580|consensus | 281 | 99.9 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.89 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0589|consensus | 426 | 99.89 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.89 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.89 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.89 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.89 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.89 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.89 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.89 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.89 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.89 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.89 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.88 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.88 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.88 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0695|consensus | 593 | 99.88 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.88 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.88 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG4721|consensus | 904 | 99.88 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.87 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.87 | |
| KOG0662|consensus | 292 | 99.87 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.87 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.87 |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-62 Score=536.03 Aligned_cols=323 Identities=41% Similarity=0.664 Sum_probs=284.1
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccC-CCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT-QLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
...+|-|+++++||+|+-|.|.+|+|..||+.+|||+|.+. .........+.+||-||+.|.||||++||++|+++.++
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 45689999999999999999999999999999999999987 44445556789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
|+|+||++||+|++|+..+|+++|.++..+|+||+.|+.|||..+|+||||||||+|||.+++|||+|||+|..-.++..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998888999
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L 280 (708)
+.+.||+|.|+|||++.|.+|+|.++||||+|||||.||+|++||++.+.+.++.+|.+|.|.+|.++|+++++||.+||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHh---hhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCCcCCCC
Q psy2648 281 VLNPAKRASLEVSG---EVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASIA 357 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 357 (708)
.+||.+|+|+++|. |+.-.... ..+...+.+... ..+ =.+....||
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~~~------------~~~~~~~~~~~~---~i~----------------s~ps~~~ID 296 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYTSL------------PSSKSLRPPVSV---PIL----------------SIPSIQEID 296 (786)
T ss_pred ccCccccccHHHHhhCchhhcCCCC------------ChhhhcCCCccc---cee----------------ecCCcccCC
Confidence 99999999999998 65432110 000000101000 000 011234689
Q ss_pred hhhHHHHhc--CCCCHHHHHHHHhccCCCCcccccccccc
Q psy2648 358 PLDTKALVG--LGYSRSEIEESLSQAKYDDPESDGSRSGS 395 (708)
Q Consensus 358 ~~~~~~~~~--~g~~~~~i~~~l~~~~~~~~~~~y~~l~~ 395 (708)
|.+++.|.- +|-+++.+.+.|.+...|+....|+||.+
T Consensus 297 p~Il~~l~iLwc~~d~~kl~~kLls~~~n~EK~~Y~LLl~ 336 (786)
T KOG0588|consen 297 PLILQHLCILWCGRDPEKLVEKLLSPDDNDEKTLYFLLLR 336 (786)
T ss_pred HHHHhhhhheeecCChHHHHHHHcCCCcchhHHHHHHHHH
Confidence 999998875 55678899999999999999999998744
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-61 Score=528.16 Aligned_cols=319 Identities=66% Similarity=0.993 Sum_probs=293.7
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.+++.++.|.+.++||+|.|++|++|+|..|+..||||+|++...+....+++.+|+++|+.|+|||||+||++++++..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 67888999999999999999999999999999999999999999998888889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|+||||+.+|++++|+..++++.|.+++.+|.|+++|++|||+++|||||||.+||||+.+.++||+|||++..+..+.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.+.++||+++|+|||++.+.+|+++++|+|||||+||.|++|.+||++.+..++..+++.|++++|+++|.+|++||++|
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCHHHHh---hhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCCcCCC
Q psy2648 280 LVLNPAKRASLEVSG---EVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASI 356 (708)
Q Consensus 280 L~~dP~~Rps~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 356 (708)
|.++|.+|+++++++ |+..... .....+..++. +.-+
T Consensus 290 lvl~Pskr~~~dqim~~~W~n~~~~----------~~~l~p~~e~~------------------------------~~~~ 329 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWRNDLLE----------ARLLAPLIERS------------------------------TPFI 329 (596)
T ss_pred hccCccccCCHHHhhhhcccchhhh----------hhhhhcccccC------------------------------ccch
Confidence 999999999999999 5443221 01122222221 1113
Q ss_pred ChhhHHHHhcCCCCHHHHHHHHhccCCCCccccccccccccc
Q psy2648 357 APLDTKALVGLGYSRSEIEESLSQAKYDDPESDGSRSGSSLS 398 (708)
Q Consensus 357 ~~~~~~~~~~~g~~~~~i~~~l~~~~~~~~~~~y~~l~~~~~ 398 (708)
+...+..|..+|+..+++.++|..++||+..++|.++..+.+
T Consensus 330 ~~~r~~~m~~~G~~~~~i~~sL~~~k~d~i~a~y~ll~~~~~ 371 (596)
T KOG0586|consen 330 LAKRILHMNSIGHRRLKIEESLAKQKFDDINATYLLLGYRKQ 371 (596)
T ss_pred hhHHHHHHHhhccchhhHHHHHhhhhHHHHHHHHhhcchhhh
Confidence 445667899999999999999999999999999999987755
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-61 Score=508.74 Aligned_cols=320 Identities=42% Similarity=0.703 Sum_probs=282.2
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
..+...-|-|.+.++||+|.|++|.+|+|.-||++||||+|+|++++......+++|++.|+.++|||||+||+++.++.
T Consensus 11 i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 11 IYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred ccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 34555678899999999999999999999999999999999999988777778999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCcEEEEeccCccccC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADFGFSNEFT 196 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld-~~~~iKL~DFGls~~~~ 196 (708)
.+|||+|+-.+|+|++||.++ ..+.|+.++.||+||+.|+.|||+..+|||||||||+.+- +-|-|||+|||+++.|.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999999999887 5699999999999999999999999999999999998765 56899999999999999
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li 276 (708)
++.++.+.||++.|.|||++.|..|+.|++||||||||||.|+||++||+..+..+...+|+..+|.+|.++|.+|+|||
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCCc
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNT 353 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 353 (708)
..||..||.+|.++|+|. |++-+..+.. +. .| -..+.+.-.+
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s------T~---------iP-Lvsr~~L~ee------------------- 295 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDRGLS------TA---------IP-LVSRHHLPEE------------------- 295 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCCCcc------cc---------Cc-eeehhhCChH-------------------
Confidence 999999999999999997 9875543221 00 01 0111110000
Q ss_pred CCCChhhHHHHhc-CCCCHHHHHHHHhccCCCCcccccccccc
Q psy2648 354 ASIAPLDTKALVG-LGYSRSEIEESLSQAKYDDPESDGSRSGS 395 (708)
Q Consensus 354 ~~~~~~~~~~~~~-~g~~~~~i~~~l~~~~~~~~~~~y~~l~~ 395 (708)
-...|++.|.. .=-+.++|.+.|.+++||+++|+|+||..
T Consensus 296 --~Ha~IIq~Mv~G~IAs~e~Il~aLe~n~YNhiTATYfLLAE 336 (864)
T KOG4717|consen 296 --AHATIIQQMVAGAIASEEDILRALENNEYNHITATYFLLAE 336 (864)
T ss_pred --HHHHHHHHHhcccccCHHHHHHHHhccccchhhhHHHHHHH
Confidence 02356667764 34578999999999999999999999854
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-59 Score=481.11 Aligned_cols=247 Identities=41% Similarity=0.705 Sum_probs=232.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
...+.+|++++.||+|+||+||+++++.|++.||+|+++|..+- ..+.+....|..||..++||+||+|+..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45577999999999999999999999999999999999988763 34677889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~~~ 199 (708)
|||+||+.||+|+.+|.+++.++|+.|+.|+.+|+.||.|||++|||||||||||||||.+|+|+|+|||||+.. ..+.
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999865 4456
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKK 278 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~ 278 (708)
...++|||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..+++++|..++ ...|..++.++++||++
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~ 259 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKK 259 (357)
T ss_pred ccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHH
Confidence 77889999999999999999986 89999999999999999999999999999999999999 45666799999999999
Q ss_pred hhhhCCCCCCC
Q psy2648 279 FLVLNPAKRAS 289 (708)
Q Consensus 279 ~L~~dP~~Rps 289 (708)
+|..||++|..
T Consensus 260 LL~rdp~~RLg 270 (357)
T KOG0598|consen 260 LLKRDPRQRLG 270 (357)
T ss_pred HhccCHHHhcC
Confidence 99999999974
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-59 Score=485.48 Aligned_cols=257 Identities=38% Similarity=0.666 Sum_probs=232.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG-----SLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
+...+.|.+.++||+|+||.|.+|..+.||+.||||+|++.+.... ....+.+|++||++|+|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3455679999999999999999999999999999999998764321 22335799999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CcEEEEeccCcc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSN 193 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~~iKL~DFGls~ 193 (708)
.+..||||||++||+|++++..++.+.|+..+.+|+||+.||.|||++||+|||||||||||..+ -.+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999876 679999999999
Q ss_pred ccCCCCCccccccCCcccccccccCCc--cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCCCC-C---C
Q psy2648 194 EFTPGNKLDTFCGSPPYAAPELFQGKK--YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE-LRERVLRGKYRI-P---F 266 (708)
Q Consensus 194 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~-l~~~i~~~~~~~-p---~ 266 (708)
....++.++|+||||.|.|||++.+.. +++.++|||||||+||.+++|.+||.+..... +.+.|.+|.|.+ | .
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 988888999999999999999997654 34458999999999999999999999876554 999999999875 3 2
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+|+++.+||++||.+||++|||+++++ |+..
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 4789999999999999999999999988 8874
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-57 Score=493.97 Aligned_cols=258 Identities=49% Similarity=0.861 Sum_probs=242.8
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC---hhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN---PGSLQKLFREVRIMKMLD-HPNIVKLFQVIET 116 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 116 (708)
....+++|++.+.||+|+||+|++|.+..+++.||||+++++... ....+.+.+|+.+|+.+. ||||+++++++++
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 346688999999999999999999999999999999998876332 123456678999999999 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CcEEEEeccCcccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEF 195 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-~~iKL~DFGls~~~ 195 (708)
...+|||||||.||+|+++|...+++.|.+++.+|+||++||+|||++||+||||||||||+|.+ +++||+|||+++..
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999 99999999999988
Q ss_pred -CCCCCccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CHHH
Q psy2648 196 -TPGNKLDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYM-STDC 272 (708)
Q Consensus 196 -~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~-s~~~ 272 (708)
..+..+.+.|||+.|+|||++.+.. |++.++|||||||+||.|++|++||++.+...++.+|.++.+.+|.++ |+++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 5677899999999999999999988 999999999999999999999999999999999999999999999999 9999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+||.+||..||.+|+++++++ |++.
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999998 8875
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-58 Score=477.24 Aligned_cols=256 Identities=49% Similarity=0.872 Sum_probs=243.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.-+|++.++||+|.||+|.+|.....|+.||||.|+|+.+. ..++-.+.+||+||..|+|||||++|++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45899999999999999999999999999999999998774 45677889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|||+.+|+|++||.+.+.|+|.+++.+|+||++|+.|||+++++|||||.||||||.++++||+||||++.+..+..+.+
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT 211 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT 211 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
+||+|.|++||++.|.+|.|+.+|-|||||+||.|+.|..||+|.+...+..+|.+|.|+-|.. +.++.-||+.||.+|
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLmVN 290 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLMVN 290 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999999999999999999999999998864 567899999999999
Q ss_pred CCCCCCHHHHh---hhhhCCC
Q psy2648 284 PAKRASLEVSG---EVTLGGA 301 (708)
Q Consensus 284 P~~Rps~~~~~---~~~~~~~ 301 (708)
|++|.|+++|. |++++..
T Consensus 291 P~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 291 PERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred cccchhHHHHhhhheeecccc
Confidence 99999999998 7776543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=489.29 Aligned_cols=256 Identities=37% Similarity=0.678 Sum_probs=241.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+|+..+.||+|+|++||.+++..+|+.||+|++.+..+ .+...+++.+||+|.+.|+|||||++|++||+.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 469999999999999999999999999999999998765 4567788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~ 203 (708)
|+|..++|..++++++.++|.+|+.|++||+.||.|||+++|+|||||..||||+++.+|||+|||||..+. ++++-.|
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 999999999999989999999999999999999999999999999999999999999999999999999886 4477889
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
.||||.|+|||++....+ +..+||||+|||||.||+|++||+..+.++.+.+|....|.+|.++|.++++||.+||+.|
T Consensus 178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence 999999999999997775 5899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHh---hhhhCCCC
Q psy2648 284 PAKRASLEVSG---EVTLGGAP 302 (708)
Q Consensus 284 P~~Rps~~~~~---~~~~~~~~ 302 (708)
|.+|||+++++ |+..+..|
T Consensus 257 P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 257 PSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred cccCCCHHHHhcCHhhhCCCcC
Confidence 99999999998 66544443
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-56 Score=467.34 Aligned_cols=251 Identities=43% Similarity=0.741 Sum_probs=237.0
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
...+++|.+.+.||+|+||+||+|+|+.++..||||.|.+..++++..+.+..|+.||+.|+|||||+|++++++.+.+|
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 45689999999999999999999999999999999999999888888888999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC------CcEEEEeccCcccc
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE------MNIKIADFGFSNEF 195 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~------~~iKL~DFGls~~~ 195 (708)
||||||.||||.+||..++.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875 35899999999999
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCHHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP---FYMSTDC 272 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p---~~~s~~~ 272 (708)
.++..+.+.||||.|||||+++...|+ .|+|+||+|+|||+|++|+.||+..+..++...+..+...+| ...+.++
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 999999999999999999999999997 689999999999999999999999999999999999876544 4678889
Q ss_pred HHHHHHhhhhCCCCCCCHHHH
Q psy2648 273 ENLLKKFLVLNPAKRASLEVS 293 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~ 293 (708)
.+|+..+|..||.+|.++++-
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred hhhhhHHHhcCccccCchHHh
Confidence 999999999999999998753
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-56 Score=450.56 Aligned_cols=243 Identities=40% Similarity=0.730 Sum_probs=231.2
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
-.+.+|+++++||.|+||+|.+++++.+|..||+|++++... .-++.+...+|.++|+.+.||++|+|++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 668899999999999999999999999999999999998764 3456677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
|||||++||+|+.++++.++++|..|+.|+.||+.||+|||+++|++|||||||||||++|.+||+|||+++.... .+
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--rT 198 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--RT 198 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC--cE
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999987653 37
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 281 (708)
.+.||||.|+|||+++.+.| +.++|+|||||++|||+.|..||.+.+..+++++|+.+++.+|.+.+++++|||+++|+
T Consensus 199 ~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred EEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence 78999999999999999998 58999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCC
Q psy2648 282 LNPAKRA 288 (708)
Q Consensus 282 ~dP~~Rp 288 (708)
+|-.+|.
T Consensus 278 vD~t~R~ 284 (355)
T KOG0616|consen 278 VDLTKRF 284 (355)
T ss_pred hhhHhhh
Confidence 9999994
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-54 Score=460.28 Aligned_cols=251 Identities=36% Similarity=0.638 Sum_probs=232.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
..+.+|.+++.||+|+|++|++|+.+.++++||||++.|..+-. ...+-+.+|-.+|.+| .||.||+||..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 44668999999999999999999999999999999999876533 3344577899999999 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
|+|+||+++|+|+++|.+.|.|+|..++.|+.||+.||+|||++|||||||||||||||.+|++||+|||-++.+.+...
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987643211
Q ss_pred --------------ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy2648 201 --------------LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF 266 (708)
Q Consensus 201 --------------~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~ 266 (708)
..+++||..|.+||++..... ++.+|||+||||||.|+.|.+||.+.+.--+.++|+.-.|.+|.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 145899999999999987764 68999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+++++|||+++|..||.+|+|+++|+
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHh
Confidence 9999999999999999999999999987
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-55 Score=479.88 Aligned_cols=526 Identities=24% Similarity=0.352 Sum_probs=364.1
Q ss_pred EEcccCceEEEEEEE---cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 53 TIGKGNFAKVKLAKH---VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 53 ~LG~G~fg~V~la~~---~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
++|+|+||+|++++. ...|..||+|+.++.............|..++...+ ||++|+++..++++...|++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999999763 356788999999887654333335567888998887 9999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCC
Q psy2648 129 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP 208 (708)
Q Consensus 129 gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~ 208 (708)
||+|+..+.....+.+...+.+...++.|++++|+.+|+|||+|++||+++.+|++|+.|||+++........ |||.
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~ 157 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY 157 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence 9999999988888999999999999999999999999999999999999999999999999999877554333 9999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|||||++.+. ..++|+|||||++|+|++|..||.+ ++..+|.+.+..+|..++.++++++.+|+..+|.+|.
T Consensus 158 eymApEI~~gh---~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 158 EYRAPEIINGH---LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhhhHhhhcc---CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence 99999999843 3689999999999999999999987 7788899989999999999999999999999999998
Q ss_pred CH--HHHhhhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCCcCCCChhhHHHHhc
Q psy2648 289 SL--EVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVG 366 (708)
Q Consensus 289 s~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 366 (708)
.. +.+..+.....-..-.+.....+..++.+.|..........+|+ +.+..-....|.-.+. ........+
T Consensus 231 g~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~----eft~~~P~dsp~~~~~---~s~~~if~g 303 (612)
T KOG0603|consen 231 GAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDP----EFTSQVPADSPLLSAS---GSDHTIFSG 303 (612)
T ss_pred ccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCc----hhccCCcccCCCCCCC---ccccchhcC
Confidence 65 22222111100000000000122222223222111000001111 0011111111110000 000001111
Q ss_pred CCCCHHHHHHHHhccCCCCcccccccccccccccCCCCCCCCCCCCCCCCCCccccccCCCCCccccCCCCCCCCCCcCC
Q psy2648 367 LGYSRSEIEESLSQAKYDDPESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQS 446 (708)
Q Consensus 367 ~g~~~~~i~~~l~~~~~~~~~~~y~~l~~~~~~~~~~p~~~~~~~~~~g~s~~~~~~~~~~~g~~~~~~~ggg~~g~v~s 446 (708)
.-|-...+.+...... .+..|.+ ....|.| +++
T Consensus 304 ~sfva~~il~~~~~~~---~~~~y~~----------------------------------------~~~~~~g----s~s 336 (612)
T KOG0603|consen 304 PSFVAPGVLEDAVTAP---FTESYEF----------------------------------------REELGEG----SFS 336 (612)
T ss_pred CCccChHHhhccccCC---cchhhcc----------------------------------------ccccCCC----Ccc
Confidence 1111111111100000 0000100 0111111 223
Q ss_pred Ccccccccccccc--------------ccCcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHH
Q psy2648 447 PSHRGVHRSISAS--------------NAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEK 512 (708)
Q Consensus 447 ~~hr~~~R~i~~~--------------~~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~ 512 (708)
+++++.+...... ...+...-...|+||+++++++.+..+.|+|||++.|+.|.+.+.....+. .
T Consensus 337 ~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~ 415 (612)
T KOG0603|consen 337 AVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-S 415 (612)
T ss_pred ceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-H
Confidence 4444444432221 111112234589999999999999999999999999999999998877666 8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee-cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccC
Q psy2648 513 EARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL-DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTS 591 (708)
Q Consensus 513 ~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~ 591 (708)
++..|++||+.|+.|||++|||||||||+|||+ +..++++|+|||+++..... ..+.|-|..|.|||++....+...
T Consensus 416 e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~a 493 (612)
T KOG0603|consen 416 EASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEA 493 (612)
T ss_pred HHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcc
Confidence 888999999999999999999999999999999 58999999999999987655 556688999999999995555555
Q ss_pred CCCCCCCCcccCCCCCCCc------c---cc--ccc---cccccchhhhHHHHhhCCCCCCCCCCCCc
Q psy2648 592 SGGAGTNHTHNSSISPAPT------N---FK--RQN---TIDSASIKENTARLNAGRPAKNTASIAPL 645 (708)
Q Consensus 592 s~~~~~~~~~~~~~~~~~~------~---~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (708)
++-|+.+-..+.+..+... + .. +.- .-.|-.+|+++..|+.=.|++|++...-.
T Consensus 494 cD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 494 CDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred hhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 5444433333322211111 1 11 111 23378899999999999999999876543
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-53 Score=465.83 Aligned_cols=247 Identities=35% Similarity=0.659 Sum_probs=233.0
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKT 119 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 119 (708)
...+.+|.++++||+|+||+|++|..+.+++.||||+++|..+ ..++++..+.|.+|+...+ ||++++||..|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 5667899999999999999999999999999999999999864 5677888999999998886 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~ 198 (708)
+|+||||+.|||+ .+++..+.|+|..|+.|+++|+.||+|||++||||||||.+|||||.+|++||+||||++... .+
T Consensus 444 l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999999994 445556899999999999999999999999999999999999999999999999999999764 67
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~ 278 (708)
..+.|+||||.|||||++.+..|. .++|||||||+|||||.|+.||.+.+.+++...|+...+.+|.++|.|+.++|++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR 601 (694)
T ss_pred CccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence 788999999999999999999995 8999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCH
Q psy2648 279 FLVLNPAKRASL 290 (708)
Q Consensus 279 ~L~~dP~~Rps~ 290 (708)
||.+||++|...
T Consensus 602 ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 602 LLRKNPEKRLGS 613 (694)
T ss_pred HhccCcccccCC
Confidence 999999999976
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=431.81 Aligned_cols=251 Identities=30% Similarity=0.522 Sum_probs=231.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-EEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-TLYL 122 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~yl 122 (708)
.....+.++.||+|+.|+|++|+|+.|++.+|+|+|. ...++...+++.+|++|++..+|||||.+|++|..+. .++|
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 3457888999999999999999999999999999994 3456677788999999999999999999999999999 5999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
+||||.+|+|.+.+...++++|.....++.||+.||.|||+ ++||||||||+|||++..|.|||||||.|+..... ..
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 99999999999999988999999999999999999999995 99999999999999999999999999999877644 67
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCC-CCCCC-CCHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-----TLRELRERVLRGKY-RIPFY-MSTDCEN 274 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-----~~~~l~~~i~~~~~-~~p~~-~s~~~~~ 274 (708)
+++.||..|||||.+.+..|. .++||||||+.++||++|++||... +..+++..|..+.. .+|.. .|+++++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred ccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 899999999999999999986 7899999999999999999999874 78899999998754 57876 9999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
||.+||++||.+|+++++++ |+.
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 99999999999999999987 665
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=447.63 Aligned_cols=260 Identities=33% Similarity=0.592 Sum_probs=232.1
Q ss_pred cccCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEE
Q psy2648 36 SRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVI 114 (708)
Q Consensus 36 ~~~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 114 (708)
.+..+....+++|++++.||+|+||.||+|+.+.||+.||+|+++|..+ ...+++.+..|-.||...++|+||+||..|
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 3344456678899999999999999999999999999999999998865 456778899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 115 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 115 ~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
++..++||||||++|||+..+|...+.|+|+.+++|+.+++.|++.||+.|+|||||||+|+|||..|++||+|||||+.
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cCC----------------------CCC--------------------------ccccccCCcccccccccCCccCCCch
Q psy2648 195 FTP----------------------GNK--------------------------LDTFCGSPPYAAPELFQGKKYDGPEV 226 (708)
Q Consensus 195 ~~~----------------------~~~--------------------------~~~~~Gt~~Y~APE~l~~~~~~~~~~ 226 (708)
+.. ... ..+.+|||.|||||++.+..| +..+
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~c 369 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKEC 369 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-Cccc
Confidence 210 000 123579999999999999998 4899
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHh---hh
Q psy2648 227 DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF--YMSTDCENLLKKFLVLNPAKRAS---LEVSG---EV 296 (708)
Q Consensus 227 DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~Rps---~~~~~---~~ 296 (708)
||||||||+||||.|.+||.+.++.+.+.+|...+ +.+|. ..++++.|||.+||+ ||++|.. +++|+ |+
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 99999999999999999999999999999999876 45553 578999999999999 9999986 67776 65
Q ss_pred h
Q psy2648 297 T 297 (708)
Q Consensus 297 ~ 297 (708)
.
T Consensus 449 ~ 449 (550)
T KOG0605|consen 449 K 449 (550)
T ss_pred c
Confidence 4
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=424.31 Aligned_cols=248 Identities=29% Similarity=0.563 Sum_probs=226.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEE-EEEeCCE-
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQ-VIETEKT- 119 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~- 119 (708)
......|+|++.||+|+||+||++++..+|+.||.|.|+-..++.+..+....|+.+|++|+|||||++|+ .|..++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 44566799999999999999999999999999999999877778788888999999999999999999998 4544444
Q ss_pred EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQ--KK--IIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~--~g--IvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
++||||||.+|||.+.|+. +..++|..++.+|.|++.||.+||+ .. |+||||||.||+|+.+|.+||.||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999998853 3569999999999999999999999 44 99999999999999999999999999
Q ss_pred ccccCCCC-CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CC-CCC
Q psy2648 192 SNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IP-FYM 268 (708)
Q Consensus 192 s~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p-~~~ 268 (708)
++.+.... ...+.+|||.||+||.+.+.+|+ +++||||+||++|||+.-+.||.+.+..++.++|..|.++ +| .+.
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence 99886543 35678999999999999999996 8999999999999999999999999999999999999986 78 689
Q ss_pred CHHHHHHHHHhhhhCCCCCCCH
Q psy2648 269 STDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
|.++..||..|+.+||+.||+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999983
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-52 Score=437.59 Aligned_cols=259 Identities=41% Similarity=0.679 Sum_probs=228.4
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh------------hHHHHHHHHHHHHhCCCCCe
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG------------SLQKLFREVRIMKMLDHPNI 107 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~------------~~~~~~~Ei~il~~l~HpnI 107 (708)
.....+++|++++.||+|.||+|.+|++..+++.||||++.|...... ..+++.+||.||+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 344567899999999999999999999999999999999987643211 23578899999999999999
Q ss_pred eeEEEEEEeC--CEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcE
Q psy2648 108 VKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184 (708)
Q Consensus 108 v~l~~~~~~~--~~~ylVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~i 184 (708)
|+|+++..+. +.+|||+|||..|.+.. .-..+. +++.+|+.|++.++.||+|||.+|||||||||.|+||+.+|++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 9999999875 57999999999998754 222344 8999999999999999999999999999999999999999999
Q ss_pred EEEeccCccccCCC------CCccccccCCcccccccccC---CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q psy2648 185 KIADFGFSNEFTPG------NKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRE 255 (708)
Q Consensus 185 KL~DFGls~~~~~~------~~~~~~~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~ 255 (708)
||+|||.+..+..+ ..+....|||.|+|||++.+ ..|++.+.||||+||+||.|+.|++||.+....+++.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999876333 23445789999999999987 5678899999999999999999999999999999999
Q ss_pred HHHcCCCCCCCC--CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 256 RVLRGKYRIPFY--MSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 256 ~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
+|......+|.. +.++++|||.+||++||++|+++.++. |+...
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999999888876 689999999999999999999999987 76543
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-53 Score=414.50 Aligned_cols=255 Identities=38% Similarity=0.659 Sum_probs=237.5
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
..-+.|++.+.||+|.|+.|+++.|..||+.+|+|+|+-..+.....+++.+|++|-+.|+|||||+|.+.+..+...||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34467999999999999999999999999999999999887777788899999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CcEEEEeccCccccCCCC
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~~iKL~DFGls~~~~~~~ 199 (708)
|+|++.|++|+.-|..+--++|..+..+++||++||.|||.+||||||+||+|+||... .-+||+|||++.....+.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 99999999999989888889999999999999999999999999999999999999754 348999999999988777
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENL 275 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~L 275 (708)
....+.|||.|||||++...+|. ..+|||++|||||-|+.|++||.+++...++++|..|.|.+|. .+++++++|
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 78889999999999999999984 7899999999999999999999999999999999999998875 578999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
|++||..||.+|+|+.+.+ |+..
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999887 7753
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=416.53 Aligned_cols=262 Identities=36% Similarity=0.607 Sum_probs=240.9
Q ss_pred hhchhccccccCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCC
Q psy2648 28 LMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPN 106 (708)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hpn 106 (708)
.|.-...............+|..++.||+|.||+|-+|+.+.+++.||||+++|.-+ ..+++...+.|-++|+.-+||+
T Consensus 150 ~m~i~~t~~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPF 229 (516)
T KOG0690|consen 150 EMSIAETEEAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPF 229 (516)
T ss_pred eeeecccccccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcH
Confidence 333333334445556678899999999999999999999999999999999998754 4566677889999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEE
Q psy2648 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186 (708)
Q Consensus 107 Iv~l~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL 186 (708)
+..|-..|++++++|+||||+.||+|+-++.....++|+.++.|..+|++||.|||+++||+||||.||+|||++|+|||
T Consensus 230 Lt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 230 LTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred HHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEe
Confidence 99999999999999999999999999999999899999999999999999999999999999999999999999999999
Q ss_pred EeccCcccc-CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy2648 187 ADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP 265 (708)
Q Consensus 187 ~DFGls~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p 265 (708)
+||||++.- ..+....++||||.|+|||++....| +.++|||.+||++|||+||++||...+...+.+.|+.+..++|
T Consensus 310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP 388 (516)
T ss_pred eecccchhcccccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC
Confidence 999999864 56678899999999999999999988 5899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCH
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
..+|++++.|+..+|.+||.+|..-
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGg 413 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGG 413 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCC
Confidence 9999999999999999999999863
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=434.24 Aligned_cols=247 Identities=36% Similarity=0.635 Sum_probs=235.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.+|.+.+.||+|+||.||+|+.+.|.+.||||.++|...+.++++.+.+|++|++.|+|||||.++++|++..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57999999999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~ 204 (708)
||.| +|+.+|...+.++|+.++.+..|+++||.|||+++|+|||+||.||||+..|.+|+||||+++....+. .+...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 9998 999999999999999999999999999999999999999999999999999999999999999876543 34567
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
.|||.|||||++.+.+|+ ..+|+||||||+|||++|++||......++.+.|.......|...|.++.+||+.+|.+||
T Consensus 161 kGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP 239 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDP 239 (808)
T ss_pred cCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcCh
Confidence 899999999999999997 6899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHh
Q psy2648 285 AKRASLEVSG 294 (708)
Q Consensus 285 ~~Rps~~~~~ 294 (708)
.+|.+..++.
T Consensus 240 ~~RltW~~Ll 249 (808)
T KOG0597|consen 240 AQRLTWTDLL 249 (808)
T ss_pred hhcccHHHHh
Confidence 9999998766
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=396.14 Aligned_cols=258 Identities=36% Similarity=0.618 Sum_probs=238.4
Q ss_pred cCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh-hHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG-SLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 38 ~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
.....-.+++|++++.||+|-||.||+|+.+.++-.||+|++.|+++... ..+.+.+|++|...|+||||+++|++|.+
T Consensus 14 ~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 14 RATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred ccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 34445568899999999999999999999999999999999998875433 33457799999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLV--LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~--~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
+..+||++||++.|+|+..+. ...+++|..+..|+.|++.||.|||.++||||||||||+|++.++.+||+|||-+..
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999999998 567899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy2648 195 FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCEN 274 (708)
Q Consensus 195 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~ 274 (708)
- +.++-.+.|||..|.+||+..+..++ ..+|+|++||+.||++.|..||...+..+++++|.+-++.+|..++.+++|
T Consensus 174 ~-p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 174 A-PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD 251 (281)
T ss_pred c-CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence 3 36667889999999999999999987 789999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
||.+||.++|.+|.++.+++ |+.
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHH
Confidence 99999999999999999988 664
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=414.68 Aligned_cols=252 Identities=34% Similarity=0.611 Sum_probs=229.2
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
.....+++|++.+.||+|+||.||+|++..+++.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 344457899999999999999999999999999999999976532 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999976543
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~ 278 (708)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+..+...+|...+.++++||++
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 23457899999999999988774 8999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCC-----HHHHh
Q psy2648 279 FLVLNPAKRAS-----LEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps-----~~~~~ 294 (708)
||+.||.+|++ +++++
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHh
Confidence 99999999997 57766
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=396.65 Aligned_cols=248 Identities=30% Similarity=0.524 Sum_probs=213.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|+.+..+|+|+||.||+|+++.||+.||||++.....++...+-.+||+++|++|.|||+|.|.++|.....+|+|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 47999999999999999999999999999999997666556556667899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~ 203 (708)
||...-| +-+... ..++++.++.|+.|++.|+.|||+++|||||||||||||+.+|.+||||||+|+... ++.....
T Consensus 82 ~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9987444 444443 579999999999999999999999999999999999999999999999999999887 6777778
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------------CC-----CCC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--------------GK-----YRI 264 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--------------~~-----~~~ 264 (708)
++.|..|.|||++.|....|+.+||||+||++.||++|..-|.+.+.-+..-.|.. .. .++
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 89999999999999965558999999999999999999999998754433323321 11 112
Q ss_pred CC------------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 PF------------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p~------------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
|. ..+.-+.||+++||..||++|++.++++
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 21 2455688999999999999999999876
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=415.56 Aligned_cols=255 Identities=42% Similarity=0.697 Sum_probs=233.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKT 119 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 119 (708)
+..-..|++.+.||+|.||.||+|+++.||+.||+|+|.+.... ....+.+.+|+.||++|. |||||+++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 33445799999999999999999999999999999999987653 334567889999999999 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC----CcEEEEeccCcccc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEF 195 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~----~~iKL~DFGls~~~ 195 (708)
+|+|||+|.||+|++.|... .++|.++..+++||+.|++|||+.||+||||||||+|+... +.+|++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999877 59999999999999999999999999999999999999744 47999999999988
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTD 271 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~ 271 (708)
..+....+.||||.|+|||++.+..|. ..+||||+||++|.|++|..||.+.+..+...+|..+++.++. .+|..
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 877788999999999999999988884 8999999999999999999999999999999999999887643 46899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+++||++||..||.+|+|+.+++ |+..
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 99999999999999999999987 7653
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.61 Aligned_cols=251 Identities=39% Similarity=0.690 Sum_probs=226.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-----Ch-hhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-----NP-GSLQKLFREVRIMKML-DHPNIVKLFQVIET 116 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-----~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 116 (708)
....|.-.+.||+|..+.|.+|.|+.+|+++|+|+|.-..- +. ...+...+|+.||+++ .||+||+|.++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34578888999999999999999999999999999975321 11 2234556899999987 59999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
+..+++|+|.|+.|+|+||+...-.++|.+++.+++||+.|++|||.++||||||||||||+|++.+|||+|||+++.+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCCcccccccccCCccC-----CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--CC--C
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI--PF--Y 267 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~-----~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~--p~--~ 267 (708)
++.++...||||.|+|||.+...-|. +..+|+||+|||||.|+.|..||......-+...|..|+|.+ |. .
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence 99999999999999999998643222 468999999999999999999998877777889999999876 43 4
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.|.+.+|||++||++||.+|+|.++.+
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHh
Confidence 688999999999999999999999887
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=400.23 Aligned_cols=256 Identities=31% Similarity=0.539 Sum_probs=228.2
Q ss_pred cCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 38 ~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
.......+..|++++.||+|.-|+||+|+.+.++..+|+|+|+|..+. .+...++..|.+||+.++||+++.||..|++
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 344556677899999999999999999999999999999999988764 4556778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
++..|+|||||+||||....+++ +.++|..|++|+.+++.||+|||-.|||+||||||||||.++|+|-|+||-|+..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999999988765 4799999999999999999999999999999999999999999999999998743
Q ss_pred cCC---------------------------------C-C-----------------------CccccccCCccccccccc
Q psy2648 195 FTP---------------------------------G-N-----------------------KLDTFCGSPPYAAPELFQ 217 (708)
Q Consensus 195 ~~~---------------------------------~-~-----------------------~~~~~~Gt~~Y~APE~l~ 217 (708)
... . . ...+++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 0 0 113467999999999999
Q ss_pred CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHhhhhCCCCCCC----HH
Q psy2648 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF--YMSTDCENLLKKFLVLNPAKRAS----LE 291 (708)
Q Consensus 218 ~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~Rps----~~ 291 (708)
|... +.++|||+|||+||||+.|..||.|.+.++....|+.....+|. .++..|+|||+++|.+||.+|.. +.
T Consensus 309 G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 309 GEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred cCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 9886 58999999999999999999999999999999999998888875 46789999999999999999998 56
Q ss_pred HHh
Q psy2648 292 VSG 294 (708)
Q Consensus 292 ~~~ 294 (708)
+|+
T Consensus 388 eIK 390 (459)
T KOG0610|consen 388 EIK 390 (459)
T ss_pred Hhh
Confidence 666
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=403.96 Aligned_cols=249 Identities=34% Similarity=0.612 Sum_probs=226.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999999975432 2234456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~~~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWTL 158 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--Ccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876543 23456
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+..+...+|...++++++||++||+.||
T Consensus 159 ~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred cCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence 899999999999888764 7999999999999999999999999999999999999999998899999999999999999
Q ss_pred CCCCC-----HHHHh---hhh
Q psy2648 285 AKRAS-----LEVSG---EVT 297 (708)
Q Consensus 285 ~~Rps-----~~~~~---~~~ 297 (708)
.+|++ +++++ |+.
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred HHccCCccCCHHHHhcCcccc
Confidence 99995 77776 664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=402.97 Aligned_cols=248 Identities=31% Similarity=0.523 Sum_probs=214.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK--TLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~yl 122 (708)
.-+|..++.||+|+||.||++.+..+|+.+|||.+..... ...+.+.+|+++|++|+|||||++++...... .++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4578999999999999999999999999999999976622 12567889999999999999999999754444 6999
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEeccCccccCC---
Q psy2648 123 VMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTP--- 197 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DFGls~~~~~--- 197 (708)
.|||+++|+|.+++...+ .++|..++.+.+||+.||.|||++|||||||||+|||++. ++.+||+|||+++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999999887 7999999999999999999999999999999999999999 79999999999987653
Q ss_pred -CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHH
Q psy2648 198 -GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGK--YRIPFYMSTDCE 273 (708)
Q Consensus 198 -~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~--~~~p~~~s~~~~ 273 (708)
........||+.|||||++.......+++|||||||++.||+||+.||.. ....+..-++.... +.+|..+|++++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 22234678999999999998533334689999999999999999999987 44444444444443 568889999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||.+||++|||+++++
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL 274 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELL 274 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHh
Confidence 999999999999999999887
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=408.31 Aligned_cols=242 Identities=37% Similarity=0.607 Sum_probs=220.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg 130 (708)
+.||+|+||.||+|++..+|+.||||++.+... .......+.+|+++|+.++||||++++++++..+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999986533 2344567789999999999999999999999999999999999999
Q ss_pred ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCCc
Q psy2648 131 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPP 209 (708)
Q Consensus 131 ~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~~ 209 (708)
+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .+......+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 999999988899999999999999999999999999999999999999999999999999987532 2334456789999
Q ss_pred ccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC-
Q psy2648 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA- 288 (708)
Q Consensus 210 Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp- 288 (708)
|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+..+...+|..+++++.+||++||+.||++||
T Consensus 161 y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred ccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999888774 79999999999999999999999999999999999888899999999999999999999999999
Q ss_pred ----CHHHHh
Q psy2648 289 ----SLEVSG 294 (708)
Q Consensus 289 ----s~~~~~ 294 (708)
++++++
T Consensus 240 ~~~~~~~~ll 249 (323)
T cd05571 240 GGPEDAKEIM 249 (323)
T ss_pred CCCCCHHHHH
Confidence 677776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=407.73 Aligned_cols=251 Identities=31% Similarity=0.581 Sum_probs=220.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTL 120 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 120 (708)
...+.|+.+++||+|.||.||+|++..||+.||+|.+..+...++...-..|||.||++|+|||||+|.++.... ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 345689999999999999999999999999999999998877677777788999999999999999999998776 689
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||+|||+. ||.-++...+ .|++.+++.|++||+.||+|||++||+|||||..|||||++|++||+|||||+.+....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999986 8887776533 79999999999999999999999999999999999999999999999999999876544
Q ss_pred --CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--C--------CCCCCC-
Q psy2648 200 --KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--G--------KYRIPF- 266 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--~--------~~~~p~- 266 (708)
.+...+-|+.|.|||++.|..-.++++|+||+||||.||++|++.|.+.+.-+-..+|.+ | ...+|.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 466778899999999999987668999999999999999999999999887665566542 1 112231
Q ss_pred ------------------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 ------------------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ------------------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++..+.+|+..||.+||.+|.|+.+++
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 3577889999999999999999999877
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=406.67 Aligned_cols=251 Identities=31% Similarity=0.583 Sum_probs=227.1
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCC-cEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTG-KEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg-~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
....+++|++.+.||+|+||.||+|.+..++ ..||||++.+... .....+.+.+|+.+|+.++||||+++++++.+++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456778999999999999999999977665 6899999976432 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999976542
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~ 278 (708)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+.+.+..+...+|...++++.++|++
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 23467899999999999887764 7999999999999999999999999999999999999888999999999999999
Q ss_pred hhhhCCCCCC-----CHHHHh
Q psy2648 279 FLVLNPAKRA-----SLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rp-----s~~~~~ 294 (708)
||+.||.+|+ ++++++
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHH
Confidence 9999999995 788876
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=401.97 Aligned_cols=242 Identities=38% Similarity=0.625 Sum_probs=220.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg 130 (708)
+.||+|+||.||+|++..+++.||||++.+... .......+.+|+++|+.++||||++++++++..+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999986543 2345567889999999999999999999999999999999999999
Q ss_pred ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccccccCCc
Q psy2648 131 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPP 209 (708)
Q Consensus 131 ~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~~Gt~~ 209 (708)
+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 9999998888899999999999999999999999999999999999999999999999999875322 233456789999
Q ss_pred ccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC-
Q psy2648 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA- 288 (708)
Q Consensus 210 Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp- 288 (708)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++.+.+..+.+.+|..+++++.+||++||..||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988877 479999999999999999999999999889888998888889999999999999999999999997
Q ss_pred ----CHHHHh
Q psy2648 289 ----SLEVSG 294 (708)
Q Consensus 289 ----s~~~~~ 294 (708)
++++++
T Consensus 240 ~~~~~~~~il 249 (328)
T cd05593 240 GGPDDAKEIM 249 (328)
T ss_pred CCCCCHHHHh
Confidence 788776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=405.33 Aligned_cols=247 Identities=31% Similarity=0.530 Sum_probs=216.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||+||+|++..+++.||||++.+... .......+.+|+.+++.++||||+++++.+++...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 379999999999999999999999999999999976532 2334456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-----
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----- 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~----- 199 (708)
|||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999988999999999999999999999999999999999999999999999999999987543210
Q ss_pred -------------------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2648 200 -------------------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS 248 (708)
Q Consensus 200 -------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~ 248 (708)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 01346899999999999988875 7999999999999999999999999
Q ss_pred CHHHHHHHHHcCC--CCCCC--CCCHHHHHHHHHhhhhCCCC---CCCHHHHh
Q psy2648 249 TLRELRERVLRGK--YRIPF--YMSTDCENLLKKFLVLNPAK---RASLEVSG 294 (708)
Q Consensus 249 ~~~~l~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~---Rps~~~~~ 294 (708)
+..+...+|.... ..+|. .+++++++||.+|+. +|.+ ||++++++
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 9988888888643 34453 468999999999876 4554 57899887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=402.05 Aligned_cols=247 Identities=29% Similarity=0.505 Sum_probs=218.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcE-EEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-EEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKE-VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-TLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~-vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~yl 122 (708)
.....+.+.||+|+||+||++.++ |+. ||||++..........+.|.+|+.+|.+|+|||||++++++..+. .+.|
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 445667777999999999999985 555 999999877666555778999999999999999999999998887 7999
Q ss_pred EEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCCEEEcCCC-cEEEEeccCccccCCC
Q psy2648 123 VMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKK-IIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPG 198 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~g-IvHRDLKPeNILld~~~-~iKL~DFGls~~~~~~ 198 (708)
||||+++|+|.+++.. ...++...+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999988 578999999999999999999999999 99999999999999998 9999999999876543
Q ss_pred -CCccccccCCccccccccc--CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHH
Q psy2648 199 -NKLDTFCGSPPYAAPELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPFYMSTDCE 273 (708)
Q Consensus 199 -~~~~~~~Gt~~Y~APE~l~--~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~~~s~~~~ 273 (708)
.......||+.|||||++. ...|+ .++|||||||+||||+||..||.+....++...+..+. ..+|...++.+.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 3334478999999999999 55775 79999999999999999999999988877777776443 346777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.||.+||..||.+||++.++.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHH
Confidence 999999999999999999887
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=390.29 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=215.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+++|+.++||||+++++++.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 489999999999999999999999999999999765432 2233457799999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 126 YASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999999887653 3689999999999999999999999999999999999999999999999999987654444556
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL----RELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~----~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+. .++...+......+|...++++.+||++|
T Consensus 161 ~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 7899999999999988875 789999999999999999999987543 34455555556667778899999999999
Q ss_pred hhhCCCCCCC-----HHHHh
Q psy2648 280 LVLNPAKRAS-----LEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps-----~~~~~ 294 (708)
|..||.+||+ +++++
T Consensus 240 l~~~P~~R~~~~~~~~~~~~ 259 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVK 259 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHh
Confidence 9999999997 56665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=397.72 Aligned_cols=236 Identities=34% Similarity=0.602 Sum_probs=215.8
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCh
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L 132 (708)
||+|+||.||+|++..+++.||||++.+... .......+.+|+.+|+.++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999999999999999976432 334456778999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccccccCCccc
Q psy2648 133 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYA 211 (708)
Q Consensus 133 ~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~~Gt~~Y~ 211 (708)
.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99999888999999999999999999999999999999999999999999999999999875432 23345678999999
Q ss_pred ccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCH
Q psy2648 212 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 212 APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+..+...+|...++++.+||.+||..||.+||++
T Consensus 161 aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 161 APELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 99999988775 7899999999999999999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=399.29 Aligned_cols=242 Identities=36% Similarity=0.614 Sum_probs=219.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg 130 (708)
+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+++|+.++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 479999999999999999999999999976532 2344566788999999999999999999999999999999999999
Q ss_pred ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCCc
Q psy2648 131 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPP 209 (708)
Q Consensus 131 ~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~~ 209 (708)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 999999888889999999999999999999999999999999999999999999999999987532 2233456789999
Q ss_pred ccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC-
Q psy2648 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA- 288 (708)
Q Consensus 210 Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp- 288 (708)
|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+......+|..+++++.+||.+||..||.+|+
T Consensus 161 y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 9999999888774 79999999999999999999999999999989998888889999999999999999999999998
Q ss_pred ----CHHHHh
Q psy2648 289 ----SLEVSG 294 (708)
Q Consensus 289 ----s~~~~~ 294 (708)
++.+++
T Consensus 240 ~~~~~~~~~l 249 (323)
T cd05595 240 GGPSDAKEVM 249 (323)
T ss_pred CCCCCHHHHH
Confidence 677766
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=394.74 Aligned_cols=243 Identities=35% Similarity=0.607 Sum_probs=220.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCEEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHP-NIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~ylVm 124 (708)
+|++++.||+|+||.||+|++..+++.||||++.+... .....+.+..|++++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986533 234456788999999999765 5889999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~ 203 (708)
||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999999888899999999999999999999999999999999999999999999999999987532 2333456
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++...+......+|...++++.+||++||..|
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred ecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 7899999999999988774 789999999999999999999999999999999999988899999999999999999999
Q ss_pred CCCCCCH
Q psy2648 284 PAKRASL 290 (708)
Q Consensus 284 P~~Rps~ 290 (708)
|.+|++.
T Consensus 240 P~~R~~~ 246 (324)
T cd05587 240 PAKRLGC 246 (324)
T ss_pred HHHcCCC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=396.86 Aligned_cols=238 Identities=36% Similarity=0.659 Sum_probs=216.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|+++.+++.||||++.+... .....+.+..|+.+++.+ +||||+++++++++.+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999976532 233456678899998876 699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 9999999888899999999999999999999999999999999999999999999999999987542 233345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++.+.+..+...+|..++.++.+||++||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 161 DYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred cccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999999887774 78999999999999999999999999999999999998889999999999999999999999999
Q ss_pred CH
Q psy2648 289 SL 290 (708)
Q Consensus 289 s~ 290 (708)
++
T Consensus 240 ~~ 241 (320)
T cd05590 240 GS 241 (320)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=396.53 Aligned_cols=246 Identities=35% Similarity=0.555 Sum_probs=219.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||.||+|++..+++.||||++.+.... ....+.+.+|+++|+.++||||++++++++..+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999999865332 234556889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
||+++|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999876543 34567
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC------CCCHHHHHHH
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF------YMSTDCENLL 276 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~------~~s~~~~~Li 276 (708)
+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... ...|. .+++++.+||
T Consensus 159 ~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred ccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 899999999999988775 79999999999999999999999998888877776543 22232 3589999999
Q ss_pred HHhhhhCCCCCCCHHHHh
Q psy2648 277 KKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~ 294 (708)
.+||..+|.+||++++++
T Consensus 238 ~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 238 TKLINDPSRRFGSLEDIK 255 (333)
T ss_pred HHHhhChhhhcCCHHHHH
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=402.07 Aligned_cols=247 Identities=31% Similarity=0.568 Sum_probs=217.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+|++++.||+|+||.||+|++..+++.||||++.+... .......+.+|+.+|+.++||||++++++++++..+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 369999999999999999999999999999999976532 2334556788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-----
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----- 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~----- 199 (708)
|||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986542211
Q ss_pred ----------------------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCC
Q psy2648 200 ----------------------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 245 (708)
Q Consensus 200 ----------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf 245 (708)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 11235799999999999888774 7999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCC--CCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHh
Q psy2648 246 DGSTLRELRERVLRGKY--RIPF--YMSTDCENLLKKFLVLNPAKRAS---LEVSG 294 (708)
Q Consensus 246 ~~~~~~~l~~~i~~~~~--~~p~--~~s~~~~~Li~~~L~~dP~~Rps---~~~~~ 294 (708)
.+.+..+....+..... .+|. .+++++.+||++||. ||.+|++ +++++
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 99988888888876543 3343 468999999999997 9999998 88876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=400.13 Aligned_cols=250 Identities=30% Similarity=0.506 Sum_probs=218.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC-EEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEK-TLY 121 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~y 121 (708)
..++|.++++||.|+||.||+|+.+.+++.||||.++++...-++ .--+||+..|++|+ |||||+|++++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 356899999999999999999999999999999999877654322 23468999999999 999999999998877 999
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
||||||.. +|++.++.++ .|+|.+++.|+.||+.||+|+|.+|+.||||||||||+.....|||+|||||+.......
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99999975 8999998764 589999999999999999999999999999999999999888999999999999887777
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-------------------CC
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-------------------GK 261 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~-------------------~~ 261 (708)
...++.|..|.|||++....+.+.++||||+|||++|+.+-+.-|.|.+..+-+.+|.. =.
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 78889999999999998777777899999999999999999999999876554444432 12
Q ss_pred CCCCC-----------CCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 262 YRIPF-----------YMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 262 ~~~p~-----------~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+++|. ..+.++.+||.+||.+||.+|||+++++.
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 33332 36889999999999999999999999883
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=393.68 Aligned_cols=243 Identities=35% Similarity=0.601 Sum_probs=220.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+|++++.||+|+||.||+|++..+++.||||++.+... .....+.+..|.+++..+ +||+|+++++++++.+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999986543 223345567888888877 5899999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~ 203 (708)
||+++|+|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543 2334456
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++.+.+......+|...+.++.+||.+||++|
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence 7899999999999988875 799999999999999999999999999999999999988899999999999999999999
Q ss_pred CCCCCCH
Q psy2648 284 PAKRASL 290 (708)
Q Consensus 284 P~~Rps~ 290 (708)
|.+|++.
T Consensus 240 p~~R~~~ 246 (323)
T cd05616 240 PGKRLGC 246 (323)
T ss_pred HHhcCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=389.87 Aligned_cols=250 Identities=36% Similarity=0.597 Sum_probs=231.2
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETE 117 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 117 (708)
+.-....+|..+.+||+|+||+|.+|..+.|.+.||||+++|+-. ..++.+--+.|-++|.... -|++++|+..|++-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 335566789999999999999999999999999999999998754 3455556678888887764 68999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-C
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-T 196 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~ 196 (708)
+.+|+||||+.||+|.-+|++-|++.|..|..|+.+|+-||-|||++|||+||||.+|||||.+|+|||+|||+++.. .
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999874 3
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li 276 (708)
.+..+.++||||.|+|||++..++| +.++||||+||+||||+.|+.||++++..++.+.|...+..+|..+|.++.+++
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 5566789999999999999999998 589999999999999999999999999999999999999999999999999999
Q ss_pred HHhhhhCCCCCCCH
Q psy2648 277 KKFLVLNPAKRASL 290 (708)
Q Consensus 277 ~~~L~~dP~~Rps~ 290 (708)
+.+|.+.|.+|...
T Consensus 582 kg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGC 595 (683)
T ss_pred HHHhhcCCccccCC
Confidence 99999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=397.93 Aligned_cols=242 Identities=38% Similarity=0.616 Sum_probs=219.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg 130 (708)
+.||+|+||.||+|++..+++.||||++.+... .......+.+|+++++.++||||++++++++....+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999986543 2334556788999999999999999999999999999999999999
Q ss_pred ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 131 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 131 ~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
+|.+++.....+++.+++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888899999999999999999999997 799999999999999999999999999987532 233445678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||+||+|++|..||.+.+..++.+.+......+|...++++.+||++||+.||++|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 161 EYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred ccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 99999999888774 79999999999999999999999999999999998888899999999999999999999999997
Q ss_pred -----CHHHHh
Q psy2648 289 -----SLEVSG 294 (708)
Q Consensus 289 -----s~~~~~ 294 (708)
++.+++
T Consensus 240 ~~~~~~~~~il 250 (325)
T cd05594 240 GGGPDDAKEIM 250 (325)
T ss_pred CCCCCCHHHHh
Confidence 787776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=403.86 Aligned_cols=246 Identities=33% Similarity=0.574 Sum_probs=220.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
...|.....||+|+-|.||.|+...+++.||||.++...... .+-++.|+.+|+..+|+|||++++.|--.+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 457999999999999999999999999999999998765433 345889999999999999999999998889999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
||++||+|.+.+. ...++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.... +-.+
T Consensus 350 Eym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred eecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999999988664 5579999999999999999999999999999999999999999999999999998876544 5678
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCC--CCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERV-LRGKY--RIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i-~~~~~--~~p~~~s~~~~~Li~~~L 280 (708)
.+|||.|||||++..+.| |+++||||||++++||+-|++||-.++.-.....| ..|.. ..|..+|++++|||.+||
T Consensus 429 mVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL 507 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL 507 (550)
T ss_pred ccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence 899999999999999998 69999999999999999999999876654444444 44544 457789999999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
+.||++|+++.+++
T Consensus 508 ~~dv~~RasA~eLL 521 (550)
T KOG0578|consen 508 VVDVEQRASAKELL 521 (550)
T ss_pred hcchhcCCCHHHHh
Confidence 99999999999877
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=394.41 Aligned_cols=242 Identities=34% Similarity=0.620 Sum_probs=218.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|++..+++.||||++.+... .....+.+..|+++++.+ +||||+++++++++++.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999976532 234455677899999865 799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 9999999888899999999999999999999999999999999999999999999999999987543 223345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++.+.+..+...+|..++.++.+||++||+.||++|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 161 DYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred cccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 99999999888774 78999999999999999999999999999999999999889999999999999999999999999
Q ss_pred -------CHHHHh
Q psy2648 289 -------SLEVSG 294 (708)
Q Consensus 289 -------s~~~~~ 294 (708)
+++++.
T Consensus 240 ~~~~~~~~~~~~~ 252 (321)
T cd05591 240 GCVASQGGEDAIK 252 (321)
T ss_pred CCCCCCCCHHHHh
Confidence 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=402.15 Aligned_cols=249 Identities=30% Similarity=0.543 Sum_probs=234.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-EEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT-LYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~ylV 123 (708)
.++|.+++.+|+|+||.+++++|+..++.||+|.|.-........+....|+.+++++.|||||.+++.|+.++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 578999999999999999999999999999999999887776666788999999999999999999999998887 9999
Q ss_pred EeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-C
Q psy2648 124 MEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-K 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~ 200 (708)
|+||+||+|.+.|.+.. .++|+.+..||.||+.||+|||+++|+|||||+.||++..++.|||.|||+|+...+.. .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999997664 58999999999999999999999999999999999999999999999999999887665 6
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~ 279 (708)
..+..|||.||+||++.+.+| +.|+|||||||++|||++-+.+|.+.+...+..+|.++. .++|...|.+++.||+.|
T Consensus 163 a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 778999999999999999999 489999999999999999999999999999999999998 468899999999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|.++|..||++.+++
T Consensus 242 l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 242 LRKNPEHRPSALELL 256 (426)
T ss_pred hhcCCccCCCHHHHh
Confidence 999999999999876
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=392.98 Aligned_cols=240 Identities=36% Similarity=0.642 Sum_probs=214.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHH---HhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIM---KMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
|++++.||+|+||.||+|.+..+++.||||++++... .....+.+.+|++++ +.++||||+++++++++.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 7899999999999999999999999999999976532 233455677777766 466799999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCcc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLD 202 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~ 202 (708)
|||+++++|..++. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 99999999998875 4679999999999999999999999999999999999999999999999999987543 233345
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 282 (708)
+.+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+..+...+|..+++++.+||++||+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred ccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 67899999999999888774 78999999999999999999999999999999999998889999999999999999999
Q ss_pred CCCCCCC
Q psy2648 283 NPAKRAS 289 (708)
Q Consensus 283 dP~~Rps 289 (708)
||.+||+
T Consensus 239 dP~~R~~ 245 (324)
T cd05589 239 NPERRLG 245 (324)
T ss_pred CHhHcCC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=402.76 Aligned_cols=247 Identities=30% Similarity=0.536 Sum_probs=214.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||.||+|++..+++.||||++.+... .....+.+.+|+++|+.++|||||++++++++...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 369999999999999999999999999999999876432 2344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-----
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----- 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~----- 199 (708)
||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999986432100
Q ss_pred -------------------------------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHH
Q psy2648 200 -------------------------------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 236 (708)
Q Consensus 200 -------------------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvily 236 (708)
.....+||+.|+|||++.+..++ .++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 00135799999999999888774 7899999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHhhhhCCCCC---CCHHHHh
Q psy2648 237 TLVSGSLPFDGSTLRELRERVLRG--KYRIPF--YMSTDCENLLKKFLVLNPAKR---ASLEVSG 294 (708)
Q Consensus 237 elltG~~Pf~~~~~~~l~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~R---ps~~~~~ 294 (708)
+|++|..||.+.+..+....+... ...+|. .++.++++||++||. +|.+| +++++++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999998888877777653 334454 478999999999998 77775 5888877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=400.95 Aligned_cols=250 Identities=30% Similarity=0.478 Sum_probs=215.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|++++.||+|+||+||+|++..+++.||||++.+... .....+.+.+|+++|+.++|||||++++++++.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999976543 33455678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-------
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG------- 198 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~------- 198 (708)
||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999998889999999999999999999999999999999999999999999999999997543100
Q ss_pred -----------------------------------------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHH
Q psy2648 199 -----------------------------------------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYT 237 (708)
Q Consensus 199 -----------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilye 237 (708)
....+.+||+.|+|||++.+..++ .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 011346899999999999888775 79999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHhhhh--CCCCCCCHHHHh---hhh
Q psy2648 238 LVSGSLPFDGSTLRELRERVLRG--KYRIPF--YMSTDCENLLKKFLVL--NPAKRASLEVSG---EVT 297 (708)
Q Consensus 238 lltG~~Pf~~~~~~~l~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~--dP~~Rps~~~~~---~~~ 297 (708)
|++|..||...+..+...++... ...+|. .+++++.+||.+||.. +|..|+++++++ |+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~ 309 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence 99999999988877766666543 334443 5789999999997654 455599999987 554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=393.38 Aligned_cols=243 Identities=37% Similarity=0.624 Sum_probs=217.5
Q ss_pred EeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 51 LKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++.||+|+||.||+|++. .+++.||||++.+... .......+.+|+.+|+.++||||++++++++.++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 5789999999976432 22334557789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~ 204 (708)
|+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999875432 3334557
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+..+...+|..+++++.+||++||+.||
T Consensus 161 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 161 CGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 899999999999887764 7899999999999999999999999998999999999999999999999999999999999
Q ss_pred CCCC-----CHHHHh
Q psy2648 285 AKRA-----SLEVSG 294 (708)
Q Consensus 285 ~~Rp-----s~~~~~ 294 (708)
++|| +++++.
T Consensus 240 ~~R~~~~~~~~~~l~ 254 (323)
T cd05584 240 SSRLGAGPGDAAEVQ 254 (323)
T ss_pred hHcCCCCCCCHHHHh
Confidence 9999 677665
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=393.94 Aligned_cols=242 Identities=35% Similarity=0.614 Sum_probs=214.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|++..+++.||||++++.... ......+.+|+.+++.+ +||||+++++++++...+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999875432 33455678899999988 799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CCCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. .......+.+||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 999999988889999999999999999999999999999999999999999999999999998753 3334455679999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---------TLRELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---------~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.|+|||++.+..++ .++|||||||++|+|++|+.||... ....+.+.+..+...+|..++.++.+||++|
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999988775 7999999999999999999999631 2234667778888889999999999999999
Q ss_pred hhhCCCCCCC------HHHHh
Q psy2648 280 LVLNPAKRAS------LEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps------~~~~~ 294 (708)
|+.||.+|++ +++++
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHh
Confidence 9999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=391.42 Aligned_cols=242 Identities=34% Similarity=0.603 Sum_probs=216.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKM-LDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|++..+++.||||++++... .....+.+..|.+++.. ++||||+++++++++.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999976532 12334566788888875 4899999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~~Gt~ 208 (708)
|+|.+++..++.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875322 23345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+..+...+|...+.++.+||++||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 161 DYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred CccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999999988775 78999999999999999999999999999999998888888889999999999999999999999
Q ss_pred CH-HHHh
Q psy2648 289 SL-EVSG 294 (708)
Q Consensus 289 s~-~~~~ 294 (708)
++ +++.
T Consensus 240 ~~~~~~~ 246 (316)
T cd05620 240 GVVGNIR 246 (316)
T ss_pred CChHHHH
Confidence 97 4554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=397.85 Aligned_cols=247 Identities=34% Similarity=0.625 Sum_probs=221.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||.||+|++..+++.||||++.+.... ......+.+|+++|+.++||||+++++++++++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4799999999999999999999999999999999865432 244566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-----
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----- 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~----- 199 (708)
||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987654332
Q ss_pred -------------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q psy2648 200 -------------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR 254 (708)
Q Consensus 200 -------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~ 254 (708)
......||+.|+|||++.+..++ .++|||||||+||+|++|+.||.+.+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 23456799999999999988774 8999999999999999999999999888888
Q ss_pred HHHHc--CCCCCCCC--CCHHHHHHHHHhhhhCCCCCCC-HHHHh
Q psy2648 255 ERVLR--GKYRIPFY--MSTDCENLLKKFLVLNPAKRAS-LEVSG 294 (708)
Q Consensus 255 ~~i~~--~~~~~p~~--~s~~~~~Li~~~L~~dP~~Rps-~~~~~ 294 (708)
.++.. ....+|.. +++++.+||.+||. ||.+|++ +++++
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 88877 44555554 49999999999997 9999999 99887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=394.95 Aligned_cols=240 Identities=34% Similarity=0.604 Sum_probs=216.8
Q ss_pred EeEEcccCceEEEEEEE---cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 51 LKTIGKGNFAKVKLAKH---VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~---~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
++.||+|+||.||++++ ..+|+.||||++.+..........+.+|+++|++++||||+++++++++++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999986 368899999999865443344556778999999999999999999999999999999999
Q ss_pred CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccccc
Q psy2648 128 SGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCG 206 (708)
Q Consensus 128 ~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~~G 206 (708)
++|+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......+|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988888999999999999999999999999999999999999999999999999998765433 33456789
Q ss_pred CCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCC
Q psy2648 207 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286 (708)
Q Consensus 207 t~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 286 (708)
++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+......+|..+++++.+||++||+.||.+
T Consensus 161 ~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 161 TVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred ChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 9999999999887764 789999999999999999999999999999999999988999999999999999999999999
Q ss_pred CCCHH
Q psy2648 287 RASLE 291 (708)
Q Consensus 287 Rps~~ 291 (708)
||++.
T Consensus 240 R~~a~ 244 (318)
T cd05582 240 RLGAG 244 (318)
T ss_pred cCCCC
Confidence 99943
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=381.92 Aligned_cols=248 Identities=29% Similarity=0.504 Sum_probs=210.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||++++++++..+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999998665444455678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--Cccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~~~~ 203 (708)
|++++.+..+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 99988776655545679999999999999999999999999999999999999999999999999998654322 2334
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------------------CCC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-------------------YRI 264 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-------------------~~~ 264 (708)
.+|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.... ...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 6799999999999888774 79999999999999999999998876544332222110 011
Q ss_pred C-------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 P-------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p-------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
| ..+|.++.+||++||++||++|||+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1 12678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=390.26 Aligned_cols=242 Identities=37% Similarity=0.662 Sum_probs=215.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKM-LDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|++..+++.||||++++... .....+.+..|..++.. ++||||++++++++....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999986532 22344556677777765 4899999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999975432 23345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+......+|...+.++.+||.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 161 DYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred cccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999999988775 78999999999999999999999999999999998888888889999999999999999999999
Q ss_pred CHH-HHh
Q psy2648 289 SLE-VSG 294 (708)
Q Consensus 289 s~~-~~~ 294 (708)
++. ++.
T Consensus 240 ~~~~~l~ 246 (316)
T cd05592 240 GVDGDIR 246 (316)
T ss_pred CChHHHH
Confidence 875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=379.89 Aligned_cols=260 Identities=32% Similarity=0.515 Sum_probs=225.9
Q ss_pred ccCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 37 RRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 37 ~~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
....-.+..+.|++...||.|.-+.||+|+++.+++.||||+++-++.+.. +..+.+|+..|+.++|||||+++..|..
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 344556677899999999999999999999999999999999998776544 7889999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
+..+|+||.|+.+|++++.|... ..+.|..+..++++++.||.|||++|.||||||+.|||||.+|.|||+|||.+..
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999999988764 4699999999999999999999999999999999999999999999999998765
Q ss_pred cC-CCCC----ccccccCCccccccccc--CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-
Q psy2648 195 FT-PGNK----LDTFCGSPPYAAPELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF- 266 (708)
Q Consensus 195 ~~-~~~~----~~~~~Gt~~Y~APE~l~--~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~- 266 (708)
+. .+.. .+++.|||+|||||++. ...|+ .|+||||||++..||++|..||....+.++.-.-+.+.++.|.
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 43 2321 26789999999999964 34565 7999999999999999999999998887766666666554321
Q ss_pred ---------CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 267 ---------YMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 267 ---------~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
..+..++.+|..||++||.+|||+++++ |+..
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~ 298 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK 298 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence 2456789999999999999999999887 6654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=391.53 Aligned_cols=248 Identities=35% Similarity=0.620 Sum_probs=216.6
Q ss_pred CeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
+|++++.||+|+||.||+|++. .+++.||||++.+... .....+.+.+|+++|+.+ +||||++++++++.++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 5889999999976432 123345677899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|+||||+++|+|.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999997654322
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYRIPFYMSTDCEN 274 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~----~~~~~l~~~i~~~~~~~p~~~s~~~~~ 274 (708)
.....+||+.|+|||++.+....+.++|||||||+||+|++|..||.. ....++...+......+|..+++++.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 234578999999999998765446789999999999999999999964 345567777777777888889999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHh
Q psy2648 275 LLKKFLVLNPAKRA-----SLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rp-----s~~~~~ 294 (708)
||.+||..||++|| +++++.
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l 265 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIK 265 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHH
Confidence 99999999999999 666666
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=381.09 Aligned_cols=249 Identities=32% Similarity=0.512 Sum_probs=209.7
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+++|++.+.||+|+||.||+|++..+++.||||+++.... ......+.+|+++++.++||||+++++++.++..+|+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 35689999999999999999999999999999999975432 22234577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCc
Q psy2648 124 MEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~ 201 (708)
|||+.+ +|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 999985 9999887654 4799999999999999999999999999999999999999999999999998754322 223
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------------------C
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-------------------Y 262 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-------------------~ 262 (708)
....|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.... +
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 456789999999998764433578999999999999999999999887766554443210 0
Q ss_pred CCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 RIP-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 ~~p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+| ..+++++.+||++||+.||.+|||+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 111 23578999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=399.64 Aligned_cols=246 Identities=30% Similarity=0.521 Sum_probs=214.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+|++++.||+|+||.||+|++..+++.||||++.+... .....+.+.+|+++|+.++|||||++++++++++.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999976432 23345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-------
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG------- 198 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~------- 198 (708)
||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999997532100
Q ss_pred -----------------------------------------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHH
Q psy2648 199 -----------------------------------------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYT 237 (708)
Q Consensus 199 -----------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilye 237 (708)
....+.+||+.|+|||++.+..|+ .++|||||||+||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHHH
Confidence 011245799999999999988875 79999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHcCC--CCCC--CCCCHHHHHHHHHhhhhCCCCCCC---HHHHh
Q psy2648 238 LVSGSLPFDGSTLRELRERVLRGK--YRIP--FYMSTDCENLLKKFLVLNPAKRAS---LEVSG 294 (708)
Q Consensus 238 lltG~~Pf~~~~~~~l~~~i~~~~--~~~p--~~~s~~~~~Li~~~L~~dP~~Rps---~~~~~ 294 (708)
|++|+.||.+.+..+...++.... ..+| ...++++.+||.+|+ .||.+|++ +++++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999988877777776533 3334 357899999999986 59999997 77766
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=391.20 Aligned_cols=239 Identities=36% Similarity=0.604 Sum_probs=213.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVR-IMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|++..+|+.||||++.+.... ....+.++.|.. +++.++||||++++++++..+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999999999999999999765332 223345566655 46789999999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999999888999999999999999999999999999999999999999999999999999875432 23345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+..+...++...++++.+||++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 161 EYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 99999999988775 78999999999999999999999999999999999988888888899999999999999999999
Q ss_pred CHH
Q psy2648 289 SLE 291 (708)
Q Consensus 289 s~~ 291 (708)
++.
T Consensus 240 ~~~ 242 (323)
T cd05575 240 GAK 242 (323)
T ss_pred CCC
Confidence 974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=400.23 Aligned_cols=247 Identities=30% Similarity=0.508 Sum_probs=214.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+|++++.||+|+||.||+|++..+++.||||++.+... .....+.+.+|+++|+.++||||+++++.+++++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999975432 2233456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC------
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG------ 198 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~------ 198 (708)
|||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999997532100
Q ss_pred --------------------------------------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc
Q psy2648 199 --------------------------------------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 240 (708)
Q Consensus 199 --------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt 240 (708)
......+||+.|+|||++.+..++ .++|||||||+||+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 001245899999999999888775 79999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCC--CCCC--CCCHHHHHHHHHhhhhCCCCCC---CHHHHh
Q psy2648 241 GSLPFDGSTLRELRERVLRGKY--RIPF--YMSTDCENLLKKFLVLNPAKRA---SLEVSG 294 (708)
Q Consensus 241 G~~Pf~~~~~~~l~~~i~~~~~--~~p~--~~s~~~~~Li~~~L~~dP~~Rp---s~~~~~ 294 (708)
|+.||.+.+..+....+..... .+|. .+++++.+||.+|+ .||.+|+ ++++++
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999888877777765432 3333 57899999999976 5999999 888877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=389.57 Aligned_cols=242 Identities=38% Similarity=0.670 Sum_probs=218.7
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|++..+++.||||++.+... .......+.+|+++++.+ +||||+++++++++.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999986532 233455677899999887 699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++.++..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++... ........+|++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 9999999888899999999999999999999999999999999999999999999999999986532 233345578999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+......+|..++.++.+||++||..||.+||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 161 DYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred cccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 99999999988875 79999999999999999999999999999999999888888989999999999999999999999
Q ss_pred CH-----HHHh
Q psy2648 289 SL-----EVSG 294 (708)
Q Consensus 289 s~-----~~~~ 294 (708)
++ .++.
T Consensus 240 s~~~~~~~~ll 250 (318)
T cd05570 240 GCLPTGEQDIK 250 (318)
T ss_pred CCCCCCHHHHh
Confidence 98 7665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=396.85 Aligned_cols=246 Identities=32% Similarity=0.559 Sum_probs=216.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.+++++.||+|.||+||+|.+..+ ..||||.+....+.+ +.|.+|++||++|+|+|||+|++++..++.+||||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 456789999999999999999643 369999998765543 4577999999999999999999999998899999999
Q ss_pred cCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 127 ASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 127 ~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
++.|+|.+||+. .+.+...+...++.|||+||+||+++++|||||...|||++++..+||+||||++...++......
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999999987 356889999999999999999999999999999999999999999999999999954443322222
Q ss_pred cc--CCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhh
Q psy2648 205 CG--SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 205 ~G--t~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~L 280 (708)
-+ ...|.|||.+....++ .++|||||||+||||+| |+.||.+.+..++.+.|.+| ..+.|..+++++-++|..||
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW 441 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCW 441 (468)
T ss_pred CCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHh
Confidence 22 2359999999988886 79999999999999999 99999999999999999998 34567789999999999999
Q ss_pred hhCCCCCCCHHHHhhhh
Q psy2648 281 VLNPAKRASLEVSGEVT 297 (708)
Q Consensus 281 ~~dP~~Rps~~~~~~~~ 297 (708)
..+|++|||++.+.+..
T Consensus 442 ~~~P~~RPtF~~L~~~l 458 (468)
T KOG0197|consen 442 HEDPEDRPTFETLREVL 458 (468)
T ss_pred hCCcccCCCHHHHHHHH
Confidence 99999999999777654
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=391.19 Aligned_cols=287 Identities=27% Similarity=0.432 Sum_probs=248.2
Q ss_pred cCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhh-HHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 38 ~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
.+..+.....|...++||+|+||.|+-|+.+.||+.||+|.+.|+.+.... ....+.|-.||++++.|+||.|-..|++
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 344566667899999999999999999999999999999999887654322 2346789999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
.+.+++||..|+||||.-+|...+ .++|..++.|+.||+.||++||+.+||+|||||+|||||++|+|+|+|+|||..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999999999998877 799999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCH
Q psy2648 195 FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRGKYRIPFYMST 270 (708)
Q Consensus 195 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~~~~~p~~~s~ 270 (708)
+..+.......||..|||||++++..|+ ..+|||||||+||+|+.|+.||... ..+++-++++.....+|...|+
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 9888888888999999999999999986 7899999999999999999999753 3457888899888889999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHH-----HHh---------hhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhh
Q psy2648 271 DCENLLKKFLVLNPAKRASLE-----VSG---------EVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 336 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~-----~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 336 (708)
++++|.+.+|++||.+|.... ++. |-.+. .....|++-|+|....--+.+|..+
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle------------agml~PPfiPdp~aVyakDv~DIeq 483 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE------------AGMLEPPFIPDPGAVYAKDVLDIEQ 483 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh------------ccCCCCCCCCCccccchhhhhhhhh
Confidence 999999999999999998764 222 32222 2345566777777665555555554
Q ss_pred h
Q psy2648 337 I 337 (708)
Q Consensus 337 ~ 337 (708)
+
T Consensus 484 F 484 (591)
T KOG0986|consen 484 F 484 (591)
T ss_pred c
Confidence 4
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=388.01 Aligned_cols=244 Identities=35% Similarity=0.604 Sum_probs=219.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVm 124 (708)
+|++.+.||+|+||.||+|++..+++.||||++.+... .....+.+..|+++++.+. ||+|+++++++++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 48899999999999999999999999999999986532 2334456778999998886 577889999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~ 203 (708)
||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875432 233456
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+......+|...+.++.+|+.+||..|
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred ccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence 7899999999999888774 799999999999999999999999999999999999988899999999999999999999
Q ss_pred CCCCCCHH
Q psy2648 284 PAKRASLE 291 (708)
Q Consensus 284 P~~Rps~~ 291 (708)
|.+|++..
T Consensus 240 p~~R~~~~ 247 (323)
T cd05615 240 PSKRLGCG 247 (323)
T ss_pred HhhCCCCC
Confidence 99999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=387.54 Aligned_cols=242 Identities=34% Similarity=0.596 Sum_probs=215.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKM-LDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|++..+++.||||++.+... .....+.+..|..+++. ++||||+++++++++.+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999986532 12334556778888876 5899999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~~Gt~ 208 (708)
|+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875422 23345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+......+|...+.++.+||.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 161 DYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred cccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence 99999999888775 79999999999999999999999999999998888887788888999999999999999999999
Q ss_pred CHH-HHh
Q psy2648 289 SLE-VSG 294 (708)
Q Consensus 289 s~~-~~~ 294 (708)
++. ++.
T Consensus 240 ~~~~~l~ 246 (316)
T cd05619 240 GVKGDIR 246 (316)
T ss_pred CChHHHH
Confidence 996 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=360.95 Aligned_cols=248 Identities=31% Similarity=0.506 Sum_probs=214.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.+|..++.||+|.||.||+|++..||+.||||.|+..+.........+|||+.|+.++|||||.|.++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47999999999999999999999999999999998776555555678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-ccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-~~~ 203 (708)
|++. ||...|+.+ -.++..+++.|+.|++.||+|||++.|+||||||.|+||+.+|.+||+|||+++.+..... ...
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 9975 898888755 3589999999999999999999999999999999999999999999999999998865433 333
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C--------------------
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K-------------------- 261 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~-------------------- 261 (708)
.+-|..|.|||++.|....+..+||||.|||+.||+.|.+-|.|.+.-+-...|.+. .
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 478899999999998776688999999999999999999989887765544555331 1
Q ss_pred CCCC------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 YRIP------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 ~~~p------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.| ...+.++.||+.+||.+||.+|+++.+++
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 1111 12567889999999999999999999887
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=394.92 Aligned_cols=247 Identities=31% Similarity=0.548 Sum_probs=215.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+.|++++.||+|+||.||+|++..+++.||||++.+... .......+.+|+.++..++||||+++++.+++.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 469999999999999999999999999999999975432 2334566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-----
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----- 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~----- 199 (708)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986442110
Q ss_pred -------------------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2648 200 -------------------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS 248 (708)
Q Consensus 200 -------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~ 248 (708)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 01246899999999999988875 7999999999999999999999999
Q ss_pred CHHHHHHHHHcCC--CCCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHh
Q psy2648 249 TLRELRERVLRGK--YRIPF--YMSTDCENLLKKFLVLNPAKRAS---LEVSG 294 (708)
Q Consensus 249 ~~~~l~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~Rps---~~~~~ 294 (708)
+..+...++.... +.+|. ..++++++||.+|+ .||.+|++ +++++
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9888888887643 33443 36899999999987 49999985 56665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=388.37 Aligned_cols=238 Identities=35% Similarity=0.635 Sum_probs=210.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|++..+++.||+|++.+... .......+.+|+.++..+ +||||+++++++++.+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987643 234455678899998776 799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 9999999888899999999999999999999999999999999999999999999999999987532 333445678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---------STLRELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~---------~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.. .....+.+.+......+|...+.++.+||++|
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999988774 789999999999999999999952 12344667777888889999999999999999
Q ss_pred hhhCCCCCCCH
Q psy2648 280 LVLNPAKRASL 290 (708)
Q Consensus 280 L~~dP~~Rps~ 290 (708)
|..||.+|++.
T Consensus 240 L~~dP~~R~~~ 250 (329)
T cd05618 240 LNKDPKERLGC 250 (329)
T ss_pred hcCCHHHcCCC
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=394.60 Aligned_cols=255 Identities=29% Similarity=0.515 Sum_probs=221.1
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++.+.||+|+||.||+|++..+++.||||++.+.... ....+.+.+|+.+|+.++||||++++++++++..+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567899999999999999999999999999999999764322 23344577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999998754 578999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccccCCcccccccccCCc---cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCCHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKK---YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF--YMSTD 271 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~---~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~--~~s~~ 271 (708)
.....+||+.|+|||++.+.. +.+.++|||||||+||+|++|..||.+.+....+..+.... ..+|. .+|.+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 234578999999999987543 23578999999999999999999999999888888887754 34454 47899
Q ss_pred HHHHHHHhhhhCCCC--CCCHHHHh---hhh
Q psy2648 272 CENLLKKFLVLNPAK--RASLEVSG---EVT 297 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~--Rps~~~~~---~~~ 297 (708)
+.+||++||+.+|.+ |+++++++ |+.
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 999999999999998 99999987 654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=386.74 Aligned_cols=239 Identities=35% Similarity=0.594 Sum_probs=213.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVR-IMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|++..+++.||||++.+... .......+.+|.. +++.++||||+++++++++.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999976533 2223345566654 67889999999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|..++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999987532 223345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+..+...+|...+.++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 161 EYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 99999999888775 78999999999999999999999999999999999988888888999999999999999999999
Q ss_pred CHH
Q psy2648 289 SLE 291 (708)
Q Consensus 289 s~~ 291 (708)
+..
T Consensus 240 ~~~ 242 (321)
T cd05603 240 GAK 242 (321)
T ss_pred CCC
Confidence 863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=387.73 Aligned_cols=240 Identities=35% Similarity=0.577 Sum_probs=212.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVR-IMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|++..+++.||+|++.+.... ......+..|.. +++.++||||++++++++..+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999764321 222334555544 56789999999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999987543 233345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+......++..++.++.+||++||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 161 EYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred cccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999999988775 78999999999999999999999999999989988887777778999999999999999999999
Q ss_pred CHHH
Q psy2648 289 SLEV 292 (708)
Q Consensus 289 s~~~ 292 (708)
++.+
T Consensus 240 ~~~~ 243 (325)
T cd05602 240 GAKD 243 (325)
T ss_pred CCCC
Confidence 9763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=385.74 Aligned_cols=239 Identities=33% Similarity=0.622 Sum_probs=212.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|++..+++.||||++.+.... ....+.+.+|+.++.++ +||||+++++++++.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999875432 34456678999999888 699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CCCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 999999988889999999999999999999999999999999999999999999999999998753 2333445688999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhh
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-------STLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-------~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 281 (708)
.|+|||++.+..++ .++|||||||+||+|++|..||.. .....+.+.+.....++|..++.++.++|++||.
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999888774 799999999999999999999953 2334566777777788999999999999999999
Q ss_pred hCCCCCCCHH
Q psy2648 282 LNPAKRASLE 291 (708)
Q Consensus 282 ~dP~~Rps~~ 291 (708)
.||.+|++++
T Consensus 240 ~dP~~R~~~~ 249 (327)
T cd05617 240 KDPKERLGCQ 249 (327)
T ss_pred cCHHHcCCCC
Confidence 9999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=392.87 Aligned_cols=255 Identities=31% Similarity=0.544 Sum_probs=219.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||++++++++++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 4456789999999999999999999999999999999976432 223345577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|+|||||++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999999999998864 468999999999999999999999999999999999999999999999999997654322
Q ss_pred -CccccccCCcccccccccCCc---cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCCHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKK---YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF--YMSTD 271 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~---~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~--~~s~~ 271 (708)
...+.+||+.|+|||++.+.. +.+.++|||||||+||+|++|..||.+.+..+...++.... +.+|. .++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 234678999999999997643 23578999999999999999999999998888888887654 44554 46899
Q ss_pred HHHHHHHhhhhCCCC--CCCHHHHh---hhh
Q psy2648 272 CENLLKKFLVLNPAK--RASLEVSG---EVT 297 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~--Rps~~~~~---~~~ 297 (708)
+++||.+||..++.+ |+++++++ |+.
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 999999999865544 88999887 664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=380.32 Aligned_cols=250 Identities=27% Similarity=0.484 Sum_probs=215.6
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.++|++++.||+|+||.||+|++..++..||+|++.... .+...+.+.+|+++|+.++||||+++++++...+.+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 468999999999999999999999999999999997542 3445567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..... .....
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~ 161 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANS 161 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-ccccc
Confidence 9999999999998888899999999999999999999986 699999999999999999999999999876543 23345
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc------------------------
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR------------------------ 259 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~------------------------ 259 (708)
.+|++.|+|||++.+..++ .++|||||||++|+|++|+.||...+..++...+..
T Consensus 162 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 6899999999999988775 799999999999999999999987666554332211
Q ss_pred ----------------------CC-CCCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 260 ----------------------GK-YRIP-FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 260 ----------------------~~-~~~p-~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.. ...| ...++++.+||.+||++||++|||+++++ |+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 00 0111 13578999999999999999999999987 665
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=386.94 Aligned_cols=239 Identities=34% Similarity=0.569 Sum_probs=213.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVR-IMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|++..+|+.||||++.+... .......+..|.. +++.++||||++++++++..+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999976532 2233445666665 46789999999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 9999999888899999999999999999999999999999999999999999999999999987532 223345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+.+..+...++...+.++.++|++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 161 EYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 99999999988875 78999999999999999999999999999999999888777778899999999999999999999
Q ss_pred CHH
Q psy2648 289 SLE 291 (708)
Q Consensus 289 s~~ 291 (708)
++.
T Consensus 240 ~~~ 242 (325)
T cd05604 240 GAK 242 (325)
T ss_pred CCC
Confidence 874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=389.87 Aligned_cols=241 Identities=33% Similarity=0.529 Sum_probs=212.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC---CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML---DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
||+|+||+||+|++..+++.||||++.+... ..........|..++..+ +||||+++++++++...+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999976432 223344566788887765 699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~~~Gt~ 208 (708)
|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 9999999988999999999999999999999999999999999999999999999999999987543 233345678999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHhhhhCCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF-YMSTDCENLLKKFLVLNPAKR 287 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~-~~s~~~~~Li~~~L~~dP~~R 287 (708)
.|+|||++.+....+.++|||||||++|+|++|..||.+.+..++.+.+..+...+|. .+++++.+||++||..||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 9999999976553458999999999999999999999999999999999988888775 478999999999999999999
Q ss_pred C----CHHHHh
Q psy2648 288 A----SLEVSG 294 (708)
Q Consensus 288 p----s~~~~~ 294 (708)
| ++++++
T Consensus 241 ~~~~~~~~~ll 251 (330)
T cd05586 241 LGAHRDAVELK 251 (330)
T ss_pred CCCCCCHHHHh
Confidence 8 466655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=375.05 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=215.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+|++.+.||+|+||.||++.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 5899999999999999999999999999999997654322 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 126 YASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999888654 4689999999999999999999999999999999999999999999999999977654444456
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR----ELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~----~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.. ++...+..+...+|...++.+.+||.+|
T Consensus 161 ~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred ccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 6899999999999887764 7899999999999999999999886553 3444555555566777899999999999
Q ss_pred hhhCCCCCC-----CHHHHh
Q psy2648 280 LVLNPAKRA-----SLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rp-----s~~~~~ 294 (708)
|..||.+|| +++++.
T Consensus 240 l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHh
Confidence 999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.48 Aligned_cols=249 Identities=27% Similarity=0.507 Sum_probs=206.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----KTLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~y 121 (708)
+|++.+.||+|+||.||+|.+..+++.||||++...........++.+|+++|+.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999975433334456788999999999999999999988543 3589
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-- 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-- 199 (708)
+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999995 6899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred --CccccccCCcccccccccC--CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------------cC
Q psy2648 200 --KLDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL---------------RG 260 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~--~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~---------------~~ 260 (708)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.+.......+. ..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred cccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1234679999999999865 444 479999999999999999999998766433221111 00
Q ss_pred -----------CCCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 261 -----------KYRIP-----FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 261 -----------~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
....+ ...++++.+||.+||+.||++|||+++++ |+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 00111 13567899999999999999999999988 664
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.61 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=216.6
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTL 120 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 120 (708)
..|..|+.+..|++|+||.||+|+++.|++.||+|.++.+.-....--.-+|||.+|.+++|||||.+-++.... +.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 446789999999999999999999999999999999987653323223467999999999999999999988654 579
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG- 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~- 198 (708)
|||||||+. ||...+...+ +|.+.+++.++.|++.||+|||.+.|+||||||+|+|+.+.|.+||+|||||+.+...
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999986 8998887665 8999999999999999999999999999999999999999999999999999988643
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------C-------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-----------G------- 260 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~-----------~------- 260 (708)
......+-|..|.|||++.|.+-.+.++|+||+|||+.||+++.+-|.|.+..+-..+|.+ |
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 3456678899999999999877666899999999999999999999999775544444432 1
Q ss_pred -CCCCC------------CC-CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 261 -KYRIP------------FY-MSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 261 -~~~~p------------~~-~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.+.+| .. +|....+|+..+|.+||.+|.|+++.+ |+...
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 01111 11 568889999999999999999999887 77654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.90 Aligned_cols=248 Identities=29% Similarity=0.510 Sum_probs=204.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.++|++.+.||+|+||.||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.++..+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 36899999999999999999999999999999999754322 22345678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcc
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~ 202 (708)
||+. ++|.+++..+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 9996 6888888665 5689999999999999999999999999999999999999999999999999865432 22334
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHc--CCC---------CC------
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLR--GKY---------RI------ 264 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~--~~~---------~~------ 264 (708)
..+|++.|+|||++.+....+.++|||||||++|+|++|..||.+.. ..+..+.+.. +.. ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 56789999999998765434578999999999999999999998753 2222222211 000 00
Q ss_pred ------C---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 ------P---------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 ------p---------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
| ...++++.+||++||+.||.+|||+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 0 01346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=397.99 Aligned_cols=249 Identities=35% Similarity=0.561 Sum_probs=220.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCC-CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPT-GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~t-g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+....|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+++|+.++|||||+++++++.++.+|
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 3455699999999999999999998887 788999987543 2334456778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 122 LVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
|||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999988754 34689999999999999999999999999999999999999999999999999987643
Q ss_pred CC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHH
Q psy2648 198 GN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCE 273 (708)
Q Consensus 198 ~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~ 273 (708)
.. ...+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++...+..+.+. +|..++.++.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 32 23467899999999999888774 7899999999999999999999999998988888887664 5677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||++||+++++.
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred HHHHHHhccChhhCcCHHHHH
Confidence 999999999999999999876
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=385.64 Aligned_cols=247 Identities=30% Similarity=0.519 Sum_probs=215.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++.+.||+|+||.||+|++..+++.||||++++... .....+.+.+|+.+++.++||||+++++++++...+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 369999999999999999999999999999999986543 2334456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--c
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--L 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~--~ 201 (708)
||+++|+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999876 6899999999999999999999999999999999999999999999999999976543322 2
Q ss_pred cccccCCcccccccccC------CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCCHH
Q psy2648 202 DTFCGSPPYAAPELFQG------KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF--YMSTD 271 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~------~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~--~~s~~ 271 (708)
...+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||...+..+....+.... ..+|. ..+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred ecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 34579999999999873 333 478999999999999999999999988888778777643 23333 57899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+||++||. ||.+||+++++.
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHh
Confidence 9999999998 999999999887
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=383.14 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=206.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC-
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE- 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~- 117 (708)
-++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+|+.+ +|||||++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 358999999999999999999853 456789999987542 334456788999999999 899999999988764
Q ss_pred CEEEEEEeccCCCChHHHHHHc----------------------------------------------------------
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH---------------------------------------------------------- 139 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~---------------------------------------------------------- 139 (708)
..+|+||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC---ccccccCCcccc
Q psy2648 140 ----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAA 212 (708)
Q Consensus 140 ----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~A 212 (708)
..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2377788899999999999999999999999999999999999999999999976532211 123345678999
Q ss_pred cccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCC
Q psy2648 213 PELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLR-ELRERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRAS 289 (708)
Q Consensus 213 PE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~-~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps 289 (708)
||++.+..++ .++|||||||+||+|++ |..||.+.... .+...+..+. ...|...++++.+||.+||..||.+|||
T Consensus 245 PE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 245 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred cHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999888775 79999999999999997 99999876543 3444555443 3456778899999999999999999999
Q ss_pred HHHHh
Q psy2648 290 LEVSG 294 (708)
Q Consensus 290 ~~~~~ 294 (708)
++++.
T Consensus 324 ~~el~ 328 (338)
T cd05102 324 FSALV 328 (338)
T ss_pred HHHHH
Confidence 99887
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=399.89 Aligned_cols=250 Identities=32% Similarity=0.551 Sum_probs=223.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK----- 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 118 (708)
..++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+|..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346999999999999999999999999999999999877666666777889999999999999999998775432
Q ss_pred ---EEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 119 ---TLYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 119 ---~~ylVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
.+++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 478999999999999998653 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC---CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCC
Q psy2648 192 SNEFTPG---NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFY 267 (708)
Q Consensus 192 s~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~ 267 (708)
++.+... ....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|+.||.+.+..++...+..+.+. +|..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 9765422 223567899999999999988775 7999999999999999999999999999988888887653 6778
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++++.+||.+||..||.+||++.+++
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 899999999999999999999999876
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=367.91 Aligned_cols=251 Identities=35% Similarity=0.577 Sum_probs=221.6
Q ss_pred CCCCccCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q psy2648 40 RDEPHIGKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE 117 (708)
Q Consensus 40 ~~~~~~~~Y~i~-~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 117 (708)
.+...+++|.+- .+||-|-.|+|..|.|+.||+++|+|++.- ..+..+|+++.-+. .|||||+++++|+..
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 444567789885 689999999999999999999999999853 24567898886555 599999999998753
Q ss_pred ----CEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CcEEEEe
Q psy2648 118 ----KTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIAD 188 (708)
Q Consensus 118 ----~~~ylVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~~iKL~D 188 (708)
..+.||||.++||+|++.|..++. ++|.+|..+++||+.|+.|||+.+|.||||||||+|.... -.+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 468899999999999999999876 9999999999999999999999999999999999999754 4689999
Q ss_pred ccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCC
Q psy2648 189 FGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST----LRELRERVLRGKYRI 264 (708)
Q Consensus 189 FGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~----~~~l~~~i~~~~~~~ 264 (708)
||+++.-.....+.+-|-||.|.|||++-..+|+ ..+|+||+||++|.|+||.+||.... ...+..+|..|.|.+
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9999987766778899999999999999988886 78999999999999999999998643 356889999999999
Q ss_pred CC----CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 265 PF----YMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 265 p~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
|. .+|++++|+|++||..+|.+|.|+++.+ |+..
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 85 4789999999999999999999999988 7753
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=387.45 Aligned_cols=252 Identities=32% Similarity=0.563 Sum_probs=215.6
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++++...+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3345799999999999999999999999999999999976432 223345577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|+|||||++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 999999999999998864 468999999999999999999999999999999999999999999999999997654322
Q ss_pred -CccccccCCcccccccccCCc---cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCCHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKK---YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF--YMSTD 271 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~---~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~--~~s~~ 271 (708)
...+.+||+.|+|||++.+.. +.+.++|||||||+||+|++|..||.+.+.......|.... ..+|. .++.+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 234678999999999997643 23578999999999999999999999999888888887654 33443 57899
Q ss_pred HHHHHHHhhhhCCCC--CCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAK--RASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~--Rps~~~~~ 294 (708)
+++||.+||..++.+ |+++++++
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~ 302 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIK 302 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHh
Confidence 999999999844433 77888877
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=380.35 Aligned_cols=252 Identities=29% Similarity=0.495 Sum_probs=209.6
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK---- 118 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 118 (708)
..+++|++.+.||+|+||.||+|.+..+|+.||||++.+..........+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3468999999999999999999999999999999999766544455667889999999999999999999986543
Q ss_pred --EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 119 --TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 119 --~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999975 5666653 458999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------------------
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL------------------ 258 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~------------------ 258 (708)
.........||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 44444567899999999999988875 78999999999999999999998766433222111
Q ss_pred ----cCCCCC--------------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 259 ----RGKYRI--------------------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 259 ----~~~~~~--------------------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
...... +...++++.+||.+||+.||++|||+++++ |+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 111110 112457899999999999999999999988 7754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=370.55 Aligned_cols=243 Identities=33% Similarity=0.508 Sum_probs=209.4
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCh
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L 132 (708)
||+|+||+||+|.+..+++.||||++.+..... ...+.+..|+++|+.++||||++++++++.+..+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999999999999997654322 2345677899999999999999999999999999999999999999
Q ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-CccccccC
Q psy2648 133 FDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGS 207 (708)
Q Consensus 133 ~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~Gt 207 (708)
.+++.. +..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.....+. ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 888743 3468999999999999999999999999999999999999999999999999987654332 23456899
Q ss_pred CcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 208 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST----LRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 208 ~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~----~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
+.|+|||++.+..++ .++|||||||++|+|++|+.||.... ..++...+......+|...++++.+|+.+||+.|
T Consensus 161 ~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 161 PGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred cCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 999999999988875 78999999999999999999998643 3445556666666677788999999999999999
Q ss_pred CCCCC-----CHHHHh---hhh
Q psy2648 284 PAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 284 P~~Rp-----s~~~~~---~~~ 297 (708)
|++|| +++++. |+.
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~ 261 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFR 261 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhh
Confidence 99999 556665 664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=370.26 Aligned_cols=246 Identities=29% Similarity=0.450 Sum_probs=205.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC---CCCCeeeEEEEEE-----eC
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVP-TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML---DHPNIVKLFQVIE-----TE 117 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~~ 117 (708)
+|++.+.||+|+||+||+|++.. +++.||||++............+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 79999999999999999999865 468899999876544333344566788887765 6999999999985 24
Q ss_pred CEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 56999999997 5899998764 35899999999999999999999999999999999999999999999999999776
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----C-------
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-----R------- 263 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-----~------- 263 (708)
.........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+....- .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred cCCcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 544445567899999999999887775 789999999999999999999998877666666643210 0
Q ss_pred ---------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 ---------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 ---------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+++++.+||.+||+.||++|||+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0123577889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=392.95 Aligned_cols=247 Identities=32% Similarity=0.412 Sum_probs=204.6
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------- 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 117 (708)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 457999999999999999999999999999999886432 1234799999999999999999887432
Q ss_pred -CEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccC
Q psy2648 118 -KTLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGF 191 (708)
Q Consensus 118 -~~~ylVmEy~~gg~L~~~i~----~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGl 191 (708)
..+|+||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 257899999985 6776664 245799999999999999999999999999999999999999765 699999999
Q ss_pred ccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----------
Q psy2648 192 SNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG----------- 260 (708)
Q Consensus 192 s~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~----------- 260 (708)
++.+..+......+||+.|+|||++.+....+.++|||||||+||+|++|.+||.+.+..+...++...
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 987765555556789999999999876543358999999999999999999999987665444433220
Q ss_pred ------CC------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 ------KY------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 ------~~------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+ .+|...++++.+||++||++||.+|||+.+++ |+..
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01 12445678999999999999999999999988 7653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=378.50 Aligned_cols=249 Identities=31% Similarity=0.550 Sum_probs=212.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||.||++++..+++.||||++.+... .....+.+.+|+.+++.++||||+++++++++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999976432 2334456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--c
Q psy2648 125 EYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--L 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~--~ 201 (708)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 45799999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccCCcccccccccC----CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC---CCCHHH
Q psy2648 202 DTFCGSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF---YMSTDC 272 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~---~~s~~~ 272 (708)
...+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||.+.+..+....+.... +.+|. ..++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23579999999999973 2223578999999999999999999999988888877776543 33332 468999
Q ss_pred HHHHHHhhhhCCCC--CCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAK--RASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~--Rps~~~~~ 294 (708)
++||++||..++.+ |+++++++
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l 264 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFK 264 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHh
Confidence 99999999764444 78998887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.37 Aligned_cols=246 Identities=29% Similarity=0.510 Sum_probs=209.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-----EKTLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~y 121 (708)
.|..++.||+|+||.|+.|.+..||+.||||.|.....+.-..++.+||+++|+.++|+|||.+++++.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4666899999999999999999999999999998766667778899999999999999999999999876 25799
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC---C
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP---G 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~---~ 198 (708)
+|+|+++ .||...|+.+..++++.++.++.||+.||.|+|+.+|+||||||.|+|++.+..+||+|||||+.... .
T Consensus 103 iV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 103 LVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred EehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 9999994 58888777776799999999999999999999999999999999999999999999999999987753 4
Q ss_pred CCccccccCCcccccccccC-CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHH----
Q psy2648 199 NKLDTFCGSPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR---------------ERVL---- 258 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~-~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~---------------~~i~---- 258 (708)
..++..+.|..|.|||++.. ..| +.++||||+||||.||++|+.-|.|.+.-+-. .+|.
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Y-t~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEY-TKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred cchhcceeeeeecCHHHHhccccc-cchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 45567889999999999754 455 58999999999999999999999986532222 2222
Q ss_pred ----cCCCC---CC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 ----RGKYR---IP-----FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 ----~~~~~---~p-----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.-.. .| ...++++.||+.+||..||.+|+|+++++
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 11111 11 25789999999999999999999999987
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=375.34 Aligned_cols=250 Identities=27% Similarity=0.489 Sum_probs=212.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
-++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 468999999999999999999999999999999987643 3344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||+++|+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..... .....
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~ 161 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANS 161 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-hcccc
Confidence 9999999999998888899999999999999999999985 799999999999999999999999999875532 22345
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------------------------
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERV-------------------------- 257 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i-------------------------- 257 (708)
.+|++.|+|||++.+..++ .++|||||||++|+|++|+.||......++...+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240 (333)
T ss_pred CCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence 6899999999999887764 7899999999999999999999876544432211
Q ss_pred ------------------HcCC-CCCCC-CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 258 ------------------LRGK-YRIPF-YMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 258 ------------------~~~~-~~~p~-~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.... ...+. ..+.++.+||.+||++||++|||+++++ |+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 1111 11111 2567899999999999999999999987 664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.54 Aligned_cols=250 Identities=36% Similarity=0.583 Sum_probs=219.0
Q ss_pred CCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEE
Q psy2648 46 GKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 46 ~~Y~i~-~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylV 123 (708)
+-|++. +.||+|+|+.|--|....||.+||||+|+|.. .....+++||++++.+.+ |+||++|+++|+++..+|||
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 346664 68999999999999999999999999999873 345678999999999875 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---EEEEeccCccccCCC--
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFTPG-- 198 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~---iKL~DFGls~~~~~~-- 198 (708)
||-+.||.|..+|.++..|+|.+|..+.++|+.||.|||.+||.||||||||||..+... ||||||-|.......
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999999999999999999999999999999999999999999999999999976654 799999987543211
Q ss_pred ------CCccccccCCccccccccc-----CCccCCCchhHHHHHHHHHHHHcCCCCCCCC---------------CHHH
Q psy2648 199 ------NKLDTFCGSPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---------------TLRE 252 (708)
Q Consensus 199 ------~~~~~~~Gt~~Y~APE~l~-----~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---------------~~~~ 252 (708)
..+.+-||+..|||||++. ...|+ .++|.||||||||.||+|.+||.|. -...
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YD-KrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYD-KRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhcccccccc-ccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 2355789999999999873 23454 7899999999999999999999863 1467
Q ss_pred HHHHHHcCCCCCCC----CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 253 LRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 253 l~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+.+.|..|+|.+|. ++|.+++|||+.+|..|+.+|.++.+.. |++.
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 89999999999995 5899999999999999999999988766 6653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=383.91 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=212.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-----TLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~y 121 (708)
.|++++.||+|+||.||+|.+..+++.||||++..........+++.+|+++|+.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478999999999999999999999999999998765444445567889999999999999999999998876 899
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC--C
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG--N 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~--~ 199 (708)
+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999997 589998888888999999999999999999999999999999999999999999999999999765322 2
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-------------------- 259 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~-------------------- 259 (708)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....|..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 233456899999999998765445789999999999999999999998776554443321
Q ss_pred ---CCC---------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 260 ---GKY---------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 260 ---~~~---------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
... .+....++++.+||.+||+.||.+|||+++++ |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 111 12234578999999999999999999999987 7654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=378.19 Aligned_cols=248 Identities=30% Similarity=0.544 Sum_probs=212.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++.+.||+|+||.||++++..+++.||||++.+... .......+.+|+.+++.++||||+++++++++++.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999976422 2233445778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--c
Q psy2648 125 EYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--L 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~--~ 201 (708)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999987 46799999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccCCcccccccccC-----CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC---CCCHH
Q psy2648 202 DTFCGSPPYAAPELFQG-----KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF---YMSTD 271 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~-----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~---~~s~~ 271 (708)
...+||+.|+|||++.+ ..+ +.++|||||||+||+|++|+.||.+.+..+...++.... +.+|. .++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 34689999999999875 234 478999999999999999999999988888888887654 33443 35899
Q ss_pred HHHHHHHhhhhCCCC--CCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAK--RASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~--Rps~~~~~ 294 (708)
+.+||.+||..++++ |+++++++
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~ 264 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFK 264 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHh
Confidence 999999999976654 46787776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=382.99 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=204.4
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++++.||+|+||.||+|.+..+++.||||+... ..+.+|+++|+.|+|||||++++++..+...|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 445689999999999999999999999999999997532 346789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC--CCC
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP--GNK 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~--~~~ 200 (708)
|||++. ++|..++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999995 68999998888899999999999999999999999999999999999999999999999999865322 123
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHH----------------
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-------LRELRERV---------------- 257 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-------~~~l~~~i---------------- 257 (708)
....+||+.|+|||++.+..|+ +++|||||||+||+|++|..||.... .......+
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3457899999999999888774 89999999999999999998875321 11111111
Q ss_pred ----------HcCCCCCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 258 ----------LRGKYRIP---------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 258 ----------~~~~~~~p---------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.......| ..++.++.+||.+||+.||.+|||+++++ |+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 11111111 12456899999999999999999999987 7653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=380.59 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=210.6
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
......|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+++|+.++||||++++++++..+.+|
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 344678999999999999999999999999999999996543 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~ 200 (708)
+||||+.+|+|.+. ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999999998653 34678888999999999999999999999999999999999999999999999765432 22
Q ss_pred ccccccCCcccccccccC----CccCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcC-CCCCCCCCCHHH
Q psy2648 201 LDTFCGSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGSLPFDGST---LRELRERVLRG-KYRIPFYMSTDC 272 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~---~~~l~~~i~~~-~~~~p~~~s~~~ 272 (708)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||.... ...+...+... ....+...+.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 345689999999999853 2344568999999999999999999997432 23333333322 334566789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+||.+||..||++||++++++ |+..
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 9999999999999999999988 6643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=405.74 Aligned_cols=264 Identities=31% Similarity=0.526 Sum_probs=220.9
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-- 116 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 116 (708)
...+..+++|++++.||+|+||.||+|++..+++.||+|++............+.+|+.+|+.|+|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 455677889999999999999999999999999999999998766665666788999999999999999999998854
Q ss_pred CCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCCEEEcC-----
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQK-------KIIHRDLKAENLLLDS----- 180 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~-------gIvHRDLKPeNILld~----- 180 (708)
...+|||||||++|+|.++|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 45799999999999999998653 5799999999999999999999984 4999999999999964
Q ss_pred ------------CCcEEEEeccCccccCCCCCccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2648 181 ------------EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDG 247 (708)
Q Consensus 181 ------------~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~ 247 (708)
.+.+||+|||++............+||+.|+|||++.+.. ..++++||||||||||+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2358999999998765444455678999999999986532 224789999999999999999999976
Q ss_pred CC-HHHHHHHHHcCCCCCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhCCCCc
Q psy2648 248 ST-LRELRERVLRGKYRIP-FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLGGAPV 303 (708)
Q Consensus 248 ~~-~~~l~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~~~~~ 303 (708)
.+ ...+...+..+ ..+| ...+.++.+||.+||..||.+||++.+++ |+.....++
T Consensus 246 ~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p~ 305 (1021)
T PTZ00266 246 ANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPPV 305 (1021)
T ss_pred CCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCCc
Confidence 54 44555555444 3333 35689999999999999999999999987 776544443
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=364.97 Aligned_cols=249 Identities=32% Similarity=0.498 Sum_probs=212.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCC-----
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN-IVKLFQVIETEK----- 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~----- 118 (708)
...|+.+++||+|+||+||+|+.+.+|+.||+|.+.-.......-....+|+.+|+.|+|+| ||+|++++.+++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688888999999999999999999999999999866443223345789999999999999 999999998877
Q ss_pred -EEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 119 -TLYLVMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 119 -~~ylVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
.+|+|+||+.. ||..|+.... .++...++.+++||+.||+|||+++|+||||||+||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999999975 9999998766 57888999999999999999999999999999999999999999999999999
Q ss_pred ccC-CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--C----------
Q psy2648 194 EFT-PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--G---------- 260 (708)
Q Consensus 194 ~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--~---------- 260 (708)
.+. +........+|..|.|||++.|.......+||||+|||++||++++.-|.+.+..+...+|.+ |
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776 444466678999999999999985556889999999999999999999999887666666642 1
Q ss_pred ------CCCCCC------------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 ------KYRIPF------------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 ------~~~~p~------------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+..+|. ..+++..+|+.+||++||.+|.|++.++
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 111111 1235889999999999999999998766
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=365.61 Aligned_cols=246 Identities=29% Similarity=0.429 Sum_probs=204.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC---CCCCeeeEEEEEEe-----CC
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML---DHPNIVKLFQVIET-----EK 118 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~~ 118 (708)
+|++.+.||+|+||.||+|+++.+++.||||++............+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999999976543333334466788777665 79999999999864 34
Q ss_pred EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
.+++||||+.+ +|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 68999999985 898888764 348999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----------CC--
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-----------YR-- 263 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-----------~~-- 263 (708)
.........|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+...++.... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 44444556789999999999887764 78999999999999999999998876665554443210 00
Q ss_pred --------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 --------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 --------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....++.++.+||.+||++||++|||++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 0113567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=378.00 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=209.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------ 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 117 (708)
.+++|++.+.||+|+||.||+|.+..+++.||||++.+........+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 46799999999999999999999999999999999976654555567788999999999999999999998654
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999975 6777664 3588999999999999999999999999999999999999999999999999986654
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----------------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG----------------- 260 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~----------------- 260 (708)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 4445567899999999999988875 7899999999999999999999887644332222110
Q ss_pred -----C-----CC---------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 -----K-----YR---------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 -----~-----~~---------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
. .. .+...+.++.+||.+||..||++|||+++++ |+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0 00 0112356789999999999999999999988 6653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=377.37 Aligned_cols=251 Identities=27% Similarity=0.480 Sum_probs=211.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------ 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 117 (708)
..++|++.+.||+|+||.||+|.+..+++.||||++.+........+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 46799999999999999999999999999999999986554445566788999999999999999999987643
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+|+||||+.+ +|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 358999999975 6777764 3588999999999999999999999999999999999999999999999999986654
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK---------------- 261 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~---------------- 261 (708)
........||+.|+|||++.+..++ .++|||||||+||+|++|+.||.+.+..+...++....
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 4444567899999999999988875 78999999999999999999999877665554443210
Q ss_pred ------CC--------------CC------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 262 ------YR--------------IP------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 262 ------~~--------------~p------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.. .| ...+.++.+||.+||+.||.+|||+++++ |+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 00 11246789999999999999999999988 7653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=368.64 Aligned_cols=251 Identities=31% Similarity=0.507 Sum_probs=210.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+.+|++.+.||+|+||.||+|++..+++.||||+++..... .....+.+|+++++.++||||+++++++..++.+|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 56899999999999999999999999999999999755322 22345678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcc
Q psy2648 125 EYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~ 202 (708)
||+++ +|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 99985 8888887654 5899999999999999999999999999999999999999999999999998754322 2233
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------CCC
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------------KYR 263 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------------~~~ 263 (708)
...+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.+. .+.
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 4578999999999876543357999999999999999999999987765544443221 011
Q ss_pred CC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 264 IP-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 264 ~p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.| ..+++++.+||.+||..||.+|||+++++ |+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 11 13678999999999999999999999987 765
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=375.54 Aligned_cols=249 Identities=30% Similarity=0.531 Sum_probs=212.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++||||+++++++++...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 379999999999999999999999999999999975432 2223345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--c
Q psy2648 125 EYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--L 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~--~ 201 (708)
||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999977 46799999999999999999999999999999999999999999999999999876533222 2
Q ss_pred cccccCCcccccccccC----CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--CCCC---CCCHHH
Q psy2648 202 DTFCGSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY--RIPF---YMSTDC 272 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~--~~p~---~~s~~~ 272 (708)
...+||+.|+|||++.+ ....+.++|||||||+||+|++|+.||.+.+..+...++..... .+|. .+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 34689999999999863 22225789999999999999999999999998888888876543 3333 568999
Q ss_pred HHHHHHhhhhCCCC--CCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAK--RASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~--Rps~~~~~ 294 (708)
.+||++||..++.+ |+++++++
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~ 264 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFK 264 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHh
Confidence 99999999765554 68888877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=412.49 Aligned_cols=249 Identities=32% Similarity=0.520 Sum_probs=222.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.++|.|++.||+|+||.|.+++++.|++.||+|+++|-.+- ..+..-|..|-.||..-+.+.||+|+..|++++++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 45899999999999999999999999999999999875432 23334577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--c
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--L 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~--~ 201 (708)
|||++||||...+.+.++++|+.|++|..+|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-.+..+.. .
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 99999999999999989999999999999999999999999999999999999999999999999998866653332 3
Q ss_pred cccccCCcccccccccCC----ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCCCC--CCCCHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGK----KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KYRIP--FYMSTDCE 273 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~----~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~~~p--~~~s~~~~ 273 (708)
...+|||-|++||+++.. ...|+.+||||+||++|||+.|..||...+.-+.+.+|..- .+.+| ..+|++++
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeak 313 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAK 313 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHH
Confidence 457899999999999632 23478999999999999999999999999999999999877 56677 56899999
Q ss_pred HHHHHhhhhCCCCCCC---HHHHh
Q psy2648 274 NLLKKFLVLNPAKRAS---LEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps---~~~~~ 294 (708)
+||.++|. +|+.|.+ ++++.
T Consensus 314 dLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 314 DLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHHHHHhc-ChhhhcccccHHHHH
Confidence 99999988 7888888 88877
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=355.62 Aligned_cols=248 Identities=31% Similarity=0.524 Sum_probs=216.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh---hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP---GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
++|++.+.||+|+||.||+|.+..+++.||||.+....... ...+.+.+|+++++.++||||++++++++.+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987654322 234567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-- 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-- 200 (708)
||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred --ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Q psy2648 201 --LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KYRIPFYMSTDCENLL 276 (708)
Q Consensus 201 --~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~~~p~~~s~~~~~Li 276 (708)
....+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+... ...+|...+.++.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 134578899999999988776 48999999999999999999999887665555454443 3446777899999999
Q ss_pred HHhhhhCCCCCCCHHHHh
Q psy2648 277 KKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~ 294 (708)
.+||..||.+||++.++.
T Consensus 241 ~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 241 RRTFVENAKKRPSAEELL 258 (263)
T ss_pred HHHhhcCcccCCCHHHHh
Confidence 999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=385.28 Aligned_cols=257 Identities=33% Similarity=0.574 Sum_probs=238.2
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
-....+.+.+++.+||-|+||.|-+++.......+|+|+++|... +.++.+.++.|-+||...+.|+||+||..|.+++
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 344557789999999999999999999876666799999998765 4556678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
++|+.||-|-||+|...++.++.|++..+++|...+++|++|||++|||+|||||||+|||.+|.+||.|||+++.+..+
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KYRIPFYMSTDCENLL 276 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~~~p~~~s~~~~~Li 276 (708)
.++.++||||.|.|||++..+..+ .++|.||||+++|||++|.+||.+.++...++.|++| .+.+|..++..+.+||
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 999999999999999999988876 7999999999999999999999999999999999998 4678999999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHh---hhh
Q psy2648 277 KKFLVLNPAKRAS-----LEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps-----~~~~~---~~~ 297 (708)
+++...+|.+|.. +.+|. |+.
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 9999999999987 45665 764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=363.86 Aligned_cols=239 Identities=17% Similarity=0.256 Sum_probs=208.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEEEEEec
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQVIET----EKTLYLVMEY 126 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ylVmEy 126 (708)
..||+|+++.||+|.+ +|+.||||++.+..... ...+.+.+|+++|++++|||||++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999987 78999999998654432 234667899999999999999999999876 3578999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~ 205 (708)
+++|+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++..... .....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNV 181 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--ccccc
Confidence 9999999999888889999999999999999999998 49999999999999999999999999998765332 23457
Q ss_pred cCCcccccccccC--CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHhhh
Q psy2648 206 GSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 206 Gt~~Y~APE~l~~--~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~~~s~~~~~Li~~~L~ 281 (708)
|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..++...+..+. +.+|...++++.+||.+||+
T Consensus 182 ~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred CcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 8999999999976 455 479999999999999999999999999888888886553 44555688999999999999
Q ss_pred hCCCCCCCHHHHhh
Q psy2648 282 LNPAKRASLEVSGE 295 (708)
Q Consensus 282 ~dP~~Rps~~~~~~ 295 (708)
.||++|||++++..
T Consensus 261 ~dp~~Rps~~ell~ 274 (283)
T PHA02988 261 HDSIKRPNIKEILY 274 (283)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999998874
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=380.51 Aligned_cols=246 Identities=31% Similarity=0.497 Sum_probs=218.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.|..++.||+|+||.||+|.+..|++.||||+++-... ..+.+.+.+|+.+|.++++|||.++|+.|.....+||+|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 58888999999999999999999999999999986653 34566788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~ 205 (708)
|.||++.+.+...+.+.|.++..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++.+..... ...++.
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv 172 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV 172 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence 9999999999877777999999999999999999999999999999999999999999999999998765433 337899
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhhhhCC
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP 284 (708)
|||.|||||++++..|+ .++||||||++.|||++|.+||....+..+...|-+..+ .+....|+.+++||..||.+||
T Consensus 173 GTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred ccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 99999999999988886 799999999999999999999988776544433433322 2334678899999999999999
Q ss_pred CCCCCHHHHh
Q psy2648 285 AKRASLEVSG 294 (708)
Q Consensus 285 ~~Rps~~~~~ 294 (708)
+.||++.+++
T Consensus 252 ~~RpsA~~LL 261 (467)
T KOG0201|consen 252 EFRPSAKELL 261 (467)
T ss_pred ccCcCHHHHh
Confidence 9999998776
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=362.32 Aligned_cols=246 Identities=38% Similarity=0.707 Sum_probs=223.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+|++.+.||+|+||.||++.+..+++.||||++.+... .....+.+.+|+++|+.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 369999999999999999999999999999999976543 2344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||+|.|||++.++.+||+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL 158 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence 99999999999998889999999999999999999999999999999999999999999999999998765433 3456
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..++.+.+..+...+|...+.++.++|++||..||
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 159 CGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence 89999999999987765 47899999999999999999999988888888888888888898899999999999999999
Q ss_pred CCCC-----CHHHHh
Q psy2648 285 AKRA-----SLEVSG 294 (708)
Q Consensus 285 ~~Rp-----s~~~~~ 294 (708)
.+|+ +++++.
T Consensus 238 ~~R~~~~~~~~~~l~ 252 (290)
T cd05580 238 TKRLGNLKNGVNDIK 252 (290)
T ss_pred HHccCcccCCHHHHH
Confidence 9999 777766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=362.37 Aligned_cols=238 Identities=28% Similarity=0.466 Sum_probs=203.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCh
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L 132 (708)
||+|+||.||++++..+|+.||+|++.+..... .....+..|+++|++++||||+++++++++...+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999997644322 2233456799999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCcc
Q psy2648 133 FDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPY 210 (708)
Q Consensus 133 ~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y 210 (708)
.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............|++.|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 98886554 4888999999999999999999999999999999999999999999999998766544444456799999
Q ss_pred cccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCC-CCCCHHHHHHHHHhhhhCCC
Q psy2648 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST----LRELRERVLRGKYRIP-FYMSTDCENLLKKFLVLNPA 285 (708)
Q Consensus 211 ~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~----~~~l~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~ 285 (708)
+|||++.+..++ .++|||||||++|+|++|..||.+.. ..++...+.......+ ...++++.+||++||++||.
T Consensus 161 ~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 999999888764 78999999999999999999997643 3345555555544433 35789999999999999999
Q ss_pred CCCCHHH
Q psy2648 286 KRASLEV 292 (708)
Q Consensus 286 ~Rps~~~ 292 (708)
+||++.+
T Consensus 240 ~R~~~~~ 246 (277)
T cd05607 240 DRLGSRE 246 (277)
T ss_pred hCCCCcc
Confidence 9999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=356.86 Aligned_cols=248 Identities=34% Similarity=0.622 Sum_probs=226.1
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKT 119 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 119 (708)
..-+.+|.++++||+|+|++|.+++++.|.+.||+|+++|...+ .++..-+..|-.+..+. +||++|-|+.+|+++..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 44567899999999999999999999999999999999988665 34555667787777665 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~~ 198 (708)
+++|.||++||+|..+++++.+++|+.|+.|..+|+.||.|||++|||+||||.+|+|||..|+|||+|+|+++.- .++
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999874 567
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-------C-CHHHHHHHHHcCCCCCCCCCCH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-------S-TLRELRERVLRGKYRIPFYMST 270 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-------~-~~~~l~~~i~~~~~~~p~~~s~ 270 (708)
..+.++||||.|+|||++.|..| +..+|||+|||++|||+.|+.||+- . +..-+.+-|+...+++|..+|.
T Consensus 406 d~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv 484 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV 484 (593)
T ss_pred cccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence 78889999999999999999998 6899999999999999999999962 2 2344778889999999999999
Q ss_pred HHHHHHHHhhhhCCCCCCCH
Q psy2648 271 DCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~ 290 (708)
.+..+++..|.+||.+|...
T Consensus 485 kas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCC
Confidence 99999999999999999764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=359.56 Aligned_cols=246 Identities=40% Similarity=0.711 Sum_probs=211.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
|++++.||+|+||.||+|++..+++.||+|++..............+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999877544444445567999999999999999999999999999999999
Q ss_pred CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CCCCCcccccc
Q psy2648 128 SGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCG 206 (708)
Q Consensus 128 ~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~~~~~~~~~G 206 (708)
.+++|.+++...+.+++.++..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++... .........++
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999998889999999999999999999999999999999999999999999999999998753 23344566789
Q ss_pred CCccccccccc-CCccCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Q psy2648 207 SPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGST---LRELRERVLRGKYRIPF----YMSTDCENLLKK 278 (708)
Q Consensus 207 t~~Y~APE~l~-~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~---~~~l~~~i~~~~~~~p~----~~s~~~~~Li~~ 278 (708)
++.|+|||++. +..+ +.++||||||+++|+|++|..||...+ ......+........+. ..++++.+||.+
T Consensus 161 ~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred cccccccccccccccc-cccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 99999999998 5554 589999999999999999999999873 33333333332222111 224899999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||++||+++++.
T Consensus 240 ~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELL 255 (260)
T ss_dssp HSSSSGGGSTTHHHHH
T ss_pred HccCChhHCcCHHHHh
Confidence 9999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=362.90 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=210.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|++.+.||+|+||.||+|.+..+++.||||.+.+..... .....+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4889999999999999999999999999999987654332 233457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 126 YASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|+++++|.+++...+ .+++.++..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 999999999886543 589999999999999999999999999999999999999999999999999876554444455
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH-HcCCCCCCCCCCHHHHHHHHHh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR---ELRERV-LRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~---~l~~~i-~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.+|++.|+|||++.+..++ .++|||||||++|+|++|..||...... +....+ ......++...++++.+||.+|
T Consensus 161 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 6899999999999888775 7899999999999999999999865321 112222 2222345667889999999999
Q ss_pred hhhCCCCCCC-----HHHHh
Q psy2648 280 LVLNPAKRAS-----LEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps-----~~~~~ 294 (708)
|+.||.+||| +++++
T Consensus 240 l~~~p~~R~s~~~~~~~~~~ 259 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVK 259 (285)
T ss_pred hhcCHHHccCCCCCchHHHH
Confidence 9999999999 66666
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=361.22 Aligned_cols=243 Identities=26% Similarity=0.452 Sum_probs=211.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|++.+.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+++|+.++|+||+.+++.+..++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4888999999999999999999999999999997654432 233456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 126 YASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99999999888654 3699999999999999999999999999999999999999999999999999876544444455
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE----LRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~----l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
..|++.|+|||++.+..++ .++|||||||++|+|++|..||.+..... +..++......++...++++.+||.+|
T Consensus 161 ~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 6899999999999887775 78999999999999999999998766543 344445555556667889999999999
Q ss_pred hhhCCCCCCCH
Q psy2648 280 LVLNPAKRASL 290 (708)
Q Consensus 280 L~~dP~~Rps~ 290 (708)
|+.||++||+.
T Consensus 240 l~~~P~~R~~~ 250 (285)
T cd05632 240 LTKDPKQRLGC 250 (285)
T ss_pred ccCCHhHcCCC
Confidence 99999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=353.01 Aligned_cols=246 Identities=30% Similarity=0.581 Sum_probs=218.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||++++..+++.||+|.++.... ....+.+.+|+.+++.++||||+++++.+++++.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 58999999999999999999999999999999875432 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 127 ASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 9999999988653 358999999999999999999999999999999999999999999999999987654322 2334
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~ 282 (708)
..|++.|+|||++.+..+ ++++|+||||+++|+|++|..||...+.......+..+.+. +|...+.++.+||.+||+.
T Consensus 160 ~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 160 YVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred ccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence 678999999999988776 47899999999999999999999998888888888777654 5677889999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||++||+++++.
T Consensus 239 ~P~~Rp~~~~il 250 (255)
T cd08219 239 NPRSRPSATTIL 250 (255)
T ss_pred CcccCCCHHHHh
Confidence 999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=356.92 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=213.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
..+|++.+.||+|+||.||+|.+. ..+..||+|+++... .......+.+|+.+|++++||||+++++++...+.+|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 347999999999999999999875 456789999987543 2334456889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
|||||+++|+|.+++... +.+++.+++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999999999999875 5789999999999999999999999999999999999999999999999998765322211
Q ss_pred c--cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q psy2648 201 L--DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLL 276 (708)
Q Consensus 201 ~--~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li 276 (708)
. ....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+.+..+. .+.|...+..+.+++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLM 241 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 1 123456789999999887774 79999999999999775 999999988888888887663 345667889999999
Q ss_pred HHhhhhCCCCCCCHHHHhh
Q psy2648 277 KKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~~ 295 (708)
.+||..||.+||+++++..
T Consensus 242 ~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHcCCCchhCCCHHHHHH
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.80 Aligned_cols=247 Identities=30% Similarity=0.516 Sum_probs=221.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.|.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+++++.++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 48899999999999999999999999999999987665666677888999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 127 ASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999775 568999999999999999999999999999999999999999999999999987654432 2345
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~ 282 (708)
.+|++.|+|||++.+..++ .++|||||||++|+|++|+.||...+..++..++..+.+. ++...+.++.++|.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred cccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence 6789999999999887764 7899999999999999999999998888888888777653 4556789999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||++||++.++.
T Consensus 240 ~p~~Rp~~~~ll 251 (256)
T cd08529 240 DYRQRPDTFQLL 251 (256)
T ss_pred CcccCcCHHHHh
Confidence 999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=363.06 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=206.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcC----------------CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCee
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVP----------------TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 108 (708)
-++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+++|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999998643 34579999987543 334456788999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCChHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy2648 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------------------RMKEKEARAKFRQIVSAVQYCHQKKIIHR 169 (708)
Q Consensus 109 ~l~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~-------------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHR 169 (708)
++++++.+.+.+|+||||+++|+|.+++.... .+++.++..++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999986532 35677889999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc--CCCC
Q psy2648 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS--GSLP 244 (708)
Q Consensus 170 DLKPeNILld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt--G~~P 244 (708)
||||+|||++.++.+||+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999976543321 2234567889999999877764 79999999999999986 6789
Q ss_pred CCCCCHHHHHHHHHc----C----CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 245 FDGSTLRELRERVLR----G----KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 245 f~~~~~~~l~~~i~~----~----~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
|.+.+..++...+.. . ....|...+.++.+||.+||..||.+|||++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 988776665544421 1 1123456788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=359.28 Aligned_cols=248 Identities=26% Similarity=0.437 Sum_probs=216.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTG-----KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
+.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+++|+.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 457999999999999999999986655 789999986443 33445668899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy2648 120 LYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN 183 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~ 183 (708)
.|++|||+++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||+++++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999999999999765 45788899999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q psy2648 184 IKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR 259 (708)
Q Consensus 184 iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~ 259 (708)
+||+|||++....... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987543322 12345678899999999877764 79999999999999998 9999999999999888877
Q ss_pred CCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 GKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 ~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.. ..|...++++.+|+.+||+.||.+||+++++.
T Consensus 242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~ 277 (283)
T cd05048 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIH 277 (283)
T ss_pred CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 654 45677899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=349.79 Aligned_cols=247 Identities=31% Similarity=0.552 Sum_probs=217.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-EKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ylVmE 125 (708)
+|++++.||+|+||.||++.+..+++.||||.+..........+.+.+|+++++.++||||+++++.+.. ...+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999999999999997665555556678899999999999999999998864 446899999
Q ss_pred ccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcc
Q psy2648 126 YASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLD 202 (708)
Q Consensus 126 y~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~ 202 (708)
|+++++|.+++... ..+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999998763 4589999999999999999999999999999999999999999999999999876532 22334
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~ 281 (708)
...|++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.. ..|...++++.++|.+||+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239 (257)
T ss_pred cccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence 56789999999999887764 789999999999999999999998888777777777655 4566788999999999999
Q ss_pred hCCCCCCCHHHHh
Q psy2648 282 LNPAKRASLEVSG 294 (708)
Q Consensus 282 ~dP~~Rps~~~~~ 294 (708)
.||.+||++.++.
T Consensus 240 ~~p~~Rp~~~~~l 252 (257)
T cd08223 240 KRPEKRPSVKSIL 252 (257)
T ss_pred cCcccCCCHHHHh
Confidence 9999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=377.55 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=207.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTG-----KEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 116 (708)
...++|++.+.||+|+||.||+|.+..++ +.||||++..... ....+.+.+|+++|+.+ +|||||++++++..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 33457999999999999999999875544 5799999976532 33456788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHc---------------------------------------------------------
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH--------------------------------------------------------- 139 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~--------------------------------------------------------- 139 (708)
...+|+|||||++|+|.+++..+
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999998643
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc---cc
Q psy2648 140 -------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL---DT 203 (708)
Q Consensus 140 -------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~---~~ 203 (708)
.++++.+++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++........ .+
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 13678889999999999999999999999999999999999999999999998765433211 12
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG--KYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~--~~~~p~~~s~~~~~Li~~~L 280 (708)
..+++.|+|||++.+..++ .++|||||||++|+|++ |..||...........+... ....|...++++.++|.+||
T Consensus 274 ~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 2345679999999877774 79999999999999997 99999876554433333333 23456677899999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
+.||.+||+++++.
T Consensus 353 ~~dp~~RPs~~~l~ 366 (374)
T cd05106 353 NLEPTERPTFSQIS 366 (374)
T ss_pred CCChhhCcCHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.98 Aligned_cols=252 Identities=31% Similarity=0.500 Sum_probs=211.1
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 467899999999999999999999999999999998754322 2234577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCc
Q psy2648 124 MEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~ 201 (708)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 99997 5899888764 46899999999999999999999999999999999999999999999999998754322 223
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------CC
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------------KY 262 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------------~~ 262 (708)
....+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 34567899999999876554457899999999999999999999988766554443221 01
Q ss_pred CCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 263 RIP-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 263 ~~p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..| ..+++++.+||.+||+.||.+|||+++++ |+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 112 13678899999999999999999999987 664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=347.86 Aligned_cols=247 Identities=32% Similarity=0.548 Sum_probs=222.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++++.||+|+||.|+++++..+++.||+|.+.....+....+.+.+|+++|++++||||+++++++.+...++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 59999999999999999999999999999999987666666667788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 127 ASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
+++++|.+++... ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999765 468999999999999999999999999999999999999999999999999987654322 3345
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~ 282 (708)
..|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+..+.+. .+...+.++.++|.+||..
T Consensus 161 ~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred cCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 6789999999999877654 7899999999999999999999998888888888877654 3455789999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||.+||++++++
T Consensus 240 ~p~~R~s~~~ll 251 (256)
T cd08221 240 DPEKRPTADEVL 251 (256)
T ss_pred CcccCCCHHHHh
Confidence 999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.31 Aligned_cols=240 Identities=28% Similarity=0.467 Sum_probs=208.8
Q ss_pred EEcccCceEEEEEEE--cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Q psy2648 53 TIGKGNFAKVKLAKH--VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 53 ~LG~G~fg~V~la~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg 130 (708)
+||+|+||.||+|.+ ..+++.||||+++....+....+.+.+|+.+++.++||||++++++++. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999965 4678899999997665555556778899999999999999999998864 5679999999999
Q ss_pred ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC----cccccc
Q psy2648 131 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK----LDTFCG 206 (708)
Q Consensus 131 ~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~----~~~~~G 206 (708)
+|.+++.....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++....... .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 9999998888899999999999999999999999999999999999999999999999999876543221 122344
Q ss_pred CCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 207 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 207 t~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
++.|+|||++....++ .++|||||||++|+|++ |..||.+.+..++.+.+..+. ...|...++++.+||.+||+.||
T Consensus 161 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 161 PVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred CccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence 6789999998776654 78999999999999998 999999988888888888764 35677889999999999999999
Q ss_pred CCCCCHHHHh
Q psy2648 285 AKRASLEVSG 294 (708)
Q Consensus 285 ~~Rps~~~~~ 294 (708)
++||+++++.
T Consensus 240 ~~Rp~~~~i~ 249 (257)
T cd05116 240 DERPGFAVVE 249 (257)
T ss_pred hhCcCHHHHH
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=370.84 Aligned_cols=250 Identities=24% Similarity=0.440 Sum_probs=207.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------C
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------K 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 118 (708)
.++|++++.||+|+||.||+|.+..+++.||||++.+........+.+.+|+++|+.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 4689999999999999999999999999999999976543334456678999999999999999999988643 4
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|++||++ +++|.+++. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 170 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170 (343)
T ss_pred cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-
Confidence 579999998 678887664 56799999999999999999999999999999999999999999999999999976532
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK----------------- 261 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~----------------- 261 (708)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 171 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 33456899999999999874434579999999999999999999998876554443332110
Q ss_pred ------CCCC--------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 262 ------YRIP--------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 262 ------~~~p--------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
...| ...++.+.+||.+||..||.+|||+++++ |+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0011 12456789999999999999999999988 6653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=385.19 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=200.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC------CCCeeeEEEEEEeC-
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD------HPNIVKLFQVIETE- 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~- 117 (708)
.++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+++++.++ |++|+++++++..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 468999999999999999999999999999999996432 22234556777777665 45689999998765
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCC--------------
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEM-------------- 182 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~-------------- 182 (708)
.++|||||++ |++|.+++...+.+++.+++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 5789999998 67999999888899999999999999999999998 5999999999999998765
Q ss_pred --cEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q psy2648 183 --NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG 260 (708)
Q Consensus 183 --~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~ 260 (708)
.+||+|||++.... ......+||+.|+|||++.+..|+ .++|||||||+||||++|++||.+.+..+....+...
T Consensus 284 ~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 284 PCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 49999999875432 233567899999999999998875 7999999999999999999999987765544333221
Q ss_pred CCCCC------------------------C------------------CCCHHHHHHHHHhhhhCCCCCCCHHHHh---h
Q psy2648 261 KYRIP------------------------F------------------YMSTDCENLLKKFLVLNPAKRASLEVSG---E 295 (708)
Q Consensus 261 ~~~~p------------------------~------------------~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~ 295 (708)
.-.+| . ..++.+.|||.+||++||.+|||+++++ |
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 00000 0 1135577999999999999999999988 7
Q ss_pred hhh
Q psy2648 296 VTL 298 (708)
Q Consensus 296 ~~~ 298 (708)
+..
T Consensus 441 ~~~ 443 (467)
T PTZ00284 441 VLK 443 (467)
T ss_pred ccc
Confidence 753
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=359.40 Aligned_cols=249 Identities=28% Similarity=0.485 Sum_probs=212.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||++.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++.+++.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36999999999999999999999999999999987542 33445668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
|+++++|.+++...+.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..... ......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~ 158 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSF 158 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc-cccccC
Confidence 99999999999888899999999999999999999997 6999999999999999999999999999875532 223557
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC------------------------
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------------------ 260 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------------------ 260 (708)
+|++.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+...
T Consensus 159 ~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 899999999999887764 7899999999999999999999766544433322111
Q ss_pred -------------CCCCCC-CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 261 -------------KYRIPF-YMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 261 -------------~~~~p~-~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
....|. ..+.++.+||.+||..||++||+++++. |+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 111121 2577899999999999999999999987 664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.81 Aligned_cols=247 Identities=31% Similarity=0.498 Sum_probs=204.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999999876544333445678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccc
Q psy2648 127 ASGGEVFDYLVLH---GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLD 202 (708)
Q Consensus 127 ~~gg~L~~~i~~~---~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~ 202 (708)
++ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 98 5898888643 468999999999999999999999999999999999999999999999999987543222 223
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C-------------------
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K------------------- 261 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~------------------- 261 (708)
...+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 3467889999999876543357899999999999999999999876543322221110 0
Q ss_pred --C------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 --Y------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 --~------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
. .....+++++.+||++||+.||.+|||+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 0 01224688999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=373.71 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=207.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 118 (708)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.... ....+.+.+|+++|+.+ +|||||++++++....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34799999999999999999974 35677899999975432 23456788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcC----------------------------------------------------------
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG---------------------------------------------------------- 140 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~---------------------------------------------------------- 140 (708)
..|+|||||++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986532
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc--
Q psy2648 141 -----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-- 201 (708)
Q Consensus 141 -----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~-- 201 (708)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 3678889999999999999999999999999999999999999999999999765432211
Q ss_pred -cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy2648 202 -DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLR-ELRERVLRGK-YRIPFYMSTDCENLLK 277 (708)
Q Consensus 202 -~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~-~l~~~i~~~~-~~~p~~~s~~~~~Li~ 277 (708)
....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.... .+.+.+..+. ...|...+.++.+||.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 351 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK 351 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence 123355679999999888775 79999999999999998 99999876543 4444444442 2345667889999999
Q ss_pred HhhhhCCCCCCCHHHHhh
Q psy2648 278 KFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~~ 295 (708)
+||..||++||++.++..
T Consensus 352 ~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHccCChhHCcCHHHHHH
Confidence 999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.40 Aligned_cols=250 Identities=29% Similarity=0.429 Sum_probs=210.8
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcE--EEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKT 119 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 119 (708)
..+++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||++++++++..+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 3467899999999999999999999888865 466665432 2334456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN 183 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~ 183 (708)
+|+||||+++++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999997543 4788999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-
Q psy2648 184 IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK- 261 (708)
Q Consensus 184 iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~- 261 (708)
+||+|||+++............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++.+.+..+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence 99999999864322111122234567999999987765 479999999999999998 999999888888877776552
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 ~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...|...++++.+||.+||..||++||+++++.
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 274 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 345666789999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=352.89 Aligned_cols=247 Identities=32% Similarity=0.557 Sum_probs=219.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.... ....+.+.+|++++++++||||+++++.++....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 599999999999999999999999999999999875443 2456778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC 205 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~ 205 (708)
|+.+++|.+++.....+++.++..++.||+.||.|||+++|+|+||||+||++++++.++|+|||++.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99999999999888889999999999999999999999999999999999999999999999999987665444445667
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhh
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST---LRELRERVLRGKYRIPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~---~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 282 (708)
|+..|+|||++.+..+ +.++|+||||+++|+|++|..||...+ ...+.+.........|...+.++.++|++||..
T Consensus 161 ~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 161 GTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred CChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence 8999999999987775 479999999999999999999999876 455555554455667778899999999999999
Q ss_pred CCCCCCCH--HHHh
Q psy2648 283 NPAKRASL--EVSG 294 (708)
Q Consensus 283 dP~~Rps~--~~~~ 294 (708)
||.+||++ ++++
T Consensus 240 ~p~~R~~~~~~~l~ 253 (258)
T cd05578 240 DPQKRLGDNLKDLK 253 (258)
T ss_pred ChhHcCCccHHHHh
Confidence 99999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.70 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=208.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 479999999999999999999999999999999975432 233457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
|+++++|.+++...+.+++.++..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++...... ......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998765432 223446
Q ss_pred ccCCcccccccccC---CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-----CCCCHHHHHHH
Q psy2648 205 CGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP-----FYMSTDCENLL 276 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p-----~~~s~~~~~Li 276 (708)
.|++.|+|||.+.+ ..+ +.++|||||||++|+|++|..||...+..+....+....+..| ...+.++.+||
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245 (267)
T ss_pred ccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHH
Confidence 78999999999853 223 3689999999999999999999976554433333323332222 24578999999
Q ss_pred HHhhhhCCCCCCCHHHHhh
Q psy2648 277 KKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~~ 295 (708)
++||..||++||+++++..
T Consensus 246 ~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 246 KISLTKNPKKRPTAERLLT 264 (267)
T ss_pred HHHhhCChhhCcCHHHHhc
Confidence 9999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=348.71 Aligned_cols=249 Identities=26% Similarity=0.512 Sum_probs=213.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+++|++.+.||+|+||.||+|++..+++.||||.+..... .......+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 4689999999999999999999999999999999875432 344456688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 124 MEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988753 2458999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCC-CC-CCCCHHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS--TLRELRERVLRGKYR-IP-FYMSTDCEN 274 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~--~~~~l~~~i~~~~~~-~p-~~~s~~~~~ 274 (708)
......|++.|+|||.+.+..++ .++|||||||++|+|++|..||... +..++.+.+....++ .| ...+.++.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 23346789999999999887764 7899999999999999999999764 345566666554332 22 356788999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|.+||..||++||+++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl 259 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVH 259 (267)
T ss_pred HHHHHCCCCcccCcCHHHHH
Confidence 99999999999999999887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=352.13 Aligned_cols=249 Identities=31% Similarity=0.511 Sum_probs=208.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||++++++++....+|+|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999999999999999987554333334557899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~ 204 (708)
|++++.|..++.....+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99998888877766789999999999999999999999999999999999999999999999999997664433 23345
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------------CC----CCC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG---------------KY----RIP 265 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~---------------~~----~~p 265 (708)
.++..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... .+ ..|
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 68889999999877543457899999999999999999999876654433322210 00 011
Q ss_pred ------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 ------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 ------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.+||.+||..||++||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 13577899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=353.56 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=215.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVP-----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.++|.+.+.||+|+||.||+|.+.. +++.||||++..... .+..+.+.+|+++|+.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 4579999999999999999998753 468899999875432 3345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEE
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG--------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIK 185 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~--------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iK 185 (708)
.|+||||+++++|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 999999999999999997653 378889999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q psy2648 186 IADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK 261 (708)
Q Consensus 186 L~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~ 261 (708)
|+|||++....... ......+++.|+|||++.+..++ +++|||||||++|+|++ |..||.+.+..++...+..+.
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987543221 11233467889999999888775 78999999999999998 999999988888888888776
Q ss_pred CC-CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 262 YR-IPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 262 ~~-~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
.. .|...+.++.+||.+||..||++||+++++..
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54 35578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=374.22 Aligned_cols=234 Identities=26% Similarity=0.446 Sum_probs=209.0
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 49 ~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
.-++.||.|+-|.||+|+. .++.||||.++.. -..+|+.|++|+|||||.+.++|....-++||||||.
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 3467899999999999986 5789999987521 2357888999999999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCC
Q psy2648 129 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP 208 (708)
Q Consensus 129 gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~ 208 (708)
.|.|+..|+....+.......|..+|+.|++|||.+.|||||||.-||||..+..|||+|||-++.....+..-.+|||.
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence 99999999998899999999999999999999999999999999999999999999999999999887666667899999
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHhhhhCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KYRIPFYMSTDCENLLKKFLVLNPAK 286 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~ 286 (708)
.|||||++...+.. .|+|||||||+|||||||..||.+-+...++.-|-.. ..++|..++..++-||++||.-.|..
T Consensus 276 aWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred hhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 99999999998875 8999999999999999999999987766555444333 34578888999999999999999999
Q ss_pred CCCHHHHh
Q psy2648 287 RASLEVSG 294 (708)
Q Consensus 287 Rps~~~~~ 294 (708)
||++.+|+
T Consensus 355 RPSFrqil 362 (904)
T KOG4721|consen 355 RPSFRQIL 362 (904)
T ss_pred CccHHHHH
Confidence 99998876
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=355.35 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=210.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCc--EEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGK--EVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~yl 122 (708)
++|++.+.||+|+||+||+|....++. .+|+|.++.. ......+.+.+|+++++++ +||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 579999999999999999999887775 4788887632 2334456788999999999 79999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEE
Q psy2648 123 VMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL 186 (708)
||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999997542 4788999999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCC
Q psy2648 187 ADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRI 264 (708)
Q Consensus 187 ~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~ 264 (708)
+|||++..............+..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+++..+. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999998643221111122334579999999887764 78999999999999997 999999999888888887663 345
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
|..++.++.+||.+||..||.+||+++++.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 269 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQIS 269 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 667889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.90 Aligned_cols=252 Identities=33% Similarity=0.569 Sum_probs=220.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+|++.+.||+|+||.||+|.+..+++.||||.+.+..... ...+.+..|+++++.++||||+++++.++....+|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36999999999999999999999999999999998765442 34567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---
Q psy2648 125 EYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--- 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--- 199 (708)
||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 568999999999999999999999999999999999999999999999999986542211
Q ss_pred ---------------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy2648 200 ---------------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE 252 (708)
Q Consensus 200 ---------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~ 252 (708)
......|+..|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1123468899999999988776 478999999999999999999999888877
Q ss_pred HHHHHHcCCCCCCCC--CCHHHHHHHHHhhhhCCCCCCC----HHHHh---hhhh
Q psy2648 253 LRERVLRGKYRIPFY--MSTDCENLLKKFLVLNPAKRAS----LEVSG---EVTL 298 (708)
Q Consensus 253 l~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~Rps----~~~~~---~~~~ 298 (708)
....+......+|.. .+.++.++|.+||..||++||+ +++++ |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777777666666554 6899999999999999999999 88877 7754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=344.05 Aligned_cols=247 Identities=35% Similarity=0.592 Sum_probs=220.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|.+..+++.||||.+..........+.+.+|+++|+.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 59999999999999999999999999999999987766656667888999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCccccCCCCCccc
Q psy2648 127 ASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~~~~~~~~ 203 (708)
+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9999999999764 3489999999999999999999999999999999999998654 579999999987654444455
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~ 282 (708)
..|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+..+.. .+|...++++.++|.+||..
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 161 VVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred cccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence 678999999999987765 4789999999999999999999999888777777766543 46667899999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||.+|||++++.
T Consensus 240 ~p~~Rpt~~~ll 251 (256)
T cd08220 240 DPSKRPQLSQIM 251 (256)
T ss_pred ChhhCCCHHHHh
Confidence 999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.29 Aligned_cols=247 Identities=30% Similarity=0.530 Sum_probs=204.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++.+...+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 59999999999999999999999999999999976543333345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 127 ASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 127 ~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
+.+ +|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 974 78888765 467999999999999999999999999999999999999999999999999998765432 222345
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcC----------------CC-----
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGSTLRELRERVLRG----------------KY----- 262 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf-~~~~~~~l~~~i~~~----------------~~----- 262 (708)
.+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+..+..+.+.+. .+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 67899999999877654457899999999999999998885 444544443333211 00
Q ss_pred --------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 --------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 --------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.....+++++.+||++||..||.+|||+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il 279 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence 00123678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=347.43 Aligned_cols=247 Identities=30% Similarity=0.491 Sum_probs=213.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-------hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-------GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
+|.+.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788999999999999999999999999999987654321 123457789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
.|+||||+++++|.+++...+.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654211
Q ss_pred -------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHH
Q psy2648 200 -------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-KYRIPFYMSTD 271 (708)
Q Consensus 200 -------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~ 271 (708)
......|++.|+|||.+.+..++ .++|||||||++|+|++|..||.+.+.......+... ...+|...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11245689999999999887764 7899999999999999999999887655544454443 33466778899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.++|++||+.||.+||+++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il 262 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELL 262 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHh
Confidence 99999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.44 Aligned_cols=247 Identities=34% Similarity=0.636 Sum_probs=220.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKTLYLVM 124 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ylVm 124 (708)
+|++++.||.|+||.||+|.+..+++.||+|++..........+.+..|+++++.++||||+++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999998766666666778899999999999999999998754 45789999
Q ss_pred eccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 125 EYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCH-----QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 125 Ey~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH-----~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
||+++++|.+++.. ...+++.+++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999876 357899999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCC-ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHH
Q psy2648 196 TPGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCE 273 (708)
Q Consensus 196 ~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~ 273 (708)
..... .....|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+..++.+.+..+.+ .+|...+.++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 54332 3456789999999999887764 789999999999999999999999888888888887765 35677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++.+||..||.+||+++++.
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred HHHHHHccCCcccCCCHHHHh
Confidence 999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=348.34 Aligned_cols=246 Identities=23% Similarity=0.410 Sum_probs=210.9
Q ss_pred eEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-----
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT----- 119 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 119 (708)
|++++.||+|+||.||+|.+.. ++..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999999765 34789999998665555556778999999999999999999998765443
Q ss_pred -EEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 120 -LYLVMEYASGGEVFDYLVLH------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 120 -~ylVmEy~~gg~L~~~i~~~------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
.++||||+++|+|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999988543 35899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy2648 193 NEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFY 267 (708)
Q Consensus 193 ~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~ 267 (708)
+....... .....++..|+|||.+.+..++ .++|||||||++|||++ |..||.+.+..++.+.+..+. ...|..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence 76543221 1123456789999999877664 79999999999999999 999999988888888877664 346778
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.++.++|.+||+.||++||++.++.
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~ 266 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLR 266 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.59 Aligned_cols=249 Identities=23% Similarity=0.432 Sum_probs=213.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEc----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHV----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.+..|++.+.||+|+||.||+|... .+++.||+|.+.... .......+.+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 3567999999999999999999863 456789999987533 23445678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG-----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 182 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~-----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~ 182 (708)
.|+||||+++++|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999999999999986432 378889999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q psy2648 183 NIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258 (708)
Q Consensus 183 ~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~ 258 (708)
.+||+|||+++...... ......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999997653322 22344567789999999877764 79999999999999998 999999888888888777
Q ss_pred cCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 RGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 ~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.... ..|...++++.++|.+||+.||.+||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 277 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 6543 45667889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.50 Aligned_cols=246 Identities=28% Similarity=0.456 Sum_probs=208.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999999999987543 2234457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
|+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999998655322 223456
Q ss_pred ccCCccccccccc---CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-----CCCCHHHHHHH
Q psy2648 205 CGSPPYAAPELFQ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP-----FYMSTDCENLL 276 (708)
Q Consensus 205 ~Gt~~Y~APE~l~---~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p-----~~~s~~~~~Li 276 (708)
.|++.|+|||++. ...+ ..++|||||||++|+|++|..||...........+....+..| ...+.++.++|
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred cCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 7999999999974 3334 4789999999999999999999976554433333333333222 13567899999
Q ss_pred HHhhhhCCCCCCCHHHHh
Q psy2648 277 KKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~ 294 (708)
.+||..||++||+++++.
T Consensus 246 ~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 246 KMALTKNPKKRPTAEKLL 263 (267)
T ss_pred HHHccCCchhCcCHHHHh
Confidence 999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.24 Aligned_cols=245 Identities=34% Similarity=0.587 Sum_probs=214.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+|++.+.||+|+||.||++.+..+++.||||.+.+.... ......+.+|+++++.++||||+++++.++.+..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3699999999999999999999999999999999765432 234557789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC------
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG------ 198 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~------ 198 (708)
||++|++|.+++...+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998632110
Q ss_pred ----------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--
Q psy2648 199 ----------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF-- 266 (708)
Q Consensus 199 ----------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~-- 266 (708)
.......|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..++.+.+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 01123568889999999987766 47899999999999999999999998888888888877655443
Q ss_pred -CCCHHHHHHHHHhhhhCCCCCCCHH
Q psy2648 267 -YMSTDCENLLKKFLVLNPAKRASLE 291 (708)
Q Consensus 267 -~~s~~~~~Li~~~L~~dP~~Rps~~ 291 (708)
..+.++.++|++||..||++||+..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCcc
Confidence 5688999999999999999999853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=345.01 Aligned_cols=243 Identities=31% Similarity=0.524 Sum_probs=207.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGE 131 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~ 131 (708)
+.||+|+||.||+|.+..+++.||+|.+.... ..+....+.+|+++++.++||||+++++++.....+|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999999999999999886432 33445678899999999999999999999999999999999999999
Q ss_pred hHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc---ccccC
Q psy2648 132 VFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGS 207 (708)
Q Consensus 132 L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~---~~~Gt 207 (708)
|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....+.... ...++
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 999997654 58999999999999999999999999999999999999999999999999987543221111 11224
Q ss_pred CcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCC
Q psy2648 208 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFLVLNPA 285 (708)
Q Consensus 208 ~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~ 285 (708)
..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+..+ ....|...+..+.+|+.+||+.||+
T Consensus 160 ~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 160 VKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred eeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 569999999887764 78999999999999997 99999888777776666554 3355667789999999999999999
Q ss_pred CCCCHHHHhhh
Q psy2648 286 KRASLEVSGEV 296 (708)
Q Consensus 286 ~Rps~~~~~~~ 296 (708)
+|||++++.+.
T Consensus 239 ~Rps~~~~~~~ 249 (252)
T cd05084 239 QRPSFSTVHQE 249 (252)
T ss_pred hCcCHHHHHHH
Confidence 99999988753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.52 Aligned_cols=247 Identities=31% Similarity=0.582 Sum_probs=219.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||++.+..+++.||||.+..........+.+.+|+++++.++||||++++++++..+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 59999999999999999999999999999999976555555566788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 127 ASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
+.+++|.+++.... .+++.++..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999987643 57899999999999999999999999999999999999999999999999987654322 1234
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~ 282 (708)
..|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+..+....+..+... .|...+.++.++|.+||+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 161 CIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred ccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence 5688999999999887764 7899999999999999999999988888888888777653 5677899999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||.+||++++++
T Consensus 240 ~p~~Rp~~~~vl 251 (256)
T cd08218 240 NPRDRPSVNSIL 251 (256)
T ss_pred ChhhCcCHHHHh
Confidence 999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=352.08 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=213.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+|.+.+.||+|+||+||++.+. .++..||+|.+... .....+.+.+|+.+|+.++||||+++++++.....+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46999999999999999999863 34567999988653 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEE
Q psy2648 121 YLVMEYASGGEVFDYLVLHG-------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIA 187 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~-------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~ 187 (708)
|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999997654 38999999999999999999999999999999999999999999999
Q ss_pred eccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-
Q psy2648 188 DFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY- 262 (708)
Q Consensus 188 DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~- 262 (708)
|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..++...+..+..
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875532211 1233457789999999877664 79999999999999998 9999999888888888888764
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 263 RIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 263 ~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
..+...+.++.+||.+||+.||.+|||++++..
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 456678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.50 Aligned_cols=246 Identities=29% Similarity=0.478 Sum_probs=213.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.....+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 579999999999999999999999999999999976532 245678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
|+++++|.+++... ..+++.++..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999998776 789999999999999999999999999999999999999999999999999987654322 3345
Q ss_pred cccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----CCCCCHHHHHH
Q psy2648 204 FCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI-----PFYMSTDCENL 275 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~-----p~~~s~~~~~L 275 (708)
..++..|+|||++.+. .++ .++|||||||++|+|++|..||.+.+..+....+....+.. +...+.++.++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred ccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence 6789999999999766 554 78999999999999999999998877665555554443322 23456789999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+|||++++.
T Consensus 240 i~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred HHHHcCCChhhCCCHHHHh
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.49 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=215.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
...|.+.+.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+++++.++||||+++++++..+..+|+||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 346999999999999999999999999999999987542 23456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc-
Q psy2648 125 EYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL- 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~- 201 (708)
||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999999997643 5889999999999999999999999999999999999999999999999998765433211
Q ss_pred -cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Q psy2648 202 -DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 202 -~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~ 278 (708)
....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+ ....|...+.++.++|.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred cCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 122345679999999888764 78999999999999998 99999998888888887765 345667788999999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||++||+++++.
T Consensus 241 cl~~~p~~Rp~~~~l~ 256 (263)
T cd05052 241 CWQWNPSDRPSFAEIH 256 (263)
T ss_pred HccCCcccCCCHHHHH
Confidence 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.51 Aligned_cols=244 Identities=27% Similarity=0.482 Sum_probs=211.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
..|++.+.||+|+||.||++.+.. +..||+|.+.+.... ...+.+|+.+|+.++||||+++++++.....+|+|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 469999999999999999998754 567999998754432 3467889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc--c
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL--D 202 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~--~ 202 (708)
|+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999998754 56899999999999999999999999999999999999999999999999998765332221 1
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L 280 (708)
...++..|+|||++.+..+. .++|||||||++|+|++ |+.||...+..++...+..+.. ..|...+.++.++|.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~ 238 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCW 238 (256)
T ss_pred CCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 22345679999999877764 79999999999999999 9999999988888888887643 346667889999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
..||++||+++++.
T Consensus 239 ~~~p~~Rps~~~l~ 252 (256)
T cd05114 239 HEKPEGRPTFAELL 252 (256)
T ss_pred cCCcccCcCHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.92 Aligned_cols=247 Identities=33% Similarity=0.610 Sum_probs=222.1
Q ss_pred CeEEE--eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 47 KYKLL--KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 47 ~Y~i~--~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
-|+|. ++||+|.||.||-|.|+.+|+.||||+|+|.++..+....+..|+.||+++.||.||.|-..|++.+.+++||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 47765 7999999999999999999999999999998887666677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CcEEEEeccCccccCCCC
Q psy2648 125 EYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~~iKL~DFGls~~~~~~~ 199 (708)
|-+. ||..++|.. .++++|...++++.||+.||.|||-++|+|+|||||||||... -++||||||+++.+...+
T Consensus 643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 9995 587787754 5899999999999999999999999999999999999999754 369999999999988777
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENL 275 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~L 275 (708)
.-.+..|||.|+|||+++.+.|. ..-|+||.|||+|.-+.|.+||... +++..+|....+-+|. .+++++.||
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred hhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHH
Confidence 77889999999999999999985 7889999999999999999999653 4567788888777664 478999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|..+|++.=.+|.|++..+ |++
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhh
Confidence 9999999999999999766 665
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.84 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=209.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCc--EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------CE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGK--EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------KT 119 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 119 (708)
|.+.+.||+|+||.||+|+...++. .||||.++.........+.+.+|+++|+.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999887775 699999876655556667888999999999999999999976432 25
Q ss_pred EEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 120 LYLVMEYASGGEVFDYLVLH------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 79999999999999987532 247899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q psy2648 194 EFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYM 268 (708)
Q Consensus 194 ~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~ 268 (708)
....... .....+++.|+|||++.+..+ ++++|||||||++|+|++ |..||.+....++...+..+.. ..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6543321 123346778999999988776 479999999999999999 8999998888888888877653 456677
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.++.++|.+||+.||++|||++++.
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~ 265 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLR 265 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 88999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=353.81 Aligned_cols=241 Identities=32% Similarity=0.495 Sum_probs=204.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--C---EEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--K---TLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~---~~y 121 (708)
.|.-.+.+|.|+||.||.|....+++.||||..-.+.. ---+|++||+.++|||||+|..+|... . ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 68999999999999999999999999999998754432 123799999999999999999888643 2 356
Q ss_pred EEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CcEEEEeccCccccC
Q psy2648 122 LVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFT 196 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-~~iKL~DFGls~~~~ 196 (708)
+||||++. +|+++++. +.+++.-+++.|..||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+...
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999975 89988874 5689999999999999999999999999999999999999987 899999999999998
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------------C--
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--------------G-- 260 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--------------~-- 260 (708)
.++...+...|..|.|||++.|....+.+.||||.|||+.||+-|++-|.|.+..+-...|.+ .
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 888778888999999999999876667899999999999999999999999765433222211 0
Q ss_pred -CCCCC------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 -KYRIP------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 -~~~~p------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+| ...++|+.+|+.++|.++|.+|.+.-+++
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 11112 24688999999999999999999998776
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=359.84 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=203.1
Q ss_pred EEeEEccc--CceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 50 LLKTIGKG--NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 50 i~~~LG~G--~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
++++||+| +|++||++.++.+|+.||||+++.........+.+.+|+++++.++|||||++++++..++.+|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7899999999999999999999876554455566778999999999999999999999999999999999
Q ss_pred CCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CC-----
Q psy2648 128 SGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GN----- 199 (708)
Q Consensus 128 ~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~----- 199 (708)
++|+|.+++..+ ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++++||+.+..... +.
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999998654 4589999999999999999999999999999999999999999999999986543221 11
Q ss_pred --CccccccCCcccccccccCC--ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------------
Q psy2648 200 --KLDTFCGSPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR------------ 263 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~--~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~------------ 263 (708)
......++..|+|||++.+. .| +.++|||||||++|+|++|..||..............+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred ccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11234577889999999763 35 47899999999999999999999876554433333322111
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 264 ----------------------------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 264 ----------------------------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.....++++.+||.+||+.||++|||++++. |+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 0112467899999999999999999999987 654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=357.43 Aligned_cols=246 Identities=25% Similarity=0.448 Sum_probs=209.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcE----EEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.+|++.+.||+|+||.||+|.+..+++. ||||++.... .....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 4699999999999999999998776664 8999986432 334456788999999999999999999998764 578
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
+|+||+++|+|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999999875 4688999999999999999999999999999999999999999999999999987653332
Q ss_pred c---cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 201 L---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 201 ~---~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
. ....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....++.+.+..+. ...|...+.++.++
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred ceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 2 223346789999999887775 79999999999999998 999999988877766555443 23456678899999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+||++.++.
T Consensus 244 i~~cl~~~p~~Rps~~~l~ 262 (316)
T cd05108 244 MVKCWMIDADSRPKFRELI 262 (316)
T ss_pred HHHHccCChhhCcCHHHHH
Confidence 9999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.82 Aligned_cols=248 Identities=22% Similarity=0.354 Sum_probs=210.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 457999999999999999999875 345789999986532 22344568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEec
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG----------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 189 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DF 189 (708)
.|+||||+++++|.+++.... .++...+..++.||+.||+|||+.+++||||||+|||++.++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999999987532 2467788899999999999999999999999999999999999999999
Q ss_pred cCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CC
Q psy2648 190 GFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RI 264 (708)
Q Consensus 190 Gls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~ 264 (708)
|+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+.. ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 99875432211 1123557789999999877764 78999999999999999 7999999888888877766543 45
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
|...+..+.++|.+||+.||++|||+.++.
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 667888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.16 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=210.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC----hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN----PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
+|++.+.||+|+||.||+|.. .+++.||||.+...... ......+.+|+++++.++||||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 57899999998754322 2234567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-----
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP----- 197 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~----- 197 (708)
||||+++++|.+++...+.+++..+..++.||+.||+|||+.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875421
Q ss_pred --CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCHHH
Q psy2648 198 --GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG---KYRIPFYMSTDC 272 (708)
Q Consensus 198 --~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~---~~~~p~~~s~~~ 272 (708)
........|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+... ....|...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1122345789999999999887764 7899999999999999999999876654443333333 124566788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++|++||..||.+||+++++.
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHh
Confidence 9999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=350.29 Aligned_cols=246 Identities=30% Similarity=0.488 Sum_probs=211.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+.|++++.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 5699999999999999999999999999999998754 34456778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccc
Q psy2648 126 YASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~ 203 (708)
|+++++|..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... .....
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 9999999888765 356899999999999999999999999999999999999999999999999998654322 22345
Q ss_pred cccCCcccccccccCC-----ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHH
Q psy2648 204 FCGSPPYAAPELFQGK-----KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENL 275 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~-----~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~~L 275 (708)
..+++.|+|||++.+. .+ +.++|||||||++|+|++|..||...+..+...++..... ..|...+.++.++
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred ecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 6788999999998532 23 3689999999999999999999988776666655554432 2345678899999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||++||+++++.
T Consensus 249 i~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 249 LKTALDKHPETRPSAAQLL 267 (292)
T ss_pred HHHHhcCCcccCcCHHHHh
Confidence 9999999999999999876
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.88 Aligned_cols=241 Identities=24% Similarity=0.422 Sum_probs=205.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|.+..+++.||||++.+.. .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 6889999999999999999999999999999997643 334456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCG 206 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~G 206 (708)
+++++|..+ ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...... .....+|
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVG 155 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCC
Confidence 999998654 36789999999999999999999999999999999999999999999999998765432 3345689
Q ss_pred CCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCC-CCCC-CCCCHHHHHHHH
Q psy2648 207 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-------LRELRERVLRGK-YRIP-FYMSTDCENLLK 277 (708)
Q Consensus 207 t~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-------~~~l~~~i~~~~-~~~p-~~~s~~~~~Li~ 277 (708)
++.|+|||++.+..++ .++|||||||++|+|++|..||.... ..+..+.+.... ...| ...++++.++|.
T Consensus 156 ~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 156 TNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred ChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 9999999999887764 79999999999999999999996532 122333333222 2222 346789999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||+.||++||+++++.
T Consensus 235 ~~l~~~P~~Rp~~~eil 251 (279)
T cd06619 235 QCMRKQPKERPAPENLM 251 (279)
T ss_pred HHhhCChhhCCCHHHHh
Confidence 99999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=343.88 Aligned_cols=247 Identities=29% Similarity=0.492 Sum_probs=210.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC---ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL---NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 120 (708)
.+|++.+.||+|+||.||+|.+..+++.||||.+..... .....+.+.+|+++++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 369999999999999999999999999999999864322 123456788999999999999999999998763 568
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC--
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-- 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-- 198 (708)
|+||||+++++|.+++...+.+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred --CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Q psy2648 199 --NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPFYMSTDCEN 274 (708)
Q Consensus 199 --~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~~~s~~~~~ 274 (708)
......+|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.... ...|...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 12344678999999999988776 478999999999999999999998765554444444332 2356667889999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|++||. +|++||+++++.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il 259 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELL 259 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHh
Confidence 9999995 999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=350.46 Aligned_cols=246 Identities=31% Similarity=0.513 Sum_probs=214.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 4699999999999999999999999999999998643 33455678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~ 203 (708)
|+++++|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++...... .....
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 99999999998764 46999999999999999999999999999999999999999999999999988654322 22334
Q ss_pred cccCCcccccccccCC-----ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHH
Q psy2648 204 FCGSPPYAAPELFQGK-----KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENL 275 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~-----~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~~L 275 (708)
..|++.|+|||++... .+ +.++|||||||++|+|++|..||.+.+..+....+..+.. ..|...+.++.+|
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~-~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCC-CccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 6789999999998532 23 3689999999999999999999998887777777776643 2355678999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+||++++++
T Consensus 242 i~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred HHHHhccChhhCcCHHHHh
Confidence 9999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.69 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=213.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPT-----GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.++|++.+.||+|+||.||+|.+... +..||||.+.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45799999999999999999998654 4889999986443 23344568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEec
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG----------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 189 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DF 189 (708)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 999999999999999986532 3677889999999999999999999999999999999999999999999
Q ss_pred cCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCC
Q psy2648 190 GFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRI 264 (708)
Q Consensus 190 Gls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~ 264 (708)
|+++...... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++.+.+..+. ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 9987553322 2234567789999999987766 478999999999999998 999999988888887777553 456
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
|...+.++.++|.+||+.||++|||++++.
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 777899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=371.38 Aligned_cols=245 Identities=33% Similarity=0.467 Sum_probs=207.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-C-----CCeeeEEEEEEeCCE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-H-----PNIVKLFQVIETEKT 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~~ 119 (708)
.+|.|++.||+|+||+|-+|.+..|++.||||+|+.. +....+...|+.||..|+ | -|||+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3899999999999999999999999999999999754 344566778999999997 4 389999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC--cEEEEeccCcccc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM--NIKIADFGFSNEF 195 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~--~iKL~DFGls~~~ 195 (708)
+|||+|.++ -+|+++|+.+. .++...++.+..||+.||.+||+.+|||+|||||||||.+.+ .|||+|||.|...
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999996 49999998874 588999999999999999999999999999999999997654 6999999999765
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------------
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR---------------- 259 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~---------------- 259 (708)
.. ...+.+-|..|.|||+|.|.+|+ .+.||||||||+.||++|.+-|.|.+..+.+..|..
T Consensus 342 ~q--~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 342 SQ--RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred CC--cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 43 34488899999999999999996 799999999999999999999999876554444421
Q ss_pred ------------------------------------CCCCCCC-----------CCCHHHHHHHHHhhhhCCCCCCCHHH
Q psy2648 260 ------------------------------------GKYRIPF-----------YMSTDCENLLKKFLVLNPAKRASLEV 292 (708)
Q Consensus 260 ------------------------------------~~~~~p~-----------~~s~~~~~Li~~~L~~dP~~Rps~~~ 292 (708)
++...|. .....+.|||++||++||.+|+|..+
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 1111221 01124689999999999999999998
Q ss_pred Hh---hhh
Q psy2648 293 SG---EVT 297 (708)
Q Consensus 293 ~~---~~~ 297 (708)
++ |+.
T Consensus 499 al~Hpfl~ 506 (586)
T KOG0667|consen 499 ALNHPFLT 506 (586)
T ss_pred HhcCcccc
Confidence 87 664
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=366.48 Aligned_cols=244 Identities=26% Similarity=0.431 Sum_probs=202.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEc--CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+|++++.||+|+||.||+|... .+++.||||.+.... ...+|+++|+.++|||||++++++.....+|+|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 46999999999999999999754 466889999886432 245799999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---C
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---K 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~---~ 200 (708)
||++. ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 99996 6899999777889999999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHH---HHHcC-------------
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL----RELRE---RVLRG------------- 260 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~----~~l~~---~i~~~------------- 260 (708)
.....||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+... ..+.. .+...
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 2346799999999999988875 789999999999999999999976432 11111 11000
Q ss_pred ------------CCCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 ------------KYRIP-----FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 ------------~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+..| ...+.++.+||++||..||++|||+++++ |+..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 01111 12466889999999999999999999987 7654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.32 Aligned_cols=250 Identities=30% Similarity=0.521 Sum_probs=213.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..+|++.+.||+|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 46899999999999999999999999999999999765432 3456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
||+++++|.+++. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 97 e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999999999885 4568999999999999999999999999999999999999999999999999987654322 2234
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCC--CCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL-RGKY--RIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~-~~~~--~~p~~~s~~~~~Li~~~L 280 (708)
..|++.|+|||.+.+..++ .++|||||||++|+|++|+.||...+.......+. .+.. ..|...+..+.+||.+||
T Consensus 176 ~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred ccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 5789999999999877664 79999999999999999999998876544332232 2222 235567889999999999
Q ss_pred hhCCCCCCCHHHHh---hhhh
Q psy2648 281 VLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~ 298 (708)
..||++||+++++. |+..
T Consensus 255 ~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 255 DMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred cCCcccCcCHHHHhhChhhhc
Confidence 99999999999887 5543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=343.76 Aligned_cols=248 Identities=24% Similarity=0.409 Sum_probs=214.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.++|++.+.||+|+||.||+|.+..+ ...||||++.... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 35799999999999999999998754 4589999987543 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-C
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-N 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~ 199 (708)
+||||+++++|.+++..+ +.+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++...... .
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999999765 47899999999999999999999999999999999999999999999999999876421 1
Q ss_pred Cc--cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q psy2648 200 KL--DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENL 275 (708)
Q Consensus 200 ~~--~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~L 275 (708)
.. ....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||......++...+..+ ....|...+.++.+|
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11 123446789999999887764 78999999999999998 99999988888888888765 234556778999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
+.+||+.||++||+++++.
T Consensus 241 i~~cl~~~p~~Rp~~~ei~ 259 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIV 259 (266)
T ss_pred HHHHcCCCcccCcCHHHHH
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.36 Aligned_cols=247 Identities=33% Similarity=0.504 Sum_probs=210.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 59999999999999999999999999999999987655445556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--Cccc
Q psy2648 127 ASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~~~~ 203 (708)
+ +++|.+++... ..+++.+++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 99999998654 568999999999999999999999999999999999999999999999999987654332 2344
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------CCCC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------------KYRI 264 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------------~~~~ 264 (708)
..|+..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+...++... ...+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 678999999999876654468999999999999999999999877655544444321 0000
Q ss_pred -----------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 -----------PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 -----------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+.++.+||++||..||.+||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l 280 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence 013468899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.57 Aligned_cols=246 Identities=26% Similarity=0.466 Sum_probs=211.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++++.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 4568999999999999999999864 567899999865432 346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-
Q psy2648 124 MEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK- 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~- 200 (708)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999998764 4688899999999999999999999999999999999999999999999999976543221
Q ss_pred -ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy2648 201 -LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLK 277 (708)
Q Consensus 201 -~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~ 277 (708)
.....++..|+|||++.+..++ +++|||||||++|+|++ |..||.+.+..++...+..+. ++.+...+.++.++|.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred ccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1223456789999999877764 78999999999999998 999999888888877776652 2334467889999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..||++||+++++.
T Consensus 239 ~~l~~~p~~Rp~~~~i~ 255 (261)
T cd05072 239 TCWKEKAEERPTFDYLQ 255 (261)
T ss_pred HHccCCcccCcCHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.77 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=213.8
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcC-------CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVP-------TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQV 113 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 113 (708)
+...++|.+.+.||+|+||.||+|++.. +...||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4445789999999999999999998753 33579999997643 234456788999999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 177 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNIL 177 (708)
+.....+|+||||+++|+|.+++.... .++..++..++.||+.||+|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997642 4788899999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q psy2648 178 LDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253 (708)
Q Consensus 178 ld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l 253 (708)
++.++.+||+|||++........ .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999876532211 1122345689999999887764 78999999999999998 9999999888888
Q ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 254 RERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 254 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+..+. ...|...+.++.+||.+||..+|.+||+++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 293 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 88777664 356677889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.60 Aligned_cols=239 Identities=26% Similarity=0.496 Sum_probs=189.2
Q ss_pred EeEEcccCceEEEEEEEc--CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEEec
Q psy2648 51 LKTIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKTLYLVMEY 126 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ylVmEy 126 (708)
.+.||+|+||.||+|+++ .+++.||||.+..... ...+.+|+++|+.++||||+++++++.. ...+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999976 4778999999975432 2346789999999999999999999854 4578999999
Q ss_pred cCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCcEEEEeccCcc
Q psy2648 127 ASGGEVFDYLVLH---------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL----DSEMNIKIADFGFSN 193 (708)
Q Consensus 127 ~~gg~L~~~i~~~---------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl----d~~~~iKL~DFGls~ 193 (708)
+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 864 888887542 248999999999999999999999999999999999999 456789999999997
Q ss_pred ccCCC----CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHHc-
Q psy2648 194 EFTPG----NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL---------RELRERVLR- 259 (708)
Q Consensus 194 ~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~---------~~l~~~i~~- 259 (708)
.+... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||..... .....++..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 65422 2334578999999999998755445889999999999999999999975321 011111110
Q ss_pred ---------------------------CCCCC----------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 ---------------------------GKYRI----------PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 ---------------------------~~~~~----------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+.. ....+.++.+||.+||+.||.+|||+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l 312 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 312 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence 00000 012346789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=351.73 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=214.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPT-----GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
.+.+|++.+.||+|+||.||+|.+..+ ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 345688999999999999999987643 5789999997543 2333456789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 182 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~ 182 (708)
..++++||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998632 3478888999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q psy2648 183 NIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258 (708)
Q Consensus 183 ~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~ 258 (708)
.+||+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+.+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999876543221 2334567889999999877764 78999999999999998 999999998889998888
Q ss_pred cCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 RGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 ~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.. ..|...+.++.+|+.+||+.||.+||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~ 277 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIH 277 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 8764 35677889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.12 Aligned_cols=246 Identities=29% Similarity=0.500 Sum_probs=216.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+++++.++||||+++++++.++..+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 47999999999999999999999999999999987653 23345567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
|+++++|.+++... .+++..+..++.||+.||.|||+++|+||||+|+||++++++.++|+|||++...... ......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 99999999998755 8999999999999999999999999999999999999999999999999998776433 233456
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCC-CCHHHHHHHHHhhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFY-MSTDCENLLKKFLVL 282 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~-~s~~~~~Li~~~L~~ 282 (708)
.|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+..+.. .++.. .+.++.++|.+||..
T Consensus 159 ~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237 (274)
T ss_pred cCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence 789999999999887764 799999999999999999999988776666666665533 33444 788999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||++||+++++.
T Consensus 238 ~p~~Rpt~~~il 249 (274)
T cd06609 238 DPKERPSAKELL 249 (274)
T ss_pred ChhhCcCHHHHh
Confidence 999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.44 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=211.5
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTLY 121 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~y 121 (708)
.+++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++... +.+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 46789999999999999999999999999999999975543333333466899999999999999999998765 5689
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
+||||+.+ +|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99999975 788887653 678999999999999999999999999999999999999999999999999987664322
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------------- 260 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------------- 260 (708)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2223346788999999876544457899999999999999999999988877766655431
Q ss_pred CCCCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 261 KYRIP-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 261 ~~~~p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.+..+ ...++++.+||++||+.||++|||++++. |+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 11111 12578899999999999999999999987 77643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.19 Aligned_cols=250 Identities=28% Similarity=0.534 Sum_probs=215.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+++++.++|+||+++++++...+..|+|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 3689999999999999999999999999999999875433 334466788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 124 MEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||+++++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999998864 2458999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCC-CCC-CCCHHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS--TLRELRERVLRGKYR-IPF-YMSTDCEN 274 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~--~~~~l~~~i~~~~~~-~p~-~~s~~~~~ 274 (708)
......|++.|+|||.+.+..++ .++|||||||++|+|++|..||... +..++.+.+..+.+. .|. ..+.++.+
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred cccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 23346789999999999887775 7899999999999999999999654 344566666655442 444 67789999
Q ss_pred HHHHhhhhCCCCCCCHHHHhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+|.+||..+|++||++.++..
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.09 Aligned_cols=244 Identities=32% Similarity=0.511 Sum_probs=210.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
|++.+.||+|+||.||+|++..++..||+|.+... .....+.+.+|+++++.++||||+++++++......|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 78899999999999999999999999999998654 2345567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccccc
Q psy2648 128 SGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFC 205 (708)
Q Consensus 128 ~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~~ 205 (708)
++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 99999988765 457999999999999999999999999999999999999999999999999998754322 2234567
Q ss_pred cCCcccccccccC-----CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHH
Q psy2648 206 GSPPYAAPELFQG-----KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLLK 277 (708)
Q Consensus 206 Gt~~Y~APE~l~~-----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~~Li~ 277 (708)
|++.|+|||++.. ..+ +.++|||||||++|+|++|..||...+..+....+..... ..|...+.++.+||.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred ccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 8999999999842 333 3689999999999999999999998877666666554432 345567899999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..||.+||+++++.
T Consensus 244 ~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 244 KCLEKNVDARWTTTQLL 260 (282)
T ss_pred HHccCChhhCcCHHHHh
Confidence 99999999999999877
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.83 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=212.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++++.||+|+||.||+|.+..+++.||+|.+... ........+.+|+++++.++||||+++++.+...+.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 3689999999999999999999999999999998654 234445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 126 YASGGEVFDYLVLH---GRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 126 y~~gg~L~~~i~~~---~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
|+++++|..++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+.. ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~ 158 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLA 158 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC-Ccc
Confidence 99999999888653 378999999999999999999997 5999999999999999999999999999876532 233
Q ss_pred cccccCCcccccccccCCcc-----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHcCC-CCCCCCCCHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKKY-----DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRER---VLRGK-YRIPFYMSTDC 272 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~-----~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~---i~~~~-~~~p~~~s~~~ 272 (708)
....|++.|+|||++.+... .+.++|||||||++|+|++|..||...+....... +..+. ..+|...+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 45678899999999865432 14689999999999999999999987655544333 33333 34666789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+||.+||+.||++||+++++. |+.
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~ 266 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLV 266 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhh
Confidence 9999999999999999999887 654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.54 Aligned_cols=248 Identities=31% Similarity=0.508 Sum_probs=214.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||.|+||.||+|.+..++..||+|++....... ..+.+.+|+.+|+.++||||+++++.+.....+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999999999999999997655433 55678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q psy2648 126 YASGGEVFDYLVLH---GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-- 200 (708)
Q Consensus 126 y~~gg~L~~~i~~~---~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-- 200 (708)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999999764 4589999999999999999999999999999999999999999999999999876644322
Q ss_pred ---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CC-----CCCCHH
Q psy2648 201 ---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IP-----FYMSTD 271 (708)
Q Consensus 201 ---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p-----~~~s~~ 271 (708)
....+|++.|+|||++......+.++|+|||||++|+|++|+.||...+..+....+...... ++ ..++++
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 234578999999999877633457899999999999999999999887766666665554322 22 145788
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.++|.+||..||++||+++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHh
Confidence 99999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=381.78 Aligned_cols=245 Identities=33% Similarity=0.533 Sum_probs=207.8
Q ss_pred CccC--CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEE-Ee--
Q psy2648 43 PHIG--KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVI-ET-- 116 (708)
Q Consensus 43 ~~~~--~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~-~~-- 116 (708)
..+| +++|.+.|.+|+|+.||+|+....|..||+|++-.. +...++.+.+||++|++|. |||||.+++.. ..
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 3455 467889999999999999999998899999998654 5567788899999999997 99999999932 11
Q ss_pred ----CCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCcEEEEe
Q psy2648 117 ----EKTLYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMNIKIAD 188 (708)
Q Consensus 117 ----~~~~ylVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~~~~iKL~D 188 (708)
.-.++|.||||.||.|.|++.. ..+|+|.+++.||.|++.||.+||... |||||||-|||||+.+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 1258999999999999999974 357999999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCC-Ccc---------ccccCCcccccccc---cCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q psy2648 189 FGFSNEFTPGN-KLD---------TFCGSPPYAAPELF---QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRE 255 (708)
Q Consensus 189 FGls~~~~~~~-~~~---------~~~Gt~~Y~APE~l---~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~ 255 (708)
||.+......- ... ...-|+.|.|||++ .+... +.|+|||+|||+||.|+....||++... -
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----l 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----L 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----e
Confidence 99876432211 110 12468999999998 34444 5899999999999999999999987632 3
Q ss_pred HHHcCCCCCCC--CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGKYRIPF--YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|+.++|.+|. ..+..+.+||+.||+.||.+||++-+++
T Consensus 265 aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~ 305 (738)
T KOG1989|consen 265 AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVL 305 (738)
T ss_pred eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHH
Confidence 68899999986 4788999999999999999999998776
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.34 Aligned_cols=241 Identities=31% Similarity=0.530 Sum_probs=213.7
Q ss_pred eEEcccCceEEEEEEEcCC---CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 52 KTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
+.||+|+||.||+|.+... +..||||++....... ..+.+.+|+++++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4699999999999999866 8999999997654332 46678899999999999999999999999999999999999
Q ss_pred CCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 129 GGEVFDYLVLH---------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 129 gg~L~~~i~~~---------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+++|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999875 779999999999999999999999999999999999999999999999999997664332
Q ss_pred ---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 200 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 200 ---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+..++.+.+..+. ...|...++++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence 2334567889999999987766 478999999999999999 699999998888888887653 3467778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|.+||..||++|||++++.
T Consensus 239 li~~~l~~~p~~Rps~~~l~ 258 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELV 258 (262)
T ss_pred HHHHHccCCcccCcCHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=358.14 Aligned_cols=250 Identities=28% Similarity=0.509 Sum_probs=208.3
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------ 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 117 (708)
..++|++.+.||+|+||.||+|.+..+++.||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 35689999999999999999999999999999999976544445556788999999999999999999998654
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+|+||||+.+ +|.+++... +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 357999999964 888877543 89999999999999999999999999999999999999999999999999986654
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----------------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG----------------- 260 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~----------------- 260 (708)
........+++.|+|||++.+..++ .++|||||||++|+|++|+.||...+.......+...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 4444556789999999999988875 7899999999999999999999876644333332210
Q ss_pred -----CCC--------------C-------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 261 -----KYR--------------I-------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 261 -----~~~--------------~-------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
... . +...+.++.+||.+||+.||++|||+++++ |+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000 0 112355789999999999999999999987 665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.70 Aligned_cols=251 Identities=26% Similarity=0.518 Sum_probs=214.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+++|++.+.||+|+||.||+|.+..+++.||||.+.+... .......+.+|+++++.++||||+++++++...+.+|++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4689999999999999999999999999999998876433 334456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 124 MEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998864 3468999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCC-CC-CCCCHHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST--LRELRERVLRGKYR-IP-FYMSTDCEN 274 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~--~~~l~~~i~~~~~~-~p-~~~s~~~~~ 274 (708)
.....+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.. ..++.+.+....+. .| ...++++.+
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 23456799999999999887764 78999999999999999999997653 34555566554433 22 357889999
Q ss_pred HHHHhhhhCCCCCCCHHHHhhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
+|.+||..||++|||++++...
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHH
Confidence 9999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=339.62 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=215.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC---ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL---NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+|+..+.||+|+||+||+|....+++.||||.+..... ..+..+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58888999999999999999998999999999876432 234556788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|||+++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999876544433456
Q ss_pred cccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-C-CCCCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-G-KYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~-~-~~~~p~~~s~~~~~Li~~~L 280 (708)
..|++.|+|||.+.... + +.++|+|||||++|+|++|..||......+....+.. . ...+|...++++.++|.+||
T Consensus 161 ~~~~~~y~~pe~~~~~~~~-~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGY-GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred cCCCcceeCHHHhcCCCCC-CchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 77999999999987665 4 4789999999999999999999987765554444443 2 23456678899999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
..||.+||+++++.
T Consensus 240 ~~~p~~Rp~~~~~l 253 (258)
T cd06632 240 QRDPSLRPTAAELL 253 (258)
T ss_pred hcCcccCcCHHHHh
Confidence 99999999999876
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.14 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=211.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.++|++.+.||+|+||.||+|.+. .++.||||.+...... .+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 357999999999999999999875 4578999998765432 345788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc-
Q psy2648 125 EYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL- 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~- 201 (708)
||+++++|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999999997654 6899999999999999999999999999999999999999999999999998765422111
Q ss_pred -cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Q psy2648 202 -DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 202 -~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~ 278 (708)
.....+..|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..++...+... ....|...+.++.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 112234579999999877764 78999999999999999 99999998888887777654 234556678999999999
Q ss_pred hhhhCCCCCCCHHHHhhh
Q psy2648 279 FLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~~~ 296 (708)
||..||.+||+++++.+.
T Consensus 240 ~l~~~P~~Rp~~~~l~~~ 257 (261)
T cd05068 240 CWKEDPDDRPTFETLQWK 257 (261)
T ss_pred HhhcCcccCCCHHHHHHH
Confidence 999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.08 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=212.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVP-----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4579999999999999999999987 78899999886433 23334568899999999999999999999998889
Q ss_pred EEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---cEEEEec
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM---NIKIADF 189 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~-------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~---~iKL~DF 189 (708)
.|+||||+++++|.+++...+ .+++.++..++.||+.||+|||+++++||||||+|||++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999997653 488999999999999999999999999999999999998765 5999999
Q ss_pred cCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCC
Q psy2648 190 GFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRI 264 (708)
Q Consensus 190 Gls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~ 264 (708)
|+++....... ......++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+... ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 99976532211 1122335679999999887774 79999999999999997 99999998888877777654 3455
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 265 PFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 265 p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
|..++.++.++|.+||+.||++||+++++..
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6778899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=346.94 Aligned_cols=249 Identities=30% Similarity=0.520 Sum_probs=210.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|.+..+++.||||+++.........+.+.+|+++++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999999999999987655444455678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--Cccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~~~~ 203 (708)
|++++.+..++.....+++.++..++.||+.||.|||+++|+||||||+||++++++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 99987777766666779999999999999999999999999999999999999999999999999987665433 3345
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------------------C-CC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--------------------G-KY 262 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--------------------~-~~ 262 (708)
..++..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.. + .+
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 67889999999998873335799999999999999999999987654433222211 0 00
Q ss_pred -----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 -----------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 -----------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+|..+++++.+||++||..||++||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 12334588999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.85 Aligned_cols=246 Identities=28% Similarity=0.469 Sum_probs=206.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE------ 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------ 117 (708)
-+.|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4679999999999999999999999999999999975432 234678899999998 699999999998753
Q ss_pred CEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
..+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||++++++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999999999998764 36899999999999999999999999999999999999999999999999998765
Q ss_pred CCC-CCccccccCCcccccccccC-----CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCC
Q psy2648 196 TPG-NKLDTFCGSPPYAAPELFQG-----KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFY 267 (708)
Q Consensus 196 ~~~-~~~~~~~Gt~~Y~APE~l~~-----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~--~p~~ 267 (708)
... ......+|++.|+|||++.+ ..+ ..++|||||||++|+|++|..||...........+...... .+..
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 322 23345689999999999863 234 36899999999999999999999876655544444433222 2345
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.++.+||.+||..||.+|||++++.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 678999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=341.71 Aligned_cols=243 Identities=26% Similarity=0.491 Sum_probs=209.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|.+. ++..+|||++.+.... ...+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 5889999999999999999886 4678999998754432 24577899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc--cc
Q psy2648 127 ASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL--DT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~--~~ 203 (708)
+++++|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........ ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999999764 46899999999999999999999999999999999999999999999999998755332211 11
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~L~ 281 (708)
..++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..++...+..+ ....|...+.++.+++.+||.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH 239 (256)
T ss_pred CCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234579999999887774 78999999999999999 89999988888888877766 334566789999999999999
Q ss_pred hCCCCCCCHHHHh
Q psy2648 282 LNPAKRASLEVSG 294 (708)
Q Consensus 282 ~dP~~Rps~~~~~ 294 (708)
.+|++|||++++.
T Consensus 240 ~~p~~Rpt~~~~l 252 (256)
T cd05059 240 EKPEDRPAFKKLL 252 (256)
T ss_pred CChhhCcCHHHHH
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=346.96 Aligned_cols=250 Identities=32% Similarity=0.523 Sum_probs=215.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..+|++.+.||.|+||.||+|.+..+++.||||.+..... ...+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4579999999999999999999999999999999875432 23456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
||+++++|.+++.. ..+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 99999999998864 468999999999999999999999999999999999999999999999999987654332 2234
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK---YRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~---~~~p~~~s~~~~~Li~~~L 280 (708)
.+|++.|+|||.+.+..++ .++|||||||++|+|++|..||.+.+..+....+.... ...|..+++.+.+||++||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred cCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 5789999999999877664 78999999999999999999999877655444443332 2345667899999999999
Q ss_pred hhCCCCCCCHHHHh---hhhh
Q psy2648 281 VLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~ 298 (708)
..||.+||+++++. |+..
T Consensus 254 ~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 254 EMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred hcChhhCCCHHHHhhChHhhh
Confidence 99999999999887 7764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=366.23 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=208.3
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPT-----GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIET 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 116 (708)
...++|++++.||+|+||.||+|.+... +..||||++.+.. .....+.+.+|+++|+.++ |||||++++++..
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3356899999999999999999987533 3579999997543 2334567889999999996 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHc---------------------------------------------------------
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH--------------------------------------------------------- 139 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~--------------------------------------------------------- 139 (708)
...+|||||||++|+|.++|..+
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 99999999999999999998653
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC
Q psy2648 140 ---------------------------------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 180 (708)
Q Consensus 140 ---------------------------------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~ 180 (708)
..+++.++..++.||+.||+|||+++|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 13677888999999999999999999999999999999999
Q ss_pred CCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHH
Q psy2648 181 EMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLR-ELRE 255 (708)
Q Consensus 181 ~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~-~l~~ 255 (708)
++.+||+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... .+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999876533221 2234577889999999887764 79999999999999997 99999876543 3444
Q ss_pred HHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..+ ....|...+.++.++|.+||..||++||++.++.
T Consensus 352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 45444 2345667889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.94 Aligned_cols=243 Identities=38% Similarity=0.682 Sum_probs=215.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCh
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L 132 (708)
||.|+||.||+|.+..+++.||||++.+.... ....+.+.+|+.+++.++||||+++++.+.+...+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999875442 34456788999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCcccc
Q psy2648 133 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 212 (708)
Q Consensus 133 ~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~A 212 (708)
.+++.....+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|||++............+|++.|+|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998888899999999999999999999999999999999999999999999999999987654433445678999999
Q ss_pred cccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHH--cCCCCCCCCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST--LRELRERVL--RGKYRIPFYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 213 PE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~--~~~l~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
||++.+..++ .++|+|||||++|+|++|..||.... ..++...+. .....+|...++++.++|.+||..||++||
T Consensus 161 PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 161 PEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 9999877764 78999999999999999999998776 667777777 345567777789999999999999999999
Q ss_pred C-----HHHHh---hhh
Q psy2648 289 S-----LEVSG---EVT 297 (708)
Q Consensus 289 s-----~~~~~---~~~ 297 (708)
+ ++++. |+.
T Consensus 240 ~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 240 GNLKGGIKDIKKHKWFN 256 (262)
T ss_pred CCcccCHHHHhcChhhh
Confidence 9 77776 654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.69 Aligned_cols=244 Identities=28% Similarity=0.479 Sum_probs=203.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--CEEEEEE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETE--KTLYLVM 124 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~ylVm 124 (708)
|++.+.||+|+||.||+|.+..+++.||||++.+..... .....++|+.+++++. ||||+++++++.+. +.+|+||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 788999999999999999999999999999987653322 2234568999999885 99999999999987 8899999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||++ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++...........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 9997 5888888764 57899999999999999999999999999999999999999 9999999999986654444445
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc------------------CCCCCC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR------------------GKYRIP 265 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~------------------~~~~~p 265 (708)
..+++.|+|||++....+.+.++|||||||++|+|++|..||.+.+..+....+.. ..+.+|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 67899999999876544446799999999999999999999998776554443321 011111
Q ss_pred -----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 -----------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 -----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.+||.+||.+||++||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 23578999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=368.86 Aligned_cols=252 Identities=27% Similarity=0.471 Sum_probs=217.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCc---E-EEEEEeccC-CCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGK---E-VAIKIIDKT-QLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~-vAvK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
-.+-.+.+.||+|+||.||+|..+..+. . ||||..... .........+++|+++|++++|||||++|++...+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3445566999999999999999876433 3 899998753 3566778889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
+|||||+|.||+|.+||++++. ++..+-..++.|.+.||+|||++++|||||-.+|+|++.++.+||+||||++.-...
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 9999999999999999999874 999999999999999999999999999999999999999999999999998754311
Q ss_pred CCccccc-cCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHH
Q psy2648 199 NKLDTFC-GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCEN 274 (708)
Q Consensus 199 ~~~~~~~-Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~--~p~~~s~~~~~ 274 (708)
......+ --..|+|||.+....|+ +++|||||||++||+.+ |..||.+.+..++..+|....++ .|...+.++..
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred eeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 1112133 23479999999988775 89999999999999998 89999999999999999776665 45667889999
Q ss_pred HHHHhhhhCCCCCCCHHHHh-hhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG-EVT 297 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~-~~~ 297 (708)
++.+|+..||++||++.++. ++.
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred HHHHhccCChhhccCHHHHHHHHH
Confidence 99999999999999999887 443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.19 Aligned_cols=240 Identities=34% Similarity=0.514 Sum_probs=207.6
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCh
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L 132 (708)
||+|+||.||+|.+..+|+.||+|++.+.... ....+.+.+|+++|+.++||||++++++++..+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999765432 22344567899999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCcc
Q psy2648 133 FDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPY 210 (708)
Q Consensus 133 ~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y 210 (708)
.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99998766 7999999999999999999999999999999999999999999999999998765444344456688899
Q ss_pred cccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCC
Q psy2648 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL----RELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286 (708)
Q Consensus 211 ~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~----~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 286 (708)
+|||++.+..++ .++|||||||++|+|++|+.||..... .++.+.+.......|...++++.++|.+||+.||.+
T Consensus 161 ~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 161 MAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred CCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 999999887764 789999999999999999999987543 445555555555667778999999999999999999
Q ss_pred CC-----CHHHHh
Q psy2648 287 RA-----SLEVSG 294 (708)
Q Consensus 287 Rp-----s~~~~~ 294 (708)
|| +++++.
T Consensus 240 R~~~~~~~~~~ll 252 (277)
T cd05577 240 RLGCRGGSADEVR 252 (277)
T ss_pred ccCCCcccHHHHH
Confidence 99 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.85 Aligned_cols=246 Identities=26% Similarity=0.456 Sum_probs=211.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..+|++++.||+|+||.||+|++.. +..||||.+...... ...+.+|+.+++.++||||+++++++.....+|+||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 3569999999999999999998754 456999998754432 345789999999999999999999999888999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc-
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD- 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~- 202 (708)
||+.+|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999999764 468999999999999999999999999999999999999999999999999987654332111
Q ss_pred -ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHh
Q psy2648 203 -TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKF 279 (708)
Q Consensus 203 -~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~ 279 (708)
...++..|+|||++.+..++ .++|||||||++|+|++ |..||...+..++...+..+... .|...+..+.++|.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 12345679999999877764 78999999999999998 99999988888888888776433 4556789999999999
Q ss_pred hhhCCCCCCCHHHHhh
Q psy2648 280 LVLNPAKRASLEVSGE 295 (708)
Q Consensus 280 L~~dP~~Rps~~~~~~ 295 (708)
|..||.+||++.++..
T Consensus 238 l~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 238 WHEKAEERPTFQQLLS 253 (256)
T ss_pred cCCCcccCCCHHHHHH
Confidence 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=343.96 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=204.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHH-HHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI-MKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++.+.||+|+||.||+|.+..+|+.||||++++...... ...+..|+.+ ++.++||||+++++++..+..+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 479999999999999999999999999999999976543332 3455666665 67789999999999999999999999
Q ss_pred eccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 125 EYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 578777654 24689999999999999999999997 99999999999999999999999999987654332
Q ss_pred CccccccCCcccccccccCC----ccCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCCC-CCCCHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGK----KYDGPEVDVWSLGVILYTLVSGSLPFDGS--TLRELRERVLRGKYRIP-FYMSTDC 272 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~----~~~~~~~DIWSlGvilyelltG~~Pf~~~--~~~~l~~~i~~~~~~~p-~~~s~~~ 272 (708)
......|+..|+|||++.+. .+ +.++|+|||||++|+|++|+.||... ....+...+......+| ...+.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred ccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 22335789999999998652 23 47899999999999999999999753 23444433333333444 3468999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+||.+||..||++||+++++. |+..
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 9999999999999999999987 6653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.04 Aligned_cols=240 Identities=28% Similarity=0.441 Sum_probs=203.7
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhh-HHHHHHHH---HHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 53 TIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREV---RIMKMLDHPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 53 ~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~-~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
.||+|+||.||+|.+..+++.||||++.+....... ...+..|. ++++..+||||++++++++..+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999876543211 12233444 34455689999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCC
Q psy2648 129 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP 208 (708)
Q Consensus 129 gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~ 208 (708)
|++|.+++...+.+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..+... .....+|++
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence 9999999988888999999999999999999999999999999999999999999999999998765322 234568999
Q ss_pred cccccccccCC-ccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 209 PYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 209 ~Y~APE~l~~~-~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
.|+|||++.+. .+ +.++|||||||++|+|++|..||.+. ........+......+|...+.++.++|.+||..||
T Consensus 160 ~y~aPE~~~~~~~~-~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 160 GYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred CCcCcHHhcCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence 99999999754 44 47899999999999999999999876 444555555555667777789999999999999999
Q ss_pred CCCC-----CHHHHh
Q psy2648 285 AKRA-----SLEVSG 294 (708)
Q Consensus 285 ~~Rp-----s~~~~~ 294 (708)
.+|| +++++.
T Consensus 239 ~~R~~~~~~~~~~ll 253 (278)
T cd05606 239 NRRLGCLGRGAQEVK 253 (278)
T ss_pred HhccCCCCCCHHHHH
Confidence 9999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=339.14 Aligned_cols=247 Identities=30% Similarity=0.540 Sum_probs=213.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999987655545677899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-----c
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-----L 201 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-----~ 201 (708)
+++++|.+++.....+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 99999999998877799999999999999999999999999999999999999999999999999876543221 2
Q ss_pred cccccCCcccccccccCCc---cCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcC-CCCCCCCC--CHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKK---YDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRERVLRG-KYRIPFYM--STDCEN 274 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~---~~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~l~~~i~~~-~~~~p~~~--s~~~~~ 274 (708)
...++++.|+|||++.+.. + ..++|||||||++|+|++|..||... +.......+..+ ...+|... ++++.+
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~-~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGH-GRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCC-CcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 2457889999999998765 4 47899999999999999999999765 333333334333 33455544 889999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
||.+||+.||.+||+++++.
T Consensus 240 li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 240 FLDRCLESDPKKRPTASELL 259 (264)
T ss_pred HHHHHccCCcccCCCHHHHh
Confidence 99999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.57 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=214.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTG-----KEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIE 115 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 115 (708)
+...++|++.+.||+|+||.||++.+.... ..||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 344568999999999999999999987543 789999987643 234456688999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
..+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999999999998642 4588999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRE 255 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~ 255 (708)
.++.+||+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999976543221 1122345679999998877764 78999999999999998 999999988888888
Q ss_pred HHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..+. ...|...+.++.+|+.+||..||.+|||++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil 285 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 777664 345667889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=341.85 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=212.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.++|++.+.||+|+||.||+|.+..++. .||+|.++... .....+.+.+|+.+++.++||||+++++++..++.+|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4579999999999999999999875554 79999987543 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
+||||+++++|.+++... +.+++.++..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999999775 4689999999999999999999999999999999999999999999999999876543221
Q ss_pred -c---cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 201 -L---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 201 -~---~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
. ....++..|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+..++...+..+. .+.+...++++.+
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240 (267)
T ss_pred eeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence 1 11223567999999988776 479999999999999886 999999888877777777652 2334567889999
Q ss_pred HHHHhhhhCCCCCCCHHHHhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~~ 295 (708)
++.+||+.+|.+||+++++..
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=347.49 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=210.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCC----------------cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCee
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTG----------------KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg----------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 108 (708)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+.+|+++|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 458999999999999999999877544 568999987553 234556788999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy2648 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-----------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 177 (708)
Q Consensus 109 ~l~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNIL 177 (708)
++++++..+..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999998765 6899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q psy2648 178 LDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS--GSLPFDGSTLRE 252 (708)
Q Consensus 178 ld~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt--G~~Pf~~~~~~~ 252 (708)
++.++.+||+|||+++...... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9999999999999987643322 12234567789999999876664 89999999999999998 789998877776
Q ss_pred HHHHHHcC------C--CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 253 LRERVLRG------K--YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 253 l~~~i~~~------~--~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+... . ...|...+.++.+||.+||+.||.+|||+.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 66655432 1 123445678999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=385.91 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=204.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+++|++.+.||+|+||.||+|.+..+++.||||++..... .....+++.+|+++++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 5799999999999999999999999999999999976533 233456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 124 MEYASGGEVFDYLVLH-----------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-----------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988642 23455678889999999999999999999999999999999999999999999
Q ss_pred cccCCC-------------------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy2648 193 NEFTPG-------------------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL 253 (708)
Q Consensus 193 ~~~~~~-------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l 253 (708)
+..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..++
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765210 011235799999999999888774 799999999999999999999987655443
Q ss_pred HHHHHc-CCCCC-C-CCCCHHHHHHHHHhhhhCCCCCCCHHH
Q psy2648 254 RERVLR-GKYRI-P-FYMSTDCENLLKKFLVLNPAKRASLEV 292 (708)
Q Consensus 254 ~~~i~~-~~~~~-p-~~~s~~~~~Li~~~L~~dP~~Rps~~~ 292 (708)
...... ..... | ..+++.+.+++.+||..||++|++..+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 322111 11111 1 256788999999999999999987543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=369.82 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=200.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+.|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++|+|||||++++++...+..||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4479999999999999999999999999999996421 23568999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---C
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---K 200 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~---~ 200 (708)
|++. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9995 6899988765 469999999999999999999999999999999999999999999999999997653321 1
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHcCCCC---CC----
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS--------TLRELRERVLRGKYR---IP---- 265 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~--------~~~~l~~~i~~~~~~---~p---- 265 (708)
....+||+.|+|||++.+..++ .++|||||||+||||++|..|+... ...++.+.+....+. +|
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2346799999999999988875 7999999999999999987665321 223444444332211 01
Q ss_pred ---------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 ---------------------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 ---------------------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.+||.+||+.||.+|||+++++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL 453 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL 453 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh
Confidence 02456899999999999999999999988
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=341.13 Aligned_cols=246 Identities=26% Similarity=0.449 Sum_probs=209.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.++|++.+.||+|+||.||+|.+..+ ..||||++.+.... .+.+.+|+++++.++||||++++++++. ...|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 46799999999999999999988765 46999999764432 2467889999999999999999998754 5689999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc-
Q psy2648 125 EYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL- 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~- 201 (708)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999764 35789999999999999999999999999999999999999999999999998765433211
Q ss_pred -cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q psy2648 202 -DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKK 278 (708)
Q Consensus 202 -~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~ 278 (708)
....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...+...+.++.+||.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 223466789999998877764 78999999999999999 999999888888877776552 33455678999999999
Q ss_pred hhhhCCCCCCCHHHHhhh
Q psy2648 279 FLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~~~ 296 (708)
||..||++||+++++.++
T Consensus 239 ~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 239 CWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HccCCcccCCCHHHHHHH
Confidence 999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=360.31 Aligned_cols=239 Identities=23% Similarity=0.398 Sum_probs=196.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.+|++++.||+|+||.||+|++..+++.||+|+..+.. ...|+.+|+.++|||||++++++......|+|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 46999999999999999999999999999999864332 3569999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
|+. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 996 5888888654 56899999999999999999999999999999999999999999999999998754433334457
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCC-CCCCCCCH----------HHHHHHHHc-C--CCCCC-----
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS-LPFDGSTL----------RELRERVLR-G--KYRIP----- 265 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~-~Pf~~~~~----------~~l~~~i~~-~--~~~~p----- 265 (708)
.||+.|+|||++.+..++ .++|||||||++|+|+++. .+|..... ..+...+.. + ...+|
T Consensus 217 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 217 AGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred cccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 899999999999888875 7999999999999999854 44443211 111111111 0 00011
Q ss_pred -------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 -------------------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 -------------------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.+||.+||+.||.+|||+++++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 13466788899999999999999999987
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=350.21 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=212.8
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcC-------CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVP-------TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVI 114 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 114 (708)
...++|.+.+.||+|+||.||+|++.. ....||+|++.... .......+.+|+++++.+ +||||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344689999999999999999998642 34579999987543 334456788999999999 699999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q psy2648 115 ETEKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 178 (708)
Q Consensus 115 ~~~~~~ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl 178 (708)
.....+|+||||+++|+|.+++... ..++..++..++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999999763 247888999999999999999999999999999999999
Q ss_pred cCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q psy2648 179 DSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELR 254 (708)
Q Consensus 179 d~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~ 254 (708)
+.++.+||+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999976543211 1222345679999999887764 78999999999999999 99999999888888
Q ss_pred HHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 255 ERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 255 ~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+..+. ...|...+.++.+||.+||..||++||+++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 287 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 8887664 345667788999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.82 Aligned_cols=249 Identities=29% Similarity=0.486 Sum_probs=209.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|.+..+++.||||++.+........+.+.+|+++|+.++||||+++++++.++..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999999999999999987654433344567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
|++++.|..++.....+++.++..++.||+.||.|||+.+|+||||+|+||++++++.+||+|||++...... ......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 9999999887776677999999999999999999999999999999999999999999999999998765432 223345
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------CCCC-
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------------KYRI- 264 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------------~~~~- 264 (708)
.++..|+|||++.+....+.++|||||||++|+|++|..||...+..+....+... ....
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 68899999999876554457899999999999999999999876644333332210 0001
Q ss_pred -----------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 -----------PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 -----------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+..++.++.+||.+||..||++||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 124578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=338.31 Aligned_cols=243 Identities=31% Similarity=0.556 Sum_probs=213.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..+|++.+.||+|+||.||+|... |+.||||.+..... ..+++.+|+.+++.++||||+++++++.+....|+||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 457999999999999999999874 88999999975432 4567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc
Q psy2648 125 EYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~ 202 (708)
||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~ 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--D 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--c
Confidence 9999999999998765 68999999999999999999999999999999999999999999999999987653221 2
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~L 280 (708)
...++..|+|||++.+..+. .++|||||||++|+|++ |..||...+..++...+..+ ....|...++++.++|.+||
T Consensus 158 ~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred cCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence 33455679999999877664 78999999999999997 99999999888888877665 33456677899999999999
Q ss_pred hhCCCCCCCHHHHhh
Q psy2648 281 VLNPAKRASLEVSGE 295 (708)
Q Consensus 281 ~~dP~~Rps~~~~~~ 295 (708)
..||++||+++++..
T Consensus 237 ~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 237 ELDPAKRPTFKQLRE 251 (256)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=367.23 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=220.5
Q ss_pred cCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 38 ~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
.+..+...+...++..||+|+||+||+|+|..+ ||||+++....+++.++.|..|+.++++-+|.||+-+.+++...
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 355566677889999999999999999999643 99999999888889999999999999999999999999999877
Q ss_pred CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF- 195 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~- 195 (708)
.. .||+.+|+|.+|+.+|.-. .+|.....+.|++||+.||.|||.++|||||||..||+|.+++.|||.||||+..-
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 65 9999999999999998643 56888899999999999999999999999999999999999999999999998542
Q ss_pred --CCCCCccccccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----C
Q psy2648 196 --TPGNKLDTFCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI-----P 265 (708)
Q Consensus 196 --~~~~~~~~~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~-----p 265 (708)
.....+..-.|+..|||||++... +| .+.+|||||||++|||++|.+||...+.++++-+|-+|-... -
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 334456667899999999999643 45 478999999999999999999999888888888888883221 1
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
...+.++++|+..||..++++||.+.+++.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 245568999999999999999999999884
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=340.95 Aligned_cols=246 Identities=30% Similarity=0.509 Sum_probs=209.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC---hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN---PGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKTLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~y 121 (708)
+|++.+.||+|+||.||+|.+..+++.||+|++...... .+..+.+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 699999999999999999999999999999998765332 2344567899999999999999999999876 36789
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC----
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP---- 197 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~---- 197 (708)
++|||+++++|.+++...+.+++...+.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KYRIPFYMSTDCENL 275 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~~~p~~~s~~~~~L 275 (708)
........++..|+|||++.+..++ .++|||||||++|+|++|+.||......+....+... ...+|...++.+.+|
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1222345688999999999887764 7899999999999999999999876655444333322 234566788999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
| +||..||++||+++++.
T Consensus 242 i-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 242 L-GCIFVEARHRPSAEELL 259 (266)
T ss_pred H-HHhcCChhhCcCHHHHh
Confidence 9 57778999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=338.91 Aligned_cols=240 Identities=28% Similarity=0.437 Sum_probs=206.9
Q ss_pred eEEcccCceEEEEEEEcCCC---cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTG---KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
+.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+++|+.++|||||+++++++. ..+++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 47999999999999876655 78999999765543 345678899999999999999999998764 46899999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc----ccc
Q psy2648 129 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL----DTF 204 (708)
Q Consensus 129 gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~----~~~ 204 (708)
+|+|.+++.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 9999999988888999999999999999999999999999999999999999999999999998765433221 111
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~ 282 (708)
.++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..++...+..+.. ..|...+..+.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 237 (257)
T cd05060 159 RWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY 237 (257)
T ss_pred cccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence 234679999999887764 79999999999999998 9999998888888877776643 45667889999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||++||++.++.
T Consensus 238 ~p~~Rp~~~~l~ 249 (257)
T cd05060 238 RPEDRPTFSELE 249 (257)
T ss_pred ChhhCcCHHHHH
Confidence 999999999887
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=341.41 Aligned_cols=248 Identities=23% Similarity=0.405 Sum_probs=212.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
++.|++.+.||+|+||.||+|.+..+++ .||||++.+.. .....+.+..|+.+++.++||||+++++++.++..+|
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 4679999999999999999999987765 59999986542 3445667889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
+||||+++++|.+++... +.+++.+++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999998764 5689999999999999999999999999999999999999999999999999875533221
Q ss_pred cc---ccc---cCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHH
Q psy2648 201 LD---TFC---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDC 272 (708)
Q Consensus 201 ~~---~~~---Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~ 272 (708)
.. ... .+..|+|||++.+..++ .++|||||||++|||++ |..||...+..++.+.+... ..+.|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 240 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence 11 111 23579999999887774 78999999999999886 99999998888888877654 223445678899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+++.+||..||++||+++++.
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~ 262 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIV 262 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=348.33 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=210.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC---hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN---PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+|++.+.||+|+||.||+|.+..+++.||||.+...... ......+..|+++++.++||||+++++++.++..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999866443 23345577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCc
Q psy2648 124 MEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~ 201 (708)
|||+ +++|.+++.... .+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999998766 7999999999999999999999999999999999999999999999999999765433 223
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------------C---
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK----------------Y--- 262 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~----------------~--- 262 (708)
....+++.|+|||++.+......++|||||||++|+|++|..||.+.+..+...++.... +
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 344578889999998664444578999999999999999988898776555444443210 0
Q ss_pred ----C-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 ----R-----IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 ----~-----~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
. .....+.++.+||.+||..||++|||+++++ |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0 0123467899999999999999999999988 6654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=343.16 Aligned_cols=242 Identities=30% Similarity=0.445 Sum_probs=204.2
Q ss_pred eEEcccCceEEEEEEEcCCCc--EEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGK--EVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
+.||+|+||.||+|+...++. .+|+|.+... ......+.+.+|+++++++ +||||+++++++.....+|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999988876 4688887632 2334456788999999999 79999999999999999999999999
Q ss_pred CCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 129 GGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 129 gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997643 4788999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCH
Q psy2648 193 NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMST 270 (708)
Q Consensus 193 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~ 270 (708)
..............++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+.+..+. ...|...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 643211111122345679999999877664 79999999999999997 999999988888887776653 345667789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
++.+|+.+||..||.+|||++++..
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=339.79 Aligned_cols=239 Identities=28% Similarity=0.439 Sum_probs=203.4
Q ss_pred EEcccCceEEEEEEEc--CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Q psy2648 53 TIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 53 ~LG~G~fg~V~la~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg 130 (708)
.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++++++||||++++++++. ..+|+||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999875 455679999986542 33445678899999999999999999999864 5789999999999
Q ss_pred ChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc----cccc
Q psy2648 131 EVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL----DTFC 205 (708)
Q Consensus 131 ~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~----~~~~ 205 (708)
+|.+++.. ...+++.++..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......... ....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999875 457899999999999999999999999999999999999999999999999998755432211 1122
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhC
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~d 283 (708)
+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+....++...+..+. ...|...++++.++|.+||..|
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 160 WPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 35689999999877764 78999999999999996 999999988888887777764 3466778899999999999999
Q ss_pred CCCCCCHHHHh
Q psy2648 284 PAKRASLEVSG 294 (708)
Q Consensus 284 P~~Rps~~~~~ 294 (708)
|++||+++++.
T Consensus 239 ~~~Rp~~~~i~ 249 (257)
T cd05115 239 WEDRPNFAKVE 249 (257)
T ss_pred hhhCcCHHHHH
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=342.92 Aligned_cols=247 Identities=25% Similarity=0.431 Sum_probs=211.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
..+|++++.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 4579999999999999999999888876 48999986543 33445678899999999999999999999875 457
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+++|||+++|+|.+++..+ +.+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 8999999999999999764 569999999999999999999999999999999999999999999999999998664322
Q ss_pred Cc---cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 200 KL---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 200 ~~---~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
.. ....+++.|+|||++.+..++ .++|||||||++|||++ |..||......++...+..+. ...|...+.++.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 11 122346789999999887775 78999999999999998 999999888887777776654 3445678899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|.+||..||++||++.++.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~ 262 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELV 262 (279)
T ss_pred HHHHHcCCChhhCcCHHHHH
Confidence 99999999999999999877
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=347.90 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=214.7
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEc-------CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHV-------PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQ 112 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 112 (708)
.+...++|.+.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 3455678999999999999999999863 234579999986542 334556788999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy2648 113 VIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 176 (708)
Q Consensus 113 ~~~~~~~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNI 176 (708)
++.....+|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999997642 467788899999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q psy2648 177 LLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252 (708)
Q Consensus 177 Lld~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~ 252 (708)
|++.++.+||+|||+++...... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999987654322 12233456789999999887775 78999999999999998 899999999999
Q ss_pred HHHHHHcCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 253 LRERVLRGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 253 l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+.+..+.. ..|...+.++.+||.+||..+|.+||++.++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 8888876542 35667889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.46 Aligned_cols=247 Identities=32% Similarity=0.522 Sum_probs=206.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|++..+++.||||++............+.+|+++++.++||||+++++++++.+.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999999999999999876544344445788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 127 ASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 127 ~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
+. ++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 96 5899888653 568999999999999999999999999999999999999999999999999987653321 2233
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-C-----------------CC--
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-K-----------------YR-- 263 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-~-----------------~~-- 263 (708)
..+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+...++... . ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 467889999999877655457899999999999999999999876644332222210 0 00
Q ss_pred ---------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 ---------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 ---------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+++++.++|.+||+.||.+|||+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 1124678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.79 Aligned_cols=247 Identities=26% Similarity=0.469 Sum_probs=210.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC----hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN----PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
+|+..+.||+|+||.||++....+++.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999999754422 1234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCccccCCCC--
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGN-- 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~~~~-- 199 (708)
||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 59999999987654321
Q ss_pred ---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH--cCCCCCCCCCCHH
Q psy2648 200 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE---LRERVL--RGKYRIPFYMSTD 271 (708)
Q Consensus 200 ---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~---l~~~i~--~~~~~~p~~~s~~ 271 (708)
......|+..|+|||++.+..++ .++|||||||++|+|++|..||....... ....+. .....+|...+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 11235688999999999877764 78999999999999999999997644322 222222 2234466678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.++|.+||..||.+||++.++.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHh
Confidence 99999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.75 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=211.7
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVP-----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
...++|++.+.||+|+||.||+|.++. .+..||||.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345689999999999999999997652 345899999865432 23344678899999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEE
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHG----------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIA 187 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~ 187 (708)
...|+||||+++|+|.+++...+ .++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997532 24567888999999999999999999999999999999999999999
Q ss_pred eccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-C
Q psy2648 188 DFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-Y 262 (708)
Q Consensus 188 DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~ 262 (708)
|||+++....... .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999875432211 1223456789999999877764 79999999999999998 899999988888887777654 3
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhhh
Q psy2648 263 RIPFYMSTDCENLLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 263 ~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
..|...++++.++|.+||+.||++|||+.++...
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 274 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4566778999999999999999999999998843
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=345.10 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=212.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.++|.+.+.||+|+||.||+|++. .++..||+|.+.... ....+.+.+|+++++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 457999999999999999999864 345679999886432 2334568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN 183 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~ 183 (708)
.++||||+++++|.+++..++ .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999997643 3789999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q psy2648 184 IKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR 259 (708)
Q Consensus 184 iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~ 259 (708)
+||+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..++.+.+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 99999999875433221 2234567889999999887764 78999999999999998 9999998888888888877
Q ss_pred CCCC-CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 GKYR-IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 ~~~~-~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+... .+...+.++.++|.+||+.||.+||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 6553 4556788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=344.39 Aligned_cols=240 Identities=28% Similarity=0.455 Sum_probs=199.8
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhh-HHHHHHHHHHHH---hCCCCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 53 TIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMK---MLDHPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 53 ~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~-~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
.||+|+||.||++.+..+++.||||++.+....... ...+.+|..+++ ..+||||+.+++++..++.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999999999999999999876543222 223345544443 4579999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCC
Q psy2648 129 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP 208 (708)
Q Consensus 129 gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~ 208 (708)
+++|.+++..++.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... ......|++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCCc
Confidence 9999999988889999999999999999999999999999999999999999999999999998755332 223457999
Q ss_pred cccccccccC-CccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 209 PYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 209 ~Y~APE~l~~-~~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
.|+|||++.. ..+ +.++|||||||++|+|++|..||... ....+.+........+|...++++.++|++||..||
T Consensus 160 ~y~aPE~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 160 GYMAPEVLQKGTAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred CccCHHHhcCCCCC-CchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 9999999864 444 47899999999999999999999753 333444444444556777889999999999999999
Q ss_pred CCCC-----CHHHHh
Q psy2648 285 AKRA-----SLEVSG 294 (708)
Q Consensus 285 ~~Rp-----s~~~~~ 294 (708)
.+|+ +++++.
T Consensus 239 ~~R~~~~~~~~~~~~ 253 (279)
T cd05633 239 SKRLGCLGRGAQEVK 253 (279)
T ss_pred HHhcCCCCCCHHHHH
Confidence 9999 477665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.38 Aligned_cols=250 Identities=30% Similarity=0.470 Sum_probs=210.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTLY 121 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~y 121 (708)
.+++|++.+.||+|+||.||+|.+..+++.||||.++...........+.+|+.+++.++||||+++++++... ..+|
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35689999999999999999999999999999999976544433344567899999999999999999998877 8999
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-C
Q psy2648 122 LVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-N 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~ 199 (708)
|||||+.+ +|.+++.... .+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... .
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999985 8999887654 5899999999999999999999999999999999999999999999999998765433 2
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK------------------ 261 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~------------------ 261 (708)
......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+..+...++....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 33445678899999998765544578999999999999999999999877665554443210
Q ss_pred -------------CCCCCC-CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 -------------YRIPFY-MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 -------------~~~p~~-~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+|.. +++.+.+||++||+.||++|||+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 012222 578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=343.74 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=211.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+|.+.++||+|+||.||+|... .++..||+|.+... .....+.+.+|+++++.++||||+++++++.....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46889999999999999999743 35678999988643 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEE
Q psy2648 121 YLVMEYASGGEVFDYLVLHG---------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIK 185 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~---------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iK 185 (708)
|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+++++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 99999999999999997653 478899999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q psy2648 186 IADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK 261 (708)
Q Consensus 186 L~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~ 261 (708)
|+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||......+....+..+.
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 999999875532221 1223456789999999888775 78999999999999998 999998888777777776664
Q ss_pred -CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 -YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 -~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...|...++++.+||.+||+.||.+||+++++.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~ 275 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIH 275 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 345667889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.01 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=208.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcE----EEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.++|++++.||+|+||.||+|.+..+++. ||+|.+... ........+..|+.+++.++||||+++++++. ....
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 35799999999999999999999888874 666766432 12234456778888999999999999999875 4567
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
++||||+++|+|.+++... +.+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 8999999999999999764 568999999999999999999999999999999999999999999999999997654332
Q ss_pred C---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHH
Q psy2648 200 K---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCEN 274 (708)
Q Consensus 200 ~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~ 274 (708)
. .....++..|+|||++.+..++ .++|||||||++|||++ |..||.+....++.+.+..+.. ..|...+.++.+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM 242 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence 1 2334577789999999877775 79999999999999998 9999999888877777766643 345566789999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||..||++|||++++.
T Consensus 243 li~~c~~~~p~~Rps~~el~ 262 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELA 262 (279)
T ss_pred HHHHHcCCCcccCcCHHHHH
Confidence 99999999999999999887
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.93 Aligned_cols=244 Identities=33% Similarity=0.557 Sum_probs=206.2
Q ss_pred EEEeEEcccCceEEEEEEEc----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 49 KLLKTIGKGNFAKVKLAKHV----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 49 ~i~~~LG~G~fg~V~la~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++.+.||.|+||.||+|.+. ..+..|+||+++. .......+.+.+|+++|++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 57889999999999999988 4567899999954 334455778999999999999999999999999888899999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q psy2648 125 EYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-- 200 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-- 200 (708)
|||++|+|.++|... ..+++.....++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999987 6799999999999999999999999999999999999999999999999999876632221
Q ss_pred -ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q psy2648 201 -LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLK 277 (708)
Q Consensus 201 -~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~ 277 (708)
.....+...|+|||.+.+..++ .++||||||+++|||++ |+.||.+.+..++..++..+.. ..|..++.++.++|.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence 1234567789999999887764 89999999999999999 7899999999998888876643 356678999999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..||.+||+++++.
T Consensus 240 ~C~~~~p~~RPs~~~i~ 256 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEIL 256 (259)
T ss_dssp HHT-SSGGGS--HHHHH
T ss_pred HHcCCChhhCcCHHHHH
Confidence 99999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.62 Aligned_cols=245 Identities=28% Similarity=0.476 Sum_probs=209.5
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.+++.++||||+++++++. ....|+|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 3467999999999999999999765 5677999998765443 345889999999999999999999885 4568999
Q ss_pred EeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 124 MEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||+++++.+||+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999998764 35899999999999999999999999999999999999999999999999999765432211
Q ss_pred --cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Q psy2648 202 --DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLK 277 (708)
Q Consensus 202 --~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~ 277 (708)
....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+ ..+.|...+.++.+||.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred cccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 123355679999998877764 78999999999999999 99999998888888777655 34566678899999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||++|||++++.
T Consensus 238 ~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 238 QCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HHcccCcccCcCHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=347.28 Aligned_cols=252 Identities=29% Similarity=0.522 Sum_probs=204.0
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK--- 118 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 118 (708)
...+++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+++++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 34577999999999999999999999999999999998754333333345678999999999999999999987653
Q ss_pred -----EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 119 -----TLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 119 -----~~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
..|+||||+.+ +|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 46999999975 7888776543 6899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CC----
Q psy2648 193 NEFTPGN-----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--GK---- 261 (708)
Q Consensus 193 ~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--~~---- 261 (708)
....... ......++..|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.. +.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 7653221 123456788999999987654335789999999999999999999988765543332221 10
Q ss_pred -------------CCCC-------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 -------------YRIP-------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 -------------~~~p-------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+| ...++.+.+||.+||..||.+|||+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 0011 12356788999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.08 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=204.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC-C
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE-K 118 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~ 118 (708)
++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 47999999999999999999754 456889999987543 234456788999999999 899999999987654 5
Q ss_pred EEEEEEeccCCCChHHHHHHc-----------------------------------------------------------
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH----------------------------------------------------------- 139 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~----------------------------------------------------------- 139 (708)
.+|++|||+++++|.++|...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC---ccccccCCcccccc
Q psy2648 140 --GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPE 214 (708)
Q Consensus 140 --~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE 214 (708)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... .....++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 2578889999999999999999999999999999999999999999999999976532211 12334567899999
Q ss_pred cccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHH
Q psy2648 215 LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE-LRERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLE 291 (708)
Q Consensus 215 ~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~-l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~ 291 (708)
++.+..++ .++|||||||+||+|++ |..||.+....+ +...+..+. ...|...++++.+++.+||+.+|++||+++
T Consensus 246 ~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 246 SIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99888875 78999999999999997 999998754433 334444432 234667789999999999999999999999
Q ss_pred HHh
Q psy2648 292 VSG 294 (708)
Q Consensus 292 ~~~ 294 (708)
++.
T Consensus 325 ell 327 (337)
T cd05054 325 ELV 327 (337)
T ss_pred HHH
Confidence 887
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.99 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=201.2
Q ss_pred CCe-EEEeEEcccCceEEEEEE----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--C
Q psy2648 46 GKY-KLLKTIGKGNFAKVKLAK----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--K 118 (708)
Q Consensus 46 ~~Y-~i~~~LG~G~fg~V~la~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 118 (708)
++| ++++.||+|+||+||++. ...+++.||+|++.... .......+.+|+++|+.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 456 999999999999998865 34578899999987542 233456688999999999999999999987653 4
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+++++|.+++.. ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....+
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 68999999999999999865 46999999999999999999999999999999999999999999999999998765433
Q ss_pred CC----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHHc
Q psy2648 199 NK----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR---------------ELRERVLR 259 (708)
Q Consensus 199 ~~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~---------------~l~~~i~~ 259 (708)
.. .....++..|+|||++.+..++ .++|||||||++|+|++|..||...... .+.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 21 1223456679999999877664 7999999999999999999998653211 11111111
Q ss_pred C-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhhh
Q psy2648 260 G-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 260 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
+ ....|...+.++.+++.+||..||++|||++++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~ 277 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI 277 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1 123355678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.34 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=210.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVP-----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+|++.+.||+|+||.||+|.+.. ....||+|.+.... .....+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 58899999999999999998753 33679999886543 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy2648 122 LVMEYASGGEVFDYLVLH------------------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 177 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~------------------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNIL 177 (708)
+||||+.+++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999999999998642 24778889999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q psy2648 178 LDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253 (708)
Q Consensus 178 ld~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l 253 (708)
+++++.+||+|||+++...... .....+++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....++
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999987543221 12234567789999999877764 78999999999999998 9999999888888
Q ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 254 RERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 254 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.+..+ ....|...+.++.++|.+||+.||.+||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 8777654 3345677889999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=339.82 Aligned_cols=248 Identities=30% Similarity=0.497 Sum_probs=208.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC----
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEK---- 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---- 118 (708)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.+ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35899999999999999999999999999999999875432 345688999999998 7999999999997644
Q ss_pred --EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 119 --TLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 119 --~~ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
.+|+||||+++++|.+++.. ...+++..++.++.||+.||+|||+++|+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999998865 357899999999999999999999999999999999999999999999999998
Q ss_pred cccCCC-CCccccccCCcccccccccCCc----cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---C
Q psy2648 193 NEFTPG-NKLDTFCGSPPYAAPELFQGKK----YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---I 264 (708)
Q Consensus 193 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~----~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~ 264 (708)
...... .......|++.|+|||++.... ..+.++|||||||+||+|++|..||...........+..+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 654322 2234567899999999986432 1236899999999999999999999876655555555554321 2
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+.++.+||++||..||++|||++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 334678999999999999999999999876
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.84 Aligned_cols=241 Identities=32% Similarity=0.525 Sum_probs=208.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI-ETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~ylV 123 (708)
..+|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.+++.++||||+++++++ .....+|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 45799999999999999999976 47889999986432 245688999999999999999999975 455679999
Q ss_pred EeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 124 MEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
|||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||+++..... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--C
Confidence 99999999999997654 3789999999999999999999999999999999999999999999999998754322 2
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~ 279 (708)
....++..|+|||++.+..++ .++|||||||++|+|++ |..||...+..++...+..+. ...+...++.+.++|.+|
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred CCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 334556789999999887764 78999999999999997 999999988888888776652 345567889999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|..||++|||++++.
T Consensus 236 l~~~p~~Rpt~~~l~ 250 (256)
T cd05082 236 WHLDAATRPSFLQLR 250 (256)
T ss_pred hcCChhhCcCHHHHH
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=342.53 Aligned_cols=246 Identities=29% Similarity=0.491 Sum_probs=213.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
..|+.++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 358889999999999999999999999999999875532 3445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~ 204 (708)
|+++++|.+++. .+.+++.++..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 999999999886 4679999999999999999999999999999999999999999999999999987654322 22335
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~d 283 (708)
.++..|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+..+. ..++...+.++.++|.+||..|
T Consensus 162 ~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred cCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence 688899999999877664 78999999999999999999999887776665554442 2344567789999999999999
Q ss_pred CCCCCCHHHHh
Q psy2648 284 PAKRASLEVSG 294 (708)
Q Consensus 284 P~~Rps~~~~~ 294 (708)
|++||+++++.
T Consensus 241 p~~Rp~~~~il 251 (277)
T cd06640 241 PSFRPTAKELL 251 (277)
T ss_pred cccCcCHHHHH
Confidence 99999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.37 Aligned_cols=246 Identities=24% Similarity=0.416 Sum_probs=213.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
-.+|++++.||.|+||.||+|.+.. ++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 3469999999999999999999987 88999999876532 23456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-c
Q psy2648 125 EYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-L 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-~ 201 (708)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 999999999999753 4589999999999999999999999999999999999999999999999999876543221 1
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~ 279 (708)
....++..|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..++...+..+ ....|...++++.++|.+|
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred cCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence 233456789999999877764 78999999999999998 89999998888887777755 3345667889999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|..||++|||+.++.
T Consensus 241 l~~~p~~Rpt~~~l~ 255 (261)
T cd05148 241 WAAEPEDRPSFKALR 255 (261)
T ss_pred cCCCchhCcCHHHHH
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.62 Aligned_cols=244 Identities=32% Similarity=0.519 Sum_probs=211.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+.+|+++++.++||||+++++++.+...+|++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57999999999999999999999999999999986432 25678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
|+++++|.+++... ..+++.+++.++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++....... ....
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999999998764 568999999999999999999999999999999999999999999999999987654433 2334
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK---YRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~---~~~p~~~s~~~~~Li~~~L 280 (708)
..|+..|+|||++.+..++ .++|||||||++|+|++|+.||...+..+....+.... ...|...+.++.++|.+||
T Consensus 159 ~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred ccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 5688999999999888764 78999999999999999999998776555444433221 2234456789999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
+.||.+|||+++++
T Consensus 238 ~~~P~~Rps~~~il 251 (256)
T cd06612 238 VKDPEERPSAIQLL 251 (256)
T ss_pred hcChhhCcCHHHHh
Confidence 99999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=345.69 Aligned_cols=247 Identities=28% Similarity=0.495 Sum_probs=211.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..+|++++.||+|+||.||++.+..+++.||+|++.... .....+.+.+|+++++.++||||+++++.+.....+|+||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 457999999999999999999999999999999987543 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||+++++|.+++...+.+++..++.++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++..... .....
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-~~~~~ 161 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-SIADT 161 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh-hccCc
Confidence 999999999999888889999999999999999999997 6999999999999999999999999999865432 22345
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHcCC-CCCCCC-CCH
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-----------RELRERVLRGK-YRIPFY-MST 270 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-----------~~l~~~i~~~~-~~~p~~-~s~ 270 (708)
.+|+..|+|||++.+..++ .++|||||||++|+|++|..||..... .++...+.... ..++.. .+.
T Consensus 162 ~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 6899999999999877654 789999999999999999999986543 13333443332 223333 678
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||..||++|||++++.
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~ 264 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLC 264 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHh
Confidence 899999999999999999999877
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.70 Aligned_cols=246 Identities=32% Similarity=0.568 Sum_probs=221.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||++.+..+++.||||.+.+..........+.+|+++++.++||||+++++++.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58999999999999999999999999999999987665555667788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc
Q psy2648 127 ASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202 (708)
Q Consensus 127 ~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~ 202 (708)
+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 999999999866 356899999999999999999999999999999999999999999999999998765443 334
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~ 281 (708)
...+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+..++...+..+.+. .+...+.++.++|.+||.
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred cccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence 46789999999999887764 7899999999999999999999999988888888777653 556788999999999999
Q ss_pred hCCCCCCCHHHHh
Q psy2648 282 LNPAKRASLEVSG 294 (708)
Q Consensus 282 ~dP~~Rps~~~~~ 294 (708)
.||++||+++++.
T Consensus 239 ~~p~~Rp~~~~~l 251 (256)
T cd08530 239 VKPKLRPNCDKIL 251 (256)
T ss_pred CCcccCCCHHHHh
Confidence 9999999998765
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.28 Aligned_cols=249 Identities=31% Similarity=0.534 Sum_probs=202.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+++|++.+.||+|+||.||+|.++.+++.||||.+...... .....+.+|+++++.++||||+++++++.+++..|+|
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 357899999999999999999999999999999998754322 1223467899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCc
Q psy2648 124 MEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~ 201 (708)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999985 999988765 4689999999999999999999999999999999999999999999999999865322 1122
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcC-------------------C
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLRG-------------------K 261 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~~-------------------~ 261 (708)
....+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+ ..+....+... .
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 234578899999998764433578999999999999999999997665 22222222110 0
Q ss_pred CCCC-----------CCCC--HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 YRIP-----------FYMS--TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 ~~~p-----------~~~s--~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+ ..++ .++.++|.+||+.||++|||+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 0000 1233 7889999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.19 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=211.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
..+|+..+.||+|+||.||+|.+..+++ .||||.+.... .....+.+..|+++++.++||||+++++++...+.+|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4578999999999999999999876665 79999986543 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
+||||+++++|.+++..+ +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999999998764 5789999999999999999999999999999999999999999999999999876532211
Q ss_pred c--c--ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 201 L--D--TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 201 ~--~--~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
. . ....++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..++...+..+. .+.+...+.++.+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1 1 11234579999999877764 78999999999999997 999999888888877776552 2334457889999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||..||++||+++++.
T Consensus 242 li~~c~~~~p~~Rp~~~~i~ 261 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIV 261 (268)
T ss_pred HHHHHcCCCcccCcCHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.84 Aligned_cols=250 Identities=30% Similarity=0.455 Sum_probs=206.1
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEE----
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIE---- 115 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~---- 115 (708)
-....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34456789999999999999999999999999999999865321 234577899999999 6999999999873
Q ss_pred -eCCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEecc
Q psy2648 116 -TEKTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190 (708)
Q Consensus 116 -~~~~~ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFG 190 (708)
....+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 44679999999999999988753 3568999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCC-CccccccCCcccccccccC-----CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--
Q psy2648 191 FSNEFTPGN-KLDTFCGSPPYAAPELFQG-----KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-- 262 (708)
Q Consensus 191 ls~~~~~~~-~~~~~~Gt~~Y~APE~l~~-----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-- 262 (708)
++....... ......|++.|+|||++.. ..+ +.++|||||||++|+|++|..||...+.......+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 987654322 2334579999999999853 234 4689999999999999999999987765444333333221
Q ss_pred -CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 -RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 -~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..|...+.++.+||.+||..||++||+++++.
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 23445678999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.05 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=214.3
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 3467999999999999999999875 367899999987543 3334456889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG----------------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 176 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~----------------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNI 176 (708)
.+|+||||+++|+|.+++.... .+++.++..++.||+.||.|||+++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999997532 367888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q psy2648 177 LLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252 (708)
Q Consensus 177 Lld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~ 252 (708)
|++.++.+||+|||++........ ......++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999875432211 1223456779999999887764 79999999999999997 999999988888
Q ss_pred HHHHHHcCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhhh
Q psy2648 253 LRERVLRGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 253 l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
+...+..+.. ..|...+.++.+||.+||+.||.+|||++++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8888877754 3466778999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=367.85 Aligned_cols=242 Identities=35% Similarity=0.564 Sum_probs=215.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM-LDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~y 121 (708)
+....|++...+|.|+|+.|..|.+..+++..|||++.+...+ ..+|+.++.. -+||||+++++++.+..+.|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceee
Confidence 4567899999999999999999999999999999999876322 2356766544 47999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE-cCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL-DSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl-d~~~~iKL~DFGls~~~~~~~~ 200 (708)
+|||++.|+.|.+.+.....+. .++..|++||+.|+.|||++|||||||||+|||+ ++.++++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999999998776666 8889999999999999999999999999999999 69999999999999876544
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~-~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
..+-|-|..|.|||++....|+ +++|||||||+||+||+|+.||...... ++..+|..+++. ..+|.+++|||++|
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQL 546 (612)
T ss_pred hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHh
Confidence 4566788899999999988886 8999999999999999999999876555 888888877666 68999999999999
Q ss_pred hhhCCCCCCCHHHHh---hh
Q psy2648 280 LVLNPAKRASLEVSG---EV 296 (708)
Q Consensus 280 L~~dP~~Rps~~~~~---~~ 296 (708)
|+.||.+|++++++. |+
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 999999999999987 76
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.55 Aligned_cols=249 Identities=31% Similarity=0.527 Sum_probs=212.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..+|++.+.||+|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 47899999999999999999999999999999999754432 3456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99999999998854 568999999999999999999999999999999999999999999999999987654332 2234
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CC--CCCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-GK--YRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~-~~--~~~p~~~s~~~~~Li~~~L 280 (708)
..+++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+.. +. ...|...+..+.+||.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253 (297)
T ss_pred ccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence 578999999999988776 4799999999999999999999987654332222222 21 1245567888999999999
Q ss_pred hhCCCCCCCHHHHh---hhh
Q psy2648 281 VLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~ 297 (708)
..||++||+++++. |+.
T Consensus 254 ~~~p~~Rps~~~il~~~~~~ 273 (297)
T cd06656 254 EMDVDRRGSAKELLQHPFLK 273 (297)
T ss_pred cCChhhCcCHHHHhcCchhc
Confidence 99999999999887 654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=363.18 Aligned_cols=244 Identities=30% Similarity=0.539 Sum_probs=210.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..-|..++.||-|+||+|.|++...|...||+|.+.|... .......+..|..||...+.+.||+||..|++++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3468899999999999999999999999999999987642 344556678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC------
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP------ 197 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~------ 197 (708)
|||++|||+..+|.+.+-|.|+.|++|+.+|.+|+++.|..|+|||||||+|||||.+|+|||+||||+.-|..
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999864421
Q ss_pred ---CC----------------------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc
Q psy2648 198 ---GN----------------------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 240 (708)
Q Consensus 198 ---~~----------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt 240 (708)
+. .....+||+.|+|||++....|. ..+||||.|||||||+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhh
Confidence 00 01235699999999999988885 68999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCC--CCCC--CCCCHHHHHHHHHhhhhCCCCCCCH
Q psy2648 241 GSLPFDGSTLRELRERVLRGK--YRIP--FYMSTDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 241 G~~Pf~~~~~~~l~~~i~~~~--~~~p--~~~s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
|+.||.+.+.-+...+|..-. ..+| ..+|+||.+||.++.+ +++.|..-
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGk 919 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGK 919 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcc
Confidence 999999877766655554432 2233 4689999999998765 78888753
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.62 Aligned_cols=247 Identities=25% Similarity=0.439 Sum_probs=213.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.++|++.+.||+|+||.||+|.++.+|+ .||+|.+.+... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 3579999999999999999999887765 589998875532 4455678899999999999999999999987 789
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999999875 468999999999999999999999999999999999999999999999999997664332
Q ss_pred Cc---cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 200 KL---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 200 ~~---~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
.. ....++..|+|||.+....++ .++|||||||++|+|++ |..||.+....++.+.+..+. ...|...+.++.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 21 112235679999999877664 78999999999999998 999999999888888888764 3456677899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|.+||..||.+||++.++.
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred HHHHHcCCChhhCCCHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=368.32 Aligned_cols=246 Identities=30% Similarity=0.496 Sum_probs=221.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+.|+|+..||.|+||+||+|..+.++-..|-|+|... ..+.++.++-||+||...+||+||+|++.|..++.+||..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4689999999999999999999999999999999754 35677889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCccc
Q psy2648 126 YASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~~~ 203 (708)
||.||-....+..-+ .|.|.+++.+++|++.||.|||+++|||||||..|||+.-+|.|+|+|||.+.... .-..-.+
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 999999988776654 59999999999999999999999999999999999999999999999999986442 2234578
Q ss_pred cccCCccccccccc-----CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHH
Q psy2648 204 FCGSPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---IPFYMSTDCENL 275 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~-----~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~p~~~s~~~~~L 275 (708)
+.|||.|||||+.. ..+|+ .++||||||++|.+|.-+.+|....++..++-+|.+..++ -|..++..+.|+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred ccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 99999999999874 45776 7999999999999999999999999998888888877654 478899999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|++||.+||..||+..++.
T Consensus 269 Lk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred HHHHHhcCCccCCCHHHHh
Confidence 9999999999999998776
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.99 Aligned_cols=246 Identities=28% Similarity=0.451 Sum_probs=207.9
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+..+ ..||+|++..... ..+.+.+|+++++.++||||+++++++.. ...|+|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV 78 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence 346799999999999999999987655 4699998865432 23567889999999999999999998854 568999
Q ss_pred EeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-
Q psy2648 124 MEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK- 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~- 200 (708)
|||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999999997643 478899999999999999999999999999999999999999999999999976543221
Q ss_pred -ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Q psy2648 201 -LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLK 277 (708)
Q Consensus 201 -~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~ 277 (708)
.....++..|+|||.+.+..++ .++|||||||++|+|++ |.+||.+.+..+....+..+ ....|...+..+.++|+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 1223456789999998877764 78999999999999999 99999998888877777665 23455667899999999
Q ss_pred HhhhhCCCCCCCHHHHhh
Q psy2648 278 KFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~~ 295 (708)
+||.+||.+||+++++..
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.86 Aligned_cols=248 Identities=30% Similarity=0.457 Sum_probs=203.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE-----
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKT----- 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~----- 119 (708)
++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998765433333456788999999995 6999999999887665
Q ss_pred EEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEeccCcc
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSN 193 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DFGls~ 193 (708)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 899888653 34799999999999999999999999999999999999998 8899999999987
Q ss_pred ccCCC-CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--C--------
Q psy2648 194 EFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--Y-------- 262 (708)
Q Consensus 194 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~-------- 262 (708)
.+... .......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+...++.... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 65322 222334678899999998764433579999999999999999999998876554433332210 0
Q ss_pred -------CCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 -------RIP-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 -------~~p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..| ...++++.+||.+||..||.+||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 001 23678899999999999999999999887
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.97 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=209.0
Q ss_pred CccCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 116 (708)
...++|.+.+.||+|+||.||+|.+ ..++..||||++++.. .....+.+.+|+++++++ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 3345799999999999999999975 3456689999987543 233456788999999999 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
.+.+|+||||+.+|+|.+++.... .+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||+++.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999999997643 389999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC--CCCCCC
Q psy2648 195 FTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY--RIPFYM 268 (708)
Q Consensus 195 ~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~--~~p~~~ 268 (708)
...... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+...+.....+ ..|...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 543221 1223457789999999887764 78999999999999998 9999988765544433333222 345567
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++++.+||.+||..||++||+++++.
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell 295 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIV 295 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 89999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.34 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=209.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
-++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+|+.++||||+++++++. .+.+|+||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 357999999999999999999854 6788999999765443 346789999999999999999999874 45789999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q psy2648 125 EYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-- 200 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-- 200 (708)
||+.+++|.+++... ..+++.++..++.||+.||+|||++|++||||||+||++++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999999998764 3588999999999999999999999999999999999999999999999999876542221
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKK 278 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~ 278 (708)
.....++..|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..++...+..+. ...|...+.++.++|.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred ccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 123345678999999987766 478999999999999999 999999988888877776552 34566778899999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||++||+++++.
T Consensus 239 ~l~~~p~~Rp~~~~l~ 254 (260)
T cd05067 239 CWKEKPEERPTFEYLR 254 (260)
T ss_pred HccCChhhCCCHHHHH
Confidence 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.31 Aligned_cols=249 Identities=30% Similarity=0.507 Sum_probs=214.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+++++.++||||+++++++..+..+|+|||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 468889999999999999999999999999999976543 3445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|+++++|.+++... ..+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~ 158 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-AKT 158 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-hhc
Confidence 99999999999876 789999999999999999999999 999999999999999999999999999986553222 123
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCC-CCCCCC-CCHHHHHHH
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-----TLRELRERVLRGK-YRIPFY-MSTDCENLL 276 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-----~~~~l~~~i~~~~-~~~p~~-~s~~~~~Li 276 (708)
..++..|+|||.+.+..++ .++|||||||++|+|++|..||... ...+..+.+.... ...|.. .+.++.++|
T Consensus 159 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred ccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 7789999999999888764 7899999999999999999999764 3344445554443 234444 788999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+||..||.+||++++++ |++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCchhh
Confidence 999999999999999987 664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.05 Aligned_cols=247 Identities=31% Similarity=0.576 Sum_probs=214.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|.+.+.||+|+||.||+|.+..+|..||+|.+..........+.+.+|+++++.++||||+++++.++....+|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58999999999999999999999999999999977654444556778999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-EEEEeccCccccCCCC-Ccc
Q psy2648 127 ASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGN-KLD 202 (708)
Q Consensus 127 ~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~-iKL~DFGls~~~~~~~-~~~ 202 (708)
+++++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+||++++++. +||+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999987654 4789999999999999999999999999999999999998864 6999999987654332 223
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~ 281 (708)
...|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+..+....+..+... .+...+.++.++|.+||.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred ccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 35689999999999877664 7899999999999999999999988777766666655432 444578899999999999
Q ss_pred hCCCCCCCHHHHh
Q psy2648 282 LNPAKRASLEVSG 294 (708)
Q Consensus 282 ~dP~~Rps~~~~~ 294 (708)
.||++|||++++.
T Consensus 240 ~~p~~Rpt~~~ll 252 (257)
T cd08225 240 VSPRDRPSITSIL 252 (257)
T ss_pred cChhhCcCHHHHh
Confidence 9999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.16 Aligned_cols=248 Identities=28% Similarity=0.458 Sum_probs=205.7
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe-----
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET----- 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----- 116 (708)
...+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 34579999999999999999999999999999999986542 2345677899999988 79999999999843
Q ss_pred -CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 117 -EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 117 -~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 46789999999999999998764 358899999999999999999999999999999999999999999999999987
Q ss_pred ccCC-CCCccccccCCcccccccccC-----CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-C-CC
Q psy2648 194 EFTP-GNKLDTFCGSPPYAAPELFQG-----KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-R-IP 265 (708)
Q Consensus 194 ~~~~-~~~~~~~~Gt~~Y~APE~l~~-----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~-~p 265 (708)
.... ........|++.|+|||++.. ..++ .++|||||||++|+|++|..||......+....+..... . .+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 5432 122345679999999999863 3343 689999999999999999999987665444333333321 1 12
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.+||.+||..||.+||++++++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 34688999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=332.59 Aligned_cols=240 Identities=30% Similarity=0.468 Sum_probs=205.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGE 131 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~ 131 (708)
+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+++++.++||||+++++++......|+||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999864 68899999987543 33344568899999999999999999999999999999999999999
Q ss_pred hHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--ccccccCC
Q psy2648 132 VFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSP 208 (708)
Q Consensus 132 L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~--~~~~~Gt~ 208 (708)
|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....+.. .....+++
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 99998754 4678999999999999999999999999999999999999999999999999875432211 11224456
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAK 286 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~ 286 (708)
.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. ...|...+.++.+++.+||..||++
T Consensus 159 ~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 159 KWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred cccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 79999999877664 78999999999999998 999999888888777776653 3456678899999999999999999
Q ss_pred CCCHHHHh
Q psy2648 287 RASLEVSG 294 (708)
Q Consensus 287 Rps~~~~~ 294 (708)
||+++++.
T Consensus 238 Rp~~~~l~ 245 (250)
T cd05085 238 RPKFSELQ 245 (250)
T ss_pred CCCHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.66 Aligned_cols=247 Identities=37% Similarity=0.648 Sum_probs=221.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||++.+..+++.||+|++..........+.+.+|+++++.++|||++++++.+.....+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58999999999999999999999999999999987665556667788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cc
Q psy2648 127 ASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KL 201 (708)
Q Consensus 127 ~~gg~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~ 201 (708)
+++++|.+++... ..+++.++..++.||+.||.|||++|++|+||+|+||+++.+++++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999999764 679999999999999999999999999999999999999999999999999987654432 33
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L 280 (708)
...+|++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..++...+..... .+|...+.++.++|.+||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 456789999999998887764 789999999999999999999998888888777766643 456678899999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
..||++||++++++
T Consensus 240 ~~~p~~Rp~~~~ll 253 (258)
T cd08215 240 QKDPEERPSIAQIL 253 (258)
T ss_pred CCChhhCcCHHHHh
Confidence 99999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.38 Aligned_cols=246 Identities=32% Similarity=0.518 Sum_probs=216.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 689999999999999999999999999999998765432 4456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc-ccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTF 204 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~-~~~ 204 (708)
+++++|.+++.....+++..+..++.||+.||+|||+ ++++||||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9999999999888889999999999999999999999 99999999999999999999999999998766433322 256
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCC-CCCCCC-CCHHHHHHHHHh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGK-YRIPFY-MSTDCENLLKKF 279 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~-~~~p~~-~s~~~~~Li~~~ 279 (708)
.++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...++...+.... ...+.. .+..+.++|++|
T Consensus 161 ~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 78899999999987765 47899999999999999999999876 5566666666443 334555 788999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|..+|++||+++++.
T Consensus 240 l~~~p~~R~~~~~ll 254 (264)
T cd06623 240 LQKDPKKRPSAAELL 254 (264)
T ss_pred ccCChhhCCCHHHHH
Confidence 999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.71 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=205.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCC--------------cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTG--------------KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL 110 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg--------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 110 (708)
..+|++.+.||+|+||.||+|++..++ ..||||++.... .......+.+|+++|+.++||||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 358999999999999999999876432 359999987542 34445678899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q psy2648 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHG------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 178 (708)
Q Consensus 111 ~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl 178 (708)
++++......|+||||+.+++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999986542 36788899999999999999999999999999999999
Q ss_pred cCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHHH
Q psy2648 179 DSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS--GSLPFDGSTLREL 253 (708)
Q Consensus 179 d~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt--G~~Pf~~~~~~~l 253 (708)
+.++.+||+|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..++
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999876533221 122345678999999987776 489999999999999988 7889988776666
Q ss_pred HHHHHc-----CC---CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 254 RERVLR-----GK---YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 254 ~~~i~~-----~~---~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.. +. ...+...++++.+||.+||..||++||+++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 554422 11 123455788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.81 Aligned_cols=246 Identities=30% Similarity=0.524 Sum_probs=206.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+.++++++||||+++++++.+.+.+||||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 59999999999999999999999999999999976532 22345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccc
Q psy2648 127 ASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLD 202 (708)
Q Consensus 127 ~~gg~L~~~i~~~~---~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~ 202 (708)
+++ +|.+++...+ .+++.++..++.||+.||.|||++||+||||||+||++++++.+||+|||++....... ...
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 985 8998887653 58999999999999999999999999999999999999999999999999987553321 223
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------------------CCC
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK------------------YRI 264 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~------------------~~~ 264 (708)
...+++.|++||++.+....+.++|||||||++|+|++|..||.+.+..+....+.... ..+
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 45678899999998775444578999999999999999999999877665554443210 001
Q ss_pred C-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 P-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
| ...++++.++|.+||+.||.+||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 1 23577899999999999999999999876
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.35 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=207.3
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC-----
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE----- 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----- 117 (708)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 36789999999999999999999999999999999865422 234567899999998 899999999998754
Q ss_pred CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
..+|+||||+++++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 368999999999999998753 3568999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CccccccCCcccccccccCCcc----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCC
Q psy2648 194 EFTPGN-KLDTFCGSPPYAAPELFQGKKY----DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIP 265 (708)
Q Consensus 194 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~----~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p 265 (708)
...... .....+|++.|+|||++..... .+.++|||||||++|+|++|+.||...+..+....+.++.. ..|
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP 256 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcc
Confidence 654322 2234578999999999864321 24789999999999999999999988776555555554422 234
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.+||.+||..||++||+++++.
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 45678899999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=337.37 Aligned_cols=248 Identities=30% Similarity=0.441 Sum_probs=207.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC--------hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN--------PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
+|.+.+.||+|+||.||+|.+..+++.||||.+...... ....+.+.+|+.+++.++||||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999999999999988643211 112345778999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998754321
Q ss_pred ---CCccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCCCCC----CC
Q psy2648 199 ---NKLDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KYRIPF----YM 268 (708)
Q Consensus 199 ---~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~~~p~----~~ 268 (708)
.......|+..|+|||++.... ..+.++|+|||||++|+|++|..||......+....+... ...+|. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1123457889999999987654 1247899999999999999999999766554433333222 122232 35
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.++.++|.+||..||++||++++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 78999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=375.45 Aligned_cols=247 Identities=27% Similarity=0.457 Sum_probs=217.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+-+..+.||+|.||+||+|+-. .....||||.++... +....+.|.||+++|..|+|||||+|++++..++.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45677899999999999999854 334679999997553 334567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEE
Q psy2648 121 YLVMEYASGGEVFDYLVLHG--------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~--------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL 186 (708)
|+|+||+..|||.+||+.++ .++..+...++.||+.||+||-++.+|||||...|+|+.++..|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 99999999999999998643 2678899999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCccc---cccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q psy2648 187 ADFGFSNEFTPGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY 262 (708)
Q Consensus 187 ~DFGls~~~~~~~~~~~---~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~ 262 (708)
+||||++..-..+..+. ..=-..|||||.|...+|+ .++||||+||+|||+++ |..||.+.+.+|+++.|..|+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 99999986543322211 1223579999999999996 79999999999999998 9999999999999999999975
Q ss_pred -CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 -RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 -~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..|..++.++.+||..||+.+|.+||++.+|.
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 56889999999999999999999999999987
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.51 Aligned_cols=239 Identities=28% Similarity=0.480 Sum_probs=187.7
Q ss_pred EeEEcccCceEEEEEEEcC--CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEEec
Q psy2648 51 LKTIGKGNFAKVKLAKHVP--TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKTLYLVMEY 126 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ylVmEy 126 (708)
...||+|+||.||+|++.. +++.||+|.+..... ...+.+|+++|+.++||||+++++++.. +..+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4689999999999999764 668999999875432 2356789999999999999999999853 5678999999
Q ss_pred cCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCcEEEEeccCcc
Q psy2648 127 ASGGEVFDYLVLH---------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL----DSEMNIKIADFGFSN 193 (708)
Q Consensus 127 ~~gg~L~~~i~~~---------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl----d~~~~iKL~DFGls~ 193 (708)
+.+ +|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 788877532 247899999999999999999999999999999999999 566789999999997
Q ss_pred ccCCC----CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----------HHHHHH--
Q psy2648 194 EFTPG----NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR----------ELRERV-- 257 (708)
Q Consensus 194 ~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~----------~l~~~i-- 257 (708)
..... .......||+.|+|||++.+....+.++|||||||++|+|++|..||...... .+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 65432 12345678999999999987554468999999999999999999999753211 110000
Q ss_pred -------------------------HcCCCC----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 258 -------------------------LRGKYR----------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 258 -------------------------~~~~~~----------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+. .....+..+.+||.+||+.||.+|||+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 000000 0112345688999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.30 Aligned_cols=247 Identities=29% Similarity=0.491 Sum_probs=218.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|++.+.||+|+||.||++.+..+++.||||.+..........+.+.+|+++++.++||||+++++++.+...+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999999999999999987765555667889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-ccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-~~~~~ 205 (708)
+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 99999999998888999999999999999999999999999999999999999999999999999876644322 23467
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL-RGKYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~-~~~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
++..|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+. .....+|...+.++.++|.+||..||
T Consensus 161 ~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 161 GTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred cchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence 8999999999887765 478999999999999999999998766554444443 33445677788999999999999999
Q ss_pred CCCCCHHHHh
Q psy2648 285 AKRASLEVSG 294 (708)
Q Consensus 285 ~~Rps~~~~~ 294 (708)
++||+++++.
T Consensus 240 ~~R~~~~~~l 249 (254)
T cd06627 240 NLRPTAKQLL 249 (254)
T ss_pred hhCcCHHHHh
Confidence 9999998865
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=333.76 Aligned_cols=246 Identities=29% Similarity=0.510 Sum_probs=211.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCC---CChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ---LNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~y 121 (708)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|++++++++||||+++++.+.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 6999999999999999999999999999999986432 1234456788999999999999999999998764 5689
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC----
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP---- 197 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~---- 197 (708)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||+++....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPFYMSTDCENL 275 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~~~s~~~~~L 275 (708)
........|+..|+|||++.+..++ .++|||||||++|+|++|+.||.+....+...++.... ..+|..+++++.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence 1122346789999999999887664 78999999999999999999998876555444544332 34677889999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||. +|.+||+.+++.
T Consensus 242 i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred HHHHhc-CcccCccHHHHh
Confidence 999999 679999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=339.92 Aligned_cols=248 Identities=28% Similarity=0.479 Sum_probs=200.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+++++.++||||+++++++..+...|+||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35799999999999999999999999999999999754322 22335678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcc
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~ 202 (708)
||+. ++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9996 6888777654 5688999999999999999999999999999999999999999999999999875422 22234
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHc--C--------------CC---
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLR--G--------------KY--- 262 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~-~l~~~i~~--~--------------~~--- 262 (708)
...+++.|+|||++.+......++|||||||++|+|++|..||.+.+.. +....+.. + .+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 4567899999999876543347899999999999999999999865431 22222110 0 00
Q ss_pred CC----C---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 RI----P---------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 ~~----p---------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.. + ...++++.++|.+||+.||.+|||+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 00 0 01256889999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=340.64 Aligned_cols=237 Identities=23% Similarity=0.368 Sum_probs=198.9
Q ss_pred eEEcccCceEEEEEEEcCCCc-------EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGK-------EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~-------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+.||+|+||.||+|.+..++. .||+|++.... ....+.+..|+.+|+.++|||||++++++......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999999876554 48888876432 234457888999999999999999999999989999999
Q ss_pred eccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--------EEEEeccCcccc
Q psy2648 125 EYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN--------IKIADFGFSNEF 195 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~--------iKL~DFGls~~~ 195 (708)
||+++|+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997654 5899999999999999999999999999999999999987764 699999998655
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-SLPFDGSTLRELRERVLRGKYRIPFYMSTDCEN 274 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG-~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~ 274 (708)
.. .....+++.|+|||++.+....+.++|||||||++|+|++| ..||...+...... +......+|...+.++.+
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (258)
T cd05078 159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTELAN 234 (258)
T ss_pred CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcHHHHH
Confidence 33 23457889999999998744335789999999999999998 57777666554433 344456677777899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
||.+||+.||++|||++++.
T Consensus 235 li~~~l~~~p~~Rps~~~il 254 (258)
T cd05078 235 LINQCMDYEPDFRPSFRAII 254 (258)
T ss_pred HHHHHhccChhhCCCHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.08 Aligned_cols=245 Identities=31% Similarity=0.496 Sum_probs=212.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCC----cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTG----KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+++.+.||.|+||.||+|++..++ ..||+|++..... ....+.+..|+++++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 357889999999999999998776 8999999965432 22556788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 124 MEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
|||+++++|.+++..... +++.++..++.||+.||.|||+++++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999999976554 999999999999999999999999999999999999999999999999998765433211
Q ss_pred c--ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q psy2648 202 D--TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLK 277 (708)
Q Consensus 202 ~--~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~ 277 (708)
. ...+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..++.+.+..+.. ..|...+.++.+++.
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML 238 (258)
T ss_pred ccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 1 1236788999999976665 489999999999999998 8999999888888888877644 345668899999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..||++|||++++.
T Consensus 239 ~~l~~~p~~Rpt~~~ll 255 (258)
T smart00219 239 QCWAEDPEDRPTFSELV 255 (258)
T ss_pred HHCcCChhhCcCHHHHH
Confidence 99999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.39 Aligned_cols=249 Identities=32% Similarity=0.531 Sum_probs=211.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD---HPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ylV 123 (708)
.|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++ ||||+++++++.....+|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 4888999999999999999999999999999987543 2334566889999999986 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLD 202 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~ 202 (708)
|||+++++|.+++.. +.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 999999999998854 589999999999999999999999999999999999999999999999999987654332 234
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCC-CCCHHHHHHHHHhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPF-YMSTDCENLLKKFL 280 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~-~~s~~~~~Li~~~L 280 (708)
...|++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+.......+..... .++. ..+.++.++|.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHc
Confidence 457899999999987654445789999999999999999999988776655444433322 2333 26789999999999
Q ss_pred hhCCCCCCCHHHHh---hhh
Q psy2648 281 VLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~ 297 (708)
..||++||+++++. |+.
T Consensus 240 ~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 240 DEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred CCCcccCcCHHHHhhChHhh
Confidence 99999999999887 664
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=347.92 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=212.7
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCC-------CcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPT-------GKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQ 112 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~t-------g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 112 (708)
.+....+|++++.||+|+||.||+|++... +..||+|++... ......+.+.+|+++++++ +||||+++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 344445799999999999999999987532 236999988643 2334556788999999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy2648 113 VIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 176 (708)
Q Consensus 113 ~~~~~~~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNI 176 (708)
++.....+|+||||+++|+|.+++.... .++..++..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999997542 367788889999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q psy2648 177 LLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252 (708)
Q Consensus 177 Lld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~ 252 (708)
|++.++.+||+|||+++....... .....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999876533221 1222345679999999887775 78999999999999998 999999999888
Q ss_pred HHHHHHcCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 253 LRERVLRGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 253 l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+..+.. ..|...+.++.+||.+||..+|.+||+++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell 287 (334)
T cd05100 245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287 (334)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 8888876543 45667789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=339.29 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=206.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+++++.++||||+++++++.+...+|+||
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 36899999999999999999999999999999998765443334456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEeccCccccCCC-CC
Q psy2648 125 EYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTPG-NK 200 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DFGls~~~~~~-~~ 200 (708)
||++ ++|.+++..... +++..+..++.||+.||+|||+++|+||||||+||+++. ++.+||+|||++...... ..
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9996 588888866543 578888999999999999999999999999999999985 457999999998754322 22
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C-----------------
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K----------------- 261 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~----------------- 261 (708)
.....+++.|+|||++.+......++|||||||++|+|++|..||...+..+...++... .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 234467889999999876544457899999999999999999999877655444333210 0
Q ss_pred ----CC------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 262 ----YR------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 262 ----~~------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+. .....++++.++|.+||..||++||+++++. |+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 00 0124578899999999999999999999887 654
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.03 Aligned_cols=247 Identities=26% Similarity=0.448 Sum_probs=212.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVP-----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+|++++.||+|+||.||+|+++. +.+.||+|.+.... .....+.+.+|++++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 479999999999999999999764 34679999886532 223456788999999999999999999999998999
Q ss_pred EEEEeccCCCChHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG---------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~---------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999998765 689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC--CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC--CCC
Q psy2648 192 SNEFTPG--NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR--IPF 266 (708)
Q Consensus 192 s~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~--~p~ 266 (708)
+...... .......+++.|+|||.+.+..+ .+++|||||||++|+|++ |..||.+.+...+...+..+... .+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence 8644221 12234456778999999887765 478999999999999998 89999888888888888766544 355
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+..+.++|.+||..||.+||+++++.
T Consensus 243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l 270 (275)
T cd05046 243 GCPSRLYKLMTRCWAVNPKDRPSFSELV 270 (275)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 6788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=332.33 Aligned_cols=246 Identities=28% Similarity=0.472 Sum_probs=212.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+. .++.||||.+...... .+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 3467999999999999999999975 4578999998765433 35678999999999999999999999998999999
Q ss_pred EeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-
Q psy2648 124 MEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK- 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~- 200 (708)
|||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.....
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999999997653 689999999999999999999999999999999999999999999999999876543211
Q ss_pred -ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Q psy2648 201 -LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLK 277 (708)
Q Consensus 201 -~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~ 277 (708)
.....++..|+|||.+.+..+ ++++|||||||++|+|++ |+.||.+.+..+..+.+..+ ....|...+.++.+++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 112234568999999987766 478999999999999998 99999998888888887765 23455667889999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..||++||+++++.
T Consensus 239 ~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 239 QCWDKDPEERPTFEYLQ 255 (261)
T ss_pred HHcccCcccCCCHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.79 Aligned_cols=246 Identities=32% Similarity=0.538 Sum_probs=205.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
|++.+.||.|++|.||+|.+..+|+.||||++............+.+|+++++.++||||+++++++.+....|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67899999999999999999999999999999765443334456788999999999999999999999999999999999
Q ss_pred CCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 128 SGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 128 ~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
+ ++|.+++.... .+++..+..++.||+.||+|||+++++||||+|+|||++.++.+||+|||++...... ......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5 68999987766 7899999999999999999999999999999999999999999999999998754322 122334
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC------------------------
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------------------ 260 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------------------ 260 (708)
.+++.|+|||++.+......++|||||||++|+|++|..||.+.+.......+.+.
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 56889999999876543347899999999999999999999876654332222211
Q ss_pred -CC----CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 -KY----RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 -~~----~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.. ......+.++.++|.+||+.||.+|||+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 00 01234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.46 Aligned_cols=250 Identities=30% Similarity=0.508 Sum_probs=212.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
..|.....||+|+||.||++.+..+++.||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 34666788999999999999999999999999986532 2345568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
|+++++|.+++. .+.+++.++..++.||+.||+|||+++|+||||||+||++++++.+||+|||++...... ......
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 999999999774 567999999999999999999999999999999999999999999999999998654322 223456
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~~Li~~~L~ 281 (708)
+|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+..... ..+...+.++.++|.+||.
T Consensus 179 ~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (292)
T cd06658 179 VGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257 (292)
T ss_pred ecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence 789999999999877764 789999999999999999999998877666555544321 1223468899999999999
Q ss_pred hCCCCCCCHHHHh---hhhhC
Q psy2648 282 LNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 282 ~dP~~Rps~~~~~---~~~~~ 299 (708)
.||.+|||++++. |+...
T Consensus 258 ~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 258 REPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred CChhHCcCHHHHhhChhhhcc
Confidence 9999999999987 76644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=359.17 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=208.8
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIE 115 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 115 (708)
+...++|.+.+.||+|+||.||+|.+. .+++.||||+++.... ....+.+.+|+++|..++ |||||++++++.
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 334457899999999999999999964 4557899999976432 334457889999999998 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcC-------------------------------------------------------
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHG------------------------------------------------------- 140 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~------------------------------------------------------- 140 (708)
.+..+|||||||++|+|.+++...+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999996532
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy2648 141 -------------------------------------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 177 (708)
Q Consensus 141 -------------------------------------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNIL 177 (708)
.+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 2566778889999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q psy2648 178 LDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253 (708)
Q Consensus 178 ld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l 253 (708)
+++++.+||+|||+++....... ....++++.|+|||++.+..+ ++++|||||||++|||++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999999999999876432221 223467889999999987776 478999999999999998 9999987655544
Q ss_pred -HHHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 254 -RERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 254 -~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+..+ ....|...+.++.+||.+||..||.+||+++++.
T Consensus 351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 3444444 2345667899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=333.59 Aligned_cols=240 Identities=28% Similarity=0.476 Sum_probs=206.2
Q ss_pred eEEcccCceEEEEEEEcC-CCc--EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q psy2648 52 KTIGKGNFAKVKLAKHVP-TGK--EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYAS 128 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~-tg~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~ 128 (708)
+.||+|+||.||+|.+.. .++ .||||.+...... ...+.+.+|++++++++||||+++++++.. ..+|+||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999999865 333 6999999876543 556778899999999999999999999988 88999999999
Q ss_pred CCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC----Ccc
Q psy2648 129 GGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----KLD 202 (708)
Q Consensus 129 gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~----~~~ 202 (708)
+++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++..+.... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999997764 68999999999999999999999999999999999999999999999999987664321 112
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK--YRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~--~~~p~~~s~~~~~Li~~~ 279 (708)
...++..|+|||++.+..++ .++|||||||++|+|++ |..||...+..++...+.... ...|...+.++.+++.+|
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred CCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 34577889999999887764 78999999999999998 999999888877777666432 234556788999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|..+|++||+++++.
T Consensus 238 l~~~p~~Rps~~~~~ 252 (257)
T cd05040 238 WAHNPADRPTFAALR 252 (257)
T ss_pred CCCCcccCCCHHHHH
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.40 Aligned_cols=239 Identities=33% Similarity=0.549 Sum_probs=205.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHH-HhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIM-KMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|.+..+++.||||++.+.... ......+..|..++ ..++||||++++++++..+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765432 22233455565554 456899999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCc
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP 209 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~ 209 (708)
++|.+++...+.+++.++..++.||+.||.|||+++|+||||+|+|||++.++.+||+|||++..... .....|++.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999998888899999999999999999999999999999999999999999999999999875432 234578899
Q ss_pred ccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHhhhhCCC
Q psy2648 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENLLKKFLVLNPA 285 (708)
Q Consensus 210 Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~ 285 (708)
|+|||.+.+..+ +.++|||||||++|+|++|..||...+..++...+..+....+ ..+++++.++|.+||+.||+
T Consensus 159 y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 159 YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred ccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 999999988775 4799999999999999999999999888888887776654332 35789999999999999999
Q ss_pred CCCCH---HHHh
Q psy2648 286 KRASL---EVSG 294 (708)
Q Consensus 286 ~Rps~---~~~~ 294 (708)
+||++ ++++
T Consensus 238 ~R~~~~~~~~~l 249 (260)
T cd05611 238 KRLGANGYQEIK 249 (260)
T ss_pred HccCCCcHHHHH
Confidence 99965 5654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.15 Aligned_cols=240 Identities=38% Similarity=0.616 Sum_probs=213.5
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCh
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L 132 (708)
||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+++++.++||||+++++.++....+|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999976543 234456788999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---------Cccc
Q psy2648 133 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---------KLDT 203 (708)
Q Consensus 133 ~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~---------~~~~ 203 (708)
.+++...+.+++.++..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887889999999999999999999999999999999999999999999999999987543221 2234
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYM--STDCENLLKKFLV 281 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~--s~~~~~Li~~~L~ 281 (708)
.++++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..++...+..+.+..|... +.++.++|++||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 578889999999987765 4789999999999999999999999999998888888777777665 8999999999999
Q ss_pred hCCCCCCCH---HHHh
Q psy2648 282 LNPAKRASL---EVSG 294 (708)
Q Consensus 282 ~dP~~Rps~---~~~~ 294 (708)
.||.+|||+ .+++
T Consensus 240 ~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 240 PDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCHhhcCCCccHHHHh
Confidence 999999999 6555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=342.99 Aligned_cols=248 Identities=29% Similarity=0.480 Sum_probs=212.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+++++.++||||+++++++..+..+|+||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 47778889999999999999999999999999875533 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~ 205 (708)
+++++|.+++. .+.+++..++.++.||+.||.|||+++|+|+||+|+||++++++.+||+|||++....... ......
T Consensus 84 ~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06642 84 LGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred cCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence 99999999875 4678999999999999999999999999999999999999999999999999987654322 223456
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
|+..|+|||++.+..++ .++|||||||++|+|++|..||...........+..+. ..++...+.++.++|.+||..+|
T Consensus 163 ~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 163 GTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred CcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence 88999999999887764 78999999999999999999998776665555544432 23445578899999999999999
Q ss_pred CCCCCHHHHh---hhh
Q psy2648 285 AKRASLEVSG---EVT 297 (708)
Q Consensus 285 ~~Rps~~~~~---~~~ 297 (708)
++||+++++. |+.
T Consensus 242 ~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 242 RFRPTAKELLKHKFIT 257 (277)
T ss_pred ccCcCHHHHHHhHHHH
Confidence 9999999887 654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=330.12 Aligned_cols=246 Identities=26% Similarity=0.455 Sum_probs=211.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
...|++.+.||+|+||.||+|.+. .+..+|||++...... ...+.+|+++++.++||||++++++++....+|+||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 457999999999999999999875 4778999998755433 245788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--c
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--L 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~--~ 201 (708)
||+++++|.+++... +.++++.++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999998764 5689999999999999999999999999999999999999999999999999875432211 1
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~ 279 (708)
....++..|+|||++.+..++ .++|||||||++|+|++ |..||......++.+.+..+. ...|...+.++.+|+.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 122345689999999877764 78999999999999998 999999988888888877653 334666789999999999
Q ss_pred hhhCCCCCCCHHHHhh
Q psy2648 280 LVLNPAKRASLEVSGE 295 (708)
Q Consensus 280 L~~dP~~Rps~~~~~~ 295 (708)
|..||++||+++++..
T Consensus 238 l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 238 WKERPEDRPSFSLLLH 253 (256)
T ss_pred cccChhhCCCHHHHHH
Confidence 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.68 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=208.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----KTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 120 (708)
.+|++.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 479999999999999999999999999999999876543334455678999999999999999999987654 358
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-C
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-N 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~ 199 (708)
||||||+. ++|.+++...+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 99999996 689999988889999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-------------------- 259 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~-------------------- 259 (708)
......++..|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 334567899999999986533345799999999999999999999987654332222210
Q ss_pred ---CCC--------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 260 ---GKY--------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 260 ---~~~--------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
... ......++++.+||++||+.||++|||+++++ |+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000 01124688999999999999999999999987 7653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=341.21 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=204.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcC----------------CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeee
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVP----------------TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVK 109 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 109 (708)
++|++.+.||+|+||.||+|++.. +...||||++.... .....+.+.+|+++|+.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 479999999999999999986543 34579999986542 3344567889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q psy2648 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHG-----------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 178 (708)
Q Consensus 110 l~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl 178 (708)
+++++.....+|+||||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999987643 35677899999999999999999999999999999999
Q ss_pred cCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHHH
Q psy2648 179 DSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS--GSLPFDGSTLREL 253 (708)
Q Consensus 179 d~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt--G~~Pf~~~~~~~l 253 (708)
+.++.+||+|||+++.+..... .....+++.|+|||+..+..++ .++|||||||++|+|++ |..||...+..+.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999999876533221 1223446789999998777764 79999999999999998 8899988776665
Q ss_pred HHHHHc--------CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 254 RERVLR--------GKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 254 ~~~i~~--------~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
...+.. .....|...++.+.+||.+||+.||.+||+++++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 543321 112345567789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.53 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=205.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE-----TEKTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 120 (708)
.+|+|.+.||+|+|+.|+++++..+++.||+|.|.... .++.+..++|++..++++||||+++++..- .....
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 48999999999999999999999999999999987554 466788999999999999999999987643 23469
Q ss_pred EEEEeccCCCChHHHHHHc---C-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 121 YLVMEYASGGEVFDYLVLH---G-RMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~---~-~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
||++.|...|+|.++|... + .++|.++..||.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999998653 3 6899999999999999999999998 99999999999999999999999998765
Q ss_pred cCC---CC-------CccccccCCcccccccccCCcc--CCCchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcC
Q psy2648 195 FTP---GN-------KLDTFCGSPPYAAPELFQGKKY--DGPEVDVWSLGVILYTLVSGSLPFDGSTLR--ELRERVLRG 260 (708)
Q Consensus 195 ~~~---~~-------~~~~~~Gt~~Y~APE~l~~~~~--~~~~~DIWSlGvilyelltG~~Pf~~~~~~--~l~~~i~~~ 260 (708)
..- ++ ....-..|.+|.|||++.-+.+ .+.++|||||||+||+|+.|.-||+..-.+ .+.-.|..+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 321 11 0112346889999999864433 257999999999999999999999642111 122345666
Q ss_pred CCCCCC--CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 KYRIPF--YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 ~~~~p~--~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+|. ..|+.+.+||+.||++||.+||++.++.
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll 294 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELL 294 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 777774 4789999999999999999999998765
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=336.26 Aligned_cols=248 Identities=22% Similarity=0.357 Sum_probs=211.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcC----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVP----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-EKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 119 (708)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ......+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4589999999999999999999876 3688999988643 344556678899999999999999999998665 567
Q ss_pred EEEEEeccCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLH--------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~--------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
.++++||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998764 3588999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCC
Q psy2648 192 SNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPF 266 (708)
Q Consensus 192 s~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~ 266 (708)
++.+..... .....++..|+|||++.+..++ .++|||||||++|+|++ |+.||...+..++...+..+. +..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 986543321 1223456789999999877764 78999999999999999 999999988888877776652 23445
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..++++.+++.+||..||++|||++++.
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLV 270 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 6688999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.53 Aligned_cols=247 Identities=39% Similarity=0.696 Sum_probs=220.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVm 124 (708)
+|++.+.||+|+||.||+|....+++.||||++.+.... ....+.+.+|+.+++.++ ||||+++++++...+.+|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 699999999999999999999999999999999875432 333456789999999998 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-----
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----- 199 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~----- 199 (708)
||+++++|.+++...+.+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence 999999999999988899999999999999999999999999999999999999999999999999987553221
Q ss_pred ----------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q psy2648 200 ----------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR 263 (708)
Q Consensus 200 ----------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~ 263 (708)
......|+..|+|||++.+..+ +.++|||||||++|+|++|..||...+.....+.+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05581 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240 (280)
T ss_pred CCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence 1234567899999999887665 47899999999999999999999988877777888888888
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCH----HHHh
Q psy2648 264 IPFYMSTDCENLLKKFLVLNPAKRASL----EVSG 294 (708)
Q Consensus 264 ~p~~~s~~~~~Li~~~L~~dP~~Rps~----~~~~ 294 (708)
+|...++++.+||.+||..||.+||++ ++++
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 888899999999999999999999999 7765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=330.59 Aligned_cols=240 Identities=32% Similarity=0.483 Sum_probs=206.7
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGE 131 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~ 131 (708)
+.||+|+||.||+|.+.. ++.||+|++...... ...+.+.+|++++++++||||+++++++.+....|+||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 469999999999999887 999999998765432 345678899999999999999999999999999999999999999
Q ss_pred hHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc---cccccC
Q psy2648 132 VFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL---DTFCGS 207 (708)
Q Consensus 132 L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~---~~~~Gt 207 (708)
|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++......... ....++
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 99999764 46889999999999999999999999999999999999999999999999998755422111 122335
Q ss_pred CcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCC
Q psy2648 208 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFLVLNPA 285 (708)
Q Consensus 208 ~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~ 285 (708)
..|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+ ....|...+.++.++|.+||..||+
T Consensus 159 ~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 237 (251)
T cd05041 159 IKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE 237 (251)
T ss_pred eccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence 67999999987766 479999999999999999 89999988887777777654 2345667889999999999999999
Q ss_pred CCCCHHHHh
Q psy2648 286 KRASLEVSG 294 (708)
Q Consensus 286 ~Rps~~~~~ 294 (708)
+||+++++.
T Consensus 238 ~Rp~~~ell 246 (251)
T cd05041 238 NRPSFSEIY 246 (251)
T ss_pred hCcCHHHHH
Confidence 999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.44 Aligned_cols=247 Identities=31% Similarity=0.532 Sum_probs=218.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTLYLVM 124 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ylVm 124 (708)
+|.+.+.||+|+||.||+|.+..+++.|++|++..........+.+.+|+.++++++||||+++++.+... ..+|+||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999999999999999987655455677889999999999999999999999988 8999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC---c
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---L 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~---~ 201 (708)
||+++++|.+++.....+++.++..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||.+........ .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999877654432 3
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHc--CCCCCCCCCCHHHHHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLR--GKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~--~~~~~p~~~s~~~~~Li~~ 278 (708)
....++..|+|||.+.+..+ ..++||||||+++|+|++|..||.... .......+.. ....+|...+.++.++|.+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred cCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence 45678999999999987765 478999999999999999999998765 3344444442 3345677789999999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||++||++.++.
T Consensus 240 ~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 240 CLRRDPKKRPTADELL 255 (260)
T ss_pred hCcCChhhCCCHHHHh
Confidence 9999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=338.54 Aligned_cols=248 Identities=32% Similarity=0.597 Sum_probs=211.2
Q ss_pred CeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCC--hhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
+|++.+.||+|+||.||+|++. .+|+.||+|++.+.... ....+.+.+|+++|+.+ +||||++++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 48899999999764321 22345677899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRGKYRIPFYMSTDCE 273 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~~~~~p~~~s~~~~ 273 (708)
.....+|+..|+|||.+.+.. ..+.++|||||||++|+|++|..||... ...++.+.+......+|...++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 223567999999999987532 2347899999999999999999999643 3455666666666677778899999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHh
Q psy2648 274 NLLKKFLVLNPAKRA-----SLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rp-----s~~~~~ 294 (708)
+||++||..||++|| +++++.
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 999999999999998 556554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.74 Aligned_cols=238 Identities=31% Similarity=0.528 Sum_probs=199.9
Q ss_pred cCCeEEEeEE--cccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTI--GKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM-LDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~L--G~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~y 121 (708)
.+.|++.+.+ |+|+||.||+++++.+++.+|+|++.+..... .|+.+... .+||||+++++.+...+.+|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 4567777766 99999999999999999999999987654321 12222222 27999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~~~~~ 200 (708)
+||||+++++|.+++..+..+++.+++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999999999998888999999999999999999999999999999999999999998 9999999998755322
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHcCCCCCCCCCCHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE-----LRERVLRGKYRIPFYMSTDCENL 275 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~-----l~~~i~~~~~~~p~~~s~~~~~L 275 (708)
....|++.|+|||++.+..++ +++|||||||++|+|++|..||....... +.... ......+...++++.+|
T Consensus 164 -~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDF 240 (267)
T ss_pred -ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHH
Confidence 245789999999999888775 78999999999999999999998654332 32332 33344555789999999
Q ss_pred HHHhhhhCCCCCCC-HHHHh
Q psy2648 276 LKKFLVLNPAKRAS-LEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps-~~~~~ 294 (708)
|.+||+.||.+||+ +++++
T Consensus 241 i~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred HHHHhccChhhCCchHHHHh
Confidence 99999999999996 68877
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.74 Aligned_cols=252 Identities=26% Similarity=0.466 Sum_probs=208.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET----EKTLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~y 121 (708)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||++++++++. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57999999999999999999999999999999998654444455678899999999999999999998863 35789
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-- 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-- 199 (708)
+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999996 5899998877889999999999999999999999999999999999999999999999999987653221
Q ss_pred ---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------------
Q psy2648 200 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR----------------- 259 (708)
Q Consensus 200 ---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~----------------- 259 (708)
.....+|+..|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 123457899999999986643345789999999999999999999987654332222111
Q ss_pred ---------CCCCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 260 ---------GKYRIP-----FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 260 ---------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.....+ ...+.++.++|++||+.||++||+++++. |+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 000111 23578999999999999999999999877 7753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.26 Aligned_cols=237 Identities=21% Similarity=0.334 Sum_probs=195.0
Q ss_pred eEEcccCceEEEEEEEcCC------------CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 52 KTIGKGNFAKVKLAKHVPT------------GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~t------------g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
+.||+|+||.||+|..... ...||+|++.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3689999999999985432 2368999876542 2344567889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-------EEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-------IKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~-------iKL~DFGl 191 (708)
.++||||+++|+|..++... +.+++..+..++.||+.||+|||+++|+||||||+|||++.++. +|++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999988754 56899999999999999999999999999999999999987764 89999999
Q ss_pred ccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Q psy2648 192 SNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV-SGSLPFDGSTLRELRERVLRGKYRIPFYMST 270 (708)
Q Consensus 192 s~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyell-tG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~ 270 (708)
+..... .....++..|+|||++.+....+.++|||||||++|+|+ .|..||......+.. .+..+.+......+.
T Consensus 159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (262)
T cd05077 159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSCK 234 (262)
T ss_pred CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCChH
Confidence 865432 234568889999999874333357899999999999998 599999877655543 333444444444568
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||..||.+||++.++.
T Consensus 235 ~~~~li~~cl~~dp~~Rp~~~~il 258 (262)
T cd05077 235 ELADLMTHCMNYDPNQRPFFRAIM 258 (262)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHH
Confidence 899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=337.78 Aligned_cols=236 Identities=22% Similarity=0.321 Sum_probs=195.2
Q ss_pred EEcccCceEEEEEEEcCCC------------------------cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCee
Q psy2648 53 TIGKGNFAKVKLAKHVPTG------------------------KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108 (708)
Q Consensus 53 ~LG~G~fg~V~la~~~~tg------------------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 108 (708)
.||+|+||.||+|....++ ..||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5899999999999864322 358999886432 23345688899999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-----
Q psy2648 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM----- 182 (708)
Q Consensus 109 ~l~~~~~~~~~~ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~----- 182 (708)
++++++......|+||||+++|+|..++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999998875 46789999999999999999999999999999999999998654
Q ss_pred --cEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHc
Q psy2648 183 --NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV-SGSLPFDGSTLRELRERVLR 259 (708)
Q Consensus 183 --~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyell-tG~~Pf~~~~~~~l~~~i~~ 259 (708)
.+||+|||++...... ....+++.|+|||++.+....++++|||||||++|+|+ +|..||.+.+..+.... ..
T Consensus 160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~ 235 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YE 235 (274)
T ss_pred cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HH
Confidence 3899999987644322 23467889999999876433358999999999999995 69999988776655433 33
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 GKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 ~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.....|...++++.++|.+||+.||++||+++++.
T Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il 270 (274)
T cd05076 236 KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270 (274)
T ss_pred hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHH
Confidence 44556666778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=333.33 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=195.4
Q ss_pred eEEcccCceEEEEEEEc--CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+...+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999864 4567899998865432 23345688899999999999999999999998999999999999
Q ss_pred CChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---Cc
Q psy2648 130 GEVFDYLVLHG-----RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KL 201 (708)
Q Consensus 130 g~L~~~i~~~~-----~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~---~~ 201 (708)
|+|.+++.... ..++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999987532 35667788999999999999999999999999999999999999999999986543221 12
Q ss_pred cccccCCcccccccccCCcc------CCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCC--C---CCC
Q psy2648 202 DTFCGSPPYAAPELFQGKKY------DGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRI--P---FYM 268 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~------~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~--p---~~~ 268 (708)
...+|++.|+|||++.+... .+.++|||||||++|+|++ |..||...+..+.......+ ...+ | ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 23567889999999864321 2468999999999999996 99999877666554433322 2222 2 245
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHhhh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
++.+.++|++|+ .||++|||++++.+.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 788999999998 689999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.45 Aligned_cols=245 Identities=29% Similarity=0.502 Sum_probs=212.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
-|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++.+..+..+|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 37889999999999999999999999999999865432 23445688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~ 205 (708)
+++++|.+++. .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ......
T Consensus 84 ~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 99999999875 4578999999999999999999999999999999999999999999999999987654321 223457
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhhhhCC
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP 284 (708)
|+..|+|||.+.+..++ .++|+|||||++|+|++|..||...+.......+..+.. .++...+.++.++|.+||..||
T Consensus 163 ~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 163 GTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 88899999999876654 789999999999999999999988777666666655433 3556678999999999999999
Q ss_pred CCCCCHHHHh
Q psy2648 285 AKRASLEVSG 294 (708)
Q Consensus 285 ~~Rps~~~~~ 294 (708)
.+||+++++.
T Consensus 242 ~~Rp~~~~~l 251 (277)
T cd06641 242 SFRPTAKELL 251 (277)
T ss_pred hhCcCHHHHH
Confidence 9999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.40 Aligned_cols=249 Identities=26% Similarity=0.441 Sum_probs=204.6
Q ss_pred cCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC-
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE- 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~- 117 (708)
-++|++.+.||+|+||.||+|.+ ..+++.||||+++.... ......+.+|+.+|..+ +|||||++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 45899999999999999999985 35678999999975432 33456788999999999 689999999987654
Q ss_pred CEEEEEEeccCCCChHHHHHHcC---------------------------------------------------------
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHG--------------------------------------------------------- 140 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~--------------------------------------------------------- 140 (708)
..+|+|||||++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56899999999999999986531
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC---ccccccC
Q psy2648 141 ----------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGS 207 (708)
Q Consensus 141 ----------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt 207 (708)
.++...+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .....++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 357778889999999999999999999999999999999999999999999876532211 1223456
Q ss_pred CcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHHHcC-CCCCCCCCCHHHHHHHHHhhhhCC
Q psy2648 208 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTL-RELRERVLRG-KYRIPFYMSTDCENLLKKFLVLNP 284 (708)
Q Consensus 208 ~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~-~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 284 (708)
+.|+|||++.+..++ .++|||||||++|+|++ |..||.+... .++...+..+ ....|...++++.+++.+||..||
T Consensus 245 ~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 245 LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred cceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 789999999887774 78999999999999997 9999987543 3344444444 334566788999999999999999
Q ss_pred CCCCCHHHHhh
Q psy2648 285 AKRASLEVSGE 295 (708)
Q Consensus 285 ~~Rps~~~~~~ 295 (708)
++||+++++..
T Consensus 324 ~~Rps~~eil~ 334 (343)
T cd05103 324 SQRPTFSELVE 334 (343)
T ss_pred hhCcCHHHHHH
Confidence 99999998874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=346.26 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=207.9
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK----- 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 118 (708)
..++|++++.||+|+||.||+|.+..+++.||||++.+........+.+.+|+++|+.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 356899999999999999999999999999999998765433444556889999999999999999999987654
Q ss_pred -EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 -TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 -~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
.+|+||||+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 469999999 678887765 46799999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---------------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY--------------- 262 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~--------------- 262 (708)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 171 --EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred --CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 234457889999999987643345789999999999999999999987765443333322110
Q ss_pred ----------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 ----------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 ----------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+....++++.++|.+||..||.+|||+.++. |+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 01124678899999999999999999999887 7653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.22 Aligned_cols=251 Identities=29% Similarity=0.497 Sum_probs=203.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----KT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 119 (708)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 368999999999999999999999999999999986432 223445678899999999999999999987654 35
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|+||||+.+ +|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 8999999975 8887764 4679999999999999999999999999999999999999999999999999987653221
Q ss_pred ----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc---------------C
Q psy2648 200 ----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR---------------G 260 (708)
Q Consensus 200 ----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~---------------~ 260 (708)
.....+|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.. .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 223467899999999876543335789999999999999999999987654332222110 0
Q ss_pred -----------CCCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 -----------KYRIP-----FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 -----------~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
....+ ...++++.+||.+||+.||.+|||++++. |+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 00011 23578899999999999999999999987 6653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.07 Aligned_cols=244 Identities=30% Similarity=0.451 Sum_probs=207.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 469999999999999999999999999999999875432 3344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 125 EYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||+. |+|.+++.. ...+++.++..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++...... ..
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 9997 577777654 457899999999999999999999999999999999999999999999999998754332 34
Q ss_pred cccCCcccccccccC---CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCC-CCCCCHHHHHHHHH
Q psy2648 204 FCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-YRI-PFYMSTDCENLLKK 278 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-~~~-p~~~s~~~~~Li~~ 278 (708)
..|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+.... ... +...+.++.++|.+
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~-~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249 (307)
T ss_pred ccCCccccCceeeeccCCCCC-CcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence 578899999999852 334 478999999999999999999999887766555554432 222 23467889999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||++||++.++.
T Consensus 250 ~l~~~p~~Rp~~~~il 265 (307)
T cd06607 250 CLQKIPQDRPSSEELL 265 (307)
T ss_pred HhcCChhhCcCHHHHh
Confidence 9999999999999886
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.41 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=208.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||++.+. .+..||+|.+.... ...+.+.+|+++++.++|+||+++++++.. ..+|+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 44578999999999999999999854 45679999886532 234568899999999999999999999887 77899
Q ss_pred EEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 123 VMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
+|||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999764 3578888999999999999999999999999999999999999999999999876543221
Q ss_pred c--cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q psy2648 201 L--DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLL 276 (708)
Q Consensus 201 ~--~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li 276 (708)
. ....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+...+..+. ...+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 1 12335567999999987765 478999999999999998 999999988888777776652 234556788999999
Q ss_pred HHhhhhCCCCCCCHHHHhh
Q psy2648 277 KKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~~ 295 (708)
.+||..||++||+++++..
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=334.58 Aligned_cols=246 Identities=32% Similarity=0.539 Sum_probs=207.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEEEe
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTLYLVME 125 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ylVmE 125 (708)
|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+++++.++||||+++++++... +..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999999999999999987643334455688999999999999999999999988 89999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--Ccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLD 202 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~~~ 202 (708)
|+++ +|.+++... ..+++.+++.++.||+.||+|||++|++|+||||+|||+++++.+||+|||++....... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9975 898888765 579999999999999999999999999999999999999999999999999987654332 123
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----C--------------
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-----R-------------- 263 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-----~-------------- 263 (708)
...++..|+|||.+.+....++++|||||||++|+|++|..||...+.......+....- .
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 346788899999887654345899999999999999999999998776655554432100 0
Q ss_pred ------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 ------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 ------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+++++.++|++||..||.+||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 282 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0011378899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=346.50 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=214.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-----TLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~y 121 (708)
+|++.+.||+|+||.||+|++..+++.||||++.+........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999999999999999765433455667889999999999999999999988775 799
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-- 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-- 199 (708)
+||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999998 4899998877789999999999999999999999999999999999999999999999999998665432
Q ss_pred --CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--------------
Q psy2648 200 --KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-------------- 263 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-------------- 263 (708)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....-.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2345678999999999988733357899999999999999999999988876655555431100
Q ss_pred -----------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 264 -----------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 264 -----------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.....++++.+||.+||+.||.+||++++++ |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0123578899999999999999999999987 7753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=340.96 Aligned_cols=245 Identities=27% Similarity=0.513 Sum_probs=210.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.-|.....||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 346667789999999999999999999999999875432 234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
|+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ......
T Consensus 99 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 999999998764 467899999999999999999999999999999999999999999999999998755332 223456
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---IPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~p~~~s~~~~~Li~~~L~ 281 (708)
+|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+...... .+...+.++.++|.+||+
T Consensus 178 ~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 178 VGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred ecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 799999999999887764 7899999999999999999999887766666666544322 234567899999999999
Q ss_pred hCCCCCCCHHHHh
Q psy2648 282 LNPAKRASLEVSG 294 (708)
Q Consensus 282 ~dP~~Rps~~~~~ 294 (708)
.||.+||+++++.
T Consensus 257 ~~P~~Rps~~~ll 269 (297)
T cd06659 257 REPQERATAQELL 269 (297)
T ss_pred CCcccCcCHHHHh
Confidence 9999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.15 Aligned_cols=245 Identities=28% Similarity=0.424 Sum_probs=202.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
......||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 334468999999999999999999999999987543 334567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEeccCccccCCCC-Ccc
Q psy2648 128 SGGEVFDYLVLH-GRM--KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTPGN-KLD 202 (708)
Q Consensus 128 ~gg~L~~~i~~~-~~l--~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DFGls~~~~~~~-~~~ 202 (708)
++++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++....... ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 999999999765 455 88889999999999999999999999999999999986 6789999999987553222 223
Q ss_pred ccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH-HHcCCCCCCCCCCHHHHHHHHH
Q psy2648 203 TFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGSTLR--ELRER-VLRGKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~~~~--~l~~~-i~~~~~~~p~~~s~~~~~Li~~ 278 (708)
...|++.|+|||++.+.. ..+.++|||||||++|+|++|..||...... ..... .......+|...++++.+||++
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 456889999999986543 1247899999999999999999999764322 11111 1223345677788999999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..+|.+|||++++.
T Consensus 248 ~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 248 CFEPDPDKRASAHDLL 263 (268)
T ss_pred HcCCCchhCCCHHHHH
Confidence 9999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.57 Aligned_cols=247 Identities=30% Similarity=0.481 Sum_probs=199.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcC--CCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVP--TGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTLY 121 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~--tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~y 121 (708)
+|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 899999999987432 123345678899999999999999999999988 8899
Q ss_pred EEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC----CCcEEEEeccCc
Q psy2648 122 LVMEYASGGEVFDYLVLH-----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS----EMNIKIADFGFS 192 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~----~~~iKL~DFGls 192 (708)
+||||+++ +|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 677766432 26899999999999999999999999999999999999999 899999999998
Q ss_pred cccCCCC----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHH-
Q psy2648 193 NEFTPGN----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE---------LRERVL- 258 (708)
Q Consensus 193 ~~~~~~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~---------l~~~i~- 258 (708)
....... .....++++.|+|||++.+....+.++|||||||++|+|++|+.||.+..... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 7653221 22346789999999998765433578999999999999999999998654321 000000
Q ss_pred -------------------------cCCCCCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 -------------------------RGKYRIP-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 -------------------------~~~~~~p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.....++ ...+.++.++|.+||+.||++|||++++.
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0000111 14567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=344.64 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=201.0
Q ss_pred eEEccc--CceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKG--NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G--~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
..||+| +||.||+|++..+|+.||||++.......+..+.+.+|+.+++.++||||++++++++.+..+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 999999999999999999999987655555667788999999999999999999999999999999999999
Q ss_pred CChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCC------
Q psy2648 130 GEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNK------ 200 (708)
Q Consensus 130 g~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~------ 200 (708)
++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++||+.+..... +..
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999998764 3589999999999999999999999999999999999999999999999986432211 111
Q ss_pred -ccccccCCcccccccccCCcc-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--------------
Q psy2648 201 -LDTFCGSPPYAAPELFQGKKY-DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI-------------- 264 (708)
Q Consensus 201 -~~~~~Gt~~Y~APE~l~~~~~-~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~-------------- 264 (708)
.....++..|+|||++.+..+ .+.++|||||||++|+|++|..||.+....+....+..+....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 111235677999999976432 2478999999999999999999998876554443333322111
Q ss_pred ---------------------------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 265 ---------------------------------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 265 ---------------------------------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+...++++.+||++||+.||++|||+++++ |+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 122456789999999999999999999987 7653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.58 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=202.3
Q ss_pred CeEEEeEEcccCceEEEEEEE----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKH----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTL 120 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 120 (708)
.|++++.||+|+||.||+|+. ..+++.||+|.+.... .......+.+|+++++.++||||+++++++... ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478999999999999999984 4678899999986543 234456788999999999999999999998875 578
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|+||||++|++|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 99999999999999987653 58999999999999999999999999999999999999999999999999987654322
Q ss_pred C----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHHcC
Q psy2648 200 K----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---------------TLRELRERVLRG 260 (708)
Q Consensus 200 ~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---------------~~~~l~~~i~~~ 260 (708)
. .....++..|+|||++.+..++ +++|||||||++|+|+++..|+... ........+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 1 2345677789999999877664 7899999999999999987765321 111222222223
Q ss_pred C-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 K-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 ~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
. ...+...+.++.+||.+||+.||++||+++++.
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 277 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 2 234566789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=339.72 Aligned_cols=251 Identities=29% Similarity=0.506 Sum_probs=206.2
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK---- 118 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 118 (708)
..+++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999999999999999999765433333456778999999999999999999987654
Q ss_pred ------EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 119 ------TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 119 ------~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
.+|+||||+++ +|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 79999999986 777777654 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CCC---
Q psy2648 192 SNEFTPGN--KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG---KYR--- 263 (708)
Q Consensus 192 s~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~---~~~--- 263 (708)
+....... ......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+..+....+... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 87654332 1122356788999999876544457899999999999999999999877655444333321 100
Q ss_pred ------------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 ------------------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 ------------------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....++..+.+||.+||..||.+||+++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0113578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=340.74 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=202.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------ 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 117 (708)
.+++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 37899999999999999999999999999999999876543333334567899999999999999999987543
Q ss_pred --CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 118 --KTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 118 --~~~ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
..+|+||||+.+ +|...+.. ...+++.+++.++.||+.||+|||++||+||||||+|||+++++.+||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999975 67776654 35799999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCC------------ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q psy2648 195 FTPGNK------------LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY 262 (708)
Q Consensus 195 ~~~~~~------------~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~ 262 (708)
...... .....|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.....+.+....-
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 432211 12345788899999987654335789999999999999999999998877655554432100
Q ss_pred -----------------------CCC-------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 -----------------------RIP-------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 -----------------------~~p-------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..| ...++++.++|.+||..||.+|||++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 000 12346789999999999999999998876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.84 Aligned_cols=243 Identities=23% Similarity=0.405 Sum_probs=193.8
Q ss_pred eEEcccCceEEEEEEEcC--CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHVP--TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|.... ....||+|.+.... .......+.+|+.+++.++||||+++++.+.+...+|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 368999999999997543 44578888875432 233445678999999999999999999999999999999999999
Q ss_pred CChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC---c
Q psy2648 130 GEVFDYLVLHG-----RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---L 201 (708)
Q Consensus 130 g~L~~~i~~~~-----~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~---~ 201 (708)
|+|.+++.... ..++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999997643 246778899999999999999999999999999999999999999999999865432211 1
Q ss_pred cccccCCcccccccccCC------ccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH-cCCCCC-----CCCC
Q psy2648 202 DTFCGSPPYAAPELFQGK------KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL-RGKYRI-----PFYM 268 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~------~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~-~~~~~~-----p~~~ 268 (708)
....+++.|+|||++... ...+.++|||||||++|+|++ |..||......+....+. .+...+ +...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 223456789999997532 122478999999999999999 899998877665554443 333332 3356
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHhhh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
++.+.+++..|+ .||++|||++++..+
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 788899999998 599999999988754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.81 Aligned_cols=244 Identities=30% Similarity=0.518 Sum_probs=211.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.|...+.||+|+||.||++.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 3555679999999999999999999999999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~ 205 (708)
+++++|.+++.. +++++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ......
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999998876 689999999999999999999999999999999999999999999999999876543221 223457
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCHHHHHHHHHhhhh
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI---PFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~---p~~~s~~~~~Li~~~L~~ 282 (708)
|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+..+.... +...+.++.+||.+||..
T Consensus 177 ~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 89999999999887764 78999999999999999999999888777777776653322 233678999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||++||+++++.
T Consensus 256 ~p~~Rpt~~~il 267 (285)
T cd06648 256 DPAQRATAAELL 267 (285)
T ss_pred ChhhCcCHHHHc
Confidence 999999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=332.38 Aligned_cols=246 Identities=30% Similarity=0.457 Sum_probs=206.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--KTLYLV 123 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ylV 123 (708)
++|+..+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+++++.++||||+++++++... ..+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999999999999999975432 24456788999999999999999999988653 478999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 124 MEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999999887653 3458999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCC-CCC------CC
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-----TLRELRERVLRGKY-RIP------FY 267 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-----~~~~l~~~i~~~~~-~~p------~~ 267 (708)
.....++..|+|||.+.+..++ .++|||||||++|+|++|..||... ...++...+..... .++ ..
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred -cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 2345688899999999887775 7899999999999999999999865 33455555544221 111 12
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++++.+||.+||..||.+|||+.++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 357899999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=372.37 Aligned_cols=151 Identities=34% Similarity=0.606 Sum_probs=140.2
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
|.+++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++.....+|
T Consensus 1 p~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred CccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 357899999999999999999999999999999999976543 3444567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
|||||+.|++|.+++...+.+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999888889999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.82 Aligned_cols=246 Identities=27% Similarity=0.448 Sum_probs=208.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
.+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++++ ...|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4689999999999999999987654 3569999886432 23455678899999999999999999999876 45789
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 123 VMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 999999999999997654 5899999999999999999999999999999999999999999999999998765433211
Q ss_pred --cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy2648 202 --DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLK 277 (708)
Q Consensus 202 --~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~ 277 (708)
....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...+.++.++|.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 242 (270)
T ss_pred ecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 122345679999998877664 78999999999999996 999999888777777777664 3456778899999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..+|.+|||+.++.
T Consensus 243 ~~l~~~P~~Rpt~~~~~ 259 (270)
T cd05056 243 KCWAYDPSKRPRFTELK 259 (270)
T ss_pred HHcCCChhhCcCHHHHH
Confidence 99999999999998876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=330.06 Aligned_cols=234 Identities=22% Similarity=0.336 Sum_probs=195.4
Q ss_pred eEEcccCceEEEEEEEcCCC----------cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 52 KTIGKGNFAKVKLAKHVPTG----------KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg----------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+.||+|+||.||+|.+..++ ..|++|++..... ....+.+|+.+|+.++||||+++++++.. ...|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999998777 3588887754321 15678899999999999999999999887 7789
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-------cEEEEeccCcc
Q psy2648 122 LVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-------NIKIADFGFSN 193 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-------~iKL~DFGls~ 193 (708)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999999998766 789999999999999999999999999999999999999888 79999999987
Q ss_pred ccCCCCCccccccCCcccccccccCC--ccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Q psy2648 194 EFTPGNKLDTFCGSPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYMST 270 (708)
Q Consensus 194 ~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~ 270 (708)
.... .....++..|+|||++.+. .+ +.++|||||||++|+|++ |..||...+..+...... .....|.....
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~-~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASL-TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA 231 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCc-chhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence 6543 2234677889999999876 44 578999999999999999 689998775444333332 22334444458
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.++|.+||..||.+||++.++.
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il 255 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAIL 255 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.34 Aligned_cols=247 Identities=29% Similarity=0.476 Sum_probs=208.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
..+|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3578999999999999999999988886 47888886543 233344678999999999999999999998754 47
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
++++||+++|+|.+++..+. .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 89999999999999987754 68999999999999999999999999999999999999999999999999998654332
Q ss_pred C---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 200 K---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 200 ~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
. .....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....++.+.+..+. +..|...+.++.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 2 2234457789999999877764 78999999999999997 999999887777766665543 3344567889999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|.+||..||++||+++++.
T Consensus 243 li~~c~~~~p~~Rp~~~~l~ 262 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELA 262 (303)
T ss_pred HHHHHcCCChhhCcCHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=365.03 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=191.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCC-cEEEEEEec--------------cC-CCChhhHHHHHHHHHHHHhCCCCC
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTG-KEVAIKIID--------------KT-QLNPGSLQKLFREVRIMKMLDHPN 106 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg-~~vAvK~i~--------------~~-~~~~~~~~~~~~Ei~il~~l~Hpn 106 (708)
..+++|++++.||+|+||+||+|.++... ..+++|.+. +. .........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34678999999999999999999865432 233333111 11 111223445779999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC
Q psy2648 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 181 (708)
Q Consensus 107 Iv~l~~~~~~~~~~ylVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~ 181 (708)
||+++++++..+..|+|||++. ++|++++... ......+++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999995 5788877543 234467788999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCC--ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCC-CCCC---CHHHHHH
Q psy2648 182 MNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGS---TLRELRE 255 (708)
Q Consensus 182 ~~iKL~DFGls~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~P-f~~~---~~~~l~~ 255 (708)
+.+||+|||+++.+..... ....+||+.|+|||++.+..|+ .++|||||||+||||++|.+| |.+. ...++.+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999987643322 2346899999999999988875 789999999999999998764 4322 1223322
Q ss_pred HHHcC---------------------CC-----CCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRG---------------------KY-----RIP-----FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~---------------------~~-----~~p-----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..- .+ .++ ..++.++.++|.+||..||.+|||+++++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 22110 00 000 12456788999999999999999999987
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.77 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=203.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------- 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 117 (708)
-++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3689999999999999999999999999999999875533 3456688999999999999999999876654
Q ss_pred -------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEec
Q psy2648 118 -------KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADF 189 (708)
Q Consensus 118 -------~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DF 189 (708)
..+|+||||++ ++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35899999997 58888775 457999999999999999999999999999999999999985 457899999
Q ss_pred cCccccCCCC----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----
Q psy2648 190 GFSNEFTPGN----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK---- 261 (708)
Q Consensus 190 Gls~~~~~~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~---- 261 (708)
|++....... ......|+..|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987543211 11234678899999987654434578999999999999999999998776544433332210
Q ss_pred ---------------------CC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 262 ---------------------YR-----IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 262 ---------------------~~-----~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.. ....++.++.+||.+||+.||.+|||+++++ |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 1124678899999999999999999999987 7753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.56 Aligned_cols=240 Identities=31% Similarity=0.492 Sum_probs=206.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+.+|++.+.||+|+||.||++. .+++.||+|++.... ..+.+.+|+.+++.++||||+++++++..+ ..|+||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 4679999999999999999986 478899999986432 235688999999999999999999998654 579999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc
Q psy2648 125 EYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~ 202 (708)
||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VD 155 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CC
Confidence 9999999999997654 4789999999999999999999999999999999999999999999999998754322 22
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L 280 (708)
....+..|+|||.+.+..++ .++|||||||++|+|++ |+.||...+..++...+..+. ...+...+.++.++|.+||
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence 23445679999999877764 78999999999999997 999999998888888877663 2334567889999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
..+|++||+++++.
T Consensus 235 ~~~p~~Rp~~~~l~ 248 (254)
T cd05083 235 ETEPKKRPSFHKLR 248 (254)
T ss_pred CCChhhCcCHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.72 Aligned_cols=250 Identities=31% Similarity=0.515 Sum_probs=212.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.++|++.+.||+|+||.||++....+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+.+|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4789999999999999999999999999999999864432 23456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
||+++++|.+++.. ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99999999998864 468899999999999999999999999999999999999999999999999987654332 2334
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CC--CCCCCCCHHHHHHHHHhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-KY--RIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-~~--~~p~~~s~~~~~Li~~~L 280 (708)
..|++.|+|||.+.+..++ .++|||||||++|+|++|..||...+..+....+..+ .. ..+..++.++.++|.+||
T Consensus 175 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253 (293)
T ss_pred ccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence 5789999999999877664 7899999999999999999999877654433333222 22 223456788999999999
Q ss_pred hhCCCCCCCHHHHh---hhhh
Q psy2648 281 VLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~ 298 (708)
..||++||+++++. |+..
T Consensus 254 ~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 254 EMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred cCChhhCcCHHHHhcCHHHhc
Confidence 99999999999987 6653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=328.58 Aligned_cols=241 Identities=24% Similarity=0.414 Sum_probs=200.8
Q ss_pred eEEcccCceEEEEEEEcC---CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCCEEEEEEecc
Q psy2648 52 KTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE-TEKTLYLVMEYA 127 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~ylVmEy~ 127 (708)
+.||+|+||.||+|.+.. ....||||.+.... .....+.+.+|+.+++.++||||+++++++. .+...|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998753 34579999885432 3345567889999999999999999999765 455689999999
Q ss_pred CCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-----Cc
Q psy2648 128 SGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-----KL 201 (708)
Q Consensus 128 ~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-----~~ 201 (708)
.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999999764 356778888999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKF 279 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~ 279 (708)
....+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..++...+..+.. ..|...++.+.+++.+|
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred ccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 233467789999999877764 79999999999999999 6778888888888877776643 34566788999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|..||++||++.++.
T Consensus 239 l~~~p~~Rp~~~~il 253 (262)
T cd05058 239 WHPKPEMRPTFSELV 253 (262)
T ss_pred cCCChhhCCCHHHHH
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.54 Aligned_cols=245 Identities=34% Similarity=0.566 Sum_probs=212.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.|.+.+.||+|+||.||++.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++......|+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 48899999999999999999999999999999976543 3456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccc
Q psy2648 127 ASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~ 205 (708)
+++++|.+++... ..+++.++..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 9999999998776 579999999999999999999999999999999999999999999999999987765443245567
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCHHHHHHHHHhhhh
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-KYRIPFY--MSTDCENLLKKFLVL 282 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-~~~~p~~--~s~~~~~Li~~~L~~ 282 (708)
|+..|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+....+... ....+.. .+.++.++|.+||..
T Consensus 159 ~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 159 GTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred cCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 8999999999987765 47899999999999999999999887555444444332 2233333 378999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||++|||+++++
T Consensus 238 ~p~~R~t~~~~l 249 (253)
T cd05122 238 NPEKRPTAEQLL 249 (253)
T ss_pred ChhhCCCHHHHh
Confidence 999999998875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.28 Aligned_cols=240 Identities=41% Similarity=0.735 Sum_probs=215.4
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCh
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L 132 (708)
||+|+||.||++.+..+++.||+|++.+.... ......+..|+.+++.++||||+++++.++.+..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999999999999999876442 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccccccCCccc
Q psy2648 133 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYA 211 (708)
Q Consensus 133 ~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~~Gt~~Y~ 211 (708)
.+++.....+++.++..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 999988888999999999999999999999999999999999999999999999999998765433 2344567899999
Q ss_pred ccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCH-
Q psy2648 212 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASL- 290 (708)
Q Consensus 212 APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~- 290 (708)
|||.+.+... +.++|+||||+++|+|++|..||...+..++.+.+......+|...+.++.++|++||..||++||++
T Consensus 161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 9999987765 47899999999999999999999988888888888888888888889999999999999999999999
Q ss_pred --HHHh
Q psy2648 291 --EVSG 294 (708)
Q Consensus 291 --~~~~ 294 (708)
+++.
T Consensus 240 ~~~~l~ 245 (250)
T cd05123 240 GAEEIK 245 (250)
T ss_pred cHHHHH
Confidence 5544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.35 Aligned_cols=247 Identities=28% Similarity=0.540 Sum_probs=212.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeccCCC--------ChhhHHHHHHHHHHHHh-CCCCCeeeEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVP-TGKEVAIKIIDKTQL--------NPGSLQKLFREVRIMKM-LDHPNIVKLFQVIET 116 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~-tg~~vAvK~i~~~~~--------~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 116 (708)
.|++.+.||+|+||.||+|.+.. +++.||||.+..... .......+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 788999999864321 22344567789998864 799999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CC-CCC
Q psy2648 192 SNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI-PF-YMS 269 (708)
Q Consensus 192 s~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~-p~-~~s 269 (708)
+.............|+..|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.+.. +. ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 876554444456678999999999988776 579999999999999999999999888887777777665542 22 467
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++.++|.+||+.||++||++.++.
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~ 264 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVS 264 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHH
Confidence 8999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=332.59 Aligned_cols=242 Identities=26% Similarity=0.433 Sum_probs=205.0
Q ss_pred eEEcccCceEEEEEEEcCCC------cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 52 KTIGKGNFAKVKLAKHVPTG------KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+.||+|+||.||+|++.... +.||||.+.+.. .......+.+|+.+|+.++||||+++++++......|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 36899999999999986544 689999986542 22345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-----cEEEEeccCcc
Q psy2648 126 YASGGEVFDYLVLH-------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-----NIKIADFGFSN 193 (708)
Q Consensus 126 y~~gg~L~~~i~~~-------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-----~iKL~DFGls~ 193 (708)
|+++++|.+++... ..+++.++..++.||+.||+|||+++++|+||||+|||++.++ .+||+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999753 2478899999999999999999999999999999999999887 89999999987
Q ss_pred ccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCC
Q psy2648 194 EFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYM 268 (708)
Q Consensus 194 ~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~ 268 (708)
....... .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..++...+..+ .+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 5432211 123345678999999987776 489999999999999998 99999988877777776654 34566778
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+.++.+||.+||..+|.+||+++++..
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999999999999999998764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.98 Aligned_cols=246 Identities=25% Similarity=0.449 Sum_probs=207.9
Q ss_pred eEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC------
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK------ 118 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 118 (708)
|.+.+.||+|+||.||+|... .+++.||||++..........+.+.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 36789999999766555556677889999999999999999999886532
Q ss_pred EEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
..++++||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247899999999999887532 24788999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy2648 193 NEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFY 267 (708)
Q Consensus 193 ~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~ 267 (708)
+....+.. .....+++.|++||.+.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 76543221 1233456789999999877664 78999999999999999 999999988888877776653 344556
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.++.+++.+||..+|++||++.++.
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~ 266 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLR 266 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=336.89 Aligned_cols=246 Identities=28% Similarity=0.438 Sum_probs=201.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|+..+.||+|+||.||++.+..+++.||||.+.+.... .....+.+|+.++.++. ||||+++++++..+...|++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4577788999999999999999999999999999765433 44567889999999996 999999999999999999999
Q ss_pred eccCCCChHH---HHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 125 EYASGGEVFD---YLV--LHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 125 Ey~~gg~L~~---~i~--~~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
||+.. +|.+ ++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 99874 4443 332 236799999999999999999999974 9999999999999999999999999998765443
Q ss_pred CCccccccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCC-CCC----CCCC
Q psy2648 199 NKLDTFCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGKY-RIP----FYMS 269 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~~-~~p----~~~s 269 (708)
.......|++.|+|||++.+. .+ +.++|||||||++|+|++|..||..... .+....+..+.. .++ ...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CccccccCccCccCHHHhccccccCC-cchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 333445789999999999776 34 4789999999999999999999976542 122223333322 222 2368
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++.+||++||..||.+|||++++.
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHh
Confidence 8999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=345.38 Aligned_cols=254 Identities=34% Similarity=0.535 Sum_probs=209.0
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--CE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE--KT 119 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~ 119 (708)
...++|++.+.||+|+||.||+|.+..+++.||||.+.+..........+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 456789999999999999999999999999999999876544444456678899999999 999999999998654 46
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999997 5999988655 78999999999999999999999999999999999999999999999999987654322
Q ss_pred ------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------
Q psy2648 200 ------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------- 260 (708)
Q Consensus 200 ------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------- 260 (708)
......|++.|+|||++.+....+.++|||||||++|+|++|+.||.+....+...++...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 2234578999999999876544457899999999999999999999876554433332211
Q ss_pred --------------CCC----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 --------------KYR----IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 --------------~~~----~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
... .....+.++.+||.+||+.||++|||+.++. |+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 000 0112578899999999999999999999988 6643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.80 Aligned_cols=245 Identities=31% Similarity=0.494 Sum_probs=205.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC---CCCCeeeEEEEEEeCCE-----
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML---DHPNIVKLFQVIETEKT----- 119 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~----- 119 (708)
|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999976543333334566788887766 69999999999988776
Q ss_pred EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
+|++|||+.+ +|.+++.... .+++.+++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 8999887643 589999999999999999999999999999999999999999999999999877654
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----CCCC-------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK-----YRIP------- 265 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~-----~~~p------- 265 (708)
........+++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+...++.... ...|
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CcccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 4444556688999999999887764 78999999999999999999999888776666554310 0000
Q ss_pred ---------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 ---------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 ---------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...++++.++|.+||+.||.+||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 12457789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.03 Aligned_cols=243 Identities=28% Similarity=0.494 Sum_probs=213.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
-|.++.+||+|+||.||+|.|+.+|+.||||.+.-+ .+++.+..|+.||++.+.|+||++|+.|-....+||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 488999999999999999999999999999988643 4678899999999999999999999999888899999999
Q ss_pred cCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 127 ASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 127 ~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
|..|++.+.++.+ ..++|.++..+++..+.||+|||...-||||||..||||+.+|..||+|||.+..+.+. .+-++.
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 9999999988755 67999999999999999999999999999999999999999999999999999776432 345688
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK---YRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~---~~~p~~~s~~~~~Li~~~L~ 281 (708)
.|||.|||||++..-.|+ .++||||||++..||..|++||.+..+...+-.|-... ++-|...|.++.|+|++||.
T Consensus 190 IGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred ccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 999999999999988887 68999999999999999999998865544333332221 22355678899999999999
Q ss_pred hCCCCCCCHHHHh
Q psy2648 282 LNPAKRASLEVSG 294 (708)
Q Consensus 282 ~dP~~Rps~~~~~ 294 (708)
++|++|.|+-++.
T Consensus 269 K~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 269 KKPEERKTALRLC 281 (502)
T ss_pred CCHHHHHHHHHHh
Confidence 9999999987765
|
|
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=387.63 Aligned_cols=252 Identities=29% Similarity=0.491 Sum_probs=219.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+++-...||.|.||+||-|.+..+|+..|||-|............+.+|..++..|+|||+|++|++=...+.+||.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 56778899999999999999999999999999876544444455678999999999999999999998888899999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-----CCc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-----NKL 201 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-----~~~ 201 (708)
|++|+|.+.+...+-.+|...+.|..|++.|+.|||++|||||||||+||||+.+|.||+.|||.|..+... ..+
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999999998876566788888999999999999999999999999999999999999999999998765432 345
Q ss_pred cccccCCcccccccccCCcc--CCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKKY--DGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRERVLRGK-YRIPFYMSTDCENLLK 277 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~--~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~ 277 (708)
+...|||.|||||++.+..- ++.+.||||||||+.||+||+.||... +.-.+.-+|..|. +++|..+|.+.+|||.
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle 1475 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLE 1475 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHH
Confidence 67889999999999987542 356899999999999999999999764 3446667777774 5689999999999999
Q ss_pred HhhhhCCCCCCCHHHHhhhhh
Q psy2648 278 KFLVLNPAKRASLEVSGEVTL 298 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~~~~~ 298 (708)
+||+.||.+|-++.|+++...
T Consensus 1476 ~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred HHHhcCchhhhHHHHHHHhhc
Confidence 999999999999888876554
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.15 Aligned_cols=245 Identities=28% Similarity=0.406 Sum_probs=201.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|++++.||+|+.++||++..-. .+.||+|.+.-...+...+..+..|+.+|.+|+ |-+||+|||+-..++.+|||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 59999999999999999998643 455777766655566777888999999999996 9999999999989999999999
Q ss_pred ccCCCChHHHHHHcCCCC-HHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---Cc
Q psy2648 126 YASGGEVFDYLVLHGRMK-EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KL 201 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~-e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~---~~ 201 (708)
|-+ -||...|....... ...++.|..|++.|+.++|++||||.||||.|+|+-+ |.+||+|||+|+.+..+. .-
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~k 518 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVK 518 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceee
Confidence 754 58999888776544 4688999999999999999999999999999999874 789999999998876543 23
Q ss_pred cccccCCcccccccccCCccC----------CCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcC--CCCCCCCC
Q psy2648 202 DTFCGSPPYAAPELFQGKKYD----------GPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLRG--KYRIPFYM 268 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~----------~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~~--~~~~p~~~ 268 (708)
.+.|||+.||+||.+....++ ++++||||||||||+|+.|+.||.... ...-+..|..- ++.+|..-
T Consensus 519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~ 598 (677)
T KOG0596|consen 519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP 598 (677)
T ss_pred ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC
Confidence 578999999999999655443 578999999999999999999997532 22333344433 23556554
Q ss_pred CHH-HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 269 STD-CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 269 s~~-~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.. +.++++.||..||.+||++.+++
T Consensus 599 ~~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 599 ENDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred CchHHHHHHHHHHhcCcccCCCcHHHh
Confidence 444 99999999999999999999866
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.16 Aligned_cols=250 Identities=29% Similarity=0.451 Sum_probs=210.8
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
...+...+++..||.|+.|.|++++++.+|...|||.+.++. +.++.+++++.++++.+- +.|+||+.|++|-++..+
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 444556677889999999999999999999999999998764 567778899999887554 589999999999999999
Q ss_pred EEEEeccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 121 YLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~-~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
+|.||.+.- .+...++ ..++++|.-+-.+..-++.||.||-. ++|+|||+||+|||||..|+|||||||++..+.+.
T Consensus 167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 999999853 3333333 34679999999999999999999975 68999999999999999999999999999877665
Q ss_pred CCccccccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCC-CCC--CCCHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRERVLRGKYR-IPF--YMSTD 271 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~l~~~i~~~~~~-~p~--~~s~~ 271 (708)
.......|.+.|||||.+.-. .|+ .++|||||||.|+||+||+.||.+. +..++..+|+...++ +|. ..|++
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~ 324 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPD 324 (391)
T ss_pred cccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHH
Confidence 555567899999999998533 565 6899999999999999999999984 455777888876543 343 37999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++|+..||++|+.+||...+++
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHh
Confidence 99999999999999999988765
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.45 Aligned_cols=245 Identities=31% Similarity=0.470 Sum_probs=199.3
Q ss_pred CeEEEeEEcccCceEEEEEEE----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKH----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKTL 120 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 120 (708)
+|++.+.||+|+||.||+|.. ..+++.||||.+... .....+.+.+|+++++.++||||+++++++.. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 699999999999999999984 467889999998654 23445678899999999999999999998654 3468
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|+||||+++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999998654332
Q ss_pred Cc----cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHc
Q psy2648 200 KL----DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR----------------ELRERVLR 259 (708)
Q Consensus 200 ~~----~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~----------------~l~~~i~~ 259 (708)
.. ....++..|+|||++.+..+ +.++|||||||++|+|++|..|+...... .+.+.+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 11 11223456999999987776 47899999999999999988776543211 11122222
Q ss_pred C-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 G-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+ .+..+...+.++.+||.+||..||++|||++++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 277 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 2 2234456788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.29 Aligned_cols=248 Identities=33% Similarity=0.596 Sum_probs=211.3
Q ss_pred CeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCC--hhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
+|++.+.||+|+||.||+|++. .+++.||||++.+.... ....+.+.+|+++++.+ +||||++++++++....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999999764321 22345678999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
|+||||+++|+|.+++.....+++.+++.++.|++.||+|||+.+++||||||+|||++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543321
Q ss_pred --ccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCHHHH
Q psy2648 201 --LDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRGKYRIPFYMSTDCE 273 (708)
Q Consensus 201 --~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~~~~~p~~~s~~~~ 273 (708)
....+|++.|+|||.+.+.. ....++||||||+++|+|++|..||... ...++.+.+.......|...+.++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 23457899999999987654 2347899999999999999999999643 2455666666777777888899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++|.+||+.||++|||+.++.
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~ 261 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGAD 261 (288)
T ss_pred HHHHHHhcCCHhhccCcchHH
Confidence 999999999999999976553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=339.62 Aligned_cols=251 Identities=26% Similarity=0.443 Sum_probs=204.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCC--CcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe----CCE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPT--GKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET----EKT 119 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~t--g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~ 119 (708)
+|++.+.||+|+||.||+|++..+ ++.||||++..........+.+.+|+++++.+ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999988 99999999875433333456678999999999 59999999987543 246
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|++|||+. ++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 899999986 5899999888889999999999999999999999999999999999999999999999999997654321
Q ss_pred -----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--------------
Q psy2648 200 -----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------- 260 (708)
Q Consensus 200 -----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------- 260 (708)
......|++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.....+.+...
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 2234679999999998866432357899999999999999999999876644433322211
Q ss_pred -----------C---CCCC---CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 -----------K---YRIP---FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 -----------~---~~~p---~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
. ..++ ...+.++.+||.+||+.||.+|||++++. |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 0 0011 12478899999999999999999999987 7654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.84 Aligned_cols=250 Identities=26% Similarity=0.458 Sum_probs=205.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------C
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------K 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 118 (708)
.++|.+.+.||+|+||.||+|.+..+++.||||++.+........+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 3689999999999999999999999999999999976543334456688999999999999999999988643 3
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+++|++ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+||++++++.+||+|||++....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~-- 171 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 171 (345)
T ss_pred cEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc--
Confidence 478899887 778987765 4579999999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---------------- 262 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---------------- 262 (708)
.......|++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 2234567899999999987643335789999999999999999999987665443333322100
Q ss_pred -------CCC--------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 -------RIP--------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 -------~~p--------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
..| ...++++.+||.+||+.||.+||++.++. |+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 011 13578899999999999999999999887 7654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.66 Aligned_cols=251 Identities=33% Similarity=0.531 Sum_probs=216.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
....|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+++++.++||||+++++.+.....+|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 34569999999999999999999999999999999975432 456688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCc
Q psy2648 124 MEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKL 201 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~ 201 (708)
+||+++++|.+++.... .+++.++..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++...... ...
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 99999999999998877 8999999999999999999999999999999999999999999999999987654322 122
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCHHHHHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RI--PFYMSTDCENLLKK 278 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~--p~~~s~~~~~Li~~ 278 (708)
....+++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+..... .. +..++.++.++|++
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred ccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 345688899999999887764 789999999999999999999998776655555443322 22 22367899999999
Q ss_pred hhhhCCCCCCCHHHHh---hhhh
Q psy2648 279 FLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~---~~~~ 298 (708)
||+.||.+||+++++. |+..
T Consensus 253 ~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 253 CLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999987 6653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.21 Aligned_cols=253 Identities=28% Similarity=0.383 Sum_probs=208.8
Q ss_pred cCCeEE-EeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh------------hHHHHHHHHHHHHhCCCCCeeeEE
Q psy2648 45 IGKYKL-LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG------------SLQKLFREVRIMKMLDHPNIVKLF 111 (708)
Q Consensus 45 ~~~Y~i-~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~ 111 (708)
-++|.. .+.||+|+||.||+|.+..+++.||||++........ ....+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 457864 5779999999999999999999999999875432210 012467899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 112 QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 112 ~~~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
+++..++.+|+||||+. |+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999997 59999998888899999999999999999999999999999999999999999999999999
Q ss_pred ccccCC---------------CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q psy2648 192 SNEFTP---------------GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRER 256 (708)
Q Consensus 192 s~~~~~---------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~ 256 (708)
+..... ........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 875541 11122345788999999997755445799999999999999999999998876665554
Q ss_pred HHcCC--C-------------------C-------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 257 VLRGK--Y-------------------R-------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 257 i~~~~--~-------------------~-------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+.... . . .....+.++.++|.+||..||++||++++++ |+..
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 43210 0 0 0123478899999999999999999999988 6653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.33 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=209.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-----
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT----- 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 119 (708)
-++|++.+.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 468999999999999999999999999999999987654444445667899999999999999999998876554
Q ss_pred -EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 -LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 -~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
+|+|+||+ +++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~- 170 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD- 170 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc-
Confidence 89999999 5699888764 5799999999999999999999999999999999999999999999999999876533
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---------------- 262 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---------------- 262 (708)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+....-
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred -cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 234567899999999987643445799999999999999999999988776554444432110
Q ss_pred ---------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 ---------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 ---------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
......++++.+||.+||..||.+|||+++++ |+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 00113588999999999999999999999987 6653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=357.20 Aligned_cols=241 Identities=27% Similarity=0.458 Sum_probs=208.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCC
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGE 131 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~ 131 (708)
-+||+|.||.||-|++..|....|||-|... +....+-+..||.+.++|+|.|||++++.+..++++-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 3799999999999999999999999998743 33455668899999999999999999999999999999999999999
Q ss_pred hHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEeccCccccCCC-CCcccccc
Q psy2648 132 VFDYLVLH-GRM--KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTPG-NKLDTFCG 206 (708)
Q Consensus 132 L~~~i~~~-~~l--~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DFGls~~~~~~-~~~~~~~G 206 (708)
|.+.+... |++ .|..+-.|.+||++||.|||++.|||||||-+|+|++. .|.+||+|||-++....- ..+.++.|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999876 777 78889999999999999999999999999999999975 689999999999876432 34578999
Q ss_pred CCcccccccccC-CccCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHhhhh
Q psy2648 207 SPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRERV--LRGKYRIPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 207 t~~Y~APE~l~~-~~~~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~l~~~i--~~~~~~~p~~~s~~~~~Li~~~L~~ 282 (708)
|..|||||++.. ..-.|+++|||||||++.||.||++||... +++...-++ .+..+++|..+|.+++++|.+|+..
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 999999999953 333478999999999999999999999753 233322222 2345678999999999999999999
Q ss_pred CCCCCCCHHHHh
Q psy2648 283 NPAKRASLEVSG 294 (708)
Q Consensus 283 dP~~Rps~~~~~ 294 (708)
||.+||++.+++
T Consensus 819 d~~~R~sA~~LL 830 (1226)
T KOG4279|consen 819 DPCDRPSAKDLL 830 (1226)
T ss_pred CcccCccHHHhc
Confidence 999999999877
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.26 Aligned_cols=242 Identities=33% Similarity=0.520 Sum_probs=201.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC------E
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK------T 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~ 119 (708)
+.+...+.||+|+||.||+++++.||+.||||.+++.. .....++..+|++||++|+|||||+++++=++.. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 56788899999999999999999999999999998754 3445677889999999999999999999866543 4
Q ss_pred EEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--CCCc--EEEEeccCc
Q psy2648 120 LYLVMEYASGGEVFDYLVLH---GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD--SEMN--IKIADFGFS 192 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~---~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld--~~~~--iKL~DFGls 192 (708)
..+|||||+||+|+..+.+- ..|+|.+.+.++..++.||.|||++||+||||||+||++- .+|. -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999998643 4699999999999999999999999999999999999984 3454 499999999
Q ss_pred cccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcC--------
Q psy2648 193 NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRG-------- 260 (708)
Q Consensus 193 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~-------- 260 (708)
+...+++...++.||+.|.+||++..+.+.+..+|.|||||++|+.+||.+||... +..++...+...
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 99999999999999999999999986444567899999999999999999999642 223343333321
Q ss_pred -------C------CCCCCCCCHH----HHHHHHHhhhhCCCCCC
Q psy2648 261 -------K------YRIPFYMSTD----CENLLKKFLVLNPAKRA 288 (708)
Q Consensus 261 -------~------~~~p~~~s~~----~~~Li~~~L~~dP~~Rp 288 (708)
. +++|..+++. +..++..||..||++|-
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 2234445543 45677889999999998
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.08 Aligned_cols=246 Identities=32% Similarity=0.528 Sum_probs=207.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+|+.++||||+++++++..+..+|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999999999999999766544445567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccccc
Q psy2648 128 SGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFC 205 (708)
Q Consensus 128 ~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~ 205 (708)
++ +|.+++... ..+++.++..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 75 888888764 578999999999999999999999999999999999999999999999999987664433 223346
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------CCCC--
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------------KYRI-- 264 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------------~~~~-- 264 (708)
++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+...++... ...+
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 7889999999987633457999999999999999999999887765544443221 0001
Q ss_pred ---------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 ---------PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 ---------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+.++.++|.+||..||.+||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 113577899999999999999999999876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.36 Aligned_cols=243 Identities=30% Similarity=0.467 Sum_probs=211.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|.=++.||.|+||.||-|++..+.+.||||.+.-... ..+..+.++.|+++|++|+|||+|.+-++|-.+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46678899999999999999999999999999976533 34567789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 126 YASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
||-| +-.|.+.- +.++.|.++..|..+.+.||.|||+++.||||||..||||.+.|.|||+|||.+....+ .+++
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsF 182 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSF 182 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhcc
Confidence 9976 44555433 46799999999999999999999999999999999999999999999999998876544 4689
Q ss_pred ccCCcccccccccC---CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCC-CCCHHHHHHHHHh
Q psy2648 205 CGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPF-YMSTDCENLLKKF 279 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~-~~s~~~~~Li~~~ 279 (708)
+|||.|||||++.. ..|++ ++|||||||+..||...++|+..++.......|..... .++. ..|..+++|+..|
T Consensus 183 vGTPywMAPEVILAMDEGqYdg-kvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 261 (948)
T ss_pred cCCccccchhHheeccccccCC-ccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence 99999999999853 45775 89999999999999999999999988776666665443 3443 4688899999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|++-|.+|||.++++
T Consensus 262 LqKipqeRptse~ll 276 (948)
T KOG0577|consen 262 LQKIPQERPTSEELL 276 (948)
T ss_pred HhhCcccCCcHHHHh
Confidence 999999999999766
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.06 Aligned_cols=247 Identities=18% Similarity=0.246 Sum_probs=194.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeccCCCCh--hh-------HHHHHHHHHHHHhCCCCCeeeEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLNP--GS-------LQKLFREVRIMKMLDHPNIVKLFQV 113 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~t---g~~vAvK~i~~~~~~~--~~-------~~~~~~Ei~il~~l~HpnIv~l~~~ 113 (708)
.+|++.+.||+|+||.||+|.+..+ +..+|+|+........ +. ......+...+..++|+||+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5899999999999999999999887 7788888754332111 00 0112233445567789999999997
Q ss_pred EEeCC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEec
Q psy2648 114 IETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 189 (708)
Q Consensus 114 ~~~~~----~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DF 189 (708)
..... ..|++||++.. ++.+.+......++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 65543 45889998754 66666665556789999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH---------HH
Q psy2648 190 GFSNEFTPGN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL---------RE 252 (708)
Q Consensus 190 Gls~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~---------~~ 252 (708)
|+++.+.... ......||+.|+|||++.+..++ .++|||||||+||+|++|.+||.+.+. .+
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 9997653221 12335799999999999988874 899999999999999999999987632 12
Q ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 253 LRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 253 l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+..++..++..++ ..++++.++++.||..+|++||+++++..
T Consensus 250 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 250 FIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3455555554444 45789999999999999999999998763
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=370.27 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=213.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCc-----EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGK-----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+-++.+.||+|.||.||.|....-.. .||||.+.+.. +..+...|++|+.+|+.++|||||++++++-+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 356789999999999999998764332 49999887543 456677899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 121 YLVMEYASGGEVFDYLVLH-------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
+|++|||+||||..||++. ..++..+...++.||+.|++||+++++|||||...|+||+....+||+|||||+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999999876 247889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCc-cccccC--CcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc-CCCCCCCCC
Q psy2648 194 EFTPGNKL-DTFCGS--PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR-GKYRIPFYM 268 (708)
Q Consensus 194 ~~~~~~~~-~~~~Gt--~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~-~~~~~p~~~ 268 (708)
........ ....+. ..|||||.+....+. .++|||||||+|||+++ |..||.+.+..++...+++ |....|.++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C 929 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC 929 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence 54322211 111223 469999999987775 79999999999999999 9999999999988885554 566788999
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+..+.++|..||..+|++||++..+..
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999987663
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.05 Aligned_cols=243 Identities=29% Similarity=0.447 Sum_probs=208.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|...+.||+|+||.||++++..+++.||||++.+... ..+....+.+|+++++.++||||+++++++..+...|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48899999999999999999999999999999976533 23445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 126 YASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
|+.| +|.+.+.. ...+++.++..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++..... ....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~ 181 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSF 181 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccc
Confidence 9975 77777654 45689999999999999999999999999999999999999999999999999865432 2345
Q ss_pred ccCCccccccccc---CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-C-CCCCCHHHHHHHHHh
Q psy2648 205 CGSPPYAAPELFQ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-I-PFYMSTDCENLLKKF 279 (708)
Q Consensus 205 ~Gt~~Y~APE~l~---~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~-p~~~s~~~~~Li~~~ 279 (708)
.|++.|+|||++. ...+ ..++|||||||++|+|++|..||...+.......+..+... . +...++.+.+||.+|
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred cCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 7899999999984 2334 47899999999999999999999887776666666554332 2 335678899999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|+.||.+||+++++.
T Consensus 261 l~~~p~~Rpt~~~il 275 (317)
T cd06635 261 LQKIPQDRPTSEELL 275 (317)
T ss_pred ccCCcccCcCHHHHH
Confidence 999999999999887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.95 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=205.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
...+++|++.+.||+|+||.||+|.+..+++.||||++.+.... .....+.+|+.++..+ +||||+++++++.+...+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 34567899999999999999999999999999999999765432 3345667788777666 499999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 121 YLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
|+||||+.+ +|.+++.. .+.+++..+..++.||+.||.|||+ +||+||||+|+|||+++++.+||+|||++..+...
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999864 77776654 4578999999999999999999997 69999999999999999999999999998765443
Q ss_pred CCccccccCCcccccccccCCc----cCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCC-CCCCC--CCCH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKK----YDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGK-YRIPF--YMST 270 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~----~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~-~~~p~--~~s~ 270 (708)
.......+++.|+|||++.+.. + +.++|||||||++|+|++|+.||..... .+....+.... ...+. ..+.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKY-DIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCcccc-ccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 3334456888999999997654 3 3689999999999999999999976332 34444554443 23332 3678
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||..||.+||+++++.
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il 271 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELL 271 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHh
Confidence 999999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=328.82 Aligned_cols=245 Identities=32% Similarity=0.500 Sum_probs=204.3
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEec
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
|++.+.||+|+||.||+|....+++.||||.+.+.... .......+|+..++.++ ||||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 78899999999999999999999999999998765332 22234567999999999 99999999999999999999999
Q ss_pred cCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 127 ASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 127 ~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
+ +|+|.+++.... .+++.++..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++............
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 789999988765 7899999999999999999999999999999999999999999999999999766544444556
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------CCCCC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------------KYRIP 265 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------------~~~~p 265 (708)
.++..|+|||++.+......++|+|||||++|+|++|+.||...+..+....+... ...+|
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 78999999999865443357899999999999999999999876654433332210 00111
Q ss_pred -----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 -----------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 -----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.+||++||+.||++||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 12367899999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.65 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=193.2
Q ss_pred EEcccCceEEEEEEEcCC--CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Q psy2648 53 TIGKGNFAKVKLAKHVPT--GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 53 ~LG~G~fg~V~la~~~~t--g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg 130 (708)
.||+|+||.||+++.... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+...+|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 699999999999975433 2356677665432 2334567899999999999999999999999999999999999999
Q ss_pred ChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC---CCccc
Q psy2648 131 EVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---NKLDT 203 (708)
Q Consensus 131 ~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~---~~~~~ 203 (708)
+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999999764 23567788899999999999999999999999999999999999999999997542211 12234
Q ss_pred cccCCcccccccccCCcc------CCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-C-----CCCCCCCH
Q psy2648 204 FCGSPPYAAPELFQGKKY------DGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-Y-----RIPFYMST 270 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~------~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~-----~~p~~~s~ 270 (708)
.+|++.|+|||++....+ .+.++|||||||++|+|++ |..||...+..+....+..+. . .++...++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 678999999999853211 1468999999999999996 688998877777666655442 2 22334678
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.++|.+|| .||++||+++++.
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~ 263 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVH 263 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHH
Confidence 8999999999 6899999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=338.56 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=202.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------CE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------KT 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 119 (708)
++|.+.+.||+|+||.||+|.+..+++.||||++.+..........+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 589999999999999999999999999999999976543333445678999999999999999999998754 35
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|+||||+.. +|..++ ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-- 169 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-- 169 (342)
T ss_pred EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--
Confidence 7999999974 676654 34789999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------------- 260 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------------- 260 (708)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 2334578899999999876433357899999999999999999999987654444333221
Q ss_pred ----CCCCC--------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 261 ----KYRIP--------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 261 ----~~~~p--------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
....| ...++++.+||.+||+.||.+||+++++. |+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 00001 13567899999999999999999999987 654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=330.94 Aligned_cols=246 Identities=30% Similarity=0.508 Sum_probs=208.9
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 50 LLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 50 i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
....||+|+||.||++.+..+++.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3467999999999999999999999999985432 23445688999999999999999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-CccccccCC
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~Gt~ 208 (708)
++|.+++ ..+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....... .....+|++
T Consensus 102 ~~L~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 102 GALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred CcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 9999876 45678999999999999999999999999999999999999999999999999886543221 223457899
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHhhhhCCC
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLLKKFLVLNPA 285 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~ 285 (708)
.|+|||++.+..+ +.++|+|||||++|+|++|..||.+....+....+..... ......++++.++|.+||..||.
T Consensus 181 ~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 181 YWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred cccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 9999999887666 4789999999999999999999998877666555544322 12335688999999999999999
Q ss_pred CCCCHHHHh---hhhhC
Q psy2648 286 KRASLEVSG---EVTLG 299 (708)
Q Consensus 286 ~Rps~~~~~---~~~~~ 299 (708)
+||+++++. |+...
T Consensus 260 ~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 260 QRATAAELLKHPFLAKA 276 (292)
T ss_pred cCcCHHHHhcChHHhcc
Confidence 999999987 66543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.82 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=194.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCChHHHHH
Q psy2648 58 NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV 137 (708)
Q Consensus 58 ~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L~~~i~ 137 (708)
++|.||++++..+++.||||++..........+.+.+|+++|+.++||||+++++++...+.+|++|||+++|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 45667777777899999999998765555667789999999999999999999999999999999999999999999987
Q ss_pred Hc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--------CccccccC
Q psy2648 138 LH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--------KLDTFCGS 207 (708)
Q Consensus 138 ~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--------~~~~~~Gt 207 (708)
.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||.+....... ......++
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 64 468999999999999999999999999999999999999999999999999886543211 12344577
Q ss_pred CcccccccccCC--ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCCC----------------------
Q psy2648 208 PPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL-RERVLRGKY---------------------- 262 (708)
Q Consensus 208 ~~Y~APE~l~~~--~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l-~~~i~~~~~---------------------- 262 (708)
..|+|||++.+. .+ +.++|||||||++|+|++|..||........ .+++.....
T Consensus 172 ~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 172 LPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred ccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 889999998763 34 4789999999999999999999987654332 233221100
Q ss_pred -----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 263 -----------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 263 -----------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..+...+.++.+||.+||+.||++|||+++++ |+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 00112346789999999999999999999987 654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.76 Aligned_cols=246 Identities=28% Similarity=0.478 Sum_probs=202.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-EKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ylV 123 (708)
.++|++.+.||+|+||.||+|.+..+++.||||++.+........+.+.+|+++++.++||||+++++++.. ...+|+|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 468999999999999999999999999999999987654434445667899999999999999999999875 5679999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
|||+ +++|.+++. ...+++..+..++.||+.||.|||+++|+||||||.|||++.++.+||+|||++..... ....
T Consensus 89 ~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~ 164 (328)
T cd07856 89 TELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTG 164 (328)
T ss_pred eehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCC
Confidence 9998 568887764 45789999999999999999999999999999999999999999999999999875432 2344
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------------cC--------
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL---------------RG-------- 260 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~---------------~~-------- 260 (708)
..+++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+. ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 5788899999998663333589999999999999999999998765432211111 00
Q ss_pred ---CCCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 ---KYRIP-----FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 ---~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....| ...++++.++|++||+.||++||+++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00111 23578899999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=351.28 Aligned_cols=247 Identities=26% Similarity=0.502 Sum_probs=216.4
Q ss_pred ccCCe-EEEeEEcccCceEEEEEEEcCCCcEEEEEEeccC--CCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-
Q psy2648 44 HIGKY-KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT--QLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT- 119 (708)
Q Consensus 44 ~~~~Y-~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 119 (708)
.-|+| +....||+|+|-+||+|.+..+|.+||--.++.. ...++.++++..|+.+|+.|+|||||++|++|.+...
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 35677 5567999999999999999999999996444332 2356778999999999999999999999999987654
Q ss_pred -EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcC-CCcEEEEeccCcccc
Q psy2648 120 -LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDS-EMNIKIADFGFSNEF 195 (708)
Q Consensus 120 -~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~-~~~iKL~DFGls~~~ 195 (708)
+.+|+|++..|+|..|+++.+++....++.|++||+.||.|||++. |||||||.+||+|+. .|.|||.|+|||...
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8999999999999999999999999999999999999999999985 999999999999985 489999999999876
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCC--CCCCHHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGKYRIP--FYMSTDC 272 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~~~~p--~~~s~~~ 272 (708)
.. .......|||.|||||++. ..|+ ..+||||||++|.||+|+.+||.. .+..+++++|..|..+-- .--.+++
T Consensus 197 r~-s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPev 273 (632)
T KOG0584|consen 197 RK-SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEV 273 (632)
T ss_pred hc-cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence 54 3445589999999999997 5675 799999999999999999999975 678899999999976532 2346899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++||.+||.. ..+|+|+.+++
T Consensus 274 r~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 274 REFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred HHHHHHHhcC-chhccCHHHHh
Confidence 9999999999 99999999887
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.41 Aligned_cols=247 Identities=31% Similarity=0.470 Sum_probs=204.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEc----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHV----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKT 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 119 (708)
..|++.+.||+|+||.||+|.+. .+++.||||++...... ...+.+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46889999999999999999865 35889999999765433 345678899999999999999999999887 567
Q ss_pred EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.|+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999999997654 6899999999999999999999999999999999999999999999999999766432
Q ss_pred CCc----cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH---------------HHHHHHHHc
Q psy2648 199 NKL----DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL---------------RELRERVLR 259 (708)
Q Consensus 199 ~~~----~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~---------------~~l~~~i~~ 259 (708)
... ....++..|+|||.+.+..++ .++|||||||++|+|++|..||..... ..+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 211 122345569999999877664 789999999999999999999876432 222233332
Q ss_pred C-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 G-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+ ....|...+.++.+|+.+||..||++||++.++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 277 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHH
Confidence 2 2233456678999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.96 Aligned_cols=246 Identities=30% Similarity=0.525 Sum_probs=210.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCC---CChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ---LNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+|.+.+.||+|+||.||++.+..++..+++|+++... ........+.+|+.+++.++||||+++++.+.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5999999999999999999999888888888776432 2233344577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 124 MEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||+++++|.+++.. ...+++.+++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988864 356899999999999999999999999999999999999985 569999999987654332
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLK 277 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~ 277 (708)
......|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.+.+..++...+..+.. ..|...+.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 23356789999999999877765 689999999999999999999998877777777766643 356677899999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..||++||+++++.
T Consensus 239 ~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 239 SMLNKDPSLRPSAAEIL 255 (260)
T ss_pred HHhcCChhhCcCHHHHh
Confidence 99999999999999887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.80 Aligned_cols=243 Identities=28% Similarity=0.430 Sum_probs=205.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|...+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+++++.++||||+++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 37778899999999999999999999999999976543 23445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
|+. |+|.+++... ..+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.... .....
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~ 177 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSF 177 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCc
Confidence 996 5787777653 568999999999999999999999999999999999999999999999999986432 23456
Q ss_pred ccCCcccccccccC---CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CC-CCCCCHHHHHHHHHh
Q psy2648 205 CGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RI-PFYMSTDCENLLKKF 279 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~-p~~~s~~~~~Li~~~ 279 (708)
.|+..|+|||++.. ..+ ..++|||||||++|+|++|..||...+.......+..... .. ....+..+++||.+|
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~-~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred cccccccChhhccccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 78999999999842 334 4689999999999999999999988776655555544332 22 224567899999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|+.+|.+||+++++.
T Consensus 257 l~~~P~~Rp~~~~~l 271 (313)
T cd06633 257 LQKIPQERPASAELL 271 (313)
T ss_pred ccCChhhCcCHHHHh
Confidence 999999999999877
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.27 Aligned_cols=246 Identities=33% Similarity=0.549 Sum_probs=207.3
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
|++.+.||+|.||.||+|.+..+++.||+|++..........+.+..|+.+++.++||||+++++++.+...+|+||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999999876533344566788999999999999999999999999999999999
Q ss_pred CCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccccc
Q psy2648 128 SGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFC 205 (708)
Q Consensus 128 ~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~~ 205 (708)
+ ++|.+++... ..+++..+..++.||+.||+|||++||+||||+|+||++++++.+||+|||++....... ......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 8 5899999876 579999999999999999999999999999999999999999999999999987654322 233456
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC------------------CCCCC--
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------------KYRIP-- 265 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------------~~~~p-- 265 (708)
++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+...++... ...+|
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 6788999999877633357899999999999999999999887765544443320 00011
Q ss_pred ---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 ---------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 ---------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+.++.++|.+||..||++||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 12367899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=366.46 Aligned_cols=247 Identities=30% Similarity=0.533 Sum_probs=202.6
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEE--------
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI-------- 114 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-------- 114 (708)
+...+|+.++.||+|+||.||+|+++.+|+.||||.|.... ......++++|+.+|.+|+|||||++|..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567899999999999999999999999999999998765 556667899999999999999999987310
Q ss_pred ----------------------------------------------------E------e--------------------
Q psy2648 115 ----------------------------------------------------E------T-------------------- 116 (708)
Q Consensus 115 ----------------------------------------------------~------~-------------------- 116 (708)
. .
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0 0
Q ss_pred -------------------------C--------CEEEEEEeccCCCChHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHH
Q psy2648 117 -------------------------E--------KTLYLVMEYASGGEVFDYLVLHGRM-KEKEARAKFRQIVSAVQYCH 162 (708)
Q Consensus 117 -------------------------~--------~~~ylVmEy~~gg~L~~~i~~~~~l-~e~~~~~i~~QI~~aL~yLH 162 (708)
+ ..+||-||||+.-.|.++|..+... ...+++++|+||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 2379999999987777777655444 57889999999999999999
Q ss_pred HCCceecCCCCCCEEEcCCCcEEEEeccCccccC-------------------CCCCccccccCCcccccccccCCc---
Q psy2648 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-------------------PGNKLDTFCGSPPYAAPELFQGKK--- 220 (708)
Q Consensus 163 ~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-------------------~~~~~~~~~Gt~~Y~APE~l~~~~--- 220 (708)
++|||||||||.||+||.+++|||.|||+++... .....++..||..|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999997621 011345678999999999998765
Q ss_pred cCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 221 YDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 221 ~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
|+ .|+|+||||||||||+ .||.- +....+...+.++.++.|. ..-+.-..+|+.||+.||.+|||+.+++
T Consensus 795 Yn-~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 795 YN-SKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cc-chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 64 7999999999999997 47754 3344566777777776661 2335568999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.74 Aligned_cols=243 Identities=30% Similarity=0.443 Sum_probs=206.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|...+.||+|+||.||+|++..+++.||||.+..... .....+.+.+|+++++.++||||+++++++......|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 48889999999999999999999999999999875432 23445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 126 YASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
|+. |+|.+++.. ...+++.++..++.||+.||.|||+++++||||||+|||++.++.+||+|||++...... ...
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 171 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXF 171 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccc
Confidence 997 578777654 346899999999999999999999999999999999999999999999999998765432 345
Q ss_pred ccCCcccccccccC---CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHh
Q psy2648 205 CGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCENLLKKF 279 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~--~p~~~s~~~~~Li~~~ 279 (708)
.|++.|+|||++.+ ..+ ..++|||||||++|+|++|..||...+..+....+..+... .+...+..+.+||++|
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred cCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence 78999999999853 233 46899999999999999999999887665555555544332 2335778899999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|..+|.+||+++++.
T Consensus 251 l~~~P~~Rp~~~~ll 265 (308)
T cd06634 251 LQKIPQDRPTSEVLL 265 (308)
T ss_pred hhCCcccCCCHHHHh
Confidence 999999999999887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.35 Aligned_cols=221 Identities=26% Similarity=0.376 Sum_probs=188.3
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCChHHHH
Q psy2648 57 GNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL 136 (708)
Q Consensus 57 G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L~~~i 136 (708)
|.||+||+|++..+++.||+|++.+.. ...+|...+....||||+++++++.....+|+||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999999999999999997642 1234555566677999999999999999999999999999999999
Q ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCcccccccc
Q psy2648 137 VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 216 (708)
Q Consensus 137 ~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l 216 (708)
.....+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|||++
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVG 154 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCccc
Confidence 88888999999999999999999999999999999999999999999999999987655432 2345667889999999
Q ss_pred cCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHH
Q psy2648 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291 (708)
Q Consensus 217 ~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~ 291 (708)
.+..+ ++++||||+||++|+|++|..||...... .. ......+|...++++.+||.+||+.||++|+++.
T Consensus 155 ~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 155 GISEE-TEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 87766 47899999999999999999998653221 10 0122456778899999999999999999999964
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=374.42 Aligned_cols=459 Identities=29% Similarity=0.451 Sum_probs=318.6
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~yl 122 (708)
...|.+.+.||+|+|+.|-++... .+...+|+|.+............+..|..+-+.+. |+|++++++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 346999999999999999998764 44556888887765433344455667888888887 9999999999999999999
Q ss_pred EEeccCCCChHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCEEEcCCC-cEEEEeccCccccCC-
Q psy2648 123 VMEYASGGEVFDYL-VLHG-RMKEKEARAKFRQIVSAVQYCH-QKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTP- 197 (708)
Q Consensus 123 VmEy~~gg~L~~~i-~~~~-~l~e~~~~~i~~QI~~aL~yLH-~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~~- 197 (708)
++||..|+++++.+ .... .++...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .+|++|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999988 5554 6888999999999999999999 99999999999999999999 999999999987755
Q ss_pred C---CCcccccc-CCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHc-CC--CCCCCCC
Q psy2648 198 G---NKLDTFCG-SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL--RERVLR-GK--YRIPFYM 268 (708)
Q Consensus 198 ~---~~~~~~~G-t~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l--~~~i~~-~~--~~~p~~~ 268 (708)
. ......|| ++.|+|||.+.+..|.++..|+||+|+++..|++|..||.......- ...+.. +. ......+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 2 23456789 99999999999988889999999999999999999999986543321 111111 11 1222357
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh-CCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG---EVTL-GGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARL 344 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 344 (708)
+....+++.++|..+|..|.+++++. |+.. ..... ... +. .+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~-------~~n-------~~---------~~~~--------- 306 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFS-------KSN-------PC---------ADSL--------- 306 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccccccccc-------ccc-------cc---------cccc---------
Confidence 78899999999999999999998765 5433 00000 000 00 0000
Q ss_pred ccCCCCCCcCCCChhhHHHHhcCCCCHHHHHHHHhccCCCCcccccccccccccccCCCCCCCCCCCCCCCCCCcccccc
Q psy2648 345 NAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDDPESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQ 424 (708)
Q Consensus 345 ~~~~p~~~~~~~~~~~~~~~~~~g~~~~~i~~~l~~~~~~~~~~~y~~l~~~~~~~~~~p~~~~~~~~~~g~s~~~~~~~ 424 (708)
..+.. ..++. .+|-. .. +.-+.+..++......+...
T Consensus 307 ---~~~~~-------------~~~~~----------~~y~~-------------~~----~~~g~ga~g~~~~~~~~~~~ 343 (601)
T KOG0590|consen 307 ---TIAKS-------------PIGFS----------EKYGK-------------PG----RVLGSGAYGSVRIAKRRSDL 343 (601)
T ss_pred ---ccccC-------------ccccc----------cccCC-------------cc----ceeeecccCceEEEEecCCC
Confidence 00000 00000 00000 00 00000000000000000000
Q ss_pred CCCCCccccCCCCCCCCCC--cCCCccccccccccccccCcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHH
Q psy2648 425 PGSGGVATGGSGGGGGGGA--AQSPSHRGVHRSISASNAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDY 502 (708)
Q Consensus 425 ~~~~g~~~~~~~ggg~~g~--v~s~~hr~~~R~i~~~~~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~ 502 (708)
+ ......+-. ......+..... ...+-.......|+|++.....+++....+-+||||++ ||+.+
T Consensus 344 ~---------~~~~~~~r~~~~~~~s~~~~~~~---i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~ 410 (601)
T KOG0590|consen 344 K---------SFPEKEFRVRVKPTESERKYNYN---ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSL 410 (601)
T ss_pred c---------cchhhhhhcccCCcccHHHHhhh---hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHH
Confidence 0 000000000 000000000000 11112223456788888777777777777777999999 99999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCC-----CcccccccCCcc
Q psy2648 503 LVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-----NKLDTFCGSPPY 577 (708)
Q Consensus 503 l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~-----~~~~~~~Gt~~Y 577 (708)
+...+.+...++..++.|++.||+|+|+.||.||||||+|+|++..|.+||+|||.+..+... .....++|+..|
T Consensus 411 ~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY 490 (601)
T KOG0590|consen 411 VMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPY 490 (601)
T ss_pred HhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcC
Confidence 998889999999999999999999999999999999999999999999999999998765322 234668999999
Q ss_pred cccccccCCCCccC
Q psy2648 578 AAPELFQGGAPVTS 591 (708)
Q Consensus 578 ~APEvl~g~~~~~~ 591 (708)
+|||++.+..+-..
T Consensus 491 ~apE~~~~~~ydpr 504 (601)
T KOG0590|consen 491 LAPEVLTGKEYDPR 504 (601)
T ss_pred cCcccccccccCcc
Confidence 99999987764433
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.20 Aligned_cols=242 Identities=27% Similarity=0.484 Sum_probs=213.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+-.+..+||-|.||.||.|.|+.-.-.||||.++.+.+ .++.|+.|+.+|+.+.|||+|+|+++|..+..+|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34567899999999999999999999999999976654 467899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc
Q psy2648 127 ASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~ 204 (708)
|..|+|++||++..+ ++.-....++.||.+|++||..+++|||||...|+|+.++..|||+||||++.+..+. ....
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAH 423 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecc
Confidence 999999999987654 4555566777899999999999999999999999999999999999999999876543 2333
Q ss_pred cc---CCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Q psy2648 205 CG---SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCENLLKK 278 (708)
Q Consensus 205 ~G---t~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~--~p~~~s~~~~~Li~~ 278 (708)
.| ...|.|||-+..+.+. .++|||+|||+|||+.| |-.||.+.+..+++..+.+| |+ -|..+++...+||..
T Consensus 424 AGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred cCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccccCCCCCCHHHHHHHHH
Confidence 34 3469999999988885 79999999999999998 99999999999999887766 54 588999999999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||+++|.+||++.++.
T Consensus 502 CW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HhcCCcccCccHHHHH
Confidence 9999999999998764
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.44 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=215.5
Q ss_pred CccCCeEEE-------eEEcccCceEEEEEEEcCC--Cc--EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEE
Q psy2648 43 PHIGKYKLL-------KTIGKGNFAKVKLAKHVPT--GK--EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLF 111 (708)
Q Consensus 43 ~~~~~Y~i~-------~~LG~G~fg~V~la~~~~t--g~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 111 (708)
|...+|++. +.||.|.||.||.|..... |+ -||||..+.+ ..++..++|+.|+-+|++++|||||+|+
T Consensus 379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 334466654 6789999999999986432 33 5888987653 4566788999999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEecc
Q psy2648 112 QVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190 (708)
Q Consensus 112 ~~~~~~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFG 190 (708)
+++.. ..+|||||+++-|+|..|+..+ ..++......|+.||+.||.|||+...|||||...|||+.....|||+|||
T Consensus 458 Gv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 458 GVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccc
Confidence 99975 5699999999999999999876 468989999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCccccccCC--cccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCC
Q psy2648 191 FSNEFTPGNKLDTFCGSP--PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPF 266 (708)
Q Consensus 191 ls~~~~~~~~~~~~~Gt~--~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~ 266 (708)
|++.+..........|-+ .|||||.+.-..++ .++|||-|||++||++. |..||.+-...+++-+|.+|. .+.|.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~ 615 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP 615 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC
Confidence 999887665554445544 59999999888775 79999999999999987 999999988888888888884 57889
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+++-+..|+.+||.+||.+||.+.++.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 9999999999999999999999998776
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.56 Aligned_cols=247 Identities=28% Similarity=0.378 Sum_probs=197.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-EEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-TLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~ylVm 124 (708)
++|.--..||+|+||.||+|.-.. |+.||||.+....... .+.|.+|+.+|.+++|||+|+|+++|.+.+ +.+||.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 577778899999999999998754 4899999886544321 345999999999999999999999999888 599999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEEcCCCcEEEEeccCccccCC-C
Q psy2648 125 EYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKK---IIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-G 198 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~g---IvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~ 198 (708)
||+++|+|.+++.... .+++..-..|+.+++.||+|||... ||||||||.|||||++++.||+|||+|+.... .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 9999999999997765 7899999999999999999999854 99999999999999999999999999976543 3
Q ss_pred CCcccc-ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHH----HHHcCCC------CC
Q psy2648 199 NKLDTF-CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST---LRELRE----RVLRGKY------RI 264 (708)
Q Consensus 199 ~~~~~~-~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~---~~~l~~----~i~~~~~------~~ 264 (708)
....+. .||..|+|||++..... +.++|||||||+|.||++|+.|.+... ...+.. .+..+.+ .+
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred cceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 333333 89999999999976554 479999999999999999998887432 111222 2333321 11
Q ss_pred C-CCCC--HH---HHHHHHHhhhhCCCCCCCHHHHhhh
Q psy2648 265 P-FYMS--TD---CENLLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 265 p-~~~s--~~---~~~Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
. .... .+ +..+..+|++.+|.+||++.++.+.
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 1 1112 12 4566779999999999999987644
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.19 Aligned_cols=250 Identities=27% Similarity=0.472 Sum_probs=220.0
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
+.....-+|.++||.|.||+|++|+.+..|+ .||||.++.. ...+....|+.|+.||-+++|||||+|-++....+
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 3444556899999999999999999987774 6999999643 34556678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
.+-||+|||++|+|+.||+.+ +.|...+...+++.|+.||+||-++|+|||||...|||++.+-.+|++||||++.+.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999999999877 6788899999999999999999999999999999999999999999999999997754
Q ss_pred CCC--ccccccC--CcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC--CCCCH
Q psy2648 198 GNK--LDTFCGS--PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP--FYMST 270 (708)
Q Consensus 198 ~~~--~~~~~Gt--~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~~p--~~~s~ 270 (708)
+.. ..+.-|. ..|.|||.+...+++ .++||||+||+|||.++ |..||.+.+.+++++.|..| |++| -.++.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g-yRLPpPmDCP~ 861 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG-YRLPPPMDCPA 861 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhc-cCCCCCCCCcH
Confidence 431 2233333 469999999999885 79999999999999887 99999999999999999877 6654 46778
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..|+..||++|-.+||.+++|.
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV 885 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIV 885 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHH
Confidence 899999999999999999999987
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.33 Aligned_cols=246 Identities=29% Similarity=0.492 Sum_probs=216.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCC-Cc--EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPT-GK--EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~t-g~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
++.++.+.||+|+||.|++|.|... |+ .||||++.....+. ....|++|+.+|.+|+|||+|+||++..+ ..+-|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3566778999999999999998743 33 59999998776554 56789999999999999999999999987 67899
Q ss_pred EEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 123 VMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
|||+|+.|+|.+.|.+ ++.|.......|+.||+.||.||.++++|||||...||||.....|||+||||.+.+..+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999999987 35688888999999999999999999999999999999999999999999999988766554
Q ss_pred cccccc----CCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 201 LDTFCG----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 201 ~~~~~G----t~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
...+.+ -..|.|||.+...+++ .++|||++||+||||++ |+.||.|..-.++.++|-.+. ..-|..+++++.+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred ceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence 433332 3469999999999886 69999999999999998 999999999999999998664 4568899999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
++++||..+|++|||+..|.
T Consensus 347 imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred HHHHhccCCccccccHHHHH
Confidence 99999999999999998774
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=288.87 Aligned_cols=247 Identities=30% Similarity=0.540 Sum_probs=208.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
+|.-.++||+|.||+||+|+++.+++.||+|.+.-+..+...-...++|+.+|+.|.|.|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 57778899999999999999999999999999976654444456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccccc
Q psy2648 127 ASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTF 204 (708)
Q Consensus 127 ~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~ 204 (708)
|.. +|..|... +|.++.+.++.++.|++.||.|||++++.||||||.|+||+.+|.+||+|||+++.+.-.- -...-
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 964 77777654 5789999999999999999999999999999999999999999999999999998875432 22334
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc--CC-----C----------CCCC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR--GK-----Y----------RIPF 266 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~--~~-----~----------~~p~ 266 (708)
.-|..|.+|.++.|.+......|+||-|||+.|+.. |++-|.+.+..+-..+|.. |. + .+|.
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 568899999999987766688999999999999997 8999999988776666643 11 1 0111
Q ss_pred ------------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 ------------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ------------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++..-+||++++|.-+|.+|++++..+
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 1233468999999999999999998755
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.41 Aligned_cols=250 Identities=29% Similarity=0.513 Sum_probs=201.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCC----cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTG----KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-EKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 119 (708)
+..|++++.||+|.||.||+|....+. +.+|||.++-+...........||+.+++.|+|||||.|..+|-. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 567999999999999999999655443 379999997664433444667899999999999999999999877 788
Q ss_pred EEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC----CcEEEEecc
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE----MNIKIADFG 190 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~----~~iKL~DFG 190 (708)
+|+++||++. ||.+.|..+ ..++...++.++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999986 898887654 248889999999999999999999999999999999999877 899999999
Q ss_pred CccccCCC----CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHH
Q psy2648 191 FSNEFTPG----NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR---------ELRERV 257 (708)
Q Consensus 191 ls~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~---------~l~~~i 257 (708)
|++.+... ...+..+-|..|.|||++.|....+++.||||+|||+.||++-++-|.+...+ +-..+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99887532 23345677899999999999877679999999999999999999888763210 111222
Q ss_pred Hc--CCC---------CCCC--------------------------CCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 258 LR--GKY---------RIPF--------------------------YMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 258 ~~--~~~---------~~p~--------------------------~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
.+ |.+ .+|. ..++...+|+.+||++||.+|+|++++++
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 11 100 1121 13455889999999999999999998873
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.28 Aligned_cols=250 Identities=32% Similarity=0.491 Sum_probs=206.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-----GSLQKLFREVRIMKMLDHPNIVKLFQVIET-EK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~ 118 (708)
-++|-++..||+|+|++||+|.+....+.||||+-.-.+... ...+...+|.+|.+.|+||-||++|++|.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 358999999999999999999999999999999965433211 223457799999999999999999999964 46
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCCEEEcC---CCcEEEEeccCcc
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK--KIIHRDLKAENLLLDS---EMNIKIADFGFSN 193 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~--gIvHRDLKPeNILld~---~~~iKL~DFGls~ 193 (708)
.+|-|+|||+|.||..||+.+..++|.+|+.|+.||+.||.||... -|||-||||.||||-+ .|.|||+||||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7999999999999999999999999999999999999999999976 5999999999999954 4789999999999
Q ss_pred ccCCCCC--------ccccccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHH--HHHc
Q psy2648 194 EFTPGNK--------LDTFCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRE--RVLR 259 (708)
Q Consensus 194 ~~~~~~~--------~~~~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~l~~--~i~~ 259 (708)
.+...+. +....||..|++||.|.-. +-...++||||+|||+|..+.|+-||... +.+++.+ -|++
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 8764321 2457899999999998432 22346899999999999999999999753 3333332 2222
Q ss_pred -CCCCCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 -GKYRIP--FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 -~~~~~p--~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+| .-++.++++||++||++.-++|..+.++.
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 234455 35899999999999999999999887765
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=309.88 Aligned_cols=249 Identities=30% Similarity=0.536 Sum_probs=205.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------- 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 117 (708)
.+.|+-+..||+|.||+||+|+++.+|+.||+|++-.+......-...++|+++|..|.|+|++.++++|.+.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 5679899999999999999999999999999987654332223334568999999999999999998877532
Q ss_pred -CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 118 -KTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 118 -~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
..+|+||.+|+. ||+-.+... -+++..+++.++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+++.+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 359999999986 888877654 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCC-----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CC-------
Q psy2648 196 TPGN-----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--GK------- 261 (708)
Q Consensus 196 ~~~~-----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--~~------- 261 (708)
.... .....+-|+.|.+||.+.|....+++.|||.-|||+.||.+|.+-|.+.+.++-...|.. |.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 4322 233456699999999999987778999999999999999999999998776554443321 11
Q ss_pred --------------------CC------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 --------------------YR------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 --------------------~~------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++ -|.-..+++.|||.+||..||.+|+..+++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 10 1222355889999999999999999999877
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=322.85 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=206.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
...+.++||+|.||+|.+|.-.. +.+||||+++... +......|.+|+++|.+|+|||||+|+++|..++.+++||||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 56788999999999999998643 6899999997654 233456799999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc--
Q psy2648 127 ASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD-- 202 (708)
Q Consensus 127 ~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~-- 202 (708)
+++|+|.+|+.++. .+.......++.||++||+||.+.++|||||.+.|+|+|.++++||+|||+++.+-.+....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 99999999999873 34556677899999999999999999999999999999999999999999998654443222
Q ss_pred -ccccCCcccccccccCCccCCCchhHHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHH---cCC-----CCCCCCCCHH
Q psy2648 203 -TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV--SGSLPFDGSTLRELRERVL---RGK-----YRIPFYMSTD 271 (708)
Q Consensus 203 -~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyell--tG~~Pf~~~~~~~l~~~i~---~~~-----~~~p~~~s~~ 271 (708)
...-...|||||.+.-.+++ .++|+|+|||+|||++ |...||...+.+++.+... .+. ...|.-++..
T Consensus 697 gr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~ 775 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQG 775 (807)
T ss_pred cceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHH
Confidence 12334689999999888885 7999999999999976 5889999888777665432 221 2356778889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+||-+||..|-.+||+++++.
T Consensus 776 lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 776 LYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred HHHHHHHHhchhhhcCCCHHHHH
Confidence 99999999999999999999876
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.94 Aligned_cols=383 Identities=27% Similarity=0.418 Sum_probs=291.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
-++|+++..+|.|+||.||+|+++.+++..|||+++-..- .+..-+..|+-+++.-+|||||.+++.+-....+||+|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3579999999999999999999999999999999976532 34455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~ 203 (708)
|||.||+|.+--.-.+.++|.++....++.+.||+|||++|=+|||||-.|||+++.|.+|++|||.+..+... .+-..
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 99999999987666789999999999999999999999999999999999999999999999999998766432 24467
Q ss_pred cccCCccccccccc---CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-----CCCCHHHHHH
Q psy2648 204 FCGSPPYAAPELFQ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP-----FYMSTDCENL 275 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~---~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p-----~~~s~~~~~L 275 (708)
+.|||.|||||+-. ...| ...+|||++|+...|+-.-+.|-.+...........+..|..| ...++-+.+|
T Consensus 172 fiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred ccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 89999999999863 2334 4789999999999999998988776666655555555555554 3467889999
Q ss_pred HHHhhhhCCCCCCCHHHHhhhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCCcCC
Q psy2648 276 LKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTAS 355 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 355 (708)
++.+|.++|++||+.+.++-. + .... . .
T Consensus 251 vK~altknpKkRptaeklL~h-----~---------------fvs~--------~-l----------------------- 278 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQH-----P---------------FVSQ--------T-L----------------------- 278 (829)
T ss_pred HHHHhcCCCccCCChhhheec-----e---------------eecc--------c-h-----------------------
Confidence 999999999999998843211 0 0000 0 0
Q ss_pred CChhhHHHHhcCCCCHHHHHHHHhccCCCCcccccccccccccccCCCCCCCCCCCCCCCCCCccccccCCCCCccccCC
Q psy2648 356 IAPLDTKALVGLGYSRSEIEESLSQAKYDDPESDGSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGS 435 (708)
Q Consensus 356 ~~~~~~~~~~~~g~~~~~i~~~l~~~~~~~~~~~y~~l~~~~~~~~~~p~~~~~~~~~~g~s~~~~~~~~~~~g~~~~~~ 435 (708)
++.-.++.|. +.|++..
T Consensus 279 --------------~~rl~~eLLd--K~n~P~~----------------------------------------------- 295 (829)
T KOG0576|consen 279 --------------SRRLAIELLD--KVNNPNP----------------------------------------------- 295 (829)
T ss_pred --------------hhHHHHHHHH--HccCCCC-----------------------------------------------
Confidence 0000111111 1222111
Q ss_pred CCCCCCCCcCCCccccccccccccccCcccccccccCceeEEEEEEEeCCEEEEEEeccCCC-C-HHHHHHhcCCCCHHH
Q psy2648 436 GGGGGGGAAQSPSHRGVHRSISASNAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGG-E-VFDYLVLHGRMKEKE 513 (708)
Q Consensus 436 ~ggg~~g~v~s~~hr~~~R~i~~~~~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg-~-L~~~l~~~~~l~e~~ 513 (708)
.|..++-++.++..+++|++|.++ + ....-...-.+.+-+
T Consensus 296 --------------------------------------~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~ 337 (829)
T KOG0576|consen 296 --------------------------------------VVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQ 337 (829)
T ss_pred --------------------------------------cccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhh
Confidence 122233345566788889998877 2 111111111233344
Q ss_pred HHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 514 ARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 514 ~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.....+.-..++.++|+..=+||| |||..+ +..|..||+....+.......++.+|+.++|||++++...
T Consensus 338 ~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 338 FAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTI 407 (829)
T ss_pred hhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhccccc
Confidence 445566777889999998889999 777655 7889999999988877666778899999999999876653
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.30 Aligned_cols=204 Identities=36% Similarity=0.650 Sum_probs=184.4
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh------hhHHHHHHHHHHHHhCC---CCCeeeEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP------GSLQKLFREVRIMKMLD---HPNIVKLFQV 113 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~l~---HpnIv~l~~~ 113 (708)
..+..|..++.+|+|+||+|++|.|+.....|+||.|.|++.-. ..+-.+-.||+||..|+ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34567999999999999999999999999999999999876421 12223557999999998 9999999999
Q ss_pred EEeCCEEEEEEec-cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 114 IETEKTLYLVMEY-ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 114 ~~~~~~~ylVmEy-~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
||+++++||+||- =+|-||++||..+.+++|.++..+|+|++.|+++||++||||||||-||+.+|.+|.+||+|||.+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 9999999999995 477899999999999999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2648 193 NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 247 (708)
Q Consensus 193 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~ 247 (708)
... ......++.||..|+|||++.|.+|-|..-|||+|||+||.++...-||..
T Consensus 718 a~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 644 345678999999999999999999999999999999999999999999864
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=313.42 Aligned_cols=244 Identities=28% Similarity=0.458 Sum_probs=200.6
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC--CC----eeeEEEEEEeCC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH--PN----IVKLFQVIETEK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pn----Iv~l~~~~~~~~ 118 (708)
..+|++.+++|+|.||+|-.|.+..++..||||+|+.- .+..+..+-|+++|++|++ |+ +|++.++|+-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 46899999999999999999999999999999998632 2344567789999999953 32 788999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC----------------
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---------------- 180 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---------------- 180 (708)
+++||+|.+ |-++++|+..++ +++...++.+.+||+.+++|||+.+++|-||||||||+-+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999987 568999998764 6889999999999999999999999999999999999832
Q ss_pred ----CCcEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH---H
Q psy2648 181 ----EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE---L 253 (708)
Q Consensus 181 ----~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~---l 253 (708)
+-.|||+|||.+....... .+.+.|..|.|||++.+..++ .++||||+||||+|+++|..-|+..+..| +
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 2358999999887544333 677899999999999999986 68999999999999999999998765444 5
Q ss_pred HHHHHc------------------CCCCCCC----------------------CCC---HHHHHHHHHhhhhCCCCCCCH
Q psy2648 254 RERVLR------------------GKYRIPF----------------------YMS---TDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 254 ~~~i~~------------------~~~~~p~----------------------~~s---~~~~~Li~~~L~~dP~~Rps~ 290 (708)
.++|+. +....|. ..+ .++.|||++||..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 555542 1111111 011 246799999999999999999
Q ss_pred HHHhh
Q psy2648 291 EVSGE 295 (708)
Q Consensus 291 ~~~~~ 295 (708)
.+++|
T Consensus 401 ~EAL~ 405 (415)
T KOG0671|consen 401 REALS 405 (415)
T ss_pred HHHhc
Confidence 99884
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.91 Aligned_cols=235 Identities=49% Similarity=0.821 Sum_probs=207.3
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCChHHHHH
Q psy2648 58 NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV 137 (708)
Q Consensus 58 ~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L~~~i~ 137 (708)
+||.||+|.+..+++.||+|++........ .+.+.+|+++++.++|+||+++++.+......+++|||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999999999999999976543221 5678899999999999999999999999999999999999999999998
Q ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCccccccccc
Q psy2648 138 LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217 (708)
Q Consensus 138 ~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~ 217 (708)
....+++..+..++.|++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++.............++..|++||.+.
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence 77668999999999999999999999999999999999999999999999999988765544556678899999999998
Q ss_pred CCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCCCC---CCHHHHHHHHHhhhhCCCCCCCHHHH
Q psy2648 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGKYRIPFY---MSTDCENLLKKFLVLNPAKRASLEVS 293 (708)
Q Consensus 218 ~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~~~~p~~---~s~~~~~Li~~~L~~dP~~Rps~~~~ 293 (708)
+..++ +++||||||+++|+|++|..||.. .+...+.+.+..+....+.. ++.++.+++.+||..||++||++.++
T Consensus 160 ~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 160 GKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred cCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 77765 699999999999999999999988 66677777776665554333 78899999999999999999999987
Q ss_pred h
Q psy2648 294 G 294 (708)
Q Consensus 294 ~ 294 (708)
.
T Consensus 239 ~ 239 (244)
T smart00220 239 L 239 (244)
T ss_pred h
Confidence 6
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=303.38 Aligned_cols=246 Identities=29% Similarity=0.447 Sum_probs=200.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHH-HhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIM-KMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+.+-+..||.|+||.|++-.|+++|+..|||.|..... ..+.++++.|.+.. +.-+.||||++|+.+-.++..||.||
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34556789999999999999999999999999987654 34566788888764 55679999999999999999999999
Q ss_pred ccCCCChHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 126 YASGGEVFDYL-----VLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 126 y~~gg~L~~~i-----~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
++.- +|..+. ..+.+++|.-.-.+....+.||+||-. ..|||||+||+|||||..|.|||||||++..+...-
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 9953 444332 345679998888888889999999975 589999999999999999999999999987664433
Q ss_pred CccccccCCcccccccccC--CccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCC---C---CCCCH
Q psy2648 200 KLDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLRGKYRI---P---FYMST 270 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~--~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~~~~~~---p---~~~s~ 270 (708)
....-.|..+|||||.+.. ..|+ .++||||||++|||+.||.+||.+.+ ..+-...|..|.+++ + .+.|.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 3334578899999999853 3465 68999999999999999999998754 334445566676553 2 23788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
.+..+|.-||.+|-..||..++++.
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhc
Confidence 9999999999999999999998773
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=290.96 Aligned_cols=243 Identities=24% Similarity=0.498 Sum_probs=203.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--CEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETE--KTL 120 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~ 120 (708)
.+++|++.+.+|+|-|++||.|.+..+.++++||++++ -..+++.||+.||+.|. |||||+|+++..+. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 46789999999999999999999999999999999864 34567899999999997 99999999999775 467
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-~~iKL~DFGls~~~~~~~ 199 (708)
.||+||+.+.|.... -..++..+++.++.||+.||.|||++||+|||+||.|++||.. ..++|+|+||+..+.++.
T Consensus 111 aLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 899999998775543 3578899999999999999999999999999999999999975 469999999999999998
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC--CCHHHHH------------HHHHcCCCCC-
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--STLRELR------------ERVLRGKYRI- 264 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~--~~~~~l~------------~~i~~~~~~~- 264 (708)
..+....+..|--||++..-......-|+|||||+|..|+..+-||.. .+..++. .-+.+-...+
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 888889999999999997655445789999999999999999999853 2333322 1111111111
Q ss_pred -------------C----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 -------------P----------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 -------------p----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
| .-.++++.|||.++|.+|.++|+|+.+++
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 1 12468999999999999999999999877
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=329.17 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=176.8
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCC----CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEE---
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPT----GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV--- 113 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~t----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~--- 113 (708)
.....++|++.+.||+|+||.||+|.+..+ +..||||.+..... .+....| + ++...+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e-~-l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE-R-VRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH-H-HHhhchhhHHHHHHhhhc
Confidence 344578999999999999999999999998 99999998864321 1111111 1 122222222222211
Q ss_pred ---EEeCCEEEEEEeccCCCChHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy2648 114 ---IETEKTLYLVMEYASGGEVFDYLVLHGR--------------------MKEKEARAKFRQIVSAVQYCHQKKIIHRD 170 (708)
Q Consensus 114 ---~~~~~~~ylVmEy~~gg~L~~~i~~~~~--------------------l~e~~~~~i~~QI~~aL~yLH~~gIvHRD 170 (708)
......+||||||+.+++|.+++..... ..+..+..++.||+.||+|||+++|+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456689999999999999998865421 12344678999999999999999999999
Q ss_pred CCCCCEEEcC-CCcEEEEeccCccccCCC--CCccccccCCcccccccccCCccC---------------------CCch
Q psy2648 171 LKAENLLLDS-EMNIKIADFGFSNEFTPG--NKLDTFCGSPPYAAPELFQGKKYD---------------------GPEV 226 (708)
Q Consensus 171 LKPeNILld~-~~~iKL~DFGls~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~---------------------~~~~ 226 (708)
|||+|||++. ++.+||+|||+++.+..+ ....+++|++.|+|||++....+. ..++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999996 579999999999765432 234567899999999976432211 1356
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---------------------CCCCCCHHHHHHHHHhhhhCCC
Q psy2648 227 DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---------------------IPFYMSTDCENLLKKFLVLNPA 285 (708)
Q Consensus 227 DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---------------------~p~~~s~~~~~Li~~~L~~dP~ 285 (708)
|||||||+||||+++.+|+... ...+...+....+. +......+..+||.+||++||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999988876532 22222222221111 0011223455899999999999
Q ss_pred CCCCHHHHh---hhh
Q psy2648 286 KRASLEVSG---EVT 297 (708)
Q Consensus 286 ~Rps~~~~~---~~~ 297 (708)
+|||+++++ |+.
T Consensus 440 kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 440 QRISAKAALAHPYFD 454 (566)
T ss_pred cCCCHHHHhCCcCcC
Confidence 999999988 664
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=323.05 Aligned_cols=246 Identities=30% Similarity=0.499 Sum_probs=209.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe-----CC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET-----EK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-----~~ 118 (708)
-+.|+|.++||+|.+|+||+++++.+++.+||||+.... +..+.+..|.+||+.+ +|||++.+|++|.- .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 357999999999999999999999999999999987653 2335577899999877 59999999999863 46
Q ss_pred EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
.+|||||||.||+.-|+++.. .++.|+.+..|++.++.||.+||.+.++|||||-.||||+.++.|||+|||++....
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 899999999999999988654 578899999999999999999999999999999999999999999999999998775
Q ss_pred CC-CCccccccCCcccccccccCC-----ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Q psy2648 197 PG-NKLDTFCGSPPYAAPELFQGK-----KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---IPFY 267 (708)
Q Consensus 197 ~~-~~~~~~~Gt~~Y~APE~l~~~-----~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~p~~ 267 (708)
.. ....++.|||.|||||++... .|+ ..+|+||||++..||.-|.+|+-+..+...+-.|-+...+ -|..
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 43 345788999999999999643 243 5789999999999999999999888766554444433221 2456
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.++.++|+.||.+|-.+||+..+++
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhc
Confidence 788999999999999999999987654
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=325.62 Aligned_cols=247 Identities=29% Similarity=0.501 Sum_probs=212.9
Q ss_pred CeEEEeEEcccCceEEEEEEEc---C----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHV---P----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEK 118 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~---~----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 118 (708)
+.++.+.||+|.||+|++|.-. . ....||||.++..... .+.+.+..|+++|+.+. ||||+.+++++...+
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3356779999999999998743 1 1457999998765544 66778999999999885 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 182 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~ 182 (708)
.+++|+|||..|+|.+|++.+. .++..+...+..||+.|++||++..+|||||-..|||+.++.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999998766 388899999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCc--cccccCCc--ccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCC-HHHHHHH
Q psy2648 183 NIKIADFGFSNEFTPGNKL--DTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGST-LRELRER 256 (708)
Q Consensus 183 ~iKL~DFGls~~~~~~~~~--~~~~Gt~~--Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~-~~~l~~~ 256 (708)
.+||+|||+++........ ....|+.+ |||||.+....|+ .++||||+||+|||+++ |..||.+.. ..++.+.
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 9999999999865443322 22233344 9999999998885 79999999999999999 999999865 7788888
Q ss_pred HHcCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 257 VLRGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 257 i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+..|.. ..|.++++++.++++.||..+|++||++.++..
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 888854 679999999999999999999999999988773
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=349.37 Aligned_cols=235 Identities=22% Similarity=0.310 Sum_probs=187.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
..|...+.||+|+||.||+|++..+++.||||.+...... ...|+++|++++|||||++++++.++...|+|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3566678999999999999999999999999998643211 1346889999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH---QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH---~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~ 202 (708)
|+++|+|.+++. .+++.+...++.||+.||+||| +.+|+||||||+|||++.++..++. ||........ .
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~ 836 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---T 836 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---C
Confidence 999999999985 4889999999999999999999 6699999999999999999888875 6665433211 2
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHcC-C------CCC------
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-----LRELRERVLRG-K------YRI------ 264 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-----~~~l~~~i~~~-~------~~~------ 264 (708)
...||+.|+|||++.+..|+ .++|||||||++|||++|+.||.... ..+........ . ..+
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 837 KCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 34688999999999988875 79999999999999999999996421 11111111100 0 001
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.....++.+++.+||+.||++||+++++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 111123567899999999999999999887
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=311.91 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=184.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEc----------------CCCcEEEEEEeccCCCCh------------hhHHHHHHH
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHV----------------PTGKEVAIKIIDKTQLNP------------GSLQKLFRE 95 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~----------------~tg~~vAvK~i~~~~~~~------------~~~~~~~~E 95 (708)
..++|++.+.||+|+||.||+|... ..++.||||.+....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4568999999999999999999752 345689999986432110 011223457
Q ss_pred HHHHHhCCCCCe-----eeEEEEEEe--------CCEEEEEEeccCCCChHHHHHHcC----------------------
Q psy2648 96 VRIMKMLDHPNI-----VKLFQVIET--------EKTLYLVMEYASGGEVFDYLVLHG---------------------- 140 (708)
Q Consensus 96 i~il~~l~HpnI-----v~l~~~~~~--------~~~~ylVmEy~~gg~L~~~i~~~~---------------------- 140 (708)
+.++.+++|.++ ++++++|.. ++..||||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 566666542 356899999999999999886421
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcccc--ccCCcccccccc
Q psy2648 141 --RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF--CGSPPYAAPELF 216 (708)
Q Consensus 141 --~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~--~Gt~~Y~APE~l 216 (708)
.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.....+...... .+++.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 2345678889999999999999999999999999999999999999999999765443333333 347899999998
Q ss_pred cCCc--------------------cC-CCchhHHHHHHHHHHHHcCCC-CCCCCCH-----------HHHHHHHHcCCCC
Q psy2648 217 QGKK--------------------YD-GPEVDVWSLGVILYTLVSGSL-PFDGSTL-----------RELRERVLRGKYR 263 (708)
Q Consensus 217 ~~~~--------------------~~-~~~~DIWSlGvilyelltG~~-Pf~~~~~-----------~~l~~~i~~~~~~ 263 (708)
.... |. ..+.||||+||+||+|++|.+ ||.+... ......+....+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 6432 11 124799999999999999986 7764211 1111223334444
Q ss_pred CC--CCCCHHHHHHHHHhhhhCC---CCCCCHHHHh
Q psy2648 264 IP--FYMSTDCENLLKKFLVLNP---AKRASLEVSG 294 (708)
Q Consensus 264 ~p--~~~s~~~~~Li~~~L~~dP---~~Rps~~~~~ 294 (708)
++ ...++++.|||.+||..+| .+|+|+++++
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 43 3468899999999999876 6899999987
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=315.30 Aligned_cols=244 Identities=28% Similarity=0.476 Sum_probs=214.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+..++||+|+||.||+|.+...|+ +||||++.... .++..+.+++|+-+|..|+|||+++|++++.... +-||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3456899999999999999988776 58888886544 3445567999999999999999999999998765 8899
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc
Q psy2648 124 MEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~ 202 (708)
++|++.|.|.+|++.+ +.+...+...|..||++||.|||.+++|||||-..|+|+..-..+||.|||+++...++....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999999876 578899999999999999999999999999999999999999999999999999876554322
Q ss_pred c-cc--cCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy2648 203 T-FC--GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLK 277 (708)
Q Consensus 203 ~-~~--Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~ 277 (708)
. .. -.+.|||-|.+....|. .++|||||||++||++| |..||.+...+++...+..|. ...|...+-|+.-++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 2 22 24579999999988885 79999999999999999 999999999999988888874 4567889999999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..|+..||+++++.
T Consensus 935 kCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHhccCcccCccHHHHH
Confidence 99999999999998876
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=271.07 Aligned_cols=217 Identities=25% Similarity=0.472 Sum_probs=175.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHH-HhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIM-KMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+....+..||+|+||.|-+-+|..+|+..|+|.+... .+....++.++|+.+. +....|++|.+|+.+..+..+||.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 4555678899999999999999999999999999754 4455667888999885 4568999999999999999999999
Q ss_pred eccCCCChHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 125 EYASGGEVFDYL----VLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 125 Ey~~gg~L~~~i----~~~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|.+.- +|..|. ...+.++|.-+-+++.-++.||.|||++ .|||||+||.||||+.+|++||||||++..+...-
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 99863 665543 3346799999999999999999999986 89999999999999999999999999987654332
Q ss_pred CccccccCCcccccccccCC----ccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcC-CCCCC
Q psy2648 200 KLDTFCGSPPYAAPELFQGK----KYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRG-KYRIP 265 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~----~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~-~~~~p 265 (708)
...-..|.-+|||||.+... .|+ -++||||||+.++||.++++||+. .+..+...+|... .+.+|
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 22225788899999998532 454 689999999999999999999975 3444444444443 33344
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=295.81 Aligned_cols=207 Identities=29% Similarity=0.379 Sum_probs=160.7
Q ss_pred CCCCCCCCCCcCCCcccccccccccc----------------ccCcccccccccCceeEEEEEEEeCCEEEEEEeccCCC
Q psy2648 434 GSGGGGGGGAAQSPSHRGVHRSISAS----------------NAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGG 497 (708)
Q Consensus 434 ~~~ggg~~g~v~s~~hr~~~R~i~~~----------------~~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg 497 (708)
...|.|++|.|..++++...+--..+ ..+........||.||+|+..||+.+.+|||+||+.||
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GG 110 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGG 110 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCc
Confidence 34567788888877777443311110 11222335579999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCcccc-CCCCcccccccCCc
Q psy2648 498 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPP 576 (708)
Q Consensus 498 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~-~~~~~~~~~~Gt~~ 576 (708)
+|+.+|.++++|+|+.|++|+++|+.||.|||++|||||||||||||||..|+++|+||||++.. ..+....++|||+.
T Consensus 111 eLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~e 190 (357)
T KOG0598|consen 111 ELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPE 190 (357)
T ss_pred cHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999954 55567788999999
Q ss_pred ccccccccCCCCccCCCCCCCCCcccCC-----CCCCCcc---------c--cccccccccchhhhHHHHhhCCCCCCCC
Q psy2648 577 YAAPELFQGGAPVTSSGGAGTNHTHNSS-----ISPAPTN---------F--KRQNTIDSASIKENTARLNAGRPAKNTA 640 (708)
Q Consensus 577 Y~APEvl~g~~~~~~s~~~~~~~~~~~~-----~~~~~~~---------~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (708)
|||||++.+..+..+.+-|+.+.+.+.+ +..+... . .......+..+++++.+|+.-.|.+|+|
T Consensus 191 YmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 191 YMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 9999999988544444333222222222 2222221 0 1122235889999999999999999999
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=282.06 Aligned_cols=244 Identities=29% Similarity=0.507 Sum_probs=201.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC------E
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK------T 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~ 119 (708)
.+|.-++.+|.|.= .|..|.+.-+++.||+|.+.....+....++..+|..+|..++|+|||+++.+|.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47888999999988 7778889999999999998776656566778999999999999999999999986543 5
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|+||||+.. +|.+.+. -.++-+.+..++.|++.|++|||+.||+||||||+||++..+..+||.|||+++.-...-
T Consensus 96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccc
Confidence 8999999964 8888776 356778899999999999999999999999999999999999999999999998655443
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-------------------- 259 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~-------------------- 259 (708)
...-...|..|.|||++.+..|. ..+||||+||++.||++|..-|.|.+.-+-..+|.+
T Consensus 173 ~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred ccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 45567889999999999999875 789999999999999999999998654322222210
Q ss_pred --C--C---CC----CCC-----------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 --G--K---YR----IPF-----------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 --~--~---~~----~p~-----------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
- + +. +|. .-+..+++|+.+||..||++|.++++++
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 0 0 00 121 1234579999999999999999999987
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.92 Aligned_cols=241 Identities=28% Similarity=0.465 Sum_probs=193.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHH--hCCCCCeeeEEEEEEeC----CE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK--MLDHPNIVKLFQVIETE----KT 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~--~l~HpnIv~l~~~~~~~----~~ 119 (708)
.+-.+.+.||+|.||+||+|+++ |+.||||++... +.+..+||.+|.+ +|+|+||+.+++.-..+ .+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 35789999999999999999984 899999998643 3457889999987 67999999998764332 26
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK--------KIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~--------gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
+|||++|-+.|+|+|||.+ ..++.+.+.+++.-+++||+|||-. .|.|||||..|||+.+++.+-|+|+||
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999999999999986 6899999999999999999999952 499999999999999999999999999
Q ss_pred ccccCCC-----CCccccccCCcccccccccCCc----cC-CCchhHHHHHHHHHHHHcC----------CCCCCC----
Q psy2648 192 SNEFTPG-----NKLDTFCGSPPYAAPELFQGKK----YD-GPEVDVWSLGVILYTLVSG----------SLPFDG---- 247 (708)
Q Consensus 192 s~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~----~~-~~~~DIWSlGvilyelltG----------~~Pf~~---- 247 (708)
|-..... ...+..+||-.|||||++...- ++ -..+||||||.|+||++.. ++||.+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9765433 2346689999999999996432 11 2468999999999999863 688875
Q ss_pred -CCHHHHHHHHHcCCCC--CCC-CCCH----HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 248 -STLRELRERVLRGKYR--IPF-YMST----DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 248 -~~~~~l~~~i~~~~~~--~p~-~~s~----~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.+++.+-|.-.+++ +|. +-|. .+..||+.||..||.-|.|+=-+.
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 4566766655544433 443 2332 346789999999999999875444
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-34 Score=284.40 Aligned_cols=246 Identities=28% Similarity=0.484 Sum_probs=203.2
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEEE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-----TLYL 122 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~yl 122 (708)
-+-.+.||-|+||+||-+.+..+|+.||+|.+..-..+-...+++++|+++|..++|.|++..+++.+... .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999999999999999988755444456678999999999999999999999987653 4789
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-- 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-- 200 (708)
|+|++.. ||...|..-..++.+.++-++.||+.||+|||+.+|.||||||.|+|++.+-.+|||||||++.......
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 9999864 8888888878899999999999999999999999999999999999999999999999999987654432
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----------------------H
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRER-----------------------V 257 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~-----------------------i 257 (708)
...-.-|..|.|||++.|......++||||.|||+.||+-.+.-|...+.-+-.+. +
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 23345678899999999876556799999999999999999999987654433222 3
Q ss_pred HcCCCCCCC-----------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 258 LRGKYRIPF-----------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 258 ~~~~~~~p~-----------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++....|. .-.-+..+++.+||..||++|++.++..
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~ 341 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEAL 341 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhc
Confidence 334333332 1234678899999999999999998765
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=292.55 Aligned_cols=164 Identities=34% Similarity=0.550 Sum_probs=139.3
Q ss_pred cCCCCCCCCCCcCCCcccccccccccccc--C-------------cccccccccCceeEEEEEEEeCCEEEEEEeccCCC
Q psy2648 433 GGSGGGGGGGAAQSPSHRGVHRSISASNA--K-------------PSRRASSGGETLLKLFQVIETEKTLYLVMEYASGG 497 (708)
Q Consensus 433 ~~~~ggg~~g~v~s~~hr~~~R~i~~~~~--~-------------~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg 497 (708)
....|.|.|++|+..+|+..+..+..+.. + -.......|||||.|++++++++++|||||||.||
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 44577888888888888776654333211 1 11224568999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC------CCEEEeeccCccccCCCCccccc
Q psy2648 498 EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE------MNIKIADFGFSNEFTPGNKLDTF 571 (708)
Q Consensus 498 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~------~~vKl~DFGla~~~~~~~~~~~~ 571 (708)
||.++|..++.++|+.++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+.++....+.
T Consensus 95 DLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tl 174 (429)
T KOG0595|consen 95 DLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETL 174 (429)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHh
Confidence 999999999999999999999999999999999999999999999999865 45899999999999999999999
Q ss_pred ccCCcccccccccCCCCccCCCCCC
Q psy2648 572 CGSPPYAAPELFQGGAPVTSSGGAG 596 (708)
Q Consensus 572 ~Gt~~Y~APEvl~g~~~~~~s~~~~ 596 (708)
||||.||||||++...+...++-|+
T Consensus 175 cGSplYMAPEV~~~~~YdAKADLWS 199 (429)
T KOG0595|consen 175 CGSPLYMAPEVIMSQQYDAKADLWS 199 (429)
T ss_pred hCCccccCHHHHHhccccchhhHHH
Confidence 9999999999998777655554443
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=288.46 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=197.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHH--hCCCCCeeeEEEEEEeCC----
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK--MLDHPNIVKLFQVIETEK---- 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~--~l~HpnIv~l~~~~~~~~---- 118 (708)
+..-+++..||+|.||.||+|+. +++.||||++.. .+.+.+..|-+|.+ .+.|+||++++.+-+...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 45677889999999999999976 569999999863 45667888888877 468999999998765544
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---------CCceecCCCCCCEEEcCCCcEEEEec
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ---------KKIIHRDLKAENLLLDSEMNIKIADF 189 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~---------~gIvHRDLKPeNILld~~~~iKL~DF 189 (708)
.++||+||.+.|+|.+||..+ .++..+..+++.-++.||+|||+ ..|+|||||..|||+.+|+..-|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 799999999999999999754 78999999999999999999996 35999999999999999999999999
Q ss_pred cCccccCCCC---CccccccCCcccccccccCCccC-----CCchhHHHHHHHHHHHHcCC------------CCCC---
Q psy2648 190 GFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGS------------LPFD--- 246 (708)
Q Consensus 190 Gls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~-----~~~~DIWSlGvilyelltG~------------~Pf~--- 246 (708)
|||..+.++. .+...+||..|||||++.|.-.- -.+.||||+|.|||||++.. +||+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998876543 34457899999999999775321 13679999999999999853 3454
Q ss_pred --CCCHHHHHHHHHcCC--CCCCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 247 --GSTLRELRERVLRGK--YRIPFY-----MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 247 --~~~~~~l~~~i~~~~--~~~p~~-----~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+.+++...+.+.+ +.+|.. --.-+++.|..||..||+-|.|+.-+.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 235677777776654 335532 123578999999999999999987554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.74 Aligned_cols=214 Identities=46% Similarity=0.742 Sum_probs=187.7
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~ 127 (708)
|.+.+.||+|+||.||++.+..+++.||||.+...... ...+.+.+|++.++.++|+||+++++.+......|+++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 67889999999999999999999999999999865433 24567889999999999999999999999989999999999
Q ss_pred CCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--Ccccc
Q psy2648 128 SGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTF 204 (708)
Q Consensus 128 ~gg~L~~~i~~~~~-l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~~~~~ 204 (708)
.+++|.+++..... +++..+..++.|++.+|.|||+++++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 99999999987766 8999999999999999999999999999999999999999999999999987765432 34556
Q ss_pred ccCCcccccccc-cCCccCCCchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHcCCCC
Q psy2648 205 CGSPPYAAPELF-QGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--STLRELRERVLRGKYR 263 (708)
Q Consensus 205 ~Gt~~Y~APE~l-~~~~~~~~~~DIWSlGvilyelltG~~Pf~~--~~~~~l~~~i~~~~~~ 263 (708)
+++..|++||++ ....++ .++||||||+++|+|++|+.||.. .+..++.+.+..+...
T Consensus 160 ~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred eccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 788999999998 555554 589999999999999999999987 4555788888877643
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=291.71 Aligned_cols=204 Identities=30% Similarity=0.507 Sum_probs=175.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC------CCCeeeEEEEEEeCCE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD------HPNIVKLFQVIETEKT 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~~~ 119 (708)
++|.+....|+|-|+.|..|.+...|..||||||..... ..+.=++|++||++|+ --|+++|+..|...++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 489999999999999999999999999999999976432 1233468999999996 3489999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-EEEEeccCcccc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEF 195 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~-iKL~DFGls~~~ 195 (708)
+|||+|-+. .+|.+.|.+.| .|....++.|..||..||..|-..||+|.||||+|||+++..+ +||||||.|...
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 999999875 58999888766 4788899999999999999999999999999999999998755 699999987654
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRE 255 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~ 255 (708)
.. +...-+.-+..|.|||++.|.+|+ ...|+||.||+||||.||+.-|.|.+...++.
T Consensus 588 ~e-neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 588 SE-NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred cc-ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 43 334445667789999999999997 67999999999999999999999987665543
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=272.88 Aligned_cols=242 Identities=26% Similarity=0.492 Sum_probs=193.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEE-EEeCCEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQV-IETEKTLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~~~~~yl 122 (708)
.+.|.|.+.||+|.||++.+|+|+.+.+.+|+|.+.+... ..+.|.+|...--.|. |.|||..|++ |++.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 4689999999999999999999999999999999976543 3456788877655554 8999999986 889999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--CCcEEEEeccCccccCCCCC
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~--~~~iKL~DFGls~~~~~~~~ 200 (708)
+||||+.|||.+-+.. ..+.|.-.+.++.|+++||+|+|++++||||||.+||||-. ...|||||||+.+.. +..
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--GTT 176 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--Cce
Confidence 9999999999987754 56889999999999999999999999999999999999843 347999999987542 333
Q ss_pred ccccccCCcccccccccCCc---c-CCCchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHcCCCCCCC---CC
Q psy2648 201 LDTFCGSPPYAAPELFQGKK---Y-DGPEVDVWSLGVILYTLVSGSLPFDGSTL-----RELRERVLRGKYRIPF---YM 268 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~---~-~~~~~DIWSlGvilyelltG~~Pf~~~~~-----~~l~~~i~~~~~~~p~---~~ 268 (708)
....--+..|.+||++.... + ..+.+|||.||+++|..+||.+||+.... -+..+...+.....|. ..
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f 256 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF 256 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence 33444566799999874322 1 24678999999999999999999985322 2333333333445553 46
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHH
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEV 292 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~ 292 (708)
|+.+..+.++.|..+|++|.-+-+
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred CHHHHHHHHHhcCCcccccchhHH
Confidence 889999999999999999966543
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=304.50 Aligned_cols=232 Identities=27% Similarity=0.481 Sum_probs=189.0
Q ss_pred eEEcccCce-EEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFA-KVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg-~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.+|.|+-| .||+|.. .|+.||||.+-.. ....+.+||..|+.- +|||||++|..-.+....||..|.|..
T Consensus 515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY--EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HHcccCCCCcEEEEEee--CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 567888876 4788876 6889999987543 344577999999876 499999999999999999999999975
Q ss_pred CChHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CC--cEEEEeccCccccCCCC-
Q psy2648 130 GEVFDYLVLHGR----MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EM--NIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 130 g~L~~~i~~~~~----l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~--~iKL~DFGls~~~~~~~- 199 (708)
+|.+++...+. ....+.+..+.|+++||++||+.+||||||||.||||+. ++ .++|+|||+++....+.
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 89999976421 111456788999999999999999999999999999986 34 58999999999876543
Q ss_pred ---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC---CCCHHH
Q psy2648 200 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPF---YMSTDC 272 (708)
Q Consensus 200 ---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~~p~---~~s~~~ 272 (708)
...+..||-.|+|||++..... ..++||+||||++|+.++ |..||.+.-.++ ..|+.+.+.+-. ....++
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHH
Confidence 3456789999999999987764 468999999999999998 599997754443 468888776422 111289
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.|||.+||.+||..||++.+++
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHh
Confidence 9999999999999999999887
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=250.25 Aligned_cols=209 Identities=47% Similarity=0.780 Sum_probs=183.5
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCChH
Q psy2648 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVF 133 (708)
Q Consensus 54 LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~gg~L~ 133 (708)
||+|++|.||++....+++.++||++....... ..+.+.+|+++++.+.|++|+++++++......+++|||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999998889999999997654321 3467889999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEeccCccccCCCC-CccccccCCcc
Q psy2648 134 DYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTPGN-KLDTFCGSPPY 210 (708)
Q Consensus 134 ~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DFGls~~~~~~~-~~~~~~Gt~~Y 210 (708)
+++... ..+++..+..++.|++.+|+|||++|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 998766 57899999999999999999999999999999999999999 8999999999987654332 13345678899
Q ss_pred cccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCH
Q psy2648 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 211 ~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
++||.+......+.++|+|+||+++|+| ..+.+++.+||..||.+||++
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 9999997752335789999999999999 678999999999999999999
Q ss_pred HHHh
Q psy2648 291 EVSG 294 (708)
Q Consensus 291 ~~~~ 294 (708)
+++.
T Consensus 209 ~~l~ 212 (215)
T cd00180 209 KEIL 212 (215)
T ss_pred HHHh
Confidence 8764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.28 Aligned_cols=129 Identities=25% Similarity=0.474 Sum_probs=113.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-----C---CCeeeEEEEEEeC
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-----H---PNIVKLFQVIETE 117 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~~ 117 (708)
++|.+.++||-|.|++||||.+....+.||+|+.+..+ ...+..+.||++|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 79999999999999999999999999999999987543 34456789999999873 3 3699999999753
Q ss_pred ----CEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEE
Q psy2648 118 ----KTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLL 178 (708)
Q Consensus 118 ----~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILl 178 (708)
.+++||+|++ |.+|+.+|... ..++...++.|++||+.||.|||. .||||-|||||||||
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 5899999998 66899998765 469999999999999999999996 599999999999996
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=269.04 Aligned_cols=174 Identities=33% Similarity=0.479 Sum_probs=139.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....||.+|+|+..|.+...+||||||++||.|+.++++.++|+|..|++|++||+.||+|||+++||+|||||||||+|
T Consensus 99 ~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD 178 (355)
T KOG0616|consen 99 KAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD 178 (355)
T ss_pred hhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec
Confidence 45679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCC-CcccCCCCCCCccc-----ccccc---
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTN-HTHNSSISPAPTNF-----KRQNT--- 617 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~-~~~~~~~~~~~~~~-----~~~~~--- 617 (708)
..|++||+|||+|+..... ..+.||||.|+|||++++.. +..+..++.. -+-+.+..+-+..+ .....
T Consensus 179 ~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 179 QNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred cCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 9999999999999987543 66889999999999998655 4444433321 11111111111111 11111
Q ss_pred -------ccccchhhhHHHHhhCCCCCCCCCCC
Q psy2648 618 -------IDSASIKENTARLNAGRPAKNTASIA 643 (708)
Q Consensus 618 -------~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (708)
.-+..++|++..|+.-+-++|.|...
T Consensus 256 ~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlk 288 (355)
T KOG0616|consen 256 GKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLK 288 (355)
T ss_pred CcccCCcccCHHHHHHHHHHHhhhhHhhhcCcC
Confidence 12788999999999988888866554
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=269.33 Aligned_cols=176 Identities=27% Similarity=0.441 Sum_probs=144.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....||+||+++++|+.++..||||||++||+|++.+..++.+.|+..+.+++|++.||.|||++||+||||||||||+.
T Consensus 231 kkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~ 310 (475)
T KOG0615|consen 231 KKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLS 310 (475)
T ss_pred HhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEec
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CC---CCEEEeeccCccccCCCCcccccccCCcccccccccCCC--------CccCCCCCCCCCcccCCCCCCCc-----
Q psy2648 547 SE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA--------PVTSSGGAGTNHTHNSSISPAPT----- 610 (708)
Q Consensus 547 ~~---~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~--------~~~~s~~~~~~~~~~~~~~~~~~----- 610 (708)
.+ ..+||+|||+|+.......+.++||||.|.||||+.+.. ..|+.|...+-.+.+.+++...+
T Consensus 311 ~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 311 NDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL 390 (475)
T ss_pred cCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence 76 679999999999998888899999999999999998542 23455655555555544432222
Q ss_pred ---------cc-cccccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 611 ---------NF-KRQNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 611 ---------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
.| +-+-.--+-.++++..+++.=.|..|-...
T Consensus 391 ~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ 432 (475)
T KOG0615|consen 391 KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSAD 432 (475)
T ss_pred HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHH
Confidence 12 122222266788888888888888775443
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=260.17 Aligned_cols=247 Identities=21% Similarity=0.373 Sum_probs=207.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTG-----KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI-ETEKT 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~ 119 (708)
.++++...+-+|.||+||.|.++... +.|-+|.++. ..++-+...++.|...+..+.|||+..+..+. ++...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46888889999999999999876433 3466676643 23444566788999999999999999999885 45567
Q ss_pred EEEEEeccCCCChHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG--------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~--------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
.+++..+..-|+|..|+.... .++..+...++.||+.|++|||++||||.||...|.+||+.-.+||+|-.|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 788899999999999997321 366778888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCC
Q psy2648 192 SNEFTPGNKL---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPF 266 (708)
Q Consensus 192 s~~~~~~~~~---~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~ 266 (708)
++..-++... +.---...||+||.++...|+ .++|+|||||+||||+| |+.||...++.|+...++.|. ...|.
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~ 521 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF 521 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC
Confidence 9876554321 111234579999999999986 78999999999999998 999999999999998888873 35689
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++++++-.++..||..+|++||+++|+.
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 9999999999999999999999999875
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=263.18 Aligned_cols=168 Identities=27% Similarity=0.430 Sum_probs=141.7
Q ss_pred ccCCCCCCCCCCcCCCccccccccccccc----cCcc----------cccccccCceeEEEEEEEeCC-EEEEEEeccCC
Q psy2648 432 TGGSGGGGGGGAAQSPSHRGVHRSISASN----AKPS----------RRASSGGETLLKLFQVIETEK-TLYLVMEYASG 496 (708)
Q Consensus 432 ~~~~~ggg~~g~v~s~~hr~~~R~i~~~~----~~~~----------~~~~~~~~~Iv~L~~~~~~~~-~~yLVmEy~~g 496 (708)
..+..|.|.+|.|+.+.|+..++.-..+. .++. ......+|+||++|+.|..+. .++|+||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 35667888888999888887665322221 1111 123458999999999999999 59999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCC
Q psy2648 497 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP 575 (708)
Q Consensus 497 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~ 575 (708)
|+|.+.+...++++|.....++.+|++||.|||+ ++||||||||+|||++..|+|||||||+|+.+... ..++++||.
T Consensus 163 GSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~ 241 (364)
T KOG0581|consen 163 GSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTS 241 (364)
T ss_pred CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccc
Confidence 9999999999999999999999999999999995 99999999999999999999999999999987655 668999999
Q ss_pred cccccccccCCCCccCCCCCCCCCc
Q psy2648 576 PYAAPELFQGGAPVTSSGGAGTNHT 600 (708)
Q Consensus 576 ~Y~APEvl~g~~~~~~s~~~~~~~~ 600 (708)
.|||||.+.|+.+..+++-|+.+++
T Consensus 242 ~YMsPERi~g~~Ys~~sDIWSLGLs 266 (364)
T KOG0581|consen 242 AYMSPERISGESYSVKSDIWSLGLS 266 (364)
T ss_pred cccChhhhcCCcCCcccceecccHH
Confidence 9999999999987777766654443
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=272.02 Aligned_cols=168 Identities=38% Similarity=0.633 Sum_probs=139.1
Q ss_pred cCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC-C
Q psy2648 471 GETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-M 549 (708)
Q Consensus 471 ~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-~ 549 (708)
||||+++++++++...+|+|||||.||+|++++...+++.|.+++.+|+||+.||.|||++||+||||||||||++.+ +
T Consensus 79 HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~ 158 (370)
T KOG0583|consen 79 HPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG 158 (370)
T ss_pred CCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999999 9
Q ss_pred CEEEeeccCcccc-CCCCcccccccCCcccccccccCCC-CccCCCCCC------CCCcccCCCCCCCc-----------
Q psy2648 550 NIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGA-PVTSSGGAG------TNHTHNSSISPAPT----------- 610 (708)
Q Consensus 550 ~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~-~~~~s~~~~------~~~~~~~~~~~~~~----------- 610 (708)
++||+|||++... .......++|||+.|+|||++.+.. +.......+ +..+.+..+.....
T Consensus 159 ~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 159 NLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG 238 (370)
T ss_pred CEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC
Confidence 9999999999988 5677889999999999999999866 332322222 22222222222211
Q ss_pred --cccccccccccchhhhHHHHhhCCCCCCCC
Q psy2648 611 --NFKRQNTIDSASIKENTARLNAGRPAKNTA 640 (708)
Q Consensus 611 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (708)
.++.... |+.+++++.+++.-.|.+|.-
T Consensus 239 ~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t 268 (370)
T KOG0583|consen 239 EFKIPSYLL--SPEARSLIEKMLVPDPSTRIT 268 (370)
T ss_pred CccCCCCcC--CHHHHHHHHHHcCCCcccCCC
Confidence 1222222 888999999999999998653
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=270.54 Aligned_cols=175 Identities=30% Similarity=0.488 Sum_probs=145.4
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
.++||.||+||..|+++..+|+|+||+++|||.++|++.|.|+|..+++|++||+.||+|||++|||||||||||||||.
T Consensus 130 L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~ 209 (604)
T KOG0592|consen 130 LSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK 209 (604)
T ss_pred hhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC
Confidence 45999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCC--------------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCC-----CCC
Q psy2648 548 EMNIKIADFGFSNEFTPGN--------------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSI-----SPA 608 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~--------------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~-----~~~ 608 (708)
++++||+|||-|+.+.+.. ...+++||..|++||+|.......+++-|+.+++.+-++ +.+
T Consensus 210 dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 210 DGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred CCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 9999999999998765321 125699999999999999887777777666666655443 333
Q ss_pred Ccccc-----cccccc-----ccchhhhHHHHhhCCCCCCCCCC
Q psy2648 609 PTNFK-----RQNTID-----SASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 609 ~~~~~-----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
.+.+. ....++ ...+.++..+|+.-+|.+|++..
T Consensus 290 ~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 290 ANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred ccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 33211 011111 57889999999999999887763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-27 Score=243.76 Aligned_cols=244 Identities=38% Similarity=0.654 Sum_probs=206.6
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh-hHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCEEEEEEe
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG-SLQKLFREVRIMKMLDHP-NIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~ylVmE 125 (708)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...... ....+.+|+.++..+.|+ +|+++++.+......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999987 8899999987654432 567789999999999988 79999999988888999999
Q ss_pred ccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCccccCCCC--
Q psy2648 126 YASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGN-- 199 (708)
Q Consensus 126 y~~gg~L~~~i~~~~---~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~~~~-- 199 (708)
|+.+++|.+++.... .+.+..+..++.|++.++.|+|+.+++|||+||+|||++..+ .++++|||++..+....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777665 799999999999999999999999999999999999999998 69999999987554332
Q ss_pred -----CccccccCCcccccccccCC--ccCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCC-CCCC
Q psy2648 200 -----KLDTFCGSPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGST----LRELRERVLRGKYR-IPFY 267 (708)
Q Consensus 200 -----~~~~~~Gt~~Y~APE~l~~~--~~~~~~~DIWSlGvilyelltG~~Pf~~~~----~~~l~~~i~~~~~~-~p~~ 267 (708)
.....+||..|+|||.+.+. .+.....|+||+|++++++++|..||.... .......+...... .+..
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 34678999999999999874 344578999999999999999999998776 35666666555433 2222
Q ss_pred CC--------HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MS--------TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s--------~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.. ..+.+++.+++..+|..|.+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 11 4789999999999999999987544
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=273.22 Aligned_cols=174 Identities=39% Similarity=0.598 Sum_probs=144.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....||||+.||+++++..++|||+||++||.|++++.++|+++|.+++.+++||+.|+.|||..+|+||||||||+|||
T Consensus 67 kLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd 146 (786)
T KOG0588|consen 67 KLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD 146 (786)
T ss_pred HHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh
Confidence 34689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCC-CCCcccCCCCCCCcc----------cccc
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAG-TNHTHNSSISPAPTN----------FKRQ 615 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~-~~~~~~~~~~~~~~~----------~~~~ 615 (708)
..+++||+|||+|..-.++..+.+.||+|+|.|||++.|..+......++ ++-.+++...+.... -+.+
T Consensus 147 ~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~ 226 (786)
T KOG0588|consen 147 VKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR 226 (786)
T ss_pred cccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 99999999999999888888999999999999999999887655444333 333333332222220 0122
Q ss_pred cccc-----ccchhhhHHHHhhCCCCCCCC
Q psy2648 616 NTID-----SASIKENTARLNAGRPAKNTA 640 (708)
Q Consensus 616 ~~~~-----~~~~~~~~~~~~~~~~~~~~~ 640 (708)
..++ +..+++++.|++.=+|+++.-
T Consensus 227 G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT 256 (786)
T KOG0588|consen 227 GVFEMPSNISSEAQDLLRRMLDVDPSTRIT 256 (786)
T ss_pred CcccCCCcCCHHHHHHHHHHhccCcccccc
Confidence 2222 778899999988888887754
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-30 Score=293.28 Aligned_cols=254 Identities=29% Similarity=0.484 Sum_probs=204.9
Q ss_pred cCCe-EEEeEEcccCceEEEEEEEcCCCcEEEEEEecc----CCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKY-KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK----TQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y-~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~----~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
...| .....+|.|+||.|+.+......+.++.|.... ..........+..|..+-..|.||||+..+..+.....
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3456 456789999999999998887777777775542 11111122236678888889999999988887777766
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG- 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~- 198 (708)
++-+||||++ ||+.++...+.+...++..+|+||+.||+|||++||.||||||+|+|+..+|.+||+|||.+..+.-+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6667999999 99999988889999999999999999999999999999999999999999999999999998766432
Q ss_pred ----CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-------HHcCCCCCC
Q psy2648 199 ----NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL--RER-------VLRGKYRIP 265 (708)
Q Consensus 199 ----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l--~~~-------i~~~~~~~p 265 (708)
.....++|+.+|+|||++.+..|+...+||||.||+++.|++|+.||.-....+- .+. +..|..++-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 2346789999999999999999999999999999999999999999975433221 111 112222222
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
..++.+++.+|.+||++||.+|.|+++|+ |++..
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 34678899999999999999999999998 98753
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=272.92 Aligned_cols=181 Identities=30% Similarity=0.458 Sum_probs=147.9
Q ss_pred cccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 465 RRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 465 ~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
...+..|||||++|++|++.+++|||+|+|+.++|..++++++.++|.+|+.|++||+.||.|||+++|||||||..|++
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlf 150 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLF 150 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhee
Confidence 34678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCC-----ccCCCCCCCCCcccCCCCCCCc-----ccc
Q psy2648 545 LDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAP-----VTSSGGAGTNHTHNSSISPAPT-----NFK 613 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~-----~~~s~~~~~~~~~~~~~~~~~~-----~~~ 613 (708)
|+.+.+|||+|||||..+. +++...+.||||.|+||||+..... .|+.|.+-+.++.+.+++-.-. ...
T Consensus 151 L~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 151 LNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred ecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 9999999999999999886 4477889999999999999986543 4444444444444433332111 011
Q ss_pred ccccc-----cccchhhhHHHHhhCCCCCCCCCCCCc
Q psy2648 614 RQNTI-----DSASIKENTARLNAGRPAKNTASIAPL 645 (708)
Q Consensus 614 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (708)
.++.. -|..++++.+.|+.-.|.+|..-.+.+
T Consensus 231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL 267 (592)
T KOG0575|consen 231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVL 267 (592)
T ss_pred HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 22222 278899999999999999886554444
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=280.45 Aligned_cols=208 Identities=29% Similarity=0.395 Sum_probs=157.6
Q ss_pred cCCCCCCCCCCcCCCccccccccccccccC-----cc------------cccccccCceeEEEEEEEeCCEEEEEEeccC
Q psy2648 433 GGSGGGGGGGAAQSPSHRGVHRSISASNAK-----PS------------RRASSGGETLLKLFQVIETEKTLYLVMEYAS 495 (708)
Q Consensus 433 ~~~~ggg~~g~v~s~~hr~~~R~i~~~~~~-----~~------------~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~ 495 (708)
....|.|.||.|.....++....-..+..+ .. ......||.+++||..|++++++|+||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 556788999988777665554421111100 00 1122489999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccC-CCCcccccccC
Q psy2648 496 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGS 574 (708)
Q Consensus 496 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~-~~~~~~~~~Gt 574 (708)
|||++ ++...+.|+|..+++|+++|+.||+|||++||||||||.+|||||.+|++||+|||+++... .+..+.++|||
T Consensus 453 Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGT 531 (694)
T KOG0694|consen 453 GGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGT 531 (694)
T ss_pred CCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCC
Confidence 99944 45555789999999999999999999999999999999999999999999999999999754 67788999999
Q ss_pred CcccccccccCCCCccCCCCCCCCCc------ccCCCCCCCcc---c-------cccccccccchhhhHHHHhhCCCCCC
Q psy2648 575 PPYAAPELFQGGAPVTSSGGAGTNHT------HNSSISPAPTN---F-------KRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 575 ~~Y~APEvl~g~~~~~~s~~~~~~~~------~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
|.|||||++.+.. |+.+..|+.... .+-++.++-.. | ++.-..-|..+-.++.||+...|.++
T Consensus 532 pey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 532 PEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKR 610 (694)
T ss_pred hhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccc
Confidence 9999999998877 455544443221 12222232221 1 01111127888899999999999999
Q ss_pred CCCC
Q psy2648 639 TASI 642 (708)
Q Consensus 639 ~~~~ 642 (708)
+|+.
T Consensus 611 LG~~ 614 (694)
T KOG0694|consen 611 LGSG 614 (694)
T ss_pred cCCC
Confidence 9996
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=254.55 Aligned_cols=182 Identities=24% Similarity=0.421 Sum_probs=151.8
Q ss_pred CCCCCCCCCcCCCccccccccccccc-cCcc--------------cccccccCceeEEEEEEEeCCEEEEEEeccCCCCH
Q psy2648 435 SGGGGGGGAAQSPSHRGVHRSISASN-AKPS--------------RRASSGGETLLKLFQVIETEKTLYLVMEYASGGEV 499 (708)
Q Consensus 435 ~~ggg~~g~v~s~~hr~~~R~i~~~~-~~~~--------------~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L 499 (708)
..|.|..|.|...+++..++-...+. .+.. ......|||+|.|.++|.....+|||+|||+..-|
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL 88 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL 88 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence 35667778777777766655322211 1111 11346899999999999999999999999998666
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccC-CCCcccccccCCccc
Q psy2648 500 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYA 578 (708)
Q Consensus 500 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~ 578 (708)
.+.-.....++++.++.|++|++.|+.|||+++||||||||||||++..|.+||||||+|+.+. ++...+.++.|.||+
T Consensus 89 ~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYR 168 (396)
T KOG0593|consen 89 HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYR 168 (396)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhcc
Confidence 5555555679999999999999999999999999999999999999999999999999999886 777888899999999
Q ss_pred ccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCCCCCC
Q psy2648 579 APELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTAS 641 (708)
Q Consensus 579 APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (708)
|||++.|...|..+ +|.|.++|+.++|..|+|==++-|
T Consensus 169 aPELLvGDtqYG~p-------------------------VDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 169 APELLVGDTQYGKP-------------------------VDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred ChhhhcccCcCCCc-------------------------ccchhhhHHHHHHhcCCcCCCCcc
Confidence 99999999988888 899999999999999998654444
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=269.20 Aligned_cols=206 Identities=26% Similarity=0.371 Sum_probs=151.6
Q ss_pred CCCCCCCCCcCCCcccccccccccc----------------ccCcccccccccCceeEEEEEEEeCCEEEEEEeccCCCC
Q psy2648 435 SGGGGGGGAAQSPSHRGVHRSISAS----------------NAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGE 498 (708)
Q Consensus 435 ~~ggg~~g~v~s~~hr~~~R~i~~~----------------~~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~ 498 (708)
.-|.|++|-|..+..+..+..-..+ .++-........+.||+||..|++.+++||||||++|||
T Consensus 148 ~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD 227 (550)
T KOG0605|consen 148 VIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGD 227 (550)
T ss_pred eeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCcc
Confidence 3466777777666655544321111 112223355788999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCC--------------
Q psy2648 499 VFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-------------- 564 (708)
Q Consensus 499 L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~-------------- 564 (708)
+..+|.+.+.|+|+++++|+++++.|+.-+|+.|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 228 ~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~ 307 (550)
T KOG0605|consen 228 MMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQ 307 (550)
T ss_pred HHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999742110
Q ss_pred --------C--C------------------------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCC--CC
Q psy2648 565 --------G--N------------------------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSIS--PA 608 (708)
Q Consensus 565 --------~--~------------------------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~--~~ 608 (708)
. . ...+++|||-||||||+.+..+.-..+-|+.+++.+.... |+
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPP 387 (550)
T KOG0605|consen 308 INLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPP 387 (550)
T ss_pred hhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCC
Confidence 0 0 0124789999999999998774333333332322222211 11
Q ss_pred Ccc------------------ccccccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 609 PTN------------------FKRQNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 609 ~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
... |+....+ +..++|+..||+. .|++++|++
T Consensus 388 F~s~tp~~T~rkI~nwr~~l~fP~~~~~-s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 388 FCSETPQETYRKIVNWRETLKFPEEVDL-SDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred CCCCCHHHHHHHHHHHhhhccCCCcCcc-cHHHHHHHHHHhc-CHHHhcCcc
Confidence 110 2222222 5789999999999 999999943
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=259.66 Aligned_cols=242 Identities=29% Similarity=0.481 Sum_probs=192.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~y 121 (708)
..|.+..+||+|+|+.||+|.... ..+.||+|.|..... ..++..|+++|..+. +.||+.+.+.+..++.+.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 468999999999999999999887 789999999976543 346889999999885 899999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CcEEEEeccCccccC----
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFT---- 196 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-~~iKL~DFGls~~~~---- 196 (708)
+||||++.-+..++.. .++-.+++.|++.++.||.++|.+|||||||||.|+|.+.. +.-.|+||||+....
T Consensus 112 ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999988877765 56789999999999999999999999999999999999865 556899999986210
Q ss_pred -------------C--CCC---------------c-----------cccccCCcccccccccCCccCCCchhHHHHHHHH
Q psy2648 197 -------------P--GNK---------------L-----------DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 235 (708)
Q Consensus 197 -------------~--~~~---------------~-----------~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvil 235 (708)
+ +.. . -...||+.|.|||++...+-.++++||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 000 0 0134999999999998877667899999999999
Q ss_pred HHHHcCCCCCCCCCH--------------HHHHHH-HHcCC------CCCC-----------------------------
Q psy2648 236 YTLVSGSLPFDGSTL--------------RELRER-VLRGK------YRIP----------------------------- 265 (708)
Q Consensus 236 yelltG~~Pf~~~~~--------------~~l~~~-i~~~~------~~~p----------------------------- 265 (708)
.-++++.+||..... .++.+. ...|. -.+|
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 999999999964211 111110 00111 0000
Q ss_pred --CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 --FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 --~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+..+.||+.+||+.||.+|+|+|+.+
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 01234688999999999999999999765
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=253.22 Aligned_cols=124 Identities=50% Similarity=0.889 Sum_probs=118.7
Q ss_pred ccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 466 RASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 466 ~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
..+.+||||+.+|++|+..+.+.|||||.++|+|+++|.+++.|+|.+++.+|+||++|+.|||.++|+|||||.+|||+
T Consensus 107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL 186 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL 186 (668)
T ss_pred HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee
Confidence 36789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPV 589 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~ 589 (708)
|.++++||+||||+..+.....+.+|||+|-|.+||++.|..+.
T Consensus 187 D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~ 230 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYK 230 (668)
T ss_pred cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCC
Confidence 99999999999999998888889999999999999999876543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=293.09 Aligned_cols=193 Identities=18% Similarity=0.159 Sum_probs=143.5
Q ss_pred hCCC-CCeeeEEEEE-------EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy2648 101 MLDH-PNIVKLFQVI-------ETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 171 (708)
Q Consensus 101 ~l~H-pnIv~l~~~~-------~~~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDL 171 (708)
.++| +||.+++++| .....++++|||+ +++|.++|... ..+++.+++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4456 5888888877 2234678889987 56999999653 46999999999999999999999999999999
Q ss_pred CCCCEEEcC-------------------CCcEEEEeccCccccCCC-----------------CCccccccCCccccccc
Q psy2648 172 KAENLLLDS-------------------EMNIKIADFGFSNEFTPG-----------------NKLDTFCGSPPYAAPEL 215 (708)
Q Consensus 172 KPeNILld~-------------------~~~iKL~DFGls~~~~~~-----------------~~~~~~~Gt~~Y~APE~ 215 (708)
||+||||+. ++.+||+|||+++..... ......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999965 445666666666532100 00012468899999999
Q ss_pred ccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 216 l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+..| +.++|||||||+||||++|..||.... .....+.....+ .+....++..+++.+||.+||.+||++.++.
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 998888 489999999999999999999876422 122222211111 1112356778999999999999999999987
Q ss_pred ---hhh
Q psy2648 295 ---EVT 297 (708)
Q Consensus 295 ---~~~ 297 (708)
|+.
T Consensus 264 ~h~~~~ 269 (793)
T PLN00181 264 QSEFIN 269 (793)
T ss_pred hchhhh
Confidence 664
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=241.25 Aligned_cols=152 Identities=39% Similarity=0.656 Sum_probs=132.1
Q ss_pred cccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 465 RRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 465 ~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
.++.++||+|++|+++|+++..+++|+|+|+.|+|+++|...-.++|.+++.+|+|++.|+.|||.++||||||||||||
T Consensus 76 LRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENIL 155 (411)
T KOG0599|consen 76 LRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENIL 155 (411)
T ss_pred HHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhee
Confidence 34678999999999999999999999999999999999999989999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+|++.++||+|||+|+.+.++..+...||||.|+|||.+...-+-+.-|.. .-+|.|..+
T Consensus 156 lddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs--------------------~EVD~Wa~G 215 (411)
T KOG0599|consen 156 LDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYS--------------------KEVDEWACG 215 (411)
T ss_pred eccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCcc--------------------chhhHHHHH
Confidence 999999999999999999999999999999999999999754432222211 115556666
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
-.+=-|++|+|+
T Consensus 216 VImyTLLaGcpP 227 (411)
T KOG0599|consen 216 VIMYTLLAGCPP 227 (411)
T ss_pred HHHHHHHcCCCc
Confidence 666666777665
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=255.90 Aligned_cols=145 Identities=28% Similarity=0.529 Sum_probs=130.1
Q ss_pred ccccccCceeEEEEEEEeC--CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 466 RASSGGETLLKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 466 ~~~~~~~~Iv~L~~~~~~~--~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
.....|||||+|.+...+. ..+|||+|||+. ||.-++...+ .|++.+++.||.||+.||.|||++||+|||||..|
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SN 248 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSN 248 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccc
Confidence 3567999999999998877 689999999987 8888776643 69999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
||||.+|.+||+|||||+.+.... .++..+.|+||.|||+|+|...|+.+ ||.
T Consensus 249 iLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~a-------------------------VDl 303 (560)
T KOG0600|consen 249 ILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTA-------------------------VDL 303 (560)
T ss_pred eEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccc-------------------------eee
Confidence 999999999999999999765443 56778999999999999999999988 899
Q ss_pred cchhhhHHHHhhCCCC
Q psy2648 621 ASIKENTARLNAGRPA 636 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~ 636 (708)
|+.+|++++|.+|.|-
T Consensus 304 WS~GCIl~El~~gkPI 319 (560)
T KOG0600|consen 304 WSVGCILAELFLGKPI 319 (560)
T ss_pred hhhhHHHHHHHcCCCC
Confidence 9999999999887763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=252.73 Aligned_cols=170 Identities=19% Similarity=0.223 Sum_probs=136.1
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeccCCC---ChhhHHHHHHHHHHHHhCCCCCeee-EEEE
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP-TGKEVAIKIIDKTQL---NPGSLQKLFREVRIMKMLDHPNIVK-LFQV 113 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~-tg~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~ 113 (708)
+...+..++|.+.+.||+|+||+||+|++.. +++.||||++..... .....+.+.+|+++|+.|+|+|||. +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3445667789999999999999999999886 778889998764321 2334556889999999999999984 5542
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEEcCCCcEEEEeccCc
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL-KAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDL-KPeNILld~~~~iKL~DFGls 192 (708)
+..|||||||+|++|.. +. ... ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||++
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45899999999999963 21 111 2468899999999999999999999 999999999999999999999
Q ss_pred cccCCCC---------CccccccCCcccccccccCC
Q psy2648 193 NEFTPGN---------KLDTFCGSPPYAAPELFQGK 219 (708)
Q Consensus 193 ~~~~~~~---------~~~~~~Gt~~Y~APE~l~~~ 219 (708)
+.+.... ...+.++++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 8764432 12457789999999998643
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=252.10 Aligned_cols=147 Identities=29% Similarity=0.393 Sum_probs=133.1
Q ss_pred cccccCceeEEEEEEEeC-----CEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q psy2648 467 ASSGGETLLKLFQVIETE-----KTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~-----~~~yLVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 537 (708)
....|||||+|..+|... -++.||||||+. +|.+.++. +..++.-.++.|+.||++||.|||+.||+|||
T Consensus 72 ~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRD 150 (364)
T KOG0658|consen 72 RKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRD 150 (364)
T ss_pred HhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCC
Confidence 357999999999998643 246799999986 88888874 56799999999999999999999999999999
Q ss_pred CCCCCeeecCC-CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccc
Q psy2648 538 LKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQN 616 (708)
Q Consensus 538 lKp~NILl~~~-~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 616 (708)
|||+|||+|.+ |.+||||||.|+.+..++...++..|.+|+|||++.|...|+++
T Consensus 151 IKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~------------------------ 206 (364)
T KOG0658|consen 151 IKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTS------------------------ 206 (364)
T ss_pred CChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCce------------------------
Confidence 99999999976 89999999999999988888999999999999999999999999
Q ss_pred cccccchhhhHHHHhhCCCCCCC
Q psy2648 617 TIDSASIKENTARLNAGRPAKNT 639 (708)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~ 639 (708)
||-|+++|+.++|+.|+|==.+
T Consensus 207 -IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 207 -IDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred -eEEhhhhHHHHHHhcCCcccCC
Confidence 9999999999999999996444
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=240.68 Aligned_cols=148 Identities=26% Similarity=0.384 Sum_probs=132.1
Q ss_pred ccccCceeEEEEEEEeC--CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 468 SSGGETLLKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~--~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
..+|||||.+.++.... +.+|||||||+. ||...+..-+ +|.+.+++.++.|++.||+|||.+.|+||||||+|+|
T Consensus 131 ~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL 209 (419)
T KOG0663|consen 131 KARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL 209 (419)
T ss_pred hcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee
Confidence 45799999999998754 679999999986 8888887554 8999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 545 LDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
++..|.+||+|||+|+.+... ...+..+.|.||+|||+++|...|+++ ||.|++
T Consensus 210 m~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~-------------------------iDMWSv 264 (419)
T KOG0663|consen 210 LSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTA-------------------------VDMWSV 264 (419)
T ss_pred eccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcc-------------------------hhhhhH
Confidence 999999999999999987543 446778899999999999999999988 999999
Q ss_pred hhhHHHHhhCCCCCCCCC
Q psy2648 624 KENTARLNAGRPAKNTAS 641 (708)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~ 641 (708)
+|.+++++.+.|-=++-+
T Consensus 265 GCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 265 GCIFAELLTQKPLFPGKS 282 (419)
T ss_pred HHHHHHHHhcCCCCCCCc
Confidence 999999998887655443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=223.80 Aligned_cols=152 Identities=24% Similarity=0.310 Sum_probs=123.7
Q ss_pred CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCC
Q psy2648 130 GEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP 208 (708)
Q Consensus 130 g~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~ 208 (708)
|+|.+++..+ ..+++.+++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++..... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6899999875 45999999999999999999999998 999999999999999 9998765432 237899
Q ss_pred cccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCC-------CCCCCH--HHHHHHHH
Q psy2648 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGKYRI-------PFYMST--DCENLLKK 278 (708)
Q Consensus 209 ~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~~~~-------p~~~s~--~~~~Li~~ 278 (708)
.|||||++.+..|+ .++|||||||++|+|++|+.||..... ......+....... +...+. ++.++|.+
T Consensus 69 ~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 69 YFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred cccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 99999999988875 799999999999999999999976532 23333333322211 112233 69999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||.+||++.++.
T Consensus 148 cl~~~p~~Rp~~~~ll 163 (176)
T smart00750 148 CASRLPQRREAANHYL 163 (176)
T ss_pred HHhcccccccCHHHHH
Confidence 9999999999999876
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-27 Score=232.77 Aligned_cols=143 Identities=27% Similarity=0.395 Sum_probs=124.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||.|.++|...+.+.||+|||+ .||...|+... .++..+++.|+.|++.||.|||++.|+||||||.|+|+
T Consensus 56 qel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi 134 (318)
T KOG0659|consen 56 QELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI 134 (318)
T ss_pred HHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE
Confidence 45689999999999999999999999997 48988887544 59999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc-ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~-~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.+|.+||+|||+|+.+.+... ....+.|.||+|||++.|...|++. +|.|+++
T Consensus 135 s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~-------------------------VDmWavG 189 (318)
T KOG0659|consen 135 SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTG-------------------------VDMWAVG 189 (318)
T ss_pred cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCc-------------------------chhhhHH
Confidence 9999999999999998754433 3344899999999999999988877 6677777
Q ss_pred hhHHHHhhCCC
Q psy2648 625 ENTARLNAGRP 635 (708)
Q Consensus 625 ~~~~~~~~~~~ 635 (708)
|.+++|+.+.|
T Consensus 190 CI~AELllr~P 200 (318)
T KOG0659|consen 190 CIFAELLLRVP 200 (318)
T ss_pred HHHHHHHccCC
Confidence 77777665444
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=222.06 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=189.3
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC-CCeeeEEEEEEeC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH-PNIVKLFQVIETE 117 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~ 117 (708)
..+...+|+|++++.||.|+||.+|+|.+..+|++||||+-......+ .+..|.++.+.|+| ..|..+..+....
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhcccc
Confidence 344566889999999999999999999999999999999876543332 36789999999985 5677777777778
Q ss_pred CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CcEEEEeccCcc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSN 193 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~~iKL~DFGls~ 193 (708)
.+-.+|||++ |-+|.+..... .+++...+.-++-|++.-++|+|.++.|||||||+|+|..-. ..+.|+|||||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 8889999998 55777766543 568889999999999999999999999999999999998643 468999999998
Q ss_pred ccCCCC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCC
Q psy2648 194 EFTPGN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKY 262 (708)
Q Consensus 194 ~~~~~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~~ 262 (708)
.+.+.. .-....||..|++-....+...+ ...|+-|+|.+|.++..|.+||++. +..+-+++|.+.+.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 764321 22456799999998887776653 7889999999999999999999985 34556777877766
Q ss_pred CCCC-----CCCHHHHHHHHHhhhh
Q psy2648 263 RIPF-----YMSTDCENLLKKFLVL 282 (708)
Q Consensus 263 ~~p~-----~~s~~~~~Li~~~L~~ 282 (708)
..|. ..+.|+...|.-|=..
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L 266 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGL 266 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhc
Confidence 6552 3455665555555443
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=250.38 Aligned_cols=127 Identities=28% Similarity=0.445 Sum_probs=116.3
Q ss_pred ccccccCceeEEEEEEEeCC-EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 466 RASSGGETLLKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 466 ~~~~~~~~Iv~L~~~~~~~~-~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
+....|||||+|++++.+.+ .+|||||||+. +|+++++.++ .|+|..++.|+.||+.||.|+|.+|+.|||+|||||
T Consensus 63 ~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENi 141 (538)
T KOG0661|consen 63 RKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENI 141 (538)
T ss_pred HhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhhe
Confidence 34567999999999999988 99999999974 9999998654 599999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCC
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSG 593 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~ 593 (708)
|+.....|||+|||+||........+.++.|.||+|||+++....|+...
T Consensus 142 Li~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pv 191 (538)
T KOG0661|consen 142 LISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPV 191 (538)
T ss_pred EecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCch
Confidence 99999999999999999998888888999999999999999887777653
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=233.21 Aligned_cols=179 Identities=33% Similarity=0.469 Sum_probs=150.3
Q ss_pred ccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
.++|+|||.++++|++ ...+.+|||+|+||+|++.|..++. |+|.+|..+++||+.|+.|||+.+|.|||||||
T Consensus 111 ~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpE 190 (400)
T KOG0604|consen 111 ASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPE 190 (400)
T ss_pred hcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChh
Confidence 4799999999999875 4679999999999999999998876 999999999999999999999999999999999
Q ss_pred CeeecCC---CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCC--------------CCCCCCCcccCC
Q psy2648 542 NLLLDSE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSS--------------GGAGTNHTHNSS 604 (708)
Q Consensus 542 NILl~~~---~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s--------------~~~~~~~~~~~~ 604 (708)
|+|.... ..+||+|||||+.......+.+.|.||+|.|||++..+++--+. |...+..+|+-.
T Consensus 191 NLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 191 NLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred heeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 9999754 56999999999988777778899999999999999766532222 344466777777
Q ss_pred CCCCCcccccccccc---------ccchhhhHHHHhhCCCCCCCCCCCCcc
Q psy2648 605 ISPAPTNFKRQNTID---------SASIKENTARLNAGRPAKNTASIAPLD 646 (708)
Q Consensus 605 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (708)
++|+.....+-..+. |-.+|++..-|++=.|.+++-.....|
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 888887655444443 788999999999999999987655544
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=234.49 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=191.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCC-cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC----CCeeeEEEEE-EeCCEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTG-KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH----PNIVKLFQVI-ETEKTL 120 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~ 120 (708)
+|++.+.||+|+||.||+|.+..++ +.+|+|+......... ..+..|+.+|+.+.. +++.++++.. ..+..-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999998775 6899998876432211 146679999988873 6999999999 577889
Q ss_pred EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-----CcEEEEeccCcc
Q psy2648 121 YLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-----MNIKIADFGFSN 193 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-----~~iKL~DFGls~ 193 (708)
||||+.+ |.+|.+..... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999987 67999876544 579999999999999999999999999999999999999865 369999999998
Q ss_pred ccC--CCC--------C-ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--
Q psy2648 194 EFT--PGN--------K-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-- 260 (708)
Q Consensus 194 ~~~--~~~--------~-~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-- 260 (708)
.+. ... . ...+.||..|+++.+..+... +++.|+||++.++.+|+.|.+||.+........++...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 322 111 1 123559999999999998876 68999999999999999999999875532222222221
Q ss_pred -CC-C-CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 -KY-R-IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 -~~-~-~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.. . .....+.++..+...+-..+...+|..+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 11 1 2233456777777777778899999887665
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=248.69 Aligned_cols=133 Identities=31% Similarity=0.532 Sum_probs=118.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||.++++|++..++|+|.|||.| +|+.+|...+.++|+.++.+..+++.||.|||+++|+|||+||.|||++
T Consensus 56 r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 56 RSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE 134 (808)
T ss_pred HhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec
Confidence 467999999999999999999999999998 9999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCc
Q psy2648 547 SEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHT 600 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~ 600 (708)
..|.+|+||||+|+.+..+. ...+.-|||.|||||++.+..+..+++-|+.++.
T Consensus 135 ~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGci 189 (808)
T KOG0597|consen 135 KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCI 189 (808)
T ss_pred CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHH
Confidence 99999999999999886554 3566789999999999996665555544433333
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=241.71 Aligned_cols=208 Identities=25% Similarity=0.315 Sum_probs=152.9
Q ss_pred CCCCCCCCCCcCCCcccccccccccc----------------ccCcccccccccCceeEEEEEEEeCCEEEEEEeccCCC
Q psy2648 434 GSGGGGGGGAAQSPSHRGVHRSISAS----------------NAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGG 497 (708)
Q Consensus 434 ~~~ggg~~g~v~s~~hr~~~R~i~~~----------------~~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg 497 (708)
...|.|..|.|+.+.-++..+.-..+ ..+.......+||.+++||..|++++.+|||||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 34567777777766665543311111 11222345689999999999999999999999999999
Q ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccC------------
Q psy2648 498 EVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT------------ 563 (708)
Q Consensus 498 ~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~------------ 563 (708)
||...++++ ++|++..+++|+++|+.||+|||-.|||+||||||||||-++|+|-|+||-|+....
T Consensus 163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~ 242 (459)
T KOG0610|consen 163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPR 242 (459)
T ss_pred cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCC
Confidence 999988765 469999999999999999999999999999999999999999999999998753210
Q ss_pred ----------------------C-C----------------------CcccccccCCcccccccccCCC-----CccCCC
Q psy2648 564 ----------------------P-G----------------------NKLDTFCGSPPYAAPELFQGGA-----PVTSSG 593 (708)
Q Consensus 564 ----------------------~-~----------------------~~~~~~~Gt~~Y~APEvl~g~~-----~~~~s~ 593 (708)
. . ....+++||-.|+|||||.|.. .+|+-|
T Consensus 243 ~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfG 322 (459)
T KOG0610|consen 243 SSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFG 322 (459)
T ss_pred CCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHH
Confidence 0 0 1124689999999999999765 222222
Q ss_pred CCCCCCcccCCCCCCCcc-------------ccccccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 594 GAGTNHTHNSSISPAPTN-------------FKRQNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
-..+..+++..++.+..+ |+ ..+-.+..++|+..+|+.+.|.+++|+-
T Consensus 323 IflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp-~~~~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 323 IFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP-EEPEVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred HHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC-CCCcchhHHHHHHHHHhccChhhhhccc
Confidence 222233333333333221 21 1225578999999999999999999953
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=234.10 Aligned_cols=150 Identities=28% Similarity=0.431 Sum_probs=126.8
Q ss_pred cccccCc-eeEEEEEEEeCC------EEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy2648 467 ASSGGET-LLKLFQVIETEK------TLYLVMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQKKIIH 535 (708)
Q Consensus 467 ~~~~~~~-Iv~L~~~~~~~~------~~yLVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiH 535 (708)
....|+| ||.|++++.+.+ .+||||||++. ||..++.... .++...++.+++||+.||.|||+++|+|
T Consensus 65 k~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlH 143 (323)
T KOG0594|consen 65 KRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILH 143 (323)
T ss_pred HHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3457777 999999999988 89999999975 9999997655 5788899999999999999999999999
Q ss_pred CCCCCCCeeecCCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccc
Q psy2648 536 RDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKR 614 (708)
Q Consensus 536 RDlKp~NILl~~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~ 614 (708)
|||||+|||++..|.+||+|||+|+... +.......++|.+|.|||++.|...|.++
T Consensus 144 RDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~---------------------- 201 (323)
T KOG0594|consen 144 RDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTS---------------------- 201 (323)
T ss_pred ccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCC----------------------
Confidence 9999999999999999999999999765 44556778999999999999999877776
Q ss_pred cccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 615 QNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
+|.|+++|..+++..++|=-...|.
T Consensus 202 ---vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 202 ---VDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred ---cchHhHHHHHHHHHhCCCCCCCCcH
Confidence 5666666666666665555444443
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=222.90 Aligned_cols=210 Identities=28% Similarity=0.450 Sum_probs=178.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|+++++||+|+||+.++|.+..+++.||||.-.+.... -.+..|.+..+.|. .++|.++|.+-+...+-.||||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 799999999999999999999999999999987654332 34667888888886 6899999988888888899999
Q ss_pred ccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-----cEEEEeccCccccCCCC
Q psy2648 126 YASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-----NIKIADFGFSNEFTPGN 199 (708)
Q Consensus 126 y~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-----~iKL~DFGls~~~~~~~ 199 (708)
++ |-+|.|.....+ +|+...+.-++.|++.-++|+|++.+|+|||||+|+||...+ .|.|+|||+++.+.+..
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 98 557877776664 699999999999999999999999999999999999998654 48999999999875432
Q ss_pred --------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCC
Q psy2648 200 --------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKY 262 (708)
Q Consensus 200 --------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~~ 262 (708)
..++..||..||+-....|.+.+ ...|+-|||-++++.|.|.+||.|. +.++-+++|-..+-
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 33567899999999999988865 7899999999999999999999974 55666777765543
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-27 Score=247.26 Aligned_cols=211 Identities=24% Similarity=0.301 Sum_probs=164.2
Q ss_pred ccCCCCCCCCCCcCCCccccccccc-----cccccC---cc--------cccccccCceeEEEEEEEeCCEEEEEEeccC
Q psy2648 432 TGGSGGGGGGGAAQSPSHRGVHRSI-----SASNAK---PS--------RRASSGGETLLKLFQVIETEKTLYLVMEYAS 495 (708)
Q Consensus 432 ~~~~~ggg~~g~v~s~~hr~~~R~i-----~~~~~~---~~--------~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~ 495 (708)
.....|.||||-|.....+...+.- ..+..+ .. ...-...+.||.|-..|++.+.++|||..|.
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 4556677888877666555544321 111000 00 0111244589999999999999999999999
Q ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCccccccc
Q psy2648 496 GGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCG 573 (708)
Q Consensus 496 gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~G 573 (708)
||||..+|.+.+ .|+|..+++|++||+.||.+||+.+||+|||||+|||||+.|+++|+|+|||..+..+......+|
T Consensus 269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvG 348 (591)
T KOG0986|consen 269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVG 348 (591)
T ss_pred CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccC
Confidence 999999998877 799999999999999999999999999999999999999999999999999999988888888899
Q ss_pred CCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccc-----cc--------------ccchhhhHHHHhhCC
Q psy2648 574 SPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNT-----ID--------------SASIKENTARLNAGR 634 (708)
Q Consensus 574 t~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------------~~~~~~~~~~~~~~~ 634 (708)
|.+||||||++++.+..+.+-++.+++.+.++-+-.....++.. +| |-.++++.+-|+...
T Consensus 349 T~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kd 428 (591)
T KOG0986|consen 349 TVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKD 428 (591)
T ss_pred cccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccC
Confidence 99999999999999555555555555666555433332111111 11 788999999999999
Q ss_pred CCCCCCCC
Q psy2648 635 PAKNTASI 642 (708)
Q Consensus 635 ~~~~~~~~ 642 (708)
|++++|.-
T Consensus 429 p~~RLGcr 436 (591)
T KOG0986|consen 429 PEKRLGCR 436 (591)
T ss_pred HHHhccCC
Confidence 99999975
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=226.87 Aligned_cols=178 Identities=28% Similarity=0.437 Sum_probs=144.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+|++.+..+...|||+|+|+|++|..-|..+--++|..+..+++||+.||.|||.+||||||+||+|+|+.
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA 144 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA 144 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence 45799999999999999999999999999999999888777789999999999999999999999999999999999996
Q ss_pred CC---CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCC------------------C
Q psy2648 547 SE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSS------------------I 605 (708)
Q Consensus 547 ~~---~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~------------------~ 605 (708)
+. .-+||+|||+|..+..+..+..++|||.|||||++....+.....-|+.+-..+-. +
T Consensus 145 SK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I 224 (355)
T KOG0033|consen 145 SKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI 224 (355)
T ss_pred eccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 54 45999999999999988889999999999999999877655444444332222221 2
Q ss_pred CCCCcccc-ccccccccchhhhHHHHhhCCCCCCCCCCCC
Q psy2648 606 SPAPTNFK-RQNTIDSASIKENTARLNAGRPAKNTASIAP 644 (708)
Q Consensus 606 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (708)
.-+.+++. ++-+-.+.+++++..|.+.=.|+|+--..+-
T Consensus 225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 22233332 2444447889999999999999998654443
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-27 Score=234.03 Aligned_cols=137 Identities=20% Similarity=0.355 Sum_probs=117.2
Q ss_pred cccccCceeEEEE-EEEeCCE-EEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccC
Q psy2648 467 ASSGGETLLKLFQ-VIETEKT-LYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQ--KK--IIHR 536 (708)
Q Consensus 467 ~~~~~~~Iv~L~~-~~~~~~~-~yLVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~--~~--IiHR 536 (708)
....|||||+.++ .|.++.. ++||||||.+|||.++|+. ++.++|..++.++.|+|.||.+||+ .. |+||
T Consensus 73 kQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHR 152 (375)
T KOG0591|consen 73 KQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHR 152 (375)
T ss_pred HhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeec
Confidence 4579999999998 5555554 9999999999999999963 3469999999999999999999999 45 9999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccC
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNS 603 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~ 603 (708)
||||.||+|+.+|.|||.||||++.+.... ...+++|||+||+||++.+..+...|+-|+.++....
T Consensus 153 DIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyE 220 (375)
T KOG0591|consen 153 DIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYE 220 (375)
T ss_pred cCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 999999999999999999999999886544 3567899999999999999888888866655544443
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-27 Score=236.83 Aligned_cols=234 Identities=30% Similarity=0.393 Sum_probs=176.5
Q ss_pred ccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 466 RASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 466 ~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
.....||.+..|...|++.+++++||||+.||+|+.+|.+...|+|+.+++|-.+|++||.|||+++||+||||.+|+|+
T Consensus 222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL 301 (516)
T KOG0690|consen 222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL 301 (516)
T ss_pred HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee
Confidence 34568999999999999999999999999999999999999899999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccc-cCCCCcccccccCCcccccccccCCCCccCCCCCCC-CCcccCCCCCCCccccccc-------
Q psy2648 546 DSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGT-NHTHNSSISPAPTNFKRQN------- 616 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~-~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~-~~~~~~~~~~~~~~~~~~~------- 616 (708)
|++|++||+|||+++. +..+..+.++||||.|+||||+... .|..+..++. +-.-+.++.+....+...+
T Consensus 302 DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 302 DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred ccCCceEeeecccchhcccccceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 9999999999999986 4667788999999999999999644 3444433332 1112223333333211110
Q ss_pred ---c-----ccccchhhhHHHHhhCCCCCCCCCCCCc-------------------cccCCCCCCCcccccccCc-----
Q psy2648 617 ---T-----IDSASIKENTARLNAGRPAKNTASIAPL-------------------DTNTSNIGKPRGVTKSNTM----- 664 (708)
Q Consensus 617 ---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~----- 664 (708)
. --+..++.+++-|+...|.|++|-+.-- .-...++=||.-++..+|.
T Consensus 381 l~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~E 460 (516)
T KOG0690|consen 381 LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEE 460 (516)
T ss_pred HhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhh
Confidence 0 1177899999999999999999865321 2236788899866665553
Q ss_pred -CCCccccCCCCCcc--------ccc---cchhhhhhhccccccCCCC
Q psy2648 665 -TGNRTTLTPGGSVG--------RRS---TISYDAKAASNEKTNTAGD 700 (708)
Q Consensus 665 -~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~ 700 (708)
|+.-.++||+-.-| ||+ ..||-+...|.+++.++..
T Consensus 461 FT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~~~s~~r~~~~~~ 508 (516)
T KOG0690|consen 461 FTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSASMGSINRIHEASE 508 (516)
T ss_pred hhcceeEecCCCCCCcccchhhhhccCCcceeeecchhhhhchhhccc
Confidence 46666777763322 333 3567666666666655443
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-26 Score=236.32 Aligned_cols=143 Identities=27% Similarity=0.466 Sum_probs=130.8
Q ss_pred ccccCceeEEEEEEEe-----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIET-----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~-----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+|||.+++++.. -..+|+|+|+| +.||...|+.+..++++.++.++.||+.||+|+|+.+|+||||||.|
T Consensus 77 ~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsN 155 (359)
T KOG0660|consen 77 HLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSN 155 (359)
T ss_pred HhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhh
Confidence 4569999999999976 36799999999 56888888887779999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCC---CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTP---GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~---~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
+|++.++.+||||||+|+.... ...++..+.|.||.|||++.....|+.+ ||
T Consensus 156 ll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~a-------------------------iD 210 (359)
T KOG0660|consen 156 LLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKA-------------------------ID 210 (359)
T ss_pred eeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccch-------------------------hh
Confidence 9999999999999999998753 4456778999999999999999999998 99
Q ss_pred ccchhhhHHHHhhCCCC
Q psy2648 620 SASIKENTARLNAGRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~ 636 (708)
.|+++|.+++++.|.|-
T Consensus 211 iWSvGCI~AEmL~gkpl 227 (359)
T KOG0660|consen 211 IWSVGCILAEMLTGKPL 227 (359)
T ss_pred hhhhhHHHHHHHcCCCC
Confidence 99999999999999986
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=255.96 Aligned_cols=212 Identities=34% Similarity=0.613 Sum_probs=173.2
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
+..+.-.+|..++.|-.|+||.||+++|+.+.+.+|+| |+++.+ ++|- |+.....|++|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV----------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee-----------
Confidence 34455568999999999999999999999999999994 554432 2221 55556677766
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC--
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-- 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-- 197 (708)
||=...++.-+.++.+- +.|++|||+.||+|||+||+|.||..-|++|+.|||+++....
T Consensus 136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 55555555556666433 7899999999999999999999999999999999999875321
Q ss_pred ------CC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q psy2648 198 ------GN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR 263 (708)
Q Consensus 198 ------~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~ 263 (708)
+. .-+..||||.|.|||++..+.| |..+|||++|+|+|+.+.|+.||.+.+.++|+..+......
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 10 0134699999999999998888 68999999999999999999999999999999999988777
Q ss_pred CCC---CCCHHHHHHHHHhhhhCCCCCCCHH
Q psy2648 264 IPF---YMSTDCENLLKKFLVLNPAKRASLE 291 (708)
Q Consensus 264 ~p~---~~s~~~~~Li~~~L~~dP~~Rps~~ 291 (708)
+|. .+.+|++++|.++|+.+|..|..-.
T Consensus 277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 774 4678999999999999999997543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=244.75 Aligned_cols=197 Identities=20% Similarity=0.181 Sum_probs=138.5
Q ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEeCC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy2648 90 QKLFREVRIMKMLDHPNIVKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165 (708)
Q Consensus 90 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~g 165 (708)
.....|...+..+.|+|++.++.+--... .+.+..|+|+.-++...+..-+.++.+.++.+..++++||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 33445667788889999999998854332 23456689999999999988899999999999999999999999986
Q ss_pred ceecCCCCC---CEEEcCCCcEEEE--eccCccccCCCCCccccccCCcccccccccCCccC-CCchhHHHHHHHHHHHH
Q psy2648 166 IIHRDLKAE---NLLLDSEMNIKIA--DFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 239 (708)
Q Consensus 166 IvHRDLKPe---NILld~~~~iKL~--DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~~~~DIWSlGvilyell 239 (708)
..|.-|--. +-..+.++.+.+. ||+.+.............-...+.+||......+. ....|+|.+|..+..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 655544444 3344556666666 88887766544433344445668888888766554 12369999999999998
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 240 SGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 240 tG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
.|..+-.-. .+...++ +.....+..+++.+|+.-|+++|++..++..
T Consensus 387 ~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 387 QGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred hcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 876542111 1111111 1111116778899999999999999988763
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=244.98 Aligned_cols=178 Identities=56% Similarity=0.748 Sum_probs=146.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
.+..|||||+||++++++..+||||||+.+|++++++.+++++.+..++.++.|+++|++|||+++|||||||.+||||+
T Consensus 110 k~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~ 189 (596)
T KOG0586|consen 110 KSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD 189 (596)
T ss_pred HhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc
Confidence 56799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCc------cCCCCCCCCCcccCCCCCCCccc--------
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPV------TSSGGAGTNHTHNSSISPAPTNF-------- 612 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~------~~s~~~~~~~~~~~~~~~~~~~~-------- 612 (708)
.+.++||+|||++..+..+....++||++.|.|||++.|..+. ++.|...+.+.+++.++-+.+-.
T Consensus 190 ~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~ 269 (596)
T KOG0586|consen 190 ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR 269 (596)
T ss_pred cccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee
Confidence 9999999999999999999999999999999999999987643 33333333433333332222211
Q ss_pred --cccccccccchhhhHHHHhhCCCCCCCCCCCC
Q psy2648 613 --KRQNTIDSASIKENTARLNAGRPAKNTASIAP 644 (708)
Q Consensus 613 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (708)
-|-....+.+-++++.+++.-.|.++.-.++-
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqi 303 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQI 303 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHh
Confidence 12233347788888888888888887654443
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-27 Score=249.24 Aligned_cols=175 Identities=29% Similarity=0.448 Sum_probs=151.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
....+.||+||-.|.++.++|+.||-|-||+|...|+.++.|++..+++|+..+++|+.|||++|||+|||||||+|+|.
T Consensus 476 ~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~ 555 (732)
T KOG0614|consen 476 ECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN 555 (732)
T ss_pred hcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc
Confidence 34578899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCCcccccccCCcccccccccCCC-----CccCCCCCCCCCcccCCCCCCCcccccccccc---
Q psy2648 548 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA-----PVTSSGGAGTNHTHNSSISPAPTNFKRQNTID--- 619 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~-----~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 619 (708)
.|++||.|||+|+.+..+..+.++||||.|.|||+++... .|++.|-.-+.++.+.+++.+...+...+.|=
T Consensus 556 ~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 556 RGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred CCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 9999999999999999999999999999999999998543 45555544456666777766666544333322
Q ss_pred ---------ccchhhhHHHHhhCCCCCCCCCC
Q psy2648 620 ---------SASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 620 ---------~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
...+.++..+|-+..|+.++|+.
T Consensus 636 d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~ 667 (732)
T KOG0614|consen 636 DKIEFPRRITKTATDLIKKLCRDNPTERLGYQ 667 (732)
T ss_pred hhhhcccccchhHHHHHHHHHhcCcHhhhccc
Confidence 55678889999999999999953
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-25 Score=238.84 Aligned_cols=177 Identities=34% Similarity=0.480 Sum_probs=141.2
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
++|+|||.|+++|++...+|||||+|.||+|++.|.+. .++|..+..+++||+.++.|||+.|||||||||||+|+...
T Consensus 93 ~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~ 171 (382)
T KOG0032|consen 93 SGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASK 171 (382)
T ss_pred cCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccc
Confidence 34999999999999999999999999999999999887 59999999999999999999999999999999999999643
Q ss_pred ----CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCC-----CCCcccCCCCCCCcc--------
Q psy2648 549 ----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAG-----TNHTHNSSISPAPTN-------- 611 (708)
Q Consensus 549 ----~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~-----~~~~~~~~~~~~~~~-------- 611 (708)
+.+|++|||+|....++......|||+.|+|||++.+..+....+.|+ +..+.+.+++-+...
T Consensus 172 ~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~ 251 (382)
T KOG0032|consen 172 DEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL 251 (382)
T ss_pred cCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH
Confidence 479999999999988877888999999999999998655444444333 222333333222221
Q ss_pred -----c-cccccccccchhhhHHHHhhCCCCCCCCCCCCcc
Q psy2648 612 -----F-KRQNTIDSASIKENTARLNAGRPAKNTASIAPLD 646 (708)
Q Consensus 612 -----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (708)
| ....+--+.++++...+++.-.|.+|.-...-+.
T Consensus 252 ~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 252 RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1 1111122888999999999999988876555443
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=232.07 Aligned_cols=145 Identities=40% Similarity=0.740 Sum_probs=129.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...+|||||+||+++.+...+|||+|+-.+|||+++|.++. .+.|+.++.||+||+.|+.|||+..||||||||||+.+
T Consensus 72 KLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVF 151 (864)
T KOG4717|consen 72 KLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVF 151 (864)
T ss_pred HHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEE
Confidence 34699999999999999999999999999999999997664 69999999999999999999999999999999999875
Q ss_pred -cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 -DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 -~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.+-|-|||+||||+..+.++..+.+.||++.|-|||+++|..+...+ +|-|+++
T Consensus 152 FEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPA-------------------------VDiWSLG 206 (864)
T KOG4717|consen 152 FEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPA-------------------------VDIWSLG 206 (864)
T ss_pred eeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcc-------------------------hhhhHHH
Confidence 56789999999999999999999999999999999999998865555 5666666
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
-.+--|.-|||+
T Consensus 207 VILyMLVCGq~P 218 (864)
T KOG4717|consen 207 VILYMLVCGQPP 218 (864)
T ss_pred HHHHHHHhCCCc
Confidence 666666677665
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=230.66 Aligned_cols=118 Identities=30% Similarity=0.556 Sum_probs=105.1
Q ss_pred ccccCceeEEEEEEEeCC--EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 468 SSGGETLLKLFQVIETEK--TLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~--~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
...|+|||+.++...... .++|.|||+++|+|.+++.+.+ .|+|..++.|.+||+.||.|||++|||||||||+|||
T Consensus 70 ~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiL 149 (313)
T KOG0198|consen 70 RLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANIL 149 (313)
T ss_pred hCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEE
Confidence 345999999999755544 7999999999999999999887 7999999999999999999999999999999999999
Q ss_pred ecC-CCCEEEeeccCccccCC----CCcccccccCCcccccccccC
Q psy2648 545 LDS-EMNIKIADFGFSNEFTP----GNKLDTFCGSPPYAAPELFQG 585 (708)
Q Consensus 545 l~~-~~~vKl~DFGla~~~~~----~~~~~~~~Gt~~Y~APEvl~g 585 (708)
++. ++.+||+|||+++.... ......+.||+.|||||++..
T Consensus 150 l~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 150 LDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred EeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC
Confidence 999 79999999999987653 122446889999999999996
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=240.61 Aligned_cols=175 Identities=23% Similarity=0.382 Sum_probs=140.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||++++.|--.+.+|.|||||+||+|.+.+... .++|.+++.++++++.||.|||.+||||||||.+|||++
T Consensus 325 ~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~ 403 (550)
T KOG0578|consen 325 RDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT 403 (550)
T ss_pred HhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec
Confidence 4679999999999999999999999999999998877654 699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc-------
Q psy2648 547 SEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI------- 618 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~------- 618 (708)
.+|.+||+||||+..+.... ...+.+|||+|||||++....+-+.-+-|+.+.|.-.++-+.+.+|. .+++
T Consensus 404 ~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa 482 (550)
T KOG0578|consen 404 MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIA 482 (550)
T ss_pred cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHh
Confidence 99999999999998876554 66788999999999999876655555555555555555554444432 1111
Q ss_pred ------------cccchhhhHHHHhhCCCCCCCCCCC
Q psy2648 619 ------------DSASIKENTARLNAGRPAKNTASIA 643 (708)
Q Consensus 619 ------------~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (708)
-|...++-+.|-+.=++.++.-..+
T Consensus 483 ~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 483 TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 1667777777777767766655443
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=256.79 Aligned_cols=203 Identities=24% Similarity=0.313 Sum_probs=150.2
Q ss_pred CCCCCCCCcCCCccccccccccccc----------------cCcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCH
Q psy2648 436 GGGGGGGAAQSPSHRGVHRSISASN----------------AKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEV 499 (708)
Q Consensus 436 ~ggg~~g~v~s~~hr~~~R~i~~~~----------------~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L 499 (708)
-|.|+||-|..++|++..+.-..+. .+-...+....+.||.||..|+++.++||||||++||||
T Consensus 83 IGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDl 162 (1317)
T KOG0612|consen 83 IGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDL 162 (1317)
T ss_pred hcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchH
Confidence 3678888888888877654321111 111122445678899999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCc--ccccccCCcc
Q psy2648 500 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSPPY 577 (708)
Q Consensus 500 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y 577 (708)
..++.+.++++|+.|++|+++|+.||.-||+.|.|||||||+|||||..|++||+|||.+-.+..+.. ....+|||-|
T Consensus 163 ltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDY 242 (1317)
T KOG0612|consen 163 LTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDY 242 (1317)
T ss_pred HHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCc
Confidence 99999988999999999999999999999999999999999999999999999999998876654332 4567899999
Q ss_pred cccccccCCC----CccCCCCCCCCCcccC-CCCCCC--------------------ccccccccccccchhhhHHHHhh
Q psy2648 578 AAPELFQGGA----PVTSSGGAGTNHTHNS-SISPAP--------------------TNFKRQNTIDSASIKENTARLNA 632 (708)
Q Consensus 578 ~APEvl~g~~----~~~~s~~~~~~~~~~~-~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~ 632 (708)
++||+++... .|...-.|+..+.+.- ++-+.. -.|+ ...-.|.-++++..+|+.
T Consensus 243 ISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~~~VSeeakdLI~~ll~ 321 (1317)
T KOG0612|consen 243 ISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DETDVSEEAKDLIEALLC 321 (1317)
T ss_pred cCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cccccCHHHHHHHHHHhc
Confidence 9999997432 2222222221111100 010000 0134 333468889999999888
Q ss_pred CCCCCCCC
Q psy2648 633 GRPAKNTA 640 (708)
Q Consensus 633 ~~~~~~~~ 640 (708)
.|..++|
T Consensus 322 -~~e~RLg 328 (1317)
T KOG0612|consen 322 -DREVRLG 328 (1317)
T ss_pred -Chhhhcc
Confidence 7888888
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=234.98 Aligned_cols=176 Identities=32% Similarity=0.449 Sum_probs=132.0
Q ss_pred cccccCceeEEEEEEEeC--CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~--~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
.-..|+|||+|+++..+. +.+|||+|||..|.+...-.....+++.+|+.|++.++.||.|||.+|||||||||.|+|
T Consensus 163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLL 242 (576)
T ss_pred HhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 346889999999999875 689999999999987643322223999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCC------CCcccccccCCcccccccccCCCCccCCC---------CCCCCCcccCCCCCCC
Q psy2648 545 LDSEMNIKIADFGFSNEFTP------GNKLDTFCGSPPYAAPELFQGGAPVTSSG---------GAGTNHTHNSSISPAP 609 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~------~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~---------~~~~~~~~~~~~~~~~ 609 (708)
|+.+|+|||+|||++..... ...+...+|||.|||||.+.++.....+| .-.++..++..++-+-
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 99999999999999876522 22345579999999999999865333332 2223444333333222
Q ss_pred cccc------------ccccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 610 TNFK------------RQNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 610 ~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
..+. .-++.-...++|++.||+.++|.++..-.
T Consensus 323 ~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~ 367 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLP 367 (576)
T ss_pred hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehh
Confidence 2111 11223367889999999999999886543
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=235.84 Aligned_cols=129 Identities=29% Similarity=0.579 Sum_probs=112.0
Q ss_pred ccccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 464 SRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 464 ~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
...+..+.+.||+||..|++.+.+|+||||++|||+..+|.+.+.|+|+.|++|++++.+|+++.|..|.|||||||+||
T Consensus 681 DILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNI 760 (1034)
T KOG0608|consen 681 DILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 760 (1034)
T ss_pred hhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccce
Confidence 34467788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccC---------CC------------------C----------------cccccccCCccccc
Q psy2648 544 LLDSEMNIKIADFGFSNEFT---------PG------------------N----------------KLDTFCGSPPYAAP 580 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~---------~~------------------~----------------~~~~~~Gt~~Y~AP 580 (708)
|||.+|++||+||||+.-+. .+ . ...+.+||+.|+||
T Consensus 761 LIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiap 840 (1034)
T KOG0608|consen 761 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAP 840 (1034)
T ss_pred EEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccCh
Confidence 99999999999999975321 10 0 01246899999999
Q ss_pred ccccCCCCccCC
Q psy2648 581 ELFQGGAPVTSS 592 (708)
Q Consensus 581 Evl~g~~~~~~s 592 (708)
|||....+....
T Consensus 841 evl~r~g~~q~c 852 (1034)
T KOG0608|consen 841 EVLARTGYTQLC 852 (1034)
T ss_pred HHhcccCccccc
Confidence 999866644444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=212.77 Aligned_cols=141 Identities=25% Similarity=0.236 Sum_probs=112.6
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhh------------------------HHHHHHHHHHHHhCCCCC
Q psy2648 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS------------------------LQKLFREVRIMKMLDHPN 106 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~Hpn 106 (708)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+++|+.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 8999999999765321111 112345999999998877
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCCEEEcCCCcEE
Q psy2648 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC-HQKKIIHRDLKAENLLLDSEMNIK 185 (708)
Q Consensus 107 Iv~l~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yL-H~~gIvHRDLKPeNILld~~~~iK 185 (708)
|...+.+ .... .||||||++|+++...+...+.+++.++..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~-~~~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPI-LLKS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEE-EecC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6443322 2222 389999999988876655567899999999999999999999 799999999999999998 47899
Q ss_pred EEeccCcccc
Q psy2648 186 IADFGFSNEF 195 (708)
Q Consensus 186 L~DFGls~~~ 195 (708)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-25 Score=229.67 Aligned_cols=172 Identities=31% Similarity=0.411 Sum_probs=135.8
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.-|.+++||..|++-+++|+||||+.||||..+|++-|+|.|..|.+|+++|+.||-+||++|||+||||.+|||||.+|
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC
Confidence 44679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccc-CCCCcccccccCCcccccccccCCCCccCCCCCCCC-CcccCCCCCCCccccc-----------cc
Q psy2648 550 NIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTN-HTHNSSISPAPTNFKR-----------QN 616 (708)
Q Consensus 550 ~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~-~~~~~~~~~~~~~~~~-----------~~ 616 (708)
++||+|||++++- .++..+.++||||.|+|||++.-.. |..|..|+.. -+.+.+.-+ ...|.+ ..
T Consensus 488 HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaG-QpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 488 HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAG-QPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred ceEeeecccccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHc
Confidence 9999999999874 4566778999999999999997654 4544443322 122221111 111110 00
Q ss_pred ccc-----ccchhhhHHHHhhCCCCCCCCCCC
Q psy2648 617 TID-----SASIKENTARLNAGRPAKNTASIA 643 (708)
Q Consensus 617 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 643 (708)
+.. |..+.+.-.-++...|+|++|...
T Consensus 566 nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~ 597 (683)
T KOG0696|consen 566 NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGP 597 (683)
T ss_pred cCcCcccccHHHHHHHHHHhhcCCccccCCCC
Confidence 111 555666667788999999998753
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=232.35 Aligned_cols=129 Identities=27% Similarity=0.429 Sum_probs=113.0
Q ss_pred cccccCceeEEEEEEEeCC-EEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEK-TLYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKK-IIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~-~~yLVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~N 542 (708)
....|||||++++++.++. .+.|||||+++|+|.+++.. ++.++...+..++.||+.||.|||+++ ||||||||+|
T Consensus 94 ~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~N 173 (362)
T KOG0192|consen 94 SRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDN 173 (362)
T ss_pred HhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhh
Confidence 4489999999999999988 89999999999999999987 578999999999999999999999999 9999999999
Q ss_pred eeecCCC-CEEEeeccCccccCCC-CcccccccCCcccccccccCC--CCccCCCCC
Q psy2648 543 LLLDSEM-NIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGG--APVTSSGGA 595 (708)
Q Consensus 543 ILl~~~~-~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~--~~~~~s~~~ 595 (708)
||++..+ ++||||||+++..... .......||+.|||||++.+. .+...++..
T Consensus 174 iLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~Dvy 230 (362)
T KOG0192|consen 174 ILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVY 230 (362)
T ss_pred EEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhh
Confidence 9999998 9999999999876544 344457899999999999963 444444433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-24 Score=233.56 Aligned_cols=129 Identities=29% Similarity=0.491 Sum_probs=111.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|++|+++++++++...+|||||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 56 ~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~ 135 (363)
T cd05628 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135 (363)
T ss_pred HhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC------------------------------------cccccccCCcccccccccCCCCcc
Q psy2648 547 SEMNIKIADFGFSNEFTPGN------------------------------------KLDTFCGSPPYAAPELFQGGAPVT 590 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~------------------------------------~~~~~~Gt~~Y~APEvl~g~~~~~ 590 (708)
.++.+||+|||+++...... .....+||+.|||||++.+.....
T Consensus 136 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 215 (363)
T cd05628 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK 215 (363)
T ss_pred CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence 99999999999987542210 113468999999999998765444
Q ss_pred CCCCC
Q psy2648 591 SSGGA 595 (708)
Q Consensus 591 ~s~~~ 595 (708)
.++-+
T Consensus 216 ~~Dvw 220 (363)
T cd05628 216 LCDWW 220 (363)
T ss_pred chhhh
Confidence 44333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=227.76 Aligned_cols=175 Identities=32% Similarity=0.413 Sum_probs=139.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++|++.+.+|||||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 50 ~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~ 129 (323)
T cd05571 50 QNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD 129 (323)
T ss_pred HhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccc-CCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc------------
Q psy2648 547 SEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK------------ 613 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~------------ 613 (708)
.++.+||+|||+++.. .........+||+.|||||++.+..+...++-++.+.+......+......
T Consensus 130 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05571 130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (323)
T ss_pred CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999999998754 233344567899999999999877655555555444443333221111000
Q ss_pred ---ccccccccchhhhHHHHhhCCCCCCCCC
Q psy2648 614 ---RQNTIDSASIKENTARLNAGRPAKNTAS 641 (708)
Q Consensus 614 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (708)
.....-+..+.+++.+++..+|.+|.+.
T Consensus 210 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05571 210 EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence 0001125678899999999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=226.01 Aligned_cols=179 Identities=32% Similarity=0.398 Sum_probs=140.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl 545 (708)
....|+||++++++|+++..+|||||||++|+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 50 ~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll 129 (325)
T cd05594 50 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 129 (325)
T ss_pred HhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE
Confidence 3467999999999999999999999999999999999888889999999999999999999997 799999999999999
Q ss_pred cCCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc-----------
Q psy2648 546 DSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK----------- 613 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~----------- 613 (708)
+.++.+||+|||+++... ........+||+.|||||++.+......++-++.+.+......+......
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~ 209 (325)
T cd05594 130 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209 (325)
T ss_pred CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh
Confidence 999999999999987543 23334567899999999999877655555555544444333222111100
Q ss_pred ----ccccccccchhhhHHHHhhCCCCCCCCCCCCc
Q psy2648 614 ----RQNTIDSASIKENTARLNAGRPAKNTASIAPL 645 (708)
Q Consensus 614 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (708)
......+..+.+++.+++.-+|.+|.+...|.
T Consensus 210 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 245 (325)
T cd05594 210 MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDD 245 (325)
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCC
Confidence 00112366788999999999999997654443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=205.61 Aligned_cols=143 Identities=23% Similarity=0.245 Sum_probs=115.1
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh----------------------h--HHHHHHHHHHHHhCCCC
Q psy2648 50 LLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG----------------------S--LQKLFREVRIMKMLDHP 105 (708)
Q Consensus 50 i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~----------------------~--~~~~~~Ei~il~~l~Hp 105 (708)
+.+.||+|+||.||+|.+. +|+.||||++++...... . ...+.+|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999986532100 0 11235799999999999
Q ss_pred CeeeEEEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcE
Q psy2648 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNI 184 (708)
Q Consensus 106 nIv~l~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~i 184 (708)
+|.....+.... .||||||++|+++.........+++.++..++.|++.+|.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 875443333222 48999999998665544456778999999999999999999999 9999999999999999 8899
Q ss_pred EEEeccCccccC
Q psy2648 185 KIADFGFSNEFT 196 (708)
Q Consensus 185 KL~DFGls~~~~ 196 (708)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=213.08 Aligned_cols=207 Identities=28% Similarity=0.418 Sum_probs=150.6
Q ss_pred cCCCCCCCCCCcCCCccccccccccccc----------------cCcccccccccCceeEEEEEEEeCCEEEEEEeccCC
Q psy2648 433 GGSGGGGGGGAAQSPSHRGVHRSISASN----------------AKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASG 496 (708)
Q Consensus 433 ~~~~ggg~~g~v~s~~hr~~~R~i~~~~----------------~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~g 496 (708)
+.-.|.|-||-|+..+++..+.-+..+. .+-..+....||||++||.+|.++..+||++||...
T Consensus 27 gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~ 106 (281)
T KOG0580|consen 27 GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPR 106 (281)
T ss_pred cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCC
Confidence 3345667777776666555443222211 122234567999999999999999999999999999
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccC
Q psy2648 497 GEVFDYLV--LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 574 (708)
Q Consensus 497 g~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt 574 (708)
|+|+..|. ...+|+|..+..|+.|++.||.|||.++||||||||+|+|++..+.+|++|||-+-... .....+.|||
T Consensus 107 gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt 185 (281)
T KOG0580|consen 107 GELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGT 185 (281)
T ss_pred chHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecc
Confidence 99999998 66679999999999999999999999999999999999999999999999999876543 5667789999
Q ss_pred CcccccccccCCCCccCCCCCCCCCcccCCC--CCCCcc------c--cccc-----cccccchhhhHHHHhhCCCCCCC
Q psy2648 575 PPYAAPELFQGGAPVTSSGGAGTNHTHNSSI--SPAPTN------F--KRQN-----TIDSASIKENTARLNAGRPAKNT 639 (708)
Q Consensus 575 ~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~--~~~~~~------~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 639 (708)
.-|.+||.+.+......-.-+...-.++.-+ .|+... + .++. ..-+..++|+..||+...|.++.
T Consensus 186 ~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~ 265 (281)
T KOG0580|consen 186 LDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERL 265 (281)
T ss_pred cccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccc
Confidence 9999999998765333222221111111111 111110 0 0111 22377889999999999888876
Q ss_pred C
Q psy2648 640 A 640 (708)
Q Consensus 640 ~ 640 (708)
.
T Consensus 266 ~ 266 (281)
T KOG0580|consen 266 A 266 (281)
T ss_pred c
Confidence 4
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=212.23 Aligned_cols=172 Identities=15% Similarity=0.158 Sum_probs=134.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHH------HHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQK------LFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
-++|++.+.||.|+||.||++.. ++..||||++....... ...++ +.+|++.+.+++||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 36899999999999999999755 47789999997654432 22233 46899999999999999999886643
Q ss_pred --------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEec
Q psy2648 118 --------KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 189 (708)
Q Consensus 118 --------~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DF 189 (708)
...||||||++|.+|.++. .+++ ....||+.+|..||++|++|||+||.|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3579999999999998863 2333 2456999999999999999999999999999999 999999
Q ss_pred cCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHH
Q psy2648 190 GFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 239 (708)
Q Consensus 190 Gls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyell 239 (708)
|........... ..++....|. .++|+|||||.+..+.
T Consensus 179 g~~~~~~e~~a~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 987655322111 1144555676 7899999999876543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=231.02 Aligned_cols=94 Identities=33% Similarity=0.641 Sum_probs=89.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|++||+++++|+++..+|||||||++|+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 56 ~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~ 135 (382)
T cd05625 56 AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID 135 (382)
T ss_pred HhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 44589999999999999999999999999999999998888899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcc
Q psy2648 547 SEMNIKIADFGFSN 560 (708)
Q Consensus 547 ~~~~vKl~DFGla~ 560 (708)
.++.+||+|||+++
T Consensus 136 ~~g~~kL~DFGla~ 149 (382)
T cd05625 136 RDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCEEEeECCCCc
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=226.43 Aligned_cols=179 Identities=31% Similarity=0.375 Sum_probs=138.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++++++.+||||||+++|+|..++...+.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 50 ~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 129 (328)
T cd05593 50 KNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD 129 (328)
T ss_pred HhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC
Confidence 44579999999999999999999999999999999998888899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCC-----CCCCcccc-------
Q psy2648 547 SEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSI-----SPAPTNFK------- 613 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~-----~~~~~~~~------- 613 (708)
.++.+||+|||+++... ........+||+.|+|||++.+......++-++.+.+..... ........
T Consensus 130 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~ 209 (328)
T cd05593 130 KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (328)
T ss_pred CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc
Confidence 99999999999987643 223345678999999999998766544454444333322221 11111000
Q ss_pred cc---ccccccchhhhHHHHhhCCCCCCCCCCCCc
Q psy2648 614 RQ---NTIDSASIKENTARLNAGRPAKNTASIAPL 645 (708)
Q Consensus 614 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (708)
.. ...-+..+.+++.+++.-.|.+|.+...|.
T Consensus 210 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (328)
T cd05593 210 EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDD 244 (328)
T ss_pred CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 00 011256788999999999999997654443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=223.79 Aligned_cols=176 Identities=26% Similarity=0.345 Sum_probs=138.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++|+.++.+|||||||++|+|..++...+.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~ 130 (325)
T cd05604 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD 130 (325)
T ss_pred HhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 34689999999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc------------
Q psy2648 547 SEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK------------ 613 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~------------ 613 (708)
.++.+||+|||+++... ........+||+.|||||++.+......++-++.+.+......+......
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~ 210 (325)
T cd05604 131 SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210 (325)
T ss_pred CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999999987542 22334567899999999999877655555544444443333221111100
Q ss_pred ---ccccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 614 ---RQNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 614 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
...+-.+..+.+++.+++..+|.+|....
T Consensus 211 ~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 211 KPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 01112355677899999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=225.00 Aligned_cols=176 Identities=28% Similarity=0.367 Sum_probs=138.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++++.+.+|||||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 51 ~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~ 130 (325)
T cd05602 51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 130 (325)
T ss_pred HhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence 34689999999999999999999999999999999998888899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccc------------c
Q psy2648 547 SEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNF------------K 613 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~------------~ 613 (708)
.++.+||+|||+++... ........+||+.|||||++.+......++-++.+.+......+..... .
T Consensus 131 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (325)
T cd05602 131 SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210 (325)
T ss_pred CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 99999999999997542 2333456789999999999987665555554443333322221111100 0
Q ss_pred ---ccccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 614 ---RQNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 614 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
...+--+..+++++.+++...|.+|....
T Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 211 KPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred CCcCCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 01112256778999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=225.06 Aligned_cols=121 Identities=37% Similarity=0.649 Sum_probs=109.6
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|+||++++++|++...+|||||||++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 53 ~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~ 132 (329)
T cd05588 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE 132 (329)
T ss_pred cCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 37999999999999999999999999999999999888899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccc-CCCCcccccccCCcccccccccCCCCc
Q psy2648 549 MNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPV 589 (708)
Q Consensus 549 ~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~~~ 589 (708)
+.+||+|||+++.. .........+||+.|+|||++.+....
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05588 133 GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred CCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCC
Confidence 99999999998753 333445567899999999999875533
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=227.59 Aligned_cols=194 Identities=23% Similarity=0.370 Sum_probs=152.0
Q ss_pred CCCCCCCCCCcCCCcccccccccccccc------Cccc---------ccccccCceeEEEEEEEeCCE-EEEEEeccCCC
Q psy2648 434 GSGGGGGGGAAQSPSHRGVHRSISASNA------KPSR---------RASSGGETLLKLFQVIETEKT-LYLVMEYASGG 497 (708)
Q Consensus 434 ~~~ggg~~g~v~s~~hr~~~R~i~~~~~------~~~~---------~~~~~~~~Iv~L~~~~~~~~~-~yLVmEy~~gg 497 (708)
...|.|+||.+..+.|+.....+..+.. .+.+ .....|||||...+.|..++. ++||||||+||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 3457788998888888877664333211 1111 133699999999999999988 99999999999
Q ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCC-cccccccC
Q psy2648 498 EVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGS 574 (708)
Q Consensus 498 ~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~-~~~~~~Gt 574 (708)
+|.+.|.+++ .|+|+.+..|+.|++.||.|||++.|+|||||+.||++++++.|||.|||+|+.+.+.. ...+.+||
T Consensus 90 ~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGT 169 (426)
T KOG0589|consen 90 DLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGT 169 (426)
T ss_pred CHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCC
Confidence 9999997654 59999999999999999999999999999999999999999999999999999998776 67889999
Q ss_pred CcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCC
Q psy2648 575 PPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGR 634 (708)
Q Consensus 575 ~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (708)
|.||.||++.+-.+-..++-|..++-.+..- --+..+.+.+...+..++..+.
T Consensus 170 p~YmcPEil~d~pYn~KSDiWsLGC~~yEm~-------~lk~aF~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 170 PYYMCPEILSDIPYNEKSDIWSLGCCLYEMC-------TLKPAFKASNMSELILKINRGL 222 (426)
T ss_pred CcccCHHHhCCCCCCccCcchhhcchHHHHH-------hcccccCccchHHHHHHHhhcc
Confidence 9999999999877666665554333322211 2234455666666666666655
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=229.86 Aligned_cols=94 Identities=31% Similarity=0.563 Sum_probs=90.2
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+|||+++++|++...+|||||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 57 ~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred hCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 46899999999999999999999999999999999988889999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccc
Q psy2648 548 EMNIKIADFGFSNE 561 (708)
Q Consensus 548 ~~~vKl~DFGla~~ 561 (708)
++.+||+|||+|+.
T Consensus 137 ~~~~kl~DfGla~~ 150 (377)
T cd05629 137 GGHIKLSDFGLSTG 150 (377)
T ss_pred CCCEEEeecccccc
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=223.93 Aligned_cols=172 Identities=27% Similarity=0.368 Sum_probs=134.5
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.|++|++++++|++...+|||||||++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~ 133 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG 133 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC
Confidence 79999999999999999999999999999999999888999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccC-CCCcccccccCCcccccccccCCCCcc-CCCCCCCCCcccCCCCCCCcccc------------c-
Q psy2648 550 NIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVT-SSGGAGTNHTHNSSISPAPTNFK------------R- 614 (708)
Q Consensus 550 ~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~-~s~~~~~~~~~~~~~~~~~~~~~------------~- 614 (708)
.+||+|||+++... ........+||+.|||||++.+...++ .++-++.+.+......+...... .
T Consensus 134 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999987543 233345678999999999998654333 34434333333322211111000 0
Q ss_pred ---cccccccchhhhHHHHhhCCCCCCCCC
Q psy2648 615 ---QNTIDSASIKENTARLNAGRPAKNTAS 641 (708)
Q Consensus 615 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (708)
....-+..+.+++.+++.-+|.+|...
T Consensus 214 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 214 VRFPKNVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 001235667889999999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=222.64 Aligned_cols=175 Identities=27% Similarity=0.374 Sum_probs=137.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|++.+.+|||||||++|+|..++.....+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 51 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~ 130 (321)
T cd05603 51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD 130 (321)
T ss_pred HhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence 45689999999999999999999999999999999998888899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccc-CCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc------------
Q psy2648 547 SEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK------------ 613 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~------------ 613 (708)
.++.+||+|||+++.. .........+||+.|+|||++.+......++-++.+.+......+......
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (321)
T cd05603 131 SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210 (321)
T ss_pred CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc
Confidence 9999999999998763 223334567899999999999876544445544444343333221111100
Q ss_pred ---ccccccccchhhhHHHHhhCCCCCCCCC
Q psy2648 614 ---RQNTIDSASIKENTARLNAGRPAKNTAS 641 (708)
Q Consensus 614 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (708)
......+..+.+++.+++...|.+|.+.
T Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 241 (321)
T cd05603 211 KPLQLPGGKTVAACDLLVGLLHKDQRRRLGA 241 (321)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCHhhcCCC
Confidence 0011234567889999999999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=202.12 Aligned_cols=187 Identities=16% Similarity=0.162 Sum_probs=143.2
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC--hhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEe
Q psy2648 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 49 ~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.+...|++|+||+|+++.. .+.+|+.+.+.....- .-....+.+|+++|++|+ |++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998765 6778887777644331 112235779999999996 5889999886 34699999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEEcCCCcEEEEeccCccccCCCCCc---
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL-KAENLLLDSEMNIKIADFGFSNEFTPGNKL--- 201 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDL-KPeNILld~~~~iKL~DFGls~~~~~~~~~--- 201 (708)
|+.|.+|.+.+.. . ...++.|++.+|++||++||+|||| ||+|||++.++.++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999998754321 1 2457899999999999999999999 799999999999999999999865543321
Q ss_pred -c----------ccccCCcccccccccCC-ccCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2648 202 -D----------TFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGS 248 (708)
Q Consensus 202 -~----------~~~Gt~~Y~APE~l~~~-~~~~~~~DIWSlGvilyelltG~~Pf~~~ 248 (708)
. -...++.|++|+...-. ..+-...++++.|.-+|.|+|+.+|+.+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 11257888999865432 12225679999999999999999998654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=229.18 Aligned_cols=95 Identities=32% Similarity=0.586 Sum_probs=90.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|++||++++++++.+.+|||||||++|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 56 ~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~ 135 (381)
T cd05626 56 AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID 135 (381)
T ss_pred HhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC
Confidence 34589999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccc
Q psy2648 547 SEMNIKIADFGFSNE 561 (708)
Q Consensus 547 ~~~~vKl~DFGla~~ 561 (708)
..+.+||+|||+++.
T Consensus 136 ~~~~~kL~DFGl~~~ 150 (381)
T cd05626 136 LDGHIKLTDFGLCTG 150 (381)
T ss_pred CCCCEEEeeCcCCcc
Confidence 999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=221.35 Aligned_cols=127 Identities=34% Similarity=0.562 Sum_probs=112.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|.++..+|||||||++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 48 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~ 127 (312)
T cd05585 48 AQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD 127 (312)
T ss_pred HhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC
Confidence 34589999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSG 593 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~ 593 (708)
.++.+||+|||+++.... .......+||+.|+|||++.+......++
T Consensus 128 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 175 (312)
T cd05585 128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175 (312)
T ss_pred CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccc
Confidence 999999999999875432 23345578999999999998765444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=222.45 Aligned_cols=176 Identities=29% Similarity=0.374 Sum_probs=138.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++++.+.+|||||||++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~ 130 (323)
T cd05575 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD 130 (323)
T ss_pred hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence 34689999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccc-------------
Q psy2648 547 SEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNF------------- 612 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~------------- 612 (708)
.++.+||+|||+++... ........+||+.|||||++.+......++-++.+.+............
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 210 (323)
T cd05575 131 SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210 (323)
T ss_pred CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999999987542 2333455789999999999987665444544443333333221111100
Q ss_pred --cccccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 613 --KRQNTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 613 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
....+.-+..+.+++.+++...|.+|....
T Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 211 KPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 011112266788999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=227.98 Aligned_cols=126 Identities=32% Similarity=0.553 Sum_probs=109.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++|+++..+|||||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 56 ~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~ 135 (364)
T cd05599 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD 135 (364)
T ss_pred HhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC---------------------------------------cccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGN---------------------------------------KLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~---------------------------------------~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+++.+.... ...+.+||+.|||||++.+..
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 99999999999986542111 112357999999999997655
Q ss_pred CccCC
Q psy2648 588 PVTSS 592 (708)
Q Consensus 588 ~~~~s 592 (708)
....+
T Consensus 216 ~~~~~ 220 (364)
T cd05599 216 YNKEC 220 (364)
T ss_pred CCCee
Confidence 43333
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=221.40 Aligned_cols=128 Identities=39% Similarity=0.605 Sum_probs=112.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++++...+|||||||++|+|..++...+.+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~ 131 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC
Confidence 34799999999999999999999999999999999988889999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCC
Q psy2648 548 EMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGA 595 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~ 595 (708)
++.+||+|||+++.... .......+||+.|||||++.+......++-+
T Consensus 132 ~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 180 (316)
T cd05592 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180 (316)
T ss_pred CCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccch
Confidence 99999999999976432 2334567899999999999876544444333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=224.24 Aligned_cols=176 Identities=26% Similarity=0.355 Sum_probs=138.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||++++++.++..+|||||||++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 86 ~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~ 165 (340)
T PTZ00426 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165 (340)
T ss_pred HhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCc-----ccc--------
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPT-----NFK-------- 613 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~-----~~~-------- 613 (708)
.++.+||+|||+++.... .....+||+.|||||++.+......++-++.+.+......+... ...
T Consensus 166 ~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 166 KDGFIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred CCCCEEEecCCCCeecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 999999999999986543 23457899999999999876554445444433333222211111 100
Q ss_pred --ccccccccchhhhHHHHhhCCCCCCCCCCCC
Q psy2648 614 --RQNTIDSASIKENTARLNAGRPAKNTASIAP 644 (708)
Q Consensus 614 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (708)
.....-+..+++++.+++..+|.+|.+...|
T Consensus 244 ~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~ 276 (340)
T PTZ00426 244 IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKK 276 (340)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCC
Confidence 0011125567899999999999999765444
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=227.15 Aligned_cols=119 Identities=33% Similarity=0.562 Sum_probs=106.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++|+++..+|||||||++|+|.+++... .+++.+++.++.||+.||.|||+++|+||||||+|||++
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~ 176 (370)
T cd05621 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176 (370)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC
Confidence 3468999999999999999999999999999999988654 689999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGG 586 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~ 586 (708)
.++.+||+|||+|....... ...+.+||+.|||||++.+.
T Consensus 177 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhcc
Confidence 99999999999998764332 23467899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=221.80 Aligned_cols=127 Identities=38% Similarity=0.586 Sum_probs=112.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++|...+.+|||||||++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 50 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 129 (323)
T cd05595 50 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 129 (323)
T ss_pred HhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc
Confidence 34579999999999999999999999999999999998888899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCC
Q psy2648 547 SEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSG 593 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~ 593 (708)
.++.+||+|||+++... ........+||+.|||||++.+......++
T Consensus 130 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 177 (323)
T cd05595 130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177 (323)
T ss_pred CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhc
Confidence 99999999999987642 233345578999999999998765444443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=220.86 Aligned_cols=128 Identities=33% Similarity=0.499 Sum_probs=112.3
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|++|++++++|+++..+|||||||++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~ 132 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 47999999999999999999999999999999999888899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCC
Q psy2648 549 MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAG 596 (708)
Q Consensus 549 ~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~ 596 (708)
+.+||+|||+++... ........+||+.|+|||++.+......++-++
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 181 (321)
T cd05591 133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWA 181 (321)
T ss_pred CCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceec
Confidence 999999999987543 233345678999999999998765444444333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=221.54 Aligned_cols=127 Identities=38% Similarity=0.610 Sum_probs=112.0
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|+|||++++++.+...+|||||||++|+|..++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~ 132 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 47999999999999999999999999999999999888899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccc-CCCCcccccccCCcccccccccCCCCccCCCCC
Q psy2648 549 MNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGA 595 (708)
Q Consensus 549 ~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~ 595 (708)
+.+||+|||+++.. .........+||+.|+|||++.+......++-+
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 180 (329)
T cd05618 133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180 (329)
T ss_pred CCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCcccee
Confidence 99999999998753 233344567899999999999876544444333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=221.15 Aligned_cols=121 Identities=36% Similarity=0.654 Sum_probs=109.4
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|++|++++++|++...+|||||||++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~ 132 (327)
T cd05617 53 SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD 132 (327)
T ss_pred cCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC
Confidence 47899999999999999999999999999999999888899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccc-CCCCcccccccCCcccccccccCCCCc
Q psy2648 549 MNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPV 589 (708)
Q Consensus 549 ~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~~~ 589 (708)
+.+||+|||+++.. .........+||+.|+|||++.+....
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 133 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred CCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCC
Confidence 99999999998753 233344567899999999999866543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-23 Score=220.73 Aligned_cols=127 Identities=37% Similarity=0.541 Sum_probs=111.7
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|+||++++++|++.+.+|||||||++|+|.+++...+.+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~ 132 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE 132 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 36999999999999999999999999999999999888899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCC
Q psy2648 549 MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGA 595 (708)
Q Consensus 549 ~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~ 595 (708)
+.+||+|||+++... ........+||+.|||||++.+......++-+
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 180 (320)
T cd05590 133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180 (320)
T ss_pred CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchh
Confidence 999999999987642 23334567899999999999866544444333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=226.63 Aligned_cols=136 Identities=28% Similarity=0.489 Sum_probs=113.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|++|++++++|++++.+|||||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 56 ~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~ 135 (376)
T cd05598 56 AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135 (376)
T ss_pred HhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC
Confidence 34689999999999999999999999999999999999888899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC--------------------------------------------CcccccccCCccccccc
Q psy2648 547 SEMNIKIADFGFSNEFTPG--------------------------------------------NKLDTFCGSPPYAAPEL 582 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~--------------------------------------------~~~~~~~Gt~~Y~APEv 582 (708)
.++.+||+|||+|..+... ......+||+.|||||+
T Consensus 136 ~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 215 (376)
T cd05598 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215 (376)
T ss_pred CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHH
Confidence 9999999999997532100 00124589999999999
Q ss_pred ccCCCCccCCCCCCCCCccc
Q psy2648 583 FQGGAPVTSSGGAGTNHTHN 602 (708)
Q Consensus 583 l~g~~~~~~s~~~~~~~~~~ 602 (708)
+.+......++-++.+.+..
T Consensus 216 ~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 216 LLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred HcCCCCCcceeeeeccceee
Confidence 98766544554444444433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-23 Score=219.26 Aligned_cols=124 Identities=38% Similarity=0.588 Sum_probs=110.4
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|++|++++++|++.+.+|||||||.+|+|..++...+.+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~ 132 (316)
T cd05620 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132 (316)
T ss_pred cCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 47899999999999999999999999999999999888899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCC
Q psy2648 549 MNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 549 ~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
+.+||+|||+++.... .......+||+.|+|||++.+......+
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (316)
T cd05620 133 GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177 (316)
T ss_pred CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCccc
Confidence 9999999999875322 2234567899999999999876544334
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.9e-23 Score=219.45 Aligned_cols=127 Identities=39% Similarity=0.542 Sum_probs=111.9
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..+++|+++++++++.+.+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~ 137 (323)
T cd05616 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE 137 (323)
T ss_pred cCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC
Confidence 46789999999999999999999999999999999888899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCC
Q psy2648 549 MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGA 595 (708)
Q Consensus 549 ~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~ 595 (708)
+.+||+|||+++... ........+||+.|||||++.+......++-+
T Consensus 138 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 185 (323)
T cd05616 138 GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185 (323)
T ss_pred CcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchh
Confidence 999999999997643 23344567899999999999876644444333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=221.34 Aligned_cols=173 Identities=25% Similarity=0.392 Sum_probs=131.5
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|++|++++++|++...+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 57 ~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred hCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 45789999999999999999999999999999999998889999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCC------------------------------------cccccccCCcccccccccCCCCccC
Q psy2648 548 EMNIKIADFGFSNEFTPGN------------------------------------KLDTFCGSPPYAAPELFQGGAPVTS 591 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~------------------------------------~~~~~~Gt~~Y~APEvl~g~~~~~~ 591 (708)
++.+||+|||+++...... ...+.+||+.|||||++.+......
T Consensus 137 ~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 216 (360)
T cd05627 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL 216 (360)
T ss_pred CCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc
Confidence 9999999999986542110 1124689999999999987665555
Q ss_pred CCCCCCCCcccCCCCCCC-----ccc---------ccccc-----ccccchhhhHHHHhhCCCCCCCCC
Q psy2648 592 SGGAGTNHTHNSSISPAP-----TNF---------KRQNT-----IDSASIKENTARLNAGRPAKNTAS 641 (708)
Q Consensus 592 s~~~~~~~~~~~~~~~~~-----~~~---------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 641 (708)
++-++.+.+......+.. ... ..... .-+..+++++.++.. .|.++.+.
T Consensus 217 ~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred ceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 544443333333221111 100 00000 124567778888765 77777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=212.92 Aligned_cols=124 Identities=36% Similarity=0.659 Sum_probs=117.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
+.+.+|.+|.|+..|+++..+++|.||+.||||..+++++..++|+.|++|..+|+.||.|||++|||+||||.+|+|+|
T Consensus 306 ~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 306 QASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred hccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 55789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccc-cCCCCcccccccCCcccccccccCCCCcc
Q psy2648 547 SEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGGAPVT 590 (708)
Q Consensus 547 ~~~~vKl~DFGla~~-~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~ 590 (708)
..|++||+|+|+++. +.++....++||||.|+|||+++|..+-.
T Consensus 386 aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygf 430 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 430 (593)
T ss_pred cCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCc
Confidence 999999999999986 46788889999999999999999887433
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=217.66 Aligned_cols=120 Identities=37% Similarity=0.606 Sum_probs=108.3
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.|++|++++++|+.+..+|||||||++|+|.+++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG 142 (332)
T ss_pred CCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC
Confidence 68999999999999999999999999999999998888899999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccCCC--CcccccccCCcccccccccCCCCc
Q psy2648 550 NIKIADFGFSNEFTPG--NKLDTFCGSPPYAAPELFQGGAPV 589 (708)
Q Consensus 550 ~vKl~DFGla~~~~~~--~~~~~~~Gt~~Y~APEvl~g~~~~ 589 (708)
.+||+|||+++..... ......+||+.|||||++.+...+
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 184 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184 (332)
T ss_pred CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCC
Confidence 9999999999865332 233457899999999999875433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=219.22 Aligned_cols=174 Identities=27% Similarity=0.419 Sum_probs=137.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||++++++.+++.+|+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 73 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~ 152 (329)
T PTZ00263 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD 152 (329)
T ss_pred HhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC
Confidence 34689999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCC-----CCcccc-------c
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISP-----APTNFK-------R 614 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~-----~~~~~~-------~ 614 (708)
.++.+||+|||+++..... ....+||+.|+|||++.+......++-++.+.+......+ ...... .
T Consensus 153 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 230 (329)
T PTZ00263 153 NKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230 (329)
T ss_pred CCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 9999999999999866432 2356899999999999877655445444433322222111 111000 0
Q ss_pred c---ccccccchhhhHHHHhhCCCCCCCCCC
Q psy2648 615 Q---NTIDSASIKENTARLNAGRPAKNTASI 642 (708)
Q Consensus 615 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (708)
. ...-+..+++++.+++...|.+|.++.
T Consensus 231 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 261 (329)
T PTZ00263 231 RLKFPNWFDGRARDLVKGLLQTDHTKRLGTL 261 (329)
T ss_pred CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 0 111245678999999999999998753
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=222.65 Aligned_cols=119 Identities=33% Similarity=0.564 Sum_probs=106.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++++++..+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~ 176 (371)
T cd05622 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176 (371)
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC
Confidence 3468999999999999999999999999999999988654 689999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGG 586 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~ 586 (708)
.++.+||+|||+++...... .....+||+.|||||++.+.
T Consensus 177 ~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 177 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc
Confidence 99999999999998764332 23467899999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=223.04 Aligned_cols=151 Identities=23% Similarity=0.360 Sum_probs=126.0
Q ss_pred CCCCCCCCcCCCccccccccc----cccccCcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCH
Q psy2648 436 GGGGGGGAAQSPSHRGVHRSI----SASNAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE 511 (708)
Q Consensus 436 ~ggg~~g~v~s~~hr~~~R~i----~~~~~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e 511 (708)
.|.|+.|+|+...-++..-.+ ...+..-+-..-..|+|||++.+|+.....++||||||..|-|...|+....+..
T Consensus 132 lGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp 211 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITP 211 (904)
T ss_pred hccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCH
Confidence 456667777766544432221 1111112222346899999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCC
Q psy2648 512 KEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586 (708)
Q Consensus 512 ~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~ 586 (708)
.....|..+|+.|++|||.+.|||||||..||||..+..|||+|||-++....-....+|+||..|||||+|...
T Consensus 212 ~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrne 286 (904)
T KOG4721|consen 212 SLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNE 286 (904)
T ss_pred HHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcC
Confidence 999999999999999999999999999999999999999999999999988766667789999999999998654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=217.70 Aligned_cols=119 Identities=39% Similarity=0.605 Sum_probs=107.2
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.+++|+++++++++.+.+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~ 138 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG 138 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC
Confidence 56788999999999999999999999999999999888999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccCC-CCcccccccCCcccccccccCCCC
Q psy2648 550 NIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 550 ~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.+||+|||+++.... .......+||+.|||||++.+...
T Consensus 139 ~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 178 (323)
T cd05615 139 HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178 (323)
T ss_pred CEEEeccccccccCCCCccccCccCCccccCHHHHcCCCC
Confidence 999999999876432 223456789999999999976553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=216.27 Aligned_cols=119 Identities=39% Similarity=0.597 Sum_probs=106.4
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.+++|++++++|.+.+.+|||||||++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 138 (324)
T cd05587 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG 138 (324)
T ss_pred CCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC
Confidence 44569999999999999999999999999999998888999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccC-CCCcccccccCCcccccccccCCCC
Q psy2648 550 NIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 550 ~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.+||+|||+++... ........+||+.|+|||++.+...
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 178 (324)
T cd05587 139 HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178 (324)
T ss_pred CEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCC
Confidence 99999999987532 2333456789999999999987653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=216.41 Aligned_cols=124 Identities=36% Similarity=0.566 Sum_probs=110.1
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|++|+++++++++.+.+|||||||++|+|..++.....+++.++..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~ 132 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC
Confidence 58999999999999999999999999999999999888889999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCC
Q psy2648 549 MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 549 ~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
+.+||+|||+++... ........+||+.|||||++.+......+
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (316)
T cd05619 133 GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177 (316)
T ss_pred CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchh
Confidence 999999999987532 22334567899999999999866544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-23 Score=194.86 Aligned_cols=125 Identities=25% Similarity=0.486 Sum_probs=110.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|.|||+|+++.+.+..+-||+|||.. +|..+... +|.++.+.++.++.|++.||.+||+++++||||||+|+|++
T Consensus 57 elkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin 135 (292)
T KOG0662|consen 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN 135 (292)
T ss_pred HhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec
Confidence 45789999999999999999999999975 77776653 56799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSG 593 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~ 593 (708)
.+|.+|++|||+|+.+.-. ......+.|.+|.+|.++.|.+-|++|.
T Consensus 136 ~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsi 183 (292)
T KOG0662|consen 136 RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183 (292)
T ss_pred cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccch
Confidence 9999999999999976433 2345567899999999999999888883
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=215.43 Aligned_cols=177 Identities=28% Similarity=0.377 Sum_probs=137.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++|+++..+||||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 55 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 134 (323)
T cd05584 55 EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134 (323)
T ss_pred HhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 45689999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCC-----CCCCccc-------c
Q psy2648 547 SEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSI-----SPAPTNF-------K 613 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~-----~~~~~~~-------~ 613 (708)
.++.+||+|||+++... ........+||+.|+|||++.+......++-++.+.+..... ....... .
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 135 AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999999987543 233344568999999999998765444444444333322221 1111100 0
Q ss_pred c---cccccccchhhhHHHHhhCCCCCCCCCCC
Q psy2648 614 R---QNTIDSASIKENTARLNAGRPAKNTASIA 643 (708)
Q Consensus 614 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (708)
. ....-+..+.+++.+++.-.|.+|.++..
T Consensus 215 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 247 (323)
T cd05584 215 GKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGP 247 (323)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCC
Confidence 0 01122556789999999999999975443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=226.91 Aligned_cols=124 Identities=35% Similarity=0.592 Sum_probs=108.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
....|+|||+++++|++++.+|||||||++|+|.+++.. ...+++.++..++.||+.||.|||+++||||||||+|
T Consensus 120 ~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N 199 (478)
T PTZ00267 120 AACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199 (478)
T ss_pred HhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHh
Confidence 457899999999999999999999999999999987753 3468999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCcc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVT 590 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~ 590 (708)
||++.++.+||+|||+++...... .....+||+.|||||++.+.....
T Consensus 200 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 250 (478)
T PTZ00267 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250 (478)
T ss_pred EEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCc
Confidence 999999999999999998764332 234578999999999997665433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=197.84 Aligned_cols=135 Identities=21% Similarity=0.344 Sum_probs=109.5
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCC---EEE-
Q psy2648 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-----DHPNIVKLFQVIETEK---TLY- 121 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~y- 121 (708)
.+.||+|+||.||. |..++.. +||++..... ...+.+.+|+++++.+ +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46899999999995 7777776 6999876432 2345688999999999 6799999999999974 434
Q ss_pred EEEec--cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCCEEEcCC----CcEEEEeccCcc
Q psy2648 122 LVMEY--ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV-QYCHQKKIIHRDLKAENLLLDSE----MNIKIADFGFSN 193 (708)
Q Consensus 122 lVmEy--~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL-~yLH~~gIvHRDLKPeNILld~~----~~iKL~DFGls~ 193 (708)
+|||| +.+|+|.+++.. +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. ..++|+||+.++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 89999 568999999965 456666 35688888888 99999999999999999999743 379999955443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-23 Score=215.82 Aligned_cols=142 Identities=35% Similarity=0.601 Sum_probs=121.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++.+...+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 56 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~ 135 (291)
T cd05612 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD 135 (291)
T ss_pred HhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 44579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.++.+||+|||+++..... ....+||+.|+|||++.+...... .|-|+++++
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~--------------------------~DiwSlG~i 187 (291)
T cd05612 136 KEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKA--------------------------VDWWALGIL 187 (291)
T ss_pred CCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCch--------------------------hhHHHHHHH
Confidence 9999999999999865432 235689999999999876543221 455666667
Q ss_pred HHHHhhCCCC
Q psy2648 627 TARLNAGRPA 636 (708)
Q Consensus 627 ~~~~~~~~~~ 636 (708)
+-++..|.+.
T Consensus 188 l~~l~~g~~p 197 (291)
T cd05612 188 IYEMLVGYPP 197 (291)
T ss_pred HHHHHhCCCC
Confidence 6666666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 708 | ||||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-138 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-58 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-137 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-57 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-137 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-58 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-136 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-58 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-136 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-58 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-136 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-57 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-135 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-57 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-134 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-57 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-131 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-55 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-129 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-58 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-72 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-72 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-33 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-71 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-33 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-71 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-33 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-68 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-35 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-67 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-34 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-67 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-66 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-33 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-61 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-49 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-49 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-48 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-48 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-48 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-47 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-47 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-47 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-47 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-46 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-46 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-46 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-46 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-46 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-45 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-45 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-45 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-45 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-44 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-44 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-44 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-44 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-44 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-44 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-44 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-44 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-43 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-43 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-43 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-43 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-43 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-43 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-43 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-43 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-43 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-43 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-43 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-43 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-43 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-43 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-43 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-43 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-43 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-43 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-43 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-43 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-43 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-43 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-43 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-43 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-43 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-43 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-43 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-43 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-42 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-42 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-42 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-42 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-42 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-21 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-42 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-42 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-42 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-42 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-42 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-42 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-42 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-18 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-42 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-42 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-42 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-41 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-41 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-41 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-18 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-41 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-41 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-18 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-41 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-41 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-41 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-41 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-41 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-41 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-41 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-20 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-41 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-41 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-41 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-41 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-41 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-41 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-41 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-41 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-41 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-41 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-41 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-41 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-41 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-41 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-41 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-41 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-41 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-41 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-41 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-41 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-41 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-41 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-40 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-40 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-40 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-40 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-40 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-40 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-40 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-40 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-40 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-40 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-40 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-40 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-40 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-40 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-40 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-40 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-40 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-40 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-40 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-40 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-40 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-40 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-40 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-40 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-20 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-40 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-40 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-19 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-40 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-39 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-19 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-39 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-19 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-39 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-39 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-39 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-39 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-39 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-39 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-39 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-39 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-39 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-39 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-39 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-39 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-39 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-39 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-39 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-39 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-39 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-39 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-39 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-39 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-39 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-39 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-39 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-39 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-38 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-38 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-38 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-38 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-38 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-38 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-38 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-38 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-38 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-38 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-38 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-38 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-38 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-38 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-38 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-38 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-38 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-38 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-38 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-38 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-38 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-38 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-38 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-38 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-37 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-37 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-37 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-37 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-37 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-37 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-37 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-37 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-37 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-37 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-37 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-37 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-37 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-37 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-37 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-37 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-37 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-37 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-37 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-37 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-36 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-36 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-36 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-36 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-36 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-36 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-36 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-35 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-35 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-35 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-35 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-35 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-35 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-35 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-35 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-35 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-35 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-35 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-35 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-35 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-35 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-35 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-35 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-35 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-35 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-35 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-35 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-35 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-34 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-34 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-34 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-34 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-34 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-34 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-34 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-34 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-34 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-34 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-34 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-33 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-33 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-33 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-33 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-33 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-33 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-32 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-32 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-32 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-32 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-32 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-31 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-31 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-31 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-31 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-31 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-30 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-30 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-30 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-30 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-30 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-30 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-30 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-30 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-30 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-30 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-29 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-29 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-29 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-28 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-28 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-28 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-28 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-28 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-28 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-28 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-28 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-28 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-28 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-28 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-28 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-28 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-28 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-28 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-28 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-28 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-28 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-28 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-28 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-28 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-28 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-28 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-28 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-28 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-28 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-28 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-28 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-28 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-28 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-28 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-28 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-28 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-27 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-27 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-27 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-27 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-27 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-27 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-27 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-27 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-27 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-27 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-27 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-27 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-27 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-27 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-27 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-27 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-27 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-27 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-27 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-27 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-27 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-27 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-27 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-27 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-27 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-27 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-27 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-27 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-27 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-27 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-27 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-27 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-27 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-27 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-27 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-27 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-27 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-27 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-27 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-27 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-27 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-26 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-26 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-26 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-26 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-25 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-25 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-25 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-25 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-25 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-25 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-25 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-25 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-25 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-25 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-25 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-25 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-24 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-24 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-24 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-24 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-24 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-24 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-24 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-24 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-24 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-24 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-23 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-23 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-23 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-23 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-22 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-22 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-22 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-22 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-22 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-22 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-22 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-22 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-22 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-22 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-21 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-21 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-21 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-21 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-21 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-21 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-21 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-20 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-20 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-20 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-20 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-20 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-20 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-20 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-20 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-20 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-20 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-20 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-20 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-20 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-20 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-20 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-20 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-20 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-20 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-20 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-20 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-20 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-20 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-19 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-19 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-19 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-19 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-19 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-19 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-19 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-19 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-19 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-19 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-19 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-19 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-19 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-19 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-19 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-19 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-19 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-18 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-18 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-18 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-18 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-17 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-17 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-17 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-15 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-15 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-15 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-15 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-15 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-15 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-15 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-15 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-15 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-14 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-14 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-14 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-14 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-14 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-14 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-14 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-14 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-14 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-14 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-14 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-14 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-14 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-14 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-13 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-13 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 |
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 708 | |||
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 0.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-76 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-169 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-72 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-168 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-70 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-167 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-69 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-166 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 8e-69 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-161 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-69 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-157 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-68 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-156 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-66 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-156 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-68 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-152 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-64 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-152 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-64 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-151 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-61 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-143 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-59 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-142 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 7e-60 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-141 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-59 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-136 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-56 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-133 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-56 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-130 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-56 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-128 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-54 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-124 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-55 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-118 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-56 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-118 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-56 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-113 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-50 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-112 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-48 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-112 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 7e-50 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-111 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-47 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-110 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-48 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-109 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-48 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-108 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-51 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-108 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-47 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-108 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-46 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-107 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-44 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-107 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-48 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-106 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-50 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-104 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-42 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-104 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-41 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-102 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-41 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-102 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-39 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-101 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 5e-44 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-101 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-42 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-101 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-42 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-101 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-42 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-100 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-39 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-100 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-41 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-99 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-36 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-44 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-43 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-43 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-43 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-43 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-43 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-42 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 9e-43 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-41 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-39 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-91 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-41 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-39 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-91 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-33 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 9e-89 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-40 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-88 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-38 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-87 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-37 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-83 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-37 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 8e-83 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-36 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-82 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-81 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 9e-36 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-80 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-78 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-31 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-78 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-29 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-78 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-32 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 5e-77 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-35 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-77 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-33 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 6e-76 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-33 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-75 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-30 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-73 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-33 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-73 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-33 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 9e-73 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 7e-33 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-72 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 9e-33 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-71 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-33 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-71 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-32 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-70 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-32 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-70 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 7e-28 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-70 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-30 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-69 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-30 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-69 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-33 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-69 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-32 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-68 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-33 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-68 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-32 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-68 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 8e-31 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-68 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-32 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-67 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-30 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-67 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 8e-31 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-66 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-30 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-63 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-23 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 7e-63 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-24 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-62 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-30 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-61 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-24 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-59 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-25 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-58 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 8e-24 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-57 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-23 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-56 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-22 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-56 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-24 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-56 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-23 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-55 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-23 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-55 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-25 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-55 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-23 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-55 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-23 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-55 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-23 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 7e-55 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-21 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-54 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-24 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-53 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-21 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-53 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-23 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-53 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-23 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-52 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-23 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-52 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-23 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-51 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-22 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-50 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-20 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-50 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-20 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-50 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 7e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-50 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-50 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-22 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-50 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-19 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-50 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-19 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-49 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-49 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-20 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-49 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-49 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-19 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 9e-49 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-27 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-14 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-48 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-48 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-19 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-48 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-20 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 7e-48 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-20 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-47 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-47 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-17 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-46 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-46 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 9e-18 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-45 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-18 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-44 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-16 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-44 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-44 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-18 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-44 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 8e-44 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-43 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-13 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-43 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-14 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-43 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-13 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-42 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-14 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-42 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-20 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-42 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-15 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-42 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-14 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-42 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-15 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-42 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-20 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 7e-42 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-15 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-42 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-15 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-42 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-15 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 8e-42 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-42 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-42 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-15 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-41 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-15 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-41 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-14 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-41 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 7e-15 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-41 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-15 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-41 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-15 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-41 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-15 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-41 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-40 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-17 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-40 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-14 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-40 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-15 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-40 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-40 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-40 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-40 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 9e-10 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-40 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-14 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-40 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-14 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-40 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-40 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-09 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 9e-40 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-39 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-11 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-39 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-19 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-39 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-14 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-39 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-15 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-39 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-14 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-38 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-38 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-09 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-38 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-12 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-38 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-38 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-09 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-38 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-14 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-38 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-14 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-38 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-10 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 7e-38 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-18 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-37 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 9e-14 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-37 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-12 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-37 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-11 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-37 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-10 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-36 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 9e-09 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-36 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-36 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-12 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-13 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-36 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-12 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-36 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-12 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-35 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-13 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-35 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-13 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-35 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-13 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-34 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-34 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-34 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-09 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-34 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-12 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-34 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-33 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-32 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-12 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-32 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-32 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-12 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-31 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 6e-12 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-31 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-12 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-31 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-12 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-31 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 8e-31 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-07 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-30 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-11 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-28 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-27 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-25 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 9e-06 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-24 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-11 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-24 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-24 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 9e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-24 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-24 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 9e-24 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 7e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-23 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-05 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-22 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-09 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-22 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-22 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-21 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-19 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-08 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-18 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 9e-17 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-07 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 3e-05 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 1e-04 |
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 517 bits (1334), Expect = 0.0
Identities = 238/355 (67%), Positives = 268/355 (75%), Gaps = 45/355 (12%)
Query: 35 SSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFR 94
+ ++PHIG Y+LLKTIGKGNFAKVKLA+H+ TG+EVAIKIIDKTQLNP SLQKLFR
Sbjct: 4 IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR 63
Query: 95 EVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQI 154
EVRIMK+L+HPNIVKLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEAR+KFRQI
Sbjct: 64 EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 214
VSAVQYCHQK+I+HRDLKAENLLLD++MNIKIADFGFSNEFT G KLD FCG+PPYAAPE
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCEN 274
LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG L+ELRERVLRGKYRIPFYMSTDCEN
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 243
Query: 275 LLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNH----THNSSISPAPTNFKRQN 330
LLK+FLVLNP KR +LE ++ + P +
Sbjct: 244 LLKRFLVLNPIKRGTLE---QI--------------MKDRWINAGHEEDELKPFVEPELD 286
Query: 331 TIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDD 385
D I +VG+GYS+ EI+ESLS+ KYD+
Sbjct: 287 ISDQKRID------------------------IMVGMGYSQEEIQESLSKMKYDE 317
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 3e-76
Identities = 98/111 (88%), Positives = 107/111 (96%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KLF+VIETEKTLYL+MEYASGGEVFDYLV HGRMKEKEAR+KFRQIVSAVQYCHQK+I+
Sbjct: 77 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLKAENLLLD++MNIKIADFGFSNEFT G KLD FCG+PPYAAPELFQG
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG 187
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 485 bits (1252), Expect = e-169
Identities = 122/255 (47%), Positives = 173/255 (67%), Gaps = 1/255 (0%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL-QKLFREV 96
+ IG Y L T+G G F KVK+ +H TG +VA+KI+++ ++ + K+ RE+
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 97 RIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVS 156
+ +K+ HP+I+KL+QVI T ++VMEY SGGE+FDY+ HGR++E EAR F+QI+S
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 216
AV YCH+ ++HRDLK EN+LLD+ MN KIADFG SN + G L T CGSP YAAPE+
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182
Query: 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276
G+ Y GPEVD+WS GVILY L+ G+LPFD + L +++ G + IP Y++ LL
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242
Query: 277 KKFLVLNPAKRASLE 291
L ++P KRA+++
Sbjct: 243 MHMLQVDPLKRATIK 257
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-72
Identities = 66/111 (59%), Positives = 83/111 (74%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL+QVI T ++VMEY SGGE+FDY+ HGR++E EAR F+QI+SAV YCH+ ++
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK EN+LLD+ MN KIADFG SN + G L T CGSP YAAPE+ G
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 491 bits (1265), Expect = e-168
Identities = 147/513 (28%), Positives = 227/513 (44%), Gaps = 85/513 (16%)
Query: 35 SSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLF 93
++ IG Y L T+G G F KVK+ KH TG +VA+KI+++ ++ + + K+
Sbjct: 5 EKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR 64
Query: 94 REVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQ 153
RE++ +K+ HP+I+KL+QVI T +++VMEY SGGE+FDY+ +GR+ EKE+R F+Q
Sbjct: 65 REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ 124
Query: 154 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAP 213
I+S V YCH+ ++HRDLK EN+LLD+ MN KIADFG SN + G L T CGSP YAAP
Sbjct: 125 ILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCE 273
E+ G+ Y GPEVD+WS GVILY L+ G+LPFD + L +++ G + P Y++
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 274 NLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHT-----HNSSISPAPTNFKR 328
+LLK L ++P KRA+++ ++ H + P ++
Sbjct: 245 SLLKHMLQVDPMKRATIK---DI--------------REHEWFKQDLPKYLFPEDPSYSS 287
Query: 329 QNTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYSRSEIEESLSQAKYDDPES 388
ID ++KE S E+ L + DP +
Sbjct: 288 TM-IDDEALKE-----------------------VCEKFECSEEEVLSCLYNRNHQDPLA 323
Query: 389 D----------GSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGG 438
L P S + A
Sbjct: 324 VAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDEL 383
Query: 439 GGGGAAQSPSHRGVHRSISASNAKPS---------------------------RRASSGG 471
+ + S ++P+ RR +
Sbjct: 384 NPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT 443
Query: 472 ETLLKL-FQVIETEKTLYLVMEYASGGEVFDYL 503
T K+ Q+ + + YL+ + E+ + L
Sbjct: 444 STFSKMSLQLYQVDSRTYLLDFRSIDDEILEVL 476
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 5e-70
Identities = 64/111 (57%), Positives = 83/111 (74%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL+QVI T +++VMEY SGGE+FDY+ +GR+ EKE+R F+QI+S V YCH+ ++
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK EN+LLD+ MN KIADFG SN + G L T CGSP YAAPE+ G
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 189
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 482 bits (1244), Expect = e-167
Identities = 119/254 (46%), Positives = 173/254 (68%), Gaps = 2/254 (0%)
Query: 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ-KLFREVR 97
+ HIG Y + +T+G+G+F KVKLA H T ++VA+K I + L + ++ RE+
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 98 IMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSA 157
+K+L HP+I+KL+ VI T + +V+EYA GGE+FDY+V RM E E R F+QI+ A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
++YCH+ KI+HRDLK ENLLLD +N+KIADFG SN T GN L T CGSP YAAPE+
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
GK Y GPEVDVWS G++LY ++ G LPFD + L ++V Y +P ++S ++L++
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240
Query: 278 KFLVLNPAKRASLE 291
+ +V +P +R +++
Sbjct: 241 RMIVADPMQRITIQ 254
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-69
Identities = 65/111 (58%), Positives = 81/111 (72%), Gaps = 1/111 (0%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL+ VI T + +V+EYA GGE+FDY+V RM E E R F+QI+ A++YCH+ KI+
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK ENLLLD +N+KIADFG SN T GN L T CGSP YAAPE+ G
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING 181
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 467 bits (1203), Expect = e-161
Identities = 90/269 (33%), Positives = 134/269 (49%), Gaps = 13/269 (4%)
Query: 30 SSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL----- 84
+ + + KY + +G G F V A KEV +K I K ++
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 85 -NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME-YASGGEVFDYLVLHGRM 142
L K+ E+ I+ ++H NI+K+ + E + LVME + SG ++F ++ H R+
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127
Query: 143 KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202
E A FRQ+VSAV Y K IIHRD+K EN+++ + IK+ DFG + G
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187
Query: 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY 262
TFCG+ Y APE+ G Y GPE+++WSLGV LYTLV PF E +
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAI 241
Query: 263 RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
P+ +S + +L+ L P +R +LE
Sbjct: 242 HPPYLVSKELMSLVSGLLQPVPERRTTLE 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-69
Identities = 45/112 (40%), Positives = 65/112 (58%), Gaps = 1/112 (0%)
Query: 475 LKLFQVIETEKTLYLVME-YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+K+ + E + LVME + SG ++F ++ H R+ E A FRQ+VSAV Y K I
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
IHRD+K EN+++ + IK+ DFG + G TFCG+ Y APE+ G
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 457 bits (1177), Expect = e-157
Identities = 91/257 (35%), Positives = 147/257 (57%), Gaps = 7/257 (2%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
P + + L++T+G+G + +V+LA + T + VA+KI+D + + + +E+ I K
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINK 60
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
ML+H N+VK + YL +EY SGGE+FD + M E +A+ F Q+++ V Y
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQ 217
H I HRD+K ENLLLD N+KI+DFG + F N+ L+ CG+ PY APEL +
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFD--GSTLRELRERVLRGKYRIPF-YMSTDCEN 274
+++ VDVWS G++L +++G LP+D + +E + + Y P+ + +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 275 LLKKFLVLNPAKRASLE 291
LL K LV NP+ R ++
Sbjct: 241 LLHKILVENPSARITIP 257
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-68
Identities = 49/122 (40%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+K + YL +EY SGGE+FD + M E +A+ F Q+++ V Y H I
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQG----GA 587
HRD+K ENLLLD N+KI+DFG + F N+ L+ CG+ PY APEL +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 588 PV 589
PV
Sbjct: 188 PV 189
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-156
Identities = 98/270 (36%), Positives = 146/270 (54%), Gaps = 11/270 (4%)
Query: 30 SSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL 89
+ +Y +K IG GNF +L + T + VA+K I++
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID--- 60
Query: 90 QKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA 149
+ + RE+ + L HPNIV+ +VI T L ++MEYASGGE+++ + GR E EAR
Sbjct: 61 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF 120
Query: 150 KFRQIVSAVQYCHQKKIIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGS 207
F+Q++S V YCH +I HRDLK EN LLD +KI DFG+S ++ + G+
Sbjct: 121 FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 180
Query: 208 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL----RELRERVLRGKYR 263
P Y APE+ ++YDG DVWS GV LY ++ G+ PF+ R+ +R+L KY
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240
Query: 264 IP--FYMSTDCENLLKKFLVLNPAKRASLE 291
IP +S +C +L+ + V +PA R S+
Sbjct: 241 IPDDIRISPECCHLISRIFVADPATRISIP 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-66
Identities = 48/113 (42%), Positives = 68/113 (60%), Gaps = 2/113 (1%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
++ +VI T L ++MEYASGGE+++ + GR E EAR F+Q++S V YCH +I
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 535 HRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK EN LLD +KI DFG+S ++ + G+P Y APE+
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 451 bits (1163), Expect = e-156
Identities = 91/257 (35%), Positives = 147/257 (57%), Gaps = 7/257 (2%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
P + + L++T+G+G + +V+LA + T + VA+KI+D + + + +E+ I K
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINK 60
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
ML+H N+VK + YL +EY SGGE+FD + M E +A+ F Q+++ V Y
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQ 217
H I HRD+K ENLLLD N+KI+DFG + F N+ L+ CG+ PY APEL +
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFD--GSTLRELRERVLRGKYRIPF-YMSTDCEN 274
+++ VDVWS G++L +++G LP+D + +E + + Y P+ + +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 275 LLKKFLVLNPAKRASLE 291
LL K LV NP+ R ++
Sbjct: 241 LLHKILVENPSARITIP 257
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-68
Identities = 49/122 (40%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+K + YL +EY SGGE+FD + M E +A+ F Q+++ V Y H I
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQG----GA 587
HRD+K ENLLLD N+KI+DFG + F N+ L+ CG+ PY APEL +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 588 PV 589
PV
Sbjct: 188 PV 189
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 444 bits (1143), Expect = e-152
Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 17/272 (6%)
Query: 30 SSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS- 88
+ + E +Y+L +GKG F V + +VAIK+I + ++ S
Sbjct: 15 GTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP 74
Query: 89 ---LQKLFREVRIMKMLD----HPNIVKLFQVIETEKTLYLVMEYA-SGGEVFDYLVLHG 140
EV ++ + HP +++L ET++ LV+E ++FDY+ G
Sbjct: 75 LSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG 134
Query: 141 RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGN 199
+ E +R F Q+V+A+Q+CH + ++HRD+K EN+L+D K+ DFG
Sbjct: 135 PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDE 193
Query: 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR 259
F G+ Y+ PE +Y VWSLG++LY +V G +PF+ + +L
Sbjct: 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILE 247
Query: 260 GKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
+ P ++S DC L+++ L P+ R SLE
Sbjct: 248 AELHFPAHVSPDCCALIRRCLAPKPSSRPSLE 279
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-64
Identities = 38/122 (31%), Positives = 61/122 (50%), Gaps = 7/122 (5%)
Query: 475 LKLFQVIETEKTLYLVMEYA-SGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++L ET++ LV+E ++FDY+ G + E +R F Q+V+A+Q+CH + +
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGV 160
Query: 534 IHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG----GAP 588
+HRD+K EN+L+D K+ DFG F G+ Y+ PE P
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDEPYTDFDGTRVYSPPEWISRHQYHALP 219
Query: 589 VT 590
T
Sbjct: 220 AT 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 443 bits (1142), Expect = e-152
Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 15/287 (5%)
Query: 13 SETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK 72
+G + + + + + EP +Y++ +G G F V V
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 73 EVAIKIIDKTQLN----PGSLQKLFREVRIMKMLDH--PNIVKLFQVIETEKTLYLVMEY 126
VAIK ++K +++ + ++ EV ++K + +++L E + L++E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 127 ASG-GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNI 184
++FD++ G ++E+ AR+ F Q++ AV++CH ++HRD+K EN+L+D +
Sbjct: 130 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 185 KIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 244
K+ DFG F G+ Y+ PE + +Y G VWSLG++LY +V G +P
Sbjct: 190 KLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
Query: 245 FDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
F+ E ++RG+ +S++C++L++ L L P+ R + E
Sbjct: 249 FEH------DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFE 289
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-64
Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 7/122 (5%)
Query: 475 LKLFQVIETEKTLYLVMEYASG-GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++L E + L++E ++FD++ G ++E+ AR+ F Q++ AV++CH +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 170
Query: 534 IHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG----GAP 588
+HRD+K EN+L+D +K+ DFG F G+ Y+ PE + G
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 229
Query: 589 VT 590
Sbjct: 230 AA 231
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 441 bits (1136), Expect = e-151
Identities = 84/257 (32%), Positives = 137/257 (53%), Gaps = 11/257 (4%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKML 102
IGKY + +G+G++ KVK T A+KI+ K +L P + +E+++++ L
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 103 DHPNIVKLFQVI--ETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAV 158
H N+++L V+ E ++ +Y+VMEY G E+ D + R +A F Q++ +
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGL 122
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN---EFTPGNKLDTFCGSPPYAAPEL 215
+Y H + I+H+D+K NLLL + +KI+ G + F + T GSP + PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 216 FQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCEN 274
G + G +VD+WS GV LY + +G PF+G + +L E + +G Y IP +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 275 LLKKFLVLNPAKRASLE 291
LLK L PAKR S+
Sbjct: 243 LLKGMLEYEPAKRFSIR 259
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-61
Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 8/118 (6%)
Query: 475 LKLFQVI--ETEKTLYLVMEYASGG--EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 530
++L V+ E ++ +Y+VMEY G E+ D + R +A F Q++ ++Y H
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS 127
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSN---EFTPGNKLDTFCGSPPYAAPELFQG 585
+ I+H+D+K NLLL + +KI+ G + F + T GSP + PE+ G
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 420 bits (1083), Expect = e-143
Identities = 85/270 (31%), Positives = 136/270 (50%), Gaps = 3/270 (1%)
Query: 24 SSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ 83
+ +E D +Y + +GKG FAK T + A KI+ K+
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 84 L-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRM 142
L P +K+ E+ I + L H ++V E +++V+E + + +
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 138
Query: 143 KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKL 201
E EAR RQIV QY H+ ++IHRDLK NL L+ ++ +KI DFG + + G +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198
Query: 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK 261
CG+P Y APE+ K + EVDVWS+G I+YTL+ G PF+ S L+E R+ + +
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257
Query: 262 YRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
Y IP +++ +L++K L +P R ++
Sbjct: 258 YSIPKHINPVAASLIQKMLQTDPTARPTIN 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-59
Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 1/112 (0%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+ E +++V+E + + + E EAR RQIV QY H+ ++I
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
HRDLK NL L+ ++ +KI DFG + + G + CG+P Y APE+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 215
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 418 bits (1076), Expect = e-142
Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 3/261 (1%)
Query: 33 RESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQK 91
+E D +Y + +GKG FAK T + A KI+ K+ L P +K
Sbjct: 2 KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 61
Query: 92 LFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF 151
+ E+ I + L H ++V E +++V+E + + + E EAR
Sbjct: 62 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 121
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPY 210
RQIV QY H+ ++IHRDLK NL L+ ++ +KI DFG + + G + CG+P Y
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMST 270
APE+ K + EVDVWS+G I+YTL+ G PF+ S L+E R+ + +Y IP +++
Sbjct: 182 IAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
Query: 271 DCENLLKKFLVLNPAKRASLE 291
+L++K L +P R ++
Sbjct: 241 VAASLIQKMLQTDPTARPTIN 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 7e-60
Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 1/112 (0%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+ E +++V+E + + + E EAR RQIV QY H+ ++I
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
HRDLK NL L+ ++ +KI DFG + + G + CG+P Y APE+
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 413 bits (1064), Expect = e-141
Identities = 91/288 (31%), Positives = 144/288 (50%), Gaps = 32/288 (11%)
Query: 35 SSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL---------- 84
SS D + +Y L IGKG++ VKLA + A+K++ K +L
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 85 --------------NPGSLQKLFREVRIMKMLDHPNIVKLFQVIE--TEKTLYLVMEYAS 128
G ++++++E+ I+K LDHPN+VKL +V++ E LY+V E +
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 129 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIAD 188
G V + + E +AR F+ ++ ++Y H +KIIHRD+K NLL+ + +IKIAD
Sbjct: 122 QGPVMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 189 FGFSNEFTPGNK-LDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPF 245
FG SNEF + L G+P + APE K + G +DVW++GV LY V G PF
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 246 DGSTLRELRERVLRGKYRIPFY--MSTDCENLLKKFLVLNPAKRASLE 291
+ L ++ P ++ D ++L+ + L NP R +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP 288
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 3e-59
Identities = 43/116 (37%), Positives = 66/116 (56%), Gaps = 4/116 (3%)
Query: 474 LLKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
++KL +V++ E LY+V E + G V + + E +AR F+ ++ ++Y H +
Sbjct: 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQ 156
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQGG 586
KIIHRD+K NLL+ + +IKIADFG SNEF + L G+P + APE
Sbjct: 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 399 bits (1029), Expect = e-136
Identities = 101/251 (40%), Positives = 144/251 (57%), Gaps = 4/251 (1%)
Query: 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML 102
I +K+ +GKG+FA V A+ + TG EVAIK+IDK + G +Q++ EV+I L
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYC 161
HP+I++L+ E +YLV+E GE+ YL E EAR QI++ + Y
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKK 220
H I+HRDL NLLL MNIKIADFG + + P K T CG+P Y +PE+
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280
+ G E DVWSLG + YTL+ G PFD T++ +V+ Y +P ++S + ++L+ + L
Sbjct: 189 H-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 281 VLNPAKRASLE 291
NPA R SL
Sbjct: 248 RRNPADRLSLS 258
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-56
Identities = 46/113 (40%), Positives = 60/113 (53%), Gaps = 2/113 (1%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+L+ E +YLV+E GE+ YL E EAR QI++ + Y H I
Sbjct: 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
+HRDL NLLL MNIKIADFG + + P K T CG+P Y +PE+
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-133
Identities = 85/257 (33%), Positives = 145/257 (56%), Gaps = 3/257 (1%)
Query: 36 SRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-LFR 94
+ + + I + + + +GKG F V LA+ +A+K++ K+QL ++ L R
Sbjct: 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 95 EVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQI 154
E+ I L HPNI++++ K +YL++E+A GE++ L HGR E+ + ++
Sbjct: 64 EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 214
A+ YCH++K+IHRD+K ENLL+ + +KIADFG+S P + T CG+ Y PE
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRTMCGTLDYLPPE 182
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCEN 274
+ +GK +D +VD+W GV+ Y + G PFD + E R++ + P ++S ++
Sbjct: 183 MIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241
Query: 275 LLKKFLVLNPAKRASLE 291
L+ K L +P +R L+
Sbjct: 242 LISKLLRYHPPQRLPLK 258
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 42/112 (37%), Positives = 69/112 (61%), Gaps = 1/112 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+L+++ K +YL++E+A GE++ L HGR E+ + ++ A+ YCH++K+
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
IHRD+K ENLL+ + +KIADFG+S P + T CG+ Y PE+ +G
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRTMCGTLDYLPPEMIEG 186
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-130
Identities = 67/321 (20%), Positives = 128/321 (39%), Gaps = 48/321 (14%)
Query: 16 GRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVA 75
G S + + + + +I Y++++T+ +G F K+ L + K A
Sbjct: 1 GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYA 58
Query: 76 IKIIDKTQL---------------NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120
+K +K+ L E++I+ + + + +I +
Sbjct: 59 LKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEV 118
Query: 121 YLVMEYASGGEVFDYLVLHGRMK--------EKEARAKFRQIVSAVQYCH-QKKIIHRDL 171
Y++ EY + + + + + + ++++ Y H +K I HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 172 KAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK-YDGPEVDVWS 230
K N+L+D +K++DFG S K+ G+ + PE F + Y+G +VD+WS
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 231 LGVILYTLVSGSLPFDG-STLRELRERVLRGKYRIPF-------------------YMST 270
LG+ LY + +PF +L EL + P ++S
Sbjct: 238 LGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN 297
Query: 271 DCENLLKKFLVLNPAKRASLE 291
+ + LK FL NPA+R + E
Sbjct: 298 EDIDFLKLFLRKNPAERITSE 318
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 26/121 (21%), Positives = 50/121 (41%), Gaps = 10/121 (8%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK--------EKEARAKFRQIVSAV 525
L +I +Y++ EY + + + + + + ++++
Sbjct: 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSF 164
Query: 526 QYCH-QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
Y H +K I HRD+K N+L+D +K++DFG S K+ G+ + PE F
Sbjct: 165 SYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFS 223
Query: 585 G 585
Sbjct: 224 N 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-128
Identities = 85/254 (33%), Positives = 146/254 (57%), Gaps = 3/254 (1%)
Query: 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL-QKLFREVR 97
++ + + +++ + +GKG F V LA+ + +A+K++ K QL + +L REV
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 98 IMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSA 157
I L HPNI++L+ +YL++EYA G V+ L + E+ ++ +A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
+ YCH K++IHRD+K ENLLL S +KIADFG+S P ++ CG+ Y PE+ +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIE 180
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
G+ +D +VD+WSLGV+ Y + G PF+ +T +E +R+ R ++ P +++ +L+
Sbjct: 181 GRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239
Query: 278 KFLVLNPAKRASLE 291
+ L NP++R L
Sbjct: 240 RLLKHNPSQRPMLR 253
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-54
Identities = 41/112 (36%), Positives = 64/112 (57%), Gaps = 1/112 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+L+L+ +YL++EYA G V+ L + E+ ++ +A+ YCH K++
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
IHRD+K ENLLL S +KIADFG+S P ++ CG+ Y PE+ +G
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEG 181
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 383 bits (984), Expect = e-124
Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 38/291 (13%)
Query: 37 RRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREV 96
G +++ + +G G F V H TG++VAIK + +L+P + ++ E+
Sbjct: 5 SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEI 63
Query: 97 RIMKMLDHPNIVKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGR---MKEKEA 147
+IMK L+HPN+V +V + + L L MEY GG++ YL +KE
Sbjct: 64 QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 148 RAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLDTF 204
R I SA++Y H+ +IIHRDLK EN++L + KI D G++ E G F
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI 264
G+ Y APEL + KKY VD WS G + + ++G PF + +R K
Sbjct: 184 VGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
Query: 265 PFYMSTDC------------------------ENLLKKFLVLNPAKRASLE 291
+ D E L+ L+ + +R +
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 2e-55
Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 12/122 (9%)
Query: 476 KLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQ 526
+V + + L L MEY GG++ YL +KE R I SA++
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 527 YCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 583
Y H+ +IIHRDLK EN++L + KI D G++ E G F G+ Y APEL
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 584 QG 585
+
Sbjct: 196 EQ 197
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-118
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 46/289 (15%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
+ L +G+G A V +H TG AIK+ + + RE ++K L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNI 69
Query: 108 VKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCH 162
VKLF + E T + L+ME+ G ++ L + E E R +V + +
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 163 QKKIIHRDLKAENLLL----DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
+ I+HR++K N++ D + K+ DFG + E + + G+ Y P++++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 219 K-------KYDGPEVDVWSLGVILYTLVSGSLPFD----GSTLRELRERVLRGKY----- 262
K G VD+WS+GV Y +GSLPF +E+ +++ GK
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 263 --------------------RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
+ + +L L + K +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 28/127 (22%), Positives = 54/127 (42%), Gaps = 9/127 (7%)
Query: 476 KLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQ 530
KLF + E T + L+ME+ G ++ L + E E R +V + + +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 531 KKIIHRDLKAENLLL----DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
I+HR++K N++ D + K+ DFG + E + + G+ Y P++++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 587 APVTSSG 593
Sbjct: 191 VLRKDHQ 197
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 358 bits (919), Expect = e-118
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 46/289 (15%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
+ L +G+G A V +H TG AIK+ + + RE ++K L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNI 69
Query: 108 VKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCH 162
VKLF + E T + L+ME+ G ++ L + E E R +V + +
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 163 QKKIIHRDLKAENLLL----DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
+ I+HR++K N++ D + K+ DFG + E + + G+ Y P++++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 219 K-------KYDGPEVDVWSLGVILYTLVSGSLPFD----GSTLRELRERVLRGKY----- 262
K G VD+WS+GV Y +GSLPF +E+ +++ GK
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 263 --------------------RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
+ + +L L + K +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 7e-56
Identities = 28/127 (22%), Positives = 54/127 (42%), Gaps = 9/127 (7%)
Query: 476 KLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQ 530
KLF + E T + L+ME+ G ++ L + E E R +V + + +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 531 KKIIHRDLKAENLLL----DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
I+HR++K N++ D + K+ DFG + E + + G+ Y P++++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 587 APVTSSG 593
Sbjct: 191 VLRKDHQ 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-113
Identities = 102/261 (39%), Positives = 144/261 (55%), Gaps = 17/261 (6%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS------LQKLFREVRIMK 100
+Y + KT+G G +VKLA T K+VAIKII K + GS + E+ I+K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
L+HP I+K+ + E Y+V+E GGE+FD +V + R+KE + F Q++ AVQY
Sbjct: 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 161 CHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
H+ IIHRDLK EN+LL S + IKI DFG S + + T CG+P Y APE+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 218 GKKYD--GPEVDVWSLGVILYTLVSGSLPF-DGSTLRELRERVLRGKYRIP----FYMST 270
VD WSLGVIL+ +SG PF + T L++++ GKY +S
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 271 DCENLLKKFLVLNPAKRASLE 291
+L+KK LV++P R + E
Sbjct: 250 KALDLVKKLLVVDPKARFTTE 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 48/114 (42%), Positives = 67/114 (58%), Gaps = 4/114 (3%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+K+ + E Y+V+E GGE+FD +V + R+KE + F Q++ AVQY H+ II
Sbjct: 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 535 HRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK EN+LL S + IKI DFG S + + T CG+P Y APE+
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-112
Identities = 72/301 (23%), Positives = 128/301 (42%), Gaps = 21/301 (6%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHV 68
T ++ R ++ + SS E Y +LK IG G +KV +
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN- 77
Query: 69 PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN--IVKLFQVIETEKTLYLVMEY 126
+ AIK ++ + + +L E+ + L + I++L+ T++ +Y+VME
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186
++ +L + E ++ ++ ++ AV HQ I+H DLK N L+ + +K+
Sbjct: 138 G-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 195
Query: 187 ADFGFSNEF---TPGNKLDTFCGSPPYAAPELFQGKKYD----------GPEVDVWSLGV 233
DFG +N+ T D+ G+ Y PE + P+ DVWSLG
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255
Query: 234 ILYTLVSGSLPFDGSTLR-ELRERVLRGKYRIPF--YMSTDCENLLKKFLVLNPAKRASL 290
ILY + G PF + ++ + I F D +++LK L +P +R S+
Sbjct: 256 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315
Query: 291 E 291
Sbjct: 316 P 316
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 32/133 (24%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
+L+ T++ +Y+VME ++ +L + E ++ ++ ++ AV HQ I+H
Sbjct: 120 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEF---TPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
DLK N L+ + +K+ DFG +N+ T D+ G+ Y PE + + +
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 593 GGAGTNHTHNSSI 605
G + + + S +
Sbjct: 238 GKSKSKISPKSDV 250
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-112
Identities = 89/252 (35%), Positives = 141/252 (55%), Gaps = 11/252 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y L TIG+G++ +VK+A T A K I K + + + +E+ IMK LDHPN
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPN 67
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
I++L++ E +YLVME +GGE+F+ +V +E +A + ++SAV YCH+ +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 167 IHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
HRDLK EN L + + +K+ DFG + F PG + T G+P Y +P++ +G Y G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LY-G 185
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
PE D WS GV++Y L+ G PF T E+ ++ G + P +S E+L+++
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL 245
Query: 280 LVLNPAKRASLE 291
L +P +R +
Sbjct: 246 LTKSPKQRITSL 257
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-50
Identities = 41/114 (35%), Positives = 67/114 (58%), Gaps = 3/114 (2%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
+L++ E +YLVME +GGE+F+ +V +E +A + ++SAV YCH+ + H
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 536 RDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
RDLK EN L + + +K+ DFG + F PG + T G+P Y +P++ +G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-111
Identities = 92/250 (36%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y + + +GKG F+ V+ H TG E A KII+ +L+ QKL RE RI + L HPN
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV+L I+ E YLV + +GGE+F+ +V E +A +QI+ ++ YCH I
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 167 IHRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+HR+LK ENLLL S+ +K+ADFG + E F G+P Y +PE+ + Y
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-S 185
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
VD+W+ GVILY L+ G PF L ++ G Y P ++ + ++L+
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 280 LVLNPAKRAS 289
L +NP KR +
Sbjct: 246 LTVNPKKRIT 255
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-47
Identities = 41/114 (35%), Positives = 64/114 (56%), Gaps = 3/114 (2%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
++L I+ E YLV + +GGE+F+ +V E +A +QI+ ++ YCH I+
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 535 HRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HR+LK ENLLL S+ +K+ADFG + E F G+P Y +PE+ +
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-110
Identities = 77/255 (30%), Positives = 133/255 (52%), Gaps = 13/255 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+ + +G G F V L + +G E IK I+K + ++++ E+ ++K LDHPN
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPN 81
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYCH 162
I+K+F+V E +Y+VME GGE+ + +V + E +Q+++A+ Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 163 QKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK 219
+ ++H+DLK EN+L IKI DFG + F G+ Y APE+F+
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLL 276
+ D+WS GV++Y L++G LPF G++L E++++ + ++ +LL
Sbjct: 201 DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259
Query: 277 KKFLVLNPAKRASLE 291
K+ L +P +R S
Sbjct: 260 KQMLTKDPERRPSAA 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-48
Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 7/118 (5%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYCHQK 531
K+F+V E +Y+VME GGE+ + +V + E +Q+++A+ Y H +
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 532 KIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
++H+DLK EN+L IKI DFG + F G+ Y APE+F+
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD 201
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-109
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 21/290 (7%)
Query: 20 ENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII 79
++ S + E+ + Y +LK IG G +KV + + AIK +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 80 DKTQLNPGSLQKLFREVRIMKMLDHPN--IVKLFQVIETEKTLYLVMEYASGGEVFDYLV 137
+ + + +L E+ + L + I++L+ T++ +Y+VME ++ +L
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK 119
Query: 138 LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-- 195
+ E ++ ++ ++ AV HQ I+H DLK N L+ + +K+ DFG +N+
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178
Query: 196 -TPGNKLDTFCGSPPYAAPELFQGKKYD----------GPEVDVWSLGVILYTLVSGSLP 244
T D+ G+ Y PE + P+ DVWSLG ILY + G P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 245 FDGSTLR-ELRERVLRGKYRIPF--YMSTDCENLLKKFLVLNPAKRASLE 291
F + ++ + I F D +++LK L +P +R S+
Sbjct: 239 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-48
Identities = 32/133 (24%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
+L+ T++ +Y+VME ++ +L + E ++ ++ ++ AV HQ I+H
Sbjct: 92 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 150
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEF---TPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
DLK N L+ + +K+ DFG +N+ T D+ G+ Y PE + + +
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 593 GGAGTNHTHNSSI 605
G + + + S +
Sbjct: 210 GKSKSKISPKSDV 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 329 bits (847), Expect = e-108
Identities = 98/260 (37%), Positives = 143/260 (55%), Gaps = 17/260 (6%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-------LFREVRIM 99
Y+ + +G+G + V+ H PT KE A+KIID T S ++ +EV I+
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 100 KMLD-HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
+ + HPNI++L ET +LV + GE+FDYL + EKE R R ++ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
H+ I+HRDLK EN+LLD +MNIK+ DFGFS + PG KL CG+P Y APE+ +
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 219 KKYD-----GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMS 269
D G EVD+WS GVI+YTL++GS PF + ++ G Y+ S
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 257
Query: 270 TDCENLLKKFLVLNPAKRAS 289
++L+ +FLV+ P KR +
Sbjct: 258 DTVKDLVSRFLVVQPQKRYT 277
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 49/119 (41%), Positives = 67/119 (56%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
++L ET +LV + GE+FDYL + EKE R R ++ + H+ I+
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIV 146
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSG 593
HRDLK EN+LLD +MNIK+ DFGFS + PG KL CG+P Y APE+ + G
Sbjct: 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-108
Identities = 101/261 (38%), Positives = 146/261 (55%), Gaps = 17/261 (6%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK------LFREVRIMK 100
+Y + KT+G G +VKLA T K+VAI+II K + GS ++ + E+ I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
L+HP I+K+ + E Y+V+E GGE+FD +V + R+KE + F Q++ AVQY
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 161 CHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
H+ IIHRDLK EN+LL S + IKI DFG S + + T CG+P Y APE+
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 218 GKKYD--GPEVDVWSLGVILYTLVSGSLPF-DGSTLRELRERVLRGKYRIP----FYMST 270
VD WSLGVIL+ +SG PF + T L++++ GKY +S
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 271 DCENLLKKFLVLNPAKRASLE 291
+L+KK LV++P R + E
Sbjct: 375 KALDLVKKLLVVDPKARFTTE 395
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-47
Identities = 48/115 (41%), Positives = 67/115 (58%), Gaps = 4/115 (3%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+K+ + E Y+V+E GGE+FD +V + R+KE + F Q++ AVQY H+ II
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 535 HRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
HRDLK EN+LL S + IKI DFG S + + T CG+P Y APE+
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 316
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-108
Identities = 95/250 (38%), Positives = 146/250 (58%), Gaps = 9/250 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y ++ +GKG+F +V K T +E A+K+I+K + REV ++K LDHPN
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
I+KLF+++E + Y+V E +GGE+FD ++ R E +A +Q+ S + Y H+ I
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 167 IHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+HRDLK EN+LL+S + +IKI DFG S F K+ G+ Y APE+ + Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTY-D 200
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
+ DVWS GVILY L+SG+ PF G ++ +RV GKY +S D ++L++K
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260
Query: 280 LVLNPAKRAS 289
L +P+ R +
Sbjct: 261 LTFHPSLRIT 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 45/116 (38%), Positives = 70/116 (60%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++KLF+++E + Y+V E +GGE+FD ++ R E +A +Q+ S + Y H+ I
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 534 IHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
+HRDLK EN+LL+S + +IKI DFG S F K+ G+ Y APE+ +G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-107
Identities = 92/250 (36%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y + + +GKG F+ V+ H TG E A KII+ +L+ QKL RE RI + L HPN
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV+L I+ E YLV + +GGE+F+ +V E +A +QI+ ++ YCH I
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 167 IHRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+HR+LK ENLLL S+ +K+ADFG + E F G+P Y +PE+ + Y
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-S 208
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
VD+W+ GVILY L+ G PF L ++ G Y P ++ + ++L+
Sbjct: 209 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268
Query: 280 LVLNPAKRAS 289
L +NP KR +
Sbjct: 269 LTVNPKKRIT 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 41/114 (35%), Positives = 64/114 (56%), Gaps = 3/114 (2%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
++L I+ E YLV + +GGE+F+ +V E +A +QI+ ++ YCH I+
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 535 HRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HR+LK ENLLL S+ +K+ADFG + E F G+P Y +PE+ +
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-107
Identities = 67/263 (25%), Positives = 118/263 (44%), Gaps = 21/263 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y +LK IG G +KV + + AIK ++ + + +L E+ + L +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 107 --IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
I++L+ T++ +Y+VME ++ +L + E ++ ++ ++ AV HQ
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEF---TPGNKLDTFCGSPPYAAPELFQGKKY 221
I+H DLK N L+ + +K+ DFG +N+ T D+ G+ Y PE +
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 222 D----------GPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLRGKYRIPF--YM 268
P+ DVWSLG ILY + G PF + ++ + I F
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 269 STDCENLLKKFLVLNPAKRASLE 291
D +++LK L +P +R S+
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIP 269
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-48
Identities = 32/133 (24%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
+L+ T++ +Y+VME ++ +L + E ++ ++ ++ AV HQ I+H
Sbjct: 73 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 131
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEF---TPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
DLK N L+ + +K+ DFG +N+ T D+ G+ Y PE + + +
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 593 GGAGTNHTHNSSI 605
G + + + S +
Sbjct: 191 GKSKSKISPKSDV 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-106
Identities = 90/298 (30%), Positives = 143/298 (47%), Gaps = 17/298 (5%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIG-KYKLLKTIGKGNFAKVKLAKH 67
+ K + + + KY IG+G + V+ H
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115
Query: 68 VPTGKEVAIKIIDKTQLNP------GSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120
TG E A+KI++ T + RE I++ + HP+I+ L E+ +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 180
+LV + GE+FDYL + EKE R+ R ++ AV + H I+HRDLK EN+LLD
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235
Query: 181 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD-----GPEVDVWSLGVIL 235
M I+++DFGFS PG KL CG+P Y APE+ + + G EVD+W+ GVIL
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 236 YTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRAS 289
+TL++GS PF + ++ G+Y+ S+ ++L+ + L ++P R +
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-50
Identities = 49/119 (41%), Positives = 68/119 (57%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+ L E+ ++LV + GE+FDYL + EKE R+ R ++ AV + H I+
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSG 593
HRDLK EN+LLD M I+++DFGFS PG KL CG+P Y APE+ + T G
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-104
Identities = 100/275 (36%), Positives = 154/275 (56%), Gaps = 13/275 (4%)
Query: 23 ISSSRLMSSRRESSRRERDEPHIGK-YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK 81
+ SS RE+ + + Y ++ +GKG+F +V K T +E A+K+I+K
Sbjct: 1 MHHHHHHSSGRENLYFQGT---FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK 57
Query: 82 TQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR 141
+ REV ++K LDHPNI+KLF+++E + Y+V E +GGE+FD ++ R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 142 MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPG 198
E +A +Q+ S + Y H+ I+HRDLK EN+LL+S + +IKI DFG S F
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL 258
K+ G+ Y APE+ +G Y + DVWS GVILY L+SG+ PF G ++ +RV
Sbjct: 178 TKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 259 RGKYRIPF----YMSTDCENLLKKFLVLNPAKRAS 289
GKY +S D ++L++K L +P+ R +
Sbjct: 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 45/114 (39%), Positives = 69/114 (60%), Gaps = 3/114 (2%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KLF+++E + Y+V E +GGE+FD ++ R E +A +Q+ S + Y H+ I+
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 535 HRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK EN+LL+S + +IKI DFG S F K+ G+ Y APE+ +G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-104
Identities = 93/251 (37%), Positives = 143/251 (56%), Gaps = 9/251 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+L + +GKG F+ V+ V G+E A II+ +L+ QKL RE RI ++L HPN
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV+L I E YL+ + +GGE+F+ +V E +A +QI+ AV +CHQ +
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 167 IHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQGKKYD 222
+HR+LK ENLLL S+ +K+ADFG + E + F G+P Y +PE+ + Y
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY- 190
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKK 278
G VD+W+ GVILY L+ G PF L +++ G Y P ++ + ++L+ K
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250
Query: 279 FLVLNPAKRAS 289
L +NP+KR +
Sbjct: 251 MLTINPSKRIT 261
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-41
Identities = 44/122 (36%), Positives = 68/122 (55%), Gaps = 7/122 (5%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
++L I E YL+ + +GGE+F+ +V E +A +QI+ AV +CHQ ++
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 535 HRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQG---GA 587
HR+LK ENLLL S+ +K+ADFG + E + F G+P Y +PE+ + G
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192
Query: 588 PV 589
PV
Sbjct: 193 PV 194
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-102
Identities = 101/278 (36%), Positives = 152/278 (54%), Gaps = 9/278 (3%)
Query: 19 SENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKI 78
N+ + + + Y+ +K +G G + +V L + T E AIKI
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 79 IDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVL 138
I KT ++ S KL EV ++K+LDHPNI+KL+ E ++ YLVME GGE+FD ++
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 139 HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEF 195
+ E +A +Q++S V Y H+ I+HRDLK ENLLL+S + IKI DFG S F
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
Query: 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRE 255
K+ G+ Y APE+ + KY + DVWS+GVIL+ L++G PF G T +E+
Sbjct: 190 ENQKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
Query: 256 RVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRAS 289
+V +GKY +S ++L+K+ L + +R S
Sbjct: 248 KVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 46/114 (40%), Positives = 66/114 (57%), Gaps = 3/114 (2%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL+ E ++ YLVME GGE+FD ++ + E +A +Q++S V Y H+ I+
Sbjct: 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 535 HRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK ENLLL+S + IKI DFG S F K+ G+ Y APE+ +
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-102
Identities = 95/329 (28%), Positives = 142/329 (43%), Gaps = 62/329 (18%)
Query: 19 SENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKI 78
++ S + + S + KY L IG+G++ V++A T AIKI
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQK-----KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKI 58
Query: 79 IDKTQL---NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDY 135
++K ++ NP ++++ EVR+MK L HPNI +L++V E E+ + LVME GG + D
Sbjct: 59 MNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118
Query: 136 LVLHGRMK----------------------------------------EKEARAKFRQIV 155
L + EK RQI
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGN-----KLDTFCGSP 208
SA+ Y H + I HRD+K EN L + IK+ DFG S EF N + T G+P
Sbjct: 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 209 PYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF 266
+ APE+ + Y GP+ D WS GV+L+ L+ G++PF G + +VL K
Sbjct: 239 YFVAPEVLNTTNESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN 297
Query: 267 ----YMSTDCENLLKKFLVLNPAKRASLE 291
+S +LL L N +R
Sbjct: 298 PNYNVLSPLARDLLSNLLNRNVDERFDAM 326
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 44/159 (27%), Positives = 61/159 (38%), Gaps = 47/159 (29%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK----------------------- 510
+ +L++V E E+ + LVME GG + D L +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 511 -----------------EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS--EMNI 551
EK RQI SA+ Y H + I HRD+K EN L + I
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 552 KIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQG 585
K+ DFG S EF N + T G+P + APE+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-101
Identities = 65/288 (22%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 35 SSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFR 94
S R D ++ + +G+G F +V A++ + AIK I T+ L +
Sbjct: 1 SLRYASD------FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILS 51
Query: 95 EVRIMKMLDHPNIVKLFQV-------------IETEKTLYLVMEYASGGEVFDYLVLHGR 141
EV ++ L+H +V+ + ++ + TL++ MEY G ++D +
Sbjct: 52 EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111
Query: 142 MKEKEARAK-FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-------- 192
++++ + FRQI+ A+ Y H + IIHRDLK N+ +D N+KI DFG +
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 193 -------NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 245
N + L + G+ Y A E+ G + ++D++SLG+I + ++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FS 229
Query: 246 DGSTLRELRERVLRGKYRIPFYM----STDCENLLKKFLVLNPAKRAS 289
G + +++ P + +++ + +P KR
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 16/123 (13%)
Query: 479 QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK-FRQIVSAVQYCHQKKIIHRD 537
++ + TL++ MEY G ++D + ++++ + FRQI+ A+ Y H + IIHRD
Sbjct: 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRD 141
Query: 538 LKAENLLLDSEMNIKIADFGFS---------------NEFTPGNKLDTFCGSPPYAAPEL 582
LK N+ +D N+KI DFG + N + L + G+ Y A E+
Sbjct: 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201
Query: 583 FQG 585
G
Sbjct: 202 LDG 204
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-101
Identities = 90/250 (36%), Positives = 131/250 (52%), Gaps = 11/250 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+ ++ +G G F++V L K TGK A+K I K+ L E+ ++K + H N
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHEN 67
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV L + E+ YLVM+ SGGE+FD ++ G EK+A +Q++SAV+Y H+ I
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 167 IHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+HRDLK ENLL + I I DFG S G + T CG+P Y APE+ K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPY-S 185
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
VD WS+GVI Y L+ G PF T +L E++ G Y +S ++ +
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL 245
Query: 280 LVLNPAKRAS 289
L +P +R +
Sbjct: 246 LEKDPNERYT 255
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 47/114 (41%), Positives = 65/114 (57%), Gaps = 4/114 (3%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+ L + E+ YLVM+ SGGE+FD ++ G EK+A +Q++SAV+Y H+ I+
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 535 HRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK ENLL + I I DFG S G + T CG+P Y APE+
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ 181
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-101
Identities = 103/251 (41%), Positives = 151/251 (60%), Gaps = 10/251 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHP 105
+YK + +GKG+F +V L K TG+E A+K+I K Q+ + L REV+++K LDHP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
NI+KL++ E + YLV E +GGE+FD ++ R E +A RQ++S + Y H+ K
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 166 IIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD 222
I+HRDLK ENLLL+S + NI+I DFG S F K+ G+ Y APE+ G Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TY- 204
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKK 278
+ DVWS GVILY L+SG PF+G+ ++ ++V +GKY +S ++L++K
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 279 FLVLNPAKRAS 289
L P+ R S
Sbjct: 265 MLTYVPSMRIS 275
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-42
Identities = 48/114 (42%), Positives = 68/114 (59%), Gaps = 3/114 (2%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL++ E + YLV E +GGE+FD ++ R E +A RQ++S + Y H+ KI+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148
Query: 535 HRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK ENLLL+S + NI+I DFG S F K+ G+ Y APE+ G
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-101
Identities = 93/261 (35%), Positives = 146/261 (55%), Gaps = 20/261 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-----------NPGSLQKLFRE 95
Y ++ +G G + +V L K E AIK+I K+Q ++++ E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 96 VRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIV 155
+ ++K LDHPNI+KLF V E +K YLV E+ GGE+F+ ++ + E +A +QI+
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 212
S + Y H+ I+HRD+K EN+LL++ +NIKI DFG S+ F+ KL G+ Y A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YM 268
PE+ + KY + DVWS GVI+Y L+ G PF G +++ ++V +GKY F +
Sbjct: 217 PEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 269 STDCENLLKKFLVLNPAKRAS 289
S + + L+K L + KR +
Sbjct: 275 SDEAKELIKLMLTYDYNKRCT 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-42
Identities = 46/113 (40%), Positives = 69/113 (61%), Gaps = 3/113 (2%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
KLF V E +K YLV E+ GGE+F+ ++ + E +A +QI+S + Y H+ I+H
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVH 169
Query: 536 RDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
RD+K EN+LL++ +NIKI DFG S+ F+ KL G+ Y APE+ +
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-100
Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 25/268 (9%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y ++ +G+G F+ V L + + G A+K I + ++ RE + ++ +HPN
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHPN 87
Query: 107 IVKLFQVIETEKT----LYLVMEYASGGEVFDYL----VLHGRMKEKEARAKFRQIVSAV 158
I++L E+ +L++ + G +++ + + E + I +
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN----------EFTPGNKLDTFCGSP 208
+ H K HRDLK N+LL E + D G N + +
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 209 PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLRGKYRIP 265
Y APELF + + DVWSLG +LY ++ G P+D + + ++ + IP
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 266 FY--MSTDCENLLKKFLVLNPAKRASLE 291
S+ LL + ++P +R +
Sbjct: 268 QSPRHSSALWQLLNSMMTVDPHQRPHIP 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 27/129 (20%), Positives = 45/129 (34%), Gaps = 18/129 (13%)
Query: 475 LKLFQVIETEKT----LYLVMEYASGGEVFDYL----VLHGRMKEKEARAKFRQIVSAVQ 526
L+L E+ +L++ + G +++ + + E + I ++
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN----------EFTPGNKLDTFCGSPP 576
H K HRDLK N+LL E + D G N + +
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 577 YAAPELFQG 585
Y APELF
Sbjct: 209 YRAPELFSV 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-100
Identities = 88/258 (34%), Positives = 143/258 (55%), Gaps = 17/258 (6%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL---NPGSLQKLFREVRIMKMLD 103
Y+L + IGKG F+ V+ + TG++ A+KI+D + S + L RE I ML
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQ 159
HP+IV+L + ++ LY+V E+ G ++ +V E A RQI+ A++
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 160 YCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPEL 215
YCH IIHRD+K +LL S+ +K+ FG + + G G+P + APE+
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTD 271
+ + Y G VDVW GVIL+ L+SG LPF G+ L E +++GKY++ ++S
Sbjct: 205 VKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262
Query: 272 CENLLKKFLVLNPAKRAS 289
++L+++ L+L+PA+R +
Sbjct: 263 AKDLVRRMLMLDPAERIT 280
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-41
Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 8/118 (6%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQYCHQK 531
+L + ++ LY+V E+ G ++ +V E A RQI+ A++YCH
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 532 KIIHRDLKAENLLLDSE---MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQG 585
IIHRD+K +LL S+ +K+ FG + + G G+P + APE+ +
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = 3e-99
Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 14/263 (5%)
Query: 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
Y++L TIG G++ + + + GK + K +D + Q L EV +++
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 102 LDHPNIVKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIV 155
L HPNIV+ + I T TLY+VMEY GG++ + + + E+ Q+
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 156 SAVQYCHQKK-----IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPP 209
A++ CH++ ++HRDLK N+ LD + N+K+ DFG + TF G+P
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYM 268
Y +PE Y+ + D+WSLG +LY L + PF + +EL ++ GK+ RIP+
Sbjct: 182 YMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 269 STDCENLLKKFLVLNPAKRASLE 291
S + ++ + L L R S+E
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVE 263
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 35/116 (30%), Positives = 57/116 (49%), Gaps = 10/116 (8%)
Query: 480 VIETEKTLYLVMEYASGGEVFDYLVLHGRMK----EKEARAKFRQIVSAVQYCHQKK--- 532
+ T TLY+VMEY GG++ + + + E+ Q+ A++ CH++
Sbjct: 75 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGG 134
Query: 533 --IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQG 585
++HRDLK N+ LD + N+K+ DFG + TF G+P Y +PE
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = 3e-98
Identities = 88/255 (34%), Positives = 139/255 (54%), Gaps = 13/255 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL----NPGSLQKLFREVRIMKML 102
Y++ + +G G FA V+ + TGKE A K I K +L S +++ REV I++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
HPNI+ L + E + + L++E SGGE+FD+L + E EA +QI+ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 163 QKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
K+I H DLK EN++L + IK+ DFG +++ GN+ G+P + APE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCEN 274
+ G E D+WS+GVI Y L+SG+ PF G T +E + Y F S ++
Sbjct: 186 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244
Query: 275 LLKKFLVLNPAKRAS 289
+++ LV +P +R +
Sbjct: 245 FIRRLLVKDPKRRMT 259
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 40/112 (35%), Positives = 63/112 (56%), Gaps = 4/112 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L + E + + L++E SGGE+FD+L + E EA +QI+ V Y H K+I
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129
Query: 534 IHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
H DLK EN++L + IK+ DFG +++ GN+ G+P + APE
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 2e-97
Identities = 88/255 (34%), Positives = 135/255 (52%), Gaps = 13/255 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL----NPGSLQKLFREVRIMKML 102
Y + +G G FA VK + TG + A K I K + S + + REV I+K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
HPN++ L +V E + + L++E +GGE+FD+L + E+EA +QI++ V Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 QKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
+I H DLK EN++L IKI DFG +++ GN+ G+P + APE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCEN 274
+ G E D+WS+GVI Y L+SG+ PF G T +E V Y F S ++
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 275 LLKKFLVLNPAKRAS 289
+++ LV +P KR +
Sbjct: 251 FIRRLLVKDPKKRMT 265
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 40/112 (35%), Positives = 64/112 (57%), Gaps = 4/112 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L +V E + + L++E +GGE+FD+L + E+EA +QI++ V Y H +I
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 534 IHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
H DLK EN++L IKI DFG +++ GN+ G+P + APE
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 3e-97
Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 38/294 (12%)
Query: 30 SSRRESSRRERDEPHIG--KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG 87
+S R+ S +G + ++ + + +G FA V A+ V +G+E A+K +
Sbjct: 10 ASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEE 67
Query: 88 SLQKLFREVRIMKML-DHPNIVKLF-------QVIETEKTLYLVMEYASGGEVFDYLV-- 137
+ + +EV MK L HPNIV+ + +T + +L++ G++ ++L
Sbjct: 68 KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 138 -LHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMNIKIADFGFSNE 194
G + F Q AVQ+ H++K IIHRDLK ENLLL ++ IK+ DFG +
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 195 FTPGNKLD-------------TFCGSPPYAAPELFQ--GKKYDGPEVDVWSLGVILYTLV 239
+ T +P Y PE+ G + D+W+LG ILY L
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 240 SGSLPFDGSTLRELRERVLRGKYRIPFY--MSTDCENLLKKFLVLNPAKRASLE 291
PF+ R++ GKY IP + T +L++ L +NP +R S+
Sbjct: 248 FRQHPFEDGAKL----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 20/132 (15%)
Query: 479 QVIETEKTLYLVMEYASGGEVFDYLV---LHGRMKEKEARAKFRQIVSAVQYCHQKK--I 533
+ +T + +L++ G++ ++L G + F Q AVQ+ H++K I
Sbjct: 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI 159
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD-------------TFCGSPPYAAP 580
IHRDLK ENLLL ++ IK+ DFG + + T +P Y P
Sbjct: 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 581 ELFQ--GGAPVT 590
E+ P+
Sbjct: 220 EIIDLYSNFPIG 231
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 1e-96
Identities = 95/300 (31%), Positives = 154/300 (51%), Gaps = 17/300 (5%)
Query: 2 NDKSFRYSTGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIG----KYKLLKTIGKG 57
+ S G S +++++S + D + +++ +G+G
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64
Query: 58 NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117
+ V K T K A+K++ KT + + E+ ++ L HPNI+KL ++ ET
Sbjct: 65 ATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 177
+ LV+E +GGE+FD +V G E++A +QI+ AV Y H+ I+HRDLK ENLL
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180
Query: 178 L---DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 234
+ +KIADFG S + T CG+P Y APE+ +G Y GPEVD+WS+G+I
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGII 239
Query: 235 LYTLVSGSLPFDGSTL-RELRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRAS 289
Y L+ G PF + + R+L +Y +S + ++L++K +VL+P KR +
Sbjct: 240 TYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT 299
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-43
Identities = 48/114 (42%), Positives = 68/114 (59%), Gaps = 3/114 (2%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL ++ ET + LV+E +GGE+FD +V G E++A +QI+ AV Y H+ I+
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 535 HRDLKAENLLL---DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
HRDLK ENLL + +KIADFG S + T CG+P Y APE+ +G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 1e-96
Identities = 89/255 (34%), Positives = 135/255 (52%), Gaps = 13/255 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL----NPGSLQKLFREVRIMKML 102
Y + + +G G FA VK + TG E A K I K Q S +++ REV I++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
H N++ L V E + L++E SGGE+FD+L + E+EA + +QI+ V Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 163 QKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
KKI H DLK EN++L + +IK+ DFG ++E G + G+P + APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCEN 274
+ G E D+WS+GVI Y L+SG+ PF G T +E + Y F + S ++
Sbjct: 193 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251
Query: 275 LLKKFLVLNPAKRAS 289
++K LV KR +
Sbjct: 252 FIRKLLVKETRKRLT 266
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 42/112 (37%), Positives = 64/112 (57%), Gaps = 4/112 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L V E + L++E SGGE+FD+L + E+EA + +QI+ V Y H KKI
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 534 IHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
H DLK EN++L + +IK+ DFG ++E G + G+P + APE
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 4e-96
Identities = 85/256 (33%), Positives = 136/256 (53%), Gaps = 20/256 (7%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHP 105
Y++ + IG G+++ K H T E A+KIIDK++ +P E+ I+ HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP------TEEIEILLRYGQHP 76
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
NI+ L V + K +Y+V E GGE+ D ++ E+EA A I V+Y H +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 166 IIHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQGKK 220
++HRDLK N+L E +I+I DFGF+ + N L T C + + APE+ + +
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKYRIPF----YMSTDCE 273
YD D+WSLGV+LYT+++G PF T E+ R+ GK+ + +S +
Sbjct: 197 YD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 274 NLLKKFLVLNPAKRAS 289
+L+ K L ++P +R +
Sbjct: 256 DLVSKMLHVDPHQRLT 271
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 39/116 (33%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+ L V + K +Y+V E GGE+ D ++ E+EA A I V+Y H + ++
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 535 HRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQG 585
HRDLK N+L E +I+I DFGF+ + N L T C + + APE+ +
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 8e-96
Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 12/254 (4%)
Query: 47 KYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH- 104
Y L K +G+G FA V+ TG+E A K + K + ++ E+ ++++
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV--LHGRMKEKEARAKFRQIVSAVQYCH 162
P ++ L +V E + L++EYA+GGE+F + L + E + +QI+ V Y H
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 163 QKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK 219
Q I+H DLK +N+LL S +IKI DFG S + +L G+P Y APE+
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCENL 275
D+W++G+I Y L++ + PF G +E + + F +S +
Sbjct: 209 PI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267
Query: 276 LKKFLVLNPAKRAS 289
++ LV NP KR +
Sbjct: 268 IQSLLVKNPEKRPT 281
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 42/113 (37%), Positives = 62/113 (54%), Gaps = 5/113 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLV--LHGRMKEKEARAKFRQIVSAVQYCHQK 531
++ L +V E + L++EYA+GGE+F + L + E + +QI+ V Y HQ
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 532 KIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
I+H DLK +N+LL S +IKI DFG S + +L G+P Y APE
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 5e-95
Identities = 90/255 (35%), Positives = 134/255 (52%), Gaps = 13/255 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL----NPGSLQKLFREVRIMKML 102
Y + + +G G FA VK + TG E A K I K Q +++ REV I++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
HPNI+ L V E + L++E SGGE+FD+L + E+EA + +QI+ V Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 163 QKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
KKI H DLK EN++L + +IK+ DFG ++E G + G+P + APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCEN 274
+ G E D+WS+GVI Y L+SG+ PF G T +E + Y F S ++
Sbjct: 193 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251
Query: 275 LLKKFLVLNPAKRAS 289
++K LV KR +
Sbjct: 252 FIRKLLVKETRKRLT 266
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 42/112 (37%), Positives = 64/112 (57%), Gaps = 4/112 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L V E + L++E SGGE+FD+L + E+EA + +QI+ V Y H KKI
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 534 IHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
H DLK EN++L + +IK+ DFG ++E G + G+P + APE
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 1e-94
Identities = 91/262 (34%), Positives = 138/262 (52%), Gaps = 25/262 (9%)
Query: 47 KYKLL---KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
Y L K +G+G+F+ + H + + A+KII K +E+ +K+ +
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCE 63
Query: 104 -HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
HPNIVKL +V + +LVME +GGE+F+ + E EA R++VSAV + H
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 163 QKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQG 218
++HRDLK ENLL E + IKI DFGF+ P N+ L T C + YAAPEL
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGST-------LRELRERVLRGKYRIPF----Y 267
YD D+WSLGVILYT++SG +PF E+ +++ +G +
Sbjct: 184 NGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 268 MSTDCENLLKKFLVLNPAKRAS 289
+S + ++L++ L ++P KR
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLK 264
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 48/115 (41%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
+KL +V + +LVME +GGE+F+ + E EA R++VSAV + H ++
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 535 HRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQG 585
HRDLK ENLL E + IKI DFGF+ P N+ L T C + YAAPEL
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 3e-92
Identities = 63/250 (25%), Positives = 120/250 (48%), Gaps = 11/250 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY + + +G+G F V + K K + + + +E+ I+ + H N
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRN 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 165
I+ L + E+ + L ++ E+ SG ++F+ + + E+E + Q+ A+Q+ H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 166 IIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
I H D++ EN++ + + IKI +FG + + PG+ +P Y APE+ Q
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-S 181
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCENLLKKF 279
D+WSLG ++Y L+SG PF T +++ E ++ +Y F +S + + + +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 280 LVLNPAKRAS 289
LV R +
Sbjct: 242 LVKERKSRMT 251
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 31/111 (27%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 532
+L L + E+ + L ++ E+ SG ++F+ + + E+E + Q+ A+Q+ H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 533 IIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
I H D++ EN++ + + IKI +FG + + PG+ +P Y APE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 5e-92
Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 10/287 (3%)
Query: 10 TGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP 69
GK + + ++ + + + Y +L+ +G G F V
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 70 TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129
TG+ K I+ + E+ IM L HP ++ L E + + L++E+ SG
Sbjct: 75 TGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 130 GEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS--EMNIKI 186
GE+FD + +M E E RQ +++ H+ I+H D+K EN++ ++ ++KI
Sbjct: 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKI 192
Query: 187 ADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 246
DFG + + P + + +AAPE+ + G D+W++GV+ Y L+SG PF
Sbjct: 193 IDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFA 251
Query: 247 GSTLRELRERVLRGKY---RIPF-YMSTDCENLLKKFLVLNPAKRAS 289
G E + V R + F +S + ++ +K L P KR +
Sbjct: 252 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 33/115 (28%), Positives = 60/115 (52%), Gaps = 3/115 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 532
L+ L E + + L++E+ SGGE+FD + +M E E RQ +++ H+
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 533 IIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
I+H D+K EN++ ++ ++KI DFG + + P + + +AAPE+
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-91
Identities = 87/280 (31%), Positives = 132/280 (47%), Gaps = 40/280 (14%)
Query: 47 KYKLLK-TIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DH 104
Y+L + +G+G A+V+ ++ T +E A+KII+K + ++FREV ++ H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGH 70
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
N+++L + E E YLV E GG + ++ E EA + + SA+ + H K
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 165 KIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAP 213
I HRDLK EN+L + +KI DF + +L T CGS Y AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 214 ELFQG-----KKYDGPEVDVWSLGVILYTLVSGSLPFDG---------------STLREL 253
E+ + YD D+WSLGVILY L+SG PF G + L
Sbjct: 191 EVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 254 RERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRAS 289
E + GKY P ++S ++L+ K LV + +R S
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 40/129 (31%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKII 534
L+L + E E YLV E GG + ++ E EA + + SA+ + H K I
Sbjct: 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 535 HRDLKAENLLLDSE---MNIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELF 583
HRDLK EN+L + +KI DF + +L T CGS Y APE+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 584 QGGAPVTSS 592
+ + S
Sbjct: 194 EAFSEEASI 202
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 3e-91
Identities = 89/300 (29%), Positives = 135/300 (45%), Gaps = 27/300 (9%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLL-KTIGKGNFAKVKLAKH 67
T + +S + + I YK+ + +G G KV +
Sbjct: 24 PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83
Query: 68 VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET----EKTLYL 122
T ++ A+K++ K REV + P+IV++ V E K L +
Sbjct: 84 KRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 123 VMEYASGGEVFDYLVLHGRMK--EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 180
VME GGE+F + G E+EA + I A+QY H I HRD+K ENLL S
Sbjct: 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196
Query: 181 E---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYT 237
+ +K+ DFGF+ E T N L T C +P Y APE+ +KYD D+WSLGVI+Y
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYI 255
Query: 238 LVSGSLPFDG----STLRELRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRAS 289
L+ G PF + ++ R+ G+Y P +S + + L++ L P +R +
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 315
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-39
Identities = 46/115 (40%), Positives = 60/115 (52%), Gaps = 9/115 (7%)
Query: 476 KLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMK--EKEARAKFRQIVSAVQYCH 529
++ V E K L +VME GGE+F + G E+EA + I A+QY H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 530 QKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
I HRD+K ENLL S+ +K+ DFGF+ E T N L T C +P Y APE
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 9e-91
Identities = 75/266 (28%), Positives = 141/266 (53%), Gaps = 5/266 (1%)
Query: 30 SSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL 89
SS + + KY L+ IG+G+F K L K G++ IK I+ ++++
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 90 QKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEA 147
++ REV ++ + HPNIV+ + E +LY+VM+Y GG++F + +E +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 148 RAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCG 206
F QI A+++ H +KI+HRD+K++N+ L + +++ DFG + +L G
Sbjct: 128 LDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG 187
Query: 207 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIP 265
+P Y +PE+ + K Y+ + D+W+LG +LY L + F+ +++ L +++ G + +
Sbjct: 188 TPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS 246
Query: 266 FYMSTDCENLLKKFLVLNPAKRASLE 291
+ S D +L+ + NP R S+
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVN 272
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 32/113 (28%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKI 533
+ + E +LY+VM+Y GG++F + +E + F QI A+++ H +KI
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPELFQG 585
+HRD+K++N+ L + +++ DFG + +L G+P Y +PE+ +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 9e-89
Identities = 79/252 (31%), Positives = 128/252 (50%), Gaps = 12/252 (4%)
Query: 47 KYKLLKT--IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
Y + KT +G G F +V + TG ++A KII + +++ E+ +M LDH
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDH 145
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQ 163
N+++L+ E++ + LVMEY GGE+FD ++ + E + +QI +++ HQ
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 164 KKIIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
I+H DLK EN+L + IKI DFG + + P KL G+P + APE+ +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DF 264
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCENLLK 277
D+WS+GVI Y L+SG PF G E +L ++ F +S + + +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324
Query: 278 KFLVLNPAKRAS 289
K L+ + R S
Sbjct: 325 KLLIKEKSWRIS 336
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 532
L++L+ E++ + LVMEY GGE+FD ++ + E + +QI +++ HQ
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 533 IIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
I+H DLK EN+L + IKI DFG + + P KL G+P + APE+
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY 262
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 1e-88
Identities = 87/262 (33%), Positives = 131/262 (50%), Gaps = 28/262 (10%)
Query: 47 KYKLLK-TIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DH 104
Y+L K +G G KV H TG++ A+K++ + K +EV
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGG 81
Query: 105 PNIVKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMK--EKEARAKFRQIVSAV 158
P+IV + V E ++ L ++ME GGE+F + G E+EA R I +A+
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 159 QYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 215
Q+ H I HRD+K ENLL S+ +K+ DFGF+ E T L T C +P Y APE+
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEV 200
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST----LRELRERVLRGKYRIPF----Y 267
+KYD D+WSLGVI+Y L+ G PF +T ++ R+ G+Y P
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 268 MSTDCENLLKKFLVLNPAKRAS 289
+S D + L++ L +P +R +
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLT 281
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 46/122 (37%), Positives = 65/122 (53%), Gaps = 10/122 (8%)
Query: 469 SGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMK--EKEARAKFRQIV 522
SGG ++ + V E ++ L ++ME GGE+F + G E+EA R I
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 523 SAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
+A+Q+ H I HRD+K ENLL S+ +K+ DFGF+ E T L T C +P Y A
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVA 197
Query: 580 PE 581
PE
Sbjct: 198 PE 199
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 284 bits (727), Expect = 4e-87
Identities = 71/250 (28%), Positives = 121/250 (48%), Gaps = 10/250 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y + + +G G F V TG A K + + + + +E++ M +L HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPT 215
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKK 165
+V L E + + ++ E+ SGGE+F+ + H +M E EA RQ+ + + H+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 166 IIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+H DLK EN++ + +K+ DFG + P + G+ +AAPE+ +GK G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPF-YMSTDCENLLKKF 279
D+WS+GV+ Y L+SG PF G E V + F +S D ++ ++K
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394
Query: 280 LVLNPAKRAS 289
L+ +P R +
Sbjct: 395 LLADPNTRMT 404
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 34/115 (29%), Positives = 60/115 (52%), Gaps = 3/115 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKK 532
L+ L E + + ++ E+ SGGE+F+ + H +M E EA RQ+ + + H+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 533 IIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
+H DLK EN++ + +K+ DFG + P + G+ +AAPE+ +G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-83
Identities = 73/263 (27%), Positives = 109/263 (41%), Gaps = 31/263 (11%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
+K ++ IG G F +V AKH GK IK + +K REV+ + LDH NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNI 66
Query: 108 VKLFQVIETE----------------KTLYLVMEYASGGEVFDYLVLH--GRMKEKEARA 149
V + K L++ ME+ G + ++ ++ + A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 150 KFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP 209
F QI V Y H KK+I+RDLK N+ L +KI DFG K G+
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR 186
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPFYM 268
Y +PE + Y EVD+++LG+IL L+ F+ S + + G I
Sbjct: 187 YMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS---KFFTDLRDGI--ISDIF 240
Query: 269 STDCENLLKKFLVLNPAKRASLE 291
+ LL+K L P R +
Sbjct: 241 DKKEKTLLQKLLSKKPEDRPNTS 263
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 2/105 (1%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540
K L++ ME+ G + ++ ++ + A F QI V Y H KK+I+RDLK
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKP 150
Query: 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
N+ L +KI DFG K G+ Y +PE
Sbjct: 151 SNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS 195
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 8e-83
Identities = 90/249 (36%), Positives = 139/249 (55%), Gaps = 15/249 (6%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPN 106
+K K +G+G+F+ V LA+ + T +E AIKI++K + + + RE +M LDHP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 107 IVKL---FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYC 161
VKL FQ ++ LY + YA GE+ Y+ G E +F +IVSA++Y
Sbjct: 92 FVKLYFTFQ---DDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYL 146
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGSPPYAAPELFQG 218
H K IIHRDLK EN+LL+ +M+I+I DFG + +P +K +F G+ Y +PEL
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278
K D+W+LG I+Y LV+G PF + +++++ +Y P +L++K
Sbjct: 207 KSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 279 FLVLNPAKR 287
LVL+ KR
Sbjct: 266 LLVLDATKR 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 44/113 (38%), Positives = 64/113 (56%), Gaps = 10/113 (8%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ ++ LY + YA GE+ Y+ G E +F +IVSA++Y H K IIH
Sbjct: 99 FQ---DDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGKGIIH 153
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGSPPYAAPELFQG 585
RDLK EN+LL+ +M+I+I DFG + +P +K +F G+ Y +PEL
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 6e-82
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 49/283 (17%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HP 105
K +G G+ V G+ VA+K + E++++ D HP
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHP 69
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKFRQIVSAV 158
N+++ + T++ LY+ +E + D + KE + RQI S V
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 159 QYCHQKKIIHRDLKAENLLLDSE-------------MNIKIADFGFSNEFTPGN-----K 200
+ H KIIHRDLK +N+L+ + + I I+DFG + G
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 201 LDTFCGSPPYAAPELFQG------KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253
L+ G+ + APEL + K+ +D++S+G + Y ++S G PF RE
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247
Query: 254 RERVLRGKYRIPFY-------MSTDCENLLKKFLVLNPAKRAS 289
++RG + + + + +L+ + + +P KR +
Sbjct: 248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 26/148 (17%)
Query: 475 LKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKFRQIVSAVQY 527
++ + T++ LY+ +E + D + KE + RQI S V +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 528 CHQKKIIHRDLKAENLLLDSE-------------MNIKIADFGFSNEFTPGN-----KLD 569
H KIIHRDLK +N+L+ + + I I+DFG + G L+
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 570 TFCGSPPYAAPELFQGGAPVTSSGGAGT 597
G+ + APEL + + +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTR 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-81
Identities = 73/291 (25%), Positives = 119/291 (40%), Gaps = 10/291 (3%)
Query: 2 NDKSFRYSTGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAK 61
+ + S + + R S +S L S + SR E ++ L +G G++ +
Sbjct: 15 TENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ--SFQRLSRLGHGSYGE 72
Query: 62 VKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIM-KMLDHPNIVKLFQVIETEKTL 120
V + G+ A+K P + EV K+ HP V+L Q E L
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132
Query: 121 YLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179
YL E G + + G + E + R + A+ + H + ++H D+K N+ L
Sbjct: 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191
Query: 180 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 239
K+ DFG E + G P Y APEL QG Y DV+SLG+ + +
Sbjct: 192 PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVA 249
Query: 240 SG-SLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
LP G ++LR+ L +S++ ++L L +P RA+
Sbjct: 250 CNMELPHGGEGWQQLRQGYLPP--EFTAGLSSELRSVLVMMLEPDPKLRAT 298
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 32/112 (28%), Positives = 47/112 (41%), Gaps = 2/112 (1%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKII 534
+L Q E LYL E G + + G + E + R + A+ + H + ++
Sbjct: 121 RLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
H D+K N+ L K+ DFG E + G P Y APEL QG
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS 231
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 2e-80
Identities = 42/323 (13%), Positives = 96/323 (29%), Gaps = 51/323 (15%)
Query: 13 SETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK 72
SE + + +++ S+ L ++ + +G+ + A TG+
Sbjct: 40 SEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 99
Query: 73 EVAIKIIDKTQLNPGS-LQKLFREVRIMKML-------------------------DHPN 106
+ + T+ P + ++++ EV +++L
Sbjct: 100 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159
Query: 107 IVKLFQVIETE--KTLYLVMEYAS------GGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
++++ + + + G + + H + Q++ +
Sbjct: 160 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 219
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ- 217
H ++H L+ +++LD + + F S + PEL
Sbjct: 220 ASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEAR 276
Query: 218 ---------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYM 268
+ D W+LG+++Y + LP E + R IP
Sbjct: 277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIP--- 333
Query: 269 STDCENLLKKFLVLNPAKRASLE 291
LL+ FL R
Sbjct: 334 -QPVRALLEGFLRYPKEDRLLPL 355
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 16/122 (13%), Positives = 36/122 (29%), Gaps = 9/122 (7%)
Query: 486 TLYLVMEYAS------GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 539
+ + + G + + H + Q++ + H ++H L+
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 233
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNH 599
+++LD + + F S + PEL A ++ T
Sbjct: 234 PVDIVLDQRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290
Query: 600 TH 601
T
Sbjct: 291 TF 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 1e-78
Identities = 66/286 (23%), Positives = 135/286 (47%), Gaps = 14/286 (4%)
Query: 19 SENNISSSRLMSSRRESSRRERDEPH---IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVA 75
E + + + + R + + +++ K IG+G F++V A + G VA
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61
Query: 76 IKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFD 134
+K + L + + +E+ ++K L+HPN++K + + L +V+E A G++
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 135 YLVLHGR----MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190
+ + + E+ F Q+ SA+++ H ++++HRD+K N+ + + +K+ D G
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181
Query: 191 FSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS- 248
F+ + G+P Y +PE Y+ + D+WSLG +LY + + PF G
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDK 240
Query: 249 -TLRELRERVLRGKY-RIPF-YMSTDCENLLKKFLVLNPAKRASLE 291
L L +++ + Y +P + S + L+ + +P KR +
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVT 286
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 25/110 (22%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKFRQIVSAVQYCHQKKIIHR 536
+ L +V+E A G++ + + + E+ F Q+ SA+++ H ++++HR
Sbjct: 101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQG 585
D+K N+ + + +K+ D G F+ + G+P Y +PE
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-78
Identities = 80/275 (29%), Positives = 123/275 (44%), Gaps = 48/275 (17%)
Query: 34 ESSRRERDEPHIGKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL 92
+S + + I YK+ + +G G KV + T ++ A+K++ K
Sbjct: 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KA 57
Query: 93 FREVRIM-KMLDHPNIVKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMK--EK 145
REV + + P+IV++ V E K L +VME GGE+F + G E+
Sbjct: 58 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 146 EARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGNKLD 202
EA + I A+QY H I HRD+K ENLL S+ +K+ DFGF
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------- 166
Query: 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVL 258
A E G+KYD D+WSLGVI+Y L+ G PF + ++ R+
Sbjct: 167 ---------AKET-TGEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215
Query: 259 RGKYRIPF----YMSTDCENLLKKFLVLNPAKRAS 289
G+Y P +S + + L++ L P +R +
Sbjct: 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 250
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 37/100 (37%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 476 KLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMK--EKEARAKFRQIVSAVQYCH 529
++ V E K L +VME GGE+F + G E+EA + I A+QY H
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 530 QKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGN 566
I HRD+K ENLL S+ +K+ DFGF+ E T
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 2e-78
Identities = 94/285 (32%), Positives = 153/285 (53%), Gaps = 13/285 (4%)
Query: 11 GKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKL-----LKTIGKGNFAKVKLA 65
G + + S ++ +E ++ + P +L +KT+G G+F +V L
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 66 KHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124
KH +G A+KI+DK + + ++ E RI++ ++ P +VKL + LY+VM
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 125 EYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 182
EY +GGE+F +L GR E A+F QIV +Y H +I+RDLK ENLL+D +
Sbjct: 121 EYVAGGEMFSHLRRIGRFSE--PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
Query: 183 NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 242
I++ DFGF+ + T CG+P APE+ K Y VD W+LGV++Y + +G
Sbjct: 179 YIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGY 235
Query: 243 LPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
PF ++ E+++ GK R P + S+D ++LL+ L ++ KR
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 45/115 (39%), Positives = 62/115 (53%), Gaps = 9/115 (7%)
Query: 473 TLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQ 530
L F+ LY+VMEY +GGE+F +L GR E A+F QIV +Y H
Sbjct: 105 KLEFSFK---DNSNLYMVMEYVAGGEMFSHLRRIGRFSE--PHARFYAAQIVLTFEYLHS 159
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
+I+RDLK ENLL+D + I++ DFGF+ + T CG+P APE+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS 212
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 5e-77
Identities = 80/249 (32%), Positives = 133/249 (53%), Gaps = 16/249 (6%)
Query: 50 LLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDHPNIV 108
+L+ IGKG+F KV + + T K A+K ++K + + ++ +F+E++IM+ L+HP +V
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 109 KL---FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQ 163
L FQ E+ +++V++ GG++ +L + KE K ++V A+ Y
Sbjct: 79 NLWYSFQ---DEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELVMALDYLQN 133
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
++IIHRD+K +N+LLD ++ I DF + ++ T G+ PY APE+F +K G
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 224 --PEVDVWSLGVILYTLVSGSLPFDGST---LRELRERVLRGKYRIPFYMSTDCENLLKK 278
VD WSLGV Y L+ G P+ + +E+ P S + +LLKK
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 279 FLVLNPAKR 287
L NP +R
Sbjct: 254 LLEPNPDQR 262
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 7/109 (6%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ E+ +++V++ GG++ +L + KE K ++V A+ Y ++IIH
Sbjct: 84 FQ---DEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELVMALDYLQNQRIIH 138
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
RD+K +N+LLD ++ I DF + ++ T G+ PY APE+F
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 6e-77
Identities = 60/279 (21%), Positives = 115/279 (41%), Gaps = 26/279 (9%)
Query: 30 SSRRESSRRERDEPHIGK--YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG 87
S ++ E +GK + +G G + + + + ++VA+K I
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECF--- 61
Query: 88 SLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRM-KEK 145
REV++++ D HPN+++ F + + Y+ +E + +Y+
Sbjct: 62 --SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGL 118
Query: 146 EARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL-----DSEMNIKIADFGFSNEFTPG-- 198
E +Q S + + H I+HRDLK N+L+ ++ I+DFG + G
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 199 --NKLDTFCGSPPYAAPELFQGKKYD--GPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253
++ G+ + APE+ + VD++S G + Y ++S GS PF S R+
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238
Query: 254 RERVLRGKY---RIPFYMSTDCENLLKKFLVLNPAKRAS 289
+ + L++K + ++P KR S
Sbjct: 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 27/130 (20%), Positives = 52/130 (40%), Gaps = 11/130 (8%)
Query: 466 RASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRM-KEKEARAKFRQIVSA 524
R S +++ F + + Y+ +E + +Y+ E +Q S
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 525 VQYCHQKKIIHRDLKAENLLL-----DSEMNIKIADFGFSNEFTPG----NKLDTFCGSP 575
+ + H I+HRDLK N+L+ ++ I+DFG + G ++ G+
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 576 PYAAPELFQG 585
+ APE+
Sbjct: 191 GWIAPEMLSE 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 6e-76
Identities = 77/250 (30%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIMKML 102
+++L+T+G G+F +V L + G+ A+K++ K + ++ E ++ ++
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV----VRLKQVEHTNDERLMLSIV 63
Query: 103 DHPNIVKL---FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSA 157
HP I+++ FQ + ++++M+Y GGE+F L R AKF ++ A
Sbjct: 64 THPFIIRMWGTFQ---DAQQIFMIMDYIEGGELFSLLRKSQRFPN--PVAKFYAAEVCLA 118
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
++Y H K II+RDLK EN+LLD +IKI DFGF+ + T CG+P Y APE+
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVS 176
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
K Y +D WS G+++Y +++G PF S + E++L + R P + + D ++LL
Sbjct: 177 TKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235
Query: 278 KFLVLNPAKR 287
+ + + ++R
Sbjct: 236 RLITRDLSQR 245
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 2e-33
Identities = 43/110 (39%), Positives = 61/110 (55%), Gaps = 9/110 (8%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ + ++++M+Y GGE+F L R AKF ++ A++Y H K II+
Sbjct: 75 FQ---DAQQIFMIMDYIEGGELFSLLRKSQRFPN--PVAKFYAAEVCLALEYLHSKDIIY 129
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
RDLK EN+LLD +IKI DFGF+ + T CG+P Y APE+
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 177
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 6e-75
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 35/278 (12%)
Query: 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
++ ++ ++ +G+G F V AK+ AIK I + +K+ REV+ + L+
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLE 61
Query: 104 HPNIVKLFQVIETE------------KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK- 150
HP IV+ F + LY+ M+ + D++ ++E+E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 151 --FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-------------NEF 195
F QI AV++ H K ++HRDLK N+ + +K+ DFG
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELR 254
+ G+ Y +PE G Y +VD++SLG+IL+ L+ PF R
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 255 ERVLRGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
V K+ + +++ L +P +R
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 28/120 (23%), Positives = 48/120 (40%), Gaps = 16/120 (13%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK---FRQIVSAVQYCHQKKIIHRDL 538
+ LY+ M+ + D++ ++E+E F QI AV++ H K ++HRDL
Sbjct: 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDL 144
Query: 539 KAENLLLDSEMNIKIADFGFS-------------NEFTPGNKLDTFCGSPPYAAPELFQG 585
K N+ + +K+ DFG + G+ Y +PE G
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-73
Identities = 94/251 (37%), Positives = 139/251 (55%), Gaps = 21/251 (8%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIMKML 102
+ LK +GKG F KV L + TG+ A+KI+ K + + K E R+++
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVLQNT 62
Query: 103 DHPNIVKL---FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSA 157
HP + L FQ T L VMEYA+GGE+F +L E+ RA+F +IVSA
Sbjct: 63 RHPFLTALKYAFQ---THDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSA 117
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELF 216
++Y H + +++RD+K ENL+LD + +IKI DFG E + G + TFCG+P Y APE+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276
+ Y G VD W LGV++Y ++ G LPF L E +L + R P +S + ++LL
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236
Query: 277 KKFLVLNPAKR 287
L +P +R
Sbjct: 237 AGLLKKDPKQR 247
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 49/111 (44%), Positives = 70/111 (63%), Gaps = 8/111 (7%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ T L VMEYA+GGE+F +L E+ RA+F +IVSA++Y H + +++
Sbjct: 74 FQ---THDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHSRDVVY 128
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
RD+K ENL+LD + +IKI DFG E + G + TFCG+P Y APE+ +
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 238 bits (611), Expect = 4e-73
Identities = 91/250 (36%), Positives = 137/250 (54%), Gaps = 17/250 (6%)
Query: 49 KLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKMLD 103
+LL+ +GKG + KV + V TGK A+K++ K + N E I++ +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 104 HPNIVKL---FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAV 158
HP IV L FQ T LYL++EY SGGE+F L G E A F +I A+
Sbjct: 80 HPFIVDLIYAFQ---TGGKLYLILEYLSGGELFMQLEREGIFMED--TACFYLAEISMAL 134
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQ 217
+ HQK II+RDLK EN++L+ + ++K+ DFG E G TFCG+ Y APE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
+ VD WSLG ++Y +++G+ PF G ++ +++L+ K +P Y++ + +LLK
Sbjct: 195 RSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 278 KFLVLNPAKR 287
K L N A R
Sbjct: 254 KLLKRNAASR 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 46/111 (41%), Positives = 62/111 (55%), Gaps = 8/111 (7%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ T LYL++EY SGGE+F L G E A F +I A+ + HQK II+
Sbjct: 90 FQ---TGGKLYLILEYLSGGELFMQLEREGIFMED--TACFYLAEISMALGHLHQKGIIY 144
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
RDLK EN++L+ + ++K+ DFG E G TFCG+ Y APE+
Sbjct: 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 9e-73
Identities = 89/277 (32%), Positives = 145/277 (52%), Gaps = 19/277 (6%)
Query: 20 ENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP---TGKEVAI 76
E +I + +E + +++LLK +G+G+F KV L K + + A+
Sbjct: 2 EGSIKEIAITHHVKEGHEKAD----PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAM 57
Query: 77 KIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKL---FQVIETEKTLYLVMEYASGGEVF 133
K++ K L + E I+ ++HP IVKL FQ TE LYL++++ GG++F
Sbjct: 58 KVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ---TEGKLYLILDFLRGGDLF 114
Query: 134 DYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191
L E+ KF ++ A+ + H II+RDLK EN+LLD E +IK+ DFG
Sbjct: 115 TRLSKEVMFTEE--DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 192 SNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
S E K +FCG+ Y APE+ + + D WS GV+++ +++G+LPF G
Sbjct: 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 251 RELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
+E +L+ K +P ++S + ++LL+ NPA R
Sbjct: 232 KETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 43/111 (38%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ TE LYL++++ GG++F L E+ KF ++ A+ + H II+
Sbjct: 95 FQ---TEGKLYLILDFLRGGDLFTRLSKEVMFTEE--DVKFYLAELALALDHLHSLGIIY 149
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
RDLK EN+LLD E +IK+ DFG S E K +FCG+ Y APE+
Sbjct: 150 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-72
Identities = 92/291 (31%), Positives = 143/291 (49%), Gaps = 24/291 (8%)
Query: 11 GKSETGRGSENNISSSRLMSSRRESSRRERDEPHIG--KYKLLKTIGKGNFAKVKLAKHV 68
G S+ N + + + ++ + PH + LK IGKG+F KV LA+H
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 69 PTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIM-KMLDHPNIVKL---FQVIETEKT 119
A+K++ K + L+K + E ++ K + HP +V L FQ T
Sbjct: 61 AEEVFYAVKVLQKKAI----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ---TADK 113
Query: 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLL 177
LY V++Y +GGE+F +L E RA+F +I SA+ Y H I++RDLK EN+L
Sbjct: 114 LYFVLDYINGGELFYHLQRERCFLEP--RARFYAAEIASALGYLHSLNIVYRDLKPENIL 171
Query: 178 LDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 236
LDS+ +I + DFG E + TFCG+P Y APE+ + Y VD W LG +LY
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLY 230
Query: 237 TLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
++ G PF E+ + +L ++ ++ +LL+ L + KR
Sbjct: 231 EMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-33
Identities = 46/111 (41%), Positives = 63/111 (56%), Gaps = 8/111 (7%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ T LY V++Y +GGE+F +L E RA+F +I SA+ Y H I++
Sbjct: 108 FQ---TADKLYFVLDYINGGELFYHLQRERCFLEP--RARFYAAEIASALGYLHSLNIVY 162
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
RDLK EN+LLDS+ +I + DFG E + TFCG+P Y APE+
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-71
Identities = 89/252 (35%), Positives = 134/252 (53%), Gaps = 22/252 (8%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIMKM- 101
+ L K +GKG+F KV LA+ T + AIK + K + L E R++ +
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV----LMDDDVECTMVEKRVLSLA 74
Query: 102 LDHPNIVKL---FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVS 156
+HP + + FQ T++ L+ VMEY +GG++ ++ + RA F +I+
Sbjct: 75 WEHPFLTHMFCTFQ---TKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIIL 129
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPEL 215
+Q+ H K I++RDLK +N+LLD + +IKIADFG E K +TFCG+P Y APE+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENL 275
G+KY VD WS GV+LY ++ G PF G EL + P ++ + ++L
Sbjct: 190 LLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248
Query: 276 LKKFLVLNPAKR 287
L K V P KR
Sbjct: 249 LVKLFVREPEKR 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 45/111 (40%), Positives = 67/111 (60%), Gaps = 8/111 (7%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ T++ L+ VMEY +GG++ ++ + RA F +I+ +Q+ H K I++
Sbjct: 87 FQ---TKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILGLQFLHSKGIVY 141
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
RDLK +N+LLD + +IKIADFG E K +TFCG+P Y APE+ G
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 192
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-71
Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 18/268 (6%)
Query: 30 SSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL 89
+ + + RD + + L +GKG+F KV L++ T + A+KI+ K + +
Sbjct: 4 TVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV----I 59
Query: 90 QK-----LFREVRIM-KMLDHPNIVKL---FQVIETEKTLYLVMEYASGGEVFDYLVLHG 140
Q E R++ P + +L FQ T LY VMEY +GG++ ++ G
Sbjct: 60 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ---TMDRLYFVMEYVNGGDLMYHIQQVG 116
Query: 141 RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGN 199
R KE A +I + + K II+RDLK +N++LDSE +IKIADFG E G
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
Query: 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR 259
TFCG+P Y APE+ + Y G VD W+ GV+LY +++G PF+G EL + ++
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
Query: 260 GKYRIPFYMSTDCENLLKKFLVLNPAKR 287
P MS + + K + +P KR
Sbjct: 236 HNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 47/109 (43%), Positives = 62/109 (56%), Gaps = 4/109 (3%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
FQ T LY VMEY +GG++ ++ GR KE A +I + + K II+RD
Sbjct: 90 FQ---TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 538 LKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
LK +N++LDSE +IKIADFG E G TFCG+P Y APE+
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 195
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-70
Identities = 94/270 (34%), Positives = 143/270 (52%), Gaps = 20/270 (7%)
Query: 30 SSRRESSRRERDEPHIG--KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG 87
SS+ + +G ++ ++ +GKG+F KV LA+ TG A+K++ K +
Sbjct: 5 SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--- 61
Query: 88 SLQK-----LFREVRIM-KMLDHPNIVKL---FQVIETEKTLYLVMEYASGGEVFDYLVL 138
LQ E RI+ +HP + +L FQ T L+ VME+ +GG++ ++
Sbjct: 62 -LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ---TPDRLFFVMEFVNGGDLMFHIQK 117
Query: 139 HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TP 197
R E AR +I+SA+ + H K II+RDLK +N+LLD E + K+ADFG E
Sbjct: 118 SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177
Query: 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERV 257
G TFCG+P Y APE+ Q Y GP VD W++GV+LY ++ G PF+ +L E +
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236
Query: 258 LRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
L + P ++ D +LK F+ NP R
Sbjct: 237 LNDEVVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 46/109 (42%), Positives = 64/109 (58%), Gaps = 4/109 (3%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
FQ T L+ VME+ +GG++ ++ R E AR +I+SA+ + H K II+RD
Sbjct: 93 FQ---TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRD 149
Query: 538 LKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
LK +N+LLD E + K+ADFG E G TFCG+P Y APE+ Q
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 2e-70
Identities = 45/313 (14%), Positives = 94/313 (30%), Gaps = 45/313 (14%)
Query: 22 NISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK 81
++ + E++ K KL++ + G+ + V L + V ++ A+K+
Sbjct: 38 EAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM 97
Query: 82 TQLNPGS-LQKLFREVRIMKMLDHPNIVKLFQVI-------------------------- 114
N S L++L L + +
Sbjct: 98 GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157
Query: 115 ETEKTLYLVMEYASG-----GEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIH 168
L+M AS D++ + + A Q++ K ++H
Sbjct: 158 YAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217
Query: 169 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD-GPEVD 227
+NL + + + + D + G + YA E ++
Sbjct: 218 GHFTPDNLFIMPDGRLMLGDVSALWK--VGTRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 228 VWSLGVILYTLVSGSLPFDGST-----LRELRERVLRGKYRIPFY----MSTDCENLLKK 278
W LG+ +Y + LPF T + + G + F + + L+ +
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
Query: 279 FLVLNPAKRASLE 291
FL + +R
Sbjct: 336 FLNFDRRRRLLPL 348
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 7e-28
Identities = 16/107 (14%), Positives = 32/107 (29%), Gaps = 8/107 (7%)
Query: 487 LYLVMEYASG-----GEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDLKA 540
L+M AS D++ + + A Q++ K ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222
Query: 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587
+NL + + + + D + G + YA E
Sbjct: 223 DNLFIMPDGRLMLGDVSALWK--VGTRGPASSVPVTYAPREFLNAST 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-70
Identities = 99/291 (34%), Positives = 148/291 (50%), Gaps = 26/291 (8%)
Query: 21 NNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIID 80
+ S + S + + + +++ LK +GKG F KV L K TG+ A+KI+
Sbjct: 123 GSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK 182
Query: 81 KTQLNPGSLQK-----LFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDY 135
K + + K E R+++ HP + L +T L VMEYA+GGE+F +
Sbjct: 183 KEVI----VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH 238
Query: 136 LVLHGRMKEKEARAKF--RQIVSAVQYCHQKK-IIHRDLKAENLLLDSEMNIKIADFGFS 192
L E RA+F +IVSA+ Y H +K +++RDLK ENL+LD + +IKI DFG
Sbjct: 239 LSRERVFSED--RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
Query: 193 NE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR 251
E G + TFCG+P Y APE+ + Y G VD W LGV++Y ++ G LPF
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355
Query: 252 ELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGEVTLGGAP 302
+L E +L + R P + + ++LL L +P +R LGG
Sbjct: 356 KLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR----------LGGGS 396
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 51/116 (43%), Positives = 69/116 (59%), Gaps = 6/116 (5%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 531
L L +T L VMEYA+GGE+F +L E RA+F +IVSA+ Y H +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED--RARFYGAEIVSALDYLHSE 267
Query: 532 K-IIHRDLKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
K +++RDLK ENL+LD + +IKI DFG E G + TFCG+P Y APE+ +
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-69
Identities = 84/292 (28%), Positives = 142/292 (48%), Gaps = 32/292 (10%)
Query: 21 NNISSSRLMSSRRESSRRERDEPHIGKYK----------LLKTIGKGNFAKVKLAKHVPT 70
++ L ++ + R + I K + ++K IG+G F +V+L +H T
Sbjct: 34 YDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST 93
Query: 71 GKEVAIKIIDKTQLNPGSLQKLFR-EVRIMKMLDHPNIVKL---FQVIETEKTLYLVMEY 126
K A+K++ K ++ S F E IM + P +V+L FQ ++ LY+VMEY
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ---DDRYLYMVMEY 150
Query: 127 ASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184
GG++ + + E A+F ++V A+ H IHRD+K +N+LLD ++
Sbjct: 151 MPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 207
Query: 185 KIADFGFSNEFTPGNKL--DTFCGSPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLV 239
K+ADFG + + DT G+P Y +PE+ + + D G E D WS+GV LY ++
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 240 SGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKR 287
G PF +L +++ K + F +S + +NL+ FL + R
Sbjct: 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVR 318
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 37/112 (33%), Positives = 60/112 (53%), Gaps = 10/112 (8%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ ++ LY+VMEY GG++ + + E A+F ++V A+ H IH
Sbjct: 138 FQ---DDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSMGFIH 191
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL--DTFCGSPPYAAPELFQG 585
RD+K +N+LLD ++K+ADFG + + DT G+P Y +PE+ +
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-69
Identities = 87/256 (33%), Positives = 145/256 (56%), Gaps = 21/256 (8%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIM-KM 101
+ LL+ IG+G++AKV L + T + A+K++ K + + E + +
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV----NDDEDIDWVQTEKHVFEQA 66
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
+HP +V L +TE L+ V+EY +GG++ ++ ++ E+ AR +I A+ Y
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKK 220
H++ II+RDLK +N+LLDSE +IK+ D+G E PG+ TFCG+P Y APE+ +G+
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 186
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPF---------DGSTLRELRERVLRGKYRIPFYMSTD 271
Y G VD W+LGV+++ +++G PF D +T L + +L + RIP +S
Sbjct: 187 Y-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 272 CENLLKKFLVLNPAKR 287
++LK FL +P +R
Sbjct: 246 AASVLKSFLNKDPKER 261
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 46/109 (42%), Positives = 70/109 (64%), Gaps = 4/109 (3%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
FQ TE L+ V+EY +GG++ ++ ++ E+ AR +I A+ Y H++ II+RD
Sbjct: 79 FQ---TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 135
Query: 538 LKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
LK +N+LLDSE +IK+ D+G E PG+ TFCG+P Y APE+ +G
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 5e-69
Identities = 89/297 (29%), Positives = 156/297 (52%), Gaps = 33/297 (11%)
Query: 13 SETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP--- 69
++ G G E ++ + + + E+ ++LLK +G G + KV L + +
Sbjct: 23 ADGGDGGEQLLTVKHELRTANLTGHAEKVGIE--NFELLKVLGTGAYGKVFLVRKISGHD 80
Query: 70 TGKEVAIKIIDKTQLNPGSLQKL------FREVRIMKMLDH-PNIVKL---FQVIETEKT 119
TGK A+K++ K + +QK E ++++ + P +V L FQ TE
Sbjct: 81 TGKLYAMKVLKKATI----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---TETK 133
Query: 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLL 177
L+L+++Y +GGE+F +L R E + +IV A+++ H+ II+RD+K EN+L
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEH--EVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 178 LDSEMNIKIADFGFSNEF--TPGNKLDTFCGSPPYAAPELFQGKKY-DGPEVDVWSLGVI 234
LDS ++ + DFG S EF + FCG+ Y AP++ +G VD WSLGV+
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 235 LYTLVSGSLPFDG----STLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
+Y L++G+ PF ++ E+ R+L+ + P MS ++L+++ L+ +P KR
Sbjct: 252 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 42/112 (37%), Positives = 66/112 (58%), Gaps = 9/112 (8%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ TE L+L+++Y +GGE+F +L R E + +IV A+++ H+ II+
Sbjct: 128 FQ---TETKLHLILDYINGGELFTHLSQRERFTEH--EVQIYVGEIVLALEHLHKLGIIY 182
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEF--TPGNKLDTFCGSPPYAAPELFQG 585
RD+K EN+LLDS ++ + DFG S EF + FCG+ Y AP++ +G
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-68
Identities = 89/301 (29%), Positives = 157/301 (52%), Gaps = 21/301 (6%)
Query: 3 DKSFRYSTGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKV 62
+ T ++ +G+ + + S + + + LL+ IG+G++AKV
Sbjct: 9 HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKV 68
Query: 63 KLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIM-KMLDHPNIVKLFQVIET 116
L + T + A++++ K + + E + + +HP +V L +T
Sbjct: 69 LLVRLKKTDRIYAMRVVKKELV----NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124
Query: 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 176
E L+ V+EY +GG++ ++ ++ E+ AR +I A+ Y H++ II+RDLK +N+
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 177 LLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 235
LLDSE +IK+ D+G E PG+ TFCG+P Y APE+ +G+ Y G VD W+LGV++
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLM 243
Query: 236 YTLVSGSLPF---------DGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAK 286
+ +++G PF D +T L + +L + RIP +S ++LK FL +P +
Sbjct: 244 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKE 303
Query: 287 R 287
R
Sbjct: 304 R 304
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 46/109 (42%), Positives = 70/109 (64%), Gaps = 4/109 (3%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
FQ TE L+ V+EY +GG++ ++ ++ E+ AR +I A+ Y H++ II+RD
Sbjct: 122 FQ---TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 178
Query: 538 LKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
LK +N+LLDSE +IK+ D+G E PG+ TFCG+P Y APE+ +G
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-68
Identities = 68/251 (27%), Positives = 123/251 (49%), Gaps = 16/251 (6%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIMKML 102
++ + +GKG F +V + TGK A K ++K ++ ++ E +I++ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI----KKRKGEAMALNEKQILEKV 241
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQY 160
+ +V L ET+ L LV+ +GG++ ++ G+ EARA F +I ++
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H+++I++RDLK EN+LLD +I+I+D G + G + G+ Y APE+ + ++
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYRIPFYMSTDCENLL 276
Y D W+LG +LY +++G PF E+ V S +L
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420
Query: 277 KKFLVLNPAKR 287
+ L +PA+R
Sbjct: 421 SQLLCKDPAER 431
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 36/114 (31%), Positives = 63/114 (55%), Gaps = 2/114 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 531
++ L ET+ L LV+ +GG++ ++ G+ EARA F +I ++ H++
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
+I++RDLK EN+LLD +I+I+D G + G + G+ Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-68
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 28/294 (9%)
Query: 20 ENNISSSRLMSSRRESSRRERDEPHIGKYK----------LLKTIGKGNFAKVKLAKHVP 69
+ +S L + + + EP + + K +LK IG+G F++V + K
Sbjct: 25 HQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ 84
Query: 70 TGKEVAIKIIDKTQLNPGSLQKLFR-EVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYAS 128
TG+ A+KI++K + FR E ++ D I +L + E LYLVMEY
Sbjct: 85 TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144
Query: 129 GGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186
GG++ L G + A+F +IV A+ H+ +HRD+K +N+LLD +I++
Sbjct: 145 GGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRL 203
Query: 187 ADFGFSNEFTPGNKL--DTFCGSPPYAAPELFQGKKYD------GPEVDVWSLGVILYTL 238
ADFG + + G+P Y +PE+ Q GPE D W+LGV Y +
Sbjct: 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 239 VSGSLPFDGSTLRELRERVLRGKYRIPF-----YMSTDCENLLKKFLVLNPAKR 287
G PF + E +++ K + + + + +++ L P R
Sbjct: 264 FYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETR 316
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 41/123 (33%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIH 535
FQ E LYLVMEY GG++ L G + A+F +IV A+ H+ +H
Sbjct: 130 FQ---DENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL--DTFCGSPPYAAPELFQGGAPVTSSG 593
RD+K +N+LLD +I++ADFG + + G+P Y +PE+ Q +G
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 594 GAG 596
G
Sbjct: 246 SYG 248
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 5e-68
Identities = 41/268 (15%), Positives = 89/268 (33%), Gaps = 33/268 (12%)
Query: 47 KYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+ +G+G FA+V A ++ +K+ NP + + +K
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-----MKEKEARAKFRQIVS 156
+K + + LV E S G + + + L+ M + + +++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 157 AVQYCHQKKIIHRDLKAENLLL-----------DSEMNIKIADFGFS---NEFTPGNKLD 202
++ H +IIH D+K +N +L D + + D G S F G
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGSTLRELRERVLRGK 261
C + + E+ K ++ ++D + + +Y ++ G+ E + R
Sbjct: 244 AKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL 302
Query: 262 YRIPFYMSTDCENLLKKFLVLNPAKRAS 289
+ + L +
Sbjct: 303 PHLDMW-----NEFFHVMLNIPDCHHLP 325
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 5e-32
Identities = 24/131 (18%), Positives = 47/131 (35%), Gaps = 19/131 (14%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-----MKEKEARAKFRQIVSAVQYC 528
+K + + LV E S G + + + L+ M + + +++ ++
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 529 HQKKIIHRDLKAENLLL-----------DSEMNIKIADFGFS---NEFTPGNKLDTFCGS 574
H +IIH D+K +N +L D + + D G S F G C +
Sbjct: 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248
Query: 575 PPYAAPELFQG 585
+ E+
Sbjct: 249 SGFQCVEMLSN 259
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-67
Identities = 79/253 (31%), Positives = 127/253 (50%), Gaps = 19/253 (7%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRIMKMLD 103
+ +G+G F +V + TGK A K ++K +L ++ E +I+ +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL----KKRKGYQGAMVEKKILAKVH 243
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE--KEARAKF--RQIVSAVQ 159
IV L ET+ L LVM +GG++ ++ +E RA F QIVS ++
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 218
+ HQ+ II+RDLK EN+LLD + N++I+D G + E K + G+P + APEL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYRIPFYMSTDCEN 274
++Y VD ++LGV LY +++ PF +EL++RVL P S ++
Sbjct: 364 EEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 275 LLKKFLVLNPAKR 287
+ L +P KR
Sbjct: 423 FCEALLQKDPEKR 435
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 43/117 (36%), Positives = 66/117 (56%), Gaps = 5/117 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKE--KEARAKF--RQIVSAVQYCH 529
++ L ET+ L LVM +GG++ ++ +E RA F QIVS +++ H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQG 585
Q+ II+RDLK EN+LLD + N++I+D G + E K + G+P + APEL G
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-67
Identities = 87/276 (31%), Positives = 136/276 (49%), Gaps = 12/276 (4%)
Query: 19 SENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKI 78
+ + + RD + + L +GKG+F KV L++ T + A+KI
Sbjct: 314 GTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI 373
Query: 79 IDKTQLNPGSLQK-----LFREVRIMKM-LDHPNIVKLFQVIETEKTLYLVMEYASGGEV 132
+ K + +Q E R++ + P + +L +T LY VMEY +GG++
Sbjct: 374 LKKDVV----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 133 FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192
++ GR KE A +I + + K II+RDLK +N++LDSE +IKIADFG
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 193 NE-FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR 251
E G TFCG+P Y APE+ + Y G VD W+ GV+LY +++G PF+G
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDED 548
Query: 252 ELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
EL + ++ P MS + + K + +P KR
Sbjct: 549 ELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-31
Identities = 47/109 (43%), Positives = 62/109 (56%), Gaps = 4/109 (3%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
FQ T LY VMEY +GG++ ++ GR KE A +I + + K II+RD
Sbjct: 411 FQ---TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 538 LKAENLLLDSEMNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQG 585
LK +N++LDSE +IKIADFG E G TFCG+P Y APE+
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-66
Identities = 83/290 (28%), Positives = 138/290 (47%), Gaps = 30/290 (10%)
Query: 24 SSSRLMSSRRESSRRERDEPHIGKYK----------LLKTIGKGNFAKVKLAKHVPTGKE 73
++S L + E +P K K +LK IG+G F +V + K K
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 74 VAIKIIDKTQLNPGSLQKLFR-EVRIMKMLDHPNIVKL---FQVIETEKTLYLVMEYASG 129
A+KI++K ++ + FR E ++ D I L FQ + LYLVM+Y G
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ---DDNNLYLVMDYYVG 158
Query: 130 GEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIAD 188
G++ L R+ E+ AR ++V A+ HQ +HRD+K +N+L+D +I++AD
Sbjct: 159 GDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 189 FGFSNEFTPGNKL--DTFCGSPPYAAPELFQGKKYD----GPEVDVWSLGVILYTLVSGS 242
FG + + G+P Y +PE+ Q + GPE D WSLGV +Y ++ G
Sbjct: 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
Query: 243 LPFDGSTLRELRERVLRGKYRIPF-----YMSTDCENLLKKFLVLNPAKR 287
PF +L E +++ K R F +S + ++L+++ + + R
Sbjct: 279 TPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHR 327
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 6/111 (5%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536
FQ + LYLVM+Y GG++ L R+ E+ AR ++V A+ HQ +HR
Sbjct: 143 FQ---DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKL--DTFCGSPPYAAPELFQG 585
D+K +N+L+D +I++ADFG + + G+P Y +PE+ Q
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 4e-63
Identities = 42/326 (12%), Positives = 92/326 (28%), Gaps = 47/326 (14%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLL---KTIGKGNFAKVKLA 65
T ++ S S + + + L +G+ + A
Sbjct: 38 QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEA 97
Query: 66 KHVPTGKEVAIKIIDKTQLNPGS-LQKLFREVRIMK----------------------ML 102
TG+ + + T+ P + ++++ EV ++ ++
Sbjct: 98 TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157
Query: 103 DHPNIVKLFQVIETEK-----TLYLVMEYASG------GEVFDYLVLHGRMKEKEARAKF 151
P K+ +V E+ + + + + + H +
Sbjct: 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 217
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPP 209
Q++ + H ++H L+ +++LD + + F P
Sbjct: 218 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPE 277
Query: 210 YAAPELFQGKKYD----GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP 265
A + ++ D W+LG+ +Y + LP E + R IP
Sbjct: 278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP 337
Query: 266 FYMSTDCENLLKKFLVLNPAKRASLE 291
LL+ FL R
Sbjct: 338 ----QPVRALLEGFLRYPKEDRLLPL 359
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 11/118 (9%), Positives = 30/118 (25%), Gaps = 8/118 (6%)
Query: 486 TLYLVMEYASG------GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 539
+ + + + + H + Q++ + H ++H L+
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQGGAPVTSSGGA 595
+++LD + + F P A + G +
Sbjct: 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 7e-63
Identities = 62/269 (23%), Positives = 103/269 (38%), Gaps = 33/269 (12%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIM-KMLDHP 105
++ L+ IG G F V G AIK K Q REV + H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKFRQIVSAVQYC 161
++V+ F + + + EY +GG + D + + R KE E + Q+ ++Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 162 HQKKIIHRDLKAENLLLDSEMNI-------------------KIADFGFSNEFTPGNKLD 202
H ++H D+K N+ + KI D G T +
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQ 188
Query: 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS-LPFDGSTLRELRERVLRGK 261
G + A E+ Q P+ D+++L + + LP +G E+R +G+
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR----QGR 244
Query: 262 Y-RIPFYMSTDCENLLKKFLVLNPAKRAS 289
RIP +S + LLK + +P +R S
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPS 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 25/130 (19%), Positives = 44/130 (33%), Gaps = 26/130 (20%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
+ + + EY +GG + D + + R KE E + Q+ ++Y H ++H D
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMD 140
Query: 538 LKAENLLLDSEMNI-------------------KIADFGFSNEFTPGNKLDTFCGSPPYA 578
+K N+ + KI D G T + G +
Sbjct: 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEGDSRFL 197
Query: 579 APELFQGGAP 588
A E+ Q
Sbjct: 198 ANEVLQENYT 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-62
Identities = 65/250 (26%), Positives = 115/250 (46%), Gaps = 16/250 (6%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-----LFREVRI---MK 100
+ + IG+G F +V + TGK A+K +DK ++ K E + +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI----KMKQGETLALNERIMLSLVS 247
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
D P IV + T L +++ +GG++ +L HG E + R +I+ +++
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H + +++RDLK N+LLD +++I+D G + +F K G+ Y APE+ Q
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGV 366
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLR---ELRERVLRGKYRIPFYMSTDCENLLK 277
D +SLG +L+ L+ G PF + E+ L +P S + +LL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 278 KFLVLNPAKR 287
L + +R
Sbjct: 427 GLLQRDVNRR 436
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 33/119 (27%), Positives = 62/119 (52%), Gaps = 1/119 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ + T L +++ +GG++ +L HG E + R +I+ +++ H + +
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
++RDLK N+LLD +++I+D G + +F K G+ Y APE+ Q G SS
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-61
Identities = 69/247 (27%), Positives = 116/247 (46%), Gaps = 11/247 (4%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+ + IG G+F V A+ G +VA+KI+ + + + + REV IMK L HPNIV
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQYCHQKK 165
+ L +V EY S G ++ L G ++ + R + + + Y H +
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 166 --IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQGKKYD 222
I+HR+LK+ NLL+D + +K+ DFG S G+P + APE+ + + +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCENLLKKFL 280
+ DV+S GVIL+ L + P+ ++ V R IP ++ +++
Sbjct: 218 -EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 281 VLNPAKR 287
P KR
Sbjct: 277 TNEPWKR 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQYCHQKK--IIHRDLKAE 541
L +V EY S G ++ L G ++ + R + + + Y H + I+HR+LK+
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQG 585
NLL+D + +K+ DFG S G+P + APE+ +
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 8e-59
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 20/277 (7%)
Query: 30 SSRRESSRRERDEPHI------GKY-KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT 82
++ E E G++ K IG+G+F V T EVA +
Sbjct: 3 ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62
Query: 83 QLNPGSLQKLFREVRIMKMLDHPNIVKLF----QVIETEKTLYLVMEYASGGEVFDYLVL 138
+L Q+ E ++K L HPNIV+ + ++ +K + LV E + G + YL
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 139 HGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEM-NIKIADFGFSNEF 195
MK K R+ RQI+ +Q+ H + IIHRDLK +N+ + ++KI D G +
Sbjct: 123 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TL 181
Query: 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGSTLRELR 254
+ G+P + APE+++ K VDV++ G+ + + + P+ + ++
Sbjct: 182 KRASFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239
Query: 255 ERVLRGK--YRIPFYMSTDCENLLKKFLVLNPAKRAS 289
RV G + + +++ + N +R S
Sbjct: 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLK 539
+ +K + LV E + G + YL MK K R+ RQI+ +Q+ H + IIHRDLK
Sbjct: 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158
Query: 540 AENLLLDSEM-NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
+N+ + ++KI D G + + G+P + APE+++
Sbjct: 159 CDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMYEEK 205
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 6e-58
Identities = 77/255 (30%), Positives = 119/255 (46%), Gaps = 22/255 (8%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKII--DKTQLNPGSLQKLFREVRIMKMLDHPN 106
L + IG G F KV A G EVA+K D + +++ + +E ++ ML HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 165
I+ L V E L LVME+A GG + L G+ + + QI + Y H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 166 ---IIHRDLKAENLLLDSEM--------NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 214
IIHRDLK+ N+L+ ++ +KI DFG + E+ K+ + G+ + APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPE 184
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFYMSTDC 272
+ + + DVWS GV+L+ L++G +PF G + V K IP
Sbjct: 185 VIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF 243
Query: 273 ENLLKKFLVLNPAKR 287
L++ +P R
Sbjct: 244 AKLMEDCWNPDPHSR 258
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 37/124 (29%), Positives = 60/124 (48%), Gaps = 15/124 (12%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
++ L V E L LVME+A GG + L G+ + + QI + Y H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 533 ---IIHRDLKAENLLLDSEM--------NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
IIHRDLK+ N+L+ ++ +KI DFG + E+ K+ + G+ + APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPE 184
Query: 582 LFQG 585
+ +
Sbjct: 185 VIRA 188
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 7e-57
Identities = 48/249 (19%), Positives = 104/249 (41%), Gaps = 16/249 (6%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
L + + + ++ + G ++ +K++ + + E +++ HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 109 KLFQVIET--EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA-KF-RQIVSAVQYCHQK 164
+ ++ L+ + G +++ L +++A KF + + + H
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 165 K--IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD 222
+ I L + ++++D +M +I+ F + +P + APE Q K D
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQKKPED 186
Query: 223 GPE--VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCENLLKK 278
D+WS V+L+ LV+ +PF + E+ +V R IP +S L+K
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI 246
Query: 279 FLVLNPAKR 287
+ +PAKR
Sbjct: 247 CMNEDPAKR 255
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 18/106 (16%), Positives = 41/106 (38%), Gaps = 8/106 (7%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA-KF-RQIVSAVQYCHQKK--IIHRDLK 539
L+ + G +++ L +++A KF + + + H + I L
Sbjct: 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
+ ++++D +M +I+ F + +P + APE Q
Sbjct: 141 SRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQK 182
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 28/260 (10%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-----LQKLFREVRIMKMLD 103
+ K IGKG F V + V VAIK + + Q+ REV IM L+
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQY 160
HPNIVKL+ + +VME+ G+++ L + + K R I ++Y
Sbjct: 82 HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHR--LLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 161 CHQKK--IIHRDLKAENLLLDS-----EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAP 213
+ I+HRDL++ N+ L S + K+ADFG S + + + G+ + AP
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAP 195
Query: 214 ELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR--ERVLRGKYR--IPFY 267
E + Y + D +S +ILYT+++G PFD + +++ + R IP
Sbjct: 196 ETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 268 MSTDCENLLKKFLVLNPAKR 287
N+++ +P KR
Sbjct: 255 CPPRLRNVIELCWSGDPKKR 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 14/111 (12%)
Query: 485 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQYCHQKK--IIHRDLK 539
+VME+ G+++ L + + K R I ++Y + I+HRDL+
Sbjct: 94 NPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151
Query: 540 AENLLLDS-----EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
+ N+ L S + K+ADFG S + + + G+ + APE
Sbjct: 152 SPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGA 200
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 27/292 (9%)
Query: 18 GSENNIS--SSRLMSSRRESSRRERDEPHI--GKYKLLKTIGKGNFAKVKLAKHVPTGKE 73
G E N+S S+R + + E I + ++ + IGKG F +V + E
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW---HGE 57
Query: 74 VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVF 133
VAI++ID + N L+ REV + H N+V + L ++ G ++
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 134 DYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192
+ + + + ++IV + Y H K I+H+DLK++N+ D + I DFG
Sbjct: 118 SVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 193 NEFTP------GNKLDTFCGSPPYAAPELFQGKKYDGPE--------VDVWSLGVILYTL 238
+ +KL G + APE+ + D E DV++LG I Y L
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 239 VSGSLPFDGSTLRELRERVLRGKYR---IPFYMSTDCENLLKKFLVLNPAKR 287
+ PF + ++ G + M + ++L +R
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTG-MKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 26/120 (21%), Positives = 50/120 (41%), Gaps = 8/120 (6%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDLKAENLLL 545
L ++ G ++ + + + + ++IV + Y H K I+H+DLK++N+
Sbjct: 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY 163
Query: 546 DSEMNIKIADFGFSNEFTP------GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNH 599
D + I DFG + +KL G + APE+ + +P T +
Sbjct: 164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 7e-56
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 19/274 (6%)
Query: 24 SSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ 83
+ S + S + D P + L+ IGKG+F +V T K VAIKIID +
Sbjct: 2 AHSPVQSGLPGMQNLKAD-PE-ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE 59
Query: 84 LNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK 143
++ + +E+ ++ D P + K + + L+++MEY GG D L+ G +
Sbjct: 60 AED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLD 117
Query: 144 EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLD 202
E + R+I+ + Y H +K IHRD+KA N+LL +K+ADFG + + T K +
Sbjct: 118 ETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177
Query: 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGSTLREL----RER- 256
TF G+P + APE+ + YD + D+WSLG+ L G P + ++ L +
Sbjct: 178 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP 236
Query: 257 -VLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
L G Y S + ++ L P+ R +
Sbjct: 237 PTLEGNY------SKPLKEFVEACLNKEPSFRPT 264
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 38/104 (36%), Positives = 60/104 (57%), Gaps = 2/104 (1%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
+ L+++MEY GG D L+ G + E + R+I+ + Y H +K IHRD+KA N+
Sbjct: 92 DTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150
Query: 544 LLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGG 586
LL +K+ADFG + + T K +TF G+P + APE+ +
Sbjct: 151 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 69/254 (27%), Positives = 133/254 (52%), Gaps = 22/254 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
IG+G+ V LA+ +G++VA+K++D + + LF EV IM+ H N
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFN 103
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
+V++++ + L+++ME+ GG + D +V R+ E++ ++ A+ Y H + +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+K++++LL + +K++DFGF + + K + G+P + APE+ Y E
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA-TE 221
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----------FYMSTDCENL 275
VD+WSLG+++ +V G P+ + ++ R+ +S +
Sbjct: 222 VDIWSLGIMVIEMVDGEPPY-------FSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274
Query: 276 LKKFLVLNPAKRAS 289
L++ LV +P +RA+
Sbjct: 275 LERMLVRDPQERAT 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 30/102 (29%), Positives = 59/102 (57%), Gaps = 2/102 (1%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546
L+++ME+ GG + D +V R+ E++ ++ A+ Y H + +IHRD+K++++LL
Sbjct: 117 LWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
Query: 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGA 587
+ +K++DFGF + + K + G+P + APE+
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 23/293 (7%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHV 68
S G E + L++ + + E E + +G+G+F +V K
Sbjct: 22 SGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 69 PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYAS 128
TG + A+K + E+ L P IV L+ + + + ME
Sbjct: 81 QTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 129 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIA 187
GG + + G + E A Q + ++Y H ++I+H D+KA+N+LL S+ +
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALC 193
Query: 188 DFGFSNEFTPGN------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 241
DFG + P D G+ + APE+ GK D VD+WS ++ +++G
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNG 252
Query: 242 SLPFDGSTLRELRERVLRGKYR-----IPFYMSTDCENLLKKFLVLNPAKRAS 289
P+ + + IP + +++ L P RAS
Sbjct: 253 CHPW--TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 7/111 (6%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+ + ME GG + + G + E A Q + ++Y H ++I+H D+KA+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 542 NLLLDSE-MNIKIADFGFSNEFTPGN------KLDTFCGSPPYAAPELFQG 585
N+LL S+ + DFG + P D G+ + APE+ G
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 81/254 (31%), Positives = 131/254 (51%), Gaps = 22/254 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY + IG+G V A V TG+EVAI+ ++ Q + + E+ +M+ +PN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPN 78
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV L++VMEY +GG + D +V M E + A R+ + A+++ H ++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGKKYDGPE 225
IHRD+K++N+LL + ++K+ DFGF + TP +K T G+P + APE+ K Y P+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PK 196
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----------FYMSTDCENL 275
VD+WSLG++ ++ G P+ L E LR Y I +S +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY-------LNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 276 LKKFLVLNPAKRAS 289
L + L ++ KR S
Sbjct: 250 LNRCLEMDVEKRGS 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 38/105 (36%), Positives = 64/105 (60%), Gaps = 2/105 (1%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
L++VMEY +GG + D +V M E + A R+ + A+++ H ++IHRD+K++N+
Sbjct: 89 GDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 544 LLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGA 587
LL + ++K+ DFGF + TP +K T G+P + APE+ A
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 67/260 (25%), Positives = 111/260 (42%), Gaps = 26/260 (10%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+ +GKG F + H TG+ + +K + + + + + +EV++M+ L+HPN++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKII 167
K V+ +K L + EY GG + + R F + I S + Y H II
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 168 HRDLKAENLLLDSEMNIKIADFGFS---------------NEFTPGNKLDTFCGSPPYAA 212
HRDL + N L+ N+ +ADFG + + K T G+P + A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLRGKYRIPFYMSTD 271
PE+ G+ YD +VDV+S G++L ++ R +RG +
Sbjct: 191 PEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--CPPN 247
Query: 272 CENLLKKFLV----LNPAKR 287
C V L+P KR
Sbjct: 248 CPPSFFPITVRCCDLDPEKR 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 36/129 (27%), Positives = 53/129 (41%), Gaps = 16/129 (12%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
+LK V+ +K L + EY GG + + R F + I S + Y H
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS---------------NEFTPGNKLDTFCGSPPY 577
IIHRDL + N L+ N+ +ADFG + + K T G+P +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 578 AAPELFQGG 586
APE+ G
Sbjct: 189 MAPEMINGR 197
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 77/251 (30%), Positives = 120/251 (47%), Gaps = 25/251 (9%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF-REVRIMKMLDHPNI 107
++ + +G+G F V AK K+VAIK + S +K F E+R + ++HPNI
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQ-----IESESERKAFIVELRQLSRVNHPNI 63
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQYCHQ- 163
VKL+ + LVMEYA GG +++ L + A Q V Y H
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 164 --KKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
K +IHRDLK NLLL + +KI DFG + + + GS + APE+F+G
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSN 179
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDG--STLRELRERVLRGKYR--IPFYMSTDCENLL 276
Y + DV+S G+IL+ +++ PFD + V G R + + E+L+
Sbjct: 180 YS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLIKNLPKPIESLM 237
Query: 277 KKFLVLNPAKR 287
+ +P++R
Sbjct: 238 TRCWSKDPSQR 248
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 9/108 (8%)
Query: 485 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR---QIVSAVQYCHQ---KKIIHRDL 538
+ LVMEYA GG +++ L + A Q V Y H K +IHRDL
Sbjct: 72 NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 539 KAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
K NLLL + +KI DFG + + + GS + APE+F+G
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG 177
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-55
Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 56/287 (19%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY+ + IG+G++ V ++ TG+ VAIK +++ +P + RE+R++K L HPN
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKK 165
+V L +V ++ L+LV EY V L + R + E ++ Q + AV +CH+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAPE 214
IHRD+K EN+L+ IK+ DFGF+ P Y +PE
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLL----------TGPSDYYDDEVATRWYRSPE 172
Query: 215 -LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-----------TLRELRERVLRG-- 260
L +Y GP VDVW++G + L+SG + G TL +L R +
Sbjct: 173 LLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 261 ------KYRIPFY------------MSTDCENLLKKFLVLNPAKRAS 289
+IP +S LLK L ++P +R +
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 35/119 (29%), Positives = 52/119 (43%), Gaps = 23/119 (19%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKII 534
L +V ++ L+LV EY V L + R + E ++ Q + AV +CH+ I
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAPEL 582
HRD+K EN+L+ IK+ DFGF+ P Y +PEL
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLL----------TGPSDYYDDEVATRWYRSPEL 173
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 30 SSRRESSRRERDEPHI--GKYKLLKTIGKGNFAKVKLAK-HVPTGKEVAIKIIDKTQLNP 86
SR D+ I G+ + + IG G+F V K H +VA+K+++ T P
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTP 61
Query: 87 GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKE 146
LQ EV +++ H NI+ T L +V ++ G ++ +L E +
Sbjct: 62 QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 147 ARAKF-RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLD 202
RQ + Y H K IIHRDLK+ N+ L + +KI DFG + + ++ ++ +
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 203 TFCGSPPYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLR 259
GS + APE+ + + + + DV++ G++LY L++G LP+ + ++ E V R
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240
Query: 260 GKYRIPFYMS--TDCENLLKKFLV----LNPAKR 287
G P ++C +K+ + +R
Sbjct: 241 G-SLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 4/110 (3%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDLKAE 541
T L +V ++ G ++ +L E + RQ + Y H K IIHRDLK+
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN 149
Query: 542 NLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPYAAPELFQGGAP 588
N+ L + +KI DFG + + ++ ++ + GS + APE+ +
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-53
Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 59/308 (19%)
Query: 30 SSRRESSRRERDEPHIG-----KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL 84
SS + ++ KY+ L +G+G++ V ++ TG+ VAIK ++
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD 63
Query: 85 NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MK 143
+ + RE++++K L H N+V L +V + +K YLV E+ + D L L +
Sbjct: 64 DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLD 122
Query: 144 EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203
+ + QI++ + +CH IIHRD+K EN+L+ +K+ DFGF+
Sbjct: 123 YQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-------- 174
Query: 204 FCGSPP-----------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---- 248
+P Y APEL G G VDVW++G ++ + G F G
Sbjct: 175 --AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232
Query: 249 -------TLRELRERVLRGKYRIPFY--------------------MSTDCENLLKKFLV 281
L L R + P + +S +L KK L
Sbjct: 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292
Query: 282 LNPAKRAS 289
++P KR
Sbjct: 293 IDPDKRPF 300
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 35/121 (28%), Positives = 55/121 (45%), Gaps = 23/121 (19%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKK 532
L+ L +V + +K YLV E+ + D L L + + + QI++ + +CH
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAPE 581
IIHRD+K EN+L+ +K+ DFGF+ +P Y APE
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTL----------AAPGEVYDDEVATRWYRAPE 194
Query: 582 L 582
L
Sbjct: 195 L 195
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-53
Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 23/280 (8%)
Query: 25 SSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL 84
S R S + + +GKG + V + + +AIK I +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-- 58
Query: 85 NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMK 143
+ Q L E+ + K L H NIV+ + + ME GG + L G +K
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 144 EKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGN- 199
+ E F +QI+ ++Y H +I+HRD+K +N+L+++ +KI+DFG S N
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178
Query: 200 KLDTFCGSPPYAAPELFQGKK--YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRE-- 255
+TF G+ Y APE+ Y D+WSLG + + +G PF EL E
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPF-----YELGEPQ 232
Query: 256 ----RVLRGKYR--IPFYMSTDCENLLKKFLVLNPAKRAS 289
+V K IP MS + + + K +P KRA
Sbjct: 233 AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 35/113 (30%), Positives = 57/113 (50%), Gaps = 5/113 (4%)
Query: 480 VIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHR 536
+ + ME GG + L G +K+ E F +QI+ ++Y H +I+HR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 537 DLKAENLLLDSEM-NIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGA 587
D+K +N+L+++ +KI+DFG S N +TF G+ Y APE+ G
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-53
Identities = 76/256 (29%), Positives = 129/256 (50%), Gaps = 26/256 (10%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+ +L+ +G+G++ V A H TG+ VAIK + LQ++ +E+ IM+ D P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPH 85
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
+VK + L++VMEY G V D + + + E E + + ++Y H +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGKKYDGP 224
IHRD+KA N+LL++E + K+ADFG + + T K +T G+P + APE+ Q Y+
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-C 204
Query: 225 EVDVWSLGVILYTLVSGSLP-FDGSTLRELRERVLRGKYRIP----------FYMSTDCE 273
D+WSLG+ + G P D +R + + IP S +
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAI--------FMIPTNPPPTFRKPELWSDNFT 256
Query: 274 NLLKKFLVLNPAKRAS 289
+ +K+ LV +P +RA+
Sbjct: 257 DFVKQCLVKSPEQRAT 272
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 484 EKTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
L++VMEY G V D + + + E E + + ++Y H + IHRD+KA N
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGN 155
Query: 543 LLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGA 587
+LL++E + K+ADFG + + T K +T G+P + APE+ Q
Sbjct: 156 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 201
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 29/279 (10%)
Query: 29 MSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS 88
M RE RD ++++ +G G F KV AK+ TG A K+I+
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--E 59
Query: 89 LQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFD-YLVLHGRMKEKEA 147
L+ E+ I+ DHP IVKL + L++++E+ GG V L L + E +
Sbjct: 60 LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 148 RAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTFCG 206
+ RQ++ A+ + H K+IIHRDLKA N+L+ E +I++ADFG S + K D+F G
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 207 SPPYAAPEL-----FQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGSTLRELRERVLRG 260
+P + APE+ + YD + D+WSLG+ L + P + + +R L
Sbjct: 180 TPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVL------- 231
Query: 261 KYRIPF----------YMSTDCENLLKKFLVLNPAKRAS 289
+I S + + LK L NP R S
Sbjct: 232 -LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS 269
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 38/100 (38%), Positives = 61/100 (61%), Gaps = 2/100 (2%)
Query: 484 EKTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542
+ L++++E+ GG V L L + E + + RQ++ A+ + H K+IIHRDLKA N
Sbjct: 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147
Query: 543 LLLDSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPE 581
+L+ E +I++ADFG S + K D+F G+P + APE
Sbjct: 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 4/210 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
++ + +G GN V H P+G +A K+I + P ++ RE++++ + P I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYI 93
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KI 166
V + ++ + + ME+ GG + L GR+ E+ ++ + Y +K KI
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 153
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEV 226
+HRD+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG Y +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV-QS 211
Query: 227 DVWSLGVILYTLVSGSLPFDGSTLRELRER 256
D+WS+G+ L + G P +EL
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELM 241
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 2/105 (1%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAE 541
++ + + ME+ GG + L GR+ E+ ++ + Y +K KI+HRD+K
Sbjct: 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
N+L++S IK+ DFG S + + ++F G+ Y +PE QG
Sbjct: 162 NILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGT 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 67/292 (22%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII----DKTQLNPGSLQKLFREVRIMKML 102
KY+ L+ IG+G + V AK+ T + VA+K + D + +L RE+ ++K L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKEL 58
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAV 158
H NIV+L V+ ++K L LV E+ D Y +G + + ++ Q++ +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 209
+CH + ++HRDLK +NLL++ +K+A+FG + F G P
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF----------GIPVRCYSAEVVT 164
Query: 210 --YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGST-LRELR----------E 255
Y P++ G K +D+WS G I L + P F G+ +L+ E
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 256 RVLRGKYRIPFY------------------MSTDCENLLKKFLVLNPAKRAS 289
++P Y ++ +LL+ L NP +R S
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 31/125 (24%), Positives = 57/125 (45%), Gaps = 29/125 (23%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAVQYCHQK 531
+L V+ ++K L LV E+ D Y +G + + ++ Q++ + +CH +
Sbjct: 65 RLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAP 580
++HRDLK +NLL++ +K+A+FG + F G P Y P
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAF----------GIPVRCYSAEVVTLWYRPP 170
Query: 581 ELFQG 585
++ G
Sbjct: 171 DVLFG 175
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 31/269 (11%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
Y+L + IG G A V+ A P ++VAIK I+ + S+ +L +E++ M HPNI
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDELLKEIQAMSQCHHPNI 75
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYL--------VLHGRMKEKEARAKFRQIVSAVQ 159
V + + L+LVM+ SGG V D + G + E R+++ ++
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------NEFTPGNKLDTFCGSPPYAAP 213
Y H+ IHRD+KA N+LL + +++IADFG S + T TF G+P + AP
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 214 E-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGSTLR-----------ELRERVLRG 260
E + Q + YD + D+WS G+ L +G+ P+ ++ L V
Sbjct: 196 EVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 254
Query: 261 KYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
+ + ++ L +P KR +
Sbjct: 255 EMLKKY--GKSFRKMISLCLQKDPEKRPT 281
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 14/112 (12%)
Query: 487 LYLVMEYASGGEVFDYL--------VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 538
L+LVM+ SGG V D + G + E R+++ ++Y H+ IHRD+
Sbjct: 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV 147
Query: 539 KAENLLLDSEMNIKIADFGFS------NEFTPGNKLDTFCGSPPYAAPELFQ 584
KA N+LL + +++IADFG S + T TF G+P + APE+ +
Sbjct: 148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-50
Identities = 78/295 (26%), Positives = 120/295 (40%), Gaps = 36/295 (12%)
Query: 19 SENNISSSRLMSSRRESSRRERDEPHI----------GKYKLLKTIGKGNFAKVKLAKHV 68
+EN + +P + + L+ IG G+F V A+ V
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76
Query: 69 PTGKEVAIKIIDKTQLNPG-SLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYA 127
+ VAIK + + Q + +EVR ++ L HPN ++ E T +LVMEY
Sbjct: 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136
Query: 128 SGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIA 187
G V ++E E A + + Y H +IHRD+KA N+LL +K+
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 196
Query: 188 DFGFSNEFTPGNKLDTFCGSPPYAAPEL---FQGKKYDGPEVDVWSLGVILYTLVSGSLP 244
DFG ++ P N +F G+P + APE+ +YD +VDVWSLG+ L P
Sbjct: 197 DFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPP 252
Query: 245 -FDGSTLRELRERVLRGKYRIPF---------YMSTDCENLLKKFLVLNPAKRAS 289
F+ + + L Y I + S N + L P R +
Sbjct: 253 LFNMNAMSAL--------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 299
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
E T +LVMEY G V ++E E A + + Y H +IHRD+KA N+
Sbjct: 126 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185
Query: 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE 581
LL +K+ DFG ++ P N +F G+P + APE
Sbjct: 186 LLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPE 220
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 38/126 (30%), Positives = 58/126 (46%), Gaps = 30/126 (23%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YLVLHGR--MKEKEARAKFRQIVSAVQYCHQ 530
KL VI TE LYLV E+ D ++ + ++ Q++ + +CH
Sbjct: 66 KLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAA 579
+++HRDLK +NLL+++E IK+ADFG + F G P Y A
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------GVPVRTYTHEVVTLWYRA 171
Query: 580 PELFQG 585
PE+ G
Sbjct: 172 PEILLG 177
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 66/254 (25%), Positives = 106/254 (41%), Gaps = 11/254 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI-MKMLDHPN 106
+ L +G G +V + TG +A+K + ++ N +++ ++ + +K D P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDCPY 85
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH-QKK 165
IV+ F T +++ ME + G + E+ IV A+ Y +
Sbjct: 86 IVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+IHRD+K N+LLD IK+ DFG S D G Y APE P+
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 226 ----VDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRG---KYRIPFYMSTDCENLLK 277
DVWSLG+ L L +G P+ T E+ +VL+ S D ++ +K
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265
Query: 278 KFLVLNPAKRASLE 291
L + KR
Sbjct: 266 DCLTKDHRKRPKYN 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 31/107 (28%), Positives = 43/107 (40%), Gaps = 1/107 (0%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH-QKKIIHRDLKAE 541
T +++ ME + G + E+ IV A+ Y + +IHRD+K
Sbjct: 95 TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588
N+LLD IK+ DFG S D G Y APE P
Sbjct: 155 NILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-50
Identities = 71/328 (21%), Positives = 131/328 (39%), Gaps = 75/328 (22%)
Query: 19 SENNISSSRLMSSRRESSRRERDEP----HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEV 74
++ L + + I +Y+ + +G+G + +V A T + V
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 75 AIKII----DKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGG 130
AIK I ++ + ++ REV ++K L H NI++L VI L+L+ EYA
Sbjct: 63 AIKRIRLEHEEEGVPGTAI----REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-- 116
Query: 131 EVFD---YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-----EM 182
D Y+ + + + ++ Q+++ V +CH ++ +HRDLK +NLLL
Sbjct: 117 --NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP 174
Query: 183 NIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAPELFQGKKYDGPEVDVWSL 231
+KI DFG + F G P Y PE+ G ++ VD+WS+
Sbjct: 175 VLKIGDFGLARAF----------GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSI 224
Query: 232 GVILYTLVSGSLPFDGST-------------------------LRELRERVLRGKYR--- 263
I ++ + F G + L + ++ + + +
Sbjct: 225 ACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLK 284
Query: 264 --IPFYMSTDCENLLKKFLVLNPAKRAS 289
+ + + +LL L ++P KR S
Sbjct: 285 RVLGALLDDEGLDLLTAMLEMDPVKRIS 312
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 33/126 (26%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 532
+L VI L+L+ EYA D Y+ + + + ++ Q+++ V +CH ++
Sbjct: 97 ELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 533 IIHRDLKAENLLLDS-----EMNIKIADFGFSNEFTPGNKLDTFCGSPP----------- 576
+HRDLK +NLLL +KI DFG + F G P
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF----------GIPIRQFTHEIITLW 202
Query: 577 YAAPEL 582
Y PE+
Sbjct: 203 YRPPEI 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 8e-50
Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 16/231 (6%)
Query: 29 MSSRRESSRRERDEPHIGKYKLLKTIGKG--NFAKVKLAKHVPTGKEVAIKIIDKTQLNP 86
M + G Y+LL IGKG + V LA++ PTG+ V ++ I+ +
Sbjct: 9 MENLYFQGMSSFLPEG-GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 87 GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKE 144
+ L E+ + K+ +HPNIV + L++V + + G D + H M E
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 145 KEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF--------T 196
+ ++ A+ Y H +HR +KA ++L+ + + ++ +
Sbjct: 128 LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 197 PGNKLDTFCGSPPYAAPELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLPF 245
+ P+ +PE+ Q + YD + D++S+G+ L +G +PF
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF 237
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 19/108 (17%), Positives = 42/108 (38%), Gaps = 10/108 (9%)
Query: 487 LYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
L++V + + G D + H M E + ++ A+ Y H +HR +KA ++L
Sbjct: 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL 160
Query: 545 LDSEMNIKIADFGFSNEF--------TPGNKLDTFCGSPPYAAPELFQ 584
+ + + ++ + + P+ +PE+ Q
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 71/313 (22%)
Query: 29 MSSRRESSRRERDEPHIGK---YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII----DK 81
M S + G Y+ L+ +G+G + V AK G+ VA+K I +
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED 59
Query: 82 TQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFD---YL-V 137
+ ++ RE+ ++K L HPNIV L VI +E+ L LV E+ D L
Sbjct: 60 EGIPSTAI----REISLLKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDE 111
Query: 138 LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197
+++ + + Q++ V +CHQ +I+HRDLK +NLL++S+ +K+ADFG + F
Sbjct: 112 NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF-- 169
Query: 198 GNKLDTFCGSPP-----------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 246
G P Y AP++ G K VD+WS+G I +++G F
Sbjct: 170 --------GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221
Query: 247 G-------------------------STLRELRERVLRGKYRIPF-----YMSTDCENLL 276
G L ++R + + P+ + +LL
Sbjct: 222 GVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 277 KKFLVLNPAKRAS 289
L +P KR S
Sbjct: 282 SNMLCFDPNKRIS 294
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 37/125 (29%), Positives = 59/125 (47%), Gaps = 29/125 (23%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAVQYCHQK 531
L VI +E+ L LV E+ D L +++ + + Q++ V +CHQ
Sbjct: 83 SLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAP 580
+I+HRDLK +NLL++S+ +K+ADFG + F G P Y AP
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAF----------GIPVRSYTHEVVTLWYRAP 188
Query: 581 ELFQG 585
++ G
Sbjct: 189 DVLMG 193
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 74/300 (24%), Positives = 121/300 (40%), Gaps = 75/300 (25%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG----SLQKLFREVRIMKML 102
++K L+ +G G +A V + TG VA+K + K G ++ RE+ +MK L
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAI----REISLMKEL 60
Query: 103 DHPNIVKLFQVIETEKTLYLVMEY-----ASGGEVFDYLVLHGRMKEKEARAKFRQIVSA 157
H NIV+L+ VI TE L LV E+ + ++ + Q++
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-------- 209
+ +CH+ KI+HRDLK +NLL++ +K+ DFG + F G P
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF----------GIPVNTFSSEVV 170
Query: 210 ---YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST----------------- 249
Y AP++ G + +D+WS G IL +++G F G+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 250 --------------------LRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
R+LR+ + + + + + L L LNP R S
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVL---QPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 32/123 (26%), Positives = 53/123 (43%), Gaps = 26/123 (21%)
Query: 476 KLFQVIETEKTLYLVMEY-----ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 530
+L+ VI TE L LV E+ + ++ + Q++ + +CH+
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAA 579
KI+HRDLK +NLL++ +K+ DFG + F G P Y A
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAF----------GIPVNTFSSEVVTLWYRA 176
Query: 580 PEL 582
P++
Sbjct: 177 PDV 179
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-49
Identities = 82/291 (28%), Positives = 132/291 (45%), Gaps = 67/291 (23%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII----DKTQLNPGSLQKLFREVRIMKML 102
KY L+ IG+G + V A++ G+ A+K I + + ++ RE+ I+K L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI----REISILKEL 57
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAV 158
H NIVKL+ VI T+K L LV E+ D L V G ++ A++ Q+++ +
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 209
YCH ++++HRDLK +NLL++ E +KIADFG + F G P
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEIVT 163
Query: 210 --YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELR----------ER 256
Y AP++ G K +D+WS+G I +V+G+ F G + +L +
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 257 VLRGKYRIPFY------------------MSTDCENLLKKFLVLNPAKRAS 289
+P Y + +LL K L L+P +R +
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 41/125 (32%), Positives = 63/125 (50%), Gaps = 29/125 (23%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAVQYCHQK 531
KL+ VI T+K L LV E+ D L V G ++ A++ Q+++ + YCH +
Sbjct: 64 KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAP 580
+++HRDLK +NLL++ E +KIADFG + F G P Y AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEIVTLWYRAP 169
Query: 581 ELFQG 585
++ G
Sbjct: 170 DVLMG 174
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-49
Identities = 75/292 (25%), Positives = 114/292 (39%), Gaps = 68/292 (23%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG----SLQKLFREVRIMKML 102
Y L +G+G +A V K T VA+K I + + G ++ REV ++K L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAI----REVSLLKDL 57
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAV 158
H NIV L +I TEK+L LV EY D YL + + Q++ +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 209
YCH++K++HRDLK +NLL++ +K+ADFG + P
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK----------SIPTKTYDNEVVT 163
Query: 210 --YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST------------------ 249
Y P++ G ++D+W +G I Y + +G F GST
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223
Query: 250 -------LRELRERVLRGKYRIPF-----YMSTDCENLLKKFLVLNPAKRAS 289
E + + +D +LL K L R S
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 29/125 (23%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAVQYCHQK 531
L +I TEK+L LV EY D YL + + Q++ + YCH++
Sbjct: 64 TLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----------YAAP 580
K++HRDLK +NLL++ +K+ADFG + P Y P
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAK----------SIPTKTYDNEVVTLWYRPP 169
Query: 581 ELFQG 585
++ G
Sbjct: 170 DILLG 174
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-49
Identities = 55/287 (19%), Positives = 104/287 (36%), Gaps = 22/287 (7%)
Query: 23 ISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT 82
I +R + R + + +++ + + + + D
Sbjct: 39 IRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
Query: 83 QLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRM 142
+P + ++R M N V Q + LY+ M+ + D++ +
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 143 KEKE---ARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------- 192
+++E F QI AV++ H K ++HRDLK N+ + +K+ DFG
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 193 ------NEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 246
G+ Y +PE G Y +VD++SLG+IL+ L+ F
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLY---SFS 274
Query: 247 GSTLR-ELRERVLRGKYRIPFYMSTDCE-NLLKKFLVLNPAKRASLE 291
R + V K+ + F E +++ L +P +R
Sbjct: 275 TQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 16/120 (13%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKE---ARAKFRQIVSAVQYCHQKKIIHRDL 538
+ LY+ M+ + D++ ++++E F QI AV++ H K ++HRDL
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190
Query: 539 KAENLLLDSEMNIKIADFGFS-------------NEFTPGNKLDTFCGSPPYAAPELFQG 585
K N+ + +K+ DFG G+ Y +PE G
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 23/77 (29%), Positives = 38/77 (49%), Gaps = 7/77 (9%)
Query: 35 SSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFR 94
+SR D ++ ++ +G+G F V AK+ AIK I + +K+ R
Sbjct: 1 ASRYLTD------FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMR 53
Query: 95 EVRIMKMLDHPNIVKLF 111
EV+ + L+HP IV+ F
Sbjct: 54 EVKALAKLEHPGIVRYF 70
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 78/302 (25%), Positives = 115/302 (38%), Gaps = 86/302 (28%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKL------FREVRIMK 100
+Y+ L +G+G FA V A+ T + VAIK K +L S K RE+++++
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEY---------ASGGEVFDYLVLHGRMKEKEARAKF 151
L HPNI+ L + + LV ++ V +A
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLT---------PSHIKAYM 118
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-- 209
+ ++Y HQ I+HRDLK NLLLD +K+ADFG + F GSP
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF----------GSPNRA 168
Query: 210 ---------YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG------------------ 241
Y APE LF + Y G VD+W++G IL L+
Sbjct: 169 YTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227
Query: 242 --------------SLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
SLP D T + L + D +L++ + NP R
Sbjct: 228 TLGTPTEEQWPDMCSLP-DYVTFKSFPGIPLHHIFS---AAGDDLLDLIQGLFLFNPCAR 283
Query: 288 AS 289
+
Sbjct: 284 IT 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 34/130 (26%), Positives = 46/130 (35%), Gaps = 39/130 (30%)
Query: 476 KLFQVIETEKTLYLVMEY---------ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
L + + LV ++ V +A + ++
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLT---------PSHIKAYMLMTLQGLE 126
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP---------- 576
Y HQ I+HRDLK NLLLD +K+ADFG + F GSP
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF----------GSPNRAYTHQVVTR 176
Query: 577 -YAAPELFQG 585
Y APEL G
Sbjct: 177 WYRAPELLFG 186
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 16/259 (6%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI-MKMLDHPN 106
K L IG+G + V H P+G+ +A+K I T ++ ++L ++ + M+ D P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDY----LVLHGRMKEKEARAKFRQIVSAVQYCH 162
IV+ + + E ++ ME S Y VL + E+ V A+ +
Sbjct: 83 IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 163 QK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
+ KIIHRD+K N+LLD NIK+ DFG S + G PY APE
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 222 DGP---EVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRG-----KYRIPFYMSTDC 272
DVWSLG+ LY L +G P+ +++ + +V++G S
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 273 ENLLKKFLVLNPAKRASLE 291
N + L + +KR +
Sbjct: 263 INFVNLCLTKDESKRPKYK 281
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 35/109 (32%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 484 EKTLYLVMEYASGGEVFDY----LVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDL 538
E ++ ME S Y VL + E+ V A+ + + KIIHRD+
Sbjct: 93 EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI 152
Query: 539 KAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587
K N+LLD NIK+ DFG S + G PY APE A
Sbjct: 153 KPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 14/254 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI-MKMLDHPN 106
+ + +G+G + V+ +HVP+G+ +A+K I T +N ++L ++ I M+ +D P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPF 67
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDY---LVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
V + + E +++ ME Y + + E IV A+++ H
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 164 K-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE----LFQG 218
K +IHRD+K N+L+++ +K+ DFG S D G PY APE
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGK--YRIPFYMSTDCENL 275
K Y D+WSLG+ + L P+D T + ++V+ S + +
Sbjct: 188 KGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDF 246
Query: 276 LKKFLVLNPAKRAS 289
+ L N +R +
Sbjct: 247 TSQCLKKNSKERPT 260
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 4/107 (3%)
Query: 483 TEKTLYLVMEYASGGEVFDY---LVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDL 538
E +++ ME Y + + E IV A+++ H K +IHRD+
Sbjct: 77 REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 136
Query: 539 KAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
K N+L+++ +K+ DFG S D G PY APE
Sbjct: 137 KPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-48
Identities = 73/254 (28%), Positives = 123/254 (48%), Gaps = 17/254 (6%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKMLD 103
+YK++ +G G + V LA+ +VAIK I +L++ REV L
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLS 69
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
H NIV + V E + YLVMEY G + +Y+ HG + A QI+ +++ H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGF-----SNEFTPGNKLDTFCGSPPYAAPELFQG 218
+I+HRD+K +N+L+DS +KI DFG T N G+ Y +PE +G
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYFSPEQAKG 186
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGST-----LRELRERVLRGKYRIPFYMSTDCE 273
+ D D++S+G++LY ++ G PF+G T ++ +++ V + +
Sbjct: 187 EATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 274 NLLKKFLVLNPAKR 287
N++ + + A R
Sbjct: 246 NVILRATEKDKANR 259
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 37/111 (33%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
E + YLVMEY G + +Y+ HG + A QI+ +++ H +I+HRD+K +
Sbjct: 81 EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140
Query: 542 NLLLDSEMNIKIADFGF-----SNEFTPGNKLDTFCGSPPYAAPELFQGGA 587
N+L+DS +KI DFG T N G+ Y +PE +G A
Sbjct: 141 NILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYFSPEQAKGEA 188
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 20/239 (8%)
Query: 22 NISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK 81
+++S S E +P G ++L++ +G G + +V +HV TG+ AIK++D
Sbjct: 1 SMASDSPARSLDEIDLSALRDPA-GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD- 58
Query: 82 TQLNPGSLQKLFREVRIMKML-DHPNIVKLF------QVIETEKTLYLVMEYASGGEVFD 134
+ +++ +E+ ++K H NI + + L+LVME+ G V D
Sbjct: 59 --VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 135 YL--VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 192
+ +KE+ R+I+ + + HQ K+IHRD+K +N+LL +K+ DFG S
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 193 NEFTPG-NKLDTFCGSPPYAAPELFQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 245
+ + +TF G+P + APE+ + YD + D+WSLG+ + G+ P
Sbjct: 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPL 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 487 LYLVMEYASGGEVFDYL--VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544
L+LVME+ G V D + +KE+ R+I+ + + HQ K+IHRD+K +N+L
Sbjct: 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161
Query: 545 LDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPE 581
L +K+ DFG S + + +TF G+P + APE
Sbjct: 162 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-47
Identities = 70/300 (23%), Positives = 135/300 (45%), Gaps = 63/300 (21%)
Query: 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII----DKTQLNPGSLQKLFREVRIM 99
+ KY+ L IG+G F +V A+H TG++VA+K + +K +L RE++I+
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKIL 70
Query: 100 KMLDHPNIVKLFQVIETEKT--------LYLVMEYASGGEVFD---YL-VLHGRMKEKEA 147
++L H N+V L ++ T+ + +YLV ++ D L + + E
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEI 126
Query: 148 RAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 207
+ + +++ + Y H+ KI+HRD+KA N+L+ + +K+ADFG + F+ +
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 208 PP-----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG--------------------- 241
Y PEL G++ GP +D+W G I+ + +
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246
Query: 242 -----------SLP-FDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289
+ ++ L + ++R ++ + + + +L+ K LVL+PA+R
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDKLLVLDPAQRID 305
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 13/113 (11%)
Query: 482 ETEKTLYLVMEYASGGEVFD---YL-VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
+ ++YLV ++ D L + + E + + +++ + Y H+ KI+HRD
Sbjct: 94 RCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-----YAAPELFQG 585
+KA N+L+ + +K+ADFG + F+ + Y PEL G
Sbjct: 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKML 102
G Y+L + +G+G V A+ + VA+K++ L +P ++ RE R L
Sbjct: 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRL 91
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
P++V + E + LY+ M +G ++ L G + A A RQI SA+ H
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGF-----SNEFTPGNKLDTFCGSPPYAAPELFQ 217
HRD+K EN+L+ ++ + DFG + T G+ Y APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG---NTVGTLYYMAPERFS 208
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
D+++L +LY ++GS P+ G L
Sbjct: 209 ESHAT-YRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 8/111 (7%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
E + LY+ M +G ++ L G + A A RQI SA+ H HRD+K E
Sbjct: 104 EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163
Query: 542 NLLLDSEMNIKIADFGF-----SNEFTPGNKLDTFCGSPPYAAPELFQGGA 587
N+L+ ++ + DFG + T G+ Y APE F
Sbjct: 164 NILVSADDFAYLVDFGIASATTDEKLTQLG---NTVGTLYYMAPERFSESH 211
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 71/303 (23%), Positives = 108/303 (35%), Gaps = 76/303 (25%)
Query: 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII-------DKTQLNPGSLQKLFREV 96
+Y+ + IG G + V A+ +G VA+K + L ++ REV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV----REV 62
Query: 97 RIMKML---DHPNIVKLFQVI-----ETEKTLYLVMEYASGGEVFD---YLVLHGRMKEK 145
+++ L +HPN+V+L V + E + LV E+ D YL
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLP 118
Query: 146 EARAK--FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203
K RQ + + + H I+HRDLK EN+L+ S +K+ADFG + +
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-------- 170
Query: 204 FCGSPP----------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST---- 249
Y APE+ Y VD+WS+G I + F G++
Sbjct: 171 --SYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227
Query: 250 ------------------LRELRERVLRGKYRIPF-----YMSTDCENLLKKFLVLNPAK 286
L + P M LL + L NP K
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 287 RAS 289
R S
Sbjct: 288 RIS 290
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 32/127 (25%), Positives = 47/127 (37%), Gaps = 34/127 (26%)
Query: 476 KLFQVI-----ETEKTLYLVMEYASGGEVFD---YLVLHGRMKEKEARAK--FRQIVSAV 525
+L V + E + LV E+ D YL K RQ + +
Sbjct: 78 RLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 576
+ H I+HRDLK EN+L+ S +K+ADFG + +
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY----------SYQMALTPVVVTL 183
Query: 577 -YAAPEL 582
Y APE+
Sbjct: 184 WYRAPEV 190
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 76/308 (24%)
Query: 39 ERDEP--HIGKYKLLKTIGKGNFAKVKLAKHV-PTGKEVAIKII----DKTQLNPGSLQK 91
E+D +Y+ + IG+G + KV A+ + G+ VA+K + + + ++
Sbjct: 2 EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-- 59
Query: 92 LFREVRIMKML---DHPNIVKLFQVI-----ETEKTLYLVMEYASGGEVFD---YLVLHG 140
REV +++ L +HPN+V+LF V + E L LV E+ D YL
Sbjct: 60 --REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVP 113
Query: 141 RMKEKEARAK--FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198
K Q++ + + H +++HRDLK +N+L+ S IK+ADFG + +
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--- 170
Query: 199 NKLDTFCGSPP----------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS 248
Y APE+ Y VD+WS+G I + F GS
Sbjct: 171 -------SFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGS 222
Query: 249 TLRELRERVLR--G--------------KYRIPFY-----------MSTDCENLLKKFLV 281
+ + ++L G + + ++LL K L
Sbjct: 223 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 282
Query: 282 LNPAKRAS 289
NPAKR S
Sbjct: 283 FNPAKRIS 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 32/127 (25%), Positives = 49/127 (38%), Gaps = 34/127 (26%)
Query: 476 KLFQVI-----ETEKTLYLVMEYASGGEVFD---YLVLHGRMKEKEARAK--FRQIVSAV 525
+LF V + E L LV E+ D YL K Q++ +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--------- 576
+ H +++HRDLK +N+L+ S IK+ADFG + +
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----------SFQMALTSVVVTL 183
Query: 577 -YAAPEL 582
Y APE+
Sbjct: 184 WYRAPEV 190
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 70/226 (30%), Positives = 106/226 (46%), Gaps = 16/226 (7%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
L + IG+GNF +V + VA+K + L P K +E RI+K HPNIV
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKII 167
+L V ++ +Y+VME GG+ +L G + + + ++Y K I
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 168 HRDLKAENLLLDSEMNIKIADFGFS-----NEFTPGNKLDTFCGSPPY--AAPELFQGKK 220
HRDL A N L+ + +KI+DFG S + L P APE +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV----PVKWTAPEALNYGR 291
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
Y E DVWS G++L+ S G+ P+ + ++ RE V +G R+P
Sbjct: 292 YS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLP 335
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 1/87 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
+++L V ++ +Y+VME GG+ +L G + + + ++Y K
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRDL A N L+ + +KI+DFG S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 18/257 (7%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKMLD 103
+Y+L + +G G ++V LA+ + ++VA+K++ + L +P + RE + L+
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALN 70
Query: 104 HPNIVKLFQVIETE----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 159
HP IV ++ E E Y+VMEY G + D + G M K A A+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPEL 215
+ HQ IIHRD+K N+++ + +K+ DFG ++ + G+ Y +PE
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-----LRELRERVLRGKYRIPFYMST 270
+G D DV+SLG +LY +++G PF G + + +RE + R +S
Sbjct: 191 ARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE-GLSA 248
Query: 271 DCENLLKKFLVLNPAKR 287
D + ++ K L NP R
Sbjct: 249 DLDAVVLKALAKNPENR 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 488 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547
Y+VMEY G + D + G M K A A+ + HQ IIHRD+K N+++ +
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 548 EMNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587
+K+ DFG ++ + G+ Y +PE +G +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
K +K +G G F V +P G++ VAIK + + +P + +++ E +M +D+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDN 76
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIV 155
P++ +L + T+ L+ + G + DY+ +E + QI
Sbjct: 77 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYV--------REHKDNIGSQYLLNWCVQIA 127
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEF---TPGNKLDTFCGS 207
+ Y ++++HRDL A N+L+ + ++KI DFG + E G K+
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV------ 181
Query: 208 P-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
P + A E + Y + DVWS GV ++ L++ GS P+DG E+ + +G R+P
Sbjct: 182 PIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 18/95 (18%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIVSA 524
+ +L + T+ L+ + G + DY+ +E + QI
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYV--------REHKDNIGSQYLLNWCVQIAKG 129
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ Y ++++HRDL A N+L+ + ++KI DFG +
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-44
Identities = 74/332 (22%), Positives = 130/332 (39%), Gaps = 87/332 (26%)
Query: 32 RRESSRRERDEPHIGKYKLLKT-IGKGNFAKVKLA--KHVPTGKEVAIKIIDKTQLNPGS 88
+ SS RER E ++ +G+G + V A K K+ A+K I+ T ++ +
Sbjct: 9 VKLSSERERVED---LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65
Query: 89 LQKLFREVRIMKMLDHPNIVKLFQVI--ETEKTLYLVMEYASGGEVFD---YLVLHGRMK 143
RE+ +++ L HPN++ L +V ++ ++L+ +YA D + H K
Sbjct: 66 C----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASK 117
Query: 144 EKEARAKF---------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN----IKIADFG 190
+ + QI+ + Y H ++HRDLK N+L+ E +KIAD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 191 FSNEFTPGNKLDTFCGSPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 244
F+ F + L P Y APEL G ++ +D+W++G I L++
Sbjct: 178 FARLF--NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235
Query: 245 FDGST-------------------------------LRELRE-RVLRGKYRIPFY----- 267
F ++++ E L +R Y
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295
Query: 268 ----------MSTDCENLLKKFLVLNPAKRAS 289
+ +LL+K L ++P KR +
Sbjct: 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 34/131 (25%), Positives = 53/131 (40%), Gaps = 30/131 (22%)
Query: 476 KLFQVI--ETEKTLYLVMEYASGGEVFD---YLVLHGRMKEKEARAKF---------RQI 521
L +V ++ ++L+ +YA D + H K + + QI
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 522 VSAVQYCHQKKIIHRDLKAENLLLDSEMN----IKIADFGFSNEFTPGNKLDTFCGSPP- 576
+ + Y H ++HRDLK N+L+ E +KIAD GF+ F + L P
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPV 195
Query: 577 -----YAAPEL 582
Y APEL
Sbjct: 196 VVTFWYRAPEL 206
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-43
Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 54/292 (18%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIK--IIDKTQLNPGSLQKLFREVRI 98
E Y K IG G+F V AK V + EVAIK + DK N RE++I
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN--------RELQI 85
Query: 99 MKMLDHPNIVKLFQVI------ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK--EARAK 150
M+++ HPN+V L + E L LV+EY V+ + ++K+ K
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIK 144
Query: 151 FR--QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGS 207
Q++ ++ Y H I HRD+K +NLLLD +K+ DFG + G ++ S
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
Query: 208 PPYAAPEL-FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRE--RVL----- 258
Y APEL F Y +D+WS G ++ L+ G F G S + +L E +VL
Sbjct: 205 RYYRAPELIFGATNYTTN-IDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 259 ---------RGKYRIPFY------------MSTDCENLLKKFLVLNPAKRAS 289
+++ P D +L+ + L P+ R +
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 6/106 (5%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK--EARAKFR--QIVSAVQYCHQKKIIHRD 537
+ E L LV+EY V+ + ++K+ K Q++ ++ Y H I HRD
Sbjct: 108 KDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166
Query: 538 LKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
+K +NLLLD +K+ DFG + G ++ S Y APEL
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 69/284 (24%), Positives = 130/284 (45%), Gaps = 52/284 (18%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHP 105
Y+L++ +G+G +++V A ++ ++V +KI+ P +K+ RE++I++ L P
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGP 91
Query: 106 NIVKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
NI+ L ++ +T LV E+ D+ L+ + + + R +I+ A+ YCH
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 148
Query: 164 KKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE-LFQGKKY 221
I+HRD+K N+++D E +++ D+G + + PG + + S + PE L + Y
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 208
Query: 222 DGPEVDVWSLGVILYTLVSGSLP-FDG-STLRELRE--RVL--------RGKY------- 262
D +D+WSLG +L +++ P F G +L +VL KY
Sbjct: 209 D-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 263 ---------RIPF----------YMSTDCENLLKKFLVLNPAKR 287
R + +S + + L K L + R
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 31/117 (26%), Positives = 59/117 (50%), Gaps = 6/117 (5%)
Query: 469 SGGETLLKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 526
GG ++ L ++ +T LV E+ D+ L+ + + + R +I+ A+
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALD 144
Query: 527 YCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
YCH I+HRD+K N+++D E +++ D+G + + PG + + S + PEL
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-43
Identities = 88/334 (26%), Positives = 132/334 (39%), Gaps = 68/334 (20%)
Query: 9 STGKSETGRGSENNISSSRLMSSRRESSR-----RERDEPHIGKYKLLKTIGKGNFAKVK 63
+ K + ++ SR + ++ + D P Y K IG G+F V
Sbjct: 12 ESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVY 71
Query: 64 LAKHVPTGKEVAIK--IIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI------E 115
AK +G+ VAIK + DK N RE++IM+ LDH NIV+L +
Sbjct: 72 QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 116 TEKTLYLVMEYASGGEVFD---YLVLHGRMKEK----EARAKFR--QIVSAVQYCHQKKI 166
E L LV++Y Y V + K K Q+ ++ Y H I
Sbjct: 124 DEVYLNLVLDY------VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 167 IHRDLKAENLLLDSEMNI-KIADFGFSNEFTPGNKLDTFCGSPPYAAPEL-FQGKKYDGP 224
HRD+K +NLLLD + + K+ DFG + + G ++ S Y APEL F Y
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 237
Query: 225 EVDVWSLGVILYTLVSGSLPFDG-STLRELRE--RVL--------------RGKYRIPFY 267
+DVWS G +L L+ G F G S + +L E +VL +++ P
Sbjct: 238 -IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 296
Query: 268 ------------MSTDCENLLKKFLVLNPAKRAS 289
+ L + L P R +
Sbjct: 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 16/109 (14%)
Query: 484 EKTLYLVMEYASGGEVFD---YLVLHGRMKEK----EARAKFR--QIVSAVQYCHQKKII 534
E L LV++Y Y V + K K Q+ ++ Y H I
Sbjct: 125 EVYLNLVLDY------VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178
Query: 535 HRDLKAENLLLDSEMNI-KIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
HRD+K +NLLLD + + K+ DFG + + G ++ S Y APEL
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 75/227 (33%), Positives = 114/227 (50%), Gaps = 26/227 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF-REVRIMKMLDHPNI 107
KLL+TIGKG F V L + G +VA+K + + + F E +M L H N+
Sbjct: 24 KLLQTIGKGEFGDVMLGDY--RGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNL 76
Query: 108 VKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQK 164
V+L VI EK LY+V EY + G + DYL GR KF + A++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPY--AAPELFQGK 219
+HRDL A N+L+ + K++DFG + + KL P APE + K
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-------PVKWTAPEALREK 189
Query: 220 KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
K+ + DVWS G++L+ + S G +P+ L+++ RV +G Y++
Sbjct: 190 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 234
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 474 LLKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQ 530
L++L VI EK LY+V EY + G + DYL GR KF + A++Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL A N+L+ + K++DFG +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 60/286 (20%), Positives = 102/286 (35%), Gaps = 56/286 (19%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM--LDHPN 106
LL+ +GKG + +V G+ VA+KI + + FRE + L H N
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHEN 63
Query: 107 IVKLF----QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYC 161
I+ + L+L+ Y G ++DYL + + + I S + +
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 162 H--------QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD-----TFCGSP 208
H + I HRDLK++N+L+ IAD G + + G+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 209 PYAAPELFQGKKYDGPE-----VDVWSLGVILYTLVSGS----------LPFDG-----S 248
Y APE+ VD+W+ G++L+ + PF
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 249 TLRELRERVLRGKYRIPFYMSTDCENLLKKFLVL-------NPAKR 287
+ ++R+ V + R + L L NP+ R
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 27/113 (23%), Positives = 45/113 (39%), Gaps = 16/113 (14%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCH--------QKKIIHRD 537
L+L+ Y G ++DYL + + + I S + + H + I HRD
Sbjct: 81 LWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLD-----TFCGSPPYAAPELFQG 585
LK++N+L+ IAD G + + G+ Y APE+
Sbjct: 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 29/249 (11%)
Query: 34 ESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAK-HVPTGKE--VAIKIIDKTQLNPGSLQ 90
+S E + +LL+ +G G+F V+ + P+GK VA+K + L+
Sbjct: 9 QSLTCLIGEKDL---RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 91 KLF-REVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA 149
F REV M LDH N+++L+ V+ + +V E A G + D L H +
Sbjct: 66 DDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 124
Query: 150 KF-RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-------NEFTP--GN 199
++ Q+ + Y K+ IHRDL A NLLL + +KI DFG + +
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 200 KLDTFCGSPPYA--APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRER 256
K+ P+A APE + + + D W GV L+ + + G P+ G ++ +
Sbjct: 185 KV-------PFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236
Query: 257 VLRGKYRIP 265
+ + R+P
Sbjct: 237 IDKEGERLP 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
L++L+ V+ + +V E A G + D L H +++ Q+ + Y K+
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRDL A NLLL + +KI DFG
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 74/227 (32%), Positives = 114/227 (50%), Gaps = 26/227 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF-REVRIMKMLDHPNI 107
KLL+TIGKG F V L + G +VA+K + + + F E +M L H N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQLRHSNL 248
Query: 108 VKLFQVI-ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQK 164
V+L VI E + LY+V EY + G + DYL GR KF + A++Y
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPY--AAPELFQGK 219
+HRDL A N+L+ + K++DFG + + KL P APE + K
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-------PVKWTAPEALREK 361
Query: 220 KYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
K+ + DVWS G++L+ + S G +P+ L+++ RV +G Y++
Sbjct: 362 KFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 406
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 37/116 (31%), Positives = 54/116 (46%), Gaps = 15/116 (12%)
Query: 474 LLKLFQVI-ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQ 530
L++L VI E + LY+V EY + G + DYL GR KF + A++Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPY--AAPE 581
+HRDL A N+L+ + K++DFG + + KL P APE
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-------PVKWTAPE 356
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-42
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG--SLQKLFREVRIMKMLDHPN 106
+ +G G + +V VA+K L +++ +E +MK + HPN
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQK 164
+V+L V E Y++ E+ + G + DYL R + QI SA++Y +K
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTPGNKLDTFCGSPPY--AAPELFQ 217
IHR+L A N L+ +K+ADFG S + +T P APE
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-----AKFPIKWTAPESLA 392
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
K+ + DVW+ GV+L+ + + G P+ G L ++ E + + YR+
Sbjct: 393 YNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 439
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQK 531
L++L V E Y++ E+ + G + DYL R + QI SA++Y +K
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
IHR+L A N L+ +K+ADFG S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL--QKLFREVRIMKMLDHPN 106
+ +G G + +V VA+K L ++ ++ +E +MK + HPN
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK-----TLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQK 164
+V+L V E Y++ E+ + G + DYL R + QI SA++Y +K
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPY--AAPEL 215
IHRDL A N L+ +K+ADFG S + +T G K P APE
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-------PIKWTAPES 183
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
K+ + DVW+ GV+L+ + + G P+ G L ++ E + + YR+
Sbjct: 184 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 232
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQK 531
L++L V E Y++ E+ + G + DYL R + QI SA++Y +K
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRDL A N L+ +K+ADFG S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 73/241 (30%), Positives = 118/241 (48%), Gaps = 31/241 (12%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL--QKLFRE 95
E I LLK +G G F VKL K VA+K + GS+ + F+E
Sbjct: 3 MELKREEI---TLLKELGSGQFGVVKLGKWKGQYD-VAVK-----MIKEGSMSEDEFFQE 53
Query: 96 VRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQI 154
+ M L HP +VK + V E +Y+V EY S G + +YL HG+ E + +
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGS 207
+ + + IHRDL A N L+D ++ +K++DFG + +++ G K
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF------ 167
Query: 208 PPY--AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI 264
P +APE+F KY + DVW+ G++++ + S G +P+D T E+ +V +G +R+
Sbjct: 168 -PVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRL 224
Query: 265 P 265
Sbjct: 225 Y 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
L+K + V E +Y+V EY S G + +YL HG+ E + + + + +
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRDL A N L+D ++ +K++DFG +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 66/237 (27%), Positives = 114/237 (48%), Gaps = 16/237 (6%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLF 93
R E + + LK +G G F V +P G+ V IK+I + + S Q +
Sbjct: 8 RIFKETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT 63
Query: 94 REVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFR 152
+ + LDH +IV+L + +L LV +Y G + D++ H G + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS--P-P 209
QI + Y + ++HR+L A N+LL S +++ADFG ++ P +K + + P
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ A E KY + DVWS GV ++ L++ G+ P+ G L E+ + + +G R+
Sbjct: 183 WMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLA 237
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 24/87 (27%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+++L + +L LV +Y G + D++ H G + + QI + Y +
Sbjct: 77 IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
++HR+L A N+LL S +++ADFG +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-42
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 28/230 (12%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL--QKLFREVRIMKMLDHPN 106
++ IG G F V L + K VAIK + G++ + E +M L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIK-----TIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 165
+V+L+ V + + LV E+ G + DYL + E + + Y +
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPY--AAPELF 216
+IHRDL A N L+ IK++DFG + +++T G K P A+PE+F
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF-------PVKWASPEVF 177
Query: 217 QGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+Y + DVWS GV+++ + S G +P++ + E+ E + G +R+
Sbjct: 178 SFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLY 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 1/87 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
L++L+ V + + LV E+ G + DYL + E + + Y +
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+IHRDL A N L+ IK++DFG +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-42
Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 60/297 (20%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ LK IG G V A + VAIK + + N ++ +RE+ +MK ++H N
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 107 IVKLFQVI------ETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFR--QIVS 156
I+ L V E + +Y+VME + L +M+ R + Q++
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMD----AN---LCQVIQMELDHERMSYLLYQMLC 138
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 216
+++ H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-------------------TLRELRERV 257
G Y VD+WS+G I+ ++ G + F G+ +++L+ V
Sbjct: 199 LGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 258 ------LRGKYRIPF-----------------YMSTDCENLLKKFLVLNPAKRASLE 291
F ++ +LL K LV++ +KR S++
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFR--QIVSAVQYCHQKKIIHR 536
+E + +Y+VME + L +M+ R + Q++ +++ H IIHR
Sbjct: 99 LEEFQDVYIVMELMD----AN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 151
Query: 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
DLK N+++ S+ +KI DFG + + + + Y APE+
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-42
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 12/222 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+L +G+G F +V + T + VAIK + ++P + +E ++MK L H +V
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 242
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--FRQIVSAVQYCHQKKI 166
+L+ V+ +E+ +Y+V EY S G + D+L + + QI S + Y +
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPY--AAPELFQGKKYDGP 224
+HRDL+A N+L+ + K+ADFG + P APE ++
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-I 360
Query: 225 EVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ DVWS G++L L + G +P+ G RE+ ++V RG YR+P
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--FRQIVSAVQYCHQK 531
L++L+ V+ +E+ +Y+V EY S G + D+L + + QI S + Y +
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL+A N+L+ + K+ADFG +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 52 KTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVK 109
K +G GNF VK + VA+KI+ +P +L E +M+ LD+P IV+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
+ + ++ LVME A G + YL + +K+K Q+ ++Y + +HR
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 170 DLKAENLLLDSEMNIKIADFGFS-------NEFTP--GNKLDTFCGSPPY--AAPELFQG 218
DL A N+LL ++ KI+DFG S N + K P APE
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW-------PVKWYAPECINY 194
Query: 219 KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
K+ + DVWS GV+++ S G P+ G E+ + +G R+
Sbjct: 195 YKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMG 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 26/86 (30%), Positives = 46/86 (53%), Gaps = 1/86 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++++ + ++ LVME A G + YL + +K+K Q+ ++Y +
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL A N+LL ++ KI+DFG S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 71/233 (30%), Positives = 116/233 (49%), Gaps = 34/233 (14%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL--QKLFREVRIMKMLDHPN 106
KL++ +G G F +V + + K VA+K L GS+ E +MK L H
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVK-----SLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR----AKFRQIVSAVQYCH 162
+V+L+ V+ T++ +Y++ EY G + D+L +K + A QI + +
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIE 126
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPY--AAP 213
++ IHRDL+A N+L+ ++ KIADFG + NE+T G K P AP
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-------PIKWTAP 179
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
E + + DVWS G++L +V+ G +P+ G T E+ + + RG YR+
Sbjct: 180 EAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 28/90 (31%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR----AKFRQIVSAVQYCH 529
L++L+ V+ T++ +Y++ EY G + D+L +K + A QI + +
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIE 126
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
++ IHRDL+A N+L+ ++ KIADFG +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 62/232 (26%), Positives = 112/232 (48%), Gaps = 25/232 (10%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
K +K +G G F V +P G++ VAIK + + +P + +++ E +M +D+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDN 76
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 163
P++ +L + T+ L+ + G + DY+ H + + QI + Y
Sbjct: 77 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEF---TPGNKLDTFCGSP-PYAAPE 214
++++HRDL A N+L+ + ++KI DFG + E G K+ P + A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV------PIKWMALE 189
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ Y + DVWS GV ++ L++ GS P+DG E+ + +G R+P
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 22/87 (25%), Positives = 43/87 (49%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+ +L + T+ L+ + G + DY+ H + + QI + Y ++
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
++HRDL A N+L+ + ++KI DFG +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 79/279 (28%), Positives = 124/279 (44%), Gaps = 44/279 (15%)
Query: 19 SENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP----TGKEV 74
+EN + S+ + + +E H+ K L+ +GKGNF V++ ++ P TG+ V
Sbjct: 17 TENLYFQGAMGSAFEDRDPTQFEERHL---KFLQQLGKGNFGSVEMCRYDPLQDNTGEVV 73
Query: 75 AIKIIDKTQLNPGS---LQKLFREVRIMKMLDHPNIVKLFQVIET--EKTLYLVMEYASG 129
A+K +L + L+ RE+ I+K L H NIVK V + + L L+MEY
Sbjct: 74 AVK-----KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 130 GEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIAD 188
G + DYL H R+ + QI ++Y K+ IHRDL N+L+++E +KI D
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188
Query: 189 FGFSNEFTPGNKLDTFCGSPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-- 240
FG + + + P + APE K+ DVWS GV+LY L +
Sbjct: 189 FGLTKVLPQDK--EYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYI 245
Query: 241 --------------GSLPFDGSTLRELRERVLRGKYRIP 265
G+ + L E + R+P
Sbjct: 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-GRLP 283
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 474 LLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 530
++K V + + L L+MEY G + DYL H R+ + QI ++Y
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K+ IHRDL N+L+++E +KI DFG +
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 73/242 (30%), Positives = 110/242 (45%), Gaps = 30/242 (12%)
Query: 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREV 96
+RD I +L G GNF V+ + K+ VAIK++ K +++ RE
Sbjct: 7 KRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 61
Query: 97 RIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIV 155
+IM LD+P IV+L V + L LVME A GG + +LV A+ Q+
Sbjct: 62 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-------NEFTP--GNKLDTFCG 206
++Y +K +HRDL A N+LL + KI+DFG S + +T K
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW----- 175
Query: 207 SPPYA--APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR 263
P APE +K+ DVWS GV ++ +S G P+ E+ + +G R
Sbjct: 176 --PLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KR 231
Query: 264 IP 265
+
Sbjct: 232 ME 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
+++L V + L LVME A GG + +LV A+ Q+ ++Y +K
Sbjct: 72 IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL A N+LL + KI+DFG S
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 77/260 (29%), Positives = 117/260 (45%), Gaps = 44/260 (16%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP----TGKEVAIKIIDKTQLNPGS---LQ 90
+ +E H+ K L+ +GKGNF V++ ++ P TG+ VA+K +L + L+
Sbjct: 5 TQFEERHL---KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLR 56
Query: 91 KLFREVRIMKMLDHPNIVKLFQVIET--EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEA 147
RE+ I+K L H NIVK V + + L L+MEY G + DYL H R+ +
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 148 RAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 207
QI ++Y K+ IHRDL N+L+++E +KI DFG + + F
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EFFKVK 174
Query: 208 PP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS----------------GSLPF 245
P + APE K+ DVWS GV+LY L + G+
Sbjct: 175 EPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 246 DGSTLRELRERVLRGKYRIP 265
+ L E + R+P
Sbjct: 234 GQMIVFHLIELLKNN-GRLP 252
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 474 LLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 530
++K V + + L L+MEY G + DYL H R+ + QI ++Y
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
K+ IHRDL N+L+++E +KI DFG +
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 58/305 (19%), Positives = 109/305 (35%), Gaps = 57/305 (18%)
Query: 30 SSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL 89
SS + + +LL+ +G F V A+ + VA+KI
Sbjct: 9 SSGVDLGTENLYFQSM-PLQLLEVKARGRFGCVWKAQL--LNEYVAVKI-----FPIQDK 60
Query: 90 QKLFREVRI--MKMLDHPNIVKLF----QVIETEKTLYLVMEYASGGEVFDYLVLHGRMK 143
Q E + + + H NI++ + + L+L+ + G + D+L +
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVV 118
Query: 144 EKEARAKF-RQIVSAVQYCHQK----------KIIHRDLKAENLLLDSEMNIKIADFGFS 192
+ + Y H+ I HRD+K++N+LL + + IADFG +
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 193 NEFTPGNKLD---TFCGSPPYAAPELFQGKKYDGPE----VDVWSLGVILYTLVSGSLPF 245
+F G G+ Y APE+ +G + +D++++G++L+ L S
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 246 DGS----------------TLRELRERVLRGKYRIPFYMSTDCENLLKKFLVL------- 282
DG +L +++E V+ K R +
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 283 NPAKR 287
+ R
Sbjct: 299 DAEAR 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 16/114 (14%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQK----------KIIH 535
L+L+ + G + D+L + + + Y H+ I H
Sbjct: 97 LWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---TFCGSPPYAAPELFQGG 586
RD+K++N+LL + + IADFG + +F G G+ Y APE+ +G
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-40
Identities = 78/377 (20%), Positives = 144/377 (38%), Gaps = 42/377 (11%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVP-TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
G+Y++ I G + LA G+ V +K + + + E + + + H
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVH 138
Query: 105 PNIVKLFQVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 159
P+IV++F +E Y+VMEY G + ++ EA A +I+ A+
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALS 196
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK 219
Y H +++ DLK EN++L E +K+ D G + G+P + APE+ +
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG---YLYGTPGFQAPEIVRT- 251
Query: 220 KYDGPEV--DVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
GP V D++++G L L +G + L E + LL+
Sbjct: 252 ---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVL--KTYDSY----GRLLR 302
Query: 278 KFLVLNPAKR-------------ASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAPT 324
+ + +P +R EV + T P S+ + + T + A T
Sbjct: 303 RAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHT 362
Query: 325 NFKRQNTIDSASIKENTARLNAGRPAKNTASIAPLDTKALVGLGYSR-SEIEESLSQAKY 383
+ + + + N P + +A L S+ + +SL A++
Sbjct: 363 DVYLDGQVHAEKLTANEIVTALSVPLVDPTDVA---ASVLQATVLSQPVQTLDSLRAARH 419
Query: 384 DDPESDGSRSGSSLSLR 400
++DG S+ L
Sbjct: 420 GALDADGVDFSESVELP 436
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543
+ Y+VMEY G + ++ EA A +I+ A+ Y H +++ DLK EN+
Sbjct: 156 DPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENI 213
Query: 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTS 591
+L E +K+ D G + G+P + APE+ + G V +
Sbjct: 214 MLTEE-QLKLIDLGAVSRINSFG---YLYGTPGFQAPEIVRTGPTVAT 257
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 73/253 (28%), Positives = 114/253 (45%), Gaps = 32/253 (12%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLF 93
+ ++ K ++ +G+G+F KV L + PT VA+K + K P
Sbjct: 26 TVFHKRYL---KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWK 81
Query: 94 REVRIMKMLDHPNIVKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF 151
+E+ I++ L H +I+K +L LVMEY G + DYL H + +
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSP 208
+QI + Y H + IHRDL A N+LLD++ +KI DFG + G+ ++ SP
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 209 -PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS---------------GSLPFDGSTLRE 252
+ APE + K+ DVWS GV LY L++ + T+
Sbjct: 201 VFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 253 LRERVLRGKYRIP 265
L E + RG R+P
Sbjct: 260 LTELLERG-ERLP 271
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 3/88 (3%)
Query: 474 LLKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
++K +L LVMEY G + DYL H + + +QI + Y H +
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRDL A N+LLD++ +KI DFG +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 70/247 (28%), Positives = 110/247 (44%), Gaps = 29/247 (11%)
Query: 35 SSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQK 91
S RE + I + K IG G+ +V + G+ VAIK + K +
Sbjct: 41 SFTREIEASRI---HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRD 96
Query: 92 LFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAK 150
E IM DHPNI++L V+ + +V EY G + +L H G+ +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 151 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF---------TPGNKL 201
R + + ++Y +HRDL A N+L+DS + K++DFG S T G K+
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 202 DTFCGSPPY--AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258
P APE + + DVWS GV+++ +++ G P+ T R++ V
Sbjct: 217 -------PIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
Query: 259 RGKYRIP 265
G YR+P
Sbjct: 269 EG-YRLP 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 25/87 (28%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+++L V+ + +V EY G + +L H G+ + R + + ++Y
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL A N+L+DS + K++DFG S
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 63/256 (24%), Positives = 112/256 (43%), Gaps = 36/256 (14%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLF 93
++ + K ++ +G+G+F KV+L ++ P G VA+K + K + + L
Sbjct: 16 THFEKRFL---KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLK 71
Query: 94 REVRIMKMLDHPNIVKLFQVIETEKT--LYLVMEYASGGEVFDYLVLH-GRMKEKEARAK 150
+E+ I++ L H NIVK + + + L+ME+ G + +YL + ++ K+
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 151 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP- 209
QI + Y ++ +HRDL A N+L++SE +KI DFG + + +
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EYYTVKDDR 189
Query: 210 -----YAAPELFQGKKYDGPEVDVWSLGVILYTLVS---------------GSLPFDGST 249
+ APE K+ DVWS GV L+ L++ T
Sbjct: 190 DSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 250 LRELRERVLRGKYRIP 265
+ L + G R+P
Sbjct: 249 VTRLVNTLKEG-KRLP 263
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 25/89 (28%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 474 LLKLFQVIETEKT--LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 530
++K + + + L+ME+ G + +YL + ++ K+ QI + Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
++ +HRDL A N+L++SE +KI DFG +
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 44/238 (18%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSL--QKLFREVRIMKMLDHPN 106
LK +G G F VK K +VAIK + GS+ + E ++M L H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQ-YDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEK 80
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIVSA 157
+V+L+ V ++ ++++ EY + G + +YL +E R +F + + A
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYL--------REMRHRFQTQQLLEMCKDVCEA 132
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPY 210
++Y K+ +HRDL A N L++ + +K++DFG S +E+T G+K P
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-------PV 185
Query: 211 --AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ PE+ K+ + D+W+ GV+++ + S G +P++ T E E + +G R+
Sbjct: 186 RWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLY 241
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 26/95 (27%), Positives = 52/95 (54%), Gaps = 17/95 (17%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIVSA 524
L++L+ V ++ ++++ EY + G + +YL +E R +F + + A
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYL--------REMRHRFQTQQLLEMCKDVCEA 132
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
++Y K+ +HRDL A N L++ + +K++DFG S
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 46/284 (16%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y +G G + V A +G++VAIK + + + ++ +RE+ ++K + H N
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 107 IVKLFQVI------ETEKTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKFRQIVSAVQ 159
++ L V YLVM + D ++ + E++ + Q++ ++
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 160 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG- 218
Y H ++HRDLK NL ++ + +KI DFG + ++ + + Y APE+
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSW 198
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRE---------------------- 255
Y+ VD+WS+G I+ +++G F G L +L +
Sbjct: 199 MHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257
Query: 256 ---RVLRGKYRIPFY-----MSTDCENLLKKFLVLNPAKRASLE 291
+ L R F S +LL+K L L+ KR +
Sbjct: 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 25/103 (24%), Positives = 49/103 (47%), Gaps = 7/103 (6%)
Query: 481 IETEKTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 539
+ YLVM + D ++ + E++ + Q++ ++Y H ++HRDLK
Sbjct: 98 LRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 153
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
NL ++ + +KI DFG + ++ + + Y APE+
Sbjct: 154 PGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEV 194
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 53/288 (18%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ L +G G + V A TG VA+K + + + ++ +RE+R++K + H N
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 107 IVKLFQVI------ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARAKF--RQIV 155
++ L V E +YLV D L+ +K + + +F QI+
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA----D---LNNIVKCQKLTDDHVQFLIYQIL 142
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE- 214
++Y H IIHRDLK NL ++ + +KI DFG + ++ + + Y APE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEI 200
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRE------------------ 255
+ Y+ VD+WS+G I+ L++G F G + +L+
Sbjct: 201 MLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 256 -------RVLRGKYRIPFY-----MSTDCENLLKKFLVLNPAKRASLE 291
+ L ++ F + +LL+K LVL+ KR +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARAKF--RQIVSAVQYCHQKKIIH 535
+E +YLV D L+ +K + + +F QI+ ++Y H IIH
Sbjct: 103 LEEFNDVYLVTHLMGA----D---LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
RDLK NL ++ + +KI DFG + ++ + + Y APE+
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEI 200
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 25/231 (10%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
+L + IG+G F V ++ VAIK K + +K +E M+ DHP
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHP 76
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQK 164
+IVKL VI TE ++++ME + GE+ +L + + Q+ +A+ Y K
Sbjct: 77 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPP--YAAPEL 215
+ +HRD+ A N+L+ S +K+ DFG S + + KL P + APE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-------PIKWMAPES 188
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+++ DVW GV ++ ++ G PF G ++ R+ G R+P
Sbjct: 189 INFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 237
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
++KL VI TE ++++ME + GE+ +L + + Q+ +A+ Y K+
Sbjct: 78 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRD+ A N+L+ S +K+ DFG S
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-40
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 12/222 (5%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+L +G+G F +V + T + VAIK + ++P + +E ++MK L H +V
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 325
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--FRQIVSAVQYCHQKKI 166
+L+ V+ +E+ +Y+V EY S G + D+L + + QI S + Y +
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPY--AAPELFQGKKYDGP 224
+HRDL+A N+L+ + K+ADFG + P APE ++
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-I 443
Query: 225 EVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ DVWS G++L L + G +P+ G RE+ ++V RG YR+P
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--FRQIVSAVQYCHQK 531
L++L+ V+ +E+ +Y+V EY S G + D+L + + QI S + Y +
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL+A N+L+ + K+ADFG +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 23/230 (10%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
L + +G+G F +V + E VA+K K + +K E IMK LDHP
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQK 164
+IVKL +I E+ +++ME GE+ YL + +K QI A+ Y
Sbjct: 74 HIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSP-PYAAPELF 216
+HRD+ N+L+ S +K+ DFG S ++ +L P + +PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL------PIKWMSPESI 186
Query: 217 QGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+++ DVW V ++ ++S G PF +++ + +G R+P
Sbjct: 187 NFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLP 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
++KL +I E+ +++ME GE+ YL + +K QI A+ Y
Sbjct: 75 IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRD+ N+L+ S +K+ DFG S
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 75/308 (24%), Positives = 121/308 (39%), Gaps = 64/308 (20%)
Query: 39 ERDEPHIG-KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR 97
+R +I ++L +G+G + V A H PTG+ VAIK I+ P + RE++
Sbjct: 3 KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIK 61
Query: 98 IMKMLDHPNIVKLFQVI-----ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARA 149
I+K H NI+ +F + E +Y++ E D LH + + +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT----D---LHRVISTQMLSDDHI 114
Query: 150 KF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 207
++ Q + AV+ H +IHRDLK NLL++S ++K+ DFG + ++
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 208 PP-----------YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS------- 248
Y APE + KY +DVWS G IL L F G
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 249 ---------TLRELRERV-----------LRGKYRIPFY-----MSTDCENLLKKFLVLN 283
+ L P ++ +LL++ LV +
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 284 PAKRASLE 291
PAKR + +
Sbjct: 294 PAKRITAK 301
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 22/74 (29%), Positives = 34/74 (45%), Gaps = 11/74 (14%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--- 576
Q + AV+ H +IHRDLK NLL++S ++K+ DFG + ++
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 577 --------YAAPEL 582
Y APE+
Sbjct: 180 VEFVATRWYRAPEV 193
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 66/286 (23%), Positives = 105/286 (36%), Gaps = 56/286 (19%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM--LDHPN 106
L ++IGKG F +V K G+EVA+KI + + FRE I + L H N
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHEN 97
Query: 107 IVKLF----QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYC 161
I+ + T L+LV +Y G +FDYL + E K S + +
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHL 155
Query: 162 HQK--------KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF-----CGSP 208
H + I HRDLK++N+L+ IAD G + G+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 209 PYAAPELFQGKKYDGPE-----VDVWSLGVILYTLVSGS----------LPFDG-----S 248
Y APE+ D++++G++ + + LP+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 249 TLRELRERVLRGKYRIPFYMSTDCENLLKKFLVL-------NPAKR 287
++ E+R+ V K R L+ + N A R
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 30/113 (26%), Positives = 44/113 (38%), Gaps = 16/113 (14%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQK--------KIIHRD 537
L+LV +Y G +FDYL + E K S + + H + I HRD
Sbjct: 115 LWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF-----CGSPPYAAPELFQG 585
LK++N+L+ IAD G + G+ Y APE+
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ LK IG G V A + VAIK + + N ++ +RE+ +MK ++H N
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 107 IVKLFQVI------ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
I+ L V E + +YLVME + V+ + + Q++ +++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELM---DANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGS-------------------TLRELRERV---- 257
Y VD+WS+G I+ +V + F G +++L+ V
Sbjct: 240 YK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 258 --LRGKYRIPF-----------------YMSTDCENLLKKFLVLNPAKRASLE 291
+ F ++ +LL K LV++PAKR S++
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540
+E + +YLVME + V+ + + Q++ +++ H IIHRDLK
Sbjct: 136 LEEFQDVYLVMELM---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192
Query: 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
N+++ S+ +KI DFG + + + + Y APE+
Sbjct: 193 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 64/284 (22%), Positives = 112/284 (39%), Gaps = 52/284 (18%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
+++K IGKG + +V + K G++VA+K+ T+ + E+ ++ H NI+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENIL 94
Query: 109 KLF----QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQ 163
+ + LYL+ +Y G ++DYL + ++ K VS + + H
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 164 K--------KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF-----CGSPPY 210
+ I HRDLK++N+L+ IAD G + +F G+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 211 AAPELFQGKKYDGPE-----VDVWSLGVILYTLVSGS----------LPFDG-----STL 250
PE+ D++S G+IL+ + LP+ +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 251 RELRERVLRGKYRIPFYMSTDCENLLKKFLVL-------NPAKR 287
++RE V K R F + L++ L NPA R
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 29/117 (24%), Positives = 48/117 (41%), Gaps = 16/117 (13%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQK--------KI 533
+ LYL+ +Y G ++DYL + ++ K VS + + H + I
Sbjct: 106 SWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF-----CGSPPYAAPELFQG 585
HRDLK++N+L+ IAD G + +F G+ Y PE+
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-39
Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 26/229 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIV 108
KL K +G G F +V +A + K VA+K + ++ + E +MK L H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLV 246
Query: 109 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQKKI 166
KL V+ T++ +Y++ E+ + G + D+L K+ + F QI + + Q+
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFS-----NEFTP--GNKLDTFCGSPPY--AAPELFQ 217
IHRDL+A N+L+ + + KIADFG + NE+T G K P APE
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-------PIKWTAPEAIN 358
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + DVWS G++L +V+ G +P+ G + E+ + RG YR+P
Sbjct: 359 FGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 3/88 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEAR-AKF-RQIVSAVQYCHQK 531
L+KL V+ T++ +Y++ E+ + G + D+L K+ + F QI + + Q+
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRDL+A N+L+ + + KIADFG +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 75/254 (29%), Positives = 113/254 (44%), Gaps = 33/254 (12%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLF 93
+E H+ K + +GKGNF V+L ++ P G VA+K + + P +
Sbjct: 18 TIFEERHL---KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQ 72
Query: 94 REVRIMKMLDHPNIVKLFQVIET--EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAK 150
RE++I+K L IVK V ++L LVMEY G + D+L H R+
Sbjct: 73 REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 151 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGS 207
QI ++Y ++ +HRDL A N+L++SE ++KIADFG + + S
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 208 P-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPF--------------DGSTLR 251
P + APE + + DVWS GV+LY L + D L
Sbjct: 193 PIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 252 ELRERVLRGKYRIP 265
L E + G R+P
Sbjct: 252 RLLELLEEG-QRLP 264
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 474 LLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 530
++K V ++L LVMEY G + D+L H R+ QI ++Y
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFS 559
++ +HRDL A N+L++SE ++KIADFG +
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-39
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
+L + IG+G F V ++ VAIK K + +K +E M+ DHP
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHP 451
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQK 164
+IVKL VI TE ++++ME + GE+ +L + + Q+ +A+ Y K
Sbjct: 452 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTPGNKLDTFCGSPP--YAAPELFQ 217
+ +HRD+ A N+L+ S +K+ DFG S + + +K G P + APE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-----GKLPIKWMAPESIN 565
Query: 218 GKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+++ DVW GV ++ ++ G PF G ++ R+ G R+P
Sbjct: 566 FRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 612
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
++KL VI TE ++++ME + GE+ +L + + Q+ +A+ Y K+
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRD+ A N+L+ S +K+ DFG S
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 76/315 (24%), Positives = 123/315 (39%), Gaps = 60/315 (19%)
Query: 26 SRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII--DKTQ 83
+MS ++ ER + ++++ + G+G F V+L K TG VAIK + D
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 84 LNPGSLQKLFREVRIMKML---DHPNIVKLFQVIETEKT-------LYLVMEY--ASGGE 131
N RE++IM+ L HPNIV+L T L +VMEY +
Sbjct: 63 RN--------RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114
Query: 132 VFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQK--KIIHRDLKAENLLLDSEMN-IKIA 187
+ Q++ ++ H + HRD+K N+L++ +K+
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 188 DFGFSNEFTPGNKLDTFCGSPPYAAPEL-FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 246
DFG + + +P + S Y APEL F + Y VD+WS+G I ++ G F
Sbjct: 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFR 233
Query: 247 G-STLRELRE--RVL------------RGKYRIPFY-----------------MSTDCEN 274
G ++ +L E RVL + Y + + +
Sbjct: 234 GDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD 293
Query: 275 LLKKFLVLNPAKRAS 289
LL L P +R
Sbjct: 294 LLSALLQYLPEERMK 308
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 19/66 (28%), Positives = 34/66 (51%), Gaps = 3/66 (4%)
Query: 520 QIVSAVQYCHQK--KIIHRDLKAENLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPP 576
Q++ ++ H + HRD+K N+L++ +K+ DFG + + +P + S
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 577 YAAPEL 582
Y APEL
Sbjct: 197 YRAPEL 202
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 53/288 (18%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y+ L+ +G G + V A TG +VAIK + + + ++ +RE+R++K + H N
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 107 IVKLFQVI------ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARAKF--RQIV 155
++ L V + YLVM + D L MK + E R +F Q++
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT----D---LGKLMKHEKLGEDRIQFLVYQML 138
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPE- 214
++Y H IIHRDLK NL ++ + +KI DFG + + ++ + + Y APE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEV 196
Query: 215 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRE------------------ 255
+ +Y VD+WS+G I+ +++G F G L +L+E
Sbjct: 197 ILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 256 -------RVLRGKYRIPFY-----MSTDCENLLKKFLVLNPAKRASLE 291
+ L + F S NLL+K LVL+ +R +
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 12/84 (14%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARAKF--RQIVSAVQYCHQKKIIH 535
++ YLVM + D L MK + E R +F Q++ ++Y H IIH
Sbjct: 99 LDDFTDFYLVMPFMGT----D---LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIH 151
Query: 536 RDLKAENLLLDSEMNIKIADFGFS 559
RDLK NL ++ + +KI DFG +
Sbjct: 152 RDLKPGNLAVNEDCELKILDFGLA 175
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 77/316 (24%), Positives = 120/316 (37%), Gaps = 81/316 (25%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY L KT+G G+F V + +GK A+K K +P + RE+ IMK+LDH N
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDP---RYKNRELDIMKVLDHVN 61
Query: 107 IVKLFQVI--------------------------------------ETEKTLYLVMEYAS 128
I+KL K L ++MEY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 129 GGEVFDYLVLHGRMKEK--EARAKFR--QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184
+ L R Q+ AV + H I HRD+K +NLL++S+ N
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 185 -KIADFGFSNEFTPGNKLDTFCGSPPYAAPEL-FQGKKYDGPEVDVWSLGVILYTLVSGS 242
K+ DFG + + P + S Y APEL +Y P +D+WS+G + L+ G
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYT-PSIDLWSIGCVFGELILGK 239
Query: 243 LPFDG-STLRELRE--RVL--------------RGKYRIPFY------------MSTDCE 273
F G +++ +L +++ + R P +
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 274 NLLKKFLVLNPAKRAS 289
+LL++ L P R +
Sbjct: 300 DLLEQILRYEPDLRIN 315
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 6/138 (4%)
Query: 450 RGVHRSISASNAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRM 509
+ K + + + K L ++MEY + L R
Sbjct: 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRS 134
Query: 510 KEK--EARAKFR--QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI-KIADFGFSNEFTP 564
Q+ AV + H I HRD+K +NLL++S+ N K+ DFG + + P
Sbjct: 135 GRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP 194
Query: 565 GNKLDTFCGSPPYAAPEL 582
+ S Y APEL
Sbjct: 195 SEPSVAYICSRFYRAPEL 212
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 68/244 (27%), Positives = 111/244 (45%), Gaps = 29/244 (11%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFR 94
+E D +I + K +G G F +V + K+ VAIK + K +
Sbjct: 40 KELDATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLG 95
Query: 95 EVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQ 153
E IM DHPNI++L V+ K + +V EY G + +L H + + R
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 154 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF---------TPGNKLDTF 204
I S ++Y +HRDL A N+L++S + K++DFG T G K+
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--- 212
Query: 205 CGSPPY--AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK 261
P +PE +K+ DVWS G++L+ ++S G P+ + +++ + V G
Sbjct: 213 ----PIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG- 266
Query: 262 YRIP 265
YR+P
Sbjct: 267 YRLP 270
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 25/87 (28%), Positives = 44/87 (50%), Gaps = 1/87 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+++L V+ K + +V EY G + +L H + + R I S ++Y
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL A N+L++S + K++DFG
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 76/291 (26%), Positives = 120/291 (41%), Gaps = 55/291 (18%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y L IG+G + V A VAIK I + + Q+ RE++I+ H N
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 86
Query: 107 IVKLFQVI-----ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARAKF--RQIVS 156
I+ + +I E K +Y+V + D L+ +K + + QI+
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET----D---LYKLLKTQHLSNDHICYFLYQILR 139
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF----CGSPPYAA 212
++Y H ++HRDLK NLLL++ ++KI DFG + P + F + Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 213 PE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRE--------------- 255
PE + K Y +D+WS+G IL ++S F G L +L
Sbjct: 200 PEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 256 ----------RVLRGKYRIPFY-----MSTDCENLLKKFLVLNPAKRASLE 291
L K ++P+ + +LL K L NP KR +E
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 4/67 (5%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF----CGSP 575
QI+ ++Y H ++HRDLK NLLL++ ++KI DFG + P + F +
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 576 PYAAPEL 582
Y APE+
Sbjct: 196 WYRAPEI 202
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-38
Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 30/249 (12%)
Query: 32 RRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSL 89
+ + +RD I +L G GNF V+ + K+ VAIK++ K
Sbjct: 326 KDKKLFLKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADT 380
Query: 90 QKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA 149
+++ RE +IM LD+P IV+L V + L LVME A GG + +LV A
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 439
Query: 150 KF-RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-------NEFTP--GN 199
+ Q+ ++Y +K +HR+L A N+LL + KI+DFG S + +T
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
Query: 200 KLDTFCGSPPYA--APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRER 256
K P APE +K+ DVWS GV ++ +S G P+ E+
Sbjct: 500 KW-------PLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551
Query: 257 VLRGKYRIP 265
+ +G R+
Sbjct: 552 IEQG-KRME 559
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 4e-14
Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
+++L V + L LVME A GG + +LV A+ Q+ ++Y +K
Sbjct: 398 IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HR+L A N+LL + KI+DFG S
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-38
Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 38/249 (15%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAK-HVPTGKE---VAIKIIDKTQLNPGS----L 89
E + K IG G F +V +GK+ VAIK L G
Sbjct: 39 TEIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-----TLKAGYTEKQR 90
Query: 90 QKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARA 149
E IM H NI++L VI K + ++ EY G + +L
Sbjct: 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV 150
Query: 150 KF-RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF---------TPGN 199
R I + ++Y +HRDL A N+L++S + K++DFG S T G
Sbjct: 151 GMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 200 KLDTFCGSPPY--AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRER 256
K+ P APE +K+ DVWS G++++ +++ G P+ + E+ +
Sbjct: 211 KI-------PIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262
Query: 257 VLRGKYRIP 265
+ G +R+P
Sbjct: 263 INDG-FRLP 270
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 1/87 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
+++L VI K + ++ EY G + +L R I + ++Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
+HRDL A N+L++S + K++DFG S
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 67/320 (20%), Positives = 112/320 (35%), Gaps = 66/320 (20%)
Query: 29 MSSRRESSRRERDEP--HIG-KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL- 84
M ++ E++ R+ + Y + + I G++ V G VAIK + T
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSD 60
Query: 85 --------NPGSLQKLFREVRIMKMLDHPNIVKLFQVI-----ETEKTLYLVMEYASGGE 131
+ +++ RE+R++ HPNI+ L + LYLV E
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR--- 117
Query: 132 VFDYLVLH-----GRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184
D L R+ ++ I+ + H+ ++HRDL N+LL +I
Sbjct: 118 -TD---LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173
Query: 185 KIADFGFSNEFTPGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSL 243
I DF + E T + Y APE + Q K + VD+WS G ++ + +
Sbjct: 174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKA 232
Query: 244 PFDG-STLRELR--------------------------ERVLRGKYRIPFY-----MSTD 271
F G + +L L +
Sbjct: 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPV 292
Query: 272 CENLLKKFLVLNPAKRASLE 291
+L+ K L NP +R S E
Sbjct: 293 ALDLIAKMLEFNPQRRISTE 312
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 20/63 (31%), Positives = 29/63 (46%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAA 579
I+ + H+ ++HRDL N+LL +I I DF + E T + Y A
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRA 201
Query: 580 PEL 582
PEL
Sbjct: 202 PEL 204
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 7e-38
Identities = 62/307 (20%), Positives = 109/307 (35%), Gaps = 69/307 (22%)
Query: 41 DEPHI--GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI 98
EP + KLL+ IG+G + V + VA+K+ + + Q E I
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKV-----FSFANRQNFINEKNI 58
Query: 99 MKM--LDHPNIVKLF-----QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF 151
++ ++H NI + + LVMEY G + YL LH +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLA 117
Query: 152 RQIVSAVQYCH---------QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202
+ + Y H + I HRDL + N+L+ ++ I+DFG S T +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 203 ---------TFCGSPPYAAPELFQGK------KYDGPEVDVWSLGVILYTLVSGS----- 242
+ G+ Y APE+ +G + +VD+++LG+I + +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 243 --------LPFDGS-----TLRELRERVLRGKYR--IPFYMSTDCENLLKKFLVL----- 282
+ F T +++ V R K R P + ++
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLKETIEDCW 296
Query: 283 --NPAKR 287
+ R
Sbjct: 297 DQDAEAR 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 31/118 (26%), Positives = 47/118 (39%), Gaps = 19/118 (16%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH---------QKKIIHRD 537
LVMEY G + YL LH + + + Y H + I HRD
Sbjct: 87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRD 145
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLD---------TFCGSPPYAAPELFQGG 586
L + N+L+ ++ I+DFG S T + + G+ Y APE+ +G
Sbjct: 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 17/238 (7%)
Query: 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFRE 95
+ + IG+G+F V + + A+K + + G + + E
Sbjct: 21 GPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTE 76
Query: 96 VRIMKMLDHPNIVKLFQVI-ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQ 153
IMK HPN++ L + +E + +V+ Y G++ +++ + F Q
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 154 IVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPP- 209
+ ++Y KK +HRDL A N +LD + +K+ADFG + + + + P
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 210 -YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ A E Q +K+ + DVWS GV+L+ L++ G+ P+ ++ +L+G R+
Sbjct: 197 KWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLL 252
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 22/81 (27%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 480 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDL 538
+ +E + +V+ Y G++ +++ + F Q+ ++Y KK +HRDL
Sbjct: 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDL 154
Query: 539 KAENLLLDSEMNIKIADFGFS 559
A N +LD + +K+ADFG +
Sbjct: 155 AARNCMLDEKFTVKVADFGLA 175
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 51/236 (21%), Positives = 93/236 (39%), Gaps = 27/236 (11%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGK-------EVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+++G+G F K+ G EV +K++DK N + F +M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFFEAASMMSK 68
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQY 160
L H ++V + V LV E+ G + YL + + + +Q+ +A+ +
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 161 CHQKKIIHRDLKAENLLLDSEMN--------IKIADFGFSNEFTPGNKLDTFCGSP-PYA 211
+ +IH ++ A+N+LL E + IK++D G S P P+
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWV 184
Query: 212 APE-LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
PE + K + D WS G L+ + S G P + + +++P
Sbjct: 185 PPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLP 238
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 9/95 (9%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
L+ + V LV E+ G + YL + + + +Q+ +A+ + +
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 533 IIHRDLKAENLLLDSEMN--------IKIADFGFS 559
+IH ++ A+N+LL E + IK++D G S
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 60/269 (22%), Positives = 110/269 (40%), Gaps = 45/269 (16%)
Query: 7 RYSTGKSETGRGSENNISSSRLMSSRRESSRRERDEP--HIG-KYKLLKTIGKGNFAKVK 63
++++G T GS+ + S + ++ R I +Y++ IG G++ V
Sbjct: 11 QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVC 70
Query: 64 LAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----K 118
A + VAIK I + + +++ RE+ I+ L+H ++VK+ ++ +
Sbjct: 71 EAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 119 TLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAEN 175
LY+V+E A D + + E K ++ V+Y H I+HRDLK N
Sbjct: 131 ELYVVLEIADS----DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 176 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP-------------------------- 209
L++ + ++K+ DFG + ++ P
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
Query: 210 --YAAPE-LFQGKKYDGPEVDVWSLGVIL 235
Y APE + + Y +DVWS+G I
Sbjct: 247 RWYRAPELILLQENYT-EAIDVWSIGCIF 274
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 27/122 (22%), Positives = 46/122 (37%), Gaps = 7/122 (5%)
Query: 481 IETEKTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRD 537
+E LY+V+E A D + + E K ++ V+Y H I+HRD
Sbjct: 126 VEKFDELYVVLEIADS----DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRD 181
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGT 597
LK N L++ + ++K+ DFG + ++ P + T
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 598 NH 599
H
Sbjct: 242 GH 243
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-37
Identities = 75/354 (21%), Positives = 124/354 (35%), Gaps = 97/354 (27%)
Query: 30 SSRRESSRRERDEPHIG-KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS 88
S R + H+ Y + IG+G++ V LA T K VAIK +++ +
Sbjct: 9 SGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID 68
Query: 89 LQKLFREVRIMKMLDHPNIVKLFQVI-----ETEKTLYLVMEYASGGEVFD-YLVLHGRM 142
+++ RE+ I+ L I++L+ +I LY+V+E A D + +
Sbjct: 69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPI 124
Query: 143 KEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG----FSNEFT 196
E K ++ + H+ IIHRDLK N LL+ + ++K+ DFG ++E
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 197 PGNKLDTFCGSPP-------------------YAAPE-LFQGKKYDGPEVDVWSLGVILY 236
D P Y APE + + Y +D+WS G I
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFA 243
Query: 237 TLVSGSLP-----------FDGSTLRELRE------------------------------ 255
L++ F GS+ L
Sbjct: 244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD 303
Query: 256 -------------RVLRGKYRIPFY-----MSTDCENLLKKFLVLNPAKRASLE 291
++ + I +S D NLL+ L NP KR +++
Sbjct: 304 LKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITID 357
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 23/76 (30%), Positives = 36/76 (47%), Gaps = 7/76 (9%)
Query: 485 KTLYLVMEYASGGEVFD-YLVLHGRMKEKEARAKF--RQIVSAVQYCHQKKIIHRDLKAE 541
LY+V+E A D + + E K ++ + H+ IIHRDLK
Sbjct: 103 DELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPA 158
Query: 542 NLLLDSEMNIKIADFG 557
N LL+ + ++K+ DFG
Sbjct: 159 NCLLNQDCSVKVCDFG 174
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 65/300 (21%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y LK +G G V A K VAIK I +P S++ RE++I++ LDH N
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDN 69
Query: 107 IVKLFQVI--------------ETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARA 149
IVK+F+++ ++Y+V EY D L +++ E A
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D---LANVLEQGPLLEEHA 122
Query: 150 KF--RQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFG----FSNEFTPGNKLD 202
+ Q++ ++Y H ++HRDLK NL +++E + +KI DFG ++ L
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 203 TFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS------------- 248
+ Y +P L Y +D+W+ G I +++G F G+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 249 ------TLRELRERV------LRGKYRIPFY-----MSTDCENLLKKFLVLNPAKRASLE 291
+EL + + P +S + + L++ L +P R + E
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 17/112 (15%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEK---EARAKF--RQIVSAVQYCHQKKIIH 535
+ ++Y+V EY D L +++ E A+ Q++ ++Y H ++H
Sbjct: 91 LTELNSVYIVQEYMET----D---LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLH 143
Query: 536 RDLKAENLLLDSE-MNIKIADFG----FSNEFTPGNKLDTFCGSPPYAAPEL 582
RDLK NL +++E + +KI DFG ++ L + Y +P L
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 23/241 (9%)
Query: 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFR 94
ER H + IGKG+F V +++ + AIK + ++ R
Sbjct: 18 HERVVTHSDR-----VIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLR 71
Query: 95 EVRIMKMLDHPNIVKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-R 152
E +M+ L+HPN++ L + + E ++++ Y G++ ++ R + F
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-----NEFTPGNKLDTFCGS 207
Q+ ++Y ++K +HRDL A N +LD +K+ADFG + E+ +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ--HRHAR 189
Query: 208 PP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI 264
P + A E Q ++ + DVWS GV+L+ L++ G+ P+ +L + +G R+
Sbjct: 190 LPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRL 247
Query: 265 P 265
P
Sbjct: 248 P 248
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 474 LLKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQK 531
+L L + + E ++++ Y G++ ++ R + F Q+ ++Y ++
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFS 559
K +HRDL A N +LD +K+ADFG +
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 42/290 (14%), Positives = 90/290 (31%), Gaps = 47/290 (16%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ-LNPGSLQKLFREVRIMKMLDH 104
G+Y+LL G + A ++VA+ +D L LQ+ + +D
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
P + ++ V+ T +V E+ GG + + V A + + +A H+
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
+ + + + ++ +A P
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA--------NP 181
Query: 225 EVDVWSLGVILYTLVSGSLPFDGST--------LRELRERVLRGKYR---IPFYMSTDCE 273
+ D+ +G LY L+ P + R+ + + IPF +S
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 274 NLLKKFLVLNPAKRASLEVSGEVTLGGAPVTSSGGAGTNHTHNSSISPAP 323
++ + R++ + + A + + +S AP
Sbjct: 242 RSVQG----DGGIRSASTLLNL--MQQATAVADRTEVLGPIDEAPVSAAP 285
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 12/87 (13%), Positives = 29/87 (33%), Gaps = 2/87 (2%)
Query: 478 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537
V+ T +V E+ GG + + V A + + +A H+ +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGVALSI 154
Query: 538 LKAENLLLDSEMNIKIADFGFSNEFTP 564
+ + + ++ +A + P
Sbjct: 155 DHPSRVRVSIDGDVVLAYPATMPDANP 181
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 57/242 (23%), Positives = 102/242 (42%), Gaps = 33/242 (13%)
Query: 49 KLLKTIGKGNFAKV---KLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
L + +GKG F V +L + + +VA+K++ + +++ RE MK DHP
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 106 NIVKLFQV------IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVS-AV 158
++ KL V +++ + G++ +L+ R+ E + +V V
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFMV 144
Query: 159 Q------YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------NEFTPGNKLDTFCG 206
Y + IHRDL A N +L +M + +ADFG S + + G
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA-----S 199
Query: 207 SPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR 263
P + A E Y DVW+ GV ++ +++ G P+ G E+ ++ G R
Sbjct: 200 KLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-NR 257
Query: 264 IP 265
+
Sbjct: 258 LK 259
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 21/85 (24%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVS-AVQ------YCHQKKII 534
+++ + G++ +L+ R+ E + +V V Y + I
Sbjct: 101 GRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159
Query: 535 HRDLKAENLLLDSEMNIKIADFGFS 559
HRDL A N +L +M + +ADFG S
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 60/270 (22%), Positives = 114/270 (42%), Gaps = 34/270 (12%)
Query: 22 NISSSRLMSSRRESSRRERDEPHI--GKYKLLKTIGKGNFAKV---KLAKHVPTGKEVAI 76
+ SS L+ E + + ++ I L K +G+G F V L + T +VA+
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 77 KIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI-----ETEKTLYLVMEYASGGE 131
K + + +++ E MK HPN+++L V + +++ + G+
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 132 VFDYLVLHGRMKEKEARAKFRQIVS-AVQ------YCHQKKIIHRDLKAENLLLDSEMNI 184
+ YL+ R++ + ++ V Y + +HRDL A N +L +M +
Sbjct: 128 LHTYLLYS-RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186
Query: 185 KIADFGFS------NEFTPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILY 236
+ADFG S + + G P + A E + Y + DVW+ GV ++
Sbjct: 187 CVADFGLSKKIYSGDYYRQGRI-----AKMPVKWIAIESLADRVYT-SKSDVWAFGVTMW 240
Query: 237 TLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
+ + G P+ G E+ + +L G +R+
Sbjct: 241 EIATRGMTPYPGVQNHEMYDYLLHG-HRLK 269
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 19/81 (23%), Positives = 37/81 (45%), Gaps = 8/81 (9%)
Query: 486 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVS-AVQ------YCHQKKIIHRDL 538
+++ + G++ YL+ R++ + ++ V Y + +HRDL
Sbjct: 115 KPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 539 KAENLLLDSEMNIKIADFGFS 559
A N +L +M + +ADFG S
Sbjct: 174 AARNCMLRDDMTVCVADFGLS 194
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 66/264 (25%), Positives = 104/264 (39%), Gaps = 45/264 (17%)
Query: 36 SRRERDEPHI--GKYKLLKTIGKGNFAKVKL--AKHVPTGKE---VAIKIIDKTQLNPGS 88
HI L + +G+G F KV L ++ K+ VA+K L +
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA-----LKDPT 57
Query: 89 LQ---KLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEK 145
L RE ++ L H +IVK + V L +V EY G++ +L HG
Sbjct: 58 LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 146 EARAKFR----------------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 189
+ R QI S + Y + +HRDL N L+ + + +KI DF
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 190 GFS-----NEFTPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-G 241
G S ++ P + PE +K+ E DVWS GVIL+ + + G
Sbjct: 178 GMSRDVYSTDYYRVGGHTML----PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYG 232
Query: 242 SLPFDGSTLRELRERVLRGKYRIP 265
P+ + E+ E + +G +
Sbjct: 233 KQPWFQLSNTEVIECITQG-RVLE 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------------- 519
++K + V L +V EY G++ +L HG + R
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 520 --QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
QI S + Y + +HRDL N L+ + + +KI DFG S
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 54/253 (21%), Positives = 101/253 (39%), Gaps = 38/253 (15%)
Query: 41 DEPHI--GKYKLLKTIGKGNFAKV--KLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLF 93
DE + K + + +G+G+F V +AK V + VAIK + + +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 76
Query: 94 REVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-- 151
E +MK + ++V+L V+ + ++ME + G++ YL
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 152 --------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE--------F 195
+I + Y + K +HRDL A N ++ + +KI DFG + +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 196 TPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252
L P + +PE + + DVWS GV+L+ + + P+ G + +
Sbjct: 197 GGKGLL-------PVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 253 LRERVLRGKYRIP 265
+ V+ G +
Sbjct: 249 VLRFVMEG-GLLD 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 21/96 (21%), Positives = 40/96 (41%), Gaps = 10/96 (10%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----------RQIVS 523
+++L V+ + ++ME + G++ YL +I
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ Y + K +HRDL A N ++ + +KI DFG +
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 59/270 (21%), Positives = 116/270 (42%), Gaps = 14/270 (5%)
Query: 7 RYSTGKSETGRGSENNISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAK 66
+ + + +I S L ++ + P + IG+G+F V
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109
Query: 67 HVPTGKE---VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI-ETEKTLYL 122
+ + A+K + + G + + E IMK HPN++ L + +E + +
Sbjct: 110 LLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168
Query: 123 VMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDLKAENLLLDSE 181
V+ Y G++ +++ + F Q+ +++ KK +HRDL A N +LD +
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228
Query: 182 MNIKIADFGFSNEFTPGNKLDTFCGSP---P--YAAPELFQGKKYDGPEVDVWSLGVILY 236
+K+ADFG + + + P + A E Q +K+ + DVWS GV+L+
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLW 287
Query: 237 TLVS-GSLPFDGSTLRELRERVLRGKYRIP 265
L++ G+ P+ ++ +L+G R+
Sbjct: 288 ELMTRGAPPYPDVNTFDITVYLLQG-RRLL 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 480 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDL 538
+ +E + +V+ Y G++ +++ + F Q+ +++ KK +HRDL
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 218
Query: 539 KAENLLLDSEMNIKIADFGFS 559
A N +LD + +K+ADFG +
Sbjct: 219 AARNCMLDEKFTVKVADFGLA 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 74/244 (30%), Positives = 104/244 (42%), Gaps = 37/244 (15%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKML-DHP 105
K IG+GNF +V A+ G AIK + K + + E+ ++ L HP
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-------------- 151
NI+ L E LYL +EYA G + D+L ++ A A
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 152 --RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-----TPGNKLDTF 204
+ + Y QK+ IHRDL A N+L+ KIADFG S +L
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--- 203
Query: 205 CGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK 261
P + A E Y DVWS GV+L+ +VS G P+ G T EL E++ +G
Sbjct: 204 ----PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 257
Query: 262 YRIP 265
YR+
Sbjct: 258 YRLE 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 31/102 (30%), Positives = 43/102 (42%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
++ L E LYL +EYA G + D+L ++ A A
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 519 -RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+ + Y QK+ IHRDL A N+L+ KIADFG S
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 56/260 (21%), Positives = 96/260 (36%), Gaps = 38/260 (14%)
Query: 34 ESSRRERDEPHI--GKYKLLKTIGKGNFAKV--KLAKHVPTGKE---VAIKIIDKTQLNP 86
+ D + L++ +G G F +V +P VA+K + +
Sbjct: 16 GKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSE 74
Query: 87 GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKE 146
E I+ +H NIV+ V +++ME +GG++ +L +
Sbjct: 75 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP 134
Query: 147 ARAKFRQIVS-AVQ------YCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNE-- 194
+ ++ A Y + IHRD+ A N LL KI DFG + +
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 195 ------FTPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPF 245
L P + PE F + + D WS GV+L+ + S G +P+
Sbjct: 195 RASYYRKGGCAML-------PVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPY 246
Query: 246 DGSTLRELRERVLRGKYRIP 265
+ +E+ E V G R+
Sbjct: 247 PSKSNQEVLEFVTSG-GRMD 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVS-AVQ------ 526
+++ V +++ME +GG++ +L + + ++ A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 527 YCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFS 559
Y + IHRD+ A N LL KI DFG +
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 55/251 (21%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 49 KLLKTIGKGNFAKV---KLAKHVPTGKE--VAIKIIDKTQLNPGS----LQKLFREVRIM 99
+ ++ +G+ F KV L P + VAIK L + ++ E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-----LKDKAEGPLREEFRHEAMLR 66
Query: 100 KMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-------- 151
L HPN+V L V+ ++ L ++ Y S G++ ++LV+ + +
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 152 --------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------NEFTP 197
QI + ++Y ++H+DL N+L+ ++N+KI+D G + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 198 GNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELR 254
P + APE K+ + D+WS GV+L+ + S G P+ G + +++
Sbjct: 187 LGN-----SLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 255 ERVLRGKYRIP 265
E + +P
Sbjct: 241 EMIRNR-QVLP 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 21/102 (20%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
++ L V+ ++ L ++ Y S G++ ++LV+ + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 519 -RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
QI + ++Y ++H+DL N+L+ ++N+KI+D G
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 84/329 (25%), Positives = 132/329 (40%), Gaps = 87/329 (26%)
Query: 42 EPHIG-KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+ H+ KY+L+K +GKG + V + TG+ VA+K I N Q+ FRE+ I+
Sbjct: 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 101 -MLDHPNIVKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHGRMKE---KEARAKF--R 152
+ H NIV L V+ + + +YLV +Y D LH ++ + ++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET----D---LHAVIRANILEPVHKQYVVY 116
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP--- 209
Q++ ++Y H ++HRD+K N+LL++E ++K+ADFG S F ++
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 210 -------------------YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-S 248
Y APE L KY +D+WSLG IL ++ G F G S
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSS 235
Query: 249 TLRELRE-------------------------RVLRGKYRIPFY---------------- 267
T+ +L L+ K I
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295
Query: 268 -----MSTDCENLLKKFLVLNPAKRASLE 291
+ + +LL K L NP KR S
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISAN 324
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 31/124 (25%), Positives = 58/124 (46%), Gaps = 14/124 (11%)
Query: 472 ETLLKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHGRMKE---KEARAKF--RQIVSA 524
E ++ L V+ + + +YLV +Y D LH ++ + ++ Q++
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET----D---LHAVIRANILEPVHKQYVVYQLIKV 121
Query: 525 VQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
++Y H ++HRD+K N+LL++E ++K+ADFG S F ++ E F
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 585 GGAP 588
P
Sbjct: 182 DDQP 185
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 48/251 (19%)
Query: 49 KLLKTIGKGNFAKVKL--AKHVPTGKE---VAIKIIDKTQLNPGS---LQKLFREVRIMK 100
L +G+G F KV L ++ ++ VA+K L S Q RE ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK-----ALKEASESARQDFQREAELLT 98
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------- 151
ML H +IV+ F V + L +V EY G++ +L HG + A +
Sbjct: 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 152 ------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE--------FTP 197
Q+ + + Y +HRDL N L+ + +KI DFG S +
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 198 GNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELR 254
L P + PE +K+ E DVWS GV+L+ + + G P+ + E
Sbjct: 219 RTML-------PIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 255 ERVLRGKYRIP 265
+ + +G +
Sbjct: 271 DCITQG-RELE 280
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 25/101 (24%), Positives = 42/101 (41%), Gaps = 15/101 (14%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
+++ F V + L +V EY G++ +L HG + A +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ + + Y +HRDL N L+ + +KI DFG S
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 55/260 (21%), Positives = 96/260 (36%), Gaps = 38/260 (14%)
Query: 34 ESSRRERDEPHI--GKYKLLKTIGKGNFAKV--KLAKHVPTGKE---VAIKIIDKTQLNP 86
+ D + L++ +G G F +V +P VA+K + +
Sbjct: 57 GKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSE 115
Query: 87 GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKE 146
E I+ +H NIV+ V ++++E +GG++ +L +
Sbjct: 116 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 147 ARAKFRQIVS-AVQ------YCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNE-- 194
+ ++ A Y + IHRD+ A N LL KI DFG + +
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 195 ------FTPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPF 245
L P + PE F + + D WS GV+L+ + S G +P+
Sbjct: 236 RAGYYRKGGCAML-------PVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPY 287
Query: 246 DGSTLRELRERVLRGKYRIP 265
+ +E+ E V G R+
Sbjct: 288 PSKSNQEVLEFVTSG-GRMD 306
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVS-AVQ------ 526
+++ V ++++E +GG++ +L + + ++ A
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 527 YCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFS 559
Y + IHRD+ A N LL KI DFG +
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 68/256 (26%), Positives = 113/256 (44%), Gaps = 48/256 (18%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
L KT+G+G F KV A VA+K++ K +P L+ L E ++K ++
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVN 84
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF------------ 151
HP+++KL+ + L L++EYA G + +L ++ +
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 152 ------------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------N 193
QI +QY + K++HRDL A N+L+ +KI+DFG S +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 194 EFTPGNKLDTFCGSPP--YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGST 249
+ ++ G P + A E LF Y + DVWS GV+L+ +V+ G P+ G
Sbjct: 205 SYVKRSQ-----GRIPVKWMAIESLFDH-IYT-TQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 250 LRELRERVLRGKYRIP 265
L + G +R+
Sbjct: 258 PERLFNLLKTG-HRME 272
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 24/110 (21%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
++KL+ + L L++EYA G + +L ++ +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 519 ---------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
QI +QY + K++HRDL A N+L+ +KI+DFG S
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 64/251 (25%), Positives = 99/251 (39%), Gaps = 42/251 (16%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKML- 102
KT+G G F KV A K VA+K++ K + + L E++++ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLG 84
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL-----------VLHGRMKEKEARAKF 151
+H NIV L ++ EY G++ ++L M++ E
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 152 RQIVS-AVQ------YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------NEFTPG 198
++S + Q + K IHRDL A N+LL KI DFG + + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 199 NKLDTFCGSPPY--AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDG-STLRELR 254
P APE Y E DVWS G+ L+ L S GS P+ G +
Sbjct: 205 GN-----ARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 255 ERVLRGKYRIP 265
+ + G +R+
Sbjct: 259 KMIKEG-FRML 268
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 24/104 (23%), Positives = 40/104 (38%), Gaps = 18/104 (17%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL-----------VLHGRMKEKEARAKFRQIV 522
++ L ++ EY G++ ++L M++ E ++
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 523 S-AVQ------YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
S + Q + K IHRDL A N+LL KI DFG +
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 52/258 (20%)
Query: 49 KLLKTIGKGNFAKVKL--AKHVPTGKE---VAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
+ ++ IG+G F +V A + + VA+K++ K + + RE +M D
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFD 108
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF------------ 151
+PNIVKL V K + L+ EY + G++ ++L
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 152 ------------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE----- 194
RQ+ + + Y ++K +HRDL N L+ M +KIADFG S
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 195 ---FTPGNKLDTFCGSPP--YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDG 247
+ + P + PE +F +Y E DVW+ GV+L+ + S G P+ G
Sbjct: 229 YYKADGNDAI-------PIRWMPPESIFYN-RYT-TESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 248 STLRELRERVLRGKYRIP 265
E+ V G +
Sbjct: 280 MAHEEVIYYVRDG-NILA 296
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 27/110 (24%), Positives = 44/110 (40%), Gaps = 24/110 (21%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
++KL V K + L+ EY + G++ ++L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 519 ---------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
RQ+ + + Y ++K +HRDL N L+ M +KIADFG S
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 38/247 (15%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
+ KT+G G F KV A GKE VA+K++ K+ + + L E++IM L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLG 107
Query: 104 -HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF----------- 151
H NIV L + ++ EY G++ ++L R+ E +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 152 ---RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------NEFTPGNKLD 202
Q+ + + K IHRD+ A N+LL + KI DFG + + +
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-- 225
Query: 203 TFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGS-TLRELRERVL 258
P + APE Y + DVWS G++L+ + S G P+ G + + V
Sbjct: 226 ---ARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281
Query: 259 RGKYRIP 265
G Y++
Sbjct: 282 DG-YQMA 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 21/87 (24%), Positives = 37/87 (42%), Gaps = 14/87 (16%)
Query: 487 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------RQIVSAVQYCHQKK 532
+ ++ EY G++ ++L R+ E + Q+ + + K
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFS 559
IHRD+ A N+LL + KI DFG +
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 43/251 (17%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE-------VAIKIIDKTQLNPGSLQKLFREVRIMKM 101
L K +G+G F +V +A+ V K+ VA+K++ K L L E+ +MKM
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKM 96
Query: 102 L-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------- 152
+ H NI+ L + LY+++EYAS G + +YL + + R
Sbjct: 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 153 --------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS------NEFTPG 198
Q+ ++Y +K IHRDL A N+L+ +KIADFG + + +
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 199 NKLDTFCGSPP--YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELR 254
G P + APE LF Y + DVWS GV+++ + + G P+ G + EL
Sbjct: 217 TN-----GRLPVKWMAPEALFDR-VYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 255 ERVLRGKYRIP 265
+ + G +R+
Sbjct: 270 KLLKEG-HRMD 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR-------------- 519
++ L + LY+++EYAS G + +YL + + R
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 520 --QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ ++Y +K IHRDL A N+L+ +KIADFG +
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 47/253 (18%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE-------VAIKIIDKTQLNPGSLQKLFREVRIMKM 101
L K +G+G F +V LA+ + K+ VA+K++ K+ L L E+ +MKM
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKM 130
Query: 102 L-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------- 151
+ H NI+ L + LY+++EYAS G + +YL + +
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 152 -------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN--------EFT 196
Q+ ++Y KK IHRDL A N+L+ + +KIADFG + + T
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 197 PGNKLDTFCGSPP--YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252
+L P + APE LF Y + DVWS GV+L+ + + G P+ G + E
Sbjct: 251 TNGRL-------PVKWMAPEALFDR-IYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 253 LRERVLRGKYRIP 265
L + + G +R+
Sbjct: 302 LFKLLKEG-HRMD 313
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 16/102 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
++ L + LY+++EYAS G + +YL + +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 519 -RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ ++Y KK IHRDL A N+L+ + +KIADFG +
Sbjct: 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 63/252 (25%), Positives = 102/252 (40%), Gaps = 45/252 (17%)
Query: 49 KLLKTIGKGNFAKVKLAK-----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
KL K +G+G F +V A T + VA+K++ K + L E++I+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIG 88
Query: 104 -HPNIVKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR--------- 152
H N+V L + L +++E+ G + YL A
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 153 -------QIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN--------EFTP 197
Q+ +++ +K IHRDL A N+LL + +KI DFG +
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 198 GNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDG-STLREL 253
+L P + APE + Y + DVWS GV+L+ + S G+ P+ G E
Sbjct: 209 DARL-------PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 254 RERVLRGKYRIP 265
R+ G R+
Sbjct: 261 CRRLKEG-TRMR 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 16/96 (16%)
Query: 480 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFR----------------QIVS 523
+ L +++E+ G + YL A Q+
Sbjct: 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 159
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
+++ +K IHRDL A N+LL + +KI DFG +
Sbjct: 160 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 70/253 (27%), Positives = 111/253 (43%), Gaps = 47/253 (18%)
Query: 49 KLLKTIGKGNFAKVK--LAKHVPTGKE-----VAIKIIDKTQLNPGSLQKLFREVRIMKM 101
L K +G+G F +V A + K VA+K++ K L L E+ +MKM
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKM 142
Query: 102 L-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------- 151
+ H NI+ L + LY+++EYAS G + +YL R E
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINRVPEEQMT 201
Query: 152 --------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN--------EF 195
Q+ ++Y +K IHRDL A N+L+ +KIADFG + +
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 196 TPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE 252
T +L P + APE + Y + DVWS GV+++ + + G P+ G + E
Sbjct: 262 TTNGRL-------PVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 253 LRERVLRGKYRIP 265
L + + G +R+
Sbjct: 314 LFKLLKEG-HRMD 325
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 18/103 (17%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
++ L + LY+++EYAS G + +YL R E
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 519 --RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ ++Y +K IHRDL A N+L+ +KIADFG +
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 62/318 (19%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML--- 102
+Y L++ +G G+F+ V LAK + VA+KI+ + + E+++++ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDA 75
Query: 103 -----DHP---NIVKL---FQVIETEKT-LYLVMEYASGGEVFDYLVL--HGRMKEKEAR 148
D +I+KL F + +V E G + + H + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 149 AKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSE------MNIKIADFGFSNEFTPGNKL 201
+Q++ + Y H++ IIH D+K EN+L++ + IKIAD G + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWY-DEHY 192
Query: 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL-------- 253
+ Y +PE+ G + D+WS +++ L++G F+
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 254 ----------------------------------------RERVLRGKYRIPFYMSTDCE 273
E VL KY+ + +
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 274 NLLKKFLVLNPAKRASLE 291
+ L L L+P KRA
Sbjct: 312 DFLSPMLQLDPRKRADAG 329
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 9/78 (11%)
Query: 515 RAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSE------MNIKIADFGFSNEFTPGNK 567
+ +Q++ + Y H++ IIH D+K EN+L++ + IKIAD G + +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWY-DEH 191
Query: 568 LDTFCGSPPYAAPELFQG 585
+ Y +PE+ G
Sbjct: 192 YTNSIQTREYRSPEVLLG 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 61/261 (23%), Positives = 99/261 (37%), Gaps = 57/261 (21%)
Query: 49 KLLKTIGKGNFAKVKLAKHVPTGKE-----VAIKIIDKTQLNPGS----LQKLFREVRIM 99
+ K +G G F KV A K VA+K L + + L E+++M
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-----MLKEKADSSEREALMSELKMM 102
Query: 100 KML-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF------- 151
L H NIV L +YL+ EY G++ +YL R K E ++
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK-REKFSEDEIEYENQKRLE 161
Query: 152 -----------------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-- 192
Q+ +++ K +HRDL A N+L+ +KI DFG +
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 193 ----NEFTPGNKLDTFCGSPP--YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPF 245
+ + P + APE Y + DVWS G++L+ + S G P+
Sbjct: 222 IMSDSNYVVRGN-----ARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPY 275
Query: 246 DG-STLRELRERVLRGKYRIP 265
G + + G +++
Sbjct: 276 PGIPVDANFYKLIQNG-FKMD 295
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 25/110 (22%), Positives = 43/110 (39%), Gaps = 25/110 (22%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--------------- 518
++ L +YL+ EY G++ +YL R K E ++
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK-REKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 519 ---------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ +++ K +HRDL A N+L+ +KI DFG +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-28
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 24/239 (10%)
Query: 44 HI-GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML 102
H+ +Y++LK IGKG+F +V A + VA+K++ ++ E+RI++ L
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHL 150
Query: 103 ------DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQI 154
+ N++ + + + + E S +++ + + R I
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEM--NIKIADFG---FSNEFTPGNKLDTFCGSPP 209
+ + H+ +IIH DLK EN+LL + IK+ DFG + ++ ++ T+ S
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRF 264
Query: 210 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYM 268
Y APE+ G +Y P +D+WSLG IL L++G G + ++ +
Sbjct: 265 YRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEM--NIKIADFG---FSNE 561
I+ + H+ +IIH DLK EN+LL + IK+ DFG + ++
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 29/240 (12%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFR-----EVRIMK 100
+Y++ IGKG+F +V A + VAIKII +K F EVR+++
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--------KKAFLNQAQIEVRLLE 105
Query: 101 ML------DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFR 152
++ IV L + L LV E S ++D L + R +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 153 QIVSAVQYCHQKK--IIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGSP 208
Q+ +A+ + + IIH DLK EN+LL + IKI DFG S+ G ++ + S
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL-GQRIYQYIQSR 222
Query: 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYM 268
Y +PE+ G YD +D+WSLG IL + +G F G+ + +++ P ++
Sbjct: 223 FYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 519 RQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGS 574
+Q+ +A+ + + IIH DLK EN+LL + IKI DFG S+ G ++ + S
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL-GQRIYQYIQS 221
Query: 575 PPYAAPE 581
Y +PE
Sbjct: 222 RFYRSPE 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 58/273 (21%), Positives = 104/273 (38%), Gaps = 53/273 (19%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFR----EVRIMKM 101
+ +++ +G G F +V L +H+ K A+K++ +++K R E I+K
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKK 87
Query: 102 L-----DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQI 154
+ ++ NIVK + L+ E G +++ + + ++ + +I
Sbjct: 88 IQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 155 VSAVQYCHQKKIIHRDLKAENLLLDSEM-------------------------NIKIADF 189
+ A+ Y + + H DLK EN+LLD IK+ DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 190 G---FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 246
G F ++ + + Y APE+ +D D+WS G +L L +GSL F
Sbjct: 207 GCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFR 260
Query: 247 GSTLRELRERVLRGKYRIPFYMSTDCENLLKKF 279
E + IP M +
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSK 293
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 18/71 (25%), Positives = 27/71 (38%), Gaps = 28/71 (39%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-------------------------NIKI 553
+I+ A+ Y + + H DLK EN+LLD IK+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 554 ADFG---FSNE 561
DFG F ++
Sbjct: 204 IDFGCATFKSD 214
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ--KLFR-EVRIMKMLDHPNIVKL 110
+G+G F V K VA+K + ++ + + + F E+++M H N+V+L
Sbjct: 39 MGEGGFGVV--YKGYVNNTTVAVKKL-AAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEK----EARAKFRQIV--SA--VQYCH 162
L LV Y G + D L R K I +A + + H
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK---IAQGAANGINFLH 150
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-------LDTFCGSPPYAAPEL 215
+ IHRD+K+ N+LLD KI+DFG + + + T Y APE
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT-A---YMAPEA 206
Query: 216 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS 248
+G+ + D++S GV+L +++G D
Sbjct: 207 LRGEITP--KSDIYSFGVVLLEIITGLPAVDEH 237
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 20/62 (32%), Positives = 29/62 (46%), Gaps = 11/62 (17%)
Query: 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-------LDTFCGSPPYAA 579
+ H+ IHRD+K+ N+LLD KI+DFG + + + T Y A
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT-A---YMA 203
Query: 580 PE 581
PE
Sbjct: 204 PE 205
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 68/255 (26%), Positives = 109/255 (42%), Gaps = 38/255 (14%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH- 104
+Y+L + IG G+F + L + G+EVAIK+ +P L E +I KM+
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 64
Query: 105 PNIVKLFQVIETEKTLYLVMEY--ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
I + +VME S ++F++ + K Q++S ++Y H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH 122
Query: 163 QKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNKLD--------TFCGSPPYA 211
K IHRD+K +N L+ + I DFG + ++ G+ YA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 212 AP----ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---STLRELRERVLRGKYRI 264
+ + Q ++ D D+ SLG +L GSLP+ G +T R+ ER+ K
Sbjct: 183 SINTHLGIEQSRR-D----DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--- 234
Query: 265 PFYMSTDCENLLKKF 279
MST E L K +
Sbjct: 235 ---MSTPIEVLCKGY 246
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 16/47 (34%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFT 563
Q++S ++Y H K IHRD+K +N L+ + I DFG + ++
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 65/325 (20%), Positives = 117/325 (36%), Gaps = 93/325 (28%)
Query: 46 GKYKLLKTIGKGNFAKVKLAK-HVPTGKEVAIKIIDKTQLNPGSLQKLFR----EVRIMK 100
+Y+++ +G+G F KV H +VA+KII ++ K E+ ++K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLK 71
Query: 101 ML------DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFR 152
+ + V + + + E G F++L + R
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-------------------IKIADFG--- 190
Q+ A+++ H+ ++ H DLK EN+L + I++ADFG
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
F +E T + Y PE+ + P DVWS+G IL+ G F
Sbjct: 191 FDHE-----HHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 251 RE-LR--ERVL------------RGKY----RIPFYMST--------------------- 270
RE L E++L + KY + + ++
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 271 ----DCENLLKKFLVLNPAKRASLE 291
+L+++ L +PA+R +L
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLA 329
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 17/65 (26%), Positives = 29/65 (44%), Gaps = 22/65 (33%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-------------------IKIADFG-- 557
Q+ A+++ H+ ++ H DLK EN+L + I++ADFG
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 558 -FSNE 561
F +E
Sbjct: 190 TFDHE 194
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 75/325 (23%), Positives = 122/325 (37%), Gaps = 93/325 (28%)
Query: 46 GKYKLLKTIGKGNFAKVKLAK-HVPTGKEVAIKIIDKTQLNPGSLQKLFR----EVRIMK 100
+Y+++ T+G+G F KV H G+ VA+KI+ ++ + E+++++
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLE 66
Query: 101 ML------DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFR 152
L V++ + E + +V E G +D++ +G + R
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 153 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-------------------IKIADFG--- 190
QI +V + H K+ H DLK EN+L IK+ DFG
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL 250
+ +E T + Y APE+ + P DVWS+G IL G F
Sbjct: 186 YDDE-----HHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 251 RE-LR--ERVL-----------------------------RGKYRIP-------FYMSTD 271
+E L ER+L G+Y F +S D
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 272 CEN-----LLKKFLVLNPAKRASLE 291
E+ L++K L +PAKR +L
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLR 324
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 18/65 (27%), Positives = 25/65 (38%), Gaps = 22/65 (33%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-------------------IKIADFG-- 557
QI +V + H K+ H DLK EN+L IK+ DFG
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 558 -FSNE 561
+ +E
Sbjct: 185 TYDDE 189
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 54 IGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ--KLFR-EVRIMKMLDHPNIVKL 110
IG G F KV + G +VA+K + P S Q + F E+ + HP++V L
Sbjct: 47 IGHGVFGKVYKG-VLRDGAKVALK-----RRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEK-----EARAKFRQIV--SA--VQYC 161
+ + L+ +Y G + +L +G E R + I +A + Y
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLE---ICIGAARGLHYL 155
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFC-GSPPYAAPELFQ- 217
H + IIHRD+K+ N+LLD KI DFG S + T ++ L T G+ Y PE F
Sbjct: 156 HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE 252
G+ + + DV+S GV+L+ ++ S RE
Sbjct: 216 GRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPRE 248
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 17/110 (15%)
Query: 489 LVMEYASGGEVFDYLVLHGRMKEK-----EARAKFRQIV--SA--VQYCHQKKIIHRDLK 539
L+ +Y G + +L +G E R + I +A + Y H + IIHRD+K
Sbjct: 112 LIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLE---ICIGAARGLHYLHTRAIIHRDVK 166
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFC-GSPPYAAPELFQGG 586
+ N+LLD KI DFG S + T ++ L T G+ Y PE F G
Sbjct: 167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG 216
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 67/264 (25%), Positives = 110/264 (41%), Gaps = 54/264 (20%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH- 104
+++ K IG GNF +++L K++ T + VAIK+ P L E R K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSG 64
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF---------RQIV 155
I +++ K +V+E G + D L R F Q++
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLI 115
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMN-----IKIADFGFSNEFT--------PGNKLD 202
S ++Y H K +I+RD+K EN L+ N I I DF + E+ P +
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 203 TFCGSPPYAAP----ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---STLRELRE 255
+ G+ Y + Q ++ D D+ +LG + + GSLP+ G TL+E +
Sbjct: 176 SLTGTARYMSINTHLGKEQSRR-D----DLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230
Query: 256 RVLRGKYRIPFYMSTDCENLLKKF 279
++ K +T E L + F
Sbjct: 231 KIGDTK------RATPIEVLCENF 248
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 18/48 (37%), Positives = 28/48 (58%), Gaps = 5/48 (10%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-----IKIADFGFSNEF 562
Q++S ++Y H K +I+RD+K EN L+ N I I DF + E+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/257 (22%), Positives = 104/257 (40%), Gaps = 40/257 (15%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH- 104
YK+ + IG+G+F + ++ ++VAIK + P L E R K+L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGC 65
Query: 105 PNIVKLFQVIETEKTLYLVMEY--ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
I ++ + LV++ S ++ D + K +Q+++ VQ H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 163 QKKIIHRDLKAENLLLDSEMN-----IKIADFGFSNEFT--------PGNKLDTFCGSPP 209
+K +++RD+K +N L+ + I + DFG + P + G+
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 210 YAAPE----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---STLRELRERVLRGKY 262
Y + Q ++ D D+ +LG + + GSLP+ G +T ++ ER+ K
Sbjct: 184 YMSINTHLGREQSRR-D----DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK- 237
Query: 263 RIPFYMSTDCENLLKKF 279
ST L F
Sbjct: 238 -----QSTPLRELCAGF 249
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 14/48 (29%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-----IKIADFGFSNEF 562
Q+++ VQ H+K +++RD+K +N L+ + I + DFG +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 54 IGKGNFAKV---KLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFR----EVRIMKMLDHPN 106
+G+G F KV +L G VA+K +L Q EV ++ M H N
Sbjct: 38 LGRGGFGKVYKGRL----ADGTLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEA---RAKFRQIVSA---VQY 160
+++L T LV Y + G V L R + + + R + + + Y
Sbjct: 89 LLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 161 CHQK---KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPE- 214
H KIIHRD+KA N+LLD E + DFG + + T G+ + APE
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 206
Query: 215 LFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL 258
L GK K DV+ GV+L L++G FD + L + +L
Sbjct: 207 LSTGKSSEK-----TDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 31/104 (29%), Positives = 45/104 (43%), Gaps = 13/104 (12%)
Query: 489 LVMEYASGGEVFDYLVLHGRMKEKEA---RAKFRQIVSA---VQYCHQK---KIIHRDLK 539
LV Y + G V L R + + + R + + + Y H KIIHRD+K
Sbjct: 104 LVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPE 581
A N+LLD E + DFG + + T G+ + APE
Sbjct: 162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 48/267 (17%), Positives = 99/267 (37%), Gaps = 45/267 (16%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
++ L K IG G F + LA ++ A ++ ++ LF E++ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV---KVEYQENGPLFSELKFYQRVAKK 93
Query: 106 NIVKLFQVIETEKTL-------------------YLVMEYASGGEVFDYLVLHGRMKEKE 146
+ +K + + L ++VME G ++ +G K+
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKST 152
Query: 147 ARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD--SEMNIKIADFGFSNEFTPGNKL--- 201
+++ ++Y H+ + +H D+KA NLLL + + +AD+G S + P
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 202 -----DTFCGSPPYAAPELFQGKKY---DGPEVDVWSLGVILYTLVSGSLPFDGSTLREL 253
G+ + + + +G DV LG + + G LP++ +
Sbjct: 213 QENPRKGHNGTIEFTSLDAHKGVALSRRS----DVEILGYCMLRWLCGKLPWEQ--NLKD 266
Query: 254 RERVLRGKYRIPFYMSTDCENLLKKFL 280
V K + +++LK
Sbjct: 267 PVAVQTAKTN---LLDELPQSVLKWAP 290
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 488 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD- 546
++VME G ++ +G K+ +++ ++Y H+ + +H D+KA NLLL
Sbjct: 128 FMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186
Query: 547 -SEMNIKIADFGFSNEFTPGNK 567
+ + +AD+G S + P
Sbjct: 187 KNPDQVYLADYGLSYRYCPNGN 208
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 7e-22
Identities = 64/260 (24%), Positives = 119/260 (45%), Gaps = 39/260 (15%)
Query: 42 EPHIG-KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
EP +G K++L + IG G+F ++ L ++ T +EVAIK+ + +P L E +I +
Sbjct: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYR 57
Query: 101 ML-DHPNIVKLFQVIETEKTLYLVMEY--ASGGEVFDYLVLHGRMKEKEARAKFRQIVSA 157
+L I + LVM+ S ++F++ ++ K Q+++
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINR 115
Query: 158 VQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFT--------PGNKLDTFCG 206
V++ H K +HRD+K +N L+ + I DFG + ++ P + G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 207 SPPYAAP----ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---STLRELRERVLR 259
+ YA+ + Q ++ D D+ SLG +L + GSLP+ G T ++ E++
Sbjct: 176 TARYASVNTHLGIEQSRR-D----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
Query: 260 GKYRIPFYMSTDCENLLKKF 279
K ++T E L + +
Sbjct: 231 KK------VATSIEALCRGY 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 14/47 (29%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFT 563
Q+++ V++ H K +HRD+K +N L+ + I DFG + ++
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-21
Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 73/267 (27%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML--- 102
G+Y +++ +G G+F+ V L+ + K VA+K++ + + E+R++K +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNS 93
Query: 103 --DHPN---IVKL---FQVIETEKT-LYLVMEYASGGEVFDYLVL--HGRMKEKEARAKF 151
+ PN +V+L F++ T + +V E G + +++ + + +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 152 RQIVSAVQYCHQK-KIIHRDLKAENLLLDSE----------------------------- 181
+Q++ + Y H K +IIH D+K EN+LL
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 182 --------------------MNIKIADFGFSNEFTPGNKLDTFCGSPP-YAAPELFQGKK 220
+ +KIAD G + +K T Y + E+ G
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGSG 269
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDG 247
Y+ P D+WS + + L +G F+
Sbjct: 270 YNTP-ADIWSTACMAFELATGDYLFEP 295
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 20/137 (14%)
Query: 489 LVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLL 545
+V E G + +++ + + + +Q++ + Y H K +IIH D+K EN+LL
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180
Query: 546 DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAP--------------ELFQGGAPVTS 591
I + GS AP + +
Sbjct: 181 SVN-EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 592 SGGAG-TNHTHNSSISP 607
G A + I
Sbjct: 240 LGNACWVHKHFTEDIQT 256
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 41/270 (15%), Positives = 92/270 (34%), Gaps = 68/270 (25%)
Query: 46 GKYKLLKTIGKGNFAKVKLA-----KHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+K+ IG+G F + LA + V + +K+ P LF E++ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV------EPSDNGPLFTELKFYQ 88
Query: 101 MLDHPNIVKLFQVIETEKTL-------------------YLVMEYASGGEVFDYLVLHGR 141
P ++ + K L +++M+ G ++ + +
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK 147
Query: 142 MKEKEARAKF---------RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN--IKIADFG 190
+F +I+ ++Y H+ + +H D+KA NLLL+ + + + D+G
Sbjct: 148 --------RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 191 FSNEFTPGNKLD--------TFCGSPPYAAPELFQGKKY---DGPEVDVWSLGVILYTLV 239
+ + P G+ + + + G D+ LG + +
Sbjct: 200 LAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG----DLEILGYCMIQWL 255
Query: 240 SGSLPFDG---STLRELRERVLRGKYRIPF 266
+G LP++ ++ +
Sbjct: 256 TGHLPWEDNLKDPKYVRDSKIRYRENIASL 285
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 14/50 (28%), Positives = 29/50 (58%), Gaps = 2/50 (4%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNK 567
+I+ ++Y H+ + +H D+KA NLLL+ + + + D+G + + P
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 84.5 bits (208), Expect = 7e-18
Identities = 43/234 (18%), Positives = 70/234 (29%), Gaps = 65/234 (27%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKII--DKTQLNPGSLQK----LFREVRIMK 100
K + + IG+G F +V VAIKII + L GS QK + E+ I K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 101 ML---------DHPNIVKLFQV------------------------------IETEKTLY 121
L + L V + L+
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDS 180
+V+E+ GG + + A++ Q+ +++ + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 181 EMNIKIADFGFSNEFTPGN------------KLDTFCGSPPYA----APELFQG 218
K+ T + G + +LF G
Sbjct: 198 TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 4e-10
Identities = 20/120 (16%), Positives = 39/120 (32%), Gaps = 18/120 (15%)
Query: 483 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAE 541
+ L++V+E+ GG + + A++ Q+ +++ + HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191
Query: 542 NLLLDSEMNIKIADFGFSNEFTPGN------------KLDTFCGSPPYA----APELFQG 585
N+LL K+ T + G + +LF G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 43/271 (15%), Positives = 95/271 (35%), Gaps = 54/271 (19%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTG--------KEVAIKIIDKTQLNPGSLQKLFREVR 97
++KL + N + A T ++ ++K+ K +LF E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-------RLFNEQN 94
Query: 98 IMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDY--LV--LHGR----MKEKEARA 149
+ P V ++ + + L + G Y LV GR + +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH 154
Query: 150 KF---------RQIVSAVQYCHQKKIIHRDLKAENLLL--DSEMNIKIADFGFSNEFTPG 198
+++ A+++ H+ + +H ++ AEN+ + + + + +A +GF+ + P
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 199 --------NKLDTFCGSPPYAAPELFQGKKY---DGPEVDVWSLGVILYTLVSGSLPFDG 247
G + + +L +G D+ SLG + + G LP+
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS----DLQSLGYCMLKWLYGFLPWTN 270
Query: 248 ---STLRELRERVLRGKYRIPFYMSTDCENL 275
+T ++++ PF C +
Sbjct: 271 CLPNTEDIMKQKQKFVDKPGPF--VGPCGHW 299
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 11/50 (22%), Positives = 31/50 (62%), Gaps = 2/50 (4%)
Query: 520 QIVSAVQYCHQKKIIHRDLKAENLLL--DSEMNIKIADFGFSNEFTPGNK 567
+++ A+++ H+ + +H ++ AEN+ + + + + +A +GF+ + P K
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 36/119 (30%), Positives = 58/119 (48%), Gaps = 7/119 (5%)
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS-NEFTPGNKLDTFCGSPPY 210
Q+ +++ +K IHRDL A N+LL + +KI DFG + + + + + P
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 211 A--APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDG-STLRELRERVLRGKYRIP 265
APE + Y + DVWS GV+L+ + S G+ P+ G E R+ G R+
Sbjct: 260 KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMR 316
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 35/168 (20%), Positives = 61/168 (36%), Gaps = 12/168 (7%)
Query: 49 KLLKTIGKGNFAKVKLAK-----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
KL K +G+G F +V A T + VA+K++ K + L E++I+ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIG 83
Query: 104 -HPNIVKLF-QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
H N+V L + L +++E+ G + YL R K E + Q
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQGK 139
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPP 209
I DLK + S + + F + + +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 16/41 (39%), Positives = 25/41 (60%)
Query: 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFS 559
Q+ +++ +K IHRDL A N+LL + +KI DFG +
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 8e-09
Identities = 47/269 (17%), Positives = 78/269 (28%), Gaps = 87/269 (32%)
Query: 50 LLKTIGK---------GNFAKVKLAKHVPTGKEVAIKIIDKT--QLNPGSLQKLFREVRI 98
L I + N+ V K II+ + L P +K+F + +
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKL--------TTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 99 MKMLDHPNI-VKLFQVIETEKTLYLVMEYASGGEVFDY-LV----------LHG-----R 141
+I L +I + VM + ++ Y LV + +
Sbjct: 381 FP--PSAHIPTILLSLIWFDVIKSDVMVVVN--KLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 142 MKEKEARAKFRQIVSAVQYCHQKKIIHRDL------------------KAENLLLDSEMN 183
+K + A R IV Y K DL E+ +
Sbjct: 437 VKLENEYALHRSIVD--HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 184 IKIADFGFSNEFTPGNKL---DTFCGSPPYAAPELFQGKKY------DGPEVDVWSLGVI 234
+ DF F K+ T + L Q K Y + P+ +
Sbjct: 495 MVFLDFRFL-----EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE------- 542
Query: 235 LYTLVSGSLPFDGSTLRELRERVLRGKYR 263
LV+ L F L ++ E ++ KY
Sbjct: 543 --RLVNAILDF----LPKIEENLICSKYT 565
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 8e-07
Identities = 85/590 (14%), Positives = 159/590 (26%), Gaps = 189/590 (32%)
Query: 36 SRRERD----EPHI--GKYKLLKTI-GKGN-----FAKVKLAKHVPTGKEVAIKIIDKTQ 83
S+ E D G +L T+ K F + L + IK +
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS-PIKTEQR-- 103
Query: 84 LNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL---VMEYASGGEVFDYLVLHG 140
P + +++ E R D+ K V + L L ++E +++ G
Sbjct: 104 -QPSMMTRMYIEQRDRLYNDNQVFAKYN-VSRLQPYLKLRQALLELRPA----KNVLIDG 157
Query: 141 RMK--------------EKEARAKFRQI--VSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184
+ K +I ++ ++ C+ + + L + LL + N
Sbjct: 158 -VLGSGKTWVALDVCLSYKVQCKMDFKIFWLN-LKNCNSPETVLEML--QKLLYQIDPNW 213
Query: 185 KIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY-------DGPEVDVWSLGVILYT 237
SN + + L + K Y +V +
Sbjct: 214 TSRSDHSSNIKLRIHSIQA-------ELRRLLKSKPYENCLLVLL----NVQNAKAWNA- 261
Query: 238 LVSGSLPFDGS--TLRELRER----VLRGKYRIPFYMS--------TDCENLLKKFLVLN 283
F+ S L R + L + + ++LL K+L
Sbjct: 262 -------FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 284 PAKRASLEVSGEVTLGGAPVTSSG-GA----GTNHTHNSSISPAPTNFKRQNTIDSASIK 338
P ++ EV L P S G N N + TI +S+
Sbjct: 315 PQ-----DLPREV-LTTNPRRLSIIAESIRDGLATWDNWK----HVNCDKLTTIIESSLN 364
Query: 339 ENTARLNAG--RPAKNTASIAPLDTK----ALVGL--GYSRSEIEESLSQ-AKYDDPESD 389
L R + S+ P L + +S++ +++ KY E
Sbjct: 365 V----LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 390 GSRSGSSLSLRNLQPGSGGGATGGSGSSRSWRNMQPGSGGVATGGSGGGGGGGAAQSPSH 449
S++S+ ++ ++ + +
Sbjct: 421 PKE--STISIPSIY-----------------LELK-------------------VKLENE 442
Query: 450 RGVHRSISASNAKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRM 509
+HRSI P + S L Q Y + ++ H +
Sbjct: 443 YALHRSIVDHYNIP-KTFDSDDLIPPYLDQ--------Y----------FYSHIGHH--L 481
Query: 510 KEKEARAK---FRQIVSAVQYCH----QKKIIHRDLKAE------NLLLD 546
K E + FR + + ++KI H N L
Sbjct: 482 KNIEHPERMTLFRMV-----FLDFRFLEQKIRHDSTAWNASGSILNTLQQ 526
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 33/164 (20%), Positives = 62/164 (37%), Gaps = 29/164 (17%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGK--EVAIKI--------------------IDKTQLN 85
+ I G A V A V GK +A+KI D +++
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 86 PGSLQKL--FREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV--LHGR 141
P + +E R ++ V + Q K + L+ME+ E+ + L
Sbjct: 109 PKEKVFIWTEKEFRNLERA-KEAGVSVPQPYTYMKNV-LLMEFIGEDELPAPTLVELGRE 166
Query: 142 MKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNI 184
+KE + F +V V+ +Q+ +++H DL N++ ++
Sbjct: 167 LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDKVYF 210
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 25/159 (15%), Positives = 51/159 (32%), Gaps = 29/159 (18%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN----------------PGSLQK 91
+ K +G+G + V E +K + +++
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 92 LFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF 151
E R ++ L + K++ ++ME E++ + +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKELYRV-------RVENPDEVL 199
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190
I+ V + + I+H DL N+L+ E I DF
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFP 237
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 708 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.98 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.97 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.95 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.95 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.92 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.92 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.92 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.91 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.91 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.91 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.91 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.91 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.91 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.91 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.91 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.91 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.91 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.9 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.9 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.9 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.9 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.9 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.9 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.9 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.9 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.9 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.9 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.89 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.89 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.89 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.89 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.89 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.89 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.89 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.89 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.89 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.89 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.89 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.89 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.89 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.89 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.88 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.88 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.88 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.88 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.88 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.88 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.88 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.88 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.88 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.88 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.88 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.88 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.88 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.88 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.88 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.88 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.88 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.88 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.88 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.87 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.87 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.87 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.87 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.87 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.87 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.87 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.87 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.87 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.87 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.87 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.87 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.87 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.87 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.87 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.87 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.87 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.87 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.87 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.87 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.87 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.87 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.86 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.86 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.86 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.86 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.86 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.86 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.86 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.86 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.86 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.86 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.86 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.86 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.86 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.86 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.86 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.86 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.86 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.86 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.86 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.85 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.85 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.85 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.85 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.85 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.85 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.85 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.85 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.85 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.85 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.85 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.85 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.85 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.85 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.85 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.85 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.85 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.85 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.85 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.85 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.85 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.85 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.84 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.84 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.84 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.84 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.84 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.84 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.84 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.84 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.84 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.84 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.84 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.84 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.84 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.84 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.84 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.84 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.84 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.84 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.84 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.84 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.84 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.84 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.83 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.83 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.83 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.83 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.83 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.83 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.83 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.83 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.83 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.83 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.83 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.83 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.83 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.83 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.83 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.83 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.83 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.83 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.83 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.83 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.83 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.83 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.83 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.83 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.82 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.82 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.82 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.82 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.82 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.82 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.82 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.82 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.82 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.82 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.82 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.82 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.82 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.82 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.82 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.82 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.82 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.82 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.82 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.82 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.82 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.82 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.82 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.82 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.82 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.81 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.81 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.81 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.81 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.81 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.81 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.81 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.81 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.81 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.81 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.81 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.81 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.81 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.81 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.81 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.81 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.81 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.8 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.8 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.8 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.8 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.8 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.8 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.8 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.8 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.79 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.79 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=523.41 Aligned_cols=257 Identities=49% Similarity=0.877 Sum_probs=220.8
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
...+|+|++++.||+|+||+||+|+++.+|+.||||++++.... ....+++.+|+++|+.++|||||++++++++++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 34589999999999999999999999999999999999877553 34456789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
||||||| +|+|++++..++.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.......
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999999 689999999999999999999999999999999999999999999999999999999999999988776666
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L 280 (708)
..+.|||+.|||||++.+..|+++++|||||||+||+|++|+.||.+.+..++.+.|..+.+.+|..+|+++++||++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 247 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 247 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHS
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 77899999999999999999888899999999999999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHh---hhhhC
Q psy2648 281 VLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~~ 299 (708)
++||++|||+++++ |++..
T Consensus 248 ~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 248 IVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp CSSGGGSCCHHHHHHCHHHHTT
T ss_pred cCChhHCcCHHHHHcCcccccC
Confidence 99999999999998 88643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-64 Score=532.14 Aligned_cols=250 Identities=35% Similarity=0.627 Sum_probs=233.5
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
..++|++++.||+|+||+||+|+++.+|+.||||++++... +....+.+.+|+++|+.|+|||||+++++|++++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45689999999999999999999999999999999987543 22345678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC---C
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---N 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~---~ 199 (708)
|||||+||+|+++|...+.++|.+++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+... .
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999876433 3
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
...+.|||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..++.++|.++.+.+|..+|+++++||++|
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence 45688999999999999998884 89999999999999999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|++||.+|||++++.
T Consensus 269 L~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 269 LVLDATKRLGCEEME 283 (311)
T ss_dssp SCSSGGGSTTSGGGT
T ss_pred ccCCHhHCcChHHHc
Confidence 999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=527.79 Aligned_cols=253 Identities=28% Similarity=0.558 Sum_probs=228.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||+||+|+++.+|+.||||++++........+.+.+|+++|+.|+|||||++++++++++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 56899999999999999999999999999999999988777777888999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cc
Q psy2648 125 EYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KL 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~ 201 (708)
|||+||+|+++|..++ .++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 9999999999997653 57999999999999999999999999999999999999999999999999998765332 34
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L 280 (708)
.+.|||+.|||||++.+..|+ .++|||||||+||||++|+.||.+.+..++..+|..+.+ .+|..+|+++++||.+||
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 261 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 567999999999999999885 799999999999999999999999999999999999876 467789999999999999
Q ss_pred hhCCCCCCCHHHHh---hhhh
Q psy2648 281 VLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~ 298 (708)
++||++|||+++++ |+..
T Consensus 262 ~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 262 KRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CSSGGGSCCHHHHHTSHHHHT
T ss_pred cCChhHCcCHHHHhcCHHhhc
Confidence 99999999999987 7753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-62 Score=517.06 Aligned_cols=253 Identities=33% Similarity=0.581 Sum_probs=225.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
...+|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+++|++|+|||||++++++++++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 3468999999999999999999985 4788999999987654444445688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~ 199 (708)
|||||||+||+|.++|...+.++|.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986543 34
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
...+.|||+.|||||++.+..|+ .++|||||||+||||++|+.||.+.+..++..+|.++.+.+|..+|+++++||++|
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 260 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence 55678999999999999999886 79999999999999999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCC-----HHHHh---hhh
Q psy2648 280 LVLNPAKRAS-----LEVSG---EVT 297 (708)
Q Consensus 280 L~~dP~~Rps-----~~~~~---~~~ 297 (708)
|++||++||| +++++ |+.
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred cccCHHHCCCCCcCCHHHHHcCcccc
Confidence 9999999998 46766 664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-60 Score=507.92 Aligned_cols=321 Identities=74% Similarity=1.158 Sum_probs=285.2
Q ss_pred cccCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q psy2648 36 SRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE 115 (708)
Q Consensus 36 ~~~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 115 (708)
+....+++.+++|++++.||+|+||.||+|++..+|+.||||++.+...+....+++.+|+++|+.++||||++++++++
T Consensus 5 ~s~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 5 ASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ------CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34566778899999999999999999999999999999999999887777777788999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
+.+.+|+||||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENL 275 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~L 275 (708)
..+......+||+.|+|||++.+..++++++|||||||++|+|++|+.||.+.+..++.+++..+.+.+|..+++++.+|
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 77777788999999999999999888778999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCC
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKN 352 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 352 (708)
|++||..||.+|||+++++ |+..... .....+...|..
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~~----------~~~~~~~~~~~~----------------------------- 285 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHE----------EDELKPFVEPEL----------------------------- 285 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTCT----------TCCCCCCCCCCC-----------------------------
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCCc----------ccccCcccCCCc-----------------------------
Confidence 9999999999999999998 7754321 111112211111
Q ss_pred cCCCChhhHHHHhcCCCCHHHHHHHHhccCCCCccccccccccc
Q psy2648 353 TASIAPLDTKALVGLGYSRSEIEESLSQAKYDDPESDGSRSGSS 396 (708)
Q Consensus 353 ~~~~~~~~~~~~~~~g~~~~~i~~~l~~~~~~~~~~~y~~l~~~ 396 (708)
...++...+.|..+||+.+++.+.|....+++.+++|+||+++
T Consensus 286 -~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~y~ll~~k 328 (328)
T 3fe3_A 286 -DISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATYLLLGRK 328 (328)
T ss_dssp -CCCCHHHHHHHHHTTCCHHHHHHHHHTTCCSHHHHHHHHHTC-
T ss_pred -CcccHHHHHHHHHCCCCHHHHHHHHHcCCCCHHHHHHHHhcCC
Confidence 1124567788999999999999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=513.09 Aligned_cols=250 Identities=29% Similarity=0.490 Sum_probs=227.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
..|++++.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+++|+.|+|||||+++++|++++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4699999999999999999999999999999999865432 23457899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~ 204 (708)
||+||+|.+++. +++++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.. .....+.
T Consensus 152 y~~gg~L~~~l~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 152 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp CCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCcHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 999999999886 46899999999999999999999999999999999999999999999999999987654 3456789
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~~Li~~~L~ 281 (708)
|||+.|||||++.+..|+ .++|||||||+||||++|+.||.+.+..++...|..+.. ..+..+|+++++||.+||+
T Consensus 231 ~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 309 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 309 (346)
T ss_dssp CSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred ccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence 999999999999999885 899999999999999999999999999999999887643 2334689999999999999
Q ss_pred hCCCCCCCHHHHh---hhhhC
Q psy2648 282 LNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 282 ~dP~~Rps~~~~~---~~~~~ 299 (708)
+||++|||+++++ |+...
T Consensus 310 ~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 310 RDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp SSTTTSCCHHHHTTCGGGGGC
T ss_pred CChhHCcCHHHHhcCHhhcCC
Confidence 9999999999998 88654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-59 Score=514.71 Aligned_cols=250 Identities=29% Similarity=0.490 Sum_probs=227.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
..|++++.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|+.|+|||||+++++|++++.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5799999999999999999999999999999999865432 33568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~~ 204 (708)
||+||+|.+++. .++++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.. .....+.
T Consensus 229 y~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 229 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp CCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 999999999885 56899999999999999999999999999999999999999999999999999987654 3456789
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~~Li~~~L~ 281 (708)
|||+.|||||++.+..|+ .++|||||||+||||++|+.||.+.+..++...|..+.. ..+..+|+++++||.+||+
T Consensus 308 ~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp EECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred ccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 999999999999999885 899999999999999999999999999999998887633 3445789999999999999
Q ss_pred hCCCCCCCHHHHh---hhhhC
Q psy2648 282 LNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 282 ~dP~~Rps~~~~~---~~~~~ 299 (708)
+||++|||+++++ |+...
T Consensus 387 ~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 387 RDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SSTTTSCCHHHHTTCGGGGGC
T ss_pred CChhHCcCHHHHhcCHHhcCC
Confidence 9999999999998 88654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-60 Score=506.81 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=220.5
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+..|++.+.||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.|+|||||++|+++++++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456799999999999999999999999999999999865432 4699999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCccccCCCC---
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGN--- 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~~~~--- 199 (708)
||||+||+|.++|...+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999999999999999999999999999999999999999999999999998 59999999998765432
Q ss_pred ---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHH
Q psy2648 200 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---IPFYMSTDCE 273 (708)
Q Consensus 200 ---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~p~~~s~~~~ 273 (708)
...+.|||+.|||||++.+..|+ .++|||||||+||||++|+.||.+.+..++..+|..+..+ +|..+|+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 12457899999999999999886 7999999999999999999999998888888888887653 5778999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||++||.+|||++++.
T Consensus 288 ~li~~~L~~dP~~R~sa~el~ 308 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELR 308 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHH
Confidence 999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-59 Score=492.45 Aligned_cols=249 Identities=28% Similarity=0.462 Sum_probs=223.4
Q ss_pred CCe-EEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEE
Q psy2648 46 GKY-KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET----EKTL 120 (708)
Q Consensus 46 ~~Y-~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 120 (708)
++| ++.+.||+|+||+||+|.++.+++.||||++.+........+++.+|+++|++|+|||||+++++|++ +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 566 78889999999999999999999999999998877777777889999999999999999999999976 3568
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcC-CCcEEEEeccCccccCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDS-EMNIKIADFGFSNEFTP 197 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~-~~~iKL~DFGls~~~~~ 197 (708)
|||||||+||+|.++|...+.+++.+++.++.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+.. .
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~-~ 183 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-R 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-C
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-C
Confidence 999999999999999999999999999999999999999999999 999999999999985 799999999999754 3
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGKYR--IPFYMSTDCEN 274 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~~~--~p~~~s~~~~~ 274 (708)
.....+.||||.|||||++.+ .|+ .++|||||||+||||+||+.||.+ .+...+...+..+..+ +|...++++++
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 455678899999999999976 475 899999999999999999999976 4567777888776543 45678899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
||.+||++||++|||+++++ |++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccc
Confidence 99999999999999999987 664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=495.19 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=224.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------CE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------KT 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 119 (708)
++|++++.||+|+||+||+|+++.+|+.||||+|++........+++.+|+++|+.|+|||||++++++.+. +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 479999999999999999999999999999999987766666677899999999999999999999998643 57
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC--
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-- 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-- 197 (708)
+|||||||+ |+|+++|..++.+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 999999996 68999999889999999999999999999999999999999999999999999999999999986532
Q ss_pred ---CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------
Q psy2648 198 ---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI---------- 264 (708)
Q Consensus 198 ---~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~---------- 264 (708)
.....+.|||+.|||||++.+..+.+.++||||||||||||++|+.||.+.+..+..++|.......
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 2345678999999999999987776789999999999999999999999999888888776431111
Q ss_pred ----------C-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 265 ----------P-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 265 ----------p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
| ...|+++.|||++||++||.+|||+++++ |+...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 1 24689999999999999999999999998 87643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-57 Score=480.61 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=221.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
-.+|.+.+.||+|+||+||+|++. .+++.||||+++.. +....+.|.+|+++|++|+|||||++++++.+++.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 357999999999999999999975 46789999999753 34556789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEE
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG-------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~-------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL 186 (708)
+|||||||++|+|.++|..++ .+++.++..++.||+.||+|||+++||||||||+||||++++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999999997643 6999999999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q psy2648 187 ADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY 262 (708)
Q Consensus 187 ~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~ 262 (708)
+|||+|+....... ....+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...|..+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999986543322 2345799999999999988885 89999999999999998 9999999999999999998864
Q ss_pred -CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh-hhh
Q psy2648 263 -RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG-EVT 297 (708)
Q Consensus 263 -~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~-~~~ 297 (708)
..|..+++++.+||.+||+.||++|||++++. |+.
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 57888999999999999999999999999987 543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=479.12 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=215.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
..+|.+.++||+|+||+||+|+++ .+++.||||+++.. +....+.|.+|+++|++|+|||||++++++.+.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 457999999999999999999875 46889999999753 44556789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcE
Q psy2648 120 LYLVMEYASGGEVFDYLVLH---------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~---------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~i 184 (708)
+|||||||++|+|.++|... +.+++.++..++.||+.||+|||+++||||||||+||||++++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 99999999999999999754 358999999999999999999999999999999999999999999
Q ss_pred EEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q psy2648 185 KIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260 (708)
Q Consensus 185 KL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~ 260 (708)
||+|||+|+...... .....+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...|..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998664332 22457899999999999999885 89999999999999999 99999999999999999887
Q ss_pred C-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 K-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 ~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
. ...|..+++++.+||.+||+.||++|||++++.
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 311 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 4 567888999999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-56 Score=509.43 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=227.1
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHH---HHHHHHHhCCCCCeeeEEEEEE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLF---REVRIMKMLDHPNIVKLFQVIE 115 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~ 115 (708)
..+..+++|++++.||+|+||+||+|+++.+|+.||||+|++..... .....+. +++.+++.++|||||+++++|+
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 44777899999999999999999999999999999999998654311 1122333 3466677889999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
+++.+|||||||+||+|+++|...+.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccccccCCcccccccccC-CccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKYRIPFYMSTD 271 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~~~~p~~~s~~ 271 (708)
.. ....+.|||+.|||||++.+ ..| +.++|||||||+||||++|..||.+. +..++...+....+.+|..+|++
T Consensus 343 ~~-~~~~t~~GTp~YmAPEvl~~~~~y-~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 343 SK-KKPHASVGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp SS-CCCCSCCSCGGGCCHHHHSTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CC-CCCCCccCCcCccCHHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 53 34678899999999999975 456 58999999999999999999999763 56678888999999999999999
Q ss_pred HHHHHHHhhhhCCCCCCC-----HHHHh---hhh
Q psy2648 272 CENLLKKFLVLNPAKRAS-----LEVSG---EVT 297 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps-----~~~~~---~~~ 297 (708)
+++||.+||++||.+|++ +++++ |+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 999999999999999998 57776 664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-56 Score=471.15 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=223.4
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE 115 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 115 (708)
.+.....+++++.||+|+||+||+|++. .+++.||||+++... .....+.|.+|+.+|++|+|||||++++++.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 3455678999999999999999999864 467899999997543 3344567999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
+++.+|||||||++|+|.++|..+ ..+++.++..++.||+.||+|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999653 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCC---CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRE 255 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~ 255 (708)
+++++||+|||+|+..... ....+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..++.+
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865432 234567899999999999988885 89999999999999998 999999999999999
Q ss_pred HHHcCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.|..+.. +.|..+++++.+||.+||+.||++|||++++.
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~ 298 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 298 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9988754 56888999999999999999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=469.69 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=211.3
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
..+....++++.+.||+|+||+||+|++. ..||||+++....+....+.|.+|+++|++|+|||||++++++. ++.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~ 105 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN 105 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence 34566678999999999999999999864 35999999876666777788999999999999999999999875 456
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
+|||||||+||+|.++|... +.+++.++..++.||+.||+|||+++||||||||+||||++++++||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 89999999999999999765 57999999999999999999999999999999999999999999999999999865432
Q ss_pred ---CCccccccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCC-----CCCC
Q psy2648 199 ---NKLDTFCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGKY-----RIPF 266 (708)
Q Consensus 199 ---~~~~~~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~~-----~~p~ 266 (708)
....+.+||+.|||||++.+. .| +.++|||||||+||||+||+.||.+.+. ..+...+..+.. ..|.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 234568999999999999754 35 4799999999999999999999988654 445555555422 2345
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+++++.+||.+||+.||++|||++++.
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 6889999999999999999999999886
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=471.76 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=200.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK------ 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 118 (708)
+.+|++++.||+|+||+||+|+++.+|+.||||+++... .....+++.+|+++|++|+|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 457999999999999999999999999999999997654 3445567899999999999999999999987544
Q ss_pred ------EEEEEEeccCCCChHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEec
Q psy2648 119 ------TLYLVMEYASGGEVFDYLVLHGRM---KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADF 189 (708)
Q Consensus 119 ------~~ylVmEy~~gg~L~~~i~~~~~l---~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DF 189 (708)
.+|||||||+||+|.+++...+.+ ++..++.++.||+.||+|||++|||||||||+||||+.++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 479999999999999999877654 45668899999999999999999999999999999999999999999
Q ss_pred cCccccCCCC-------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHH
Q psy2648 190 GFSNEFTPGN-------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRE 255 (708)
Q Consensus 190 Gls~~~~~~~-------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~ 255 (708)
|+|+.+.... ...+.|||+.|||||++.+..|+ .++|||||||+||||++ ||.+... .....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9998764322 12456899999999999999885 89999999999999996 8875432 23444
Q ss_pred HHHcCCCC-CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 256 RVLRGKYR-IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 256 ~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+....++ .+...++++.+||++||++||.+|||+++++ |+.
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~ 284 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 55554432 1223567889999999999999999999987 654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=475.29 Aligned_cols=313 Identities=40% Similarity=0.708 Sum_probs=271.6
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
...+++|++.+.||+|+||.||+|.+..+++.||||++.+.... ....+.+.+|+.+|+.++||||+++++++++...+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45789999999999999999999999999999999999754321 12235688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
||||||+ +|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....+..
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999999 789999999999999999999999999999999999999999999999999999999999999988777767
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L 280 (708)
..+.+||+.|+|||++.+..+.++++|||||||++|+|++|..||.+....++.+.+..+.+.+|..+++++.+||++||
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence 77889999999999999988877899999999999999999999998877777777777788889999999999999999
Q ss_pred hhCCCCCCCHHHHh---hhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCCcCCCC
Q psy2648 281 VLNPAKRASLEVSG---EVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTASIA 357 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 357 (708)
..||.+|||+++++ |+...... ...|.... .....+
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~~~~~~---------------~~~~~~~~--------------------------~~~~~~ 282 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFNVNLPD---------------YLRPMEEV--------------------------QGSYAD 282 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHHTTCCG---------------GGSCCCCC--------------------------CCCCCC
T ss_pred CCChhHCcCHHHHHhChhhccCCcc---------------ccCCchhc--------------------------ccccCC
Confidence 99999999999998 88653221 11111100 001234
Q ss_pred hhhHHHH-hcCCCCHHHHHHHHhccCCCCccccccccccc
Q psy2648 358 PLDTKAL-VGLGYSRSEIEESLSQAKYDDPESDGSRSGSS 396 (708)
Q Consensus 358 ~~~~~~~-~~~g~~~~~i~~~l~~~~~~~~~~~y~~l~~~ 396 (708)
+.+...+ ..+||+.++|.++|...++|+.+++|++|...
T Consensus 283 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~y~ll~~~ 322 (336)
T 3h4j_B 283 SRIVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLHEN 322 (336)
T ss_dssp HHHHHHHHHTTCCCHHHHHHHTTSSSCCSSTTHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHHHHHHHHhcCCCCHHHHHHHHHHhC
Confidence 5555554 57999999999999999999999999998654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=499.81 Aligned_cols=252 Identities=28% Similarity=0.530 Sum_probs=232.7
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+++|+.|+|||||+|+++|+++..+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999999997643 34456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--CcEEEEeccCccccCCCCC
Q psy2648 124 MEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE--MNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~--~~iKL~DFGls~~~~~~~~ 200 (708)
||||+||+|+++|.. .+.++|.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 999999999999964 4689999999999999999999999999999999999999864 8999999999998887777
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENLL 276 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~Li 276 (708)
..+.|||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+..++..+|..+.+.+| ..+|+++++||
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred eeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 7889999999999999999884 899999999999999999999999999999999999887665 36899999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
++||++||.+|||+++++ |+..
T Consensus 392 ~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 392 RKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHccCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999988 7654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=464.84 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=204.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
.++|++.+.||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+++|+.+ +|||||+++++|++++++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 467999999999999999999985 467899999986543 235678999999988 699999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CcEEEEeccCccccCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPG- 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-~~iKL~DFGls~~~~~~- 198 (708)
|||||||+||+|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999988 469999999999999999999999999999999999999877 79999999999754321
Q ss_pred ----------------------------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-C
Q psy2648 199 ----------------------------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-T 249 (708)
Q Consensus 199 ----------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-~ 249 (708)
....+.|||+.|+|||++.+..+.+.++||||+||++|+|++|+.||... +
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 12345689999999999988765568999999999999999999999643 3
Q ss_pred HHHHHHHHHc--------------------------------------CCCCC----------------CCCCCHHHHHH
Q psy2648 250 LRELRERVLR--------------------------------------GKYRI----------------PFYMSTDCENL 275 (708)
Q Consensus 250 ~~~l~~~i~~--------------------------------------~~~~~----------------p~~~s~~~~~L 275 (708)
..+...+|.. ..... ...+|+++.||
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 3333332211 01111 12478999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|++||++||.+|+|+++++ |+.
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~ 357 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFK 357 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHCcCChhHCcCHHHHhcCcccC
Confidence 9999999999999999988 764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=464.51 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=217.6
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC-CCeeeEEEEEEe
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTG-----KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH-PNIVKLFQVIET 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~ 116 (708)
...++|++++.||+|+||+||+|.+..++ +.||||++.... .....+.+.+|+++|++++| ||||+++++|..
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 34568999999999999999999987543 689999997643 34456779999999999976 999999999865
Q ss_pred -CCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 117 -EKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 117 -~~~~ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
.+.+|||||||++|+|.++|... ..+++.++..++.||+.||+|||+++||||||||+||||+
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 45799999999999999999763 3489999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCC-HHHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGST-LRELR 254 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~-~~~l~ 254 (708)
+++.+||+|||+|+...... ...+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+ .+.+.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998764432 23457899999999999998885 89999999999999998 999999865 45566
Q ss_pred HHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 255 ERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 255 ~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+..+. ...|..+++++.+||.+||+.||++|||++++.
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil 339 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 339 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 6676663 567888999999999999999999999999887
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=467.11 Aligned_cols=318 Identities=40% Similarity=0.689 Sum_probs=246.0
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
......+++|++++.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++++.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34556789999999999999999999999999999999999764321 12356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+|||||||++|+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999988776
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~ 277 (708)
+....+.|||+.|+|||++.+..+.++++|||||||++|+|++|..||.+.+..++..++..+.+..|..+++++.+||+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 66677889999999999999988777899999999999999999999999999999999999999999999999999999
Q ss_pred HhhhhCCCCCCCHHHHh---hhhhCCCCcccCCCCCCCccCCCCCCCCCCccccccccchhhhhhhhhhhccCCCCCCcC
Q psy2648 278 KFLVLNPAKRASLEVSG---EVTLGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTA 354 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 354 (708)
+||+.||.+|||++++. |+...... ...|..... ....+
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~---------------~~~~~~~~~-~~~~~---------------------- 290 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFKQDLPK---------------YLFPEDPSY-SSTMI---------------------- 290 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHTTCCT---------------TTTTSSSCS-SCSHH----------------------
T ss_pred HHcCCCchhCcCHHHHHhCHHhhhcCcc---------------ccCCCCccc-ccccC----------------------
Confidence 99999999999999998 87643210 111110000 00111
Q ss_pred CCChhhHH-HHhcCCCCHHHHHHHHhccC-CCCccccccccccc
Q psy2648 355 SIAPLDTK-ALVGLGYSRSEIEESLSQAK-YDDPESDGSRSGSS 396 (708)
Q Consensus 355 ~~~~~~~~-~~~~~g~~~~~i~~~l~~~~-~~~~~~~y~~l~~~ 396 (708)
+..... .+..++++.+++.+.|.+.. .|..+++|.++...
T Consensus 291 --~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~ 332 (476)
T 2y94_A 291 --DDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDN 332 (476)
T ss_dssp --HHHHHHSCCCC-------------------------------
T ss_pred --CHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhc
Confidence 112222 23457788888888887654 57788889887554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=447.07 Aligned_cols=258 Identities=34% Similarity=0.612 Sum_probs=225.5
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIET 116 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 116 (708)
......+++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+++|+.+ +||||+++++++++
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT 95 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence 3345668899999999999999999999999999999999976532 223456688999999988 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
.+.+|||||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998643
Q ss_pred -CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy2648 197 -PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENL 275 (708)
Q Consensus 197 -~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~L 275 (708)
.+....+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++.++|..+.+.+|..+++++.+|
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 33445678999999999999888774 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhhCCCCCCCH------HHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASL------EVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~------~~~~---~~~ 297 (708)
|++||++||.+||++ ++++ |+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 999999999999998 6666 654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=439.45 Aligned_cols=253 Identities=35% Similarity=0.598 Sum_probs=232.9
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++||||+++++++++.+.+||
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 46789999999999999999999999999999999976432 22345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-CCCCc
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKL 201 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~~~~~ 201 (708)
||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... .+...
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999998643 34456
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 281 (708)
.+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++.+.+..+.+.+|..+++++.+||.+||+
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 241 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 778999999999999988874 8999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCC-----CHHHHh---hhh
Q psy2648 282 LNPAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 282 ~dP~~Rp-----s~~~~~---~~~ 297 (708)
.||.+|| ++++++ |+.
T Consensus 242 ~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 242 KDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred cCHHHhcCCCCCCHHHHHcCCCcC
Confidence 9999999 888887 654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=436.21 Aligned_cols=252 Identities=35% Similarity=0.566 Sum_probs=231.6
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
....++|++++.||+|+||.||+|.++.+|+.||||++.+..... ...+.+.+|+.+|+.++||||+++++++++.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 345578999999999999999999999999999999998765322 2356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----cEEEEeccCcc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM----NIKIADFGFSN 193 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~----~iKL~DFGls~ 193 (708)
..+||||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999998888999999999999999999999999999999999999998877 79999999998
Q ss_pred ccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Q psy2648 194 EFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMS 269 (708)
Q Consensus 194 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s 269 (708)
....+......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++...|..+.+.++ ...+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 87766667788999999999999988774 899999999999999999999999999999999999887765 4689
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++++||.+||..||.+|||+++++
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHh
Confidence 9999999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=437.94 Aligned_cols=254 Identities=34% Similarity=0.581 Sum_probs=229.1
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE 117 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 117 (708)
.....+++|++.+.||+|+||+||+|+++.+++.||||++++... .....+.+.+|.++|+.+ +||||+++++++++.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 334567899999999999999999999999999999999976432 123345678899999876 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+|||||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999986432
Q ss_pred -CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy2648 198 -GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276 (708)
Q Consensus 198 -~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li 276 (708)
.....+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++.++|..+...+|..+++++.+||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 3445678999999999999988874 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhhhhCCCCCCCHH-HHh
Q psy2648 277 KKFLVLNPAKRASLE-VSG 294 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~-~~~ 294 (708)
.+||+.||.+||++. +++
T Consensus 250 ~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGG
T ss_pred HHHhcCCHhHcCCChHHHH
Confidence 999999999999997 665
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=440.32 Aligned_cols=248 Identities=35% Similarity=0.628 Sum_probs=224.1
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKT 119 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 119 (708)
...+.+|++++.||+|+||+||+|+++.+++.||||++++.... ....+.+.+|+.+|+++ +|||||+++++++++..
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 44577999999999999999999999999999999999876543 23345678899999876 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~~ 198 (708)
+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.. ..+
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999863 445
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCC
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---------TLRELRERVLRGKYRIPFYMS 269 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---------~~~~l~~~i~~~~~~~p~~~s 269 (708)
....+.|||+.|+|||++.+..|+ .++|||||||++|+|++|+.||... ....+.+.+..+.+.+|..++
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 286 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSC
T ss_pred CccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCC
Confidence 566788999999999999998884 8999999999999999999999642 345678889999999999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCH
Q psy2648 270 TDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~ 290 (708)
+++.+||++||++||.+||++
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHHHHhcCCHhHcCCC
Confidence 999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=433.29 Aligned_cols=240 Identities=25% Similarity=0.373 Sum_probs=193.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHH--HHHHHHHhCCCCCeeeEEEEEEeCC----E
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF--REVRIMKMLDHPNIVKLFQVIETEK----T 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~--~Ei~il~~l~HpnIv~l~~~~~~~~----~ 119 (708)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... .+.+. .|+.++.+++|||||++++++..++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 3689999999999999999987 68999999996432 22333 4555667899999999999997653 6
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK--------KIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~--------gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
+|||||||++|+|.++|.. ..++++++..++.|++.||+|||++ +||||||||+|||||.++++||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 8999999999999999965 5799999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCC-----CccccccCCcccccccccCCc------cCCCchhHHHHHHHHHHHHcCCCCCC----------C---
Q psy2648 192 SNEFTPGN-----KLDTFCGSPPYAAPELFQGKK------YDGPEVDVWSLGVILYTLVSGSLPFD----------G--- 247 (708)
Q Consensus 192 s~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~------~~~~~~DIWSlGvilyelltG~~Pf~----------~--- 247 (708)
|+...... ...+.+||+.|||||++.+.. | +.++|||||||+||||+||..||. +
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~-~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES-FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHH-HHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCcc-ChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 98764332 223568999999999997652 3 368999999999999999976553 2
Q ss_pred --CCHHHHHHHHHcCCCC--CCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 248 --STLRELRERVLRGKYR--IPFY-----MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 248 --~~~~~l~~~i~~~~~~--~p~~-----~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....++...+.....+ +|.. .+..+.+||.+||+.||++|||++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 289 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 2345666666655443 3322 124678999999999999999999887
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=436.20 Aligned_cols=253 Identities=33% Similarity=0.565 Sum_probs=229.1
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEK 118 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 118 (708)
....+++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|.++|+.+ +||||+++++++++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 34567899999999999999999999999999999999976432 123456788999999987 7999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-C
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-P 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~ 197 (708)
.+||||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... .
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999998643 3
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~ 277 (708)
+....+.|||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..++.++|..+.+.+|..+++++.+||+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 4456678999999999999988874 899999999999999999999999999999999999999999999999999999
Q ss_pred HhhhhCCCCCCC-----HHHHh
Q psy2648 278 KFLVLNPAKRAS-----LEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps-----~~~~~ 294 (708)
+||..||.+||+ +++++
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHH
T ss_pred HHhhcCHHHcCCCCCCCHHHHh
Confidence 999999999996 46665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=430.14 Aligned_cols=249 Identities=35% Similarity=0.640 Sum_probs=226.6
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEK 118 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 118 (708)
....+++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+.+|+.+ +|||||+++++++++.
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 34567899999999999999999999999999999999987654 344566788999999987 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TP 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~ 197 (708)
.+||||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. ..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999864 33
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHHcCCCCCCCCC
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---------STLRELRERVLRGKYRIPFYM 268 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~---------~~~~~l~~~i~~~~~~~p~~~ 268 (708)
+....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .+...+.+.+..+.+.+|..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 445677899999999999998887 4899999999999999999999975 345677888888989999999
Q ss_pred CHHHHHHHHHhhhhCCCCCCCH
Q psy2648 269 STDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
++++.+||++||+.||.+||++
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTC
T ss_pred CHHHHHHHHHHhcCCHhHCCCC
Confidence 9999999999999999999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=428.07 Aligned_cols=252 Identities=29% Similarity=0.590 Sum_probs=231.2
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
..+++|++++.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3467899999999999999999999999999999999764321 133566789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~ 160 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT 160 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999986532 34
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 281 (708)
.+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++.++|..+...+|..+++++.+||++||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 568999999999999988875 7999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCC-----CHHHHh---hhh
Q psy2648 282 LNPAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 282 ~dP~~Rp-----s~~~~~---~~~ 297 (708)
.||.+|| ++++++ |+.
T Consensus 240 ~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred cCHHHcCCCcCCCHHHHhcCcccc
Confidence 9999999 788877 664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=433.47 Aligned_cols=256 Identities=35% Similarity=0.619 Sum_probs=234.8
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
......+++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++||||+++++++++.
T Consensus 34 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp CCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 4456678999999999999999999999999999999999976432 123456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+||||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~ 277 (708)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++.++|..+.+.+|..+++++.+||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 34567999999999999988875 899999999999999999999999999999999999999999999999999999
Q ss_pred HhhhhCCCCCCC-----HHHHh---hhh
Q psy2648 278 KFLVLNPAKRAS-----LEVSG---EVT 297 (708)
Q Consensus 278 ~~L~~dP~~Rps-----~~~~~---~~~ 297 (708)
+||+.||.+||+ +++++ |+.
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 999999999998 78776 654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=433.39 Aligned_cols=253 Identities=36% Similarity=0.647 Sum_probs=233.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+..+++.||||++.+........+.+.+|+++|+.++|||||++++++++.+.+|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34689999999999999999999999999999999988777767778899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---cEEEEeccCccccCCCCC
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM---NIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~---~iKL~DFGls~~~~~~~~ 200 (708)
||||+||+|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999999998888899999999999999999999999999999999999998654 599999999987766666
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLL 276 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~Li 276 (708)
....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++...+..+.+.+|. .+++++.+||
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 6678999999999999988875 7999999999999999999999999999999999999887664 4689999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+||..||.+||++++++ |+.
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHcCCChhhCcCHHHHhcCcccC
Confidence 999999999999999987 775
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=435.65 Aligned_cols=251 Identities=33% Similarity=0.565 Sum_probs=221.6
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHH-HHhCCCCCeeeEEEEEEeC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRI-MKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~ 117 (708)
.....+++|++++.||+|+||+||+|+++.+++.||||++.+.... ......+.+|..+ ++.++|||||++++++++.
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 3455678999999999999999999999999999999999876542 3344567788887 5778999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC-
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT- 196 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~- 196 (708)
+.+||||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999999998999999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li 276 (708)
......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++.++|..+...+|..+++++.+||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 34456778999999999999988875 89999999999999999999999999999999999998899999999999999
Q ss_pred HHhhhhCCCCCCCHH
Q psy2648 277 KKFLVLNPAKRASLE 291 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~ 291 (708)
++||+.||.+||++.
T Consensus 271 ~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHTCSSGGGSTTTT
T ss_pred HHHcccCHHhCCCCC
Confidence 999999999999973
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=440.59 Aligned_cols=253 Identities=36% Similarity=0.630 Sum_probs=230.7
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++++.||+|+||.||+|.++.+|+.||+|++.+........+.+.+|+++|+.++|||||++++++++++.+|||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 34689999999999999999999999999999999988776666677889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---CCCcEEEEeccCccccCCC-C
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD---SEMNIKIADFGFSNEFTPG-N 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld---~~~~iKL~DFGls~~~~~~-~ 199 (708)
||||.||+|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...... .
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999999999999999999999999999999999999999999999998 4578999999999776543 3
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENL 275 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~L 275 (708)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++.+.+..+.+.+|. .+++++.+|
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 34567999999999999988875 8999999999999999999999999999999999999877653 578999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|.+||+.||.+|||+++++ |+.
T Consensus 248 i~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred HHHHcCCChhHCCCHHHHhcCcccc
Confidence 9999999999999999988 765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=434.09 Aligned_cols=255 Identities=31% Similarity=0.562 Sum_probs=231.1
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
......+++|++++.||+|+||.||+|++..+++.||||++.+... .....+.+.+|+++|+.++|||||++++++++.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456678899999999999999999999999999999999976432 223456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999988776
Q ss_pred CCCccccccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDG---STLRELRERVLRGKYRIPFYMSTD 271 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~---~~~~~l~~~i~~~~~~~p~~~s~~ 271 (708)
.....+.+||+.|+|||++.+. .| +.++|||||||++|+|++|..||.. ....++...+......+|..++++
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 246 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence 6677889999999999999743 35 4799999999999999999999974 456778888888888899999999
Q ss_pred HHHHHHHhhhhCCCCCCC-HHHHh
Q psy2648 272 CENLLKKFLVLNPAKRAS-LEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps-~~~~~ 294 (708)
+.+||.+||..||.+||+ ++++.
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred HHHHHHHHhcCCHhHhcccHHHHH
Confidence 999999999999999998 77776
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=420.06 Aligned_cols=251 Identities=25% Similarity=0.467 Sum_probs=229.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++++.+.+|+|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 357899999999999999999999999999999999643 23455688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--CCcEEEEeccCccccCCCCC
Q psy2648 124 MEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~--~~~iKL~DFGls~~~~~~~~ 200 (708)
||||+||+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....+..
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 99999999999997654 7999999999999999999999999999999999999997 78999999999988776666
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENLL 276 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~Li 276 (708)
....+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..+++++.+||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 677889999999999988876 4899999999999999999999999999999999999887765 36899999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+||..||.+|||+++++ |+..
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHcCCChhHCcCHHHHhcChhhcc
Confidence 999999999999999988 7763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=418.92 Aligned_cols=253 Identities=34% Similarity=0.578 Sum_probs=218.9
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCC--hhhHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKMLDHPNIVKLFQVIE 115 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 115 (708)
.....++|++.+.||+|+||.||+|++. .+++.||||++.+.... ......+.+|+++|+.++||||++++++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3455678999999999999999999986 68999999999876432 234456789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
+.+.+||||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999998764
Q ss_pred C-CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy2648 196 T-PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCEN 274 (708)
Q Consensus 196 ~-~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~ 274 (708)
. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++..++..+.+.+|..+++++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 250 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 3 2334456789999999999988877 4899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHh
Q psy2648 275 LLKKFLVLNPAKRA-----SLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rp-----s~~~~~ 294 (708)
||.+||..||.+|| ++++++
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHH
Confidence 99999999999999 677776
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=418.63 Aligned_cols=252 Identities=35% Similarity=0.572 Sum_probs=229.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
+...++|++.+.||+|+||.||+|.+..+++.||||++.+..... ...+.+.+|+.+|+.++||||+++++++++.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 344567999999999999999999999999999999998764321 2356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----cEEEEeccCcc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM----NIKIADFGFSN 193 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~----~iKL~DFGls~ 193 (708)
..+|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999998888899999999999999999999999999999999999999887 79999999998
Q ss_pred ccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Q psy2648 194 EFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMS 269 (708)
Q Consensus 194 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s 269 (708)
...........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+....+.++ ...+
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 77666666678999999999999888774 899999999999999999999999999998888888776654 4678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++.+||.+||..||.+|||+++++
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHh
Confidence 9999999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=432.30 Aligned_cols=255 Identities=31% Similarity=0.553 Sum_probs=224.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+.+|+.++|||||++++++++...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3456789999999999999999999999999999999975321 111223477899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|||||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999999999998864 579999999999999999999999999999999999999999999999999998765433
Q ss_pred -CccccccCCcccccccccCCc----cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCC--CCCCH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKK----YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIP--FYMST 270 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~----~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p--~~~s~ 270 (708)
...+.|||+.|+|||++.+.. | +.++|||||||+||+|++|+.||.+.+..++..+|..+. +.+| ..+|+
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYY-GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEE-ETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCC-CCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 245789999999999998765 4 479999999999999999999999999999999998753 3444 36899
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHh---hhhh
Q psy2648 271 DCENLLKKFLVLNPAK--RASLEVSG---EVTL 298 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~--Rps~~~~~---~~~~ 298 (708)
++++||++||+.+|.+ |+++++++ |+..
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 9999999999999988 99999998 7754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=437.16 Aligned_cols=256 Identities=36% Similarity=0.593 Sum_probs=223.0
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.....++|++++.||+|+||.||+|++..+++.||||++.+... .......+.+|+++|+.++||||+++++++.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34557899999999999999999999999999999999976432 23344567899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccC-C
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-P 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~-~ 197 (708)
+||||||+++|+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++... .
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999999999988999999999999999999999998 999999999999999999999999999997643 3
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~ 277 (708)
.....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|+.||.+.+..++...+....+.+|..+++++.+||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 3445678999999999999988874 899999999999999999999999999999999999999999999999999999
Q ss_pred HhhhhCCCCCC-----CHHHHh---hhh
Q psy2648 278 KFLVLNPAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 278 ~~L~~dP~~Rp-----s~~~~~---~~~ 297 (708)
+||+.||.+|| ++++++ |+.
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 99999999999 999887 664
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=421.27 Aligned_cols=253 Identities=39% Similarity=0.654 Sum_probs=215.4
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++++.||+|+||.||+|++..+++.||||++.+.... .+.+.+|+.+++.++|||||++++++.+...+||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3457899999999999999999999999999999999765432 2457799999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--EEEEeccCccccCCCCC
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNK 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~--iKL~DFGls~~~~~~~~ 200 (708)
|||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999999999999998899999999999999999999999999999999999999988765 99999999976554455
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCC--CCCHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRGKYRIPF--YMSTDCEN 274 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~~~~~p~--~~s~~~~~ 274 (708)
....+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+. ....+.+.+....+.+|. .+++++.+
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 566789999999999998888766699999999999999999999874 346677778777777765 57999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
||++||+.||.+|||+++++ |+..
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHccCChhHCcCHHHHHhCcchhc
Confidence 99999999999999999998 8754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=398.99 Aligned_cols=255 Identities=36% Similarity=0.638 Sum_probs=234.3
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35789999999999999999999999999999999987776666778889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---EEEEeccCccccCCCCC
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~---iKL~DFGls~~~~~~~~ 200 (708)
|||+++++|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999999899999999999999999999999999999999999999987665 99999999987766555
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLL 276 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~Li 276 (708)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+..+.+..|. .+++++.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence 6678899999999999988774 7999999999999999999999999999999999888776653 5789999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.+||+.||.+|||+++++ |+...
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 243 DSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHcccChhhCCCHHHHhcCccccCC
Confidence 999999999999999988 77643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.82 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=216.6
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.+++.+||||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 46899999999999999999999999999999999877655556677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcc
Q psy2648 125 EYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~ 202 (708)
||+.+ +|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 99986 56655554 578999999999999999999999999999999999999999999999999999866432 3345
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHcC--CC-----------------
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGSTLRELRERVLRG--KY----------------- 262 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~P-f~~~~~~~l~~~i~~~--~~----------------- 262 (708)
..+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+..+....+... ..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 678999999999998776446899999999999999988777 5666766666665431 00
Q ss_pred ----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 263 ----------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 263 ----------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..+..+++++.+||++||+.||++|||+++++ |+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 287 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence 11124688999999999999999999999988 765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=407.78 Aligned_cols=251 Identities=30% Similarity=0.511 Sum_probs=222.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 467899999999999999999999999999999999765432 345688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLD 202 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~ 202 (708)
|||+++|+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 999999999998865 47999999999999999999999999999999999999999999999999998766443 3345
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG---KYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~---~~~~p~~~s~~~~~Li~~~ 279 (708)
..+||+.|+|||++.+..|+ +++|||||||++|+|++|..||.+.+.......+... ....|..+++++.+||.+|
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 67899999999999988874 8999999999999999999999998877665555433 2334667899999999999
Q ss_pred hhhCCCCCCCHHHHh---hhhh
Q psy2648 280 LVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 280 L~~dP~~Rps~~~~~---~~~~ 298 (708)
|+.||.+|||+++++ |+..
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCChhHCcCHHHHhhChhhcc
Confidence 999999999999987 7654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=407.94 Aligned_cols=254 Identities=35% Similarity=0.622 Sum_probs=217.5
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh------------------------hhHHHHHHH
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP------------------------GSLQKLFRE 95 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~------------------------~~~~~~~~E 95 (708)
.....+++|++.+.||+|+||.||+|++..+++.||||++.+..... ...+.+.+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34456789999999999999999999999999999999997654211 123568899
Q ss_pred HHHHHhCCCCCeeeEEEEEEe--CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy2648 96 VRIMKMLDHPNIVKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 173 (708)
Q Consensus 96 i~il~~l~HpnIv~l~~~~~~--~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKP 173 (708)
+++|+.++||||+++++++.+ ...+||||||+++++|.+++ ....+++.+++.++.||+.||+|||++||+||||||
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999999999999999999987 56899999999999998854 346799999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCccccCCCC-CccccccCCcccccccccCCcc--CCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q psy2648 174 ENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKY--DGPEVDVWSLGVILYTLVSGSLPFDGSTL 250 (708)
Q Consensus 174 eNILld~~~~iKL~DFGls~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~--~~~~~DIWSlGvilyelltG~~Pf~~~~~ 250 (708)
+|||++.++.+||+|||++....... .....+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999998765432 3456789999999999987542 35789999999999999999999999998
Q ss_pred HHHHHHHHcCCCCCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 251 RELRERVLRGKYRIP--FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 251 ~~l~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+...+......+| ..+++++.+||.+||..||.+|||+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 888888888766655 36889999999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=420.01 Aligned_cols=253 Identities=34% Similarity=0.599 Sum_probs=221.6
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC---ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL---NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
...++|++.+.||+|+||.||+|.++.+++.||||++.+... .....+.+.+|+.+|+.++|||||++++++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 344689999999999999999999999999999999965321 11235678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---EEEEeccCc
Q psy2648 120 LYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFS 192 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~---iKL~DFGls 192 (708)
+|||||||+|++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999999888654 24899999999999999999999999999999999999987665 999999999
Q ss_pred cccCCCC-CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CC
Q psy2648 193 NEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FY 267 (708)
Q Consensus 193 ~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~ 267 (708)
....... .....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+. ..++...+..+.+..+ ..
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence 8765433 24567899999999999988874 8999999999999999999999875 4567778888877654 46
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+++++.+||.+||..||.+|||+++++ |+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 899999999999999999999999987 775
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=433.61 Aligned_cols=256 Identities=29% Similarity=0.523 Sum_probs=223.6
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++++.||+|+||+||+|+++.+++.||||++.+.... ....+.+.+|+.+|+.++||||+++++++++.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 34467899999999999999999999999999999999753211 11223477899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999999987 4789999999999999999999999999999999999999999999999999997664433
Q ss_pred C--ccccccCCccccccccc-----CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCC---C
Q psy2648 200 K--LDTFCGSPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPF---Y 267 (708)
Q Consensus 200 ~--~~~~~Gt~~Y~APE~l~-----~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~---~ 267 (708)
. ....+||+.|+|||++. ...| +.++|||||||+||||++|+.||.+.+..++..+|.... +.+|. .
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 2 34579999999999997 3445 589999999999999999999999999999998887643 45554 4
Q ss_pred CCHHHHHHHHHhhhhCCCC--CCCHHHHh---hhhh
Q psy2648 268 MSTDCENLLKKFLVLNPAK--RASLEVSG---EVTL 298 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~--Rps~~~~~---~~~~ 298 (708)
+++++++||++||+.+|++ |+++++++ |+..
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 8999999999999998888 99999988 7753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=428.63 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=222.7
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++++.||+|+||+||+|+++.+++.||||++++... .....+.+.+|+.+|..++||||+++++++++.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3456789999999999999999999999999999999976422 122334577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
||||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999999998764 79999999999999999999999999999999999999999999999999998765443
Q ss_pred C--ccccccCCccccccccc-------CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCC---
Q psy2648 200 K--LDTFCGSPPYAAPELFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIP--- 265 (708)
Q Consensus 200 ~--~~~~~Gt~~Y~APE~l~-------~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p--- 265 (708)
. ....|||+.|+|||++. +..| +.++|||||||++|||++|+.||.+.+..++..+|.... +.+|
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 2 34579999999999997 3445 489999999999999999999999999999988887643 3344
Q ss_pred CCCCHHHHHHHHHhhhhCCCCC---CCHHHHh---hhhh
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKR---ASLEVSG---EVTL 298 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~R---ps~~~~~---~~~~ 298 (708)
..+|+++++||++||+ ||.+| +++++++ |+..
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 4789999999999999 99998 5898887 7753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=455.00 Aligned_cols=255 Identities=33% Similarity=0.547 Sum_probs=231.8
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKT 119 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 119 (708)
...+++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|.++|..+ +||||+++++++++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 4457899999999999999999999999999999999976432 123446678999999987 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc-CCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~-~~~ 198 (708)
+||||||++||+|.+++...+.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.. ..+
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999999999999899999999999999999999999999999999999999999999999999999864 334
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~ 278 (708)
....+.+||+.|+|||++.+..|+ .++|||||||+||||++|+.||.+.+..++.++|..+.+.+|..+++++.+||++
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 575 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 456778999999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCH-----HHHh---hhh
Q psy2648 279 FLVLNPAKRASL-----EVSG---EVT 297 (708)
Q Consensus 279 ~L~~dP~~Rps~-----~~~~---~~~ 297 (708)
||++||.+||++ ++++ |+.
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred HccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 999999999997 6666 554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=399.67 Aligned_cols=259 Identities=47% Similarity=0.845 Sum_probs=225.4
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
.....+++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+++++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 445667899999999999999999999999999999999975422 1233457889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+++++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999876655
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~ 278 (708)
......+|++.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+..++.+.+..+.+.+|..++.++.+||.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH 244 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHH
Confidence 55566789999999999988776567999999999999999999999999999999999999888898999999999999
Q ss_pred hhhhCCCCCCCHHHHh---hhhh
Q psy2648 279 FLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~---~~~~ 298 (708)
||..||.+|||++++. |+..
T Consensus 245 ~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 245 MLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HTCSSGGGSCCHHHHHHSHHHHT
T ss_pred HccCChhhCCCHHHHHhChhhcc
Confidence 9999999999999987 7764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=434.09 Aligned_cols=256 Identities=36% Similarity=0.623 Sum_probs=229.5
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-----------hhHHHHHHHHHHHHhCCCCCeeeE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-----------GSLQKLFREVRIMKMLDHPNIVKL 110 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l 110 (708)
....++|++++.||+|+||.||+|++..+++.||||++.+..... ...+.+.+|+.+|+.++|||||++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345678999999999999999999999999999999998754321 235678899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---cEEEE
Q psy2648 111 FQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM---NIKIA 187 (708)
Q Consensus 111 ~~~~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~---~iKL~ 187 (708)
++++++...+|||||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876 69999
Q ss_pred eccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--
Q psy2648 188 DFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP-- 265 (708)
Q Consensus 188 DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p-- 265 (708)
|||++..+.........+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+..++...+..+.+.++
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 9999988776666777899999999999875 45 4799999999999999999999999999999999999987765
Q ss_pred --CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 266 --FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 266 --~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
..+++++.+||++||+.||.+|||+++++ |+...
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 46899999999999999999999999988 88653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=420.39 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=219.3
Q ss_pred CCCCCccCCeEEEeEEccc--CceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 39 ERDEPHIGKYKLLKTIGKG--NFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G--~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
..-.+..++|++++.||+| +||.||+|++..+++.||||++..........+.+.+|+++|+.++|||||++++++.+
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 3445667899999999999 99999999999999999999998776666667778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
.+.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999999876 6799999999999999999999999999999999999999999999999998754
Q ss_pred cCCC--------CCccccccCCcccccccccC--CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--
Q psy2648 195 FTPG--------NKLDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-- 262 (708)
Q Consensus 195 ~~~~--------~~~~~~~Gt~~Y~APE~l~~--~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-- 262 (708)
.... ......+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+.+..+....+..+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 3211 12234589999999999987 455 4799999999999999999999987654444333322211
Q ss_pred --------------------------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---h
Q psy2648 263 --------------------------------------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---E 295 (708)
Q Consensus 263 --------------------------------------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~ 295 (708)
..+..+++++.+||.+||+.||.+|||+++++ |
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 13345788999999999999999999999988 7
Q ss_pred hhh
Q psy2648 296 VTL 298 (708)
Q Consensus 296 ~~~ 298 (708)
+..
T Consensus 337 f~~ 339 (389)
T 3gni_B 337 FKQ 339 (389)
T ss_dssp GGG
T ss_pred HHH
Confidence 754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=435.20 Aligned_cols=255 Identities=37% Similarity=0.670 Sum_probs=228.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
....++|++++.||+|+||.||+|++..+++.||||++.+..........+.+|+++|+.++|||||++++++++...+|
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 34557899999999999999999999999999999999764333334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---CCCcEEEEeccCccccCCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD---SEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld---~~~~iKL~DFGls~~~~~~ 198 (708)
+|||||.+|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+...
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999999999999999999999999999999999999999999999999995 4567999999999877666
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCEN 274 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~ 274 (708)
......+||+.|+|||++.+. | +.++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..+|+++.+
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp ----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 666778999999999999874 5 4799999999999999999999999999999999999877654 257899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
||.+||+.||.+|||+++++ |+..
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 99999999999999999988 8864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=413.92 Aligned_cols=255 Identities=35% Similarity=0.578 Sum_probs=218.0
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.+.+++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 35688999999999999999999999999999999999755322 23356789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC---
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG--- 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~--- 198 (708)
||||||++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999987788999999999999999999999999999999999999999999999999999765322
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCC--CCCCHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLRGKYRIP--FYMSTDCENL 275 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~-~l~~~i~~~~~~~p--~~~s~~~~~L 275 (708)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.. .............+ ..+++++.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 23456789999999999988877667899999999999999999999875542 22333333333222 3578999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|.+||..||.+|||+++++ |+.
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred HHHHccCChhhCcCHHHHhhChhhc
Confidence 9999999999999999988 664
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=399.74 Aligned_cols=257 Identities=33% Similarity=0.619 Sum_probs=229.3
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.+..+++|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 355678999999999999999999999999999999999654322 1234567899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|+||||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-~ 162 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-S 162 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-c
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999865432 2
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.....+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+..+.+......+|...++++.+||.+|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 241 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence 3355689999999999988776 479999999999999999999999999999999999998999999999999999999
Q ss_pred hhhCCCCCCCHHHHh---hhhhC
Q psy2648 280 LVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 280 L~~dP~~Rps~~~~~---~~~~~ 299 (708)
|..||.+|||+++++ |+...
T Consensus 242 l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 242 LKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp CCSSGGGSCCHHHHHHCHHHHHH
T ss_pred hccChhhCCCHHHHhhCccccCC
Confidence 999999999999998 87643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=431.57 Aligned_cols=255 Identities=39% Similarity=0.651 Sum_probs=226.0
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
....++|++++.||+|+||.||+|++..+++.||||++.+..........+.+|+.+|+.++|||||++++++++...+|
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 33456799999999999999999999999999999999876654445567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CcEEEEeccCccccCCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPG 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~~iKL~DFGls~~~~~~ 198 (708)
||||||++|+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++..+...
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999999999999999999999999999999999999999999999999999764 45999999999887666
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCEN 274 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~ 274 (708)
......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..+++++.+
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 66677899999999999875 45 4799999999999999999999999999999999999887654 357899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
||++||+.||.+|||+++++ |+..
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999999999999988 8764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=399.99 Aligned_cols=252 Identities=28% Similarity=0.471 Sum_probs=217.6
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+++.++||||+++++++++.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 3445789999999999999999999999999999999976543 345567789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|+||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999998664332
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCCHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-----IPFYMSTDCE 273 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-----~p~~~s~~~~ 273 (708)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+...+....... .+..+++.+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp --------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred cccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 23456899999999999988774 7899999999999999999999998887766666555432 3456889999
Q ss_pred HHHHHhhhhCCCCCC-CHHHHh
Q psy2648 274 NLLKKFLVLNPAKRA-SLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rp-s~~~~~ 294 (708)
++|.+||..||.+|| +++++.
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMK 267 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHH
T ss_pred HHHHHHhcCCHhHccccHHHHH
Confidence 999999999999999 677665
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=440.93 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=231.4
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
..+...++|++.+.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+++|+.++|||||++++++++.+
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 4456678899999999999999999999999999999999764321 223456789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
.+||||||++||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987654 9999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCHHH
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRGKYRIPFYMSTDC 272 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~~~~~p~~~s~~~ 272 (708)
.+....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+. ...++...+......+|..+++++
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cCccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 66666678999999999999988875 8999999999999999999999875 457788888888888888999999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHh---hhh
Q psy2648 273 ENLLKKFLVLNPAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rp-----s~~~~~---~~~ 297 (708)
.+||++||+.||.+|| ++++++ |+.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 9999999999999999 678877 665
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=415.32 Aligned_cols=248 Identities=33% Similarity=0.588 Sum_probs=221.5
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~y 121 (708)
...++|++.+.||+|+||+||+|.++.+++.||||++.+.... ..+|+++|..+ +||||+++++++++...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3457899999999999999999999999999999999876432 34688888887 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC----CcEEEEeccCccccCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFTP 197 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~----~~iKL~DFGls~~~~~ 197 (708)
||||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988899999999999999999999999999999999999998543 3599999999987643
Q ss_pred C-CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHcCCCCCC----CCCC
Q psy2648 198 G-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---STLRELRERVLRGKYRIP----FYMS 269 (708)
Q Consensus 198 ~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~---~~~~~l~~~i~~~~~~~p----~~~s 269 (708)
. ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+ .+..++...+..+.+.++ ..++
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 3 345678999999999999887775 799999999999999999999986 567889999999887765 4589
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+++.+||++||..||.+|||+++++ |+.
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 9999999999999999999999988 774
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=408.02 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=204.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+++|+.++||||+++++++++++.+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4689999999999999999999999999999999976542 233456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 125 EYASGGEVFDYLVLH------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
||++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 5999998765 35899999999999999999999999999999999999999999999999999866432
Q ss_pred -CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC-------------
Q psy2648 199 -NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KY------------- 262 (708)
Q Consensus 199 -~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~------------- 262 (708)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 33456789999999999987543358999999999999999999999998887776666431 00
Q ss_pred -------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhCC
Q psy2648 263 -------------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLGG 300 (708)
Q Consensus 263 -------------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~~ 300 (708)
..+...++++.+||.+||+.||.+|||+++++ |+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 01124688999999999999999999999998 876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=394.09 Aligned_cols=251 Identities=35% Similarity=0.657 Sum_probs=230.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+... ...+.+.+|+++|+.++||||+++++++.+...+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 45689999999999999999999999999999999976533 2356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCcEEEEeccCccccCCCCC
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl---d~~~~iKL~DFGls~~~~~~~~ 200 (708)
|||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 9999999999999988999999999999999999999999999999999999999 7889999999999987776666
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLL 276 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~Li 276 (708)
....+||+.|+|||++.+. + ++++|||||||++|+|++|..||.+.+..++...+..+.+..|. .+++++.+||
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI 242 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred hhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence 6778999999999999765 4 58999999999999999999999999999999999998887774 6899999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+||+.||.+|||+++++ |+..
T Consensus 243 ~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHccCChhhCcCHHHHhcCHHHhc
Confidence 999999999999999987 7753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=405.32 Aligned_cols=251 Identities=35% Similarity=0.556 Sum_probs=228.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
...++|++.+.||+|+||.||+|++..+++.||||++.+..... ...+.+.+|+.+|+.++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34567999999999999999999999999999999998754321 13567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----cEEEEeccCccc
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM----NIKIADFGFSNE 194 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~----~iKL~DFGls~~ 194 (708)
.+|+||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999998888899999999999999999999999999999999999999888 799999999987
Q ss_pred cCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCH
Q psy2648 195 FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMST 270 (708)
Q Consensus 195 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~ 270 (708)
..........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+....+.++ ...++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 7666556677899999999999888774 899999999999999999999999999999999988877655 46889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||..||.+|||+++++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l 271 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEAL 271 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHh
Confidence 999999999999999999999887
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=418.94 Aligned_cols=253 Identities=28% Similarity=0.507 Sum_probs=227.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
....++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+++|+.++|||||++++++++...+|
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 445678999999999999999999999999999999997543 334557889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--CCcEEEEeccCccccCCC
Q psy2648 122 LVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~--~~~iKL~DFGls~~~~~~ 198 (708)
|||||+++|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999987654 7999999999999999999999999999999999999984 477999999999877665
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCEN 274 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~ 274 (708)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+.++ ..+++++.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred cceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 55566789999999999998877 4899999999999999999999999999888888888776544 357899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
||.+||..||.+|||+++++ |+.
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred HHHHHcCCChhHCcCHHHHhhCcccc
Confidence 99999999999999999988 654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=405.38 Aligned_cols=253 Identities=27% Similarity=0.471 Sum_probs=216.0
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
...+...++|++.+.||+|+||.||+|++ +++.||||++.+........+.+.+|+++|++++||||+++++++.+..
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 33445567999999999999999999987 6889999999877766677778999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~---l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
.+|+||||+++|+|.+++...+. +++.++..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999986653 999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCC-CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCH
Q psy2648 194 EFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--GKYRIPFYMST 270 (708)
Q Consensus 194 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--~~~~~p~~~s~ 270 (708)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+.. ....+|..+++
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cccccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 54332 22345789999999999998877 4899999999999999999999999998888777743 34567888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||..||.+|||++++.
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll 290 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIM 290 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999999999999999887
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=432.24 Aligned_cols=255 Identities=40% Similarity=0.686 Sum_probs=232.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++.+.||+|+||.||+|++..+++.||||++.+.... ....+.+.+|+.+|+.++|||||++++++++...+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34456899999999999999999999999999999999876543 34567789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCcEEEEeccCccccCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl---d~~~~iKL~DFGls~~~~~ 197 (708)
|+|||||.+|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999988999999999999999999999999999999999999999 4678999999999988776
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCE 273 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~ 273 (708)
.......+||+.|+|||++.+ .| ++++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..+++++.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 666677899999999999987 45 4799999999999999999999999999999999999877654 35789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+||++||+.||.+|||+++++ |+..
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 999999999999999999988 8764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=405.67 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=212.3
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
..+...++|++++.||+|+||.||+|++. +++.||||++..........+.+.+|+++|+.++||||+++++++.++..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 44556789999999999999999999985 59999999997665444455678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
+||||||+++ +|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999985 888888765 45999999999999999999999999999999999999999999999999999876432
Q ss_pred -CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CCCC------------
Q psy2648 199 -NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--GKYR------------ 263 (708)
Q Consensus 199 -~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--~~~~------------ 263 (708)
......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.. +...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 3345568999999999998754446899999999999999999999988765555444432 1000
Q ss_pred ----------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 264 ----------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 264 ----------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+....++++.+||++||+.||.+|||+++++ |+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 1124678999999999999999999999988 765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=394.60 Aligned_cols=256 Identities=33% Similarity=0.554 Sum_probs=233.7
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 345689999999999999999999999999999999987643 3455677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~ 200 (708)
+||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999976542 333
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L 280 (708)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..+.+.+|..+++++.+||.+||
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence 455789999999999988776 4799999999999999999999999999998899999888899999999999999999
Q ss_pred hhCCCCCCCHHHHh---hhhhC
Q psy2648 281 VLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~~ 299 (708)
..||.+|||++++. |+...
T Consensus 251 ~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 251 QTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccChhhCcCHHHHhhChheecC
Confidence 99999999999988 77643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=418.39 Aligned_cols=252 Identities=31% Similarity=0.505 Sum_probs=207.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC--EE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEK--TL 120 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~ 120 (708)
..++|++++.||+|+||.||+|.+..+++.||||++.+........+++.+|+.+|+.+. |||||++++++..++ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 467899999999999999999999999999999999876666667788899999999997 999999999998654 79
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC---
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP--- 197 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~--- 197 (708)
|||||||+ ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999998 589888865 6899999999999999999999999999999999999999999999999999976532
Q ss_pred -------------------CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy2648 198 -------------------GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL 258 (708)
Q Consensus 198 -------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~ 258 (708)
.......+||+.|+|||++.+....+.++|||||||+||+|++|+.||.+.+..+...+|.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1123457899999999999874433589999999999999999999999988777666664
Q ss_pred cCCCC------------------------------------------------CCCCCCHHHHHHHHHhhhhCCCCCCCH
Q psy2648 259 RGKYR------------------------------------------------IPFYMSTDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 259 ~~~~~------------------------------------------------~p~~~s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
.. .. .+...++++.+||.+||+.||.+|||+
T Consensus 245 ~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 245 GV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred Hh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 21 00 112568899999999999999999999
Q ss_pred HHHh---hhhh
Q psy2648 291 EVSG---EVTL 298 (708)
Q Consensus 291 ~~~~---~~~~ 298 (708)
++++ |+..
T Consensus 324 ~e~l~Hp~~~~ 334 (388)
T 3oz6_A 324 NDALKHPFVSI 334 (388)
T ss_dssp HHHTTSTTTTT
T ss_pred HHHhCCHHHHH
Confidence 9988 6653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=400.47 Aligned_cols=251 Identities=31% Similarity=0.504 Sum_probs=211.6
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||.||+|++ .+++.||||++..........+.+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 46899999999999999999998 68999999999765443334467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcc
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~ 202 (708)
||+.+ +|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 99986 899988764 6799999999999999999999999999999999999999999999999999876542 22344
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC------------------
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KY------------------ 262 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~------------------ 262 (708)
..+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.+. ..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 5689999999999987553458999999999999999999999998877666655431 00
Q ss_pred ---------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 263 ---------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 263 ---------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..+..+++++.+||.+||+.||.+|||+++++ |+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 01134688999999999999999999999987 664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=404.49 Aligned_cols=257 Identities=33% Similarity=0.547 Sum_probs=234.7
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
...++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++++.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 345689999999999999999999999999999999986643 3455677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~ 200 (708)
+||||+.+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999976542 334
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L 280 (708)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..+.+.+|..+++++.+||.+||
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence 456789999999999988877 4799999999999999999999999999998889998988999999999999999999
Q ss_pred hhCCCCCCCHHHHh---hhhhCC
Q psy2648 281 VLNPAKRASLEVSG---EVTLGG 300 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~~~~ 300 (708)
..||.+|||+++++ |+....
T Consensus 277 ~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 277 QTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cCChhHCcCHHHHhcCccccCCC
Confidence 99999999999988 776543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=434.96 Aligned_cols=249 Identities=32% Similarity=0.485 Sum_probs=224.7
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.....++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|+.++||||+++++++++...
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 445678999999999999999999999999999999999765322 2334678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 120 LYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
+||||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999999764 36999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC-ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCH
Q psy2648 196 TPGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRGKYRIPFYMST 270 (708)
Q Consensus 196 ~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~~~~~p~~~s~ 270 (708)
..... ..+.+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+. ...++.+.+......+|..+++
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cCCCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 54433 3457999999999999998875 8999999999999999999999875 5678888999998899999999
Q ss_pred HHHHHHHHhhhhCCCCCCCH
Q psy2648 271 DCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~ 290 (708)
++.+||++||++||.+||++
T Consensus 419 ~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCC
T ss_pred HHHHHHHHhccCCHhHCCCC
Confidence 99999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=419.31 Aligned_cols=251 Identities=35% Similarity=0.568 Sum_probs=210.6
Q ss_pred CCCCccCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHH-HhCCCCCeeeEEEEEEe-
Q psy2648 40 RDEPHIGKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIM-KMLDHPNIVKLFQVIET- 116 (708)
Q Consensus 40 ~~~~~~~~Y~i~-~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~- 116 (708)
.....+++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++ +.++||||++++++++.
T Consensus 55 ~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 344567889987 7899999999999999999999999999632 3467888887 45689999999999876
Q ss_pred ---CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCcEEEEe
Q psy2648 117 ---EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIAD 188 (708)
Q Consensus 117 ---~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~~iKL~D 188 (708)
...+|||||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567999999999999999998654 5999999999999999999999999999999999999998 78899999
Q ss_pred ccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCCCC
Q psy2648 189 FGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR----ELRERVLRGKYRI 264 (708)
Q Consensus 189 FGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~----~l~~~i~~~~~~~ 264 (708)
||+++.........+.+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+.+.. .+...+..+.+.+
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 9999876655556778999999999999888875 7999999999999999999999875432 2556777777766
Q ss_pred C----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 265 P----FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 265 p----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
| ..+++++.+||++||..||.+|||+++++ |+..
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 5 35899999999999999999999999998 7763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=395.80 Aligned_cols=257 Identities=33% Similarity=0.640 Sum_probs=231.9
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
.....+++|++.+.||+|+||.||+|++..+++.||||++.+.... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 3455678999999999999999999999999999999999754321 122456889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+++++|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~ 278 (708)
......+|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+......+|..++.++.+||.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 234567899999999999988774 7999999999999999999999999999999999998888999999999999999
Q ss_pred hhhhCCCCCCCHHHHh---hhhh
Q psy2648 279 FLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~---~~~~ 298 (708)
||..||.+||++++++ |+..
T Consensus 246 ~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HSCSSGGGSCCHHHHHTCHHHHH
T ss_pred HhhcCHhhCCCHHHHhhCHHHHh
Confidence 9999999999999987 8764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=410.65 Aligned_cols=251 Identities=36% Similarity=0.596 Sum_probs=206.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+...++|++.+.||+|+||.||+|++..+++.||||++.+.. ..+.+.+|+++|+.++||||+++++++++...+|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 344578999999999999999999999999999999997543 2345778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCcEEEEeccCccccCCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~~iKL~DFGls~~~~~~ 198 (708)
|||||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999999988888999999999999999999999999999999999999975 889999999999876555
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCC----CCCCHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGKYRIP----FYMSTDCE 273 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~~~~p----~~~s~~~~ 273 (708)
......+||+.|+|||++.+..++ +++|||||||++|+|++|..||.+... ..+...+..+.+..+ ..++.++.
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp --------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred cccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 555678899999999999988774 899999999999999999999987654 447778887766543 35789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+||++||..||++|||+++++ |+.
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccC
Confidence 999999999999999999987 554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=398.27 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=213.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+++++.++||||+++++++...+.+|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 57899999999999999999999999999999999776655555677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~~ 203 (708)
||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 9999999999888888899999999999999999999999999999999999999999999999999976643 233456
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------CCCC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------------------KYRI 264 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------------------~~~~ 264 (708)
.+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... ....
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 789999999999987444468999999999999999999999998776655444321 0011
Q ss_pred C------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 265 P------------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 265 p------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
| ..+++++.+||.+||..||.+|||+++++ |+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 1 24688899999999999999999999987 765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=407.42 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=209.0
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.....+++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+++|+.++||||++++++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34556789999999999999999999999999999999998765444455667899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-----CCCcEEEEeccCccc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-----SEMNIKIADFGFSNE 194 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld-----~~~~iKL~DFGls~~ 194 (708)
+||||||+++ +|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 9999999988999999999999999999999999999999999999994 455699999999976
Q ss_pred cCCC-CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CC--------
Q psy2648 195 FTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YR-------- 263 (708)
Q Consensus 195 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~-------- 263 (708)
.... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.... ..
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 5422 334556889999999999876544689999999999999999999999988777666654320 00
Q ss_pred --------CC------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 264 --------IP------------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 264 --------~p------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+| ..+++++.+||.+||+.||.+|||+++++ |+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 323 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence 00 11678999999999999999999999988 765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=407.84 Aligned_cols=251 Identities=36% Similarity=0.617 Sum_probs=203.8
Q ss_pred CCccCCeEEE---eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Q psy2648 42 EPHIGKYKLL---KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETE 117 (708)
Q Consensus 42 ~~~~~~Y~i~---~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 117 (708)
.+...+|++. +.||+|+||.||+|.+..+++.||||++.+. ....+.+|+.+|+.+. ||||+++++++++.
T Consensus 4 ~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp CHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 4455678886 7899999999999999999999999999653 3456778999999997 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---cEEEEeccCccc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM---NIKIADFGFSNE 194 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~---~iKL~DFGls~~ 194 (708)
..+||||||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999999999999989999999999999999999999999999999999999998766 799999999986
Q ss_pred cCCC-CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHcCCCCCCC
Q psy2648 195 FTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-------TLRELRERVLRGKYRIPF 266 (708)
Q Consensus 195 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-------~~~~l~~~i~~~~~~~p~ 266 (708)
.... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+. ...++..++..+.+.++.
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp CCC----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 5433 334567899999999999988875 7999999999999999999999864 346788888888877653
Q ss_pred ----CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 267 ----YMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 267 ----~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.+++++.+||.+||..||.+|||+++++ |+..
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 5799999999999999999999999887 7753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=393.21 Aligned_cols=252 Identities=31% Similarity=0.570 Sum_probs=216.8
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||+|++..+++.||||++.+... ....+.+.+|+++|+.++||||+++++++.+...+|+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 345789999999999999999999999999999999976542 2345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCcEEEEeccCcccc
Q psy2648 123 VMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNIKIADFGFSNEF 195 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl---d~~~~iKL~DFGls~~~ 195 (708)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999998643 679999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCHHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP---FYMSTDC 272 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p---~~~s~~~ 272 (708)
.........+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..++...+.......+ ...++++
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred CCcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 65555567789999999999865 34 4799999999999999999999999999988888876655443 2478999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+||.+||+.||.+|||+++++ |+.
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 9999999999999999999987 664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=404.24 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=215.9
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-- 118 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 118 (708)
....++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+++++.++||||++++++++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 3456789999999999999999999999999999999987644 3445567889999999999999999999987653
Q ss_pred --EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 119 --TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 119 --~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
.+||||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 359999999999999999988999999999999999999999999999999999999999999999999999997654
Q ss_pred CCC----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----CCCC
Q psy2648 197 PGN----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI----PFYM 268 (708)
Q Consensus 197 ~~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~----p~~~ 268 (708)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++...+....... +..+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 321 23346799999999999988774 79999999999999999999999998888776666654433 2458
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
++++.+||.+||..||.+||+..+++ |+..
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 89999999999999999999876655 6553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=428.22 Aligned_cols=251 Identities=28% Similarity=0.485 Sum_probs=210.5
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------ 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 117 (708)
..++|++++.||+|+||.||+|++..+++.||||++.+........+++.+|+.+|+.++|||||++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35789999999999999999999999999999999987655566677899999999999999999999999654
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..+||||||+.+ +|.+.+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 468999999986 4666663 4699999999999999999999999999999999999999999999999999987766
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C--------------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K-------------- 261 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~-------------- 261 (708)
.......+||+.|+|||++.+..|+ .++|||||||+||+|++|+.||.+.+..+...+|... .
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 5566778999999999999998885 7999999999999999999999998877666665431 0
Q ss_pred -----------CC----CCCC-----------CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 262 -----------YR----IPFY-----------MSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 262 -----------~~----~p~~-----------~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.. +|.. .++++.+||.+||+.||.+|||+++++ |+..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00 0100 156799999999999999999999988 7764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=412.31 Aligned_cols=248 Identities=36% Similarity=0.596 Sum_probs=221.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh------hHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG------SLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
..++|++.+.||+|+||.||+|.+..+++.||||++.+...... ..+.+.+|+.+|+.++||||+++++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45689999999999999999999999999999999987653221 334567899999999999999999999999
Q ss_pred CEEEEEEeccCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 118 KTLYLVMEYASGG-EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 118 ~~~ylVmEy~~gg-~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
+.+|+||||+.+| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999776 999999988899999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li 276 (708)
........+||+.|+|||++.+..+.++++|||||||++|+|++|..||.... .........|..+++++.+||
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~li 255 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSLV 255 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHHH
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHHH
Confidence 66666778999999999999988876789999999999999999999997632 233445566778899999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+||..||.+|||+++++ |+.
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 256 SGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp HHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred HHHccCChhhCcCHHHHhcCcccc
Confidence 999999999999999987 654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=390.24 Aligned_cols=251 Identities=35% Similarity=0.613 Sum_probs=222.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
++|++.+.||+|+||.||+|++..+++.||||++.+..... ...+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999999999999999998764322 23567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----cEEEEeccCccccCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM----NIKIADFGFSNEFTP 197 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~----~iKL~DFGls~~~~~ 197 (708)
+||||+++++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999999887 899999999987665
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCE 273 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~ 273 (708)
.......+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+....+..+ ...++++.
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred CCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence 5555667899999999999887764 799999999999999999999999999988888887766554 46789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+||.+||..||.+|||+++++ |+.
T Consensus 244 ~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 999999999999999999887 665
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=397.90 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=213.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC---hhhHHHHHHHHHHHHhC---CCCCeeeEEEEEEeC
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN---PGSLQKLFREVRIMKML---DHPNIVKLFQVIETE 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~ 117 (708)
..++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+++++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999999999999999999754321 11224566788777766 499999999999876
Q ss_pred C-----EEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEecc
Q psy2648 118 K-----TLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190 (708)
Q Consensus 118 ~-----~~ylVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFG 190 (708)
. .+|+||||+. ++|.+++..... +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 5899999997 599999987654 9999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CC-----
Q psy2648 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YR----- 263 (708)
Q Consensus 191 ls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~----- 263 (708)
++............+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+...++.... ..
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 99877666666778999999999999888875 79999999999999999999999998887777665321 00
Q ss_pred --------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 264 --------------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 264 --------------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
....+++++.+||.+||+.||.+|||+++++ |+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~ 301 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence 1124678999999999999999999999987 664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=398.24 Aligned_cols=253 Identities=34% Similarity=0.553 Sum_probs=216.2
Q ss_pred CCccCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCE
Q psy2648 42 EPHIGKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM-LDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 42 ~~~~~~Y~i~-~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~ 119 (708)
....++|++. +.||+|+||.||+|.+..+++.||||++.+.. ....+.+.+|+++|++ ++||||+++++++.+++.
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3445689996 78999999999999999999999999997653 2345678899999988 479999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---EEEEeccCccccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFT 196 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~---iKL~DFGls~~~~ 196 (708)
+||||||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999999998899999999999999999999999999999999999999998776 9999999987653
Q ss_pred CC--------CCccccccCCcccccccccC-----CccCCCchhHHHHHHHHHHHHcCCCCCCCCC--------------
Q psy2648 197 PG--------NKLDTFCGSPPYAAPELFQG-----KKYDGPEVDVWSLGVILYTLVSGSLPFDGST-------------- 249 (708)
Q Consensus 197 ~~--------~~~~~~~Gt~~Y~APE~l~~-----~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-------------- 249 (708)
.. ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 21 12335679999999999875 334 479999999999999999999998754
Q ss_pred -HHHHHHHHHcCCCCCC----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 250 -LRELRERVLRGKYRIP----FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 250 -~~~l~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
...+.+.+..+.+.+| ..+++++.+||++||..||.+|||+++++ |+.
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 3557788888887776 35889999999999999999999999987 654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=395.39 Aligned_cols=251 Identities=40% Similarity=0.670 Sum_probs=200.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
..+++|++.+.||+|+||.||+|++..+++.||||++.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 3467899999999999999999999999999999999754221 123467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-C
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-N 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~ 199 (708)
+||||+++++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999999865 57999999999999999999999999999999999999999999999999999765422 2
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKF 279 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~ 279 (708)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+....+..|...+.++.+||.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 3345789999999999988776 479999999999999999999999877666666666677778888999999999999
Q ss_pred hhhCCCCCCCHHHHh
Q psy2648 280 LVLNPAKRASLEVSG 294 (708)
Q Consensus 280 L~~dP~~Rps~~~~~ 294 (708)
|..||.+|||+++++
T Consensus 247 l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 247 LRRNPADRLSLSSVL 261 (278)
T ss_dssp SCSSGGGSCCHHHHT
T ss_pred cccCHhhCCCHHHHh
Confidence 999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=409.42 Aligned_cols=248 Identities=31% Similarity=0.525 Sum_probs=218.5
Q ss_pred CeEE--EeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 47 KYKL--LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 47 ~Y~i--~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.|.+ .+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+++|+.++|||||++++++++.+.+||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4555 678999999999999999999999999997643 344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE--cCCCcEEEEeccCccccCCCCCc
Q psy2648 125 EYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL--DSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl--d~~~~iKL~DFGls~~~~~~~~~ 201 (708)
||+++++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999999999998765 469999999999999999999999999999999999999 56788999999999887766666
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENLLK 277 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~Li~ 277 (708)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+.++ ..+++++.+||.
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred ccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 77789999999999988776 4799999999999999999999999999998889888876654 357899999999
Q ss_pred HhhhhCCCCCCCHHHHh---hhh
Q psy2648 278 KFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+||+.||.+|||+++++ |+.
T Consensus 325 ~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHcCCChhhCCCHHHHhcCcCcC
Confidence 99999999999999987 765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=408.47 Aligned_cols=249 Identities=28% Similarity=0.475 Sum_probs=220.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEc-------CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHV-------PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIE 115 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 115 (708)
..++|++.+.||+|+||.||+|++. .++..||||+++.. ......+.+.+|+++|+.+ +|||||++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 4578999999999999999999975 34568999999754 3345567889999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
+.+.+||||||+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999998753 478999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRE 255 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~ 255 (708)
.++.+||+|||+++...... ......+|+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..++..
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999998654322 22345678899999999988775 89999999999999999 999999999888888
Q ss_pred HHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..+. ...|..+++++.+||.+||..||.+||+++++.
T Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 356 (370)
T 2psq_A 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356 (370)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 887774 356778899999999999999999999999877
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=405.19 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=216.1
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET------- 116 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 116 (708)
.+++|++++.||+|+||.||+|++..+++.||||++............+.+|+++|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4789999999999999999999999999999999997765544445567899999999999999999999987
Q ss_pred -CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 -EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 -~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
.+.+||||||+++ +|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4568999999986 777777654 5799999999999999999999999999999999999999999999999999976
Q ss_pred cCC-----CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q psy2648 195 FTP-----GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY-- 267 (708)
Q Consensus 195 ~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~-- 267 (708)
+.. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 542 2233557899999999999875544689999999999999999999999998887776665422111110
Q ss_pred ------------------------------CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 268 ------------------------------MSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 268 ------------------------------~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.++++.+||.+||+.||.+|||+++++ |+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 267899999999999999999999988 7753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=417.61 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=196.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-----EKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 119 (708)
.++|++++.||+|+||.||+|++..+++.||||++.+........+++.+|+++|+.++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999999999999999998766566667889999999999999999999999843 357
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG- 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~- 198 (708)
+||||||+. ++|.+++.....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999999985 699999988888999999999999999999999999999999999999999999999999999865321
Q ss_pred ---------------------------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-----------
Q psy2648 199 ---------------------------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS----------- 240 (708)
Q Consensus 199 ---------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt----------- 240 (708)
......+||+.|+|||++......+.++|||||||+||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 123456899999999987544333589999999999999999
Q ss_pred CCCCCCCCCH--------------------HHHHHHHHc--CCC-----------------------------CCCCCCC
Q psy2648 241 GSLPFDGSTL--------------------RELRERVLR--GKY-----------------------------RIPFYMS 269 (708)
Q Consensus 241 G~~Pf~~~~~--------------------~~l~~~i~~--~~~-----------------------------~~p~~~s 269 (708)
|..||.+.+. .+....|.. |.. ......+
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 7777876541 111111110 000 0112458
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+++.+||++||..||.+|||+++++ |+..
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 9999999999999999999999998 7764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=391.79 Aligned_cols=251 Identities=31% Similarity=0.593 Sum_probs=223.8
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKTL 120 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 120 (708)
...++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 45679999999999999999999999999999999998877666677789999999999999999999998754 5789
Q ss_pred EEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQKK-----IIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~QI~~aL~yLH~~g-----IvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
|+||||+++++|.+++.... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997643 4999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCC-CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q psy2648 192 SNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMS 269 (708)
Q Consensus 192 s~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s 269 (708)
+....... .....+|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..++...+..+.+ .+|...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred heeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence 87654332 22356799999999999888774 899999999999999999999999999999899988876 5677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++.+||.+||..||.+||+++++.
T Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~ll 266 (279)
T 2w5a_A 242 DELNEIITRMLNLKDYHRPSVEEIL 266 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHH
Confidence 9999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=399.92 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=220.9
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
..+...++|++.+.||+|+||.||+|++..+++ .||||++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 344556799999999999999999999986665 49999997543 44556778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
.+.+||||||+++|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999755 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Q psy2648 196 TPGNK----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMS 269 (708)
Q Consensus 196 ~~~~~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s 269 (708)
..... .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+ ....|..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 43221 2234567789999999888774 79999999999999999 99999999999998888876 345677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++.+||.+||..||.+|||++++.
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil 305 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIV 305 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999999999999999887
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=401.81 Aligned_cols=248 Identities=37% Similarity=0.675 Sum_probs=224.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC--Chh----hHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL--NPG----SLQKLFREVRIMKML-DHPNIVKLFQVIETEK 118 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~--~~~----~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 118 (708)
++|++.+.||+|+||.||+|.+..+|+.||||++..... ... ..+.+.+|+.+++.+ +||||++++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999999999999999976542 222 235677999999999 7999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999887766
Q ss_pred CCccccccCCcccccccccCC------ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCC
Q psy2648 199 NKLDTFCGSPPYAAPELFQGK------KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYM 268 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~------~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~ 268 (708)
......+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||.+.+..++...+..+.+..+ ...
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 332 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred cccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence 667778999999999998632 34 4789999999999999999999999998888888888877654 367
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++++.+||.+||..||.+|||+++++
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell 358 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQAL 358 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 89999999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=391.01 Aligned_cols=250 Identities=36% Similarity=0.577 Sum_probs=223.1
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++++...+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 34689999999999999999999999999999999986432 2234678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCcEEEEeccCccccCCCCC
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl---d~~~~iKL~DFGls~~~~~~~~ 200 (708)
|||+++++|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..... ..
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~ 163 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GI 163 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BT
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Cc
Confidence 9999999999999988999999999999999999999999999999999999999 7889999999999875432 23
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENLL 276 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~Li 276 (708)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..+++++.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 4456899999999999888774 899999999999999999999999999999999988876543 45789999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+||..||.+|||+++++ |+.
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHcCCChhHCcCHHHHhcCcccc
Confidence 999999999999999987 775
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=410.09 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=207.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----KT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 119 (708)
.++|++++.||+|+||.||+|.+..+++.||||++.+........+++.+|+++|+.++|||||++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999999999999999987655666677899999999999999999999999776 57
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+||||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 999999987 5999999888889999999999999999999999999999999999999999999999999998654321
Q ss_pred -----------------------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcC-----------CCCC
Q psy2648 200 -----------------------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-----------SLPF 245 (708)
Q Consensus 200 -----------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG-----------~~Pf 245 (708)
.....+||+.|+|||++......+.++|||||||+||+|++| ..+|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 236689999999999975444335899999999999999985 4444
Q ss_pred CCCC------------------HH-----------------------HHHHHHHcCCCCCC-------CCCCHHHHHHHH
Q psy2648 246 DGST------------------LR-----------------------ELRERVLRGKYRIP-------FYMSTDCENLLK 277 (708)
Q Consensus 246 ~~~~------------------~~-----------------------~l~~~i~~~~~~~p-------~~~s~~~~~Li~ 277 (708)
.+.+ .. .....+.......+ ...++++.+||+
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 4432 01 11111111111111 347899999999
Q ss_pred HhhhhCCCCCCCHHHHh---hhhh
Q psy2648 278 KFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+||+.||.+|||+++++ |+..
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHhcCCcccCCCHHHHhcChhhhh
Confidence 99999999999999998 7754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=400.38 Aligned_cols=248 Identities=28% Similarity=0.480 Sum_probs=211.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK--TLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~yl 122 (708)
-++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+++|+.++||||+++++++.... .+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4579999999999999999999999999999999975432 223566789999999999999999999998765 7899
Q ss_pred EEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCcEEEEeccCcccc
Q psy2648 123 VMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL----DSEMNIKIADFGFSNEF 195 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~---l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl----d~~~~iKL~DFGls~~~ 195 (708)
||||+++++|.+++..... +++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999986543 9999999999999999999999999999999999999 78888999999999887
Q ss_pred CCCCCccccccCCccccccccc--------CCccCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCC-
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQ--------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGS----TLRELRERVLRGKY- 262 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~--------~~~~~~~~~DIWSlGvilyelltG~~Pf~~~----~~~~l~~~i~~~~~- 262 (708)
.........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||... ...++..++..+..
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 6666667788999999999986 3455 47999999999999999999999743 23455555655432
Q ss_pred ------------------CCC------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 ------------------RIP------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 ------------------~~p------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+| ..++..+.+||.+||+.||++|||+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell 301 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhh
Confidence 111 12345788999999999999999999988
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=386.28 Aligned_cols=255 Identities=38% Similarity=0.648 Sum_probs=227.1
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC---Ch----hhHHHHHHHHHHHHhCC-CCCeeeEEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL---NP----GSLQKLFREVRIMKMLD-HPNIVKLFQV 113 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~---~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~ 113 (708)
....++|++.+.||+|+||.||+|.+..+++.||||+++.... .. ...+.+.+|+++|+++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3456799999999999999999999999999999999976542 11 22456789999999995 9999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
++....+|+||||+++++|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccCCccccccccc------CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-
Q psy2648 194 EFTPGNKLDTFCGSPPYAAPELFQ------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF- 266 (708)
Q Consensus 194 ~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~- 266 (708)
...........+|++.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+..++...+..+.+..+.
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 776666667788999999999985 2334 47999999999999999999999999998888888888766543
Q ss_pred ---CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 267 ---YMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 267 ---~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..+.++.+||.+||..||.+|||+++++ |+.
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 4788999999999999999999999987 654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=393.39 Aligned_cols=248 Identities=27% Similarity=0.499 Sum_probs=220.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++...+.+|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 58999999999999999999999999999999976542 3356688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~~ 205 (708)
+++++|.+++. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+
T Consensus 124 ~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 124 LQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp CCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence 99999999875 467999999999999999999999999999999999999999999999999998765433 2345678
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHhhhh
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---IPFYMSTDCENLLKKFLVL 282 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~ 282 (708)
||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+...... .+..+++++.+||.+||..
T Consensus 203 gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp SCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred CCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence 99999999999888774 7999999999999999999999999888888877765432 2335789999999999999
Q ss_pred CCCCCCCHHHHh---hhhh
Q psy2648 283 NPAKRASLEVSG---EVTL 298 (708)
Q Consensus 283 dP~~Rps~~~~~---~~~~ 298 (708)
||.+|||+++++ |+..
T Consensus 282 dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 282 DPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp STTTSCCHHHHHTSGGGGG
T ss_pred ChhhCcCHHHHhcChhhcc
Confidence 999999999987 6653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=404.84 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=208.1
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK----- 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 118 (708)
..++|++++.||+|+||.||+|.+..+++.||||++.+........+.+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 467999999999999999999999999999999999876656666678899999999999999999999998765
Q ss_pred -EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 -TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 -~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
.+||||||+.+ +|.+++. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 79999999985 7888775 5699999999999999999999999999999999999999999999999999987655
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--------------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-------------- 263 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-------------- 263 (708)
.......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+......
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp ----------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 4445667899999999999988875 7999999999999999999999998887777666543110
Q ss_pred ----------------------CCCC------CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 264 ----------------------IPFY------MSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 264 ----------------------~p~~------~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
+|.. .++++.+||++||+.||.+|||+++++ |+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0100 156789999999999999999999988 87643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=398.49 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=218.1
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.-..+++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+++++.++||||+++++++.+.+.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 34457899999999999999999999999999999999977665555566788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~ 199 (708)
|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999999998887778899999999999999999999999999999999999999999999999999976543 23
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------------- 260 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------------- 260 (708)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 3456789999999999987644468999999999999999999999988776655444321
Q ss_pred CCCCC------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 KYRIP------------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 ~~~~p------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
....| ..+++++.+||.+||..||.+|||+++++ |+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 01111 24688999999999999999999999987 7753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=387.99 Aligned_cols=253 Identities=38% Similarity=0.679 Sum_probs=228.3
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||+|++..+++.||||++.+........+.+.+|+++++.++||||+++++++.....+|+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999999999999999998765444556788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CcEEEEeccCccccCCCC
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---MNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~~iKL~DFGls~~~~~~~ 199 (708)
||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999999999888899999999999999999999999999999999999999764 469999999998766555
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENL 275 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~L 275 (708)
......|++.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..++...+..+.+..+ ..+++++.+|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred ccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 55667899999999999875 4 4799999999999999999999999999999999988876544 3578999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|.+||..||.+|||+++++ |+.
T Consensus 257 i~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHcccChhhCcCHHHHhcCHHHh
Confidence 9999999999999999987 665
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=405.62 Aligned_cols=258 Identities=32% Similarity=0.581 Sum_probs=223.2
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChhhHHHHHHHHHHHHhC-CCCCeeeEEEE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKML-DHPNIVKLFQV 113 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 113 (708)
.....+++|++++.||+|+||.||+|++. .+++.||||++++... .....+.+.+|+++|+.+ +||||++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 34455789999999999999999999985 5899999999975432 112234566899999999 69999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
++.+..+||||||+++|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999999988999999999999999999999999999999999999999999999999999997
Q ss_pred ccCCC--CCccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHHcCCCCCCC
Q psy2648 194 EFTPG--NKLDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYRIPF 266 (708)
Q Consensus 194 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~----~~~~~l~~~i~~~~~~~p~ 266 (708)
.+... ......+||+.|+|||++.+.. ..+.++|||||||+||+|++|..||.. ....++...+......+|.
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence 65332 2234578999999999998632 235789999999999999999999974 3456777788888888888
Q ss_pred CCCHHHHHHHHHhhhhCCCCCC-----CHHHHh---hhh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rp-----s~~~~~---~~~ 297 (708)
.++..+.+||.+||..||.+|| ++++++ |+.
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 9999999999999999999999 888887 554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=395.88 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=211.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+++|+.++||||+++++++.+++.+|+|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 357899999999999999999999999999999998542 455667889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q psy2648 124 MEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-- 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-- 200 (708)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999999987 46799999999999999999999999999999999999999999999999999976533221
Q ss_pred -------------ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHcCCC
Q psy2648 201 -------------LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE-----LRERVLRGKY 262 (708)
Q Consensus 201 -------------~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~-----l~~~i~~~~~ 262 (708)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||....... ....... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--~ 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--R 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--H
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--c
Confidence 1256899999999999988875 79999999999999999999987532110 0001111 1
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 ~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..|..+++++.+||.+||..||++|||++++.
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~ 274 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 24667889999999999999999999999887
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=391.80 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=207.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||+||+|++..+++.||||++...............|+..+..+ +||||+++++++++.+.+||||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 679999999999999999999999999999999877655555555666777666555 8999999999999999999999
Q ss_pred eccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 125 EYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||+ +++|.+++...+ .+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 999 669999887654 599999999999999999999999999999999999999999999999999987665555566
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHhhh
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY--RIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~--~~p~~~s~~~~~Li~~~L~ 281 (708)
.+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.. ....+..+.. .++..+++++.+||.+||+
T Consensus 216 ~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 216 QEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp CCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred cCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHHcC
Confidence 789999999999987 45 479999999999999999976665432 2333444432 2345789999999999999
Q ss_pred hCCCCCCCHHHHh---hhh
Q psy2648 282 LNPAKRASLEVSG---EVT 297 (708)
Q Consensus 282 ~dP~~Rps~~~~~---~~~ 297 (708)
.||++|||+++++ |++
T Consensus 291 ~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 291 PDPKLRATAEALLALPVLR 309 (311)
T ss_dssp SSTTTSCCHHHHHTSGGGS
T ss_pred CChhhCcCHHHHHhCcccc
Confidence 9999999999987 653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=399.13 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=221.4
Q ss_pred CccCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEE
Q psy2648 43 PHIGKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTL 120 (708)
Q Consensus 43 ~~~~~Y~i~-~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 120 (708)
..-++|.+. +.||+|+||.||+|.+..+++.||||++.+..........+.+|+.+++.+. ||||+++++++++...+
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 345678888 8999999999999999999999999999876555555678899999999995 69999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCcEEEEeccCcccc
Q psy2648 121 YLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEF 195 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~~iKL~DFGls~~~ 195 (708)
|+||||+.+|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999988543 67999999999999999999999999999999999999998 789999999999877
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTD 271 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~ 271 (708)
.........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.......+ ..++++
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 655556677899999999999988775 799999999999999999999999998888888877655443 357899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+.+||.+||+.||.+|||+++++ |+.
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 99999999999999999999988 765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=406.26 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=220.3
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEE-----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEE
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAK-----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 113 (708)
...+...++|++++.||+|+||.||+|+ +..+++.||||++... ........+.+|+.+|+.++|||||+++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3344556789999999999999999999 5567889999999643 234455678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---c
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM---N 183 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~-------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~---~ 183 (708)
+.+....|||||||++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 999999999999999999999998763 489999999999999999999999999999999999999655 5
Q ss_pred EEEEeccCccccCC---CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q psy2648 184 IKIADFGFSNEFTP---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLR 259 (708)
Q Consensus 184 iKL~DFGls~~~~~---~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~ 259 (708)
+||+|||+++.... .......+||+.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..++...+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999975421 1233456789999999999887774 89999999999999998 9999999999999999887
Q ss_pred CC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 260 GK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 260 ~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+. ...|..++.++.+||.+||+.||.+||+++++.
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil 337 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 75 456778899999999999999999999999887
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=400.64 Aligned_cols=253 Identities=37% Similarity=0.582 Sum_probs=216.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCC---CChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQ---LNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.++|++.+.||+|+||.||+|.+..+++.||||++.+.. ......+.+.+|+++|+.++||||+++++++++.+.+|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 358999999999999999999999999999999997542 23455678899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q psy2648 122 LVMEYASGGEVFDYLVL----------------------------------------HGRMKEKEARAKFRQIVSAVQYC 161 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~i~~QI~~aL~yL 161 (708)
||||||++|+|.+++.. ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998842 11236788899999999999999
Q ss_pred HHCCceecCCCCCCEEEcCCC--cEEEEeccCccccCCCC-----CccccccCCcccccccccC--CccCCCchhHHHHH
Q psy2648 162 HQKKIIHRDLKAENLLLDSEM--NIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLG 232 (708)
Q Consensus 162 H~~gIvHRDLKPeNILld~~~--~iKL~DFGls~~~~~~~-----~~~~~~Gt~~Y~APE~l~~--~~~~~~~~DIWSlG 232 (708)
|++||+||||||+|||++.++ .+||+|||++..+.... .....+||+.|+|||++.+ ..+ ++++||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG 263 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAG 263 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHHHH
Confidence 999999999999999998776 89999999997653211 2346789999999999975 444 5799999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 233 VILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 233 vilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
|++|+|++|..||.+.+..+....+..+...++. .+++++.+||.+||..||.+||++++++ |+..
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 9999999999999999998888888887665443 3789999999999999999999999987 7764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=404.00 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=210.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------C
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------K 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 118 (708)
.++|++++.||+|+||.||+|.+..+|+.||||++.+........+++.+|+++|+.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4689999999999999999999999999999999977655556667889999999999999999999999875 3
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~-- 179 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-- 179 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc--
Confidence 469999999 7899998865 689999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccCCcccccccccC-CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC-------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KY------------- 262 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~-~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~------------- 262 (708)
......+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+.+..+....|... ..
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 23456789999999999987 445 58999999999999999999999998876665555421 00
Q ss_pred ----------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 ----------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 ----------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.++...++++.+||.+||+.||.+|||+++++ |+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 12235689999999999999999999999987 6653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=396.44 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=212.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCCEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH--PNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~yl 122 (708)
-++|++++.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+|+.++| |||+++++++.+...+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34699999999999999999988 468999999998776666667788999999999987 999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--- 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--- 199 (708)
||| +.+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 999 56789999999999999999999999999999999999999999999999997 6789999999998764332
Q ss_pred CccccccCCcccccccccC-----------CccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcC--CCCCC
Q psy2648 200 KLDTFCGSPPYAAPELFQG-----------KKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLRG--KYRIP 265 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~-----------~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~~--~~~~p 265 (708)
.....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.. .......+... ...+|
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 2346789999999999864 334 478999999999999999999998743 33334444433 34567
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
...+.++.+||.+||+.||.+|||+++++ |+...
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 77889999999999999999999999988 87654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=404.02 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=214.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCEEEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD--HPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~ylVm 124 (708)
+|++++.||+|+||.||+|.+.. ++.||||++.+........+.+.+|+++|+.++ |||||++++++..++.+||||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 59999999999999999999865 999999999877666667788999999999997 599999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---Cc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KL 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~---~~ 201 (708)
| +.+++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.+.... ..
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence 9 67889999999988999999999999999999999999999999999999996 5889999999998764432 23
Q ss_pred cccccCCcccccccccCC-----------ccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCC--CCCCC
Q psy2648 202 DTFCGSPPYAAPELFQGK-----------KYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLRGKY--RIPFY 267 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~-----------~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~~~~--~~p~~ 267 (708)
...+||+.|+|||++.+. .| +.++|||||||+||+|++|..||.+.. .......+..... .+|..
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCC
T ss_pred CCCCcCCCccChHHhhhccccccccccccCC-CChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCcc
Confidence 567899999999999752 34 478999999999999999999998753 3345555665543 45677
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.+.++.+||.+||..||.+|||+++++ |+...
T Consensus 293 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred chHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 789999999999999999999999988 87643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=381.72 Aligned_cols=246 Identities=23% Similarity=0.352 Sum_probs=214.3
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~y 121 (708)
...++|++.+.||+|+||.||+|.+..+++.||||++.+..........+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 345689999999999999999999999999999999987665555667888999999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC----------------
Q psy2648 122 LVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---------------- 181 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---------------- 181 (708)
|||||+++++|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999765 679999999999999999999999999999999999999844
Q ss_pred ---CcEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy2648 182 ---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL 258 (708)
Q Consensus 182 ---~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~ 258 (708)
..+||+|||++...... ...+||+.|+|||++.+....++++|||||||++|+|++|..||.... ....+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~ 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHH
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHH
Confidence 47999999998765432 345799999999999876444579999999999999999998876543 234455
Q ss_pred cCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 RGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 ~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.. .+|..+++++.+||.+||..||.+|||+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 5544 56778999999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=398.09 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=221.4
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
...++|++.+.||+|+||.||+|++. .+++.||||++.+.. .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 34578999999999999999999997 456899999997543 344566789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH------------------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 173 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~------------------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKP 173 (708)
+.+||||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999999874 5689999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCccccCCC---CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q psy2648 174 ENLLLDSEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGST 249 (708)
Q Consensus 174 eNILld~~~~iKL~DFGls~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~ 249 (708)
+|||++.++.+||+|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999998755322 122345788999999999887774 89999999999999999 999999999
Q ss_pred HHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 250 LRELRERVLRGKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 250 ~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..++...+..+.. ..|..+++++.+||.+||..||.+||+++++.
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~ 327 (343)
T 1luf_A 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327 (343)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 9999988888765 46778899999999999999999999999887
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=396.36 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=206.3
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK----- 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 118 (708)
.+++|++++.||+|+||.||+|+++.+++.||||++.... .....+.+.+|+++|+.++|||||++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 4578999999999999999999999999999999997654 3345577899999999999999999999986543
Q ss_pred ----------------------------------------------------EEEEEEeccCCCChHHHHHHcCC---CC
Q psy2648 119 ----------------------------------------------------TLYLVMEYASGGEVFDYLVLHGR---MK 143 (708)
Q Consensus 119 ----------------------------------------------------~~ylVmEy~~gg~L~~~i~~~~~---l~ 143 (708)
.+|+|||||++++|.+++..... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987654 45
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-------------CccccccCCcc
Q psy2648 144 EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-------------KLDTFCGSPPY 210 (708)
Q Consensus 144 e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-------------~~~~~~Gt~~Y 210 (708)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 66789999999999999999999999999999999999999999999998765431 23446899999
Q ss_pred cccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCHHHHHHHHHhhhhCCCCCCC
Q psy2648 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI-PFYMSTDCENLLKKFLVLNPAKRAS 289 (708)
Q Consensus 211 ~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~Rps 289 (708)
+|||++.+..++ .++|||||||++|+|++|..|+.. ...+...+....++. +...++++.+||.+||..||.+|||
T Consensus 243 ~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 999999988874 899999999999999999887632 233444444443322 2345788999999999999999999
Q ss_pred HHHHh
Q psy2648 290 LEVSG 294 (708)
Q Consensus 290 ~~~~~ 294 (708)
+++++
T Consensus 320 ~~~~l 324 (332)
T 3qd2_B 320 ATDII 324 (332)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=397.21 Aligned_cols=253 Identities=30% Similarity=0.467 Sum_probs=208.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+++|+.++||||+++++++.+.+.+||||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 46899999999999999999999999999999999754321 11123457999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCcc
Q psy2648 125 EYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKLD 202 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~~ 202 (708)
||+. |+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 9998 58999988764 589999999999999999999999999999999999999999999999999876542 23344
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC-----------------C
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KY-----------------R 263 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~-----------------~ 263 (708)
..+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... .. .
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 5689999999999987544458999999999999999999999999888776666441 00 0
Q ss_pred -----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 264 -----------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 264 -----------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.+..+++++.+||.+||+.||.+|||+++++ |+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 1124678999999999999999999999998 87643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=397.57 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=212.7
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-----CCCeeeEEEEEEe
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-----HPNIVKLFQVIET 116 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~ 116 (708)
...-++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+|+.+. |||||++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34457899999999999999999999999999999999642 344556778999999986 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--------------
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-------------- 180 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-------------- 180 (708)
.+.+||||||+ +++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 899999998764 5999999999999999999999999999999999999975
Q ss_pred -----------CCcEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q psy2648 181 -----------EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST 249 (708)
Q Consensus 181 -----------~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~ 249 (708)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78899999999976432 33567899999999999988875 89999999999999999999999988
Q ss_pred HHHHHHHHHcCCCCCC--------------------------C--------------------CCCHHHHHHHHHhhhhC
Q psy2648 250 LRELRERVLRGKYRIP--------------------------F--------------------YMSTDCENLLKKFLVLN 283 (708)
Q Consensus 250 ~~~l~~~i~~~~~~~p--------------------------~--------------------~~s~~~~~Li~~~L~~d 283 (708)
..+....+......+| . ..++++.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 7776666544322222 1 12367889999999999
Q ss_pred CCCCCCHHHHh
Q psy2648 284 PAKRASLEVSG 294 (708)
Q Consensus 284 P~~Rps~~~~~ 294 (708)
|.+|||+++++
T Consensus 344 P~~Rpta~elL 354 (360)
T 3llt_A 344 PTLRPSPAELL 354 (360)
T ss_dssp GGGSCCHHHHT
T ss_pred hhhCCCHHHHh
Confidence 99999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=381.72 Aligned_cols=248 Identities=18% Similarity=0.328 Sum_probs=220.6
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--C
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--K 118 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 118 (708)
.+..+++|++.+.||+|+||.||+|++. ++.||||++..........+.+.+|+.+|+.++||||+++++++.+. .
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 4556789999999999999999999984 88999999988766666777899999999999999999999999887 7
Q ss_pred EEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
.+|+||||+++|+|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8999999999999999998765 4899999999999999999999999 99999999999999999999999998754
Q ss_pred cCCCCCccccccCCcccccccccCCccCCC--chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCH
Q psy2648 195 FTPGNKLDTFCGSPPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--YRIPFYMST 270 (708)
Q Consensus 195 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~--~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~~~p~~~s~ 270 (708)
.. ....+||+.|+|||++.+..+... ++|||||||++|+|++|+.||.+.+..+....+.... ..+|..+++
T Consensus 163 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 163 FQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp TS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred ec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 32 234578999999999988765432 7999999999999999999999998888777766553 346778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||..||.+|||++++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il 262 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIV 262 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHH
Confidence 999999999999999999999887
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=390.07 Aligned_cols=255 Identities=32% Similarity=0.569 Sum_probs=221.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC--hhhHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKMLDHPNIVKLFQVIE--TEKT 119 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~ 119 (708)
.+++|++.+.||+|+||.||+|.+..+++.||||++.+.... ....+.+.+|+++++.++||||+++++++. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 468999999999999999999999999999999999764321 234567889999999999999999999984 4567
Q ss_pred EEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 120 LYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
+||||||+.++ |.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999999987 7777765 35699999999999999999999999999999999999999999999999999976542
Q ss_pred ---CCCccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Q psy2648 198 ---GNKLDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCE 273 (708)
Q Consensus 198 ---~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~ 273 (708)
........||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+..++.+.+..+.+.+|...++++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 22234567999999999997643 23578999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
+||.+||..||.+|||++++. |+...
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999987 77653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=406.81 Aligned_cols=251 Identities=30% Similarity=0.478 Sum_probs=220.8
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||+|++..+++.||||++... ......+.+.+|+++|+.++|||||++++++..++.+||
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3456899999999999999999999999999999998754 334455678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCc
Q psy2648 123 VMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~ 201 (708)
||||+++|+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....+...
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999999998764 6999999999999999999999999999999999999999999999999999764332111
Q ss_pred ---cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q psy2648 202 ---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLL 276 (708)
Q Consensus 202 ---~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li 276 (708)
....+++.|+|||++.+..++ .++|||||||+||||++ |..||.+.+..++.+.+..+. ...|..+++++.+||
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 122356789999999877774 79999999999999998 999999999988888887763 456778899999999
Q ss_pred HHhhhhCCCCCCCHHHHhh
Q psy2648 277 KKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~~ 295 (708)
.+||..||.+|||++++..
T Consensus 349 ~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999998873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=384.92 Aligned_cols=250 Identities=35% Similarity=0.589 Sum_probs=216.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.+++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 46789999999999999999999999999999999975433 23456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC---CC
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---NK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~---~~ 200 (708)
|||+++++|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 999999999999987778999999999999999999999999999999999999999999999999998765322 22
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCC--CCCCHHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLRGKYRIP--FYMSTDCENLLK 277 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~-~l~~~i~~~~~~~p--~~~s~~~~~Li~ 277 (708)
....+|++.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.. .....+.......+ ...++++.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence 456789999999999988776567899999999999999999999876532 22333333332222 357899999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||..||.+|||++++.
T Consensus 244 ~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 244 KILVENPSARITIPDIK 260 (276)
T ss_dssp HHSCSSTTTSCCHHHHT
T ss_pred HHCCCCchhCCCHHHHh
Confidence 99999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=400.54 Aligned_cols=251 Identities=28% Similarity=0.484 Sum_probs=222.7
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCC-------cEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTG-------KEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQV 113 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 113 (708)
+...++|++.+.||+|+||.||+|++..++ ..||||++... ......+.+.+|+++++.+ +|||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 444578999999999999999999986433 57999999765 3455667889999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 177 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNIL 177 (708)
+.+.+.+||||||+++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999998764 4999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q psy2648 178 LDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253 (708)
Q Consensus 178 ld~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l 253 (708)
++.++.+||+|||+++...... ......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999998664332 23445678899999999988774 89999999999999999 9999999999999
Q ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 254 RERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 254 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+.+..+. ...|..+++++.+||.+||..||.+|||++++.
T Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 98888774 456778899999999999999999999999887
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=390.59 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=221.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
+....+|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+++|+.++||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 444578999999999999999999984 456899999997543 45566788999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGR------------------------MKEKEARAKFRQIVSAVQYCHQKKIIHRDLK 172 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~------------------------l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLK 172 (708)
.+.+|+||||+++++|.+++..... +++.+++.++.||+.||+|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 9999999999999999999987543 8999999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q psy2648 173 AENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGS 248 (708)
Q Consensus 173 PeNILld~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~ 248 (708)
|+|||++.++.+||+|||++....... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997654332 12345678899999999887774 89999999999999999 99999999
Q ss_pred CHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 249 TLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 249 ~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+..++...+..+. ...|..+++++.+||.+||..||.+||+++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 8888888887764 346778899999999999999999999999876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=385.13 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=201.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+...++|++.+.||+|+||.||+|++..+++.||||++..........+.+.++...++.++||||+++++++.+++.+|
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 34567899999999999999999999999999999999765433333344455566688899999999999999999999
Q ss_pred EEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 122 LVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
+||||+++ +|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999985 88777654 46799999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccCCcccccccc----cCCccCCCchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHcCCCCCC-CCCC
Q psy2648 197 PGNKLDTFCGSPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--STLRELRERVLRGKYRIP-FYMS 269 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l----~~~~~~~~~~DIWSlGvilyelltG~~Pf~~--~~~~~l~~~i~~~~~~~p-~~~s 269 (708)
........+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.. .....+...+.......+ ...+
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred ccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 55555566899999999997 34444 5799999999999999999999985 333444455555444444 3688
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+++.+||.+||+.||.+|||+++++ |+..
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 9999999999999999999999987 7753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=412.73 Aligned_cols=251 Identities=39% Similarity=0.628 Sum_probs=207.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC------hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN------PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
.++|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+++|++++|||||+++++++. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 47899999999999999999999999999999999865321 1122347899999999999999999999865 5
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---cEEEEeccCcccc
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM---NIKIADFGFSNEF 195 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~---~iKL~DFGls~~~ 195 (708)
.+||||||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888999999999999999999999999999999999999997544 5999999999877
Q ss_pred CCCCCccccccCCcccccccccC---CccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCC----CC
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLRGKYRIP----FY 267 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~~~~~~p----~~ 267 (708)
.......+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.. ...+...+..+.+..+ ..
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp C-----------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred CCCccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 66656677899999999999864 334 468999999999999999999998653 3345667777766543 35
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+++++.+||.+||+.||.+|||+++++ |+.
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 789999999999999999999999987 653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=381.87 Aligned_cols=246 Identities=26% Similarity=0.453 Sum_probs=218.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
...+|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|++++++++||||+++++++.+...+|+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3468999999999999999999987 5778999999865433 35688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--C
Q psy2648 124 MEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--K 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~ 200 (708)
|||+++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999999999754 468999999999999999999999999999999999999999999999999997654321 2
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKK 278 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li~~ 278 (708)
.....+++.|+|||++.+..++ +++|||||||++|+|++ |..||.+.+..++...+..+ ....|...++++.+||.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 2345677889999999877774 89999999999999999 99999999999999888877 344567789999999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||.+||+++++.
T Consensus 243 ~l~~~p~~Rps~~~ll 258 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLL 258 (269)
T ss_dssp HTCSSGGGSCCHHHHH
T ss_pred HccCCcccCcCHHHHH
Confidence 9999999999999877
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=382.02 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=219.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET----EKTLYL 122 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~yl 122 (708)
.|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 5899999999999999999999999999999998776667777889999999999999999999999876 456899
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEc-CCCcEEEEeccCccccCCCC
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld-~~~~iKL~DFGls~~~~~~~ 199 (708)
||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... ..
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~-~~ 185 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS 185 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-cc
Confidence 9999999999999998899999999999999999999999999 99999999999998 78999999999986543 23
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGKY--RIPFYMSTDCENLL 276 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~~--~~p~~~s~~~~~Li 276 (708)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+...+...+..+.. .++...++++.+||
T Consensus 186 ~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 263 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp SBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred ccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHH
Confidence 34567899999999998754 4 4799999999999999999999987 455666666666533 24556789999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+||..||.+|||+++++ |+.
T Consensus 264 ~~~l~~dp~~Rps~~ell~h~~f~ 287 (290)
T 1t4h_A 264 EGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHccCChhhCCCHHHHhhCcccc
Confidence 999999999999999987 664
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=387.69 Aligned_cols=250 Identities=23% Similarity=0.449 Sum_probs=211.1
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEe--
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIET-- 116 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-- 116 (708)
..-...++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+++|+.++ ||||+++++++.+
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 3344467899999999999999999999999999999999643 2456889999999997 9999999999998
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCcccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEF 195 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~ 195 (708)
...+|+||||+.+++|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 678999999999999998874 589999999999999999999999999999999999999777 8999999999877
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHH-------------HHHHHHcCC
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRE-------------LRERVLRGK 261 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~-------------l~~~i~~~~ 261 (708)
.........+||+.|+|||++.+....+.++|||||||++|+|++|..||... +..+ +...+....
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 66666677899999999999987443458999999999999999999999543 2222 122222222
Q ss_pred CCC------------------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 262 YRI------------------------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 262 ~~~------------------------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
... +..+++++.+||.+||..||.+|||+++++ |+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 111 112689999999999999999999999988 665
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=378.18 Aligned_cols=248 Identities=28% Similarity=0.485 Sum_probs=218.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||+|++. ++..||||++...... .+.+.+|+++++.++||||+++++++.+...+|+
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 34568999999999999999999876 5778999999765433 3568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-
Q psy2648 123 VMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK- 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~- 200 (708)
||||+++++|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999999998765 499999999999999999999999999999999999999999999999999976544322
Q ss_pred -ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q psy2648 201 -LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLK 277 (708)
Q Consensus 201 -~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~ 277 (708)
.....+|+.|+|||++.+..++ +++|||||||++|+|++ |..||...+..+....+..+.. ..|...++++.+||.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY 239 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHH
Confidence 2234567789999999887775 79999999999999999 9999999999888888887754 456678999999999
Q ss_pred HhhhhCCCCCCCHHHHhh
Q psy2648 278 KFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~~ 295 (708)
+||..||.+|||++++..
T Consensus 240 ~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp HTTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999998873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.17 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=211.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylV 123 (708)
-++|++.+.||+|+||.||+|++..+++.||||++...... +.+.+|+++|+.| +||||+++++++......|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 35799999999999999999999999999999999765322 2477899999999 999999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-----EEEEeccCccccCC
Q psy2648 124 MEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-----IKIADFGFSNEFTP 197 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~-----iKL~DFGls~~~~~ 197 (708)
|||+ +++|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.+..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999 99999999874 68999999999999999999999999999999999999999887 99999999986543
Q ss_pred CCC--------ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHcCCCCCCC
Q psy2648 198 GNK--------LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---STLRELRERVLRGKYRIPF 266 (708)
Q Consensus 198 ~~~--------~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~---~~~~~l~~~i~~~~~~~p~ 266 (708)
... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ ....+....+.......|.
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 221 346789999999999998887 4899999999999999999999987 4455666666555444332
Q ss_pred ----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 ----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+++.+||.+||..||.+||+++++.
T Consensus 242 ~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~ 273 (330)
T 2izr_A 242 EVLCENFPEMATYLRYVRRLDFFEKPDYDYLR 273 (330)
T ss_dssp HHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHhccChHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 2234999999999999999999998876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.54 Aligned_cols=252 Identities=23% Similarity=0.425 Sum_probs=203.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
....++|++.+.||+|+||.||+|++..++. .||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445689999999999999999999887775 8999999876555566788999999999999999999999998876
Q ss_pred EE------EEEEeccCCCChHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEE
Q psy2648 119 TL------YLVMEYASGGEVFDYLVLHG------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186 (708)
Q Consensus 119 ~~------ylVmEy~~gg~L~~~i~~~~------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL 186 (708)
.. |+||||+.+|+|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 99999999999999997543 5999999999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCc---cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-
Q psy2648 187 ADFGFSNEFTPGNKL---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK- 261 (708)
Q Consensus 187 ~DFGls~~~~~~~~~---~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~- 261 (708)
+|||+++........ ....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 999999765443322 234567889999999888774 89999999999999999 999999988888888887764
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 ~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...|..+++++.+||.+||..||.+|||++++.
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 290 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 456778899999999999999999999988766
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.56 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=212.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCC-------cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTG-------KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.+.. ....+.+.+|+++|+.++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 4568999999999999999999998887 479999996542 3445678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--------EEEE
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN--------IKIA 187 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~--------iKL~ 187 (708)
.+..|+||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999999987654 999999999999999999999999999999999999998887 9999
Q ss_pred eccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy2648 188 DFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPF 266 (708)
Q Consensus 188 DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~~p~ 266 (708)
|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++ |..||...+...... +......+|.
T Consensus 164 Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (289)
T 4fvq_A 164 DPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQLPA 239 (289)
T ss_dssp CCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCCCCC
T ss_pred cCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCCCCC
Confidence 9999865432 2345789999999999874434689999999999999999 566666666555443 4445567777
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..++++.+||.+||+.||.+|||++++.
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll 267 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAII 267 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 7889999999999999999999999988
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=401.19 Aligned_cols=247 Identities=30% Similarity=0.429 Sum_probs=209.7
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET------- 116 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 116 (708)
..++|++.+.||+|+||.||+|++..+|+.||||++...... ..+|+++|+.++|||||++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 356899999999999999999999999999999998754321 2379999999999999999999844
Q ss_pred -------------------------------CCEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Q psy2648 117 -------------------------------EKTLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYC 161 (708)
Q Consensus 117 -------------------------------~~~~ylVmEy~~gg~L~~~i~----~~~~l~e~~~~~i~~QI~~aL~yL 161 (708)
...+|+||||+++ +|.+.+. ....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458999999985 7766654 356799999999999999999999
Q ss_pred HHCCceecCCCCCCEEEc-CCCcEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc
Q psy2648 162 HQKKIIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 240 (708)
Q Consensus 162 H~~gIvHRDLKPeNILld-~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt 240 (708)
|++||+||||||+|||++ .++.+||+|||+++...........+||+.|+|||++.+....+.++|||||||++|+|++
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999999998 6889999999999877666666678899999999999876534589999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcC-----------------CCC------------CCCCCCHHHHHHHHHhhhhCCCCCCCHH
Q psy2648 241 GSLPFDGSTLRELRERVLRG-----------------KYR------------IPFYMSTDCENLLKKFLVLNPAKRASLE 291 (708)
Q Consensus 241 G~~Pf~~~~~~~l~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~ 291 (708)
|+.||.+.+..+....+... ... +|...++++.+||.+||+.||.+|||++
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999998877666555421 011 3456789999999999999999999999
Q ss_pred HHh---hhh
Q psy2648 292 VSG---EVT 297 (708)
Q Consensus 292 ~~~---~~~ 297 (708)
+++ |+.
T Consensus 318 e~l~hp~f~ 326 (383)
T 3eb0_A 318 EAMAHPFFD 326 (383)
T ss_dssp HHHTSGGGH
T ss_pred HHhcCHHHH
Confidence 987 765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=387.02 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=210.7
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
.....+++|++.+.||+|+||.||+|.+..+++.||||++.+... .....+.+.+|+.+++.++||||+++++++..++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 445668999999999999999999999999999999999976543 2344567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHH
Q psy2648 199 N--KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCE 273 (708)
Q Consensus 199 ~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---~~p~~~s~~~~ 273 (708)
. .....+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+..... ..+..+++++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 2 23456899999999999887764 799999999999999999999998877766666654432 24557889999
Q ss_pred HHHHHhhhhCCCCCC-CHHHHh
Q psy2648 274 NLLKKFLVLNPAKRA-SLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rp-s~~~~~ 294 (708)
+||.+||..||.+|| +++++.
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHH
Confidence 999999999999999 888877
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=393.49 Aligned_cols=247 Identities=30% Similarity=0.434 Sum_probs=216.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
..|++++.||+|+||.||+|++..+++.||||++...... ....+.+.+|+++|+.++|||||++++++.+++.+||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999999999999999999865433 344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 125 EYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||+. |+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence 9998 578887754 46799999999999999999999999999999999999999999999999999976543 345
Q ss_pred cccCCccccccccc---CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Q psy2648 204 FCGSPPYAAPELFQ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCENLLKK 278 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~---~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~--~p~~~s~~~~~Li~~ 278 (708)
.+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+..+....+..+... .+...++++.+||.+
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 78999999999985 3445 47999999999999999999999998877766666665433 244678999999999
Q ss_pred hhhhCCCCCCCHHHHh---hhh
Q psy2648 279 FLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~---~~~ 297 (708)
||+.||.+|||+++++ |+.
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHH
T ss_pred HcccChhhCcCHHHHhhChhhh
Confidence 9999999999999987 665
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=395.38 Aligned_cols=255 Identities=27% Similarity=0.482 Sum_probs=218.9
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+++|+.++||||+++++++.+.+.+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3455678999999999999999999999999999999997653 455567789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
||||||+++++|.+++...+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..... .
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~ 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-S 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-H
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-c
Confidence 99999999999999999889999999999999999999999996 999999999999999999999999999865432 2
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----------------------
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRER----------------------- 256 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~----------------------- 256 (708)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..++...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 23456899999999999988775 899999999999999999999988766554322
Q ss_pred -------------------HHcCCC-CCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 257 -------------------VLRGKY-RIP-FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 257 -------------------i~~~~~-~~p-~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+..... ..| ..++.++.+||.+||..||.+|||+++++ |+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 222221 122 24688999999999999999999999988 7753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=381.51 Aligned_cols=249 Identities=24% Similarity=0.444 Sum_probs=216.9
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+....+|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+++|+.++||||+++++++.+.+.+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 3455678999999999999999999886 6778999999865433 35688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|+||||+++++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999976 4679999999999999999999999999999999999999999999999999997654321
Q ss_pred --CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 200 --KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+. ...|...++++.+|
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 12234567889999999877764 89999999999999998 999999999999888888774 34567789999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+|||++++.
T Consensus 254 i~~~l~~~p~~Rps~~~ll 272 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILL 272 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHH
T ss_pred HHHHccCChhHCcCHHHHH
Confidence 9999999999999999877
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=383.48 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=208.5
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
.+...++|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++. +
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 345567899999999999999999998754 4579999986542 3445667889999999999999999999984 5
Q ss_pred CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
+.+|+||||+++++|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 67899999999999999998664 69999999999999999999999999999999999999999999999999997664
Q ss_pred CCCC--ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHH
Q psy2648 197 PGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDC 272 (708)
Q Consensus 197 ~~~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~ 272 (708)
.... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|..+++++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 246 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 3322 2334577899999999877774 79999999999999996 999999988888888887764 45677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+||.+||..||.+|||++++.
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~ 268 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELK 268 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHH
Confidence 9999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.50 Aligned_cols=248 Identities=40% Similarity=0.647 Sum_probs=210.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC------hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN------PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
.++|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+++|+.++||||++++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35799999999999999999999999999999999765421 122345789999999999999999999998765
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---EEEEeccCcccc
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEF 195 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~---iKL~DFGls~~~ 195 (708)
+|+||||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988889999999999999999999999999999999999999987665 999999999876
Q ss_pred CCCCCccccccCCccccccccc---CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCC----CC
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGKYRIP----FY 267 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~~~~p----~~ 267 (708)
.........+||+.|+|||++. ...+ +.++|||||||++|+|++|..||..... ..+...+..+.+..+ ..
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred ccccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence 5444445678999999999974 3444 4799999999999999999999976543 245566666665432 46
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++++.+||.+||..||.+||++++++
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 789999999999999999999999887
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=382.66 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=217.0
Q ss_pred CccCCeEEEe-EEcccCceEEEEEEE--cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 43 PHIGKYKLLK-TIGKGNFAKVKLAKH--VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 43 ~~~~~Y~i~~-~LG~G~fg~V~la~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
....+|++.+ .||+|+||.||+|.+ ..+++.||||++..........+.+.+|+++++.++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456899998 999999999999954 56789999999987655555567889999999999999999999999 5567
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|+||||+++++|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999999999999988889999999999999999999999999999999999999999999999999997664432
Q ss_pred C----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 200 K----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 200 ~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
. .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|..+++++.
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 250 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 2 1234567889999999887764 79999999999999999 999999999999888888765 456778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+||+++++.
T Consensus 251 ~li~~~l~~dp~~Rps~~~l~ 271 (291)
T 1xbb_A 251 DLMNLCWTYDVENRPGFAAVE 271 (291)
T ss_dssp HHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHH
Confidence 999999999999999999876
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=395.75 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=210.3
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh---hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP---GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
...++|++++.||+|+||.||+|.+..+|+.||||++....... ...+.+.+|+++|+.++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999999999999999997643321 122467899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP- 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~- 197 (708)
+|+||||+++ +|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999986 888888665 3689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC---CC--------
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KY---RI-------- 264 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~---~~-------- 264 (708)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+...++... .. ..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 334456789999999999976554458999999999999999999999998887777666542 10 00
Q ss_pred ---------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 265 ---------------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 265 ---------------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
....++++.+||++||..||.+|||+++++ |+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 134578999999999999999999999988 7754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=391.81 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=216.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEE--EEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEV--AIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKT 119 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~v--AvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 119 (708)
...++|++.+.||+|+||.||+|++..++..+ |||++.... .....+.+.+|+++|+.+ +||||+++++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 44679999999999999999999999999865 999987532 334456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN 183 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~ 183 (708)
+||||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999997654 6999999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-
Q psy2648 184 IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK- 261 (708)
Q Consensus 184 iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~- 261 (708)
+||+|||+++............+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+.
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 999999998754333333445678899999999887764 89999999999999998 999999999999888887763
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 262 YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 262 ~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...|..+++++.+||.+||..||.+|||++++.
T Consensus 260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 292 (327)
T 1fvr_A 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 456778899999999999999999999999887
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=379.64 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=212.7
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~y 121 (708)
..-++|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+++++.+ +||||+++++++......|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 345679999999999999999999999999999999975432 23467899999999 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-----EEEEeccCcccc
Q psy2648 122 LVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN-----IKIADFGFSNEF 195 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~-----iKL~DFGls~~~ 195 (708)
+||||+ +++|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 999999998764 5999999999999999999999999999999999999988776 999999999765
Q ss_pred CCCC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCC
Q psy2648 196 TPGN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKYRI 264 (708)
Q Consensus 196 ~~~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~~~~ 264 (708)
.... .....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+. ...+....+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 4322 2346789999999999998877 48999999999999999999999873 4555555554443222
Q ss_pred -----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 -----PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 -----p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+..+++++.+||.+||..||.+||+++++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~ 275 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 275 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 246789999999999999999999999887
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=396.24 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=213.1
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQV 113 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 113 (708)
..+...++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34455679999999999999999999983 466789999997543 233456788999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHG-----------------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~-----------------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRD 170 (708)
+...+.+||||||+++|+|.+++.... .+++.+++.++.||+.||+|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997653 278999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCC
Q psy2648 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFD 246 (708)
Q Consensus 171 LKPeNILld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~ 246 (708)
|||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++ +++|||||||++|+|++ |..||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999976543322 2345678899999999877764 89999999999999998 999998
Q ss_pred CCCHHHH-HHHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 247 GSTLREL-RERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 247 ~~~~~~l-~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+..+. ...+..+ ....|...++++.+||.+||..||.+|||++++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 326 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 8764443 3334433 3345777899999999999999999999999887
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=398.62 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=214.0
Q ss_pred CccCCeEEEeEEcccCceEEEEEE-----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAK-----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 116 (708)
...++|++.+.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+++|+.+ +|||||++++++..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 345789999999999999999999 55677999999997543 344567789999999999 79999999999987
Q ss_pred CC-EEEEEEeccCCCChHHHHHHcCC------------------------------------------------------
Q psy2648 117 EK-TLYLVMEYASGGEVFDYLVLHGR------------------------------------------------------ 141 (708)
Q Consensus 117 ~~-~~ylVmEy~~gg~L~~~i~~~~~------------------------------------------------------ 141 (708)
.+ .+|+|||||++|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 65 49999999999999999976543
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---Ccccccc
Q psy2648 142 ------------MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCG 206 (708)
Q Consensus 142 ------------l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~---~~~~~~G 206 (708)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 8999999999999999999999999999999999999999999999999998653322 2335678
Q ss_pred CCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHHHcC-CCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 207 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTL-RELRERVLRG-KYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 207 t~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~-~~l~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+. ..+...+..+ ....|...++++.+||.+||..|
T Consensus 258 t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp CGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 9999999999887775 89999999999999998 9999988653 3444444444 44577789999999999999999
Q ss_pred CCCCCCHHHHh
Q psy2648 284 PAKRASLEVSG 294 (708)
Q Consensus 284 P~~Rps~~~~~ 294 (708)
|.+|||++++.
T Consensus 337 P~~Rps~~ell 347 (359)
T 3vhe_A 337 PSQRPTFSELV 347 (359)
T ss_dssp GGGSCCHHHHH
T ss_pred hhhCCCHHHHH
Confidence 99999999877
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=379.86 Aligned_cols=250 Identities=29% Similarity=0.485 Sum_probs=223.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
..|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 469999999999999999999999999999999976543 2346778999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Ccccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~~ 204 (708)
|+++++|.+++. .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 101 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (303)
T 3a7i_A 101 YLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179 (303)
T ss_dssp CCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCC
T ss_pred eCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCcc
Confidence 999999999875 4689999999999999999999999999999999999999999999999999997654332 33567
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhhhhC
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~d 283 (708)
+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..++...+..+.. .++...+.++.+||.+||..|
T Consensus 180 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 258 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 258 (303)
T ss_dssp CSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSS
T ss_pred CCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCC
Confidence 899999999999888775 799999999999999999999999888887777766543 456678999999999999999
Q ss_pred CCCCCCHHHHh---hhhh
Q psy2648 284 PAKRASLEVSG---EVTL 298 (708)
Q Consensus 284 P~~Rps~~~~~---~~~~ 298 (708)
|.+|||++++. |+..
T Consensus 259 p~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 259 PSFRPTAKELLKHKFILR 276 (303)
T ss_dssp GGGSCCHHHHTTCHHHHH
T ss_pred hhhCcCHHHHhhChhhhc
Confidence 99999999987 6653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=384.79 Aligned_cols=250 Identities=29% Similarity=0.420 Sum_probs=208.9
Q ss_pred CCccCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAK----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
+...++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+++|+.++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3445789999999999999999999 5678999999999754 345567789999999999999999999998543
Q ss_pred --CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 118 --KTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 118 --~~~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
..+|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 56899999999999999998764 599999999999999999999999999999999999999999999999999986
Q ss_pred cCCCC----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHH
Q psy2648 195 FTPGN----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR----------------ELR 254 (708)
Q Consensus 195 ~~~~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~----------------~l~ 254 (708)
..... ......+++.|+|||++.+..++ .++|||||||++|+|++|..||...... .+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 64332 12334577789999999888774 8999999999999999999998753221 233
Q ss_pred HHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 255 ERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 255 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+..+ ....|..+++++.+||.+||..||.+|||++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~ 283 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 333333 4456778899999999999999999999999877
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=410.18 Aligned_cols=244 Identities=14% Similarity=0.188 Sum_probs=202.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHH---HHHhCCCCCeeeEE-------EE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVR---IMKMLDHPNIVKLF-------QV 113 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~ 113 (708)
.++|++.+.||+|+||.||+|++..+|+.||||++.+... .....+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4689999999999999999999999999999999986543 3445677889995 45566899999998 88
Q ss_pred EEeCCE-----------------EEEEEeccCCCChHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q psy2648 114 IETEKT-----------------LYLVMEYASGGEVFDYLVLHGRMKE-------KEARAKFRQIVSAVQYCHQKKIIHR 169 (708)
Q Consensus 114 ~~~~~~-----------------~ylVmEy~~gg~L~~~i~~~~~l~e-------~~~~~i~~QI~~aL~yLH~~gIvHR 169 (708)
+++.+. .||||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 876643 89999999 6799999988766766 7777899999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCcccccccccCC-----------ccCCCchhHHHHHHHHHHH
Q psy2648 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK-----------KYDGPEVDVWSLGVILYTL 238 (708)
Q Consensus 170 DLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~~~~~~DIWSlGvilyel 238 (708)
||||+|||++.++.+||+|||+++.. +......+| +.|+|||++.+. .| +.++|||||||+||+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHHH
Confidence 99999999999999999999999753 334556788 999999999877 66 4899999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 239 VSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 239 ltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
++|+.||.+.+..+....+. ..+..+++++.+||.+||+.||.+|||+++++ |+.
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred HHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 99999998766544433333 23356789999999999999999999999987 664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=386.53 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=209.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK- 118 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 118 (708)
...++|++.+.||+|+||.||+|.+.. +++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 334689999999999999999998875 5668999999877666666778999999999999999999999998754
Q ss_pred ----EEEEEEeccCCCChHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEe
Q psy2648 119 ----TLYLVMEYASGGEVFDYLVL------HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIAD 188 (708)
Q Consensus 119 ----~~ylVmEy~~gg~L~~~i~~------~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~D 188 (708)
..|+||||+++|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 35999999999999999853 24699999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CC
Q psy2648 189 FGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YR 263 (708)
Q Consensus 189 FGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~ 263 (708)
||++....... ......+++.|+|||++.+..++ +++|||||||++|+|++ |..||.+.+..++...+..+. ..
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 269 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence 99997654332 12335678899999999888774 89999999999999999 999999988888888887764 45
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 ~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.|..+++++.+||.+||..||.+|||++++.
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 300 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 6778899999999999999999999999877
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=402.76 Aligned_cols=250 Identities=28% Similarity=0.394 Sum_probs=207.5
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE---- 117 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 117 (708)
.+...+|++.+.||+|+||.||+|++..+++.||||++.+... ...+|+++|+.|+|||||++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 3445579999999999999999999999999999999975432 123799999999999999999998542
Q ss_pred --CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CcEEEEecc
Q psy2648 118 --KTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFG 190 (708)
Q Consensus 118 --~~~ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-~~iKL~DFG 190 (708)
..+++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 247899999986 66665542 4679999999999999999999999999999999999999965 568999999
Q ss_pred CccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------
Q psy2648 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR----------- 259 (708)
Q Consensus 191 ls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~----------- 259 (708)
+++....+......+||+.|+|||++.+....+.++|||||||+||||++|+.||.+.+..+....+..
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 998776655556778999999999997753335899999999999999999999999876655444432
Q ss_pred ------CCCCC------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 260 ------GKYRI------------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 260 ------~~~~~------------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
..+.+ +...++++.+||++||++||.+|||+++++ |+..
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 11122 235689999999999999999999999987 7753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=399.97 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=198.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------C
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE------K 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 118 (708)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+++.+|+++|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3689999999999999999999999999999999987655556677889999999999999999999999754 5
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 689999999 6899988764 6899999999999999999999999999999999999999999999999999976532
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C---------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K--------------- 261 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~--------------- 261 (708)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....|.+. .
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 3456789999999999987433358999999999999999999999998876665555431 0
Q ss_pred ------CCC--------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 262 ------YRI--------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 262 ------~~~--------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
... ....++++.+||++||+.||.+|||+++++ |+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 001 124678999999999999999999999988 7754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=400.42 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=209.8
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
.+....+|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 3455678999999999999999999987 567789999997543 445567789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
..+||||||+++|+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998764 69999999999999999999999999999999999999999999999999998654
Q ss_pred CCCC----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCH
Q psy2648 197 PGNK----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMST 270 (708)
Q Consensus 197 ~~~~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~ 270 (708)
.... .....+++.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..++...+..+. ...|..++.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 3221 1223457789999999887775 79999999999999998 999999999999888887763 345567889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||+.||.+||+++++.
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~ 301 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIV 301 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHH
Confidence 999999999999999999999887
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=381.92 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=223.0
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
+..+....+|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+++++.++||||+++++++.++.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 344556678999999999999999999999999999999997543 34567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
.+|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999999998753 48999999999999999999999999999999999999999999999999997654
Q ss_pred CCC--CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHH
Q psy2648 197 PGN--KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDC 272 (708)
Q Consensus 197 ~~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~ 272 (708)
... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+.+... ....|..+++++
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 332 22345678899999999887774 89999999999999999 99999998888887777766 345677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+||.+||..||.+|||++++.
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~ 263 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIH 263 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHH
Confidence 9999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=405.53 Aligned_cols=245 Identities=32% Similarity=0.523 Sum_probs=215.8
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-E
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-T 119 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~ 119 (708)
.+...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+++|++++|||||++++++.... .
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 3455678999999999999999999885 7899999997643 3456889999999999999999999987665 7
Q ss_pred EEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
+||||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999987754 79999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENL 275 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~L 275 (708)
. .....+++.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..++...+..+ ....|..+++++.+|
T Consensus 342 ~--~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 418 (450)
T 1k9a_A 342 T--QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred c--ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 2 2334678999999999988875 89999999999999998 99999998888888888776 345677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+|||++++.
T Consensus 419 i~~cl~~dp~~Rpt~~~l~ 437 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLR 437 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHH
T ss_pred HHHHcCCChhHCcCHHHHH
Confidence 9999999999999999887
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.61 Aligned_cols=248 Identities=31% Similarity=0.467 Sum_probs=205.5
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC--hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
...++|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+++++.++||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 35679999999999999999999984 889999998765332 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEEcC--------CCcEEEEec
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK---IIHRDLKAENLLLDS--------EMNIKIADF 189 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~g---IvHRDLKPeNILld~--------~~~iKL~DF 189 (708)
|+||||+++++|.+++. ...+++.++..++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998874 568999999999999999999999999 899999999999986 678999999
Q ss_pred cCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--CCCCC
Q psy2648 190 GFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY--RIPFY 267 (708)
Q Consensus 190 Gls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~--~~p~~ 267 (708)
|++....... .....||+.|+|||++.+..++ +++|||||||++|+|++|+.||.+.+.......+..... ..|..
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 9997654332 2356899999999999887764 899999999999999999999999988887777776654 45677
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
.++++.+||.+||..||.+|||++++..
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 8999999999999999999999998773
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=397.03 Aligned_cols=253 Identities=26% Similarity=0.485 Sum_probs=222.9
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh---------------hhHHHHHHHHHHHHhCC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP---------------GSLQKLFREVRIMKMLD 103 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~---------------~~~~~~~~Ei~il~~l~ 103 (708)
......+++|++.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+++++.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 44456678999999999999999999999 89999999997542211 11267889999999999
Q ss_pred CCCeeeEEEEEEeCCEEEEEEeccCCCChHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCC
Q psy2648 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDY------LVL--HGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAE 174 (708)
Q Consensus 104 HpnIv~l~~~~~~~~~~ylVmEy~~gg~L~~~------i~~--~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPe 174 (708)
||||+++++++.+.+.+|+||||+++++|.++ +.. ...+++.+++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 655 5679999999999999999999999 99999999999
Q ss_pred CEEEcCCCcEEEEeccCccccCCCCCccccccCCcccccccccCC-ccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HH
Q psy2648 175 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RE 252 (708)
Q Consensus 175 NILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~ 252 (708)
|||++.++.+||+|||++...... .....+|++.|+|||++.+. .++..++|||||||++|+|++|..||...+. .+
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred hEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999999765433 44567899999999999877 5543489999999999999999999998776 78
Q ss_pred HHHHHHcCCCCCC-------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 253 LRERVLRGKYRIP-------------------FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 253 l~~~i~~~~~~~p-------------------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+..+...+| ..+++++.+||.+||..||.+|||+++++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l 321 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 8888888877777 56889999999999999999999999887
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=377.70 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=210.0
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhh-----HHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGS-----LQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
...++|++.+.||+|+||.||+|++..+++.||||++......... .+.+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4457899999999999999999999999999999999765432211 16788999999999999999999999766
Q ss_pred CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCc-----EEEEec
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMN-----IKIADF 189 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~~~~-----iKL~DF 189 (708)
. ++||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 7999999999999988765 46999999999999999999999999 999999999999988876 999999
Q ss_pred cCccccCCCCCccccccCCcccccccccC--CccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCC--CC
Q psy2648 190 GFSNEFTPGNKLDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR--ELRERVLRGK--YR 263 (708)
Q Consensus 190 Gls~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~--~l~~~i~~~~--~~ 263 (708)
|+++... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+.. .....+.... ..
T Consensus 174 g~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 174 GLSQQSV--HSVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred Ccccccc--ccccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 9997543 23456789999999999843 334 47899999999999999999999875433 3344444433 34
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 ~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+|..+++++.+||.+||..||.+|||++++.
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 281 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 6778899999999999999999999999877
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=386.30 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=215.0
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCC----cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEE
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTG----KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI 114 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 114 (708)
...+....+|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+++++.++||||+++++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 334555678999999999999999999987654 459999997543 344556788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 115 ETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 115 ~~~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
...+.+||||||+++|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999999775 579999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCC----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCC
Q psy2648 194 EFTPGNK----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFY 267 (708)
Q Consensus 194 ~~~~~~~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~ 267 (708)
....... .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+ ....|..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCccc
Confidence 6543221 1223467889999999888774 79999999999999999 99999999999988888876 3456677
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++++.+||.+||..||.+||+++++.
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~ 301 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIV 301 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 899999999999999999999999876
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=382.41 Aligned_cols=252 Identities=31% Similarity=0.477 Sum_probs=213.5
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
......++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++|+.++||||+++++++...+.
T Consensus 13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 33445678999999999999999999999999999999987543 3345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-
Q psy2648 120 LYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP- 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~- 197 (708)
+|+||||+++++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999998876 46799999999999999999999999999999999999999999999999998753211
Q ss_pred CCCccccccCCccccccccc-----CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Q psy2648 198 GNKLDTFCGSPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---IPFYMS 269 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~-----~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~p~~~s 269 (708)
.......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+..+....+..+... .|..++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred ccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 11224568999999999984 4444 47999999999999999999999998888777777665432 345678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++.+||.+||..||.+|||++++.
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred HHHHHHHHHHcccChhhCCCHHHHh
Confidence 9999999999999999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=389.68 Aligned_cols=247 Identities=25% Similarity=0.440 Sum_probs=208.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEE----EEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEV----AIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~v----AvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.++|++.+.||+|+||.||+|++..+++.| |+|.+.... .....+.+.+|+.+|+.++||||+++++++.+.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 467999999999999999999999888765 666665332 2344567899999999999999999999998765 7
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
++||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 8999999999999999874 579999999999999999999999999999999999999999999999999997664332
Q ss_pred C---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 200 K---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 200 ~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
. .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|...+.++.+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred ccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 2 2234568899999999888774 89999999999999999 999999988888887777664 4567778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
||.+||+.||.+||++.++.
T Consensus 251 li~~~l~~~p~~Rps~~ell 270 (327)
T 3poz_A 251 IMVKCWMIDADSRPKFRELI 270 (327)
T ss_dssp HHHHHTCSCGGGSCCHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHH
Confidence 99999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=392.24 Aligned_cols=248 Identities=26% Similarity=0.437 Sum_probs=212.9
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcE----EEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
...+|++++.||+|+||.||+|.+..+++. ||+|++.... .....+.+.+|+.+++.++||||++++++++. ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence 356899999999999999999999988876 7777765432 12223456789999999999999999999864 56
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
+|+||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 89999999999999999765 57999999999999999999999999999999999999999999999999999876443
Q ss_pred C---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 199 N---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 199 ~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
. ......|++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|...+.++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY 247 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTT
T ss_pred cccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHH
Confidence 2 22446788899999999877774 89999999999999999 999999988888888888764 456777889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+||+++++.
T Consensus 248 ~li~~~l~~dp~~Rps~~el~ 268 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELA 268 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHH
Confidence 999999999999999999887
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=386.17 Aligned_cols=249 Identities=28% Similarity=0.479 Sum_probs=218.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEc-------CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHV-------PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIE 115 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 115 (708)
..++|++.+.||+|+||.||+|++. .+++.||||++.... .....+.+.+|+++|+.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3478999999999999999999986 467889999997543 445567789999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
+.+.+|+||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 9999999999999999999998654 389999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRE 255 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~ 255 (708)
.++.+||+|||++....... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++..
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 99999999999997654332 12344678899999999887764 89999999999999999 999999999999888
Q ss_pred HHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..+. ...|..+++++.+||.+||..||.+||+++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 887764 456778899999999999999999999999877
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=399.66 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=213.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC------CCCCeeeEEEEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML------DHPNIVKLFQVIE 115 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~ 115 (708)
....++|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+++++.+ +||||+++++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 34456899999999999999999999999999999999653 33445677899988876 6789999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--EEEEeccC
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN--IKIADFGF 191 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~--iKL~DFGl 191 (708)
....+||||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 59999998764 4999999999999999999999999999999999999999987 99999999
Q ss_pred ccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC-------
Q psy2648 192 SNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KY------- 262 (708)
Q Consensus 192 s~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~------- 262 (708)
+.... ....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+.+..+....+... ..
T Consensus 249 a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 249 SCYEH--QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CEETT--CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ceecC--CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 97543 334567999999999999988874 8999999999999999999999998877665554421 00
Q ss_pred ---------------------------------------C-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHH
Q psy2648 263 ---------------------------------------R-----------IPFYMSTDCENLLKKFLVLNPAKRASLEV 292 (708)
Q Consensus 263 ---------------------------------------~-----------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~ 292 (708)
. ++...++++.+||++||+.||.+|||+++
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 0 11123788999999999999999999999
Q ss_pred Hh---hhhh
Q psy2648 293 SG---EVTL 298 (708)
Q Consensus 293 ~~---~~~~ 298 (708)
++ |+..
T Consensus 406 ~L~Hpw~~~ 414 (429)
T 3kvw_A 406 ALRHPWLRR 414 (429)
T ss_dssp HHTSTTTC-
T ss_pred HhCChhhcc
Confidence 88 7653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=391.76 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=212.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----KTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 120 (708)
++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+++|+.++||||+++++++... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 58999999999999999999999999999999997533 344557788999999999999999999999765 468
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
|+||||+.+ +|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 999999985 89998864 579999999999999999999999999999999999999999999999999997654321
Q ss_pred ---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC------------
Q psy2648 200 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--KY------------ 262 (708)
Q Consensus 200 ---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~~------------ 262 (708)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+... ..
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 2345689999999999766553458999999999999999999999987766555554320 00
Q ss_pred -----------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 263 -----------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 263 -----------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.++...++++.+||.+||+.||.+|||+++++ |+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01235688999999999999999999999998 77643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=371.90 Aligned_cols=246 Identities=26% Similarity=0.442 Sum_probs=218.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+++++.++||||+++++++.+++.+|+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 3468999999999999999999986 6788999999865433 35688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--C
Q psy2648 124 MEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--K 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~ 200 (708)
|||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999999875 568999999999999999999999999999999999999999999999999987654321 1
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKK 278 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~ 278 (708)
.....|++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|...++++.+||.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHH
Confidence 2345678899999999877764 89999999999999999 999999999999888888774 34566789999999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||.+||+++++.
T Consensus 241 ~l~~~p~~Rps~~~ll 256 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLL 256 (267)
T ss_dssp HTCSSGGGSCCHHHHH
T ss_pred HccCChhhCcCHHHHH
Confidence 9999999999999877
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=378.27 Aligned_cols=251 Identities=30% Similarity=0.495 Sum_probs=214.3
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ..+.+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34568999999999999999999999999999999997643 23568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CC
Q psy2648 123 VMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NK 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~ 200 (708)
||||+++++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 9999999999999874 467999999999999999999999999999999999999999999999999999765432 23
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK---YRIPFYMSTDCENLLK 277 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~---~~~p~~~s~~~~~Li~ 277 (708)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.... +..|..++.++.+||.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 3456899999999999888775 79999999999999999999999887766655554442 2335567899999999
Q ss_pred HhhhhCCCCCCCHHHHh---hhhh
Q psy2648 278 KFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+||..||.+|||+++++ |+..
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred HHccCChhhCcCHHHHHhCHHHhc
Confidence 99999999999999987 7653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=383.29 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=214.5
Q ss_pred CccCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 116 (708)
...++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+++|+.+ +||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 3456899999999999999999985 4577899999997553 334567788999999999 99999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHG------------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 178 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~------------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl 178 (708)
.+..|+||||+++|+|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999998764 38999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH-H
Q psy2648 179 DSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRE-L 253 (708)
Q Consensus 179 d~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~-l 253 (708)
+.++.+||+|||++........ .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+..... +
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 9999999999999986654332 2345678899999999877764 89999999999999999 999998876443 3
Q ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 254 RERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 254 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+..+ ....|...++++.+||.+||..||.+|||++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 3333333 2334667899999999999999999999999887
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=376.49 Aligned_cols=252 Identities=25% Similarity=0.484 Sum_probs=208.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
...+++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 4567899999999999999999999999999999999986433 455667788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 121 YLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
|+||||+.+++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999865 3568999999999999999999999999999999999999999999999999987654
Q ss_pred CC-CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCC--CCCCCHH
Q psy2648 197 PG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS--TLRELRERVLRGKYRI--PFYMSTD 271 (708)
Q Consensus 197 ~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~--~~~~l~~~i~~~~~~~--p~~~s~~ 271 (708)
.. .......|++.|+|||++.+..++ .++|||||||++|+|++|..||.+. +..++...+..+.+.. +..++++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 32 223456799999999999888774 7999999999999999999999764 4556777777665542 2467899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+||.+||..||.+|||++++.
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il 289 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVY 289 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHH
Confidence 99999999999999999999877
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=383.64 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=221.7
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI 114 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 114 (708)
..+...++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+++|+.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 34455678999999999999999999987 467899999997543 344556788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcE
Q psy2648 115 ETEKTLYLVMEYASGGEVFDYLVLH----------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184 (708)
Q Consensus 115 ~~~~~~ylVmEy~~gg~L~~~i~~~----------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~i 184 (708)
.+.+.+|+||||+++|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999998753 356899999999999999999999999999999999999999999
Q ss_pred EEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q psy2648 185 KIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG 260 (708)
Q Consensus 185 KL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~ 260 (708)
||+|||++....... ......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 999999997653322 12345678999999999877764 79999999999999999 99999999999988888877
Q ss_pred CC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 261 KY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 261 ~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.. ..|..+++++.+||.+||..||.+|||++++.
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l 291 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 54 46778899999999999999999999999887
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=381.34 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=213.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC---CCCCeeeEEEEEE-----
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML---DHPNIVKLFQVIE----- 115 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----- 115 (708)
.++|++.+.||+|+||.||+|++. .+++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999995 7789999999976543322223466788877766 8999999999987
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
....+|+||||+. |+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 4567999999998 59999998754 49999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C----------
Q psy2648 194 EFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K---------- 261 (708)
Q Consensus 194 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~---------- 261 (708)
...........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred cccCCCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 76544445667899999999999888774 7999999999999999999999998887776666531 0
Q ss_pred ---------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 262 ---------------YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 262 ---------------~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..++..+++++.+||.+||..||.+|||+++++ |+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 301 (326)
T 1blx_A 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301 (326)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence 012245788999999999999999999999987 665
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=398.16 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=207.2
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-- 118 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 118 (708)
.+...++|++.+.||+|+||.||+|++..+++ ||||++...... ..+|+++|+.++|||||++++++....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 34455689999999999999999999987776 888877644321 236999999999999999999986543
Q ss_pred ----EEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCcEEEEec
Q psy2648 119 ----TLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADF 189 (708)
Q Consensus 119 ----~~ylVmEy~~gg~L~~~i~----~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld-~~~~iKL~DF 189 (708)
.+|+||||++++ +.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 389999999875 433332 356799999999999999999999999999999999999999 7899999999
Q ss_pred cCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Q psy2648 190 GFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--------- 260 (708)
Q Consensus 190 Gls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--------- 260 (708)
|+++....+......+||+.|+|||++.+....+.++|||||||+||+|++|+.||.+.+..+....+.+.
T Consensus 187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99988766666667889999999999987653458999999999999999999999998876655554331
Q ss_pred --------CCC------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 --------KYR------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 --------~~~------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
... ++...++++.+||.+||+.||.+|||+++++ |+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 001 2334789999999999999999999999988 7653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=379.66 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=209.4
Q ss_pred cCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--C
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAK----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE--K 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 118 (708)
..+|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+++|+.++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3469999999999999999999 56789999999997653 233456788999999999999999999999876 6
Q ss_pred EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
.+|+||||+++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 799999999999999999554 5799999999999999999999999999999999999999999999999999987654
Q ss_pred CC----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHH
Q psy2648 198 GN----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---------------TLRELRERVL 258 (708)
Q Consensus 198 ~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---------------~~~~l~~~i~ 258 (708)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|..||... ....+...+.
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 32 23346788899999999888775 7999999999999999999986432 2233444444
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 RG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+ ....|..+++++.+||.+||..||.+|||++++.
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 294 (302)
T 4e5w_A 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 294 (302)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 44 3456778899999999999999999999999877
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=388.40 Aligned_cols=248 Identities=25% Similarity=0.444 Sum_probs=210.1
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEE----EEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEV----AIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~v----AvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
..++|++++.||+|+||.||+|++..+++.| |+|.+.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 3568999999999999999999999888865 556554322 3345677899999999999999999999998765
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.++||||+.+|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 88999999999999999874 57999999999999999999999999999999999999999999999999999865433
Q ss_pred CC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 199 NK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 199 ~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
.. .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|...+.++.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 249 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred cccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 22 2334567889999999988775 89999999999999999 999999998888888877764 456778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+||+++++.
T Consensus 250 ~li~~~l~~dp~~Rps~~ell 270 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELI 270 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHH
Confidence 999999999999999999887
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=393.82 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=202.9
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK-- 118 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 118 (708)
....+++|++.+.||+|+||.||+|++..+++.||||++...... ..+..+|++.++.++||||+++++++....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345578999999999999999999999999999999998654322 234567888889999999999999987643
Q ss_pred -----EEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEEcC-CCcEEE
Q psy2648 119 -----TLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYCH--QKKIIHRDLKAENLLLDS-EMNIKI 186 (708)
Q Consensus 119 -----~~ylVmEy~~gg~L~~~i~----~~~~l~e~~~~~i~~QI~~aL~yLH--~~gIvHRDLKPeNILld~-~~~iKL 186 (708)
.+|+||||+++ +|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 38999999987 4444433 4567899999999999999999999 999999999999999997 899999
Q ss_pred EeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----
Q psy2648 187 ADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---- 262 (708)
Q Consensus 187 ~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---- 262 (708)
+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.+..-
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 9999998776665566778999999999997766446899999999999999999999999888776666643100
Q ss_pred ----------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 263 ----------------------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 263 ----------------------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
..+...++++.+||.+||+.||.+|||+++++ |+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 01122567899999999999999999999988 87653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.43 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=210.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe-----
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET----- 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----- 116 (708)
...++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 346789999999999999999999999999999999975432 235678999999998 79999999999987
Q ss_pred -CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 117 -EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 117 -~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
...+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 46899999999999999999864 579999999999999999999999999999999999999999999999999987
Q ss_pred ccCCC-CCccccccCCccccccccc-----CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CC
Q psy2648 194 EFTPG-NKLDTFCGSPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IP 265 (708)
Q Consensus 194 ~~~~~-~~~~~~~Gt~~Y~APE~l~-----~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~--~p 265 (708)
..... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+...... .+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256 (326)
T ss_dssp -------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence 65432 2334568999999999997 3444 47899999999999999999999988877766666655432 23
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..+++++.+||.+||..||.+||++++++ |+.
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 56789999999999999999999999987 664
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=409.08 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=221.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+....+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+++|++++|||||++++++.....+|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 3445689999999999999999999999999999999976543 3567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999999874 358999999999999999999999999999999999999999999999999998764332
Q ss_pred C--ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q psy2648 200 K--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENL 275 (708)
Q Consensus 200 ~--~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~L 275 (708)
. .....+++.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..++.+.+..+ ....|..+++++.+|
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 2234567889999999887775 79999999999999999 99999999888888877765 335677889999999
Q ss_pred HHHhhhhCCCCCCCHHHHhh
Q psy2648 276 LKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~~ 295 (708)
|.+||+.||.+|||++++..
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=377.47 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=204.1
Q ss_pred ccCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 37 RRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 37 ~~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
..+..+..-++|++.+.||+|+||.||+|++. ..||||++..........+.+.+|+++|+.++||||++++++. .
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 34455666789999999999999999999864 3599999987766667778899999999999999999999965 5
Q ss_pred CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
...+++||||+++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 56789999999999999998544 56999999999999999999999999999999999999999999999999998755
Q ss_pred CC---CCCccccccCCccccccccc---CCccCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCC----
Q psy2648 196 TP---GNKLDTFCGSPPYAAPELFQ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRERVLRGKYRI---- 264 (708)
Q Consensus 196 ~~---~~~~~~~~Gt~~Y~APE~l~---~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~l~~~i~~~~~~~---- 264 (708)
.. .......+||+.|+|||++. +..+ +.++|||||||++|+|++|+.||.+. +...+.+.+..+....
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 32 22334568999999999986 4444 46899999999999999999999874 4555666666654432
Q ss_pred -CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 -PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 -p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+..+++++.+||.+||..||.+|||++++.
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 280 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 346789999999999999999999999887
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=391.66 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=211.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE----
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL---- 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~---- 120 (708)
.++|++.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3689999999999999999999999999999999987665556667889999999999999999999999877654
Q ss_pred --EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 121 --YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 121 --ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
|+||||+. ++|.+++ ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-- 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-- 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc--
Confidence 99999998 5888776 3469999999999999999999999999999999999999999999999999997553
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--C--------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--Y-------------- 262 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~-------------- 262 (708)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.... .
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 234567899999999999873333589999999999999999999999988776666554310 0
Q ss_pred ---------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 ---------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 ---------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
..+...++++.+||.+||+.||.+|||+++++ |+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 01235689999999999999999999999987 7753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=381.09 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=211.3
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEE-cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCC------eeeEEEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKH-VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN------IVKLFQV 113 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~-~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~ 113 (708)
.+...++|++.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+++++.++|++ |++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 344557999999999999999999998 568899999999643 344567889999999887654 9999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-----------
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS----------- 180 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~----------- 180 (708)
+++.+.+||||||+ +++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999999 889999998776 6899999999999999999999999999999999999987
Q ss_pred --------CCcEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy2648 181 --------EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRE 252 (708)
Q Consensus 181 --------~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~ 252 (708)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999976432 33567899999999999988875 79999999999999999999999888766
Q ss_pred HHHHHHcCCCCCC--------------------------------------------CCCCHHHHHHHHHhhhhCCCCCC
Q psy2648 253 LRERVLRGKYRIP--------------------------------------------FYMSTDCENLLKKFLVLNPAKRA 288 (708)
Q Consensus 253 l~~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~dP~~Rp 288 (708)
....+......+| ...++++.+||.+||..||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 5544432111111 11246788999999999999999
Q ss_pred CHHHHh---hhh
Q psy2648 289 SLEVSG---EVT 297 (708)
Q Consensus 289 s~~~~~---~~~ 297 (708)
|+++++ |+.
T Consensus 322 t~~ell~hp~f~ 333 (339)
T 1z57_A 322 TLREALKHPFFD 333 (339)
T ss_dssp CHHHHTTSGGGG
T ss_pred CHHHHhcCHHHH
Confidence 999987 665
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=385.90 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=201.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----EE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK----TL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 120 (708)
.++|++.+.||+|+||.||+|++. ++.||||++... ........+|+.+|+.++|||||++++++.... .+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 468999999999999999999875 799999999653 233345667999999999999999999998743 48
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCCEEEcCCCcEEEEecc
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK----------KIIHRDLKAENLLLDSEMNIKIADFG 190 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~----------gIvHRDLKPeNILld~~~~iKL~DFG 190 (708)
|+|||||++|+|.+++.. ..+++.+++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 98 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999999865 5699999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC---CccccccCCcccccccccCCcc----CCCchhHHHHHHHHHHHHcCCCCCCCC---------------
Q psy2648 191 FSNEFTPGN---KLDTFCGSPPYAAPELFQGKKY----DGPEVDVWSLGVILYTLVSGSLPFDGS--------------- 248 (708)
Q Consensus 191 ls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~----~~~~~DIWSlGvilyelltG~~Pf~~~--------------- 248 (708)
+++...... .....+||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+.
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 997654332 2344689999999999987321 135789999999999999999999753
Q ss_pred -CHHHHHHHHHcCCCCC--CC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 249 -TLRELRERVLRGKYRI--PF-----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 249 -~~~~l~~~i~~~~~~~--p~-----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...++...+....... +. ..++++.+||.+||+.||.+|||++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 3344444444433221 11 1234599999999999999999999887
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=374.27 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=216.0
Q ss_pred cCCeEEEe-EEcccCceEEEEEEEc--CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLK-TIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~-~LG~G~fg~V~la~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.++|.+.+ .||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+++|+.++||||++++++++ .+.+|
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcE
Confidence 46788887 9999999999999864 577889999997653 4456678899999999999999999999994 45699
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
+||||+++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999998654 4699999999999999999999999999999999999999999999999999986643321
Q ss_pred ----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 201 ----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 201 ----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
.....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|..+++++.+
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 244 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence 2234578899999999877764 79999999999999998 999999988888888888775 4567789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
||.+||..||.+||+++++.
T Consensus 245 li~~~l~~~p~~Rps~~~l~ 264 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVE 264 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHH
Confidence 99999999999999999877
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=377.77 Aligned_cols=252 Identities=28% Similarity=0.460 Sum_probs=207.7
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE--------
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE-------- 115 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-------- 115 (708)
..++|++++.||+|+||.||+|.+..+++.||||++... +....+.+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 346899999999999999999999999999999998754 3456678899999999999999999999874
Q ss_pred ------eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCcEEEEe
Q psy2648 116 ------TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIAD 188 (708)
Q Consensus 116 ------~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld-~~~~iKL~D 188 (708)
....+|+||||+. |+|.+++. .+.+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3468999999998 59999875 56899999999999999999999999999999999999997 567899999
Q ss_pred ccCccccCCC----CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-
Q psy2648 189 FGFSNEFTPG----NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR- 263 (708)
Q Consensus 189 FGls~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~- 263 (708)
||++...... .......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999865322 22345678999999999876333358999999999999999999999998877766665432110
Q ss_pred -----------------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 264 -----------------------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 264 -----------------------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.+..+++++.+||++||+.||.+|||+++++ |+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 1235789999999999999999999999987 87643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=402.77 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=217.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+....+|++.+.||+|+||.||+|.+. .+..||||+++.... ..+.+.+|+++|+.++|||||++++++. ...+|
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 344568999999999999999999986 467899999976442 3567899999999999999999999986 56789
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999999754 368999999999999999999999999999999999999999999999999998654321
Q ss_pred --CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 200 --KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
......+++.|+|||++.+..++ .++|||||||+||||++ |..||.+.+..++...+..+. ...|..+++++.+|
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred eeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 12234567889999999877774 89999999999999999 999999999999888887763 34567889999999
Q ss_pred HHHhhhhCCCCCCCHHHHhhh
Q psy2648 276 LKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~~~ 296 (708)
|.+||..||.+|||++++...
T Consensus 418 i~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999998743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=386.35 Aligned_cols=252 Identities=29% Similarity=0.572 Sum_probs=218.1
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhCC--CCCeeeEEE
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKMLD--HPNIVKLFQ 112 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~ 112 (708)
...+...++|++.+.||+|+||.||+|.+..+++.||||++.+..... ...+.+.+|+.+++.++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344556778999999999999999999999999999999997654321 12234668999999996 599999999
Q ss_pred EEEeCCEEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCcEEEEecc
Q psy2648 113 VIETEKTLYLVMEYASG-GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADFG 190 (708)
Q Consensus 113 ~~~~~~~~ylVmEy~~g-g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld-~~~~iKL~DFG 190 (708)
++...+.+|+||||+.+ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++ +++.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999999986 89999999989999999999999999999999999999999999999999 78999999999
Q ss_pred CccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Q psy2648 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMST 270 (708)
Q Consensus 191 ls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~ 270 (708)
++..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||... ..+..+...++..+++
T Consensus 196 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~~ 268 (320)
T 3a99_A 196 SGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSS 268 (320)
T ss_dssp TCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCH
T ss_pred ccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhcccccccccCCH
Confidence 9976643 33455789999999999987776567899999999999999999999763 2344566677788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
++.+||.+||..||.+|||++++. |+.
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~ 298 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence 999999999999999999999987 654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=374.18 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=206.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEE-EEeCCEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV-IETEKTLYL 122 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~yl 122 (708)
..++|++.+.||+|+||.||+|++..+++.||||++...... +.+.+|+.+++.++|++++..+.. ......+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 346899999999999999999999999999999998765432 347889999999998876655554 467788999
Q ss_pred EEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCcEEEEeccCccccCCC
Q psy2648 123 VMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl---d~~~~iKL~DFGls~~~~~~ 198 (708)
||||+ +++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 8999999974 4579999999999999999999999999999999999999 48899999999999765433
Q ss_pred CC--------ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCC--
Q psy2648 199 NK--------LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST---LRELRERVLRGKYRIP-- 265 (708)
Q Consensus 199 ~~--------~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~---~~~l~~~i~~~~~~~p-- 265 (708)
.. ....+||+.|+|||++.+..++ +++|||||||++|+|++|+.||.+.+ ..+....+.......|
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 21 3457899999999999988774 89999999999999999999998732 2233344443333333
Q ss_pred ---CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 ---FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 ---~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+++++.+||.+||+.||.+||+++++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 272 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 272 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHH
Confidence 57889999999999999999999999887
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=370.79 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=216.6
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
+.+...++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+++|+.++||||+++++++.. +.
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 34455678999999999999999999975 567899999976543 24568899999999999999999999864 56
Q ss_pred EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
+|+||||+++++|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 899999999999999986543 799999999999999999999999999999999999999999999999999986643
Q ss_pred CCC--ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 198 GNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 198 ~~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+.+..+. ...|...++++.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence 321 2334578899999999877764 79999999999999999 999999999988888887763 345677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+|||++++.
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~ 261 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLR 261 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHH
Confidence 999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=372.45 Aligned_cols=239 Identities=30% Similarity=0.424 Sum_probs=210.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-------- 116 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 116 (708)
.++|++.+.||+|+||.||+|.+..+++.||||++.... +.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 357999999999999999999999999999999997542 246689999999999999999999865
Q ss_pred --------CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEE
Q psy2648 117 --------EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKI 186 (708)
Q Consensus 117 --------~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL 186 (708)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 44589999999999999999765 57999999999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy2648 187 ADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF 266 (708)
Q Consensus 187 ~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~ 266 (708)
+|||++............+||+.|+|||++.+..++ .++|||||||++|+|++|..||.. .......+..+ .++.
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~--~~~~ 238 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDG--IISD 238 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTT--CCCT
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcc--cccc
Confidence 999999877655555667899999999999988774 899999999999999999999853 23344445444 3456
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 267 YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 267 ~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..++++.+||.+||..||.+|||++++.
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l 266 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRPNTSEIL 266 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 7889999999999999999999999887
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=383.27 Aligned_cols=255 Identities=23% Similarity=0.377 Sum_probs=216.2
Q ss_pred cCCCCCccCCeEEEeEEcccCceEEEEEE-----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEE
Q psy2648 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAK-----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQ 112 (708)
Q Consensus 38 ~~~~~~~~~~Y~i~~~LG~G~fg~V~la~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 112 (708)
..-.+...++|++.+.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 34445566799999999999999999999 56788999999996443 3455567889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---C
Q psy2648 113 VIETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE---M 182 (708)
Q Consensus 113 ~~~~~~~~ylVmEy~~gg~L~~~i~~~~-------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~---~ 182 (708)
++.....+||||||+++++|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||++.+ .
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 9999999999999999999999998763 48999999999999999999999999999999999999954 4
Q ss_pred cEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q psy2648 183 NIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258 (708)
Q Consensus 183 ~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~ 258 (708)
.+||+|||++....... ......|++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 69999999987543221 22345789999999999877764 89999999999999998 999999999988888888
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 RGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 ~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+. ...|..+++++.+||.+||..||.+||+++++.
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 296 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 764 345677899999999999999999999999887
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=392.11 Aligned_cols=250 Identities=19% Similarity=0.236 Sum_probs=202.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeccCCCChh---------hHHHHHHHHHHHHhCCCCCeeeEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQLNPG---------SLQKLFREVRIMKMLDHPNIVKLFQ 112 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~---tg~~vAvK~i~~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~~ 112 (708)
.++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 889999999986542110 1123567899999999999999999
Q ss_pred EEEe----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC--cEEE
Q psy2648 113 VIET----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM--NIKI 186 (708)
Q Consensus 113 ~~~~----~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~--~iKL 186 (708)
++.. ...+||||||+ +++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 77899999999 999999998888999999999999999999999999999999999999999887 9999
Q ss_pred EeccCccccCCCC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHH
Q psy2648 187 ADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--STLRELRER 256 (708)
Q Consensus 187 ~DFGls~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~--~~~~~l~~~ 256 (708)
+|||+++.+.... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+ .+...+...
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999997653221 12456899999999999988774 899999999999999999999965 333332222
Q ss_pred HHcCCCCCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHhhh
Q psy2648 257 VLRGKYRIP---------FYMSTDCENLLKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 257 i~~~~~~~p---------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~~ 296 (708)
.......+| ..+++++.+||.+||..||.+||+++++...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 211111222 1678999999999999999999999998843
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=373.07 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=213.5
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
....++|++.+.||+|+||.||+|.+.. ++..||||++.+.. .....+.+.+|+++++.++||||++++++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 4456789999999999999999999764 34569999997653 345567789999999999999999999998754
Q ss_pred EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
..|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 5799999999999999997764 599999999999999999999999999999999999999999999999999976543
Q ss_pred CC--CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 198 GN--KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 198 ~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
.. ......+++.|+|||++.+..++ +++|||||||++|+|++ |..||...+..++...+..+. ...|...++++.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY 244 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHH
T ss_pred ccccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 32 22345678899999999877764 79999999999999998 999998877777777776653 456777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+||+++++.
T Consensus 245 ~li~~~l~~~p~~Rps~~ell 265 (281)
T 3cc6_A 245 TLMTRCWDYDPSDRPRFTELV 265 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHccCCchhCcCHHHHH
Confidence 999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=400.49 Aligned_cols=248 Identities=28% Similarity=0.487 Sum_probs=210.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK--TLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~yl 122 (708)
-++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+++|+.++||||+++++++.... .+||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4579999999999999999999999999999999975432 223566789999999999999999999998765 7899
Q ss_pred EEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCcEEEEeccCcccc
Q psy2648 123 VMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL----DSEMNIKIADFGFSNEF 195 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~---l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl----d~~~~iKL~DFGls~~~ 195 (708)
|||||++|+|.+++..... +++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999999999876433 9999999999999999999999999999999999999 77888999999999877
Q ss_pred CCCCCccccccCCcccccccccC--------CccCCCchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHHcCCCC
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQG--------KKYDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYR 263 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~--------~~~~~~~~DIWSlGvilyelltG~~Pf~~----~~~~~l~~~i~~~~~~ 263 (708)
.........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.. ....++..++..+...
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 66655667889999999999865 334 4789999999999999999999974 2344556666655421
Q ss_pred -------------------CC--C----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 -------------------IP--F----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 -------------------~p--~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+| . .++..+.+||.+||+.||++||+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l 301 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHH
Confidence 11 1 1335678999999999999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=392.36 Aligned_cols=245 Identities=23% Similarity=0.421 Sum_probs=202.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC--------CCCeeeEEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD--------HPNIVKLFQVI 114 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~ 114 (708)
...++|++.+.||+|+||.||+|++..+++.||||++.+. ....+.+.+|+++|+.++ ||||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3457899999999999999999999999999999999643 344567889999999885 78899999998
Q ss_pred E----eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCC-----
Q psy2648 115 E----TEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEM----- 182 (708)
Q Consensus 115 ~----~~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~----- 182 (708)
. ....+||||||+ +++|.+++... ..+++.+++.++.||+.||+|||++ ||+||||||+||||+.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 8 456899999999 66777777665 4699999999999999999999998 999999999999999775
Q ss_pred --------------------------------------------cEEEEeccCccccCCCCCccccccCCcccccccccC
Q psy2648 183 --------------------------------------------NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218 (708)
Q Consensus 183 --------------------------------------------~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~ 218 (708)
.+||+|||++..... .....+||+.|+|||++.+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHT
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcC
Confidence 799999999976543 2455689999999999998
Q ss_pred CccCCCchhHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH------------cCCC------------------
Q psy2648 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGST------LRELRERVL------------RGKY------------------ 262 (708)
Q Consensus 219 ~~~~~~~~DIWSlGvilyelltG~~Pf~~~~------~~~l~~~i~------------~~~~------------------ 262 (708)
..|+ .++|||||||+||+|++|+.||.+.+ .......+. .+.+
T Consensus 268 ~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 8875 79999999999999999999998644 112122211 1111
Q ss_pred ------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 ------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 ------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+...++++.+||.+||+.||.+|||+++++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 390 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHH
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 11222345788999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=384.86 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=210.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-----
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT----- 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 119 (708)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999998765555566788999999999999999999999987653
Q ss_pred -EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 120 -LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 120 -~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
+|+||||+. ++|.+++. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 599999998 58888763 4699999999999999999999999999999999999999999999999999976432
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C---------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K--------------- 261 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~--------------- 261 (708)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 2345689999999999987433358999999999999999999999998876665554321 0
Q ss_pred --------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 262 --------------YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 262 --------------~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
...+...++++.+||.+||..||.+|||+++++ |+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012235789999999999999999999999987 7653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=383.73 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=214.6
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCc-----EEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK-----EVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIE 115 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 115 (708)
+...++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+++|+.+ +||||+++++++.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445789999999999999999999987765 79999997543 344567789999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLH--------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 181 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~--------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~ 181 (708)
..+.+|+||||+++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999999753 357999999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q psy2648 182 MNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERV 257 (708)
Q Consensus 182 ~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i 257 (708)
+.+||+|||++........ .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 9999999999976543221 2345678899999999887774 89999999999999998 99999886654433333
Q ss_pred HcCC--CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 258 LRGK--YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 258 ~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.... ...|...++++.+||.+||..||.+|||++++.
T Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 318 (333)
T 2i1m_A 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318 (333)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 3332 345667899999999999999999999999887
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=388.69 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=203.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC---------hhhHHHHHHHHHHHHhCCCCCeeeEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN---------PGSLQKLFREVRIMKMLDHPNIVKLFQVI 114 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~---------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 114 (708)
..++|++.+.||+|+||.||+|.+.. ++.||||++...... ....+.+.+|+++|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 35689999999999999999999865 999999999654322 22346789999999999999999999998
Q ss_pred Ee-----CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEe
Q psy2648 115 ET-----EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIAD 188 (708)
Q Consensus 115 ~~-----~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~D 188 (708)
.. ...+|+||||+. |+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 54 347899999998 5888888755 3699999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--------
Q psy2648 189 FGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-------- 260 (708)
Q Consensus 189 FGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-------- 260 (708)
||++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 999986555555566789999999999987433458999999999999999999999998877766655421
Q ss_pred ----------------CCC--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 261 ----------------KYR--------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 261 ----------------~~~--------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
... .+...++++.+||.+||..||.+|||+++++ |+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 000 1234688899999999999999999999988 77643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=381.06 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=210.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----C
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----K 118 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 118 (708)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+++|+.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3568999999999999999999999999999999996432 344556788999999999999999999988654 6
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+||||+. ++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 7999999998 589988865 67999999999999999999999999999999999999999999999999999765422
Q ss_pred C-----------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CCC---
Q psy2648 199 N-----------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR--GKY--- 262 (708)
Q Consensus 199 ~-----------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~--~~~--- 262 (708)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.. +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 123468999999999986533345899999999999999999999999886655444321 000
Q ss_pred -------------------C--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 -------------------R--------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 -------------------~--------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
. .+..+++++.+||.+||..||.+|||+++++ |+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 1135788999999999999999999999987 7764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=392.78 Aligned_cols=248 Identities=16% Similarity=0.232 Sum_probs=199.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeccCCCChh-hH--------HHHHHHHHHHHhCCCCCeeeE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPT-----GKEVAIKIIDKTQLNPG-SL--------QKLFREVRIMKMLDHPNIVKL 110 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~t-----g~~vAvK~i~~~~~~~~-~~--------~~~~~Ei~il~~l~HpnIv~l 110 (708)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........ +. ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34899999999999999999999765 58899999876531100 00 123456677788899999999
Q ss_pred EEEEEeC----CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--CCCc
Q psy2648 111 FQVIETE----KTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD--SEMN 183 (708)
Q Consensus 111 ~~~~~~~----~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld--~~~~ 183 (708)
++++... ..+||||||+ |++|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 4689999999 99999999876 6799999999999999999999999999999999999999 8899
Q ss_pred EEEEeccCccccCCCC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHH
Q psy2648 184 IKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELR 254 (708)
Q Consensus 184 iKL~DFGls~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~ 254 (708)
+||+|||+++.+.... .....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+... ....
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999997654221 1245679999999999998887 4899999999999999999999986321 1111
Q ss_pred HHHHcC---CC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 255 ERVLRG---KY-------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 255 ~~i~~~---~~-------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...... .. -.+...++++.+||.+||..||.+||+++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~ 321 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR 321 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence 111100 00 01246789999999999999999999999877
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=397.63 Aligned_cols=249 Identities=16% Similarity=0.191 Sum_probs=189.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhC--CCCCeeeEE-------EEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKML--DHPNIVKLF-------QVI 114 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~ 114 (708)
..+|++.+.||+|+||.||+|++..+++.||||++.+.... ....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999887653 34455677886555544 699988865 566
Q ss_pred EeC-----------------CEEEEEEeccCCCChHHHHHHcCC-CCHHHH------HHHHHHHHHHHHHHHHCCceecC
Q psy2648 115 ETE-----------------KTLYLVMEYASGGEVFDYLVLHGR-MKEKEA------RAKFRQIVSAVQYCHQKKIIHRD 170 (708)
Q Consensus 115 ~~~-----------------~~~ylVmEy~~gg~L~~~i~~~~~-l~e~~~------~~i~~QI~~aL~yLH~~gIvHRD 170 (708)
..+ ..+|||||||+ |+|.+++...+. +.+... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 544 34899999999 899999987533 433333 45669999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCcccccccccC--CccCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2648 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGS 248 (708)
Q Consensus 171 LKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~~~~DIWSlGvilyelltG~~Pf~~~ 248 (708)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..| +.++|||||||+||+|++|+.||.+.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999986532 2224567799999999987 556 48999999999999999999999876
Q ss_pred CHHHH--HHH-----HHcCCCCCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 249 TLREL--RER-----VLRGKYRIP--FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 249 ~~~~l--~~~-----i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+.... ... .....+.+| ..+++++.+||.+||+.||++|||+++++ |+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 42210 000 011122233 46799999999999999999999999987 765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=373.39 Aligned_cols=244 Identities=32% Similarity=0.526 Sum_probs=207.5
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-KTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~ 120 (708)
....++|++.+.||+|+||.||+|.+ +++.||||++.... ..+.+.+|+++++.++||||+++++++... +.+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 45578999999999999999999987 48899999987542 346788999999999999999999987544 578
Q ss_pred EEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
|+||||+++++|.+++...+. +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999999987654 899999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLL 276 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li 276 (708)
.....+++.|+|||++.+..++ +++|||||||++|+|++ |..||...+..++...+..+ ....|...++++.+||
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred --ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 2345788999999999877764 79999999999999998 99999998888888887766 3456778899999999
Q ss_pred HHhhhhCCCCCCCHHHHh
Q psy2648 277 KKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~ 294 (708)
.+||..||.+||+++++.
T Consensus 248 ~~~l~~~p~~Rps~~~l~ 265 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLR 265 (278)
T ss_dssp HHHTCSSGGGSCCHHHHH
T ss_pred HHHhcCChhhCCCHHHHH
Confidence 999999999999999876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.62 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=193.3
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4456789999999999999999999999999999999875432 233456889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 122 LVMEYASGGEVFDYLVL--------HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~--------~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
+||||+++++|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999999874 3569999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Q psy2648 194 EFTPGN------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---- 263 (708)
Q Consensus 194 ~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---- 263 (708)
...... .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+...........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 654321 2245689999999999875322358999999999999999999999987665555444443221
Q ss_pred ------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 ------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 ------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+...++++.+||.+||..||.+||+++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 2235688999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=378.82 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=214.3
Q ss_pred CccCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIET 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 116 (708)
...++|++.+.||+|+||.||+|++ ..+++.||||++.... .....+.+.+|+++|+.+ +||||+++++++..
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 3357899999999999999999985 4577899999997653 344556788999999999 69999999999877
Q ss_pred CC-EEEEEEeccCCCChHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 117 EK-TLYLVMEYASGGEVFDYLVLHGR----------------MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 117 ~~-~~ylVmEy~~gg~L~~~i~~~~~----------------l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
.+ .+|+||||+++|+|.+++..... +++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 59999999999999999987654 89999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-HHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTL-RELR 254 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~-~~l~ 254 (708)
.++.+||+|||++........ .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+. ..+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999976543322 2345688999999999887774 89999999999999998 9999987653 3445
Q ss_pred HHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 255 ERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 255 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+..+ ....|...++++.++|.+||..||.+|||++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 555554 3456778899999999999999999999999887
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=374.43 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=196.7
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
...+++|++++.||+|+||.||+|++..+++.||||++..........+.+.++..+++.++||||+++++++.+++.+|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 45578999999999999999999999999999999999876543333344445566788899999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 122 LVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999999 4455544433 46899999999999999999999995 99999999999999999999999999997765555
Q ss_pred CccccccCCccccccccc-----CCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CC--CCCCH
Q psy2648 200 KLDTFCGSPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGKYR-IP--FYMST 270 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~-----~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~~~-~p--~~~s~ 270 (708)
.....+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.. .+..++...+..+... +| ..+++
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp -------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred cccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 555678999999999995 3344 4789999999999999999999987 4555666666665433 33 35789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
++.+||.+||..||.+||++++++ |+.
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 999999999999999999999987 654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=375.14 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=213.1
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCC---cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEE-Ee
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTG---KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVI-ET 116 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~ 116 (708)
-.+...+|++.+.||+|+||.||+|.+..++ ..||||++... ......+.+.+|+.+|++++||||+++++++ +.
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3445568999999999999999999976443 35899998753 2445567789999999999999999999985 45
Q ss_pred CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
++..|+||||+++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 66889999999999999999764 45899999999999999999999999999999999999999999999999999765
Q ss_pred CCCC-----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Q psy2648 196 TPGN-----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR-IPFYM 268 (708)
Q Consensus 196 ~~~~-----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~-~p~~~ 268 (708)
.... ......||+.|+|||++.+..++ +++|||||||++|+|++ |.+||.+.+..++...+..+... .|...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence 4322 22345678899999999887774 89999999999999999 77888888777777777776544 46778
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++++.+||.+||..||.+|||++++.
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell 283 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELV 283 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999999999999999999999877
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=381.24 Aligned_cols=251 Identities=31% Similarity=0.567 Sum_probs=209.5
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhC----CCCCeeeEE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKML----DHPNIVKLF 111 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~l~ 111 (708)
..+...++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999999999999999997654321 1223456799999998 899999999
Q ss_pred EEEEeCCEEEEEEec-cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCcEEEEec
Q psy2648 112 QVIETEKTLYLVMEY-ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADF 189 (708)
Q Consensus 112 ~~~~~~~~~ylVmEy-~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld-~~~~iKL~DF 189 (708)
+++...+.+|+|||| +.+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 79999999999888999999999999999999999999999999999999999 8899999999
Q ss_pred cCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy2648 190 GFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMS 269 (708)
Q Consensus 190 Gls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s 269 (708)
|++..... ......+|++.|+|||++.+..+.+.++|||||||++|+|++|+.||... ..+......+|..++
T Consensus 185 g~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 185 GSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVS 257 (312)
T ss_dssp SSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSC
T ss_pred chhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCC
Confidence 99986643 33456789999999999987776556899999999999999999999753 234456677888899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+++.+||.+||..||.+|||++++. |+.
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 9999999999999999999999987 654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=379.58 Aligned_cols=247 Identities=30% Similarity=0.452 Sum_probs=212.3
Q ss_pred cCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAK----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE--TEK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~ 118 (708)
..+|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+++|+.++||||+++++++. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4589999999999999999999 4678999999999754 3455667899999999999999999999987 456
Q ss_pred EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
.+||||||+++++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 799999999999999999874 5699999999999999999999999999999999999999999999999999986643
Q ss_pred CC----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH---------------HHHHHHHH
Q psy2648 198 GN----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL---------------RELRERVL 258 (708)
Q Consensus 198 ~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~---------------~~l~~~i~ 258 (708)
.. ......||+.|+|||++.+..++ +++|||||||++|+|++|..||..... ..+.+.+.
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 32 12345688889999999888774 799999999999999999999965432 23344444
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 259 RG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 259 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+ ....|..+++++.+||.+||..||.+|||++++.
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 295 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 43 3346678899999999999999999999999887
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.96 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=202.4
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEE-EEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV-IETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~ylV 123 (708)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+.. +......|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 46899999999999999999999999999999997654322 246789999999998876665554 4677889999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCcEEEEeccCccccCCCC
Q psy2648 124 MEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl---d~~~~iKL~DFGls~~~~~~~ 199 (708)
|||+ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999 9999999875 4579999999999999999999999999999999999999 788999999999998654332
Q ss_pred --------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCCC---
Q psy2648 200 --------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL---RELRERVLRGKYRIP--- 265 (708)
Q Consensus 200 --------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~---~~l~~~i~~~~~~~p--- 265 (708)
.....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+.+. .+....+.......|
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 2345789999999999998887 4899999999999999999999987432 223333333333333
Q ss_pred --CCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 266 --FYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 266 --~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+++++.+||.+||..||.+|||++++.
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 272 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 272 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHH
Confidence 56789999999999999999999999877
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=388.98 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=209.3
Q ss_pred cCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 38 ~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
...-+...++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++|+.++||||+++++++...
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3444556789999999999999999999964 78999999987543 33456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
+.+|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999999886543 58999999999999999999999999999999999999999999999999997
Q ss_pred ccCCC---CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCCC
Q psy2648 194 EFTPG---NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL-------RERVLRGKYR 263 (708)
Q Consensus 194 ~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l-------~~~i~~~~~~ 263 (708)
..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+....+. ......+.+.
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 64322 223456799999999999887774 899999999999999999999976432211 1111122111
Q ss_pred ------C----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 264 ------I----PFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 264 ------~----p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
. +...+.++.++|.+||..||++|||++++.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 308 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 1123457889999999999999999998873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=372.66 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=207.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcC-CCc--EEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVP-TGK--EVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~-tg~--~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.++|++.+.||+|+||.||+|++.. +++ .||||++..... .....+.+.+|+++++.++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4589999999999999999998754 333 699999976543 2345677899999999999999999999998765 8
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
++||||+++++|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999999775 579999999999999999999999999999999999999999999999999997664332
Q ss_pred C----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHH
Q psy2648 200 K----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR--IPFYMSTDC 272 (708)
Q Consensus 200 ~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~--~p~~~s~~~ 272 (708)
. .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+...... .+..+++++
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred cchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 1 2345678899999999887774 79999999999999999 99999999999988888776443 456789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHh-hhh
Q psy2648 273 ENLLKKFLVLNPAKRASLEVSG-EVT 297 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rps~~~~~-~~~ 297 (708)
.++|.+||..||.+|||++++. ++.
T Consensus 255 ~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 255 YNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHH
Confidence 9999999999999999999887 443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=371.05 Aligned_cols=244 Identities=26% Similarity=0.482 Sum_probs=202.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-------- 116 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 116 (708)
.++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 45799999999999999999999999999999999643 3455678899999999999999999998865
Q ss_pred -----CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEecc
Q psy2648 117 -----EKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFG 190 (708)
Q Consensus 117 -----~~~~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFG 190 (708)
...+|+||||+++|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 357899999999999999998654 57889999999999999999999999999999999999999999999999
Q ss_pred CccccCCC---------------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHH
Q psy2648 191 FSNEFTPG---------------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELR 254 (708)
Q Consensus 191 ls~~~~~~---------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~ 254 (708)
++...... ......+||+.|+|||++.+....+.++|||||||++|+|++ ||.. .+..++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 98765321 223456799999999999865433589999999999999998 6653 3445666
Q ss_pred HHHHcCCCCCCC----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 255 ERVLRGKYRIPF----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 255 ~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+......+|. ..++.+.+||.+||..||.+|||++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 282 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHh
Confidence 777766555543 4567799999999999999999999887
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=397.54 Aligned_cols=248 Identities=26% Similarity=0.436 Sum_probs=212.2
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+++|+.++||||+++++++.. +.+||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 445689999999999999999999875 467999999765433 3568899999999999999999999876 67899
Q ss_pred EEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 123 VMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
||||+++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999999999753 569999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLL 276 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li 276 (708)
......+++.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..++...+..+. ...|..+++++.+||
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 414 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 414 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 12234567889999999877774 89999999999999999 999999999999988888763 456778899999999
Q ss_pred HHhhhhCCCCCCCHHHHhhh
Q psy2648 277 KKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~~~ 296 (708)
.+||..||.+|||++++...
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999998743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=369.37 Aligned_cols=247 Identities=23% Similarity=0.418 Sum_probs=213.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE-E
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL-Y 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-y 121 (708)
-.|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+|+.++||||+++++++.+.+.. |
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 368888999999999999999876665 79999997532 345567889999999999999999999999876655 9
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC--
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-- 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-- 198 (708)
+||||+.+|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999999763 56899999999999999999999999999999999999999999999999999755322
Q ss_pred ---CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 199 ---NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 199 ---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
.......+++.|+|||++.+..++ +++|||||||++|+|++ |.+||...+..++...+..+. ...|...++++.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 223456788999999999988774 89999999999999999 566677777777777777664 456777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+|||++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll 279 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLV 279 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHH
Confidence 999999999999999999877
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=412.73 Aligned_cols=245 Identities=28% Similarity=0.441 Sum_probs=213.5
Q ss_pred eEE-EeEEcccCceEEEEEEE--cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 48 YKL-LKTIGKGNFAKVKLAKH--VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 48 Y~i-~~~LG~G~fg~V~la~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+.+ .+.||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+++|+.++|||||+++++++. +.+||||
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~ 448 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 448 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEE
Confidence 444 35899999999999955 4677899999998765555567789999999999999999999999975 4589999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC----
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---- 200 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~---- 200 (708)
|||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999987644321
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKK 278 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~ 278 (708)
.....||+.|+|||++.+..++ .++|||||||+||+|++ |+.||.+.+..++.+.+..+. ...|..+++++.+||.+
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 607 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 607 (635)
T ss_dssp ------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 2234577889999999887775 89999999999999998 999999999999999988875 45678899999999999
Q ss_pred hhhhCCCCCCCHHHHh
Q psy2648 279 FLVLNPAKRASLEVSG 294 (708)
Q Consensus 279 ~L~~dP~~Rps~~~~~ 294 (708)
||..||++||+++++.
T Consensus 608 cl~~dP~~RPs~~~l~ 623 (635)
T 4fl3_A 608 CWTYDVENRPGFAAVE 623 (635)
T ss_dssp HTCSSTTTSCCHHHHH
T ss_pred HcCCCHhHCcCHHHHH
Confidence 9999999999999877
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=378.81 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=209.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCC-cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCC------eeeEEEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTG-KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN------IVKLFQVIE 115 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~ 115 (708)
...++|++.+.||+|+||.||+|.+..++ +.||||++... ....+.+.+|+++|+.++|++ |+.+++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 34578999999999999999999998877 68999999643 344566788999999987765 999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---------------
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL--------------- 178 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl--------------- 178 (708)
..+.+||||||+ +++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 678888887664 69999999999999999999999999999999999999
Q ss_pred ----cCCCcEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q psy2648 179 ----DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR 254 (708)
Q Consensus 179 ----d~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~ 254 (708)
+.++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 6678999999999976432 33567899999999999988875 7999999999999999999999988776654
Q ss_pred HHHHcCCCCCC--------------------------------------------CCCCHHHHHHHHHhhhhCCCCCCCH
Q psy2648 255 ERVLRGKYRIP--------------------------------------------FYMSTDCENLLKKFLVLNPAKRASL 290 (708)
Q Consensus 255 ~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~dP~~Rps~ 290 (708)
..+......+| ...++++.+||++||+.||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 44432111111 0113578899999999999999999
Q ss_pred HHHh---hhhh
Q psy2648 291 EVSG---EVTL 298 (708)
Q Consensus 291 ~~~~---~~~~ 298 (708)
++++ |+..
T Consensus 329 ~e~l~hp~f~~ 339 (355)
T 2eu9_A 329 AEALLHPFFAG 339 (355)
T ss_dssp HHHTTSGGGGG
T ss_pred HHHhcChhhcC
Confidence 9987 7653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=371.47 Aligned_cols=244 Identities=26% Similarity=0.416 Sum_probs=198.8
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHh--CCCCCeeeEEEEEEe----
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM--LDHPNIVKLFQVIET---- 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~---- 116 (708)
...++|++++.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 4457899999999999999999988 6899999998643 34556678888776 899999999998654
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEEcCCCcEEEEe
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH--------QKKIIHRDLKAENLLLDSEMNIKIAD 188 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH--------~~gIvHRDLKPeNILld~~~~iKL~D 188 (708)
...+|+||||+++|+|.+++. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 246899999999999999984 567999999999999999999999 99999999999999999999999999
Q ss_pred ccCccccCCCCC-----ccccccCCcccccccccCCccC-----CCchhHHHHHHHHHHHHcC----------CCCCCCC
Q psy2648 189 FGFSNEFTPGNK-----LDTFCGSPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSG----------SLPFDGS 248 (708)
Q Consensus 189 FGls~~~~~~~~-----~~~~~Gt~~Y~APE~l~~~~~~-----~~~~DIWSlGvilyelltG----------~~Pf~~~ 248 (708)
||++........ ....+||+.|+|||++.+.... ++++|||||||++|+|++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999976543221 2345899999999999876321 2689999999999999999 8898653
Q ss_pred -----CHHHHHHHHHcCCC--CCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 249 -----TLRELRERVLRGKY--RIPF-----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 249 -----~~~~l~~~i~~~~~--~~p~-----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+...+..... .+|. ..++++.+||.+||+.||.+|||++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 23344333332221 2221 1346799999999999999999999887
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=385.79 Aligned_cols=240 Identities=18% Similarity=0.281 Sum_probs=202.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCC--------CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeee--------
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPT--------GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVK-------- 109 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~t--------g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-------- 109 (708)
++|++.+.||+|+||.||+|++..+ ++.||||++.+. +.+.+|+++++.++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 6899999999999999999999884 889999999754 24778999999999999988
Q ss_pred -------EEEEEEe-CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 110 -------LFQVIET-EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 110 -------l~~~~~~-~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
+++++.. ...+||||||+ +++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 6777766 78899999999 99999999876 7899999999999999999999999999999999999999
Q ss_pred CCC--cEEEEeccCccccCCCC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-
Q psy2648 180 SEM--NIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS- 248 (708)
Q Consensus 180 ~~~--~iKL~DFGls~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~- 248 (708)
.++ .+||+|||+++.+.... .....+||+.|+|||++.+..++ .++|||||||+||+|++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccCC
Confidence 998 89999999997654321 12345899999999999988774 8999999999999999999999875
Q ss_pred -CHHHHHHHH---HcCCCCCCC------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 249 -TLRELRERV---LRGKYRIPF------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 249 -~~~~l~~~i---~~~~~~~p~------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+.... ......++. .+++++.+||.+||..||.+||+++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 333333332 222222221 4689999999999999999999999887
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=370.85 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=210.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD--HPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~yl 122 (708)
-++|++++.||+|+||.||+|.+. +++.||||++..........+.+.+|+++|+.++ ||||+++++++.....+||
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 346999999999999999999985 5899999999877666667788999999999997 5999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--- 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--- 199 (708)
||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 999 668899999998889999999999999999999999999999999999999974 899999999998664332
Q ss_pred CccccccCCcccccccccC-----------CccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCC--CCCC
Q psy2648 200 KLDTFCGSPPYAAPELFQG-----------KKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVLRGK--YRIP 265 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~-----------~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~~~~--~~~p 265 (708)
.....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.... .......+.... ..+|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CC-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccC-CchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 2245689999999999976 233 478999999999999999999998753 333344444443 3456
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 266 FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 266 ~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
...+.++.+||.+||..||.+||++++++ |+...
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 67789999999999999999999999987 77653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=392.37 Aligned_cols=251 Identities=25% Similarity=0.459 Sum_probs=191.6
Q ss_pred ccCCeEE-EeEEcccCceEEEEEEEc--CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CC
Q psy2648 44 HIGKYKL-LKTIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EK 118 (708)
Q Consensus 44 ~~~~Y~i-~~~LG~G~fg~V~la~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 118 (708)
..+.|++ .++||+|+||.||+|+++ .+++.||||++...... ..+.+|+.+|+.|+|||||++++++.. ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3456887 568999999999999977 57899999999765433 357799999999999999999999955 67
Q ss_pred EEEEEEeccCCCChHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCcEE
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG---------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL----DSEMNIK 185 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~---------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl----d~~~~iK 185 (708)
.+||||||+.+ +|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 89999999975 8888876432 49999999999999999999999999999999999999 7788999
Q ss_pred EEeccCccccCCC----CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------H
Q psy2648 186 IADFGFSNEFTPG----NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR---------E 252 (708)
Q Consensus 186 L~DFGls~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~---------~ 252 (708)
|+|||+++.+... ......+||+.|+|||++.+....+.++|||||||+||+|++|..||.+.+.. +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999999865432 23456789999999999988654468999999999999999999999865431 2
Q ss_pred HHHHHHc--CCCC------------------------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 253 LRERVLR--GKYR------------------------------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 253 l~~~i~~--~~~~------------------------------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+.. +... .....++++.+||.+||+.||.+|||+++++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 2222221 1000 0011267899999999999999999999998
Q ss_pred ---hhhhC
Q psy2648 295 ---EVTLG 299 (708)
Q Consensus 295 ---~~~~~ 299 (708)
|+...
T Consensus 333 ~hp~f~~~ 340 (405)
T 3rgf_A 333 QDPYFLED 340 (405)
T ss_dssp TSGGGTSS
T ss_pred cChhhccC
Confidence 87643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=379.42 Aligned_cols=250 Identities=34% Similarity=0.568 Sum_probs=181.7
Q ss_pred CCCccCCeEEEe-EEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe---
Q psy2648 41 DEPHIGKYKLLK-TIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--- 116 (708)
Q Consensus 41 ~~~~~~~Y~i~~-~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--- 116 (708)
.....++|++.+ .||+|+||.||+|.+..+++.||||++... ... ..+....++.++||||++++++++.
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 345567999965 699999999999999999999999999653 111 1222334567899999999999976
Q ss_pred -CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCcEEEEecc
Q psy2648 117 -EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFG 190 (708)
Q Consensus 117 -~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~~iKL~DFG 190 (708)
...+|||||||++|+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998764 6999999999999999999999999999999999999986 4559999999
Q ss_pred CccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHcCCCCCC-
Q psy2648 191 FSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL----RERVLRGKYRIP- 265 (708)
Q Consensus 191 ls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l----~~~i~~~~~~~p- 265 (708)
++..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+ ...+..+.+.+|
T Consensus 177 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 177 FAKETTQ-NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp TCEEC-----------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred cceeccc-cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 9976543 334567899999999999888775 799999999999999999999987654443 334444444443
Q ss_pred ---CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 266 ---FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 266 ---~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
..+++++.+||.+||..||.+|||+++++ |+..
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 36789999999999999999999999988 8764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=368.67 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=207.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.|.....||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3444458999999999999999999999999997653 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCcEEEEeccCccccCCC-CCc
Q psy2648 127 ASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-EMNIKIADFGFSNEFTPG-NKL 201 (708)
Q Consensus 127 ~~gg~L~~~i~~~~---~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-~~~iKL~DFGls~~~~~~-~~~ 201 (708)
+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ...
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 99999999998652 4678899999999999999999999999999999999997 899999999999765432 223
Q ss_pred cccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HH-HHH-HHHcCCCCCCCCCCHHHHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RE-LRE-RVLRGKYRIPFYMSTDCENLLK 277 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~-l~~-~i~~~~~~~p~~~s~~~~~Li~ 277 (708)
....|++.|+|||++.+.. ..+.++|||||||++|+|++|..||..... .. +.. ........+|..+++++.+||.
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 260 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHH
Confidence 4568999999999997643 124789999999999999999999976432 22 222 2233345677788999999999
Q ss_pred HhhhhCCCCCCCHHHHh---hhh
Q psy2648 278 KFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+||..||++||++++++ |+.
T Consensus 261 ~~l~~dp~~Rps~~~ll~~~~~~ 283 (295)
T 2clq_A 261 KCFEPDPDKRACANDLLVDEFLK 283 (295)
T ss_dssp HTTCSSTTTSCCHHHHHTSGGGC
T ss_pred HHccCChhhCCCHHHHhcChhhh
Confidence 99999999999999987 664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=375.77 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=204.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET----EKTL 120 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 120 (708)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+++++.++||||+++++++.. ...+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 35799999999999999999999999999999998653 34556778899999999999999999999863 3478
Q ss_pred EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 121 YLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
|+||||+.+|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999999876 3679999999999999999999999999999999999999999999999999987543
Q ss_pred CCC----------CccccccCCcccccccccCCcc--CCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcC-C
Q psy2648 197 PGN----------KLDTFCGSPPYAAPELFQGKKY--DGPEVDVWSLGVILYTLVSGSLPFDGST--LRELRERVLRG-K 261 (708)
Q Consensus 197 ~~~----------~~~~~~Gt~~Y~APE~l~~~~~--~~~~~DIWSlGvilyelltG~~Pf~~~~--~~~l~~~i~~~-~ 261 (708)
... ......||+.|+|||++.+... .++++|||||||++|+|++|..||.... ...+...+... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence 211 0123467999999999976542 2479999999999999999999995411 01122222221 2
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 262 YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 262 ~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
.+.+...++++.+||.+||..||.+|||++++..
T Consensus 266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2334567899999999999999999999999883
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=376.27 Aligned_cols=248 Identities=29% Similarity=0.417 Sum_probs=208.7
Q ss_pred ccCCe-EEEeEEcccCceEEEEEEE----cCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-
Q psy2648 44 HIGKY-KLLKTIGKGNFAKVKLAKH----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE- 117 (708)
Q Consensus 44 ~~~~Y-~i~~~LG~G~fg~V~la~~----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 117 (708)
.-++| ++++.||+|+||.||+|.+ ..+++.||||++... ......+.+.+|+++|+.++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 34455 9999999999999988764 458899999999765 3445567789999999999999999999999884
Q ss_pred -CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 118 -KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 118 -~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
..+|+||||+++|+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 689999999999999999865 459999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHH
Q psy2648 197 PGNK----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR---------------ELRERV 257 (708)
Q Consensus 197 ~~~~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~---------------~l~~~i 257 (708)
.... .....|++.|+|||++.+..++ .++|||||||++|+|++|..||...... ++.+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 4332 2345688899999999888775 7999999999999999999999764221 233334
Q ss_pred HcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 258 LRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 258 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+ ....|..+++++.+||.+||..||.+|||++++.
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 302 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 433 3356778899999999999999999999999887
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=377.96 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=189.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVR-IMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
....++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+. +++.++||||+++++++...+.+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 445679999999999999999999999999999999997653 3334455666666 77788999999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 121 YLVMEYASGGEVFDYLVL-----HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~-----~~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
||||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999999986 78877763 56799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccCCcccccccc----cCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCC-CCC---
Q psy2648 195 FTPGNKLDTFCGSPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGKY-RIP--- 265 (708)
Q Consensus 195 ~~~~~~~~~~~Gt~~Y~APE~l----~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~~-~~p--- 265 (708)
..........+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.+.+. .+....+..+.. .++
T Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254 (327)
T ss_dssp ------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred cccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence 6554444456899999999998 34445 4799999999999999999999987532 222222333322 222
Q ss_pred -CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 266 -FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 266 -~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
...++++.+||.+||..||.+|||++++. |+.
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 35789999999999999999999999987 665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=376.32 Aligned_cols=243 Identities=30% Similarity=0.438 Sum_probs=186.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEE--------e
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIE--------T 116 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--------~ 116 (708)
.+|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.+. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3799999999999999999999999999999998654 3445567889999999996 999999999984 3
Q ss_pred CCEEEEEEeccCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVL---HGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~---~~~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
...+|+||||+. |+|.+++.. .+.+++.+++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 446899999996 699998865 467999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCC-------------ccccccCCcccccccc---cCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q psy2648 192 SNEFTPGNK-------------LDTFCGSPPYAAPELF---QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRE 255 (708)
Q Consensus 192 s~~~~~~~~-------------~~~~~Gt~~Y~APE~l---~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~ 255 (708)
+........ ....+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.+.....+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 976543221 1256799999999998 44444 479999999999999999999998765444332
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
... ....+...+.++.+||.+||+.||.+|||++++.
T Consensus 264 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 300 (337)
T 3ll6_A 264 GKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300 (337)
T ss_dssp --C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Ccc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHH
Confidence 211 1233456678899999999999999999999887
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=384.07 Aligned_cols=251 Identities=29% Similarity=0.396 Sum_probs=211.3
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CC-----CeeeEEEE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HP-----NIVKLFQV 113 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~ 113 (708)
..+...++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+++++.++ |+ +|++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3445578999999999999999999999999999999999743 334566778999998885 55 49999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEEc--CCCcEEEE
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCH--QKKIIHRDLKAENLLLD--SEMNIKIA 187 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH--~~gIvHRDLKPeNILld--~~~~iKL~ 187 (708)
+...+.+||||||+.+ +|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999964 999999876 46999999999999999999999 57999999999999995 47789999
Q ss_pred eccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Q psy2648 188 DFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---- 263 (708)
Q Consensus 188 DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---- 263 (708)
|||+++.... .....+||+.|+|||++.+..|+ .++|||||||+||+|++|+.||.+.+..+....+......
T Consensus 204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccCceeccc--ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999976543 34567899999999999988875 8999999999999999999999998887776666532100
Q ss_pred --------------CC-------------------CC---------------------------CCHHHHHHHHHhhhhC
Q psy2648 264 --------------IP-------------------FY---------------------------MSTDCENLLKKFLVLN 283 (708)
Q Consensus 264 --------------~p-------------------~~---------------------------~s~~~~~Li~~~L~~d 283 (708)
+| .. .++++.+||.+||+.|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 00 00 0137899999999999
Q ss_pred CCCCCCHHHHh---hhh
Q psy2648 284 PAKRASLEVSG---EVT 297 (708)
Q Consensus 284 P~~Rps~~~~~---~~~ 297 (708)
|.+|||+++++ |+.
T Consensus 361 P~~Rpta~e~L~hp~f~ 377 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFK 377 (382)
T ss_dssp TTTSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccc
Confidence 99999999987 664
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=386.85 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=203.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCC---cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCCEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTG---KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE-TEKTLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~y 121 (708)
..|++.+.||+|+||.||+|.+..++ ..||||+++... .....+.+.+|+.+|+.++||||+++++++. .++..|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 46899999999999999999986443 468999986532 3455678999999999999999999999864 456889
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999999765 358899999999999999999999999999999999999999999999999997653322
Q ss_pred ----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHH
Q psy2648 200 ----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCE 273 (708)
Q Consensus 200 ----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~-~~p~~~s~~~~ 273 (708)
......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+.. ..|..+++++.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 12334678899999999887774 89999999999999999 7889988777777777777654 45677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+||+++++.
T Consensus 327 ~li~~cl~~dp~~RPs~~ell 347 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELV 347 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHH
Confidence 999999999999999999887
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=401.94 Aligned_cols=249 Identities=26% Similarity=0.439 Sum_probs=217.1
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
+...++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+++|+.|+|||||++++++.. +.+|
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 3445689999999999999999999875 467999999765433 3568899999999999999999999866 6789
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
|||||+.+|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999999753 569999999999999999999999999999999999999999999999999997654321
Q ss_pred --CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 200 --KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
......+++.|+|||++.+..++ .++|||||||+||||++ |..||.+.+..++...+..+. ...|..+++++.+|
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 12234567889999999877774 79999999999999999 999999999999988888763 34567889999999
Q ss_pred HHHhhhhCCCCCCCHHHHhhh
Q psy2648 276 LKKFLVLNPAKRASLEVSGEV 296 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~~~ 296 (708)
|.+||..||++|||++++...
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999998843
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=405.86 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=211.2
Q ss_pred CCeEEEe-EEcccCceEEEEEEEcC--CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 46 GKYKLLK-TIGKGNFAKVKLAKHVP--TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 46 ~~Y~i~~-~LG~G~fg~V~la~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
++|.+.+ .||+|+||.||+|.++. ++..||||++++.. .....+.+.+|+++|+.++|||||+++++++. +.+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 4566666 89999999999998763 56679999997653 33456789999999999999999999999986 56999
Q ss_pred EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC-
Q psy2648 123 VMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK- 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~- 200 (708)
|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 99999999999999754 4599999999999999999999999999999999999999999999999999987643321
Q ss_pred ---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 201 ---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 201 ---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
.....+++.|+|||++.+..++ .++|||||||+||||++ |+.||.+.+..++...+..+. ...|..+++++.+|
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 571 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 571 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 1223456899999999877775 79999999999999998 999999999889999888875 35677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+||+++++.
T Consensus 572 i~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 572 MSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHTTCSSTTTSCCHHHHH
T ss_pred HHHHcCCChhHCcCHHHHH
Confidence 9999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.23 Aligned_cols=240 Identities=32% Similarity=0.490 Sum_probs=199.7
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|+++|+.++||||+++++++.+ ..|+|
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 4568999999999999999999884 789999998643 345678899999999999999999998764 47999
Q ss_pred EeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCCEEEcCCCc-EEEEeccCccccC
Q psy2648 124 MEYASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQ---KKIIHRDLKAENLLLDSEMN-IKIADFGFSNEFT 196 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~---~l~e~~~~~i~~QI~~aL~yLH~---~gIvHRDLKPeNILld~~~~-iKL~DFGls~~~~ 196 (708)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999999998655 37899999999999999999999 89999999999999998887 7999999987543
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS--TLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~--~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||... ....+...+..+. ...+..+++++.
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 158 T--HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred c--ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence 2 23445799999999999988774 7999999999999999999999854 3344444454443 345667899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||..||.+|||++++.
T Consensus 235 ~li~~~l~~dp~~Rps~~ell 255 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIV 255 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHH
Confidence 999999999999999999887
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=378.71 Aligned_cols=250 Identities=22% Similarity=0.396 Sum_probs=204.7
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-----------CCCeeeE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-----------HPNIVKL 110 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l 110 (708)
....++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++ ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 33457899999999999999999999999999999999743 334566789999998886 8999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEc----
Q psy2648 111 FQVIETEK----TLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLD---- 179 (708)
Q Consensus 111 ~~~~~~~~----~~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~-gIvHRDLKPeNILld---- 179 (708)
++++...+ .+++||||+ +++|.+++... ..+++.+++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998654 799999999 89999999874 4599999999999999999999998 999999999999994
Q ss_pred --CCCcEEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH------H
Q psy2648 180 --SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL------R 251 (708)
Q Consensus 180 --~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~------~ 251 (708)
..+.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||+||+|++|..||.+.+. .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 444799999999976543 23456899999999999988874 899999999999999999999986541 1
Q ss_pred HHHHHHH------------------------------------------cCCCCCCCCCCHHHHHHHHHhhhhCCCCCCC
Q psy2648 252 ELRERVL------------------------------------------RGKYRIPFYMSTDCENLLKKFLVLNPAKRAS 289 (708)
Q Consensus 252 ~l~~~i~------------------------------------------~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps 289 (708)
+....+. ...+.+|...++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111 1122233345678899999999999999999
Q ss_pred HHHHh---hhhh
Q psy2648 290 LEVSG---EVTL 298 (708)
Q Consensus 290 ~~~~~---~~~~ 298 (708)
+++++ |+..
T Consensus 328 ~~ell~hp~f~~ 339 (373)
T 1q8y_A 328 AGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhhChhhhc
Confidence 99988 7764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=381.02 Aligned_cols=240 Identities=17% Similarity=0.283 Sum_probs=197.7
Q ss_pred cCCeEEEeEEcccCceEEEEE-----EEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC---CCCeeeEEEEEEe
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLA-----KHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD---HPNIVKLFQVIET 116 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la-----~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~ 116 (708)
-++|++.+.||+|+||.||+| .+..+++.||||++... ....+.+|+++++.+. ||||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 357999999999999999999 57789999999999754 2345778888888887 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-----------
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVL-----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS----------- 180 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~-----~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~----------- 180 (708)
.+..|||||||++|+|.+++.. ...+++.+++.++.||+.||+|||++|||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred CCcEEEEeccCccccC---CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q psy2648 181 EMNIKIADFGFSNEFT---PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERV 257 (708)
Q Consensus 181 ~~~iKL~DFGls~~~~---~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i 257 (708)
++.+||+|||+++... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||........ .
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~--~- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC--K- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE--E-
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCce--e-
Confidence 8999999999996542 33445678899999999999998875 899999999999999999999965321100 0
Q ss_pred HcCCCCCCCCCCHHHHHHHHHhhhhCCCCCC-CHHHHh
Q psy2648 258 LRGKYRIPFYMSTDCENLLKKFLVLNPAKRA-SLEVSG 294 (708)
Q Consensus 258 ~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp-s~~~~~ 294 (708)
....+. ....++.+.+++.+||..+|.+|+ +++++.
T Consensus 295 ~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 295 PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 001111 123467899999999999999995 455443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=376.30 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=213.7
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
...+...++|++.+.||+|+||.||+|.+.. .||||++..........+.+.+|+.+++.++||||+++++++.+..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 4445567899999999999999999999854 4999999866544444456778999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
.+|+||||+++++|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999999997654 699999999999999999999999999999999999998 68999999999865421
Q ss_pred ------CCCccccccCCcccccccccCC---------ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q psy2648 198 ------GNKLDTFCGSPPYAAPELFQGK---------KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY 262 (708)
Q Consensus 198 ------~~~~~~~~Gt~~Y~APE~l~~~---------~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~ 262 (708)
........||+.|+|||++.+. .+ +.++|||||||++|+|++|..||.+.+..++...+..+..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF-SKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCC-CHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 1233456799999999999752 23 4789999999999999999999999999988888877754
Q ss_pred CC--CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 263 RI--PFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 263 ~~--p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
.. +..++.++.+||.+||..||.+|||++++..
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 32 2357889999999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.93 Aligned_cols=250 Identities=29% Similarity=0.414 Sum_probs=210.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAK----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
....++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+++|+.++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3445689999999999999999999 4678999999999764 344567789999999999999999999998664
Q ss_pred C--EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 118 K--TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 118 ~--~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
+ .+|+||||+++++|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 3 689999999999999999876 4699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCH----------------HHHH
Q psy2648 195 FTPGNK----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTL----------------RELR 254 (708)
Q Consensus 195 ~~~~~~----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~----------------~~l~ 254 (708)
...... .....+++.|+|||++.+..++ .++|||||||++|+|++|..||..... ..+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 644322 2234677889999999887774 799999999999999999999864311 1223
Q ss_pred HHHHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 255 ERVLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 255 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+..+ ....|..+++++.+||.+||..||.+|||++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 314 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 333333 3456778899999999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.48 Aligned_cols=243 Identities=27% Similarity=0.433 Sum_probs=198.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC--CCCCeeeEEEEEEeC----
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML--DHPNIVKLFQVIETE---- 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~---- 117 (708)
..++|++.+.||+|+||.||+|++. ++.||||++... ......+|.+++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3468999999999999999999885 899999998643 234455666666554 899999999999887
Q ss_pred CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEcCCCcEEEEec
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK--------KIIHRDLKAENLLLDSEMNIKIADF 189 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~--------gIvHRDLKPeNILld~~~~iKL~DF 189 (708)
..+|+||||+++|+|.+++.. ..+++.++..++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 789999999999999999964 5799999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCC-----ccccccCCcccccccccCCccCCC-----chhHHHHHHHHHHHHcC----------CCCCCCC-
Q psy2648 190 GFSNEFTPGNK-----LDTFCGSPPYAAPELFQGKKYDGP-----EVDVWSLGVILYTLVSG----------SLPFDGS- 248 (708)
Q Consensus 190 Gls~~~~~~~~-----~~~~~Gt~~Y~APE~l~~~~~~~~-----~~DIWSlGvilyelltG----------~~Pf~~~- 248 (708)
|++..+..... ....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99976543221 235689999999999987765432 38999999999999999 7787653
Q ss_pred ----CHHHHHHHHHcCCC--CCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 249 ----TLRELRERVLRGKY--RIPF-----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 249 ----~~~~l~~~i~~~~~--~~p~-----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+...+..... .+|. ..++++.+||.+||..||.+|||++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 33444444433322 2232 2346689999999999999999999887
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=387.14 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=208.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH-PNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~y 121 (708)
...++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.|+| ++|..+..++......|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999998765432 236789999999987 56666777777888999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCcEEEEeccCccccCC
Q psy2648 122 LVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---DSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILl---d~~~~iKL~DFGls~~~~~ 197 (708)
|||||+ +++|.+++.. ...+++.+++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 4679999999999999999999999999999999999999 6889999999999987644
Q ss_pred CCC--------ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCC----
Q psy2648 198 GNK--------LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST---LRELRERVLRGKY---- 262 (708)
Q Consensus 198 ~~~--------~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~---~~~l~~~i~~~~~---- 262 (708)
... ....+||+.|+|||++.+..++ .++|||||||+||+|++|+.||.+.. ..+.+.++.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 321 2367899999999999988874 89999999999999999999998743 3444444433322
Q ss_pred -CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 -RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 -~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.++..+++++.+||.+||..||++||+++++.
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~ 270 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLK 270 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 22356789999999999999999999998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=367.93 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=192.3
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHH--HHhCCCCCeeeEEEEEEe-
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRI--MKMLDHPNIVKLFQVIET- 116 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~~- 116 (708)
.....+++|++++.||+|+||.||+|++ +++.||||++.... ...+..|.++ ++.++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 4456788999999999999999999976 78999999996432 2344445555 446899999999986543
Q ss_pred ----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCCEEEcCCCc
Q psy2648 117 ----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK---------KIIHRDLKAENLLLDSEMN 183 (708)
Q Consensus 117 ----~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~---------gIvHRDLKPeNILld~~~~ 183 (708)
...+|||||||++|+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 23689999999999999998654 568999999999999999999999 9999999999999999999
Q ss_pred EEEEeccCccccCCC---------CCccccccCCcccccccccCC-------ccCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2648 184 IKIADFGFSNEFTPG---------NKLDTFCGSPPYAAPELFQGK-------KYDGPEVDVWSLGVILYTLVSGSLPFDG 247 (708)
Q Consensus 184 iKL~DFGls~~~~~~---------~~~~~~~Gt~~Y~APE~l~~~-------~~~~~~~DIWSlGvilyelltG~~Pf~~ 247 (708)
+||+|||++..+... ......+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||..
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999765422 122356899999999999873 33 3689999999999999999777643
Q ss_pred C------------------CHHHHHHHHHcCC--CCCCCC------CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 248 S------------------TLRELRERVLRGK--YRIPFY------MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 248 ~------------------~~~~l~~~i~~~~--~~~p~~------~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
. ...++...+.... ..+|.. .++++.+||.+||..||.+|||++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l 310 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence 1 1122222222221 223332 234799999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=373.08 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=202.2
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++.+.||+|+||.||+|++ .+++.||||++...... .....+.+|+++++.++||||+++++++.+....|+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 3456899999999999999999985 46899999999765422 122357899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 123 VMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQK---KIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~QI~~aL~yLH~~---gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999999999997653 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC--CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHcC-CC--
Q psy2648 196 TPG--NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS--------TLRELRERVLRG-KY-- 262 (708)
Q Consensus 196 ~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~--------~~~~l~~~i~~~-~~-- 262 (708)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ...+........ ..
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred CcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 432 22345679999999999988776 48999999999999999999999521 111111111111 00
Q ss_pred --------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 263 --------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 263 --------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
..+...+.++.+||.+||..||.+|||++++..
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 011112367899999999999999999999883
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.15 Aligned_cols=241 Identities=27% Similarity=0.407 Sum_probs=203.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHh--CCCCCeeeEEEEEEeCC----E
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM--LDHPNIVKLFQVIETEK----T 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~----~ 119 (708)
++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|+++++. ++||||+++++++.... .
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 6899999999999999999998 5899999998643 34567889999987 78999999999998876 8
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH--------QKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH--------~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
+|+||||+++|+|.+++.. ..+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999999965 57999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCC-----CccccccCCcccccccccCCccC-----CCchhHHHHHHHHHHHHcC----------CCCCCCC---
Q psy2648 192 SNEFTPGN-----KLDTFCGSPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSG----------SLPFDGS--- 248 (708)
Q Consensus 192 s~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~~-----~~~~DIWSlGvilyelltG----------~~Pf~~~--- 248 (708)
+....... .....+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 97654433 23456899999999999875321 1589999999999999999 8899764
Q ss_pred --CHHHHHHHHHcCCCC--CCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 249 --TLRELRERVLRGKYR--IPF-----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 249 --~~~~l~~~i~~~~~~--~p~-----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+...+...... +|. ..+..+.+||.+||..||.+|||++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 455666666554332 222 1234688999999999999999999887
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=398.83 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=214.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
..++|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+|+.++|||||++++++. ++.+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 356899999999999999999998754 4579999986532 3445577899999999999999999999984 4668
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
||||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 99999999999999998664 68999999999999999999999999999999999999999999999999998764332
Q ss_pred C--ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 200 K--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 200 ~--~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
. .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+. ...|..+++++.+|
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 624 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 624 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence 2 2234677899999999887774 79999999999999997 999999999999888888764 45778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+|||++++.
T Consensus 625 i~~~l~~dP~~RPs~~el~ 643 (656)
T 2j0j_A 625 MTKCWAYDPSRRPRFTELK 643 (656)
T ss_dssp HHHHTCSSGGGSCCHHHHH
T ss_pred HHHHcCCChhHCcCHHHHH
Confidence 9999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=364.94 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=201.6
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC--ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL--NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
|...+.||+|+||.||+|.+ +++.||||++..... .....+.+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55568999999999999986 688999999976432 23445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---
Q psy2648 126 YASGGEVFDYLVLH---GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--- 199 (708)
Q Consensus 126 y~~gg~L~~~i~~~---~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--- 199 (708)
|+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99999999998743 458999999999999999999999999999999999999999999999999987654322
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCCC-----------C
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR----ELRERVLRGKYR-----------I 264 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~----~l~~~i~~~~~~-----------~ 264 (708)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.... .+.+.+...... .
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 12346799999999998764 4 47999999999999999999999875432 233333322211 1
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 265 PFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 265 p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+...+.++.+||.+||..||.+|||++++.
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~ 298 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 222346789999999999999999999877
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=354.52 Aligned_cols=231 Identities=34% Similarity=0.552 Sum_probs=192.7
Q ss_pred CCCCCccCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHH-HhCCCCCeeeEEEEEEe
Q psy2648 39 ERDEPHIGKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIM-KMLDHPNIVKLFQVIET 116 (708)
Q Consensus 39 ~~~~~~~~~Y~i~-~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~ 116 (708)
......+++|.+. +.||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3445678899998 7899999999999999999999999999642 3467899888 66799999999999987
Q ss_pred ----CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCcEEEE
Q psy2648 117 ----EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIA 187 (708)
Q Consensus 117 ----~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~~iKL~ 187 (708)
...+||||||+++|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 678999999999999999998765 6999999999999999999999999999999999999998 7889999
Q ss_pred eccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHcCCCC
Q psy2648 188 DFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR----ERVLRGKYR 263 (708)
Q Consensus 188 DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~----~~i~~~~~~ 263 (708)
|||++.... +..+ +.++|||||||++|+|++|..||.+.+..... ..+..+.+.
T Consensus 163 Dfg~a~~~~---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 163 DFGFAKETT---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp CCTTCEECT---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccccc---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 999986432 1234 37899999999999999999999876554432 122223334
Q ss_pred CC----CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 264 IP----FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 264 ~p----~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
+| ..+++++.+||.+||..||.+|||+++++ |+..
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 44 46789999999999999999999999988 7753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=376.05 Aligned_cols=242 Identities=26% Similarity=0.457 Sum_probs=190.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~y 121 (708)
..-+.|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+++|+.+ +|||||+++++++++..+|
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 33445677899999999999875 4568999999998653 234578999999876 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCC-------HHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-------------
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMK-------EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE------------- 181 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~-------e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~------------- 181 (708)
||||||. |+|.+++....... +.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999996 59999997654332 33457899999999999999999999999999999754
Q ss_pred CcEEEEeccCccccCCCC-----CccccccCCcccccccccC-------CccCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q psy2648 182 MNIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQG-------KKYDGPEVDVWSLGVILYTLVS-GSLPFDGS 248 (708)
Q Consensus 182 ~~iKL~DFGls~~~~~~~-----~~~~~~Gt~~Y~APE~l~~-------~~~~~~~~DIWSlGvilyellt-G~~Pf~~~ 248 (708)
+.+||+|||+++....+. .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++ |..||.+.
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 489999999998765432 2345689999999999976 334 589999999999999999 99999876
Q ss_pred CHHHHHHHHHcCCCCCCC-------CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 249 TLRELRERVLRGKYRIPF-------YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 249 ~~~~l~~~i~~~~~~~p~-------~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
...+ ..+..+.+..+. .+++++.+||.+||+.||.+|||+++++
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 5443 345555544432 2347899999999999999999999887
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=376.38 Aligned_cols=240 Identities=23% Similarity=0.380 Sum_probs=190.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+|.+.+.||+|+||.|+. ....+++.||||++.+... ..+.+|+++|+.+ +|||||++++++.+...+|||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 499999999999999764 4557899999999975432 2256899999999 79999999999999999999999
Q ss_pred ccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-----CCcEEEEeccCccccCCC-
Q psy2648 126 YASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-----EMNIKIADFGFSNEFTPG- 198 (708)
Q Consensus 126 y~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-----~~~iKL~DFGls~~~~~~- 198 (708)
||. |+|.+++.... .+.+.++..++.||+.||+|||++||+||||||+|||++. ...+||+|||+++....+
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 997 59999997654 4666778899999999999999999999999999999953 235889999999876533
Q ss_pred ---CCccccccCCcccccccccC---CccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC---CCCC
Q psy2648 199 ---NKLDTFCGSPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRI---PFYM 268 (708)
Q Consensus 199 ---~~~~~~~Gt~~Y~APE~l~~---~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~~---p~~~ 268 (708)
......+||+.|+|||++.+ ..+ +.++|||||||++|+|++ |..||...........+....... +...
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred cceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 23345789999999999974 333 468999999999999999 999997766555433322222211 1223
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 269 STDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 269 s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+..+.+||.+||+.||.+|||+++++
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 45689999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=352.42 Aligned_cols=221 Identities=16% Similarity=0.188 Sum_probs=187.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
.-++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+.+|+++++.++||||+++++++++++.+||
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 347899999999999999999999999999999999876543 4556788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~ 202 (708)
||||++|++|.+++.. ...+.++..++.||+.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999999843 34667889999999999999999999999999999999999999998543
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHcCCCC----CCCCCCHHHHHH
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRE---RVLRGKYR----IPFYMSTDCENL 275 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~---~i~~~~~~----~p~~~s~~~~~L 275 (708)
|++| + +.++|||||||+||+|++|+.||.+.+..+... +...+... .+..+++++.+|
T Consensus 175 -------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 175 -------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239 (286)
T ss_dssp -------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred -------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence 3333 3 479999999999999999999998765432110 11122211 234688999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||+.||.+| |++++.
T Consensus 240 i~~~l~~dP~~R-s~~el~ 257 (286)
T 3uqc_A 240 AARSVQGDGGIR-SASTLL 257 (286)
T ss_dssp HHHHHCTTSSCC-CHHHHH
T ss_pred HHHHcccCCccC-CHHHHH
Confidence 999999999999 999887
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=395.99 Aligned_cols=251 Identities=33% Similarity=0.531 Sum_probs=204.2
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET----- 116 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----- 116 (708)
...+++|++.+.||+|+||.||+|.+..+|+.||||++... ......+.+.+|+++|+.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 44568999999999999999999999999999999998754 345566788999999999999999999999765
Q ss_pred -CCEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---EEEEec
Q psy2648 117 -EKTLYLVMEYASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADF 189 (708)
Q Consensus 117 -~~~~ylVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~---iKL~DF 189 (708)
.+..|||||||+||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 667899999999999999998654 5899999999999999999999999999999999999997765 999999
Q ss_pred cCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------H-----
Q psy2648 190 GFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR---------E----- 255 (708)
Q Consensus 190 Gls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~---------~----- 255 (708)
|++............+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.....-. .
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 999887666666678999999999999988875 7999999999999999999999765322110 0
Q ss_pred HHHcCCCCC------CC----CCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGKYRI------PF----YMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~~~~------p~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....+.+.+ |. .+++++.+||.+||..||.+|||+++++
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 001111111 11 2457899999999999999999998766
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=368.03 Aligned_cols=240 Identities=15% Similarity=0.176 Sum_probs=188.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCC-CCe----------------
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDH-PNI---------------- 107 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~H-pnI---------------- 107 (708)
..|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.+.| +|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458999999999999999999999999999999974432 22345678899999999987 221
Q ss_pred -----eeEEEEEEe-----CCEEEEEEeccCCCChHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy2648 108 -----VKLFQVIET-----EKTLYLVMEYASGGEVFDYLVL-------HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 170 (708)
Q Consensus 108 -----v~l~~~~~~-----~~~~ylVmEy~~gg~L~~~i~~-------~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRD 170 (708)
..++.++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111122222 12467788876 5799988842 23467788889999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCccccCCCCCccccccCCcccccccc----------cCCccCCCchhHHHHHHHHHHHHc
Q psy2648 171 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF----------QGKKYDGPEVDVWSLGVILYTLVS 240 (708)
Q Consensus 171 LKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~~~~~~DIWSlGvilyellt 240 (708)
|||+||||+.++.+||+|||+++.... ...+.+| +.|+|||++ .+..| +.++|||||||+||+|++
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHH
Confidence 999999999999999999999875432 3566788 999999999 44455 479999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 241 GSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 241 G~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
|+.||.+.+..+....+... ...+++++.+||.+||+.||.+||++.+++
T Consensus 313 g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999887655444444332 235679999999999999999999998876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=390.28 Aligned_cols=234 Identities=23% Similarity=0.366 Sum_probs=193.6
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE---
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVP-TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT--- 119 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--- 119 (708)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+++|+.++|||||+++++++..+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34899999999999999999999986 78999999986542 34555678899999999999999999999987655
Q ss_pred --EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 120 --LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 120 --~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
+||||||++|++|.+++.. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 7999999999999987653 89999999999999999999999999999999999999985 899999999986643
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~ 277 (708)
. ...+||+.|+|||++.+.. +.++|||||||+||+|++|..||.+.....+. ........++++.+||.
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHHHHHH
T ss_pred C---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHHHHHh
Confidence 3 4568999999999997653 57999999999999999999998753211000 00000123578999999
Q ss_pred HhhhhCCCCCCCHHH
Q psy2648 278 KFLVLNPAKRASLEV 292 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~ 292 (708)
+||..||.+||+..+
T Consensus 303 ~~l~~dP~~R~~~~~ 317 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAE 317 (681)
T ss_dssp HHTCSSGGGSCSSHH
T ss_pred hhccCChhhCCCHHH
Confidence 999999999997543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.69 Aligned_cols=236 Identities=19% Similarity=0.262 Sum_probs=191.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC------ChhhHHHHHHHHHHHHhCC---------CCCeee
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL------NPGSLQKLFREVRIMKMLD---------HPNIVK 109 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------HpnIv~ 109 (708)
.++|++++.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+++|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 789999999987642 2234467889999998885 888888
Q ss_pred EEEEEE------------------------------eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q psy2648 110 LFQVIE------------------------------TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQ 159 (708)
Q Consensus 110 l~~~~~------------------------------~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~ 159 (708)
+++++. ....+|||||||++|++.+.+.. +.+++.+++.++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 877643 26789999999999987777643 67899999999999999999
Q ss_pred HHH-HCCceecCCCCCCEEEcCCC--------------------cEEEEeccCccccCCCCCccccccCCcccccccccC
Q psy2648 160 YCH-QKKIIHRDLKAENLLLDSEM--------------------NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218 (708)
Q Consensus 160 yLH-~~gIvHRDLKPeNILld~~~--------------------~iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~ 218 (708)
||| ++||+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 99999999999999999987 8999999999876532 4589999999999987
Q ss_pred CccCCCchhHHHHHHH-HHHHHcCCCCCCCCCH-HHHHHHHHcC-CCCC------CCCCCHHHHHHHHHhhhhCCCCCCC
Q psy2648 219 KKYDGPEVDVWSLGVI-LYTLVSGSLPFDGSTL-RELRERVLRG-KYRI------PFYMSTDCENLLKKFLVLNPAKRAS 289 (708)
Q Consensus 219 ~~~~~~~~DIWSlGvi-lyelltG~~Pf~~~~~-~~l~~~i~~~-~~~~------p~~~s~~~~~Li~~~L~~dP~~Rps 289 (708)
.. +.++|||||+++ .+++++|..||.+... ..+...+... .+.. +..+++++.+||++||++| |
T Consensus 252 ~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred CC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 76 579999998776 7889999999964321 2233444422 1111 1236788999999999987 8
Q ss_pred HHHHh
Q psy2648 290 LEVSG 294 (708)
Q Consensus 290 ~~~~~ 294 (708)
+++++
T Consensus 325 a~e~l 329 (336)
T 2vuw_A 325 ATDLL 329 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=339.15 Aligned_cols=223 Identities=16% Similarity=0.091 Sum_probs=158.5
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC----C----hhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEE
Q psy2648 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL----N----PGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~----~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~y 121 (708)
...++.|++|.+..++...+|+.||||++.+... . ....+.+.+|+++|+++ .|+||+++++++++++.+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 3456888999999888888999999999987632 1 22345688999999999 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~ 200 (708)
||||||+|++|.++|...+.+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.... ...
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 999999999999999988888865 4789999999999999999999999999999999999999999987653 344
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L 280 (708)
..+.|||+.|||||++.+.. ..++|+||+|+++|+|.++..|| ...+.. .|.. ...+.++...++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~----~~~~-~~~~~~l~~~l~ 460 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ----EPVE-RWNFVLLLALFE 460 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHT----SCGG-GCSHHHHHHHHH
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchh--------HHHhhc----CCCC-CCcHHHHHHHHh
Confidence 56789999999999998764 36799999999999887765543 122211 1111 113456777777
Q ss_pred hhCCCCCCCHH
Q psy2648 281 VLNPAKRASLE 291 (708)
Q Consensus 281 ~~dP~~Rps~~ 291 (708)
..+|..|+...
T Consensus 461 ~~~~~~~~~~~ 471 (569)
T 4azs_A 461 KKAKLPSAEQQ 471 (569)
T ss_dssp TGGGSCCGGGS
T ss_pred CCCCCCCCChh
Confidence 78887777653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=301.27 Aligned_cols=177 Identities=29% Similarity=0.456 Sum_probs=142.3
Q ss_pred CCCCCCCCCcCCCccccccccccccc----------------cCcccccccccCceeEEEEEEEeCCEEEEEEeccCCCC
Q psy2648 435 SGGGGGGGAAQSPSHRGVHRSISASN----------------AKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGE 498 (708)
Q Consensus 435 ~~ggg~~g~v~s~~hr~~~R~i~~~~----------------~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~ 498 (708)
..|.|++|.|+.+.++...+....+. .+........|||||+|+++|++++.+|||||||+|||
T Consensus 39 ~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~ 118 (311)
T 4aw0_A 39 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118 (311)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence 35667777777666655443221111 01112245689999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCC---CcccccccCC
Q psy2648 499 VFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---NKLDTFCGSP 575 (708)
Q Consensus 499 L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~---~~~~~~~Gt~ 575 (708)
|+++|.+.+.++|.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+... ....++|||+
T Consensus 119 L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp 198 (311)
T 4aw0_A 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198 (311)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCG
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCc
Confidence 9999999999999999999999999999999999999999999999999999999999999976433 3456789999
Q ss_pred cccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 576 PYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 576 ~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|||||++.+.. |+.. .|-|++++++=+++.|.|.=
T Consensus 199 ~YmAPEvl~~~~-y~~~-------------------------~DiWSlGvilyeml~G~~PF 234 (311)
T 4aw0_A 199 QYVSPELLTEKS-ACKS-------------------------SDLWALGCIIYQLVAGLPPF 234 (311)
T ss_dssp GGCCHHHHHHSC-BCHH-------------------------HHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCHHHHcCCC-CCcH-------------------------HHHHHHHHHHHHHHhCCCCC
Confidence 999999998654 3322 56677777777777777653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9e-33 Score=289.04 Aligned_cols=145 Identities=47% Similarity=0.737 Sum_probs=119.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|++++.+||||||| +|+|.+++.+++.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 68 ~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~ 146 (275)
T 3hyh_A 68 RLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 146 (275)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC
T ss_pred HHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC
Confidence 3468999999999999999999999999 689999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.++.+||+|||+|+.........+.+||+.|||||++.+..+++.+ .|-|+++++
T Consensus 147 ~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~-------------------------~DiwSlGvi 201 (275)
T 3hyh_A 147 EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE-------------------------VDVWSCGVI 201 (275)
T ss_dssp TTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTH-------------------------HHHHHHHHH
T ss_pred CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCCh-------------------------hhhHHHHHH
Confidence 9999999999999987766667788999999999999876654433 688888999
Q ss_pred HHHHhhCCCCC
Q psy2648 627 TARLNAGRPAK 637 (708)
Q Consensus 627 ~~~~~~~~~~~ 637 (708)
+-+++.|.++=
T Consensus 202 ly~lltg~~PF 212 (275)
T 3hyh_A 202 LYVMLCRRLPF 212 (275)
T ss_dssp HHHHHHSSCSS
T ss_pred HHHHHHCCCCC
Confidence 99999888764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=295.41 Aligned_cols=177 Identities=21% Similarity=0.288 Sum_probs=141.5
Q ss_pred CCCCCCCCcCCCccccccccccccc--------cCcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC
Q psy2648 436 GGGGGGGAAQSPSHRGVHRSISASN--------AKPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG 507 (708)
Q Consensus 436 ~ggg~~g~v~s~~hr~~~R~i~~~~--------~~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~ 507 (708)
.|.|++|.|+...++...+....+. .+........|||||+++++|+++..+|||||||+||+|.++|.+.+
T Consensus 66 lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~ 145 (336)
T 4g3f_A 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS
T ss_pred eccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC
Confidence 4667777777666554433221111 11112345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC-CEEEeeccCccccCCCC------cccccccCCccccc
Q psy2648 508 RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGN------KLDTFCGSPPYAAP 580 (708)
Q Consensus 508 ~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~------~~~~~~Gt~~Y~AP 580 (708)
.+++.+++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+.... ....+|||+.||||
T Consensus 146 ~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAP 225 (336)
T 4g3f_A 146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225 (336)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCH
Confidence 999999999999999999999999999999999999999988 69999999998765432 12357899999999
Q ss_pred ccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCCC
Q psy2648 581 ELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 581 Evl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
|++.+.. ++.. .|-|++++++-+++.|.|+=.
T Consensus 226 E~~~~~~-y~~~-------------------------~DiwSlGvilyemltG~~Pf~ 257 (336)
T 4g3f_A 226 EVVMGKP-CDAK-------------------------VDIWSSCCMMLHMLNGCHPWT 257 (336)
T ss_dssp HHHTTCC-CCTH-------------------------HHHHHHHHHHHHHHHSSCSST
T ss_pred HHHCCCC-CCcH-------------------------HHHHHHHHHHHHHHHCcCCCC
Confidence 9998754 3333 688999999999999988743
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=295.99 Aligned_cols=144 Identities=25% Similarity=0.466 Sum_probs=128.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+|+++|++++.+|||||||+||+|.+++.+ +.++|.+++.|+.||+.||.|||++|||||||||+||||+
T Consensus 126 ~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 204 (346)
T 4fih_A 126 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 204 (346)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC
Confidence 346899999999999999999999999999999998865 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.+|.+||+|||+|+.+... ....++|||+.|||||++.+.. |+.. .|-|++++
T Consensus 205 ~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~-------------------------~DiWSlGv 258 (346)
T 4fih_A 205 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPE-------------------------VDIWSLGI 258 (346)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTH-------------------------HHHHHHHH
T ss_pred CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCC-CCcH-------------------------HHHHHHHH
Confidence 9999999999999877543 4567889999999999997654 3333 68889999
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-+++.|.|.=
T Consensus 259 ilyeml~G~~PF 270 (346)
T 4fih_A 259 MVIEMVDGEPPY 270 (346)
T ss_dssp HHHHHHHSSCTT
T ss_pred HHHHHHHCCCCC
Confidence 999999998863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=290.67 Aligned_cols=146 Identities=32% Similarity=0.455 Sum_probs=126.1
Q ss_pred ccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 466 RASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 466 ~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
.....|||||+++++|++++.+|||||||+||+|.++|.+.+.+++.+++.++.||+.||.|||++|||||||||+|||+
T Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 159 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159 (304)
T ss_dssp CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE
Confidence 34568999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.+|.+||+|||+|+.... .....+.|||+.|||||++.+..+ +.+ .|-|+++
T Consensus 160 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~-------------------------~DiwSlG 213 (304)
T 3ubd_A 160 DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQS-------------------------ADWWSFG 213 (304)
T ss_dssp CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCC-CTH-------------------------HHHHHHH
T ss_pred cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCC-CCC-------------------------CcccchH
Confidence 9999999999999987543 345567899999999999986543 322 4667777
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
+++-+++.|.+.=
T Consensus 214 vilyemltG~~PF 226 (304)
T 3ubd_A 214 VLMFEMLTGTLPF 226 (304)
T ss_dssp HHHHHHHHSSCSS
T ss_pred HHHHHHHhCCCCC
Confidence 7777777777653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=295.54 Aligned_cols=156 Identities=24% Similarity=0.397 Sum_probs=120.9
Q ss_pred CCCCCCCCCcCCCcccccccccccccc---------------CcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCH
Q psy2648 435 SGGGGGGGAAQSPSHRGVHRSISASNA---------------KPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEV 499 (708)
Q Consensus 435 ~~ggg~~g~v~s~~hr~~~R~i~~~~~---------------~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L 499 (708)
..|.|++|.|+...++...+....+.. +........|||||+++++|++++.+|||||||+||+|
T Consensus 31 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L 110 (350)
T 4b9d_A 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL 110 (350)
T ss_dssp EC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 356777887776666544432221110 11112346899999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCC-cccccccCCc
Q psy2648 500 FDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPP 576 (708)
Q Consensus 500 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~ 576 (708)
.++|..++ .++|.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...... ...+.|||+.
T Consensus 111 ~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~ 190 (350)
T 4b9d_A 111 FKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190 (350)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCT
T ss_pred HHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCcc
Confidence 99997543 57999999999999999999999999999999999999999999999999998765432 3456799999
Q ss_pred ccccccccCCCCcc
Q psy2648 577 YAAPELFQGGAPVT 590 (708)
Q Consensus 577 Y~APEvl~g~~~~~ 590 (708)
|||||++.+..+..
T Consensus 191 YmAPE~l~~~~y~~ 204 (350)
T 4b9d_A 191 YLSPEICENKPYNN 204 (350)
T ss_dssp TCCHHHHTTCCCCH
T ss_pred ccCHHHHCCCCCCc
Confidence 99999998765433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=298.41 Aligned_cols=144 Identities=25% Similarity=0.466 Sum_probs=128.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+|+++|++++.+|||||||+||+|.+++.. +.++|.+++.|+.||+.||.|||++|||||||||+||||+
T Consensus 203 ~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~ 281 (423)
T 4fie_A 203 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 281 (423)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred HhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 346899999999999999999999999999999998864 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.+|.+||+|||+|+.+... ....++|||++|||||++.+.. |+.. .|-|++++
T Consensus 282 ~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~-------------------------~DiWSlGv 335 (423)
T 4fie_A 282 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPE-------------------------VDIWSLGI 335 (423)
T ss_dssp TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC-BCTH-------------------------HHHHHHHH
T ss_pred CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCC-CCcH-------------------------HHHHHHHH
Confidence 9999999999999877543 4567889999999999997654 3333 68889999
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-+++.|.|.=
T Consensus 336 ilyeml~G~~PF 347 (423)
T 4fie_A 336 MVIEMVDGEPPY 347 (423)
T ss_dssp HHHHHHHSSCTT
T ss_pred HHHHHHHCCCCC
Confidence 999999998863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=281.84 Aligned_cols=143 Identities=25% Similarity=0.421 Sum_probs=125.8
Q ss_pred cccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 540 (708)
....|||||+++++|++ +..+|||||||+||+|.++|.+.+.+++..++.++.||+.||.|||+++ ||||||||
T Consensus 80 ~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp 159 (290)
T 3fpq_A 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp HTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCG
T ss_pred HhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccCh
Confidence 45689999999999976 3569999999999999999999999999999999999999999999998 99999999
Q ss_pred CCeeecC-CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 541 ENLLLDS-EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 541 ~NILl~~-~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
+|||++. ++.+||+|||+|+... .....+.+||+.|||||++.+. ++.. .|
T Consensus 160 ~NILl~~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~~--y~~~-------------------------~D 211 (290)
T 3fpq_A 160 DNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEK--YDES-------------------------VD 211 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGTC--CCTH-------------------------HH
T ss_pred hheeEECCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCCC--CCcH-------------------------HH
Confidence 9999985 7999999999998643 3455678999999999998642 3333 68
Q ss_pred ccchhhhHHHHhhCCCCC
Q psy2648 620 SASIKENTARLNAGRPAK 637 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~ 637 (708)
-|++++++-+++.|.++=
T Consensus 212 iwSlGvilyelltg~~Pf 229 (290)
T 3fpq_A 212 VYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp HHHHHHHHHHHHHSSCTT
T ss_pred HHHHHHHHHHHHHCCCCC
Confidence 899999999999998864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=307.23 Aligned_cols=178 Identities=24% Similarity=0.334 Sum_probs=145.0
Q ss_pred CCCCCCCCCCcCCCcccccccccccccc-------C------------cccccccccCceeEEEEEEEeCCEEEEEEecc
Q psy2648 434 GSGGGGGGGAAQSPSHRGVHRSISASNA-------K------------PSRRASSGGETLLKLFQVIETEKTLYLVMEYA 494 (708)
Q Consensus 434 ~~~ggg~~g~v~s~~hr~~~R~i~~~~~-------~------------~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~ 494 (708)
...|.|++|.|+.+.++...+....+.. . -.......|||||+|+++|++++.+|||||||
T Consensus 195 k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~ 274 (689)
T 3v5w_A 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274 (689)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecC
Confidence 3456778888877666554432211110 0 01123458999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccC
Q psy2648 495 SGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS 574 (708)
Q Consensus 495 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt 574 (708)
+||+|+++|.+.+.|+|..++.|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+... ...++|||
T Consensus 275 ~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-~~~t~~GT 353 (689)
T 3v5w_A 275 NGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 353 (689)
T ss_dssp CSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-CCCSCCSC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-CCCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999876543 45678999
Q ss_pred CcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 575 PPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 575 ~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
+.|||||++.++..|+.+ .|-|++++++=+++.|.|+=
T Consensus 354 p~YmAPEvl~~~~~y~~~-------------------------vDiWSLGvilYEmLtG~~PF 391 (689)
T 3v5w_A 354 HGYMAPEVLQKGVAYDSS-------------------------ADWFSLGCMLFKLLRGHSPF 391 (689)
T ss_dssp GGGCCHHHHSTTCCCCTH-------------------------HHHHHHHHHHHHHHHSSCTT
T ss_pred cCccCHHHHhCCCCCCcH-------------------------HHHHHHHHHHHHHHhCCCCC
Confidence 999999999876656555 57777777777777777764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=279.86 Aligned_cols=141 Identities=23% Similarity=0.356 Sum_probs=123.6
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|||||+|+++|++++.+|||||||+||+|.+++ +.+++.+++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 77 ~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~ 153 (361)
T 4f9c_A 77 GGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR 153 (361)
T ss_dssp CSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred cCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC
Confidence 47999999999999999999999999999999988 369999999999999999999999999999999999999876
Q ss_pred -CCEEEeeccCccccCCC-----------------------------CcccccccCCcccccccccCCCCccCCCCCCCC
Q psy2648 549 -MNIKIADFGFSNEFTPG-----------------------------NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTN 598 (708)
Q Consensus 549 -~~vKl~DFGla~~~~~~-----------------------------~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~ 598 (708)
+.+||+|||+|+..... ....+.|||++|||||++.+...++.+
T Consensus 154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~------ 227 (361)
T 4f9c_A 154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA------ 227 (361)
T ss_dssp TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTH------
T ss_pred CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCc------
Confidence 89999999999754321 123456899999999999887666655
Q ss_pred CcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 599 HTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
+|-|++++++-+++.|.++=
T Consensus 228 -------------------~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 228 -------------------IDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp -------------------HHHHHHHHHHHHHHHTCSSS
T ss_pred -------------------cchhhhHHHHHHHHHCCCCC
Confidence 89999999999999999754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=282.39 Aligned_cols=177 Identities=21% Similarity=0.338 Sum_probs=142.5
Q ss_pred CCCCCCCCCcCCCcccccccccccccc---------------CcccccccccCceeEEEEEEEeC------CEEEEEEec
Q psy2648 435 SGGGGGGGAAQSPSHRGVHRSISASNA---------------KPSRRASSGGETLLKLFQVIETE------KTLYLVMEY 493 (708)
Q Consensus 435 ~~ggg~~g~v~s~~hr~~~R~i~~~~~---------------~~~~~~~~~~~~Iv~L~~~~~~~------~~~yLVmEy 493 (708)
..|.|++|.|+...++...+....+.. +........|||||+|++++++. ..+||||||
T Consensus 61 ~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~ 140 (398)
T 4b99_A 61 TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL 140 (398)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEEC
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeC
Confidence 356677777776665544332221110 11112346899999999998653 679999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCC-----CCcc
Q psy2648 494 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-----GNKL 568 (708)
Q Consensus 494 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~-----~~~~ 568 (708)
|+ |+|+++|...+.+++.+++.+++||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+.. ....
T Consensus 141 ~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~ 219 (398)
T 4b99_A 141 ME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219 (398)
T ss_dssp CS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCC
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcccccccc
Confidence 96 68999999989999999999999999999999999999999999999999999999999999987532 2345
Q ss_pred cccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 569 DTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 569 ~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.+++||++|||||++.+..+++.+ +|-|++++++-+++.|.|.=
T Consensus 220 ~~~~GT~~Y~APEv~~~~~~~~~~-------------------------~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 220 TEYVATRWYRAPELMLSLHEYTQA-------------------------IDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp CSSCCCCTTCCHHHHTTCSCCCTH-------------------------HHHHHHHHHHHHHHHTSCSS
T ss_pred ccceeChHhcCHHHhcCCCCCCCh-------------------------hheehhHHHHHHHHHCCCCC
Confidence 678999999999999987766655 79999999999999998864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-31 Score=279.15 Aligned_cols=174 Identities=18% Similarity=0.274 Sum_probs=124.1
Q ss_pred cccccCceeEEEEEEEeCC------------EEEEEEeccCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhC
Q psy2648 467 ASSGGETLLKLFQVIETEK------------TLYLVMEYASGGEVFDYLVLHGRM---KEKEARAKFRQIVSAVQYCHQK 531 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~------------~~yLVmEy~~gg~L~~~l~~~~~l---~e~~~~~~~~qi~~aL~ylH~~ 531 (708)
....|||||+++++|.+.+ .+|||||||+||+|.+++...+.+ ++..++.++.||+.||.|||++
T Consensus 58 ~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~ 137 (299)
T 4g31_A 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK 137 (299)
T ss_dssp TTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC
Confidence 4568999999999997654 489999999999999999877654 4566889999999999999999
Q ss_pred CCccCCCCCCCeeecCCCCEEEeeccCccccCCCC-------------cccccccCCcccccccccCCCCccCCCCCCCC
Q psy2648 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-------------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTN 598 (708)
Q Consensus 532 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~-------------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~ 598 (708)
|||||||||+|||++.++.+||+|||+|+...... ...+.|||+.|||||++.+..+...++-++.+
T Consensus 138 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG 217 (299)
T 4g31_A 138 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLG 217 (299)
T ss_dssp TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHH
T ss_pred cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHH
Confidence 99999999999999999999999999998764322 22456899999999999987655444444433
Q ss_pred CcccCCCCCCCcccc--------cccc------ccccchhhhHHHHhhCCCCCCCC
Q psy2648 599 HTHNSSISPAPTNFK--------RQNT------IDSASIKENTARLNAGRPAKNTA 640 (708)
Q Consensus 599 ~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 640 (708)
.+......|...... +... -.+....+++.+++...|.+|..
T Consensus 218 vilyell~Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps 273 (299)
T 4g31_A 218 LILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273 (299)
T ss_dssp HHHHHHHSCCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHccCCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcC
Confidence 333332223222110 1111 11344567888999999998854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=267.10 Aligned_cols=144 Identities=23% Similarity=0.370 Sum_probs=118.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++. ++.+|||||||+||+|.++|... +.+++.++..++.||+.||.|||+++||||||||+||||
T Consensus 87 ~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl 165 (307)
T 3omv_A 87 RKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL 165 (307)
T ss_dssp TTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE
T ss_pred HhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE
Confidence 4568999999999875 56789999999999999999754 579999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC---CcccccccCCcccccccccCCC--CccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGA--PVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~--~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
+.++.+||+|||+|+..... ....+.+||+.|||||++.+.. +++.. .|-
T Consensus 166 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-------------------------sDV 220 (307)
T 3omv_A 166 HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-------------------------SDV 220 (307)
T ss_dssp ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHH-------------------------HHH
T ss_pred CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcH-------------------------HHh
Confidence 99999999999999875432 2345679999999999997543 23322 577
Q ss_pred cchhhhHHHHhhCCCC
Q psy2648 621 ASIKENTARLNAGRPA 636 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~ 636 (708)
|+.+.++=++..|+++
T Consensus 221 wS~Gvvl~Elltg~~P 236 (307)
T 3omv_A 221 YSYGIVLYELMTGELP 236 (307)
T ss_dssp HHHHHHHHHHHHSSCT
T ss_pred HhHHHHHHHHHHCCCC
Confidence 7888888888888765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=287.62 Aligned_cols=185 Identities=20% Similarity=0.216 Sum_probs=144.6
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChh------hHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 49 KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPG------SLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 49 ~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...+.||+|+||.||+| ...++.+|+|++........ ..+++.+|+++|++++||||+++..++......||
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44679999999999999 45688999998765443211 23457899999999999999943333336667799
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK-- 200 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~-- 200 (708)
|||||+|++|.+++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999998864 6689999999999999999999999999999998 999999999987654321
Q ss_pred ------ccccccCCcccccccccC--CccCCCchhHHHHHHHHHHHHcCCCCCC
Q psy2648 201 ------LDTFCGSPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFD 246 (708)
Q Consensus 201 ------~~~~~Gt~~Y~APE~l~~--~~~~~~~~DIWSlGvilyelltG~~Pf~ 246 (708)
..+.+||+.|||||++.+ ..|. ..+|+||..+-..+.+.++-+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 246799999999999986 5564 57899999998888888777763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-29 Score=264.53 Aligned_cols=126 Identities=24% Similarity=0.367 Sum_probs=111.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------------RMKEKEARAKFRQIVSAVQYCHQKKI 533 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~ylH~~~I 533 (708)
....|||||+|++++.+++.+|||||||++|+|.++|...+ .+++.++..++.||+.||.|||+++|
T Consensus 70 ~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i 149 (299)
T 4asz_A 70 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHF 149 (299)
T ss_dssp TTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 45689999999999999999999999999999999997643 69999999999999999999999999
Q ss_pred ccCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCC
Q psy2648 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 534 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
|||||||+|||++.++.+||+|||+|+....... ....+||+.|||||++.+..+...+
T Consensus 150 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~ 211 (299)
T 4asz_A 150 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 211 (299)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred ccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence 9999999999999999999999999986543322 2345799999999999877654444
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=262.91 Aligned_cols=126 Identities=23% Similarity=0.334 Sum_probs=104.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH---------------GRMKEKEARAKFRQIVSAVQYCHQK 531 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qi~~aL~ylH~~ 531 (708)
....|||||+|++++.++..+|||||||++|+|.++|... +.+++.++..++.||+.||.|||++
T Consensus 98 ~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 177 (329)
T 4aoj_A 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177 (329)
T ss_dssp TTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 4568999999999999999999999999999999999754 3589999999999999999999999
Q ss_pred CCccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCC
Q psy2648 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 532 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
+||||||||+|||++.++.+||+|||+|+...... .....+||+.|||||++.+..+...+
T Consensus 178 ~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~s 241 (329)
T 4aoj_A 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES 241 (329)
T ss_dssp TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHH
T ss_pred CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccc
Confidence 99999999999999999999999999998764332 23457899999999999887655544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=282.87 Aligned_cols=121 Identities=29% Similarity=0.569 Sum_probs=112.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||+|+++|+++..+|||||||+||+|+++|.. .+.|++.+++.|++||+.||.|||++|||||||||+|||+
T Consensus 209 ~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill 288 (573)
T 3uto_A 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288 (573)
T ss_dssp HHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccc
Confidence 346899999999999999999999999999999999964 4689999999999999999999999999999999999999
Q ss_pred cCC--CCEEEeeccCccccCCCCcccccccCCcccccccccCCC
Q psy2648 546 DSE--MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 546 ~~~--~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+.+ +.+||+|||+|+.+.+.....+.|||+.|||||++.+..
T Consensus 289 ~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~ 332 (573)
T 3uto_A 289 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332 (573)
T ss_dssp SSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCC
T ss_pred cCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCC
Confidence 854 899999999999988777778899999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=259.14 Aligned_cols=126 Identities=23% Similarity=0.410 Sum_probs=111.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQ 530 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~ 530 (708)
....|||||+|++++.++..+|||||||++|+|.++|..+ ..+++.++..++.||+.||.|||+
T Consensus 84 ~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 163 (308)
T 4gt4_A 84 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 163 (308)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4468999999999999999999999999999999999653 358999999999999999999999
Q ss_pred CCCccCCCCCCCeeecCCCCEEEeeccCccccCCC---CcccccccCCcccccccccCCCCccCC
Q psy2648 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 531 ~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
++||||||||+|||++.++.+||+|||+|+..... ......+||+.|||||++.++.+...+
T Consensus 164 ~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ks 228 (308)
T 4gt4_A 164 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS 228 (308)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHH
T ss_pred CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccc
Confidence 99999999999999999999999999999876432 234557899999999999887655544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-28 Score=256.24 Aligned_cols=150 Identities=21% Similarity=0.268 Sum_probs=120.7
Q ss_pred cccccCceeEEEEEEEeCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCc
Q psy2648 467 ASSGGETLLKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK--------KII 534 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~----~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~--------~Ii 534 (708)
....|||||++++++.+++ .+|||||||++|+|.++|... .++++.+..++.|++.||.|||++ +||
T Consensus 52 ~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~Ii 130 (303)
T 3hmm_A 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130 (303)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEE
T ss_pred hcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEe
Confidence 3468999999999998654 689999999999999999764 689999999999999999999987 999
Q ss_pred cCCCCCCCeeecCCCCEEEeeccCccccCCCC-----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCC
Q psy2648 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAP 609 (708)
Q Consensus 535 HRDlKp~NILl~~~~~vKl~DFGla~~~~~~~-----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~ 609 (708)
||||||+|||++.++.+||+|||+|+...... .....+||+.|||||++.+.......
T Consensus 131 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~----------------- 193 (303)
T 3hmm_A 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF----------------- 193 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCH-----------------
T ss_pred eccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCC-----------------
Confidence 99999999999999999999999998764432 22346899999999999865421100
Q ss_pred ccccccccccccchhhhHHHHhhCCCCC
Q psy2648 610 TNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.+ -...|-|+.+.++-++..|.|..
T Consensus 194 -~~--~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 194 -ES--FKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp -HH--HHHHHHHHHHHHHHHHHHTBCBT
T ss_pred -cc--ChhHhhhhHHHHHHHHHHCCCCC
Confidence 00 11268889999999999987753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-28 Score=261.50 Aligned_cols=123 Identities=21% Similarity=0.294 Sum_probs=106.6
Q ss_pred ccCceeEEEEEEEe-CCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2648 470 GGETLLKLFQVIET-EKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKK 532 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~-~~~~yLVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~ 532 (708)
.|+|||+|+++|.+ ...+|||||||++|+|.++|... ..+++.++..++.||+.||.|||+++
T Consensus 126 hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~ 205 (353)
T 4ase_A 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 205 (353)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC
Confidence 45899999999866 46799999999999999999753 34899999999999999999999999
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCC
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
||||||||+|||++.++.+||+|||+|+...... ...+.+||+.|||||++.+..+...+
T Consensus 206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ks 268 (353)
T 4ase_A 206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 268 (353)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcc
Confidence 9999999999999999999999999999764433 23457899999999999877654444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=251.72 Aligned_cols=143 Identities=36% Similarity=0.601 Sum_probs=125.8
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|||||+|+++|+++..+|||||||+||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~ 189 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC
Confidence 47999999999999999999999999999999999998999999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccc-cCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhH
Q psy2648 549 MNIKIADFGFSNE-FTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENT 627 (708)
Q Consensus 549 ~~vKl~DFGla~~-~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (708)
+.+||+|||+|+. ........+.+||+.|||||++.+..+ +.+ .|-|+++.++
T Consensus 190 g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~-------------------------~DiwslGvll 243 (396)
T 4dc2_A 190 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFS-------------------------VDWWALGVLM 243 (396)
T ss_dssp SCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCB-CTH-------------------------HHHHHHHHHH
T ss_pred CCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCC-ChH-------------------------HHHHHHHHHH
Confidence 9999999999986 344556678899999999999986542 222 5667777777
Q ss_pred HHHhhCCCCC
Q psy2648 628 ARLNAGRPAK 637 (708)
Q Consensus 628 ~~~~~~~~~~ 637 (708)
-+++.|.|.=
T Consensus 244 yell~G~~Pf 253 (396)
T 4dc2_A 244 FEMMAGRSPF 253 (396)
T ss_dssp HHHHHSSCSS
T ss_pred HHHHhCCCCC
Confidence 7777776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=239.88 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=115.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----------------hhHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q psy2648 52 KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----------------GSLQKLFREVRIMKMLDHPNIVKLFQVIE 115 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----------------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 115 (708)
+.||+|+||.||+|.+ .+|+.||||++....... .....+.+|+++|+.++| +++++++.
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence 9999999999999999 889999999997543211 134568899999999984 55555554
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCcccc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~ 195 (708)
. +..|+||||++|++|.+ + ...++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~- 241 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE- 241 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-
T ss_pred c-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-
Confidence 4 44699999999999987 4 1234567999999999999999999999999999999 99999999999853
Q ss_pred CCCCCccccccCCcccccccccC
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQG 218 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~ 218 (708)
+..|+|||++..
T Consensus 242 -----------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 -----------VGEEGWREILER 253 (282)
T ss_dssp -----------TTSTTHHHHHHH
T ss_pred -----------CCCCCHHHHHHH
Confidence 345789998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-26 Score=245.11 Aligned_cols=122 Identities=80% Similarity=1.250 Sum_probs=114.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||++++++++++..+|||||||++|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 70 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~ 149 (328)
T 3fe3_A 70 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA 149 (328)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC
Confidence 45799999999999999999999999999999999999899999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCc
Q psy2648 548 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPV 589 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~ 589 (708)
++.+||+|||+++...........+||+.|+|||++.+....
T Consensus 150 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 191 (328)
T 3fe3_A 150 DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191 (328)
T ss_dssp TSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCC
T ss_pred CCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcC
Confidence 999999999999887777777788999999999999876544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=245.35 Aligned_cols=121 Identities=37% Similarity=0.583 Sum_probs=111.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|++.+.+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 94 ~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~ 173 (373)
T 2r5t_A 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173 (373)
T ss_dssp CCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred HhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC
Confidence 45689999999999999999999999999999999999988999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccc-CCCCcccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++++||+|||+++.. .......+.+||+.|+|||++.+..
T Consensus 174 ~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (373)
T 2r5t_A 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215 (373)
T ss_dssp TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC
T ss_pred CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCC
Confidence 9999999999999864 3344566789999999999997654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-26 Score=263.37 Aligned_cols=116 Identities=17% Similarity=0.211 Sum_probs=102.7
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|+||++|+++++++..+|||||||+|++|.++|...+++++. .++.||+.||.|||++|||||||||+|||++.+
T Consensus 299 ~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d 375 (569)
T 4azs_A 299 PAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR 375 (569)
T ss_dssp CTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT
T ss_pred CCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC
Confidence 47899999999999999999999999999999999999999875 478999999999999999999999999999999
Q ss_pred CCEEEeeccCccccCCC-CcccccccCCcccccccccCCC
Q psy2648 549 MNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 549 ~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
|.+||+|||+|+..... ....+.+||+.|||||++.|..
T Consensus 376 g~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~ 415 (569)
T 4azs_A 376 QHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENK 415 (569)
T ss_dssp SCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC----
T ss_pred CCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCC
Confidence 99999999999876443 3456789999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=240.64 Aligned_cols=121 Identities=40% Similarity=0.639 Sum_probs=111.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....||||++++++|++.+.+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 60 ~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 139 (337)
T 1o6l_A 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp HSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred HhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccc-CCCCcccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+++.. .......+.+||+.|+|||++.+..
T Consensus 140 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 181 (337)
T 1o6l_A 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC
T ss_pred CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCC
Confidence 9999999999999864 3344566789999999999997654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=244.87 Aligned_cols=147 Identities=26% Similarity=0.457 Sum_probs=130.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|++...+|||||||.||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 70 ~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~ 149 (384)
T 4fr4_A 70 QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD 149 (384)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC
Confidence 34589999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCC--CccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA--PVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~--~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+|+.........+.+||+.|+|||++.+.. .++.. .|-|+++
T Consensus 150 ~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-------------------------~DiwSlG 204 (384)
T 4fr4_A 150 EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA-------------------------VDWWSLG 204 (384)
T ss_dssp TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTT-------------------------HHHHHHH
T ss_pred CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCcc-------------------------ceeechH
Confidence 99999999999999877666777889999999999997532 22222 6778888
Q ss_pred hhHHHHhhCCCCCC
Q psy2648 625 ENTARLNAGRPAKN 638 (708)
Q Consensus 625 ~~~~~~~~~~~~~~ 638 (708)
+++-.++.|.+.-.
T Consensus 205 ~il~elltG~~Pf~ 218 (384)
T 4fr4_A 205 VTAYELLRGRRPYH 218 (384)
T ss_dssp HHHHHHHHSSCSSC
T ss_pred HHHHHHHhCCCCCC
Confidence 88888888877643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=241.37 Aligned_cols=119 Identities=36% Similarity=0.607 Sum_probs=110.1
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|||||+++++|++...+|||||||+||+|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 154 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 154 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC
Confidence 38999999999999999999999999999999999988899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccC-CCCcccccccCCcccccccccCCC
Q psy2648 549 MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 549 ~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+.+||+|||+|+... ......+.+||+.|+|||++.+..
T Consensus 155 g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (345)
T 1xjd_A 155 GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 194 (345)
T ss_dssp SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred CCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCC
Confidence 999999999998653 233456789999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=240.44 Aligned_cols=143 Identities=36% Similarity=0.584 Sum_probs=124.4
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|||||+++++|+++..+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 67 ~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 146 (345)
T 3a8x_A 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred CCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC
Confidence 47999999999999999999999999999999999988899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccc-CCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhH
Q psy2648 549 MNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENT 627 (708)
Q Consensus 549 ~~vKl~DFGla~~~-~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (708)
+.+||+|||+++.. .........+||+.|+|||++.+..+ +.+ .|-|++++++
T Consensus 147 g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~-------------------------~DiwslG~il 200 (345)
T 3a8x_A 147 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFS-------------------------VDWWALGVLM 200 (345)
T ss_dssp SCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTH-------------------------HHHHHHHHHH
T ss_pred CCEEEEeccccccccCCCCcccccCCCccccCccccCCCCC-ChH-------------------------HhHHHHHHHH
Confidence 99999999999864 33445667899999999999976432 222 5666777777
Q ss_pred HHHhhCCCCC
Q psy2648 628 ARLNAGRPAK 637 (708)
Q Consensus 628 ~~~~~~~~~~ 637 (708)
-++..|.+.-
T Consensus 201 ~ell~g~~pf 210 (345)
T 3a8x_A 201 FEMMAGRSPF 210 (345)
T ss_dssp HHHHHSSCTT
T ss_pred HHHHhCCCCc
Confidence 7777776653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=241.41 Aligned_cols=119 Identities=39% Similarity=0.598 Sum_probs=110.0
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|++|++++++|++.+.+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 78 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~ 157 (353)
T 2i0e_A 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157 (353)
T ss_dssp TCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred CCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC
Confidence 37999999999999999999999999999999999988899999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccC-CCCcccccccCCcccccccccCCC
Q psy2648 549 MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 549 ~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+.+||+|||+|+... ......+.+||+.|+|||++.+..
T Consensus 158 g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 197 (353)
T 2i0e_A 158 GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 197 (353)
T ss_dssp SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred CcEEEEeCCcccccccCCcccccccCCccccChhhhcCCC
Confidence 999999999998643 344566789999999999997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=248.50 Aligned_cols=117 Identities=31% Similarity=0.572 Sum_probs=107.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+|||+|+++|+++..+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 130 ~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209 (437)
T ss_dssp HSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc
Confidence 45899999999999999999999999999999999987 57899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc--ccccccCCccccccccc
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQ 584 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~ 584 (708)
.++.+||+|||+|+....... ....+||+.|||||++.
T Consensus 210 ~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHh
Confidence 999999999999987654332 34578999999999997
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-25 Score=239.52 Aligned_cols=119 Identities=39% Similarity=0.616 Sum_probs=104.5
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|+|||+++++|++...+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 81 ~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~ 160 (353)
T 3txo_A 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE 160 (353)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred cCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC
Confidence 37999999999999999999999999999999999998999999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccC-CCCcccccccCCcccccccccCCC
Q psy2648 549 MNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 549 ~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+.+||+|||+|+... ......+.+||+.|||||++.+..
T Consensus 161 g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 200 (353)
T 3txo_A 161 GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200 (353)
T ss_dssp SCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHH
T ss_pred CCEEEccccceeecccCCccccccCCCcCeEChhhcCCCC
Confidence 999999999998643 334456789999999999997654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=234.59 Aligned_cols=119 Identities=33% Similarity=0.607 Sum_probs=109.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|++...+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 61 ~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 140 (318)
T 1fot_A 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140 (318)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred hhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc
Confidence 34689999999999999999999999999999999999988999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+++.... ...+.+||+.|+|||++.+..
T Consensus 141 ~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~ 179 (318)
T 1fot_A 141 KNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKP 179 (318)
T ss_dssp TTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCC
T ss_pred CCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCC
Confidence 999999999999987543 345679999999999997654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-25 Score=245.70 Aligned_cols=120 Identities=33% Similarity=0.556 Sum_probs=108.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|+++..+|||||||+||+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~ 202 (410)
T 3v8s_A 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202 (410)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC
Confidence 346899999999999999999999999999999998865 4799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+|+...... ...+.+||+.|||||++.+..
T Consensus 203 ~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTT
T ss_pred CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccC
Confidence 99999999999998765443 234789999999999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-25 Score=244.48 Aligned_cols=118 Identities=33% Similarity=0.550 Sum_probs=107.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|++||+++++|+++..+|||||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 117 ~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld 196 (412)
T 2vd5_A 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD 196 (412)
T ss_dssp HSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec
Confidence 4589999999999999999999999999999999998764 799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc--ccccccCCcccccccccC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQG 585 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~g 585 (708)
.++++||+|||+|+....... ....+||+.|||||++.+
T Consensus 197 ~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~ 237 (412)
T 2vd5_A 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237 (412)
T ss_dssp TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHH
T ss_pred CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhh
Confidence 999999999999987654433 345799999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=237.12 Aligned_cols=143 Identities=34% Similarity=0.520 Sum_probs=124.7
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|||||+++++|++...+|||||||+||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 71 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 150 (361)
T 2yab_A 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (361)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred hCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC
Confidence 45799999999999999999999999999999999998889999999999999999999999999999999999999988
Q ss_pred CC----CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 548 EM----NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 548 ~~----~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
.+ .+||+|||+++...........+||+.|+|||++.+..+ +.. .|.|++
T Consensus 151 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~-------------------------~Diwsl 204 (361)
T 2yab_A 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLE-------------------------ADMWSI 204 (361)
T ss_dssp TTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTH-------------------------HHHHHH
T ss_pred CCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCC-Ccc-------------------------ccHHHH
Confidence 76 799999999988776666677899999999999976432 211 466666
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
+.++-.+..|.|.
T Consensus 205 Gvil~~ll~g~~P 217 (361)
T 2yab_A 205 GVITYILLSGASP 217 (361)
T ss_dssp HHHHHHHHHSCCS
T ss_pred HHHHHHHHhCCCC
Confidence 7777777776664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=235.96 Aligned_cols=119 Identities=39% Similarity=0.593 Sum_probs=109.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||++++++|++...+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 96 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 175 (350)
T 1rdq_E 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175 (350)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC
Confidence 44689999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+++.... ...+.+||+.|+|||++.+..
T Consensus 176 ~~g~~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~ 214 (350)
T 1rdq_E 176 QQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKG 214 (350)
T ss_dssp TTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCC
T ss_pred CCCCEEEcccccceeccC--CcccccCCccccCHHHhcCCC
Confidence 999999999999987643 234679999999999997654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=235.27 Aligned_cols=144 Identities=36% Similarity=0.529 Sum_probs=115.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+|||++++++.+...+|||||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 72 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~ 151 (361)
T 3uc3_A 72 SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG 151 (361)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS
T ss_pred hCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 45799999999999999999999999999999999998889999999999999999999999999999999999999987
Q ss_pred CCC--EEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 548 EMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 548 ~~~--vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
++. +||+|||+|+...........+||+.|+|||++.+....+.. .|-|++++
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-------------------------~DiwslG~ 206 (361)
T 3uc3_A 152 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI-------------------------ADVWSCGV 206 (361)
T ss_dssp SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHH-------------------------HHHHHHHH
T ss_pred CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCe-------------------------eeeehhHH
Confidence 765 999999999865544455667899999999999776543332 46777777
Q ss_pred hHHHHhhCCCC
Q psy2648 626 NTARLNAGRPA 636 (708)
Q Consensus 626 ~~~~~~~~~~~ 636 (708)
++-.+..|.+.
T Consensus 207 il~ell~g~~P 217 (361)
T 3uc3_A 207 TLYVMLVGAYP 217 (361)
T ss_dssp HHHHHHHSSCS
T ss_pred HHHHHHhCCCC
Confidence 77777777665
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=254.27 Aligned_cols=155 Identities=34% Similarity=0.458 Sum_probs=126.3
Q ss_pred cCCCCCCCCCCcCCCccccccccccccccC----------------cc-cccccccCceeEEEEEEEeCCEEEEEEeccC
Q psy2648 433 GGSGGGGGGGAAQSPSHRGVHRSISASNAK----------------PS-RRASSGGETLLKLFQVIETEKTLYLVMEYAS 495 (708)
Q Consensus 433 ~~~~ggg~~g~v~s~~hr~~~R~i~~~~~~----------------~~-~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~ 495 (708)
....|.|++|.|+.+.++...+....+..+ .. ......|++|++|+++|++.+.+|||||||+
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 345677888888766655443321111100 00 1122478999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCcccc-CCCCcccccccC
Q psy2648 496 GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGS 574 (708)
Q Consensus 496 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~-~~~~~~~~~~Gt 574 (708)
||+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+.. .......+++||
T Consensus 426 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT 505 (674)
T 3pfq_A 426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 505 (674)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCC
Confidence 9999999999899999999999999999999999999999999999999999999999999999864 334456678999
Q ss_pred CcccccccccCCC
Q psy2648 575 PPYAAPELFQGGA 587 (708)
Q Consensus 575 ~~Y~APEvl~g~~ 587 (708)
+.|||||++.+..
T Consensus 506 ~~Y~APE~l~~~~ 518 (674)
T 3pfq_A 506 PDYIAPEIIAYQP 518 (674)
T ss_dssp SSSCCHHHHTCCC
T ss_pred CcccCHhhhcCCC
Confidence 9999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=233.87 Aligned_cols=144 Identities=19% Similarity=0.264 Sum_probs=123.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|++|+++++++...+..|||||||++|+|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~N 202 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN 202 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 34589999999999999999999999999999999974 4569999999999999999999999999999999999
Q ss_pred eeecC-----------CCCEEEeeccCccccC---CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCC
Q psy2648 543 LLLDS-----------EMNIKIADFGFSNEFT---PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPA 608 (708)
Q Consensus 543 ILl~~-----------~~~vKl~DFGla~~~~---~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~ 608 (708)
||++. .+.+||+|||+|+.+. ........+||+.|||||++.+.. ++..
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~---------------- 265 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQ---------------- 265 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTH----------------
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCcc----------------
Confidence 99998 8999999999997543 333456678999999999998754 3322
Q ss_pred CccccccccccccchhhhHHHHhhCCCCC
Q psy2648 609 PTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|+++.++-++..|.+..
T Consensus 266 ---------~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 266 ---------IDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp ---------HHHHHHHHHHHHHHHSSCCC
T ss_pred ---------ccHHHHHHHHHHHHhCCCcc
Confidence 57788888888888887653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-24 Score=233.37 Aligned_cols=143 Identities=31% Similarity=0.544 Sum_probs=123.7
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|||||+++++++++..+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 84 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 35799999999999999999999999999999999998889999999999999999999999999999999999999986
Q ss_pred CC---CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 EM---NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ~~---~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.+ .+||+|||++............+||+.|+|||++.+..+.. . .|-|+++
T Consensus 164 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~-------------------------~DiwslG 217 (362)
T 2bdw_A 164 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK-P-------------------------VDIWACG 217 (362)
T ss_dssp SSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCT-H-------------------------HHHHHHH
T ss_pred CCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCc-h-------------------------hhHHHHH
Confidence 54 59999999998876666666789999999999997643221 1 4666677
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.|.
T Consensus 218 ~il~~ll~g~~P 229 (362)
T 2bdw_A 218 VILYILLVGYPP 229 (362)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHHCCCC
Confidence 777777777664
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-24 Score=239.98 Aligned_cols=145 Identities=37% Similarity=0.528 Sum_probs=124.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl 545 (708)
....|+|||+++++|.+.+.+|||||||++|+|.+++...+.+++..+..++.||+.||.|||+ +|||||||||+|||+
T Consensus 203 ~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll 282 (446)
T 4ejn_A 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 282 (446)
T ss_dssp CCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE
T ss_pred HhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE
Confidence 4567999999999999999999999999999999999988899999999999999999999998 999999999999999
Q ss_pred cCCCCEEEeeccCccccC-CCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||+|+... ........+||+.|||||++.+..+ +. ..|-|+++
T Consensus 283 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~DiwslG 336 (446)
T 4ejn_A 283 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GR-------------------------AVDWWGLG 336 (446)
T ss_dssp CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCC-CT-------------------------HHHHHHHH
T ss_pred CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCC-CC-------------------------ccchhhhH
Confidence 999999999999998643 3344567899999999999976542 22 25777778
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
+++-++..|.+.-
T Consensus 337 ~il~ell~g~~Pf 349 (446)
T 4ejn_A 337 VVMYEMMCGRLPF 349 (446)
T ss_dssp HHHHHHHHSSCSS
T ss_pred HHHHHHhhCCCCC
Confidence 8888888777653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-24 Score=238.37 Aligned_cols=143 Identities=31% Similarity=0.486 Sum_probs=123.5
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec-
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD- 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~- 546 (708)
...|||||+++++|+++..+|||||||+||+|.+.+...+.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 66 ~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~ 145 (444)
T 3soa_A 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145 (444)
T ss_dssp HCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred hCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 4589999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred --CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 547 --SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 547 --~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
.++.+||+|||+|+..... ......+||+.|+|||++.+..+ +.. .|-|++
T Consensus 146 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~-------------------------~DIwSl 199 (444)
T 3soa_A 146 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKP-------------------------VDLWAC 199 (444)
T ss_dssp SSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCB-CTH-------------------------HHHHHH
T ss_pred cCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCC-CCc-------------------------cccHHH
Confidence 4578999999999876543 33456789999999999976532 211 466777
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
+.++-.+..|.|.
T Consensus 200 Gvilyell~G~~P 212 (444)
T 3soa_A 200 GVILYILLVGYPP 212 (444)
T ss_dssp HHHHHHHHHSSCS
T ss_pred HHHHHHHHhCCCC
Confidence 7777777777665
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=239.36 Aligned_cols=144 Identities=36% Similarity=0.519 Sum_probs=115.4
Q ss_pred ccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+|||+++++|+. ...+|||||||+||+|.+++...+ .+++.++..++.||+.||.|||++|||||||||+
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence 3579999999999986 678999999999999999998654 5999999999999999999999999999999999
Q ss_pred CeeecC---CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 542 NLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 542 NILl~~---~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
|||++. ++.+||+|||+++...........+||+.|+|||++.+..+ +. ..
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~ 244 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DK-------------------------SC 244 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCS-SS-------------------------HH
T ss_pred eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCC-CC-------------------------cc
Confidence 999997 78899999999987765555667899999999999865432 21 25
Q ss_pred cccchhhhHHHHhhCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAK 637 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~ 637 (708)
|-|++++++-.+..|.+.-
T Consensus 245 DiwslG~il~ell~g~~pf 263 (400)
T 1nxk_A 245 DMWSLGVIMYILLCGYPPF 263 (400)
T ss_dssp HHHHHHHHHHHHHHSSCSC
T ss_pred cHHHHHHHHHHHHhCCCCC
Confidence 7788888888888887653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=242.76 Aligned_cols=122 Identities=52% Similarity=0.903 Sum_probs=113.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||++++++++...+|||||||++|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 71 ~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~ 150 (476)
T 2y94_A 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD 150 (476)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.++.+||+|||+++.........+.+||+.|+|||++.+...
T Consensus 151 ~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 192 (476)
T 2y94_A 151 AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192 (476)
T ss_dssp TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCB
T ss_pred cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCC
Confidence 999999999999998776666778899999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-24 Score=229.94 Aligned_cols=143 Identities=26% Similarity=0.450 Sum_probs=124.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|||||++++++++...+|||||||+||+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 57 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp HSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred hCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 4579999999999999999999999999999999997654 799999999999999999999999999999999999998
Q ss_pred C--CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 S--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~--~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
. ++.+||+|||+++...........+||+.|+|||++.+..... ..|-|+++
T Consensus 137 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~DiwslG 190 (321)
T 1tki_A 137 TRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST--------------------------ATDMWSLG 190 (321)
T ss_dssp SSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECH--------------------------HHHHHHHH
T ss_pred cCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCc--------------------------hhhHHHHH
Confidence 7 7899999999999877666667788999999999997653211 14667777
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.+.
T Consensus 191 ~il~~ll~g~~p 202 (321)
T 1tki_A 191 TLVYVLLSGINP 202 (321)
T ss_dssp HHHHHHHHSSCT
T ss_pred HHHHHHHhCCCC
Confidence 777777777664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.4e-24 Score=227.24 Aligned_cols=144 Identities=48% Similarity=0.764 Sum_probs=128.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||++++++.++..+||||||| +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 64 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 142 (336)
T 3h4j_B 64 KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142 (336)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc
Confidence 3457999999999999999999999999 789999999889999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.++.+||+|||++............+||+.|+|||++.+....+.. .|-|+++.+
T Consensus 143 ~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-------------------------~DiwslG~i 197 (336)
T 3h4j_B 143 DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE-------------------------VDVWSCGIV 197 (336)
T ss_dssp TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHH-------------------------HHHHHHHHH
T ss_pred CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCc-------------------------cchhHHHHH
Confidence 9999999999999887766667788999999999999765533222 577788888
Q ss_pred HHHHhhCCCC
Q psy2648 627 TARLNAGRPA 636 (708)
Q Consensus 627 ~~~~~~~~~~ 636 (708)
+-.+..|.+.
T Consensus 198 l~~ll~g~~P 207 (336)
T 3h4j_B 198 LYVMLVGRLP 207 (336)
T ss_dssp HHHHHHSSCS
T ss_pred HHHHHhCCCC
Confidence 8888888765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=247.01 Aligned_cols=144 Identities=26% Similarity=0.357 Sum_probs=125.0
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+|||+++++|++...+|||||||+||+|.+++...+. +++..++.++.||+.||.|||++|||||||||+|||+
T Consensus 240 ~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl 319 (576)
T 2acx_A 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319 (576)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE
Confidence 45899999999999999999999999999999999987554 9999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
+.++.+||+|||+|+...........+||+.|||||++.+.. ++.+ .|-|+++.
T Consensus 320 d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~-------------------------~DiwSLGv 373 (576)
T 2acx_A 320 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFS-------------------------PDWWALGC 373 (576)
T ss_dssp CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSH-------------------------HHHHHHHH
T ss_pred eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCC-CCcc-------------------------chHHHHHH
Confidence 999999999999998876666666789999999999997653 2222 46667777
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|.+.=
T Consensus 374 ilyeLltG~~PF 385 (576)
T 2acx_A 374 LLYEMIAGQSPF 385 (576)
T ss_dssp HHHHHHHSSCSS
T ss_pred HHHHHHhCCCCC
Confidence 777777776653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-24 Score=224.12 Aligned_cols=146 Identities=29% Similarity=0.486 Sum_probs=122.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++++++.+|||||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 66 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 145 (294)
T 4eqm_A 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145 (294)
T ss_dssp TTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred hcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 34579999999999999999999999999999999999988999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+++...... .....+||+.|+|||++.+... +. ..|-|+++
T Consensus 146 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~Di~slG 199 (294)
T 4eqm_A 146 SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT-DE-------------------------CTDIYSIG 199 (294)
T ss_dssp TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCC-CT-------------------------THHHHHHH
T ss_pred CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCC-Cc-------------------------hHhHHHHH
Confidence 99999999999998764332 2345689999999999976542 21 15788899
Q ss_pred hhHHHHhhCCCCCC
Q psy2648 625 ENTARLNAGRPAKN 638 (708)
Q Consensus 625 ~~~~~~~~~~~~~~ 638 (708)
.++-++..|.+.-.
T Consensus 200 ~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 200 IVLYEMLVGEPPFN 213 (294)
T ss_dssp HHHHHHHHSSCSSC
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999887644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.9e-24 Score=225.86 Aligned_cols=144 Identities=32% Similarity=0.490 Sum_probs=125.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|||||+++++|.+...+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 70 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 149 (326)
T 2y0a_A 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149 (326)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec
Confidence 35799999999999999999999999999999999988888999999999999999999999999999999999999998
Q ss_pred CC----CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 548 EM----NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 548 ~~----~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
++ .+||+|||+++...........+||+.|+|||++.+... +. ..|-|++
T Consensus 150 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~Diwsl 203 (326)
T 2y0a_A 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GL-------------------------EADMWSI 203 (326)
T ss_dssp SSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCC-CT-------------------------HHHHHHH
T ss_pred CCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCC-Cc-------------------------HHHHHHH
Confidence 77 799999999988765555667789999999999965432 11 1567777
Q ss_pred hhhHHHHhhCCCCC
Q psy2648 624 KENTARLNAGRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~~~~~~ 637 (708)
+.++-.+..|.+.-
T Consensus 204 G~il~~ll~g~~pf 217 (326)
T 2y0a_A 204 GVITYILLSGASPF 217 (326)
T ss_dssp HHHHHHHHHSCCSS
T ss_pred HHHHHHHHHCcCCC
Confidence 88888888877653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-24 Score=231.95 Aligned_cols=142 Identities=27% Similarity=0.516 Sum_probs=120.2
Q ss_pred ccCceeEEEEEEEeCC--EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 470 GGETLLKLFQVIETEK--TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~--~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
+|+|||+++++|..++ .+|||||||+ |+|..++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~ 144 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA 144 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC
Confidence 5999999999998654 7999999998 589888865 57999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCC----------------------CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCC
Q psy2648 548 EMNIKIADFGFSNEFTP----------------------GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSI 605 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~----------------------~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~ 605 (708)
++.+||+|||+|+.... .......+||++|+|||++.+...++.+
T Consensus 145 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------------- 211 (388)
T 3oz6_A 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG------------- 211 (388)
T ss_dssp TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH-------------
T ss_pred CCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh-------------
Confidence 99999999999976532 1123457899999999999875545443
Q ss_pred CCCCccccccccccccchhhhHHHHhhCCCCCC
Q psy2648 606 SPAPTNFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.|-|++++++-++..|.|.=.
T Consensus 212 ------------~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 212 ------------IDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp ------------HHHHHHHHHHHHHHHSSCSCC
T ss_pred ------------hhHHHHHHHHHHHHhCCCCCC
Confidence 788999999999999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-24 Score=237.95 Aligned_cols=141 Identities=25% Similarity=0.339 Sum_probs=118.2
Q ss_pred ccccCceeEEEEEEEe-----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIET-----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~-----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+|||+++++|.. ...+|||||||. |+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|
T Consensus 108 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~N 186 (458)
T 3rp9_A 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186 (458)
T ss_dssp HCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred hCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhh
Confidence 4589999999999943 367999999985 7999999888889999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCC----------------------------CcccccccCCcccccccccCCCCccCCCC
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPG----------------------------NKLDTFCGSPPYAAPELFQGGAPVTSSGG 594 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~----------------------------~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~ 594 (708)
||++.++.+||+|||+|+..... ......+||++|||||++.+...++.+
T Consensus 187 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~-- 264 (458)
T 3rp9_A 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-- 264 (458)
T ss_dssp EEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH--
T ss_pred EEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH--
Confidence 99999999999999999865321 123456899999999998765545544
Q ss_pred CCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCC
Q psy2648 595 AGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGR 634 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (708)
.|-|++++++-+++.|.
T Consensus 265 -----------------------~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 265 -----------------------IDVWSIGCIFAELLNMI 281 (458)
T ss_dssp -----------------------HHHHHHHHHHHHHHTTS
T ss_pred -----------------------hHHHHHHHHHHHHHHhc
Confidence 78999999999999843
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=225.51 Aligned_cols=175 Identities=27% Similarity=0.402 Sum_probs=135.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGG-EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg-~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||+++++|.+...+||||||+.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 163 (335)
T 3dls_A 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163 (335)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE
Confidence 3457999999999999999999999999777 999999988899999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccC-CCCCC-----CCCcccCCCCCCCccc----ccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTS-SGGAG-----TNHTHNSSISPAPTNF----KRQ 615 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~-s~~~~-----~~~~~~~~~~~~~~~~----~~~ 615 (708)
+.++.+||+|||+++...........+||+.|+|||++.+...++. ++-++ +....+..+....... ...
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 243 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP 243 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCC
T ss_pred cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCC
Confidence 9999999999999988766666667889999999999987654332 21111 1111111111111110 111
Q ss_pred ccccccchhhhHHHHhhCCCCCCCCC
Q psy2648 616 NTIDSASIKENTARLNAGRPAKNTAS 641 (708)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (708)
....+..+.+++.+++.-.|.+|...
T Consensus 244 ~~~~~~~l~~li~~~L~~dP~~Rps~ 269 (335)
T 3dls_A 244 PYLVSKELMSLVSGLLQPVPERRTTL 269 (335)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CcccCHHHHHHHHHHccCChhhCcCH
Confidence 11235678888888888888888543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-24 Score=222.67 Aligned_cols=144 Identities=28% Similarity=0.508 Sum_probs=125.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|.+.+.+|||||||++|+|.+++... .+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (297)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence 3468999999999999999999999999999999998764 699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||++....... .....+||+.|+|||++.+..+ +. ..|-|+++.
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~DiwslG~ 204 (297)
T 3fxz_A 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP-------------------------KVDIWSLGI 204 (297)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCB-CT-------------------------HHHHHHHHH
T ss_pred CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCC-Cc-------------------------HHHHHHHHH
Confidence 99999999999998765433 3456789999999999976442 21 257888888
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|.+.-
T Consensus 205 il~ell~g~~pf 216 (297)
T 3fxz_A 205 MAIEMIEGEPPY 216 (297)
T ss_dssp HHHHHHHSSCTT
T ss_pred HHHHHHhCCCCC
Confidence 998998887753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=220.03 Aligned_cols=146 Identities=25% Similarity=0.370 Sum_probs=123.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.++..+|||||||++|+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 62 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~ 141 (310)
T 3s95_A 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141 (310)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred HhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence 345799999999999999999999999999999999987 5679999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc---------------ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK---------------LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPT 610 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~---------------~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~ 610 (708)
+.++.+||+|||+++....... ....+||+.|+|||++.+... +.
T Consensus 142 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~------------------- 201 (310)
T 3s95_A 142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DE------------------- 201 (310)
T ss_dssp CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCC-CT-------------------
T ss_pred CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCC-Cc-------------------
Confidence 9999999999999976533221 125689999999999976432 11
Q ss_pred cccccccccccchhhhHHHHhhCCCCCC
Q psy2648 611 NFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
..|-|+++.++-++..|.+...
T Consensus 202 ------~~Di~slG~~l~el~~g~~~~~ 223 (310)
T 3s95_A 202 ------KVDVFSFGIVLCEIIGRVNADP 223 (310)
T ss_dssp ------HHHHHHHHHHHHHHHHTCCSST
T ss_pred ------HHHHHHHHHHHHHHhcCCCCCc
Confidence 2578888999999998876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-24 Score=233.45 Aligned_cols=143 Identities=26% Similarity=0.402 Sum_probs=120.1
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
...|+|||+++++|+++..+|||||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 82 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NI 161 (351)
T 3c0i_A 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCV 161 (351)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHe
Confidence 357999999999999999999999999999999888643 2589999999999999999999999999999999999
Q ss_pred eecCCCC---EEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 544 LLDSEMN---IKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 544 Ll~~~~~---vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
|++.++. +||+|||+++...... .....+||+.|+|||++.+..+ +. ..|
T Consensus 162 l~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~D 215 (351)
T 3c0i_A 162 LLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GK-------------------------PVD 215 (351)
T ss_dssp EECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CT-------------------------HHH
T ss_pred EEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCC-Cc-------------------------hHh
Confidence 9987654 9999999998765433 2456789999999999976542 21 156
Q ss_pred ccchhhhHHHHhhCCCC
Q psy2648 620 SASIKENTARLNAGRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~ 636 (708)
-|++++++-.+..|.+.
T Consensus 216 iwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 216 VWGCGVILFILLSGCLP 232 (351)
T ss_dssp HHHHHHHHHHHHHSSCS
T ss_pred hHHHHHHHHHHHHCCCC
Confidence 77777777777777665
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-24 Score=229.95 Aligned_cols=118 Identities=32% Similarity=0.556 Sum_probs=106.4
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|+|||+++++|++...+|||||||+||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||+...
T Consensus 73 ~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~ 152 (342)
T 2qr7_A 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDE 152 (342)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecC
Confidence 47999999999999999999999999999999999988899999999999999999999999999999999999998543
Q ss_pred ----CCEEEeeccCccccCCC-CcccccccCCcccccccccCC
Q psy2648 549 ----MNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGG 586 (708)
Q Consensus 549 ----~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~ 586 (708)
+.+||+|||+++..... ....+.+||+.|+|||++.+.
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 195 (342)
T 2qr7_A 153 SGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195 (342)
T ss_dssp SCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH
T ss_pred CCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC
Confidence 35999999999876443 345677999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-24 Score=226.69 Aligned_cols=141 Identities=36% Similarity=0.520 Sum_probs=103.4
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
+|+|||+++++|+++..+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 64 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~ 143 (325)
T 3kn6_A 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN 143 (325)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC--
T ss_pred CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC
Confidence 59999999999999999999999999999999999988999999999999999999999999999999999999998765
Q ss_pred ---CEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 550 ---NIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 550 ---~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.+||+|||+++..... ......+||+.|+|||++.+..+.. ..|-|+++.
T Consensus 144 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--------------------------~~DiwslG~ 197 (325)
T 3kn6_A 144 DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDE--------------------------SCDLWSLGV 197 (325)
T ss_dssp --CEEEECCCTTCEECCC----------------------CCCCH--------------------------HHHHHHHHH
T ss_pred CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCC--------------------------ccchHHHHH
Confidence 7999999999865433 3345678999999999986554222 146667777
Q ss_pred hHHHHhhCCCC
Q psy2648 626 NTARLNAGRPA 636 (708)
Q Consensus 626 ~~~~~~~~~~~ 636 (708)
++-.+..|.+.
T Consensus 198 il~~ll~g~~p 208 (325)
T 3kn6_A 198 ILYTMLSGQVP 208 (325)
T ss_dssp HHHHHHHSSCT
T ss_pred HHHHHHhCCCC
Confidence 77777777654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-24 Score=241.07 Aligned_cols=143 Identities=31% Similarity=0.444 Sum_probs=122.1
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
...|+|||+++++|++...+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||
T Consensus 241 ~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NI 320 (543)
T 3c4z_A 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320 (543)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHE
Confidence 458999999999999999999999999999999999764 3699999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCCc-ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~~-~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
|++.+|.+||+|||+++....... ....+||+.|||||++.+..+ +.+ .|-|+
T Consensus 321 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~-------------------------~DiwS 374 (543)
T 3c4z_A 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFS-------------------------VDYFA 374 (543)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCB-CTH-------------------------HHHHH
T ss_pred EEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCC-ChH-------------------------HhcCc
Confidence 999999999999999987654433 445799999999999986542 222 46666
Q ss_pred hhhhHHHHhhCCCC
Q psy2648 623 IKENTARLNAGRPA 636 (708)
Q Consensus 623 ~~~~~~~~~~~~~~ 636 (708)
+++++-+++.|.|.
T Consensus 375 lGvilyelltG~~P 388 (543)
T 3c4z_A 375 LGVTLYEMIAARGP 388 (543)
T ss_dssp HHHHHHHHHHSSCS
T ss_pred chHHHHHHHhCCCC
Confidence 67777777766654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=222.09 Aligned_cols=120 Identities=37% Similarity=0.575 Sum_probs=105.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+|||+++++|++...+|||||||++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~ 156 (327)
T 3a62_A 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH 156 (327)
T ss_dssp HCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT
T ss_pred hCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC
Confidence 45799999999999999999999999999999999998889999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccC-CCCcccccccCCcccccccccCCC
Q psy2648 548 EMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~-~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
++.+||+|||+++... ........+||+.|+|||++.+..
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 197 (327)
T 3a62_A 157 QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG 197 (327)
T ss_dssp TSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSC
T ss_pred CCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCC
Confidence 9999999999997643 233445678999999999997654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=216.82 Aligned_cols=141 Identities=26% Similarity=0.371 Sum_probs=119.8
Q ss_pred ccCceeEEEEEEEeCC-----EEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 470 GGETLLKLFQVIETEK-----TLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~-----~~yLVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
.|+||+++++++.+.. .+|+||||+. |+|.+++..... +++.++..++.||+.||.|||++||+||||||+|
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 150 (308)
T 3g33_A 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN 150 (308)
T ss_dssp CCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred CCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 5999999999998865 6899999998 599999987654 9999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
||++.++.+||+|||+|+...........+||+.|+|||++.+...... .|-|+
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------------------~Diws 204 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP--------------------------VDMWS 204 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST--------------------------HHHHH
T ss_pred EEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCch--------------------------HHHHH
Confidence 9999999999999999987766666677899999999999976553222 45666
Q ss_pred hhhhHHHHhhCCCCC
Q psy2648 623 IKENTARLNAGRPAK 637 (708)
Q Consensus 623 ~~~~~~~~~~~~~~~ 637 (708)
+++++-++..|.|.-
T Consensus 205 lG~il~~l~~g~~pf 219 (308)
T 3g33_A 205 VGCIFAEMFRRKPLF 219 (308)
T ss_dssp HHHHHHHTTTSSCSC
T ss_pred HHHHHHHHHhCCCCC
Confidence 666666666666543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-24 Score=227.78 Aligned_cols=144 Identities=35% Similarity=0.547 Sum_probs=123.4
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+|||++++++.+....|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 61 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~ 140 (323)
T 3tki_A 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (323)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred hCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC
Confidence 45899999999999999999999999999999999988888999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCC---CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 EMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
++.+||+|||+++..... ......+||+.|+|||++.+....+.. .|-|+++
T Consensus 141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-------------------------~DiwslG 195 (323)
T 3tki_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-------------------------VDVWSCG 195 (323)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHH-------------------------HHHHHHH
T ss_pred CCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCc-------------------------ccHHHHH
Confidence 999999999999765322 234567899999999999765543322 4666677
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.+.
T Consensus 196 ~il~~ll~g~~p 207 (323)
T 3tki_A 196 IVLTAMLAGELP 207 (323)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHhCCCC
Confidence 777777777654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=219.70 Aligned_cols=144 Identities=28% Similarity=0.486 Sum_probs=122.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp 540 (708)
....|+|||++++++.+++.+|||||||+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 58 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp 136 (317)
T 2pmi_A 58 KELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP 136 (317)
T ss_dssp TTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCh
Confidence 34579999999999999999999999998 5999988754 3589999999999999999999999999999999
Q ss_pred CCeeecCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 541 ENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 541 ~NILl~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
+|||++.++.+||+|||+++..... ......+||+.|+|||++.+...++.. .|
T Consensus 137 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~D 191 (317)
T 2pmi_A 137 QNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTS-------------------------ID 191 (317)
T ss_dssp GGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTH-------------------------HH
T ss_pred HHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcH-------------------------HH
Confidence 9999999999999999999876432 334567899999999999765433322 57
Q ss_pred ccchhhhHHHHhhCCCC
Q psy2648 620 SASIKENTARLNAGRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~ 636 (708)
.|++++++-++..|.+.
T Consensus 192 iwslG~il~el~~g~~p 208 (317)
T 2pmi_A 192 IWSCGCILAEMITGKPL 208 (317)
T ss_dssp HHHHHHHHHHHHHSSCS
T ss_pred HHHHHHHHHHHHhCCCC
Confidence 77888888888888765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-23 Score=217.40 Aligned_cols=123 Identities=23% Similarity=0.489 Sum_probs=106.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.++..+|||||||++ +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 56 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~ 134 (292)
T 3o0g_A 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134 (292)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 345799999999999999999999999986 5555554 46789999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCcc
Q psy2648 546 DSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVT 590 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~ 590 (708)
+.++.+||+|||+++..... ......+||+.|+|||++.+...++
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (292)
T 3o0g_A 135 NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_dssp CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcC
Confidence 99999999999999876432 3345678999999999998765443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=224.45 Aligned_cols=145 Identities=26% Similarity=0.417 Sum_probs=118.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||++++++.++..+|||||||++ +|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~ 166 (329)
T 3gbz_A 88 KELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166 (329)
T ss_dssp GGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred HHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEe
Confidence 345899999999999999999999999985 9999999988999999999999999999999999999999999999995
Q ss_pred -----CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 547 -----SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 547 -----~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
..+.+||+|||+++..... ......+||+.|+|||++.+...++.. .|-
T Consensus 167 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Di 221 (329)
T 3gbz_A 167 VSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTS-------------------------VDI 221 (329)
T ss_dssp C-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTH-------------------------HHH
T ss_pred cCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcH-------------------------HHH
Confidence 4456999999999865432 334556899999999999875544433 577
Q ss_pred cchhhhHHHHhhCCCCC
Q psy2648 621 ASIKENTARLNAGRPAK 637 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~~ 637 (708)
|++++++-++..|.+.-
T Consensus 222 wslG~il~ell~g~~pf 238 (329)
T 3gbz_A 222 WSIACIWAEMLMKTPLF 238 (329)
T ss_dssp HHHHHHHHHHHHSSCSS
T ss_pred HHHHHHHHHHHHCCCCc
Confidence 88888888888887654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-23 Score=233.47 Aligned_cols=142 Identities=25% Similarity=0.370 Sum_probs=121.2
Q ss_pred ccccCceeEEEEEEEeC-----CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~-----~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+|||++++++... ..+|||||||. |+|.+++.....+++..++.++.||+.||.|||++|||||||||+|
T Consensus 81 ~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~N 159 (432)
T 3n9x_A 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPAN 159 (432)
T ss_dssp HCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 45799999999999876 67999999997 5999999888889999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCC-----------------------cccccccCCcccccccccCCCCccCCCCCCCCC
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGN-----------------------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNH 599 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~-----------------------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~ 599 (708)
||++.++.+||+|||+|+...... .....+||++|+|||++.+...++.+
T Consensus 160 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~------- 232 (432)
T 3n9x_A 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS------- 232 (432)
T ss_dssp EEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH-------
T ss_pred eEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc-------
Confidence 999999999999999998754321 23567999999999998766555444
Q ss_pred cccCCCCCCCccccccccccccchhhhHHHHhhCCC
Q psy2648 600 THNSSISPAPTNFKRQNTIDSASIKENTARLNAGRP 635 (708)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (708)
.|-|++++++.+++.|.+
T Consensus 233 ------------------~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 233 ------------------IDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp ------------------HHHHHHHHHHHHHHTTCT
T ss_pred ------------------cccchHHHHHHHHHhccc
Confidence 799999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-23 Score=234.13 Aligned_cols=142 Identities=35% Similarity=0.601 Sum_probs=121.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec-
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD- 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~- 546 (708)
...|||||++++++++...+|||||||++|+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||++
T Consensus 77 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred hCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 4589999999999999999999999999999999999888999999999999999999999999999999999999995
Q ss_pred --CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 --SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 --~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+|+...........+||+.|+|||++.+. ++. ..|-|+++
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-------------------------~~DiwslG 209 (486)
T 3mwu_A 157 KEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDE-------------------------KCDVWSAG 209 (486)
T ss_dssp SSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSC--CCH-------------------------HHHHHHHH
T ss_pred CCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCC--CCc-------------------------hhhHHHHH
Confidence 4567999999999887666666778999999999998652 221 25777777
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.|.
T Consensus 210 ~il~~ll~g~~p 221 (486)
T 3mwu_A 210 VILYILLSGTPP 221 (486)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHhCCCC
Confidence 888888877765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=234.12 Aligned_cols=143 Identities=37% Similarity=0.564 Sum_probs=124.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|++...+|||||||++|+|.+++.....+++..+..++.||+.||.|||++|||||||||+|||++
T Consensus 91 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 170 (494)
T 3lij_A 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170 (494)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEe
Confidence 44689999999999999999999999999999999999888999999999999999999999999999999999999997
Q ss_pred CC---CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 547 SE---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 547 ~~---~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
.. +.+||+|||+|+...........+||+.|+|||++.+. ++. ..|-|++
T Consensus 171 ~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~-------------------------~~Diwsl 223 (494)
T 3lij_A 171 SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--YDE-------------------------KCDVWSI 223 (494)
T ss_dssp CSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTC--BCT-------------------------HHHHHHH
T ss_pred CCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHccc--CCC-------------------------chhHHHH
Confidence 64 45999999999887666666778999999999998532 222 1467777
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
+.++-.+..|.|.
T Consensus 224 G~il~~ll~g~~p 236 (494)
T 3lij_A 224 GVILFILLAGYPP 236 (494)
T ss_dssp HHHHHHHHHSSCS
T ss_pred HHHHHHHHhCCCC
Confidence 7777777777665
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=225.08 Aligned_cols=143 Identities=38% Similarity=0.591 Sum_probs=114.2
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+|||++++++.+...+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~ 183 (349)
T 2w4o_A 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183 (349)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESS
T ss_pred hCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEec
Confidence 45799999999999999999999999999999999998888999999999999999999999999999999999999976
Q ss_pred ---CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 ---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ---~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
++.+||+|||+++...........+||+.|+|||++.+... +. ..|-|+++
T Consensus 184 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~DiwslG 237 (349)
T 2w4o_A 184 PAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP-------------------------EVDMWSVG 237 (349)
T ss_dssp SSTTCCEEECCCC----------------CGGGSCHHHHTTCCC-CT-------------------------HHHHHHHH
T ss_pred CCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCC-Cc-------------------------ccchHHHH
Confidence 78999999999987665555567789999999999976432 11 25778888
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
+++-++..|.+.
T Consensus 238 ~il~ell~g~~p 249 (349)
T 2w4o_A 238 IITYILLCGFEP 249 (349)
T ss_dssp HHHHHHHHSSCT
T ss_pred HHHHHHHhCCCC
Confidence 888888888665
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-23 Score=220.22 Aligned_cols=116 Identities=28% Similarity=0.405 Sum_probs=102.3
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
..|+|||++++++.+...+||||||| +++|.+++...+ .+++..+..++.||+.||.|||+++||||||||+|||++.
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 192 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP 192 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 38999999999999999999999999 679988887654 5999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCCcccccccCCcccccccccC
Q psy2648 548 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g 585 (708)
++.+||+|||+++...........+||+.|+|||++.+
T Consensus 193 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 193 RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp GGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT
T ss_pred CCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC
Confidence 99999999999987765555566789999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-23 Score=225.49 Aligned_cols=145 Identities=30% Similarity=0.467 Sum_probs=124.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.+...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 141 ~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 220 (373)
T 2x4f_A 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220 (373)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence 3458999999999999999999999999999999988654 469999999999999999999999999999999999999
Q ss_pred --cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 --DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 --~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+..+.+||+|||+++...........+||+.|+|||++.+..... ..|-|++
T Consensus 221 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~Diwsl 274 (373)
T 2x4f_A 221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSF--------------------------PTDMWSV 274 (373)
T ss_dssp EETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCH--------------------------HHHHHHH
T ss_pred ecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCc--------------------------HHhHHHH
Confidence 567889999999999877666666778999999999986543211 2577888
Q ss_pred hhhHHHHhhCCCCC
Q psy2648 624 KENTARLNAGRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~~~~~~ 637 (708)
++++-++..|.+.-
T Consensus 275 G~il~elltg~~pf 288 (373)
T 2x4f_A 275 GVIAYMLLSGLSPF 288 (373)
T ss_dssp HHHHHHHHHSSCTT
T ss_pred HHHHHHHHhCCCCC
Confidence 88888888887653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=228.89 Aligned_cols=144 Identities=26% Similarity=0.427 Sum_probs=121.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||+++++|++...+|||||||++|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 103 ~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll 182 (387)
T 1kob_A 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 182 (387)
T ss_dssp TTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEE
Confidence 34579999999999999999999999999999999987654 69999999999999999999999999999999999999
Q ss_pred cC--CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 DS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 ~~--~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+. .+.+||+|||+++...........+||+.|+|||++.+...... .|-|++
T Consensus 183 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------------------~DiwSl 236 (387)
T 1kob_A 183 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY--------------------------TDMWAI 236 (387)
T ss_dssp SSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHH--------------------------HHHHHH
T ss_pred ecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCc--------------------------ccEeeH
Confidence 74 47799999999988766655666789999999999976542211 356666
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
++++-.+..|.+.
T Consensus 237 G~il~elltg~~P 249 (387)
T 1kob_A 237 GVLGYVLLSGLSP 249 (387)
T ss_dssp HHHHHHHHHSCCS
T ss_pred hHHHHHHHhCCCC
Confidence 6666666666654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-23 Score=233.16 Aligned_cols=142 Identities=37% Similarity=0.578 Sum_probs=124.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|||||+++++|++...+|||||||++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181 (504)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESS
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEec
Confidence 45799999999999999999999999999999999998889999999999999999999999999999999999999987
Q ss_pred CC---CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 EM---NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ~~---~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.+ .+||+|||+|+...........+||+.|+|||++.+. ++. ..|-|+++
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-------------------------~~DiwslG 234 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK--YNE-------------------------KCDVWSCG 234 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC--BCT-------------------------HHHHHHHH
T ss_pred CCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccC--CCc-------------------------hHHHHHHH
Confidence 76 6999999999887766666778999999999998632 222 25677777
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.|.
T Consensus 235 ~il~~ll~g~~p 246 (504)
T 3q5i_A 235 VIMYILLCGYPP 246 (504)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHhCCCC
Confidence 777788777665
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-23 Score=217.48 Aligned_cols=145 Identities=31% Similarity=0.454 Sum_probs=120.3
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|+||+++++++.+++.+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 147 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP 147 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCS
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccC
Confidence 57999999999999999999999999999999999988899999999999999999999999999999999999999987
Q ss_pred CC---EEEeeccCccccCCC--------CcccccccCCcccccccccCCC----CccCCCCCCCCCcccCCCCCCCcccc
Q psy2648 549 MN---IKIADFGFSNEFTPG--------NKLDTFCGSPPYAAPELFQGGA----PVTSSGGAGTNHTHNSSISPAPTNFK 613 (708)
Q Consensus 549 ~~---vKl~DFGla~~~~~~--------~~~~~~~Gt~~Y~APEvl~g~~----~~~~s~~~~~~~~~~~~~~~~~~~~~ 613 (708)
+. +||+|||+++..... ......+||+.|+|||++.+.. .++.
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~---------------------- 205 (316)
T 2ac3_A 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK---------------------- 205 (316)
T ss_dssp SSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTT----------------------
T ss_pred CCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCc----------------------
Confidence 66 999999998765321 1223467999999999997532 1221
Q ss_pred ccccccccchhhhHHHHhhCCCCCC
Q psy2648 614 RQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
..|.|++++++-++..|.+.-.
T Consensus 206 ---~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 206 ---RCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp ---THHHHHHHHHHHHHHHSSCSCC
T ss_pred ---ccccHhHHHHHHHHHHCCCCCc
Confidence 2688889999999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.1e-23 Score=217.84 Aligned_cols=141 Identities=22% Similarity=0.304 Sum_probs=120.6
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
.|+||+++++++.+....||||||| +++|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||++.+
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~ 141 (330)
T 2izr_A 63 SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP 141 (330)
T ss_dssp SCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG
T ss_pred CCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC
Confidence 8999999999999999999999999 9999999986 4679999999999999999999999999999999999999988
Q ss_pred CC-----EEEeeccCccccCCCCc--------ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccc
Q psy2648 549 MN-----IKIADFGFSNEFTPGNK--------LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQ 615 (708)
Q Consensus 549 ~~-----vKl~DFGla~~~~~~~~--------~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~ 615 (708)
+. +||+|||+|+....... ....+||+.|+|||++.+.....
T Consensus 142 ~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~------------------------- 196 (330)
T 2izr_A 142 GNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSR------------------------- 196 (330)
T ss_dssp GGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-------------------------
T ss_pred CCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCc-------------------------
Confidence 87 99999999986543221 24678999999999998654222
Q ss_pred ccccccchhhhHHHHhhCCCCC
Q psy2648 616 NTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
..|-|+++.++-++..|.+.-
T Consensus 197 -~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 197 -RDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp -HHHHHHHHHHHHHHHHSSCTT
T ss_pred -hhHHHHHHHHHHHHhcCCCCc
Confidence 146677777888888776653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.8e-23 Score=212.16 Aligned_cols=144 Identities=33% Similarity=0.613 Sum_probs=127.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee-
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL- 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl- 545 (708)
....|+||+++++++.+...+|+|||||++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 140 (277)
T 3f3z_A 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140 (277)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred HhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEe
Confidence 3458999999999999999999999999999999999988899999999999999999999999999999999999999
Q ss_pred --cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 --DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 --~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+.++.+||+|||++............+||+.|+|||++.+. ++. ..|-|++
T Consensus 141 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~-------------------------~~Di~sl 193 (277)
T 3f3z_A 141 TDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGP-------------------------ECDEWSA 193 (277)
T ss_dssp SSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC--BCT-------------------------THHHHHH
T ss_pred cCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc--CCc-------------------------hhhehhH
Confidence 77899999999999887766666778899999999998643 221 2577888
Q ss_pred hhhHHHHhhCCCCC
Q psy2648 624 KENTARLNAGRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~~~~~~ 637 (708)
+.++-++..|.+.-
T Consensus 194 G~~l~~l~~g~~p~ 207 (277)
T 3f3z_A 194 GVMMYVLLCGYPPF 207 (277)
T ss_dssp HHHHHHHHHSSCSS
T ss_pred HHHHHHHHHCCCCC
Confidence 88888888887653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=225.13 Aligned_cols=146 Identities=29% Similarity=0.387 Sum_probs=123.9
Q ss_pred cccccCceeEEEEEEEe--------------------------------------CCEEEEEEeccCCCCHHHHHH----
Q psy2648 467 ASSGGETLLKLFQVIET--------------------------------------EKTLYLVMEYASGGEVFDYLV---- 504 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~--------------------------------------~~~~yLVmEy~~gg~L~~~l~---- 504 (708)
....|+|||+++++|.. ...+|||||||++ +|.+.+.
T Consensus 55 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~ 133 (383)
T 3eb0_A 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR 133 (383)
T ss_dssp TTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHH
T ss_pred HHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh
Confidence 44689999999999944 4459999999995 7666654
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec-CCCCEEEeeccCccccCCCCcccccccCCcccccccc
Q psy2648 505 LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 583 (708)
Q Consensus 505 ~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl 583 (708)
..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...........+||+.|+|||++
T Consensus 134 ~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 134 SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELM 213 (383)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHh
Confidence 356799999999999999999999999999999999999998 6789999999999987666666678899999999999
Q ss_pred cCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCCC
Q psy2648 584 QGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 584 ~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.+...++.. .|-|++++++-++..|+|.-.
T Consensus 214 ~~~~~~~~~-------------------------~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 214 LGATEYTPS-------------------------IDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp TTCSSCCTH-------------------------HHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCCCCcc-------------------------hhhhhHHHHHHHHHhCCCCCC
Confidence 876544443 688889999999999887643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.7e-23 Score=225.25 Aligned_cols=146 Identities=16% Similarity=0.248 Sum_probs=124.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+|||+++++|.++..+|||||||++|+|.+++... +.+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 82 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll 161 (389)
T 3gni_B 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 161 (389)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 457999999999999999999999999999999999876 679999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC--------CcccccccCCcccccccccCC-CCccCCCCCCCCCcccCCCCCCCccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPG--------NKLDTFCGSPPYAAPELFQGG-APVTSSGGAGTNHTHNSSISPAPTNFKRQN 616 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~--------~~~~~~~Gt~~Y~APEvl~g~-~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 616 (708)
+.++.+||+|||++...... ......+||+.|+|||++.+. ..++..
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~------------------------ 217 (389)
T 3gni_B 162 SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK------------------------ 217 (389)
T ss_dssp CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH------------------------
T ss_pred cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcH------------------------
Confidence 99999999999987643211 122345899999999999864 222222
Q ss_pred cccccchhhhHHHHhhCCCCCC
Q psy2648 617 TIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.|-|++++++-++..|.+.-.
T Consensus 218 -~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 218 -SDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTT
T ss_pred -hHHHHHHHHHHHHHHCCCCCC
Confidence 688889999999999887643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-23 Score=233.61 Aligned_cols=144 Identities=36% Similarity=0.575 Sum_probs=126.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee-
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL- 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl- 545 (708)
....|||||+++++|++...+|||||||.+|+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 81 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 160 (484)
T 3nyv_A 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLE 160 (484)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEe
Confidence 3458999999999999999999999999999999999998899999999999999999999999999999999999999
Q ss_pred --cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 --DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 --~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+.++.+||+|||+|+...........+||+.|+|||++.+. ++. ..|-|++
T Consensus 161 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-------------------------~~Diwsl 213 (484)
T 3nyv_A 161 SKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDE-------------------------KCDVWST 213 (484)
T ss_dssp SSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTC--CCT-------------------------HHHHHHH
T ss_pred cCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCC--CCC-------------------------cceeHHH
Confidence 46789999999999887766666678899999999998652 221 2577888
Q ss_pred hhhHHHHhhCCCCC
Q psy2648 624 KENTARLNAGRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~~~~~~ 637 (708)
+.++-.+..|.|.=
T Consensus 214 G~il~~ll~g~~pf 227 (484)
T 3nyv_A 214 GVILYILLSGCPPF 227 (484)
T ss_dssp HHHHHHHHHSSCSS
T ss_pred HHHHHHHHHCCCCC
Confidence 88888888887764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-23 Score=227.28 Aligned_cols=147 Identities=28% Similarity=0.319 Sum_probs=122.6
Q ss_pred cccccCceeEEEEEEEeCC------EEEEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q psy2648 467 ASSGGETLLKLFQVIETEK------TLYLVMEYASGGEVFDYL---VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRD 537 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~------~~yLVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 537 (708)
....|+|||+++++|.... .+|||||||+++.+.... .....+++..++.++.||+.||.|||++||+|||
T Consensus 87 ~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 166 (394)
T 4e7w_A 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166 (394)
T ss_dssp HTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence 3468999999999996543 489999999975433322 2356799999999999999999999999999999
Q ss_pred CCCCCeeec-CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccc
Q psy2648 538 LKAENLLLD-SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQN 616 (708)
Q Consensus 538 lKp~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 616 (708)
|||+|||++ .++.+||+|||+|+...........+||+.|+|||++.+...++..
T Consensus 167 lkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~------------------------ 222 (394)
T 4e7w_A 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTN------------------------ 222 (394)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTH------------------------
T ss_pred CCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcH------------------------
Confidence 999999999 7899999999999887666666678899999999999876544443
Q ss_pred cccccchhhhHHHHhhCCCCCC
Q psy2648 617 TIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.|-|++++++-++..|+|.-.
T Consensus 223 -~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 223 -IDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSC
T ss_pred -HHHHHHHHHHHHHHhCCCCCC
Confidence 688889999999999887643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=232.08 Aligned_cols=141 Identities=21% Similarity=0.357 Sum_probs=114.1
Q ss_pred ccccCceeEEEEEEEeC------CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETE------KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~------~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+|||+++++|... ..+|||||||+++ |.+.+. ..+++..++.++.||+.||.|||++|||||||||+
T Consensus 117 ~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~ 193 (464)
T 3ttj_A 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193 (464)
T ss_dssp HCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred hCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChH
Confidence 45899999999999655 4689999999864 666664 35999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+||+|||+|+...........+||++|+|||++.+.. ++.. .|-|
T Consensus 194 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~-------------------------~Diw 247 (464)
T 3ttj_A 194 NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN-------------------------VDIW 247 (464)
T ss_dssp GEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCC-CCTT-------------------------HHHH
T ss_pred hEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCC-CCHH-------------------------HHHH
Confidence 9999999999999999998876666667789999999999998653 3322 6888
Q ss_pred chhhhHHHHhhCCCCC
Q psy2648 622 SIKENTARLNAGRPAK 637 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~ 637 (708)
++++++-++..|.|.=
T Consensus 248 SlG~il~ell~g~~pF 263 (464)
T 3ttj_A 248 SVGCIMGEMVRHKILF 263 (464)
T ss_dssp HHHHHHHHHHHSSCSS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 8999999999888764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.3e-23 Score=217.36 Aligned_cols=151 Identities=21% Similarity=0.367 Sum_probs=122.3
Q ss_pred ccccCceeEEEEEEEeCC--EEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEK--TLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~--~~yLVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+||+++++++.... .+|||||||++|+|.+++..... +++.++..++.||+.||.|||++||+||||||+|
T Consensus 63 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (319)
T 4euu_A 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142 (319)
T ss_dssp HCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred hcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHH
Confidence 457999999999998765 88999999999999999976543 9999999999999999999999999999999999
Q ss_pred eee----cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 543 LLL----DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 543 ILl----~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
||+ +..+.+||+|||+++...........+||+.|+|||++.+.......+.. --...
T Consensus 143 Ill~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~------------------~~~~~ 204 (319)
T 4euu_A 143 IMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKK------------------YGATV 204 (319)
T ss_dssp EEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCC------------------BCTTH
T ss_pred EEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCC------------------CCcHH
Confidence 999 77788999999999887766666678899999999998643211100000 00125
Q ss_pred cccchhhhHHHHhhCCCC
Q psy2648 619 DSASIKENTARLNAGRPA 636 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~ 636 (708)
|-|++++++-++..|.+.
T Consensus 205 DiwslG~il~el~~g~~p 222 (319)
T 4euu_A 205 DLWSIGVTFYHAATGSLP 222 (319)
T ss_dssp HHHHHHHHHHHHHHSSCS
T ss_pred HHHHHHHHHHHHHhCCCC
Confidence 677777777777777654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-23 Score=219.77 Aligned_cols=145 Identities=26% Similarity=0.422 Sum_probs=115.3
Q ss_pred cccccCceeEEEEEEEeCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~----~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
....|+|||++++++.... .+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|
T Consensus 67 ~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 146 (311)
T 3ork_A 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 146 (311)
T ss_dssp CCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 4458999999999988654 459999999999999999988899999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCC----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
||++.++.+||+|||+++...... .....+||+.|+|||++.+..... ..
T Consensus 147 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~ 200 (311)
T 3ork_A 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA--------------------------RS 200 (311)
T ss_dssp EEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCH--------------------------HH
T ss_pred EEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCc--------------------------hH
Confidence 999999999999999998654322 233467999999999997653221 25
Q ss_pred cccchhhhHHHHhhCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAK 637 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~ 637 (708)
|-|+++.++-++..|.+.-
T Consensus 201 Di~slG~~l~~ll~g~~pf 219 (311)
T 3ork_A 201 DVYSLGCVLYEVLTGEPPF 219 (311)
T ss_dssp HHHHHHHHHHHHHHSSCSC
T ss_pred hHHHHHHHHHHHHhCCCCC
Confidence 7778888888888887653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-23 Score=221.95 Aligned_cols=144 Identities=17% Similarity=0.260 Sum_probs=119.9
Q ss_pred ccccCceeEEEEEEEeC----CEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETE----KTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~----~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+||+++++++... ..+||||||| |++|.+++... +.+++..+..++.||+.||.|||++|||||||||+|
T Consensus 104 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~N 182 (364)
T 3op5_A 104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASN 182 (364)
T ss_dssp TCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHH
Confidence 45699999999998775 5689999999 99999999876 579999999999999999999999999999999999
Q ss_pred eeec--CCCCEEEeeccCccccCCCC--------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccc
Q psy2648 543 LLLD--SEMNIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNF 612 (708)
Q Consensus 543 ILl~--~~~~vKl~DFGla~~~~~~~--------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~ 612 (708)
||++ .++.+||+|||+|+.+.... .....+||+.|||||++.+..+..
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---------------------- 240 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR---------------------- 240 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH----------------------
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc----------------------
Confidence 9999 88999999999997653221 124467999999999997654322
Q ss_pred cccccccccchhhhHHHHhhCCCCCC
Q psy2648 613 KRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
..|-|+++.++-++..|.+.=.
T Consensus 241 ----~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 241 ----RGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp ----HHHHHHHHHHHHHHHHSCCTTG
T ss_pred ----hhhHHHHHHHHHHHHhCCCCcc
Confidence 2467778888888888776533
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=219.22 Aligned_cols=142 Identities=34% Similarity=0.550 Sum_probs=123.6
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.|+||+++++++.++..+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 196 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 196 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 68999999999999999999999999999999999888999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccCCC--CcccccccCCcccccccccCCCC-ccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 550 NIKIADFGFSNEFTPG--NKLDTFCGSPPYAAPELFQGGAP-VTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 550 ~vKl~DFGla~~~~~~--~~~~~~~Gt~~Y~APEvl~g~~~-~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.+||+|||+++..... ......+||+.|+|||++.+... ++. ..|-|+++++
T Consensus 197 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-------------------------~~DvwslG~i 251 (355)
T 1vzo_A 197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK-------------------------AVDWWSLGVL 251 (355)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CT-------------------------HHHHHHHHHH
T ss_pred cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCc-------------------------hhhHHHHHHH
Confidence 9999999999865322 22345789999999999986431 222 2577888888
Q ss_pred HHHHhhCCCC
Q psy2648 627 TARLNAGRPA 636 (708)
Q Consensus 627 ~~~~~~~~~~ 636 (708)
+-++..|.+.
T Consensus 252 l~ell~g~~p 261 (355)
T 1vzo_A 252 MYELLTGASP 261 (355)
T ss_dssp HHHHHHSSCT
T ss_pred HHHHHHCCCC
Confidence 8888888765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.5e-23 Score=222.01 Aligned_cols=141 Identities=26% Similarity=0.345 Sum_probs=119.3
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKI 533 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~ylH~~~I 533 (708)
.|+|||++++++.+...+|||||||++|+|.+++...+ .+++.++..++.||+.||.|||++||
T Consensus 145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 224 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224 (370)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 79999999999999999999999999999999998653 47899999999999999999999999
Q ss_pred ccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCc
Q psy2648 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPT 610 (708)
Q Consensus 534 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~ 610 (708)
|||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..+..
T Consensus 225 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-------------------- 284 (370)
T 2psq_A 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-------------------- 284 (370)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH--------------------
T ss_pred eccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc--------------------
Confidence 999999999999999999999999998654332 223456789999999997644222
Q ss_pred cccccccccccchhhhHHHHhh-CCCC
Q psy2648 611 NFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 285 ------~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 285 ------QSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp ------HHHHHHHHHHHHHHHTTSCCS
T ss_pred ------HHHHHHHHHHHHHHHcCCCCC
Confidence 1467778888888776 6554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-23 Score=228.89 Aligned_cols=144 Identities=36% Similarity=0.555 Sum_probs=115.5
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+|||++++++.. ..+|||||||++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 196 ~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp HCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred hCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 4589999999999864 568999999999999999988889999999999999999999999999999999999999976
Q ss_pred CC---CEEEeeccCccccCCCCcccccccCCcccccccccCC--CCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 548 EM---NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG--APVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 548 ~~---~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~--~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
.+ .+||+|||+|+...........+||+.|+|||++.+. ..++. ..|-|+
T Consensus 275 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-------------------------~~Diws 329 (419)
T 3i6u_A 275 QEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR-------------------------AVDCWS 329 (419)
T ss_dssp SSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHH-------------------------HHHHHH
T ss_pred CCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCc-------------------------hhhhHh
Confidence 54 5999999999987666566678999999999998642 21221 368899
Q ss_pred hhhhHHHHhhCCCCC
Q psy2648 623 IKENTARLNAGRPAK 637 (708)
Q Consensus 623 ~~~~~~~~~~~~~~~ 637 (708)
++.++-.+..|.+.-
T Consensus 330 lG~il~~lltg~~pf 344 (419)
T 3i6u_A 330 LGVILFICLSGYPPF 344 (419)
T ss_dssp HHHHHHHHHHSSCSS
T ss_pred HHHHHHHHHHCCCCC
Confidence 999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.1e-23 Score=217.35 Aligned_cols=143 Identities=34% Similarity=0.519 Sum_probs=125.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+...+|||||||++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~ 150 (321)
T 2a2a_A 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (321)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred hCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEec
Confidence 35799999999999999999999999999999999998888999999999999999999999999999999999999998
Q ss_pred CC----CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 548 EM----NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 548 ~~----~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
++ .+||+|||+++...........+||+.|+|||++.+... +. ..|-|++
T Consensus 151 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~Di~sl 204 (321)
T 2a2a_A 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GL-------------------------EADMWSI 204 (321)
T ss_dssp TTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCC-CT-------------------------HHHHHHH
T ss_pred CCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCC-CC-------------------------ccccHHH
Confidence 87 799999999988766555667789999999999965432 11 2577788
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
+.++-.+..|.+.
T Consensus 205 G~il~~l~~g~~p 217 (321)
T 2a2a_A 205 GVITYILLSGASP 217 (321)
T ss_dssp HHHHHHHHHSCCS
T ss_pred HHHHHHHHHCCCC
Confidence 8888888888764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-23 Score=227.31 Aligned_cols=145 Identities=28% Similarity=0.370 Sum_probs=119.1
Q ss_pred cccccCceeEEEEEEEeC------CEEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q psy2648 467 ASSGGETLLKLFQVIETE------KTLYLVMEYASGGEVFDYLV----LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~------~~~yLVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 536 (708)
....|+|||+++++|... ..+|||||||++ +|.+.+. ....+++..++.++.||+.||.|||++|||||
T Consensus 102 ~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 180 (420)
T 1j1b_A 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 180 (420)
T ss_dssp HTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred HHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 345899999999998542 247899999986 5655554 34679999999999999999999999999999
Q ss_pred CCCCCCeeecCC-CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccc
Q psy2648 537 DLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQ 615 (708)
Q Consensus 537 DlKp~NILl~~~-~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~ 615 (708)
||||+|||++.+ +.+||+|||+|+...........+||+.|+|||++.+...++..
T Consensus 181 Dlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~----------------------- 237 (420)
T 1j1b_A 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS----------------------- 237 (420)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTH-----------------------
T ss_pred CCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCch-----------------------
Confidence 999999999965 56899999999987665556678899999999999876544433
Q ss_pred ccccccchhhhHHHHhhCCCCC
Q psy2648 616 NTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|++++++-+++.|+|.=
T Consensus 238 --~DiwSlG~il~ell~G~~pf 257 (420)
T 1j1b_A 238 --IDVWSAGCVLAELLLGQPIF 257 (420)
T ss_dssp --HHHHHHHHHHHHHHHSSCSS
T ss_pred --hhhHHHHHHHHHHHhCCCCC
Confidence 67788888888888887653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=213.97 Aligned_cols=102 Identities=25% Similarity=0.450 Sum_probs=87.5
Q ss_pred EEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCcccc
Q psy2648 486 TLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562 (708)
Q Consensus 486 ~~yLVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~ 562 (708)
.+|||||||++|+|.+++..... .++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 48999999999999999987654 456678999999999999999999999999999999999999999999999876
Q ss_pred CCCC-------------cccccccCCcccccccccCCC
Q psy2648 563 TPGN-------------KLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 563 ~~~~-------------~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.... .....+||+.|+|||++.+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 252 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHCCC
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcCCC
Confidence 5432 234468999999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=211.21 Aligned_cols=143 Identities=31% Similarity=0.551 Sum_probs=125.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+....|+|||||++++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 140 (284)
T 3kk8_A 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 140 (284)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred HcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEec
Confidence 35799999999999999999999999999999999998889999999999999999999999999999999999999987
Q ss_pred CCC---EEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 EMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ~~~---vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
++. +||+|||++.............||+.|+|||++.+... +. ..|-|+++
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~-------------------------~~Di~slG 194 (284)
T 3kk8_A 141 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SK-------------------------PVDIWACG 194 (284)
T ss_dssp SSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCB-CT-------------------------HHHHHHHH
T ss_pred CCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCC-Cc-------------------------ccchHHHH
Confidence 655 99999999987766666667889999999999976432 11 25777788
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.+.
T Consensus 195 ~~l~~l~~g~~p 206 (284)
T 3kk8_A 195 VILYILLVGYPP 206 (284)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHHCCCC
Confidence 888888887765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=209.44 Aligned_cols=139 Identities=19% Similarity=0.339 Sum_probs=115.7
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
.|+||+++++++.+++.+|||||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 8999999999999999999999999999999999765 679999999999999999999999999999999999999
Q ss_pred cCC-------------------CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCC
Q psy2648 546 DSE-------------------MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSIS 606 (708)
Q Consensus 546 ~~~-------------------~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~ 606 (708)
+.+ ..+||+|||++...... ....||+.|+|||++.+...++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~-------------- 211 (289)
T 1x8b_A 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPK-------------- 211 (289)
T ss_dssp C--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHH--------------
T ss_pred cCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCch--------------
Confidence 844 47999999999876432 234699999999999865433222
Q ss_pred CCCccccccccccccchhhhHHHHhhCCCC
Q psy2648 607 PAPTNFKRQNTIDSASIKENTARLNAGRPA 636 (708)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (708)
.|-|+++.++-.+..|.|.
T Consensus 212 -----------~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 212 -----------ADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -----------HHHHHHHHHHHHHTTCCCC
T ss_pred -----------hhHHHHHHHHHHHhcCCCC
Confidence 4556666666666666553
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=218.86 Aligned_cols=148 Identities=37% Similarity=0.677 Sum_probs=129.3
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.|+||++++++++....+|||||||+|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 79999999999999999999999999999999999888999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHH
Q psy2648 550 NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTAR 629 (708)
Q Consensus 550 ~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (708)
.+||+|||++............+||+.|+|||++.+........ + -...|-|+++.++-+
T Consensus 238 ~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~------------------~--~~~~Di~slG~il~e 297 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG------------------Y--GKEVDLWACGVILFT 297 (365)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCC------------------B--CTTHHHHHHHHHHHH
T ss_pred CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcC------------------C--CchhhHHhHHHHHHH
Confidence 99999999998877666667789999999999997553211100 0 112678888999999
Q ss_pred HhhCCCCC
Q psy2648 630 LNAGRPAK 637 (708)
Q Consensus 630 ~~~~~~~~ 637 (708)
+..|.+.-
T Consensus 298 ll~g~~pf 305 (365)
T 2y7j_A 298 LLAGSPPF 305 (365)
T ss_dssp HHHSSCSS
T ss_pred HHHCCCCC
Confidence 99988753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.6e-23 Score=215.10 Aligned_cols=145 Identities=28% Similarity=0.427 Sum_probs=120.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+...+|||||||++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~ 137 (311)
T 4agu_A 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK 137 (311)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred hCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC
Confidence 45799999999999999999999999999999999888888999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 548 EMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
++.+||+|||++..... .......+||+.|+|||++.+...++.. .|-|+++.+
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-------------------------~Di~slG~i 192 (311)
T 4agu_A 138 HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP-------------------------VDVWAIGCV 192 (311)
T ss_dssp TSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTH-------------------------HHHHHHHHH
T ss_pred CCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcc-------------------------hhhHHHHHH
Confidence 99999999999987653 2334567899999999999765444332 678888899
Q ss_pred HHHHhhCCCCC
Q psy2648 627 TARLNAGRPAK 637 (708)
Q Consensus 627 ~~~~~~~~~~~ 637 (708)
+-++..|.+.-
T Consensus 193 l~~l~~g~~p~ 203 (311)
T 4agu_A 193 FAELLSGVPLW 203 (311)
T ss_dssp HHHHHHSSCSC
T ss_pred HHHHHhCCCCC
Confidence 99999887764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.9e-23 Score=215.25 Aligned_cols=145 Identities=32% Similarity=0.525 Sum_probs=121.5
Q ss_pred ccccCceeEEEEEEEe--CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~--~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+||+++++++.+ ...+|||||||++++|.+++ ..+.+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 4579999999999987 67899999999999998754 34579999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||+++...... .....+||+.|+|||++.+...... ....|-|+++
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----------------------~~~~Di~slG 227 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFS-----------------------GKALDVWAMG 227 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEE-----------------------SHHHHHHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCC-----------------------CchhhhHhHH
Confidence 999999999999998765432 3456789999999999976542110 0125778888
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-++..|.+.
T Consensus 228 ~~l~~l~~g~~p 239 (298)
T 2zv2_A 228 VTLYCFVFGQCP 239 (298)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHHCCCC
Confidence 888899888765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=215.39 Aligned_cols=144 Identities=23% Similarity=0.464 Sum_probs=123.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||++++++.....+|||||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175 (321)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 345799999999999999999999999999999998764 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||+++..... ......+||+.|+|||++.+... +. ..|-|+++.
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~Dv~slG~ 229 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-AT-------------------------EVDIWSLGI 229 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCB-CT-------------------------HHHHHHHHH
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCC-Cc-------------------------hhhHHHHHH
Confidence 9999999999999876443 23456789999999999965432 11 257788888
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|.+.-
T Consensus 230 il~el~~g~~pf 241 (321)
T 2c30_A 230 MVIEMVDGEPPY 241 (321)
T ss_dssp HHHHHHHSSCTT
T ss_pred HHHHHHhCCCCC
Confidence 888888887653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=220.82 Aligned_cols=142 Identities=25% Similarity=0.416 Sum_probs=122.9
Q ss_pred ccccCceeEEEEEEEeCC------EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEK------TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~------~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+|||++++++.... .+||||||| +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 ~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~ 157 (367)
T 1cm8_A 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 157 (367)
T ss_dssp HCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHH
Confidence 357999999999998763 569999999 8899998876 57999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+||+|||+++.... .....+||++|+|||++.+...++.. .|.|
T Consensus 158 NIll~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Diw 210 (367)
T 1cm8_A 158 NLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQT-------------------------VDIW 210 (367)
T ss_dssp GEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTT-------------------------HHHH
T ss_pred HEEEcCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChh-------------------------hhHH
Confidence 99999999999999999987543 34567899999999999875444433 6889
Q ss_pred chhhhHHHHhhCCCCCC
Q psy2648 622 SIKENTARLNAGRPAKN 638 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ 638 (708)
++++++.++..|.|.=.
T Consensus 211 slG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 211 SVGCIMAEMITGKTLFK 227 (367)
T ss_dssp HHHHHHHHHHHSSCSSC
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 99999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=216.16 Aligned_cols=143 Identities=23% Similarity=0.395 Sum_probs=114.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~N 542 (708)
...|+|||++++++.+...+|||||||++|+|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|
T Consensus 90 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~N 169 (309)
T 3p86_A 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169 (309)
T ss_dssp HCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGG
T ss_pred hCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhh
Confidence 45799999999999999999999999999999999987653 999999999999999999999999 9999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
||++.++.+||+|||+++...... .....+||+.|+|||++.+... +. ..|-|
T Consensus 170 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~Diw 223 (309)
T 3p86_A 170 LLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NE-------------------------KSDVY 223 (309)
T ss_dssp EEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCC-CT-------------------------THHHH
T ss_pred EEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCC-Cc-------------------------hhhHH
Confidence 999999999999999997654332 2345789999999999976542 11 25788
Q ss_pred chhhhHHHHhhCCCC
Q psy2648 622 SIKENTARLNAGRPA 636 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~ 636 (708)
+++.++-++..|.+.
T Consensus 224 slG~il~elltg~~P 238 (309)
T 3p86_A 224 SFGVILWELATLQQP 238 (309)
T ss_dssp HHHHHHHHHHHCCCT
T ss_pred HHHHHHHHHHhCCCC
Confidence 888999999988765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=217.16 Aligned_cols=139 Identities=22% Similarity=0.303 Sum_probs=120.8
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
.|+|||++++++...+.+||||||| +++|.+++.... .+++.+++.++.||+.||.|||++|||||||||+|||++.
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 5999999999999999999999999 999999998754 5999999999999999999999999999999999999975
Q ss_pred -------------------------CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCccc
Q psy2648 548 -------------------------EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHN 602 (708)
Q Consensus 548 -------------------------~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~ 602 (708)
.+.+||+|||+|+.... .....+||+.|+|||++.+.. ++..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~---------- 239 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVS---------- 239 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTT----------
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCc----------
Confidence 78899999999986433 234678999999999997654 2222
Q ss_pred CCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 603 SSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|++++++-++..|.+.=
T Consensus 240 ---------------~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 240 ---------------SDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ---------------HHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------cchHHHHHHHHHHHHCCCCC
Confidence 57888899999999988754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-22 Score=215.55 Aligned_cols=145 Identities=24% Similarity=0.394 Sum_probs=120.6
Q ss_pred ccccCceeEEEEEEEe--------CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q psy2648 468 SSGGETLLKLFQVIET--------EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 538 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~--------~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 538 (708)
...|+||+++++++.+ ...+|||||||++ +|.+.+... ..+++.+++.++.||+.||.|||++||+||||
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 150 (351)
T 3mi9_A 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 150 (351)
T ss_dssp HCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCC
Confidence 4579999999999987 4579999999986 777776543 57999999999999999999999999999999
Q ss_pred CCCCeeecCCCCEEEeeccCccccCC-----CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc
Q psy2648 539 KAENLLLDSEMNIKIADFGFSNEFTP-----GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK 613 (708)
Q Consensus 539 Kp~NILl~~~~~vKl~DFGla~~~~~-----~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 613 (708)
||+|||++.++.+||+|||+|+.... .......+||+.|+|||++.+...++..
T Consensus 151 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------------- 209 (351)
T 3mi9_A 151 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP--------------------- 209 (351)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTH---------------------
T ss_pred CHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcH---------------------
Confidence 99999999999999999999976542 2233556899999999999775544433
Q ss_pred ccccccccchhhhHHHHhhCCCCCC
Q psy2648 614 RQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.|-|++++++-++..|.|.-.
T Consensus 210 ----~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 210 ----IDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp ----HHHHHHHHHHHHHHHSSCSCC
T ss_pred ----hHHHHHHHHHHHHHhCCCCCC
Confidence 678888888888888877643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=210.26 Aligned_cols=144 Identities=31% Similarity=0.486 Sum_probs=117.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
....|+||+++++++.+...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 75 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 154 (285)
T 3is5_A 75 KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154 (285)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred HhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHH
Confidence 3458999999999999999999999999999999988543 679999999999999999999999999999999999
Q ss_pred eee---cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 543 LLL---DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 543 ILl---~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
||+ +..+.+||+|||+++...........+||+.|+|||++.+. ++. ..|
T Consensus 155 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~-------------------------~~D 207 (285)
T 3is5_A 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD--VTF-------------------------KCD 207 (285)
T ss_dssp EEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTC--CCH-------------------------HHH
T ss_pred EEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccC--CCc-------------------------ccC
Confidence 999 44578999999999876655555677899999999998532 111 257
Q ss_pred ccchhhhHHHHhhCCCCC
Q psy2648 620 SASIKENTARLNAGRPAK 637 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~ 637 (708)
-|+++.++-.+..|.+.-
T Consensus 208 i~slG~il~~ll~g~~pf 225 (285)
T 3is5_A 208 IWSAGVVMYFLLTGCLPF 225 (285)
T ss_dssp HHHHHHHHHHHHHSSCSS
T ss_pred eehHHHHHHHHHhCCCCC
Confidence 888899999999887653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=215.79 Aligned_cols=144 Identities=28% Similarity=0.482 Sum_probs=115.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.++..+|||||||+ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 133 (324)
T 3mtl_A 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI 133 (324)
T ss_dssp SCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE
T ss_pred HhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE
Confidence 44579999999999999999999999998 58999887654 59999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||+++.... .......+||+.|+|||++.+...++.. .|-|+++
T Consensus 134 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~DiwslG 188 (324)
T 3mtl_A 134 NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ-------------------------IDMWGVG 188 (324)
T ss_dssp CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTH-------------------------HHHHHHH
T ss_pred CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcH-------------------------HHHHHHH
Confidence 9999999999999976542 2334556899999999999875544433 5667777
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.+.
T Consensus 189 ~il~~l~~g~~p 200 (324)
T 3mtl_A 189 CIFYEMATGRPL 200 (324)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHhCCCC
Confidence 777777777654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=213.55 Aligned_cols=144 Identities=28% Similarity=0.456 Sum_probs=122.1
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+|||++++++.++..+|||||||++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 75 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~ 153 (311)
T 3niz_A 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN 153 (311)
T ss_dssp HCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred HcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC
Confidence 45799999999999999999999999985 888877654 4599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||+++..... ......+||+.|+|||++.+...++.. .|-|++++
T Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~DiwslG~ 208 (311)
T 3niz_A 154 SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS-------------------------VDIWSIGC 208 (311)
T ss_dssp TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTH-------------------------HHHHHHHH
T ss_pred CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCch-------------------------HHhHHHHH
Confidence 9999999999999876432 334556899999999999775544333 67888889
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|.+.-
T Consensus 209 il~~ll~g~~pf 220 (311)
T 3niz_A 209 IFAEMITGKPLF 220 (311)
T ss_dssp HHHHHHHSSCSC
T ss_pred HHHHHHhCCCCC
Confidence 999998887654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-22 Score=209.95 Aligned_cols=145 Identities=30% Similarity=0.493 Sum_probs=118.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+||+++++++.+...+||||||+++ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 133 (288)
T 1ob3_A 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133 (288)
T ss_dssp GGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 345799999999999999999999999986 899888764 679999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||+++..... ......+||+.|+|||++.+...++.. .|-|+++
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~DiwslG 188 (288)
T 1ob3_A 134 NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT-------------------------IDIWSVG 188 (288)
T ss_dssp CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTH-------------------------HHHHHHH
T ss_pred cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcH-------------------------HHHHHHH
Confidence 99999999999999765432 234456899999999999765433322 5777788
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
+++-++..|.+.-
T Consensus 189 ~il~~l~~g~~pf 201 (288)
T 1ob3_A 189 CIFAEMVNGTPLF 201 (288)
T ss_dssp HHHHHHHHSSCSC
T ss_pred HHHHHHHhCCCCC
Confidence 8888888877653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-22 Score=216.35 Aligned_cols=149 Identities=23% Similarity=0.374 Sum_probs=123.9
Q ss_pred cccccCceeEEEEEEEeCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------C
Q psy2648 467 ASSGGETLLKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK----------K 532 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~----~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~----------~ 532 (708)
....|+|||++++++.+.. .+|||||||++|+|.+++... .+++..+..++.||+.||.|||+. +
T Consensus 73 ~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ 151 (322)
T 3soc_A 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA 151 (322)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE
T ss_pred hcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC
Confidence 4457999999999998744 589999999999999999764 699999999999999999999999 9
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCC
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAP 609 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~ 609 (708)
||||||||+|||++.++.+||+|||+|+...... .....+||+.|+|||++.+.......
T Consensus 152 ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~----------------- 214 (322)
T 3soc_A 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD----------------- 214 (322)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHH-----------------
T ss_pred EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcC-----------------
Confidence 9999999999999999999999999997654332 23446899999999999865322111
Q ss_pred ccccccccccccchhhhHHHHhhCCCCC
Q psy2648 610 TNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
--...|-|++++++-++..|.+.-
T Consensus 215 ----~~~~~DiwslG~il~el~tg~~pf 238 (322)
T 3soc_A 215 ----AFLRIDMYAMGLVLWELASRCTAA 238 (322)
T ss_dssp ----HHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred ----CCccchhHHHHHHHHHHHhCCCCC
Confidence 011258899999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-22 Score=222.43 Aligned_cols=144 Identities=27% Similarity=0.450 Sum_probs=112.6
Q ss_pred ccccCceeEEEEEEEe--CCEEEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q psy2648 468 SSGGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHG---------RMKEKEARAKFRQIVSAVQYCHQKKIIHR 536 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~--~~~~yLVmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 536 (708)
...|+|||+++++|.. ...+|||||||.+ +|.+++.... .+++..++.++.||+.||.|||++|||||
T Consensus 74 ~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 152 (405)
T 3rgf_A 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152 (405)
T ss_dssp HCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred hcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCC
Confidence 4579999999999954 6799999999975 8888775321 49999999999999999999999999999
Q ss_pred CCCCCCeee----cCCCCEEEeeccCccccCCC----CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCC
Q psy2648 537 DLKAENLLL----DSEMNIKIADFGFSNEFTPG----NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPA 608 (708)
Q Consensus 537 DlKp~NILl----~~~~~vKl~DFGla~~~~~~----~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~ 608 (708)
||||+|||+ +..+.+||+|||+|+..... ......+||+.|+|||++.+...++.+
T Consensus 153 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~---------------- 216 (405)
T 3rgf_A 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA---------------- 216 (405)
T ss_dssp CCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHH----------------
T ss_pred CcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccch----------------
Confidence 999999999 67789999999999876432 234567899999999999876544433
Q ss_pred CccccccccccccchhhhHHHHhhCCCCC
Q psy2648 609 PTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|++++++-++..|.|.-
T Consensus 217 ---------~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 217 ---------IDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp ---------HHHHHHHHHHHHHHHSSCTT
T ss_pred ---------hhhHHHHHHHHHHHhCCCCC
Confidence 67778888888888877654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-22 Score=215.27 Aligned_cols=146 Identities=27% Similarity=0.463 Sum_probs=121.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+...+|||||||++++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~ 159 (331)
T 4aaa_A 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ 159 (331)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred hCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC
Confidence 45799999999999999999999999999999988887788999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 548 EMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
++.+||+|||+++.... .......+||+.|+|||++.+...++.. .|.|+++++
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Di~slG~i 214 (331)
T 4aaa_A 160 SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA-------------------------VDVWAIGCL 214 (331)
T ss_dssp TSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTH-------------------------HHHHHHHHH
T ss_pred CCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchH-------------------------HHHHHHHHH
Confidence 99999999999976543 2334567899999999999765433322 678888999
Q ss_pred HHHHhhCCCCCC
Q psy2648 627 TARLNAGRPAKN 638 (708)
Q Consensus 627 ~~~~~~~~~~~~ 638 (708)
+-++..|.+.-.
T Consensus 215 l~~l~~g~~pf~ 226 (331)
T 4aaa_A 215 VTEMFMGEPLFP 226 (331)
T ss_dssp HHHHHHSSCSCC
T ss_pred HHHHHhCCCCCC
Confidence 999999887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9e-23 Score=217.90 Aligned_cols=142 Identities=32% Similarity=0.491 Sum_probs=116.4
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
..|+||++++++|++...+|||||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 86 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 86 KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165 (327)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred cCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe
Confidence 36799999999999999999999999999999988543 6799999999999999999999999999999999999998
Q ss_pred C---CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 547 S---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 547 ~---~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
. .+.+||+|||+++...........+||+.|+|||++.+..... ..|-|++
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~Diwsl 219 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT--------------------------ATDMWNI 219 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCT--------------------------HHHHHHH
T ss_pred cCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCc--------------------------hhhHHHH
Confidence 7 7899999999998876555556678999999999996544221 1467777
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
+.++-++..|.+.
T Consensus 220 G~il~~ll~g~~p 232 (327)
T 3lm5_A 220 GIIAYMLLTHTSP 232 (327)
T ss_dssp HHHHHHHHHSSCS
T ss_pred HHHHHHHHhCCCC
Confidence 7777777777664
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.1e-22 Score=212.70 Aligned_cols=145 Identities=26% Similarity=0.307 Sum_probs=123.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
....|+||+++++++.+...+|+|||||++|+|.+++.... .+++.++..++.||+.||.|||++||+||||||+|
T Consensus 90 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N 169 (321)
T 2qkw_B 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSIN 169 (321)
T ss_dssp GSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTT
T ss_pred HhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHH
Confidence 34579999999999999999999999999999999886543 58999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCC---CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
||++.++.+||+|||+++..... ......+||+.|+|||++.+... +. ..|
T Consensus 170 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~D 223 (321)
T 2qkw_B 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TE-------------------------KSD 223 (321)
T ss_dssp EEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CT-------------------------HHH
T ss_pred EEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCC-Cc-------------------------ccc
Confidence 99999999999999999764322 22345679999999999875432 11 257
Q ss_pred ccchhhhHHHHhhCCCCC
Q psy2648 620 SASIKENTARLNAGRPAK 637 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~ 637 (708)
-|+++.++-++..|++.-
T Consensus 224 i~slG~il~ell~g~~p~ 241 (321)
T 2qkw_B 224 VYSFGVVLFEVLCARSAI 241 (321)
T ss_dssp HHHHHHHHHHHHHCCTTC
T ss_pred hHhHHHHHHHHHhCCCcc
Confidence 889999999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-22 Score=208.86 Aligned_cols=143 Identities=31% Similarity=0.572 Sum_probs=120.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++.+...+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~ 143 (279)
T 3fdn_A 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 143 (279)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC
T ss_pred HcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.++.+||+|||++...... .....+||+.|+|||++.+..... ..|-|+++.+
T Consensus 144 ~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG~i 196 (279)
T 3fdn_A 144 SAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDE--------------------------KVDLWSLGVL 196 (279)
T ss_dssp TTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCT--------------------------THHHHHHHHH
T ss_pred CCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCCCc--------------------------cchhHhHHHH
Confidence 9999999999998654332 234568999999999987543211 1577778888
Q ss_pred HHHHhhCCCC
Q psy2648 627 TARLNAGRPA 636 (708)
Q Consensus 627 ~~~~~~~~~~ 636 (708)
+-.+..|.+.
T Consensus 197 l~~l~~g~~p 206 (279)
T 3fdn_A 197 CYEFLVGKPP 206 (279)
T ss_dssp HHHHHHSSCT
T ss_pred HHHHHHCCCC
Confidence 8888887765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-22 Score=214.73 Aligned_cols=120 Identities=24% Similarity=0.347 Sum_probs=102.4
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+|||++++++. ...+|+|||||.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 71 ~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~ 149 (325)
T 3kex_A 71 SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK 149 (325)
T ss_dssp TCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES
T ss_pred cCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC
Confidence 458999999999986 45699999999999999999764 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.++.+||+|||+++...... ......||+.|+|||++.+...
T Consensus 150 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (325)
T 3kex_A 150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194 (325)
T ss_dssp SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC
T ss_pred CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCC
Confidence 99999999999998764432 2345678889999999986653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-22 Score=217.70 Aligned_cols=143 Identities=20% Similarity=0.264 Sum_probs=122.3
Q ss_pred ccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 468 SSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
...|+||+++++++.+ ...+||||||| +++|.+++...+.+++.++..++.||+.||.|||++||+||||||+||
T Consensus 104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182 (345)
T ss_dssp TCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence 3489999999999988 78999999999 999999998877999999999999999999999999999999999999
Q ss_pred eecCCC--CEEEeeccCccccCCC--------CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc
Q psy2648 544 LLDSEM--NIKIADFGFSNEFTPG--------NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK 613 (708)
Q Consensus 544 Ll~~~~--~vKl~DFGla~~~~~~--------~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 613 (708)
|++.++ .+||+|||+|+..... ......+||+.|+|||++.+.....
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----------------------- 239 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR----------------------- 239 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH-----------------------
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc-----------------------
Confidence 999887 9999999999765322 1224568999999999998654221
Q ss_pred ccccccccchhhhHHHHhhCCCCC
Q psy2648 614 RQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
..|-|+++.++-++..|.+.-
T Consensus 240 ---~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 240 ---RSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp ---HHHHHHHHHHHHHHHHSSCTT
T ss_pred ---hhhHHHHHHHHHHHHhCCCCc
Confidence 257788888888888887654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-22 Score=218.86 Aligned_cols=142 Identities=20% Similarity=0.247 Sum_probs=118.0
Q ss_pred ccCceeEEEEEEEeCC-EEEEEEeccCCCCHHHHHHhcCC----------------------------------------
Q psy2648 470 GGETLLKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGR---------------------------------------- 508 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~-~~yLVmEy~~gg~L~~~l~~~~~---------------------------------------- 508 (708)
.|+|||++++++.+.. .+|+|||||++|+|.+++.....
T Consensus 84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 7899999999998765 49999999999999999976543
Q ss_pred --------------------------CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCcccc
Q psy2648 509 --------------------------MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562 (708)
Q Consensus 509 --------------------------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~ 562 (708)
+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 899999999999999999999999999999999999999999999999999865
Q ss_pred CCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhh-CCCCC
Q psy2648 563 TPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNA-GRPAK 637 (708)
Q Consensus 563 ~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 637 (708)
.... ......||+.|+|||++.+..... ..|-|+++.++-.+.. |.+.-
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--------------------------~~Di~slG~il~ellt~g~~p~ 296 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTI--------------------------QSDVWSFGVLLWEIFSLGASPY 296 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCH--------------------------HHHHHHHHHHHHHHTTTSCCSS
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCc--------------------------hhhhhhHHHHHHHHHhcCCCCC
Confidence 3322 234567899999999997543221 2577888888888875 66553
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-22 Score=206.12 Aligned_cols=139 Identities=19% Similarity=0.233 Sum_probs=110.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcE--EEEEEeccCCCCh----------------------hhHHHHHHHHHHHHhCC
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNP----------------------GSLQKLFREVRIMKMLD 103 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~--vAvK~i~~~~~~~----------------------~~~~~~~~Ei~il~~l~ 103 (708)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+++|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999888999 9999976542110 01135778999999998
Q ss_pred CCCe--eeEEEEEEeCCEEEEEEeccCC-C----ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCC
Q psy2648 104 HPNI--VKLFQVIETEKTLYLVMEYASG-G----EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH-QKKIIHRDLKAEN 175 (708)
Q Consensus 104 HpnI--v~l~~~~~~~~~~ylVmEy~~g-g----~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH-~~gIvHRDLKPeN 175 (708)
|++| ..+++. ...||||||+.+ | .|.+++.. .++.++..++.||+.||.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8753 444443 246899999942 3 66665422 345678899999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeccCcccc
Q psy2648 176 LLLDSEMNIKIADFGFSNEF 195 (708)
Q Consensus 176 ILld~~~~iKL~DFGls~~~ 195 (708)
||++. .++|+|||+|...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99998 8999999999654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-22 Score=211.98 Aligned_cols=140 Identities=24% Similarity=0.428 Sum_probs=122.8
Q ss_pred ccCceeEEEEEEEe--CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 470 GGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~--~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
.|+||+++++++.+ ....|||||||++++|.+++. .+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~ 165 (330)
T 3nsz_A 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165 (330)
T ss_dssp TSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred CCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC
Confidence 59999999999998 678999999999999998874 4899999999999999999999999999999999999997
Q ss_pred CC-CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 548 EM-NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 548 ~~-~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
++ .+||+|||+|+...........+||+.|+|||++.+...++.. .|-|+++++
T Consensus 166 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-------------------------~DiwslG~i 220 (330)
T 3nsz_A 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS-------------------------LDMWSLGCM 220 (330)
T ss_dssp TTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTH-------------------------HHHHHHHHH
T ss_pred CCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCch-------------------------hhHHHHHHH
Confidence 77 8999999999877666666778899999999999765443332 688889999
Q ss_pred HHHHhhCCCCC
Q psy2648 627 TARLNAGRPAK 637 (708)
Q Consensus 627 ~~~~~~~~~~~ 637 (708)
+-++..|.+.-
T Consensus 221 l~~ll~g~~p~ 231 (330)
T 3nsz_A 221 LASMIFRKEPF 231 (330)
T ss_dssp HHHHHHTCSSS
T ss_pred HHHHHhCCCCc
Confidence 99999887653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.1e-22 Score=206.69 Aligned_cols=142 Identities=20% Similarity=0.288 Sum_probs=121.5
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
..|++|+++++++.+....||||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 63 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 141 (298)
T 1csn_A 63 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 141 (298)
T ss_dssp TTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECC
T ss_pred hcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecc
Confidence 37899999999999999999999999 999999998754 5999999999999999999999999999999999999987
Q ss_pred CCC-----EEEeeccCccccCCCC--------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccc
Q psy2648 548 EMN-----IKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKR 614 (708)
Q Consensus 548 ~~~-----vKl~DFGla~~~~~~~--------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~ 614 (708)
++. +||+|||+++...... .....+||+.|+|||++.+.....
T Consensus 142 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~------------------------ 197 (298)
T 1csn_A 142 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR------------------------ 197 (298)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH------------------------
T ss_pred CCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCCh------------------------
Confidence 776 9999999998654322 234568999999999987654211
Q ss_pred cccccccchhhhHHHHhhCCCCC
Q psy2648 615 QNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
..|-|+++.++-++..|.+.-
T Consensus 198 --~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 198 --RDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp --HHHHHHHHHHHHHHHHSSCTT
T ss_pred --HHHHHHHHHHHHHHHcCCCCc
Confidence 257788889999999888754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-22 Score=206.38 Aligned_cols=143 Identities=32% Similarity=0.528 Sum_probs=120.5
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+...+|+||||+++++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 143 (283)
T 3bhy_A 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143 (283)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred hCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec
Confidence 35799999999999999999999999999999999988889999999999999999999999999999999999999988
Q ss_pred CC----CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 548 EM----NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 548 ~~----~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
++ .+||+|||++.............||+.|+|||++.+..... ..|-|++
T Consensus 144 ~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~sl 197 (283)
T 3bhy_A 144 KNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL--------------------------EADMWSI 197 (283)
T ss_dssp SSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCT--------------------------HHHHHHH
T ss_pred CCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCc--------------------------chhhhhH
Confidence 77 89999999998776555556678999999999986543211 2577888
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
+.++-++..|.+.
T Consensus 198 G~il~~l~~g~~p 210 (283)
T 3bhy_A 198 GVITYILLSGASP 210 (283)
T ss_dssp HHHHHHHHHSSCT
T ss_pred HHHHHHHHHCCCC
Confidence 8888888888765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-22 Score=206.21 Aligned_cols=120 Identities=26% Similarity=0.430 Sum_probs=107.2
Q ss_pred ccccCceeEEEEEEEe----------------CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q psy2648 468 SSGGETLLKLFQVIET----------------EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCH 529 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~----------------~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH 529 (708)
...|+||+++++++.. ...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||
T Consensus 60 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 139 (284)
T 2a19_B 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH 139 (284)
T ss_dssp HCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4579999999999865 45689999999999999999754 57999999999999999999999
Q ss_pred hCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCC
Q psy2648 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 530 ~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
++||+||||||+|||++.++.+||+|||+++............||+.|+|||++.+..
T Consensus 140 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (284)
T 2a19_B 140 SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD 197 (284)
T ss_dssp HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC
T ss_pred hCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCC
Confidence 9999999999999999999999999999998776655556678999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=218.67 Aligned_cols=143 Identities=21% Similarity=0.266 Sum_probs=118.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp 540 (708)
...|+|||++++++.+....|||||||++|+|.+++...+ .+++.++..++.||+.||.|||++|||||||||
T Consensus 130 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 209 (367)
T 3l9p_A 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209 (367)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred hCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 3489999999999999999999999999999999998653 489999999999999999999999999999999
Q ss_pred CCeeecCCC---CEEEeeccCccccCC---CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccc
Q psy2648 541 ENLLLDSEM---NIKIADFGFSNEFTP---GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKR 614 (708)
Q Consensus 541 ~NILl~~~~---~vKl~DFGla~~~~~---~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~ 614 (708)
+|||++.++ .+||+|||+|+.... .......+||+.|+|||++.+.....
T Consensus 210 ~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~------------------------ 265 (367)
T 3l9p_A 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS------------------------ 265 (367)
T ss_dssp GGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCH------------------------
T ss_pred hhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCc------------------------
Confidence 999999655 499999999975421 22334567899999999997654221
Q ss_pred cccccccchhhhHHHHhh-CCCC
Q psy2648 615 QNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|++++++-++.. |.+.
T Consensus 266 --~~DvwslG~il~ellt~g~~p 286 (367)
T 3l9p_A 266 --KTDTWSFGVLLWEIFSLGYMP 286 (367)
T ss_dssp --HHHHHHHHHHHHHHHTTSCCS
T ss_pred --HHHHHHHHHHHHHHHhCCCCC
Confidence 2567777888888775 6554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-22 Score=209.01 Aligned_cols=143 Identities=20% Similarity=0.349 Sum_probs=120.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++.+...+|||||||++|+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 75 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~ 154 (283)
T 3gen_A 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154 (283)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC
T ss_pred cCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc
Confidence 45799999999999999999999999999999999976 56799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+++...... ......||+.|+|||++.+..... ..|-|+++
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Dv~slG 208 (283)
T 3gen_A 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS--------------------------KSDIWAFG 208 (283)
T ss_dssp TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSH--------------------------HHHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCc--------------------------hhhHHHHH
Confidence 99999999999998654322 123345788999999997554211 25677778
Q ss_pred hhHHHHhh-CCCC
Q psy2648 625 ENTARLNA-GRPA 636 (708)
Q Consensus 625 ~~~~~~~~-~~~~ 636 (708)
.++-++.. |.+.
T Consensus 209 ~~l~~l~t~g~~p 221 (283)
T 3gen_A 209 VLMWEIYSLGKMP 221 (283)
T ss_dssp HHHHHHHTTTCCT
T ss_pred HHHHHHHhCCCCC
Confidence 88888875 6654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.8e-22 Score=203.52 Aligned_cols=144 Identities=49% Similarity=0.769 Sum_probs=116.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+...+|||||||++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 67 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 146 (276)
T 2h6d_A 67 LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA 146 (276)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT
T ss_pred cCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC
Confidence 45799999999999999999999999999999999998889999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhH
Q psy2648 548 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENT 627 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (708)
++.+||+|||++............+||+.|+|||++.+....+. ..|.|+++.++
T Consensus 147 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-------------------------~~Di~slG~~l 201 (276)
T 2h6d_A 147 HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP-------------------------EVDIWSCGVIL 201 (276)
T ss_dssp TSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHH-------------------------HHHHHHHHHHH
T ss_pred CCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCc-------------------------cchHHHHHHHH
Confidence 99999999999987765555556789999999999976543221 25777788888
Q ss_pred HHHhhCCCC
Q psy2648 628 ARLNAGRPA 636 (708)
Q Consensus 628 ~~~~~~~~~ 636 (708)
-++..|.+.
T Consensus 202 ~~l~~g~~p 210 (276)
T 2h6d_A 202 YALLCGTLP 210 (276)
T ss_dssp HHHHHSSCS
T ss_pred HHHHhCCCC
Confidence 888887654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=9.6e-22 Score=209.42 Aligned_cols=147 Identities=23% Similarity=0.304 Sum_probs=121.6
Q ss_pred cccCceeEEEEEEEeC----CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccC
Q psy2648 469 SGGETLLKLFQVIETE----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK--------KIIHR 536 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~----~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~--------~IiHR 536 (708)
..|+||+++++++... ..+|||||||++|+|.+++... .+++..+..++.||+.||.|||++ |||||
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 166 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec
Confidence 4899999999999988 7899999999999999999654 799999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCCc-----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcc
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNK-----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTN 611 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~~-----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~ 611 (708)
||||+|||++.++.+||+|||+++....... ....+||+.|+|||++.+.......
T Consensus 167 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------------------- 227 (337)
T 3mdy_A 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF------------------- 227 (337)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCT-------------------
T ss_pred ccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccc-------------------
Confidence 9999999999999999999999976543221 2356899999999999765432221
Q ss_pred ccccccccccchhhhHHHHhhCCCC
Q psy2648 612 FKRQNTIDSASIKENTARLNAGRPA 636 (708)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (708)
......|-|+++.++-++..|...
T Consensus 228 -~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 228 -QSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp -HHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred -cCccccchHHHHHHHHHHHhccCc
Confidence 000125888999999999998543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.3e-22 Score=208.17 Aligned_cols=145 Identities=25% Similarity=0.318 Sum_probs=116.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++.++..+||||||+++++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~ 168 (309)
T 2h34_A 89 GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168 (309)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred hhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc
Confidence 34579999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||++....... .....+||+.|+|||++.+..... ..|-|+++
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 222 (309)
T 2h34_A 169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY--------------------------RADIYALT 222 (309)
T ss_dssp TTSCEEECSCCC----------------CCGGGCCGGGTCC----C--------------------------CCHHHHHH
T ss_pred CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCc--------------------------hHhHHHHH
Confidence 99999999999987654332 234568999999999997543211 14677888
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
.++-++..|.+.-
T Consensus 223 ~il~~l~~g~~pf 235 (309)
T 2h34_A 223 CVLYECLTGSPPY 235 (309)
T ss_dssp HHHHHHHHSSCSS
T ss_pred HHHHHHHHCCCCC
Confidence 8888888887653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-22 Score=208.42 Aligned_cols=145 Identities=22% Similarity=0.269 Sum_probs=111.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAE 541 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~ 541 (708)
....|+||+++++++.++..+|||||||++ +|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+
T Consensus 61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~ 139 (290)
T 3fme_A 61 RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139 (290)
T ss_dssp TTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG
T ss_pred HhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 456899999999999999999999999985 87776643 46799999999999999999999998 9999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCC---CCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG---APVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~---~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
|||++.++.+||+|||+++...........+||+.|+|||++... ..++ ...
T Consensus 140 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-------------------------~~~ 194 (290)
T 3fme_A 140 NVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS-------------------------VKS 194 (290)
T ss_dssp GCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CC-------------------------HHH
T ss_pred HEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCC-------------------------cHH
Confidence 999999999999999999877655555566899999999998432 1111 126
Q ss_pred cccchhhhHHHHhhCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAK 637 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~ 637 (708)
|-|+++.++-++..|.+.-
T Consensus 195 Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 195 DIWSLGITMIELAILRFPY 213 (290)
T ss_dssp HHHHHHHHHHHHHHTSCSS
T ss_pred HHHHHHHHHHHHHHCCCCc
Confidence 7888999999999887654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=3.8e-22 Score=215.45 Aligned_cols=143 Identities=25% Similarity=0.424 Sum_probs=121.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl 545 (708)
....|+||+++++++.++..+|||||||++|+|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||+
T Consensus 86 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~ 165 (360)
T 3eqc_A 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 165 (360)
T ss_dssp GGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred HHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE
Confidence 34579999999999999999999999999999999999888999999999999999999999995 99999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
+.++.+||+|||+++..... .....+||+.|+|||++.+..... ..|-|++++
T Consensus 166 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~Di~slG~ 218 (360)
T 3eqc_A 166 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSV--------------------------QSDIWSMGL 218 (360)
T ss_dssp CTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSH--------------------------HHHHHHHHH
T ss_pred CCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCc--------------------------hhhHHHHHH
Confidence 99999999999998754321 234568999999999997643211 257788888
Q ss_pred hHHHHhhCCCC
Q psy2648 626 NTARLNAGRPA 636 (708)
Q Consensus 626 ~~~~~~~~~~~ 636 (708)
++-.+..|.+.
T Consensus 219 il~~l~~g~~p 229 (360)
T 3eqc_A 219 SLVEMAVGRYP 229 (360)
T ss_dssp HHHHHHHTSCC
T ss_pred HHHHHHhCCCC
Confidence 88888888754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-23 Score=220.87 Aligned_cols=99 Identities=21% Similarity=0.342 Sum_probs=88.8
Q ss_pred CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCCeeecCCC-------------
Q psy2648 484 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH-QKKIIHRDLKAENLLLDSEM------------- 549 (708)
Q Consensus 484 ~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~~------------- 549 (708)
...+|||||||++|++.+.+.+ +.+++.+++.++.||+.||.||| ++|||||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~ 212 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccc
Confidence 7899999999999987777644 57999999999999999999999 99999999999999999887
Q ss_pred -------CEEEeeccCccccCCCCcccccccCCcccccccccCCC
Q psy2648 550 -------NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 550 -------~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.+||+|||+|+..... ..+||+.|||||++.+..
T Consensus 213 ~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~ 253 (336)
T 2vuw_A 213 TIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG 253 (336)
T ss_dssp EEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS
T ss_pred cccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC
Confidence 8999999999876532 458999999999998765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-22 Score=206.55 Aligned_cols=146 Identities=35% Similarity=0.536 Sum_probs=126.2
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+....|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 140 (276)
T 2yex_A 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (276)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred hcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence 45799999999999999999999999999999999987778999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCC---CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 EMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
++.+||+|||++...... ......+||+.|+|||++.+....+. ..|-|+++
T Consensus 141 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-------------------------~~Di~slG 195 (276)
T 2yex_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE-------------------------PVDVWSCG 195 (276)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHH-------------------------HHHHHHHH
T ss_pred CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCC-------------------------cchHHHHH
Confidence 999999999999765322 22456789999999999976443222 25788889
Q ss_pred hhHHHHhhCCCCCC
Q psy2648 625 ENTARLNAGRPAKN 638 (708)
Q Consensus 625 ~~~~~~~~~~~~~~ 638 (708)
.++-++..|.+.-.
T Consensus 196 ~il~~l~~g~~p~~ 209 (276)
T 2yex_A 196 IVLTAMLAGELPWD 209 (276)
T ss_dssp HHHHHHHHSSCCCS
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999877543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-22 Score=212.35 Aligned_cols=145 Identities=26% Similarity=0.302 Sum_probs=125.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQK---KIIHRDLK 539 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlK 539 (708)
....|+||+++++++.+....|||||||++|+|.+++.... .+++..+..++.||+.||.|||++ ||+|||||
T Consensus 82 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk 161 (326)
T 3uim_A 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161 (326)
T ss_dssp GTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred HhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence 44579999999999999999999999999999999997643 399999999999999999999999 99999999
Q ss_pred CCCeeecCCCCEEEeeccCccccCCC--CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccc
Q psy2648 540 AENLLLDSEMNIKIADFGFSNEFTPG--NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNT 617 (708)
Q Consensus 540 p~NILl~~~~~vKl~DFGla~~~~~~--~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (708)
|+|||++.++.+||+|||+++..... ......+||+.|+|||++.+... +. .
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~ 215 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SE-------------------------K 215 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CH-------------------------H
T ss_pred hhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCC-Cc-------------------------c
Confidence 99999999999999999999866432 23445679999999999975442 21 2
Q ss_pred ccccchhhhHHHHhhCCCCC
Q psy2648 618 IDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|+++.++-++..|.+.-
T Consensus 216 ~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 216 TDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp HHHHHHHHHHHHHHHCCCSB
T ss_pred ccchhHHHHHHHHHhCCCcc
Confidence 58889999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-22 Score=212.99 Aligned_cols=144 Identities=37% Similarity=0.576 Sum_probs=122.5
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++..+. +|+|||||++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 71 ~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp HCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred hCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 357999999999998766 8999999999999999988889999999999999999999999999999999999999987
Q ss_pred CCC---EEEeeccCccccCCCCcccccccCCcccccccccC--CCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 548 EMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG--GAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 548 ~~~---vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g--~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
++. +||+|||+++...........+||+.|+|||++.+ ...++. ..|-|+
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-------------------------~~Di~s 204 (322)
T 2ycf_A 150 QEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR-------------------------AVDCWS 204 (322)
T ss_dssp SSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTT-------------------------HHHHHH
T ss_pred CCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCc-------------------------hhhHHH
Confidence 664 99999999987755444456789999999999853 222221 257788
Q ss_pred hhhhHHHHhhCCCCC
Q psy2648 623 IKENTARLNAGRPAK 637 (708)
Q Consensus 623 ~~~~~~~~~~~~~~~ 637 (708)
++.++-++..|.+.-
T Consensus 205 lG~il~~l~~g~~pf 219 (322)
T 2ycf_A 205 LGVILFICLSGYPPF 219 (322)
T ss_dssp HHHHHHHHHHSSCSS
T ss_pred HHHHHHHHHhCCCCC
Confidence 888998999887753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.6e-22 Score=212.13 Aligned_cols=143 Identities=23% Similarity=0.315 Sum_probs=119.1
Q ss_pred cccCceeEEEEEEEeCCE-------EEEEEeccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCcc
Q psy2648 469 SGGETLLKLFQVIETEKT-------LYLVMEYASGGEVFDYL----VLHGRMKEKEARAKFRQIVSAVQYCH--QKKIIH 535 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~-------~yLVmEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH--~~~IiH 535 (708)
..|+|||+++++|..... +|||||||+++ |...+ .....+++..+..++.||+.||.||| ++||+|
T Consensus 76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH 154 (360)
T 3e3p_A 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH 154 (360)
T ss_dssp HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBC
T ss_pred cCCCCcccHHHhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeec
Confidence 489999999999976433 89999999974 44333 34567999999999999999999999 999999
Q ss_pred CCCCCCCeeecC-CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccc
Q psy2648 536 RDLKAENLLLDS-EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKR 614 (708)
Q Consensus 536 RDlKp~NILl~~-~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~ 614 (708)
|||||+|||++. ++.+||+|||+++...........+||+.|+|||++.+...++..
T Consensus 155 ~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~---------------------- 212 (360)
T 3e3p_A 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTA---------------------- 212 (360)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTH----------------------
T ss_pred CcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcH----------------------
Confidence 999999999997 899999999999887666666677899999999999765544433
Q ss_pred cccccccchhhhHHHHhhCCCCC
Q psy2648 615 QNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|+++.++-++..|.+.-
T Consensus 213 ---~Di~slG~il~ell~g~~pf 232 (360)
T 3e3p_A 213 ---VDIWSVGCIFAEMMLGEPIF 232 (360)
T ss_dssp ---HHHHHHHHHHHHHHHSSCSS
T ss_pred ---HHHHHHHHHHHHHHhCCCCc
Confidence 57788888888888887653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=203.94 Aligned_cols=148 Identities=37% Similarity=0.641 Sum_probs=127.3
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
+|+||+++++++++...+|||||||++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 161 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC
Confidence 69999999999999999999999999999999999888999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHH
Q psy2648 550 NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTAR 629 (708)
Q Consensus 550 ~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (708)
.+||+|||++............+||+.|+|||++.+....... .+ ....|-|+++.++-+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~------------------~~--~~~~Di~slG~~l~~ 221 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP------------------GY--GKEVDMWSTGVIMYT 221 (298)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSC------------------CB--CTHHHHHHHHHHHHH
T ss_pred cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccc------------------cC--CcccccHhHHHHHHH
Confidence 9999999999887666666678899999999998643210000 00 112677888899999
Q ss_pred HhhCCCCC
Q psy2648 630 LNAGRPAK 637 (708)
Q Consensus 630 ~~~~~~~~ 637 (708)
+..|.+.-
T Consensus 222 l~~g~~p~ 229 (298)
T 1phk_A 222 LLAGSPPF 229 (298)
T ss_dssp HHHSSCSS
T ss_pred HHHCCCCC
Confidence 99887653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-22 Score=209.22 Aligned_cols=144 Identities=23% Similarity=0.317 Sum_probs=118.7
Q ss_pred cccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccC
Q psy2648 469 SGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH--------QKKIIHR 536 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH--------~~~IiHR 536 (708)
..|+||+++++++.+ ...+|||||||++|+|.+++.. ..+++..+..++.||+.||.||| +++|+||
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 689999999998654 3568999999999999999954 57999999999999999999999 9999999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCCc-----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcc
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNK-----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTN 611 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~~-----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~ 611 (708)
||||+|||++.++.+||+|||+|+....... ....+||+.|+|||++.+.......
T Consensus 138 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------------------- 198 (301)
T 3q4u_A 138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF------------------- 198 (301)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCH-------------------
T ss_pred CCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcc-------------------
Confidence 9999999999999999999999976543322 2345899999999999865422110
Q ss_pred ccccccccccchhhhHHHHhhC
Q psy2648 612 FKRQNTIDSASIKENTARLNAG 633 (708)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~ 633 (708)
.--...|-|+++.++-++..|
T Consensus 199 -~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 199 -DSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp -HHHHHHHHHHHHHHHHHHHTT
T ss_pred -cCCchhhHHHHHHHHHHHHhh
Confidence 001236788899999999988
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.5e-22 Score=207.50 Aligned_cols=142 Identities=39% Similarity=0.602 Sum_probs=120.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee--
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL-- 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-- 545 (708)
...|+||+++++++.+...+|+|||||++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~ 141 (304)
T 2jam_A 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141 (304)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESS
T ss_pred hCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 457999999999999999999999999999999999988899999999999999999999999999999999999999
Q ss_pred -cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 -DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 -~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||+++..... .....+||+.|+|||++.+..... ..|-|+++
T Consensus 142 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 194 (304)
T 2jam_A 142 PEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSK--------------------------AVDCWSIG 194 (304)
T ss_dssp SSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCH--------------------------HHHHHHHH
T ss_pred CCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCc--------------------------hhhHHHHH
Confidence 77889999999998764332 334567999999999997543221 24666667
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.+.
T Consensus 195 ~il~~l~~g~~p 206 (304)
T 2jam_A 195 VITYILLCGYPP 206 (304)
T ss_dssp HHHHHHHHSSCT
T ss_pred HHHHHHHHCCCC
Confidence 777777777654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=208.64 Aligned_cols=144 Identities=30% Similarity=0.523 Sum_probs=123.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++.+.+.+|||||||++++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 96 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 175 (335)
T 2owb_A 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175 (335)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc
Confidence 34589999999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||+++.... .......+||+.|+|||++.+..... ..|.|+++.
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~Di~slG~ 229 (335)
T 2owb_A 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF--------------------------EVDVWSIGC 229 (335)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCT--------------------------HHHHHHHHH
T ss_pred CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCc--------------------------hhhHHHHHH
Confidence 999999999999987642 33445678999999999997543211 146666777
Q ss_pred hHHHHhhCCCC
Q psy2648 626 NTARLNAGRPA 636 (708)
Q Consensus 626 ~~~~~~~~~~~ 636 (708)
++-++..|.+.
T Consensus 230 il~~l~~g~~p 240 (335)
T 2owb_A 230 IMYTLLVGKPP 240 (335)
T ss_dssp HHHHHHHSSCT
T ss_pred HHHHHHHCcCC
Confidence 77777776654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=202.91 Aligned_cols=145 Identities=30% Similarity=0.512 Sum_probs=125.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+||+++++++.+.+.+|+|||||++++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 149 (294)
T 2rku_A 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149 (294)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred HhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc
Confidence 34589999999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||++..... .......+||+.|+|||++.+..... ..|.|+++.
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG~ 203 (294)
T 2rku_A 150 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF--------------------------EVDVWSIGC 203 (294)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCT--------------------------HHHHHHHHH
T ss_pred CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCc--------------------------hhhHHHHHH
Confidence 999999999999987643 23345578999999999987543211 256777788
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|.+.-
T Consensus 204 ~l~~l~~g~~p~ 215 (294)
T 2rku_A 204 IMYTLLVGKPPF 215 (294)
T ss_dssp HHHHHHHSSCTT
T ss_pred HHHHHHhCCCCC
Confidence 888888877653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=214.93 Aligned_cols=151 Identities=23% Similarity=0.395 Sum_probs=117.9
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.++|||++++++..+..+||||| +.+++|.+++...+.+++.++..++.||+.||.|||++|||||||||+|||++ ++
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~ 191 (390)
T 2zmd_A 114 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG 191 (390)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS
T ss_pred CCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC
Confidence 36999999999999999999999 67889999999988999999999999999999999999999999999999995 58
Q ss_pred CEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 550 NIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 550 ~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.+||+|||+++...... .....+||+.|||||++.+.......+.. . ..+ -...|-|+++.+
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-----------~--~~~--~~~~DiwSlGvi 256 (390)
T 2zmd_A 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS-----------K--SKI--SPKSDVWSLGCI 256 (390)
T ss_dssp CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-------------------------C--CHHHHHHHHHHH
T ss_pred eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccccccccc-----------c--cCC--CChhhHHHHHHH
Confidence 99999999998764432 23467899999999999764321111000 0 000 123677888888
Q ss_pred HHHHhhCCCCC
Q psy2648 627 TARLNAGRPAK 637 (708)
Q Consensus 627 ~~~~~~~~~~~ 637 (708)
+-+|..|.+.-
T Consensus 257 l~ell~G~~Pf 267 (390)
T 2zmd_A 257 LYYMTYGKTPF 267 (390)
T ss_dssp HHHHHHSSCTT
T ss_pred HHHHHHCCCcc
Confidence 88888888754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-22 Score=221.82 Aligned_cols=119 Identities=23% Similarity=0.469 Sum_probs=106.3
Q ss_pred ccccCceeEEEEEEEeCC--EEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEK--TLYLVMEYASGGEVFDYLVLHGR---MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~--~~yLVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+|||++++++.... .+|||||||++|+|.+++..... +++..+..++.||+.||.|||++|||||||||+|
T Consensus 63 ~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 142 (396)
T 4eut_A 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142 (396)
T ss_dssp HCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHH
Confidence 357999999999998765 78999999999999999975433 9999999999999999999999999999999999
Q ss_pred eee----cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCC
Q psy2648 543 LLL----DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586 (708)
Q Consensus 543 ILl----~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~ 586 (708)
||+ +..+.+||+|||+++...........+||+.|+|||++.+.
T Consensus 143 Ill~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (396)
T 4eut_A 143 IMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190 (396)
T ss_dssp EEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHH
T ss_pred EEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhcc
Confidence 999 77788999999999887666566678899999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.2e-22 Score=212.87 Aligned_cols=142 Identities=27% Similarity=0.414 Sum_probs=120.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.++..+|||||||. |+|.+++. ..+.+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 187 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 187 (348)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 34579999999999999999999999998 57888775 45679999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCC--CCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG--APVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~--~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+.++.+||+|||+++.... ....+||+.|+|||++.+. ..++. ..|-|++
T Consensus 188 ~~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~-------------------------~~Diwsl 239 (348)
T 1u5q_A 188 SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDG-------------------------KVDVWSL 239 (348)
T ss_dssp ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCT-------------------------HHHHHHH
T ss_pred CCCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCc-------------------------HHHHHHH
Confidence 9999999999999986543 2456899999999999642 21221 2578888
Q ss_pred hhhHHHHhhCCCCC
Q psy2648 624 KENTARLNAGRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~~~~~~ 637 (708)
+.++-++..|.+.-
T Consensus 240 G~il~ell~g~~p~ 253 (348)
T 1u5q_A 240 GITCIELAERKPPL 253 (348)
T ss_dssp HHHHHHHHHSSCTT
T ss_pred HHHHHHHHhCCCCC
Confidence 99999999888753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=5.4e-22 Score=215.94 Aligned_cols=141 Identities=25% Similarity=0.422 Sum_probs=107.7
Q ss_pred ccccCceeEEEEEEEeC------CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETE------KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~------~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+||++++++|... ..+||||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 84 ~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 161 (367)
T 2fst_X 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 161 (367)
T ss_dssp HCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred hCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHh
Confidence 45799999999999764 6689999999 6899888765 57999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+||+|||+++.... .....+||++|+|||++.+...++.. .|-|
T Consensus 162 NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Diw 214 (367)
T 2fst_X 162 NLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQT-------------------------VDIW 214 (367)
T ss_dssp GEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTT-------------------------HHHH
T ss_pred hEEECCCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCch-------------------------hhHH
Confidence 99999999999999999986543 24457899999999999875444433 6888
Q ss_pred chhhhHHHHhhCCCCC
Q psy2648 622 SIKENTARLNAGRPAK 637 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~ 637 (708)
++++++-++..|.|.=
T Consensus 215 slG~il~ell~g~~pf 230 (367)
T 2fst_X 215 SVGCIMAELLTGRTLF 230 (367)
T ss_dssp HHHHHHHHHHHSSCSC
T ss_pred HHHHHHHHHHhCCCCC
Confidence 8999999999988754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=8.1e-22 Score=214.43 Aligned_cols=140 Identities=22% Similarity=0.378 Sum_probs=109.5
Q ss_pred ccccCceeEEEEEEEeCC------EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEK------TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~------~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+||+++++++.... .+|||||||++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 80 ~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 156 (371)
T 2xrw_A 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 156 (371)
T ss_dssp HCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred hcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHH
Confidence 457999999999998765 89999999985 7888775 46999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+||+|||+++...........+||+.|+|||++.+.. ++.. .|-|
T Consensus 157 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~-------------------------~Diw 210 (371)
T 2xrw_A 157 NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN-------------------------VDIW 210 (371)
T ss_dssp GEEECTTSCEEECCCCC----------------CTTCCHHHHTTCC-CCTT-------------------------HHHH
T ss_pred HEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCC-CCch-------------------------HhHH
Confidence 9999999999999999998765554556678999999999997643 2222 6888
Q ss_pred chhhhHHHHhhCCCC
Q psy2648 622 SIKENTARLNAGRPA 636 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~ 636 (708)
++++++-++..|.+.
T Consensus 211 slG~il~el~~g~~p 225 (371)
T 2xrw_A 211 SVGCIMGEMIKGGVL 225 (371)
T ss_dssp HHHHHHHHHHHSSCS
T ss_pred HHHHHHHHHHhCCCC
Confidence 899999999998765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-22 Score=204.71 Aligned_cols=143 Identities=22% Similarity=0.292 Sum_probs=119.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++.++..+|||||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 140 (269)
T 4hcu_A 61 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 140 (269)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred hCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc
Confidence 457999999999999999999999999999999999654 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+++...... ......||+.|+|||++.+..... ..|-|+++
T Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 194 (269)
T 4hcu_A 141 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS--------------------------KSDVWSFG 194 (269)
T ss_dssp GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH--------------------------HHHHHHHH
T ss_pred CCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCc--------------------------hhhhHHHH
Confidence 99999999999998654322 223456788999999996544221 25777778
Q ss_pred hhHHHHhh-CCCC
Q psy2648 625 ENTARLNA-GRPA 636 (708)
Q Consensus 625 ~~~~~~~~-~~~~ 636 (708)
.++-.+.. |.+.
T Consensus 195 ~~l~~ll~~g~~p 207 (269)
T 4hcu_A 195 VLMWEVFSEGKIP 207 (269)
T ss_dssp HHHHHHHTTSCCT
T ss_pred HHHHHHhcCCCCC
Confidence 88888776 6654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=212.84 Aligned_cols=118 Identities=28% Similarity=0.440 Sum_probs=105.9
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKI 533 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~ylH~~~I 533 (708)
.|+|||++++++.++..+|||||||++|+|.+++.... .+++.++..++.||+.||.|||++||
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 89999999999999999999999999999999998754 49999999999999999999999999
Q ss_pred ccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCC
Q psy2648 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 534 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
|||||||+|||++.++.+||+|||+|+...... ......||+.|+|||++.+..
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 269 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC
T ss_pred ecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC
Confidence 999999999999999999999999998764332 233456889999999997654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-21 Score=201.87 Aligned_cols=143 Identities=24% Similarity=0.419 Sum_probs=122.1
Q ss_pred cccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 540 (708)
....|+||++++++|.. ...+|||||||++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||
T Consensus 80 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp 159 (290)
T 1t4h_A 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp TTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred HhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCH
Confidence 34579999999999876 4679999999999999999998889999999999999999999999999 99999999
Q ss_pred CCeeec-CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 541 ENLLLD-SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 541 ~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
+|||++ .++.+||+|||++..... ......+||+.|+|||++.+. ++. ..|
T Consensus 160 ~Nil~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~-------------------------~~D 211 (290)
T 1t4h_A 160 DNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK--YDE-------------------------SVD 211 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTC--CCT-------------------------HHH
T ss_pred HHEEEECCCCCEEEeeCCCcccccc-cccccccCCcCcCCHHHHhcc--CCC-------------------------cch
Confidence 999998 789999999999975433 234456899999999988632 111 258
Q ss_pred ccchhhhHHHHhhCCCCC
Q psy2648 620 SASIKENTARLNAGRPAK 637 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~ 637 (708)
.|+++.++-.+..|.+.-
T Consensus 212 i~slG~~l~~l~~g~~pf 229 (290)
T 1t4h_A 212 VYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp HHHHHHHHHHHHHSSCTT
T ss_pred HHHHHHHHHHHHhCCCCC
Confidence 888999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=201.65 Aligned_cols=143 Identities=31% Similarity=0.592 Sum_probs=124.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+...+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 70 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 149 (284)
T 2vgo_A 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY 149 (284)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT
T ss_pred cCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC
Confidence 45799999999999999999999999999999999998889999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhH
Q psy2648 548 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENT 627 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (708)
++.+||+|||++...... .....+||+.|+|||++.+... +. ..|-|+++.++
T Consensus 150 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~-------------------------~~Di~slG~il 202 (284)
T 2vgo_A 150 KGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTH-DE-------------------------KVDLWCAGVLC 202 (284)
T ss_dssp TCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCB-CT-------------------------THHHHHHHHHH
T ss_pred CCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCC-Cc-------------------------ccchhhHHHHH
Confidence 999999999998765432 3345789999999999975432 11 15777888888
Q ss_pred HHHhhCCCCC
Q psy2648 628 ARLNAGRPAK 637 (708)
Q Consensus 628 ~~~~~~~~~~ 637 (708)
-++..|.+.-
T Consensus 203 ~~l~~g~~pf 212 (284)
T 2vgo_A 203 YEFLVGMPPF 212 (284)
T ss_dssp HHHHHSSCTT
T ss_pred HHHHHCCCCC
Confidence 8888887653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.85 E-value=9.4e-23 Score=222.19 Aligned_cols=141 Identities=10% Similarity=0.104 Sum_probs=116.1
Q ss_pred cccccCceeEEE-------EEEEeCCE-----------------EEEEEeccCCCCHHHHHHhcCCCCH-------HHHH
Q psy2648 467 ASSGGETLLKLF-------QVIETEKT-----------------LYLVMEYASGGEVFDYLVLHGRMKE-------KEAR 515 (708)
Q Consensus 467 ~~~~~~~Iv~L~-------~~~~~~~~-----------------~yLVmEy~~gg~L~~~l~~~~~l~e-------~~~~ 515 (708)
....|||||+++ ++++++.. .||||||| +|+|.+++...+.+++ ..+.
T Consensus 131 ~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~ 209 (377)
T 3byv_A 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARL 209 (377)
T ss_dssp TTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHH
T ss_pred cccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHH
Confidence 344899999998 88887643 89999999 6899999987666666 7778
Q ss_pred HHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCC--------
Q psy2648 516 AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA-------- 587 (708)
Q Consensus 516 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~-------- 587 (708)
.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+... ......+| +.|+|||++.+..
T Consensus 210 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 286 (377)
T 3byv_A 210 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDR 286 (377)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccc
Confidence 899999999999999999999999999999999999999999998643 34556788 9999999998651
Q ss_pred --CccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCC
Q psy2648 588 --PVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPA 636 (708)
Q Consensus 588 --~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (708)
.++. ..|-|+++.++-++..|.+.
T Consensus 287 ~~~~~~-------------------------~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 287 RTLMTF-------------------------SFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp EEECCH-------------------------HHHHHHHHHHHHHHHHSSCC
T ss_pred cccCCh-------------------------hhhHHHHHHHHHHHHHCCCC
Confidence 1211 25677788888888887765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=200.82 Aligned_cols=145 Identities=36% Similarity=0.539 Sum_probs=107.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+||+++++++.+...+|||||||++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili 145 (278)
T 3cok_A 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145 (278)
T ss_dssp TTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred HhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 3457999999999999999999999999999999999865 579999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||++..... .......+||+.|+|||++.+..... ..|-|+++
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 199 (278)
T 3cok_A 146 TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL--------------------------ESDVWSLG 199 (278)
T ss_dssp CTTCCEEECCCTTCEECC------------------------------------------------------CTHHHHHH
T ss_pred cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCc--------------------------hhhHHHHH
Confidence 9999999999999986542 22334568999999999987543211 15788889
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
.++-++..|.+.-
T Consensus 200 ~il~~l~~g~~p~ 212 (278)
T 3cok_A 200 CMFYTLLIGRPPF 212 (278)
T ss_dssp HHHHHHHHSSCSS
T ss_pred HHHHHHHhCCCCC
Confidence 9999999988753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=208.12 Aligned_cols=118 Identities=29% Similarity=0.535 Sum_probs=107.0
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec-C
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASG-GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-S 547 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-~ 547 (708)
.++||+++++++.++..+|+||||+.+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC
Confidence 579999999999999999999999986 89999999888999999999999999999999999999999999999999 7
Q ss_pred CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 548 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
++.+||+|||+++..... ......||+.|+|||++.+...
T Consensus 186 ~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 225 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRY 225 (320)
T ss_dssp TTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCB
T ss_pred CCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCC
Confidence 799999999999876532 3445689999999999976553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-21 Score=204.28 Aligned_cols=139 Identities=22% Similarity=0.280 Sum_probs=119.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+||+++++++.++...|||||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 146 (289)
T 4fvq_A 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146 (289)
T ss_dssp HTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred HhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEE
Confidence 345799999999999999999999999999999999987654 9999999999999999999999999999999999999
Q ss_pred cCCCC--------EEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccc
Q psy2648 546 DSEMN--------IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNT 617 (708)
Q Consensus 546 ~~~~~--------vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (708)
+.++. +||+|||++..... .....||+.|+|||++.+...++..
T Consensus 147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~------------------------- 198 (289)
T 4fvq_A 147 IREEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLA------------------------- 198 (289)
T ss_dssp EECCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHH-------------------------
T ss_pred ecCCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCch-------------------------
Confidence 98887 99999999876532 2345789999999999864333322
Q ss_pred ccccchhhhHHHHhhC
Q psy2648 618 IDSASIKENTARLNAG 633 (708)
Q Consensus 618 ~~~~~~~~~~~~~~~~ 633 (708)
.|-|+++.++-++..|
T Consensus 199 ~DiwslG~il~el~~g 214 (289)
T 4fvq_A 199 TDKWSFGTTLWEICSG 214 (289)
T ss_dssp HHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHcC
Confidence 5788888888888885
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.6e-22 Score=216.95 Aligned_cols=144 Identities=26% Similarity=0.353 Sum_probs=118.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.++..+|||||||++|+|.+++...+ .+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 167 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~ 246 (377)
T 3cbl_A 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246 (377)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE
Confidence 34589999999999999999999999999999999998654 59999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcc---cccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKL---DTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~---~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
+.++.+||+|||+|+........ ....+++.|+|||++.++..... .|-|+
T Consensus 247 ~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--------------------------~Dvws 300 (377)
T 3cbl_A 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE--------------------------SDVWS 300 (377)
T ss_dssp CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHH--------------------------HHHHH
T ss_pred cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCch--------------------------hhHHH
Confidence 99999999999999865432211 12346778999999975542221 46677
Q ss_pred hhhhHHHHhh-CCCC
Q psy2648 623 IKENTARLNA-GRPA 636 (708)
Q Consensus 623 ~~~~~~~~~~-~~~~ 636 (708)
.+.++-++.. |.+.
T Consensus 301 lG~il~el~t~g~~p 315 (377)
T 3cbl_A 301 FGILLWETFSLGASP 315 (377)
T ss_dssp HHHHHHHHHTTSCCS
T ss_pred HHHHHHHHHhCCCCC
Confidence 7777777775 5543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=213.41 Aligned_cols=123 Identities=22% Similarity=0.339 Sum_probs=97.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.+...+|||||||++|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 180 (373)
T 2qol_A 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180 (373)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE
Confidence 34579999999999999999999999999999999998654 69999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPV 589 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~ 589 (708)
+.++.+||+|||+++....... .....+|+.|+|||++.+....
T Consensus 181 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 228 (373)
T 2qol_A 181 NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228 (373)
T ss_dssp CTTCCEEECCC----------------------CTTSCHHHHHHCCCC
T ss_pred cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcC
Confidence 9999999999999987643221 1223467889999999865533
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.9e-22 Score=213.56 Aligned_cols=145 Identities=33% Similarity=0.465 Sum_probs=116.4
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh----------------------------------------cC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL----------------------------------------HG 507 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~----------------------------------------~~ 507 (708)
...|+|||++++++.+...+|||||||++|+|.+++.. ..
T Consensus 84 ~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (345)
T 3hko_A 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDF 163 (345)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCH
T ss_pred hCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 34799999999999999999999999999999998842 11
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC--CEEEeeccCccccCCCC-----cccccccCCccccc
Q psy2648 508 RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM--NIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAP 580 (708)
Q Consensus 508 ~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~--~vKl~DFGla~~~~~~~-----~~~~~~Gt~~Y~AP 580 (708)
.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... .....+||+.|+||
T Consensus 164 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 164 VQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 246788899999999999999999999999999999998776 89999999998653211 23457899999999
Q ss_pred ccccCC-CCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 581 ELFQGG-APVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 581 Evl~g~-~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
|++.+. ..++. ..|-|+++.++-++..|.+.-
T Consensus 244 E~~~~~~~~~~~-------------------------~~DiwslG~il~el~~g~~pf 276 (345)
T 3hko_A 244 EVLNTTNESYGP-------------------------KCDAWSAGVLLHLLLMGAVPF 276 (345)
T ss_dssp HHHTCSSSCCCT-------------------------HHHHHHHHHHHHHHHHSSCSS
T ss_pred hhhccCCCCCCc-------------------------HHHHHHHHHHHHHHHHCCCCC
Confidence 999753 22221 257888888888888887753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-21 Score=210.18 Aligned_cols=143 Identities=24% Similarity=0.343 Sum_probs=118.7
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+|||+++++|.+...+|||||||++ +|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 68 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 146 (346)
T 1ua2_A 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 146 (346)
T ss_dssp HCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc
Confidence 35799999999999999999999999986 8888887653 699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||+++.... .......+||+.|+|||++.+...++.. .|-|++++
T Consensus 147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~DiwslG~ 201 (346)
T 1ua2_A 147 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG-------------------------VDMWAVGC 201 (346)
T ss_dssp TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHH-------------------------HHHHHHHH
T ss_pred CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCch-------------------------hhhHhHHH
Confidence 999999999999987643 3344567899999999999765433322 45566666
Q ss_pred hHHHHhhCCCC
Q psy2648 626 NTARLNAGRPA 636 (708)
Q Consensus 626 ~~~~~~~~~~~ 636 (708)
++-++..|.|.
T Consensus 202 il~ell~g~~~ 212 (346)
T 1ua2_A 202 ILAELLLRVPF 212 (346)
T ss_dssp HHHHHHHSSCS
T ss_pred HHHHHHHCCCC
Confidence 66666666554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=8.2e-22 Score=205.39 Aligned_cols=143 Identities=25% Similarity=0.300 Sum_probs=120.5
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+||+++++++.++..+|+|||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 65 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~ 144 (288)
T 3kfa_A 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 144 (288)
T ss_dssp HCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE
T ss_pred hCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE
Confidence 4579999999999999999999999999999999998643 49999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 DSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+.++.+||+|||++....... ......+|+.|+|||++.+..... ..|-|++
T Consensus 145 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~sl 198 (288)
T 3kfa_A 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI--------------------------KSDVWAF 198 (288)
T ss_dssp CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCH--------------------------HHHHHHH
T ss_pred cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCc--------------------------hhhHHHH
Confidence 999999999999998765333 223456788999999997554211 2467778
Q ss_pred hhhHHHHhh-CCCC
Q psy2648 624 KENTARLNA-GRPA 636 (708)
Q Consensus 624 ~~~~~~~~~-~~~~ 636 (708)
+.++-.+.. |.+.
T Consensus 199 G~il~~ll~~g~~p 212 (288)
T 3kfa_A 199 GVLLWEIATYGMSP 212 (288)
T ss_dssp HHHHHHHHTTSCCS
T ss_pred HHHHHHHHhCCCCC
Confidence 888888876 6554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=216.55 Aligned_cols=140 Identities=25% Similarity=0.329 Sum_probs=120.9
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
..++||+++++++.....+|||||||. ++|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 156 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~ 234 (429)
T 3kvw_A 156 DNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK 234 (429)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES
T ss_pred cCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc
Confidence 377899999999999999999999996 69999987654 499999999999999999999999999999999999999
Q ss_pred CCCC--EEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~--vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++. +||+|||+|+... ....+.+||+.|+|||++.+..+ +. ..|-|+++
T Consensus 235 ~~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~DiwSlG 286 (429)
T 3kvw_A 235 QQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARY-GM-------------------------PIDMWSLG 286 (429)
T ss_dssp STTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCC-CT-------------------------HHHHHHHH
T ss_pred cCCCcceEEeecccceecC--CcccccCCCCCccChHHHhCCCC-Cc-------------------------hHHHHhHH
Confidence 9887 9999999997643 23446789999999999986542 22 26888889
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
+++-++..|.|.-
T Consensus 287 ~il~elltG~~pf 299 (429)
T 3kvw_A 287 CILAELLTGYPLL 299 (429)
T ss_dssp HHHHHHHHSSCSS
T ss_pred HHHHHHHhCCCCC
Confidence 9999999987753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-21 Score=209.43 Aligned_cols=144 Identities=22% Similarity=0.287 Sum_probs=116.9
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.+...+|||||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 105 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 184 (325)
T 3kul_A 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184 (325)
T ss_dssp TTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE
Confidence 3457999999999999999999999999999999999754 579999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
+.++.+||+|||+++....... .....+|+.|+|||++.+..... ..|-|
T Consensus 185 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--------------------------~~Di~ 238 (325)
T 3kul_A 185 DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS--------------------------ASDVW 238 (325)
T ss_dssp CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECH--------------------------HHHHH
T ss_pred CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCc--------------------------HHHHH
Confidence 9999999999999987643321 22345688899999997543222 14667
Q ss_pred chhhhHHHHhh-CCCC
Q psy2648 622 SIKENTARLNA-GRPA 636 (708)
Q Consensus 622 ~~~~~~~~~~~-~~~~ 636 (708)
+++.++-++.. |.+.
T Consensus 239 slG~il~ell~~g~~p 254 (325)
T 3kul_A 239 SFGVVMWEVLAYGERP 254 (325)
T ss_dssp HHHHHHHHHHTTSCCT
T ss_pred HHHHHHHHHHcCCCCC
Confidence 77777777766 5554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-21 Score=208.70 Aligned_cols=149 Identities=23% Similarity=0.391 Sum_probs=114.7
Q ss_pred CceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCE
Q psy2648 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 551 (708)
Q Consensus 472 ~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~v 551 (708)
+||+++++++.++..+||||| +.+|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 69 ~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 69 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp TTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEE
T ss_pred CceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcE
Confidence 899999999999999999999 56889999999988999999999999999999999999999999999999997 6789
Q ss_pred EEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHH
Q psy2648 552 KIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTA 628 (708)
Q Consensus 552 Kl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (708)
||+|||+|+...... .....+||+.|+|||++.+.......+.. . ..--...|-|+++.++-
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-----------~----~~~~~~~DiwslG~il~ 211 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS-----------K----SKISPKSDVWSLGCILY 211 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC--------------------------CCHHHHHHHHHHHHH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccccccc-----------c----cCCCchhhHHHHHHHHH
Confidence 999999998764332 23457899999999999763322111000 0 00012357778888888
Q ss_pred HHhhCCCCC
Q psy2648 629 RLNAGRPAK 637 (708)
Q Consensus 629 ~~~~~~~~~ 637 (708)
++..|.+.-
T Consensus 212 ell~g~~pf 220 (343)
T 3dbq_A 212 YMTYGKTPF 220 (343)
T ss_dssp HHHHSSCTT
T ss_pred HHHhCCCcc
Confidence 888887653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=220.97 Aligned_cols=178 Identities=22% Similarity=0.253 Sum_probs=134.2
Q ss_pred cCCCCCCCCCCcCCCcccccccccccccc------------CcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCHH
Q psy2648 433 GGSGGGGGGGAAQSPSHRGVHRSISASNA------------KPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVF 500 (708)
Q Consensus 433 ~~~~ggg~~g~v~s~~hr~~~R~i~~~~~------------~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~ 500 (708)
....|.|++|.|+...++........+.. +........|+|||++++++.+...+|||||||++|+|.
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~ 304 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence 44567778888876655432221111111 011123357999999999999999999999999999999
Q ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCc--ccccccCCc
Q psy2648 501 DYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSPP 576 (708)
Q Consensus 501 ~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~ 576 (708)
+++... ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+++....... .....+++.
T Consensus 305 ~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~ 384 (495)
T 1opk_A 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384 (495)
T ss_dssp HHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGG
T ss_pred HHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcc
Confidence 999864 3589999999999999999999999999999999999999999999999999987643322 223456788
Q ss_pred ccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhh-CCCC
Q psy2648 577 YAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 577 Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
|+|||++.+..... ..|-|+.+.++-++.. |.+.
T Consensus 385 y~aPE~~~~~~~~~--------------------------~sDvwSlG~~l~el~t~g~~p 419 (495)
T 1opk_A 385 WTAPESLAYNKFSI--------------------------KSDVWAFGVLLWEIATYGMSP 419 (495)
T ss_dssp GCCHHHHHHCEECH--------------------------HHHHHHHHHHHHHHHTTSCCS
T ss_pred eeCHhHHhcCCCCc--------------------------HHhHHhHHHHHHHHHhCCCCC
Confidence 99999997654222 1466777777777776 5544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=207.83 Aligned_cols=141 Identities=26% Similarity=0.287 Sum_probs=117.3
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKI 533 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~ylH~~~I 533 (708)
.|+||+++++++.+...+|||||||++|+|.+++...+ .+++.++..++.||+.||.|||++||
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 163 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 163 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 79999999999999999999999999999999997654 69999999999999999999999999
Q ss_pred ccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc
Q psy2648 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK 613 (708)
Q Consensus 534 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 613 (708)
+||||||+|||++.++.+||+|||+++............+++.|+|||++.+.....
T Consensus 164 vH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----------------------- 220 (327)
T 1fvr_A 164 IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT----------------------- 220 (327)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-----------------------
T ss_pred cCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCc-----------------------
Confidence 999999999999999999999999987543333334456789999999986543211
Q ss_pred ccccccccchhhhHHHHhh-CCCC
Q psy2648 614 RQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 221 ---~~Di~slG~il~ellt~g~~p 241 (327)
T 1fvr_A 221 ---NSDVWSYGVLLWEIVSLGGTP 241 (327)
T ss_dssp ---HHHHHHHHHHHHHHHTTSCCT
T ss_pred ---hhcchHHHHHHHHHHcCCCCC
Confidence 1467777888888875 6654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-21 Score=200.69 Aligned_cols=142 Identities=23% Similarity=0.368 Sum_probs=119.0
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLL 544 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NIL 544 (708)
...|+||+++++++.+.. |||||||++|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||
T Consensus 79 ~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil 156 (287)
T 4f0f_A 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156 (287)
T ss_dssp TCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEE
T ss_pred hCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEE
Confidence 357999999999997766 7999999999999988654 46999999999999999999999999 999999999999
Q ss_pred ecCCCC-----EEEeeccCccccCCCCcccccccCCcccccccccCCC-CccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 545 LDSEMN-----IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA-PVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 545 l~~~~~-----vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~-~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
++.++. +||+|||+++.... .....+||+.|+|||++.+.. .++. ..
T Consensus 157 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~-------------------------~~ 209 (287)
T 4f0f_A 157 LQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTE-------------------------KA 209 (287)
T ss_dssp ESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECH-------------------------HH
T ss_pred EeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCc-------------------------hh
Confidence 988776 99999999975433 344578999999999985432 1121 26
Q ss_pred cccchhhhHHHHhhCCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~ 638 (708)
|-|+++.++-++..|.+.-.
T Consensus 210 Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 210 DTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp HHHHHHHHHHHHHHSSCTTT
T ss_pred hHHHHHHHHHHHHcCCCCCc
Confidence 78889999999999887643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=217.25 Aligned_cols=142 Identities=29% Similarity=0.382 Sum_probs=117.1
Q ss_pred cccccCceeEEEEEEEeCC-EEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 467 ASSGGETLLKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~-~~yLVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
....|+|||++++++.... .+|||||||++|+|.+++...+. +++..+..++.||+.||.|||+++||||||||+||
T Consensus 241 ~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 320 (450)
T 1k9a_A 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 320 (450)
T ss_dssp HTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 3458999999999987665 79999999999999999987654 79999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
|++.++.+||+|||+++..... .....+++.|+|||++.+..... ..|-|+.
T Consensus 321 ll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~--------------------------~sDvwsl 372 (450)
T 1k9a_A 321 LVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFST--------------------------KSDVWSF 372 (450)
T ss_dssp EECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCH--------------------------HHHHHHH
T ss_pred EECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCc--------------------------HHHHHHH
Confidence 9999999999999999865332 22346789999999997654222 1467777
Q ss_pred hhhHHHHhh-CCCC
Q psy2648 624 KENTARLNA-GRPA 636 (708)
Q Consensus 624 ~~~~~~~~~-~~~~ 636 (708)
+.++-++.. |.+.
T Consensus 373 G~~l~el~t~g~~P 386 (450)
T 1k9a_A 373 GILLWEIYSFGRVP 386 (450)
T ss_dssp HHHHHHHHTTTCCS
T ss_pred HHHHHHHHhCCCCC
Confidence 888888876 6654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=202.24 Aligned_cols=144 Identities=28% Similarity=0.471 Sum_probs=123.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+||+++++++.+...+|||||||++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 158 (314)
T 3com_A 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158 (314)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence 34589999999999999999999999999999999997 45679999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||++...... .......||+.|+|||++.+... +. ..|.|+++
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~-------------------------~~Di~slG 212 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NC-------------------------VADIWSLG 212 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCB-CT-------------------------THHHHHHH
T ss_pred CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCC-Cc-------------------------cccHHHHH
Confidence 99999999999999765433 23445689999999999975431 11 15778888
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-.+..|.+.
T Consensus 213 ~il~~l~~g~~p 224 (314)
T 3com_A 213 ITAIEMAEGKPP 224 (314)
T ss_dssp HHHHHHHHSSCT
T ss_pred HHHHHHHhCCCC
Confidence 888888888765
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.9e-22 Score=212.09 Aligned_cols=144 Identities=36% Similarity=0.565 Sum_probs=104.4
Q ss_pred cccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp 540 (708)
....|+||++++++|.. ...+|||||||++|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp 156 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP 156 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 34688999999999987 556999999999999999998764 699999999999999999999999999999999
Q ss_pred CCeeecC---CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccc
Q psy2648 541 ENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNT 617 (708)
Q Consensus 541 ~NILl~~---~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (708)
+|||++. .+.+||+|||+++.... ......+||+.|+|||++.+... +. .
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~-------------------------~ 209 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKY-DK-------------------------S 209 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC-----------------------CHH-HH-------------------------H
T ss_pred HHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCCCCC-Cc-------------------------h
Confidence 9999986 45599999999986543 23446789999999999854432 21 2
Q ss_pred ccccchhhhHHHHhhCCCCC
Q psy2648 618 IDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|+++.++-.+..|.+.-
T Consensus 210 ~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 210 CDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp HHHHHHHHHHHHHHHSSCCC
T ss_pred hhHHHHHHHHHHHHHCCCCC
Confidence 57888899999999888764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=208.47 Aligned_cols=144 Identities=24% Similarity=0.301 Sum_probs=118.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHH
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH------------------------GRMKEKEARAKFRQIV 522 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~ 522 (708)
....|+||+++++++.+...+|||||||++|+|.+++... ..+++.++..++.||+
T Consensus 105 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 184 (343)
T 1luf_A 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184 (343)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHH
Confidence 3457999999999999999999999999999999999764 5699999999999999
Q ss_pred HHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCC---CcccccccCCcccccccccCCCCccCCCCCCCCC
Q psy2648 523 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNH 599 (708)
Q Consensus 523 ~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~ 599 (708)
.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+.....
T Consensus 185 ~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--------- 255 (343)
T 1luf_A 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT--------- 255 (343)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH---------
T ss_pred HHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc---------
Confidence 9999999999999999999999999999999999998765322 1233457899999999997554222
Q ss_pred cccCCCCCCCccccccccccccchhhhHHHHhh-CCCC
Q psy2648 600 THNSSISPAPTNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 256 -----------------~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 256 -----------------ESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp -----------------HHHHHHHHHHHHHHHTTTCCT
T ss_pred -----------------ccccHHHHHHHHHHHhcCCCc
Confidence 1466777777777776 6543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=8.4e-22 Score=206.45 Aligned_cols=144 Identities=26% Similarity=0.304 Sum_probs=116.2
Q ss_pred cccccCceeEEEEEEEe--CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 467 ASSGGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~--~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
....|+||+++++++.. ...+|||||||++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 66 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni 145 (295)
T 3ugc_A 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 145 (295)
T ss_dssp HTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhE
Confidence 34579999999999865 356999999999999999997754 599999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCC----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
|++.++.+||+|||+++...... ......|++.|+|||++.+..... ..|
T Consensus 146 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~D 199 (295)
T 3ugc_A 146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSV--------------------------ASD 199 (295)
T ss_dssp EEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCH--------------------------HHH
T ss_pred EEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCCh--------------------------HHH
Confidence 99999999999999998764332 123346788899999997554211 257
Q ss_pred ccchhhhHHHHhhCCCC
Q psy2648 620 SASIKENTARLNAGRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~ 636 (708)
-|+++.++-++..|.+.
T Consensus 200 i~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 200 VWSFGVVLYELFTYIEK 216 (295)
T ss_dssp HHHHHHHHHHHHHTTCT
T ss_pred HHHHHHHHHHHHhcccc
Confidence 78888888888887654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-21 Score=203.12 Aligned_cols=147 Identities=28% Similarity=0.470 Sum_probs=120.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL--------HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 538 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 538 (708)
....|+||+++++++...+.+|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||
T Consensus 68 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 147 (303)
T 2vwi_A 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV 147 (303)
T ss_dssp CCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred hhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 345799999999999999999999999999999999874 456999999999999999999999999999999
Q ss_pred CCCCeeecCCCCEEEeeccCccccCCCC------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccc
Q psy2648 539 KAENLLLDSEMNIKIADFGFSNEFTPGN------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNF 612 (708)
Q Consensus 539 Kp~NILl~~~~~vKl~DFGla~~~~~~~------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~ 612 (708)
||+|||++.++.+||+|||++....... .....+||+.|+|||++.+...++..
T Consensus 148 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-------------------- 207 (303)
T 2vwi_A 148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-------------------- 207 (303)
T ss_dssp SGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTH--------------------
T ss_pred ChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCch--------------------
Confidence 9999999999999999999987653321 22456899999999998653322222
Q ss_pred cccccccccchhhhHHHHhhCCCCCC
Q psy2648 613 KRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.|-|+++.++-++..|.+.-.
T Consensus 208 -----~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 208 -----ADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp -----HHHHHHHHHHHHHHHSSCTTT
T ss_pred -----hhHHHHHHHHHHHHhCCCCCc
Confidence 578888999999999887643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=208.05 Aligned_cols=149 Identities=23% Similarity=0.319 Sum_probs=117.9
Q ss_pred cccccCceeEEEEEEEe-----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------C
Q psy2648 467 ASSGGETLLKLFQVIET-----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK---------K 532 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~-----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---------~ 532 (708)
....|+||+++++.+.. ...+|||||||++|+|.+++... .+++..+..++.||+.||.|||++ |
T Consensus 62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ 140 (336)
T 3g2f_A 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140 (336)
T ss_dssp TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC
T ss_pred HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence 34689999999986543 33689999999999999999765 468999999999999999999999 9
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccccCCC---------CcccccccCCcccccccccCCCCccCCCCCCCCCcccC
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---------NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNS 603 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~---------~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~ 603 (708)
||||||||+|||++.++.+||+|||+|+..... ......+||+.|+|||++.+.......
T Consensus 141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~----------- 209 (336)
T 3g2f_A 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX----------- 209 (336)
T ss_dssp EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGH-----------
T ss_pred eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccc-----------
Confidence 999999999999999999999999999765422 123356899999999999874321110
Q ss_pred CCCCCCccccccccccccchhhhHHHHhhCCC
Q psy2648 604 SISPAPTNFKRQNTIDSASIKENTARLNAGRP 635 (708)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (708)
..--...|-|++++++-++..|..
T Consensus 210 --------~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 210 --------ESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp --------HHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred --------cccccccchHHHHHHHHHHHhcCC
Confidence 000113678889999999998844
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.3e-21 Score=201.79 Aligned_cols=143 Identities=31% Similarity=0.551 Sum_probs=123.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.++..+|||||||++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 154 (303)
T 3a7i_A 76 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 154 (303)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred hCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC
Confidence 35899999999999999999999999999999998864 57999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 548 EMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
++.+||+|||++....... .....+||+.|+|||++.+..... ..|.|+++.+
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG~i 208 (303)
T 3a7i_A 155 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS--------------------------KADIWSLGIT 208 (303)
T ss_dssp TSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCT--------------------------HHHHHHHHHH
T ss_pred CCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCc--------------------------hhhhHHHHHH
Confidence 9999999999997764432 345678999999999997543111 2577888899
Q ss_pred HHHHhhCCCCC
Q psy2648 627 TARLNAGRPAK 637 (708)
Q Consensus 627 ~~~~~~~~~~~ 637 (708)
+-++..|.+.-
T Consensus 209 l~~l~~g~~p~ 219 (303)
T 3a7i_A 209 AIELARGEPPH 219 (303)
T ss_dssp HHHHHHSSCTT
T ss_pred HHHHccCCCCC
Confidence 99999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-21 Score=198.97 Aligned_cols=143 Identities=23% Similarity=0.349 Sum_probs=120.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++.++..+|+|||||++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~ 138 (268)
T 3sxs_A 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD 138 (268)
T ss_dssp HCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC
T ss_pred hCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC
Confidence 3579999999999999999999999999999999998754 499999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc--ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+++....... .....||+.|+|||++.+..... ..|-|+++
T Consensus 139 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 192 (268)
T 3sxs_A 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS--------------------------KSDVWAFG 192 (268)
T ss_dssp TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEET--------------------------THHHHHHH
T ss_pred CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCch--------------------------hhhhHHHH
Confidence 999999999999986644332 23345678899999996544221 25777788
Q ss_pred hhHHHHhh-CCCC
Q psy2648 625 ENTARLNA-GRPA 636 (708)
Q Consensus 625 ~~~~~~~~-~~~~ 636 (708)
.++-++.. |.+.
T Consensus 193 ~il~~l~~~g~~p 205 (268)
T 3sxs_A 193 ILMWEVFSLGKMP 205 (268)
T ss_dssp HHHHHHHTTTCCT
T ss_pred HHHHHHHcCCCCC
Confidence 88888876 6654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-21 Score=203.25 Aligned_cols=141 Identities=20% Similarity=0.244 Sum_probs=120.9
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG------------------RMKEKEARAKFRQIVSAVQYCHQK 531 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~ylH~~ 531 (708)
.|+||+++++++.++...|||||||++|+|.+++.... .+++.++..++.||+.||.|||++
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 164 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 79999999999999999999999999999999998654 489999999999999999999999
Q ss_pred CCccCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCC
Q psy2648 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPA 608 (708)
Q Consensus 532 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~ 608 (708)
||+||||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+.....
T Consensus 165 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~------------------ 226 (313)
T 1t46_A 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF------------------ 226 (313)
T ss_dssp TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH------------------
T ss_pred CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh------------------
Confidence 999999999999999999999999999987654332 23456889999999997543211
Q ss_pred CccccccccccccchhhhHHHHhh-CCCC
Q psy2648 609 PTNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 227 --------~~Di~slG~il~ellt~g~~p 247 (313)
T 1t46_A 227 --------ESDVWSYGIFLWELFSLGSSP 247 (313)
T ss_dssp --------HHHHHHHHHHHHHHHTTTCCS
T ss_pred --------HHHHHHHHHHHHHHHhCCCCC
Confidence 2577888888888886 6654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-21 Score=204.10 Aligned_cols=144 Identities=23% Similarity=0.272 Sum_probs=120.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHH
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR------------------------MKEKEARAKFRQIV 522 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~------------------------l~e~~~~~~~~qi~ 522 (708)
....|+|||++++++.+...+|||||||++|+|.+++..... +++.++..++.||+
T Consensus 81 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 160 (314)
T 2ivs_A 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160 (314)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHH
T ss_pred hhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHH
Confidence 345799999999999999999999999999999999987543 89999999999999
Q ss_pred HHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCC
Q psy2648 523 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNH 599 (708)
Q Consensus 523 ~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~ 599 (708)
.||.|||++||+||||||+|||++.++.+||+|||+++....... .....+|+.|+|||++.+.....
T Consensus 161 ~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------- 231 (314)
T 2ivs_A 161 QGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT--------- 231 (314)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH---------
T ss_pred HHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc---------
Confidence 999999999999999999999999999999999999986643322 23456788999999997543211
Q ss_pred cccCCCCCCCccccccccccccchhhhHHHHhh-CCCC
Q psy2648 600 THNSSISPAPTNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 232 -----------------~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 232 -----------------QSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp -----------------HHHHHHHHHHHHHHHTTSCCS
T ss_pred -----------------hhhHHHHHHHHHHHHhCCCCC
Confidence 2577788888888887 6554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=9.4e-22 Score=209.70 Aligned_cols=141 Identities=19% Similarity=0.256 Sum_probs=119.0
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--------------GRMKEKEARAKFRQIVSAVQYCHQKKIIH 535 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiH 535 (708)
.|+||+++++++.+...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||++||+|
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 187 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 7999999999999999999999999999999999753 35899999999999999999999999999
Q ss_pred CCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccc
Q psy2648 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNF 612 (708)
Q Consensus 536 RDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~ 612 (708)
|||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+.....
T Consensus 188 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---------------------- 245 (333)
T 2i1m_A 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV---------------------- 245 (333)
T ss_dssp SCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH----------------------
T ss_pred CCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCCh----------------------
Confidence 99999999999999999999999986543221 23456888999999997543221
Q ss_pred cccccccccchhhhHHHHhh-CCCC
Q psy2648 613 KRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 246 ----~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 246 ----QSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp ----HHHHHHHHHHHHHHTTTSCCS
T ss_pred ----HHHHHHHHHHHHHHHcCCCCC
Confidence 1477788888888876 6653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-21 Score=207.61 Aligned_cols=141 Identities=21% Similarity=0.309 Sum_probs=119.5
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHH
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-----------------------RMKEKEARAKFRQIVSAVQ 526 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-----------------------~l~e~~~~~~~~qi~~aL~ 526 (708)
.|+||+++++++.....+|||||||++|+|.+++.... .+++..+..++.||+.||.
T Consensus 107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 186 (344)
T 1rjb_A 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186 (344)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999997653 3799999999999999999
Q ss_pred HHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCCcccC
Q psy2648 527 YCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNS 603 (708)
Q Consensus 527 ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~ 603 (708)
|||++||+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+.....
T Consensus 187 ~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~------------- 253 (344)
T 1rjb_A 187 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI------------- 253 (344)
T ss_dssp HHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-------------
T ss_pred HHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh-------------
Confidence 99999999999999999999999999999999986543322 23456889999999997543211
Q ss_pred CCCCCCccccccccccccchhhhHHHHhh-CCCC
Q psy2648 604 SISPAPTNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 254 -------------~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 254 -------------KSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp -------------HHHHHHHHHHHHHHTTTSCCS
T ss_pred -------------hHhHHHHHHHHHHHHcCCCCC
Confidence 2577888888888886 7654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-21 Score=210.89 Aligned_cols=144 Identities=26% Similarity=0.439 Sum_probs=121.8
Q ss_pred ccccCceeEEEEEEEeC-----CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~-----~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+||+++++++... ..+|+||||+.+ +|.+++.. +.+++.++..++.||+.||.|||++||+||||||+|
T Consensus 81 ~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 158 (364)
T 3qyz_A 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 158 (364)
T ss_dssp HCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHh
Confidence 45799999999999765 479999999984 89988865 479999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCC----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
||++.++.+||+|||+++...... .....+||+.|+|||++.+...++.. .
T Consensus 159 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-------------------------~ 213 (364)
T 3qyz_A 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS-------------------------I 213 (364)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTH-------------------------H
T ss_pred EEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcc-------------------------h
Confidence 999999999999999998654322 23456899999999998766544433 6
Q ss_pred cccchhhhHHHHhhCCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~ 638 (708)
|-|++++++-++..|.|.-.
T Consensus 214 DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 214 DIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp HHHHHHHHHHHHHHSSCSSC
T ss_pred hHHHHHHHHHHHHHCCCCCC
Confidence 78888999999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-21 Score=200.87 Aligned_cols=142 Identities=23% Similarity=0.279 Sum_probs=107.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++ .++.+|||||||++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 72 ~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 150 (281)
T 1mp8_A 72 QFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 150 (281)
T ss_dssp TCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred hCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC
Confidence 45799999999998 4567899999999999999998654 699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc--ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+++....... .....+|+.|+|||++.+..... ..|-|+++
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 204 (281)
T 1mp8_A 151 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS--------------------------ASDVWMFG 204 (281)
T ss_dssp ETTEEEECC-------------------CCGGGCCHHHHHHCCCSH--------------------------HHHHHHHH
T ss_pred CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCC--------------------------ccCchHHH
Confidence 999999999999987644322 23346788999999996543211 25677778
Q ss_pred hhHHHHhh-CCCC
Q psy2648 625 ENTARLNA-GRPA 636 (708)
Q Consensus 625 ~~~~~~~~-~~~~ 636 (708)
.++-++.. |.+.
T Consensus 205 ~~l~ell~~g~~p 217 (281)
T 1mp8_A 205 VCMWEILMHGVKP 217 (281)
T ss_dssp HHHHHHHTTSCCT
T ss_pred HHHHHHHhcCCCC
Confidence 88888774 6654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-21 Score=206.22 Aligned_cols=114 Identities=31% Similarity=0.479 Sum_probs=85.1
Q ss_pred ccCceeEEEEEEE--------eCCEEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CccC
Q psy2648 470 GGETLLKLFQVIE--------TEKTLYLVMEYASGGEVFDYLVL---HGRMKEKEARAKFRQIVSAVQYCHQKK--IIHR 536 (708)
Q Consensus 470 ~~~~Iv~L~~~~~--------~~~~~yLVmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHR 536 (708)
.|+||+++++++. ....+|+|||||. |+|.+++.. .+.+++.++..++.||+.||.|||++| |+||
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 162 (337)
T 3ll6_A 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR 162 (337)
T ss_dssp TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCC
T ss_pred cCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEc
Confidence 6999999999994 4456899999996 689888864 457999999999999999999999999 9999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCCc-------------ccccccCCccccccccc
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNK-------------LDTFCGSPPYAAPELFQ 584 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~~-------------~~~~~Gt~~Y~APEvl~ 584 (708)
||||+|||++.++.+||+|||+++....... ....+||+.|+|||++.
T Consensus 163 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp CCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------
T ss_pred cCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 9999999999999999999999987643221 12457999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-21 Score=203.27 Aligned_cols=146 Identities=29% Similarity=0.470 Sum_probs=117.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++.++..+|+|||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 72 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (302)
T 2j7t_A 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151 (302)
T ss_dssp HCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred cCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence 45799999999999999999999999999999998875 45799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCC-CCcccccccCCcccccccccCC----CCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGG----APVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~----~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
.++.+||+|||++..... .......+||+.|+|||++... ..++ ...|.|
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-------------------------~~~Di~ 206 (302)
T 2j7t_A 152 LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD-------------------------YKADIW 206 (302)
T ss_dssp TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTT-------------------------THHHHH
T ss_pred CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCc-------------------------hhhhHH
Confidence 999999999998754321 1122356799999999998532 1111 125778
Q ss_pred chhhhHHHHhhCCCCCC
Q psy2648 622 SIKENTARLNAGRPAKN 638 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ 638 (708)
+++.++-++..|.+.-.
T Consensus 207 slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 207 SLGITLIEMAQIEPPHH 223 (302)
T ss_dssp HHHHHHHHHHHSSCTTT
T ss_pred HHHHHHHHHhcCCCCCc
Confidence 88888888888877543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4e-21 Score=197.71 Aligned_cols=144 Identities=15% Similarity=0.162 Sum_probs=121.6
Q ss_pred cccccCceeEEEEEEEeC--CEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~--~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 540 (708)
....|+||+++++++.+. ..+|||||||++|+|.+++.... .+++.++..++.||+.||.|||+++ |+||||||
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp 141 (271)
T 3kmu_A 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNS 141 (271)
T ss_dssp CCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSG
T ss_pred HhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCcc
Confidence 345799999999999987 78999999999999999998765 4899999999999999999999999 99999999
Q ss_pred CCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 541 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
+|||++.++.+||+|||++.... ....+||+.|+|||++.+......+ ...|-
T Consensus 142 ~Nil~~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~-----------------------~~~Di 194 (271)
T 3kmu_A 142 RSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNR-----------------------RSADM 194 (271)
T ss_dssp GGEEECTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCH-----------------------HHHHH
T ss_pred ceEEEcCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCC-----------------------chhhH
Confidence 99999999999999999875432 2345789999999999865422210 12578
Q ss_pred cchhhhHHHHhhCCCCC
Q psy2648 621 ASIKENTARLNAGRPAK 637 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~~ 637 (708)
|+++.++-++..|.+.-
T Consensus 195 ~slG~il~el~~g~~p~ 211 (271)
T 3kmu_A 195 WSFAVLLWELVTREVPF 211 (271)
T ss_dssp HHHHHHHHHHHHCSCTT
T ss_pred HHHHHHHHHHHhCCCCc
Confidence 88889999999887753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=9e-21 Score=200.48 Aligned_cols=152 Identities=21% Similarity=0.271 Sum_probs=119.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+||+++++++.+...+|+|||||++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~ 163 (319)
T 2y4i_B 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY 163 (319)
T ss_dssp TTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE
T ss_pred hcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE
Confidence 44689999999999999999999999999999999997655 69999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCC------CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTP------GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~------~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
+ ++.+||+|||+++.... ........||+.|+|||++.+..+....... .+ ....|
T Consensus 164 ~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~---------------~~--~~~~D 225 (319)
T 2y4i_B 164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL---------------PF--SKHSD 225 (319)
T ss_dssp C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCS---------------CC--CHHHH
T ss_pred e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhcccccccccc---------------CC--Cchhh
Confidence 8 68999999999875421 1223445799999999999865432221100 00 12367
Q ss_pred ccchhhhHHHHhhCCCC
Q psy2648 620 SASIKENTARLNAGRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~ 636 (708)
-|+++.++-++..|.+.
T Consensus 226 i~slG~il~el~~g~~p 242 (319)
T 2y4i_B 226 VFALGTIWYELHAREWP 242 (319)
T ss_dssp HHHHHHHHHHHHHSSCS
T ss_pred HHHHHHHHHHHHhCCCC
Confidence 78888899999888764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.1e-21 Score=200.78 Aligned_cols=143 Identities=23% Similarity=0.314 Sum_probs=120.6
Q ss_pred ccccCceeEEEEEEEeC--CEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 468 SSGGETLLKLFQVIETE--KTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~--~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
...|+||+++++++.++ ..+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 79 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 158 (302)
T 4e5w_A 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 158 (302)
T ss_dssp TCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEE
Confidence 45799999999999877 679999999999999999954 457999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
++.++.+||+|||+++....... .....||+.|+|||++.+..... ..|-
T Consensus 159 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di 212 (302)
T 4e5w_A 159 VESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYI--------------------------ASDV 212 (302)
T ss_dssp EEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEH--------------------------HHHH
T ss_pred EcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCc--------------------------chhH
Confidence 99999999999999987654332 33467899999999996543221 2578
Q ss_pred cchhhhHHHHhhCCCC
Q psy2648 621 ASIKENTARLNAGRPA 636 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~ 636 (708)
|+++.++-++..|.+.
T Consensus 213 ~slG~il~~l~~g~~p 228 (302)
T 4e5w_A 213 WSFGVTLHELLTYCDS 228 (302)
T ss_dssp HHHHHHHHHHHTTTCG
T ss_pred HHHHHHHHHHHHccCC
Confidence 8888888888887664
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=200.35 Aligned_cols=141 Identities=26% Similarity=0.380 Sum_probs=119.6
Q ss_pred ccCceeEEEEEEE-----eCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 470 GGETLLKLFQVIE-----TEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 470 ~~~~Iv~L~~~~~-----~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
.|+||+++++++. ....+||||||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~N 150 (326)
T 1blx_A 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150 (326)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHH
Confidence 7999999999997 5678999999998 59999998654 49999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
||++.++.+||+|||+++...........+||+.|+|||++.+..... ..|-|+
T Consensus 151 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~s 204 (326)
T 1blx_A 151 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT--------------------------PVDLWS 204 (326)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT--------------------------HHHHHH
T ss_pred eEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCc--------------------------chhHHH
Confidence 999999999999999998765444556678999999999997653211 146677
Q ss_pred hhhhHHHHhhCCCCC
Q psy2648 623 IKENTARLNAGRPAK 637 (708)
Q Consensus 623 ~~~~~~~~~~~~~~~ 637 (708)
++.++-++..|.+.-
T Consensus 205 lG~il~~l~~g~~pf 219 (326)
T 1blx_A 205 VGCIFAEMFRRKPLF 219 (326)
T ss_dssp HHHHHHHHHHSSCSC
T ss_pred HHHHHHHHHcCCCCC
Confidence 777777777777654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.2e-21 Score=199.33 Aligned_cols=141 Identities=29% Similarity=0.487 Sum_probs=110.3
Q ss_pred cccccCceeEEEEEEEe-------------CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2648 467 ASSGGETLLKLFQVIET-------------EKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 532 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~-------------~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~ 532 (708)
....|+||+++++++.+ ...+|||||||++|+|.+++...+ .+++..+..++.||+.||.|||++|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 136 (303)
T 1zy4_A 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG 136 (303)
T ss_dssp TTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC
Confidence 34579999999999865 467899999999999999998654 5889999999999999999999999
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccccCCC---------------CcccccccCCcccccccccCCCCccCCCCCCC
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---------------NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGT 597 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~---------------~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~ 597 (708)
|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++..
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~----- 211 (303)
T 1zy4_A 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK----- 211 (303)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTH-----
T ss_pred eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcch-----
Confidence 999999999999999999999999998765321 223456899999999999754333222
Q ss_pred CCcccCCCCCCCccccccccccccchhhhHHHHhh
Q psy2648 598 NHTHNSSISPAPTNFKRQNTIDSASIKENTARLNA 632 (708)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (708)
.|.|+++.++-++..
T Consensus 212 --------------------~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 212 --------------------IDMYSLGIIFFEMIY 226 (303)
T ss_dssp --------------------HHHHHHHHHHHHHHS
T ss_pred --------------------hhHHHHHHHHHHHHh
Confidence 466677777777664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=6.1e-22 Score=215.16 Aligned_cols=141 Identities=11% Similarity=0.074 Sum_probs=104.6
Q ss_pred ccCceeEEE-------EEEEeC-----------------CEEEEEEeccCCCCHHHHHHhcC-CCCHHHH------HHHH
Q psy2648 470 GGETLLKLF-------QVIETE-----------------KTLYLVMEYASGGEVFDYLVLHG-RMKEKEA------RAKF 518 (708)
Q Consensus 470 ~~~~Iv~L~-------~~~~~~-----------------~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~------~~~~ 518 (708)
.|||||+++ +++..+ ..+|||||||+ |+|.+++...+ .+++... ..++
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~ 200 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILT 200 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHH
Confidence 699987755 666654 34899999999 89999998643 3444434 4666
Q ss_pred HHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCC-CCccCCCCCCC
Q psy2648 519 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG-APVTSSGGAGT 597 (708)
Q Consensus 519 ~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~-~~~~~s~~~~~ 597 (708)
.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.... ......||+.|+|||++.+. ..++..
T Consensus 201 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~----- 273 (371)
T 3q60_A 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHA----- 273 (371)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHH-----
T ss_pred HHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCcc-----
Confidence 9999999999999999999999999999999999999999986532 22245677999999999652 223322
Q ss_pred CCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCCC
Q psy2648 598 NHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.|-|+++.++-++..|.+.-.
T Consensus 274 --------------------~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 274 --------------------LNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp --------------------HHHHHHHHHHHHHHHSSCSTT
T ss_pred --------------------ccHHHHHHHHHHHHhCCCCCC
Confidence 688999999999999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=198.81 Aligned_cols=143 Identities=20% Similarity=0.350 Sum_probs=112.4
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
...|+||+++++++.+...+||||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 88 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 167 (310)
T 2wqm_A 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 167 (310)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred hCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHE
Confidence 45799999999999999999999999999999998864 45699999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
|++.++.+||+|||++....... ......||+.|+|||++.+..... ..|-|+
T Consensus 168 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Dv~s 221 (310)
T 2wqm_A 168 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF--------------------------KSDIWS 221 (310)
T ss_dssp EECTTSCEEECCC------------------CCSSCCHHHHTTCCCCH--------------------------HHHHHH
T ss_pred EEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCc--------------------------hhhHHH
Confidence 99999999999999987654322 234568999999999987543211 257788
Q ss_pred hhhhHHHHhhCCCC
Q psy2648 623 IKENTARLNAGRPA 636 (708)
Q Consensus 623 ~~~~~~~~~~~~~~ 636 (708)
++.++-++..|.+.
T Consensus 222 lG~il~~l~~g~~p 235 (310)
T 2wqm_A 222 LGCLLYEMAALQSP 235 (310)
T ss_dssp HHHHHHHHHHSSCT
T ss_pred HHHHHHHHHhCCCC
Confidence 88899999988765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-21 Score=215.80 Aligned_cols=120 Identities=25% Similarity=0.428 Sum_probs=103.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
....|+|||++++++. ...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||
T Consensus 238 ~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 316 (454)
T 1qcf_A 238 KTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316 (454)
T ss_dssp TTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred hhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 3458999999999986 66799999999999999999754 36899999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCC
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
++.++.+||+|||+++...... ......+|+.|+|||++.++.
T Consensus 317 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 361 (454)
T 1qcf_A 317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361 (454)
T ss_dssp ECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC
T ss_pred ECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCC
Confidence 9999999999999998764322 122345678899999997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-21 Score=205.45 Aligned_cols=120 Identities=23% Similarity=0.323 Sum_probs=98.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+||+++++++.+.. .++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 72 ~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 150 (327)
T 3lzb_A 72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150 (327)
T ss_dssp TTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE
Confidence 3457999999999998765 88999999999999999764 569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCC
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+.++.+||+|||+++....... .....||+.|+|||++.+..
T Consensus 151 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 195 (327)
T 3lzb_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195 (327)
T ss_dssp EETTEEEECCTTC----------------CCCGGGSCHHHHHHCC
T ss_pred cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCC
Confidence 9999999999999987643322 23345788999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-21 Score=210.70 Aligned_cols=144 Identities=22% Similarity=0.279 Sum_probs=110.1
Q ss_pred cccccCceeEEEEEEE-eCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIE-TEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~-~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
....|+|||++++++. .+...|||||||++|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||
T Consensus 145 ~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 224 (373)
T 3c1x_A 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224 (373)
T ss_dssp TTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEE
Confidence 3457999999999864 5568899999999999999997654 5899999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCC-----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~-----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
++.++.+||+|||+++...... ......+|+.|+|||++.+..... ..|
T Consensus 225 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~D 278 (373)
T 3c1x_A 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT--------------------------KSD 278 (373)
T ss_dssp ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCH--------------------------HHH
T ss_pred ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCc--------------------------HHH
Confidence 9999999999999998653322 123356788999999997554222 257
Q ss_pred ccchhhhHHHHhh-CCCC
Q psy2648 620 SASIKENTARLNA-GRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~-~~~~ 636 (708)
-|+++.++-++.. |.|.
T Consensus 279 vwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 279 VWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp HHHHHHHHHHHHTTSCCS
T ss_pred HHHHHHHHHHHHhCcCCC
Confidence 7888888888887 5554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.4e-21 Score=201.98 Aligned_cols=149 Identities=26% Similarity=0.320 Sum_probs=105.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-----HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp 540 (708)
....|+||+++++++.+++.+|||||||++ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||
T Consensus 76 ~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp 154 (327)
T 3aln_A 76 RSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP 154 (327)
T ss_dssp SSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCG
T ss_pred HcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCH
Confidence 346899999999999999999999999986 77777753 56799999999999999999999998 999999999
Q ss_pred CCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 541 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
+|||++.++.+||+|||+++...........+||+.|+|||++.+....... ....|-
T Consensus 155 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~----------------------~~~~Di 212 (327)
T 3aln_A 155 SNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY----------------------DVRSDV 212 (327)
T ss_dssp GGEEEETTTEEEECCCSSSCC------------------------------C----------------------CSHHHH
T ss_pred HHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCC----------------------CchhhH
Confidence 9999999999999999999876554444556899999999998532100000 012688
Q ss_pred cchhhhHHHHhhCCCCCC
Q psy2648 621 ASIKENTARLNAGRPAKN 638 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~ 638 (708)
|+++.++-++..|.+.-.
T Consensus 213 ~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 213 WSLGITLYELATGRFPYP 230 (327)
T ss_dssp HHHHHHHHHHHHSCCCSS
T ss_pred HHHHHHHHHHHHCCCCCC
Confidence 899999999999987643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=198.89 Aligned_cols=140 Identities=24% Similarity=0.316 Sum_probs=119.0
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
.+++|+++++++++...+||||||| +++|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEec
Confidence 4556999999999999999999999 899999998765 6899999999999999999999999999999999999987
Q ss_pred -------------------CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCC
Q psy2648 548 -------------------EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPA 608 (708)
Q Consensus 548 -------------------~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~ 608 (708)
++.+||+|||+++.... .....+||+.|+|||++.+... +.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~----------------- 213 (339)
T 1z57_A 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGW-SQ----------------- 213 (339)
T ss_dssp CCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCC-CT-----------------
T ss_pred cccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCC-Cc-----------------
Confidence 66899999999976433 2345689999999999975432 11
Q ss_pred CccccccccccccchhhhHHHHhhCCCCCC
Q psy2648 609 PTNFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
..|-|++++++-++..|.+.-.
T Consensus 214 --------~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 214 --------PCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --------HHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------chhhHHHHHHHHHHHhCCCCCC
Confidence 2577888888888888876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-21 Score=204.69 Aligned_cols=118 Identities=31% Similarity=0.566 Sum_probs=102.9
Q ss_pred ccCceeEEEEEEEeCCEEEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec-C
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEY-ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD-S 547 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy-~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-~ 547 (708)
.|+||+++++++.+.+..|+|||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETT
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCC
Confidence 799999999999999999999999 78999999999888999999999999999999999999999999999999999 7
Q ss_pred CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 548 EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
++.+||+|||+++..... ......||+.|+|||++.+...
T Consensus 176 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 215 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQY 215 (312)
T ss_dssp TTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCB
T ss_pred CCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCC
Confidence 899999999999876543 3446689999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-21 Score=201.66 Aligned_cols=145 Identities=25% Similarity=0.395 Sum_probs=109.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+||++++++ .....+|+|||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~l~h~~iv~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~ 153 (289)
T 3og7_A 75 RKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL 153 (289)
T ss_dssp TTCCCTTBCCEEEE-ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCcEEEEEee-ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 44679999999995 566779999999999999999964 4569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCC---CCcccccccCCcccccccccCCC--CccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTP---GNKLDTFCGSPPYAAPELFQGGA--PVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~---~~~~~~~~Gt~~Y~APEvl~g~~--~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
+.++.+||+|||+++.... ........||+.|+|||++.... .++. ..|-
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-------------------------~~Di 208 (289)
T 3og7_A 154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF-------------------------QSDV 208 (289)
T ss_dssp ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCH-------------------------HHHH
T ss_pred CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCc-------------------------ccch
Confidence 9999999999999976532 22334568999999999997321 1111 2578
Q ss_pred cchhhhHHHHhhCCCCC
Q psy2648 621 ASIKENTARLNAGRPAK 637 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~~ 637 (708)
|+++.++-++..|.+.-
T Consensus 209 ~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 209 YAFGIVLYELMTGQLPY 225 (289)
T ss_dssp HHHHHHHHHHHHSSCTT
T ss_pred HHHHHHHHHHHHCCCCc
Confidence 88889999999887653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=6e-21 Score=199.35 Aligned_cols=145 Identities=24% Similarity=0.411 Sum_probs=120.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
....|+||+++++++.+...+|||||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 74 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 153 (295)
T 2clq_A 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153 (295)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhE
Confidence 34589999999999999999999999999999999997652 467899999999999999999999999999999999
Q ss_pred eecC-CCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCC-ccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 544 LLDS-EMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAP-VTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 544 Ll~~-~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~-~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
|++. ++.+||+|||+++..... .......||+.|+|||++.+... ++ ...|.
T Consensus 154 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-------------------------~~~Di 208 (295)
T 2clq_A 154 LINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG-------------------------KAADI 208 (295)
T ss_dssp EEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCS-------------------------HHHHH
T ss_pred EEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCC-------------------------cHHHH
Confidence 9987 899999999999866432 22345689999999999975421 11 12577
Q ss_pred cchhhhHHHHhhCCCC
Q psy2648 621 ASIKENTARLNAGRPA 636 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~ 636 (708)
|+++.++-++..|.+.
T Consensus 209 ~slG~il~~l~~g~~p 224 (295)
T 2clq_A 209 WSLGCTIIEMATGKPP 224 (295)
T ss_dssp HHHHHHHHHHHHTSCT
T ss_pred HHHHHHHHHHHHCCCC
Confidence 8888888888888765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.4e-21 Score=203.12 Aligned_cols=142 Identities=28% Similarity=0.322 Sum_probs=118.9
Q ss_pred ccccCceeEEEEEEEe--CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~--~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+||+++++++.+ ...+|||||||++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~ 167 (318)
T 3lxp_A 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167 (318)
T ss_dssp HCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred hCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence 3579999999999998 47899999999999999998765 59999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
+.++.+||+|||+++....... .....||+.|+|||++.+..... ..|-|
T Consensus 168 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~ 221 (318)
T 3lxp_A 168 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY--------------------------ASDVW 221 (318)
T ss_dssp CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEH--------------------------HHHHH
T ss_pred cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCc--------------------------HHHHH
Confidence 9999999999999987654332 23456889999999997543221 25778
Q ss_pred chhhhHHHHhhCCCC
Q psy2648 622 SIKENTARLNAGRPA 636 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~ 636 (708)
+++.++-++..|.+.
T Consensus 222 slG~il~~ll~g~~p 236 (318)
T 3lxp_A 222 SFGVTLYELLTHCDS 236 (318)
T ss_dssp HHHHHHHHHHTTTCG
T ss_pred HHHHHHHHHHhCCCc
Confidence 888888888887654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.82 E-value=7.9e-21 Score=202.81 Aligned_cols=119 Identities=21% Similarity=0.303 Sum_probs=102.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+|||++++++.+.. .++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||++
T Consensus 73 ~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~ 151 (327)
T 3poz_A 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 151 (327)
T ss_dssp HCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred hCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC
Confidence 457999999999998765 8899999999999999987 45799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+|+....... .....||+.|+|||++.+..
T Consensus 152 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 195 (327)
T 3poz_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195 (327)
T ss_dssp ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCC
T ss_pred CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCC
Confidence 999999999999987643322 23345788999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=198.70 Aligned_cols=147 Identities=27% Similarity=0.464 Sum_probs=114.9
Q ss_pred ccCceeEEEEEEEe------CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 470 GGETLLKLFQVIET------EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~------~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
.|+||+++++++.. ...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 158 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence 79999999999987 56899999999999999999764 57999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
|||++.++.+||+|||++...... ......+||+.|+|||++.+....... + ....|.
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-------------------~--~~~~Di 217 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDAT-------------------Y--DFKSDL 217 (326)
T ss_dssp GEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC---------------------------C--CTTHHH
T ss_pred HEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcC-------------------C--CccchH
Confidence 999999999999999998865432 233456899999999999753210000 0 112678
Q ss_pred cchhhhHHHHhhCCCCC
Q psy2648 621 ASIKENTARLNAGRPAK 637 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~~ 637 (708)
|++++++-++..|.+.-
T Consensus 218 ~slG~il~~l~~g~~p~ 234 (326)
T 2x7f_A 218 WSLGITAIEMAEGAPPL 234 (326)
T ss_dssp HHHHHHHHHHHHSSCTT
T ss_pred HHHHHHHHHHHhCCCCC
Confidence 88999999999988753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=196.08 Aligned_cols=141 Identities=22% Similarity=0.299 Sum_probs=116.8
Q ss_pred cCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee---c
Q psy2648 471 GETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---D 546 (708)
Q Consensus 471 ~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~ 546 (708)
+.+|..+..++......||||||| +++|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||+ +
T Consensus 64 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 142 (296)
T 4hgt_A 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp STTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG
T ss_pred CCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC
Confidence 344555666668889999999999 9999999975 4579999999999999999999999999999999999999 7
Q ss_pred CCCCEEEeeccCccccCCCC--------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
..+.+||+|||+++...... .....+||+.|+|||++.+... +. ..
T Consensus 143 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~-------------------------~~ 196 (296)
T 4hgt_A 143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SR-------------------------RD 196 (296)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CH-------------------------HH
T ss_pred CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCC-Cc-------------------------hh
Confidence 88999999999998664332 2235689999999999986542 21 25
Q ss_pred cccchhhhHHHHhhCCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~ 638 (708)
|-|+++.++-.+..|.+.-.
T Consensus 197 Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 197 DLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp HHHHHHHHHHHHHHSSCTTS
T ss_pred HHHHHHHHHHHHhcCCCCCc
Confidence 78889999999999887643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.6e-21 Score=201.36 Aligned_cols=145 Identities=18% Similarity=0.249 Sum_probs=111.3
Q ss_pred cccccCceeEEEEEEEeCCEE------EEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy2648 467 ASSGGETLLKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHG------RMKEKEARAKFRQIVSAVQYCHQKKII 534 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~------yLVmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~~Ii 534 (708)
....|+||+++++++...... |+|||||++|+|.+++.... .+++.++..++.||+.||.|||++||+
T Consensus 80 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~iv 159 (323)
T 3qup_A 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159 (323)
T ss_dssp TTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence 345899999999999887765 99999999999999996543 599999999999999999999999999
Q ss_pred cCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcc
Q psy2648 535 HRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTN 611 (708)
Q Consensus 535 HRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~ 611 (708)
||||||+|||++.++.+||+|||+|+....... .....+++.|+|||++.+.....
T Consensus 160 H~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------- 218 (323)
T 3qup_A 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV--------------------- 218 (323)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCH---------------------
T ss_pred cCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCC---------------------
Confidence 999999999999999999999999987644332 22345788999999987654221
Q ss_pred ccccccccccchhhhHHHHhh-CCCCC
Q psy2648 612 FKRQNTIDSASIKENTARLNA-GRPAK 637 (708)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~-~~~~~ 637 (708)
..|-|++++++-++.. |.+.-
T Consensus 219 -----~~Di~slG~il~ell~~g~~p~ 240 (323)
T 3qup_A 219 -----HSDVWAFGVTMWEIMTRGQTPY 240 (323)
T ss_dssp -----HHHHHHHHHHHHHHHTTSCCTT
T ss_pred -----ccchhhHHHHHHHHHhCCCCCc
Confidence 2577888888888777 66653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.8e-21 Score=205.72 Aligned_cols=143 Identities=24% Similarity=0.386 Sum_probs=118.2
Q ss_pred ccccCceeEEEEEEEeC-----CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~-----~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
...|+||+++++++... ..+|+||||+. |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 65 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (353)
T 2b9h_A 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN 142 (353)
T ss_dssp HCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred hCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 35799999999998764 78999999998 589888876 579999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCC-----------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGN-----------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTN 611 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~-----------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~ 611 (708)
||++.++.+||+|||+++...... .....+||+.|+|||++.+...++..
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------------------- 203 (353)
T 2b9h_A 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA------------------- 203 (353)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHH-------------------
T ss_pred eEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccch-------------------
Confidence 999999999999999998654221 12346899999999998764433322
Q ss_pred ccccccccccchhhhHHHHhhCCCCC
Q psy2648 612 FKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|++++++-++..|.|.-
T Consensus 204 ------~Di~slG~il~~l~~g~~pf 223 (353)
T 2b9h_A 204 ------MDVWSCGCILAELFLRRPIF 223 (353)
T ss_dssp ------HHHHHHHHHHHHHHHSSCSC
T ss_pred ------hhHHHHHHHHHHHHhCCCCC
Confidence 57788888888888887754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-20 Score=209.94 Aligned_cols=142 Identities=21% Similarity=0.337 Sum_probs=112.2
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
..|||||++++++.+...+|||||||. |+|.+++.... .+.+.++..++.||+.||.|||++|||||||||+|||++.
T Consensus 75 ~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 75 DEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153 (432)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECC
T ss_pred cCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEec
Confidence 379999999999999999999999997 59999987654 4666678899999999999999999999999999999953
Q ss_pred -----CCCEEEeeccCccccCCC----CcccccccCCcccccccccCCC--CccCCCCCCCCCcccCCCCCCCccccccc
Q psy2648 548 -----EMNIKIADFGFSNEFTPG----NKLDTFCGSPPYAAPELFQGGA--PVTSSGGAGTNHTHNSSISPAPTNFKRQN 616 (708)
Q Consensus 548 -----~~~vKl~DFGla~~~~~~----~~~~~~~Gt~~Y~APEvl~g~~--~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 616 (708)
...+||+|||+|+..... ......+||+.|+|||++.+.. .++.
T Consensus 154 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~------------------------- 208 (432)
T 3p23_A 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY------------------------- 208 (432)
T ss_dssp CBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCT-------------------------
T ss_pred CCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCc-------------------------
Confidence 235889999999876533 2334578999999999997532 1111
Q ss_pred cccccchhhhHHHHhh-CCCC
Q psy2648 617 TIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 617 ~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|++++++-+++. |.+.
T Consensus 209 ~~DiwSlG~il~ellt~g~~p 229 (432)
T 3p23_A 209 TVDIFSAGCVFYYVISEGSHP 229 (432)
T ss_dssp HHHHHHHHHHHHHHHTTSCBT
T ss_pred HHHHHHHHHHHHHHHcCCCCC
Confidence 2678888888888887 6554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=7.3e-21 Score=205.37 Aligned_cols=145 Identities=21% Similarity=0.241 Sum_probs=112.2
Q ss_pred ccccCceeEEEEEEEe-----CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIET-----EKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~-----~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+||+++++++.. ...+|||||||+ |+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 85 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 163 (362)
T 3pg1_A 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPG 163 (362)
T ss_dssp HCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred hCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChH
Confidence 4579999999999954 347999999998 5888887654 46999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+||+|||+++...........+||+.|+|||++.+...++.. .|-|
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Diw 218 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL-------------------------VDMW 218 (362)
T ss_dssp GEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTH-------------------------HHHH
T ss_pred HEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcH-------------------------hHHH
Confidence 999999999999999999866555555667899999999999864433322 5788
Q ss_pred chhhhHHHHhhCCCCCC
Q psy2648 622 SIKENTARLNAGRPAKN 638 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ 638 (708)
++++++-.+..|.+.-.
T Consensus 219 slG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 219 SAGCVMAEMFNRKALFR 235 (362)
T ss_dssp HHHHHHHHHHHSSCSCC
T ss_pred hHHHHHHHHHhCCCCCC
Confidence 88999999998877543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.82 E-value=9.7e-21 Score=195.49 Aligned_cols=142 Identities=28% Similarity=0.333 Sum_probs=112.0
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCCee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK---IIHRDLKAENLL 544 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NIL 544 (708)
...|+||+++++++.++..+|||||||++++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil 140 (271)
T 3dtc_A 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140 (271)
T ss_dssp HCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred hcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence 4579999999999999999999999999999998875 457999999999999999999999999 999999999999
Q ss_pred ecC--------CCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccc
Q psy2648 545 LDS--------EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQN 616 (708)
Q Consensus 545 l~~--------~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 616 (708)
++. .+.+||+|||+++...... .....||+.|+|||++.+... +.
T Consensus 141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~------------------------- 193 (271)
T 3dtc_A 141 ILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMF-SK------------------------- 193 (271)
T ss_dssp ESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCC-SH-------------------------
T ss_pred EecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCC-Cc-------------------------
Confidence 986 6789999999998654332 235689999999999865432 11
Q ss_pred cccccchhhhHHHHhhCCCCC
Q psy2648 617 TIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~ 637 (708)
..|-|+++.++-++..|.+.-
T Consensus 194 ~~Di~slG~~l~~l~~g~~p~ 214 (271)
T 3dtc_A 194 GSDVWSYGVLLWELLTGEVPF 214 (271)
T ss_dssp HHHHHHHHHHHHHHHHCCCTT
T ss_pred hhhHHHHHHHHHHHHhCCCCC
Confidence 257888899999999887654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=210.78 Aligned_cols=118 Identities=22% Similarity=0.373 Sum_probs=102.5
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee---
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL--- 545 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--- 545 (708)
.+++|..+..++......||||||| +++|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 61 ~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 139 (483)
T 3sv0_A 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (483)
T ss_dssp TSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG
T ss_pred CCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC
Confidence 4467777888888999999999999 9999999975 4579999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc--------ccccccCCcccccccccCCCC
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK--------LDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~--------~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
+..+.+||+|||+++....... ....+||+.|+|||++.+...
T Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 190 (483)
T 3sv0_A 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ 190 (483)
T ss_dssp GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCC
Confidence 6889999999999987644322 236789999999999987653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=194.76 Aligned_cols=142 Identities=35% Similarity=0.602 Sum_probs=123.1
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++.+...+|+||||+++++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (287)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred hccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEec
Confidence 45799999999999999999999999999999999988889999999999999999999999999999999999999976
Q ss_pred C---CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 E---MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ~---~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
. +.+||+|||++.............||+.|+|||++.+. ++. ..|.|+++
T Consensus 157 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~-------------------------~~Di~slG 209 (287)
T 2wei_A 157 KEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDE-------------------------KCDVWSAG 209 (287)
T ss_dssp SSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC--CCT-------------------------HHHHHHHH
T ss_pred CCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC--CCC-------------------------chhhHhHH
Confidence 4 46999999999877655555567899999999998642 111 25777888
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-++..|.+.
T Consensus 210 ~~l~~l~~g~~p 221 (287)
T 2wei_A 210 VILYILLSGTPP 221 (287)
T ss_dssp HHHHHHHHSSCS
T ss_pred HHHHHHHhCCCC
Confidence 888888888765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.7e-21 Score=207.21 Aligned_cols=140 Identities=23% Similarity=0.389 Sum_probs=115.6
Q ss_pred ccccCceeEEEEEEEeCCEE------EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~------yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+||++++++|...... |||||||. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 97 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 173 (371)
T 4exu_A 97 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 173 (371)
T ss_dssp HCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred hcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH
Confidence 45799999999999987765 99999998 58887763 35999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+||+|||+++.... .....+||+.|+|||++.+...++.. .|-|
T Consensus 174 NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Diw 226 (371)
T 4exu_A 174 NLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQT-------------------------VDIW 226 (371)
T ss_dssp GEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTT-------------------------HHHH
T ss_pred HeEECCCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcH-------------------------HhHH
Confidence 99999999999999999986533 23457899999999999875444433 6888
Q ss_pred chhhhHHHHhhCCCCC
Q psy2648 622 SIKENTARLNAGRPAK 637 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~ 637 (708)
++++++-++..|.+.-
T Consensus 227 slG~il~el~~g~~pf 242 (371)
T 4exu_A 227 SVGCIMAEMLTGKTLF 242 (371)
T ss_dssp HHHHHHHHHHHSSCSC
T ss_pred HHHHHHHHHHhCCCCC
Confidence 8899999999888754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.4e-21 Score=201.65 Aligned_cols=139 Identities=30% Similarity=0.398 Sum_probs=109.2
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQ---KKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~ 541 (708)
...|+|||++++++.+ ..|||||||++|+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+
T Consensus 57 ~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~ 134 (307)
T 2eva_A 57 RVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134 (307)
T ss_dssp HCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGG
T ss_pred cCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChh
Confidence 4579999999998874 4899999999999999998665 37899999999999999999999 89999999999
Q ss_pred CeeecCCCC-EEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 542 NLLLDSEMN-IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 542 NILl~~~~~-vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
|||++.++. +||+|||++...... .....||+.|+|||++.+..... ..|-
T Consensus 135 NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~Di 186 (307)
T 2eva_A 135 NLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSE--------------------------KCDV 186 (307)
T ss_dssp GEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCT--------------------------HHHH
T ss_pred HEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCc--------------------------HHHH
Confidence 999998887 799999999765322 23457999999999997643211 2567
Q ss_pred cchhhhHHHHhhCCCC
Q psy2648 621 ASIKENTARLNAGRPA 636 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~ 636 (708)
|+++.++-++..|.+.
T Consensus 187 ~slG~il~el~~g~~p 202 (307)
T 2eva_A 187 FSWGIILWEVITRRKP 202 (307)
T ss_dssp HHHHHHHHHHHHTCCT
T ss_pred HHHHHHHHHHHHCCCC
Confidence 7778888888887765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-20 Score=204.16 Aligned_cols=142 Identities=21% Similarity=0.331 Sum_probs=118.5
Q ss_pred ccCceeEEEEEEE----eCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCC
Q psy2648 470 GGETLLKLFQVIE----TEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAEN 542 (708)
Q Consensus 470 ~~~~Iv~L~~~~~----~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~N 542 (708)
.|+||++++++|. +...+||||||| +++|.+.+... +.+++..++.++.||+.||.|||++ |||||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 4889999999998 566899999999 66777777654 4699999999999999999999998 99999999999
Q ss_pred eeecCCC-------------------------------------------------CEEEeeccCccccCCCCccccccc
Q psy2648 543 LLLDSEM-------------------------------------------------NIKIADFGFSNEFTPGNKLDTFCG 573 (708)
Q Consensus 543 ILl~~~~-------------------------------------------------~vKl~DFGla~~~~~~~~~~~~~G 573 (708)
||++.++ .+||+|||+|+.... .....+|
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCC
Confidence 9999775 799999999986543 2345689
Q ss_pred CCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCCCCC
Q psy2648 574 SPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAKNTA 640 (708)
Q Consensus 574 t~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (708)
|+.|+|||++.+.. ++.. .|-|++++++-++..|.+.-...
T Consensus 256 t~~y~aPE~~~~~~-~~~~-------------------------~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 256 TRQYRSLEVLIGSG-YNTP-------------------------ADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CGGGCCHHHHHTSC-CCTH-------------------------HHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCcccCChhhcCCC-CCcH-------------------------HHHHHHHHHHHHHhhCCCCCCCC
Confidence 99999999997654 2211 58889999999999998765443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-20 Score=197.09 Aligned_cols=144 Identities=26% Similarity=0.387 Sum_probs=122.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL---HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
...|+||+++++++.+...+||||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL 165 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence 45799999999999999999999999999999999873 346999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
++.++.+||+|||+++...... .....+||+.|+|||++.+. ++. ..|-|
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~-------------------------~~Dv~ 218 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITP-------------------------KSDIY 218 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECT-------------------------HHHHH
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCc-------------------------cchhH
Confidence 9999999999999987654322 23346899999999998642 111 25888
Q ss_pred chhhhHHHHhhCCCCCC
Q psy2648 622 SIKENTARLNAGRPAKN 638 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ 638 (708)
+++.++-++..|.+.-.
T Consensus 219 slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 219 SFGVVLLEIITGLPAVD 235 (307)
T ss_dssp HHHHHHHHHHHCCCSBC
T ss_pred HHHHHHHHHHHCCCCcc
Confidence 99999999999987643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.2e-21 Score=203.48 Aligned_cols=147 Identities=20% Similarity=0.328 Sum_probs=126.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDY------LVL--HGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRD 537 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~------l~~--~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRD 537 (708)
....|+||+++++++.+.+.+|||||||++|+|.++ +.. ...+++..+..++.||+.||.|||+ +||+|||
T Consensus 98 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp TTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred HhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence 345799999999999999999999999999999998 655 5679999999999999999999999 9999999
Q ss_pred CCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccc
Q psy2648 538 LKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNT 617 (708)
Q Consensus 538 lKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (708)
|||+|||++.++.+||+|||++...... ......||+.|+|||++.+...++. ..
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~------------------------~~ 232 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNG------------------------AK 232 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEH------------------------HH
T ss_pred CChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCc------------------------ch
Confidence 9999999999999999999999875433 4456789999999999987643332 12
Q ss_pred ccccchhhhHHHHhhCCCCCC
Q psy2648 618 IDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~ 638 (708)
.|-|+++.++-++..|.+.-.
T Consensus 233 ~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 233 VDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp HHHHHHHHHHHHHHHSSCSSC
T ss_pred hhHHHHHHHHHHHHhCCCCCC
Confidence 577888888888888877644
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=199.62 Aligned_cols=144 Identities=19% Similarity=0.283 Sum_probs=119.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----------GRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 536 (708)
....|+||+++++++.+....|||||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 83 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 162 (322)
T 1p4o_A 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162 (322)
T ss_dssp GGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred HhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 3458999999999999999999999999999999999753 357999999999999999999999999999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK 613 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 613 (708)
||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+.....
T Consensus 163 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~----------------------- 219 (322)
T 1p4o_A 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT----------------------- 219 (322)
T ss_dssp CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-----------------------
T ss_pred CCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCc-----------------------
Confidence 999999999999999999999998654322 123456789999999987543221
Q ss_pred ccccccccchhhhHHHHhh-CCCC
Q psy2648 614 RQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 220 ---~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 220 ---YSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp ---HHHHHHHHHHHHHHHHTSCCT
T ss_pred ---hhhHHHHHHHHHHHHhcCCCc
Confidence 1467777888888776 5544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=202.06 Aligned_cols=141 Identities=25% Similarity=0.333 Sum_probs=117.6
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKI 533 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~ylH~~~I 533 (708)
.|+||+++++++.+...+|||||||++|+|.+++.... .+++.++..++.||+.||.|||++||
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 79999999999999999999999999999999998654 38999999999999999999999999
Q ss_pred ccCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCc
Q psy2648 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPT 610 (708)
Q Consensus 534 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~ 610 (708)
+||||||+|||++.++.+||+|||+++....... .....+|+.|+|||++.+.....
T Consensus 179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-------------------- 238 (334)
T 2pvf_A 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-------------------- 238 (334)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH--------------------
T ss_pred eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh--------------------
Confidence 9999999999999999999999999986644322 23346788999999997543211
Q ss_pred cccccccccccchhhhHHHHhh-CCCC
Q psy2648 611 NFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 239 ------~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 239 ------QSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp ------HHHHHHHHHHHHHHHTTSCCS
T ss_pred ------HHHHHHHHHHHHHHHhCCCCC
Confidence 1466677777777776 5543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.82 E-value=8e-21 Score=200.38 Aligned_cols=142 Identities=20% Similarity=0.242 Sum_probs=118.8
Q ss_pred ccCceeEEEEEEEeCC-EEEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCC
Q psy2648 470 GGETLLKLFQVIETEK-TLYLVMEYASGGEVFDYLVLHGR----------------MKEKEARAKFRQIVSAVQYCHQKK 532 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~-~~yLVmEy~~gg~L~~~l~~~~~----------------l~e~~~~~~~~qi~~aL~ylH~~~ 532 (708)
.|+||+++++++.... .+|+|||||++|+|.+++..... +++..+..++.||+.||.|||++|
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6899999999988765 59999999999999999987554 899999999999999999999999
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCC
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAP 609 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~ 609 (708)
|+||||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+.....
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~------------------- 229 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI------------------- 229 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH-------------------
T ss_pred cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccc-------------------
Confidence 99999999999999999999999999986643322 23467899999999996543211
Q ss_pred ccccccccccccchhhhHHHHhh-CCCCC
Q psy2648 610 TNFKRQNTIDSASIKENTARLNA-GRPAK 637 (708)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 637 (708)
..|-|+++.++-++.. |.+.-
T Consensus 230 -------~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 230 -------QSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp -------HHHHHHHHHHHHHHHTTSCCSS
T ss_pred -------hhHHHHHHHHHHHHHhCCCCCC
Confidence 2577888888888886 66543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=204.80 Aligned_cols=139 Identities=27% Similarity=0.330 Sum_probs=115.4
Q ss_pred cCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCCeeec
Q psy2648 471 GETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCH--QKKIIHRDLKAENLLLD 546 (708)
Q Consensus 471 ~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~ 546 (708)
+.+|+++++++.....+|||||||. |+|.+++... +.+++..++.++.||+.||.||| +.|||||||||+|||++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC 193 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEES
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEe
Confidence 3469999999999999999999996 5999999765 46999999999999999999999 57999999999999995
Q ss_pred --CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 --SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 --~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
..+.+||+|||+|+.... .....+||+.|+|||++.+... +.. .|-|+++
T Consensus 194 ~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~-------------------------~DiwSlG 245 (382)
T 2vx3_A 194 NPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPY-DLA-------------------------IDMWSLG 245 (382)
T ss_dssp STTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCC-CTH-------------------------HHHHHHH
T ss_pred cCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCC-CcH-------------------------HHHHHHH
Confidence 477899999999987643 3446789999999999986542 222 5677777
Q ss_pred hhHHHHhhCCCCCC
Q psy2648 625 ENTARLNAGRPAKN 638 (708)
Q Consensus 625 ~~~~~~~~~~~~~~ 638 (708)
+++-++..|.|.-.
T Consensus 246 ~il~elltg~~pf~ 259 (382)
T 2vx3_A 246 CILVEMHTGEPLFS 259 (382)
T ss_dssp HHHHHHHHSSCSSC
T ss_pred HHHHHHHhCCCCCC
Confidence 77777777776543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=200.74 Aligned_cols=120 Identities=23% Similarity=0.364 Sum_probs=99.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++.+...+|||||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 181 (333)
T 1mqb_A 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181 (333)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred hCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC
Confidence 457999999999999999999999999999999999765 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (333)
T 1mqb_A 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226 (333)
T ss_dssp TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCC
Confidence 999999999999987543221 12235688999999997554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=197.59 Aligned_cols=148 Identities=26% Similarity=0.383 Sum_probs=108.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NIL 544 (708)
....|+||+++++++.++..+||||||+ ++.+..+... .+.+++..+..++.||+.||.|||++ ||+||||||+|||
T Consensus 79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil 157 (318)
T 2dyl_A 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 157 (318)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEE
T ss_pred HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEE
Confidence 3458999999999999999999999999 4555554443 56799999999999999999999995 9999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
++.++.+||+|||++............+||+.|+|||++.+....... + -...|-|+++
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-------------------~--~~~~Di~slG 216 (318)
T 2dyl_A 158 LDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD-------------------Y--DIRADVWSLG 216 (318)
T ss_dssp ECTTSCEEECCCTTC--------------CCTTCCHHHHC---------------------------C--CTHHHHHHHH
T ss_pred ECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccC-------------------C--ccccchhhHH
Confidence 999999999999999876555555567899999999999643211100 0 0125778888
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
.++-++..|.+.
T Consensus 217 ~il~~l~~g~~p 228 (318)
T 2dyl_A 217 ISLVELATGQFP 228 (318)
T ss_dssp HHHHHHHHSSCT
T ss_pred HHHHHHHhCCCC
Confidence 888888888754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=220.41 Aligned_cols=143 Identities=23% Similarity=0.281 Sum_probs=115.7
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+|||++++++++ +.+|||||||++|+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 426 ~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~ 504 (635)
T 4fl3_A 426 QLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 504 (635)
T ss_dssp HCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred hCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC
Confidence 4579999999999975 458999999999999999998889999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 548 EMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
++.+||+|||+|+....... .....||+.|+|||++.+..... ..|-|++
T Consensus 505 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~--------------------------~sDvwSl 558 (635)
T 4fl3_A 505 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS--------------------------KSDVWSF 558 (635)
T ss_dssp TTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCH--------------------------HHHHHHH
T ss_pred CCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCc--------------------------HHHHHHH
Confidence 99999999999987643321 23345788999999997554222 1466777
Q ss_pred hhhHHHHhh-CCCCC
Q psy2648 624 KENTARLNA-GRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~-~~~~~ 637 (708)
+.++-++.. |++.-
T Consensus 559 Gv~l~ellt~G~~Pf 573 (635)
T 4fl3_A 559 GVLMWEAFSYGQKPY 573 (635)
T ss_dssp HHHHHHHHTTTCCSS
T ss_pred HHHHHHHHhCCCCCC
Confidence 777777775 66543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.2e-21 Score=200.42 Aligned_cols=147 Identities=20% Similarity=0.211 Sum_probs=119.8
Q ss_pred cccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q psy2648 467 ASSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 538 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 538 (708)
....|+||+++++++.. ...+|+|||||++|+|.+++.. ...+++.++..++.||+.||.|||++||+||||
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dl 160 (317)
T 2buj_A 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDL 160 (317)
T ss_dssp HTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 34589999999999873 3589999999999999999875 467999999999999999999999999999999
Q ss_pred CCCCeeecCCCCEEEeeccCccccCCCC----------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCC
Q psy2648 539 KAENLLLDSEMNIKIADFGFSNEFTPGN----------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPA 608 (708)
Q Consensus 539 Kp~NILl~~~~~vKl~DFGla~~~~~~~----------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~ 608 (708)
||+|||++.++.+||+|||++....... ......||+.|+|||++.+......
T Consensus 161 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----------------- 223 (317)
T 2buj_A 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI----------------- 223 (317)
T ss_dssp CGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEE-----------------
T ss_pred CHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCC-----------------
Confidence 9999999999999999999987543211 1123568999999999875432100
Q ss_pred CccccccccccccchhhhHHHHhhCCCC
Q psy2648 609 PTNFKRQNTIDSASIKENTARLNAGRPA 636 (708)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (708)
....|-|+++.++-++..|.+.
T Consensus 224 ------~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 224 ------DERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp ------CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ------CchhhHHHHHHHHHHHHhCCCC
Confidence 0136788889999999988765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=194.75 Aligned_cols=142 Identities=22% Similarity=0.292 Sum_probs=116.4
Q ss_pred ccCc-eeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee--
Q psy2648 470 GGET-LLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL-- 545 (708)
Q Consensus 470 ~~~~-Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-- 545 (708)
.|++ |..+..++......||||||+ +++|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 140 (296)
T 3uzp_A 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred hcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEec
Confidence 4444 555555667888999999999 9999999974 4579999999999999999999999999999999999999
Q ss_pred -cCCCCEEEeeccCccccCCCCc--------ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccc
Q psy2648 546 -DSEMNIKIADFGFSNEFTPGNK--------LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQN 616 (708)
Q Consensus 546 -~~~~~vKl~DFGla~~~~~~~~--------~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 616 (708)
+.++.+||+|||+++....... ....+||+.|+|||++.+.....
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-------------------------- 194 (296)
T 3uzp_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-------------------------- 194 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH--------------------------
T ss_pred CCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCc--------------------------
Confidence 4788999999999986543322 34568999999999998654211
Q ss_pred cccccchhhhHHHHhhCCCCCC
Q psy2648 617 TIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
..|-|+++.++-++..|.+.-.
T Consensus 195 ~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 195 RDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTS
T ss_pred chhhHHHHHHHHHHHhCCCCCC
Confidence 1578888999999999887643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-20 Score=199.93 Aligned_cols=143 Identities=25% Similarity=0.293 Sum_probs=119.2
Q ss_pred ccccCceeEEEEEEE--eCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 468 SSGGETLLKLFQVIE--TEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~--~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
...|+||+++++++. +...+|||||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 80 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl 159 (327)
T 3lxl_A 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159 (327)
T ss_dssp TCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEE
Confidence 458999999999987 45679999999999999999976 456999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
++.++.+||+|||+++....... .....||+.|+|||++.+..... ..|-
T Consensus 160 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di 213 (327)
T 3lxl_A 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR--------------------------QSDV 213 (327)
T ss_dssp EEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEH--------------------------HHHH
T ss_pred ECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCCh--------------------------HHhH
Confidence 99999999999999987643321 23456889999999987654221 2567
Q ss_pred cchhhhHHHHhhCCCC
Q psy2648 621 ASIKENTARLNAGRPA 636 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~ 636 (708)
|+++.++-.+..|++.
T Consensus 214 ~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 214 WSFGVVLYELFTYCDK 229 (327)
T ss_dssp HHHHHHHHHHHTTTCG
T ss_pred HHHHHHHHHHHhCCCC
Confidence 7777788888777654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=7.4e-21 Score=197.50 Aligned_cols=143 Identities=28% Similarity=0.365 Sum_probs=112.1
Q ss_pred cccccCceeEEEEEEEeC-CEEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 467 ASSGGETLLKLFQVIETE-KTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~-~~~yLVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
....|+||+++++++.+. ..+|+||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+||
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 148 (278)
T 1byg_A 69 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 148 (278)
T ss_dssp TTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceE
Confidence 345799999999997554 579999999999999999976543 89999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
|++.++.+||+|||+++..... .....+++.|+|||++.+..... ..|-|++
T Consensus 149 l~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~sl 200 (278)
T 1byg_A 149 LVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFST--------------------------KSDVWSF 200 (278)
T ss_dssp EECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCH--------------------------HHHHHHH
T ss_pred EEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCc--------------------------hhcHHHH
Confidence 9999999999999998765432 23446889999999986543211 2577888
Q ss_pred hhhHHHHhh-CCCCC
Q psy2648 624 KENTARLNA-GRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~-~~~~~ 637 (708)
+.++-++.. |.+.-
T Consensus 201 G~il~~l~t~g~~p~ 215 (278)
T 1byg_A 201 GILLWEIYSFGRVPY 215 (278)
T ss_dssp HHHHHHHHTTSCCSC
T ss_pred HHHHHHHHhCCCCCC
Confidence 888888886 76643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-20 Score=197.14 Aligned_cols=145 Identities=25% Similarity=0.431 Sum_probs=117.7
Q ss_pred cccccCceeEEEEEEE--------------eCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2648 467 ASSGGETLLKLFQVIE--------------TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 532 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~--------------~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~ 532 (708)
....|+||+++++++. +...+||||||++ |+|.+++.. +.+++..+..++.||+.||.|||++|
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ 140 (320)
T 2i6l_A 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN 140 (320)
T ss_dssp HTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457999999999984 4478999999998 599998854 67999999999999999999999999
Q ss_pred CccCCCCCCCeeec-CCCCEEEeeccCccccCCC----CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCC
Q psy2648 533 IIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPG----NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISP 607 (708)
Q Consensus 533 IiHRDlKp~NILl~-~~~~vKl~DFGla~~~~~~----~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~ 607 (708)
|+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+...++.
T Consensus 141 i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---------------- 204 (320)
T 2i6l_A 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK---------------- 204 (320)
T ss_dssp CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCH----------------
T ss_pred EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCc----------------
Confidence 99999999999997 5678999999999865432 22345678999999999876443332
Q ss_pred CCccccccccccccchhhhHHHHhhCCCCCC
Q psy2648 608 APTNFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
..|-|+++.++-++..|.+.-.
T Consensus 205 ---------~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 205 ---------AIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp ---------HHHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------hhhhHhHHHHHHHHHhCCCCCC
Confidence 2578888999999999877543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4e-21 Score=199.27 Aligned_cols=143 Identities=28% Similarity=0.463 Sum_probs=116.9
Q ss_pred ccccCceeEEEEEEEe--CCEEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----CccC
Q psy2648 468 SSGGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVLHG----RMKEKEARAKFRQIVSAVQYCHQKK-----IIHR 536 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~--~~~~yLVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHR 536 (708)
...|+||+++++++.+ ...+|||||||++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~ 140 (279)
T 2w5a_A 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140 (279)
T ss_dssp HCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCC
T ss_pred hcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEe
Confidence 3579999999998854 678999999999999999997542 4999999999999999999999999 9999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCCc-ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccc
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGNK-LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQ 615 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~~-~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~ 615 (708)
||||+|||++.++.+||+|||+++....... ....+||+.|+|||++.+.....
T Consensus 141 dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~------------------------- 195 (279)
T 2w5a_A 141 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE------------------------- 195 (279)
T ss_dssp CCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCH-------------------------
T ss_pred ccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCc-------------------------
Confidence 9999999999999999999999877644322 34568999999999997643211
Q ss_pred ccccccchhhhHHHHhhCCCC
Q psy2648 616 NTIDSASIKENTARLNAGRPA 636 (708)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~ 636 (708)
..|-|+++.++-++..|.+.
T Consensus 196 -~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 196 -KSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp -HHHHHHHHHHHHHHHHSSCS
T ss_pred -hhhHHHHHHHHHHHHHCCCC
Confidence 24677888888888887664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-20 Score=193.32 Aligned_cols=143 Identities=22% Similarity=0.287 Sum_probs=119.7
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++.++..+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~ 138 (267)
T 3t9t_A 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 138 (267)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred hCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC
Confidence 457999999999999999999999999999999999765 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+++...... ......||+.|+|||++.+..... ..|-|+++
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 192 (267)
T 3t9t_A 139 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS--------------------------KSDVWSFG 192 (267)
T ss_dssp GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH--------------------------HHHHHHHH
T ss_pred CCCCEEEcccccccccccccccccccccccccccChhhhcCCCccc--------------------------hhchhhhH
Confidence 99999999999988654321 123456788999999996543211 25677778
Q ss_pred hhHHHHhh-CCCC
Q psy2648 625 ENTARLNA-GRPA 636 (708)
Q Consensus 625 ~~~~~~~~-~~~~ 636 (708)
.++-++.. |.+.
T Consensus 193 ~il~~l~~~g~~p 205 (267)
T 3t9t_A 193 VLMWEVFSEGKIP 205 (267)
T ss_dssp HHHHHHHTTSCCT
T ss_pred HHHHHHhccCCCC
Confidence 88888877 6654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.81 E-value=8.7e-21 Score=212.05 Aligned_cols=119 Identities=27% Similarity=0.426 Sum_probs=98.3
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+|||++++++.+ ..+|||||||++|+|.+++... ..+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 235 ~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill 313 (452)
T 1fmk_A 235 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 313 (452)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE
Confidence 4579999999999876 6799999999999999999743 569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCC
Q psy2648 546 DSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+.++.+||+|||+++...... ......+++.|+|||++.++.
T Consensus 314 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 357 (452)
T 1fmk_A 314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357 (452)
T ss_dssp CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC
T ss_pred CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCC
Confidence 999999999999998764332 123345788999999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=7.2e-21 Score=202.65 Aligned_cols=142 Identities=22% Similarity=0.288 Sum_probs=116.4
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
..|+||+++++++.+...+|||||||++|+|.+++.... .+++.++..++.||+.||.|||++||+||||||+
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~ 169 (327)
T 2yfx_A 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 169 (327)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHh
Confidence 489999999999999999999999999999999998753 4899999999999999999999999999999999
Q ss_pred CeeecCC---CCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccc
Q psy2648 542 NLLLDSE---MNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQ 615 (708)
Q Consensus 542 NILl~~~---~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~ 615 (708)
|||++.+ ..+||+|||+++...... ......||+.|+|||++.+.....
T Consensus 170 NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~------------------------- 224 (327)
T 2yfx_A 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS------------------------- 224 (327)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCH-------------------------
T ss_pred HEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCc-------------------------
Confidence 9999854 469999999987543222 223457899999999987543211
Q ss_pred ccccccchhhhHHHHhh-CCCC
Q psy2648 616 NTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 616 ~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 225 -~~Di~slG~il~ellt~g~~p 245 (327)
T 2yfx_A 225 -KTDTWSFGVLLWEIFSLGYMP 245 (327)
T ss_dssp -HHHHHHHHHHHHHHHTTSCCS
T ss_pred -hhhHHHHHHHHHHHHcCCCCC
Confidence 2567777888888775 6544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-20 Score=198.14 Aligned_cols=146 Identities=22% Similarity=0.309 Sum_probs=122.6
Q ss_pred cccCceeEEEEEEEeCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccC
Q psy2648 469 SGGETLLKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH--------QKKIIHR 536 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~----~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH--------~~~IiHR 536 (708)
..|+||+++++++.... .+|||||||++|+|.+++.. ..+++.++..++.||+.||.||| +++|+||
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 68999999999999886 89999999999999999975 47999999999999999999999 8999999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCC-----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcc
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTN 611 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~-----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~ 611 (708)
||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+......
T Consensus 172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-------------------- 231 (342)
T 1b6c_B 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH-------------------- 231 (342)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTC--------------------
T ss_pred CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccc--------------------
Confidence 999999999999999999999998764433 2345689999999999976532210
Q ss_pred ccccccccccchhhhHHHHhhCCC
Q psy2648 612 FKRQNTIDSASIKENTARLNAGRP 635 (708)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~ 635 (708)
+..-...|-|+++.++-++..|.+
T Consensus 232 ~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 232 FESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred cccCCcccHHHHHHHHHHHHhccC
Confidence 000123678889999999998865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-20 Score=208.56 Aligned_cols=148 Identities=26% Similarity=0.421 Sum_probs=109.7
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMK-------EKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~-------e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
..|||||+++++++++..+|||||||. |+|.+++...+... +..+..++.||+.||.|||++|||||||||+
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 489999999999999999999999996 69999998665432 2345679999999999999999999999999
Q ss_pred CeeecCC-------------CCEEEeeccCccccCCCC-----cccccccCCcccccccccCCCCccCCCCCCCCCcccC
Q psy2648 542 NLLLDSE-------------MNIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNS 603 (708)
Q Consensus 542 NILl~~~-------------~~vKl~DFGla~~~~~~~-----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~ 603 (708)
|||++.. +.+||+|||+|+...... .....+||+.|+|||++.+........
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~---------- 214 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKR---------- 214 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCC----------
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccccc----------
Confidence 9999754 479999999998765432 233568999999999998743211100
Q ss_pred CCCCCCccccccccccccchhhhHHHHhh-CCCC
Q psy2648 604 SISPAPTNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
.--...|-|++++++-++.. |.+.
T Consensus 215 ---------~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 215 ---------RLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp ---------CCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred ---------CcchhhhhHhHHHHHHHHHhCCCCC
Confidence 00123678888999999887 6654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.1e-20 Score=215.41 Aligned_cols=179 Identities=27% Similarity=0.379 Sum_probs=139.0
Q ss_pred cCCCCCCCCCCcCCCcccccccccccccc--------------CcccccccccCceeEEEEEEEe------CCEEEEEEe
Q psy2648 433 GGSGGGGGGGAAQSPSHRGVHRSISASNA--------------KPSRRASSGGETLLKLFQVIET------EKTLYLVME 492 (708)
Q Consensus 433 ~~~~ggg~~g~v~s~~hr~~~R~i~~~~~--------------~~~~~~~~~~~~Iv~L~~~~~~------~~~~yLVmE 492 (708)
....|.|++|.|+...++...+....+.. +........|+|||++++++.. ....|||||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE 98 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence 44556677777766655433332111110 1111233589999999999766 678899999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCC---EEEeeccCccccCCCC
Q psy2648 493 YASGGEVFDYLVLHG---RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFTPGN 566 (708)
Q Consensus 493 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~---vKl~DFGla~~~~~~~ 566 (708)
||+||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 99 y~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~ 178 (676)
T 3qa8_A 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178 (676)
T ss_dssp CCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC
T ss_pred eCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc
Confidence 999999999998654 5999999999999999999999999999999999999997765 9999999998876666
Q ss_pred cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 567 KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 567 ~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.....+||+.|+|||++.+... +.. .|-|+++.++-++..|.+.-
T Consensus 179 ~~~~~~gt~~Y~APE~l~~~~~-s~k-------------------------sDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 179 LCTEFVGTLQYLAPELLEQKKY-TVT-------------------------VDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCCCCSCCTTCSSCSSCCSCC-STT-------------------------HHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCcccCChHHhccCCC-Cch-------------------------hHHHHHHHHHHHHHHCCCCC
Confidence 6667899999999999875432 212 57888999999999986653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=195.83 Aligned_cols=142 Identities=23% Similarity=0.278 Sum_probs=118.0
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|+||+++++++ ....+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 74 ~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~ 152 (291)
T 1xbb_A 74 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 152 (291)
T ss_dssp TCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred hCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC
Confidence 45799999999999 56778999999999999999998888999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 548 EMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
++.+||+|||+++....... .....||+.|+|||++.+..... ..|-|++
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~sl 206 (291)
T 1xbb_A 153 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS--------------------------KSDVWSF 206 (291)
T ss_dssp TTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH--------------------------HHHHHHH
T ss_pred CCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCCh--------------------------hhhHHHH
Confidence 99999999999987644332 12245678999999996543211 2567777
Q ss_pred hhhHHHHhh-CCCC
Q psy2648 624 KENTARLNA-GRPA 636 (708)
Q Consensus 624 ~~~~~~~~~-~~~~ 636 (708)
+.++-++.. |.+.
T Consensus 207 G~il~~l~~~g~~p 220 (291)
T 1xbb_A 207 GVLMWEAFSYGQKP 220 (291)
T ss_dssp HHHHHHHHTTTCCS
T ss_pred HHHHHHHHhcCCCC
Confidence 888888776 6664
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-20 Score=195.26 Aligned_cols=144 Identities=23% Similarity=0.292 Sum_probs=117.6
Q ss_pred cccccCceeEEEEEE-EeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVI-ETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~-~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
....|+||+++++++ ..+...|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil 160 (298)
T 3f66_A 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 160 (298)
T ss_dssp HTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEE
Confidence 345799999999985 5567899999999999999999754 45899999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCC-----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~-----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
++.++.+||+|||+++...... ......||+.|+|||++.+..... ..|
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~D 214 (298)
T 3f66_A 161 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT--------------------------KSD 214 (298)
T ss_dssp ECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCH--------------------------HHH
T ss_pred ECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCCh--------------------------HHH
Confidence 9999999999999998654322 223456889999999996543211 257
Q ss_pred ccchhhhHHHHhh-CCCC
Q psy2648 620 SASIKENTARLNA-GRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~-~~~~ 636 (708)
-|+++.++-++.. |.|.
T Consensus 215 i~slG~il~~l~~~~~~~ 232 (298)
T 3f66_A 215 VWSFGVLLWELMTRGAPP 232 (298)
T ss_dssp HHHHHHHHHHHHTTSCCS
T ss_pred HHHHHHHHHHHHhCCCCC
Confidence 7888888888887 5553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-20 Score=195.90 Aligned_cols=120 Identities=28% Similarity=0.527 Sum_probs=100.7
Q ss_pred cccccCceeEEEEEEE--eCCEEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIE--TEKTLYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~--~~~~~yLVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
....|+||+++++++. +...+|||||||+++ |.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~N 139 (305)
T 2wtk_C 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139 (305)
T ss_dssp TTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence 3457999999999984 456899999999987 7777764 4569999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCC---CCcccccccCCcccccccccCCC
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTP---GNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~---~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
||++.++.+||+|||++..... ........||+.|+|||++.+..
T Consensus 140 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (305)
T 2wtk_C 140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187 (305)
T ss_dssp EEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCS
T ss_pred EEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcc
Confidence 9999999999999999986543 22334567999999999997643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-20 Score=222.19 Aligned_cols=168 Identities=22% Similarity=0.340 Sum_probs=121.7
Q ss_pred cccccCceeEEEEEEEeCCE-----EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEKT-----LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~-----~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
....|+|||++++++..... +|||||||+|++|.+++.. .+++.++..++.||+.||.|||++|||||||||+
T Consensus 134 ~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~ 211 (681)
T 2pzi_A 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPE 211 (681)
T ss_dssp GGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred HhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChH
Confidence 44679999999999987665 7999999999999987754 7999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCC--CCCc-c----ccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSIS--PAPT-N----FKR 614 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~--~~~~-~----~~~ 614 (708)
|||++.+ .+||+|||+++..... ...+||+.|||||++.++. ...++-++.+.+...... ++.. . ...
T Consensus 212 NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~ 286 (681)
T 2pzi_A 212 NIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE 286 (681)
T ss_dssp GEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT
T ss_pred HeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccc
Confidence 9999875 9999999999876443 4568999999999997654 222222221111111000 0000 0 000
Q ss_pred ccc--ccccchhhhHHHHhhCCCCCCCCC
Q psy2648 615 QNT--IDSASIKENTARLNAGRPAKNTAS 641 (708)
Q Consensus 615 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 641 (708)
... -.+..+.+++.+.+...|.+|-.+
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~ 315 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTT 315 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSS
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCH
Confidence 001 113567889999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-21 Score=203.99 Aligned_cols=140 Identities=22% Similarity=0.387 Sum_probs=114.2
Q ss_pred ccccCceeEEEEEEEeCCE------EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEKT------LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~------~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|+||+++++++..... +|+||||+. ++|.+++. ..+++.++..++.||+.||.|||++||+||||||+
T Consensus 79 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 155 (353)
T 3coi_A 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 155 (353)
T ss_dssp HCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG
T ss_pred hcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 3579999999999988754 599999998 58887664 35999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+||+|||+++.... .....+||+.|+|||++.+...++.. .|-|
T Consensus 156 NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Di~ 208 (353)
T 3coi_A 156 NLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQT-------------------------VDIW 208 (353)
T ss_dssp GEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTT-------------------------HHHH
T ss_pred HEeECCCCcEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCch-------------------------hhHH
Confidence 99999999999999999986532 23456899999999999764433322 5788
Q ss_pred chhhhHHHHhhCCCCC
Q psy2648 622 SIKENTARLNAGRPAK 637 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~ 637 (708)
+++.++-++..|.+.-
T Consensus 209 slG~il~el~~g~~pf 224 (353)
T 3coi_A 209 SVGCIMAEMLTGKTLF 224 (353)
T ss_dssp HHHHHHHHHHHSSCSS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 8888888888887654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-20 Score=217.87 Aligned_cols=142 Identities=22% Similarity=0.273 Sum_probs=113.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|||||++++++. ++.+|||||||++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 447 ~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~ 525 (656)
T 2j0j_A 447 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 525 (656)
T ss_dssp HCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred hCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe
Confidence 357999999999984 567899999999999999998654 699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc--ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+++....... .....||+.|||||++.+..... ..|-|+++
T Consensus 526 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--------------------------~~DiwSlG 579 (656)
T 2j0j_A 526 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS--------------------------ASDVWMFG 579 (656)
T ss_dssp ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCH--------------------------HHHHHHHH
T ss_pred CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCc--------------------------hhhHHHHH
Confidence 999999999999987644332 22346788999999997553222 14667777
Q ss_pred hhHHHHhh-CCCC
Q psy2648 625 ENTARLNA-GRPA 636 (708)
Q Consensus 625 ~~~~~~~~-~~~~ 636 (708)
.++-++.. |.+.
T Consensus 580 ~il~ellt~g~~P 592 (656)
T 2j0j_A 580 VCMWEILMHGVKP 592 (656)
T ss_dssp HHHHHHHTTSCCT
T ss_pred HHHHHHHHcCCCC
Confidence 77777664 6543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-20 Score=192.89 Aligned_cols=142 Identities=23% Similarity=0.273 Sum_probs=115.2
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||++++++++++ ..|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 69 ~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 147 (281)
T 3cc6_A 69 NLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA 147 (281)
T ss_dssp HHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE
T ss_pred hCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC
Confidence 35799999999998754 5699999999999999997654 599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||++....... ......+|+.|+|||++.+..... ..|-|+++
T Consensus 148 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~slG 201 (281)
T 3cc6_A 148 SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT--------------------------ASDVWMFA 201 (281)
T ss_dssp ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCH--------------------------HHHHHHHH
T ss_pred CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCc--------------------------hhccHHHH
Confidence 99999999999998654332 223456788999999996543211 25777888
Q ss_pred hhHHHHhh-CCCC
Q psy2648 625 ENTARLNA-GRPA 636 (708)
Q Consensus 625 ~~~~~~~~-~~~~ 636 (708)
.++-++.. |.+.
T Consensus 202 ~il~~llt~g~~p 214 (281)
T 3cc6_A 202 VCMWEILSFGKQP 214 (281)
T ss_dssp HHHHHHHTTTCCT
T ss_pred HHHHHHHhCCCCC
Confidence 88888876 6654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=5.2e-20 Score=192.48 Aligned_cols=144 Identities=22% Similarity=0.293 Sum_probs=120.3
Q ss_pred cccccCceeEEEEEEEeCCEE-EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIETEKTL-YLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~-yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
....|+||+++++++.+.+.. |+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil 156 (298)
T 3pls_A 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCM 156 (298)
T ss_dssp HTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence 345799999999999877665 999999999999999976 456899999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCC-----CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPG-----NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~-----~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
++.++.+||+|||+++..... .......||+.|+|||++.+..... ..|
T Consensus 157 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~D 210 (298)
T 3pls_A 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT--------------------------KSD 210 (298)
T ss_dssp ECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCH--------------------------HHH
T ss_pred EcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCCh--------------------------hhc
Confidence 999999999999999765332 2234467899999999997654221 257
Q ss_pred ccchhhhHHHHhh-CCCC
Q psy2648 620 SASIKENTARLNA-GRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~-~~~~ 636 (708)
-|+++.++-.+.. |.|.
T Consensus 211 i~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 211 VWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp HHHHHHHHHHHHHTSCCT
T ss_pred hhhHHHHHHHHhhCCCCC
Confidence 7888888888888 5554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=4.2e-20 Score=195.19 Aligned_cols=144 Identities=17% Similarity=0.274 Sum_probs=111.4
Q ss_pred cccccCceeEEEEEEEeCC-----EEEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy2648 467 ASSGGETLLKLFQVIETEK-----TLYLVMEYASGGEVFDYLVL------HGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~-----~~yLVmEy~~gg~L~~~l~~------~~~l~e~~~~~~~~qi~~aL~ylH~~~IiH 535 (708)
....|+||+++++++.+.. ..|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (313)
T 3brb_A 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170 (313)
T ss_dssp HTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCC
T ss_pred hcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3457999999999998765 35999999999999999843 346999999999999999999999999999
Q ss_pred CCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccc
Q psy2648 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNF 612 (708)
Q Consensus 536 RDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~ 612 (708)
|||||+|||++.++.+||+|||+++...... ......+++.|+|||++.+.....
T Consensus 171 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---------------------- 228 (313)
T 3brb_A 171 RDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS---------------------- 228 (313)
T ss_dssp CCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCH----------------------
T ss_pred CCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccc----------------------
Confidence 9999999999999999999999998654332 123356788999999997543211
Q ss_pred cccccccccchhhhHHHHhh-CCCC
Q psy2648 613 KRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
..|-|+++.++-++.. |.+.
T Consensus 229 ----~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 229 ----KSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp ----HHHHHHHHHHHHHHHTTSCCS
T ss_pred ----hhhhHHHHHHHHHHHhcCCCC
Confidence 2577888888888887 6554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=194.55 Aligned_cols=138 Identities=20% Similarity=0.245 Sum_probs=116.3
Q ss_pred CceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee----
Q psy2648 472 ETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL---- 545 (708)
Q Consensus 472 ~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---- 545 (708)
.+++.+++++.....+||||||| +++|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 82 FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160 (355)
T ss_dssp SCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCC
T ss_pred eeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccc
Confidence 44999999999999999999999 677888777654 69999999999999999999999999999999999999
Q ss_pred ---------------cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCc
Q psy2648 546 ---------------DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPT 610 (708)
Q Consensus 546 ---------------~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~ 610 (708)
+..+.+||+|||+++.... .....+||+.|+|||++.+... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~------------------- 218 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGW-AQ------------------- 218 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCC-CT-------------------
T ss_pred ccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCC-CC-------------------
Confidence 5678999999999976433 2345689999999999975432 11
Q ss_pred cccccccccccchhhhHHHHhhCCCCCC
Q psy2648 611 NFKRQNTIDSASIKENTARLNAGRPAKN 638 (708)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (708)
..|-|+++.++-++..|.+.-.
T Consensus 219 ------~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 219 ------PCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp ------HHHHHHHHHHHHHHHHSSCSCC
T ss_pred ------ccchHHHHHHHHHHHhCCCCCC
Confidence 2578888899999998877643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-20 Score=214.64 Aligned_cols=143 Identities=24% Similarity=0.313 Sum_probs=113.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|+|||++++++.+ +.+|||||||++|+|.+++... ..+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 391 ~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 469 (613)
T 2ozo_A 391 HQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469 (613)
T ss_dssp TTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE
Confidence 34589999999999987 5699999999999999999754 459999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
+.++.+||+|||+|+....... .....+|+.|+|||++.+...... .|-|
T Consensus 470 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~--------------------------sDvw 523 (613)
T 2ozo_A 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR--------------------------SDVW 523 (613)
T ss_dssp EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHH--------------------------HHHH
T ss_pred cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcH--------------------------HHHH
Confidence 9999999999999987643321 122346789999999975543222 4666
Q ss_pred chhhhHHHHhh-CCCC
Q psy2648 622 SIKENTARLNA-GRPA 636 (708)
Q Consensus 622 ~~~~~~~~~~~-~~~~ 636 (708)
+.+.++-++.. |.+.
T Consensus 524 SlGv~l~ellt~G~~P 539 (613)
T 2ozo_A 524 SYGVTMWEALSYGQKP 539 (613)
T ss_dssp HHHHHHHHHHTTSCCT
T ss_pred HHHHHHHHHHHCCCCC
Confidence 77777777775 6554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=5e-20 Score=198.46 Aligned_cols=133 Identities=19% Similarity=0.319 Sum_probs=112.4
Q ss_pred EEEEEEe-CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC--CE
Q psy2648 477 LFQVIET-EKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM--NI 551 (708)
Q Consensus 477 L~~~~~~-~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~--~v 551 (708)
+++++.. +..+||||||| +++|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~ 200 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceE
Confidence 7788876 78999999999 99999999875 7899999999999999999999999999999999999999998 89
Q ss_pred EEeeccCccccCCCC--------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 552 KIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 552 Kl~DFGla~~~~~~~--------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
||+|||+++...... .....+||+.|+|||++.+..... ..|-|++
T Consensus 201 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--------------------------~~Di~sl 254 (352)
T 2jii_A 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR--------------------------RSDLQSL 254 (352)
T ss_dssp EECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH--------------------------HHHHHHH
T ss_pred EEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc--------------------------hhhHHHH
Confidence 999999997654221 123458999999999997653211 2577888
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
+.++-++..|.+.
T Consensus 255 G~il~el~~g~~p 267 (352)
T 2jii_A 255 GYCMLKWLYGFLP 267 (352)
T ss_dssp HHHHHHHHHSCCT
T ss_pred HHHHHHHHhCCCC
Confidence 8888888888764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-20 Score=198.31 Aligned_cols=144 Identities=26% Similarity=0.305 Sum_probs=118.6
Q ss_pred cccccCceeEEEEEEEeCC--EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 467 ASSGGETLLKLFQVIETEK--TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~--~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
....|+||+++++++.... .+|||||||++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+||
T Consensus 97 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NI 176 (326)
T 2w1i_A 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 176 (326)
T ss_dssp HTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence 3457999999999987654 789999999999999999876 4599999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
|++.++.+||+|||+++....... .....+++.|+|||++.+... +. ..|
T Consensus 177 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~-------------------------~~D 230 (326)
T 2w1i_A 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SV-------------------------ASD 230 (326)
T ss_dssp EEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EH-------------------------HHH
T ss_pred EEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCC-Cc-------------------------hhh
Confidence 999999999999999987644322 223467888999999875432 11 257
Q ss_pred ccchhhhHHHHhhCCCC
Q psy2648 620 SASIKENTARLNAGRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~ 636 (708)
-|+++.++-++..|.+.
T Consensus 231 i~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 231 VWSFGVVLYELFTYIEK 247 (326)
T ss_dssp HHHHHHHHHHHHHTTCG
T ss_pred HHHHHHHHHHHHhcCCC
Confidence 78888888888887654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-20 Score=215.05 Aligned_cols=119 Identities=27% Similarity=0.426 Sum_probs=102.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+|||++++++.+ ..+|||||||++|+|.++|... ..+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 318 ~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 396 (535)
T 2h8h_A 318 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 396 (535)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE
Confidence 4579999999999876 6799999999999999999743 469999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCC
Q psy2648 546 DSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+.++.+||+|||+++...... ......++..|+|||++.+..
T Consensus 397 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 440 (535)
T 2h8h_A 397 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440 (535)
T ss_dssp CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCC
T ss_pred cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCC
Confidence 999999999999998764321 122345778999999997654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=4e-20 Score=193.04 Aligned_cols=143 Identities=24% Similarity=0.311 Sum_probs=117.6
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++ ..+.+|+|||||++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 66 ~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~ 144 (287)
T 1u59_A 66 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 144 (287)
T ss_dssp HCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred hCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc
Confidence 35799999999999 456699999999999999999654 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
.++.+||+|||+++....... .....||+.|+|||++.+..... ..|-|+
T Consensus 145 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~s 198 (287)
T 1u59_A 145 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS--------------------------RSDVWS 198 (287)
T ss_dssp ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECH--------------------------HHHHHH
T ss_pred CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCc--------------------------hhhHHH
Confidence 999999999999987643322 22345789999999986543211 256777
Q ss_pred hhhhHHHHhh-CCCCC
Q psy2648 623 IKENTARLNA-GRPAK 637 (708)
Q Consensus 623 ~~~~~~~~~~-~~~~~ 637 (708)
++.++-++.. |.+.-
T Consensus 199 lG~il~ellt~g~~p~ 214 (287)
T 1u59_A 199 YGVTMWEALSYGQKPY 214 (287)
T ss_dssp HHHHHHHHHTTSCCTT
T ss_pred HHHHHHHHHcCCCCCc
Confidence 8888888886 76653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-20 Score=191.51 Aligned_cols=142 Identities=23% Similarity=0.390 Sum_probs=116.4
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
...|+||+++++++. .+.+|+|||||++++|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 64 ~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~ 142 (279)
T 1qpc_A 64 QLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142 (279)
T ss_dssp HCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred hCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE
Confidence 457999999999986 456899999999999999987543 69999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc--ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+.++.+||+|||++........ .....+++.|+|||++.+..... ..|-|++
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--------------------------~~Di~sl 196 (279)
T 1qpc_A 143 SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI--------------------------KSDVWSF 196 (279)
T ss_dssp CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECH--------------------------HHHHHHH
T ss_pred cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCc--------------------------hhhhHHH
Confidence 9999999999999987654332 23446788999999996543211 1466777
Q ss_pred hhhHHHHhh-CCCC
Q psy2648 624 KENTARLNA-GRPA 636 (708)
Q Consensus 624 ~~~~~~~~~-~~~~ 636 (708)
+.++-++.. |.+.
T Consensus 197 G~il~el~~~g~~p 210 (279)
T 1qpc_A 197 GILLTEIVTHGRIP 210 (279)
T ss_dssp HHHHHHHHTTTCCS
T ss_pred HHHHHHHHhCCCCC
Confidence 777777776 6654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.8e-20 Score=192.09 Aligned_cols=142 Identities=25% Similarity=0.339 Sum_probs=115.9
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|+||+++++++.++. .|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~ 155 (291)
T 1u46_A 77 SLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA 155 (291)
T ss_dssp HCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE
T ss_pred hCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc
Confidence 347999999999998765 89999999999999999764 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
.++.+||+|||+++....... .....+|+.|+|||++.+... +. ..|-|+
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~-------------------------~~Di~s 209 (291)
T 1u46_A 156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH-------------------------ASDTWM 209 (291)
T ss_dssp ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EH-------------------------HHHHHH
T ss_pred CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCC-Cc-------------------------hhhHHH
Confidence 999999999999987644322 234568889999999865432 11 256777
Q ss_pred hhhhHHHHhh-CCCC
Q psy2648 623 IKENTARLNA-GRPA 636 (708)
Q Consensus 623 ~~~~~~~~~~-~~~~ 636 (708)
++.++-++.. |.+.
T Consensus 210 lG~il~~l~~~g~~p 224 (291)
T 1u46_A 210 FGVTLWEMFTYGQEP 224 (291)
T ss_dssp HHHHHHHHHTTSCCT
T ss_pred HHHHHHHHHhCCCCC
Confidence 7888888877 6664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 708 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-90 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-88 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-32 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-88 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-87 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-85 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-85 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-84 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-84 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-83 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-83 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-82 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-79 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-27 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-79 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-33 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-79 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-78 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-78 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-78 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-78 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-77 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-75 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-23 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-75 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-24 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-74 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-73 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-73 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-71 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-71 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-69 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-69 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-26 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-20 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-67 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-67 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-21 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-66 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-19 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-65 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-65 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-64 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-64 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-15 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-62 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-62 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-62 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-60 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-22 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-18 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-21 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-19 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 279 bits (716), Expect = 6e-90
Identities = 85/248 (34%), Positives = 143/248 (57%), Gaps = 3/248 (1%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF-REVRIMKMLD 103
+ +++ + +GKG F V LA+ + +A+K++ K QL ++ REV I L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
HPNI++L+ +YL++EYA G V+ L + E+ ++ +A+ YCH
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
K++IHRD+K ENLLL S +KIADFG+S P ++ T CG+ Y PE+ +G+ +D
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHD- 182
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283
+VD+WSLGV+ Y + G PF+ +T +E +R+ R ++ P +++ +L+ + L N
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242
Query: 284 PAKRASLE 291
P++R L
Sbjct: 243 PSQRPMLR 250
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 9e-35
Identities = 42/113 (37%), Positives = 65/113 (57%), Gaps = 1/113 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+L+L+ +YL++EYA G V+ L + E+ ++ +A+ YCH K++
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
IHRD+K ENLLL S +KIADFG+S P ++ T CG+ Y PE+ +G
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 179
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (708), Expect = 2e-88
Identities = 92/259 (35%), Positives = 145/259 (55%), Gaps = 9/259 (3%)
Query: 37 RRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFRE 95
R++R E +K K +G+G+F+ V LA+ + T +E AIKI++K + + + RE
Sbjct: 3 RKKRPE----DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 58
Query: 96 VRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIV 155
+M LDHP VKL+ + ++ LY + YA GE+ Y+ G E R +IV
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAA 212
SA++Y H K IIHRDLK EN+LL+ +M+I+I DFG + +P +K ++F G+ Y +
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 213 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDC 272
PEL K D+W+LG I+Y LV+G PF + +++++ +Y P
Sbjct: 179 PELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 273 ENLLKKFLVLNPAKRASLE 291
+L++K LVL+ KR E
Sbjct: 238 RDLVEKLLVLDATKRLGCE 256
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-32
Identities = 44/116 (37%), Positives = 67/116 (57%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+KL+ + ++ LY + YA GE+ Y+ G E R +IVSA++Y H K I
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGG 586
IHRDLK EN+LL+ +M+I+I DFG + +P +K ++F G+ Y +PEL
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (706), Expect = 2e-88
Identities = 91/255 (35%), Positives = 147/255 (57%), Gaps = 7/255 (2%)
Query: 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML 102
P + + L++T+G+G + +V+LA + T + VA+KI+D + + + +E+ I KML
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKML 60
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
+H N+VK + YL +EY SGGE+FD + M E +A+ F Q+++ V Y H
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGK 219
I HRD+K ENLLLD N+KI+DFG + F N+ L+ CG+ PY APEL + +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 220 KYDGPEVDVWSLGVILYTLVSGSLPFDGST--LRELRERVLRGKYRIPF-YMSTDCENLL 276
++ VDVWS G++L +++G LP+D + +E + + Y P+ + + LL
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 277 KKFLVLNPAKRASLE 291
K LV NP+ R ++
Sbjct: 241 HKILVENPSARITIP 255
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-34
Identities = 47/116 (40%), Positives = 66/116 (56%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++K + YL +EY SGGE+FD + M E +A+ F Q+++ V Y H I
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGG 586
HRD+K ENLLLD N+KI+DFG + F N+ L+ CG+ PY APEL +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (699), Expect = 2e-87
Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 21/269 (7%)
Query: 36 SRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFRE 95
SR E Y++L TIG G++ + + + GK + K +D + Q L E
Sbjct: 1 SRAE-------DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE 53
Query: 96 VRIMKMLDHPNIVKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARA 149
V +++ L HPNIV+ + I T TLY+VMEY GG++ + + + E+
Sbjct: 54 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113
Query: 150 KFRQIVSAVQYCHQK-----KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DT 203
Q+ A++ CH++ ++HRDLK N+ LD + N+K+ DFG +
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
Query: 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY- 262
F G+P Y +PE Y+ + D+WSLG +LY L + PF + +EL ++ GK+
Sbjct: 174 FVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232
Query: 263 RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
RIP+ S + ++ + L L R S+E
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYHRPSVE 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 35/125 (28%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 474 LLKLFQVI--ETEKTLYLVMEYASGGEVFDYLVLHGR----MKEKEARAKFRQIVSAVQY 527
+++ + I T TLY+VMEY GG++ + + + E+ Q+ A++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 528 CHQK-----KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-DTFCGSPPYAAPE 581
CH++ ++HRDLK N+ LD + N+K+ DFG + F G+P Y +PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 582 LFQGG 586
Sbjct: 185 QMNRM 189
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 268 bits (687), Expect = 1e-85
Identities = 99/262 (37%), Positives = 144/262 (54%), Gaps = 17/262 (6%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQK-------LFREVRIM 99
Y+ + +G+G + V+ H PT KE A+KIID T S ++ +EV I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 100 KML-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
+ + HPNI++L ET +LV + GE+FDYL + EKE R R ++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
H+ I+HRDLK EN+LLD +MNIK+ DFGFS + PG KL CG+P Y APE+ +
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183
Query: 219 KKYD-----GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY----MS 269
D G EVD+WS GVI+YTL++GS PF + ++ G Y+ S
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243
Query: 270 TDCENLLKKFLVLNPAKRASLE 291
++L+ +FLV+ P KR + E
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAE 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (334), Expect = 2e-35
Identities = 48/111 (43%), Positives = 65/111 (58%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
+L ET +LV + GE+FDYL + EKE R R ++ + H+ I+H
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVH 133
Query: 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
RDLK EN+LLD +MNIK+ DFGFS + PG KL CG+P Y APE+ +
Sbjct: 134 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 270 bits (692), Expect = 3e-85
Identities = 70/254 (27%), Positives = 125/254 (49%), Gaps = 10/254 (3%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+ Y + + +G G F V TG A K + + + + +E++ M +L H
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRH 82
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQ 163
P +V L E + + ++ E+ SGGE+F+ + H +M E EA RQ+ + + H+
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 164 KKIIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
+H DLK EN++ ++ + +K+ DFG + P + G+ +AAPE+ +GK
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLK 277
G D+WS+GV+ Y L+SG PF G E V + + +S D ++ ++
Sbjct: 203 -GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261
Query: 278 KFLVLNPAKRASLE 291
K L+ +P R ++
Sbjct: 262 KLLLADPNTRMTIH 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (314), Expect = 7e-32
Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKK 532
L+ L E + + ++ E+ SGGE+F+ + H +M E EA RQ+ + + H+
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 533 IIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
+H DLK EN++ ++ + +K+ DFG + P + G+ +AAPE+ +G
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (682), Expect = 1e-84
Identities = 76/253 (30%), Positives = 126/253 (49%), Gaps = 11/253 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
++++ +G G F KV A++ T A K+ID + L+ E+ I+ DHPNI
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNI 71
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
VKL E L++++E+ +GG V ++ L + E + + +Q + A+ Y H KI
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGKKYD--- 222
IHRDLKA N+L + +IK+ADFG S + T + D+F G+P + APE+ +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 223 -GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---RIPFYMSTDCENLLKK 278
+ DVWSLG+ L + P + ++ + + P S++ ++ LKK
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251
Query: 279 FLVLNPAKRASLE 291
L N R +
Sbjct: 252 CLEKNVDARWTTS 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 8e-34
Identities = 40/115 (34%), Positives = 66/115 (57%), Gaps = 2/115 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKK 532
++KL E L++++E+ +GG V ++ L + E + + +Q + A+ Y H K
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGG 586
IIHRDLKA N+L + +IK+ADFG S + T + D+F G+P + APE+
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 267 bits (683), Expect = 2e-84
Identities = 75/258 (29%), Positives = 115/258 (44%), Gaps = 11/258 (4%)
Query: 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRI 98
+D+P + L+ IG G+F V A+ V + VAIK + + + Q + +EVR
Sbjct: 10 KDDPE-KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 99 MKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
++ L HPN ++ E T +LVMEY G V ++E E A + +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
Y H +IHRD+KA N+LL +K+ DFG ++ P N +F G+P + APE+
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILA 185
Query: 219 ---KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCE 273
+YDG VDVWSLG+ L P + + + + S
Sbjct: 186 MDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244
Query: 274 NLLKKFLVLNPAKRASLE 291
N + L P R + E
Sbjct: 245 NFVDSCLQKIPQDRPTSE 262
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 6e-34
Identities = 35/112 (31%), Positives = 53/112 (47%), Gaps = 3/112 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ E T +LVMEY G V ++E E A + + Y H +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
IHRD+KA N+LL +K+ DFG ++ P N +F G+P + APE+
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILA 185
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 264 bits (675), Expect = 2e-83
Identities = 95/252 (37%), Positives = 136/252 (53%), Gaps = 9/252 (3%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
Y +G G F++V LA+ T K VAIK I K L G + E+ ++ + HPN
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV L + E+ LYL+M+ SGGE+FD +V G E++A Q++ AV+Y H I
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 167 IHRDLKAENLLL---DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+HRDLK ENLL D + I I+DFG S PG+ L T CG+P Y APE+ K Y
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS- 187
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
VD WS+GVI Y L+ G PF +L E++L+ +Y +S ++ ++
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 280 LVLNPAKRASLE 291
+ +P KR + E
Sbjct: 248 MEKDPEKRFTCE 259
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (293), Expect = 2e-29
Identities = 49/116 (42%), Positives = 68/116 (58%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L + E+ LYL+M+ SGGE+FD +V G E++A Q++ AV+Y H I
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 534 IHRDLKAENLLL---DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
+HRDLK ENLL D + I I+DFG S PG+ L T CG+P Y APE+
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 265 bits (679), Expect = 3e-83
Identities = 69/254 (27%), Positives = 119/254 (46%), Gaps = 10/254 (3%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
Y +L+ +G G F V TG+ K I+ P + E+ IM L H
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHH 85
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQ 163
P ++ L E + + L++E+ SGGE+FD + +M E E RQ +++ H+
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 164 KKIIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
I+H D+K EN++ +++ +KI DFG + + P + + +AAPE+ +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLK 277
D+W++GV+ Y L+SG PF G E + V R + +S + ++ +K
Sbjct: 206 G-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
Query: 278 KFLVLNPAKRASLE 291
L P KR ++
Sbjct: 265 NLLQKEPRKRLTVH 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 123 bits (310), Expect = 2e-31
Identities = 33/116 (28%), Positives = 60/116 (51%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 532
L+ L E + + L++E+ SGGE+FD + +M E E RQ +++ H+
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 533 IIHRDLKAENLLLDSEMN--IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
I+H D+K EN++ +++ +KI DFG + + P + + +AAPE+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 203
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (669), Expect = 1e-82
Identities = 78/269 (28%), Positives = 134/269 (49%), Gaps = 12/269 (4%)
Query: 31 SRRESSRRERDEPHIG----KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP 86
S E + R +G KY + IG+G V A V TG+EVAI+ ++ Q
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP- 59
Query: 87 GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKE 146
+ + E+ +M+ +PNIV L++VMEY +GG + D + M E +
Sbjct: 60 -KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQ 117
Query: 147 ARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFC 205
A R+ + A+++ H ++IHRD+K++N+LL + ++K+ DFGF + T +K T
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG---KY 262
G+P + APE+ K Y P+VD+WSLG++ ++ G P+ + +
Sbjct: 178 GTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 263 RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
+ P +S + L + L ++ KR S +
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAK 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 35/114 (30%), Positives = 63/114 (55%), Gaps = 2/114 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L++VMEY +GG + D + M E + A R+ + A+++ H ++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFT-PGNKLDTFCGSPPYAAPELFQGG 586
IHRD+K++N+LL + ++K+ DFGF + T +K T G+P + APE+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 3e-79
Identities = 87/247 (35%), Positives = 137/247 (55%), Gaps = 4/247 (1%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK-TQLNPGSLQKLFREVRIMKM-LDHP 105
+ L K +GKG+F KV LA+ T + AIK + K L ++ E R++ + +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
+ +F +T++ L+ VMEY +GG++ ++ + A +I+ +Q+ H K
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGKKYDGP 224
I++RDLK +N+LLD + +IKIADFG E G+ K +TFCG+P Y APE+ G+KY+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-H 182
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLNP 284
VD WS GV+LY ++ G PF G EL + P ++ + ++LL K V P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 242
Query: 285 AKRASLE 291
KR +
Sbjct: 243 EKRLGVR 249
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 44/114 (38%), Positives = 69/114 (60%), Gaps = 1/114 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L +F +T++ L+ VMEY +GG++ ++ + A +I+ +Q+ H K I
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 124
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGG 586
++RDLK +N+LLD + +IKIADFG E G+ K +TFCG+P Y APE+ G
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 4e-79
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 48/290 (16%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
++ + +G GN V H P+G +A K+I ++ P ++ RE++++ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPY 65
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-K 165
IV + ++ + + ME+ GG + L GR+ E+ ++ + Y +K K
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
I+HRD+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG Y +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYS-VQ 183
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLREL---RERVLRGKYRI------------------ 264
D+WS+G+ L + G P +EL + G
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 265 -----------------------PFYMSTDCENLLKKFLVLNPAKRASLE 291
S + ++ + K L+ NPA+RA L+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 2/114 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK-K 532
++ + ++ + + ME+ GG + L GR+ E+ ++ + Y +K K
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
I+HRD+K N+L++S IK+ DFG S + + ++F G+ Y +PE QG
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGT 178
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 9e-79
Identities = 63/258 (24%), Positives = 120/258 (46%), Gaps = 16/258 (6%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
G+ + + IG G+F V K +VA+K+++ T P LQ EV +++ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 106 NIVKLFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQK 164
NI+ T L +V ++ G ++ +L ++ + + + RQ + Y H K
Sbjct: 65 NILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
IIHRDLK+ N+ L ++ +KI DFG + + ++ ++ + GS + APE+ + +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 222 D--GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY------MSTDCE 273
+ + DV++ G++LY L++G LP+ R+ ++ Y P +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 274 NLLKKFLVLNPAKRASLE 291
L+ + L +R
Sbjct: 244 RLMAECLKKKRDERPLFP 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 31/114 (27%), Positives = 58/114 (50%), Gaps = 4/114 (3%)
Query: 477 LFQVIETEKTLYLVMEYASGGEVFDYL-VLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
LF T L +V ++ G ++ +L ++ + + + RQ + Y H K IIH
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 536 RDLKAENLLLDSEMNIKIADFGFS---NEFTPGNKLDTFCGSPPYAAPELFQGG 586
RDLK+ N+ L ++ +KI DFG + + ++ ++ + GS + APE+ +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 1e-78
Identities = 62/252 (24%), Positives = 118/252 (46%), Gaps = 11/252 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY + + +G+G F V + K K + + + +E+ I+ + H N
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRN 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 165
I+ L + E+ + L ++ E+ SG ++F+ + + E+E + Q+ A+Q+ H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 166 IIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
I H D++ EN++ + IKI +FG + + PG+ +P Y APE+ Q
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS- 181
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLLKKF 279
D+WSLG ++Y L+SG PF T +++ E ++ +Y +S + + + +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 280 LVLNPAKRASLE 291
LV R +
Sbjct: 242 LVKERKSRMTAS 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 32/116 (27%), Positives = 60/116 (51%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKK 532
+L L + E+ + L ++ E+ SG ++F+ + + E+E + Q+ A+Q+ H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 533 IIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
I H D++ EN++ + IKI +FG + + PG+ +P Y APE+ Q
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 251 bits (642), Expect = 2e-78
Identities = 73/244 (29%), Positives = 138/244 (56%), Gaps = 4/244 (1%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD 103
+ +++L+T+G G+F +V L + G+ A+K++ K + ++ E ++ ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
HP I++++ + + ++++M+Y GGE+F L R A+ ++ A++Y H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
K II+RDLK EN+LLD +IKI DFGF+ + T CG+P Y APE+ K Y+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYN- 179
Query: 224 PEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283
+D WS G+++Y +++G PF S + E++L + R P + + D ++LL + + +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 284 PAKR 287
++R
Sbjct: 240 LSQR 243
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (259), Expect = 5e-25
Identities = 39/113 (34%), Positives = 64/113 (56%), Gaps = 2/113 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+++++ + + ++++M+Y GGE+F L R A+ ++ A++Y H K I
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
I+RDLK EN+LLD +IKI DFGF+ + T CG+P Y APE+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTK 176
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 3e-78
Identities = 70/257 (27%), Positives = 121/257 (47%), Gaps = 14/257 (5%)
Query: 46 GKY-KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
G++ K IG+G+F V T EVA + +L Q+ E ++K L H
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 105 PNIVKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
PNIV+ + E+ +K + LV E + G + YL MK K R+ RQI+ +Q+
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 161 CHQKK--IIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
H + IIHRDLK +N+ + ++KI D G + + G+P + APE+++
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE 186
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRERVLRGKYRIPF--YMSTDCEN 274
KYD VDV++ G+ + + + P+ ++ RV G F + +
Sbjct: 187 E-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 275 LLKKFLVLNPAKRASLE 291
+++ + N +R S++
Sbjct: 245 IIEGCIRQNKDERYSIK 261
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 4/110 (3%)
Query: 480 VIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRD 537
++ +K + LV E + G + YL MK K R+ RQI+ +Q+ H + IIHRD
Sbjct: 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 139
Query: 538 LKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
LK +N+ + ++KI D G + + G+P + APE+++
Sbjct: 140 LKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEK 188
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 7e-78
Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 13/257 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL----NPGSLQKLFREVRIMKML 102
Y + +G G FA VK + TG + A K I K + S + + REV I+K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 103 DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 162
HPN++ L +V E + + L++E +GGE+FD+L + E+EA +QI++ V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 QKKIIHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
+I H DLK EN++L IKI DFG +++ GN+ G+P + APE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCEN 274
+ E D+WS+GVI Y L+SG+ PF G T +E V Y S ++
Sbjct: 191 EPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 275 LLKKFLVLNPAKRASLE 291
+++ LV +P KR +++
Sbjct: 250 FIRRLLVKDPKKRMTIQ 266
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-25
Identities = 40/117 (34%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L +V E + + L++E +GGE+FD+L + E+EA +QI++ V Y H +I
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 534 IHRDLKAENLLLDSE----MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
H DLK EN++L IKI DFG +++ GN+ G+P + APE+
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 249 bits (636), Expect = 7e-77
Identities = 65/257 (25%), Positives = 120/257 (46%), Gaps = 8/257 (3%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLF----REVRIMK 100
+ + + + IG+G F +V + TGK A+K +DK ++ + L + ++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 101 MLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
D P IV + T L +++ +GG++ +L HG E + R +I+ +++
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKK 220
H + +++RDLK N+LLD +++I+D G + +F+ K G+ Y APE+ Q
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGV 181
Query: 221 YDGPEVDVWSLGVILYTLVSGSLPFDGSTLR---ELRERVLRGKYRIPFYMSTDCENLLK 277
D +SLG +L+ L+ G PF + E+ L +P S + +LL+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 278 KFLVLNPAKRASLEVSG 294
L + +R G
Sbjct: 242 GLLQRDVNRRLGCLGRG 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 119 bits (299), Expect = 7e-30
Identities = 33/119 (27%), Positives = 63/119 (52%), Gaps = 1/119 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ + T L +++ +GG++ +L HG E + R +I+ +++ H + +
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 128
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
++RDLK N+LLD +++I+D G + +F+ K G+ Y APE+ Q G SS
Sbjct: 129 VYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 186
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 2e-75
Identities = 71/254 (27%), Positives = 133/254 (52%), Gaps = 15/254 (5%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN----PGSLQKLFREVRIMKM 101
+Y++ +G G F V V VAIK ++K +++ + ++ EV ++K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 102 LD--HPNIVKLFQVIETEKTLYLVMEYASGG-EVFDYLVLHGRMKEKEARAKFRQIVSAV 158
+ +++L E + L++E ++FD++ G ++E+ AR+ F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 159 QYCHQKKIIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 217
++CH ++HRD+K EN+L+D + +K+ DFG F G+ Y+ PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 218 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLK 277
+Y G VWSLG++LY +V G +PF+ E ++RG+ +S++C++L++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIR 236
Query: 278 KFLVLNPAKRASLE 291
L L P+ R + E
Sbjct: 237 WCLALRPSDRPTFE 250
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 5e-26
Identities = 37/130 (28%), Positives = 68/130 (52%), Gaps = 3/130 (2%)
Query: 465 RRASSGGETLLKLFQVIETEKTLYLVMEYASGG-EVFDYLVLHGRMKEKEARAKFRQIVS 523
++ SSG +++L E + L++E ++FD++ G ++E+ AR+ F Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 524 AVQYCHQKKIIHRDLKAENLLLD-SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPEL 582
AV++CH ++HRD+K EN+L+D + +K+ DFG F G+ Y+ PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEW 180
Query: 583 FQGGAPVTSS 592
+ S
Sbjct: 181 IRYHRYHGRS 190
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 4e-75
Identities = 90/252 (35%), Positives = 136/252 (53%), Gaps = 3/252 (1%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLD 103
+ + LK +GKG F KV L + TG+ A+KI+ K + + E R+++
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
HP + L +T L VMEYA+GGE+F +L E+ AR +IVSA++Y H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYD 222
+ +++RD+K ENL+LD + +IKI DFG E + G + TFCG+P Y APE+ + Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 223 GPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVL 282
VD W LGV++Y ++ G LPF L E +L + R P +S + ++LL L
Sbjct: 184 -RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 283 NPAKRASLEVSG 294
+P +R S
Sbjct: 243 DPKQRLGGGPSD 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 48/114 (42%), Positives = 69/114 (60%), Gaps = 1/114 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L L +T L VMEYA+GGE+F +L E+ AR +IVSA++Y H + +
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGG 586
++RD+K ENL+LD + +IKI DFG E + G + TFCG+P Y APE+ +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 241 bits (615), Expect = 5e-75
Identities = 71/255 (27%), Positives = 120/255 (47%), Gaps = 14/255 (5%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDH 104
+Y+L + +G G ++V LA+ + ++VA+K++ +P + RE + L+H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 105 PNIVKLFQVIETE----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
P IV ++ E E Y+VMEY G + D + G M K A A+ +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELF 216
HQ IIHRD+K N+++ + +K+ DFG + + G+ Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFY----MSTDC 272
+G D DV+SLG +LY +++G PF G + + + +R P +S D
Sbjct: 187 RGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 273 ENLLKKFLVLNPAKR 287
+ ++ K L NP R
Sbjct: 246 DAVVLKALAKNPENR 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 100 bits (250), Expect = 3e-24
Identities = 32/121 (26%), Positives = 53/121 (43%), Gaps = 8/121 (6%)
Query: 474 LLKLFQVIETE----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 529
++ ++ E E Y+VMEY G + D + G M K A A+ + H
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128
Query: 530 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELFQG 585
Q IIHRD+K N+++ + +K+ DFG + + G+ Y +PE +G
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 586 G 586
Sbjct: 189 D 189
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (607), Expect = 6e-74
Identities = 78/250 (31%), Positives = 122/250 (48%), Gaps = 14/250 (5%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+ KLL+TIGKG F V L + G +VA+K I + Q E +M L H N
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSN 61
Query: 107 IVKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQ 163
+V+L V +E + LY+V EY + G + DYL GR + + A++Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDG 223
+HRDL A N+L+ + K++DFG + E + + DT + APE + KK+
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALREKKFS- 178
Query: 224 PEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFLV 281
+ DVWS G++L+ + S G +P+ L+++ RV +G K P ++K
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238
Query: 282 LNPAKRASLE 291
L+ A R S
Sbjct: 239 LDAAMRPSFL 248
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 8e-27
Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 474 LLKLFQV-IETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQ 530
L++L V +E + LY+V EY + G + DYL GR + + A++Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
+HRDL A N+L+ + K++DFG + E + + DT + APE +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALREK 175
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 6e-74
Identities = 87/266 (32%), Positives = 131/266 (49%), Gaps = 27/266 (10%)
Query: 45 IGKYKLL-KTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIM-KML 102
I YK+ + +G G KV + T ++ A+K++ K REV + +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRAS 62
Query: 103 DHPNIVKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVS 156
P+IV++ V E K L +VME GGE+F + G E+EA + I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAP 213
A+QY H I HRD+K ENLL S+ +K+ DFGF+ E T N L T C +P Y AP
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYRIPF--- 266
E+ +KYD D+WSLGVI+Y L+ G PF + ++ R+ G+Y P
Sbjct: 183 EVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 267 -YMSTDCENLLKKFLVLNPAKRASLE 291
+S + + L++ L P +R ++
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-29
Identities = 46/122 (37%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 474 LLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQY 527
++++ V E K L +VME GGE+F + G E+EA + I A+QY
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 528 CHQKKIIHRDLKAENLLLDSEMN---IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQ 584
H I HRD+K ENLL S+ +K+ DFGF+ E T N L T C +P Y APE+
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 585 GG 586
Sbjct: 187 PE 188
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 238 bits (609), Expect = 4e-73
Identities = 93/276 (33%), Positives = 154/276 (55%), Gaps = 8/276 (2%)
Query: 17 RGSENNISSSRLMSSRRESSRR----ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK 72
+GSE L ++ + ++ ++ + ++ +KT+G G+F +V L KH +G
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 73 EVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGE 131
A+KI+DK ++ ++ E RI++ ++ P +VKL + LY+VMEY +GGE
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 132 VFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191
+F +L GR E AR QIV +Y H +I+RDLK ENLL+D + I++ DFGF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 192 SNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR 251
+ + T CG+P APE+ K Y+ VD W+LGV++Y + +G PF
Sbjct: 188 AKRVK--GRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 252 ELRERVLRGKYRIPFYMSTDCENLLKKFLVLNPAKR 287
++ E+++ GK R P + S+D ++LL+ L ++ KR
Sbjct: 245 QIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.6 bits (229), Expect = 6e-21
Identities = 46/113 (40%), Positives = 63/113 (55%), Gaps = 2/113 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+KL + LY+VMEY +GGE+F +L GR E AR QIV +Y H +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
I+RDLK ENLL+D + I++ DFGF+ + T CG+P APE+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSK 213
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 6e-73
Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 10/248 (4%)
Query: 52 KTIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVK 109
K +G GNF VK + K VA+KI+ +P +L E +M+ LD+P IV+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 110 LFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHR 169
+ + E E LVME A G + YL + +K+K Q+ ++Y + +HR
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 170 DLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT----FCGSPPYAAPELFQGKKYDGPE 225
DL A N+LL ++ KI+DFG S + APE K+ +
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SK 190
Query: 226 VDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVLN 283
DVWS GV+++ S G P+ G E+ + +G+ P + +L+ +
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250
Query: 284 PAKRASLE 291
R
Sbjct: 251 VENRPGFA 258
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 8e-28
Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 5/123 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++++ + E E LVME A G + YL + +K+K Q+ ++Y +
Sbjct: 70 IVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT----FCGSPPYAAPELFQGGAPV 589
+HRDL A N+LL ++ KI+DFG S + APE
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 590 TSS 592
+ S
Sbjct: 189 SKS 191
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 3e-71
Identities = 70/293 (23%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
+ KY+ L IG+G F +V A+H TG++VA+K + G RE++I+++L
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 104 HPNIVKLFQVIET--------EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIV 155
H N+V L ++ T + ++YLV ++ + + E + + ++
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-----NKLDTFCGSPPY 210
+ + Y H+ KI+HRD+KA N+L+ + +K+ADFG + F+ N+ + Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----- 265
PEL G++ GP +D+W G I+ + + S G+T + + + I
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 266 ---------------------------FYMSTDCENLLKKFLVLNPAKRASLE 291
+ +L+ K LVL+PA+R +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-24
Identities = 27/116 (23%), Positives = 52/116 (44%), Gaps = 5/116 (4%)
Query: 482 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541
+ ++YLV ++ + + E + + +++ + Y H+ KI+HRD+KA
Sbjct: 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAA 146
Query: 542 NLLLDSEMNIKIADFGFSNEFTPG-----NKLDTFCGSPPYAAPELFQGGAPVTSS 592
N+L+ + +K+ADFG + F+ N+ + Y PEL G
Sbjct: 147 NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 230 bits (587), Expect = 8e-71
Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY L+ IG+G + V A++ G+ A+K I + + G RE+ I+K L H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IVKL+ VI T+K L LV E+ V G ++ A++ Q+++ + YCH +++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRDLK +NLL++ E +KIADFG + F P K + Y AP++ G K
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY----------------------- 262
+D+WS+G I +V+G+ F G + + R+ R
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 263 ------RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
+ +LL K L L+P +R + +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (249), Expect = 5e-24
Identities = 39/120 (32%), Positives = 67/120 (55%), Gaps = 1/120 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++KL+ VI T+K L LV E+ V G ++ A++ Q+++ + YCH +++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
+HRDLK +NLL++ E +KIADFG + F P K + Y AP++ G +++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 9e-71
Identities = 58/249 (23%), Positives = 116/249 (46%), Gaps = 10/249 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
LK +G G F VK K +VAIK+I + ++ + E ++M L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKL 61
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKI 166
V+L+ V ++ ++++ EY + G + +YL R + ++ + + A++Y K+
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQGKKYDGP 224
+HRDL A N L++ + +K++DFG S + ++ PE+ K+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-S 180
Query: 225 EVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKKFLVL 282
+ D+W+ GV+++ + S G +P++ T E E + +G P S ++
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240
Query: 283 NPAKRASLE 291
+R + +
Sbjct: 241 KADERPTFK 249
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-26
Identities = 26/116 (22%), Positives = 57/116 (49%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKK 532
L++L+ V ++ ++++ EY + G + +YL R + ++ + + A++Y K+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQGG 586
+HRDL A N L++ + +K++DFG S + ++ PE+
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 2e-69
Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 31/276 (11%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
++ ++ IG+G + V A++ TG+ VA+K I G RE+ ++K L+HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 107 IVKLFQVIETEKTLYLVMEYAS-GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 165
IVKL VI TE LYLV E+ + F + ++ Q++ + +CH +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 166 IIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYDGP 224
++HRDLK +NLL+++E IK+ADFG + F P + Y APE+ G KY
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 225 EVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR-----------GKYRIPFY------ 267
VD+WSLG I +V+ F G + + R+ R G +P Y
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 268 ------------MSTDCENLLKKFLVLNPAKRASLE 291
+ D +LL + L +P KR S +
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 2/115 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYAS-GGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK 532
++KL VI TE LYLV E+ + F + ++ Q++ + +CH +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGG 586
++HRDLK +NLL+++E IK+ADFG + F P + Y APE+ G
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 2e-69
Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 32/274 (11%)
Query: 50 LLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDK---TQLNPGSLQKLFREVRIMKMLDHPN 106
L +G+G FA V A+ T + VAIK I ++ G + RE+++++ L HPN
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
I+ L + + LV ++ + +A + ++Y HQ I
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQGKKYDGPE 225
+HRDLK NLLLD +K+ADFG + F N+ T + Y APEL G + G
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 226 VDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY----------------------- 262
VD+W++G IL L+ G + + R+
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 263 -----RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
I D +L++ + NP R +
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-24
Identities = 32/120 (26%), Positives = 49/120 (40%), Gaps = 1/120 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
++ L + + LV ++ + +A + ++Y HQ I
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT-FCGSPPYAAPELFQGGAPVTSS 592
+HRDLK NLLLD +K+ADFG + F N+ T + Y APEL G
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-68
Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 43/286 (15%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
+Y L IG+G + V A VAIK I + + Q+ RE++I+ H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHE 66
Query: 106 NIVKLFQVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 160
NI+ + +I K +YLV G +++ L + QI+ ++Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHL-MGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 161 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELF 216
H ++HRDLK NLLL++ ++KI DFG + P + L + + Y APE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-------------- 262
K +D+WS+G IL ++S F G + +L
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 263 -----------------RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
R+ + +LL K L NP KR +E
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 8e-23
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 474 LLKLFQVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 528
++ + +I K +YLV G +++ L + QI+ ++Y
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHL-MGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELFQ 584
H ++HRDLK NLLL++ ++KI DFG + P + L + + Y APE+
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 585 GGAPVTSS 592
T S
Sbjct: 186 NSKGYTKS 193
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (569), Expect = 4e-68
Identities = 61/263 (23%), Positives = 108/263 (41%), Gaps = 14/263 (5%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE---VAIKIIDKTQLNPGSLQKLFREVR 97
E I K+ + IG G F +V GK VAIK + + E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEAS 79
Query: 98 IMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVS 156
IM DHPN++ L V+ + ++ E+ G + +L + G+ + R I +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF------CGSPPY 210
++Y +HRDL A N+L++S + K++DFG S T+ +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYM 268
APE Q +K+ DVWS G++++ ++S G P+ T +++ + + + P
Sbjct: 200 TAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 258
Query: 269 STDCENLLKKFLVLNPAKRASLE 291
+ L+ + R
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFG 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 7e-26
Identities = 28/126 (22%), Positives = 54/126 (42%), Gaps = 7/126 (5%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
++ L V+ + ++ E+ G + +L + G+ + R I + ++Y
Sbjct: 89 VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 148
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF------CGSPPYAAPELFQGG 586
+HRDL A N+L++S + K++DFG S T+ + APE Q
Sbjct: 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 208
Query: 587 APVTSS 592
++S
Sbjct: 209 KFTSAS 214
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 6e-68
Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 37/280 (13%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGK-----EVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+ K +G G F KV A K +VA+K++ + + + + L E+++M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQ 96
Query: 102 L-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--------------------- 139
L H NIV L +YL+ EY G++ +YL
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 140 --GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197
+ ++ Q+ +++ K +HRDL A N+L+ +KI DFG + +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 198 GNKL---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLREL 253
+ + APE Y + DVWS G++L+ + S G P+ G +
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 254 RERVLRGKYR--IPFYMSTDCENLLKKFLVLNPAKRASLE 291
++++ ++ PFY + + +++ + KR S
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-27
Identities = 27/145 (18%), Positives = 49/145 (33%), Gaps = 26/145 (17%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-----------------------GRMK 510
++ L +YL+ EY G++ +YL +
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 511 EKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL-- 568
++ Q+ +++ K +HRDL A N+L+ +KI DFG + + +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 222
Query: 569 -DTFCGSPPYAAPELFQGGAPVTSS 592
+ APE G S
Sbjct: 223 RGNARLPVKWMAPESLFEGIYTIKS 247
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-67
Identities = 63/251 (25%), Positives = 118/251 (47%), Gaps = 12/251 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KL++ +G G F +V + + +VA+K + + ++P E +MK L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQR 69
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--FRQIVSAVQYCHQK 164
+V+L+ V+ T++ +Y++ EY G + D+L +K + QI + + ++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGKKYD 222
IHRDL+A N+L+ ++ KIADFG + + + APE +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 223 GPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFL 280
+ DVWS G++L +V+ G +P+ G T E+ + + RG + P + L++
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 281 VLNPAKRASLE 291
P R + +
Sbjct: 248 KERPEDRPTFD 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-24
Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 5/123 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAK--FRQIVSAVQYCHQK 531
L++L+ V+ T++ +Y++ EY G + D+L +K + QI + + ++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPV 589
IHRDL+A N+L+ ++ KIADFG + + + APE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 590 TSS 592
S
Sbjct: 189 IKS 191
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 221 bits (564), Expect = 2e-67
Identities = 66/252 (26%), Positives = 114/252 (45%), Gaps = 12/252 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+ +G G + +V VA+K + + + +++ +E +MK + HPN
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPN 74
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 164
+V+L V E Y++ E+ + G + DYL R + + QI SA++Y +K
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS---PPYAAPELFQGKKY 221
IHRDL A N L+ +K+ADFG S G+ G+ + APE K+
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 222 DGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKF 279
+ DVW+ GV+L+ + + G P+ G L ++ E + + + P L++
Sbjct: 194 S-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252
Query: 280 LVLNPAKRASLE 291
NP+ R S
Sbjct: 253 WQWNPSDRPSFA 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.0 bits (246), Expect = 2e-23
Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 6/118 (5%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF--RQIVSAVQYCHQK 531
L++L V E Y++ E+ + G + DYL R + + QI SA++Y +K
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGS---PPYAAPELFQGG 586
IHRDL A N L+ +K+ADFG S G+ G+ + APE
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-67
Identities = 71/260 (27%), Positives = 112/260 (43%), Gaps = 16/260 (6%)
Query: 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK--EVAIKIIDKTQLNPGSLQKLFREV 96
+RD I + +G GNF V+ + K +VAIK++ + +++ RE
Sbjct: 6 KRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-GTEKADTEEMMREA 60
Query: 97 RIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIV 155
+IM LD+P IV+L V + E L LVME A GG + +LV + Q+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD----TFCGSPPYA 211
++Y +K +HRDL A N+LL + KI+DFG S + +
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 212 APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKY-RIPFYMS 269
APE +K+ DVWS GV ++ +S G P+ E+ + +GK P
Sbjct: 180 APECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238
Query: 270 TDCENLLKKFLVLNPAKRAS 289
+ L+ + R
Sbjct: 239 PELYALMSDCWIYKWEDRPD 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 34/124 (27%), Positives = 52/124 (41%), Gaps = 6/124 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+++L V + E L LVME A GG + +LV + Q+ ++Y +K
Sbjct: 71 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD----TFCGSPPYAAPELFQGGAP 588
+HRDL A N+LL + KI+DFG S + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 589 VTSS 592
+ S
Sbjct: 190 SSRS 193
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 2e-67
Identities = 73/298 (24%), Positives = 132/298 (44%), Gaps = 43/298 (14%)
Query: 31 SRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQ 90
R+E ++ + Y+ L+ +G G + V A TG +VAIK + + + +
Sbjct: 5 YRQEVTKTAWEVRA--VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 62
Query: 91 KLFREVRIMKMLDHPNIVKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKE 144
+ +RE+R++K + H N++ L V ++TL YLVM + G L+ H ++ E
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE 120
Query: 145 KEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTF 204
+ Q++ ++Y H IIHRDLK NL ++ + +KI DFG + + +++ +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGY 178
Query: 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI 264
+ Y APE+ VD+WS+G I+ +++G F GS + + +++
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238
Query: 265 PFYM-------------------------------STDCENLLKKFLVLNPAKRASLE 291
P S NLL+K LVL+ +R +
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 4e-20
Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 10/125 (8%)
Query: 474 LLKLFQVIETEKTL------YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQY 527
++ L V ++TL YLVM + G L+ H ++ E + Q++ ++Y
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 528 CHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587
H IIHRDLK NL ++ + +KI DFG + + +++ + + Y APE+
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWM 194
Query: 588 PVTSS 592
T +
Sbjct: 195 RYTQT 199
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 4e-67
Identities = 65/256 (25%), Positives = 109/256 (42%), Gaps = 14/256 (5%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLD 103
+LL+ +G G+F V+ + VA+K + L+ P ++ REV M LD
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCH 162
H N+++L+ V+ T + +V E A G + D L H G Q+ + Y
Sbjct: 70 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQG 218
K+ IHRDL A NLLL + +KI DFG + + + APE +
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 219 KKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYRIPF--YMSTDCENL 275
+ + D W GV L+ + + G P+ G ++ ++ + R+P D N+
Sbjct: 189 RTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 276 LKKFLVLNPAKRASLE 291
+ + P R +
Sbjct: 248 MVQCWAHKPEDRPTFV 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 2e-22
Identities = 33/118 (27%), Positives = 49/118 (41%), Gaps = 6/118 (5%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
L++L+ V+ T + +V E A G + D L H G Q+ + Y K+
Sbjct: 73 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGG 586
IHRDL A NLLL + +KI DFG + + + APE +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 6e-67
Identities = 83/258 (32%), Positives = 144/258 (55%), Gaps = 13/258 (5%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHV---PTGKEVAIKIIDKTQL--NPGSLQKLFREVRIM 99
I ++LLK +G G + KV L + + TGK A+K++ K + + + E +++
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 100 KMLDH-PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
+ + P +V L +TE L+L+++Y +GGE+F +L R E E + +IV A+
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP--GNKLDTFCGSPPYAAPELF 216
++ H+ II+RD+K EN+LLDS ++ + DFG S EF + FCG+ Y AP++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 217 QGKKY-DGPEVDVWSLGVILYTLVSGSLPFDG----STLRELRERVLRGKYRIPFYMSTD 271
+G VD WSLGV++Y L++G+ PF ++ E+ R+L+ + P MS
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 272 CENLLKKFLVLNPAKRAS 289
++L+++ L+ +P KR
Sbjct: 263 AKDLIQRLLMKDPKKRLG 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 3e-21
Identities = 44/115 (38%), Positives = 70/115 (60%), Gaps = 2/115 (1%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
L+ L +TE L+L+++Y +GGE+F +L R E E + +IV A+++ H+ I
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTP--GNKLDTFCGSPPYAAPELFQGG 586
I+RD+K EN+LLDS ++ + DFG S EF + FCG+ Y AP++ +GG
Sbjct: 151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 2e-66
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 10/249 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNI 107
++ IG G F V L +VAIK I + + S + E +M L HP +
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKL 62
Query: 108 VKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKI 166
V+L+ V + + LV E+ G + DYL + E + + Y + +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQGKKYDGP 224
IHRDL A N L+ IK++DFG + + +A+PE+F +Y
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-S 181
Query: 225 EVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFLVL 282
+ DVWS GV+++ + S G +P++ + E+ E + G + P ST ++
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241
Query: 283 NPAKRASLE 291
P R +
Sbjct: 242 RPEDRPAFS 250
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 9e-24
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 3/116 (2%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKK 532
L++L+ V + + LV E+ G + DYL + E + + Y +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT--FCGSPPYAAPELFQGG 586
+IHRDL A N L+ IK++DFG + + +A+PE+F
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 4e-66
Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 31/276 (11%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
KY+ L+ IG+G + V AK+ T + VA+K + + G RE+ ++K L H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 166
IV+L V+ ++K L LV E+ + +G + + ++ Q++ + +CH + +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 167 IHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGKKYDGPE 225
+HRDLK +NLL++ +K+A+FG + F P + Y P++ G K
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 226 VDVWSLGVILYTLVSGSLP-FDGSTLRELRERVLRGKYRIPFY----------------- 267
+D+WS G I L + P F G+ + + +R+ R
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 268 ------------MSTDCENLLKKFLVLNPAKRASLE 291
++ +LL+ L NP +R S E
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 3e-19
Identities = 29/120 (24%), Positives = 61/120 (50%), Gaps = 1/120 (0%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKI 533
+++L V+ ++K L LV E+ + +G + + ++ Q++ + +CH + +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 534 IHRDLKAENLLLDSEMNIKIADFGFSNEF-TPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
+HRDLK +NLL++ +K+A+FG + F P + Y P++ G ++S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 7e-66
Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 12/251 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+L +G+G F +V + VAIK + ++P + +E ++MK L H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 73
Query: 107 IVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQK 164
+V+L+ V+ E +Y+V EY S G + D+L ++ + QI S + Y +
Sbjct: 74 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 165 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGKKYD 222
+HRDL+A N+L+ + K+ADFG + + APE ++
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 223 GPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLLKKFL 280
+ DVWS G++L L + G +P+ G RE+ ++V RG + P +L+ +
Sbjct: 193 -IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 251
Query: 281 VLNPAKRASLE 291
P +R + E
Sbjct: 252 RKEPEERPTFE 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 6e-23
Identities = 33/123 (26%), Positives = 54/123 (43%), Gaps = 5/123 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR--MKEKEARAKFRQIVSAVQYCHQK 531
L++L+ V+ E +Y+V EY S G + D+L ++ + QI S + Y +
Sbjct: 74 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPV 589
+HRDL+A N+L+ + K+ADFG + + APE G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 590 TSS 592
S
Sbjct: 193 IKS 195
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-65
Identities = 61/253 (24%), Positives = 117/253 (46%), Gaps = 11/253 (4%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT---QLNPGSLQKLFREVRIMKMLDH 104
+K +K +G G F V +P G++V I + K +P + +++ E +M +D+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQ 163
P++ +L + T T+ L+ + G + DY+ H + + QI + Y
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 164 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKK 220
++++HRDL A N+L+ + ++KI DFG + K + + A E +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 221 YDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR-IPFYMSTDCENLLKK 278
Y + DVWS GV ++ L++ GS P+DG E+ + +G+ P + D ++ K
Sbjct: 190 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 279 FLVLNPAKRASLE 291
+++ R
Sbjct: 249 CWMIDADSRPKFR 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 1e-22
Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 5/117 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKK 532
+ +L + T T+ L+ + G + DY+ H + + QI + Y ++
Sbjct: 73 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGG 586
++HRDL A N+L+ + ++KI DFG + K + + A E
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 2e-65
Identities = 73/265 (27%), Positives = 111/265 (41%), Gaps = 23/265 (8%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGK--EVAIKIIDKTQLNPGSLQKLFREVRIMKML-DH 104
K IG+GNF +V A+ G + AIK + + + + E+ ++ L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHH 70
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEAR 148
PNI+ L E LYL +EYA G + D+L + ++
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 149 AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSP 208
+ + Y QK+ IHRDL A N+L+ KIADFG S K
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPF 266
+ A E Y DVWS GV+L+ +VS G P+ G T EL E++ +G + P
Sbjct: 191 RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249
Query: 267 YMSTDCENLLKKFLVLNPAKRASLE 291
+ +L+++ P +R S
Sbjct: 250 NCDDEVYDLMRQCWREKPYERPSFA 274
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-25
Identities = 34/135 (25%), Positives = 49/135 (36%), Gaps = 16/135 (11%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAK 517
++ L E LYL +EYA G + D+L + ++
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 518 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPY 577
+ + Y QK+ IHRDL A N+L+ KIADFG S K +
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 578 AAPELFQGGAPVTSS 592
A E T+S
Sbjct: 193 MAIESLNYSVYTTNS 207
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 66/253 (26%), Positives = 113/253 (44%), Gaps = 11/253 (4%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPT---GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD 103
+ +L + IG+G F V ++ VAIK + +K +E M+ D
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFD 66
Query: 104 HPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCH 162
HP+IVKL VI TE ++++ME + GE+ +L + + Q+ +A+ Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 163 QKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGKK 220
K+ +HRD+ A N+L+ S +K+ DFG S K + APE ++
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 221 YDGPEVDVWSLGVILYT-LVSGSLPFDGSTLRELRERVLRGKY-RIPFYMSTDCENLLKK 278
+ DVW GV ++ L+ G PF G ++ R+ G+ +P +L+ K
Sbjct: 186 FT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 279 FLVLNPAKRASLE 291
+P++R
Sbjct: 245 CWAYDPSRRPRFT 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 1e-22
Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 4/122 (3%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKK 532
++KL VI TE ++++ME + GE+ +L + + Q+ +A+ Y K+
Sbjct: 70 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVT 590
+HRD+ A N+L+ S +K+ DFG S K + APE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 591 SS 592
+S
Sbjct: 189 AS 190
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 71/282 (25%), Positives = 121/282 (42%), Gaps = 38/282 (13%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPT-GKEVAIKIIDKTQLNPGSLQKLFREVRIMKML--- 102
+Y+ + IG+G + KV A+ + G+ VA+K + G REV +++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 103 DHPNIVKLFQVIETEKT-----LYLVMEYASGGEV-FDYLVLHGRMKEKEARAKFRQIVS 156
+HPN+V+LF V +T L LV E+ + V + + + Q++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 157 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELF 216
+ + H +++HRDLK +N+L+ S IK+ADFG + ++ L + + Y APE+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 217 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY-------------- 262
Y VD+WS+G I + F GS+ + ++L
Sbjct: 188 LQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 263 -------------RIPFYMSTDCENLLKKFLVLNPAKRASLE 291
+ + ++LL K L NPAKR S
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 9e-22
Identities = 27/106 (25%), Positives = 50/106 (47%), Gaps = 1/106 (0%)
Query: 482 ETEKTLYLVMEYASGGEV-FDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540
+ E L LV E+ + V + + + Q++ + + H +++HRDLK
Sbjct: 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 144
Query: 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGG 586
+N+L+ S IK+ADFG + ++ L + + Y APE+
Sbjct: 145 QNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 190
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 3e-64
Identities = 73/290 (25%), Positives = 115/290 (39%), Gaps = 45/290 (15%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
D P Y K IG G+F V AK +G+ VAIK + + + + RE++IM+
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMR 68
Query: 101 MLDHPNIVKLFQVIET------EKTLYLVMEYASGG---EVFDYLVLHGRMKEKEARAKF 151
LDH NIV+L + E L LV++Y Y + +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPY 210
Q+ ++ Y H I HRD+K +NLLLD + +K+ DFG + + G ++ S Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 211 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLR----------- 259
APEL G +DVWS G +L L+ G F G + + +++
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 ------GKYRIPFY------------MSTDCENLLKKFLVLNPAKRASLE 291
+++ P + L + L P R +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 5e-21
Identities = 34/115 (29%), Positives = 51/115 (44%), Gaps = 4/115 (3%)
Query: 482 ETEKTLYLVMEYASGG---EVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 538
+ E L LV++Y Y + + Q+ ++ Y H I HRD+
Sbjct: 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDI 148
Query: 539 KAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSS 592
K +NLLLD + +K+ DFG + + G ++ S Y APEL G TSS
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 8e-64
Identities = 64/281 (22%), Positives = 121/281 (43%), Gaps = 39/281 (13%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN 106
+Y+ L +G G + V A TG VA+K + + + ++ +RE+R++K + H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 107 IVKLFQVIET-----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
++ L V E ++ + G + + +V ++ + + QI+ ++Y
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 162 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKY 221
H IIHRDLK NL ++ + +KI DFG + +++ + + Y APE+ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMH 195
Query: 222 DGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYM------------- 268
VD+WS+G I+ L++G F G+ + + +LR +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 269 ------------------STDCENLLKKFLVLNPAKRASLE 291
+ +LL+K LVL+ KR +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 4e-15
Identities = 27/124 (21%), Positives = 54/124 (43%), Gaps = 8/124 (6%)
Query: 474 LLKLFQVIET-----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 528
++ L V E ++ + G + + +V ++ + + QI+ ++Y
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 529 HQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588
H IIHRDLK NL ++ + +KI DFG + +++ + + Y APE+
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMH 195
Query: 589 VTSS 592
+
Sbjct: 196 YNQT 199
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (539), Expect = 9e-64
Identities = 69/279 (24%), Positives = 111/279 (39%), Gaps = 36/279 (12%)
Query: 47 KYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+ ++ IG+G F +V A+ VA+K++ + + + RE +M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAE 72
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR-------------------- 141
D+PNIVKL V K + L+ EY + G++ ++L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 142 ----MKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197
+ E RQ+ + + Y ++K +HRDL N L+ M +KIADFG S
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 198 GNKLD---TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL-PFDGSTLREL 253
+ + PE +Y E DVW+ GV+L+ + S L P+ G E+
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 254 RERVLRGKYR-IPFYMSTDCENLLKKFLVLNPAKRASLE 291
V G P + NL++ PA R S
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.5 bits (239), Expect = 2e-22
Identities = 30/137 (21%), Positives = 48/137 (35%), Gaps = 27/137 (19%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR------------------------MKE 511
KL V K + L+ EY + G++ ++L +
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 512 KEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD-- 569
E RQ+ + + Y ++K +HRDL N L+ M +KIADFG S +
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 199
Query: 570 -TFCGSPPYAAPELFQG 585
+ PE
Sbjct: 200 GNDAIPIRWMPPESIFY 216
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (532), Expect = 1e-62
Identities = 61/264 (23%), Positives = 101/264 (38%), Gaps = 25/264 (9%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
+Y+L + IG G+F + L + G+EVAIK+ +P +L E +I KM+
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGG 62
Query: 106 NIVKLFQVIETEKT-LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
+ + E +VME + + K Q++S ++Y H K
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 165 KIIHRDLKAENLL---LDSEMNIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAP 213
IHRD+K +N L + I DFG + ++ + G+ YA+
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 214 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GSTLRELRERVLRGKYRIPF---- 266
G + D+ SLG +L GSLP+ +T R+ ER+ K P
Sbjct: 183 NTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 267 -YMSTDCENLLKKFLVLNPAKRAS 289
++ L L +
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPD 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.1 bits (225), Expect = 1e-20
Identities = 24/128 (18%), Positives = 41/128 (32%), Gaps = 11/128 (8%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
+ +VME + + K Q++S ++Y H K IH
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 536 RDLKAENLL---LDSEMNIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQ 584
RD+K +N L + I DFG + ++ + G+ YA+
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 585 GGAPVTSS 592
G
Sbjct: 187 GIEQSRRD 194
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-62
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 31/274 (11%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKE-------VAIKIIDKTQLNPGSLQKLFREVRIM 99
+ L K +G+G F +V LA+ + K+ VA+K++ L L E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMM 72
Query: 100 KML-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----------------RM 142
KM+ H NI+ L + LY+++EYAS G + +YL ++
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 143 KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--- 199
K+ + Q+ ++Y KK IHRDL A N+L+ + +KIADFG + + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258
K + APE + Y + DVWS GV+L+ + + G P+ G + EL + +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 259 RG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLE 291
G + P + + +++ P++R + +
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 3e-20
Identities = 33/132 (25%), Positives = 56/132 (42%), Gaps = 19/132 (14%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAK 517
++ L + LY+++EYAS G + +YL ++ K+ +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 518 FRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGS 574
Q+ ++Y KK IHRDL A N+L+ + +KIADFG + + + K
Sbjct: 141 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200
Query: 575 PPYAAPELFQGG 586
+ APE
Sbjct: 201 VKWMAPEALFDR 212
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 208 bits (529), Expect = 6e-62
Identities = 63/287 (21%), Positives = 128/287 (44%), Gaps = 50/287 (17%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHP 105
Y+L++ +G+G +++V A ++ ++V +KI+ + +K+ RE++I++ L P
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGP 90
Query: 106 NIVKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ 163
NI+ L +++ +T LV E+ + + L+ + + + R +I+ A+ YCH
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQ---LYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 164 KKIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYD 222
I+HRD+K N+++D E +++ D+G + + PG + + S + PEL +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 223 GPEVDVWSLGVILYTLVSGSLPF-DGSTLRELRERVLR-----------GKYRIPFY--- 267
+D+WSLG +L +++ PF G + R+ + KY I
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 268 -----------------------MSTDCENLLKKFLVLNPAKRASLE 291
+S + + L K L + R +
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 100 bits (250), Expect = 1e-23
Identities = 29/122 (23%), Positives = 59/122 (48%), Gaps = 6/122 (4%)
Query: 474 LLKLFQVIE--TEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 531
++ L +++ +T LV E+ + + L+ + + + R +I+ A+ YCH
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQ---LYQTLTDYDIRFYMYEILKALDYCHSM 148
Query: 532 KIIHRDLKAENLLLDSE-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVT 590
I+HRD+K N+++D E +++ D+G + + PG + + S + PEL
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 591 SS 592
S
Sbjct: 209 YS 210
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 203 bits (516), Expect = 2e-60
Identities = 52/264 (19%), Positives = 99/264 (37%), Gaps = 27/264 (10%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH- 104
YK+ + IG+G+F + ++ ++VAIK + P +L E R K+L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGC 60
Query: 105 PNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQK 164
I ++ + LV++ + + K +Q+++ VQ H+K
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 165 KIIHRDLKAENLLLDSEM-----NIKIADFGFS--------NEFTPGNKLDTFCGSPPYA 211
+++RD+K +N L+ I + DFG + P + G+ Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 212 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKYRIPF-- 266
+ G++ D+ +LG + + GSLP+ G T ++ ER+ K P
Sbjct: 181 SINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 267 ---YMSTDCENLLKKFLVLNPAKR 287
+ + L
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 90.6 bits (224), Expect = 1e-20
Identities = 21/124 (16%), Positives = 44/124 (35%), Gaps = 13/124 (10%)
Query: 476 KLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIH 535
++ + LV++ + + K +Q+++ VQ H+K +++
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 536 RDLKAENLLLDSEM-----NIKIADFGFS--------NEFTPGNKLDTFCGSPPYAAPEL 582
RD+K +N L+ I + DFG + P + G+ Y +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 583 FQGG 586
G
Sbjct: 185 HLGR 188
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-60
Identities = 62/275 (22%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 47 KYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+ KT+G G F KV A VA+K++ + + + L E++++
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSY 82
Query: 102 L-DHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYL------------------VLHGRM 142
L +H NIV L ++ EY G++ ++L +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 143 KEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202
++ + Q+ + + K IHRDL A N+LL KI DFG + + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 203 T---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVL 258
+ APE Y E DVWS G+ L+ L S GS P+ G + +++
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 259 RGKYR--IPFYMSTDCENLLKKFLVLNPAKRASLE 291
+ +R P + + +++K +P KR + +
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 25/140 (17%), Positives = 45/140 (32%), Gaps = 21/140 (15%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYL------------------VLHGRMKEKEAR 515
++ L ++ EY G++ ++L + ++
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 516 AKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT---FC 572
+ Q+ + + K IHRDL A N+LL KI DFG + + +
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 573 GSPPYAAPELFQGGAPVTSS 592
+ APE S
Sbjct: 209 LPVKWMAPESIFNCVYTFES 228
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-59
Identities = 62/282 (21%), Positives = 119/282 (42%), Gaps = 14/282 (4%)
Query: 22 NISSSRLMSSRRESSRRERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP---TGKEVAIKI 78
+I S L ++ + P + IG+G+F V + A+K
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 79 IDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV-IETEKTLYLVMEYASGGEVFDYLV 137
+++ + G + + E IMK HPN++ L + + +E + +V+ Y G++ +++
Sbjct: 63 LNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 138 LHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196
+ F Q+ +++ KK +HRDL A N +LD + +K+ADFG + +
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181
Query: 197 PGNKLDTFC-----GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTL 250
+ A E Q +K+ + DVWS GV+L+ L++ G+ P+
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNT 240
Query: 251 RELRERVLRGKYR-IPFYMSTDCENLLKKFLVLNPAKRASLE 291
++ +L+G+ P Y ++ K R S
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 26/118 (22%), Positives = 49/118 (41%), Gaps = 6/118 (5%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF-RQIVSAVQYCHQKKIIHRDLK 539
+ +E + +V+ Y G++ +++ + F Q+ +++ KK +HRDL
Sbjct: 98 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 157
Query: 540 AENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC-----GSPPYAAPELFQGGAPVTSS 592
A N +LD + +K+ADFG + + + A E Q T S
Sbjct: 158 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 215
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-59
Identities = 72/295 (24%), Positives = 121/295 (41%), Gaps = 52/295 (17%)
Query: 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH 104
+ +Y+ LK IG G V A + VAIK + + N ++ +RE+ +MK ++H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 105 PNIVKLFQVIETEKT------LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAV 158
NI+ L V +KT +YLVME V+ + + Q++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN---LCQVIQMELDHERMSYLLYQMLCGI 132
Query: 159 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 218
++ H IIHRDLK N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 219 KKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP------------- 265
Y VD+WS+G I+ +V + F G + +V+
Sbjct: 193 MGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 266 -----------------------------FYMSTDCENLLKKFLVLNPAKRASLE 291
++ +LL K LV++PAKR S++
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (211), Expect = 1e-18
Identities = 28/105 (26%), Positives = 49/105 (46%), Gaps = 3/105 (2%)
Query: 481 IETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540
+E + +YLVME V+ + + Q++ +++ H IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147
Query: 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQG 585
N+++ S+ +KI DFG + + + + Y APE+ G
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-58
Identities = 60/262 (22%), Positives = 103/262 (39%), Gaps = 13/262 (4%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKE----VAIKIIDKTQLNPGSLQKLFREV 96
E H K IG G F +V + + VAIK + E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEA 60
Query: 97 RIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIV 155
IM H NI++L VI K + ++ EY G + +L G + R I
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 156 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT----FCGSPPYA 211
+ ++Y +HRDL A N+L++S + K++DFG S + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 212 APELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMS 269
APE +K+ DVWS G++++ +++ G P+ + E+ + + G + P
Sbjct: 181 APEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 270 TDCENLLKKFLVLNPAKRASLE 291
+ L+ + A+R
Sbjct: 240 SAIYQLMMQCWQQERARRPKFA 261
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 3e-21
Identities = 29/124 (23%), Positives = 52/124 (41%), Gaps = 5/124 (4%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKK 532
+++L VI K + ++ EY G + +L G + R I + ++Y
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT----FCGSPPYAAPELFQGGAP 588
+HRDL A N+L++S + K++DFG S + + APE
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190
Query: 589 VTSS 592
++S
Sbjct: 191 TSAS 194
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-56
Identities = 53/265 (20%), Positives = 103/265 (38%), Gaps = 22/265 (8%)
Query: 47 KYKLLKTIGKGNFAKVKLAKH-----VPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
K + + +G+G+F V VAIK +++ + + E +MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKE 79
Query: 102 LDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR----------MKEKEARAKF 151
+ ++V+L V+ + ++ME + G++ YL +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL---DTFCGSP 208
+I + Y + K +HRDL A N ++ + +KI DFG + + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 209 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS-LPFDGSTLRELRERVLRGKYR-IPF 266
+ +PE + + DVWS GV+L+ + + + P+ G + ++ V+ G P
Sbjct: 200 RWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 267 YMSTDCENLLKKFLVLNPAKRASLE 291
L++ NP R S
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFL 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 4e-19
Identities = 24/126 (19%), Positives = 49/126 (38%), Gaps = 13/126 (10%)
Query: 474 LLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGR----------MKEKEARAKFRQIVS 523
+++L V+ + ++ME + G++ YL + +I
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKL---DTFCGSPPYAAP 580
+ Y + K +HRDL A N ++ + +KI DFG + + + + +P
Sbjct: 145 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 581 ELFQGG 586
E + G
Sbjct: 205 ESLKDG 210
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-55
Identities = 60/290 (20%), Positives = 102/290 (35%), Gaps = 50/290 (17%)
Query: 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHP 105
L ++IGKG F +V K G+EVA+KI + + E+ ML H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHE 57
Query: 106 NIVKLFQVIETE----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYC 161
NI+ + L+LV +Y G +FDYL + + S + +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116
Query: 162 HQ--------KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-----KLDTFCGSP 208
H I HRDLK++N+L+ IAD G + + G+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 209 PYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGS--------------- 248
Y APE+ D++++G++ + +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 249 TLRELRERVLRGKYRIPF---YMSTDCENLLKKF----LVLNPAKRASLE 291
++ E+R+ V K R + S + ++ K N A R +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-23
Identities = 29/130 (22%), Positives = 46/130 (35%), Gaps = 18/130 (13%)
Query: 474 LLKLFQVIETE----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH 529
+L + L+LV +Y G +FDYL + + S + + H
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLH 117
Query: 530 Q--------KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-----KLDTFCGSPP 576
I HRDLK++N+L+ IAD G + + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 577 YAAPELFQGG 586
Y APE+
Sbjct: 178 YMAPEVLDDS 187
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-55
Identities = 59/273 (21%), Positives = 109/273 (39%), Gaps = 29/273 (10%)
Query: 47 KYKLLKTIGKGNFAKVKLAK-----HVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKM 101
+ KL K +G+G F +V A T + VA+K++ + + + ++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 102 LDHPNIVKLFQVI-ETEKTLYLVMEYASGGEVFDYLVLHGR----------------MKE 144
H N+V L + L +++E+ G + YL +
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 145 KEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KL 201
+ Q+ +++ +K IHRDL A N+LL + +KI DFG + + +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-SLPFDGSTLRELRERVLRG 260
+ APE + Y + DVWS GV+L+ + S + P+ G + E R L+
Sbjct: 194 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 261 KYR--IPFYMSTDCENLLKKFLVLNPAKRASLE 291
R P Y + + + P++R +
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 285
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 1e-19
Identities = 24/126 (19%), Positives = 44/126 (34%), Gaps = 19/126 (15%)
Query: 480 VIETEKTLYLVMEYASGGEVFDYLVLHGR----------------MKEKEARAKFRQIVS 523
+ L +++E+ G + YL + + Q+
Sbjct: 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 145
Query: 524 AVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAP 580
+++ +K IHRDL A N+LL + +KI DFG + + + + AP
Sbjct: 146 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205
Query: 581 ELFQGG 586
E
Sbjct: 206 ETIFDR 211
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (412), Expect = 4e-45
Identities = 62/322 (19%), Positives = 120/322 (37%), Gaps = 77/322 (23%)
Query: 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK 100
+ +Y L++ +G G+F+ V LAK + VA+KI+ ++ + E+++++
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---EAAEDEIKLLQ 64
Query: 101 MLDHPN-----------IVKLFQVIET--EKTLYLVMEYASGGEVFDYLVL---HGRMKE 144
++ + I+KL +++VM + GE L+ H +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 145 KEARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSE------MNIKIADFGFSNEFTP 197
+ +Q++ + Y H++ IIH D+K EN+L++ + IKIAD G + +
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELR--- 254
+ Y +PE+ G + D+WS +++ L++G F+
Sbjct: 185 HY--TNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 255 ---------------------------------------------ERVLRGKYRIPFYMS 269
E VL KY+ +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 270 TDCENLLKKFLVLNPAKRASLE 291
+ + L L L+P KRA
Sbjct: 302 KEISDFLSPMLQLDPRKRADAG 323
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 61.2 bits (147), Expect = 1e-10
Identities = 33/146 (22%), Positives = 62/146 (42%), Gaps = 14/146 (9%)
Query: 459 SNAKPSRRASSGGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVL---HGRMKEKE 513
++A ++ S G +LKL +++VM + GE L+ H +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 514 ARAKFRQIVSAVQYCHQK-KIIHRDLKAENLLLDSE------MNIKIADFGFSNEFTPGN 566
+ +Q++ + Y H++ IIH D+K EN+L++ + IKIAD G + +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 567 KLDTFCGSPPYAAPELFQGGAPVTSS 592
+ Y +PE+ G +
Sbjct: 187 --TNSIQTREYRSPEVLLGAPWGCGA 210
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 114 bits (285), Expect = 1e-29
Identities = 33/201 (16%), Positives = 62/201 (30%), Gaps = 32/201 (15%)
Query: 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----------------GSLQK 91
+ K +G+G + V E +K + +++
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 92 LFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKF 151
E R ++ L + K++ ++ME E R++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKE-------LYRVRVENPDEVL 109
Query: 152 RQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYA 211
I+ V + + I+H DL N+L+ E I I DF S E +
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREIL--ERDVR 166
Query: 212 APELFQGKKYDGPEVDVWSLG 232
+ + Y E D+ S
Sbjct: 167 NIITYFSRTY-RTEKDINSAI 186
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.0 bits (160), Expect = 5e-13
Identities = 19/84 (22%), Positives = 31/84 (36%), Gaps = 8/84 (9%)
Query: 488 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547
++ME E R++ + I+ V + + I+H DL N+L+
Sbjct: 86 AVLMELIDAKE-------LYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS- 137
Query: 548 EMNIKIADFGFSNEFTPGNKLDTF 571
E I I DF S E +
Sbjct: 138 EEGIWIIDFPQSVEVGEEGWREIL 161
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 708 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.96 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.96 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.95 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.95 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.95 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.95 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.95 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.95 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.95 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.94 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.94 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.94 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.93 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.93 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.93 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.93 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.93 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.92 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.92 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.92 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.92 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.92 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.92 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.91 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.91 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.91 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.91 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.91 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.91 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.9 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.9 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.9 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.9 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.9 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.9 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.9 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.89 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.89 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.89 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.89 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.88 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.88 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.88 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.88 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.88 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.88 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.87 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.87 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.73 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.95 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.41 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.17 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 94.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 92.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 83.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 82.07 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-60 Score=491.49 Aligned_cols=252 Identities=35% Similarity=0.646 Sum_probs=234.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+++|++++.||+|+||+||+|+++.+++.||||++.+.... ....+.+.+|+++|+.++|||||++++++++++.+|||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 67899999999999999999999999999999999765432 23356688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||||++|+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.... .....
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-~~~~~ 163 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTT 163 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-CCCEE
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-Ccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999976543 34567
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
.+||+.|||||++.+..|+ +++|||||||+||+|++|+.||.+.+..++.+++.++.+.+|..+|+++++||.+||+.|
T Consensus 164 ~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp TTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCC
Confidence 8999999999999998885 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHh---hhhh
Q psy2648 284 PAKRASLEVSG---EVTL 298 (708)
Q Consensus 284 P~~Rps~~~~~---~~~~ 298 (708)
|++|||+++++ |+..
T Consensus 243 p~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 243 PSQRPMLREVLEHPWITA 260 (263)
T ss_dssp GGGSCCHHHHHTCHHHHH
T ss_pred HhHCcCHHHHHcCcCcCC
Confidence 99999999998 7753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=491.01 Aligned_cols=248 Identities=35% Similarity=0.636 Sum_probs=227.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+++|++++|||||++++++++++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976532 2234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC---CCc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---NKL 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~---~~~ 201 (708)
|||+||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||+++++.+||+|||+|+.+... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876432 234
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 281 (708)
.+.+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..++.++|.++.+.+|..+|+++++||++||+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 246 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSC
T ss_pred ccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 567899999999999998885 7999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCCHHHHh
Q psy2648 282 LNPAKRASLEVSG 294 (708)
Q Consensus 282 ~dP~~Rps~~~~~ 294 (708)
+||.+|||++++.
T Consensus 247 ~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 247 LDATKRLGCEEME 259 (288)
T ss_dssp SSGGGSTTSGGGT
T ss_pred CCHhHCcCHHHHc
Confidence 9999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=487.79 Aligned_cols=254 Identities=35% Similarity=0.577 Sum_probs=219.5
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
|.+++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+.+|+++|+.++|||||++++++++++.+||
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 5688999999999999999999999999999999999865432 234568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC---C
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG---N 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~---~ 199 (708)
|||||+||+|.++|..++.+++.+++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+..... .
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999999876432 2
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCC--CCCCCHHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR-ELRERVLRGKYRI--PFYMSTDCENLL 276 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~-~l~~~i~~~~~~~--p~~~s~~~~~Li 276 (708)
...+.+||+.|||||++.+..|++.++|||||||+||+|++|+.||...+.. .....+....... +..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 3456799999999999999888778899999999999999999999875432 2333333333222 235799999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
++||+.||++|||+++++ |++
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred HHHcCCChhHCcCHHHHhcCHhhC
Confidence 999999999999999987 664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=495.18 Aligned_cols=254 Identities=35% Similarity=0.594 Sum_probs=235.7
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
..+++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++++++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 357789999999999999999999999999999999986543 2234567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCC
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~ 200 (708)
||||||+||+|.+++...+.++|.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999987543 455
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhh
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L 280 (708)
..+.|||+.|+|||++.+..|+ +++|||||||+||+|++|+.||.+.+..++.+++..+.+.+|..+|+++++||++||
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhc
Confidence 6778999999999999999984 899999999999999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCC-----HHHHh---hhh
Q psy2648 281 VLNPAKRAS-----LEVSG---EVT 297 (708)
Q Consensus 281 ~~dP~~Rps-----~~~~~---~~~ 297 (708)
++||.+|++ +++++ |+.
T Consensus 241 ~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred cCCchhhcccccccHHHHHcCcccc
Confidence 999999995 77776 664
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-58 Score=478.77 Aligned_cols=249 Identities=31% Similarity=0.597 Sum_probs=216.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET--EKTLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~yl 122 (708)
.++|++++.||+|+||+||+|+++.+|+.||||++++...+....+.+.+|+++|++++|||||++++++.+ ++.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 467999999999999999999999999999999999887777777889999999999999999999999864 456899
Q ss_pred EEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 123 VMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKK-----IIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~QI~~aL~yLH~~g-----IvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
|||||++|+|.+++.. ...+++.+++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 357999999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCC-CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHH
Q psy2648 194 EFTPG-NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR-IPFYMSTD 271 (708)
Q Consensus 194 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~-~p~~~s~~ 271 (708)
.+... ....+.+||+.|||||++.+..|+ +++|||||||+||+|++|+.||.+.+..++..+|..+.+. +|..+|++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 76543 334578999999999999988885 8999999999999999999999999999999999988764 67789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+.+||++||+.||.+|||+++++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999999886
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-58 Score=486.08 Aligned_cols=248 Identities=38% Similarity=0.617 Sum_probs=209.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
.+.|++.+.||+|+||+||+|+++.+++.||||++.+..... ..+.+.+|+++|+.++|||||++++++++++.+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467999999999999999999999999999999998765432 2356789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---CCCcEEEEeccCccccCCCCCc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD---SEMNIKIADFGFSNEFTPGNKL 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld---~~~~iKL~DFGls~~~~~~~~~ 201 (708)
|||+||+|.++|..++.+++.+++.++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+....+...
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999999999889999999999999999999999999999999999999995 5789999999999877766667
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENLLK 277 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~Li~ 277 (708)
.+.+||+.|||||++.+..|+ +++|||||||+||+|++|+.||.+.+..++...|..+.+.++ ..+|+++.+||+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 245 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245 (307)
T ss_dssp ------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHH
Confidence 788999999999999998885 899999999999999999999999999999999999877654 468999999999
Q ss_pred HhhhhCCCCCCCHHHHh
Q psy2648 278 KFLVLNPAKRASLEVSG 294 (708)
Q Consensus 278 ~~L~~dP~~Rps~~~~~ 294 (708)
+||++||.+|||+++++
T Consensus 246 ~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 246 HLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp HHSCSSGGGSCCHHHHH
T ss_pred HHccCCHhHCcCHHHHh
Confidence 99999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=478.53 Aligned_cols=249 Identities=30% Similarity=0.521 Sum_probs=222.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+++|+.++|||||++++++++++.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999999999999999999865432 34678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCcccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTF 204 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~ 204 (708)
||+||+|.+++. ++.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+... ......
T Consensus 98 y~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 999999998765 467999999999999999999999999999999999999999999999999999876543 345677
Q ss_pred ccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-C--CCCCCCCCHHHHHHHHHhhh
Q psy2648 205 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG-K--YRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 205 ~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~-~--~~~p~~~s~~~~~Li~~~L~ 281 (708)
+||+.|+|||++.+..|+ +++|||||||+||+|++|+.||.+.+..+....+... . +..|..+|+++++||.+||+
T Consensus 177 ~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred ccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 899999999999998885 7999999999999999999999998877766665543 3 33456789999999999999
Q ss_pred hCCCCCCCHHHHh---hhhh
Q psy2648 282 LNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 282 ~dP~~Rps~~~~~---~~~~ 298 (708)
.||.+|||+++++ |++.
T Consensus 256 ~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 256 MDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp SSTTTSCCHHHHTTCGGGGG
T ss_pred CChhHCcCHHHHhcCHhhCC
Confidence 9999999999987 7754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-57 Score=473.92 Aligned_cols=253 Identities=35% Similarity=0.573 Sum_probs=233.1
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.-++|++++.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+++|++|+|||||++++++++++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3467999999999999999999999999999999998765422 245678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----cEEEEeccCcccc
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM----NIKIADFGFSNEF 195 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~----~iKL~DFGls~~~ 195 (708)
+|||||||+||+|.++|...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999999999999999999999999999999999999999999999999876 4999999999888
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTD 271 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~ 271 (708)
..+....+.+||+.|+|||++.+..| +.++|||||||+||+|++|+.||.+.+..++...|..+.+.+| ..+|++
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 77777778899999999999998877 4899999999999999999999999999999999999887654 568999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 272 CENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 272 ~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+++||++||+.||.+|||+++++ |++
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 99999999999999999999987 664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-57 Score=480.43 Aligned_cols=250 Identities=30% Similarity=0.602 Sum_probs=231.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
+.+|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++++++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 5689999999999999999999999999999999976532 223456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDT 203 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~ 203 (708)
||||+||+|..++.....+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ...+
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~~ 160 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT 160 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--cccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987543 3457
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhhhC
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 283 (708)
.+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..++..+|..+.+.+|..+++++.++|.+||++|
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred ccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhC
Confidence 8999999999999998886 799999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----CHHHHh---hhh
Q psy2648 284 PAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 284 P~~Rp-----s~~~~~---~~~ 297 (708)
|.+|+ |+++++ |+.
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~ 261 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFK 261 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGS
T ss_pred HHhccccchhhHHHHHcCcccc
Confidence 99996 888887 664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=476.53 Aligned_cols=249 Identities=31% Similarity=0.485 Sum_probs=222.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
+.|++++.||+|+||+||+|+++.+++.||||++++.. ....+.+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46999999999999999999999999999999998653 3445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDT 203 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~ 203 (708)
||++|+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..... ....+
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 99999999998764 56999999999999999999999999999999999999999999999999999765322 23456
Q ss_pred cccCCccccccccc-----CCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHH
Q psy2648 204 FCGSPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR---IPFYMSTDCENL 275 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~-----~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~---~p~~~s~~~~~L 275 (708)
.+||+.|+|||++. +..| +.++|||||||+||+|++|+.||.+.+..++..++..+... .|..+|+++.+|
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 248 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 79999999999985 3345 47999999999999999999999999888888888887543 356789999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|++||+.||.+|||+++++ |+.
T Consensus 249 i~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 249 LKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred HHHHccCChhHCcCHHHHhcCcccC
Confidence 9999999999999999987 664
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=464.99 Aligned_cols=246 Identities=28% Similarity=0.474 Sum_probs=219.6
Q ss_pred CCe-EEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEE
Q psy2648 46 GKY-KLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET----EKTL 120 (708)
Q Consensus 46 ~~Y-~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 120 (708)
|+| ++.+.||+|+||+||+|++..+++.||||++..........+.+.+|+++|++++|||||++++++++ +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 355 77889999999999999999999999999998776666677789999999999999999999999976 3568
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEc-CCCcEEEEeccCccccCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKAENLLLD-SEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~g--IvHRDLKPeNILld-~~~~iKL~DFGls~~~~~ 197 (708)
|||||||++|+|.+++...+.+++.+++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+...
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence 999999999999999999999999999999999999999999999 99999999999996 57899999999997543
Q ss_pred CCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCC--CCCCCCHHHHH
Q psy2648 198 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS-TLRELRERVLRGKYR--IPFYMSTDCEN 274 (708)
Q Consensus 198 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~-~~~~l~~~i~~~~~~--~p~~~s~~~~~ 274 (708)
.....+.+||+.|||||++.+. |+ .++|||||||+||+|++|+.||.+. +..++.+.+..+..+ ++...++++.+
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~~-~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred CCccCCcccCccccCHHHhCCC-CC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 3445678999999999999764 64 8999999999999999999999764 567777888776543 45568899999
Q ss_pred HHHHhhhhCCCCCCCHHHHh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~ 294 (708)
||.+||+.||++|||+++++
T Consensus 245 li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHh
Confidence 99999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-56 Score=483.96 Aligned_cols=257 Identities=35% Similarity=0.616 Sum_probs=236.5
Q ss_pred cCCCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q psy2648 38 RERDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIET 116 (708)
Q Consensus 38 ~~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 116 (708)
.......+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++|||||++++++++
T Consensus 33 ~~~~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 34445668999999999999999999999999999999999976432 22345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
...+|+||||+.+|+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLL 276 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li 276 (708)
. ...+.+||+.|||||++.+..|+ +++|||||||+||+|++|+.||.+.+..++..+|..+.+.+|..+++++.+||
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 3 34568999999999999998885 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhhhhCCCCCC-----CHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRA-----SLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rp-----s~~~~~---~~~ 297 (708)
++||++||.+|+ |+++++ |+.
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~ 298 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred HHHhhhCHHhccccccccHHHHHcCcccc
Confidence 999999999995 888887 664
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-56 Score=483.28 Aligned_cols=253 Identities=28% Similarity=0.523 Sum_probs=231.1
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+++|++|+|||||++++++++++.+||
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34679999999999999999999999999999999997643 3445678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--CCcEEEEeccCccccCCCC
Q psy2648 123 VMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS--EMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~--~~~iKL~DFGls~~~~~~~ 199 (708)
|||||+||+|.+++.. .+.+++.+++.++.||+.||+|||++|||||||||+||||+. ++.+||+|||+++......
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999999854 467999999999999999999999999999999999999964 5789999999998877666
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENL 275 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~L 275 (708)
...+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..++...|..+.+.+|. .+|+++++|
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred ccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 67788999999999999998885 8999999999999999999999999999999999998876653 579999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
|.+||+.||.+|||+++++ |+..
T Consensus 260 i~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999988 6653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-56 Score=483.33 Aligned_cols=252 Identities=27% Similarity=0.500 Sum_probs=230.9
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
...++|++++.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+++|++|+|||||+++++|++++.+||
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34578999999999999999999999999999999997653 3345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--CCCcEEEEeccCccccCCCC
Q psy2648 123 VMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD--SEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld--~~~~iKL~DFGls~~~~~~~ 199 (708)
|||||+||+|++++...+ ++++.+++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999999999999876654 699999999999999999999999999999999999998 57899999999999887777
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDCENL 275 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~~~L 275 (708)
...+.+||+.|+|||++.+..|+ .++|||||||+||+|++|+.||.+.+..++..+|..+.+.+| ..+|+++.+|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 77788999999999999998885 899999999999999999999999999999999999887655 3689999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|++||++||.+|||+++++ |+.
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~ 287 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLK 287 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred HHHHccCChhHCcCHHHHhcCHhhC
Confidence 9999999999999999987 664
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.5e-56 Score=462.90 Aligned_cols=253 Identities=38% Similarity=0.635 Sum_probs=229.9
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-------hhHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-------GSLQKLFREVRIMKMLD-HPNIVKLFQVIET 116 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-------~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 116 (708)
.++|++.+.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+|++++ |||||++++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999999999999999998765431 12345789999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 117 EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
++.+|||||||+||+|.++|..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCccccccCCcccccccccCCc-----cCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----C
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKK-----YDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----Y 267 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~-----~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~ 267 (708)
.+......+||+.|+|||++.+.. ..++++||||+||+||+|++|+.||.+.+..++.+.+..+.+.+|. .
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 766667789999999999986422 2257899999999999999999999999999999999998876543 6
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
+|+++++||++||++||.+|||+++++ |++
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 899999999999999999999999987 664
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-56 Score=469.92 Aligned_cols=247 Identities=29% Similarity=0.415 Sum_probs=223.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.|++++.||+|+||+||+|++..+++.||||++.+.... ....+.+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999999999999999999876554 3455678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCccccc
Q psy2648 126 YASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFC 205 (708)
Q Consensus 126 y~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~~~~ 205 (708)
||.+|+|..++..++.+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.... ....+
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~ 172 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFV 172 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccc
Confidence 999999988888888999999999999999999999999999999999999999999999999999986543 34678
Q ss_pred cCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHhh
Q psy2648 206 GSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCENLLKKFL 280 (708)
Q Consensus 206 Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~--~p~~~s~~~~~Li~~~L 280 (708)
||+.|||||++.+. .| +.++|||||||++|+|++|..||.+.+..+...++..+... .+..+|+++.+||.+||
T Consensus 173 GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred cCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 99999999999653 35 47999999999999999999999999888888888777554 24468999999999999
Q ss_pred hhCCCCCCCHHHHh---hhh
Q psy2648 281 VLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 281 ~~dP~~Rps~~~~~---~~~ 297 (708)
+.||.+|||+++++ |+.
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHH
T ss_pred cCChhHCcCHHHHHhCHHhc
Confidence 99999999999987 775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=475.12 Aligned_cols=252 Identities=34% Similarity=0.582 Sum_probs=229.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHH-hCCCCCeeeEEEEEEeCCEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMK-MLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~yl 122 (708)
+++|++++.||+|+||+||+|+++.+++.||||++++... .....+.+.+|+.++. .++|||||++++++++++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 5789999999999999999999999999999999976432 1234566778888765 6899999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCc
Q psy2648 123 VMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKL 201 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~ 201 (708)
|||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+++++++||+|||+++.... ....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986543 3344
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhhh
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENLLKKFLV 281 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 281 (708)
...+||+.|+|||++.+..|+ +++|||||||++|+|++|+.||.+.+..++..+|..+.+.+|..+|+++.+||++||+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred cccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcc
Confidence 567999999999999999886 7999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCCHH-HHh---hhh
Q psy2648 282 LNPAKRASLE-VSG---EVT 297 (708)
Q Consensus 282 ~dP~~Rps~~-~~~---~~~ 297 (708)
+||.+|||++ +++ |+.
T Consensus 240 ~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGT
T ss_pred cCCCCCcCHHHHHHhCchhc
Confidence 9999999985 565 654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=471.58 Aligned_cols=250 Identities=25% Similarity=0.471 Sum_probs=230.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
..++|++++.||+|+||+||+|.++.+++.||||++++.. .....+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3578999999999999999999999999999999997653 3345678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--CcEEEEeccCccccCCCCC
Q psy2648 124 MEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE--MNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~--~~iKL~DFGls~~~~~~~~ 200 (708)
||||+||+|.++|...+ .++|.+++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999999998765 79999999999999999999999999999999999999854 4799999999988776666
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF----YMSTDCENLL 276 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~----~~s~~~~~Li 276 (708)
..+.+||+.|+|||.+.+..|+ +++|||||||++|+|++|..||.+.+..++..+|.++.+.+|. .+|+++++||
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 6778999999999999988875 8999999999999999999999999999999999999887764 6899999999
Q ss_pred HHhhhhCCCCCCCHHHHh---hhh
Q psy2648 277 KKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
++||++||.+|||+++++ |+.
T Consensus 239 ~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHccCChhHCcCHHHHhcCHhhc
Confidence 999999999999999987 775
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=476.98 Aligned_cols=252 Identities=27% Similarity=0.486 Sum_probs=216.0
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylV 123 (708)
.-++|++++.||+|+||+||+|+++.+|+.||||++++.. .+...+.+.+|+++|+.++|||||+++++|+++..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3468999999999999999999999999999999998653 344557789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCCcc
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLD 202 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~~~ 202 (708)
||||+||+|.+++.+.+.+++.+++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+.+.. ....
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~~~ 161 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMAN 161 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-HTC-
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-Cccc
Confidence 9999999999999999999999999999999999999997 5999999999999999999999999999986543 2345
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------------------------
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLREL----------------------------- 253 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l----------------------------- 253 (708)
+.+||+.|+|||++.+..|+ +++|||||||++|||++|+.||.+.+..+.
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred cccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 68999999999999999885 799999999999999999999987543221
Q ss_pred -------------HHHHHcCC-CCCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 254 -------------RERVLRGK-YRIP-FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 254 -------------~~~i~~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
...+.... ...| ...|.++.|||.+||+.||.+|||+++++ |+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 11111111 1122 13588999999999999999999999988 7753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8e-55 Score=472.32 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=220.3
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh-hhHHHHH---HHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP-GSLQKLF---REVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~-~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+. +|+++++.++|||||++++++++++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4678999999999999999999999999999999997653321 1122233 45777778899999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN 199 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~ 199 (708)
+|||||||+||+|.++|...+.+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST---LRELRERVLRGKYRIPFYMSTDCENLL 276 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~---~~~l~~~i~~~~~~~p~~~s~~~~~Li 276 (708)
.....+||+.|+|||++......++++|||||||+||+|++|+.||.+.+ ..++...+....+.+|..+|+++++||
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence 45667999999999999754433589999999999999999999998753 445666666677778889999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHh---hhh
Q psy2648 277 KKFLVLNPAKRAS-----LEVSG---EVT 297 (708)
Q Consensus 277 ~~~L~~dP~~Rps-----~~~~~---~~~ 297 (708)
.+||++||.+||| +++++ |+.
T Consensus 241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~ 269 (364)
T d1omwa3 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 269 (364)
T ss_dssp HHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred HHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence 9999999999999 57776 664
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-54 Score=452.72 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=215.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCC-ChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----EE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQL-NPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK----TL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 120 (708)
++|++.+.||+|+||+||+|++..+|+.||||++++... +....+++.+|+++|+.++|||||+++++++..+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 569999999999999999999999999999999987655 3455667899999999999999999999998654 48
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC--
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-- 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-- 198 (708)
|||||||+|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998754322
Q ss_pred --CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Q psy2648 199 --NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIP----FYMSTDC 272 (708)
Q Consensus 199 --~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p----~~~s~~~ 272 (708)
....+.+||+.|+|||++.+..|+ +++|||||||+||+|+||+.||.+.+..++..++..+....| ..+|+++
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 245 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245 (277)
T ss_dssp ------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred cccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 234567899999999999988885 799999999999999999999999998888888777765433 4689999
Q ss_pred HHHHHHhhhhCCCCCC-CHHHHh
Q psy2648 273 ENLLKKFLVLNPAKRA-SLEVSG 294 (708)
Q Consensus 273 ~~Li~~~L~~dP~~Rp-s~~~~~ 294 (708)
.+||.+||++||.+|| |++++.
T Consensus 246 ~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 246 DAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHHHccCCHhHCHhHHHHHH
Confidence 9999999999999999 788765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=453.84 Aligned_cols=247 Identities=29% Similarity=0.563 Sum_probs=219.9
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh----hhHHHHHHHHHHHHhCC--CCCeeeEEEEEEeC
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP----GSLQKLFREVRIMKMLD--HPNIVKLFQVIETE 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~ 117 (708)
.-++|++.+.||+|+||+||+|++..+|+.||||++++..... ....++.+|+.+|++++ |||||+++++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4578999999999999999999999999999999998754321 12234668999999997 89999999999999
Q ss_pred CEEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CcEEEEeccCcccc
Q psy2648 118 KTLYLVMEYASG-GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE-MNIKIADFGFSNEF 195 (708)
Q Consensus 118 ~~~ylVmEy~~g-g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~-~~iKL~DFGls~~~ 195 (708)
+.+|+||||+.+ +++.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 6888999888999999999999999999999999999999999999999854 78999999999765
Q ss_pred CCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy2648 196 TPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPFYMSTDCENL 275 (708)
Q Consensus 196 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~~~s~~~~~L 275 (708)
. .....+.+||+.|+|||++.+..+.+.++|||||||+||+|++|+.||.+. +.+.++...+|..+|+++.+|
T Consensus 162 ~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 162 K-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHL 234 (273)
T ss_dssp C-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHH
T ss_pred c-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHH
Confidence 4 334567899999999999988887777899999999999999999999763 356778888999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 276 LKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
|++||+.||++|||+++++ |++
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~~ 259 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWMQ 259 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhC
Confidence 9999999999999999987 664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=464.76 Aligned_cols=250 Identities=35% Similarity=0.556 Sum_probs=216.6
Q ss_pred CCCccCCeEEEe-EEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHH-hCCCCCeeeEEEEEEe--
Q psy2648 41 DEPHIGKYKLLK-TIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMK-MLDHPNIVKLFQVIET-- 116 (708)
Q Consensus 41 ~~~~~~~Y~i~~-~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~-- 116 (708)
....+++|+++. .||+|+||+||+|+++.+++.||||++++. ..+.+|+.++. .++|||||+++++|++
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 344578999875 699999999999999999999999999643 35678999875 4589999999999986
Q ss_pred --CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCcEEEEec
Q psy2648 117 --EKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADF 189 (708)
Q Consensus 117 --~~~~ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~~iKL~DF 189 (708)
+..+|||||||+||+|+++|..++ .++|.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 467999999999999999998753 6999999999999999999999999999999999999986 467999999
Q ss_pred cCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCCCCC
Q psy2648 190 GFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR----ELRERVLRGKYRIP 265 (708)
Q Consensus 190 Gls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~----~l~~~i~~~~~~~p 265 (708)
|+++.........+.+||+.|||||++.+..|+ +++|||||||+||+|++|+.||.+.+.. .+..++..+.+.+|
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred ceeeeccCCCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 999887777777788999999999999998885 8999999999999999999999876533 34455556666666
Q ss_pred C----CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 266 F----YMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 266 ~----~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
. .+|+++.+||++||++||++|||+++++ |+..
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 4 4789999999999999999999999987 7753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-54 Score=452.51 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=212.1
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGK---EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK 118 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 118 (708)
+...++|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+++|++++|||||++++++.+++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 4556789999999999999999999987775 58899886543 4455678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
.+|||||||++|+|.+++... +.+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988775 5699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCc------cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Q psy2648 198 GNKL------DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMS 269 (708)
Q Consensus 198 ~~~~------~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s 269 (708)
.... ....||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..++...+..+. .+.|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 3221 224678999999999988875 79999999999999998 899999999999999998774 45677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 270 TDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 270 ~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++.+||.+||+.||.+|||++++.
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~ 284 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIV 284 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999999999999999999999887
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-54 Score=451.46 Aligned_cols=253 Identities=31% Similarity=0.501 Sum_probs=215.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|++++|||||+++++++++..+||||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 46899999999999999999999999999999999766544445567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC-CCCc
Q psy2648 125 EYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP-GNKL 201 (708)
Q Consensus 125 Ey~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~-~~~~ 201 (708)
|||.++ +.+++.. ...+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.... ....
T Consensus 81 e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp ECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred eecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 999765 4445433 35699999999999999999999999999999999999999999999999999987643 3345
Q ss_pred cccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC------------------C
Q psy2648 202 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY------------------R 263 (708)
Q Consensus 202 ~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~------------------~ 263 (708)
...+||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+..+...++..... .
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 5678999999999998888878899999999999999999999999887776666543100 0
Q ss_pred CC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 264 IP-----------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 264 ~p-----------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
.| ..+|+++.+||++||++||++|||+++++ |+..
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 01 14578999999999999999999999998 7754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-54 Score=451.54 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=222.1
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+....+|++.+.||+|+||+||+|.++.+++.||||++++... ..+.+.+|+++|++++|||||++++++.+++.+
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34455689999999999999999999999999999999976543 345789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
|||||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999999765 56899999999999999999999999999999999999999999999999999876443
Q ss_pred CC--ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCC-CCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHH
Q psy2648 199 NK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS-LPFDGSTLRELRERVLRG-KYRIPFYMSTDCEN 274 (708)
Q Consensus 199 ~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~-~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~ 274 (708)
.. .....|++.|+|||++.+..|+ .++|||||||++|||++|. +||.+.+..++.+.+..+ ....|..+++++.+
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence 22 2334588999999999988885 8999999999999999955 556677888888877766 34567789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHh-hhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSG-EVT 297 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~-~~~ 297 (708)
||.+||+.||++|||++++. |+.
T Consensus 248 li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999987 443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=445.94 Aligned_cols=241 Identities=28% Similarity=0.451 Sum_probs=211.9
Q ss_pred eEEcccCceEEEEEEEc--CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q psy2648 52 KTIGKGNFAKVKLAKHV--PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEYASG 129 (708)
Q Consensus 52 ~~LG~G~fg~V~la~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy~~g 129 (708)
+.||+|+||+||+|.+. .+++.||||+++....++...+.+.+|+++|++++|||||+++++++++ .+|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999875 4567899999976655556667899999999999999999999999765 57899999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC----ccccc
Q psy2648 130 GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK----LDTFC 205 (708)
Q Consensus 130 g~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~----~~~~~ 205 (708)
|+|.+++.....+++.++..++.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+..... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 99999999989999999999999999999999999999999999999999999999999999987644322 23457
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhhhhC
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFLVLN 283 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~d 283 (708)
||+.|||||++.+..|+ .++|||||||++|||++ |+.||.+.+..++...|.++. ...|..+++++.+||.+||+.|
T Consensus 172 gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence 99999999999888875 79999999999999998 999999999999999998875 4678889999999999999999
Q ss_pred CCCCCCHHHHh
Q psy2648 284 PAKRASLEVSG 294 (708)
Q Consensus 284 P~~Rps~~~~~ 294 (708)
|++|||++++.
T Consensus 251 p~~RPs~~~i~ 261 (277)
T d1xbba_ 251 VENRPGFAAVE 261 (277)
T ss_dssp TTTSCCHHHHH
T ss_pred HhHCcCHHHHH
Confidence 99999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=453.55 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=211.7
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCCh---hhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q psy2648 50 LLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNP---GSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVMEY 126 (708)
Q Consensus 50 i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmEy 126 (708)
.++.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5789999999999999999999999999997654322 1234688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccccc
Q psy2648 127 ASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDTFC 205 (708)
Q Consensus 127 ~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~~~ 205 (708)
|.++++..++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....+.+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 999887776666678999999999999999999999999999999999999999999999999999876443 3445678
Q ss_pred cCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--C---------C---------C-
Q psy2648 206 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGK--Y---------R---------I- 264 (708)
Q Consensus 206 Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~--~---------~---------~- 264 (708)
||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+..+...+|.+.. . . .
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 99999999999766554689999999999999999999999998888777765320 0 0 0
Q ss_pred -------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 265 -------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 265 -------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
....++++.+||++||++||++|||+++++ |+..
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 124688999999999999999999999987 7764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=449.08 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=210.6
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+...++|++.+.||+|+||+||+|++. ..||||+++....+....+.+.+|+++|++++|||||++++++. +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 3455678999999999999999999753 46999999877666677788999999999999999999999864 4668
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-
Q psy2648 121 YLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG- 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~- 198 (708)
|||||||++|+|.+++... +.+++.++..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999765 56999999999999999999999999999999999999999999999999999765432
Q ss_pred --CCccccccCCcccccccccCC---ccCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCC-----CCCCC
Q psy2648 199 --NKLDTFCGSPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGSTL-RELRERVLRGKY-----RIPFY 267 (708)
Q Consensus 199 --~~~~~~~Gt~~Y~APE~l~~~---~~~~~~~DIWSlGvilyelltG~~Pf~~~~~-~~l~~~i~~~~~-----~~p~~ 267 (708)
....+.+||+.|||||++.+. .| +.++|||||||+||||+||+.||.+.+. ..+...+..+.. .++..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~-~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CcccccccccCcccCCHHHHhcccCCCC-CchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 234567899999999999754 34 4789999999999999999999998654 455555555532 24556
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+++++.+||.+||..||.+|||++++.
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il 264 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQIL 264 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 889999999999999999999999887
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=439.25 Aligned_cols=244 Identities=26% Similarity=0.452 Sum_probs=209.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.+|++++.||+|+||.||+|+++ +++.||||++++.... .+.+.+|+++|++++|||||++++++..++.+|||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 47999999999999999999986 5678999999765433 3568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--Ccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLD 202 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~~~ 202 (708)
||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+|+++++||+|||+++...... ...
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999998765 568999999999999999999999999999999999999999999999999998764332 223
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L 280 (708)
...||+.|+|||++.+..|+ .++|||||||+||||+| |.+||...+..++.+.+..+. ...|...++++.+||.+||
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 239 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239 (263)
T ss_dssp ----CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred ceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHc
Confidence 46799999999999998885 89999999999999999 688888889999999988874 3467788999999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
+.||++|||++++.
T Consensus 240 ~~~p~~Rps~~~il 253 (263)
T d1sm2a_ 240 KERPEDRPAFSRLL 253 (263)
T ss_dssp CSSGGGSCCHHHHH
T ss_pred cCCHhHCcCHHHHH
Confidence 99999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=443.31 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=216.8
Q ss_pred CCeEEEeE-EcccCceEEEEEEEcCC--CcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q psy2648 46 GKYKLLKT-IGKGNFAKVKLAKHVPT--GKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 46 ~~Y~i~~~-LG~G~fg~V~la~~~~t--g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~yl 122 (708)
++|.+.+. ||+|+||+||+|.++.+ +..||||++++.. .....+.+.+|+++|++++|||||+++++++++ .+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 46888885 99999999999987644 4579999997643 455677899999999999999999999999764 5899
Q ss_pred EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--
Q psy2648 123 VMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-- 199 (708)
Q Consensus 123 VmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-- 199 (708)
|||||++|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999999999998654 579999999999999999999999999999999999999999999999999998765432
Q ss_pred --CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 200 --KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
.....+||+.|+|||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...|..+. ...|..+++++.+|
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 244 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 22346799999999999888875 89999999999999998 999999998889999998875 46788899999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||++|||+.++.
T Consensus 245 i~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHH
Confidence 9999999999999998875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=455.17 Aligned_cols=249 Identities=24% Similarity=0.434 Sum_probs=212.9
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCc-----EEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGK-----EVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 117 (708)
.-++|++++.||+|+||+||+|++..+++ .||||++.+.. .......+.+|+.+|+++ +|||||++++++.+.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 34689999999999999999999986654 69999987543 233446788999999988 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH-----------------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 174 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~-----------------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPe 174 (708)
+.+|||||||++|+|.++|..+ +.+++.+++.++.||+.||+|||+++||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999999999999754 24889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q psy2648 175 NLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTL 250 (708)
Q Consensus 175 NILld~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~ 250 (708)
|||++.++.+||+|||+|+....... ..+.+||+.|||||++.+..|+ +++|||||||+||||++ |..||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987644332 2356789999999999888875 89999999999999997 9999998765
Q ss_pred HHHHHHHHcCC--CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 251 RELRERVLRGK--YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 251 ~~l~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+...++.... +..|..+++++.+||.+||+.||++|||++++.
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 55445554443 346778999999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=437.92 Aligned_cols=249 Identities=24% Similarity=0.436 Sum_probs=217.3
Q ss_pred CCCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 40 RDEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 40 ~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
+.+....+|++++.||+|+||.||+|+++ +++.||||++++.... .+.+.+|+++|++++|||||++++++.+ +.
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 33444568999999999999999999975 6788999999765433 4568999999999999999999998754 56
Q ss_pred EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTP 197 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~ 197 (708)
+|||||||++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||||++++.+||+|||+|+....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 89999999999999977543 3699999999999999999999999999999999999999999999999999987654
Q ss_pred CC--CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Q psy2648 198 GN--KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCE 273 (708)
Q Consensus 198 ~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~ 273 (708)
.. ......||+.|||||++.+..|+ .++|||||||+||||+| |.+||...+..++.+.+..+. ...|..+++++.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 240 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CccccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHH
Confidence 33 23456799999999999988875 89999999999999999 567778888889999988874 456788999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+||.+||+.||++|||++++.
T Consensus 241 ~li~~cl~~~P~~Rpt~~ei~ 261 (272)
T d1qpca_ 241 QLMRLCWKERPEDRPTFDYLR 261 (272)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHH
Confidence 999999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-52 Score=440.15 Aligned_cols=252 Identities=31% Similarity=0.476 Sum_probs=216.5
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||+||+|+++ +|+.||||+++.........+++.+|+.+|++++|||||++++++..++..|++|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 368999999999999999999985 7899999999876544445678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC-CCccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG-NKLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~-~~~~~ 203 (708)
||+.++.+..+....+.+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++...... .....
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 99998887777777788999999999999999999999999999999999999999999999999999765432 33455
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---------------------
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY--------------------- 262 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~--------------------- 262 (708)
..|++.|+|||.+.+..+.++++|||||||++|+|++|+.||.+.+..+...++.....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 67999999999998877767999999999999999999999999887777666543100
Q ss_pred --------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 263 --------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 263 --------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..+...++++.|||++||++||++|||+++++ |++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11235688999999999999999999999987 654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=433.17 Aligned_cols=244 Identities=24% Similarity=0.460 Sum_probs=220.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVME 125 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVmE 125 (708)
.+|+++++||+|+||+||+|+++ +++.||||++++.... .+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 57999999999999999999985 7889999999876554 3568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC--Ccc
Q psy2648 126 YASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--KLD 202 (708)
Q Consensus 126 y~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--~~~ 202 (708)
|+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++...... ...
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999999997654 679999999999999999999999999999999999999999999999999998654332 233
Q ss_pred ccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhh
Q psy2648 203 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLLKKFL 280 (708)
Q Consensus 203 ~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li~~~L 280 (708)
..+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..++..+|..+. ...|...++++.+||++||
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 238 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred ccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHc
Confidence 46799999999999988885 79999999999999998 899999999999999998874 3567788999999999999
Q ss_pred hhCCCCCCCHHHHh
Q psy2648 281 VLNPAKRASLEVSG 294 (708)
Q Consensus 281 ~~dP~~Rps~~~~~ 294 (708)
+.||++|||++++.
T Consensus 239 ~~dP~~RPt~~eil 252 (258)
T d1k2pa_ 239 HEKADERPTFKILL 252 (258)
T ss_dssp CSSGGGSCCHHHHH
T ss_pred cCCHhHCcCHHHHH
Confidence 99999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=441.05 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=213.8
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCC-CcEEEEEEeccCCCChhhHHHHHHHHHHHHhC---CCCCeeeEEEEEEe----
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPT-GKEVAIKIIDKTQLNPGSLQKLFREVRIMKML---DHPNIVKLFQVIET---- 116 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~t-g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~---- 116 (708)
.++|++++.||+|+||+||+|++..+ ++.||||++++..........+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999766 66799999976544433334566788887765 79999999999863
Q ss_pred -CCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 -EKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 -~~~~ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
...+|++||||.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 3478999999998876554433 35699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--C-----------
Q psy2648 195 FTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG--K----------- 261 (708)
Q Consensus 195 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~--~----------- 261 (708)
........+.+||+.|+|||++.+..|+ .++|||||||++|||++|+.||.+.+..+...++... .
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hcccccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 6666666788999999999999999885 7999999999999999999999999888777766431 0
Q ss_pred --------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 262 --------------YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 262 --------------~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..++..+++++.+||++||++||++|||+++++ |+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 012345788999999999999999999999987 664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=433.27 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=208.1
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCC---cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTG---KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
-++|++++.||+|+||+||+|.+..++ ..||||+++... .....+.+.+|+++|++++|||||++++++. ++.+|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 468999999999999999999987654 468899886433 3455677899999999999999999999995 46789
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN- 199 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~- 199 (708)
||||||++|+|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999999999987664 569999999999999999999999999999999999999999999999999998764332
Q ss_pred -CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q psy2648 200 -KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENLL 276 (708)
Q Consensus 200 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~Li 276 (708)
.....+||+.|+|||++.+..|+ .++|||||||+||||++ |.+||.+.+..++..++..+. .++|..+++++.+||
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 242 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 23456789999999999988875 79999999999999998 999999999999999998885 467888999999999
Q ss_pred HHhhhhCCCCCCCHHHHh
Q psy2648 277 KKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~ 294 (708)
.+||..||++|||++++.
T Consensus 243 ~~cl~~dp~~Rps~~ei~ 260 (273)
T d1mp8a_ 243 TKCWAYDPSRRPRFTELK 260 (273)
T ss_dssp HHHTCSSGGGSCCHHHHH
T ss_pred HHHcCCCHhHCcCHHHHH
Confidence 999999999999999887
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=430.07 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=212.4
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCC----cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTG----KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE 117 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 117 (708)
+.....|++.+.||+|+||.||+|.++.++ ..||||++.... .......+.+|+++|++++|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 344467999999999999999999988665 479999997543 445566789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFT 196 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~ 196 (708)
+.+|+|||||.+++|.+++... +.+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999999988765 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCC----CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCH
Q psy2648 197 PGN----KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMST 270 (708)
Q Consensus 197 ~~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~ 270 (708)
... ......||+.|||||++.+..|+ .++|||||||+||||++ |..||.+.+..++.+.+..+. ...|..++.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 322 12345789999999999988875 79999999999999999 566677788888888888773 456778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 271 DCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 271 ~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++.+||.+||..||++|||++++.
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil 264 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIV 264 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHH
Confidence 999999999999999999999887
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=438.20 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=214.2
Q ss_pred CccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe------
Q psy2648 43 PHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET------ 116 (708)
Q Consensus 43 ~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 116 (708)
..+++|+++++||+|+||+||+|++..+|+.||||++.+........+.+.+|+++|+.++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 34899999999999999999999999999999999998766555556778899999999999999999999855
Q ss_pred --CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 117 --EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 117 --~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
+..+|+|||||.++.+..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 346899999999887776655667899999999999999999999999999999999999999999999999999976
Q ss_pred cCCC-----CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC---
Q psy2648 195 FTPG-----NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRIPF--- 266 (708)
Q Consensus 195 ~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~p~--- 266 (708)
+... ....+.+||+.|+|||++.+....++++|||||||++|+|++|+.||.+.+..+....+.......+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 5422 23455789999999999987654468999999999999999999999998887776665442111110
Q ss_pred -----------------------------CCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 267 -----------------------------YMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 267 -----------------------------~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
..++++.|||.+||++||++|||+++++ |+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 1367889999999999999999999998 765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=435.70 Aligned_cols=246 Identities=25% Similarity=0.446 Sum_probs=211.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGK----EVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.+|++++.||+|+||+||+|.+..+|+ +||||.++... .....+.+.+|+++|++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 369999999999999999999998887 57888776432 334567799999999999999999999999865 578
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
++|||+.+|+|.+++..+ ..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+++.......
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 899999999999988765 5799999999999999999999999999999999999999999999999999987654332
Q ss_pred ---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q psy2648 201 ---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCENL 275 (708)
Q Consensus 201 ---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~L 275 (708)
.....||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+..++...+..+. ...|..+++++.+|
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred cccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 2345689999999999988875 89999999999999998 899999999888888888875 46778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHh
Q psy2648 276 LKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~ 294 (708)
|.+||..||.+|||+.++.
T Consensus 246 i~~cl~~dP~~RPs~~eil 264 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELI 264 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHH
T ss_pred HHHhCCCChhhCcCHHHHH
Confidence 9999999999999999886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=423.57 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=221.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ylVm 124 (708)
+++|++++.||+|+||+||+|+++.+++.||||+++.........+++.+|+.+|+.++|||||++++++.+...+++||
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 36899999999999999999999999999999999877666667788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC-Cccc
Q psy2648 125 EYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDT 203 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~-~~~~ 203 (708)
|++.+++|..++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 999999999988888899999999999999999999999999999999999999999999999999998765433 3334
Q ss_pred cccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCC---------------------
Q psy2648 204 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGSTLRELRERVLRGK--------------------- 261 (708)
Q Consensus 204 ~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf-~~~~~~~l~~~i~~~~--------------------- 261 (708)
..+++.|+|||++.+..+.+.++|||||||++|+|++|..|| .+.+..+...++....
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 567788999999988776678999999999999999999985 5566666666553210
Q ss_pred --------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 262 --------YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 262 --------~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
...+..+++++.+||++||+.||.+|||+++++ |++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 012234678999999999999999999999988 775
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=439.09 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=211.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC------
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK------ 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 118 (708)
-.+|++++.||+|+||+||+|.++.+|+.||||++++...+....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35899999999999999999999999999999999877666667788999999999999999999999998654
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+||||||| +.+|..+ ..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 97 ~~~lv~e~~-~~~l~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~-- 172 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-- 172 (346)
T ss_dssp CCEEEEECC-SEEHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEecc-cccHHHH-HHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC--
Confidence 579999999 4566654 456789999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKY---------------- 262 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~---------------- 262 (708)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 3456678999999999998876667899999999999999999999998876665544332100
Q ss_pred ---------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 263 ---------------RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 263 ---------------~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
..+...++++.+||++||+.||.+|||+++++ |+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 12245789999999999999999999999998 7753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-51 Score=431.77 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=220.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKT 119 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 119 (708)
.++|++++.||+|+||+||+|+++ .+++.||||++++.. .....+.+.+|+++|+.++||||+++++++.+.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 457999999999999999999976 356899999997543 44556779999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHG------------------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 175 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~------------------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeN 175 (708)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 999999999999999997532 38899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCC-CCCCCCCHH
Q psy2648 176 LLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS-LPFDGSTLR 251 (708)
Q Consensus 176 ILld~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~-~Pf~~~~~~ 251 (708)
||||.++++||+|||+|+...... ...+.+|++.|+|||++.+..|+ +++|||||||+||||++|. .||.+.+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 999999999999999997654332 23457899999999999988886 8999999999999999985 689999999
Q ss_pred HHHHHHHcCCCC-CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 252 ELRERVLRGKYR-IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 252 ~l~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++...+..+... .|..+++++.+||.+||+.||++|||+.++.
T Consensus 250 e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999999988653 6778999999999999999999999999886
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=427.50 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=212.1
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 120 (708)
.+...++|++.+.||+|+||+||+|+++.+ +.||||+++..... .+.+.+|+.+|++++|||||++++++. ++.+
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~ 86 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 86 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCe
Confidence 344467899999999999999999998765 57999999765443 356889999999999999999999985 4568
Q ss_pred EEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 121 YLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
|+|||||++|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||||.++.+||+|||+++.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999999988754 357999999999999999999999999999999999999999999999999999866433
Q ss_pred C--CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Q psy2648 199 N--KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGK-YRIPFYMSTDCEN 274 (708)
Q Consensus 199 ~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~-~~~p~~~s~~~~~ 274 (708)
. .....+||+.|+|||++....++ +++|||||||+||||++ |.+||.+.+..++...+..+. .+.|..+++++.+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 2 23346799999999999888875 89999999999999999 566777888888998888774 4678889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHhh
Q psy2648 275 LLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 275 Li~~~L~~dP~~Rps~~~~~~ 295 (708)
||.+||+.||++|||++++..
T Consensus 246 li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHH
Confidence 999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=432.87 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=216.8
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcE--EEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKE--VAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETEKTL 120 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 120 (708)
..++|++.+.||+|+||+||+|+++.++.. ||||.++... .....+.+.+|+++|+++ +|||||++++++.+++.+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 346899999999999999999999988875 6677765432 234456789999999998 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcE
Q psy2648 121 YLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNI 184 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~i 184 (708)
|||||||++|+|.++|..+ ..+++.++..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999999754 568999999999999999999999999999999999999999999
Q ss_pred EEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHcC-CC
Q psy2648 185 KIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-SLPFDGSTLRELRERVLRG-KY 262 (708)
Q Consensus 185 KL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG-~~Pf~~~~~~~l~~~i~~~-~~ 262 (708)
||+|||+++...........+||+.|+|||.+.+..|+ .++|||||||++|||++| .+||.+.+..++.+.|..+ .+
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~ 245 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Confidence 99999999876554455567899999999999988885 799999999999999996 5789999999999998876 45
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 ~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..|..+++++.+||.+||+.||++|||++++.
T Consensus 246 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil 277 (309)
T d1fvra_ 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277 (309)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 56778999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=425.45 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=206.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcC-CC--cEEEEEEeccCCCC-hhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVP-TG--KEVAIKIIDKTQLN-PGSLQKLFREVRIMKMLDHPNIVKLFQVIETEKTLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~-tg--~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~y 121 (708)
.+|++++.||+|+||.||+|++.. ++ ..||||++++.... .+..+.+.+|+.+|++++|||||++++++.+ ..+|
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 479999999999999999998753 33 36899999876543 3455789999999999999999999999976 4679
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 122 LVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
+|||||++|+|.+++..+ +.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 999999999999887665 5799999999999999999999999999999999999999999999999999987644322
Q ss_pred ----ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHH
Q psy2648 201 ----LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRGKYR--IPFYMSTDCE 273 (708)
Q Consensus 201 ----~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~~~~--~p~~~s~~~~ 273 (708)
....+|++.|+|||++.+..++ .++|||||||++|||+| |..||.+.+..++..++.+...+ .|..+++++.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 2345678899999999988875 88999999999999998 89999999999999999877554 4567899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHhh
Q psy2648 274 NLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 274 ~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+||.+||..||.+|||++++..
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999998874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=433.78 Aligned_cols=257 Identities=32% Similarity=0.568 Sum_probs=222.8
Q ss_pred CCCccCCeEEEeEEcccCceEEEEEEE---cCCCcEEEEEEeccCCCC--hhhHHHHHHHHHHHHhCCC-CCeeeEEEEE
Q psy2648 41 DEPHIGKYKLLKTIGKGNFAKVKLAKH---VPTGKEVAIKIIDKTQLN--PGSLQKLFREVRIMKMLDH-PNIVKLFQVI 114 (708)
Q Consensus 41 ~~~~~~~Y~i~~~LG~G~fg~V~la~~---~~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~ 114 (708)
+...+++|++++.||+|+||+||+|++ ..+|+.||||++++.... ....+.+.+|+++|++++| |||+++++++
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 334578999999999999999999998 457999999999765431 2234567899999999977 8999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccc
Q psy2648 115 ETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNE 194 (708)
Q Consensus 115 ~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~ 194 (708)
++...+|+||||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred cCC--CCCccccccCCcccccccccCCc-cCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCCC
Q psy2648 195 FTP--GNKLDTFCGSPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGST----LRELRERVLRGKYRIPFY 267 (708)
Q Consensus 195 ~~~--~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~DIWSlGvilyelltG~~Pf~~~~----~~~l~~~i~~~~~~~p~~ 267 (708)
+.. .....+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|+.||.+.+ ...+.+........+|..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 543 23345678999999999997654 33578999999999999999999998754 445566666777788889
Q ss_pred CCHHHHHHHHHhhhhCCCCCCC-----HHHHh---hhh
Q psy2648 268 MSTDCENLLKKFLVLNPAKRAS-----LEVSG---EVT 297 (708)
Q Consensus 268 ~s~~~~~Li~~~L~~dP~~Rps-----~~~~~---~~~ 297 (708)
.|+++.+||++||++||.+||| +++++ |+.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~ 296 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence 9999999999999999999995 67776 664
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=435.06 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=208.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe------CCEE
Q psy2648 47 KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET------EKTL 120 (708)
Q Consensus 47 ~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~ 120 (708)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+++|++++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 799999999999999999999999999999999765421 2379999999999999999999854 3468
Q ss_pred EEEEeccCCCChHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCccccC
Q psy2648 121 YLVMEYASGGEVFD---YLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFT 196 (708)
Q Consensus 121 ylVmEy~~gg~L~~---~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~ 196 (708)
|||||||+++.+.. +......+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999998764332 223456799999999999999999999999999999999999999875 89999999998877
Q ss_pred CCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----------------
Q psy2648 197 PGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG---------------- 260 (708)
Q Consensus 197 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~---------------- 260 (708)
......+.+||+.|+|||++.+..+.+.++|||||||++|||++|+.||...+..+....+.+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 7777778899999999999887654568999999999999999999999988877666555420
Q ss_pred -CCCC------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 -KYRI------------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 -~~~~------------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
...+ ....++++.+||++||++||++|||+++++ |+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 0111 124688999999999999999999999988 7753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=426.18 Aligned_cols=249 Identities=28% Similarity=0.487 Sum_probs=216.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCC-------cEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTG-------KEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIE 115 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 115 (708)
..++|++++.||+|+||.||+|++..++ ..||||++++.. .......+.+|+.+++++ +|||||++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3478999999999999999999987665 379999997654 445567788999999888 7999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 116 TEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 116 ~~~~~ylVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
+++.+|+|||||++|+|.++|.... .+++.+++.++.||+.||+|||+++||||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999997553 489999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRE 255 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~ 255 (708)
.++.+||+|||+++...... .....+|++.|+|||++.+..|+ +++|||||||++|||++ |.+||.+.+..++.+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 99999999999998664332 33457899999999999988885 89999999999999998 899999999999998
Q ss_pred HHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 RVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..+. +..|..+++++.+||.+||+.||.+|||++++.
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil 288 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 888763 457788999999999999999999999999887
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=421.30 Aligned_cols=244 Identities=32% Similarity=0.516 Sum_probs=208.7
Q ss_pred CCccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCCEE
Q psy2648 42 EPHIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIE-TEKTL 120 (708)
Q Consensus 42 ~~~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~ 120 (708)
+...++|++++.||+|+||.||+|++ +|+.||||+++++. ..+.+.+|+++|++++|||||++++++. .++.+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 34566899999999999999999998 47899999997543 3466889999999999999999999884 45678
Q ss_pred EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
||||||+++|+|.++|..++ .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999999999997653 489999999999999999999999999999999999999999999999999986543
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHH
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRERVLRG-KYRIPFYMSTDCENLL 276 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~~i~~~-~~~~p~~~s~~~~~Li 276 (708)
.....++++.|+|||++.+..++ +++|||||||++|||+| |++||...+..++...|..+ .+++|...++++.+||
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred -CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 33456889999999999888874 89999999999999998 89999999999999998876 4467888999999999
Q ss_pred HHhhhhCCCCCCCHHHHh
Q psy2648 277 KKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 277 ~~~L~~dP~~Rps~~~~~ 294 (708)
++||..||.+|||+.++.
T Consensus 234 ~~cl~~dP~~Rps~~~l~ 251 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLR 251 (262)
T ss_dssp HHHTCSSGGGSCCHHHHH
T ss_pred HHHcccCHhHCcCHHHHH
Confidence 999999999999999887
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=429.56 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=208.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----EEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETEK----TLY 121 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~y 121 (708)
.+|++++.||+|+||+||+|.++.+|+.||||++++.. .....+++++|+++|++|+|||||++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46999999999999999999999999999999997654 3455678899999999999999999999997653 234
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC---
Q psy2648 122 LVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG--- 198 (708)
Q Consensus 122 lVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~--- 198 (708)
++|||+.+|+|++++.. .++++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 45556779999999864 57999999999999999999999999999999999999999999999999999765332
Q ss_pred -CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----------------
Q psy2648 199 -NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG----------------- 260 (708)
Q Consensus 199 -~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~----------------- 260 (708)
......+||+.|+|||++....+.++++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 23456789999999999976655568999999999999999999999988765544443210
Q ss_pred ---------CCC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 261 ---------KYR-----IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 261 ---------~~~-----~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
... ....+|+++.+||.+||++||.+|||+++++ |+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 000 1235688999999999999999999999988 7654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=431.50 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=215.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIETE-----KTL 120 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 120 (708)
++|++++.||+|+||+||+|+++.+|+.||||++++...+....+++.+|+++|+.++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 579999999999999999999999999999999988776666777899999999999999999999998643 345
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK 200 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~~ 200 (708)
++||||+.+|+|.+++. .+++++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++.... ..
T Consensus 98 ~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--~~ 174 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DE 174 (348)
T ss_dssp CEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--GG
T ss_pred EEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--cc
Confidence 66778888999999874 5689999999999999999999999999999999999999999999999999986543 34
Q ss_pred ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------------
Q psy2648 201 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRGKYRI---------------- 264 (708)
Q Consensus 201 ~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~~~~~---------------- 264 (708)
..+.+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......|.......
T Consensus 175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 5667899999999998887777789999999999999999999999988877776665421111
Q ss_pred ---------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhh
Q psy2648 265 ---------------PFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTL 298 (708)
Q Consensus 265 ---------------p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~ 298 (708)
....++++.|||++||+.||.+|||+++++ |+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 124789999999999999999999999998 8764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=420.50 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=202.3
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC-
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVP-----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE- 117 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~- 117 (708)
.++|++++.||+|+||+||+|++.. +++.||||+++... .....+.+.+|+.++.++ +|||||++++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3579999999999999999999764 45789999997543 344556778888888776 689999999987654
Q ss_pred CEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 181 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~ 181 (708)
..+|+|||||++|+|.++|... ..+++.+++.++.||+.||+|||+++||||||||+||||+++
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999999999754 248899999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcC-CCCCCCCC-HHHHHHH
Q psy2648 182 MNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-SLPFDGST-LRELRER 256 (708)
Q Consensus 182 ~~iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG-~~Pf~~~~-~~~l~~~ 256 (708)
+++||+|||+|+...... ...+.+||+.|+|||++.+..|+ .++|||||||++|||++| ..||.+.+ ...+...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999998654322 23456899999999999988874 899999999999999986 57888765 3445555
Q ss_pred HHcC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 257 VLRG-KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 257 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
+..+ .+..|..+++++.+||.+||+.||++|||++++.
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil 288 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 5555 3557788999999999999999999999999887
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-49 Score=421.48 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=208.2
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--CEE
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETE--KTL 120 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~ 120 (708)
..++|++++.||+|+||+||+|+++.+|+.||||++++. ..+++.+|+++|+.++ ||||++++++|+.. ..+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 356899999999999999999999999999999999753 2456889999999995 99999999999854 569
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-cEEEEeccCccccCCCC
Q psy2648 121 YLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGN 199 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~-~iKL~DFGls~~~~~~~ 199 (708)
|+|||||.+++|..+ ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999999999775 35799999999999999999999999999999999999999765 59999999998877777
Q ss_pred CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHH-------------cCCCC--
Q psy2648 200 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGST-LRELRERVL-------------RGKYR-- 263 (708)
Q Consensus 200 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~-~~~l~~~i~-------------~~~~~-- 263 (708)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.... ..+....+. .....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 77788999999999999877654689999999999999999999997643 222111111 00000
Q ss_pred ----------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhh
Q psy2648 264 ----------------------IPFYMSTDCENLLKKFLVLNPAKRASLEVSG---EVT 297 (708)
Q Consensus 264 ----------------------~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~ 297 (708)
.+..+++++.|||++||++||.+|||+++++ |++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0123688999999999999999999999988 765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=429.33 Aligned_cols=251 Identities=28% Similarity=0.483 Sum_probs=204.0
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe------CC
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET------EK 118 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 118 (708)
+.+|++++.||+|+||+||+|+++.+|+.||||++.+...+....+++.+|+.+|+.++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999999999999999998877776777789999999999999999999999964 46
Q ss_pred EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCC
Q psy2648 119 TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 119 ~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~ 198 (708)
.+|+|||||.++ +++.+ ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999765 44444 467999999999999999999999999999999999999999999999999999877766
Q ss_pred CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC------------------
Q psy2648 199 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVLRG------------------ 260 (708)
Q Consensus 199 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~~~------------------ 260 (708)
......+||+.|+|||++.+..++ +++||||+||++|+|++|+.||.+.+......++...
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 666778999999999999998775 7999999999999999999999988776665554321
Q ss_pred ----CCCC--------------C------CCCCHHHHHHHHHhhhhCCCCCCCHHHHh---hhhhC
Q psy2648 261 ----KYRI--------------P------FYMSTDCENLLKKFLVLNPAKRASLEVSG---EVTLG 299 (708)
Q Consensus 261 ----~~~~--------------p------~~~s~~~~~Li~~~L~~dP~~Rps~~~~~---~~~~~ 299 (708)
.... + ...|+++.+||++||..||++|||+++++ |+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 1000 0 01356889999999999999999999998 87653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=420.53 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=214.4
Q ss_pred ccCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q psy2648 44 HIGKYKLLKTIGKGNFAKVKLAKHV-----PTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKML-DHPNIVKLFQVIETE 117 (708)
Q Consensus 44 ~~~~Y~i~~~LG~G~fg~V~la~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 117 (708)
..++|++.+.||+|+||.||+|++. .+++.||||++++.. .......+.+|+.+++.+ +|||||++++++++.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3468999999999999999999874 567899999997654 345566788999999998 699999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy2648 118 KTLYLVMEYASGGEVFDYLVLHG------------------RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 179 (708)
Q Consensus 118 ~~~ylVmEy~~gg~L~~~i~~~~------------------~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld 179 (708)
..+|||||||++|+|.+++.... .+++.++..++.||+.||+|||+++||||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999997643 589999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCccccCCCCC---ccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy2648 180 SEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGSTLRELRE 255 (708)
Q Consensus 180 ~~~~iKL~DFGls~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyellt-G~~Pf~~~~~~~l~~ 255 (708)
.++.+||+|||+++....... ....+||+.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+..+...
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987643322 234689999999999987776 489999999999999998 777787766544444
Q ss_pred -HHHcCC-CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 -RVLRGK-YRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 -~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
.+..+. ...|...++++.+||.+||+.||.+|||++++.
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il 299 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 444442 345677899999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=418.46 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=223.7
Q ss_pred CCCCCccCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEE
Q psy2648 39 ERDEPHIGKYKLLKTIGKGNFAKVKLAKHVP-----TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQV 113 (708)
Q Consensus 39 ~~~~~~~~~Y~i~~~LG~G~fg~V~la~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 113 (708)
+..+...++|++.+.||+|+||.||+|.++. +++.||||++++.. .......+.+|+++|++++|||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 3445556899999999999999999999863 45789999997543 44555678999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy2648 114 IETEKTLYLVMEYASGGEVFDYLVLH----------GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMN 183 (708)
Q Consensus 114 ~~~~~~~ylVmEy~~gg~L~~~i~~~----------~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~ 183 (708)
+..+..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||||.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998653 24688999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCC---CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHc
Q psy2648 184 IKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-SLPFDGSTLRELRERVLR 259 (708)
Q Consensus 184 iKL~DFGls~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG-~~Pf~~~~~~~l~~~i~~ 259 (708)
+||+|||+++...... .....+||+.|+|||.+.+..++ .++|||||||+||||++| ..||.+.+..++.+.+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999998654322 23445799999999999988875 799999999999999997 689999999999999988
Q ss_pred CCC-CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhh
Q psy2648 260 GKY-RIPFYMSTDCENLLKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 260 ~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~~ 295 (708)
+.. ..|..+++++.+||.+||+.||++|||++++..
T Consensus 251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 754 467789999999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=402.72 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=199.4
Q ss_pred CccC-CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCCEE
Q psy2648 43 PHIG-KYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN-IVKLFQVIETEKTL 120 (708)
Q Consensus 43 ~~~~-~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~ 120 (708)
..+| +|++++.||+|+||+||+|++..+|+.||||++...... +.+.+|+++++.++|+| |+.++.++.+.+.+
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3454 699999999999999999999999999999998765432 24678999999998766 55566677888999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCcEEEEeccCccccC
Q psy2648 121 YLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFT 196 (708)
Q Consensus 121 ylVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~---~~~iKL~DFGls~~~~ 196 (708)
|+||||+. ++|.+.+.. .+.+++.++..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+.
T Consensus 79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99999995 466665544 467999999999999999999999999999999999999764 4579999999998764
Q ss_pred CCC--------CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cCCC---
Q psy2648 197 PGN--------KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLRELRERVL---RGKY--- 262 (708)
Q Consensus 197 ~~~--------~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~~l~~~i~---~~~~--- 262 (708)
... ...+.+||+.|||||++.+..|+ +++|||||||++|||++|..||.+....+....+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 322 23467899999999999998875 89999999999999999999998765443322221 1111
Q ss_pred --CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 263 --RIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 263 --~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
..+..+++++.+||.+||..||.+||+++++.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 12356889999999999999999999998765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=404.57 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=205.6
Q ss_pred eEEEeEEcccCceEEEEEEEcCCC---cEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTG---KEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPNIVKLFQVIET-EKTLYLV 123 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ylV 123 (708)
+.+.++||+|+||+||+|.+..++ ..||||++++. .+....+++.+|+++|++++|||||++++++.. +..+|+|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 344688999999999999987654 36999999753 345667889999999999999999999999765 5689999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccCccccCCCC---
Q psy2648 124 MEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN--- 199 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGls~~~~~~~--- 199 (708)
||||++|+|.+++... ..+++.++..++.||+.||.|||+++|+||||||+||||++++.+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999988755 357788999999999999999999999999999999999999999999999998754332
Q ss_pred --CccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCC-CCCCCCCHHHHHH
Q psy2648 200 --KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-STLRELRERVLRGKY-RIPFYMSTDCENL 275 (708)
Q Consensus 200 --~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~-~~~~~l~~~i~~~~~-~~p~~~s~~~~~L 275 (708)
......||+.|+|||.+.+..++ .++|||||||+||||++|..||.. .+..++...+..+.. ..|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 12235689999999999888774 899999999999999997666654 455667777777753 4677889999999
Q ss_pred HHHhhhhCCCCCCCHHHHhh
Q psy2648 276 LKKFLVLNPAKRASLEVSGE 295 (708)
Q Consensus 276 i~~~L~~dP~~Rps~~~~~~ 295 (708)
|.+||..||++||+++++..
T Consensus 267 i~~cl~~dP~~RPs~~ei~~ 286 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVS 286 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999998873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-46 Score=396.35 Aligned_cols=243 Identities=22% Similarity=0.320 Sum_probs=206.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH-PNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ylVm 124 (708)
++|++++.||+|+||+||+|++..+|+.||||++.+.... ..+.+|+++++.|+| +||+.+++++......|+||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 5899999999999999999999999999999998764322 236679999999976 89999999999999999999
Q ss_pred eccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-----CCcEEEEeccCccccCCC
Q psy2648 125 EYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS-----EMNIKIADFGFSNEFTPG 198 (708)
Q Consensus 125 Ey~~gg~L~~~i~~~~-~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~-----~~~iKL~DFGls~~~~~~ 198 (708)
||+ +++|.+++...+ .+++.++..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 999 689999887764 6999999999999999999999999999999999999974 578999999999875432
Q ss_pred --------CCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCC----
Q psy2648 199 --------NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGS---TLRELRERVLRGKYR---- 263 (708)
Q Consensus 199 --------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~---~~~~l~~~i~~~~~~---- 263 (708)
....+.+||+.|||||++.+..++ +++|||||||++|+|++|..||.+. +..+...++...+..
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 224467899999999999998875 8999999999999999999999864 333444444332221
Q ss_pred -CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 264 -IPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 264 -~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
++..+++++.++|..|+..+|++||+.+.+.
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 3356789999999999999999999987665
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=394.80 Aligned_cols=241 Identities=26% Similarity=0.371 Sum_probs=193.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHH--HHHHHhCCCCCeeeEEEEEEeCC----E
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFRE--VRIMKMLDHPNIVKLFQVIETEK----T 119 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~E--i~il~~l~HpnIv~l~~~~~~~~----~ 119 (708)
.+|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+.+.+| +..+++++|||||++++++.+++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 3689999999999999999986 6899999998643 22344444 44556789999999999987654 6
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 120 LYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ--------KKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 120 ~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~--------~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
+|||||||++|+|.++|.+. .+++.+...++.|++.||+|||+ +|||||||||+||||+.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 89999999999999999754 79999999999999999999996 5999999999999999999999999999
Q ss_pred ccccCCCC-----CccccccCCcccccccccCCcc-----CCCchhHHHHHHHHHHHHcCCCCCCC--------------
Q psy2648 192 SNEFTPGN-----KLDTFCGSPPYAAPELFQGKKY-----DGPEVDVWSLGVILYTLVSGSLPFDG-------------- 247 (708)
Q Consensus 192 s~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~-----~~~~~DIWSlGvilyelltG~~Pf~~-------------- 247 (708)
++...... .....+||+.|+|||++.+... .+.++|||||||+||||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98764332 2345789999999999876531 13589999999999999999887742
Q ss_pred -CCHHHHHHHHHcCCCC--CCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 248 -STLRELRERVLRGKYR--IPFY-----MSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 248 -~~~~~l~~~i~~~~~~--~p~~-----~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
....++...+.....+ +|.. ...++.+||.+||+.||++|||++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~ 289 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 2345555555554433 2221 123588999999999999999999876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-42 Score=370.63 Aligned_cols=246 Identities=25% Similarity=0.425 Sum_probs=193.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-----------CCCeeeEEEEE
Q psy2648 46 GKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-----------HPNIVKLFQVI 114 (708)
Q Consensus 46 ~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~ 114 (708)
++|+++++||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+++|+.++ |||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 57999999999999999999999999999999997542 33456788999988775 57899999987
Q ss_pred Ee--CCEEEEEEeccCCCChHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCc-----
Q psy2648 115 ET--EKTLYLVMEYASGGEVFDYLV---LHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLLDSEMN----- 183 (708)
Q Consensus 115 ~~--~~~~ylVmEy~~gg~L~~~i~---~~~~l~e~~~~~i~~QI~~aL~yLH~-~gIvHRDLKPeNILld~~~~----- 183 (708)
.. ....+++|+++..+....... ....+++..++.++.||+.||+|||+ +||+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 64 467788888876655433322 23578999999999999999999998 89999999999999987654
Q ss_pred -EEEEeccCccccCCCCCccccccCCcccccccccCCccCCCchhHHHHHHHHHHHHcCCCCCCCCCHH------H-HHH
Q psy2648 184 -IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGSTLR------E-LRE 255 (708)
Q Consensus 184 -iKL~DFGls~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~DIWSlGvilyelltG~~Pf~~~~~~------~-l~~ 255 (708)
+||+|||.+..... .....+||+.|+|||++.+..|+ +++|||||||++++|++|+.||...... + +..
T Consensus 170 ~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeeccccccccc--ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999876543 33567899999999999988885 7999999999999999999999754321 1 111
Q ss_pred H--HH---------cC------------------------------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q psy2648 256 R--VL---------RG------------------------------KYRIPFYMSTDCENLLKKFLVLNPAKRASLEVSG 294 (708)
Q Consensus 256 ~--i~---------~~------------------------------~~~~p~~~s~~~~~Li~~~L~~dP~~Rps~~~~~ 294 (708)
. +. .+ .+..+...++++.|||.+||++||.+|||+++++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 00 00 0011112356899999999999999999999998
Q ss_pred ---hhh
Q psy2648 295 ---EVT 297 (708)
Q Consensus 295 ---~~~ 297 (708)
|+.
T Consensus 327 ~Hp~f~ 332 (362)
T d1q8ya_ 327 NHPWLK 332 (362)
T ss_dssp TCGGGT
T ss_pred cCcccC
Confidence 776
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-31 Score=275.93 Aligned_cols=149 Identities=34% Similarity=0.526 Sum_probs=132.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||++++++++++.+|||||||+||+|.++|...+.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 58 ~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred HhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 34689999999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC---CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 547 SEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
.++.+||+|||+|+..... ....+.+||+.|||||++.+...++.+ .|-|++
T Consensus 138 ~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~-------------------------~DiwSl 192 (271)
T d1nvra_ 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-------------------------VDVWSC 192 (271)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHH-------------------------HHHHHH
T ss_pred CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCc-------------------------eeeeHh
Confidence 9999999999999876433 234567999999999999876654433 688999
Q ss_pred hhhHHHHhhCCCCCCCC
Q psy2648 624 KENTARLNAGRPAKNTA 640 (708)
Q Consensus 624 ~~~~~~~~~~~~~~~~~ 640 (708)
+.++-++..|++.-...
T Consensus 193 Gvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 193 GIVLTAMLAGELPWDQP 209 (271)
T ss_dssp HHHHHHHHHSSCSCSSS
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999998875443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=267.72 Aligned_cols=144 Identities=31% Similarity=0.572 Sum_probs=128.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|++++.+|||||||++|+|.+++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 61 ~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~ 140 (263)
T d2j4za1 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 140 (263)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred HhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec
Confidence 45689999999999999999999999999999999999989999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.++.+||+|||+|+..... .....+||+.|||||++.+.. ++.. .|-|+++++
T Consensus 141 ~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~-------------------------~DiwSlGvi 193 (263)
T d2j4za1 141 SAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEK-------------------------VDLWSLGVL 193 (263)
T ss_dssp TTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTT-------------------------HHHHHHHHH
T ss_pred CCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCC-CCch-------------------------hhhhhHhHH
Confidence 9999999999999876433 345678999999999998754 3333 577888888
Q ss_pred HHHHhhCCCCC
Q psy2648 627 TARLNAGRPAK 637 (708)
Q Consensus 627 ~~~~~~~~~~~ 637 (708)
+-++..|+++=
T Consensus 194 lyell~G~~Pf 204 (263)
T d2j4za1 194 CYEFLVGKPPF 204 (263)
T ss_dssp HHHHHHSSCTT
T ss_pred HHHHhcCCCCC
Confidence 88888887753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-30 Score=276.80 Aligned_cols=145 Identities=24% Similarity=0.414 Sum_probs=127.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl 545 (708)
....|||||+++++|+++..+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+|||+
T Consensus 59 ~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl 138 (322)
T d1s9ja_ 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138 (322)
T ss_dssp GGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence 4568999999999999999999999999999999999999999999999999999999999997 599999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
+.++.+||+|||+|+...+. ...+.+||++|||||++.+.. ++.. .|-|++++
T Consensus 139 ~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~-------------------------~DiWSlGv 191 (322)
T d1s9ja_ 139 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQ-------------------------SDIWSMGL 191 (322)
T ss_dssp CTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSC-CCTT-------------------------HHHHHHHH
T ss_pred CCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCC-CCcH-------------------------HHHHHHHH
Confidence 99999999999999875432 334679999999999998754 3333 68999999
Q ss_pred hHHHHhhCCCCCC
Q psy2648 626 NTARLNAGRPAKN 638 (708)
Q Consensus 626 ~~~~~~~~~~~~~ 638 (708)
++-++..|++.=.
T Consensus 192 il~ell~G~~Pf~ 204 (322)
T d1s9ja_ 192 SLVEMAVGRYPIP 204 (322)
T ss_dssp HHHHHHHSSCCSS
T ss_pred HHHHHHHCCCCCC
Confidence 9999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.3e-30 Score=275.16 Aligned_cols=122 Identities=39% Similarity=0.622 Sum_probs=113.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|++++.+|||||||+||+|.+++.+.+.++|+.++.+++||+.||.|||++|||||||||+|||++
T Consensus 60 ~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~ 139 (337)
T d1o6la_ 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp HSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred HhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec
Confidence 34679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCC-CCcccccccCCcccccccccCCCC
Q psy2648 547 SEMNIKIADFGFSNEFTP-GNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~-~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.+|.+||+|||+|+.... .....+.+||+.|||||++.+..+
T Consensus 140 ~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y 182 (337)
T d1o6la_ 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCB
T ss_pred CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCC
Confidence 999999999999987643 445677899999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=5e-30 Score=270.36 Aligned_cols=144 Identities=38% Similarity=0.582 Sum_probs=112.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|+++..+|||||||+||+|.++|...+.+++.++..++.||+.||.|||++|||||||||+|||+.
T Consensus 62 ~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~ 141 (307)
T d1a06a_ 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141 (307)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeec
Confidence 45689999999999999999999999999999999999989999999999999999999999999999999999999995
Q ss_pred ---CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 547 ---SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 547 ---~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
.++.+||+|||+|+.........+.+||+.|||||++.+..+ +.. .|-|++
T Consensus 142 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~~-------------------------~DiwSl 195 (307)
T d1a06a_ 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKA-------------------------VDCWSI 195 (307)
T ss_dssp SSSTTCCEEECCC------------------CTTSCHHHHTTCCC-CTH-------------------------HHHHHH
T ss_pred ccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCC-CcH-------------------------HHhhhh
Confidence 478999999999998776666778899999999999976542 222 567777
Q ss_pred hhhHHHHhhCCCC
Q psy2648 624 KENTARLNAGRPA 636 (708)
Q Consensus 624 ~~~~~~~~~~~~~ 636 (708)
++++-++..|.++
T Consensus 196 Gvilyell~g~~P 208 (307)
T d1a06a_ 196 GVIAYILLCGYPP 208 (307)
T ss_dssp HHHHHHHHHSSCS
T ss_pred hHHHHHHHhCCCC
Confidence 7777777777765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=265.54 Aligned_cols=144 Identities=28% Similarity=0.512 Sum_probs=126.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|++++.+|||||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 72 ~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~ 150 (293)
T d1yhwa1 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (293)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC
Confidence 346899999999999999999999999999999987765 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||+|+.+... ......+||+.|||||++.+.. ++.. .|-|+++.
T Consensus 151 ~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~-------------------------~DiwSlGv 204 (293)
T d1yhwa1 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPK-------------------------VDIWSLGI 204 (293)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC-BCTH-------------------------HHHHHHHH
T ss_pred CCCcEeeccchhheeeccccccccccccCCCccChhhhcCCC-CCch-------------------------hceehHhH
Confidence 9999999999999877543 3456778999999999998654 3322 57788888
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|.+.=
T Consensus 205 ilyemltG~~Pf 216 (293)
T d1yhwa1 205 MAIEMIEGEPPY 216 (293)
T ss_dssp HHHHHHHSSCTT
T ss_pred HHHHHhhCCCCC
Confidence 888888888753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.2e-30 Score=267.78 Aligned_cols=145 Identities=34% Similarity=0.564 Sum_probs=124.2
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|||||+++++|++++.+|||||||+||+|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.
T Consensus 64 ~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~ 143 (288)
T d1uu3a_ 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE 143 (288)
T ss_dssp HCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred HcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC
Confidence 45899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCC---CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 548 EMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
++.+||+|||+|+.+... ....+.+||+.|||||++.+..+ +.+ .|-|+++
T Consensus 144 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~-------------------------~DiwSlG 197 (288)
T d1uu3a_ 144 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKS-------------------------SDLWALG 197 (288)
T ss_dssp TSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC-CHH-------------------------HHHHHHH
T ss_pred CceEEecccccceecccCCcccccccccCCccccCceeeccCCC-Ccc-------------------------cceehhh
Confidence 999999999999876432 23456789999999999986543 222 5777788
Q ss_pred hhHHHHhhCCCCCC
Q psy2648 625 ENTARLNAGRPAKN 638 (708)
Q Consensus 625 ~~~~~~~~~~~~~~ 638 (708)
+++-+++.|.+.=.
T Consensus 198 vilyell~g~~Pf~ 211 (288)
T d1uu3a_ 198 CIIYQLVAGLPPFR 211 (288)
T ss_dssp HHHHHHHHSSCSSC
T ss_pred HHHHHHhhCCCCCC
Confidence 88888888877643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.5e-29 Score=272.97 Aligned_cols=144 Identities=26% Similarity=0.411 Sum_probs=128.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|++++.+|||||||+||+|.++|.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 62 ~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~ 141 (364)
T d1omwa3 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 141 (364)
T ss_dssp SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc
Confidence 34579999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
.++.+||+|||+|+..... .....+||+.|||||++.++..++.. .|-|+++++
T Consensus 142 ~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~-------------------------~DiwSlGvi 195 (364)
T d1omwa3 142 EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSS-------------------------ADWFSLGCM 195 (364)
T ss_dssp SSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTH-------------------------HHHHHHHHH
T ss_pred CCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcc-------------------------cchhHHHHH
Confidence 9999999999999876543 34567899999999999866555443 577888888
Q ss_pred HHHHhhCCCC
Q psy2648 627 TARLNAGRPA 636 (708)
Q Consensus 627 ~~~~~~~~~~ 636 (708)
+-+++.|.+.
T Consensus 196 lyemltG~~P 205 (364)
T d1omwa3 196 LFKLLRGHSP 205 (364)
T ss_dssp HHHHHHSSCS
T ss_pred HHHHHhCCCC
Confidence 8888888765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=4e-29 Score=263.63 Aligned_cols=142 Identities=27% Similarity=0.388 Sum_probs=125.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|.+++.+|||||||++|+|..++..++.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 70 ~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~ 149 (309)
T d1u5ra_ 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149 (309)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred HHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC
Confidence 45689999999999999999999999999999988888888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCC--CccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA--PVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~--~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
.++.+||+|||+|+.... ....+||+.|||||++.+.. .++.. .|-|+++
T Consensus 150 ~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~-------------------------~DiwSlG 201 (309)
T d1u5ra_ 150 EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGK-------------------------VDVWSLG 201 (309)
T ss_dssp TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTH-------------------------HHHHHHH
T ss_pred CCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCch-------------------------hhhhhHH
Confidence 999999999999987543 34578999999999997642 23322 5788888
Q ss_pred hhHHHHhhCCCC
Q psy2648 625 ENTARLNAGRPA 636 (708)
Q Consensus 625 ~~~~~~~~~~~~ 636 (708)
+++=++..|.++
T Consensus 202 vilyel~~g~~P 213 (309)
T d1u5ra_ 202 ITCIELAERKPP 213 (309)
T ss_dssp HHHHHHHHSSCT
T ss_pred HHHHHHHHCCCC
Confidence 888888888765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.3e-29 Score=264.73 Aligned_cols=150 Identities=29% Similarity=0.471 Sum_probs=126.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||+++++|.+++.+|||||||++|+|.+++.+ .+.+++.+++.++.||+.||.|||++|||||||||+|||+
T Consensus 64 ~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll 143 (288)
T d2jfla1 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF 143 (288)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE
Confidence 346899999999999999999999999999999998765 4569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||+|+..... ....+.+||+.|||||++.+....... + -...|-|+++
T Consensus 144 ~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~-----------------y----~~k~DiwSlG 202 (288)
T d2jfla1 144 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP-----------------Y----DYKADVWSLG 202 (288)
T ss_dssp CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSS-----------------T----TTHHHHHHHH
T ss_pred CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCC-----------------C----ChhhhHHHHH
Confidence 99999999999999765322 234567899999999999653211110 0 0126888999
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
+++-++..|.++-
T Consensus 203 vilyemltg~~Pf 215 (288)
T d2jfla1 203 ITLIEMAEIEPPH 215 (288)
T ss_dssp HHHHHHHHSSCTT
T ss_pred HHHHHHhhCCCCC
Confidence 9999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.2e-29 Score=256.68 Aligned_cols=143 Identities=25% Similarity=0.420 Sum_probs=124.3
Q ss_pred cccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKK--IIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp 540 (708)
....|||||+++++|++ +..+|||||||++|+|.+++.+.+.+++.+++.++.||+.||.|||+++ ||||||||
T Consensus 63 ~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp 142 (270)
T d1t4ha_ 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 142 (270)
T ss_dssp TTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred HhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcCh
Confidence 45689999999999976 4578999999999999999999899999999999999999999999998 99999999
Q ss_pred CCeeec-CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 541 ENLLLD-SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 541 ~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
+|||++ .++.+||+|||+|+.... ....+.+||+.|||||++.+. ++.. .|
T Consensus 143 ~NILl~~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~~--~~~~-------------------------~D 194 (270)
T d1t4ha_ 143 DNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK--YDES-------------------------VD 194 (270)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTC--CCTH-------------------------HH
T ss_pred hhceeeCCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCCC--CCCc-------------------------Cc
Confidence 999997 478999999999986433 344578999999999998642 2222 68
Q ss_pred ccchhhhHHHHhhCCCCC
Q psy2648 620 SASIKENTARLNAGRPAK 637 (708)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~ 637 (708)
-|++++++=++..|+++=
T Consensus 195 IwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 195 VYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp HHHHHHHHHHHHHSSCTT
T ss_pred hhhHHHHHHHHHHCCCCC
Confidence 899999999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=5.4e-29 Score=263.46 Aligned_cols=120 Identities=33% Similarity=0.594 Sum_probs=111.1
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|+++..+|||||||+||+|..++.....+++..++.++.||+.||.|||++|||||||||+|||++
T Consensus 59 ~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~ 138 (316)
T d1fota_ 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 138 (316)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred HhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc
Confidence 45689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.+|.+||+|||+|+.... ...+.+||+.|||||++.+..+
T Consensus 139 ~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y 178 (316)
T d1fota_ 139 KNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPY 178 (316)
T ss_dssp TTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCB
T ss_pred CCCCEEEecCccceEecc--ccccccCcccccCHHHHcCCCC
Confidence 999999999999987643 3456799999999999987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.95 E-value=3.9e-29 Score=268.15 Aligned_cols=121 Identities=29% Similarity=0.569 Sum_probs=110.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||+++++|++++.+|||||||+||+|.+++. ..+.+++.+++.++.||+.||.|||++|||||||||+|||+
T Consensus 78 ~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll 157 (350)
T d1koaa2 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157 (350)
T ss_dssp HHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeee
Confidence 34589999999999999999999999999999999985 45679999999999999999999999999999999999999
Q ss_pred cC--CCCEEEeeccCccccCCCCcccccccCCcccccccccCCC
Q psy2648 546 DS--EMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 546 ~~--~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~ 587 (708)
+. ++.+||+|||+|+.+.......+.+||+.|||||++.+..
T Consensus 158 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~ 201 (350)
T d1koaa2 158 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201 (350)
T ss_dssp SSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCC
T ss_pred ccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCC
Confidence 64 5789999999999887777777889999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.5e-29 Score=266.19 Aligned_cols=176 Identities=31% Similarity=0.424 Sum_probs=139.9
Q ss_pred CCCCCCCCcCCCcccccccccccccc--------Cccc-ccccccCceeEEEEEEEe----CCEEEEEEeccCCCCHHHH
Q psy2648 436 GGGGGGGAAQSPSHRGVHRSISASNA--------KPSR-RASSGGETLLKLFQVIET----EKTLYLVMEYASGGEVFDY 502 (708)
Q Consensus 436 ~ggg~~g~v~s~~hr~~~R~i~~~~~--------~~~~-~~~~~~~~Iv~L~~~~~~----~~~~yLVmEy~~gg~L~~~ 502 (708)
.|.|++|.|+.+.++...+....+.. +... .....|||||+++++|++ +..+|||||||+||+|+++
T Consensus 20 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~ 99 (335)
T d2ozaa1 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 99 (335)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred eeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHH
Confidence 45667777766655443332211110 1111 134589999999999986 4679999999999999999
Q ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC---CCCEEEeeccCccccCCCCcccccccCCcc
Q psy2648 503 LVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS---EMNIKIADFGFSNEFTPGNKLDTFCGSPPY 577 (708)
Q Consensus 503 l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~---~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y 577 (708)
|..++ .|+|.+++.++.||+.||.|||++|||||||||+|||++. .+.+||+|||+|+...........+||+.|
T Consensus 100 i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y 179 (335)
T d2ozaa1 100 IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179 (335)
T ss_dssp HHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSS
T ss_pred HHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCccc
Confidence 98753 6999999999999999999999999999999999999985 467999999999987777777788999999
Q ss_pred cccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 578 AAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 578 ~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
||||++.+.. ++. ..|-|++++++-++..|+|.=
T Consensus 180 ~aPE~~~~~~-y~~-------------------------~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 180 VAPEVLGPEK-YDK-------------------------SCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp CCCCCCCGGG-GSH-------------------------HHHHHHHHHHHHHHTTSSCSC
T ss_pred CCcHHHcCCC-CCH-------------------------HHHHHhhchhHHHHhhCCCCC
Confidence 9999987543 222 268899999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.95 E-value=6e-29 Score=266.88 Aligned_cols=122 Identities=27% Similarity=0.519 Sum_probs=111.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||+++++|+++..+|||||||+||+|++++...+ .+++.+++.++.||+.||.|||++|||||||||+|||+
T Consensus 81 ~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl 160 (352)
T d1koba_ 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 160 (352)
T ss_dssp TTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccc
Confidence 45689999999999999999999999999999999876554 69999999999999999999999999999999999999
Q ss_pred c--CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 546 D--SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 546 ~--~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
+ ..+.+||+|||+|+.........+.+||+.|||||++.+..+
T Consensus 161 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (352)
T d1koba_ 161 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205 (352)
T ss_dssp SSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCB
T ss_pred cccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCC
Confidence 8 568999999999998877777778899999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.4e-28 Score=257.40 Aligned_cols=144 Identities=32% Similarity=0.491 Sum_probs=129.0
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|||||+++++|+++..+|||||||+||+|.++|...+.+++.+++.++.||+.||.|||+++||||||||+|||++.
T Consensus 69 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 45899999999999999999999999999999999999899999999999999999999999999999999999999987
Q ss_pred CC----CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 548 EM----NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 548 ~~----~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
++ .+|++|||+|+.........+.+||+.|||||++.+..+ +.. .|-|++
T Consensus 149 ~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~-------------------------~DiwSl 202 (293)
T d1jksa_ 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLE-------------------------ADMWSI 202 (293)
T ss_dssp SSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCB-CTH-------------------------HHHHHH
T ss_pred CCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCC-CCc-------------------------ccchhh
Confidence 76 599999999998877777778899999999999976542 222 578888
Q ss_pred hhhHHHHhhCCCCC
Q psy2648 624 KENTARLNAGRPAK 637 (708)
Q Consensus 624 ~~~~~~~~~~~~~~ 637 (708)
+.++-++..|.+.-
T Consensus 203 Gvilyell~g~~Pf 216 (293)
T d1jksa_ 203 GVITYILLSGASPF 216 (293)
T ss_dssp HHHHHHHHHSSCSS
T ss_pred hHHHHHHHcCCCCC
Confidence 88888888887764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.95 E-value=2.9e-28 Score=253.02 Aligned_cols=149 Identities=38% Similarity=0.642 Sum_probs=130.6
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSE 548 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 548 (708)
..|||||+++++|++++.+|||||||++|+|.++|..++.+++.+++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 67 ~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~ 146 (277)
T d1phka_ 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 146 (277)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred cCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC
Confidence 35999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHH
Q psy2648 549 MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTA 628 (708)
Q Consensus 549 ~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (708)
+.+||+|||+|+...........+||+.|+|||++.+....... .+ -...|.|++++++-
T Consensus 147 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~------------------~~--~~~~DiwslGvily 206 (277)
T d1phka_ 147 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP------------------GY--GKEVDMWSTGVIMY 206 (277)
T ss_dssp CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSC------------------CB--CTHHHHHHHHHHHH
T ss_pred CCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCC------------------CC--CchheEcccchhhh
Confidence 99999999999988776666778999999999999754321111 00 11268899999999
Q ss_pred HHhhCCCCC
Q psy2648 629 RLNAGRPAK 637 (708)
Q Consensus 629 ~~~~~~~~~ 637 (708)
+++.|++.=
T Consensus 207 eml~g~~Pf 215 (277)
T d1phka_ 207 TLLAGSPPF 215 (277)
T ss_dssp HHHHSSCSS
T ss_pred hhccCCCCC
Confidence 999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=2.2e-28 Score=262.33 Aligned_cols=120 Identities=38% Similarity=0.580 Sum_probs=111.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|++...+|+|||||.+|+|.+++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 96 ~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~ 175 (350)
T d1rdqe_ 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175 (350)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC
Confidence 45689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
.++.+||+|||+|+.... ...+.+||+.|||||++.+..+
T Consensus 176 ~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~~ 215 (350)
T d1rdqe_ 176 QQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGY 215 (350)
T ss_dssp TTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCB
T ss_pred CCCCEEeeeceeeeeccc--ccccccCccccCCHHHHcCCCC
Confidence 999999999999987653 3446799999999999987653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.8e-28 Score=258.35 Aligned_cols=125 Identities=36% Similarity=0.585 Sum_probs=113.5
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
...|||||+++++|++++.+|||||||++|+|.+++...+.+++.+++.++.||+.||.|||+++||||||||+|||++.
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~ 138 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 138 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCC
Q psy2648 548 EMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 548 ~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
.+.+||+|||+|+..... ......+||+.|||||++.+..+..++
T Consensus 139 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 184 (320)
T d1xjda_ 139 DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV 184 (320)
T ss_dssp TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred CCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchh
Confidence 999999999999876433 344567899999999999876644333
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-28 Score=254.93 Aligned_cols=145 Identities=27% Similarity=0.441 Sum_probs=110.7
Q ss_pred cccccCceeEEEEEEEe--CCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ccc
Q psy2648 467 ASSGGETLLKLFQVIET--EKTLYLVMEYASGGEVFDYLVL----HGRMKEKEARAKFRQIVSAVQYCHQKK-----IIH 535 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~--~~~~yLVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~-----IiH 535 (708)
....|||||++++++.+ +..+|||||||++|+|.+++.+ .+.+++..++.++.||+.||.|||+++ |||
T Consensus 58 ~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiH 137 (269)
T d2java1 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137 (269)
T ss_dssp TSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-------
T ss_pred HHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEe
Confidence 45689999999999965 4679999999999999998864 457999999999999999999999876 999
Q ss_pred CCCCCCCeeecCCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccc
Q psy2648 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKR 614 (708)
Q Consensus 536 RDlKp~NILl~~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~ 614 (708)
|||||+|||++.++.+||+|||+|+...... ...+.+||+.|||||++.+..+.. .
T Consensus 138 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~---------------------- 194 (269)
T d2java1 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE-K---------------------- 194 (269)
T ss_dssp --CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCH-H----------------------
T ss_pred CcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCCh-H----------------------
Confidence 9999999999999999999999998765433 345689999999999997654322 2
Q ss_pred cccccccchhhhHHHHhhCCCCC
Q psy2648 615 QNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|++++++=++..|++.=
T Consensus 195 ---~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 195 ---SDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp ---HHHHHHHHHHHHHHHSSCSC
T ss_pred ---HHHHhhCHHHHHHhhCCCCC
Confidence 46777888888888887653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.8e-28 Score=257.05 Aligned_cols=146 Identities=23% Similarity=0.286 Sum_probs=128.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|.+++.+|||||||.++++..++...+.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 55 ~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~ 134 (299)
T d1ua2a_ 55 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134 (299)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred HhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec
Confidence 34589999999999999999999999999988887777677899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||+|+..... ....+.+||+.|||||++.+...++.. .|-|++++
T Consensus 135 ~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-------------------------~DiwSlGv 189 (299)
T d1ua2a_ 135 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG-------------------------VDMWAVGC 189 (299)
T ss_dssp TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHH-------------------------HHHHHHHH
T ss_pred CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChh-------------------------hhhhhcch
Confidence 9999999999999876443 344567899999999999877655544 68889999
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|.|.-
T Consensus 190 il~el~~g~~pf 201 (299)
T d1ua2a_ 190 ILAELLLRVPFL 201 (299)
T ss_dssp HHHHHHHSSCSS
T ss_pred HHHHHHhCcCCC
Confidence 999999988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.1e-27 Score=253.81 Aligned_cols=122 Identities=26% Similarity=0.517 Sum_probs=111.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||+++++|+++..+|||||||+||+|.++|...+ .+++.+++.++.||+.||.|||++|||||||||+|||+
T Consensus 56 ~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll 135 (321)
T d1tkia_ 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135 (321)
T ss_dssp HHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceee
Confidence 45689999999999999999999999999999999998765 79999999999999999999999999999999999999
Q ss_pred cCC--CCEEEeeccCccccCCCCcccccccCCcccccccccCCCC
Q psy2648 546 DSE--MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 546 ~~~--~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
+.+ ..+||+|||+++.........+.+||+.|+|||++.+..+
T Consensus 136 ~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~ 180 (321)
T d1tkia_ 136 QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp SSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEE
T ss_pred cCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCC
Confidence 854 5799999999998776666777899999999999976653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.94 E-value=1.7e-27 Score=248.37 Aligned_cols=173 Identities=23% Similarity=0.251 Sum_probs=134.1
Q ss_pred CCCCCCCCCcCCCcccccccccccccc------------CcccccccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHH
Q psy2648 435 SGGGGGGGAAQSPSHRGVHRSISASNA------------KPSRRASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDY 502 (708)
Q Consensus 435 ~~ggg~~g~v~s~~hr~~~R~i~~~~~------------~~~~~~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~ 502 (708)
..|.|++|.|+...++...+....+.. +........|||||+++++|.+++.+|||||||++|+|.++
T Consensus 24 ~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~ 103 (287)
T d1opja_ 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103 (287)
T ss_dssp ETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHH
Confidence 356777777776665544332221111 11122356899999999999999999999999999999999
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCc--ccccccCCccc
Q psy2648 503 LVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYA 578 (708)
Q Consensus 503 l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~ 578 (708)
+... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....... .....||+.||
T Consensus 104 l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~ 183 (287)
T d1opja_ 104 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183 (287)
T ss_dssp HHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGC
T ss_pred hhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeecccccccccc
Confidence 9764 4689999999999999999999999999999999999999999999999999987654332 23456899999
Q ss_pred ccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhC
Q psy2648 579 APELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAG 633 (708)
Q Consensus 579 APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (708)
|||++.++.+... .|-|+.+.++-++..|
T Consensus 184 aPE~~~~~~~~~k--------------------------~DiwS~Gv~l~ell~~ 212 (287)
T d1opja_ 184 APESLAYNKFSIK--------------------------SDVWAFGVLLWEIATY 212 (287)
T ss_dssp CHHHHHHCCCSHH--------------------------HHHHHHHHHHHHHHTT
T ss_pred ChHHHcCCCCCch--------------------------hhhhhHHHHHHHHHhC
Confidence 9999987653322 4667777777777653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.4e-28 Score=256.08 Aligned_cols=142 Identities=21% Similarity=0.308 Sum_probs=120.3
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHH
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-----------------------RMKEKEARAKFRQIVSAV 525 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-----------------------~l~e~~~~~~~~qi~~aL 525 (708)
..|||||++++++.+++.+|||||||++|+|.++|..+. .+++.++..++.||+.||
T Consensus 98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl 177 (325)
T d1rjba_ 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177 (325)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred cCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 479999999999999999999999999999999997542 489999999999999999
Q ss_pred HHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCCCCCCCCccc
Q psy2648 526 QYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHN 602 (708)
Q Consensus 526 ~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~ 602 (708)
.|||+++||||||||+|||++.++.+||+|||+|+....... ..+.+||+.|||||++.++.+...
T Consensus 178 ~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~----------- 246 (325)
T d1rjba_ 178 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK----------- 246 (325)
T ss_dssp HHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-----------
T ss_pred HHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-----------
Confidence 999999999999999999999999999999999987644332 345679999999999986653322
Q ss_pred CCCCCCCccccccccccccchhhhHHHHhh-CCCC
Q psy2648 603 SSISPAPTNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
.|-|+.+.++=++.. |.|+
T Consensus 247 ---------------~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 247 ---------------SDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ---------------HHHHHHHHHHHHHTTTSCCS
T ss_pred ---------------eeccchhHHHHHHHhCCCCC
Confidence 466777777777764 6654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.5e-27 Score=247.01 Aligned_cols=142 Identities=27% Similarity=0.431 Sum_probs=122.1
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASG-GEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
..|||||+++++|++++.+|+||||+.+ +++.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.
T Consensus 66 ~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 145 (273)
T ss_dssp SSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET
T ss_pred cCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec
Confidence 3589999999999999999999999986 688889988889999999999999999999999999999999999999985
Q ss_pred C-CCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhh
Q psy2648 548 E-MNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKEN 626 (708)
Q Consensus 548 ~-~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (708)
+ +.+||+|||+|+.... ....+.+||+.|||||++.+...++.+ .|-|+++++
T Consensus 146 ~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~-------------------------~DiwSlGvi 199 (273)
T d1xwsa_ 146 NRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRS-------------------------AAVWSLGIL 199 (273)
T ss_dssp TTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHH-------------------------HHHHHHHHH
T ss_pred CCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcc-------------------------cccccceee
Confidence 4 7899999999986543 345578999999999999876654433 466777777
Q ss_pred HHHHhhCCCC
Q psy2648 627 TARLNAGRPA 636 (708)
Q Consensus 627 ~~~~~~~~~~ 636 (708)
+-++..|++.
T Consensus 200 lyell~g~~P 209 (273)
T d1xwsa_ 200 LYDMVCGDIP 209 (273)
T ss_dssp HHHHHHSSCS
T ss_pred ehhHhhCCCC
Confidence 7777777654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.1e-27 Score=245.03 Aligned_cols=144 Identities=24% Similarity=0.379 Sum_probs=117.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++ ++..+|||||||++|+|.+++... +.+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 59 ~~l~HpnIv~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl 137 (276)
T d1uwha_ 59 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL 137 (276)
T ss_dssp TTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCEeeeeEEE-eccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE
Confidence 456899999999976 456789999999999999999754 569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC---CcccccccCCcccccccccCCC--CccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPG---NKLDTFCGSPPYAAPELFQGGA--PVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~---~~~~~~~Gt~~Y~APEvl~g~~--~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
+.++.+||+|||+|+..... ....+.+||+.|||||++.+.. +++.. .|-
T Consensus 138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~-------------------------sDi 192 (276)
T d1uwha_ 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ-------------------------SDV 192 (276)
T ss_dssp ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHH-------------------------HHH
T ss_pred cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCch-------------------------hhh
Confidence 99999999999999876432 2345678999999999997643 22222 577
Q ss_pred cchhhhHHHHhhCCCC
Q psy2648 621 ASIKENTARLNAGRPA 636 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~ 636 (708)
|+.+.++=++..|+++
T Consensus 193 wS~Gv~l~el~tg~~P 208 (276)
T d1uwha_ 193 YAFGIVLYELMTGQLP 208 (276)
T ss_dssp HHHHHHHHHHHHSSCT
T ss_pred hhhHHHHHHHHHCCCC
Confidence 8888888888888765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.93 E-value=2e-27 Score=249.34 Aligned_cols=144 Identities=20% Similarity=0.267 Sum_probs=110.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++.+++.+|||||||++|+|.+++... +.+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 82 ~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV 161 (299)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE
Confidence 4568999999999999999999999999999999988764 569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCcc------cccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNKL------DTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTID 619 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~~------~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (708)
+.++.+||+|||+|+........ ....||+.|||||++.++.+... .|
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~--------------------------sD 215 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA--------------------------SD 215 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHH--------------------------HH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcc--------------------------cc
Confidence 99999999999999876543221 22468999999999987653332 35
Q ss_pred ccchhhhHHHHhh-CCCC
Q psy2648 620 SASIKENTARLNA-GRPA 636 (708)
Q Consensus 620 ~~~~~~~~~~~~~-~~~~ 636 (708)
-|+.+.++=++.. |.|+
T Consensus 216 vwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 216 VWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp HHHHHHHHHHHHTTSCCT
T ss_pred cccchHHHHHHHhCCCCC
Confidence 6666777766664 5544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.93 E-value=4.4e-27 Score=243.67 Aligned_cols=145 Identities=26% Similarity=0.430 Sum_probs=118.1
Q ss_pred cccccCceeEEEEEEEeCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~----~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
....|||||++++++++++ .+|||||||+||+|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|
T Consensus 62 ~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~N 141 (277)
T d1o6ya_ 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141 (277)
T ss_dssp HTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcc
Confidence 3468999999999998754 489999999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCC----CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPG----NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~----~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
||++.++.++++|||+++..... ....+.+||+.|||||++.+..+ +.. .
T Consensus 142 Ill~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~-------------------------~ 195 (277)
T d1o6ya_ 142 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DAR-------------------------S 195 (277)
T ss_dssp EEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCC-CHH-------------------------H
T ss_pred cccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCC-Ccc-------------------------e
Confidence 99999999999999998754322 23456789999999999976542 212 5
Q ss_pred cccchhhhHHHHhhCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAK 637 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~ 637 (708)
|-|+++.++-+++.|+|.=
T Consensus 196 DiwSlGvilyelltG~~Pf 214 (277)
T d1o6ya_ 196 DVYSLGCVLYEVLTGEPPF 214 (277)
T ss_dssp HHHHHHHHHHHHHHSSCSC
T ss_pred ecccchHHHHHHHhCCCCC
Confidence 7888999999999998863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.4e-27 Score=239.94 Aligned_cols=123 Identities=24% Similarity=0.331 Sum_probs=99.4
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++.+++.+|||||||++|+|.+++... ..++++.+..++.||+.||.|||+++||||||||+|||+
T Consensus 55 ~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill 134 (263)
T d1sm2a_ 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134 (263)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred HhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence 4468999999999999999999999999999999988755 568999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc--ccccccCCcccccccccCCCCc
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGGAPV 589 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~g~~~~ 589 (708)
+.++.+||+|||+|+....... .....||+.|||||++.+..+.
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 180 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180 (263)
T ss_dssp CGGGCEEECSCC------------------CTTSCCHHHHTTCCCC
T ss_pred cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCC
Confidence 9999999999999987654332 3346799999999999876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-26 Score=240.12 Aligned_cols=119 Identities=28% Similarity=0.406 Sum_probs=104.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|||||+++++++++ .+|||||||++|+|.+++.. ++.+++.++..++.||+.||.|||+++||||||||+|||++
T Consensus 65 ~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~ 143 (285)
T d1u59a_ 65 QLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 143 (285)
T ss_dssp HCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred hCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec
Confidence 46899999999999764 58999999999999998865 45799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGA 587 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~ 587 (708)
.++.+||+|||+|+.+..... ....+||+.|||||++.++.
T Consensus 144 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (285)
T d1u59a_ 144 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188 (285)
T ss_dssp ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC
Confidence 999999999999987654322 23457999999999997664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.6e-25 Score=219.01 Aligned_cols=164 Identities=21% Similarity=0.206 Sum_probs=122.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCC----------------hhhHHHHHHHHHHHHhCCCCCeeeEE
Q psy2648 48 YKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLN----------------PGSLQKLFREVRIMKMLDHPNIVKLF 111 (708)
Q Consensus 48 Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~l~ 111 (708)
|.+.+.||+|+||.||+|.+. +|+.||||+++..... ......+.+|..+|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 7999999997642110 01122345789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCcEEEEeccC
Q psy2648 112 QVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGF 191 (708)
Q Consensus 112 ~~~~~~~~~ylVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH~~gIvHRDLKPeNILld~~~~iKL~DFGl 191 (708)
++. . .+++|||+++..+. .+++..+..++.||+.+|.|||++||+||||||+|||+++++ ++|+|||+
T Consensus 81 ~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred Eec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 763 2 27999999986653 356667788999999999999999999999999999999654 99999999
Q ss_pred ccccCCCCCccccccCCcccc------cccccCCccCCCchhHHHHHH
Q psy2648 192 SNEFTPGNKLDTFCGSPPYAA------PELFQGKKYDGPEVDVWSLGV 233 (708)
Q Consensus 192 s~~~~~~~~~~~~~Gt~~Y~A------PE~l~~~~~~~~~~DIWSlGv 233 (708)
+........ . .|.. .+.+ .+.|. .++|+||+.-
T Consensus 149 a~~~~~~~~-~------~~l~rd~~~~~~~f-~r~y~-~~~d~~s~~~ 187 (191)
T d1zara2 149 SVEVGEEGW-R------EILERDVRNIITYF-SRTYR-TEKDINSAID 187 (191)
T ss_dssp CEETTSTTH-H------HHHHHHHHHHHHHH-HHHHC-CCCCHHHHHH
T ss_pred cccCCCCCc-H------HHHHHHHHHHHHHH-cCCCC-CcccHHHHHH
Confidence 876542221 1 1111 1222 24454 6789999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.1e-26 Score=244.39 Aligned_cols=177 Identities=25% Similarity=0.274 Sum_probs=135.8
Q ss_pred CCCCCCCCcCCCcccccccccccccc---------CcccccccccCceeEEEEEEEe------CCEEEEEEeccCCCCHH
Q psy2648 436 GGGGGGGAAQSPSHRGVHRSISASNA---------KPSRRASSGGETLLKLFQVIET------EKTLYLVMEYASGGEVF 500 (708)
Q Consensus 436 ~ggg~~g~v~s~~hr~~~R~i~~~~~---------~~~~~~~~~~~~Iv~L~~~~~~------~~~~yLVmEy~~gg~L~ 500 (708)
.|.|++|.|+.+.++...+....+.. +-.......|+|||+++++|.. ..++|||||||+++.+.
T Consensus 28 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~ 107 (350)
T d1q5ka_ 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR 107 (350)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHH
T ss_pred EeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHH
Confidence 45667777776665543332211110 1111134589999999999854 34689999999876433
Q ss_pred HH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC-CEEEeeccCccccCCCCcccccccCCc
Q psy2648 501 DY---LVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM-NIKIADFGFSNEFTPGNKLDTFCGSPP 576 (708)
Q Consensus 501 ~~---l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~Gt~~ 576 (708)
.. ......+++.+++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.........+.+||+.
T Consensus 108 ~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~ 187 (350)
T d1q5ka_ 108 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187 (350)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTT
T ss_pred HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCccccccccccc
Confidence 32 23455799999999999999999999999999999999999999775 899999999998877777778899999
Q ss_pred ccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhHHHHhhCCCCC
Q psy2648 577 YAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 577 Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
|+|||++.+...++.. .|-|++++++-++..|.|.=
T Consensus 188 y~aPE~~~~~~~~~~~-------------------------~DIwSlG~il~el~~g~~pf 223 (350)
T d1q5ka_ 188 YRAPELIFGATDYTSS-------------------------IDVWSAGCVLAELLLGQPIF 223 (350)
T ss_dssp SCCHHHHTTCSSCCTH-------------------------HHHHHHHHHHHHHHHTSCSS
T ss_pred ccChHHhhcccCCCcc-------------------------eeecccceEEEehhhCCCCC
Confidence 9999999876655544 78888889999988888753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.7e-26 Score=236.80 Aligned_cols=146 Identities=27% Similarity=0.378 Sum_probs=122.7
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||+++++|+++..+|||||||.++.+..... ....+++.+++.++.||+.||.|||++|||||||||+|||+
T Consensus 56 ~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~ 135 (298)
T d1gz8a_ 56 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135 (298)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee
Confidence 45689999999999999999999999998654443333 34569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchh
Q psy2648 546 DSEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIK 624 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (708)
+.++.+||+|||+|+..... ......+||+.|+|||++.....++.+ .|.|+++
T Consensus 136 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~-------------------------~DiwSlG 190 (298)
T d1gz8a_ 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA-------------------------VDIWSLG 190 (298)
T ss_dssp CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTH-------------------------HHHHHHH
T ss_pred cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCcc-------------------------ccccccc
Confidence 99999999999999876543 345567899999999998876654433 5778888
Q ss_pred hhHHHHhhCCCCC
Q psy2648 625 ENTARLNAGRPAK 637 (708)
Q Consensus 625 ~~~~~~~~~~~~~ 637 (708)
.++=++..|++.=
T Consensus 191 vily~m~~G~~Pf 203 (298)
T d1gz8a_ 191 CIFAEMVTRRALF 203 (298)
T ss_dssp HHHHHHHHSSCSC
T ss_pred hhhhHHhhCCCCC
Confidence 8888888887653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.8e-26 Score=236.12 Aligned_cols=123 Identities=25% Similarity=0.348 Sum_probs=106.8
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++++++ .+|||||||++|+|.+++.....+++.++..++.||+.||.|||+++||||||||+|||++
T Consensus 63 ~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~ 141 (277)
T d1xbba_ 63 QQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 141 (277)
T ss_dssp HTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred HhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc
Confidence 456899999999999765 5789999999999999999988999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCCcc
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAPVT 590 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~~~ 590 (708)
.++.+||+|||+|+....... .....||+.|||||++.+..+..
T Consensus 142 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 189 (277)
T d1xbba_ 142 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189 (277)
T ss_dssp ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH
T ss_pred ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCc
Confidence 999999999999987654332 23457999999999998765433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.4e-26 Score=238.60 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=110.9
Q ss_pred cccCceeEEEEEEEeC-CEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy2648 469 SGGETLLKLFQVIETE-KTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQK 531 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~-~~~yLVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~ 531 (708)
..|+|||.+++++..+ ..+|+|||||++|+|.++|... ..+++.++..++.||+.||.|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4788999999997654 5799999999999999999753 2489999999999999999999999
Q ss_pred CCccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCC
Q psy2648 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPA 608 (708)
Q Consensus 532 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~ 608 (708)
+||||||||+|||++.++.+||+|||+|+...... .....+||+.|||||++.+..+...
T Consensus 154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~----------------- 216 (299)
T d1ywna1 154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----------------- 216 (299)
T ss_dssp TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-----------------
T ss_pred CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-----------------
Confidence 99999999999999999999999999998654322 2345789999999999987653322
Q ss_pred CccccccccccccchhhhHHHHhhC
Q psy2648 609 PTNFKRQNTIDSASIKENTARLNAG 633 (708)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (708)
.|-|+.++++-++..|
T Consensus 217 ---------sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 217 ---------SDVWSFGVLLWEIFSL 232 (299)
T ss_dssp ---------HHHHHHHHHHHHHHTT
T ss_pred ---------cceeehHHHHHHHHhC
Confidence 4677778888777764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.3e-26 Score=237.90 Aligned_cols=139 Identities=22% Similarity=0.368 Sum_probs=115.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH--GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
....|||||++++++. ++.+|||||||++|+|.+++... ..+++.++..++.||+.||.|||+++||||||||+|||
T Consensus 63 ~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 63 KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence 3468999999999875 45689999999999999977543 35999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
++.++.+||+|||+|+...... ......||+.|||||++.++.+... .|-|+
T Consensus 142 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~--------------------------sDvwS 195 (272)
T d1qpca_ 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK--------------------------SDVWS 195 (272)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHH--------------------------HHHHH
T ss_pred eecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCch--------------------------hhhhh
Confidence 9999999999999998775443 2345679999999999986543322 36667
Q ss_pred hhhhHHHHhh
Q psy2648 623 IKENTARLNA 632 (708)
Q Consensus 623 ~~~~~~~~~~ 632 (708)
.+.++=++..
T Consensus 196 ~Gvvl~ellt 205 (272)
T d1qpca_ 196 FGILLTEIVT 205 (272)
T ss_dssp HHHHHHHHHT
T ss_pred hHHHHHHHHh
Confidence 7777777765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.92 E-value=8.6e-26 Score=239.39 Aligned_cols=140 Identities=24% Similarity=0.435 Sum_probs=123.0
Q ss_pred cccCceeEEEEEEEeC--CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 469 SGGETLLKLFQVIETE--KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~--~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
..|+||++++++|+.. ..+|+|||||++++|..+. +.+++.+++.++.||+.||.|||++|||||||||+|||++
T Consensus 87 ~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~ 163 (328)
T d3bqca1 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163 (328)
T ss_dssp TTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred cCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence 4699999999999854 5799999999999997653 4799999999999999999999999999999999999999
Q ss_pred CCC-CEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEM-NIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~-~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++ .+||+|||+|+...........+||+.|+|||++.+...++.+ .|.|++++
T Consensus 164 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~DiwslG~ 218 (328)
T d3bqca1 164 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS-------------------------LDMWSLGC 218 (328)
T ss_dssp TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTH-------------------------HHHHHHHH
T ss_pred CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcc-------------------------cchhhhhh
Confidence 765 5999999999988777777788999999999999877655443 68889999
Q ss_pred hHHHHhhCCCC
Q psy2648 626 NTARLNAGRPA 636 (708)
Q Consensus 626 ~~~~~~~~~~~ 636 (708)
++-++..|.+.
T Consensus 219 ~l~e~~~g~~p 229 (328)
T d3bqca1 219 MLASMIFRKEP 229 (328)
T ss_dssp HHHHHHHTCSS
T ss_pred hhHHhccCCCC
Confidence 99999988775
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-25 Score=233.92 Aligned_cols=126 Identities=23% Similarity=0.348 Sum_probs=103.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++.+...+|+|||||.+|+|.+++... +.+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 64 ~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl 143 (283)
T d1mqba_ 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 143 (283)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE
Confidence 4468999999999999999999999999999999988755 579999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCC----cccccccCCcccccccccCCCCccCC
Q psy2648 546 DSEMNIKIADFGFSNEFTPGN----KLDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~----~~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
+.++.+||+|||+|+...... ......||+.|||||++.++.+...+
T Consensus 144 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~s 194 (283)
T d1mqba_ 144 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194 (283)
T ss_dssp CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcc
Confidence 999999999999998764332 22345789999999999876544433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-25 Score=232.00 Aligned_cols=146 Identities=22% Similarity=0.262 Sum_probs=109.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++. ++.+|||||||++|+|.+++.. .+.+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 63 ~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll 141 (273)
T d1mp8a_ 63 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 141 (273)
T ss_dssp HTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee
Confidence 3468999999999995 5679999999999999998765 4569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccch
Q psy2648 546 DSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASI 623 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (708)
+.++.+||+|||+|+...... .....+||+.|||||++.+..+... .|-|+.
T Consensus 142 ~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~--------------------------~DiwSl 195 (273)
T d1mp8a_ 142 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA--------------------------SDVWMF 195 (273)
T ss_dssp EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHH--------------------------HHHHHH
T ss_pred cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCc--------------------------cccccc
Confidence 999999999999998764332 2345678999999999986553332 366777
Q ss_pred hhhHHHHhh-CCCCCCC
Q psy2648 624 KENTARLNA-GRPAKNT 639 (708)
Q Consensus 624 ~~~~~~~~~-~~~~~~~ 639 (708)
+.++=++.. |.|.-..
T Consensus 196 Gvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 196 GVCMWEILMHGVKPFQG 212 (273)
T ss_dssp HHHHHHHHTTSCCTTTT
T ss_pred hHHHHHHHhcCCCCCCC
Confidence 777776654 6665433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.4e-26 Score=240.84 Aligned_cols=175 Identities=21% Similarity=0.196 Sum_probs=129.7
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----------------GRMKEKEARAKFRQIVSAVQYCHQKKI 533 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~I 533 (708)
.|||||++++++.+++.+|||||||++|+|.++|... ..+++.++..++.||+.||.|||+++|
T Consensus 69 ~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~i 148 (309)
T d1fvra_ 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 148 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCc
Confidence 6999999999999999999999999999999999754 569999999999999999999999999
Q ss_pred ccCCCCCCCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCC------CC
Q psy2648 534 IHRDLKAENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSI------SP 607 (708)
Q Consensus 534 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~------~~ 607 (708)
|||||||+|||++.++.+||+|||+|+...........+||+.|+|||.+.++.+..+++-++.+.+..... ..
T Consensus 149 iHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 149 IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 999999999999999999999999998765544455678999999999998776554444333222222111 11
Q ss_pred CCcc------ccc-----cccccccchhhhHHHHhhCCCCCCCCCCCC
Q psy2648 608 APTN------FKR-----QNTIDSASIKENTARLNAGRPAKNTASIAP 644 (708)
Q Consensus 608 ~~~~------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (708)
.... ... ...-.+..+++++.+.....|++|-....-
T Consensus 229 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei 276 (309)
T d1fvra_ 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276 (309)
T ss_dssp TCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1000 000 000124567777778888788777544333
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.7e-25 Score=227.00 Aligned_cols=126 Identities=22% Similarity=0.395 Sum_probs=110.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++.++..+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 54 ~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill 133 (258)
T d1k2pa_ 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 133 (258)
T ss_dssp HTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE
T ss_pred HhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE
Confidence 456899999999999999999999999999999998764 4579999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc--ccccccCCcccccccccCCCCccCC
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK--LDTFCGSPPYAAPELFQGGAPVTSS 592 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~--~~~~~Gt~~Y~APEvl~g~~~~~~s 592 (708)
+.++.+||+|||+|+....... .....||+.|||||++.+..+...+
T Consensus 134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ks 182 (258)
T d1k2pa_ 134 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182 (258)
T ss_dssp CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHH
T ss_pred cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcce
Confidence 9999999999999987644332 3346799999999999876644433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=4.3e-25 Score=235.78 Aligned_cols=142 Identities=25% Similarity=0.433 Sum_probs=123.2
Q ss_pred ccccCceeEEEEEEEeCC------EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 468 SSGGETLLKLFQVIETEK------TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~------~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
...|||||+++++|...+ .+||||||| +.+|..++ +.+.+++..++.++.||+.||.|||++|||||||||+
T Consensus 73 ~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~ 150 (346)
T d1cm8a_ 73 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 150 (346)
T ss_dssp HCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcc
Confidence 468999999999998765 579999999 45666554 5568999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+|++|||+|+.... .....+||+.|||||++.+..+++.+ +|.|
T Consensus 151 NIL~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-------------------------~Diw 203 (346)
T d1cm8a_ 151 NLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQT-------------------------VDIW 203 (346)
T ss_dssp GEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTT-------------------------HHHH
T ss_pred hhhcccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCcc-------------------------chhh
Confidence 99999999999999999987643 34567899999999999876655544 7899
Q ss_pred chhhhHHHHhhCCCCCC
Q psy2648 622 SIKENTARLNAGRPAKN 638 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ 638 (708)
++++++-++..|.|.-.
T Consensus 204 SlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 204 SVGCIMAEMITGKTLFK 220 (346)
T ss_dssp HHHHHHHHHHHSSCSSC
T ss_pred cchHHHHHHHHCcCCCC
Confidence 99999999999988643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.91 E-value=3.1e-25 Score=230.51 Aligned_cols=146 Identities=30% Similarity=0.452 Sum_probs=124.6
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|||||+++++|.+++.+|+||||+.++.+..+....+.+++.+++.++.||+.||+|||+++||||||||+|||++
T Consensus 55 ~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~ 134 (286)
T d1ob3a_ 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134 (286)
T ss_dssp GGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred HhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc
Confidence 45689999999999999999999999999988888877788899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCC-CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPG-NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~-~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+|++|||+|...... ......+|++.|+|||++.+..+++.. .|-|+++.
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~-------------------------~DiwslGv 189 (286)
T d1ob3a_ 135 REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT-------------------------IDIWSVGC 189 (286)
T ss_dssp TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTH-------------------------HHHHHHHH
T ss_pred CCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcc-------------------------eeehhcCc
Confidence 9999999999999876433 334556899999999999877766544 67888888
Q ss_pred hHHHHhhCCCCC
Q psy2648 626 NTARLNAGRPAK 637 (708)
Q Consensus 626 ~~~~~~~~~~~~ 637 (708)
++-++..|++.=
T Consensus 190 ~l~el~~G~~pf 201 (286)
T d1ob3a_ 190 IFAEMVNGTPLF 201 (286)
T ss_dssp HHHHHHHSSCSC
T ss_pred HHHHHHHCCCCC
Confidence 888888888763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=8.8e-25 Score=228.93 Aligned_cols=144 Identities=23% Similarity=0.319 Sum_probs=123.3
Q ss_pred cccCceeEEEEEEEe-----CCEEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 469 SGGETLLKLFQVIET-----EKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~-----~~~~yLVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
..|||||+++++|.. ...+|+|||||.++++..... ....+++..++.++.||+.||.|||+++||||||||+|
T Consensus 67 ~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 479999999999863 357899999999987765444 34569999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSAS 622 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (708)
||++..+.+||+|||+++...........+||+.|||||++.+.. ++. ..|-|+
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~-------------------------~~DiwS 200 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YAT-------------------------PVDLWS 200 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCT-------------------------HHHHHH
T ss_pred EEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCC-CCh-------------------------hehhhc
Confidence 999999999999999998776666667889999999999997654 222 278999
Q ss_pred hhhhHHHHhhCCCCCC
Q psy2648 623 IKENTARLNAGRPAKN 638 (708)
Q Consensus 623 ~~~~~~~~~~~~~~~~ 638 (708)
+++++-++..|+|.=.
T Consensus 201 lG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 201 VGCIFAEMFRRKPLFR 216 (305)
T ss_dssp HHHHHHHHHHSSCSCC
T ss_pred hHHHHHHHHHCCCCCC
Confidence 9999999999988643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=7e-25 Score=229.68 Aligned_cols=142 Identities=25% Similarity=0.354 Sum_probs=120.7
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG----------------RMKEKEARAKFRQIVSAVQYCHQKK 532 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~ylH~~~ 532 (708)
..|||||++++++.++..+|+|||||++|+|.++|..+. .+++.++..++.||+.||.|||+++
T Consensus 76 ~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ 155 (299)
T d1fgka_ 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 489999999999999999999999999999999997553 4899999999999999999999999
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCC
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAP 609 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~ 609 (708)
||||||||+|||++.++.+||+|||+++...... .....+||+.|||||++.++.+...
T Consensus 156 ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k------------------ 217 (299)
T d1fgka_ 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ------------------ 217 (299)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH------------------
T ss_pred EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch------------------
Confidence 9999999999999999999999999998764332 3345789999999999987553322
Q ss_pred ccccccccccccchhhhHHHHhh-CCCC
Q psy2648 610 TNFKRQNTIDSASIKENTARLNA-GRPA 636 (708)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 636 (708)
.|-|+.+.++-+++. |.|.
T Consensus 218 --------~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 218 --------SDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp --------HHHHHHHHHHHHHHTTSCCS
T ss_pred --------hhhHHhHHHHHHhccCCCCC
Confidence 466777777777764 5654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.1e-24 Score=228.81 Aligned_cols=149 Identities=21% Similarity=0.294 Sum_probs=121.2
Q ss_pred ccccCceeEEEEEEEeCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcc
Q psy2648 468 SSGGETLLKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQ--------KKIIH 535 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~----~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~--------~~IiH 535 (708)
...|||||++++++.++. .+|||||||++|+|.++|.+. .+++++...++.|++.||.|||+ +||||
T Consensus 53 ~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH 131 (303)
T d1vjya_ 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131 (303)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred hCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec
Confidence 457999999999998654 689999999999999999765 69999999999999999999996 59999
Q ss_pred CCCCCCCeeecCCCCEEEeeccCccccCCCC-----cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCc
Q psy2648 536 RDLKAENLLLDSEMNIKIADFGFSNEFTPGN-----KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPT 610 (708)
Q Consensus 536 RDlKp~NILl~~~~~vKl~DFGla~~~~~~~-----~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~ 610 (708)
|||||+|||++.++.+||+|||+++...... .....+||+.|||||++.+......
T Consensus 132 rDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------------------- 192 (303)
T d1vjya_ 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH------------------- 192 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTC-------------------
T ss_pred cccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccC-------------------
Confidence 9999999999999999999999998764332 2345789999999999876532110
Q ss_pred cccccccccccchhhhHHHHhhCCCCC
Q psy2648 611 NFKRQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
+.--...|-|+.++++-++..|.|..
T Consensus 193 -~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 193 -FESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp -HHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred -CCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 00012368889999999999987754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6.1e-25 Score=232.04 Aligned_cols=125 Identities=22% Similarity=0.307 Sum_probs=104.8
Q ss_pred ccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 468 SSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH-GRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 468 ~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
...|||||++++++.++ ..++|||||.+|+|.+.+... ..+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 67 ~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~ 145 (317)
T d1xkka_ 67 SVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145 (317)
T ss_dssp HCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred hCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC
Confidence 45899999999999865 578899999999999988764 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCc---ccccccCCcccccccccCCCCccCCC
Q psy2648 547 SEMNIKIADFGFSNEFTPGNK---LDTFCGSPPYAAPELFQGGAPVTSSG 593 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~~---~~~~~Gt~~Y~APEvl~g~~~~~~s~ 593 (708)
.++.+||+|||+|+....... .....||+.|||||++.++.+...++
T Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 195 (317)
T d1xkka_ 146 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195 (317)
T ss_dssp ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHH
T ss_pred CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhh
Confidence 999999999999987644332 23457899999999998776544443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=8.7e-25 Score=227.51 Aligned_cols=123 Identities=27% Similarity=0.404 Sum_probs=100.5
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL--HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
....|+|||++++++. ++.+|||||||++|+|..++.. .+.+++.++..++.||+.||.|||++||+||||||+|||
T Consensus 67 ~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIl 145 (285)
T d1fmka3 67 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 145 (285)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEE
Confidence 3468999999999985 4568999999999999988854 357999999999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCC--cccccccCCcccccccccCCCCcc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGN--KLDTFCGSPPYAAPELFQGGAPVT 590 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~--~~~~~~Gt~~Y~APEvl~g~~~~~ 590 (708)
++.++.+||+|||+|+...... .....+||+.|||||++.++....
T Consensus 146 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 193 (285)
T d1fmka3 146 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193 (285)
T ss_dssp ECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCH
T ss_pred ECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCc
Confidence 9999999999999998764332 234467999999999998766443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.3e-24 Score=232.12 Aligned_cols=145 Identities=25% Similarity=0.392 Sum_probs=121.2
Q ss_pred cccccCceeEEEEEEEeCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETEK----TLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAEN 542 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~----~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 542 (708)
....|+|||++++++..+. ..+++|||+.+|+|.+++.. +++++.+++.++.||+.||.|||++|||||||||+|
T Consensus 61 ~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~N 139 (345)
T d1pmea_ 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 139 (345)
T ss_dssp HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcce
Confidence 3468999999999997653 23444556678999999865 479999999999999999999999999999999999
Q ss_pred eeecCCCCEEEeeccCccccCCC----CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccc
Q psy2648 543 LLLDSEMNIKIADFGFSNEFTPG----NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTI 618 (708)
Q Consensus 543 ILl~~~~~vKl~DFGla~~~~~~----~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (708)
||++.++.+||+|||+|+..... ......+||+.|+|||++.....++.+ .
T Consensus 140 ILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~-------------------------~ 194 (345)
T d1pmea_ 140 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS-------------------------I 194 (345)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTH-------------------------H
T ss_pred EEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCch-------------------------h
Confidence 99999999999999999765332 224567899999999999766554433 7
Q ss_pred cccchhhhHHHHhhCCCCC
Q psy2648 619 DSASIKENTARLNAGRPAK 637 (708)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~ 637 (708)
|-|++++++-++..|.+.=
T Consensus 195 DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 195 DIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSC
T ss_pred hhhccCceehHHhhCCCCC
Confidence 8999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.1e-24 Score=229.30 Aligned_cols=148 Identities=19% Similarity=0.226 Sum_probs=124.7
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHh
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG------------------RMKEKEARAKFRQIVSAVQYCHQ 530 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~ylH~ 530 (708)
..|||||++++++.++..+|||||||++|+|.+++.... .+++..+..++.||+.||.|||+
T Consensus 84 ~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~ 163 (311)
T d1t46a_ 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163 (311)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 379999999999999999999999999999999997643 58999999999999999999999
Q ss_pred CCCccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCC
Q psy2648 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISP 607 (708)
Q Consensus 531 ~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~ 607 (708)
++||||||||+|||++.++.+|++|||+++...... .....+||+.|||||++.++.....
T Consensus 164 ~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---------------- 227 (311)
T d1t46a_ 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE---------------- 227 (311)
T ss_dssp TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH----------------
T ss_pred CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc----------------
Confidence 999999999999999999999999999998764332 2345689999999999986653332
Q ss_pred CCccccccccccccchhhhHHHHhh-CCCCCCCCCC
Q psy2648 608 APTNFKRQNTIDSASIKENTARLNA-GRPAKNTASI 642 (708)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 642 (708)
.|-|+.+.++-++.. |.|.....+.
T Consensus 228 ----------~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 228 ----------SDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp ----------HHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ----------ccccchHHHHHHHHhCCCCCCCCCCH
Confidence 356778888888775 6776544433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.89 E-value=4.9e-24 Score=222.54 Aligned_cols=142 Identities=20% Similarity=0.288 Sum_probs=118.9
Q ss_pred cccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC
Q psy2648 469 SGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS 547 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 547 (708)
..+++|+.+++++.+....|+||||| +++|.+++...+ .+++..+..++.|++.||.|||++|||||||||+|||++.
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~ 136 (293)
T d1csna_ 58 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 136 (293)
T ss_dssp TTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECC
T ss_pred cCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecC
Confidence 35689999999999999999999999 689999887654 6999999999999999999999999999999999999974
Q ss_pred -----CCCEEEeeccCccccCCC--------CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccc
Q psy2648 548 -----EMNIKIADFGFSNEFTPG--------NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKR 614 (708)
Q Consensus 548 -----~~~vKl~DFGla~~~~~~--------~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~ 614 (708)
.+.+||+|||+|+..... ....+++||+.|||||++.+..+.. .
T Consensus 137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~-~---------------------- 193 (293)
T d1csna_ 137 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR-R---------------------- 193 (293)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-H----------------------
T ss_pred cccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCCh-H----------------------
Confidence 578999999999865432 1234678999999999998654222 2
Q ss_pred cccccccchhhhHHHHhhCCCCC
Q psy2648 615 QNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|+++.++-++..|.+.=
T Consensus 194 ---~DiwSlG~~l~elltg~~Pf 213 (293)
T d1csna_ 194 ---DDLEALGHVFMYFLRGSLPW 213 (293)
T ss_dssp ---HHHHHHHHHHHHHHHSSCTT
T ss_pred ---HHHHHhhHHHHHHHhCCCcC
Confidence 46777888888888877664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.1e-24 Score=227.44 Aligned_cols=146 Identities=23% Similarity=0.356 Sum_probs=123.8
Q ss_pred cccccCceeEEEEEEEe--------CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q psy2648 467 ASSGGETLLKLFQVIET--------EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDL 538 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~--------~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 538 (708)
....|+||+++++++.. +..+|||||||+++.+.........+++..++.++.||+.||.|||++|||||||
T Consensus 64 ~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDl 143 (318)
T d3blha1 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 143 (318)
T ss_dssp HHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCc
Confidence 44689999999999865 3468999999998877766666778999999999999999999999999999999
Q ss_pred CCCCeeecCCCCEEEeeccCccccCCC-----CcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc
Q psy2648 539 KAENLLLDSEMNIKIADFGFSNEFTPG-----NKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK 613 (708)
Q Consensus 539 Kp~NILl~~~~~vKl~DFGla~~~~~~-----~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 613 (708)
||+|||++.++.+||+|||+|+..... ....+.+||+.|+|||++.+..+++..
T Consensus 144 Kp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k--------------------- 202 (318)
T d3blha1 144 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP--------------------- 202 (318)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTH---------------------
T ss_pred CchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcH---------------------
Confidence 999999999999999999999765422 233457899999999999877655544
Q ss_pred ccccccccchhhhHHHHhhCCCCC
Q psy2648 614 RQNTIDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|++++++-+|..|+|.-
T Consensus 203 ----~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 203 ----IDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp ----HHHHHHHHHHHHHHHSSCSC
T ss_pred ----HHcccCCceeeeHhhCCCCC
Confidence 78899999999999998774
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.89 E-value=4.7e-25 Score=231.13 Aligned_cols=130 Identities=25% Similarity=0.346 Sum_probs=110.2
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHH
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHG------------------------RMKEKEARAKFRQIV 522 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~------------------------~l~e~~~~~~~~qi~ 522 (708)
....|+|||++++++.+...+++|||||++|+|.+++.... .+++..+..++.||+
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 150 (301)
T d1lufa_ 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150 (301)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred HhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHH
Confidence 44689999999999999999999999999999999996532 388999999999999
Q ss_pred HHHHHHHhCCCccCCCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCC
Q psy2648 523 SAVQYCHQKKIIHRDLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAG 596 (708)
Q Consensus 523 ~aL~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~ 596 (708)
.||.|||+++||||||||+|||++.++.+||+|||+|+...+.. ...+.+||+.|||||++.+..+...++.++
T Consensus 151 ~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS 227 (301)
T d1lufa_ 151 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227 (301)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhcc
Confidence 99999999999999999999999999999999999998654332 234578999999999998776555544333
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=6.6e-25 Score=225.66 Aligned_cols=125 Identities=28% Similarity=0.401 Sum_probs=100.0
Q ss_pred cccccCceeEEEEEEE-eCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCe
Q psy2648 467 ASSGGETLLKLFQVIE-TEKTLYLVMEYASGGEVFDYLVLHG--RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENL 543 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~-~~~~~yLVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 543 (708)
....|||||++++++. ++..+|||||||++|+|.++|..++ .+++..+..++.||+.||.|||+++||||||||+||
T Consensus 55 ~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Ni 134 (262)
T d1byga_ 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 134 (262)
T ss_dssp TTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhh
Confidence 4468999999999985 4567899999999999999997553 489999999999999999999999999999999999
Q ss_pred eecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCC
Q psy2648 544 LLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSG 593 (708)
Q Consensus 544 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~ 593 (708)
|++.++.+||+|||+++.... ......+|+.|||||++.+......++
T Consensus 135 l~~~~~~~kl~dfg~s~~~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sD 182 (262)
T d1byga_ 135 LVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFSTKSD 182 (262)
T ss_dssp EECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred eecCCCCEeecccccceecCC--CCccccccccCCChHHHhCCCCChHHH
Confidence 999999999999999987543 234567899999999998776544443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.5e-23 Score=217.76 Aligned_cols=144 Identities=23% Similarity=0.379 Sum_probs=125.0
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeec
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLD 546 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 546 (708)
....|+|||+++++|.+...+++||||+.+++|..++...+.+++.+++.++.|++.||.|||++|||||||||+|||++
T Consensus 56 ~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred HhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 35689999999999999999999999999999999988888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC-cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhh
Q psy2648 547 SEMNIKIADFGFSNEFTPGN-KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKE 625 (708)
Q Consensus 547 ~~~~vKl~DFGla~~~~~~~-~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (708)
.++.+||+|||+|+...... ......++++|+|||++.+...++.+ +|-|++++
T Consensus 136 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~-------------------------~DiwSlG~ 190 (292)
T d1unla_ 136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS-------------------------IDMWSAGC 190 (292)
T ss_dssp TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTH-------------------------HHHHHHHH
T ss_pred cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCch-------------------------hhccccch
Confidence 99999999999998765433 34455788999999999877655443 57777777
Q ss_pred hHHHHhhCCC
Q psy2648 626 NTARLNAGRP 635 (708)
Q Consensus 626 ~~~~~~~~~~ 635 (708)
++-++..|..
T Consensus 191 il~ell~g~~ 200 (292)
T d1unla_ 191 IFAELANAGR 200 (292)
T ss_dssp HHHHHTTTSC
T ss_pred HHHHHhhCCC
Confidence 7777776543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.7e-24 Score=220.52 Aligned_cols=121 Identities=27% Similarity=0.374 Sum_probs=102.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeee
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVL-HGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLL 545 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 545 (708)
....|||||++++++.+ ..+|||||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 66 ~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll 144 (273)
T d1u46a_ 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144 (273)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred HhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc
Confidence 44689999999999976 467999999999999987765 4569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCccccCCCCc----ccccccCCcccccccccCCCC
Q psy2648 546 DSEMNIKIADFGFSNEFTPGNK----LDTFCGSPPYAAPELFQGGAP 588 (708)
Q Consensus 546 ~~~~~vKl~DFGla~~~~~~~~----~~~~~Gt~~Y~APEvl~g~~~ 588 (708)
+.++.+||+|||+++....... .....|++.|||||++.+..+
T Consensus 145 ~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 191 (273)
T d1u46a_ 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191 (273)
T ss_dssp EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred ccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCC
Confidence 9999999999999987644322 234568889999999987653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.4e-23 Score=224.88 Aligned_cols=142 Identities=21% Similarity=0.347 Sum_probs=110.7
Q ss_pred cccccCceeEEEEEEEe------CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy2648 467 ASSGGETLLKLFQVIET------EKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKA 540 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~------~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp 540 (708)
....|||||+++++|.. ...+|||||||.++ +.+.+ ...+++.+++.++.||+.||.|||++||+||||||
T Consensus 71 ~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP 147 (355)
T d2b1pa1 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_dssp HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCc
Confidence 34689999999999964 47899999999765 44444 35799999999999999999999999999999999
Q ss_pred CCeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccc
Q psy2648 541 ENLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDS 620 (708)
Q Consensus 541 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (708)
+|||++.++.+|++|||+++...........+||+.|+|||++.+.. ++.. .|.
T Consensus 148 ~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~-------------------------~Di 201 (355)
T d2b1pa1 148 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN-------------------------VDI 201 (355)
T ss_dssp GGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCC-CCTT-------------------------HHH
T ss_pred cccccccccceeeechhhhhccccccccccccccccccChhhhcCCC-CCCC-------------------------ccc
Confidence 99999999999999999998876666667789999999999998643 3333 688
Q ss_pred cchhhhHHHHhhCCCCC
Q psy2648 621 ASIKENTARLNAGRPAK 637 (708)
Q Consensus 621 ~~~~~~~~~~~~~~~~~ 637 (708)
|+.++.+-.+..|.|.=
T Consensus 202 wSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 202 WSVGCIMGEMVRHKILF 218 (355)
T ss_dssp HHHHHHHHHHHHSSCSS
T ss_pred ccccchHHHHhhCCCCC
Confidence 99999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.4e-23 Score=218.24 Aligned_cols=144 Identities=33% Similarity=0.530 Sum_probs=126.1
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.++||+++++++++...+|+|||||.+|+|.+++...+.+++..+..++.||+.||.|||+++||||||||+|||++.++
T Consensus 87 h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 166 (322)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred CCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC
Confidence 44899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCccccCC--CCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccccccccchhhhH
Q psy2648 550 NIKIADFGFSNEFTP--GNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSASIKENT 627 (708)
Q Consensus 550 ~vKl~DFGla~~~~~--~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (708)
.+||+|||+|+.+.. .....+.+||+.|+|||++.+...+... ..|-|++++++
T Consensus 167 ~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~------------------------ksDIWSlG~iL 222 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK------------------------AVDWWSLGVLM 222 (322)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CT------------------------HHHHHHHHHHH
T ss_pred CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCc------------------------hhhhHHHHHHH
Confidence 999999999986533 2234567899999999999876533211 26889999999
Q ss_pred HHHhhCCCCC
Q psy2648 628 ARLNAGRPAK 637 (708)
Q Consensus 628 ~~~~~~~~~~ 637 (708)
=+++.|.+.=
T Consensus 223 yelltG~~PF 232 (322)
T d1vzoa_ 223 YELLTGASPF 232 (322)
T ss_dssp HHHHHSSCTT
T ss_pred HHHHhCCCCC
Confidence 9999998773
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.88 E-value=2.8e-23 Score=216.93 Aligned_cols=141 Identities=22% Similarity=0.278 Sum_probs=113.0
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecC-
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLV-LHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDS- 547 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~- 547 (708)
.+++|+.++.++.+....|+|||||. ++|.+.+. ..+.+++..+..++.|++.||.|||++|||||||||+|||++.
T Consensus 61 ~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~ 139 (299)
T d1ckia_ 61 GGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139 (299)
T ss_dssp TSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG
T ss_pred CCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc
Confidence 44456777788889999999999995 45555554 4567999999999999999999999999999999999999764
Q ss_pred --CCCEEEeeccCccccCCCC--------cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccc
Q psy2648 548 --EMNIKIADFGFSNEFTPGN--------KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNT 617 (708)
Q Consensus 548 --~~~vKl~DFGla~~~~~~~--------~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (708)
+..+||+|||+|+...... ...+.+||+.|||||++.+..+.. .
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~------------------------- 193 (299)
T d1ckia_ 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-R------------------------- 193 (299)
T ss_dssp GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCH-H-------------------------
T ss_pred CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCC-h-------------------------
Confidence 4579999999998764322 234578999999999998654322 2
Q ss_pred ccccchhhhHHHHhhCCCCC
Q psy2648 618 IDSASIKENTARLNAGRPAK 637 (708)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~ 637 (708)
.|-|+.++++-++..|.+.=
T Consensus 194 ~DiwSlG~~l~el~tg~~P~ 213 (299)
T d1ckia_ 194 DDLESLGYVLMYFNLGSLPW 213 (299)
T ss_dssp HHHHHHHHHHHHHHHSSCTT
T ss_pred hhEEecCHHHHHHHhCCCcc
Confidence 47778888888888887763
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.4e-23 Score=223.81 Aligned_cols=143 Identities=22% Similarity=0.360 Sum_probs=118.8
Q ss_pred cccccCceeEEEEEEEeC-----CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy2648 467 ASSGGETLLKLFQVIETE-----KTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAE 541 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~-----~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 541 (708)
....|+|||+++++|... ...++|||||.+|+|.+++.. +++++.+++.++.||+.||.|||++|||||||||+
T Consensus 72 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~ 150 (348)
T d2gfsa1 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 150 (348)
T ss_dssp HHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCc
Confidence 356899999999999743 345677788889999998854 57999999999999999999999999999999999
Q ss_pred CeeecCCCCEEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccccccccccc
Q psy2648 542 NLLLDSEMNIKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQNTIDSA 621 (708)
Q Consensus 542 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (708)
|||++.++.+|++|||+|.... ....+.+||+.|+|||++.+...++.+ .|.|
T Consensus 151 NILi~~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~-------------------------~Diw 203 (348)
T d2gfsa1 151 NLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQT-------------------------VDIW 203 (348)
T ss_dssp GEEECTTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTT-------------------------HHHH
T ss_pred cccccccccccccccchhcccC--cccccccccccccCchhhcCCccCCcc-------------------------cchh
Confidence 9999999999999999987543 334567899999999998876655444 7889
Q ss_pred chhhhHHHHhhCCCCC
Q psy2648 622 SIKENTARLNAGRPAK 637 (708)
Q Consensus 622 ~~~~~~~~~~~~~~~~ 637 (708)
++++++-++..|.|.=
T Consensus 204 SlGv~l~~ll~g~~pF 219 (348)
T d2gfsa1 204 SVGCIMAELLTGRTLF 219 (348)
T ss_dssp HHHHHHHHHHHSSCSC
T ss_pred hhhHHHHHHHhCCCCC
Confidence 9999999999998864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=3.4e-23 Score=217.65 Aligned_cols=141 Identities=20% Similarity=0.276 Sum_probs=118.3
Q ss_pred cccccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q psy2648 467 ASSGGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLH----------GRMKEKEARAKFRQIVSAVQYCHQKKIIHR 536 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 536 (708)
...+|+|||++++++..+..+|||||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||
T Consensus 78 ~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHr 157 (308)
T d1p4oa_ 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 157 (308)
T ss_dssp GGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred HHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence 4568999999999999999999999999999999988643 246889999999999999999999999999
Q ss_pred CCCCCCeeecCCCCEEEeeccCccccCCCC---cccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCcccc
Q psy2648 537 DLKAENLLLDSEMNIKIADFGFSNEFTPGN---KLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFK 613 (708)
Q Consensus 537 DlKp~NILl~~~~~vKl~DFGla~~~~~~~---~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 613 (708)
||||+|||++.++.+||+|||+|+...... .....+||+.|||||.+.++.....
T Consensus 158 Dlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~---------------------- 215 (308)
T d1p4oa_ 158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY---------------------- 215 (308)
T ss_dssp CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH----------------------
T ss_pred eEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc----------------------
Confidence 999999999999999999999998664332 2344579999999999987654332
Q ss_pred ccccccccchhhhHHHHhhC
Q psy2648 614 RQNTIDSASIKENTARLNAG 633 (708)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~ 633 (708)
.|-|+.++++-++..|
T Consensus 216 ----~Dv~S~G~il~El~t~ 231 (308)
T d1p4oa_ 216 ----SDVWSFGVVLWEIATL 231 (308)
T ss_dssp ----HHHHHHHHHHHHHHHT
T ss_pred ----cccccHHHHHHHHHhC
Confidence 3556677777776655
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=6.9e-23 Score=215.66 Aligned_cols=124 Identities=22% Similarity=0.289 Sum_probs=105.9
Q ss_pred cccccCceeEEEEEEEe-CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCee
Q psy2648 467 ASSGGETLLKLFQVIET-EKTLYLVMEYASGGEVFDYLVLHG-RMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLL 544 (708)
Q Consensus 467 ~~~~~~~Iv~L~~~~~~-~~~~yLVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 544 (708)
....|||||++++++.+ +..+|+|||||++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||
T Consensus 83 ~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NIL 162 (311)
T d1r0pa_ 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 162 (311)
T ss_dssp HTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEe
Confidence 34689999999999765 568999999999999999887543 5788899999999999999999999999999999999
Q ss_pred ecCCCCEEEeeccCccccCCCCc-----ccccccCCcccccccccCCCCcc
Q psy2648 545 LDSEMNIKIADFGFSNEFTPGNK-----LDTFCGSPPYAAPELFQGGAPVT 590 (708)
Q Consensus 545 l~~~~~vKl~DFGla~~~~~~~~-----~~~~~Gt~~Y~APEvl~g~~~~~ 590 (708)
++.++.+||+|||+++....... .....||+.|+|||++.+..+..
T Consensus 163 l~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 213 (311)
T d1r0pa_ 163 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 213 (311)
T ss_dssp ECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCH
T ss_pred ECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCC
Confidence 99999999999999987643321 23357999999999998765433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.73 E-value=7.3e-19 Score=187.53 Aligned_cols=140 Identities=25% Similarity=0.304 Sum_probs=112.4
Q ss_pred cccCceeEEEEEEE--eCCEEEEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCC
Q psy2648 469 SGGETLLKLFQVIE--TEKTLYLVMEYASGGEVFDYL---VLHGRMKEKEARAKFRQIVSAVQYCHQ-KKIIHRDLKAEN 542 (708)
Q Consensus 469 ~~~~~Iv~L~~~~~--~~~~~yLVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~N 542 (708)
.+++|||+++++++ .....++||+++..++..... .....+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 36789999999876 457888888888766543333 234579999999999999999999998 899999999999
Q ss_pred eeecCCCC------EEEeeccCccccCCCCcccccccCCcccccccccCCCCccCCCCCCCCCcccCCCCCCCccccccc
Q psy2648 543 LLLDSEMN------IKIADFGFSNEFTPGNKLDTFCGSPPYAAPELFQGGAPVTSSGGAGTNHTHNSSISPAPTNFKRQN 616 (708)
Q Consensus 543 ILl~~~~~------vKl~DFGla~~~~~~~~~~~~~Gt~~Y~APEvl~g~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 616 (708)
||++..+. +|++|||.|..... .....+||+.|+|||++.+.. ++.+
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~------------------------ 209 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCG------------------------ 209 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTH------------------------
T ss_pred eeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccC-CCcc------------------------
Confidence 99987653 99999999876532 335678999999999998654 3333
Q ss_pred cccccchhhhHHHHhhCCCC
Q psy2648 617 TIDSASIKENTARLNAGRPA 636 (708)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~ 636 (708)
.|.|++++.+.++..|.+.
T Consensus 210 -~DiwSlG~il~el~~g~~p 228 (362)
T d1q8ya_ 210 -ADIWSTACLIFELITGDFL 228 (362)
T ss_dssp -HHHHHHHHHHHHHHHSSCC
T ss_pred -ccccchHHHHHHHHHCCCC
Confidence 6888888988888888775
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.41 E-value=4.9e-14 Score=136.32 Aligned_cols=82 Identities=26% Similarity=0.349 Sum_probs=67.0
Q ss_pred ccCceeEEEEEEEeCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeeecCCC
Q psy2648 470 GGETLLKLFQVIETEKTLYLVMEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCHQKKIIHRDLKAENLLLDSEM 549 (708)
Q Consensus 470 ~~~~Iv~L~~~~~~~~~~yLVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~~ 549 (708)
.+.+++..+++.. .+|||||++++.+. .+++..+..++.|++.+|.|||++||+||||||+|||++..
T Consensus 72 ~~~~v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 72 QGLAVPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp TTSSSCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-
T ss_pred cCCCcceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-
Confidence 4567777766532 27999999986653 35666778899999999999999999999999999999864
Q ss_pred CEEEeeccCccccC
Q psy2648 550 NIKIADFGFSNEFT 563 (708)
Q Consensus 550 ~vKl~DFGla~~~~ 563 (708)
.++|+|||+|....
T Consensus 140 ~~~liDFG~a~~~~ 153 (191)
T d1zara2 140 GIWIIDFPQSVEVG 153 (191)
T ss_dssp EEEECCCTTCEETT
T ss_pred CEEEEECCCcccCC
Confidence 59999999987653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=1.6e-06 Score=85.92 Aligned_cols=140 Identities=19% Similarity=0.177 Sum_probs=92.2
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEE
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYLV 123 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ylV 123 (708)
+..|++.+..+.++.+.||+.. ..++.+.||+....... ....+.+|+.++..|. +--+.+++.+.+.++..|+|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 4567877776666678999775 46677889987644221 1223667888887764 33367788888889999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy2648 124 MEYASGGEVFDYLVLHGRMKEKEARAKFRQIVSAVQYCH----------------------------------------- 162 (708)
Q Consensus 124 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~QI~~aL~yLH----------------------------------------- 162 (708)
||+++|..+.+.... .. ....+..++...+..||
T Consensus 89 ~~~l~G~~~~~~~~~--~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYED--EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTT--CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccc--cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999999877543211 00 11112222222233333
Q ss_pred ------------HC------CceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 163 ------------QK------KIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 163 ------------~~------gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
+. .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11 27899999999999977666799999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.95 E-value=7.3e-06 Score=86.80 Aligned_cols=80 Identities=19% Similarity=0.157 Sum_probs=52.0
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeccC-CC----ChhhHHHHHHHHHHHHhCC-C--CCeeeEEEEEEeCCEEEE
Q psy2648 51 LKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKT-QL----NPGSLQKLFREVRIMKMLD-H--PNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~-~~----~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~yl 122 (708)
.+.||.|....||++....+++.|+||.-... .. .+....+..+|+++|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56799999999999988778889999975431 11 1122345667888887663 2 356677655 4445689
Q ss_pred EEeccCCCCh
Q psy2648 123 VMEYASGGEV 132 (708)
Q Consensus 123 VmEy~~gg~L 132 (708)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=6.3e-05 Score=73.55 Aligned_cols=139 Identities=15% Similarity=0.138 Sum_probs=83.1
Q ss_pred eEEEeEEcccC-ceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCCEEEEEE
Q psy2648 48 YKLLKTIGKGN-FAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH--PNIVKLFQVIETEKTLYLVM 124 (708)
Q Consensus 48 Y~i~~~LG~G~-fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~ylVm 124 (708)
+... .+..|. -+.||+... ..+..+++|.-..... ..+.+|+..|+.|.. -.+.+++.+..+.+..|+||
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 4443 344444 468898764 4566688898654322 235678888876642 33677888888888999999
Q ss_pred eccCCCChHH--------------HHHH-cC------CCC--HHH----HHHHH----------------HHHHHHHHHH
Q psy2648 125 EYASGGEVFD--------------YLVL-HG------RMK--EKE----ARAKF----------------RQIVSAVQYC 161 (708)
Q Consensus 125 Ey~~gg~L~~--------------~i~~-~~------~l~--e~~----~~~i~----------------~QI~~aL~yL 161 (708)
||++|.++.+ .+.. +. .+. ... ..... ......+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 9998865422 1111 00 000 000 00000 0012223344
Q ss_pred HHC-------CceecCCCCCCEEEcCCCcEEEEeccCcc
Q psy2648 162 HQK-------KIIHRDLKAENLLLDSEMNIKIADFGFSN 193 (708)
Q Consensus 162 H~~-------gIvHRDLKPeNILld~~~~iKL~DFGls~ 193 (708)
... .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 332 37999999999999987667899999763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.0013 Score=67.02 Aligned_cols=67 Identities=10% Similarity=0.179 Sum_probs=44.1
Q ss_pred eEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCCCC-----eeeE--EEEEEeCCEEEEEEeccCCC
Q psy2648 60 AKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDHPN-----IVKL--FQVIETEKTLYLVMEYASGG 130 (708)
Q Consensus 60 g~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-----Iv~l--~~~~~~~~~~ylVmEy~~gg 130 (708)
-.||++.. .+|+.|++|+......+ .+.+..|...|..|..-. .+.. -..++..+..+.+++++.|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 57998875 57888999998765433 345677888887764211 1111 01335577889999999873
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.41 E-value=0.0022 Score=62.34 Aligned_cols=29 Identities=24% Similarity=0.336 Sum_probs=24.9
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccc
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNE 561 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~ 561 (708)
++|+|+.|.|||++..+.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCceEEEeechhccc
Confidence 78999999999998766667999998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.17 E-value=0.0063 Score=63.33 Aligned_cols=74 Identities=16% Similarity=0.190 Sum_probs=51.6
Q ss_pred EeEEcccCceEEEEEEEcC-------CCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Q psy2648 51 LKTIGKGNFAKVKLAKHVP-------TGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLD-HPNIVKLFQVIETEKTLYL 122 (708)
Q Consensus 51 ~~~LG~G~fg~V~la~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~yl 122 (708)
++.|+.|---.+|++.... ..+.|.+++..... ......+|..+++.+. +.-..+++.++.. .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 4678889999999998753 34678888765321 1234568999998875 4444578887643 68
Q ss_pred EEeccCCCCh
Q psy2648 123 VMEYASGGEV 132 (708)
Q Consensus 123 VmEy~~gg~L 132 (708)
||||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=94.91 E-value=0.008 Score=57.80 Aligned_cols=29 Identities=17% Similarity=0.194 Sum_probs=25.3
Q ss_pred CccCCCCCCCeeecCCCCEEEeeccCccc
Q psy2648 533 IIHRDLKAENLLLDSEMNIKIADFGFSNE 561 (708)
Q Consensus 533 IiHRDlKp~NILl~~~~~vKl~DFGla~~ 561 (708)
+||+|+.|.|||++.+..+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999999876678999998754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.70 E-value=0.059 Score=53.42 Aligned_cols=142 Identities=16% Similarity=0.165 Sum_probs=74.7
Q ss_pred cCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeccCCCChhhHHHHHHHHHHHHhCCC-----CCeeeEE---EEEEe
Q psy2648 45 IGKYKLLKTIGKGNFAKVKLAKHVPTGKEVAIKIIDKTQLNPGSLQKLFREVRIMKMLDH-----PNIVKLF---QVIET 116 (708)
Q Consensus 45 ~~~Y~i~~~LG~G~fg~V~la~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l~---~~~~~ 116 (708)
+|...-.+.|..|---..|+.... +..+++|+..+.. +. +.+..|+++|..|.. |..+... .+..-
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~-~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~ 90 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 90 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC-CH---HHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence 455666677778877888988753 3458999986431 22 234456666666532 2222211 02233
Q ss_pred CCEEEEEEeccCCCChHH--------------HHHHcC---------CCCHHH------------------HHHHHHHHH
Q psy2648 117 EKTLYLVMEYASGGEVFD--------------YLVLHG---------RMKEKE------------------ARAKFRQIV 155 (708)
Q Consensus 117 ~~~~ylVmEy~~gg~L~~--------------~i~~~~---------~l~e~~------------------~~~i~~QI~ 155 (708)
......++.++.+..... .+.... ...... ....+..+.
T Consensus 91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 170 (316)
T d2ppqa1 91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 170 (316)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence 456777777777643210 000000 001111 111111222
Q ss_pred HHHHHHH----HCCceecCCCCCCEEEcCCCcEEEEeccCc
Q psy2648 156 SAVQYCH----QKKIIHRDLKAENLLLDSEMNIKIADFGFS 192 (708)
Q Consensus 156 ~aL~yLH----~~gIvHRDLKPeNILld~~~~iKL~DFGls 192 (708)
..+.-.+ ..|+||+|+.++|||++.+..+-|+||+.+
T Consensus 171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 2222222 247999999999999998877789999976
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=92.97 E-value=0.038 Score=57.20 Aligned_cols=30 Identities=23% Similarity=0.330 Sum_probs=25.5
Q ss_pred CCccCCCCCCCeeecCCCCEEEeeccCcccc
Q psy2648 532 KIIHRDLKAENLLLDSEMNIKIADFGFSNEF 562 (708)
Q Consensus 532 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~ 562 (708)
.++|+|+.|.|||++.+ .++|+||-+|..-
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcccC
Confidence 58999999999999865 4899999887543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=83.61 E-value=0.13 Score=50.92 Aligned_cols=30 Identities=27% Similarity=0.398 Sum_probs=27.0
Q ss_pred CCCccCCCCCCCeeecCCCCEEEeeccCcc
Q psy2648 531 KKIIHRDLKAENLLLDSEMNIKIADFGFSN 560 (708)
Q Consensus 531 ~~IiHRDlKp~NILl~~~~~vKl~DFGla~ 560 (708)
.|+||.|+.+.|||++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 489999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=82.07 E-value=0.29 Score=50.03 Aligned_cols=28 Identities=29% Similarity=0.611 Sum_probs=21.7
Q ss_pred CccCCCCCCCeeecC----------------------------CCCEEEeeccCcc
Q psy2648 533 IIHRDLKAENLLLDS----------------------------EMNIKIADFGFSN 560 (708)
Q Consensus 533 IiHRDlKp~NILl~~----------------------------~~~vKl~DFGla~ 560 (708)
++|.|+.+.|||+.. ++.++++||-.|.
T Consensus 220 ~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~ 275 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 275 (395)
T ss_dssp EECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred EEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccC
Confidence 579999999999843 4568999997764
|